No articulo,Articulo,Palabra,Tipo entidad
0,0211-699501013259,Efecto,o
0,0211-699501013259,de,o
0,0211-699501013259,la,o
0,0211-699501013259,suplementacion,i
0,0211-699501013259,con,o
0,0211-699501013259,acido,i
0,0211-699501013259,folico,i
0,0211-699501013259,sobre,o
0,0211-699501013259,los,o
0,0211-699501013259,niveles,i
0,0211-699501013259,de,i
0,0211-699501013259,homocisteina,i
0,0211-699501013259,total,o
0,0211-699501013259,en,o
0,0211-699501013259,pacientes,o
0,0211-699501013259,en,o
0,0211-699501013259,hemodialisis,i
0,0211-699501013259,La,o
0,0211-699501013259,hiperhomocisteinemia,i
0,0211-699501013259,es,o
0,0211-699501013259,un,o
0,0211-699501013259,marcador,o
0,0211-699501013259,de,o
0,0211-699501013259,riesgo,o
0,0211-699501013259,independiente,o
0,0211-699501013259,de,o
0,0211-699501013259,morbimortalidad,o
0,0211-699501013259,cardiovascular,i
0,0211-699501013259,Hemos,o
0,0211-699501013259,intentado,o
0,0211-699501013259,prospectivamente,o
0,0211-699501013259,reducir,o
0,0211-699501013259,los,o
0,0211-699501013259,niveles,i
0,0211-699501013259,de,i
0,0211-699501013259,homocisteina,i
0,0211-699501013259,total,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,mediante,o
0,0211-699501013259,suplemento,o
0,0211-699501013259,con,o
0,0211-699501013259,acido,i
0,0211-699501013259,folico,i
0,0211-699501013259,y,o
0,0211-699501013259,vitamina,i
0,0211-699501013259,B6,i
0,0211-699501013259,pp,i
0,0211-699501013259,valorando,o
0,0211-699501013259,su,o
0,0211-699501013259,posible,o
0,0211-699501013259,correlacion,o
0,0211-699501013259,con,o
0,0211-699501013259,dosis,o
0,0211-699501013259,de,o
0,0211-699501013259,dialisis,i
0,0211-699501013259,funcion,i
0,0211-699501013259,residual,i
0,0211-699501013259,y,o
0,0211-699501013259,parametros,o
0,0211-699501013259,nutricionales,o
0,0211-699501013259,Metodos,o
0,0211-699501013259,Todos,o
0,0211-699501013259,los,o
0,0211-699501013259,pacientes,o
0,0211-699501013259,en,o
0,0211-699501013259,hemodialisis,i
0,0211-699501013259,al,o
0,0211-699501013259,comienzo,o
0,0211-699501013259,del,o
0,0211-699501013259,estudio,o
0,0211-699501013259,que,o
0,0211-699501013259,no,o
0,0211-699501013259,recibian,o
0,0211-699501013259,acido,i
0,0211-699501013259,folico,i
0,0211-699501013259,ni,o
0,0211-699501013259,vitamina,i
0,0211-699501013259,B6,i
0,0211-699501013259,asi,o
0,0211-699501013259,como,o
0,0211-699501013259,los,o
0,0211-699501013259,incorporados,o
0,0211-699501013259,posteriormente,o
0,0211-699501013259,a,o
0,0211-699501013259,partir,o
0,0211-699501013259,de,o
0,0211-699501013259,su,o
0,0211-699501013259,tercer,o
0,0211-699501013259,mes,o
0,0211-699501013259,en,o
0,0211-699501013259,hemodialisis,i
0,0211-699501013259,recibieron,o
0,0211-699501013259,5,o
0,0211-699501013259,mg,o
0,0211-699501013259,orales,o
0,0211-699501013259,de,o
0,0211-699501013259,acido,i
0,0211-699501013259,folico,i
0,0211-699501013259,cada,o
0,0211-699501013259,48,o
0,0211-699501013259,horas,o
0,0211-699501013259,y,o
0,0211-699501013259,40,o
0,0211-699501013259,mg,o
0,0211-699501013259,orales,o
0,0211-699501013259,de,o
0,0211-699501013259,vitamina,i
0,0211-699501013259,B6,i
0,0211-699501013259,cada,o
0,0211-699501013259,semana,o
0,0211-699501013259,Se,o
0,0211-699501013259,determinaron,o
0,0211-699501013259,al,o
0,0211-699501013259,comienzo,o
0,0211-699501013259,del,o
0,0211-699501013259,estudio,o
0,0211-699501013259,y,o
0,0211-699501013259,cada,o
0,0211-699501013259,2,o
0,0211-699501013259,meses,o
0,0211-699501013259,niveles,i
0,0211-699501013259,de,i
0,0211-699501013259,folato,i
0,0211-699501013259,vitamina,i
0,0211-699501013259,B12,i
0,0211-699501013259,inmunoensayo,i
0,0211-699501013259,albumina,i
0,0211-699501013259,y,o
0,0211-699501013259,cinetica,o
0,0211-699501013259,de,o
0,0211-699501013259,la,o
0,0211-699501013259,urea,i
0,0211-699501013259,KTV,o
0,0211-699501013259,KRU,o
0,0211-699501013259,PCRn,o
0,0211-699501013259,y,o
0,0211-699501013259,cada,o
0,0211-699501013259,6,o
0,0211-699501013259,meses,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,HPLC,i
0,0211-699501013259,y,o
0,0211-699501013259,pp,i
0,0211-699501013259,RIA,i
0,0211-699501013259,Resultados,o
0,0211-699501013259,80,o
0,0211-699501013259,pacientes,o
0,0211-699501013259,fueron,o
0,0211-699501013259,incluidos,o
0,0211-699501013259,en,o
0,0211-699501013259,el,o
0,0211-699501013259,estudio,o
0,0211-699501013259,basal,o
0,0211-699501013259,con,o
0,0211-699501013259,una,o
0,0211-699501013259,prevalencia,o
0,0211-699501013259,de,o
0,0211-699501013259,hiperhomocisteinemia,i
0,0211-699501013259,del,o
0,0211-699501013259,844,o
0,0211-699501013259,deficit,i
0,0211-699501013259,de,i
0,0211-699501013259,pp,i
0,0211-699501013259,en,o
0,0211-699501013259,el,o
0,0211-699501013259,32,o
0,0211-699501013259,y,o
0,0211-699501013259,folato,i
0,0211-699501013259,en,o
0,0211-699501013259,el,o
0,0211-699501013259,rango,o
0,0211-699501013259,normal,o
0,0211-699501013259,bajo,o
0,0211-699501013259,los,o
0,0211-699501013259,niveles,i
0,0211-699501013259,de,i
0,0211-699501013259,tHcy,i
0,0211-699501013259,se,o
0,0211-699501013259,correlacionaban,o
0,0211-699501013259,inversamente,o
0,0211-699501013259,con,o
0,0211-699501013259,los,o
0,0211-699501013259,del,o
0,0211-699501013259,folato,i
0,0211-699501013259,r,o
0,0211-699501013259,0336,o
0,0211-699501013259,p,o
0,0211-699501013259,001,o
0,0211-699501013259,pero,o
0,0211-699501013259,no,o
0,0211-699501013259,con,o
0,0211-699501013259,pp,i
0,0211-699501013259,B12,i
0,0211-699501013259,edad,o
0,0211-699501013259,albumina,i
0,0211-699501013259,KTV,o
0,0211-699501013259,KRU,o
0,0211-699501013259,PCRn,o
0,0211-699501013259,Cincuenta,o
0,0211-699501013259,y,o
0,0211-699501013259,ocho,o
0,0211-699501013259,pacientes,o
0,0211-699501013259,recibieron,o
0,0211-699501013259,seis,o
0,0211-699501013259,meses,o
0,0211-699501013259,de,o
0,0211-699501013259,suplementacion,i
0,0211-699501013259,con,o
0,0211-699501013259,normalizacion,o
0,0211-699501013259,del,o
0,0211-699501013259,pp,i
0,0211-699501013259,aumento,o
0,0211-699501013259,del,o
0,0211-699501013259,folato,i
0,0211-699501013259,703,o
0,0211-699501013259,IC,o
0,0211-699501013259,638,o
0,0211-699501013259,795,o
0,0211-699501013259,vs,o
0,0211-699501013259,6181,o
0,0211-699501013259,IC,o
0,0211-699501013259,4447,o
0,0211-699501013259,7811,o
0,0211-699501013259,p,o
0,0211-699501013259,0001,o
0,0211-699501013259,y,o
0,0211-699501013259,descenso,o
0,0211-699501013259,de,o
0,0211-699501013259,la,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,240,o
0,0211-699501013259,IC,o
0,0211-699501013259,213,o
0,0211-699501013259,264,o
0,0211-699501013259,vs,o
0,0211-699501013259,199,o
0,0211-699501013259,IC,o
0,0211-699501013259,175,o
0,0211-699501013259,224,o
0,0211-699501013259,p,o
0,0211-699501013259,005,o
0,0211-699501013259,Han,o
0,0211-699501013259,recibido,o
0,0211-699501013259,suplementacion,i
0,0211-699501013259,durante,o
0,0211-699501013259,12,o
0,0211-699501013259,meses,o
0,0211-699501013259,33,o
0,0211-699501013259,pacientes,o
0,0211-699501013259,pero,o
0,0211-699501013259,a,o
0,0211-699501013259,pesar,o
0,0211-699501013259,de,o
0,0211-699501013259,un,o
0,0211-699501013259,continuo,o
0,0211-699501013259,aumento,o
0,0211-699501013259,del,o
0,0211-699501013259,folato,i
0,0211-699501013259,10078,o
0,0211-699501013259,IC,o
0,0211-699501013259,7481,o
0,0211-699501013259,12674,o
0,0211-699501013259,p,o
0,0211-699501013259,0001,o
0,0211-699501013259,solo,o
0,0211-699501013259,3,o
0,0211-699501013259,pacientes,o
0,0211-699501013259,presentan,o
0,0211-699501013259,niveles,o
0,0211-699501013259,normales,o
0,0211-699501013259,de,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,correlacionandose,o
0,0211-699501013259,directamente,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,con,o
0,0211-699501013259,la,o
0,0211-699501013259,albumina,i
0,0211-699501013259,r,o
0,0211-699501013259,056,o
0,0211-699501013259,p,o
0,0211-699501013259,0001,o
0,0211-699501013259,que,o
0,0211-699501013259,se,o
0,0211-699501013259,elevo,o
0,0211-699501013259,con,o
0,0211-699501013259,respecto,o
0,0211-699501013259,al,o
0,0211-699501013259,inicio,o
0,0211-699501013259,337,o
0,0211-699501013259,IC,o
0,0211-699501013259,327,o
0,0211-699501013259,346,o
0,0211-699501013259,vs,o
0,0211-699501013259,350,o
0,0211-699501013259,IC,o
0,0211-699501013259,337,o
0,0211-699501013259,363,o
0,0211-699501013259,p,o
0,0211-699501013259,005,o
0,0211-699501013259,Conclusion,o
0,0211-699501013259,Tras,o
0,0211-699501013259,suplementacion,i
0,0211-699501013259,con,o
0,0211-699501013259,acido,i
0,0211-699501013259,folico,i
0,0211-699501013259,y,o
0,0211-699501013259,vitamina,i
0,0211-699501013259,B6,i
0,0211-699501013259,aunque,o
0,0211-699501013259,inicialmente,o
0,0211-699501013259,se,o
0,0211-699501013259,reduce,o
0,0211-699501013259,la,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,esta,o
0,0211-699501013259,respuesta,o
0,0211-699501013259,se,o
0,0211-699501013259,hace,o
0,0211-699501013259,refractaria,o
0,0211-699501013259,correlacionandose,o
0,0211-699501013259,directamente,o
0,0211-699501013259,la,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,con,o
0,0211-699501013259,la,o
0,0211-699501013259,albumina,i
0,0211-699501013259,plasmatica,i
0,0211-699501013259,La,o
0,0211-699501013259,interpretacion,o
0,0211-699501013259,de,o
0,0211-699501013259,los,o
0,0211-699501013259,niveles,i
0,0211-699501013259,de,i
0,0211-699501013259,tHcy,i
0,0211-699501013259,debe,o
0,0211-699501013259,tener,o
0,0211-699501013259,en,o
0,0211-699501013259,cuenta,o
0,0211-699501013259,la,o
0,0211-699501013259,concentracion,i
0,0211-699501013259,de,i
0,0211-699501013259,albumina,i
1,0211-699501013694,Efecto,o
1,0211-699501013694,beneficioso,o
1,0211-699501013694,de,o
1,0211-699501013694,las,o
1,0211-699501013694,membranas,o
1,0211-699501013694,de,o
1,0211-699501013694,AN69,i
1,0211-699501013694,sobre,o
1,0211-699501013694,la,o
1,0211-699501013694,anemia,i
1,0211-699501013694,de,o
1,0211-699501013694,los,o
1,0211-699501013694,pacientes,o
1,0211-699501013694,en,o
1,0211-699501013694,hemodialisis,i
1,0211-699501013694,La,o
1,0211-699501013694,utilizacion,o
1,0211-699501013694,de,o
1,0211-699501013694,membranas,o
1,0211-699501013694,de,o
1,0211-699501013694,AN69,i
1,0211-699501013694,generalmente,o
1,0211-699501013694,aumenta,o
1,0211-699501013694,el,o
1,0211-699501013694,aclaramiento,o
1,0211-699501013694,de,o
1,0211-699501013694,toxinas,i
1,0211-699501013694,uremicas,i
1,0211-699501013694,de,o
1,0211-699501013694,mayor,o
1,0211-699501013694,peso,o
1,0211-699501013694,molecular,o
1,0211-699501013694,e,o
1,0211-699501013694,induce,o
1,0211-699501013694,una,o
1,0211-699501013694,menor,o
1,0211-699501013694,activacion,o
1,0211-699501013694,de,o
1,0211-699501013694,mediadores,o
1,0211-699501013694,inflamatorios,i
1,0211-699501013694,que,o
1,0211-699501013694,las,o
1,0211-699501013694,membranas,o
1,0211-699501013694,celulosicas,i
1,0211-699501013694,ambos,o
1,0211-699501013694,procesos,o
1,0211-699501013694,podrian,o
1,0211-699501013694,tener,o
1,0211-699501013694,un,o
1,0211-699501013694,efecto,o
1,0211-699501013694,beneficioso,o
1,0211-699501013694,sobre,o
1,0211-699501013694,la,o
1,0211-699501013694,eritropoyesis,o
1,0211-699501013694,Objetivo,o
1,0211-699501013694,Valorar,o
1,0211-699501013694,la,o
1,0211-699501013694,influencia,o
1,0211-699501013694,de,o
1,0211-699501013694,las,o
1,0211-699501013694,membranas,o
1,0211-699501013694,de,o
1,0211-699501013694,AN69,i
1,0211-699501013694,sobre,o
1,0211-699501013694,la,o
1,0211-699501013694,anemia,i
1,0211-699501013694,en,o
1,0211-699501013694,pacientes,o
1,0211-699501013694,con,o
1,0211-699501013694,Insuficiencia,i
1,0211-699501013694,Renal,i
1,0211-699501013694,Cronica,i
1,0211-699501013694,en,o
1,0211-699501013694,programa,o
1,0211-699501013694,de,o
1,0211-699501013694,hemodialisis,i
1,0211-699501013694,HD,i
1,0211-699501013694,Material,o
1,0211-699501013694,y,o
1,0211-699501013694,metodos,o
1,0211-699501013694,Estudiamos,o
1,0211-699501013694,25,o
1,0211-699501013694,pacientes,o
1,0211-699501013694,en,o
1,0211-699501013694,HD,i
1,0211-699501013694,dializados,i
1,0211-699501013694,con,o
1,0211-699501013694,membrana,o
1,0211-699501013694,de,o
1,0211-699501013694,cuprofan,i
1,0211-699501013694,durante,o
1,0211-699501013694,un,o
1,0211-699501013694,minimo,o
1,0211-699501013694,de,o
1,0211-699501013694,6,o
1,0211-699501013694,meses,o
1,0211-699501013694,en,o
1,0211-699501013694,situacion,o
1,0211-699501013694,estable,o
1,0211-699501013694,en,o
1,0211-699501013694,los,o
1,0211-699501013694,que,o
1,0211-699501013694,se,o
1,0211-699501013694,descarto,o
1,0211-699501013694,otras,o
1,0211-699501013694,causas,o
1,0211-699501013694,de,o
1,0211-699501013694,anemia,i
1,0211-699501013694,ferritina,i
1,0211-699501013694,200,o
1,0211-699501013694,ngml,o
1,0211-699501013694,IST,i
1,0211-699501013694,20,o
1,0211-699501013694,Se,o
1,0211-699501013694,dividieron,o
1,0211-699501013694,en,o
1,0211-699501013694,2,o
1,0211-699501013694,grupos,o
1,0211-699501013694,homogeneos,o
1,0211-699501013694,Los,o
1,0211-699501013694,pacientes,o
1,0211-699501013694,del,o
1,0211-699501013694,grupo,o
1,0211-699501013694,I,o
1,0211-699501013694,GI,o
1,0211-699501013694,n,o
1,0211-699501013694,14,o
1,0211-699501013694,pasaron,o
1,0211-699501013694,a,o
1,0211-699501013694,dializarse,i
1,0211-699501013694,con,o
1,0211-699501013694,membrana,o
1,0211-699501013694,de,o
1,0211-699501013694,AN69,i
1,0211-699501013694,y,o
1,0211-699501013694,los,o
1,0211-699501013694,del,o
1,0211-699501013694,grupo,o
1,0211-699501013694,II,o
1,0211-699501013694,GII,o
1,0211-699501013694,n,o
1,0211-699501013694,11,o
1,0211-699501013694,permanecieron,o
1,0211-699501013694,con,o
1,0211-699501013694,membrana,o
1,0211-699501013694,cuprofan,i
1,0211-699501013694,El,o
1,0211-699501013694,seguimiento,i
1,0211-699501013694,fue,o
1,0211-699501013694,de,o
1,0211-699501013694,5,o
1,0211-699501013694,meses,o
1,0211-699501013694,Se,o
1,0211-699501013694,analizaron,o
1,0211-699501013694,hematocrito,i
1,0211-699501013694,ferritina,i
1,0211-699501013694,ngml,o
1,0211-699501013694,IST,i
1,0211-699501013694,KTV,i
1,0211-699501013694,PCR,i
1,0211-699501013694,gkgdia,o
1,0211-699501013694,y,o
1,0211-699501013694,dosis,o
1,0211-699501013694,de,o
1,0211-699501013694,EPO,i
1,0211-699501013694,UIsemana,o
1,0211-699501013694,mensual,o
1,0211-699501013694,en,o
1,0211-699501013694,GI,o
1,0211-699501013694,y,o
1,0211-699501013694,Basal,o
1,0211-699501013694,2,o
1,0211-699501013694,4,o
1,0211-699501013694,y,o
1,0211-699501013694,5,o
1,0211-699501013694,meses,o
1,0211-699501013694,en,o
1,0211-699501013694,GII,o
1,0211-699501013694,El,o
1,0211-699501013694,hematocrito,i
1,0211-699501013694,diana,o
1,0211-699501013694,fue,o
1,0211-699501013694,de,o
1,0211-699501013694,3335,o
1,0211-699501013694,Resultados,o
1,0211-699501013694,El,o
1,0211-699501013694,hematocrito,i
1,0211-699501013694,en,o
1,0211-699501013694,el,o
1,0211-699501013694,GI,o
1,0211-699501013694,aumento,o
1,0211-699501013694,de,o
1,0211-699501013694,forma,o
1,0211-699501013694,significativa,o
1,0211-699501013694,a,o
1,0211-699501013694,partir,o
1,0211-699501013694,del,o
1,0211-699501013694,2º,o
1,0211-699501013694,mes,o
1,0211-699501013694,de,o
1,0211-699501013694,tratamiento,i
1,0211-699501013694,sin,o
1,0211-699501013694,modificaciones,o
1,0211-699501013694,en,o
1,0211-699501013694,la,o
1,0211-699501013694,dosis,o
1,0211-699501013694,de,o
1,0211-699501013694,EPO,i
1,0211-699501013694,ni,o
1,0211-699501013694,en,o
1,0211-699501013694,la,o
1,0211-699501013694,dosis,o
1,0211-699501013694,de,o
1,0211-699501013694,dialisis,i
1,0211-699501013694,La,o
1,0211-699501013694,ferritina,i
1,0211-699501013694,e,o
1,0211-699501013694,IST,i
1,0211-699501013694,disminuyeron,o
1,0211-699501013694,de,o
1,0211-699501013694,forma,o
1,0211-699501013694,significativa,o
1,0211-699501013694,como,o
1,0211-699501013694,reflejo,o
1,0211-699501013694,de,o
1,0211-699501013694,una,o
1,0211-699501013694,mayor,o
1,0211-699501013694,utilizacion,o
1,0211-699501013694,En,o
1,0211-699501013694,GII,o
1,0211-699501013694,no,o
1,0211-699501013694,se,o
1,0211-699501013694,modifico,o
1,0211-699501013694,el,o
1,0211-699501013694,hematocrito,i
1,0211-699501013694,durante,o
1,0211-699501013694,los,o
1,0211-699501013694,5,o
1,0211-699501013694,meses,o
1,0211-699501013694,que,o
1,0211-699501013694,duro,o
1,0211-699501013694,el,o
1,0211-699501013694,estudio,o
1,0211-699501013694,Conclusion,o
1,0211-699501013694,La,o
1,0211-699501013694,utilizacion,o
1,0211-699501013694,de,o
1,0211-699501013694,membranas,o
1,0211-699501013694,de,o
1,0211-699501013694,AN69,i
1,0211-699501013694,aumenta,o
1,0211-699501013694,el,o
1,0211-699501013694,hematocrito,i
1,0211-699501013694,de,o
1,0211-699501013694,forma,o
1,0211-699501013694,significativa,o
1,0211-699501013694,sin,o
1,0211-699501013694,modificaciones,o
1,0211-699501013694,en,o
1,0211-699501013694,la,o
1,0211-699501013694,dosis,o
1,0211-699501013694,de,o
1,0211-699501013694,Eritropoyetina,i
2,0211-699502014854,Cambio,o
2,0211-699502014854,en,o
2,0211-699502014854,la,o
2,0211-699502014854,calidad,i
2,0211-699502014854,de,i
2,0211-699502014854,vida,i
2,0211-699502014854,relacionada,i
2,0211-699502014854,con,i
2,0211-699502014854,la,i
2,0211-699502014854,salud,i
2,0211-699502014854,durante,o
2,0211-699502014854,el,o
2,0211-699502014854,primer,o
2,0211-699502014854,año,o
2,0211-699502014854,del,o
2,0211-699502014854,trasplante,i
2,0211-699502014854,renal,i
2,0211-699502014854,Objetivo,o
2,0211-699502014854,Estudiar,o
2,0211-699502014854,los,o
2,0211-699502014854,cambios,o
2,0211-699502014854,en,o
2,0211-699502014854,la,o
2,0211-699502014854,calidad,i
2,0211-699502014854,de,i
2,0211-699502014854,vida,i
2,0211-699502014854,relacionada,i
2,0211-699502014854,con,i
2,0211-699502014854,la,i
2,0211-699502014854,salud,i
2,0211-699502014854,CVRS,i
2,0211-699502014854,en,o
2,0211-699502014854,el,o
2,0211-699502014854,primer,o
2,0211-699502014854,año,o
2,0211-699502014854,del,o
2,0211-699502014854,trasplante,i
2,0211-699502014854,renal,i
2,0211-699502014854,TR,i
2,0211-699502014854,comparando,o
2,0211-699502014854,azatioprina,i
2,0211-699502014854,vs,o
2,0211-699502014854,Mofetil,i
2,0211-699502014854,micofenolato,i
2,0211-699502014854,en,o
2,0211-699502014854,triple,o
2,0211-699502014854,terapia,i
2,0211-699502014854,inmunosupresora,i
2,0211-699502014854,con,o
2,0211-699502014854,prednisona,i
2,0211-699502014854,y,o
2,0211-699502014854,CsA,i
2,0211-699502014854,Metodos,o
2,0211-699502014854,Estudio,o
2,0211-699502014854,prospectivo,o
2,0211-699502014854,abierto,o
2,0211-699502014854,y,o
2,0211-699502014854,aleatorizado,o
2,0211-699502014854,con,o
2,0211-699502014854,26,o
2,0211-699502014854,pacientes,o
2,0211-699502014854,que,o
2,0211-699502014854,recibieron,o
2,0211-699502014854,consecutivamente,o
2,0211-699502014854,un,o
2,0211-699502014854,primer,o
2,0211-699502014854,trasplante,i
2,0211-699502014854,renal,i
2,0211-699502014854,de,o
2,0211-699502014854,cadaver,o
2,0211-699502014854,Analisis,i
2,0211-699502014854,de,i
2,0211-699502014854,variables,i
2,0211-699502014854,clinicas,i
2,0211-699502014854,disfuncion,i
2,0211-699502014854,inicial,i
2,0211-699502014854,del,i
2,0211-699502014854,injerto,i
2,0211-699502014854,rechazo,i
2,0211-699502014854,agudo,i
2,0211-699502014854,RA,i
2,0211-699502014854,infecciones,i
2,0211-699502014854,y,o
2,0211-699502014854,comorbilidad,i
2,0211-699502014854,analiticas,i
2,0211-699502014854,hemograma,i
2,0211-699502014854,albumina,i
2,0211-699502014854,y,o
2,0211-699502014854,creatinina,i
2,0211-699502014854,sericas,i
2,0211-699502014854,funcion,i
2,0211-699502014854,hepatica,i
2,0211-699502014854,niveles,i
2,0211-699502014854,de,i
2,0211-699502014854,CsA,i
2,0211-699502014854,instrumentos,o
2,0211-699502014854,de,o
2,0211-699502014854,evaluacion,i
2,0211-699502014854,de,i
2,0211-699502014854,la,i
2,0211-699502014854,CVRS,i
2,0211-699502014854,Indice,o
2,0211-699502014854,de,o
2,0211-699502014854,bienestar,o
2,0211-699502014854,psicologico,o
2,0211-699502014854,IBP,o
2,0211-699502014854,y,o
2,0211-699502014854,Cuestionario,i
2,0211-699502014854,de,o
2,0211-699502014854,salud,o
2,0211-699502014854,Euroqol5D,o
2,0211-699502014854,EQ5d,o
2,0211-699502014854,que,o
2,0211-699502014854,incluye,o
2,0211-699502014854,un,o
2,0211-699502014854,termometro,o
2,0211-699502014854,de,o
2,0211-699502014854,autovaloracion,o
2,0211-699502014854,del,o
2,0211-699502014854,estado,o
2,0211-699502014854,de,o
2,0211-699502014854,salud,o
2,0211-699502014854,EVA,i
2,0211-699502014854,Recogida,o
2,0211-699502014854,controlada,o
2,0211-699502014854,de,o
2,0211-699502014854,datos,o
2,0211-699502014854,al,o
2,0211-699502014854,alta,o
2,0211-699502014854,del,o
2,0211-699502014854,trasplante,i
2,0211-699502014854,renal,i
2,0211-699502014854,y,o
2,0211-699502014854,al,o
2,0211-699502014854,1,o
2,0211-699502014854,3,o
2,0211-699502014854,6,o
2,0211-699502014854,y,o
2,0211-699502014854,12,o
2,0211-699502014854,meses,o
2,0211-699502014854,del,o
2,0211-699502014854,primer,o
2,0211-699502014854,cuestionario,i
2,0211-699502014854,Resultados,o
2,0211-699502014854,No,o
2,0211-699502014854,hubo,o
2,0211-699502014854,diferencias,o
2,0211-699502014854,entre,o
2,0211-699502014854,los,o
2,0211-699502014854,pacientes,o
2,0211-699502014854,con,o
2,0211-699502014854,azatioprina,i
2,0211-699502014854,o,o
2,0211-699502014854,MMF,i
2,0211-699502014854,salvo,o
2,0211-699502014854,que,o
2,0211-699502014854,el,o
2,0211-699502014854,RA,i
2,0211-699502014854,fue,o
2,0211-699502014854,menos,o
2,0211-699502014854,frecuente,o
2,0211-699502014854,con,o
2,0211-699502014854,MMF,i
2,0211-699502014854,7,o
2,0211-699502014854,vs,o
2,0211-699502014854,42,o
2,0211-699502014854,p,o
2,0211-699502014854,0065,o
2,0211-699502014854,RA,i
2,0211-699502014854,global,o
2,0211-699502014854,23,o
2,0211-699502014854,Hubo,o
2,0211-699502014854,una,o
2,0211-699502014854,mejoria,o
2,0211-699502014854,de,o
2,0211-699502014854,la,o
2,0211-699502014854,CVRS,i
2,0211-699502014854,medida,o
2,0211-699502014854,por,o
2,0211-699502014854,el,o
2,0211-699502014854,aumento,o
2,0211-699502014854,progresivo,o
2,0211-699502014854,en,o
2,0211-699502014854,las,o
2,0211-699502014854,puntuaciones,o
2,0211-699502014854,del,o
2,0211-699502014854,IBP,o
2,0211-699502014854,EQ5d,o
2,0211-699502014854,y,o
2,0211-699502014854,EVA,i
2,0211-699502014854,en,o
2,0211-699502014854,los,o
2,0211-699502014854,3,o
2,0211-699502014854,primeros,o
2,0211-699502014854,meses,o
2,0211-699502014854,del,o
2,0211-699502014854,TR,i
2,0211-699502014854,Al,o
2,0211-699502014854,sexto,o
2,0211-699502014854,mes,o
2,0211-699502014854,se,o
2,0211-699502014854,observo,o
2,0211-699502014854,una,o
2,0211-699502014854,disminucion,o
2,0211-699502014854,de,o
2,0211-699502014854,la,o
2,0211-699502014854,puntuacion,o
2,0211-699502014854,en,o
2,0211-699502014854,comparacion,o
2,0211-699502014854,con,o
2,0211-699502014854,el,o
2,0211-699502014854,tercero,o
2,0211-699502014854,IBP,o
2,0211-699502014854,p,o
2,0211-699502014854,0011,o
2,0211-699502014854,y,o
2,0211-699502014854,posteriormente,o
2,0211-699502014854,mejoro,o
2,0211-699502014854,la,o
2,0211-699502014854,CVRS,i
2,0211-699502014854,pero,o
2,0211-699502014854,sin,o
2,0211-699502014854,llegar,o
2,0211-699502014854,a,o
2,0211-699502014854,las,o
2,0211-699502014854,maximas,o
2,0211-699502014854,puntuaciones,o
2,0211-699502014854,conseguidas,o
2,0211-699502014854,Conclusiones,o
2,0211-699502014854,Los,o
2,0211-699502014854,pacientes,o
2,0211-699502014854,con,o
2,0211-699502014854,MMF,i
2,0211-699502014854,presentaron,o
2,0211-699502014854,menos,o
2,0211-699502014854,episodios,o
2,0211-699502014854,de,o
2,0211-699502014854,RA,i
2,0211-699502014854,La,o
2,0211-699502014854,CVRS,i
2,0211-699502014854,disminuye,o
2,0211-699502014854,entre,o
2,0211-699502014854,el,o
2,0211-699502014854,tercer,o
2,0211-699502014854,y,o
2,0211-699502014854,sexto,o
2,0211-699502014854,mes,o
2,0211-699502014854,con,o
2,0211-699502014854,menos,o
2,0211-699502014854,intensidad,o
2,0211-699502014854,en,o
2,0211-699502014854,los,o
2,0211-699502014854,pacientes,o
2,0211-699502014854,con,o
2,0211-699502014854,MMF,i
2,0211-699502014854,en,o
2,0211-699502014854,probable,o
2,0211-699502014854,relacion,o
2,0211-699502014854,con,o
2,0211-699502014854,la,o
2,0211-699502014854,menor,o
2,0211-699502014854,tasa,o
2,0211-699502014854,de,o
2,0211-699502014854,RA,i
3,0211-699502015057,Optimizacion,o
3,0211-699502015057,de,o
3,0211-699502015057,la,o
3,0211-699502015057,dosis,o
3,0211-699502015057,de,o
3,0211-699502015057,calcitriol,i
3,0211-699502015057,en,o
3,0211-699502015057,el,o
3,0211-699502015057,tratamiento,i
3,0211-699502015057,del,o
3,0211-699502015057,hiperparatiroidismo,i
3,0211-699502015057,secundario,i
3,0211-699502015057,en,o
3,0211-699502015057,dialisis,i
3,0211-699502015057,Resultados,o
3,0211-699502015057,a,o
3,0211-699502015057,seis,o
3,0211-699502015057,meses,o
3,0211-699502015057,El,o
3,0211-699502015057,objetivo,o
3,0211-699502015057,fundamental,o
3,0211-699502015057,del,o
3,0211-699502015057,estudio,o
3,0211-699502015057,fue,o
3,0211-699502015057,valorar,i
3,0211-699502015057,la,i
3,0211-699502015057,utilidad,i
3,0211-699502015057,de,o
3,0211-699502015057,comenzar,o
3,0211-699502015057,el,o
3,0211-699502015057,tratamiento,i
3,0211-699502015057,con,o
3,0211-699502015057,calcitriol,i
3,0211-699502015057,con,o
3,0211-699502015057,dosis,o
3,0211-699502015057,iniciales,o
3,0211-699502015057,proporcionales,o
3,0211-699502015057,al,o
3,0211-699502015057,grado,o
3,0211-699502015057,de,o
3,0211-699502015057,severidad,o
3,0211-699502015057,del,o
3,0211-699502015057,hiperparatiroidismo,i
3,0211-699502015057,secundario,i
3,0211-699502015057,Se,o
3,0211-699502015057,incluyeron,o
3,0211-699502015057,pacientes,o
3,0211-699502015057,de,o
3,0211-699502015057,hemodialisis,i
3,0211-699502015057,de,o
3,0211-699502015057,28,o
3,0211-699502015057,centros,o
3,0211-699502015057,N,o
3,0211-699502015057,141,o
3,0211-699502015057,El,o
3,0211-699502015057,objetivo,o
3,0211-699502015057,final,o
3,0211-699502015057,fue,o
3,0211-699502015057,alcanzar,o
3,0211-699502015057,a,o
3,0211-699502015057,los,o
3,0211-699502015057,seis,o
3,0211-699502015057,meses,o
3,0211-699502015057,una,o
3,0211-699502015057,PTH,i
3,0211-699502015057,entre,o
3,0211-699502015057,100,o
3,0211-699502015057,y,o
3,0211-699502015057,285,o
3,0211-699502015057,pgmL,o
3,0211-699502015057,Los,o
3,0211-699502015057,criterios,o
3,0211-699502015057,principales,o
3,0211-699502015057,de,o
3,0211-699502015057,inclusion,o
3,0211-699502015057,fueron,o
3,0211-699502015057,PTH,i
3,0211-699502015057,serica,i
3,0211-699502015057,285,o
3,0211-699502015057,pgmL,o
3,0211-699502015057,Ca,i
3,0211-699502015057,105,o
3,0211-699502015057,mgdl,o
3,0211-699502015057,P,o
3,0211-699502015057,65,o
3,0211-699502015057,mgdL,o
3,0211-699502015057,y,o
3,0211-699502015057,Ca,i
3,0211-699502015057,P,o
3,0211-699502015057,60,o
3,0211-699502015057,Los,o
3,0211-699502015057,pacientes,o
3,0211-699502015057,fueron,o
3,0211-699502015057,divididos,o
3,0211-699502015057,segun,o
3,0211-699502015057,PTH,i
3,0211-699502015057,en,o
3,0211-699502015057,4,o
3,0211-699502015057,grupos,o
3,0211-699502015057,a,o
3,0211-699502015057,los,o
3,0211-699502015057,que,o
3,0211-699502015057,se,o
3,0211-699502015057,administro,o
3,0211-699502015057,dosis,o
3,0211-699502015057,diferentes,o
3,0211-699502015057,de,o
3,0211-699502015057,calcitriol,i
3,0211-699502015057,proporcionales,o
3,0211-699502015057,a,o
3,0211-699502015057,los,o
3,0211-699502015057,niveles,i
3,0211-699502015057,de,i
3,0211-699502015057,PTH,i
3,0211-699502015057,Grupo,o
3,0211-699502015057,A,o
3,0211-699502015057,PTH,i
3,0211-699502015057,285350,o
3,0211-699502015057,05,o
3,0211-699502015057,µg,o
3,0211-699502015057,grupo,o
3,0211-699502015057,B,o
3,0211-699502015057,PTH,i
3,0211-699502015057,351550,o
3,0211-699502015057,115,o
3,0211-699502015057,µg,o
3,0211-699502015057,grupo,o
3,0211-699502015057,C,o
3,0211-699502015057,PTH,i
3,0211-699502015057,551750,o
3,0211-699502015057,152,o
3,0211-699502015057,µg,o
3,0211-699502015057,y,o
3,0211-699502015057,grupo,o
3,0211-699502015057,D,o
3,0211-699502015057,PTH,i
3,0211-699502015057,750,o
3,0211-699502015057,pgmL,o
3,0211-699502015057,23,o
3,0211-699502015057,µg,o
3,0211-699502015057,De,o
3,0211-699502015057,acuerdo,o
3,0211-699502015057,a,o
3,0211-699502015057,los,o
3,0211-699502015057,resultados,o
3,0211-699502015057,el,o
3,0211-699502015057,calcitriol,i
3,0211-699502015057,se,o
3,0211-699502015057,redujo,o
3,0211-699502015057,al,o
3,0211-699502015057,50,o
3,0211-699502015057,si,o
3,0211-699502015057,la,o
3,0211-699502015057,PTH,i
3,0211-699502015057,disminuia,o
3,0211-699502015057,60,o
3,0211-699502015057,y,o
3,0211-699502015057,se,o
3,0211-699502015057,incremento,o
3,0211-699502015057,un,o
3,0211-699502015057,50,o
3,0211-699502015057,si,o
3,0211-699502015057,el,o
3,0211-699502015057,descenso,o
3,0211-699502015057,de,o
3,0211-699502015057,la,o
3,0211-699502015057,PTH,i
3,0211-699502015057,era,o
3,0211-699502015057,15,o
3,0211-699502015057,Los,o
3,0211-699502015057,pacientes,o
3,0211-699502015057,cesaban,i
3,0211-699502015057,el,i
3,0211-699502015057,tratamiento,i
3,0211-699502015057,y,o
3,0211-699502015057,eran,o
3,0211-699502015057,excluidos,o
3,0211-699502015057,del,o
3,0211-699502015057,estudio,o
3,0211-699502015057,cuando,o
3,0211-699502015057,Ca,i
3,0211-699502015057,P,o
3,0211-699502015057,y,o
3,0211-699502015057,Ca,i
3,0211-699502015057,P,o
3,0211-699502015057,sobrepasaban,o
3,0211-699502015057,lo,o
3,0211-699502015057,establecido,o
3,0211-699502015057,en,o
3,0211-699502015057,los,o
3,0211-699502015057,criterios,o
3,0211-699502015057,de,o
3,0211-699502015057,inclusion,o
3,0211-699502015057,El,o
3,0211-699502015057,estudio,o
3,0211-699502015057,fue,o
3,0211-699502015057,completado,o
3,0211-699502015057,por,o
3,0211-699502015057,100,o
3,0211-699502015057,pacientes,o
3,0211-699502015057,34,o
3,0211-699502015057,con,o
3,0211-699502015057,cumplimiento,o
3,0211-699502015057,estricto,o
3,0211-699502015057,del,o
3,0211-699502015057,protocolo,i
3,0211-699502015057,cumplidores,o
3,0211-699502015057,y,o
3,0211-699502015057,66,o
3,0211-699502015057,con,o
3,0211-699502015057,una,o
3,0211-699502015057,o,o
3,0211-699502015057,mas,o
3,0211-699502015057,violaciones,o
3,0211-699502015057,de,o
3,0211-699502015057,protocolo,i
3,0211-699502015057,siendo,o
3,0211-699502015057,la,o
3,0211-699502015057,mas,o
3,0211-699502015057,frecuente,o
3,0211-699502015057,la,o
3,0211-699502015057,falta,o
3,0211-699502015057,de,o
3,0211-699502015057,estricta,o
3,0211-699502015057,adherencia,o
3,0211-699502015057,al,o
3,0211-699502015057,regimen,i
3,0211-699502015057,de,i
3,0211-699502015057,dosis,i
3,0211-699502015057,no,o
3,0211-699502015057,cumplidores,o
3,0211-699502015057,Entre,o
3,0211-699502015057,los,o
3,0211-699502015057,cumplidores,o
3,0211-699502015057,el,o
3,0211-699502015057,824,o
3,0211-699502015057,alcanzaron,o
3,0211-699502015057,el,o
3,0211-699502015057,objetivo,o
3,0211-699502015057,final,o
3,0211-699502015057,en,o
3,0211-699502015057,contraste,o
3,0211-699502015057,con,o
3,0211-699502015057,el,o
3,0211-699502015057,138,o
3,0211-699502015057,de,o
3,0211-699502015057,los,o
3,0211-699502015057,no,o
3,0211-699502015057,cumplidores,o
3,0211-699502015057,p,o
3,0211-699502015057,0001,o
3,0211-699502015057,Ademas,o
3,0211-699502015057,los,o
3,0211-699502015057,cumplidores,o
3,0211-699502015057,mostraron,o
3,0211-699502015057,un,o
3,0211-699502015057,mayor,o
3,0211-699502015057,y,o
3,0211-699502015057,significativo,o
3,0211-699502015057,descenso,o
3,0211-699502015057,de,o
3,0211-699502015057,PTH,i
3,0211-699502015057,de,o
3,0211-699502015057,616,o
3,0211-699502015057,288,o
3,0211-699502015057,a,o
3,0211-699502015057,202,o
3,0211-699502015057,82,o
3,0211-699502015057,en,o
3,0211-699502015057,ningun,o
3,0211-699502015057,caso,o
3,0211-699502015057,hubo,o
3,0211-699502015057,un,o
3,0211-699502015057,incremento,o
3,0211-699502015057,de,o
3,0211-699502015057,PTH,i
3,0211-699502015057,en,o
3,0211-699502015057,contraste,o
3,0211-699502015057,el,o
3,0211-699502015057,215,o
3,0211-699502015057,de,o
3,0211-699502015057,los,o
3,0211-699502015057,incumplidores,o
3,0211-699502015057,aumentaron,o
3,0211-699502015057,sus,o
3,0211-699502015057,niveles,i
3,0211-699502015057,de,i
3,0211-699502015057,PTH,i
3,0211-699502015057,Los,o
3,0211-699502015057,cumplidores,o
3,0211-699502015057,mostraron,o
3,0211-699502015057,menos,o
3,0211-699502015057,efectos,i
3,0211-699502015057,adversos,i
3,0211-699502015057,que,o
3,0211-699502015057,los,o
3,0211-699502015057,no,o
3,0211-699502015057,cumplidores,o
3,0211-699502015057,25,o
3,0211-699502015057,vs,o
3,0211-699502015057,556,o
3,0211-699502015057,p,o
3,0211-699502015057,0006,o
3,0211-699502015057,Estos,o
3,0211-699502015057,resultados,o
3,0211-699502015057,demuestran,o
3,0211-699502015057,la,o
3,0211-699502015057,ventaja,o
3,0211-699502015057,de,o
3,0211-699502015057,comenzar,o
3,0211-699502015057,el,o
3,0211-699502015057,tratamiento,i
3,0211-699502015057,con,o
3,0211-699502015057,calcitriol,i
3,0211-699502015057,con,o
3,0211-699502015057,una,o
3,0211-699502015057,dosis,o
3,0211-699502015057,proporcional,o
3,0211-699502015057,a,o
3,0211-699502015057,la,o
3,0211-699502015057,severidad,o
3,0211-699502015057,del,o
3,0211-699502015057,hiperparatiroidismo,i
3,0211-699502015057,secundario,i
4,0211-699503015842,Estudio,i
4,0211-699503015842,multicentrico,i
4,0211-699503015842,de,o
4,0211-699503015842,darbepoetin,i
4,0211-699503015842,alfa,i
4,0211-699503015842,en,o
4,0211-699503015842,el,o
4,0211-699503015842,tratamiento,i
4,0211-699503015842,de,o
4,0211-699503015842,la,o
4,0211-699503015842,anemia,i
4,0211-699503015842,secundaria,o
4,0211-699503015842,a,o
4,0211-699503015842,insuficiencia,i
4,0211-699503015842,renal,i
4,0211-699503015842,cronica,i
4,0211-699503015842,en,o
4,0211-699503015842,dialisis,i
4,0211-699503015842,Este,o
4,0211-699503015842,ensayo,o
4,0211-699503015842,clinico,o
4,0211-699503015842,prospectivo,o
4,0211-699503015842,multicentrico,o
4,0211-699503015842,de,o
4,0211-699503015842,un,o
4,0211-699503015842,solo,o
4,0211-699503015842,brazo,o
4,0211-699503015842,evaluo,o
4,0211-699503015842,el,o
4,0211-699503015842,mantenimiento,o
4,0211-699503015842,de,o
4,0211-699503015842,las,o
4,0211-699503015842,concentraciones,i
4,0211-699503015842,de,i
4,0211-699503015842,hemoglobina,i
4,0211-699503015842,Hb,i
4,0211-699503015842,entre,o
4,0211-699503015842,1013,o
4,0211-699503015842,gdL,o
4,0211-699503015842,con,o
4,0211-699503015842,darbepoetin,i
4,0211-699503015842,alfa,i
4,0211-699503015842,y,o
4,0211-699503015842,la,o
4,0211-699503015842,seguridad,o
4,0211-699503015842,de,o
4,0211-699503015842,este,o
4,0211-699503015842,tratamiento,i
4,0211-699503015842,en,o
4,0211-699503015842,pacientes,o
4,0211-699503015842,con,o
4,0211-699503015842,insuficiencia,i
4,0211-699503015842,renal,i
4,0211-699503015842,cronica,i
4,0211-699503015842,IRC,i
4,0211-699503015842,en,o
4,0211-699503015842,dialisis,i
4,0211-699503015842,94,o
4,0211-699503015842,hemodialisis,i
4,0211-699503015842,6,o
4,0211-699503015842,dialisis,i
4,0211-699503015842,peritoneal,i
4,0211-699503015842,concentracion,i
4,0211-699503015842,de,i
4,0211-699503015842,Hb,i
4,0211-699503015842,basal,o
4,0211-699503015842,117,o
4,0211-699503015842,gdL,o
4,0211-699503015842,tratados,i
4,0211-699503015842,hasta,o
4,0211-699503015842,el,o
4,0211-699503015842,inicio,o
4,0211-699503015842,de,o
4,0211-699503015842,este,o
4,0211-699503015842,estudio,o
4,0211-699503015842,con,o
4,0211-699503015842,eritropoyetina,i
4,0211-699503015842,recombinante,i
4,0211-699503015842,humana,i
4,0211-699503015842,rHuEPO,o
4,0211-699503015842,Se,o
4,0211-699503015842,incluyeron,o
4,0211-699503015842,826,o
4,0211-699503015842,pacientes,o
4,0211-699503015842,con,o
4,0211-699503015842,concentraciones,i
4,0211-699503015842,de,i
4,0211-699503015842,Hb,i
4,0211-699503015842,y,o
4,0211-699503015842,dosis,o
4,0211-699503015842,de,o
4,0211-699503015842,rHuEPO,o
4,0211-699503015842,estables,o
4,0211-699503015842,824,o
4,0211-699503015842,recibieron,o
4,0211-699503015842,al,o
4,0211-699503015842,menos,o
4,0211-699503015842,una,o
4,0211-699503015842,dosis,o
4,0211-699503015842,de,o
4,0211-699503015842,darbepoetin,i
4,0211-699503015842,alfa,i
4,0211-699503015842,y,o
4,0211-699503015842,fueron,o
4,0211-699503015842,evaluables,o
4,0211-699503015842,para,o
4,0211-699503015842,el,o
4,0211-699503015842,analisis,i
4,0211-699503015842,de,i
4,0211-699503015842,seguridad,i
4,0211-699503015842,Los,o
4,0211-699503015842,pacientes,o
4,0211-699503015842,recibieron,o
4,0211-699503015842,darbepoetin,i
4,0211-699503015842,alfa,i
4,0211-699503015842,durante,o
4,0211-699503015842,24,o
4,0211-699503015842,semanas,o
4,0211-699503015842,20,o
4,0211-699503015842,de,o
4,0211-699503015842,titulacion,i
4,0211-699503015842,mas,o
4,0211-699503015842,4,o
4,0211-699503015842,de,o
4,0211-699503015842,evaluacion,i
4,0211-699503015842,La,o
4,0211-699503015842,dosis,o
4,0211-699503015842,inicial,o
4,0211-699503015842,de,o
4,0211-699503015842,darbepoetin,i
4,0211-699503015842,alfa,i
4,0211-699503015842,se,o
4,0211-699503015842,determino,o
4,0211-699503015842,a,o
4,0211-699503015842,partir,o
4,0211-699503015842,de,o
4,0211-699503015842,la,o
4,0211-699503015842,dosis,o
4,0211-699503015842,previa,o
4,0211-699503015842,de,o
4,0211-699503015842,rHuEPO,o
4,0211-699503015842,utilizando,o
4,0211-699503015842,la,o
4,0211-699503015842,equivalencia,o
4,0211-699503015842,en,o
4,0211-699503015842,masa,o
4,0211-699503015842,peptidica,i
4,0211-699503015842,entre,o
4,0211-699503015842,ambas,o
4,0211-699503015842,moleculas,o
4,0211-699503015842,y,o
4,0211-699503015842,ajustando,o
4,0211-699503015842,a,o
4,0211-699503015842,la,o
4,0211-699503015842,jeringa,o
4,0211-699503015842,precargada,o
4,0211-699503015842,mas,o
4,0211-699503015842,proxima,o
4,0211-699503015842,Se,o
4,0211-699503015842,administro,o
4,0211-699503015842,darbepoetin,i
4,0211-699503015842,alfa,i
4,0211-699503015842,1,o
4,0211-699503015842,semana,o
4,0211-699503015842,en,o
4,0211-699503015842,pacientes,o
4,0211-699503015842,en,o
4,0211-699503015842,tratamiento,i
4,0211-699503015842,previo,o
4,0211-699503015842,con,o
4,0211-699503015842,rHuEPO,o
4,0211-699503015842,23,o
4,0211-699503015842,semana,o
4,0211-699503015842,o,o
4,0211-699503015842,cada,o
4,0211-699503015842,dos,o
4,0211-699503015842,semanas,o
4,0211-699503015842,en,o
4,0211-699503015842,los,o
4,0211-699503015842,pacientes,o
4,0211-699503015842,con,o
4,0211-699503015842,rHuEPO,o
4,0211-699503015842,1,o
4,0211-699503015842,semana,o
4,0211-699503015842,El,o
4,0211-699503015842,868,o
4,0211-699503015842,de,o
4,0211-699503015842,los,o
4,0211-699503015842,pacientes,o
4,0211-699503015842,completaron,o
4,0211-699503015842,las,o
4,0211-699503015842,24,o
4,0211-699503015842,semanas,o
4,0211-699503015842,de,o
4,0211-699503015842,estudioEl,o
4,0211-699503015842,cambio,o
4,0211-699503015842,del,o
4,0211-699503015842,tratamiento,i
4,0211-699503015842,a,o
4,0211-699503015842,menor,o
4,0211-699503015842,frecuencia,o
4,0211-699503015842,de,o
4,0211-699503015842,dosificacion,o
4,0211-699503015842,no,o
4,0211-699503015842,produjo,o
4,0211-699503015842,modificaciones,o
4,0211-699503015842,clinicamente,o
4,0211-699503015842,significativas,o
4,0211-699503015842,en,o
4,0211-699503015842,la,o
4,0211-699503015842,concentracion,i
4,0211-699503015842,de,i
4,0211-699503015842,Hb,i
4,0211-699503015842,los,o
4,0211-699503015842,cambios,o
4,0211-699503015842,desde,o
4,0211-699503015842,la,o
4,0211-699503015842,visita,o
4,0211-699503015842,basal,o
4,0211-699503015842,al,o
4,0211-699503015842,periodo,o
4,0211-699503015842,de,o
4,0211-699503015842,evaluacion,i
4,0211-699503015842,consistieron,o
4,0211-699503015842,en,o
4,0211-699503015842,un,o
4,0211-699503015842,descenso,o
4,0211-699503015842,de,o
4,0211-699503015842,009,o
4,0211-699503015842,IC,o
4,0211-699503015842,95,o
4,0211-699503015842,02,o
4,0211-699503015842,00,o
4,0211-699503015842,gdL,o
4,0211-699503015842,con,o
4,0211-699503015842,aumento,o
4,0211-699503015842,de,o
4,0211-699503015842,019,o
4,0211-699503015842,IC,o
4,0211-699503015842,95,o
4,0211-699503015842,00,o
4,0211-699503015842,03,o
4,0211-699503015842,gdL,o
4,0211-699503015842,en,o
4,0211-699503015842,la,o
4,0211-699503015842,via,o
4,0211-699503015842,iv,o
4,0211-699503015842,y,o
4,0211-699503015842,descenso,o
4,0211-699503015842,de,o
4,0211-699503015842,022,o
4,0211-699503015842,IC,o
4,0211-699503015842,95,o
4,0211-699503015842,03,o
4,0211-699503015842,01,o
4,0211-699503015842,gdL,o
4,0211-699503015842,en,o
4,0211-699503015842,la,o
4,0211-699503015842,via,o
4,0211-699503015842,sc,o
4,0211-699503015842,Este,o
4,0211-699503015842,mantenimiento,o
4,0211-699503015842,de,o
4,0211-699503015842,Hb,i
4,0211-699503015842,se,o
4,0211-699503015842,acompaño,o
4,0211-699503015842,de,o
4,0211-699503015842,una,o
4,0211-699503015842,reduccion,o
4,0211-699503015842,media,o
4,0211-699503015842,de,o
4,0211-699503015842,la,o
4,0211-699503015842,dosis,o
4,0211-699503015842,de,o
4,0211-699503015842,darbepoetin,i
4,0211-699503015842,alfa,i
4,0211-699503015842,de,o
4,0211-699503015842,un,o
4,0211-699503015842,98,o
4,0211-699503015842,IC,o
4,0211-699503015842,95,o
4,0211-699503015842,129,o
4,0211-699503015842,66,o
4,0211-699503015842,197,o
4,0211-699503015842,IC,o
4,0211-699503015842,95,o
4,0211-699503015842,249142,o
4,0211-699503015842,via,o
4,0211-699503015842,iv,o
4,0211-699503015842,y,o
4,0211-699503015842,47,o
4,0211-699503015842,IC,o
4,0211-699503015842,95,o
4,0211-699503015842,85,o
4,0211-699503015842,07,o
4,0211-699503015842,via,o
4,0211-699503015842,sc,o
4,0211-699503015842,El,o
4,0211-699503015842,tratamiento,i
4,0211-699503015842,con,o
4,0211-699503015842,darbepoetin,i
4,0211-699503015842,alfa,i
4,0211-699503015842,fue,o
4,0211-699503015842,bien,o
4,0211-699503015842,tolerado,o
4,0211-699503015842,no,o
4,0211-699503015842,observandose,o
4,0211-699503015842,acontecimientos,i
4,0211-699503015842,adversos,i
4,0211-699503015842,inesperados,i
4,0211-699503015842,En,o
4,0211-699503015842,conclusion,o
4,0211-699503015842,la,o
4,0211-699503015842,sustitucion,o
4,0211-699503015842,de,o
4,0211-699503015842,rHuEPO,o
4,0211-699503015842,por,o
4,0211-699503015842,darbepoetin,i
4,0211-699503015842,alfa,i
4,0211-699503015842,en,o
4,0211-699503015842,la,o
4,0211-699503015842,terapia,i
4,0211-699503015842,de,o
4,0211-699503015842,la,o
4,0211-699503015842,anemia,i
4,0211-699503015842,secundaria,o
4,0211-699503015842,a,o
4,0211-699503015842,IRC,i
4,0211-699503015842,en,o
4,0211-699503015842,pacientes,o
4,0211-699503015842,en,o
4,0211-699503015842,dialisis,i
4,0211-699503015842,fue,o
4,0211-699503015842,eficaz,o
4,0211-699503015842,bien,o
4,0211-699503015842,tolerada,o
4,0211-699503015842,y,o
4,0211-699503015842,disminuyo,o
4,0211-699503015842,la,o
4,0211-699503015842,frecuencia,o
4,0211-699503015842,de,o
4,0211-699503015842,administracion,i
4,0211-699503015842,de,o
4,0211-699503015842,dosis,o
4,0211-699503015842,en,o
4,0211-699503015842,comparacion,o
4,0211-699503015842,con,o
4,0211-699503015842,el,o
4,0211-699503015842,tratamiento,i
4,0211-699503015842,previo,o
4,0211-699503015842,con,o
4,0211-699503015842,rHuEPO,o
4,0211-699503015842,Darbepoetin,i
4,0211-699503015842,alfa,i
4,0211-699503015842,1,o
4,0211-699503015842,vez,o
4,0211-699503015842,por,o
4,0211-699503015842,semana,o
4,0211-699503015842,o,o
4,0211-699503015842,1,o
4,0211-699503015842,vez,o
4,0211-699503015842,cada,o
4,0211-699503015842,2,o
4,0211-699503015842,semanas,o
4,0211-699503015842,mantuvo,o
4,0211-699503015842,los,o
4,0211-699503015842,niveles,i
4,0211-699503015842,de,i
4,0211-699503015842,Hb,i
4,0211-699503015842,basales,o
4,0211-699503015842,a,o
4,0211-699503015842,la,o
4,0211-699503015842,vez,o
4,0211-699503015842,que,o
4,0211-699503015842,permitio,o
4,0211-699503015842,una,o
4,0211-699503015842,reduccion,o
4,0211-699503015842,de,o
4,0211-699503015842,la,o
4,0211-699503015842,dosis,o
4,0211-699503015842,por,o
4,0211-699503015842,ambas,o
4,0211-699503015842,vias,o
4,0211-699503015842,de,o
4,0211-699503015842,administracion,i
4,0211-699503015842,siendo,o
4,0211-699503015842,mayor,o
4,0211-699503015842,en,o
4,0211-699503015842,los,o
4,0211-699503015842,pacientes,o
4,0211-699503015842,tratados,i
4,0211-699503015842,por,i
4,0211-699503015842,via,i
4,0211-699503015842,iv,i
5,0211-699504016634,Mejoria,o
5,0211-699504016634,del,o
5,0211-699504016634,estado,o
5,0211-699504016634,nutricional,o
5,0211-699504016634,con,o
5,0211-699504016634,hemodiafiltracion,i
5,0211-699504016634,en,i
5,0211-699504016634,linea,i
5,0211-699504016634,diaria,o
5,0211-699504016634,La,o
5,0211-699504016634,malnutricion,o
5,0211-699504016634,proteicocalorica,o
5,0211-699504016634,es,o
5,0211-699504016634,uno,o
5,0211-699504016634,de,o
5,0211-699504016634,los,o
5,0211-699504016634,principales,o
5,0211-699504016634,factores,o
5,0211-699504016634,que,o
5,0211-699504016634,afectan,o
5,0211-699504016634,la,o
5,0211-699504016634,morbimortalidad,o
5,0211-699504016634,de,o
5,0211-699504016634,los,o
5,0211-699504016634,pacientes,o
5,0211-699504016634,en,o
5,0211-699504016634,dialisis,i
5,0211-699504016634,Las,o
5,0211-699504016634,causas,o
5,0211-699504016634,de,o
5,0211-699504016634,anorexia,i
5,0211-699504016634,en,o
5,0211-699504016634,hemodialisis,i
5,0211-699504016634,incluyen,o
5,0211-699504016634,la,o
5,0211-699504016634,restriccion,o
5,0211-699504016634,dietetica,o
5,0211-699504016634,dialisis,i
5,0211-699504016634,inadecuada,o
5,0211-699504016634,inestabilidad,i
5,0211-699504016634,cardiovascular,i
5,0211-699504016634,vomitos,i
5,0211-699504016634,fatiga,i
5,0211-699504016634,sobrehidratacion,i
5,0211-699504016634,infeccion,i
5,0211-699504016634,yo,o
5,0211-699504016634,inflamacion,i
5,0211-699504016634,las,o
5,0211-699504016634,cuales,o
5,0211-699504016634,podrian,o
5,0211-699504016634,mejorar,o
5,0211-699504016634,con,o
5,0211-699504016634,dialisis,i
5,0211-699504016634,diaria,o
5,0211-699504016634,El,o
5,0211-699504016634,objetivo,o
5,0211-699504016634,del,o
5,0211-699504016634,estudio,o
5,0211-699504016634,fue,o
5,0211-699504016634,valorar,i
5,0211-699504016634,la,i
5,0211-699504016634,evolucion,i
5,0211-699504016634,nutricional,i
5,0211-699504016634,tras,o
5,0211-699504016634,cambiar,o
5,0211-699504016634,de,o
5,0211-699504016634,hemodiafiltracion,o
5,0211-699504016634,HDF,i
5,0211-699504016634,en,i
5,0211-699504016634,linea,i
5,0211-699504016634,en,o
5,0211-699504016634,regimen,i
5,0211-699504016634,de,o
5,0211-699504016634,3,o
5,0211-699504016634,sesiones,o
5,0211-699504016634,semanales,o
5,0211-699504016634,a,o
5,0211-699504016634,HDF,i
5,0211-699504016634,en,i
5,0211-699504016634,linea,i
5,0211-699504016634,diaria,o
5,0211-699504016634,24,o
5,0211-699504016634,pacientes,o
5,0211-699504016634,en,o
5,0211-699504016634,programa,o
5,0211-699504016634,estable,o
5,0211-699504016634,de,o
5,0211-699504016634,HDF,i
5,0211-699504016634,en,i
5,0211-699504016634,linea,i
5,0211-699504016634,en,o
5,0211-699504016634,3,o
5,0211-699504016634,sessem,o
5,0211-699504016634,durante,o
5,0211-699504016634,36,o
5,0211-699504016634,15,o
5,0211-699504016634,meses,o
5,0211-699504016634,se,o
5,0211-699504016634,incluyeron,o
5,0211-699504016634,en,o
5,0211-699504016634,el,o
5,0211-699504016634,estudio,o
5,0211-699504016634,Ocho,o
5,0211-699504016634,pacientes,o
5,0211-699504016634,6,o
5,0211-699504016634,hombres,o
5,0211-699504016634,y,o
5,0211-699504016634,2,o
5,0211-699504016634,mujeres,o
5,0211-699504016634,tiempo,o
5,0211-699504016634,275,o
5,0211-699504016634,25,o
5,0211-699504016634,min,o
5,0211-699504016634,45,o
5,0211-699504016634,h,o
5,0211-699504016634,Qb,o
5,0211-699504016634,445,o
5,0211-699504016634,59,o
5,0211-699504016634,mlmin,o
5,0211-699504016634,Qd,o
5,0211-699504016634,800,o
5,0211-699504016634,mlmin,o
5,0211-699504016634,y,o
5,0211-699504016634,97,o
5,0211-699504016634,24,o
5,0211-699504016634,l,o
5,0211-699504016634,de,o
5,0211-699504016634,reinfusion,i
5,0211-699504016634,semanal,o
5,0211-699504016634,se,o
5,0211-699504016634,pasaron,o
5,0211-699504016634,a,o
5,0211-699504016634,HDF,i
5,0211-699504016634,diaria,o
5,0211-699504016634,reduciendo,o
5,0211-699504016634,el,o
5,0211-699504016634,tiempo,o
5,0211-699504016634,a,o
5,0211-699504016634,la,o
5,0211-699504016634,mitad,o
5,0211-699504016634,129,o
5,0211-699504016634,8,o
5,0211-699504016634,min,o
5,0211-699504016634,225,o
5,0211-699504016634,h,o
5,0211-699504016634,Los,o
5,0211-699504016634,16,o
5,0211-699504016634,pacientes,o
5,0211-699504016634,restantes,o
5,0211-699504016634,permanecieron,o
5,0211-699504016634,en,o
5,0211-699504016634,HDF,i
5,0211-699504016634,en,i
5,0211-699504016634,linea,i
5,0211-699504016634,en,o
5,0211-699504016634,3,o
5,0211-699504016634,sessem,o
5,0211-699504016634,grupo,o
5,0211-699504016634,control,o
5,0211-699504016634,con,o
5,0211-699504016634,un,o
5,0211-699504016634,tiempo,o
5,0211-699504016634,de,o
5,0211-699504016634,259,o
5,0211-699504016634,31,o
5,0211-699504016634,min,o
5,0211-699504016634,QB,o
5,0211-699504016634,416,o
5,0211-699504016634,35,o
5,0211-699504016634,mlmin,o
5,0211-699504016634,QD,o
5,0211-699504016634,800,o
5,0211-699504016634,mlmin,o
5,0211-699504016634,y,o
5,0211-699504016634,84,o
5,0211-699504016634,14,o
5,0211-699504016634,l,o
5,0211-699504016634,de,o
5,0211-699504016634,reinfusion,i
5,0211-699504016634,semanal,o
5,0211-699504016634,Se,o
5,0211-699504016634,valoro,i
5,0211-699504016634,la,i
5,0211-699504016634,evolucion,i
5,0211-699504016634,del,i
5,0211-699504016634,peso,i
5,0211-699504016634,seco,i
5,0211-699504016634,y,o
5,0211-699504016634,de,o
5,0211-699504016634,marcadores,o
5,0211-699504016634,analiticos,o
5,0211-699504016634,nutricionales,o
5,0211-699504016634,durante,o
5,0211-699504016634,un,o
5,0211-699504016634,año,o
5,0211-699504016634,de,o
5,0211-699504016634,seguimiento,i
5,0211-699504016634,Resultados,o
5,0211-699504016634,Los,o
5,0211-699504016634,pacientes,o
5,0211-699504016634,que,o
5,0211-699504016634,pasaron,o
5,0211-699504016634,a,o
5,0211-699504016634,HDF,i
5,0211-699504016634,diaria,o
5,0211-699504016634,presentaron,o
5,0211-699504016634,un,o
5,0211-699504016634,incremento,o
5,0211-699504016634,progresivo,o
5,0211-699504016634,del,o
5,0211-699504016634,peso,o
5,0211-699504016634,seco,o
5,0211-699504016634,de,o
5,0211-699504016634,678,o
5,0211-699504016634,8,o
5,0211-699504016634,kg,o
5,0211-699504016634,basalmente,o
5,0211-699504016634,a,o
5,0211-699504016634,685,o
5,0211-699504016634,8,o
5,0211-699504016634,NS,o
5,0211-699504016634,a,o
5,0211-699504016634,los,o
5,0211-699504016634,3,o
5,0211-699504016634,meses,o
5,0211-699504016634,693,o
5,0211-699504016634,8,o
5,0211-699504016634,NS,o
5,0211-699504016634,a,o
5,0211-699504016634,los,o
5,0211-699504016634,seis,o
5,0211-699504016634,695,o
5,0211-699504016634,8,o
5,0211-699504016634,p,o
5,0211-699504016634,005,o
5,0211-699504016634,a,o
5,0211-699504016634,los,o
5,0211-699504016634,9,o
5,0211-699504016634,meses,o
5,0211-699504016634,y,o
5,0211-699504016634,708,o
5,0211-699504016634,8,o
5,0211-699504016634,p,o
5,0211-699504016634,001,o
5,0211-699504016634,al,o
5,0211-699504016634,año,o
5,0211-699504016634,Se,o
5,0211-699504016634,observo,o
5,0211-699504016634,un,o
5,0211-699504016634,incremento,o
5,0211-699504016634,de,o
5,0211-699504016634,la,o
5,0211-699504016634,ingesta,o
5,0211-699504016634,proteica,o
5,0211-699504016634,medida,o
5,0211-699504016634,por,o
5,0211-699504016634,el,o
5,0211-699504016634,PCRn,o
5,0211-699504016634,de,o
5,0211-699504016634,093,o
5,0211-699504016634,02,o
5,0211-699504016634,gkgd,o
5,0211-699504016634,basal,o
5,0211-699504016634,a,o
5,0211-699504016634,118,o
5,0211-699504016634,03,o
5,0211-699504016634,p,o
5,0211-699504016634,005,o
5,0211-699504016634,113,o
5,0211-699504016634,02,o
5,0211-699504016634,106,o
5,0211-699504016634,03,o
5,0211-699504016634,y,o
5,0211-699504016634,110,o
5,0211-699504016634,02,o
5,0211-699504016634,a,o
5,0211-699504016634,los,o
5,0211-699504016634,3,o
5,0211-699504016634,6,o
5,0211-699504016634,9,o
5,0211-699504016634,y,o
5,0211-699504016634,12,o
5,0211-699504016634,meses,o
5,0211-699504016634,respectivamente,o
5,0211-699504016634,No,o
5,0211-699504016634,se,o
5,0211-699504016634,observaron,o
5,0211-699504016634,cambios,o
5,0211-699504016634,en,o
5,0211-699504016634,las,o
5,0211-699504016634,proteinas,i
5,0211-699504016634,totales,i
5,0211-699504016634,albumina,i
5,0211-699504016634,prealbumina,i
5,0211-699504016634,colesterol,i
5,0211-699504016634,total,i
5,0211-699504016634,HDL,i
5,0211-699504016634,LDL,i
5,0211-699504016634,trigliceridos,i
5,0211-699504016634,y,o
5,0211-699504016634,transferrina,i
5,0211-699504016634,En,o
5,0211-699504016634,el,o
5,0211-699504016634,grupo,o
5,0211-699504016634,control,o
5,0211-699504016634,no,o
5,0211-699504016634,se,o
5,0211-699504016634,observaron,o
5,0211-699504016634,cambios,o
5,0211-699504016634,en,o
5,0211-699504016634,el,o
5,0211-699504016634,peso,o
5,0211-699504016634,seco,o
5,0211-699504016634,623,o
5,0211-699504016634,9,o
5,0211-699504016634,basal,o
5,0211-699504016634,vs,o
5,0211-699504016634,621,o
5,0211-699504016634,10,o
5,0211-699504016634,al,o
5,0211-699504016634,año,o
5,0211-699504016634,PCRn,o
5,0211-699504016634,097,o
5,0211-699504016634,02,o
5,0211-699504016634,basal,o
5,0211-699504016634,vs,o
5,0211-699504016634,103,o
5,0211-699504016634,02,o
5,0211-699504016634,al,o
5,0211-699504016634,año,o
5,0211-699504016634,ni,o
5,0211-699504016634,de,o
5,0211-699504016634,los,o
5,0211-699504016634,otros,o
5,0211-699504016634,parametros,o
5,0211-699504016634,estudiados,o
5,0211-699504016634,Conclusiones,o
5,0211-699504016634,En,o
5,0211-699504016634,este,o
5,0211-699504016634,estudio,o
5,0211-699504016634,con,o
5,0211-699504016634,HDF,i
5,0211-699504016634,en,i
5,0211-699504016634,linea,i
5,0211-699504016634,diaria,o
5,0211-699504016634,hemos,o
5,0211-699504016634,observado,o
5,0211-699504016634,un,o
5,0211-699504016634,incremento,o
5,0211-699504016634,del,o
5,0211-699504016634,apetito,o
5,0211-699504016634,con,o
5,0211-699504016634,una,o
5,0211-699504016634,ganancia,o
5,0211-699504016634,de,o
5,0211-699504016634,mas,o
5,0211-699504016634,de,o
5,0211-699504016634,3,o
5,0211-699504016634,kg,o
5,0211-699504016634,en,o
5,0211-699504016634,el,o
5,0211-699504016634,peso,o
5,0211-699504016634,corporal,i
5,0211-699504016634,al,o
5,0211-699504016634,año,o
5,0211-699504016634,de,o
5,0211-699504016634,seguimiento,i
5,0211-699504016634,No,o
5,0211-699504016634,se,o
5,0211-699504016634,ha,o
5,0211-699504016634,observado,o
5,0211-699504016634,cambios,o
5,0211-699504016634,en,o
5,0211-699504016634,el,o
5,0211-699504016634,grupo,o
5,0211-699504016634,control,o
6,0211-699504017174,Lercanidipino,i
6,0211-699504017174,en,o
6,0211-699504017174,pacientes,o
6,0211-699504017174,diabeticos,i
6,0211-699504017174,con,o
6,0211-699504017174,insuficiencia,i
6,0211-699504017174,renal,i
6,0211-699504017174,Objetivo,o
6,0211-699504017174,El,o
6,0211-699504017174,estudio,o
6,0211-699504017174,ZAFRA,o
6,0211-699504017174,se,o
6,0211-699504017174,diseño,o
6,0211-699504017174,para,o
6,0211-699504017174,evaluar,i
6,0211-699504017174,la,i
6,0211-699504017174,seguridad,i
6,0211-699504017174,de,o
6,0211-699504017174,un,o
6,0211-699504017174,nuevo,o
6,0211-699504017174,bloqueante,i
6,0211-699504017174,de,i
6,0211-699504017174,los,i
6,0211-699504017174,canales,i
6,0211-699504017174,del,i
6,0211-699504017174,calcio,i
6,0211-699504017174,lercanidipino,i
6,0211-699504017174,en,o
6,0211-699504017174,la,o
6,0211-699504017174,insuficiencia,i
6,0211-699504017174,renal,i
6,0211-699504017174,cronica,i
6,0211-699504017174,y,o
6,0211-699504017174,su,o
6,0211-699504017174,posible,o
6,0211-699504017174,efecto,o
6,0211-699504017174,protector,o
6,0211-699504017174,sobre,o
6,0211-699504017174,la,o
6,0211-699504017174,funcion,o
6,0211-699504017174,renal,i
6,0211-699504017174,en,o
6,0211-699504017174,los,o
6,0211-699504017174,pacientes,o
6,0211-699504017174,tratados,i
6,0211-699504017174,con,o
6,0211-699504017174,farmacos,i
6,0211-699504017174,que,o
6,0211-699504017174,bloquean,o
6,0211-699504017174,el,o
6,0211-699504017174,eje,o
6,0211-699504017174,reninaangiotensina,o
6,0211-699504017174,Se,o
6,0211-699504017174,han,o
6,0211-699504017174,valorado,o
6,0211-699504017174,por,o
6,0211-699504017174,separado,o
6,0211-699504017174,los,o
6,0211-699504017174,resultados,o
6,0211-699504017174,de,o
6,0211-699504017174,los,o
6,0211-699504017174,pacientes,o
6,0211-699504017174,diabeticos,i
6,0211-699504017174,incluidos,o
6,0211-699504017174,en,o
6,0211-699504017174,el,o
6,0211-699504017174,estudio,o
6,0211-699504017174,Diseño,o
6,0211-699504017174,y,o
6,0211-699504017174,metodos,o
6,0211-699504017174,El,o
6,0211-699504017174,estudio,o
6,0211-699504017174,recluto,o
6,0211-699504017174,42,o
6,0211-699504017174,pacientes,o
6,0211-699504017174,diabeticos,i
6,0211-699504017174,con,o
6,0211-699504017174,insuficiencia,i
6,0211-699504017174,renal,i
6,0211-699504017174,creatinina,i
6,0211-699504017174,14,o
6,0211-699504017174,mgdl,o
6,0211-699504017174,en,o
6,0211-699504017174,varones,o
6,0211-699504017174,o,o
6,0211-699504017174,12,o
6,0211-699504017174,mgdl,o
6,0211-699504017174,en,o
6,0211-699504017174,mujeres,o
6,0211-699504017174,o,o
6,0211-699504017174,aclaramiento,i
6,0211-699504017174,de,i
6,0211-699504017174,creatinina,i
6,0211-699504017174,70,o
6,0211-699504017174,mlmin,o
6,0211-699504017174,Todos,o
6,0211-699504017174,los,o
6,0211-699504017174,pacientes,o
6,0211-699504017174,estaban,o
6,0211-699504017174,siendo,o
6,0211-699504017174,tratados,i
6,0211-699504017174,con,o
6,0211-699504017174,IECA,i
6,0211-699504017174,o,o
6,0211-699504017174,antagonistas,i
6,0211-699504017174,de,i
6,0211-699504017174,receptores,i
6,0211-699504017174,y,o
6,0211-699504017174,la,o
6,0211-699504017174,medicacion,i
6,0211-699504017174,se,o
6,0211-699504017174,mantuvo,o
6,0211-699504017174,a,o
6,0211-699504017174,lo,o
6,0211-699504017174,largo,o
6,0211-699504017174,del,o
6,0211-699504017174,estudio,o
6,0211-699504017174,sin,o
6,0211-699504017174,que,o
6,0211-699504017174,pudieran,o
6,0211-699504017174,recibir,o
6,0211-699504017174,diureticos,i
6,0211-699504017174,a,o
6,0211-699504017174,lo,o
6,0211-699504017174,largo,o
6,0211-699504017174,del,o
6,0211-699504017174,seguimiento,i
6,0211-699504017174,Los,o
6,0211-699504017174,pacientes,o
6,0211-699504017174,eran,o
6,0211-699504017174,evaluados,o
6,0211-699504017174,clinica,o
6,0211-699504017174,y,o
6,0211-699504017174,analiticamente,o
6,0211-699504017174,1,o
6,0211-699504017174,3,o
6,0211-699504017174,y,o
6,0211-699504017174,6,o
6,0211-699504017174,meses,o
6,0211-699504017174,despues,o
6,0211-699504017174,de,o
6,0211-699504017174,iniciar,o
6,0211-699504017174,tratamiento,i
6,0211-699504017174,con,o
6,0211-699504017174,lercanidipino,i
6,0211-699504017174,Resultados,o
6,0211-699504017174,La,o
6,0211-699504017174,PA,i
6,0211-699504017174,se,o
6,0211-699504017174,redujo,o
6,0211-699504017174,significativamente,o
6,0211-699504017174,desde,o
6,0211-699504017174,163,o
6,0211-699504017174,1890,o
6,0211-699504017174,8,o
6,0211-699504017174,hasta,o
6,0211-699504017174,134,o
6,0211-699504017174,1277,o
6,0211-699504017174,9,o
6,0211-699504017174,mmHg,o
6,0211-699504017174,p,o
6,0211-699504017174,0001,o
6,0211-699504017174,Se,o
6,0211-699504017174,produjeron,o
6,0211-699504017174,reducciones,o
6,0211-699504017174,significativas,o
6,0211-699504017174,de,o
6,0211-699504017174,la,o
6,0211-699504017174,PA,i
6,0211-699504017174,en,o
6,0211-699504017174,el,o
6,0211-699504017174,500,o
6,0211-699504017174,de,o
6,0211-699504017174,los,o
6,0211-699504017174,enfermos,i
6,0211-699504017174,y,o
6,0211-699504017174,el,o
6,0211-699504017174,267,o
6,0211-699504017174,alcanzaron,o
6,0211-699504017174,la,o
6,0211-699504017174,PA,i
6,0211-699504017174,objetivo,o
6,0211-699504017174,13085,o
6,0211-699504017174,mmHg,o
6,0211-699504017174,El,o
6,0211-699504017174,200,o
6,0211-699504017174,de,o
6,0211-699504017174,los,o
6,0211-699504017174,pacientes,o
6,0211-699504017174,redujeron,o
6,0211-699504017174,su,o
6,0211-699504017174,PA,i
6,0211-699504017174,hasta,o
6,0211-699504017174,los,o
6,0211-699504017174,limites,o
6,0211-699504017174,recomendados,o
6,0211-699504017174,13080,o
6,0211-699504017174,mmHg,o
6,0211-699504017174,No,o
6,0211-699504017174,se,o
6,0211-699504017174,detectaron,o
6,0211-699504017174,reacciones,i
6,0211-699504017174,adversas,i
6,0211-699504017174,ni,o
6,0211-699504017174,aumento,o
6,0211-699504017174,de,o
6,0211-699504017174,la,o
6,0211-699504017174,incidencia,o
6,0211-699504017174,de,o
6,0211-699504017174,edema,i
6,0211-699504017174,La,o
6,0211-699504017174,creatinina,i
6,0211-699504017174,plasmatica,i
6,0211-699504017174,19,o
6,0211-699504017174,05,o
6,0211-699504017174,mgdl,o
6,0211-699504017174,no,o
6,0211-699504017174,se,o
6,0211-699504017174,habia,o
6,0211-699504017174,modificado,o
6,0211-699504017174,al,o
6,0211-699504017174,final,o
6,0211-699504017174,del,o
6,0211-699504017174,estudio,o
6,0211-699504017174,18,o
6,0211-699504017174,05,o
6,0211-699504017174,mgdl,o
6,0211-699504017174,ni,o
6,0211-699504017174,el,o
6,0211-699504017174,aclaramiento,i
6,0211-699504017174,de,i
6,0211-699504017174,creatinina,i
6,0211-699504017174,401,o
6,0211-699504017174,145,o
6,0211-699504017174,vs,o
6,0211-699504017174,455,o
6,0211-699504017174,182,o
6,0211-699504017174,Conclusiones,o
6,0211-699504017174,El,o
6,0211-699504017174,lercanidipino,i
6,0211-699504017174,ha,o
6,0211-699504017174,presentado,o
6,0211-699504017174,un,o
6,0211-699504017174,excelente,o
6,0211-699504017174,perfil,o
6,0211-699504017174,de,o
6,0211-699504017174,seguridad,o
6,0211-699504017174,en,o
6,0211-699504017174,los,o
6,0211-699504017174,pacientes,o
6,0211-699504017174,renales,i
6,0211-699504017174,destacando,o
6,0211-699504017174,la,o
6,0211-699504017174,ausencia,o
6,0211-699504017174,de,o
6,0211-699504017174,edemas,i
6,0211-699504017174,a,o
6,0211-699504017174,pesar,o
6,0211-699504017174,de,o
6,0211-699504017174,la,o
6,0211-699504017174,insuficiencia,i
6,0211-699504017174,renal,i
6,0211-699504017174,y,o
6,0211-699504017174,la,o
6,0211-699504017174,diabetes,i
6,0211-699504017174,de,o
6,0211-699504017174,los,o
6,0211-699504017174,pacientes,o
6,0211-699504017174,Se,o
6,0211-699504017174,obtuvo,o
6,0211-699504017174,una,o
6,0211-699504017174,buena,o
6,0211-699504017174,respuesta,o
6,0211-699504017174,hipotensora,o
6,0211-699504017174,a,o
6,0211-699504017174,pesar,o
6,0211-699504017174,de,o
6,0211-699504017174,que,o
6,0211-699504017174,el,o
6,0211-699504017174,porcentaje,o
6,0211-699504017174,de,o
6,0211-699504017174,pacientes,o
6,0211-699504017174,que,o
6,0211-699504017174,alcanzaron,o
6,0211-699504017174,la,o
6,0211-699504017174,PA,i
6,0211-699504017174,objetivo,o
6,0211-699504017174,fuera,o
6,0211-699504017174,pequeña,o
7,0211-699505017919X,Estres,i
7,0211-699505017919X,oxidativo,i
7,0211-699505017919X,de,o
7,0211-699505017919X,las,o
7,0211-699505017919X,lipoproteinas,i
7,0211-699505017919X,y,o
7,0211-699505017919X,efecto,o
7,0211-699505017919X,antioxidante,i
7,0211-699505017919X,de,o
7,0211-699505017919X,la,o
7,0211-699505017919X,vitamina,i
7,0211-699505017919X,C,i
7,0211-699505017919X,un,o
7,0211-699505017919X,año,o
7,0211-699505017919X,despues,o
7,0211-699505017919X,de,o
7,0211-699505017919X,iniciar,o
7,0211-699505017919X,hemodialisis,i
7,0211-699505017919X,Hemos,o
7,0211-699505017919X,estudiado,o
7,0211-699505017919X,el,o
7,0211-699505017919X,perfil,i
7,0211-699505017919X,lipidico,i
7,0211-699505017919X,y,o
7,0211-699505017919X,el,o
7,0211-699505017919X,estado,o
7,0211-699505017919X,oxidativo,o
7,0211-699505017919X,de,o
7,0211-699505017919X,las,o
7,0211-699505017919X,lipoproteinas,i
7,0211-699505017919X,en,o
7,0211-699505017919X,pacientes,o
7,0211-699505017919X,con,o
7,0211-699505017919X,insuficiencia,i
7,0211-699505017919X,renal,i
7,0211-699505017919X,cronica,i
7,0211-699505017919X,terminal,i
7,0211-699505017919X,IRCT,i
7,0211-699505017919X,que,o
7,0211-699505017919X,inician,o
7,0211-699505017919X,programa,o
7,0211-699505017919X,de,o
7,0211-699505017919X,hemodialisis,i
7,0211-699505017919X,evaluando,o
7,0211-699505017919X,el,o
7,0211-699505017919X,posible,o
7,0211-699505017919X,efecto,o
7,0211-699505017919X,de,o
7,0211-699505017919X,la,o
7,0211-699505017919X,hemodialisis,i
7,0211-699505017919X,y,o
7,0211-699505017919X,de,o
7,0211-699505017919X,la,o
7,0211-699505017919X,administracion,i
7,0211-699505017919X,de,o
7,0211-699505017919X,un,o
7,0211-699505017919X,antioxidante,i
7,0211-699505017919X,como,o
7,0211-699505017919X,la,o
7,0211-699505017919X,vitamina,i
7,0211-699505017919X,C,i
7,0211-699505017919X,al,o
7,0211-699505017919X,cabo,o
7,0211-699505017919X,de,o
7,0211-699505017919X,un,o
7,0211-699505017919X,año,o
7,0211-699505017919X,Metodos,o
7,0211-699505017919X,Se,o
7,0211-699505017919X,incluyeron,o
7,0211-699505017919X,41,o
7,0211-699505017919X,pacientes,o
7,0211-699505017919X,con,o
7,0211-699505017919X,IRCT,i
7,0211-699505017919X,que,o
7,0211-699505017919X,iniciaron,o
7,0211-699505017919X,programa,o
7,0211-699505017919X,de,o
7,0211-699505017919X,hemodialisis,i
7,0211-699505017919X,cronica,i
7,0211-699505017919X,entre,o
7,0211-699505017919X,enero,o
7,0211-699505017919X,del,o
7,0211-699505017919X,1999,o
7,0211-699505017919X,y,o
7,0211-699505017919X,enero,o
7,0211-699505017919X,del,o
7,0211-699505017919X,2000,o
7,0211-699505017919X,y,o
7,0211-699505017919X,que,o
7,0211-699505017919X,fueron,o
7,0211-699505017919X,randomizados,i
7,0211-699505017919X,para,o
7,0211-699505017919X,recibir,o
7,0211-699505017919X,1000,o
7,0211-699505017919X,mg,o
7,0211-699505017919X,dia,o
7,0211-699505017919X,de,o
7,0211-699505017919X,vitamina,i
7,0211-699505017919X,C,i
7,0211-699505017919X,o,o
7,0211-699505017919X,placebo,i
7,0211-699505017919X,antes,o
7,0211-699505017919X,del,o
7,0211-699505017919X,inicio,o
7,0211-699505017919X,del,o
7,0211-699505017919X,tratamiento,i
7,0211-699505017919X,sustitutivo,i
7,0211-699505017919X,renal,i
7,0211-699505017919X,TSR,i
7,0211-699505017919X,Se,o
7,0211-699505017919X,analizo,o
7,0211-699505017919X,el,o
7,0211-699505017919X,perfil,i
7,0211-699505017919X,lipidico,i
7,0211-699505017919X,y,o
7,0211-699505017919X,la,o
7,0211-699505017919X,susceptibilidad,o
7,0211-699505017919X,de,o
7,0211-699505017919X,la,o
7,0211-699505017919X,LDL,i
7,0211-699505017919X,y,o
7,0211-699505017919X,de,o
7,0211-699505017919X,la,o
7,0211-699505017919X,HDL,i
7,0211-699505017919X,a,o
7,0211-699505017919X,la,o
7,0211-699505017919X,oxidacion,o
7,0211-699505017919X,utilizando,o
7,0211-699505017919X,sulfato,i
7,0211-699505017919X,de,i
7,0211-699505017919X,cobre,i
7,0211-699505017919X,en,o
7,0211-699505017919X,el,o
7,0211-699505017919X,momento,o
7,0211-699505017919X,de,o
7,0211-699505017919X,la,o
7,0211-699505017919X,inclusion,o
7,0211-699505017919X,y,o
7,0211-699505017919X,un,o
7,0211-699505017919X,año,o
7,0211-699505017919X,despues,o
7,0211-699505017919X,de,o
7,0211-699505017919X,haber,o
7,0211-699505017919X,empezado,o
7,0211-699505017919X,el,o
7,0211-699505017919X,TSR,i
7,0211-699505017919X,y,o
7,0211-699505017919X,el,o
7,0211-699505017919X,antioxidante,i
7,0211-699505017919X,Resultados,o
7,0211-699505017919X,No,o
7,0211-699505017919X,se,o
7,0211-699505017919X,hallaron,o
7,0211-699505017919X,diferencias,o
7,0211-699505017919X,significativas,o
7,0211-699505017919X,en,o
7,0211-699505017919X,cuanto,o
7,0211-699505017919X,al,o
7,0211-699505017919X,estado,o
7,0211-699505017919X,oxidativo,o
7,0211-699505017919X,entre,o
7,0211-699505017919X,los,o
7,0211-699505017919X,pacientes,o
7,0211-699505017919X,tratados,i
7,0211-699505017919X,y,o
7,0211-699505017919X,los,o
7,0211-699505017919X,que,o
7,0211-699505017919X,no,o
7,0211-699505017919X,recibieron,o
7,0211-699505017919X,tratamiento,i
7,0211-699505017919X,con,o
7,0211-699505017919X,vitamina,i
7,0211-699505017919X,C,i
7,0211-699505017919X,En,o
7,0211-699505017919X,nuestros,o
7,0211-699505017919X,pacientes,o
7,0211-699505017919X,la,o
7,0211-699505017919X,hemodialisis,i
7,0211-699505017919X,por,o
7,0211-699505017919X,si,o
7,0211-699505017919X,no,o
7,0211-699505017919X,solo,o
7,0211-699505017919X,no,o
7,0211-699505017919X,provoco,o
7,0211-699505017919X,efectos,i
7,0211-699505017919X,deletereos,i
7,0211-699505017919X,sobre,o
7,0211-699505017919X,el,o
7,0211-699505017919X,perfil,i
7,0211-699505017919X,lipidico,i
7,0211-699505017919X,sino,o
7,0211-699505017919X,que,o
7,0211-699505017919X,incluso,o
7,0211-699505017919X,este,o
7,0211-699505017919X,mejoro,o
7,0211-699505017919X,discretamente,o
7,0211-699505017919X,paralelamente,o
7,0211-699505017919X,a,o
7,0211-699505017919X,la,o
7,0211-699505017919X,correccion,o
7,0211-699505017919X,parcial,o
7,0211-699505017919X,de,o
7,0211-699505017919X,la,o
7,0211-699505017919X,uremia,i
7,0211-699505017919X,observandose,o
7,0211-699505017919X,descenso,o
7,0211-699505017919X,de,o
7,0211-699505017919X,colesterol,i
7,0211-699505017919X,LDL,i
7,0211-699505017919X,y,o
7,0211-699505017919X,de,o
7,0211-699505017919X,los,o
7,0211-699505017919X,fosfolipidos,i
7,0211-699505017919X,en,o
7,0211-699505017919X,todos,o
7,0211-699505017919X,los,o
7,0211-699505017919X,pacientes,o
7,0211-699505017919X,al,o
7,0211-699505017919X,cabo,o
7,0211-699505017919X,de,o
7,0211-699505017919X,un,o
7,0211-699505017919X,año,o
7,0211-699505017919X,de,o
7,0211-699505017919X,TSR,i
7,0211-699505017919X,Respecto,o
7,0211-699505017919X,a,o
7,0211-699505017919X,los,o
7,0211-699505017919X,productos,o
7,0211-699505017919X,derivados,o
7,0211-699505017919X,de,o
7,0211-699505017919X,la,o
7,0211-699505017919X,oxidacion,o
7,0211-699505017919X,aunque,o
7,0211-699505017919X,las,o
7,0211-699505017919X,diferencias,o
7,0211-699505017919X,no,o
7,0211-699505017919X,resultaron,o
7,0211-699505017919X,significativas,o
7,0211-699505017919X,los,o
7,0211-699505017919X,parametros,o
7,0211-699505017919X,descendieron,o
7,0211-699505017919X,discretamente,o
7,0211-699505017919X,en,o
7,0211-699505017919X,aquellos,o
7,0211-699505017919X,pacientes,o
7,0211-699505017919X,que,o
7,0211-699505017919X,habian,o
7,0211-699505017919X,recibido,o
7,0211-699505017919X,el,o
7,0211-699505017919X,tratamiento,i
7,0211-699505017919X,antioxidante,i
7,0211-699505017919X,Conclusiones,o
7,0211-699505017919X,La,o
7,0211-699505017919X,correccion,o
7,0211-699505017919X,parcial,o
7,0211-699505017919X,de,o
7,0211-699505017919X,la,o
7,0211-699505017919X,uremia,i
7,0211-699505017919X,mediante,o
7,0211-699505017919X,el,o
7,0211-699505017919X,inicio,o
7,0211-699505017919X,de,o
7,0211-699505017919X,hemodialisis,i
7,0211-699505017919X,puede,o
7,0211-699505017919X,mejorar,o
7,0211-699505017919X,el,o
7,0211-699505017919X,perfil,i
7,0211-699505017919X,lipidico,i
7,0211-699505017919X,de,o
7,0211-699505017919X,los,o
7,0211-699505017919X,pacientes,o
7,0211-699505017919X,con,o
7,0211-699505017919X,Insuficiencia,i
7,0211-699505017919X,renal,i
7,0211-699505017919X,cronica,i
7,0211-699505017919X,terminal,i
7,0211-699505017919X,los,o
7,0211-699505017919X,cuales,o
7,0211-699505017919X,presentan,o
7,0211-699505017919X,un,o
7,0211-699505017919X,estado,o
7,0211-699505017919X,prooxidativo,o
7,0211-699505017919X,atribuible,o
7,0211-699505017919X,a,o
7,0211-699505017919X,la,o
7,0211-699505017919X,uremia,i
7,0211-699505017919X,per,o
7,0211-699505017919X,se,o
7,0211-699505017919X,Aunque,o
7,0211-699505017919X,nuestros,o
7,0211-699505017919X,resultados,o
7,0211-699505017919X,no,o
7,0211-699505017919X,mostraron,o
7,0211-699505017919X,diferencias,o
7,0211-699505017919X,significativas,o
7,0211-699505017919X,entre,o
7,0211-699505017919X,aquellos,o
7,0211-699505017919X,tratados,i
7,0211-699505017919X,con,o
7,0211-699505017919X,vitamina,i
7,0211-699505017919X,C,i
7,0211-699505017919X,frente,o
7,0211-699505017919X,a,o
7,0211-699505017919X,los,o
7,0211-699505017919X,que,o
7,0211-699505017919X,recibieron,o
7,0211-699505017919X,placebo,i
7,0211-699505017919X,parecio,o
7,0211-699505017919X,existir,o
7,0211-699505017919X,una,o
7,0211-699505017919X,tendencia,o
7,0211-699505017919X,al,o
7,0211-699505017919X,cabo,o
7,0211-699505017919X,de,o
7,0211-699505017919X,un,o
7,0211-699505017919X,año,o
7,0211-699505017919X,a,o
7,0211-699505017919X,la,o
7,0211-699505017919X,disminucion,o
7,0211-699505017919X,de,o
7,0211-699505017919X,los,o
7,0211-699505017919X,productos,o
7,0211-699505017919X,derivados,o
7,0211-699505017919X,de,o
7,0211-699505017919X,la,o
7,0211-699505017919X,oxidacion,o
7,0211-699505017919X,en,o
7,0211-699505017919X,nuestros,o
7,0211-699505017919X,pacientes,o
7,0211-699505017919X,lo,o
7,0211-699505017919X,que,o
7,0211-699505017919X,podria,o
7,0211-699505017919X,implicar,o
7,0211-699505017919X,un,o
7,0211-699505017919X,efecto,o
7,0211-699505017919X,beneficioso,o
7,0211-699505017919X,sobre,o
7,0211-699505017919X,la,o
7,0211-699505017919X,peroxidacion,o
7,0211-699505017919X,lipidica,i
8,0211-69950501830X,Eficacia,o
8,0211-69950501830X,y,o
8,0211-69950501830X,seguridad,o
8,0211-69950501830X,de,o
8,0211-69950501830X,dos,o
8,0211-69950501830X,pautas,i
8,0211-69950501830X,de,o
8,0211-69950501830X,suplementos,i
8,0211-69950501830X,vitaminicos,i
8,0211-69950501830X,sobre,o
8,0211-69950501830X,los,o
8,0211-69950501830X,niveles,i
8,0211-69950501830X,de,i
8,0211-69950501830X,homocisteina,i
8,0211-69950501830X,en,o
8,0211-69950501830X,pacientes,o
8,0211-69950501830X,en,o
8,0211-69950501830X,hemodialisis,i
8,0211-69950501830X,Ensayo,i
8,0211-69950501830X,clinico,i
8,0211-69950501830X,prospectivo,i
8,0211-69950501830X,y,i
8,0211-69950501830X,randomizado,i
8,0211-69950501830X,La,o
8,0211-69950501830X,hiperhomocisteinemia,i
8,0211-69950501830X,HHcys,o
8,0211-69950501830X,es,o
8,0211-69950501830X,frecuente,o
8,0211-69950501830X,en,o
8,0211-69950501830X,pacientes,o
8,0211-69950501830X,uremicos,i
8,0211-69950501830X,y,o
8,0211-69950501830X,representa,o
8,0211-69950501830X,un,o
8,0211-69950501830X,factor,o
8,0211-69950501830X,de,o
8,0211-69950501830X,riesgo,i
8,0211-69950501830X,cardiovascular,i
8,0211-69950501830X,Los,o
8,0211-69950501830X,suplementos,i
8,0211-69950501830X,vitaminicos,i
8,0211-69950501830X,reducen,o
8,0211-69950501830X,los,o
8,0211-69950501830X,niveles,i
8,0211-69950501830X,de,i
8,0211-69950501830X,homocisteina,i
8,0211-69950501830X,Hcys,i
8,0211-69950501830X,no,o
8,0211-69950501830X,estando,o
8,0211-69950501830X,bien,o
8,0211-69950501830X,definida,o
8,0211-69950501830X,la,o
8,0211-69950501830X,dosis,o
8,0211-69950501830X,optima,o
8,0211-69950501830X,y,o
8,0211-69950501830X,su,o
8,0211-69950501830X,eficacia,o
8,0211-69950501830X,El,o
8,0211-69950501830X,genotipo,o
8,0211-69950501830X,de,o
8,0211-69950501830X,la,o
8,0211-69950501830X,metilentetrahidrofolatoreductasa,i
8,0211-69950501830X,MTHFR,i
8,0211-69950501830X,puede,o
8,0211-69950501830X,modular,o
8,0211-69950501830X,su,o
8,0211-69950501830X,prevalencia,o
8,0211-69950501830X,y,o
8,0211-69950501830X,respuesta,o
8,0211-69950501830X,al,o
8,0211-69950501830X,tratamiento,i
8,0211-69950501830X,Objetivo,o
8,0211-69950501830X,Conocer,i
8,0211-69950501830X,la,i
8,0211-69950501830X,eficacia,i
8,0211-69950501830X,de,o
8,0211-69950501830X,dos,o
8,0211-69950501830X,pautas,i
8,0211-69950501830X,de,o
8,0211-69950501830X,suplementos,i
8,0211-69950501830X,vitaminicos,i
8,0211-69950501830X,sobre,o
8,0211-69950501830X,los,o
8,0211-69950501830X,niveles,i
8,0211-69950501830X,de,i
8,0211-69950501830X,Hcys,i
8,0211-69950501830X,tras,o
8,0211-69950501830X,12,o
8,0211-69950501830X,meses,o
8,0211-69950501830X,de,o
8,0211-69950501830X,tratamiento,i
8,0211-69950501830X,Metodologia,o
8,0211-69950501830X,Estudio,o
8,0211-69950501830X,prospectivo,o
8,0211-69950501830X,randomizado,o
8,0211-69950501830X,a,o
8,0211-69950501830X,doble,o
8,0211-69950501830X,ciego,o
8,0211-69950501830X,Sesenta,o
8,0211-69950501830X,pacientes,o
8,0211-69950501830X,en,o
8,0211-69950501830X,hemodialisis,i
8,0211-69950501830X,se,o
8,0211-69950501830X,aleatorizaron,i
8,0211-69950501830X,en,o
8,0211-69950501830X,dos,o
8,0211-69950501830X,grupos,o
8,0211-69950501830X,terapeuticos,o
8,0211-69950501830X,A,o
8,0211-69950501830X,Dosis,o
8,0211-69950501830X,habituales,o
8,0211-69950501830X,de,o
8,0211-69950501830X,acido,i
8,0211-69950501830X,folico,i
8,0211-69950501830X,AcF,o
8,0211-69950501830X,vitamina,i
8,0211-69950501830X,B6,i
8,0211-69950501830X,y,o
8,0211-69950501830X,B12,i
8,0211-69950501830X,a,o
8,0211-69950501830X,la,o
8,0211-69950501830X,dosis,o
8,0211-69950501830X,de,o
8,0211-69950501830X,5,o
8,0211-69950501830X,10,o
8,0211-69950501830X,y,o
8,0211-69950501830X,04,o
8,0211-69950501830X,mg,o
8,0211-69950501830X,diarios,o
8,0211-69950501830X,respectivamente,o
8,0211-69950501830X,N,o
8,0211-69950501830X,27,o
8,0211-69950501830X,y,o
8,0211-69950501830X,B,o
8,0211-69950501830X,Dosis,o
8,0211-69950501830X,suprafisiologicas,o
8,0211-69950501830X,15,o
8,0211-69950501830X,100,o
8,0211-69950501830X,y,o
8,0211-69950501830X,1,o
8,0211-69950501830X,mg,o
8,0211-69950501830X,diarios,o
8,0211-69950501830X,N,o
8,0211-69950501830X,33,o
8,0211-69950501830X,Los,o
8,0211-69950501830X,valores,i
8,0211-69950501830X,de,i
8,0211-69950501830X,Hcys,i
8,0211-69950501830X,se,o
8,0211-69950501830X,compararon,o
8,0211-69950501830X,con,o
8,0211-69950501830X,un,o
8,0211-69950501830X,grupo,o
8,0211-69950501830X,control,o
8,0211-69950501830X,similar,o
8,0211-69950501830X,en,o
8,0211-69950501830X,edad,o
8,0211-69950501830X,y,o
8,0211-69950501830X,sexo,o
8,0211-69950501830X,Resultados,o
8,0211-69950501830X,Todos,o
8,0211-69950501830X,los,o
8,0211-69950501830X,pacientes,o
8,0211-69950501830X,y,o
8,0211-69950501830X,el,o
8,0211-69950501830X,22,o
8,0211-69950501830X,de,o
8,0211-69950501830X,los,o
8,0211-69950501830X,controles,o
8,0211-69950501830X,presentaron,o
8,0211-69950501830X,HHcys,o
8,0211-69950501830X,siendo,o
8,0211-69950501830X,los,o
8,0211-69950501830X,niveles,i
8,0211-69950501830X,de,i
8,0211-69950501830X,Hcys,i
8,0211-69950501830X,25,o
8,0211-69950501830X,veces,o
8,0211-69950501830X,superiores,o
8,0211-69950501830X,en,o
8,0211-69950501830X,los,o
8,0211-69950501830X,pacientes,o
8,0211-69950501830X,que,o
8,0211-69950501830X,en,o
8,0211-69950501830X,el,o
8,0211-69950501830X,grupo,o
8,0211-69950501830X,control,o
8,0211-69950501830X,324,o
8,0211-69950501830X,89,o
8,0211-69950501830X,vs,o
8,0211-69950501830X,129,o
8,0211-69950501830X,68,o
8,0211-69950501830X,µmolL,o
8,0211-69950501830X,P,o
8,0211-69950501830X,00001,o
8,0211-69950501830X,Las,o
8,0211-69950501830X,dos,o
8,0211-69950501830X,pautas,i
8,0211-69950501830X,fueron,o
8,0211-69950501830X,igualmente,o
8,0211-69950501830X,eficaces,o
8,0211-69950501830X,en,o
8,0211-69950501830X,reducir,o
8,0211-69950501830X,la,o
8,0211-69950501830X,Hcys,i
8,0211-69950501830X,aunque,o
8,0211-69950501830X,solamente,o
8,0211-69950501830X,el,o
8,0211-69950501830X,12,o
8,0211-69950501830X,de,o
8,0211-69950501830X,los,o
8,0211-69950501830X,pacientes,o
8,0211-69950501830X,normalizaron,o
8,0211-69950501830X,sus,o
8,0211-69950501830X,niveles,o
8,0211-69950501830X,al,o
8,0211-69950501830X,finalizar,o
8,0211-69950501830X,el,o
8,0211-69950501830X,estudio,o
8,0211-69950501830X,Globalmente,o
8,0211-69950501830X,los,o
8,0211-69950501830X,niveles,i
8,0211-69950501830X,de,i
8,0211-69950501830X,Hcys,i
8,0211-69950501830X,experimentaron,o
8,0211-69950501830X,un,o
8,0211-69950501830X,descenso,o
8,0211-69950501830X,significativo,o
8,0211-69950501830X,al,o
8,0211-69950501830X,mes,o
8,0211-69950501830X,de,o
8,0211-69950501830X,tratamiento,i
8,0211-69950501830X,236,o
8,0211-69950501830X,P,o
8,0211-69950501830X,0001,o
8,0211-69950501830X,El,o
8,0211-69950501830X,mayor,o
8,0211-69950501830X,descenso,o
8,0211-69950501830X,se,o
8,0211-69950501830X,registro,o
8,0211-69950501830X,tras,o
8,0211-69950501830X,6,o
8,0211-69950501830X,meses,o
8,0211-69950501830X,283,o
8,0211-69950501830X,P,o
8,0211-69950501830X,0001,o
8,0211-69950501830X,estabilizandose,o
8,0211-69950501830X,hasta,o
8,0211-69950501830X,los,o
8,0211-69950501830X,12,o
8,0211-69950501830X,meses,o
8,0211-69950501830X,El,o
8,0211-69950501830X,mayor,o
8,0211-69950501830X,descenso,o
8,0211-69950501830X,de,o
8,0211-69950501830X,Hcys,i
8,0211-69950501830X,se,o
8,0211-69950501830X,asocio,o
8,0211-69950501830X,con,o
8,0211-69950501830X,niveles,o
8,0211-69950501830X,basales,o
8,0211-69950501830X,mas,o
8,0211-69950501830X,altos,o
8,0211-69950501830X,de,o
8,0211-69950501830X,Hcys,i
8,0211-69950501830X,r,o
8,0211-69950501830X,0500,o
8,0211-69950501830X,P,o
8,0211-69950501830X,0001,o
8,0211-69950501830X,y,o
8,0211-69950501830X,mas,o
8,0211-69950501830X,bajos,o
8,0211-69950501830X,de,o
8,0211-69950501830X,AcF,o
8,0211-69950501830X,r,o
8,0211-69950501830X,0332,o
8,0211-69950501830X,P,o
8,0211-69950501830X,0009,o
8,0211-69950501830X,El,o
8,0211-69950501830X,polimorfismo,o
8,0211-69950501830X,de,o
8,0211-69950501830X,la,o
8,0211-69950501830X,MTHFR,i
8,0211-69950501830X,no,o
8,0211-69950501830X,modifico,o
8,0211-69950501830X,significativamente,o
8,0211-69950501830X,la,o
8,0211-69950501830X,respuesta,o
8,0211-69950501830X,terapeutica,o
8,0211-69950501830X,Conclusiones,o
8,0211-69950501830X,La,o
8,0211-69950501830X,HHcys,o
8,0211-69950501830X,es,o
8,0211-69950501830X,constante,o
8,0211-69950501830X,con,o
8,0211-69950501830X,pautas,i
8,0211-69950501830X,convencionales,o
8,0211-69950501830X,de,o
8,0211-69950501830X,hemodialisis,i
8,0211-69950501830X,aunque,o
8,0211-69950501830X,no,o
8,0211-69950501830X,existan,o
8,0211-69950501830X,deficits,i
8,0211-69950501830X,vitaminicos,i
8,0211-69950501830X,Los,o
8,0211-69950501830X,suplementos,o
8,0211-69950501830X,reducen,o
8,0211-69950501830X,de,o
8,0211-69950501830X,forma,o
8,0211-69950501830X,substancial,o
8,0211-69950501830X,y,o
8,0211-69950501830X,sostenida,o
8,0211-69950501830X,los,o
8,0211-69950501830X,niveles,i
8,0211-69950501830X,de,i
8,0211-69950501830X,Hcys,i
8,0211-69950501830X,Dosis,o
8,0211-69950501830X,suprafisiologicas,o
8,0211-69950501830X,no,o
8,0211-69950501830X,suponen,o
8,0211-69950501830X,ventajas,o
8,0211-69950501830X,adicionales,o
8,0211-69950501830X,Se,o
8,0211-69950501830X,requieren,o
8,0211-69950501830X,nuevos,o
8,0211-69950501830X,estudios,o
8,0211-69950501830X,para,o
8,0211-69950501830X,demostrar,o
8,0211-69950501830X,que,o
8,0211-69950501830X,este,o
8,0211-69950501830X,descenso,o
8,0211-69950501830X,conlleve,o
8,0211-69950501830X,un,o
8,0211-69950501830X,impacto,o
8,0211-69950501830X,final,o
8,0211-69950501830X,favorable,o
8,0211-69950501830X,sobre,o
8,0211-69950501830X,la,o
8,0211-69950501830X,morbimortalidad,o
8,0211-69950501830X,cardiovascular,i
9,0211-699507021045,Utilidad,o
9,0211-699507021045,de,o
9,0211-699507021045,la,o
9,0211-699507021045,CistatinaC,o
9,0211-699507021045,en,o
9,0211-699507021045,el,o
9,0211-699507021045,ambito,o
9,0211-699507021045,hospitalario,o
9,0211-699507021045,Comparacion,o
9,0211-699507021045,con,o
9,0211-699507021045,los,o
9,0211-699507021045,distintos,o
9,0211-699507021045,metodos,o
9,0211-699507021045,de,o
9,0211-699507021045,valoracion,i
9,0211-699507021045,renal,i
9,0211-699507021045,La,o
9,0211-699507021045,prueba,i
9,0211-699507021045,utilizada,o
9,0211-699507021045,habitualmente,o
9,0211-699507021045,para,o
9,0211-699507021045,valorar,i
9,0211-699507021045,la,i
9,0211-699507021045,funcion,i
9,0211-699507021045,renal,i
9,0211-699507021045,es,o
9,0211-699507021045,la,o
9,0211-699507021045,creatinina,i
9,0211-699507021045,serica,i
9,0211-699507021045,aunque,o
9,0211-699507021045,por,o
9,0211-699507021045,sus,o
9,0211-699507021045,limitaciones,o
9,0211-699507021045,muchas,o
9,0211-699507021045,ocasiones,o
9,0211-699507021045,es,o
9,0211-699507021045,necesario,o
9,0211-699507021045,recurrir,o
9,0211-699507021045,a,o
9,0211-699507021045,la,o
9,0211-699507021045,medida,o
9,0211-699507021045,del,o
9,0211-699507021045,aclaramiento,i
9,0211-699507021045,de,i
9,0211-699507021045,creatinina,i
9,0211-699507021045,en,o
9,0211-699507021045,orina,i
9,0211-699507021045,de,o
9,0211-699507021045,24,o
9,0211-699507021045,horas,o
9,0211-699507021045,Clcr,i
9,0211-699507021045,la,o
9,0211-699507021045,formula,o
9,0211-699507021045,de,o
9,0211-699507021045,CockroftGault,o
9,0211-699507021045,CG,i
9,0211-699507021045,o,o
9,0211-699507021045,la,o
9,0211-699507021045,formula,i
9,0211-699507021045,de,i
9,0211-699507021045,Levey,i
9,0211-699507021045,MDRD,i
9,0211-699507021045,Los,o
9,0211-699507021045,distintos,o
9,0211-699507021045,metodos,o
9,0211-699507021045,pueden,o
9,0211-699507021045,dar,o
9,0211-699507021045,distintos,o
9,0211-699507021045,resultados,o
9,0211-699507021045,creando,o
9,0211-699507021045,una,o
9,0211-699507021045,situacion,o
9,0211-699507021045,de,o
9,0211-699507021045,confusion,o
9,0211-699507021045,a,o
9,0211-699507021045,los,o
9,0211-699507021045,clinicos,o
9,0211-699507021045,La,o
9,0211-699507021045,introduccion,o
9,0211-699507021045,de,o
9,0211-699507021045,la,o
9,0211-699507021045,CistatinaC,o
9,0211-699507021045,como,o
9,0211-699507021045,nuevo,o
9,0211-699507021045,marcador,o
9,0211-699507021045,de,o
9,0211-699507021045,funcion,o
9,0211-699507021045,renal,i
9,0211-699507021045,podria,o
9,0211-699507021045,suponer,o
9,0211-699507021045,una,o
9,0211-699507021045,mejora,o
9,0211-699507021045,considerable,o
9,0211-699507021045,El,o
9,0211-699507021045,objetivo,o
9,0211-699507021045,de,o
9,0211-699507021045,nuestro,o
9,0211-699507021045,estudio,o
9,0211-699507021045,fue,o
9,0211-699507021045,comparar,o
9,0211-699507021045,los,o
9,0211-699507021045,distintos,o
9,0211-699507021045,metodos,o
9,0211-699507021045,de,o
9,0211-699507021045,valoracion,i
9,0211-699507021045,renal,i
9,0211-699507021045,y,o
9,0211-699507021045,establecer,o
9,0211-699507021045,la,o
9,0211-699507021045,utilidad,o
9,0211-699507021045,de,o
9,0211-699507021045,la,o
9,0211-699507021045,cistatinaC,o
9,0211-699507021045,en,o
9,0211-699507021045,el,o
9,0211-699507021045,ambito,o
9,0211-699507021045,hospitalario,o
9,0211-699507021045,Fueron,o
9,0211-699507021045,incluidos,o
9,0211-699507021045,en,o
9,0211-699507021045,el,o
9,0211-699507021045,estudio,o
9,0211-699507021045,70,o
9,0211-699507021045,pacientes,o
9,0211-699507021045,44,o
9,0211-699507021045,hombres,o
9,0211-699507021045,seleccionados,i
9,0211-699507021045,de,i
9,0211-699507021045,manera,i
9,0211-699507021045,aleatoria,i
9,0211-699507021045,predominando,o
9,0211-699507021045,enfermos,i
9,0211-699507021045,renales,i
9,0211-699507021045,y,o
9,0211-699507021045,pacientes,o
9,0211-699507021045,diabeticos,i
9,0211-699507021045,a,o
9,0211-699507021045,los,o
9,0211-699507021045,que,o
9,0211-699507021045,se,o
9,0211-699507021045,les,o
9,0211-699507021045,realizo,o
9,0211-699507021045,el,o
9,0211-699507021045,CLcr,i
9,0211-699507021045,y,o
9,0211-699507021045,se,o
9,0211-699507021045,calculo,o
9,0211-699507021045,CG,i
9,0211-699507021045,y,o
9,0211-699507021045,MDRD,i
9,0211-699507021045,La,o
9,0211-699507021045,edad,o
9,0211-699507021045,media,o
9,0211-699507021045,de,o
9,0211-699507021045,los,o
9,0211-699507021045,pacientes,o
9,0211-699507021045,fue,o
9,0211-699507021045,6614años,o
9,0211-699507021045,peso,o
9,0211-699507021045,medio,o
9,0211-699507021045,7317Kg,o
9,0211-699507021045,creatinina,i
9,0211-699507021045,214177mgdL,o
9,0211-699507021045,cistatinac,o
9,0211-699507021045,177118mgL,o
9,0211-699507021045,CLcr,i
9,0211-699507021045,5439362mLmin,o
9,0211-699507021045,La,o
9,0211-699507021045,correlacion,o
9,0211-699507021045,entre,o
9,0211-699507021045,1Crea,o
9,0211-699507021045,con,o
9,0211-699507021045,el,o
9,0211-699507021045,Clcr,i
9,0211-699507021045,CG,i
9,0211-699507021045,y,o
9,0211-699507021045,MDRD,i
9,0211-699507021045,fue,o
9,0211-699507021045,respectivamente,o
9,0211-699507021045,07735,o
9,0211-699507021045,08269,o
9,0211-699507021045,y,o
9,0211-699507021045,09613,o
9,0211-699507021045,p,o
9,0211-699507021045,00001,o
9,0211-699507021045,La,o
9,0211-699507021045,correlacion,o
9,0211-699507021045,entre,o
9,0211-699507021045,1Cist,o
9,0211-699507021045,con,o
9,0211-699507021045,el,o
9,0211-699507021045,Clcr,i
9,0211-699507021045,CG,i
9,0211-699507021045,y,o
9,0211-699507021045,MDRD,i
9,0211-699507021045,fue,o
9,0211-699507021045,respectivamente,o
9,0211-699507021045,0836,o
9,0211-699507021045,08142,o
9,0211-699507021045,y,o
9,0211-699507021045,0832,o
9,0211-699507021045,p,o
9,0211-699507021045,0,o
9,0211-699507021045,0001,o
9,0211-699507021045,mediante,o
9,0211-699507021045,los,o
9,0211-699507021045,graficos,o
9,0211-699507021045,de,o
9,0211-699507021045,blandaltman,o
9,0211-699507021045,la,o
9,0211-699507021045,diferencia,o
9,0211-699507021045,media,o
9,0211-699507021045,observada,o
9,0211-699507021045,entre,o
9,0211-699507021045,clcr,i
9,0211-699507021045,con,o
9,0211-699507021045,cg,i
9,0211-699507021045,y,o
9,0211-699507021045,mdrd,i
9,0211-699507021045,fue,o
9,0211-699507021045,1,o
9,0211-699507021045,5,o
9,0211-699507021045,ml,o
9,0211-699507021045,min,o
9,0211-699507021045,2,o
9,0211-699507021045,8,o
9,0211-699507021045,respectivamente,o
9,0211-699507021045,comparando,o
9,0211-699507021045,cg,i
9,0211-699507021045,1,o
9,0211-699507021045,7,o
9,0211-699507021045,las,o
9,0211-699507021045,diferencias,o
9,0211-699507021045,absolutas,o
9,0211-699507021045,observadas,o
9,0211-699507021045,13,o
9,0211-699507021045,17,o
9,0211-699507021045,ambas,o
9,0211-699507021045,formulas,o
9,0211-699507021045,12,o
9,0211-699507021045,no,o
9,0211-699507021045,existen,o
9,0211-699507021045,estadisticamente,o
9,0211-699507021045,significativas,o
9,0211-699507021045,distintos,o
9,0211-699507021045,metodos,o
9,0211-699507021045,valoracion,i
9,0211-699507021045,renal,i
9,0211-699507021045,p,o
9,0211-699507021045,005,o
9,0211-699507021045,En,o
9,0211-699507021045,conclusion,o
9,0211-699507021045,la,o
9,0211-699507021045,mayoria,o
9,0211-699507021045,de,o
9,0211-699507021045,las,o
9,0211-699507021045,recogidas,i
9,0211-699507021045,de,i
9,0211-699507021045,orina,i
9,0211-699507021045,podrian,o
9,0211-699507021045,evitarse,o
9,0211-699507021045,con,o
9,0211-699507021045,la,o
9,0211-699507021045,utilizacion,o
9,0211-699507021045,de,o
9,0211-699507021045,las,o
9,0211-699507021045,formulas,o
9,0211-699507021045,La,o
9,0211-699507021045,Cistatina,i
9,0211-699507021045,es,o
9,0211-699507021045,muy,o
9,0211-699507021045,superior,o
9,0211-699507021045,a,o
9,0211-699507021045,la,o
9,0211-699507021045,creatinina,i
9,0211-699507021045,sobre,o
9,0211-699507021045,todo,o
9,0211-699507021045,para,o
9,0211-699507021045,detectar,o
9,0211-699507021045,leve,o
9,0211-699507021045,alteracion,i
9,0211-699507021045,renal,i
9,0211-699507021045,sensibilidad,o
9,0211-699507021045,804,o
9,0211-699507021045,us,o
9,0211-699507021045,447,o
9,0211-699507021045,en,o
9,0211-699507021045,hombres,o
9,0211-699507021045,convirtiendose,o
9,0211-699507021045,en,o
9,0211-699507021045,una,o
9,0211-699507021045,alternativa,o
9,0211-699507021045,prometedora,o
9,0211-699507021045,que,o
9,0211-699507021045,reduciria,o
9,0211-699507021045,a,o
9,0211-699507021045,mas,o
9,0211-699507021045,de,o
9,0211-699507021045,la,o
9,0211-699507021045,mitad,o
9,0211-699507021045,la,o
9,0211-699507021045,IRC,i
9,0211-699507021045,oculta,o
9,0211-699507021045,generada,o
9,0211-699507021045,por,o
9,0211-699507021045,la,o
9,0211-699507021045,creatinina,i
9,0211-699507021045,aunque,o
9,0211-699507021045,se,o
9,0211-699507021045,necesitan,o
9,0211-699507021045,mas,o
9,0211-699507021045,estudios,o
9,0211-699507021045,para,o
9,0211-699507021045,confirmarlo,o
10,2174-0798_2013_2_art6,Sellado,i
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,lesiones,i
10,2174-0798_2013_2_art6,de,i
10,2174-0798_2013_2_art6,caries,i
10,2174-0798_2013_2_art6,dental,i
10,2174-0798_2013_2_art6,no,i
10,2174-0798_2013_2_art6,cavitadas,i
10,2174-0798_2013_2_art6,ensayo,i
10,2174-0798_2013_2_art6,clinico,i
10,2174-0798_2013_2_art6,aleatorio,i
10,2174-0798_2013_2_art6,controlado,i
10,2174-0798_2013_2_art6,Objetivo,o
10,2174-0798_2013_2_art6,Evaluar,i
10,2174-0798_2013_2_art6,la,i
10,2174-0798_2013_2_art6,efectividad,i
10,2174-0798_2013_2_art6,del,o
10,2174-0798_2013_2_art6,sellado,i
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,lesiones,i
10,2174-0798_2013_2_art6,de,i
10,2174-0798_2013_2_art6,caries,i
10,2174-0798_2013_2_art6,dental,i
10,2174-0798_2013_2_art6,no,i
10,2174-0798_2013_2_art6,cavitadas,i
10,2174-0798_2013_2_art6,Materiales,o
10,2174-0798_2013_2_art6,y,o
10,2174-0798_2013_2_art6,Metodos,o
10,2174-0798_2013_2_art6,Se,o
10,2174-0798_2013_2_art6,realizo,o
10,2174-0798_2013_2_art6,un,o
10,2174-0798_2013_2_art6,ensayo,o
10,2174-0798_2013_2_art6,clinico,o
10,2174-0798_2013_2_art6,aleatorio,o
10,2174-0798_2013_2_art6,doble,o
10,2174-0798_2013_2_art6,ciego,o
10,2174-0798_2013_2_art6,controlado,o
10,2174-0798_2013_2_art6,y,o
10,2174-0798_2013_2_art6,diseño,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,boca,i
10,2174-0798_2013_2_art6,dividida,o
10,2174-0798_2013_2_art6,Fueron,o
10,2174-0798_2013_2_art6,seleccionados,o
10,2174-0798_2013_2_art6,262,o
10,2174-0798_2013_2_art6,primeros,i
10,2174-0798_2013_2_art6,molares,i
10,2174-0798_2013_2_art6,permanentes,i
10,2174-0798_2013_2_art6,en,o
10,2174-0798_2013_2_art6,74,o
10,2174-0798_2013_2_art6,niños,o
10,2174-0798_2013_2_art6,con,o
10,2174-0798_2013_2_art6,edad,o
10,2174-0798_2013_2_art6,media,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,74708,o
10,2174-0798_2013_2_art6,años,o
10,2174-0798_2013_2_art6,Cada,o
10,2174-0798_2013_2_art6,paciente,o
10,2174-0798_2013_2_art6,tenia,o
10,2174-0798_2013_2_art6,minimo,o
10,2174-0798_2013_2_art6,un,o
10,2174-0798_2013_2_art6,par,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,primeros,i
10,2174-0798_2013_2_art6,molares,i
10,2174-0798_2013_2_art6,permanentes,i
10,2174-0798_2013_2_art6,con,o
10,2174-0798_2013_2_art6,lesiones,i
10,2174-0798_2013_2_art6,bilaterales,i
10,2174-0798_2013_2_art6,de,i
10,2174-0798_2013_2_art6,caries,i
10,2174-0798_2013_2_art6,dental,i
10,2174-0798_2013_2_art6,codigos,o
10,2174-0798_2013_2_art6,1,o
10,2174-0798_2013_2_art6,2,o
10,2174-0798_2013_2_art6,o,o
10,2174-0798_2013_2_art6,3,o
10,2174-0798_2013_2_art6,del,o
10,2174-0798_2013_2_art6,Sistema,o
10,2174-0798_2013_2_art6,Internacional,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,Deteccion,o
10,2174-0798_2013_2_art6,y,o
10,2174-0798_2013_2_art6,Valoracion,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,Caries,i
10,2174-0798_2013_2_art6,Dental,i
10,2174-0798_2013_2_art6,Se,o
10,2174-0798_2013_2_art6,asignaron,i
10,2174-0798_2013_2_art6,aleatoriamente,i
10,2174-0798_2013_2_art6,a,o
10,2174-0798_2013_2_art6,tres,o
10,2174-0798_2013_2_art6,tipos,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,tratamiento,i
10,2174-0798_2013_2_art6,1,o
10,2174-0798_2013_2_art6,vidrio,i
10,2174-0798_2013_2_art6,ionomerico,i
10,2174-0798_2013_2_art6,3M,o
10,2174-0798_2013_2_art6,ESPE,o
10,2174-0798_2013_2_art6,Ketac,o
10,2174-0798_2013_2_art6,Molar,o
10,2174-0798_2013_2_art6,Easymix,o
10,2174-0798_2013_2_art6,2,o
10,2174-0798_2013_2_art6,Sellante,i
10,2174-0798_2013_2_art6,resinoso,i
10,2174-0798_2013_2_art6,3M,o
10,2174-0798_2013_2_art6,ESPE,o
10,2174-0798_2013_2_art6,Climpro,o
10,2174-0798_2013_2_art6,3,o
10,2174-0798_2013_2_art6,vidrio,i
10,2174-0798_2013_2_art6,ionomerico,i
10,2174-0798_2013_2_art6,modificado,i
10,2174-0798_2013_2_art6,con,i
10,2174-0798_2013_2_art6,resina,i
10,2174-0798_2013_2_art6,3M,o
10,2174-0798_2013_2_art6,ESPE,o
10,2174-0798_2013_2_art6,Ketac,o
10,2174-0798_2013_2_art6,N100,o
10,2174-0798_2013_2_art6,La,o
10,2174-0798_2013_2_art6,retencion,i
10,2174-0798_2013_2_art6,y,o
10,2174-0798_2013_2_art6,progresion,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,caries,i
10,2174-0798_2013_2_art6,dental,i
10,2174-0798_2013_2_art6,fueron,o
10,2174-0798_2013_2_art6,evaluadas,o
10,2174-0798_2013_2_art6,Los,o
10,2174-0798_2013_2_art6,datos,o
10,2174-0798_2013_2_art6,se,o
10,2174-0798_2013_2_art6,procesaron,o
10,2174-0798_2013_2_art6,con,o
10,2174-0798_2013_2_art6,el,o
10,2174-0798_2013_2_art6,programa,o
10,2174-0798_2013_2_art6,SPSS,o
10,2174-0798_2013_2_art6,V15,o
10,2174-0798_2013_2_art6,Se,o
10,2174-0798_2013_2_art6,utilizaron,o
10,2174-0798_2013_2_art6,las,o
10,2174-0798_2013_2_art6,pruebas,o
10,2174-0798_2013_2_art6,Chi,o
10,2174-0798_2013_2_art6,Cuadrado,o
10,2174-0798_2013_2_art6,y,o
10,2174-0798_2013_2_art6,Test,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,Fisher,o
10,2174-0798_2013_2_art6,Resultados,o
10,2174-0798_2013_2_art6,La,o
10,2174-0798_2013_2_art6,tasa,o
10,2174-0798_2013_2_art6,retencion,i
10,2174-0798_2013_2_art6,total,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,los,o
10,2174-0798_2013_2_art6,tratamientos,i
10,2174-0798_2013_2_art6,1,o
10,2174-0798_2013_2_art6,2,o
10,2174-0798_2013_2_art6,y,o
10,2174-0798_2013_2_art6,3,o
10,2174-0798_2013_2_art6,fue,o
10,2174-0798_2013_2_art6,respectivamente,o
10,2174-0798_2013_2_art6,517,o
10,2174-0798_2013_2_art6,434,o
10,2174-0798_2013_2_art6,y,o
10,2174-0798_2013_2_art6,264,o
10,2174-0798_2013_2_art6,no,o
10,2174-0798_2013_2_art6,obstante,o
10,2174-0798_2013_2_art6,estas,o
10,2174-0798_2013_2_art6,diferencias,o
10,2174-0798_2013_2_art6,no,o
10,2174-0798_2013_2_art6,fueron,o
10,2174-0798_2013_2_art6,significativas,o
10,2174-0798_2013_2_art6,La,o
10,2174-0798_2013_2_art6,incidencia,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,caries,i
10,2174-0798_2013_2_art6,en,i
10,2174-0798_2013_2_art6,los,i
10,2174-0798_2013_2_art6,molares,i
10,2174-0798_2013_2_art6,no,o
10,2174-0798_2013_2_art6,sellados,i
10,2174-0798_2013_2_art6,fue,o
10,2174-0798_2013_2_art6,318,o
10,2174-0798_2013_2_art6,y,o
10,2174-0798_2013_2_art6,en,o
10,2174-0798_2013_2_art6,los,o
10,2174-0798_2013_2_art6,molares,i
10,2174-0798_2013_2_art6,sellados,i
10,2174-0798_2013_2_art6,con,o
10,2174-0798_2013_2_art6,perdida,o
10,2174-0798_2013_2_art6,completa,o
10,2174-0798_2013_2_art6,del,o
10,2174-0798_2013_2_art6,material,o
10,2174-0798_2013_2_art6,285,o
10,2174-0798_2013_2_art6,No,o
10,2174-0798_2013_2_art6,se,o
10,2174-0798_2013_2_art6,encontraron,o
10,2174-0798_2013_2_art6,diferencias,o
10,2174-0798_2013_2_art6,significativas,o
10,2174-0798_2013_2_art6,en,o
10,2174-0798_2013_2_art6,la,o
10,2174-0798_2013_2_art6,progresion,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,las,o
10,2174-0798_2013_2_art6,lesiones,i
10,2174-0798_2013_2_art6,entre,o
10,2174-0798_2013_2_art6,molares,i
10,2174-0798_2013_2_art6,que,o
10,2174-0798_2013_2_art6,reciben,o
10,2174-0798_2013_2_art6,y,o
10,2174-0798_2013_2_art6,los,o
10,2174-0798_2013_2_art6,que,o
10,2174-0798_2013_2_art6,no,o
10,2174-0798_2013_2_art6,reciben,o
10,2174-0798_2013_2_art6,tratamiento,i
10,2174-0798_2013_2_art6,Conclusiones,o
10,2174-0798_2013_2_art6,En,o
10,2174-0798_2013_2_art6,este,o
10,2174-0798_2013_2_art6,estudio,o
10,2174-0798_2013_2_art6,no,o
10,2174-0798_2013_2_art6,se,o
10,2174-0798_2013_2_art6,encontraron,o
10,2174-0798_2013_2_art6,evidencias,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,diferencias,o
10,2174-0798_2013_2_art6,en,o
10,2174-0798_2013_2_art6,la,o
10,2174-0798_2013_2_art6,retencion,i
10,2174-0798_2013_2_art6,y,o
10,2174-0798_2013_2_art6,en,o
10,2174-0798_2013_2_art6,la,o
10,2174-0798_2013_2_art6,progresion,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,las,o
10,2174-0798_2013_2_art6,lesiones,i
10,2174-0798_2013_2_art6,selladas,i
10,2174-0798_2013_2_art6,y,o
10,2174-0798_2013_2_art6,no,o
10,2174-0798_2013_2_art6,selladas,i
10,2174-0798_2013_2_art6,entre,o
10,2174-0798_2013_2_art6,el,o
10,2174-0798_2013_2_art6,vidrio,i
10,2174-0798_2013_2_art6,ionomerico,i
10,2174-0798_2013_2_art6,convencional,o
10,2174-0798_2013_2_art6,de,o
10,2174-0798_2013_2_art6,alta,o
10,2174-0798_2013_2_art6,densidad,o
10,2174-0798_2013_2_art6,el,o
10,2174-0798_2013_2_art6,sellante,i
10,2174-0798_2013_2_art6,a,i
10,2174-0798_2013_2_art6,base,i
10,2174-0798_2013_2_art6,de,i
10,2174-0798_2013_2_art6,resina,i
10,2174-0798_2013_2_art6,y,o
10,2174-0798_2013_2_art6,un,o
10,2174-0798_2013_2_art6,vidrio,i
10,2174-0798_2013_2_art6,ionomerico,i
10,2174-0798_2013_2_art6,modificado,i
10,2174-0798_2013_2_art6,con,i
10,2174-0798_2013_2_art6,resina,i
11,S0004-06142008000500003,Biopsia,i
11,S0004-06142008000500003,prostatica,i
11,S0004-06142008000500003,transrectal,i
11,S0004-06142008000500003,ecodirigida,i
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,dolor,i
11,S0004-06142008000500003,Estudio,i
11,S0004-06142008000500003,prospectivo,i
11,S0004-06142008000500003,aleatorizado,i
11,S0004-06142008000500003,comparando,o
11,S0004-06142008000500003,gel,i
11,S0004-06142008000500003,lubricante,i
11,S0004-06142008000500003,gel,i
11,S0004-06142008000500003,con,o
11,S0004-06142008000500003,lidocaina,i
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,bloqueo,i
11,S0004-06142008000500003,anestesico,i
11,S0004-06142008000500003,de,i
11,S0004-06142008000500003,haces,i
11,S0004-06142008000500003,neurovasculares,i
11,S0004-06142008000500003,con,o
11,S0004-06142008000500003,lidocaina,i
11,S0004-06142008000500003,1,o
11,S0004-06142008000500003,Objetivo,o
11,S0004-06142008000500003,Cuantificar,o
11,S0004-06142008000500003,ansiedad,i
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,dolor,i
11,S0004-06142008000500003,inmediato,o
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,tardio,o
11,S0004-06142008000500003,producidos,o
11,S0004-06142008000500003,efectividad,o
11,S0004-06142008000500003,de,o
11,S0004-06142008000500003,los,o
11,S0004-06142008000500003,metodos,i
11,S0004-06142008000500003,analgesicos,i
11,S0004-06142008000500003,comunes,o
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,complicaciones,i
11,S0004-06142008000500003,Metodos,o
11,S0004-06142008000500003,117,o
11,S0004-06142008000500003,pacientes,o
11,S0004-06142008000500003,fueron,o
11,S0004-06142008000500003,distribuidos,i
11,S0004-06142008000500003,aleatoriamente,i
11,S0004-06142008000500003,en,o
11,S0004-06142008000500003,tres,o
11,S0004-06142008000500003,grupos,o
11,S0004-06142008000500003,1,o
11,S0004-06142008000500003,39,o
11,S0004-06142008000500003,lubricante,i
11,S0004-06142008000500003,gel,i
11,S0004-06142008000500003,2,o
11,S0004-06142008000500003,38,o
11,S0004-06142008000500003,lidocaina,i
11,S0004-06142008000500003,en,o
11,S0004-06142008000500003,gel,o
11,S0004-06142008000500003,intrarrectal,o
11,S0004-06142008000500003,3,o
11,S0004-06142008000500003,40,o
11,S0004-06142008000500003,bloqueo,i
11,S0004-06142008000500003,anestesico,i
11,S0004-06142008000500003,con,o
11,S0004-06142008000500003,lidocaina,i
11,S0004-06142008000500003,al,o
11,S0004-06142008000500003,1,o
11,S0004-06142008000500003,Se,o
11,S0004-06142008000500003,recogieron,o
11,S0004-06142008000500003,las,o
11,S0004-06142008000500003,complicaciones,i
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,el,o
11,S0004-06142008000500003,dolor,i
11,S0004-06142008000500003,inmediatos,o
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,tardios,o
11,S0004-06142008000500003,mediante,o
11,S0004-06142008000500003,una,o
11,S0004-06142008000500003,escala,i
11,S0004-06142008000500003,visual,i
11,S0004-06142008000500003,analogica,i
11,S0004-06142008000500003,Resultados,o
11,S0004-06142008000500003,70,o
11,S0004-06142008000500003,de,o
11,S0004-06142008000500003,pacientes,o
11,S0004-06142008000500003,estaban,o
11,S0004-06142008000500003,poco,o
11,S0004-06142008000500003,ansiosos,i
11,S0004-06142008000500003,No,o
11,S0004-06142008000500003,encontramos,o
11,S0004-06142008000500003,diferencias,o
11,S0004-06142008000500003,significativas,o
11,S0004-06142008000500003,entre,o
11,S0004-06142008000500003,la,o
11,S0004-06142008000500003,analgesia,i
11,S0004-06142008000500003,conseguida,o
11,S0004-06142008000500003,en,o
11,S0004-06142008000500003,el,o
11,S0004-06142008000500003,grupo,o
11,S0004-06142008000500003,1,o
11,S0004-06142008000500003,437241,o
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,2,o
11,S0004-06142008000500003,422246,o
11,S0004-06142008000500003,pero,o
11,S0004-06142008000500003,si,o
11,S0004-06142008000500003,con,o
11,S0004-06142008000500003,el,o
11,S0004-06142008000500003,3,o
11,S0004-06142008000500003,188203,o
11,S0004-06142008000500003,La,o
11,S0004-06142008000500003,media,o
11,S0004-06142008000500003,de,o
11,S0004-06142008000500003,dolor,i
11,S0004-06142008000500003,la,o
11,S0004-06142008000500003,tarde,o
11,S0004-06142008000500003,tras,o
11,S0004-06142008000500003,la,o
11,S0004-06142008000500003,prueba,i
11,S0004-06142008000500003,fue,o
11,S0004-06142008000500003,menor,o
11,S0004-06142008000500003,en,o
11,S0004-06142008000500003,el,o
11,S0004-06142008000500003,grupo,o
11,S0004-06142008000500003,3,o
11,S0004-06142008000500003,208,o
11,S0004-06142008000500003,228,o
11,S0004-06142008000500003,que,o
11,S0004-06142008000500003,en,o
11,S0004-06142008000500003,1,o
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,2,o
11,S0004-06142008000500003,406280,o
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,242203,o
11,S0004-06142008000500003,pero,o
11,S0004-06142008000500003,sin,o
11,S0004-06142008000500003,significacion,o
11,S0004-06142008000500003,estadistica,o
11,S0004-06142008000500003,Los,o
11,S0004-06142008000500003,pacientes,o
11,S0004-06142008000500003,no,o
11,S0004-06142008000500003,mostraron,o
11,S0004-06142008000500003,un,o
11,S0004-06142008000500003,dolor,i
11,S0004-06142008000500003,distinto,o
11,S0004-06142008000500003,al,o
11,S0004-06142008000500003,paso,o
11,S0004-06142008000500003,del,o
11,S0004-06142008000500003,transductor,o
11,S0004-06142008000500003,transrectal,o
11,S0004-06142008000500003,oscilando,o
11,S0004-06142008000500003,entre,o
11,S0004-06142008000500003,234,o
11,S0004-06142008000500003,para,o
11,S0004-06142008000500003,el,o
11,S0004-06142008000500003,grupo,o
11,S0004-06142008000500003,3,o
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,338,o
11,S0004-06142008000500003,para,o
11,S0004-06142008000500003,el,o
11,S0004-06142008000500003,grupo,o
11,S0004-06142008000500003,2,o
11,S0004-06142008000500003,Agrupados,o
11,S0004-06142008000500003,segun,o
11,S0004-06142008000500003,tono,o
11,S0004-06142008000500003,esfinteriano,i
11,S0004-06142008000500003,si,o
11,S0004-06142008000500003,encontramos,o
11,S0004-06142008000500003,diferencias,o
11,S0004-06142008000500003,bajo,o
11,S0004-06142008000500003,271276,o
11,S0004-06142008000500003,medio,o
11,S0004-06142008000500003,323238,o
11,S0004-06142008000500003,alto,o
11,S0004-06142008000500003,499222,o
11,S0004-06142008000500003,El,o
11,S0004-06142008000500003,dolor,i
11,S0004-06142008000500003,presentado,o
11,S0004-06142008000500003,por,o
11,S0004-06142008000500003,los,o
11,S0004-06142008000500003,pacientes,o
11,S0004-06142008000500003,que,o
11,S0004-06142008000500003,decian,o
11,S0004-06142008000500003,estar,o
11,S0004-06142008000500003,muy,o
11,S0004-06142008000500003,nerviosos,i
11,S0004-06142008000500003,preprueba,o
11,S0004-06142008000500003,fue,o
11,S0004-06142008000500003,de,o
11,S0004-06142008000500003,498257,o
11,S0004-06142008000500003,significativamente,o
11,S0004-06142008000500003,mayor,o
11,S0004-06142008000500003,que,o
11,S0004-06142008000500003,el,o
11,S0004-06142008000500003,presentado,o
11,S0004-06142008000500003,por,o
11,S0004-06142008000500003,los,o
11,S0004-06142008000500003,que,o
11,S0004-06142008000500003,decian,o
11,S0004-06142008000500003,estar,o
11,S0004-06142008000500003,nada,o
11,S0004-06142008000500003,nerviosos,i
11,S0004-06142008000500003,259221,o
11,S0004-06142008000500003,No,o
11,S0004-06142008000500003,encontramos,o
11,S0004-06142008000500003,diferencias,o
11,S0004-06142008000500003,en,o
11,S0004-06142008000500003,las,o
11,S0004-06142008000500003,complicaciones,i
11,S0004-06142008000500003,entre,o
11,S0004-06142008000500003,los,o
11,S0004-06142008000500003,tres,o
11,S0004-06142008000500003,grupos,o
11,S0004-06142008000500003,Conclusiones,o
11,S0004-06142008000500003,El,o
11,S0004-06142008000500003,empleo,o
11,S0004-06142008000500003,de,o
11,S0004-06142008000500003,gel,o
11,S0004-06142008000500003,intrarrectal,o
11,S0004-06142008000500003,de,o
11,S0004-06142008000500003,lidocaina,i
11,S0004-06142008000500003,no,o
11,S0004-06142008000500003,ha,o
11,S0004-06142008000500003,demostrado,o
11,S0004-06142008000500003,en,o
11,S0004-06142008000500003,nuestra,o
11,S0004-06142008000500003,serie,o
11,S0004-06142008000500003,ser,o
11,S0004-06142008000500003,mas,o
11,S0004-06142008000500003,eficaz,o
11,S0004-06142008000500003,que,o
11,S0004-06142008000500003,el,o
11,S0004-06142008000500003,uso,o
11,S0004-06142008000500003,de,o
11,S0004-06142008000500003,lubricante,i
11,S0004-06142008000500003,para,o
11,S0004-06142008000500003,el,o
11,S0004-06142008000500003,control,i
11,S0004-06142008000500003,del,i
11,S0004-06142008000500003,dolor,i
11,S0004-06142008000500003,pero,o
11,S0004-06142008000500003,si,o
11,S0004-06142008000500003,la,o
11,S0004-06142008000500003,lidocaina,i
11,S0004-06142008000500003,inyectada,i
11,S0004-06142008000500003,en,o
11,S0004-06142008000500003,apex,i
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,vesiculas,i
11,S0004-06142008000500003,seminales,i
11,S0004-06142008000500003,Tono,o
11,S0004-06142008000500003,esfinteriano,i
11,S0004-06142008000500003,y,o
11,S0004-06142008000500003,ansiedad,i
11,S0004-06142008000500003,preprueba,o
11,S0004-06142008000500003,son,o
11,S0004-06142008000500003,los,o
11,S0004-06142008000500003,factores,o
11,S0004-06142008000500003,mas,o
11,S0004-06142008000500003,determinantes,o
11,S0004-06142008000500003,en,o
11,S0004-06142008000500003,el,o
11,S0004-06142008000500003,grado,o
11,S0004-06142008000500003,de,o
11,S0004-06142008000500003,dolor,i
12,S0004-06142008000700005,Estudio,i
12,S0004-06142008000700005,randomizado,i
12,S0004-06142008000700005,sobre,o
12,S0004-06142008000700005,continencia,o
12,S0004-06142008000700005,urinaria,i
12,S0004-06142008000700005,postprostatectomia,o
12,S0004-06142008000700005,radical,o
12,S0004-06142008000700005,con,o
12,S0004-06142008000700005,rehabilitacion,i
12,S0004-06142008000700005,perineal,i
12,S0004-06142008000700005,kinesica,i
12,S0004-06142008000700005,previa,o
12,S0004-06142008000700005,Objetivo,o
12,S0004-06142008000700005,La,o
12,S0004-06142008000700005,incontinencia,i
12,S0004-06142008000700005,urinaria,i
12,S0004-06142008000700005,es,o
12,S0004-06142008000700005,una,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,las,o
12,S0004-06142008000700005,principales,o
12,S0004-06142008000700005,complicaciones,i
12,S0004-06142008000700005,luego,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,la,o
12,S0004-06142008000700005,realizacion,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,prostatectomia,i
12,S0004-06142008000700005,radical,i
12,S0004-06142008000700005,PR,i
12,S0004-06142008000700005,La,o
12,S0004-06142008000700005,rehabilitacion,i
12,S0004-06142008000700005,kinesica,i
12,S0004-06142008000700005,preoperatoria,o
12,S0004-06142008000700005,podria,o
12,S0004-06142008000700005,ser,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,utilidad,o
12,S0004-06142008000700005,como,o
12,S0004-06142008000700005,tratamiento,i
12,S0004-06142008000700005,preventivo,i
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,esta,o
12,S0004-06142008000700005,complicacion,i
12,S0004-06142008000700005,Demostrar,o
12,S0004-06142008000700005,la,o
12,S0004-06142008000700005,utilidad,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,la,o
12,S0004-06142008000700005,kinesiologia,i
12,S0004-06142008000700005,perineal,i
12,S0004-06142008000700005,preoperatoria,o
12,S0004-06142008000700005,en,o
12,S0004-06142008000700005,la,o
12,S0004-06142008000700005,recuperacion,o
12,S0004-06142008000700005,precoz,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,la,o
12,S0004-06142008000700005,continencia,o
12,S0004-06142008000700005,urinaria,i
12,S0004-06142008000700005,post,o
12,S0004-06142008000700005,prostatectomia,i
12,S0004-06142008000700005,radical,i
12,S0004-06142008000700005,Metodos,o
12,S0004-06142008000700005,Ensayo,i
12,S0004-06142008000700005,Clinico,i
12,S0004-06142008000700005,Controlado,i
12,S0004-06142008000700005,Randomizado,i
12,S0004-06142008000700005,Aleatorizado,i
12,S0004-06142008000700005,38,o
12,S0004-06142008000700005,pacientes,o
12,S0004-06142008000700005,fueron,o
12,S0004-06142008000700005,divididos,o
12,S0004-06142008000700005,en,o
12,S0004-06142008000700005,dos,o
12,S0004-06142008000700005,grupos,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,19,o
12,S0004-06142008000700005,previo,o
12,S0004-06142008000700005,a,o
12,S0004-06142008000700005,la,o
12,S0004-06142008000700005,realizacion,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,la,o
12,S0004-06142008000700005,PR,i
12,S0004-06142008000700005,El,o
12,S0004-06142008000700005,primer,o
12,S0004-06142008000700005,grupo,o
12,S0004-06142008000700005,K,o
12,S0004-06142008000700005,recibio,o
12,S0004-06142008000700005,tratamiento,i
12,S0004-06142008000700005,kinesico,i
12,S0004-06142008000700005,preoperatorio,o
12,S0004-06142008000700005,mientras,o
12,S0004-06142008000700005,que,o
12,S0004-06142008000700005,el,o
12,S0004-06142008000700005,segundo,o
12,S0004-06142008000700005,grupo,o
12,S0004-06142008000700005,NK,o
12,S0004-06142008000700005,no,o
12,S0004-06142008000700005,grupo,o
12,S0004-06142008000700005,control,o
12,S0004-06142008000700005,Se,o
12,S0004-06142008000700005,evaluo,o
12,S0004-06142008000700005,la,o
12,S0004-06142008000700005,continencia,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,orina,i
12,S0004-06142008000700005,a,o
12,S0004-06142008000700005,los,o
12,S0004-06142008000700005,14,o
12,S0004-06142008000700005,30,o
12,S0004-06142008000700005,y,o
12,S0004-06142008000700005,60,o
12,S0004-06142008000700005,dias,o
12,S0004-06142008000700005,post,o
12,S0004-06142008000700005,extraccion,i
12,S0004-06142008000700005,de,i
12,S0004-06142008000700005,sonda,i
12,S0004-06142008000700005,Resultados,o
12,S0004-06142008000700005,No,o
12,S0004-06142008000700005,hubo,o
12,S0004-06142008000700005,diferencias,o
12,S0004-06142008000700005,epidemiologicas,o
12,S0004-06142008000700005,y,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,biologia,o
12,S0004-06142008000700005,tumoral,i
12,S0004-06142008000700005,entre,o
12,S0004-06142008000700005,grupos,o
12,S0004-06142008000700005,El,o
12,S0004-06142008000700005,porcentaje,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,pacientes,o
12,S0004-06142008000700005,continentes,o
12,S0004-06142008000700005,en,o
12,S0004-06142008000700005,el,o
12,S0004-06142008000700005,grupo,o
12,S0004-06142008000700005,K,o
12,S0004-06142008000700005,al,o
12,S0004-06142008000700005,los,o
12,S0004-06142008000700005,14,o
12,S0004-06142008000700005,30,o
12,S0004-06142008000700005,y,o
12,S0004-06142008000700005,60,o
12,S0004-06142008000700005,dias,o
12,S0004-06142008000700005,respectivamente,o
12,S0004-06142008000700005,fue,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,4736,o
12,S0004-06142008000700005,4736,o
12,S0004-06142008000700005,y,o
12,S0004-06142008000700005,789,o
12,S0004-06142008000700005,respectivamente,o
12,S0004-06142008000700005,mientras,o
12,S0004-06142008000700005,que,o
12,S0004-06142008000700005,en,o
12,S0004-06142008000700005,el,o
12,S0004-06142008000700005,grupo,o
12,S0004-06142008000700005,NK,o
12,S0004-06142008000700005,fueron,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,4736,o
12,S0004-06142008000700005,4736,o
12,S0004-06142008000700005,y,o
12,S0004-06142008000700005,894,o
12,S0004-06142008000700005,respectivamente,o
12,S0004-06142008000700005,p005,o
12,S0004-06142008000700005,Conclusion,o
12,S0004-06142008000700005,Los,o
12,S0004-06142008000700005,ejercicios,i
12,S0004-06142008000700005,kinesicos,i
12,S0004-06142008000700005,perineales,i
12,S0004-06142008000700005,previos,o
12,S0004-06142008000700005,a,o
12,S0004-06142008000700005,la,o
12,S0004-06142008000700005,prostatectomia,i
12,S0004-06142008000700005,radical,i
12,S0004-06142008000700005,no,o
12,S0004-06142008000700005,disminuyeron,o
12,S0004-06142008000700005,los,o
12,S0004-06142008000700005,tiempos,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,recuperacion,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,la,o
12,S0004-06142008000700005,continencia,o
12,S0004-06142008000700005,urinaria,i
12,S0004-06142008000700005,ni,o
12,S0004-06142008000700005,la,o
12,S0004-06142008000700005,ocurrencia,o
12,S0004-06142008000700005,de,o
12,S0004-06142008000700005,la,o
12,S0004-06142008000700005,misma,o
13,S0004-06142010000200005,Efectividad,o
13,S0004-06142010000200005,en,o
13,S0004-06142010000200005,el,o
13,S0004-06142010000200005,diagnostico,i
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,cancer,i
13,S0004-06142010000200005,de,i
13,S0004-06142010000200005,prostata,i
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,dos,o
13,S0004-06142010000200005,esquemas,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,biopsia,i
13,S0004-06142010000200005,transrectal,i
13,S0004-06142010000200005,ecodirigida,i
13,S0004-06142010000200005,Estudio,i
13,S0004-06142010000200005,aletorizado,i
13,S0004-06142010000200005,Objetivo,o
13,S0004-06142010000200005,Evaluar,o
13,S0004-06142010000200005,si,o
13,S0004-06142010000200005,un,o
13,S0004-06142010000200005,esquema,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,biopsia,i
13,S0004-06142010000200005,de,i
13,S0004-06142010000200005,prostata,i
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,10,o
13,S0004-06142010000200005,cilindros,i
13,S0004-06142010000200005,es,o
13,S0004-06142010000200005,superior,o
13,S0004-06142010000200005,al,o
13,S0004-06142010000200005,esquema,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,6,o
13,S0004-06142010000200005,cilindros,i
13,S0004-06142010000200005,en,o
13,S0004-06142010000200005,el,o
13,S0004-06142010000200005,diagnostico,i
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,cancer,i
13,S0004-06142010000200005,de,i
13,S0004-06142010000200005,prostata,i
13,S0004-06142010000200005,en,o
13,S0004-06142010000200005,pacientes,o
13,S0004-06142010000200005,que,o
13,S0004-06142010000200005,van,o
13,S0004-06142010000200005,a,o
13,S0004-06142010000200005,ser,o
13,S0004-06142010000200005,sometidos,o
13,S0004-06142010000200005,a,o
13,S0004-06142010000200005,una,o
13,S0004-06142010000200005,primera,o
13,S0004-06142010000200005,biopsia,i
13,S0004-06142010000200005,con,o
13,S0004-06142010000200005,un,o
13,S0004-06142010000200005,tacto,i
13,S0004-06142010000200005,rectal,i
13,S0004-06142010000200005,no,o
13,S0004-06142010000200005,sospechoso,o
13,S0004-06142010000200005,y,o
13,S0004-06142010000200005,un,o
13,S0004-06142010000200005,PSA,i
13,S0004-06142010000200005,entre,o
13,S0004-06142010000200005,35,o
13,S0004-06142010000200005,y,o
13,S0004-06142010000200005,20,o
13,S0004-06142010000200005,ngml,o
13,S0004-06142010000200005,Metodo,o
13,S0004-06142010000200005,Estudio,i
13,S0004-06142010000200005,prospectivo,i
13,S0004-06142010000200005,aleatorizado,i
13,S0004-06142010000200005,entre,o
13,S0004-06142010000200005,2,o
13,S0004-06142010000200005,esquemas,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,biopsia,i
13,S0004-06142010000200005,de,i
13,S0004-06142010000200005,prostata,i
13,S0004-06142010000200005,con,o
13,S0004-06142010000200005,estratificacion,i
13,S0004-06142010000200005,de,i
13,S0004-06142010000200005,la,i
13,S0004-06142010000200005,aleatorizacion,i
13,S0004-06142010000200005,por,o
13,S0004-06142010000200005,volumen,i
13,S0004-06142010000200005,prostatico,i
13,S0004-06142010000200005,50,o
13,S0004-06142010000200005,cc,o
13,S0004-06142010000200005,y,o
13,S0004-06142010000200005,50,o
13,S0004-06142010000200005,cc,o
13,S0004-06142010000200005,Mediante,o
13,S0004-06142010000200005,predeterminacion,i
13,S0004-06142010000200005,del,i
13,S0004-06142010000200005,tamaño,i
13,S0004-06142010000200005,muestral,i
13,S0004-06142010000200005,se,o
13,S0004-06142010000200005,obtuvo,o
13,S0004-06142010000200005,un,o
13,S0004-06142010000200005,minimo,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,304,o
13,S0004-06142010000200005,pacientes,o
13,S0004-06142010000200005,para,o
13,S0004-06142010000200005,poder,o
13,S0004-06142010000200005,responder,o
13,S0004-06142010000200005,al,o
13,S0004-06142010000200005,objetivo,o
13,S0004-06142010000200005,principal,o
13,S0004-06142010000200005,El,o
13,S0004-06142010000200005,analisis,o
13,S0004-06142010000200005,estadistico,o
13,S0004-06142010000200005,se,o
13,S0004-06142010000200005,realizo,o
13,S0004-06142010000200005,por,o
13,S0004-06142010000200005,intencion,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,tratar,o
13,S0004-06142010000200005,mediante,o
13,S0004-06142010000200005,el,o
13,S0004-06142010000200005,test,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,la,o
13,S0004-06142010000200005,Chi,o
13,S0004-06142010000200005,cuadrado,o
13,S0004-06142010000200005,y,o
13,S0004-06142010000200005,analisis,o
13,S0004-06142010000200005,uni,o
13,S0004-06142010000200005,y,o
13,S0004-06142010000200005,multivariante,o
13,S0004-06142010000200005,mediante,o
13,S0004-06142010000200005,regresion,o
13,S0004-06142010000200005,logistica,o
13,S0004-06142010000200005,Resultados,o
13,S0004-06142010000200005,Se,o
13,S0004-06142010000200005,detecto,o
13,S0004-06142010000200005,cancer,i
13,S0004-06142010000200005,en,o
13,S0004-06142010000200005,el,o
13,S0004-06142010000200005,273,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,los,o
13,S0004-06142010000200005,casos,o
13,S0004-06142010000200005,Existio,o
13,S0004-06142010000200005,una,o
13,S0004-06142010000200005,relacion,o
13,S0004-06142010000200005,significativa,o
13,S0004-06142010000200005,entre,o
13,S0004-06142010000200005,el,o
13,S0004-06142010000200005,diagnostico,i
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,cancer,i
13,S0004-06142010000200005,y,o
13,S0004-06142010000200005,la,o
13,S0004-06142010000200005,edad,o
13,S0004-06142010000200005,p003,o
13,S0004-06142010000200005,el,o
13,S0004-06142010000200005,volumen,i
13,S0004-06142010000200005,prostatico,i
13,S0004-06142010000200005,p00001,o
13,S0004-06142010000200005,y,o
13,S0004-06142010000200005,la,o
13,S0004-06142010000200005,existencia,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,nodulo,i
13,S0004-06142010000200005,ecografico,i
13,S0004-06142010000200005,p00001,o
13,S0004-06142010000200005,No,o
13,S0004-06142010000200005,se,o
13,S0004-06142010000200005,observo,o
13,S0004-06142010000200005,relacion,o
13,S0004-06142010000200005,con,o
13,S0004-06142010000200005,el,o
13,S0004-06142010000200005,numero,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,cilindros,i
13,S0004-06142010000200005,en,o
13,S0004-06142010000200005,el,o
13,S0004-06142010000200005,total,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,la,o
13,S0004-06142010000200005,serie,o
13,S0004-06142010000200005,p037,o
13,S0004-06142010000200005,ni,o
13,S0004-06142010000200005,en,o
13,S0004-06142010000200005,la,o
13,S0004-06142010000200005,prostatas,i
13,S0004-06142010000200005,50,o
13,S0004-06142010000200005,cc,o
13,S0004-06142010000200005,p087,o
13,S0004-06142010000200005,ni,o
13,S0004-06142010000200005,en,o
13,S0004-06142010000200005,las,o
13,S0004-06142010000200005,50,o
13,S0004-06142010000200005,cc,o
13,S0004-06142010000200005,p009,o
13,S0004-06142010000200005,En,o
13,S0004-06142010000200005,el,o
13,S0004-06142010000200005,analisis,o
13,S0004-06142010000200005,multivariante,o
13,S0004-06142010000200005,la,o
13,S0004-06142010000200005,edad,o
13,S0004-06142010000200005,70,o
13,S0004-06142010000200005,años,o
13,S0004-06142010000200005,p0005,o
13,S0004-06142010000200005,el,o
13,S0004-06142010000200005,volumen,i
13,S0004-06142010000200005,de,i
13,S0004-06142010000200005,la,i
13,S0004-06142010000200005,prostata,i
13,S0004-06142010000200005,50,o
13,S0004-06142010000200005,cc,o
13,S0004-06142010000200005,p0001,o
13,S0004-06142010000200005,y,o
13,S0004-06142010000200005,la,o
13,S0004-06142010000200005,existencia,o
13,S0004-06142010000200005,del,o
13,S0004-06142010000200005,nodulo,i
13,S0004-06142010000200005,ecografico,i
13,S0004-06142010000200005,p0003,o
13,S0004-06142010000200005,se,o
13,S0004-06142010000200005,identificaron,o
13,S0004-06142010000200005,como,o
13,S0004-06142010000200005,variables,o
13,S0004-06142010000200005,independientes,o
13,S0004-06142010000200005,asociadas,o
13,S0004-06142010000200005,al,o
13,S0004-06142010000200005,diagnostico,i
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,cancer,i
13,S0004-06142010000200005,Conclusion,o
13,S0004-06142010000200005,No,o
13,S0004-06142010000200005,hemos,o
13,S0004-06142010000200005,encontrado,o
13,S0004-06142010000200005,diferencias,o
13,S0004-06142010000200005,estadisticamente,o
13,S0004-06142010000200005,significativas,o
13,S0004-06142010000200005,entre,o
13,S0004-06142010000200005,ambos,o
13,S0004-06142010000200005,esquemas,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,biopsia,i
13,S0004-06142010000200005,de,i
13,S0004-06142010000200005,prostata,i
13,S0004-06142010000200005,En,o
13,S0004-06142010000200005,las,o
13,S0004-06142010000200005,glandulas,i
13,S0004-06142010000200005,mayores,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,50,o
13,S0004-06142010000200005,cc,o
13,S0004-06142010000200005,el,o
13,S0004-06142010000200005,esquema,o
13,S0004-06142010000200005,de,o
13,S0004-06142010000200005,6,o
13,S0004-06142010000200005,cilindros,i
13,S0004-06142010000200005,puede,o
13,S0004-06142010000200005,ser,o
13,S0004-06142010000200005,insuficiente,o
14,S0009-741115000195,Eficacia,o
14,S0009-741115000195,de,o
14,S0009-741115000195,la,o
14,S0009-741115000195,dorzolamida,i
14,S0009-741115000195,para,o
14,S0009-741115000195,reducir,o
14,S0009-741115000195,el,o
14,S0009-741115000195,grosor,o
14,S0009-741115000195,retiniano,i
14,S0009-741115000195,despues,o
14,S0009-741115000195,de,o
14,S0009-741115000195,fotocoagulacion,i
14,S0009-741115000195,en,o
14,S0009-741115000195,el,o
14,S0009-741115000195,edema,i
14,S0009-741115000195,macular,i
14,S0009-741115000195,diabetico,i
14,S0009-741115000195,Antecedentes,o
14,S0009-741115000195,La,o
14,S0009-741115000195,fotocoagulacion,i
14,S0009-741115000195,focal,i
14,S0009-741115000195,interrumpe,o
14,S0009-741115000195,la,o
14,S0009-741115000195,fuga,i
14,S0009-741115000195,vascular,i
14,S0009-741115000195,en,o
14,S0009-741115000195,el,o
14,S0009-741115000195,edema,i
14,S0009-741115000195,macular,i
14,S0009-741115000195,diabetico,i
14,S0009-741115000195,con,o
14,S0009-741115000195,lo,o
14,S0009-741115000195,cual,o
14,S0009-741115000195,el,o
14,S0009-741115000195,epitelio,i
14,S0009-741115000195,pigmentario,i
14,S0009-741115000195,retiniano,i
14,S0009-741115000195,puede,o
14,S0009-741115000195,retirar,o
14,S0009-741115000195,el,o
14,S0009-741115000195,liquido,o
14,S0009-741115000195,que,o
14,S0009-741115000195,engrosa,o
14,S0009-741115000195,la,o
14,S0009-741115000195,retina,i
14,S0009-741115000195,este,o
14,S0009-741115000195,mecanismo,o
14,S0009-741115000195,podria,o
14,S0009-741115000195,facilitarse,o
14,S0009-741115000195,con,o
14,S0009-741115000195,dorzolamida,i
14,S0009-741115000195,un,o
14,S0009-741115000195,inhibidor,i
14,S0009-741115000195,topico,o
14,S0009-741115000195,de,o
14,S0009-741115000195,la,o
14,S0009-741115000195,anhidrasa,i
14,S0009-741115000195,carbonica,i
14,S0009-741115000195,Objetivo,o
14,S0009-741115000195,Determinar,o
14,S0009-741115000195,la,o
14,S0009-741115000195,efi,o
14,S0009-741115000195,de,o
14,S0009-741115000195,dorzolamida,i
14,S0009-741115000195,comparada,o
14,S0009-741115000195,contra,o
14,S0009-741115000195,placebo,i
14,S0009-741115000195,para,o
14,S0009-741115000195,reducir,o
14,S0009-741115000195,el,o
14,S0009-741115000195,grosor,o
14,S0009-741115000195,retiniano,i
14,S0009-741115000195,despues,o
14,S0009-741115000195,de,o
14,S0009-741115000195,la,o
14,S0009-741115000195,fotocoagulacion,i
14,S0009-741115000195,focal,i
14,S0009-741115000195,en,o
14,S0009-741115000195,el,o
14,S0009-741115000195,edema,i
14,S0009-741115000195,macular,i
14,S0009-741115000195,diabetico,i
14,S0009-741115000195,Material,o
14,S0009-741115000195,y,o
14,S0009-741115000195,metodos,o
14,S0009-741115000195,Estudio,o
14,S0009-741115000195,experimental,o
14,S0009-741115000195,comparativo,o
14,S0009-741115000195,prospectivo,o
14,S0009-741115000195,longitudinal,o
14,S0009-741115000195,doble,o
14,S0009-741115000195,ciego,o
14,S0009-741115000195,en,o
14,S0009-741115000195,diabeticos,i
14,S0009-741115000195,con,o
14,S0009-741115000195,edema,i
14,S0009-741115000195,macular,i
14,S0009-741115000195,focal,i
14,S0009-741115000195,tratados,o
14,S0009-741115000195,con,o
14,S0009-741115000195,fotocoagulacion,i
14,S0009-741115000195,aleatorizados,i
14,S0009-741115000195,3,o
14,S0009-741115000195,semanas,o
14,S0009-741115000195,despues,o
14,S0009-741115000195,del,o
14,S0009-741115000195,procedimiento,i
14,S0009-741115000195,para,o
14,S0009-741115000195,recibir,o
14,S0009-741115000195,dorzolamida,i
14,S0009-741115000195,grupo,o
14,S0009-741115000195,1,o
14,S0009-741115000195,o,o
14,S0009-741115000195,placebo,i
14,S0009-741115000195,grupo,o
14,S0009-741115000195,2,o
14,S0009-741115000195,Se,o
14,S0009-741115000195,compararon,o
14,S0009-741115000195,los,o
14,S0009-741115000195,promedios,o
14,S0009-741115000195,de,o
14,S0009-741115000195,agudeza,i
14,S0009-741115000195,visual,i
14,S0009-741115000195,grosor,o
14,S0009-741115000195,del,o
14,S0009-741115000195,punto,o
14,S0009-741115000195,central,o
14,S0009-741115000195,y,o
14,S0009-741115000195,volumen,o
14,S0009-741115000195,macular,i
14,S0009-741115000195,3,o
14,S0009-741115000195,y,o
14,S0009-741115000195,6,o
14,S0009-741115000195,semanas,o
14,S0009-741115000195,despues,o
14,S0009-741115000195,de,o
14,S0009-741115000195,la,o
14,S0009-741115000195,fotocoagulacion,i
14,S0009-741115000195,en,o
14,S0009-741115000195,cada,o
14,S0009-741115000195,grupo,o
14,S0009-741115000195,t,o
14,S0009-741115000195,de,o
14,S0009-741115000195,Wilcoxon,o
14,S0009-741115000195,y,o
14,S0009-741115000195,entre,o
14,S0009-741115000195,grupos,o
14,S0009-741115000195,U,o
14,S0009-741115000195,de,o
14,S0009-741115000195,MannWhitney,o
14,S0009-741115000195,Resultados,o
14,S0009-741115000195,Setenta,o
14,S0009-741115000195,y,o
14,S0009-741115000195,nueve,o
14,S0009-741115000195,ojos,i
14,S0009-741115000195,de,o
14,S0009-741115000195,pacientes,o
14,S0009-741115000195,con,o
14,S0009-741115000195,una,o
14,S0009-741115000195,edad,o
14,S0009-741115000195,desviacion,o
14,S0009-741115000195,estandar,o
14,S0009-741115000195,de,o
14,S0009-741115000195,583,o
14,S0009-741115000195,83,o
14,S0009-741115000195,años,o
14,S0009-741115000195,se,o
14,S0009-741115000195,asignaron,o
14,S0009-741115000195,37,o
14,S0009-741115000195,al,o
14,S0009-741115000195,grupo,o
14,S0009-741115000195,1,o
14,S0009-741115000195,y,o
14,S0009-741115000195,42,o
14,S0009-741115000195,al,o
14,S0009-741115000195,grupo,o
14,S0009-741115000195,2,o
14,S0009-741115000195,El,o
14,S0009-741115000195,grosor,o
14,S0009-741115000195,del,o
14,S0009-741115000195,punto,o
14,S0009-741115000195,central,o
14,S0009-741115000195,cambio,o
14,S0009-741115000195,de,o
14,S0009-741115000195,1784,o
14,S0009-741115000195,34,o
14,S0009-741115000195,μm,o
14,S0009-741115000195,a,o
14,S0009-741115000195,170,o
14,S0009-741115000195,291,o
14,S0009-741115000195,μm,o
14,S0009-741115000195,en,o
14,S0009-741115000195,el,o
14,S0009-741115000195,grupo,o
14,S0009-741115000195,1,o
14,S0009-741115000195,p,o
14,S0009-741115000195,004,o
14,S0009-741115000195,y,o
14,S0009-741115000195,de,o
14,S0009-741115000195,1792,o
14,S0009-741115000195,224,o
14,S0009-741115000195,μm,o
14,S0009-741115000195,a,o
14,S0009-741115000195,1786,o
14,S0009-741115000195,208,o
14,S0009-741115000195,μm,o
14,S0009-741115000195,en,o
14,S0009-741115000195,el,o
14,S0009-741115000195,2,o
14,S0009-741115000195,p,o
14,S0009-741115000195,07,o
14,S0009-741115000195,el,o
14,S0009-741115000195,volumen,o
14,S0009-741115000195,macular,i
14,S0009-741115000195,cambio,o
14,S0009-741115000195,de,o
14,S0009-741115000195,763,o
14,S0009-741115000195,052,o
14,S0009-741115000195,mm3,o
14,S0009-741115000195,a,o
14,S0009-741115000195,750,o
14,S0009-741115000195,050,o
14,S0009-741115000195,mm3,o
14,S0009-741115000195,en,o
14,S0009-741115000195,el,o
14,S0009-741115000195,grupo,o
14,S0009-741115000195,1,o
14,S0009-741115000195,p,o
14,S0009-741115000195,0002,o
14,S0009-741115000195,y,o
14,S0009-741115000195,de,o
14,S0009-741115000195,782,o
14,S0009-741115000195,043,o
14,S0009-741115000195,mm3,o
14,S0009-741115000195,a,o
14,S0009-741115000195,776,o
14,S0009-741115000195,042,o
14,S0009-741115000195,mm3,o
14,S0009-741115000195,en,o
14,S0009-741115000195,el,o
14,S0009-741115000195,grupo,o
14,S0009-741115000195,2,o
14,S0009-741115000195,p,o
14,S0009-741115000195,0013,o
14,S0009-741115000195,Conclusiones,o
14,S0009-741115000195,La,o
14,S0009-741115000195,dorzolamida,i
14,S0009-741115000195,aplicada,o
14,S0009-741115000195,durante,o
14,S0009-741115000195,3,o
14,S0009-741115000195,semanas,o
14,S0009-741115000195,fue,o
14,S0009-741115000195,mas,o
14,S0009-741115000195,eficaz,o
14,S0009-741115000195,que,o
14,S0009-741115000195,el,o
14,S0009-741115000195,placebo,i
14,S0009-741115000195,para,o
14,S0009-741115000195,reducir,o
14,S0009-741115000195,el,o
14,S0009-741115000195,grosor,o
14,S0009-741115000195,retiniano,i
14,S0009-741115000195,despues,o
14,S0009-741115000195,de,o
14,S0009-741115000195,la,o
14,S0009-741115000195,fotocoagulacion,i
14,S0009-741115000195,focal,i
14,S0009-741115000195,en,o
14,S0009-741115000195,diabeticos,i
14,S0009-741115000195,con,o
14,S0009-741115000195,edema,i
14,S0009-741115000195,macular,i
15,S0009-741115000870,El,o
15,S0009-741115000870,seguimiento,i
15,S0009-741115000870,telemetrico,i
15,S0009-741115000870,disminuye,o
15,S0009-741115000870,la,o
15,S0009-741115000870,visita,o
15,S0009-741115000870,a,o
15,S0009-741115000870,la,o
15,S0009-741115000870,sala,o
15,S0009-741115000870,de,o
15,S0009-741115000870,urgencias,o
15,S0009-741115000870,y,o
15,S0009-741115000870,coste,o
15,S0009-741115000870,de,o
15,S0009-741115000870,atencion,o
15,S0009-741115000870,en,o
15,S0009-741115000870,enfermos,i
15,S0009-741115000870,con,o
15,S0009-741115000870,insuficiencia,i
15,S0009-741115000870,cardiaca,i
15,S0009-741115000870,cronica,i
15,S0009-741115000870,Antecedentes,o
15,S0009-741115000870,La,o
15,S0009-741115000870,telecardiologia,i
15,S0009-741115000870,es,o
15,S0009-741115000870,el,o
15,S0009-741115000870,uso,o
15,S0009-741115000870,de,o
15,S0009-741115000870,tecnologias,o
15,S0009-741115000870,de,o
15,S0009-741115000870,la,o
15,S0009-741115000870,informacion,o
15,S0009-741115000870,que,o
15,S0009-741115000870,permiten,o
15,S0009-741115000870,prolongar,o
15,S0009-741115000870,la,o
15,S0009-741115000870,supervivencia,o
15,S0009-741115000870,mejorar,o
15,S0009-741115000870,la,o
15,S0009-741115000870,calidad,o
15,S0009-741115000870,de,o
15,S0009-741115000870,vida,o
15,S0009-741115000870,y,o
15,S0009-741115000870,reducir,o
15,S0009-741115000870,costos,o
15,S0009-741115000870,en,o
15,S0009-741115000870,la,o
15,S0009-741115000870,atencion,o
15,S0009-741115000870,de,o
15,S0009-741115000870,la,o
15,S0009-741115000870,salud,o
15,S0009-741115000870,de,o
15,S0009-741115000870,algunas,o
15,S0009-741115000870,enfermedades,i
15,S0009-741115000870,como,o
15,S0009-741115000870,la,o
15,S0009-741115000870,insuficiencia,i
15,S0009-741115000870,cardiaca,i
15,S0009-741115000870,Objetivo,o
15,S0009-741115000870,Determinar,o
15,S0009-741115000870,la,o
15,S0009-741115000870,eficacia,o
15,S0009-741115000870,del,o
15,S0009-741115000870,seguimiento,i
15,S0009-741115000870,telemetrico,i
15,S0009-741115000870,para,o
15,S0009-741115000870,el,o
15,S0009-741115000870,control,i
15,S0009-741115000870,de,o
15,S0009-741115000870,variables,o
15,S0009-741115000870,clinicas,o
15,S0009-741115000870,disminucion,o
15,S0009-741115000870,de,o
15,S0009-741115000870,visitas,o
15,S0009-741115000870,a,o
15,S0009-741115000870,urgencias,o
15,S0009-741115000870,y,o
15,S0009-741115000870,costo,o
15,S0009-741115000870,de,o
15,S0009-741115000870,atencion,o
15,S0009-741115000870,en,o
15,S0009-741115000870,un,o
15,S0009-741115000870,grupo,o
15,S0009-741115000870,de,o
15,S0009-741115000870,enfermos,i
15,S0009-741115000870,con,o
15,S0009-741115000870,insuficiencia,i
15,S0009-741115000870,cardiaca,i
15,S0009-741115000870,en,o
15,S0009-741115000870,comparacion,o
15,S0009-741115000870,con,o
15,S0009-741115000870,la,o
15,S0009-741115000870,consulta,i
15,S0009-741115000870,medica,i
15,S0009-741115000870,tradicional,o
15,S0009-741115000870,Material,o
15,S0009-741115000870,y,o
15,S0009-741115000870,metodos,o
15,S0009-741115000870,Ensayo,o
15,S0009-741115000870,clinico,o
15,S0009-741115000870,aleatorizado,o
15,S0009-741115000870,controlado,o
15,S0009-741115000870,y,o
15,S0009-741115000870,abierto,o
15,S0009-741115000870,en,o
15,S0009-741115000870,40,o
15,S0009-741115000870,enfermos,i
15,S0009-741115000870,con,o
15,S0009-741115000870,insuficiencia,i
15,S0009-741115000870,cardiaca,i
15,S0009-741115000870,en,o
15,S0009-741115000870,un,o
15,S0009-741115000870,centro,o
15,S0009-741115000870,de,o
15,S0009-741115000870,tercer,o
15,S0009-741115000870,nivel,o
15,S0009-741115000870,de,o
15,S0009-741115000870,atencion,o
15,S0009-741115000870,del,o
15,S0009-741115000870,noroeste,o
15,S0009-741115000870,de,o
15,S0009-741115000870,Mexico,o
15,S0009-741115000870,Aleatoriamente,i
15,S0009-741115000870,se,o
15,S0009-741115000870,formaron,o
15,S0009-741115000870,2,o
15,S0009-741115000870,grupos,o
15,S0009-741115000870,de,o
15,S0009-741115000870,20,o
15,S0009-741115000870,enfermos,i
15,S0009-741115000870,cada,o
15,S0009-741115000870,uno,o
15,S0009-741115000870,seguimiento,i
15,S0009-741115000870,telemetrico,i
15,S0009-741115000870,consulta,i
15,S0009-741115000870,medica,i
15,S0009-741115000870,tradicional,o
15,S0009-741115000870,Las,o
15,S0009-741115000870,variables,o
15,S0009-741115000870,evaluadas,o
15,S0009-741115000870,fueron,o
15,S0009-741115000870,presion,o
15,S0009-741115000870,arterial,i
15,S0009-741115000870,frecuencia,o
15,S0009-741115000870,cardiaca,i
15,S0009-741115000870,y,o
15,S0009-741115000870,peso,o
15,S0009-741115000870,corporal,i
15,S0009-741115000870,El,o
15,S0009-741115000870,grupo,o
15,S0009-741115000870,de,o
15,S0009-741115000870,seguimiento,i
15,S0009-741115000870,telemetrico,i
15,S0009-741115000870,se,o
15,S0009-741115000870,vigilo,o
15,S0009-741115000870,a,o
15,S0009-741115000870,distancia,o
15,S0009-741115000870,y,o
15,S0009-741115000870,el,o
15,S0009-741115000870,grupo,o
15,S0009-741115000870,de,o
15,S0009-741115000870,consulta,i
15,S0009-741115000870,medica,i
15,S0009-741115000870,tradicional,o
15,S0009-741115000870,acudio,o
15,S0009-741115000870,en,o
15,S0009-741115000870,fechas,o
15,S0009-741115000870,programadas,o
15,S0009-741115000870,al,o
15,S0009-741115000870,hospital,o
15,S0009-741115000870,Todos,o
15,S0009-741115000870,podian,o
15,S0009-741115000870,acudir,o
15,S0009-741115000870,al,o
15,S0009-741115000870,servicio,o
15,S0009-741115000870,de,o
15,S0009-741115000870,urgencias,o
15,S0009-741115000870,en,o
15,S0009-741115000870,caso,o
15,S0009-741115000870,necesario,o
15,S0009-741115000870,Resultados,o
15,S0009-741115000870,El,o
15,S0009-741115000870,grupo,o
15,S0009-741115000870,de,o
15,S0009-741115000870,seguimiento,i
15,S0009-741115000870,telemetrico,i
15,S0009-741115000870,redujo,o
15,S0009-741115000870,su,o
15,S0009-741115000870,peso,o
15,S0009-741115000870,y,o
15,S0009-741115000870,mejoro,o
15,S0009-741115000870,el,o
15,S0009-741115000870,control,i
15,S0009-741115000870,de,o
15,S0009-741115000870,su,o
15,S0009-741115000870,enfermedad,i
15,S0009-741115000870,p,o
15,S0009-741115000870,001,o
15,S0009-741115000870,La,o
15,S0009-741115000870,presion,i
15,S0009-741115000870,arterial,i
15,S0009-741115000870,sistolica,i
15,S0009-741115000870,disminuyo,o
15,S0009-741115000870,significativamente,o
15,S0009-741115000870,p,o
15,S0009-741115000870,005,o
15,S0009-741115000870,El,o
15,S0009-741115000870,coste,o
15,S0009-741115000870,de,o
15,S0009-741115000870,atencion,o
15,S0009-741115000870,se,o
15,S0009-741115000870,redujo,o
15,S0009-741115000870,en,o
15,S0009-741115000870,el,o
15,S0009-741115000870,grupo,o
15,S0009-741115000870,de,o
15,S0009-741115000870,seguimiento,i
15,S0009-741115000870,telemetrico,i
15,S0009-741115000870,51,o
15,S0009-741115000870,en,o
15,S0009-741115000870,comparacion,o
15,S0009-741115000870,con,o
15,S0009-741115000870,el,o
15,S0009-741115000870,grupo,o
15,S0009-741115000870,de,o
15,S0009-741115000870,consulta,i
15,S0009-741115000870,medica,i
15,S0009-741115000870,tradicional,o
15,S0009-741115000870,Se,o
15,S0009-741115000870,evito,o
15,S0009-741115000870,el,o
15,S0009-741115000870,ingreso,i
15,S0009-741115000870,a,i
15,S0009-741115000870,urgencias,i
15,S0009-741115000870,en,o
15,S0009-741115000870,el,o
15,S0009-741115000870,100,o
15,S0009-741115000870,de,o
15,S0009-741115000870,los,o
15,S0009-741115000870,enfermos,i
15,S0009-741115000870,del,o
15,S0009-741115000870,grupo,o
15,S0009-741115000870,de,o
15,S0009-741115000870,seguimiento,i
15,S0009-741115000870,telemetrico,i
15,S0009-741115000870,Conclusiones,o
15,S0009-741115000870,En,o
15,S0009-741115000870,enfermos,i
15,S0009-741115000870,con,o
15,S0009-741115000870,insuficiencia,i
15,S0009-741115000870,cardiaca,i
15,S0009-741115000870,el,o
15,S0009-741115000870,seguimiento,i
15,S0009-741115000870,telemetrico,i
15,S0009-741115000870,fue,o
15,S0009-741115000870,efectivo,o
15,S0009-741115000870,en,o
15,S0009-741115000870,disminuir,o
15,S0009-741115000870,las,o
15,S0009-741115000870,visitas,o
15,S0009-741115000870,a,o
15,S0009-741115000870,urgencias,o
15,S0009-741115000870,y,o
15,S0009-741115000870,ahorro,o
15,S0009-741115000870,significativamente,o
15,S0009-741115000870,recursos,o
15,S0009-741115000870,en,o
15,S0009-741115000870,la,o
15,S0009-741115000870,atencion,o
15,S0009-741115000870,durante,o
15,S0009-741115000870,el,o
15,S0009-741115000870,seguimiento,i
16,S0009-741115002261,Aplicacion,o
16,S0009-741115002261,de,o
16,S0009-741115002261,sellante,i
16,S0009-741115002261,de,i
16,S0009-741115002261,fibrina,i
16,S0009-741115002261,en,o
16,S0009-741115002261,pacientes,o
16,S0009-741115002261,operados,i
16,S0009-741115002261,por,o
16,S0009-741115002261,cancer,i
16,S0009-741115002261,diferenciado,i
16,S0009-741115002261,de,i
16,S0009-741115002261,tiroides,i
16,S0009-741115002261,Que,o
16,S0009-741115002261,mejoramos,o
16,S0009-741115002261,Antecedentes,o
16,S0009-741115002261,En,o
16,S0009-741115002261,los,o
16,S0009-741115002261,ultimos,o
16,S0009-741115002261,años,o
16,S0009-741115002261,han,o
16,S0009-741115002261,aparecido,o
16,S0009-741115002261,diferentes,o
16,S0009-741115002261,publicaciones,o
16,S0009-741115002261,que,o
16,S0009-741115002261,demuestran,o
16,S0009-741115002261,que,o
16,S0009-741115002261,los,o
16,S0009-741115002261,nuevos,o
16,S0009-741115002261,sellantes,i
16,S0009-741115002261,adhesivos,i
16,S0009-741115002261,como,o
16,S0009-741115002261,Tissucol,i
16,S0009-741115002261,que,o
16,S0009-741115002261,son,o
16,S0009-741115002261,aplicados,o
16,S0009-741115002261,en,o
16,S0009-741115002261,el,o
16,S0009-741115002261,espacio,i
16,S0009-741115002261,tiroideo,i
16,S0009-741115002261,reducen,o
16,S0009-741115002261,las,o
16,S0009-741115002261,complicaciones,i
16,S0009-741115002261,locales,i
16,S0009-741115002261,tras,o
16,S0009-741115002261,tiroidectomias,i
16,S0009-741115002261,complejas,o
16,S0009-741115002261,Objetivos,o
16,S0009-741115002261,Mostrar,o
16,S0009-741115002261,la,o
16,S0009-741115002261,eficacia,o
16,S0009-741115002261,del,o
16,S0009-741115002261,adhesivo,i
16,S0009-741115002261,de,i
16,S0009-741115002261,fibrina,i
16,S0009-741115002261,Tissucol,i
16,S0009-741115002261,en,o
16,S0009-741115002261,la,o
16,S0009-741115002261,reduccion,o
16,S0009-741115002261,de,o
16,S0009-741115002261,la,o
16,S0009-741115002261,estancia,o
16,S0009-741115002261,hospitalaria,o
16,S0009-741115002261,postoperatoria,o
16,S0009-741115002261,de,o
16,S0009-741115002261,los,o
16,S0009-741115002261,pacientes,o
16,S0009-741115002261,intervenidos,i
16,S0009-741115002261,de,o
16,S0009-741115002261,carcinoma,i
16,S0009-741115002261,diferenciado,i
16,S0009-741115002261,de,i
16,S0009-741115002261,tiroides,i
16,S0009-741115002261,en,o
16,S0009-741115002261,quienes,o
16,S0009-741115002261,se,o
16,S0009-741115002261,realizo,o
16,S0009-741115002261,tiroidectomia,i
16,S0009-741115002261,total,i
16,S0009-741115002261,con,i
16,S0009-741115002261,vaciamiento,i
16,S0009-741115002261,ganglionar,i
16,S0009-741115002261,central,o
16,S0009-741115002261,y,o
16,S0009-741115002261,unilateral,o
16,S0009-741115002261,Material,o
16,S0009-741115002261,y,o
16,S0009-741115002261,metodos,o
16,S0009-741115002261,Realizamos,o
16,S0009-741115002261,un,o
16,S0009-741115002261,estudio,i
16,S0009-741115002261,prospectivo,i
16,S0009-741115002261,y,i
16,S0009-741115002261,aleatorizado,i
16,S0009-741115002261,durante,o
16,S0009-741115002261,el,o
16,S0009-741115002261,periodo,o
16,S0009-741115002261,comprendido,o
16,S0009-741115002261,entre,o
16,S0009-741115002261,mayo,o
16,S0009-741115002261,de,o
16,S0009-741115002261,2009,o
16,S0009-741115002261,y,o
16,S0009-741115002261,octubre,o
16,S0009-741115002261,de,o
16,S0009-741115002261,2013,o
16,S0009-741115002261,en,o
16,S0009-741115002261,pacientes,o
16,S0009-741115002261,con,o
16,S0009-741115002261,carcinoma,i
16,S0009-741115002261,diferenciado,i
16,S0009-741115002261,de,i
16,S0009-741115002261,tiroides,i
16,S0009-741115002261,con,i
16,S0009-741115002261,metastasis,i
16,S0009-741115002261,ganglionares,i
16,S0009-741115002261,cervicales,i
16,S0009-741115002261,para,o
16,S0009-741115002261,la,o
16,S0009-741115002261,realizacion,o
16,S0009-741115002261,de,o
16,S0009-741115002261,cirugia,i
16,S0009-741115002261,programada,o
16,S0009-741115002261,Se,o
16,S0009-741115002261,formaron,o
16,S0009-741115002261,2,o
16,S0009-741115002261,grupos,o
16,S0009-741115002261,en,o
16,S0009-741115002261,los,o
16,S0009-741115002261,que,o
16,S0009-741115002261,se,o
16,S0009-741115002261,utilizo,o
16,S0009-741115002261,Tissucol,i
16,S0009-741115002261,grupo,o
16,S0009-741115002261,caso,o
16,S0009-741115002261,y,o
16,S0009-741115002261,en,o
16,S0009-741115002261,los,o
16,S0009-741115002261,que,o
16,S0009-741115002261,no,o
16,S0009-741115002261,grupo,o
16,S0009-741115002261,control,o
16,S0009-741115002261,Los,o
16,S0009-741115002261,pacientes,o
16,S0009-741115002261,fueron,o
16,S0009-741115002261,operados,i
16,S0009-741115002261,por,o
16,S0009-741115002261,cirujanos,o
16,S0009-741115002261,especialmente,o
16,S0009-741115002261,dedicados,o
16,S0009-741115002261,a,o
16,S0009-741115002261,patologia,i
16,S0009-741115002261,quirurgica,i
16,S0009-741115002261,endocrina,i
16,S0009-741115002261,utilizando,o
16,S0009-741115002261,la,o
16,S0009-741115002261,misma,o
16,S0009-741115002261,tecnica,o
16,S0009-741115002261,en,o
16,S0009-741115002261,todos,o
16,S0009-741115002261,ellos,o
16,S0009-741115002261,Resultados,o
16,S0009-741115002261,Realizamos,o
16,S0009-741115002261,60,o
16,S0009-741115002261,tiroidectomias,i
16,S0009-741115002261,totales,i
16,S0009-741115002261,con,i
16,S0009-741115002261,vaciamiento,i
16,S0009-741115002261,ganglionar,i
16,S0009-741115002261,30,o
16,S0009-741115002261,en,o
16,S0009-741115002261,el,o
16,S0009-741115002261,grupo,o
16,S0009-741115002261,caso,o
16,S0009-741115002261,que,o
16,S0009-741115002261,se,o
16,S0009-741115002261,compararon,o
16,S0009-741115002261,con,o
16,S0009-741115002261,30,o
16,S0009-741115002261,del,o
16,S0009-741115002261,grupo,o
16,S0009-741115002261,control,o
16,S0009-741115002261,No,o
16,S0009-741115002261,observamos,o
16,S0009-741115002261,diferencias,o
16,S0009-741115002261,significativas,o
16,S0009-741115002261,en,o
16,S0009-741115002261,la,o
16,S0009-741115002261,mayoria,o
16,S0009-741115002261,de,o
16,S0009-741115002261,las,o
16,S0009-741115002261,variables,o
16,S0009-741115002261,estudiadas,o
16,S0009-741115002261,no,o
16,S0009-741115002261,obstante,o
16,S0009-741115002261,el,o
16,S0009-741115002261,grupo,o
16,S0009-741115002261,caso,o
16,S0009-741115002261,presento,o
16,S0009-741115002261,una,o
16,S0009-741115002261,menor,o
16,S0009-741115002261,estancia,o
16,S0009-741115002261,hospitalaria,o
16,S0009-741115002261,respecto,o
16,S0009-741115002261,al,o
16,S0009-741115002261,grupo,o
16,S0009-741115002261,control,o
16,S0009-741115002261,con,o
16,S0009-741115002261,una,o
16,S0009-741115002261,diferencia,o
16,S0009-741115002261,estadisticamente,o
16,S0009-741115002261,significativa,o
16,S0009-741115002261,p,o
16,S0009-741115002261,005,o
16,S0009-741115002261,Conclusion,o
16,S0009-741115002261,La,o
16,S0009-741115002261,aplicacion,o
16,S0009-741115002261,del,o
16,S0009-741115002261,Tissucol,i
16,S0009-741115002261,ha,o
16,S0009-741115002261,permitido,o
16,S0009-741115002261,reducir,o
16,S0009-741115002261,la,o
16,S0009-741115002261,estancia,o
16,S0009-741115002261,hospitalaria,o
16,S0009-741115002261,de,o
16,S0009-741115002261,los,o
16,S0009-741115002261,pacientes,o
16,S0009-741115002261,operados,i
16,S0009-741115002261,de,o
16,S0009-741115002261,tiroidectomia,i
16,S0009-741115002261,total,i
16,S0009-741115002261,con,i
16,S0009-741115002261,vaciamiento,i
16,S0009-741115002261,cervical,i
16,S0009-741115002261,lo,o
16,S0009-741115002261,que,o
16,S0009-741115002261,representa,o
16,S0009-741115002261,para,o
16,S0009-741115002261,el,o
16,S0009-741115002261,hospital,o
16,S0009-741115002261,una,o
16,S0009-741115002261,reduccion,o
16,S0009-741115002261,de,o
16,S0009-741115002261,costos,o
16,S0009-741115002261,sin,o
16,S0009-741115002261,que,o
16,S0009-741115002261,ello,o
16,S0009-741115002261,influya,o
16,S0009-741115002261,en,o
16,S0009-741115002261,la,o
16,S0009-741115002261,aparicion,o
16,S0009-741115002261,de,o
16,S0009-741115002261,complicaciones,i
16,S0009-741115002261,relacionadas,o
16,S0009-741115002261,con,o
16,S0009-741115002261,la,o
16,S0009-741115002261,intervencion,i
17,S0009-741115002339,Aplicacion,o
17,S0009-741115002339,de,o
17,S0009-741115002339,sellante,i
17,S0009-741115002339,tisular,i
17,S0009-741115002339,como,o
17,S0009-741115002339,refuerzo,o
17,S0009-741115002339,de,o
17,S0009-741115002339,las,o
17,S0009-741115002339,anastomosis,i
17,S0009-741115002339,digestivas,i
17,S0009-741115002339,realizadas,o
17,S0009-741115002339,en,o
17,S0009-741115002339,pacientes,o
17,S0009-741115002339,con,o
17,S0009-741115002339,carcinomatosis,i
17,S0009-741115002339,peritoneal,i
17,S0009-741115002339,tratados,i
17,S0009-741115002339,con,o
17,S0009-741115002339,intencion,o
17,S0009-741115002339,curativa,o
17,S0009-741115002339,mediante,o
17,S0009-741115002339,procedimiento,i
17,S0009-741115002339,quirurgico,i
17,S0009-741115002339,de,i
17,S0009-741115002339,citorreduccion,i
17,S0009-741115002339,y,o
17,S0009-741115002339,quimioterapia,i
17,S0009-741115002339,intraperitoneal,i
17,S0009-741115002339,intraoperatoria,i
17,S0009-741115002339,hipertermica,i
17,S0009-741115002339,Antecedentes,o
17,S0009-741115002339,La,o
17,S0009-741115002339,enfermedad,i
17,S0009-741115002339,peritoneal,i
17,S0009-741115002339,diseminada,i
17,S0009-741115002339,debe,o
17,S0009-741115002339,considerarse,o
17,S0009-741115002339,como,o
17,S0009-741115002339,un,o
17,S0009-741115002339,estadio,o
17,S0009-741115002339,locorregional,o
17,S0009-741115002339,de,o
17,S0009-741115002339,la,o
17,S0009-741115002339,enfermedad,i
17,S0009-741115002339,y,o
17,S0009-741115002339,por,o
17,S0009-741115002339,tanto,o
17,S0009-741115002339,candidata,o
17,S0009-741115002339,a,o
17,S0009-741115002339,una,o
17,S0009-741115002339,opcion,o
17,S0009-741115002339,terapeutica,o
17,S0009-741115002339,con,o
17,S0009-741115002339,intencion,o
17,S0009-741115002339,curativa,o
17,S0009-741115002339,mediante,o
17,S0009-741115002339,cirugia,i
17,S0009-741115002339,citorreductora,i
17,S0009-741115002339,y,o
17,S0009-741115002339,quimioterapia,i
17,S0009-741115002339,intraperitoneal,i
17,S0009-741115002339,hipertermica,i
17,S0009-741115002339,perioperatoria,o
17,S0009-741115002339,Objetivo,o
17,S0009-741115002339,Comprobar,o
17,S0009-741115002339,si,o
17,S0009-741115002339,la,o
17,S0009-741115002339,esponja,o
17,S0009-741115002339,de,o
17,S0009-741115002339,colageno,i
17,S0009-741115002339,con,o
17,S0009-741115002339,fibrinogeno,i
17,S0009-741115002339,55,o
17,S0009-741115002339,mg,o
17,S0009-741115002339,y,o
17,S0009-741115002339,trombina,i
17,S0009-741115002339,2,o
17,S0009-741115002339,UI,o
17,S0009-741115002339,aplicada,o
17,S0009-741115002339,como,o
17,S0009-741115002339,sellante,i
17,S0009-741115002339,tisular,i
17,S0009-741115002339,contribuye,o
17,S0009-741115002339,a,o
17,S0009-741115002339,la,o
17,S0009-741115002339,reduccion,o
17,S0009-741115002339,del,o
17,S0009-741115002339,numero,o
17,S0009-741115002339,de,o
17,S0009-741115002339,dehiscencia,i
17,S0009-741115002339,anastomoticas,i
17,S0009-741115002339,Material,o
17,S0009-741115002339,y,o
17,S0009-741115002339,metodos,o
17,S0009-741115002339,Estudio,o
17,S0009-741115002339,cuasiexperimental,o
17,S0009-741115002339,comparativo,o
17,S0009-741115002339,prospectivo,o
17,S0009-741115002339,caso,o
17,S0009-741115002339,y,o
17,S0009-741115002339,controles,o
17,S0009-741115002339,en,o
17,S0009-741115002339,pacientes,o
17,S0009-741115002339,con,o
17,S0009-741115002339,carcinomatosis,i
17,S0009-741115002339,peritoneal,i
17,S0009-741115002339,de,i
17,S0009-741115002339,origen,i
17,S0009-741115002339,colorrectal,i
17,S0009-741115002339,intervenidos,i
17,S0009-741115002339,en,o
17,S0009-741115002339,nuestra,o
17,S0009-741115002339,Unidad,o
17,S0009-741115002339,de,o
17,S0009-741115002339,Cirugia,o
17,S0009-741115002339,Oncologica,o
17,S0009-741115002339,Peritoneal,o
17,S0009-741115002339,desde,o
17,S0009-741115002339,2011,o
17,S0009-741115002339,hasta,o
17,S0009-741115002339,abril,o
17,S0009-741115002339,de,o
17,S0009-741115002339,2014,o
17,S0009-741115002339,Nuestra,o
17,S0009-741115002339,serie,o
17,S0009-741115002339,consta,o
17,S0009-741115002339,de,o
17,S0009-741115002339,73,o
17,S0009-741115002339,pacientes,o
17,S0009-741115002339,43,o
17,S0009-741115002339,59,o
17,S0009-741115002339,hombres,o
17,S0009-741115002339,y,o
17,S0009-741115002339,30,o
17,S0009-741115002339,41,o
17,S0009-741115002339,mujeres,o
17,S0009-741115002339,diagnosticados,i
17,S0009-741115002339,de,o
17,S0009-741115002339,cancer,i
17,S0009-741115002339,de,i
17,S0009-741115002339,origen,i
17,S0009-741115002339,colorrectal,i
17,S0009-741115002339,y,o
17,S0009-741115002339,candidatos,o
17,S0009-741115002339,a,o
17,S0009-741115002339,cirugia,i
17,S0009-741115002339,citorreductora,i
17,S0009-741115002339,y,o
17,S0009-741115002339,quimioterapia,i
17,S0009-741115002339,intraperitoneal,i
17,S0009-741115002339,hipertermica,i
17,S0009-741115002339,perioperatoria,o
17,S0009-741115002339,En,o
17,S0009-741115002339,49,o
17,S0009-741115002339,pacientes,o
17,S0009-741115002339,67,o
17,S0009-741115002339,se,o
17,S0009-741115002339,realizaron,o
17,S0009-741115002339,anastomosis,i
17,S0009-741115002339,digestivas,i
17,S0009-741115002339,dichos,o
17,S0009-741115002339,pacientes,o
17,S0009-741115002339,se,o
17,S0009-741115002339,aleatorizaron,i
17,S0009-741115002339,en,o
17,S0009-741115002339,2,o
17,S0009-741115002339,grupos,o
17,S0009-741115002339,A,o
17,S0009-741115002339,control,o
17,S0009-741115002339,27,o
17,S0009-741115002339,y,o
17,S0009-741115002339,B,o
17,S0009-741115002339,hipotesis,o
17,S0009-741115002339,22,o
17,S0009-741115002339,con,o
17,S0009-741115002339,sutura,i
17,S0009-741115002339,reforzada,i
17,S0009-741115002339,con,i
17,S0009-741115002339,esponja,i
17,S0009-741115002339,Resultados,o
17,S0009-741115002339,El,o
17,S0009-741115002339,numero,o
17,S0009-741115002339,total,o
17,S0009-741115002339,de,o
17,S0009-741115002339,anastomosis,i
17,S0009-741115002339,fueron,o
17,S0009-741115002339,49,o
17,S0009-741115002339,x,o
17,S0009-741115002339,19,o
17,S0009-741115002339,27,o
17,S0009-741115002339,en,o
17,S0009-741115002339,el,o
17,S0009-741115002339,grupo,o
17,S0009-741115002339,A,o
17,S0009-741115002339,x,o
17,S0009-741115002339,188,o
17,S0009-741115002339,y,o
17,S0009-741115002339,22,o
17,S0009-741115002339,en,o
17,S0009-741115002339,B,o
17,S0009-741115002339,x,o
17,S0009-741115002339,216,o
17,S0009-741115002339,Las,o
17,S0009-741115002339,citorreducciones,i
17,S0009-741115002339,alcanzadas,o
17,S0009-741115002339,fueron,o
17,S0009-741115002339,citorreduccion,i
17,S0009-741115002339,completa,o
17,S0009-741115002339,0,o
17,S0009-741115002339,38,o
17,S0009-741115002339,775,o
17,S0009-741115002339,citorreduccion,i
17,S0009-741115002339,completa,o
17,S0009-741115002339,1,o
17,S0009-741115002339,7,o
17,S0009-741115002339,148,o
17,S0009-741115002339,y,o
17,S0009-741115002339,en,o
17,S0009-741115002339,4,o
17,S0009-741115002339,81,o
17,S0009-741115002339,no,o
17,S0009-741115002339,se,o
17,S0009-741115002339,realizo,o
17,S0009-741115002339,quimioterapia,i
17,S0009-741115002339,intraperitoneal,i
17,S0009-741115002339,hipertermica,i
17,S0009-741115002339,perioperatoria,o
17,S0009-741115002339,por,o
17,S0009-741115002339,citorreduccion,i
17,S0009-741115002339,completa,o
17,S0009-741115002339,2,o
17,S0009-741115002339,Fistula,i
17,S0009-741115002339,intestinal,i
17,S0009-741115002339,3,o
17,S0009-741115002339,casos,o
17,S0009-741115002339,61,o
17,S0009-741115002339,en,o
17,S0009-741115002339,el,o
17,S0009-741115002339,grupo,o
17,S0009-741115002339,A,o
17,S0009-741115002339,sin,o
17,S0009-741115002339,esponja,o
17,S0009-741115002339,medicamentosa,i
17,S0009-741115002339,frente,o
17,S0009-741115002339,a,o
17,S0009-741115002339,0,o
17,S0009-741115002339,en,o
17,S0009-741115002339,el,o
17,S0009-741115002339,grupo,o
17,S0009-741115002339,B,o
17,S0009-741115002339,Conclusion,o
17,S0009-741115002339,El,o
17,S0009-741115002339,empleo,o
17,S0009-741115002339,en,o
17,S0009-741115002339,nuestra,o
17,S0009-741115002339,serie,o
17,S0009-741115002339,de,o
17,S0009-741115002339,la,o
17,S0009-741115002339,esponja,o
17,S0009-741115002339,de,o
17,S0009-741115002339,fibrinogeno,i
17,S0009-741115002339,y,o
17,S0009-741115002339,trombina,i
17,S0009-741115002339,ha,o
17,S0009-741115002339,contribuido,o
17,S0009-741115002339,a,o
17,S0009-741115002339,una,o
17,S0009-741115002339,reduccion,o
17,S0009-741115002339,significativa,o
17,S0009-741115002339,del,o
17,S0009-741115002339,riesgo,o
17,S0009-741115002339,de,o
17,S0009-741115002339,fistulas,i
17,S0009-741115002339,digestivas,i
17,S0009-741115002339,en,o
17,S0009-741115002339,pacientes,o
17,S0009-741115002339,oncologicos,o
17,S0009-741115002339,de,o
17,S0009-741115002339,alto,o
17,S0009-741115002339,riesgo,o
18,S0009-741115002911,Impacto,o
18,S0009-741115002911,del,o
18,S0009-741115002911,manejo,o
18,S0009-741115002911,con,o
18,S0009-741115002911,cierre,i
18,S0009-741115002911,asistido,i
18,S0009-741115002911,al,i
18,S0009-741115002911,vacio,i
18,S0009-741115002911,en,o
18,S0009-741115002911,abscesos,i
18,S0009-741115002911,profundos,i
18,S0009-741115002911,de,i
18,S0009-741115002911,cuello,i
18,S0009-741115002911,Antecedentes,o
18,S0009-741115002911,La,o
18,S0009-741115002911,presencia,o
18,S0009-741115002911,de,o
18,S0009-741115002911,abscesos,i
18,S0009-741115002911,profundos,i
18,S0009-741115002911,de,i
18,S0009-741115002911,cuello,i
18,S0009-741115002911,es,o
18,S0009-741115002911,potencialmente,o
18,S0009-741115002911,grave,o
18,S0009-741115002911,incluso,o
18,S0009-741115002911,puede,o
18,S0009-741115002911,llevar,o
18,S0009-741115002911,a,o
18,S0009-741115002911,la,o
18,S0009-741115002911,muerte,i
18,S0009-741115002911,en,o
18,S0009-741115002911,un,o
18,S0009-741115002911,tiempo,o
18,S0009-741115002911,muy,o
18,S0009-741115002911,corto,o
18,S0009-741115002911,El,o
18,S0009-741115002911,cierre,i
18,S0009-741115002911,asistido,i
18,S0009-741115002911,por,i
18,S0009-741115002911,vacio,i
18,S0009-741115002911,VAC,o
18,S0009-741115002911,se,o
18,S0009-741115002911,ha,o
18,S0009-741115002911,utilizado,o
18,S0009-741115002911,en,o
18,S0009-741115002911,muchas,o
18,S0009-741115002911,areas,o
18,S0009-741115002911,de,o
18,S0009-741115002911,la,o
18,S0009-741115002911,cirugia,i
18,S0009-741115002911,para,o
18,S0009-741115002911,la,o
18,S0009-741115002911,cicatrizacion,o
18,S0009-741115002911,de,o
18,S0009-741115002911,heridas,i
18,S0009-741115002911,complejas,o
18,S0009-741115002911,Recientemente,o
18,S0009-741115002911,se,o
18,S0009-741115002911,ha,o
18,S0009-741115002911,considerado,o
18,S0009-741115002911,esta,o
18,S0009-741115002911,modalidad,o
18,S0009-741115002911,de,o
18,S0009-741115002911,tratamiento,i
18,S0009-741115002911,en,o
18,S0009-741115002911,el,o
18,S0009-741115002911,campo,o
18,S0009-741115002911,de,o
18,S0009-741115002911,la,o
18,S0009-741115002911,cirugia,i
18,S0009-741115002911,de,i
18,S0009-741115002911,cabeza,i
18,S0009-741115002911,y,i
18,S0009-741115002911,cuello,i
18,S0009-741115002911,Objetivo,o
18,S0009-741115002911,Evaluar,o
18,S0009-741115002911,la,o
18,S0009-741115002911,eficacia,o
18,S0009-741115002911,de,o
18,S0009-741115002911,la,o
18,S0009-741115002911,cicatrizacion,o
18,S0009-741115002911,mediante,o
18,S0009-741115002911,terapia,o
18,S0009-741115002911,con,o
18,S0009-741115002911,VAC,o
18,S0009-741115002911,en,o
18,S0009-741115002911,abscesos,i
18,S0009-741115002911,profundos,i
18,S0009-741115002911,de,i
18,S0009-741115002911,cuello,i
18,S0009-741115002911,Material,o
18,S0009-741115002911,y,o
18,S0009-741115002911,metodos,o
18,S0009-741115002911,Ensayo,i
18,S0009-741115002911,clinico,i
18,S0009-741115002911,abierto,i
18,S0009-741115002911,Se,o
18,S0009-741115002911,incluyo,o
18,S0009-741115002911,a,o
18,S0009-741115002911,pacientes,o
18,S0009-741115002911,con,o
18,S0009-741115002911,abscesos,i
18,S0009-741115002911,profundos,i
18,S0009-741115002911,de,i
18,S0009-741115002911,cuello,i
18,S0009-741115002911,a,o
18,S0009-741115002911,tratarse,o
18,S0009-741115002911,con,o
18,S0009-741115002911,VAC,o
18,S0009-741115002911,en,o
18,S0009-741115002911,comparacion,o
18,S0009-741115002911,con,o
18,S0009-741115002911,terapia,i
18,S0009-741115002911,convencional,i
18,S0009-741115002911,Se,o
18,S0009-741115002911,tomaron,o
18,S0009-741115002911,cultivos,i
18,S0009-741115002911,antes,o
18,S0009-741115002911,durante,o
18,S0009-741115002911,y,o
18,S0009-741115002911,previamente,o
18,S0009-741115002911,al,o
18,S0009-741115002911,cierre,i
18,S0009-741115002911,primario,i
18,S0009-741115002911,de,o
18,S0009-741115002911,la,o
18,S0009-741115002911,herida,i
18,S0009-741115002911,Se,o
18,S0009-741115002911,evaluo,o
18,S0009-741115002911,el,o
18,S0009-741115002911,porcentaje,o
18,S0009-741115002911,de,o
18,S0009-741115002911,cicatrizacion,o
18,S0009-741115002911,tejido,i
18,S0009-741115002911,viable,o
18,S0009-741115002911,tiempo,o
18,S0009-741115002911,de,o
18,S0009-741115002911,cicatrizacion,o
18,S0009-741115002911,y,o
18,S0009-741115002911,estancia,o
18,S0009-741115002911,hospitalaria,o
18,S0009-741115002911,Resultados,o
18,S0009-741115002911,Se,o
18,S0009-741115002911,incluyo,o
18,S0009-741115002911,a,o
18,S0009-741115002911,18,o
18,S0009-741115002911,pacientes,o
18,S0009-741115002911,Espacios,o
18,S0009-741115002911,de,o
18,S0009-741115002911,cuello,i
18,S0009-741115002911,afectados,o
18,S0009-741115002911,submaxilar,i
18,S0009-741115002911,29,o
18,S0009-741115002911,parafaringeo,i
18,S0009-741115002911,22,o
18,S0009-741115002911,submentoniano,i
18,S0009-741115002911,21,o
18,S0009-741115002911,y,o
18,S0009-741115002911,masticatorio,i
18,S0009-741115002911,13,o
18,S0009-741115002911,Cultivo,i
18,S0009-741115002911,posquirurgico,o
18,S0009-741115002911,final,o
18,S0009-741115002911,negativo,o
18,S0009-741115002911,en,o
18,S0009-741115002911,el,o
18,S0009-741115002911,78,o
18,S0009-741115002911,Porcentaje,o
18,S0009-741115002911,de,o
18,S0009-741115002911,tejido,i
18,S0009-741115002911,viable,o
18,S0009-741115002911,de,o
18,S0009-741115002911,la,o
18,S0009-741115002911,herida,i
18,S0009-741115002911,para,o
18,S0009-741115002911,el,o
18,S0009-741115002911,grupo,o
18,S0009-741115002911,VAC,o
18,S0009-741115002911,42,o
18,S0009-741115002911,grupo,o
18,S0009-741115002911,control,o
18,S0009-741115002911,36,o
18,S0009-741115002911,p,o
18,S0009-741115002911,0025,o
18,S0009-741115002911,Tiempo,o
18,S0009-741115002911,de,o
18,S0009-741115002911,cicatrizacion,o
18,S0009-741115002911,22,o
18,S0009-741115002911,6,o
18,S0009-741115002911,dias,o
18,S0009-741115002911,y,o
18,S0009-741115002911,38,o
18,S0009-741115002911,155,o
18,S0009-741115002911,respectivamente,o
18,S0009-741115002911,p,o
18,S0009-741115002911,001,o
18,S0009-741115002911,La,o
18,S0009-741115002911,media,o
18,S0009-741115002911,de,o
18,S0009-741115002911,dias,o
18,S0009-741115002911,de,o
18,S0009-741115002911,hospitalizacion,i
18,S0009-741115002911,fue,o
18,S0009-741115002911,de,o
18,S0009-741115002911,12,o
18,S0009-741115002911,para,o
18,S0009-741115002911,ambos,o
18,S0009-741115002911,grupos,o
18,S0009-741115002911,Conclusiones,o
18,S0009-741115002911,La,o
18,S0009-741115002911,terapia,o
18,S0009-741115002911,con,o
18,S0009-741115002911,VAC,o
18,S0009-741115002911,es,o
18,S0009-741115002911,util,o
18,S0009-741115002911,en,o
18,S0009-741115002911,el,o
18,S0009-741115002911,tratamiento,i
18,S0009-741115002911,de,o
18,S0009-741115002911,los,o
18,S0009-741115002911,abscesos,i
18,S0009-741115002911,profundos,i
18,S0009-741115002911,de,i
18,S0009-741115002911,cuello,i
18,S0009-741115002911,ya,o
18,S0009-741115002911,que,o
18,S0009-741115002911,disminuyo,o
18,S0009-741115002911,el,o
18,S0009-741115002911,tiempo,o
18,S0009-741115002911,de,o
18,S0009-741115002911,cicatrizacion,o
18,S0009-741115002911,como,o
18,S0009-741115002911,resultado,o
18,S0009-741115002911,de,o
18,S0009-741115002911,mayor,o
18,S0009-741115002911,tejido,i
18,S0009-741115002911,viable,o
18,S0009-741115002911,lo,o
18,S0009-741115002911,que,o
18,S0009-741115002911,permitio,o
18,S0009-741115002911,el,o
18,S0009-741115002911,cierre,i
18,S0009-741115002911,con,i
18,S0009-741115002911,sutura,i
18,S0009-741115002911,de,o
18,S0009-741115002911,la,o
18,S0009-741115002911,herida,i
18,S0009-741115002911,en,o
18,S0009-741115002911,un,o
18,S0009-741115002911,periodo,o
18,S0009-741115002911,mas,o
18,S0009-741115002911,corto,o
19,S0009-741116300196,Reseccion,i
19,S0009-741116300196,de,i
19,S0009-741116300196,glandulas,i
19,S0009-741116300196,submandibulares,i
19,S0009-741116300196,para,o
19,S0009-741116300196,manejo,o
19,S0009-741116300196,de,o
19,S0009-741116300196,sialorrea,i
19,S0009-741116300196,en,o
19,S0009-741116300196,pacientes,o
19,S0009-741116300196,pediatricos,o
19,S0009-741116300196,con,o
19,S0009-741116300196,paralisis,i
19,S0009-741116300196,cerebral,i
19,S0009-741116300196,y,o
19,S0009-741116300196,poca,o
19,S0009-741116300196,respuesta,o
19,S0009-741116300196,a,o
19,S0009-741116300196,la,o
19,S0009-741116300196,toxina,i
19,S0009-741116300196,botulinica,i
19,S0009-741116300196,tipo,i
19,S0009-741116300196,A,i
19,S0009-741116300196,Estudio,i
19,S0009-741116300196,piloto,i
19,S0009-741116300196,Antecedentes,o
19,S0009-741116300196,La,o
19,S0009-741116300196,prevalencia,o
19,S0009-741116300196,de,o
19,S0009-741116300196,sialorrea,i
19,S0009-741116300196,en,o
19,S0009-741116300196,pacientes,o
19,S0009-741116300196,con,o
19,S0009-741116300196,paralisis,i
19,S0009-741116300196,cerebral,i
19,S0009-741116300196,es,o
19,S0009-741116300196,del,o
19,S0009-741116300196,1058,o
19,S0009-741116300196,Puede,o
19,S0009-741116300196,tratarse,i
19,S0009-741116300196,con,o
19,S0009-741116300196,aplicacion,o
19,S0009-741116300196,de,o
19,S0009-741116300196,toxina,i
19,S0009-741116300196,botulinica,i
19,S0009-741116300196,en,o
19,S0009-741116300196,glandulas,i
19,S0009-741116300196,salivales,i
19,S0009-741116300196,o,o
19,S0009-741116300196,con,o
19,S0009-741116300196,tecnicas,i
19,S0009-741116300196,quirurgicas,i
19,S0009-741116300196,que,o
19,S0009-741116300196,disminuyen,o
19,S0009-741116300196,definitivamente,o
19,S0009-741116300196,la,o
19,S0009-741116300196,produccion,o
19,S0009-741116300196,salival,i
19,S0009-741116300196,En,o
19,S0009-741116300196,Mexico,o
19,S0009-741116300196,no,o
19,S0009-741116300196,existen,o
19,S0009-741116300196,estudios,o
19,S0009-741116300196,sobre,o
19,S0009-741116300196,la,o
19,S0009-741116300196,utilidad,o
19,S0009-741116300196,de,o
19,S0009-741116300196,la,o
19,S0009-741116300196,cirugia,i
19,S0009-741116300196,para,o
19,S0009-741116300196,manejar,o
19,S0009-741116300196,la,o
19,S0009-741116300196,sialorrea,i
19,S0009-741116300196,Objetivo,o
19,S0009-741116300196,Evaluar,i
19,S0009-741116300196,la,i
19,S0009-741116300196,eficacia,i
19,S0009-741116300196,de,o
19,S0009-741116300196,la,o
19,S0009-741116300196,reseccion,i
19,S0009-741116300196,de,i
19,S0009-741116300196,glandulas,i
19,S0009-741116300196,submandibulares,i
19,S0009-741116300196,para,o
19,S0009-741116300196,disminuir,o
19,S0009-741116300196,la,o
19,S0009-741116300196,sialorrea,i
19,S0009-741116300196,en,o
19,S0009-741116300196,pacientes,o
19,S0009-741116300196,pediatricos,o
19,S0009-741116300196,con,o
19,S0009-741116300196,paralisis,i
19,S0009-741116300196,cerebral,i
19,S0009-741116300196,y,o
19,S0009-741116300196,con,o
19,S0009-741116300196,resultados,o
19,S0009-741116300196,desfavorables,o
19,S0009-741116300196,con,o
19,S0009-741116300196,toxina,i
19,S0009-741116300196,botulinica,i
19,S0009-741116300196,Material,o
19,S0009-741116300196,y,o
19,S0009-741116300196,metodos,o
19,S0009-741116300196,Ensayo,o
19,S0009-741116300196,clinico,o
19,S0009-741116300196,experimental,o
19,S0009-741116300196,autocontrolado,o
19,S0009-741116300196,longitudinal,o
19,S0009-741116300196,y,o
19,S0009-741116300196,prospectivo,o
19,S0009-741116300196,Se,o
19,S0009-741116300196,realizo,o
19,S0009-741116300196,evaluacion,i
19,S0009-741116300196,prequirurgica,o
19,S0009-741116300196,del,o
19,S0009-741116300196,grado,o
19,S0009-741116300196,de,o
19,S0009-741116300196,sialorrea,i
19,S0009-741116300196,y,o
19,S0009-741116300196,posquirurgicas,o
19,S0009-741116300196,a,o
19,S0009-741116300196,8,o
19,S0009-741116300196,16,o
19,S0009-741116300196,y,o
19,S0009-741116300196,24,o
19,S0009-741116300196,semanas,o
19,S0009-741116300196,con,o
19,S0009-741116300196,una,o
19,S0009-741116300196,clasificacion,o
19,S0009-741116300196,validada,o
19,S0009-741116300196,Se,o
19,S0009-741116300196,aplico,o
19,S0009-741116300196,una,o
19,S0009-741116300196,prueba,o
19,S0009-741116300196,de,o
19,S0009-741116300196,medidas,o
19,S0009-741116300196,repetidas,o
19,S0009-741116300196,no,o
19,S0009-741116300196,parametrica,o
19,S0009-741116300196,para,o
19,S0009-741116300196,buscar,o
19,S0009-741116300196,significacion,o
19,S0009-741116300196,estadistica,o
19,S0009-741116300196,con,o
19,S0009-741116300196,p,o
19,S0009-741116300196,005,o
19,S0009-741116300196,Se,o
19,S0009-741116300196,analizan,o
19,S0009-741116300196,tambien,o
19,S0009-741116300196,las,o
19,S0009-741116300196,complicaciones,i
19,S0009-741116300196,observadas,o
19,S0009-741116300196,y,o
19,S0009-741116300196,los,o
19,S0009-741116300196,cambios,o
19,S0009-741116300196,en,o
19,S0009-741116300196,la,o
19,S0009-741116300196,composicion,o
19,S0009-741116300196,salival,i
19,S0009-741116300196,Resultados,o
19,S0009-741116300196,Se,o
19,S0009-741116300196,opero,i
19,S0009-741116300196,a,o
19,S0009-741116300196,3,o
19,S0009-741116300196,pacientes,o
19,S0009-741116300196,con,o
19,S0009-741116300196,sialorrea,i
19,S0009-741116300196,severa,o
19,S0009-741116300196,y,o
19,S0009-741116300196,a,o
19,S0009-741116300196,2,o
19,S0009-741116300196,con,o
19,S0009-741116300196,profusa,o
19,S0009-741116300196,con,o
19,S0009-741116300196,edad,o
19,S0009-741116300196,media,o
19,S0009-741116300196,de,o
19,S0009-741116300196,108,o
19,S0009-741116300196,años,o
19,S0009-741116300196,Los,o
19,S0009-741116300196,5,o
19,S0009-741116300196,mejoraron,o
19,S0009-741116300196,en,o
19,S0009-741116300196,severidad,o
19,S0009-741116300196,y,o
19,S0009-741116300196,frecuencia,o
19,S0009-741116300196,con,o
19,S0009-741116300196,disminucion,o
19,S0009-741116300196,promedio,o
19,S0009-741116300196,del,o
19,S0009-741116300196,7675,o
19,S0009-741116300196,y,o
19,S0009-741116300196,del,o
19,S0009-741116300196,875,o
19,S0009-741116300196,respectivamente,o
19,S0009-741116300196,El,o
19,S0009-741116300196,mejor,o
19,S0009-741116300196,resultado,o
19,S0009-741116300196,se,o
19,S0009-741116300196,observo,o
19,S0009-741116300196,a,o
19,S0009-741116300196,los,o
19,S0009-741116300196,6,o
19,S0009-741116300196,meses,o
19,S0009-741116300196,con,o
19,S0009-741116300196,diferencia,o
19,S0009-741116300196,estadisticamente,o
19,S0009-741116300196,significativa,o
19,S0009-741116300196,entre,o
19,S0009-741116300196,el,o
19,S0009-741116300196,preoperatorio,o
19,S0009-741116300196,y,o
19,S0009-741116300196,el,o
19,S0009-741116300196,postoperatorio,o
19,S0009-741116300196,p,o
19,S0009-741116300196,00039,o
19,S0009-741116300196,IC,o
19,S0009-741116300196,95,o
19,S0009-741116300196,No,o
19,S0009-741116300196,se,o
19,S0009-741116300196,observaron,o
19,S0009-741116300196,complicaciones,i
19,S0009-741116300196,importantes,o
19,S0009-741116300196,deterioro,i
19,S0009-741116300196,dental,i
19,S0009-741116300196,ni,o
19,S0009-741116300196,cambios,o
19,S0009-741116300196,importantes,o
19,S0009-741116300196,en,o
19,S0009-741116300196,la,o
19,S0009-741116300196,composicion,o
19,S0009-741116300196,salival,i
19,S0009-741116300196,Conclusiones,o
19,S0009-741116300196,La,o
19,S0009-741116300196,reseccion,i
19,S0009-741116300196,de,i
19,S0009-741116300196,glandulas,i
19,S0009-741116300196,submandibulares,i
19,S0009-741116300196,es,o
19,S0009-741116300196,efectiva,o
19,S0009-741116300196,para,o
19,S0009-741116300196,controlar,o
19,S0009-741116300196,la,o
19,S0009-741116300196,sialorrea,i
19,S0009-741116300196,en,o
19,S0009-741116300196,pacientes,o
19,S0009-741116300196,pediatricos,o
19,S0009-741116300196,con,o
19,S0009-741116300196,paralisis,i
19,S0009-741116300196,cerebral,i
19,S0009-741116300196,con,o
19,S0009-741116300196,reduccion,o
19,S0009-741116300196,superior,o
19,S0009-741116300196,al,o
19,S0009-741116300196,80,o
19,S0009-741116300196,Tiene,o
19,S0009-741116300196,una,o
19,S0009-741116300196,tasa,o
19,S0009-741116300196,baja,o
19,S0009-741116300196,de,o
19,S0009-741116300196,complicaciones,i
19,S0009-741116300196,a,o
19,S0009-741116300196,diferencia,o
19,S0009-741116300196,de,o
19,S0009-741116300196,otras,o
19,S0009-741116300196,tecnicas,o
19,S0009-741116300196,Genero,o
19,S0009-741116300196,una,o
19,S0009-741116300196,disminucion,o
19,S0009-741116300196,suficiente,o
19,S0009-741116300196,y,o
19,S0009-741116300196,evidenciable,o
19,S0009-741116300196,de,o
19,S0009-741116300196,la,o
19,S0009-741116300196,sialorrea,i
19,S0009-741116300196,en,o
19,S0009-741116300196,reposo,o
19,S0009-741116300196,sin,o
19,S0009-741116300196,necesidad,o
19,S0009-741116300196,de,o
19,S0009-741116300196,trabajar,o
19,S0009-741116300196,con,o
19,S0009-741116300196,otras,o
19,S0009-741116300196,glandulas,i
19,S0009-741116300196,salivales,i
19,S0009-741116300196,mayores,i
20,S0009-741116300330,Utilidad,o
20,S0009-741116300330,transquirurgica,o
20,S0009-741116300330,de,o
20,S0009-741116300330,la,o
20,S0009-741116300330,tomografia,i
20,S0009-741116300330,de,i
20,S0009-741116300330,coherencia,i
20,S0009-741116300330,optica,i
20,S0009-741116300330,en,o
20,S0009-741116300330,cirugia,i
20,S0009-741116300330,vitreoretiniana,o
20,S0009-741116300330,Antecedentes,o
20,S0009-741116300330,La,o
20,S0009-741116300330,tomografia,i
20,S0009-741116300330,de,i
20,S0009-741116300330,coherencia,i
20,S0009-741116300330,optica,i
20,S0009-741116300330,es,o
20,S0009-741116300330,una,o
20,S0009-741116300330,herramienta,o
20,S0009-741116300330,diagnostica,o
20,S0009-741116300330,de,o
20,S0009-741116300330,gran,o
20,S0009-741116300330,utilidad,o
20,S0009-741116300330,en,o
20,S0009-741116300330,diversos,o
20,S0009-741116300330,padecimientos,i
20,S0009-741116300330,Recientemente,o
20,S0009-741116300330,se,o
20,S0009-741116300330,ha,o
20,S0009-741116300330,descrito,o
20,S0009-741116300330,su,o
20,S0009-741116300330,uso,o
20,S0009-741116300330,transquirurgico,o
20,S0009-741116300330,con,o
20,S0009-741116300330,la,o
20,S0009-741116300330,intencion,o
20,S0009-741116300330,de,o
20,S0009-741116300330,mejorar,o
20,S0009-741116300330,los,o
20,S0009-741116300330,resultados,o
20,S0009-741116300330,anatomicos,o
20,S0009-741116300330,Objetivo,o
20,S0009-741116300330,Determinar,i
20,S0009-741116300330,la,i
20,S0009-741116300330,utilidad,i
20,S0009-741116300330,y,i
20,S0009-741116300330,seguridad,i
20,S0009-741116300330,de,o
20,S0009-741116300330,la,o
20,S0009-741116300330,tomografia,i
20,S0009-741116300330,de,i
20,S0009-741116300330,coherencia,i
20,S0009-741116300330,optica,i
20,S0009-741116300330,transquirurgica,o
20,S0009-741116300330,en,o
20,S0009-741116300330,el,o
20,S0009-741116300330,tratamiento,i
20,S0009-741116300330,de,o
20,S0009-741116300330,cirugias,i
20,S0009-741116300330,de,i
20,S0009-741116300330,retina,i
20,S0009-741116300330,y,i
20,S0009-741116300330,vitreo,i
20,S0009-741116300330,Material,o
20,S0009-741116300330,y,o
20,S0009-741116300330,metodos,o
20,S0009-741116300330,Serie,i
20,S0009-741116300330,de,i
20,S0009-741116300330,casos,i
20,S0009-741116300330,prospectiva,i
20,S0009-741116300330,Se,o
20,S0009-741116300330,evalua,o
20,S0009-741116300330,la,o
20,S0009-741116300330,influencia,o
20,S0009-741116300330,que,o
20,S0009-741116300330,tiene,o
20,S0009-741116300330,la,o
20,S0009-741116300330,imagen,o
20,S0009-741116300330,de,o
20,S0009-741116300330,tomografia,i
20,S0009-741116300330,de,i
20,S0009-741116300330,coherencia,i
20,S0009-741116300330,optica,i
20,S0009-741116300330,en,o
20,S0009-741116300330,la,o
20,S0009-741116300330,toma,o
20,S0009-741116300330,de,o
20,S0009-741116300330,decisiones,o
20,S0009-741116300330,durante,o
20,S0009-741116300330,la,o
20,S0009-741116300330,vitrectomia,i
20,S0009-741116300330,via,i
20,S0009-741116300330,pars,i
20,S0009-741116300330,plana,i
20,S0009-741116300330,Para,o
20,S0009-741116300330,la,o
20,S0009-741116300330,obtencion,o
20,S0009-741116300330,de,o
20,S0009-741116300330,imagenes,o
20,S0009-741116300330,se,o
20,S0009-741116300330,utilizo,o
20,S0009-741116300330,RESCAN,o
20,S0009-741116300330,700,o
20,S0009-741116300330,un,o
20,S0009-741116300330,microscopio,o
20,S0009-741116300330,que,o
20,S0009-741116300330,cuenta,o
20,S0009-741116300330,con,o
20,S0009-741116300330,un,o
20,S0009-741116300330,tomografo,o
20,S0009-741116300330,de,o
20,S0009-741116300330,dominio,o
20,S0009-741116300330,espectral,o
20,S0009-741116300330,integrado,o
20,S0009-741116300330,Al,o
20,S0009-741116300330,final,o
20,S0009-741116300330,de,o
20,S0009-741116300330,cada,o
20,S0009-741116300330,procedimiento,i
20,S0009-741116300330,los,o
20,S0009-741116300330,cirujanos,o
20,S0009-741116300330,contestaron,o
20,S0009-741116300330,un,o
20,S0009-741116300330,cuestionario,i
20,S0009-741116300330,para,o
20,S0009-741116300330,determinar,o
20,S0009-741116300330,si,o
20,S0009-741116300330,la,o
20,S0009-741116300330,imagen,i
20,S0009-741116300330,tomografica,i
20,S0009-741116300330,influyo,o
20,S0009-741116300330,en,o
20,S0009-741116300330,la,o
20,S0009-741116300330,toma,o
20,S0009-741116300330,de,o
20,S0009-741116300330,decisiones,o
20,S0009-741116300330,durante,o
20,S0009-741116300330,la,o
20,S0009-741116300330,cirugia,i
20,S0009-741116300330,Resultados,o
20,S0009-741116300330,Fueron,o
20,S0009-741116300330,intervenidos,i
20,S0009-741116300330,13,o
20,S0009-741116300330,pacientes,o
20,S0009-741116300330,mediante,o
20,S0009-741116300330,vitrectomia,i
20,S0009-741116300330,pars,i
20,S0009-741116300330,plana,i
20,S0009-741116300330,en,o
20,S0009-741116300330,6,o
20,S0009-741116300330,de,o
20,S0009-741116300330,ellos,o
20,S0009-741116300330,se,o
20,S0009-741116300330,realizo,o
20,S0009-741116300330,tambien,o
20,S0009-741116300330,cirugia,i
20,S0009-741116300330,de,i
20,S0009-741116300330,catarata,i
20,S0009-741116300330,En,o
20,S0009-741116300330,8,o
20,S0009-741116300330,casos,o
20,S0009-741116300330,el,o
20,S0009-741116300330,cirujano,o
20,S0009-741116300330,considero,o
20,S0009-741116300330,que,o
20,S0009-741116300330,la,o
20,S0009-741116300330,imagen,o
20,S0009-741116300330,transoperatoria,o
20,S0009-741116300330,influyo,o
20,S0009-741116300330,en,o
20,S0009-741116300330,la,o
20,S0009-741116300330,toma,o
20,S0009-741116300330,de,o
20,S0009-741116300330,decisiones,o
20,S0009-741116300330,durante,o
20,S0009-741116300330,el,o
20,S0009-741116300330,procedimiento,i
20,S0009-741116300330,Conclusiones,o
20,S0009-741116300330,La,o
20,S0009-741116300330,tomografia,i
20,S0009-741116300330,de,i
20,S0009-741116300330,coherencia,i
20,S0009-741116300330,optica,i
20,S0009-741116300330,transquirurgica,o
20,S0009-741116300330,es,o
20,S0009-741116300330,un,o
20,S0009-741116300330,auxiliar,o
20,S0009-741116300330,diagnostico,o
20,S0009-741116300330,seguro,o
20,S0009-741116300330,para,o
20,S0009-741116300330,el,o
20,S0009-741116300330,paciente,o
20,S0009-741116300330,que,o
20,S0009-741116300330,no,o
20,S0009-741116300330,influye,o
20,S0009-741116300330,en,o
20,S0009-741116300330,el,o
20,S0009-741116300330,tiempo,o
20,S0009-741116300330,quirurgico,o
20,S0009-741116300330,y,o
20,S0009-741116300330,que,o
20,S0009-741116300330,en,o
20,S0009-741116300330,algunos,o
20,S0009-741116300330,casos,o
20,S0009-741116300330,es,o
20,S0009-741116300330,de,o
20,S0009-741116300330,utilidad,o
20,S0009-741116300330,para,o
20,S0009-741116300330,la,o
20,S0009-741116300330,optimizacion,o
20,S0009-741116300330,del,o
20,S0009-741116300330,procedimiento,i
20,S0009-741116300330,en,o
20,S0009-741116300330,cirugia,i
20,S0009-741116300330,vitreomacular,o
21,S0009-741116301281,Beneficios,o
21,S0009-741116301281,del,o
21,S0009-741116301281,drenaje,i
21,S0009-741116301281,toracico,i
21,S0009-741116301281,digital,o
21,S0009-741116301281,en,o
21,S0009-741116301281,pleurodecorticacion,i
21,S0009-741116301281,por,o
21,S0009-741116301281,empiema,i
21,S0009-741116301281,Estudio,o
21,S0009-741116301281,prospectivo,o
21,S0009-741116301281,comparativo,o
21,S0009-741116301281,aleatorizado,o
21,S0009-741116301281,Antecedentes,o
21,S0009-741116301281,La,o
21,S0009-741116301281,fuga,i
21,S0009-741116301281,aerea,i
21,S0009-741116301281,prolongada,o
21,S0009-741116301281,despues,o
21,S0009-741116301281,de,o
21,S0009-741116301281,una,o
21,S0009-741116301281,pleurodecorticacion,i
21,S0009-741116301281,en,o
21,S0009-741116301281,una,o
21,S0009-741116301281,de,o
21,S0009-741116301281,las,o
21,S0009-741116301281,complicaciones,i
21,S0009-741116301281,mas,o
21,S0009-741116301281,frecuentes,o
21,S0009-741116301281,Objetivo,o
21,S0009-741116301281,El,o
21,S0009-741116301281,objetivo,o
21,S0009-741116301281,de,o
21,S0009-741116301281,este,o
21,S0009-741116301281,estudio,o
21,S0009-741116301281,es,o
21,S0009-741116301281,comparar,o
21,S0009-741116301281,la,o
21,S0009-741116301281,fuga,i
21,S0009-741116301281,aerea,i
21,S0009-741116301281,entre,o
21,S0009-741116301281,el,o
21,S0009-741116301281,sistema,o
21,S0009-741116301281,de,o
21,S0009-741116301281,drenaje,i
21,S0009-741116301281,toracico,i
21,S0009-741116301281,digital,o
21,S0009-741116301281,DCD,o
21,S0009-741116301281,y,o
21,S0009-741116301281,el,o
21,S0009-741116301281,sistema,o
21,S0009-741116301281,de,o
21,S0009-741116301281,drenaje,i
21,S0009-741116301281,clasico,o
21,S0009-741116301281,en,o
21,S0009-741116301281,pacientes,o
21,S0009-741116301281,con,o
21,S0009-741116301281,empiema,i
21,S0009-741116301281,de,o
21,S0009-741116301281,clase,o
21,S0009-741116301281,IIB,o
21,S0009-741116301281,o,o
21,S0009-741116301281,III,o
21,S0009-741116301281,clasificacion,o
21,S0009-741116301281,de,o
21,S0009-741116301281,la,o
21,S0009-741116301281,Sociedad,o
21,S0009-741116301281,Americana,o
21,S0009-741116301281,de,o
21,S0009-741116301281,Torax,o
21,S0009-741116301281,intervenidos,i
21,S0009-741116301281,mediante,o
21,S0009-741116301281,pleurodecorticacion,i
21,S0009-741116301281,Material,o
21,S0009-741116301281,y,o
21,S0009-741116301281,metodos,o
21,S0009-741116301281,De,o
21,S0009-741116301281,manera,o
21,S0009-741116301281,prospectiva,o
21,S0009-741116301281,comparativa,o
21,S0009-741116301281,y,o
21,S0009-741116301281,aleatorizada,i
21,S0009-741116301281,37,o
21,S0009-741116301281,pacientes,o
21,S0009-741116301281,fueron,o
21,S0009-741116301281,estudiados,o
21,S0009-741116301281,en,o
21,S0009-741116301281,un,o
21,S0009-741116301281,periodo,o
21,S0009-741116301281,de,o
21,S0009-741116301281,un,o
21,S0009-741116301281,año,o
21,S0009-741116301281,Divididos,o
21,S0009-741116301281,en,o
21,S0009-741116301281,2,o
21,S0009-741116301281,grupos,o
21,S0009-741116301281,se,o
21,S0009-741116301281,comparo,o
21,S0009-741116301281,la,o
21,S0009-741116301281,fuga,i
21,S0009-741116301281,aerea,i
21,S0009-741116301281,postoperatoria,o
21,S0009-741116301281,analizandose,o
21,S0009-741116301281,el,o
21,S0009-741116301281,numero,o
21,S0009-741116301281,de,o
21,S0009-741116301281,dias,o
21,S0009-741116301281,de,o
21,S0009-741116301281,internamiento,i
21,S0009-741116301281,el,o
21,S0009-741116301281,dia,o
21,S0009-741116301281,de,o
21,S0009-741116301281,retiro,o
21,S0009-741116301281,de,o
21,S0009-741116301281,los,o
21,S0009-741116301281,drenajes,i
21,S0009-741116301281,asi,o
21,S0009-741116301281,como,o
21,S0009-741116301281,las,o
21,S0009-741116301281,complicaciones,i
21,S0009-741116301281,en,o
21,S0009-741116301281,ambos,o
21,S0009-741116301281,grupos,o
21,S0009-741116301281,Resultados,o
21,S0009-741116301281,El,o
21,S0009-741116301281,porcentaje,o
21,S0009-741116301281,de,o
21,S0009-741116301281,fuga,i
21,S0009-741116301281,aerea,i
21,S0009-741116301281,prolongada,o
21,S0009-741116301281,fue,o
21,S0009-741116301281,del,o
21,S0009-741116301281,11,o
21,S0009-741116301281,en,o
21,S0009-741116301281,el,o
21,S0009-741116301281,grupo,o
21,S0009-741116301281,DCD,o
21,S0009-741116301281,y,o
21,S0009-741116301281,del,o
21,S0009-741116301281,5,o
21,S0009-741116301281,en,o
21,S0009-741116301281,el,o
21,S0009-741116301281,grupo,o
21,S0009-741116301281,de,o
21,S0009-741116301281,drenaje,i
21,S0009-741116301281,clasico,o
21,S0009-741116301281,p,o
21,S0009-741116301281,0581,o
21,S0009-741116301281,el,o
21,S0009-741116301281,numero,o
21,S0009-741116301281,de,o
21,S0009-741116301281,dias,o
21,S0009-741116301281,con,o
21,S0009-741116301281,fuga,i
21,S0009-741116301281,aerea,i
21,S0009-741116301281,fue,o
21,S0009-741116301281,de,o
21,S0009-741116301281,25,o
21,S0009-741116301281,18,o
21,S0009-741116301281,y,o
21,S0009-741116301281,24,o
21,S0009-741116301281,22,o
21,S0009-741116301281,respectivamente,o
21,S0009-741116301281,p,o
21,S0009-741116301281,0966,o
21,S0009-741116301281,El,o
21,S0009-741116301281,numero,o
21,S0009-741116301281,de,o
21,S0009-741116301281,dias,o
21,S0009-741116301281,para,o
21,S0009-741116301281,retiro,i
21,S0009-741116301281,de,i
21,S0009-741116301281,drenaje,i
21,S0009-741116301281,fue,o
21,S0009-741116301281,45,o
21,S0009-741116301281,18,o
21,S0009-741116301281,y,o
21,S0009-741116301281,51,o
21,S0009-741116301281,25,o
21,S0009-741116301281,p,o
21,S0009-741116301281,041,o
21,S0009-741116301281,la,o
21,S0009-741116301281,estancia,o
21,S0009-741116301281,intrahospitalaria,o
21,S0009-741116301281,fue,o
21,S0009-741116301281,de,o
21,S0009-741116301281,78,o
21,S0009-741116301281,37,o
21,S0009-741116301281,y,o
21,S0009-741116301281,89,o
21,S0009-741116301281,40,o
21,S0009-741116301281,dias,o
21,S0009-741116301281,p,o
21,S0009-741116301281,0441,o
21,S0009-741116301281,y,o
21,S0009-741116301281,el,o
21,S0009-741116301281,porcentaje,o
21,S0009-741116301281,de,o
21,S0009-741116301281,complicaciones,i
21,S0009-741116301281,fue,o
21,S0009-741116301281,22,o
21,S0009-741116301281,y,o
21,S0009-741116301281,36,o
21,S0009-741116301281,respectivamente,o
21,S0009-741116301281,p,o
21,S0009-741116301281,0227,o
21,S0009-741116301281,Discusion,o
21,S0009-741116301281,En,o
21,S0009-741116301281,este,o
21,S0009-741116301281,estudio,o
21,S0009-741116301281,se,o
21,S0009-741116301281,observa,o
21,S0009-741116301281,una,o
21,S0009-741116301281,tendencia,o
21,S0009-741116301281,positiva,o
21,S0009-741116301281,pero,o
21,S0009-741116301281,no,o
21,S0009-741116301281,significativa,o
21,S0009-741116301281,a,o
21,S0009-741116301281,favor,o
21,S0009-741116301281,del,o
21,S0009-741116301281,uso,o
21,S0009-741116301281,de,o
21,S0009-741116301281,los,o
21,S0009-741116301281,DCD,o
21,S0009-741116301281,cuando,o
21,S0009-741116301281,se,o
21,S0009-741116301281,comparan,o
21,S0009-741116301281,con,o
21,S0009-741116301281,el,o
21,S0009-741116301281,drenaje,i
21,S0009-741116301281,clasico,o
21,S0009-741116301281,Estudios,o
21,S0009-741116301281,mas,o
21,S0009-741116301281,largos,o
21,S0009-741116301281,y,o
21,S0009-741116301281,multicentricos,o
21,S0009-741116301281,son,o
21,S0009-741116301281,requeridos,o
22,S0025-76802004000100001,Tratamiento,i
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,Chagas,i
22,S0025-76802004000100001,con,o
22,S0025-76802004000100001,benznidazol,i
22,S0025-76802004000100001,y,o
22,S0025-76802004000100001,acido,i
22,S0025-76802004000100001,tioctico,i
22,S0025-76802004000100001,Se,o
22,S0025-76802004000100001,realizo,o
22,S0025-76802004000100001,un,o
22,S0025-76802004000100001,ensayo,o
22,S0025-76802004000100001,clinico,o
22,S0025-76802004000100001,controlado,o
22,S0025-76802004000100001,multicentrico,o
22,S0025-76802004000100001,a,o
22,S0025-76802004000100001,triple,o
22,S0025-76802004000100001,ciego,o
22,S0025-76802004000100001,para,o
22,S0025-76802004000100001,evaluar,o
22,S0025-76802004000100001,si,o
22,S0025-76802004000100001,el,o
22,S0025-76802004000100001,tratamiento,i
22,S0025-76802004000100001,oral,i
22,S0025-76802004000100001,combinado,i
22,S0025-76802004000100001,del,o
22,S0025-76802004000100001,acido,i
22,S0025-76802004000100001,tioctico,i
22,S0025-76802004000100001,AT,o
22,S0025-76802004000100001,reduce,o
22,S0025-76802004000100001,la,o
22,S0025-76802004000100001,incidencia,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,los,o
22,S0025-76802004000100001,efectos,i
22,S0025-76802004000100001,secundarios,i
22,S0025-76802004000100001,asociados,o
22,S0025-76802004000100001,al,o
22,S0025-76802004000100001,tratamiento,i
22,S0025-76802004000100001,con,o
22,S0025-76802004000100001,benznidazol,i
22,S0025-76802004000100001,BZ,i
22,S0025-76802004000100001,en,o
22,S0025-76802004000100001,pacientes,o
22,S0025-76802004000100001,infectados,i
22,S0025-76802004000100001,con,i
22,S0025-76802004000100001,Trypanosoma,i
22,S0025-76802004000100001,cruzi,i
22,S0025-76802004000100001,Cuatro,o
22,S0025-76802004000100001,esquemas,o
22,S0025-76802004000100001,fueron,o
22,S0025-76802004000100001,asignados,o
22,S0025-76802004000100001,al,o
22,S0025-76802004000100001,azar,o
22,S0025-76802004000100001,pareados,o
22,S0025-76802004000100001,por,o
22,S0025-76802004000100001,edad,o
22,S0025-76802004000100001,administrando,o
22,S0025-76802004000100001,placebo,i
22,S0025-76802004000100001,o,o
22,S0025-76802004000100001,AT,o
22,S0025-76802004000100001,por,o
22,S0025-76802004000100001,via,o
22,S0025-76802004000100001,oral,o
22,S0025-76802004000100001,a,o
22,S0025-76802004000100001,razon,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,50100,o
22,S0025-76802004000100001,mg,o
22,S0025-76802004000100001,dia,o
22,S0025-76802004000100001,a,o
22,S0025-76802004000100001,dosis,o
22,S0025-76802004000100001,e,o
22,S0025-76802004000100001,intervalos,o
22,S0025-76802004000100001,variables,o
22,S0025-76802004000100001,con,o
22,S0025-76802004000100001,y,o
22,S0025-76802004000100001,sin,o
22,S0025-76802004000100001,periodo,o
22,S0025-76802004000100001,preinduccion,o
22,S0025-76802004000100001,en,o
22,S0025-76802004000100001,combinacion,o
22,S0025-76802004000100001,con,o
22,S0025-76802004000100001,BZ,i
22,S0025-76802004000100001,a,o
22,S0025-76802004000100001,dosis,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,5,o
22,S0025-76802004000100001,mgkgdia,o
22,S0025-76802004000100001,por,o
22,S0025-76802004000100001,30,o
22,S0025-76802004000100001,dias,o
22,S0025-76802004000100001,Se,o
22,S0025-76802004000100001,realizaron,o
22,S0025-76802004000100001,evaluaciones,o
22,S0025-76802004000100001,en,o
22,S0025-76802004000100001,los,o
22,S0025-76802004000100001,dias,o
22,S0025-76802004000100001,10,o
22,S0025-76802004000100001,20,o
22,S0025-76802004000100001,37,o
22,S0025-76802004000100001,y,o
22,S0025-76802004000100001,52,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,iniciado,o
22,S0025-76802004000100001,el,o
22,S0025-76802004000100001,tratamiento,i
22,S0025-76802004000100001,Fueron,o
22,S0025-76802004000100001,enrolados,o
22,S0025-76802004000100001,249,o
22,S0025-76802004000100001,pacientes,o
22,S0025-76802004000100001,con,o
22,S0025-76802004000100001,edades,o
22,S0025-76802004000100001,entre,o
22,S0025-76802004000100001,15,o
22,S0025-76802004000100001,y,o
22,S0025-76802004000100001,44,o
22,S0025-76802004000100001,años,o
22,S0025-76802004000100001,El,o
22,S0025-76802004000100001,703,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,los,o
22,S0025-76802004000100001,pacientes,o
22,S0025-76802004000100001,completo,o
22,S0025-76802004000100001,el,o
22,S0025-76802004000100001,tratamiento,i
22,S0025-76802004000100001,y,o
22,S0025-76802004000100001,el,o
22,S0025-76802004000100001,177,o
22,S0025-76802004000100001,restante,o
22,S0025-76802004000100001,debio,o
22,S0025-76802004000100001,suspender,i
22,S0025-76802004000100001,la,i
22,S0025-76802004000100001,medicacion,i
22,S0025-76802004000100001,por,o
22,S0025-76802004000100001,causas,o
22,S0025-76802004000100001,relacionadas,o
22,S0025-76802004000100001,al,o
22,S0025-76802004000100001,BZ,i
22,S0025-76802004000100001,La,o
22,S0025-76802004000100001,proporcion,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,personas,o
22,S0025-76802004000100001,afectadas,o
22,S0025-76802004000100001,por,o
22,S0025-76802004000100001,al,o
22,S0025-76802004000100001,menos,o
22,S0025-76802004000100001,un,o
22,S0025-76802004000100001,efecto,i
22,S0025-76802004000100001,adverso,i
22,S0025-76802004000100001,fue,o
22,S0025-76802004000100001,semejante,o
22,S0025-76802004000100001,entre,o
22,S0025-76802004000100001,los,o
22,S0025-76802004000100001,4,o
22,S0025-76802004000100001,grupos,o
22,S0025-76802004000100001,entre,o
22,S0025-76802004000100001,548,o
22,S0025-76802004000100001,y,o
22,S0025-76802004000100001,58,o
22,S0025-76802004000100001,aunque,o
22,S0025-76802004000100001,en,o
22,S0025-76802004000100001,ninguno,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,ellos,o
22,S0025-76802004000100001,resulto,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,caracter,o
22,S0025-76802004000100001,grave,o
22,S0025-76802004000100001,Las,o
22,S0025-76802004000100001,manifestaciones,i
22,S0025-76802004000100001,clinicas,i
22,S0025-76802004000100001,adversas,i
22,S0025-76802004000100001,fueron,o
22,S0025-76802004000100001,exantema,i
22,S0025-76802004000100001,morbiliforme,i
22,S0025-76802004000100001,28,o
22,S0025-76802004000100001,prurito,i
22,S0025-76802004000100001,136,o
22,S0025-76802004000100001,cefalea,i
22,S0025-76802004000100001,8,o
22,S0025-76802004000100001,epigastralgia,i
22,S0025-76802004000100001,62,o
22,S0025-76802004000100001,fiebre,i
22,S0025-76802004000100001,62,o
22,S0025-76802004000100001,astenia,i
22,S0025-76802004000100001,43,o
22,S0025-76802004000100001,nauseas,i
22,S0025-76802004000100001,40,o
22,S0025-76802004000100001,mialgias,i
22,S0025-76802004000100001,43,o
22,S0025-76802004000100001,vomitos,i
22,S0025-76802004000100001,32,o
22,S0025-76802004000100001,otros,o
22,S0025-76802004000100001,215,o
22,S0025-76802004000100001,La,o
22,S0025-76802004000100001,incidencia,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,experiencias,i
22,S0025-76802004000100001,adversas,i
22,S0025-76802004000100001,no,o
22,S0025-76802004000100001,difirio,o
22,S0025-76802004000100001,significativamente,o
22,S0025-76802004000100001,entre,o
22,S0025-76802004000100001,los,o
22,S0025-76802004000100001,4,o
22,S0025-76802004000100001,esquemas,o
22,S0025-76802004000100001,terapeuticos,o
22,S0025-76802004000100001,ni,o
22,S0025-76802004000100001,entre,o
22,S0025-76802004000100001,los,o
22,S0025-76802004000100001,diferentes,o
22,S0025-76802004000100001,intervalos,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,edad,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,los,o
22,S0025-76802004000100001,pacientes,o
22,S0025-76802004000100001,La,o
22,S0025-76802004000100001,asociacion,o
22,S0025-76802004000100001,con,o
22,S0025-76802004000100001,acido,i
22,S0025-76802004000100001,tioctico,i
22,S0025-76802004000100001,no,o
22,S0025-76802004000100001,demostro,o
22,S0025-76802004000100001,prevenir,i
22,S0025-76802004000100001,las,o
22,S0025-76802004000100001,manifestaciones,i
22,S0025-76802004000100001,de,i
22,S0025-76802004000100001,intolerancia,i
22,S0025-76802004000100001,a,o
22,S0025-76802004000100001,este,o
22,S0025-76802004000100001,agente,i
22,S0025-76802004000100001,No,o
22,S0025-76802004000100001,obstante,o
22,S0025-76802004000100001,la,o
22,S0025-76802004000100001,administracion,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,BZ,i
22,S0025-76802004000100001,en,o
22,S0025-76802004000100001,un,o
22,S0025-76802004000100001,ciclo,o
22,S0025-76802004000100001,mensual,o
22,S0025-76802004000100001,unico,o
22,S0025-76802004000100001,a,o
22,S0025-76802004000100001,pacientes,o
22,S0025-76802004000100001,infectados,i
22,S0025-76802004000100001,logro,o
22,S0025-76802004000100001,una,o
22,S0025-76802004000100001,elevada,o
22,S0025-76802004000100001,tasa,o
22,S0025-76802004000100001,de,o
22,S0025-76802004000100001,adherencia,o
22,S0025-76802004000100001,al,o
22,S0025-76802004000100001,tratamiento,i
22,S0025-76802004000100001,ambulatorio,i
23,S0025-76802004000500002,Respuesta,o
23,S0025-76802004000500002,hemodinamica,o
23,S0025-76802004000500002,al,o
23,S0025-76802004000500002,estres,i
23,S0025-76802004000500002,mental,i
23,S0025-76802004000500002,y,i
23,S0025-76802004000500002,fisico,i
23,S0025-76802004000500002,en,o
23,S0025-76802004000500002,sujetos,o
23,S0025-76802004000500002,normotensos,o
23,S0025-76802004000500002,hiperreactivos,i
23,S0025-76802004000500002,Efectos,o
23,S0025-76802004000500002,del,o
23,S0025-76802004000500002,Betabloqueo,o
23,S0025-76802004000500002,El,o
23,S0025-76802004000500002,objetivo,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,nuestro,o
23,S0025-76802004000500002,trabajo,o
23,S0025-76802004000500002,fue,o
23,S0025-76802004000500002,estudiar,o
23,S0025-76802004000500002,la,o
23,S0025-76802004000500002,reactividad,o
23,S0025-76802004000500002,cardiovascular,i
23,S0025-76802004000500002,en,o
23,S0025-76802004000500002,personas,o
23,S0025-76802004000500002,sanas,o
23,S0025-76802004000500002,normotensas,o
23,S0025-76802004000500002,sin,o
23,S0025-76802004000500002,medicacion,i
23,S0025-76802004000500002,mediante,o
23,S0025-76802004000500002,la,o
23,S0025-76802004000500002,tecnica,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,Stroop,i
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,conflicto,o
23,S0025-76802004000500002,entre,o
23,S0025-76802004000500002,el,o
23,S0025-76802004000500002,color,o
23,S0025-76802004000500002,y,o
23,S0025-76802004000500002,la,o
23,S0025-76802004000500002,palabra,o
23,S0025-76802004000500002,SCWCT,o
23,S0025-76802004000500002,la,o
23,S0025-76802004000500002,respuesta,o
23,S0025-76802004000500002,anticipatoria,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,la,o
23,S0025-76802004000500002,presion,o
23,S0025-76802004000500002,arterial,i
23,S0025-76802004000500002,con,o
23,S0025-76802004000500002,el,o
23,S0025-76802004000500002,ejercicio,o
23,S0025-76802004000500002,RA,o
23,S0025-76802004000500002,y,o
23,S0025-76802004000500002,la,o
23,S0025-76802004000500002,prueba,i
23,S0025-76802004000500002,ergometrica,i
23,S0025-76802004000500002,graduada,i
23,S0025-76802004000500002,PEG,i
23,S0025-76802004000500002,Se,o
23,S0025-76802004000500002,analizo,o
23,S0025-76802004000500002,el,o
23,S0025-76802004000500002,efecto,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,un,o
23,S0025-76802004000500002,betabloqueante,i
23,S0025-76802004000500002,beta1,i
23,S0025-76802004000500002,selectivo,i
23,S0025-76802004000500002,bisoprolol,i
23,S0025-76802004000500002,B,o
23,S0025-76802004000500002,sobre,o
23,S0025-76802004000500002,la,o
23,S0025-76802004000500002,reactividad,o
23,S0025-76802004000500002,cardiovascular,i
23,S0025-76802004000500002,al,o
23,S0025-76802004000500002,estres,o
23,S0025-76802004000500002,mental,o
23,S0025-76802004000500002,EM,o
23,S0025-76802004000500002,y,o
23,S0025-76802004000500002,fisico,o
23,S0025-76802004000500002,en,o
23,S0025-76802004000500002,personas,o
23,S0025-76802004000500002,hiperreactivas,i
23,S0025-76802004000500002,Se,o
23,S0025-76802004000500002,estudiaron,o
23,S0025-76802004000500002,42,o
23,S0025-76802004000500002,personas,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,los,o
23,S0025-76802004000500002,cuales,o
23,S0025-76802004000500002,fueron,o
23,S0025-76802004000500002,incluidas,o
23,S0025-76802004000500002,solo,o
23,S0025-76802004000500002,30,o
23,S0025-76802004000500002,21,o
23,S0025-76802004000500002,mujeres,o
23,S0025-76802004000500002,y,o
23,S0025-76802004000500002,9,o
23,S0025-76802004000500002,varones,o
23,S0025-76802004000500002,que,o
23,S0025-76802004000500002,resultaron,o
23,S0025-76802004000500002,hiperreactivas,i
23,S0025-76802004000500002,con,o
23,S0025-76802004000500002,una,o
23,S0025-76802004000500002,edad,o
23,S0025-76802004000500002,media,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,425,o
23,S0025-76802004000500002,años,o
23,S0025-76802004000500002,Los,o
23,S0025-76802004000500002,mayores,o
23,S0025-76802004000500002,valores,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,la,o
23,S0025-76802004000500002,presion,o
23,S0025-76802004000500002,arterial,i
23,S0025-76802004000500002,sistolica,o
23,S0025-76802004000500002,PAS,o
23,S0025-76802004000500002,y,o
23,S0025-76802004000500002,diastolica,o
23,S0025-76802004000500002,PAD,o
23,S0025-76802004000500002,durante,o
23,S0025-76802004000500002,el,o
23,S0025-76802004000500002,EM,o
23,S0025-76802004000500002,fueron,o
23,S0025-76802004000500002,tomados,o
23,S0025-76802004000500002,como,o
23,S0025-76802004000500002,medida,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,reactividad,o
23,S0025-76802004000500002,considerandose,o
23,S0025-76802004000500002,como,o
23,S0025-76802004000500002,respuesta,i
23,S0025-76802004000500002,hiperreactiva,i
23,S0025-76802004000500002,un,o
23,S0025-76802004000500002,aumento,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,30,o
23,S0025-76802004000500002,mm,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,Hg,o
23,S0025-76802004000500002,o,o
23,S0025-76802004000500002,mayor,o
23,S0025-76802004000500002,yo,o
23,S0025-76802004000500002,15,o
23,S0025-76802004000500002,mm,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,Hg,o
23,S0025-76802004000500002,o,o
23,S0025-76802004000500002,mayor,o
23,S0025-76802004000500002,respectivamente,o
23,S0025-76802004000500002,El,o
23,S0025-76802004000500002,efecto,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,una,o
23,S0025-76802004000500002,dosis,o
23,S0025-76802004000500002,diaria,o
23,S0025-76802004000500002,oral,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,5,o
23,S0025-76802004000500002,mg,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,B,o
23,S0025-76802004000500002,vs,o
23,S0025-76802004000500002,placebo,i
23,S0025-76802004000500002,P,o
23,S0025-76802004000500002,fue,o
23,S0025-76802004000500002,estudiado,o
23,S0025-76802004000500002,en,o
23,S0025-76802004000500002,forma,o
23,S0025-76802004000500002,prospectiva,o
23,S0025-76802004000500002,randomizada,o
23,S0025-76802004000500002,y,o
23,S0025-76802004000500002,doble,o
23,S0025-76802004000500002,ciego,o
23,S0025-76802004000500002,Se,o
23,S0025-76802004000500002,analizaron,o
23,S0025-76802004000500002,los,o
23,S0025-76802004000500002,datos,o
23,S0025-76802004000500002,acerca,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,la,o
23,S0025-76802004000500002,reactividad,o
23,S0025-76802004000500002,en,o
23,S0025-76802004000500002,el,o
23,S0025-76802004000500002,SCWCT,o
23,S0025-76802004000500002,mediante,o
23,S0025-76802004000500002,el,o
23,S0025-76802004000500002,test,o
23,S0025-76802004000500002,exacto,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,Fisher,o
23,S0025-76802004000500002,En,o
23,S0025-76802004000500002,los,o
23,S0025-76802004000500002,resultados,o
23,S0025-76802004000500002,se,o
23,S0025-76802004000500002,observo,o
23,S0025-76802004000500002,una,o
23,S0025-76802004000500002,menor,o
23,S0025-76802004000500002,sensibilidad,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,RA,o
23,S0025-76802004000500002,y,o
23,S0025-76802004000500002,PEG,i
23,S0025-76802004000500002,vs,o
23,S0025-76802004000500002,SCWCT,o
23,S0025-76802004000500002,Las,o
23,S0025-76802004000500002,15,o
23,S0025-76802004000500002,personas,o
23,S0025-76802004000500002,que,o
23,S0025-76802004000500002,recibieron,o
23,S0025-76802004000500002,P,o
23,S0025-76802004000500002,continuaron,o
23,S0025-76802004000500002,hiperreactivas,i
23,S0025-76802004000500002,en,o
23,S0025-76802004000500002,tanto,o
23,S0025-76802004000500002,que,o
23,S0025-76802004000500002,6,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,las,o
23,S0025-76802004000500002,15,o
23,S0025-76802004000500002,personas,o
23,S0025-76802004000500002,tratadas,i
23,S0025-76802004000500002,con,o
23,S0025-76802004000500002,B,o
23,S0025-76802004000500002,dejaron,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,ser,o
23,S0025-76802004000500002,reactivas,o
23,S0025-76802004000500002,p0017,o
23,S0025-76802004000500002,B,o
23,S0025-76802004000500002,mostro,o
23,S0025-76802004000500002,un,o
23,S0025-76802004000500002,efecto,o
23,S0025-76802004000500002,beneficioso,o
23,S0025-76802004000500002,sobre,o
23,S0025-76802004000500002,la,o
23,S0025-76802004000500002,hiperreactividad,i
23,S0025-76802004000500002,en,o
23,S0025-76802004000500002,un,o
23,S0025-76802004000500002,significativo,o
23,S0025-76802004000500002,numero,o
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,personas,o
23,S0025-76802004000500002,en,o
23,S0025-76802004000500002,relacion,o
23,S0025-76802004000500002,a,o
23,S0025-76802004000500002,P,o
23,S0025-76802004000500002,lo,o
23,S0025-76802004000500002,cual,o
23,S0025-76802004000500002,podria,o
23,S0025-76802004000500002,ser,o
23,S0025-76802004000500002,util,o
23,S0025-76802004000500002,para,o
23,S0025-76802004000500002,la,o
23,S0025-76802004000500002,prevencion,i
23,S0025-76802004000500002,de,o
23,S0025-76802004000500002,una,o
23,S0025-76802004000500002,hipertension,i
23,S0025-76802004000500002,futura,o
24,S0025-76802012000200005,Administracion,i
24,S0025-76802012000200005,oral,i
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,preparado,i
24,S0025-76802012000200005,parenteral,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,vitamina,i
24,S0025-76802012000200005,K,i
24,S0025-76802012000200005,en,o
24,S0025-76802012000200005,anticoagulacion,i
24,S0025-76802012000200005,excesiva,o
24,S0025-76802012000200005,por,o
24,S0025-76802012000200005,warfarina,i
24,S0025-76802012000200005,La,o
24,S0025-76802012000200005,warfarina,i
24,S0025-76802012000200005,es,o
24,S0025-76802012000200005,frecuentemente,o
24,S0025-76802012000200005,usada,o
24,S0025-76802012000200005,en,o
24,S0025-76802012000200005,la,o
24,S0025-76802012000200005,terapia,i
24,S0025-76802012000200005,anticoagulante,i
24,S0025-76802012000200005,actual,o
24,S0025-76802012000200005,su,o
24,S0025-76802012000200005,accion,o
24,S0025-76802012000200005,debe,o
24,S0025-76802012000200005,ser,o
24,S0025-76802012000200005,monitorizada,i
24,S0025-76802012000200005,usando,o
24,S0025-76802012000200005,el,o
24,S0025-76802012000200005,tiempo,i
24,S0025-76802012000200005,de,i
24,S0025-76802012000200005,protrombina,i
24,S0025-76802012000200005,expresado,o
24,S0025-76802012000200005,como,o
24,S0025-76802012000200005,International,i
24,S0025-76802012000200005,Normalized,i
24,S0025-76802012000200005,Ratio,i
24,S0025-76802012000200005,INR,i
24,S0025-76802012000200005,cuando,o
24,S0025-76802012000200005,se,o
24,S0025-76802012000200005,excede,o
24,S0025-76802012000200005,el,o
24,S0025-76802012000200005,rango,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,seguridad,o
24,S0025-76802012000200005,se,o
24,S0025-76802012000200005,puede,o
24,S0025-76802012000200005,administrar,o
24,S0025-76802012000200005,vitamina,i
24,S0025-76802012000200005,K,i
24,S0025-76802012000200005,VitK,o
24,S0025-76802012000200005,preferentemente,o
24,S0025-76802012000200005,por,o
24,S0025-76802012000200005,via,o
24,S0025-76802012000200005,oral,o
24,S0025-76802012000200005,Dicha,o
24,S0025-76802012000200005,presentacion,o
24,S0025-76802012000200005,no,o
24,S0025-76802012000200005,esta,o
24,S0025-76802012000200005,disponible,o
24,S0025-76802012000200005,en,o
24,S0025-76802012000200005,Venezuela,o
24,S0025-76802012000200005,Se,o
24,S0025-76802012000200005,realizo,o
24,S0025-76802012000200005,un,o
24,S0025-76802012000200005,ensayo,o
24,S0025-76802012000200005,clinico,o
24,S0025-76802012000200005,doble,o
24,S0025-76802012000200005,ciego,o
24,S0025-76802012000200005,donde,o
24,S0025-76802012000200005,a,o
24,S0025-76802012000200005,20,o
24,S0025-76802012000200005,pacientes,o
24,S0025-76802012000200005,edad,o
24,S0025-76802012000200005,1860,o
24,S0025-76802012000200005,años,o
24,S0025-76802012000200005,sin,o
24,S0025-76802012000200005,sangrado,i
24,S0025-76802012000200005,e,o
24,S0025-76802012000200005,INR,i
24,S0025-76802012000200005,inicial,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,6,o
24,S0025-76802012000200005,a,o
24,S0025-76802012000200005,10,o
24,S0025-76802012000200005,inclusive,o
24,S0025-76802012000200005,les,o
24,S0025-76802012000200005,fue,o
24,S0025-76802012000200005,suspendida,o
24,S0025-76802012000200005,la,o
24,S0025-76802012000200005,warfarina,i
24,S0025-76802012000200005,e,o
24,S0025-76802012000200005,inmediatamente,o
24,S0025-76802012000200005,agrupados,i
24,S0025-76802012000200005,al,i
24,S0025-76802012000200005,azar,i
24,S0025-76802012000200005,a,o
24,S0025-76802012000200005,recibir,o
24,S0025-76802012000200005,dosis,o
24,S0025-76802012000200005,unica,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,VitK,o
24,S0025-76802012000200005,oral,o
24,S0025-76802012000200005,125mg,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,VitK,o
24,S0025-76802012000200005,fraccionada,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,una,o
24,S0025-76802012000200005,presentacion,o
24,S0025-76802012000200005,parenteral,o
24,S0025-76802012000200005,o,o
24,S0025-76802012000200005,placebo,i
24,S0025-76802012000200005,El,o
24,S0025-76802012000200005,punto,o
24,S0025-76802012000200005,final,o
24,S0025-76802012000200005,primario,o
24,S0025-76802012000200005,INR,i
24,S0025-76802012000200005,35,o
24,S0025-76802012000200005,a,o
24,S0025-76802012000200005,las,o
24,S0025-76802012000200005,24,o
24,S0025-76802012000200005,horas,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,administrar,o
24,S0025-76802012000200005,la,o
24,S0025-76802012000200005,dosis,o
24,S0025-76802012000200005,se,o
24,S0025-76802012000200005,alcanzo,o
24,S0025-76802012000200005,en,o
24,S0025-76802012000200005,70,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,los,o
24,S0025-76802012000200005,pacientes,o
24,S0025-76802012000200005,en,o
24,S0025-76802012000200005,VitK,o
24,S0025-76802012000200005,y,o
24,S0025-76802012000200005,20,o
24,S0025-76802012000200005,en,o
24,S0025-76802012000200005,placebo,i
24,S0025-76802012000200005,La,o
24,S0025-76802012000200005,reduccion,o
24,S0025-76802012000200005,absoluta,o
24,S0025-76802012000200005,del,o
24,S0025-76802012000200005,riesgo,o
24,S0025-76802012000200005,y,o
24,S0025-76802012000200005,su,o
24,S0025-76802012000200005,intervalo,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,confianza,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,95,o
24,S0025-76802012000200005,RAR,o
24,S0025-76802012000200005,IC95,o
24,S0025-76802012000200005,50,o
24,S0025-76802012000200005,144,o
24,S0025-76802012000200005,a,o
24,S0025-76802012000200005,856,o
24,S0025-76802012000200005,ρ,o
24,S0025-76802012000200005,0028,o
24,S0025-76802012000200005,NNT,o
24,S0025-76802012000200005,IC95,o
24,S0025-76802012000200005,213,o
24,S0025-76802012000200005,a,o
24,S0025-76802012000200005,69,o
24,S0025-76802012000200005,no,o
24,S0025-76802012000200005,se,o
24,S0025-76802012000200005,registraron,o
24,S0025-76802012000200005,eventos,i
24,S0025-76802012000200005,adversos,i
24,S0025-76802012000200005,ni,o
24,S0025-76802012000200005,INR,i
24,S0025-76802012000200005,2,o
24,S0025-76802012000200005,luego,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,24,o
24,S0025-76802012000200005,horas,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,tratamiento,i
24,S0025-76802012000200005,Los,o
24,S0025-76802012000200005,resultados,o
24,S0025-76802012000200005,obtenidos,o
24,S0025-76802012000200005,son,o
24,S0025-76802012000200005,consistentes,o
24,S0025-76802012000200005,con,o
24,S0025-76802012000200005,estudios,o
24,S0025-76802012000200005,donde,o
24,S0025-76802012000200005,se,o
24,S0025-76802012000200005,administro,o
24,S0025-76802012000200005,VitK,o
24,S0025-76802012000200005,en,o
24,S0025-76802012000200005,preparacion,o
24,S0025-76802012000200005,especifica,o
24,S0025-76802012000200005,para,o
24,S0025-76802012000200005,via,o
24,S0025-76802012000200005,oral,o
24,S0025-76802012000200005,Asi,o
24,S0025-76802012000200005,la,o
24,S0025-76802012000200005,VitK,o
24,S0025-76802012000200005,en,o
24,S0025-76802012000200005,presentacion,o
24,S0025-76802012000200005,parenteral,o
24,S0025-76802012000200005,administrada,i
24,S0025-76802012000200005,por,i
24,S0025-76802012000200005,via,i
24,S0025-76802012000200005,oral,i
24,S0025-76802012000200005,es,o
24,S0025-76802012000200005,mas,o
24,S0025-76802012000200005,efectiva,o
24,S0025-76802012000200005,y,o
24,S0025-76802012000200005,segura,o
24,S0025-76802012000200005,que,o
24,S0025-76802012000200005,simplemente,o
24,S0025-76802012000200005,detener,o
24,S0025-76802012000200005,la,o
24,S0025-76802012000200005,administracion,i
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,warfarina,i
24,S0025-76802012000200005,para,o
24,S0025-76802012000200005,revertir,o
24,S0025-76802012000200005,la,o
24,S0025-76802012000200005,excesiva,o
24,S0025-76802012000200005,anticoagulacion,i
24,S0025-76802012000200005,en,o
24,S0025-76802012000200005,donde,o
24,S0025-76802012000200005,no,o
24,S0025-76802012000200005,exista,o
24,S0025-76802012000200005,presentacion,o
24,S0025-76802012000200005,especifica,o
24,S0025-76802012000200005,oral,o
24,S0025-76802012000200005,de,o
24,S0025-76802012000200005,VitK,o
24,S0025-76802012000200005,o,o
24,S0025-76802012000200005,esta,o
24,S0025-76802012000200005,sea,o
24,S0025-76802012000200005,muy,o
24,S0025-76802012000200005,costosa,o
25,S0025-76802012000300008,Regimen,i
25,S0025-76802012000300008,con,o
25,S0025-76802012000300008,insulina,i
25,S0025-76802012000300008,lispro,i
25,S0025-76802012000300008,mix,o
25,S0025-76802012000300008,25,o
25,S0025-76802012000300008,versus,o
25,S0025-76802012000300008,insulina,i
25,S0025-76802012000300008,glargina,i
25,S0025-76802012000300008,para,o
25,S0025-76802012000300008,la,o
25,S0025-76802012000300008,diabetes,i
25,S0025-76802012000300008,tipo,i
25,S0025-76802012000300008,2,i
25,S0025-76802012000300008,La,o
25,S0025-76802012000300008,informacion,o
25,S0025-76802012000300008,sobre,o
25,S0025-76802012000300008,el,o
25,S0025-76802012000300008,inicio,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,regimenes,i
25,S0025-76802012000300008,de,i
25,S0025-76802012000300008,insulina,i
25,S0025-76802012000300008,en,o
25,S0025-76802012000300008,poblaciones,o
25,S0025-76802012000300008,especificas,o
25,S0025-76802012000300008,con,o
25,S0025-76802012000300008,diabetes,i
25,S0025-76802012000300008,tipo,i
25,S0025-76802012000300008,2,i
25,S0025-76802012000300008,DT2,i
25,S0025-76802012000300008,es,o
25,S0025-76802012000300008,limitada,o
25,S0025-76802012000300008,Se,o
25,S0025-76802012000300008,comparo,i
25,S0025-76802012000300008,eficacia,i
25,S0025-76802012000300008,y,i
25,S0025-76802012000300008,seguridad,i
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,dos,o
25,S0025-76802012000300008,regimenes,i
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,inicio,o
25,S0025-76802012000300008,insulina,i
25,S0025-76802012000300008,lispro,i
25,S0025-76802012000300008,mix,o
25,S0025-76802012000300008,25,o
25,S0025-76802012000300008,LM25,o
25,S0025-76802012000300008,e,o
25,S0025-76802012000300008,insulina,i
25,S0025-76802012000300008,glargina,i
25,S0025-76802012000300008,basal,o
25,S0025-76802012000300008,GL,o
25,S0025-76802012000300008,Se,o
25,S0025-76802012000300008,evaluaron,o
25,S0025-76802012000300008,193,o
25,S0025-76802012000300008,pacientes,o
25,S0025-76802012000300008,no,o
25,S0025-76802012000300008,tratados,i
25,S0025-76802012000300008,previamente,o
25,S0025-76802012000300008,con,o
25,S0025-76802012000300008,insulina,i
25,S0025-76802012000300008,en,o
25,S0025-76802012000300008,la,o
25,S0025-76802012000300008,fase,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,iniciacion,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,24,o
25,S0025-76802012000300008,semanas,o
25,S0025-76802012000300008,del,o
25,S0025-76802012000300008,ensayo,o
25,S0025-76802012000300008,DURABLE,o
25,S0025-76802012000300008,edades,o
25,S0025-76802012000300008,3079,o
25,S0025-76802012000300008,años,o
25,S0025-76802012000300008,DT2,i
25,S0025-76802012000300008,controlada,o
25,S0025-76802012000300008,inadecuadamente,o
25,S0025-76802012000300008,HbA1c,i
25,S0025-76802012000300008,70,o
25,S0025-76802012000300008,con,o
25,S0025-76802012000300008,2,o
25,S0025-76802012000300008,medicaciones,i
25,S0025-76802012000300008,orales,i
25,S0025-76802012000300008,antidiabeticas,i
25,S0025-76802012000300008,MOAs,o
25,S0025-76802012000300008,aleatorizados,i
25,S0025-76802012000300008,para,o
25,S0025-76802012000300008,LM25,o
25,S0025-76802012000300008,25,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,insulina,i
25,S0025-76802012000300008,lispro,i
25,S0025-76802012000300008,75,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,insulina,i
25,S0025-76802012000300008,lispro,i
25,S0025-76802012000300008,protamina,i
25,S0025-76802012000300008,en,o
25,S0025-76802012000300008,suspension,o
25,S0025-76802012000300008,dos,o
25,S0025-76802012000300008,vecesdia,o
25,S0025-76802012000300008,o,o
25,S0025-76802012000300008,GL,o
25,S0025-76802012000300008,insulina,i
25,S0025-76802012000300008,glargina,i
25,S0025-76802012000300008,basal,o
25,S0025-76802012000300008,una,o
25,S0025-76802012000300008,vez,o
25,S0025-76802012000300008,dia,o
25,S0025-76802012000300008,a,o
25,S0025-76802012000300008,las,o
25,S0025-76802012000300008,MOAs,o
25,S0025-76802012000300008,previas,o
25,S0025-76802012000300008,La,o
25,S0025-76802012000300008,eficacia,o
25,S0025-76802012000300008,primaria,o
25,S0025-76802012000300008,se,o
25,S0025-76802012000300008,midio,o
25,S0025-76802012000300008,por,o
25,S0025-76802012000300008,HbA1c,i
25,S0025-76802012000300008,a,o
25,S0025-76802012000300008,las,o
25,S0025-76802012000300008,24,o
25,S0025-76802012000300008,semanas,o
25,S0025-76802012000300008,Se,o
25,S0025-76802012000300008,midio,o
25,S0025-76802012000300008,eficacia,o
25,S0025-76802012000300008,secundaria,o
25,S0025-76802012000300008,por,o
25,S0025-76802012000300008,proporcion,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,pacientes,o
25,S0025-76802012000300008,que,o
25,S0025-76802012000300008,alcanzaron,o
25,S0025-76802012000300008,HbA1c,i
25,S0025-76802012000300008,65,o
25,S0025-76802012000300008,y,o
25,S0025-76802012000300008,70,o
25,S0025-76802012000300008,cambio,i
25,S0025-76802012000300008,en,i
25,S0025-76802012000300008,peso,i
25,S0025-76802012000300008,corporal,i
25,S0025-76802012000300008,valores,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,automonitoreo,i
25,S0025-76802012000300008,glucemico,i
25,S0025-76802012000300008,e,o
25,S0025-76802012000300008,indices,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,hipoglucemia,i
25,S0025-76802012000300008,LM25,o
25,S0025-76802012000300008,demostro,o
25,S0025-76802012000300008,mayor,o
25,S0025-76802012000300008,reduccion,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,la,o
25,S0025-76802012000300008,HbA1c,i
25,S0025-76802012000300008,24,o
25,S0025-76802012000300008,016,o
25,S0025-76802012000300008,vs,o
25,S0025-76802012000300008,20,o
25,S0025-76802012000300008,016,o
25,S0025-76802012000300008,P,o
25,S0025-76802012000300008,0002,o
25,S0025-76802012000300008,mayor,o
25,S0025-76802012000300008,proporcion,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,pacientes,o
25,S0025-76802012000300008,alcanzaron,o
25,S0025-76802012000300008,HbA1c,i
25,S0025-76802012000300008,70,o
25,S0025-76802012000300008,P,o
25,S0025-76802012000300008,0012,o
25,S0025-76802012000300008,y,o
25,S0025-76802012000300008,niveles,i
25,S0025-76802012000300008,de,i
25,S0025-76802012000300008,glucemia,i
25,S0025-76802012000300008,menores,o
25,S0025-76802012000300008,despues,o
25,S0025-76802012000300008,del,o
25,S0025-76802012000300008,desayuno,o
25,S0025-76802012000300008,P,o
25,S0025-76802012000300008,0028,o
25,S0025-76802012000300008,y,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,la,o
25,S0025-76802012000300008,cena,o
25,S0025-76802012000300008,P,o
25,S0025-76802012000300008,0011,o
25,S0025-76802012000300008,y,o
25,S0025-76802012000300008,a,o
25,S0025-76802012000300008,las,o
25,S0025-76802012000300008,3,o
25,S0025-76802012000300008,am,o
25,S0025-76802012000300008,P,o
25,S0025-76802012000300008,0005,o
25,S0025-76802012000300008,comparada,o
25,S0025-76802012000300008,con,o
25,S0025-76802012000300008,GL,o
25,S0025-76802012000300008,La,o
25,S0025-76802012000300008,glucemia,i
25,S0025-76802012000300008,en,i
25,S0025-76802012000300008,ayunas,i
25,S0025-76802012000300008,GA,i
25,S0025-76802012000300008,y,o
25,S0025-76802012000300008,la,o
25,S0025-76802012000300008,proporcion,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,pacientes,o
25,S0025-76802012000300008,que,o
25,S0025-76802012000300008,alcanzaron,o
25,S0025-76802012000300008,una,o
25,S0025-76802012000300008,HbA1c,i
25,S0025-76802012000300008,65,o
25,S0025-76802012000300008,fueron,o
25,S0025-76802012000300008,similares,o
25,S0025-76802012000300008,En,o
25,S0025-76802012000300008,ambos,o
25,S0025-76802012000300008,grupos,o
25,S0025-76802012000300008,hubo,o
25,S0025-76802012000300008,aumento,i
25,S0025-76802012000300008,del,i
25,S0025-76802012000300008,peso,i
25,S0025-76802012000300008,corporal,i
25,S0025-76802012000300008,mayor,o
25,S0025-76802012000300008,en,o
25,S0025-76802012000300008,la,o
25,S0025-76802012000300008,valoracion,o
25,S0025-76802012000300008,final,o
25,S0025-76802012000300008,con,o
25,S0025-76802012000300008,LM25,o
25,S0025-76802012000300008,635,o
25,S0025-76802012000300008,kg,o
25,S0025-76802012000300008,vs,o
25,S0025-76802012000300008,423,o
25,S0025-76802012000300008,kg,o
25,S0025-76802012000300008,P,o
25,S0025-76802012000300008,0001,o
25,S0025-76802012000300008,No,o
25,S0025-76802012000300008,hubieron,o
25,S0025-76802012000300008,diferencias,o
25,S0025-76802012000300008,en,o
25,S0025-76802012000300008,indices,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,hipoglucemia,i
25,S0025-76802012000300008,entre,o
25,S0025-76802012000300008,grupos,o
25,S0025-76802012000300008,ni,o
25,S0025-76802012000300008,eventos,i
25,S0025-76802012000300008,adversos,i
25,S0025-76802012000300008,serios,o
25,S0025-76802012000300008,en,o
25,S0025-76802012000300008,ninguno,o
25,S0025-76802012000300008,Con,o
25,S0025-76802012000300008,LM25,o
25,S0025-76802012000300008,fue,o
25,S0025-76802012000300008,mejor,o
25,S0025-76802012000300008,el,o
25,S0025-76802012000300008,control,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,glucosa,i
25,S0025-76802012000300008,riesgo,o
25,S0025-76802012000300008,de,o
25,S0025-76802012000300008,hipoglucemia,i
25,S0025-76802012000300008,similar,o
25,S0025-76802012000300008,y,o
25,S0025-76802012000300008,mayor,o
25,S0025-76802012000300008,aumento,i
25,S0025-76802012000300008,de,i
25,S0025-76802012000300008,peso,i
25,S0025-76802012000300008,que,o
25,S0025-76802012000300008,GL,o
26,S0025-76802017000100001,Revascularizacion,i
26,S0025-76802017000100001,coronaria,i
26,S0025-76802017000100001,sin,o
26,S0025-76802017000100001,circulacion,i
26,S0025-76802017000100001,extracorporea,i
26,S0025-76802017000100001,Supervivencia,o
26,S0025-76802017000100001,alejada,o
26,S0025-76802017000100001,Aunque,o
26,S0025-76802017000100001,los,o
26,S0025-76802017000100001,ensayos,i
26,S0025-76802017000100001,clinicos,i
26,S0025-76802017000100001,aleatorizados,i
26,S0025-76802017000100001,han,o
26,S0025-76802017000100001,comparado,o
26,S0025-76802017000100001,los,o
26,S0025-76802017000100001,resultados,o
26,S0025-76802017000100001,de,o
26,S0025-76802017000100001,la,o
26,S0025-76802017000100001,cirugia,i
26,S0025-76802017000100001,de,i
26,S0025-76802017000100001,revascularizacion,i
26,S0025-76802017000100001,coronaria,i
26,S0025-76802017000100001,CRM,i
26,S0025-76802017000100001,con,o
26,S0025-76802017000100001,y,o
26,S0025-76802017000100001,sin,o
26,S0025-76802017000100001,circulacion,i
26,S0025-76802017000100001,extracorporea,i
26,S0025-76802017000100001,CEC,i
26,S0025-76802017000100001,el,o
26,S0025-76802017000100001,efecto,o
26,S0025-76802017000100001,a,o
26,S0025-76802017000100001,largo,o
26,S0025-76802017000100001,plazo,o
26,S0025-76802017000100001,con,o
26,S0025-76802017000100001,la,o
26,S0025-76802017000100001,utilizacion,o
26,S0025-76802017000100001,de,o
26,S0025-76802017000100001,estas,o
26,S0025-76802017000100001,tecnicas,o
26,S0025-76802017000100001,no,o
26,S0025-76802017000100001,ha,o
26,S0025-76802017000100001,sido,o
26,S0025-76802017000100001,evaluado,o
26,S0025-76802017000100001,El,o
26,S0025-76802017000100001,objetivo,o
26,S0025-76802017000100001,del,o
26,S0025-76802017000100001,estudio,o
26,S0025-76802017000100001,fue,o
26,S0025-76802017000100001,evaluar,i
26,S0025-76802017000100001,la,i
26,S0025-76802017000100001,supervivencia,i
26,S0025-76802017000100001,alejada,o
26,S0025-76802017000100001,con,o
26,S0025-76802017000100001,la,o
26,S0025-76802017000100001,utilizacion,o
26,S0025-76802017000100001,de,o
26,S0025-76802017000100001,CRM,i
26,S0025-76802017000100001,con,o
26,S0025-76802017000100001,y,o
26,S0025-76802017000100001,sin,o
26,S0025-76802017000100001,CEC,i
26,S0025-76802017000100001,Se,o
26,S0025-76802017000100001,incluyeron,o
26,S0025-76802017000100001,todos,o
26,S0025-76802017000100001,los,o
26,S0025-76802017000100001,pacientes,o
26,S0025-76802017000100001,sometidos,o
26,S0025-76802017000100001,a,o
26,S0025-76802017000100001,CRM,i
26,S0025-76802017000100001,durante,o
26,S0025-76802017000100001,el,o
26,S0025-76802017000100001,periodo,o
26,S0025-76802017000100001,19962015,o
26,S0025-76802017000100001,n,o
26,S0025-76802017000100001,4687,o
26,S0025-76802017000100001,La,o
26,S0025-76802017000100001,supervivencia,o
26,S0025-76802017000100001,a,o
26,S0025-76802017000100001,largo,o
26,S0025-76802017000100001,plazo,o
26,S0025-76802017000100001,y,o
26,S0025-76802017000100001,la,o
26,S0025-76802017000100001,incidencia,o
26,S0025-76802017000100001,de,o
26,S0025-76802017000100001,eventos,i
26,S0025-76802017000100001,cardiacos,i
26,S0025-76802017000100001,se,o
26,S0025-76802017000100001,compararon,o
26,S0025-76802017000100001,entre,o
26,S0025-76802017000100001,los,o
26,S0025-76802017000100001,que,o
26,S0025-76802017000100001,recibieron,o
26,S0025-76802017000100001,CRM,i
26,S0025-76802017000100001,sinCEC,o
26,S0025-76802017000100001,n,o
26,S0025-76802017000100001,3402,o
26,S0025-76802017000100001,frente,o
26,S0025-76802017000100001,a,o
26,S0025-76802017000100001,los,o
26,S0025-76802017000100001,pacientes,o
26,S0025-76802017000100001,conCEC,o
26,S0025-76802017000100001,n,o
26,S0025-76802017000100001,1285,o
26,S0025-76802017000100001,El,o
26,S0025-76802017000100001,punto,o
26,S0025-76802017000100001,final,o
26,S0025-76802017000100001,primario,o
26,S0025-76802017000100001,se,o
26,S0025-76802017000100001,definio,o
26,S0025-76802017000100001,como,o
26,S0025-76802017000100001,muerte,i
26,S0025-76802017000100001,por,o
26,S0025-76802017000100001,cualquier,o
26,S0025-76802017000100001,causa,o
26,S0025-76802017000100001,analizandose,i
26,S0025-76802017000100001,la,i
26,S0025-76802017000100001,supervivencia,i
26,S0025-76802017000100001,a,o
26,S0025-76802017000100001,10,o
26,S0025-76802017000100001,años,o
26,S0025-76802017000100001,Para,o
26,S0025-76802017000100001,reducir,o
26,S0025-76802017000100001,posibles,o
26,S0025-76802017000100001,sesgos,o
26,S0025-76802017000100001,se,o
26,S0025-76802017000100001,realizo,o
26,S0025-76802017000100001,un,o
26,S0025-76802017000100001,analisis,o
26,S0025-76802017000100001,ajustado,o
26,S0025-76802017000100001,por,o
26,S0025-76802017000100001,riesgo,o
26,S0025-76802017000100001,La,o
26,S0025-76802017000100001,mortalidad,o
26,S0025-76802017000100001,hospitalaria,o
26,S0025-76802017000100001,global,o
26,S0025-76802017000100001,fue,o
26,S0025-76802017000100001,31,o
26,S0025-76802017000100001,observandose,o
26,S0025-76802017000100001,una,o
26,S0025-76802017000100001,diferencia,o
26,S0025-76802017000100001,entre,o
26,S0025-76802017000100001,ambos,o
26,S0025-76802017000100001,grupos,o
26,S0025-76802017000100001,23,o
26,S0025-76802017000100001,vs,o
26,S0025-76802017000100001,52,o
26,S0025-76802017000100001,p,o
26,S0025-76802017000100001,00001,o
26,S0025-76802017000100001,a,o
26,S0025-76802017000100001,favor,o
26,S0025-76802017000100001,de,o
26,S0025-76802017000100001,la,o
26,S0025-76802017000100001,cirugia,i
26,S0025-76802017000100001,sinCEC,o
26,S0025-76802017000100001,El,o
26,S0025-76802017000100001,analisis,i
26,S0025-76802017000100001,de,i
26,S0025-76802017000100001,la,i
26,S0025-76802017000100001,mortalidad,i
26,S0025-76802017000100001,no,o
26,S0025-76802017000100001,ajustada,o
26,S0025-76802017000100001,a,o
26,S0025-76802017000100001,largo,o
26,S0025-76802017000100001,plazo,o
26,S0025-76802017000100001,no,o
26,S0025-76802017000100001,mostro,o
26,S0025-76802017000100001,una,o
26,S0025-76802017000100001,diferencia,o
26,S0025-76802017000100001,significativa,o
26,S0025-76802017000100001,a,o
26,S0025-76802017000100001,10,o
26,S0025-76802017000100001,años,o
26,S0025-76802017000100001,sinCEC,o
26,S0025-76802017000100001,vs,o
26,S0025-76802017000100001,conCEC,o
26,S0025-76802017000100001,779,o
26,S0025-76802017000100001,12,o
26,S0025-76802017000100001,vs,o
26,S0025-76802017000100001,802,o
26,S0025-76802017000100001,13,o
26,S0025-76802017000100001,p,o
26,S0025-76802017000100001,log,o
26,S0025-76802017000100001,rank,o
26,S0025-76802017000100001,0361,o
26,S0025-76802017000100001,En,o
26,S0025-76802017000100001,el,o
26,S0025-76802017000100001,analisis,o
26,S0025-76802017000100001,ajustado,o
26,S0025-76802017000100001,por,o
26,S0025-76802017000100001,riesgo,o
26,S0025-76802017000100001,tampoco,o
26,S0025-76802017000100001,se,o
26,S0025-76802017000100001,observo,o
26,S0025-76802017000100001,una,o
26,S0025-76802017000100001,diferencia,o
26,S0025-76802017000100001,significativa,o
26,S0025-76802017000100001,de,o
26,S0025-76802017000100001,supervivencia,o
26,S0025-76802017000100001,a,o
26,S0025-76802017000100001,10,o
26,S0025-76802017000100001,años,o
26,S0025-76802017000100001,842,o
26,S0025-76802017000100001,29,o
26,S0025-76802017000100001,vs,o
26,S0025-76802017000100001,803,o
26,S0025-76802017000100001,24,o
26,S0025-76802017000100001,p,o
26,S0025-76802017000100001,0169,o
26,S0025-76802017000100001,En,o
26,S0025-76802017000100001,conclusion,o
26,S0025-76802017000100001,la,o
26,S0025-76802017000100001,CRM,i
26,S0025-76802017000100001,sinCEC,o
26,S0025-76802017000100001,presento,o
26,S0025-76802017000100001,una,o
26,S0025-76802017000100001,menor,o
26,S0025-76802017000100001,mortalidad,o
26,S0025-76802017000100001,hospitalaria,o
26,S0025-76802017000100001,y,o
26,S0025-76802017000100001,no,o
26,S0025-76802017000100001,se,o
26,S0025-76802017000100001,encontro,o
26,S0025-76802017000100001,una,o
26,S0025-76802017000100001,diferencia,o
26,S0025-76802017000100001,en,o
26,S0025-76802017000100001,la,o
26,S0025-76802017000100001,mortalidad,o
26,S0025-76802017000100001,a,o
26,S0025-76802017000100001,largo,o
26,S0025-76802017000100001,plazo,o
26,S0025-76802017000100001,en,o
26,S0025-76802017000100001,comparacion,o
26,S0025-76802017000100001,con,o
26,S0025-76802017000100001,CRM,i
26,S0025-76802017000100001,conCEC,o
27,S0034-709410700738,Estudio,i
27,S0034-709410700738,Comparativo,i
27,S0034-709410700738,del,o
27,S0034-709410700738,Bloqueo,o
27,S0034-709410700738,Combinado,o
27,S0034-709410700738,FemoralIsquiatico,o
27,S0034-709410700738,por,o
27,S0034-709410700738,Puncion,i
27,S0034-709410700738,en,i
27,S0034-709410700738,Sitio,i
27,S0034-709410700738,Unico,i
27,S0034-709410700738,con,o
27,S0034-709410700738,Anestesia,i
27,S0034-709410700738,Subaracnoidea,i
27,S0034-709410700738,para,o
27,S0034-709410700738,Cirugias,i
27,S0034-709410700738,Unilateral,i
27,S0034-709410700738,del,i
27,S0034-709410700738,Miembro,i
27,S0034-709410700738,Inferior,i
27,S0034-709410700738,Justificativa,o
27,S0034-709410700738,y,o
27,S0034-709410700738,objetivos,o
27,S0034-709410700738,La,o
27,S0034-709410700738,raquianestesia,i
27,S0034-709410700738,unilateral,i
27,S0034-709410700738,puede,o
27,S0034-709410700738,presentar,o
27,S0034-709410700738,ventajas,o
27,S0034-709410700738,en,o
27,S0034-709410700738,pacientes,o
27,S0034-709410700738,ambulatoriales,o
27,S0034-709410700738,El,o
27,S0034-709410700738,objetivo,o
27,S0034-709410700738,de,o
27,S0034-709410700738,este,o
27,S0034-709410700738,trabajo,o
27,S0034-709410700738,fue,o
27,S0034-709410700738,comparar,o
27,S0034-709410700738,la,o
27,S0034-709410700738,raquianestesia,i
27,S0034-709410700738,unilateral,i
27,S0034-709410700738,con,o
27,S0034-709410700738,el,o
27,S0034-709410700738,bloqueo,o
27,S0034-709410700738,combinado,o
27,S0034-709410700738,femoralisquiatico,o
27,S0034-709410700738,en,o
27,S0034-709410700738,cirugias,i
27,S0034-709410700738,ortopedicas,i
27,S0034-709410700738,unilaterales,i
27,S0034-709410700738,y,o
27,S0034-709410700738,ambulatoriales,o
27,S0034-709410700738,Metodo,o
27,S0034-709410700738,Sesenta,o
27,S0034-709410700738,pacientes,o
27,S0034-709410700738,fueron,o
27,S0034-709410700738,separados,i
27,S0034-709410700738,aleatoriamente,i
27,S0034-709410700738,en,o
27,S0034-709410700738,dos,o
27,S0034-709410700738,grupos,o
27,S0034-709410700738,de,o
27,S0034-709410700738,30,o
27,S0034-709410700738,para,o
27,S0034-709410700738,recibir,o
27,S0034-709410700738,6,o
27,S0034-709410700738,mg,o
27,S0034-709410700738,de,o
27,S0034-709410700738,bupivacaina,i
27,S0034-709410700738,hiperbarica,o
27,S0034-709410700738,o,o
27,S0034-709410700738,hipobarica,o
27,S0034-709410700738,grupo,o
27,S0034-709410700738,RQ,o
27,S0034-709410700738,en,o
27,S0034-709410700738,decubito,o
27,S0034-709410700738,lateral,o
27,S0034-709410700738,izquierdo,o
27,S0034-709410700738,u,o
27,S0034-709410700738,800,o
27,S0034-709410700738,mg,o
27,S0034-709410700738,de,o
27,S0034-709410700738,lidocaina,i
27,S0034-709410700738,16,o
27,S0034-709410700738,con,o
27,S0034-709410700738,epinefrina,i
27,S0034-709410700738,en,o
27,S0034-709410700738,los,o
27,S0034-709410700738,nervios,i
27,S0034-709410700738,femoral,i
27,S0034-709410700738,e,i
27,S0034-709410700738,isquiatico,i
27,S0034-709410700738,grupo,o
27,S0034-709410700738,CFI,o
27,S0034-709410700738,en,o
27,S0034-709410700738,decubito,o
27,S0034-709410700738,dorsal,i
27,S0034-709410700738,El,o
27,S0034-709410700738,bloqueo,i
27,S0034-709410700738,de,i
27,S0034-709410700738,los,i
27,S0034-709410700738,nervios,i
27,S0034-709410700738,fue,o
27,S0034-709410700738,realizado,o
27,S0034-709410700738,con,o
27,S0034-709410700738,una,o
27,S0034-709410700738,aguja,o
27,S0034-709410700738,de,o
27,S0034-709410700738,150,o
27,S0034-709410700738,mm,o
27,S0034-709410700738,conectada,o
27,S0034-709410700738,a,o
27,S0034-709410700738,un,o
27,S0034-709410700738,neuroestimulador,o
27,S0034-709410700738,e,o
27,S0034-709410700738,insertada,o
27,S0034-709410700738,en,o
27,S0034-709410700738,el,o
27,S0034-709410700738,punto,o
27,S0034-709410700738,medio,o
27,S0034-709410700738,entre,o
27,S0034-709410700738,las,o
27,S0034-709410700738,dos,o
27,S0034-709410700738,incisiones,i
27,S0034-709410700738,clasicas,o
27,S0034-709410700738,Se,o
27,S0034-709410700738,inyectaron,i
27,S0034-709410700738,15,o
27,S0034-709410700738,mL,o
27,S0034-709410700738,en,o
27,S0034-709410700738,el,o
27,S0034-709410700738,nervio,i
27,S0034-709410700738,femoral,i
27,S0034-709410700738,y,o
27,S0034-709410700738,35,o
27,S0034-709410700738,mL,o
27,S0034-709410700738,en,o
27,S0034-709410700738,el,o
27,S0034-709410700738,nervio,i
27,S0034-709410700738,isquiatico,i
27,S0034-709410700738,Fue,o
27,S0034-709410700738,mensurado,i
27,S0034-709410700738,el,i
27,S0034-709410700738,tiempo,i
27,S0034-709410700738,para,o
27,S0034-709410700738,la,o
27,S0034-709410700738,realizacion,o
27,S0034-709410700738,de,o
27,S0034-709410700738,los,o
27,S0034-709410700738,bloqueos,i
27,S0034-709410700738,y,o
27,S0034-709410700738,su,o
27,S0034-709410700738,duracion,o
27,S0034-709410700738,Veinte,o
27,S0034-709410700738,minutos,o
27,S0034-709410700738,despues,o
27,S0034-709410700738,los,o
27,S0034-709410700738,pacientes,o
27,S0034-709410700738,fueron,o
27,S0034-709410700738,evaluados,o
27,S0034-709410700738,con,o
27,S0034-709410700738,relacion,o
27,S0034-709410700738,a,o
27,S0034-709410700738,los,o
27,S0034-709410700738,bloqueos,i
27,S0034-709410700738,sensitivo,o
27,S0034-709410700738,y,o
27,S0034-709410700738,motor,o
27,S0034-709410700738,Resultados,o
27,S0034-709410700738,El,o
27,S0034-709410700738,tiempo,o
27,S0034-709410700738,para,o
27,S0034-709410700738,la,o
27,S0034-709410700738,realizacion,o
27,S0034-709410700738,de,o
27,S0034-709410700738,la,o
27,S0034-709410700738,raquianestesia,i
27,S0034-709410700738,fue,o
27,S0034-709410700738,significativamente,o
27,S0034-709410700738,menor,o
27,S0034-709410700738,que,o
27,S0034-709410700738,el,o
27,S0034-709410700738,bloqueo,o
27,S0034-709410700738,combinado,o
27,S0034-709410700738,femoralisquiatico,o
27,S0034-709410700738,El,o
27,S0034-709410700738,bloqueo,i
27,S0034-709410700738,unilateral,i
27,S0034-709410700738,se,o
27,S0034-709410700738,obtuvo,o
27,S0034-709410700738,en,o
27,S0034-709410700738,un,o
27,S0034-709410700738,90,o
27,S0034-709410700738,de,o
27,S0034-709410700738,los,o
27,S0034-709410700738,pacientes,o
27,S0034-709410700738,en,o
27,S0034-709410700738,el,o
27,S0034-709410700738,grupo,o
27,S0034-709410700738,RQ,o
27,S0034-709410700738,y,o
27,S0034-709410700738,en,o
27,S0034-709410700738,un,o
27,S0034-709410700738,100,o
27,S0034-709410700738,en,o
27,S0034-709410700738,el,o
27,S0034-709410700738,grupo,o
27,S0034-709410700738,CFI,o
27,S0034-709410700738,El,o
27,S0034-709410700738,tiempo,o
27,S0034-709410700738,para,o
27,S0034-709410700738,la,o
27,S0034-709410700738,recuperacion,o
27,S0034-709410700738,del,o
27,S0034-709410700738,bloqueo,o
27,S0034-709410700738,sensitivo,o
27,S0034-709410700738,y,o
27,S0034-709410700738,motor,o
27,S0034-709410700738,fue,o
27,S0034-709410700738,significativamente,o
27,S0034-709410700738,mayor,o
27,S0034-709410700738,en,o
27,S0034-709410700738,el,o
27,S0034-709410700738,grupo,o
27,S0034-709410700738,CFI,o
27,S0034-709410700738,No,o
27,S0034-709410700738,hubo,o
27,S0034-709410700738,bradicardia,i
27,S0034-709410700738,o,o
27,S0034-709410700738,hipotension,i
27,S0034-709410700738,Conclusiones,o
27,S0034-709410700738,Por,o
27,S0034-709410700738,medio,o
27,S0034-709410700738,de,o
27,S0034-709410700738,este,o
27,S0034-709410700738,estudio,o
27,S0034-709410700738,se,o
27,S0034-709410700738,llega,o
27,S0034-709410700738,a,o
27,S0034-709410700738,la,o
27,S0034-709410700738,conclusion,o
27,S0034-709410700738,de,o
27,S0034-709410700738,que,o
27,S0034-709410700738,es,o
27,S0034-709410700738,tecnicamente,o
27,S0034-709410700738,facil,o
27,S0034-709410700738,realizar,o
27,S0034-709410700738,el,o
27,S0034-709410700738,bloqueo,o
27,S0034-709410700738,anterior,o
27,S0034-709410700738,combinado,o
27,S0034-709410700738,femoralisquiatico,o
27,S0034-709410700738,y,o
27,S0034-709410700738,de,o
27,S0034-709410700738,que,o
27,S0034-709410700738,ese,o
27,S0034-709410700738,puede,o
27,S0034-709410700738,ser,o
27,S0034-709410700738,una,o
27,S0034-709410700738,alternativa,o
27,S0034-709410700738,para,o
27,S0034-709410700738,el,o
27,S0034-709410700738,bloqueo,i
27,S0034-709410700738,unilateral,i
27,S0034-709410700738,del,i
27,S0034-709410700738,miembro,i
27,S0034-709410700738,inferior,i
27,S0034-709410700738,La,o
27,S0034-709410700738,raquianestesia,i
27,S0034-709410700738,unilateral,i
27,S0034-709410700738,con,o
27,S0034-709410700738,bajas,o
27,S0034-709410700738,dosis,o
27,S0034-709410700738,de,o
27,S0034-709410700738,bupivacaina,i
27,S0034-709410700738,mostro,o
27,S0034-709410700738,un,o
27,S0034-709410700738,menor,o
27,S0034-709410700738,tiempo,o
27,S0034-709410700738,para,o
27,S0034-709410700738,la,o
27,S0034-709410700738,realizacion,o
27,S0034-709410700738,un,o
27,S0034-709410700738,menor,o
27,S0034-709410700738,numero,o
27,S0034-709410700738,de,o
27,S0034-709410700738,intentos,o
27,S0034-709410700738,y,o
27,S0034-709410700738,una,o
27,S0034-709410700738,recuperacion,o
27,S0034-709410700738,mas,o
27,S0034-709410700738,rapida,o
27,S0034-709410700738,del,o
27,S0034-709410700738,bloqueo,o
27,S0034-709410700738,combinado,o
27,S0034-709410700738,femoralisquiatico,o
27,S0034-709410700738,Sin,o
27,S0034-709410700738,embargo,o
27,S0034-709410700738,la,o
27,S0034-709410700738,efectividad,o
27,S0034-709410700738,fue,o
27,S0034-709410700738,la,o
27,S0034-709410700738,misma,o
28,S0034-70942002000100002,Niveles,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,sedacion,i
28,S0034-70942002000100002,determinados,o
28,S0034-70942002000100002,por,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,clonidina,i
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,midazolam,i
28,S0034-70942002000100002,en,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,medicacion,i
28,S0034-70942002000100002,preanestesica,o
28,S0034-70942002000100002,evaluacion,i
28,S0034-70942002000100002,clinica,i
28,S0034-70942002000100002,y,i
28,S0034-70942002000100002,eletroencefalografica,i
28,S0034-70942002000100002,bispectral,i
28,S0034-70942002000100002,JUSTIFICATIVA,o
28,S0034-70942002000100002,Y,o
28,S0034-70942002000100002,OBJETIVOS,o
28,S0034-70942002000100002,Verificar,o
28,S0034-70942002000100002,el,o
28,S0034-70942002000100002,efecto,o
28,S0034-70942002000100002,sedativo,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,clonidina,i
28,S0034-70942002000100002,un,o
28,S0034-70942002000100002,a2agonista,o
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,del,o
28,S0034-70942002000100002,midazolam,i
28,S0034-70942002000100002,un,o
28,S0034-70942002000100002,benzodiazepinico,i
28,S0034-70942002000100002,cuando,o
28,S0034-70942002000100002,utilizados,o
28,S0034-70942002000100002,en,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,medicacion,i
28,S0034-70942002000100002,preanestesica,o
28,S0034-70942002000100002,empleandose,o
28,S0034-70942002000100002,evaluacion,i
28,S0034-70942002000100002,clinica,i
28,S0034-70942002000100002,y,i
28,S0034-70942002000100002,eletroencefalografica,i
28,S0034-70942002000100002,bispectral,i
28,S0034-70942002000100002,METODO,o
28,S0034-70942002000100002,Despues,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,aprobacion,o
28,S0034-70942002000100002,institucional,o
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,consentimiento,i
28,S0034-70942002000100002,escrito,o
28,S0034-70942002000100002,dado,o
28,S0034-70942002000100002,45,o
28,S0034-70942002000100002,pacientes,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,18,o
28,S0034-70942002000100002,a,o
28,S0034-70942002000100002,65,o
28,S0034-70942002000100002,años,o
28,S0034-70942002000100002,estado,o
28,S0034-70942002000100002,fisico,o
28,S0034-70942002000100002,ASA,o
28,S0034-70942002000100002,I,o
28,S0034-70942002000100002,fueron,o
28,S0034-70942002000100002,aleatoriamente,i
28,S0034-70942002000100002,distribuidos,i
28,S0034-70942002000100002,en,o
28,S0034-70942002000100002,los,o
28,S0034-70942002000100002,grupos,o
28,S0034-70942002000100002,placebo,i
28,S0034-70942002000100002,P,o
28,S0034-70942002000100002,clonidina,i
28,S0034-70942002000100002,C,o
28,S0034-70942002000100002,o,o
28,S0034-70942002000100002,midazolam,i
28,S0034-70942002000100002,M,o
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,que,o
28,S0034-70942002000100002,recibieron,o
28,S0034-70942002000100002,respectivamente,o
28,S0034-70942002000100002,placebo,i
28,S0034-70942002000100002,150,o
28,S0034-70942002000100002,µg,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,clonidina,i
28,S0034-70942002000100002,o,o
28,S0034-70942002000100002,15,o
28,S0034-70942002000100002,mg,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,midazolam,i
28,S0034-70942002000100002,por,o
28,S0034-70942002000100002,via,o
28,S0034-70942002000100002,oral,o
28,S0034-70942002000100002,60,o
28,S0034-70942002000100002,minutos,o
28,S0034-70942002000100002,antes,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,induccion,i
28,S0034-70942002000100002,de,i
28,S0034-70942002000100002,la,i
28,S0034-70942002000100002,anestesia,i
28,S0034-70942002000100002,n,o
28,S0034-70942002000100002,15,o
28,S0034-70942002000100002,por,o
28,S0034-70942002000100002,grupo,o
28,S0034-70942002000100002,La,o
28,S0034-70942002000100002,monitorizacion,i
28,S0034-70942002000100002,se,o
28,S0034-70942002000100002,constituyo,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,eletrocardiograma,i
28,S0034-70942002000100002,DII,o
28,S0034-70942002000100002,presion,i
28,S0034-70942002000100002,arterial,i
28,S0034-70942002000100002,no,i
28,S0034-70942002000100002,invasiva,i
28,S0034-70942002000100002,frecuencia,i
28,S0034-70942002000100002,cardiaca,i
28,S0034-70942002000100002,saturacion,i
28,S0034-70942002000100002,de,i
28,S0034-70942002000100002,pulso,i
28,S0034-70942002000100002,de,i
28,S0034-70942002000100002,oxigeno,i
28,S0034-70942002000100002,frecuencia,i
28,S0034-70942002000100002,respiratoria,i
28,S0034-70942002000100002,temperatura,i
28,S0034-70942002000100002,axilar,i
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,sala,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,cirugia,o
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,eletroencefalograma,i
28,S0034-70942002000100002,bispectral,i
28,S0034-70942002000100002,para,o
28,S0034-70942002000100002,determinacion,i
28,S0034-70942002000100002,del,i
28,S0034-70942002000100002,indice,i
28,S0034-70942002000100002,bispectral,i
28,S0034-70942002000100002,BIS,i
28,S0034-70942002000100002,Eses,o
28,S0034-70942002000100002,atributos,o
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,escala,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,sedacion,i
28,S0034-70942002000100002,1ansioso,o
28,S0034-70942002000100002,2calmo,o
28,S0034-70942002000100002,3soñoliento,o
28,S0034-70942002000100002,4durmiendo,o
28,S0034-70942002000100002,con,o
28,S0034-70942002000100002,reflejo,o
28,S0034-70942002000100002,5durmiendo,o
28,S0034-70942002000100002,sin,o
28,S0034-70942002000100002,reflejo,o
28,S0034-70942002000100002,fueron,o
28,S0034-70942002000100002,obtenidos,o
28,S0034-70942002000100002,a,o
28,S0034-70942002000100002,los,o
28,S0034-70942002000100002,0,o
28,S0034-70942002000100002,M0,o
28,S0034-70942002000100002,15,o
28,S0034-70942002000100002,M15,o
28,S0034-70942002000100002,30,o
28,S0034-70942002000100002,M30,o
28,S0034-70942002000100002,40,o
28,S0034-70942002000100002,M40,o
28,S0034-70942002000100002,50,o
28,S0034-70942002000100002,M50,o
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,60,o
28,S0034-70942002000100002,M60,o
28,S0034-70942002000100002,minutos,o
28,S0034-70942002000100002,despues,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,medicacion,i
28,S0034-70942002000100002,RESULTADOS,o
28,S0034-70942002000100002,En,o
28,S0034-70942002000100002,los,o
28,S0034-70942002000100002,grupos,o
28,S0034-70942002000100002,no,o
28,S0034-70942002000100002,hubo,o
28,S0034-70942002000100002,alteracion,o
28,S0034-70942002000100002,significante,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,los,o
28,S0034-70942002000100002,parametros,o
28,S0034-70942002000100002,respiratorios,o
28,S0034-70942002000100002,hemodinamicos,o
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,temperatura,o
28,S0034-70942002000100002,Hubo,o
28,S0034-70942002000100002,diferencia,o
28,S0034-70942002000100002,significante,o
28,S0034-70942002000100002,entre,o
28,S0034-70942002000100002,los,o
28,S0034-70942002000100002,grupos,o
28,S0034-70942002000100002,en,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,escala,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,sedacion,i
28,S0034-70942002000100002,M60,o
28,S0034-70942002000100002,MCP,o
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,en,o
28,S0034-70942002000100002,el,o
28,S0034-70942002000100002,BIS,i
28,S0034-70942002000100002,M50,o
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,M60,o
28,S0034-70942002000100002,MCP,o
28,S0034-70942002000100002,CONCLUSIONES,o
28,S0034-70942002000100002,En,o
28,S0034-70942002000100002,las,o
28,S0034-70942002000100002,condiciones,o
28,S0034-70942002000100002,utilizadas,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,clonidina,i
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,el,o
28,S0034-70942002000100002,midazolam,i
28,S0034-70942002000100002,determinan,o
28,S0034-70942002000100002,niveles,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,sedacion,i
28,S0034-70942002000100002,adecuados,o
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,semejantes,o
28,S0034-70942002000100002,en,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,medicacion,i
28,S0034-70942002000100002,preanestesica,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,pacientes,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,estado,o
28,S0034-70942002000100002,fisico,o
28,S0034-70942002000100002,ASA,o
28,S0034-70942002000100002,I,o
28,S0034-70942002000100002,cuando,o
28,S0034-70942002000100002,evaluados,o
28,S0034-70942002000100002,por,o
28,S0034-70942002000100002,la,o
28,S0034-70942002000100002,escala,o
28,S0034-70942002000100002,de,o
28,S0034-70942002000100002,sedacion,i
28,S0034-70942002000100002,y,o
28,S0034-70942002000100002,por,o
28,S0034-70942002000100002,el,o
28,S0034-70942002000100002,indice,i
28,S0034-70942002000100002,bispectral,i
28,S0034-70942002000100002,sin,o
28,S0034-70942002000100002,determinar,o
28,S0034-70942002000100002,alteraciones,i
28,S0034-70942002000100002,hemodinamicas,i
28,S0034-70942002000100002,y,i
28,S0034-70942002000100002,respiratorias,i
29,S0034-70942004000100013,Influencia,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,la,o
29,S0034-70942004000100013,clonidina,i
29,S0034-70942004000100013,por,o
29,S0034-70942004000100013,via,o
29,S0034-70942004000100013,venosa,o
29,S0034-70942004000100013,en,o
29,S0034-70942004000100013,el,o
29,S0034-70942004000100013,costeo,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,anestesia,i
29,S0034-70942004000100013,con,o
29,S0034-70942004000100013,sevoflurano,i
29,S0034-70942004000100013,en,o
29,S0034-70942004000100013,cirugias,i
29,S0034-70942004000100013,de,i
29,S0034-70942004000100013,oido,i
29,S0034-70942004000100013,medio,i
29,S0034-70942004000100013,en,o
29,S0034-70942004000100013,regimen,i
29,S0034-70942004000100013,ambulatorial,i
29,S0034-70942004000100013,JUSTIFICATIVA,o
29,S0034-70942004000100013,Y,o
29,S0034-70942004000100013,OBJETIVOS,o
29,S0034-70942004000100013,La,o
29,S0034-70942004000100013,clonidina,i
29,S0034-70942004000100013,es,o
29,S0034-70942004000100013,un,o
29,S0034-70942004000100013,agente,o
29,S0034-70942004000100013,a2agonista,o
29,S0034-70942004000100013,que,o
29,S0034-70942004000100013,diminuye,o
29,S0034-70942004000100013,el,o
29,S0034-70942004000100013,consumo,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,anestesicos,i
29,S0034-70942004000100013,venosos,o
29,S0034-70942004000100013,e,o
29,S0034-70942004000100013,inhalatorios,o
29,S0034-70942004000100013,Este,o
29,S0034-70942004000100013,estudio,o
29,S0034-70942004000100013,viso,o
29,S0034-70942004000100013,evaluar,o
29,S0034-70942004000100013,la,o
29,S0034-70942004000100013,relacion,o
29,S0034-70942004000100013,costeobeneficio,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,la,o
29,S0034-70942004000100013,medicacion,o
29,S0034-70942004000100013,preanestesica,o
29,S0034-70942004000100013,con,o
29,S0034-70942004000100013,clonidina,i
29,S0034-70942004000100013,por,o
29,S0034-70942004000100013,via,o
29,S0034-70942004000100013,venosa,o
29,S0034-70942004000100013,en,o
29,S0034-70942004000100013,anestesia,i
29,S0034-70942004000100013,general,i
29,S0034-70942004000100013,con,o
29,S0034-70942004000100013,sevoflurano,i
29,S0034-70942004000100013,en,o
29,S0034-70942004000100013,regimen,i
29,S0034-70942004000100013,ambulatorial,i
29,S0034-70942004000100013,METODO,o
29,S0034-70942004000100013,Se,o
29,S0034-70942004000100013,trata,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,estudio,o
29,S0034-70942004000100013,encubierto,o
29,S0034-70942004000100013,aleatorio,o
29,S0034-70942004000100013,controlado,o
29,S0034-70942004000100013,con,o
29,S0034-70942004000100013,placebo,i
29,S0034-70942004000100013,realizado,o
29,S0034-70942004000100013,con,o
29,S0034-70942004000100013,pacientes,o
29,S0034-70942004000100013,con,o
29,S0034-70942004000100013,edad,o
29,S0034-70942004000100013,entre,o
29,S0034-70942004000100013,15,o
29,S0034-70942004000100013,y,o
29,S0034-70942004000100013,52,o
29,S0034-70942004000100013,años,o
29,S0034-70942004000100013,Los,o
29,S0034-70942004000100013,pacientes,o
29,S0034-70942004000100013,fueron,o
29,S0034-70942004000100013,divididos,o
29,S0034-70942004000100013,en,o
29,S0034-70942004000100013,3,o
29,S0034-70942004000100013,grupos,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,15,o
29,S0034-70942004000100013,Grupo,o
29,S0034-70942004000100013,S,o
29,S0034-70942004000100013,placebo,i
29,S0034-70942004000100013,C3,o
29,S0034-70942004000100013,clonidina,i
29,S0034-70942004000100013,3,o
29,S0034-70942004000100013,µgkg1,o
29,S0034-70942004000100013,y,o
29,S0034-70942004000100013,C5,o
29,S0034-70942004000100013,5,o
29,S0034-70942004000100013,µgkg1,o
29,S0034-70942004000100013,La,o
29,S0034-70942004000100013,induccion,i
29,S0034-70942004000100013,anestesica,i
29,S0034-70942004000100013,fue,o
29,S0034-70942004000100013,hecha,o
29,S0034-70942004000100013,con,o
29,S0034-70942004000100013,sevoflurano,i
29,S0034-70942004000100013,alfentanil,i
29,S0034-70942004000100013,30,o
29,S0034-70942004000100013,µgkg1,o
29,S0034-70942004000100013,y,o
29,S0034-70942004000100013,pancuronio,i
29,S0034-70942004000100013,008,o
29,S0034-70942004000100013,mgkg1,o
29,S0034-70942004000100013,Fueron,o
29,S0034-70942004000100013,anotados,o
29,S0034-70942004000100013,la,o
29,S0034-70942004000100013,frecuencia,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,complicaciones,i
29,S0034-70942004000100013,consumo,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,halogenados,i
29,S0034-70942004000100013,tiempo,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,anestesia,i
29,S0034-70942004000100013,tiempo,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,recuperacion,o
29,S0034-70942004000100013,parte,o
29,S0034-70942004000100013,I,o
29,S0034-70942004000100013,y,o
29,S0034-70942004000100013,II,o
29,S0034-70942004000100013,El,o
29,S0034-70942004000100013,analisis,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,gastos,o
29,S0034-70942004000100013,considero,o
29,S0034-70942004000100013,gastos,o
29,S0034-70942004000100013,directos,o
29,S0034-70942004000100013,e,o
29,S0034-70942004000100013,indirectos,o
29,S0034-70942004000100013,RESULTADOS,o
29,S0034-70942004000100013,No,o
29,S0034-70942004000100013,hubo,o
29,S0034-70942004000100013,diferencias,o
29,S0034-70942004000100013,entre,o
29,S0034-70942004000100013,los,o
29,S0034-70942004000100013,grupos,o
29,S0034-70942004000100013,en,o
29,S0034-70942004000100013,relacion,o
29,S0034-70942004000100013,a,o
29,S0034-70942004000100013,los,o
29,S0034-70942004000100013,datos,o
29,S0034-70942004000100013,demograficos,o
29,S0034-70942004000100013,frecuencia,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,complicaciones,i
29,S0034-70942004000100013,y,o
29,S0034-70942004000100013,tiempo,o
29,S0034-70942004000100013,para,o
29,S0034-70942004000100013,recuperacion,o
29,S0034-70942004000100013,anestesica,o
29,S0034-70942004000100013,parte,o
29,S0034-70942004000100013,I,o
29,S0034-70942004000100013,La,o
29,S0034-70942004000100013,recuperacion,o
29,S0034-70942004000100013,anestesica,o
29,S0034-70942004000100013,parte,o
29,S0034-70942004000100013,II,o
29,S0034-70942004000100013,fue,o
29,S0034-70942004000100013,prolongada,o
29,S0034-70942004000100013,en,o
29,S0034-70942004000100013,el,o
29,S0034-70942004000100013,grupo,o
29,S0034-70942004000100013,C5,o
29,S0034-70942004000100013,p,o
29,S0034-70942004000100013,005,o
29,S0034-70942004000100013,El,o
29,S0034-70942004000100013,consumo,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,sevoflurano,i
29,S0034-70942004000100013,por,o
29,S0034-70942004000100013,minuto,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,cirugia,i
29,S0034-70942004000100013,fue,o
29,S0034-70942004000100013,054,o
29,S0034-70942004000100013,014,o
29,S0034-70942004000100013,en,o
29,S0034-70942004000100013,el,o
29,S0034-70942004000100013,grupo,o
29,S0034-70942004000100013,S,o
29,S0034-70942004000100013,y,o
29,S0034-70942004000100013,033,o
29,S0034-70942004000100013,009,o
29,S0034-70942004000100013,y,o
29,S0034-70942004000100013,034,o
29,S0034-70942004000100013,013,o
29,S0034-70942004000100013,en,o
29,S0034-70942004000100013,los,o
29,S0034-70942004000100013,grupos,o
29,S0034-70942004000100013,C3,o
29,S0034-70942004000100013,y,o
29,S0034-70942004000100013,C5,o
29,S0034-70942004000100013,respectivamente,o
29,S0034-70942004000100013,p,o
29,S0034-70942004000100013,005,o
29,S0034-70942004000100013,En,o
29,S0034-70942004000100013,los,o
29,S0034-70942004000100013,grupos,o
29,S0034-70942004000100013,que,o
29,S0034-70942004000100013,recibieron,o
29,S0034-70942004000100013,clonidina,i
29,S0034-70942004000100013,el,o
29,S0034-70942004000100013,costeo,o
29,S0034-70942004000100013,fue,o
29,S0034-70942004000100013,diminuido,o
29,S0034-70942004000100013,en,o
29,S0034-70942004000100013,aproximadamente,o
29,S0034-70942004000100013,35,o
29,S0034-70942004000100013,CONCLUSIONES,o
29,S0034-70942004000100013,La,o
29,S0034-70942004000100013,clonidina,i
29,S0034-70942004000100013,3,o
29,S0034-70942004000100013,µgkg1,o
29,S0034-70942004000100013,por,o
29,S0034-70942004000100013,via,o
29,S0034-70942004000100013,venosa,o
29,S0034-70942004000100013,diminuye,o
29,S0034-70942004000100013,el,o
29,S0034-70942004000100013,consumo,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,sevoflurano,i
29,S0034-70942004000100013,sin,o
29,S0034-70942004000100013,aumentar,o
29,S0034-70942004000100013,el,o
29,S0034-70942004000100013,tiempo,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,recuperacion,o
29,S0034-70942004000100013,parte,o
29,S0034-70942004000100013,II,o
29,S0034-70942004000100013,La,o
29,S0034-70942004000100013,dosis,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,5,o
29,S0034-70942004000100013,µgkg1,o
29,S0034-70942004000100013,a,o
29,S0034-70942004000100013,pesar,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,disminuir,o
29,S0034-70942004000100013,el,o
29,S0034-70942004000100013,consumo,o
29,S0034-70942004000100013,de,o
29,S0034-70942004000100013,sevoflurano,i
29,S0034-70942004000100013,prolonga,o
29,S0034-70942004000100013,la,o
29,S0034-70942004000100013,recuperacion,o
29,S0034-70942004000100013,parte,o
29,S0034-70942004000100013,II,o
29,S0034-70942004000100013,no,o
29,S0034-70942004000100013,adecuandose,o
29,S0034-70942004000100013,al,o
29,S0034-70942004000100013,regimen,i
29,S0034-70942004000100013,ambulatorial,i
30,S0034-70942007000100004,Efectos,o
30,S0034-70942007000100004,del,o
30,S0034-70942007000100004,tratamiento,i
30,S0034-70942007000100004,previo,o
30,S0034-70942007000100004,con,o
30,S0034-70942007000100004,lidocaina,i
30,S0034-70942007000100004,paracetamol,i
30,S0034-70942007000100004,y,o
30,S0034-70942007000100004,lidocainafentanil,o
30,S0034-70942007000100004,intravenosos,o
30,S0034-70942007000100004,en,o
30,S0034-70942007000100004,el,o
30,S0034-70942007000100004,dolor,i
30,S0034-70942007000100004,causado,o
30,S0034-70942007000100004,por,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,inyeccion,i
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,propofol,i
30,S0034-70942007000100004,estudio,i
30,S0034-70942007000100004,comparativo,i
30,S0034-70942007000100004,JUSTIFICATIVA,o
30,S0034-70942007000100004,Y,o
30,S0034-70942007000100004,OBJETIVOS,o
30,S0034-70942007000100004,Se,o
30,S0034-70942007000100004,realizo,o
30,S0034-70942007000100004,estudio,o
30,S0034-70942007000100004,doblemente,o
30,S0034-70942007000100004,encubierto,o
30,S0034-70942007000100004,aleatorio,o
30,S0034-70942007000100004,para,o
30,S0034-70942007000100004,evaluar,i
30,S0034-70942007000100004,la,i
30,S0034-70942007000100004,eficacia,i
30,S0034-70942007000100004,del,o
30,S0034-70942007000100004,tratamiento,i
30,S0034-70942007000100004,previo,o
30,S0034-70942007000100004,intravenoso,o
30,S0034-70942007000100004,IV,o
30,S0034-70942007000100004,con,o
30,S0034-70942007000100004,lidocaina,i
30,S0034-70942007000100004,paracetamol,i
30,S0034-70942007000100004,Perfalgan,i
30,S0034-70942007000100004,o,o
30,S0034-70942007000100004,lidocaina,i
30,S0034-70942007000100004,asociada,o
30,S0034-70942007000100004,con,o
30,S0034-70942007000100004,fentanil,i
30,S0034-70942007000100004,en,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,reduccion,o
30,S0034-70942007000100004,del,o
30,S0034-70942007000100004,dolor,i
30,S0034-70942007000100004,causado,o
30,S0034-70942007000100004,por,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,inyeccion,i
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,propofol,i
30,S0034-70942007000100004,METODOS,o
30,S0034-70942007000100004,Inmediatamente,o
30,S0034-70942007000100004,despues,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,oclusion,i
30,S0034-70942007000100004,venosa,i
30,S0034-70942007000100004,con,o
30,S0034-70942007000100004,un,o
30,S0034-70942007000100004,torniquete,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,goma,o
30,S0034-70942007000100004,se,o
30,S0034-70942007000100004,hizo,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,administracion,i
30,S0034-70942007000100004,intravenosa,i
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,4,o
30,S0034-70942007000100004,mL,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,lidocaina,i
30,S0034-70942007000100004,a,o
30,S0034-70942007000100004,1,o
30,S0034-70942007000100004,Grupo,o
30,S0034-70942007000100004,L,o
30,S0034-70942007000100004,n,o
30,S0034-70942007000100004,50,o
30,S0034-70942007000100004,4,o
30,S0034-70942007000100004,mL,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,paracetamol,i
30,S0034-70942007000100004,Perfalgan,i
30,S0034-70942007000100004,40,o
30,S0034-70942007000100004,mg,o
30,S0034-70942007000100004,Grupo,o
30,S0034-70942007000100004,R,o
30,S0034-70942007000100004,n,o
30,S0034-70942007000100004,50,o
30,S0034-70942007000100004,lidocaina,i
30,S0034-70942007000100004,a,o
30,S0034-70942007000100004,2,o
30,S0034-70942007000100004,asociada,o
30,S0034-70942007000100004,con,o
30,S0034-70942007000100004,100,o
30,S0034-70942007000100004,µg,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,fentanil,i
30,S0034-70942007000100004,Grupo,o
30,S0034-70942007000100004,LF,o
30,S0034-70942007000100004,n,o
30,S0034-70942007000100004,50,o
30,S0034-70942007000100004,o,o
30,S0034-70942007000100004,4,o
30,S0034-70942007000100004,mL,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,solucion,i
30,S0034-70942007000100004,fisiologica,i
30,S0034-70942007000100004,Grupo,o
30,S0034-70942007000100004,P,o
30,S0034-70942007000100004,n,o
30,S0034-70942007000100004,50,o
30,S0034-70942007000100004,grupo,o
30,S0034-70942007000100004,control,o
30,S0034-70942007000100004,con,o
30,S0034-70942007000100004,placebo,i
30,S0034-70942007000100004,a,o
30,S0034-70942007000100004,200,o
30,S0034-70942007000100004,adultos,o
30,S0034-70942007000100004,La,o
30,S0034-70942007000100004,liberacion,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,obstruccion,i
30,S0034-70942007000100004,venosa,i
30,S0034-70942007000100004,fue,o
30,S0034-70942007000100004,hecha,o
30,S0034-70942007000100004,despues,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,60,o
30,S0034-70942007000100004,segundos,o
30,S0034-70942007000100004,siendo,o
30,S0034-70942007000100004,seguida,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,administracion,i
30,S0034-70942007000100004,intravenosa,i
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,propofol,i
30,S0034-70942007000100004,25,o
30,S0034-70942007000100004,mgkg1,o
30,S0034-70942007000100004,a,o
30,S0034-70942007000100004,una,o
30,S0034-70942007000100004,velocidad,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,05,o
30,S0034-70942007000100004,mgs1,o
30,S0034-70942007000100004,a,o
30,S0034-70942007000100004,traves,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,un,o
30,S0034-70942007000100004,cateter,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,20G,o
30,S0034-70942007000100004,insertado,o
30,S0034-70942007000100004,en,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,vena,i
30,S0034-70942007000100004,del,i
30,S0034-70942007000100004,dorso,i
30,S0034-70942007000100004,de,i
30,S0034-70942007000100004,la,i
30,S0034-70942007000100004,mano,i
30,S0034-70942007000100004,La,o
30,S0034-70942007000100004,evaluacion,i
30,S0034-70942007000100004,del,i
30,S0034-70942007000100004,dolor,i
30,S0034-70942007000100004,fue,o
30,S0034-70942007000100004,hecha,o
30,S0034-70942007000100004,durante,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,inyeccion,i
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,propofol,i
30,S0034-70942007000100004,Ella,o
30,S0034-70942007000100004,incluyo,o
30,S0034-70942007000100004,movimientos,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,mano,i
30,S0034-70942007000100004,expresion,o
30,S0034-70942007000100004,verbal,o
30,S0034-70942007000100004,espontanea,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,dolor,i
30,S0034-70942007000100004,muecas,i
30,S0034-70942007000100004,y,o
30,S0034-70942007000100004,gemidos,i
30,S0034-70942007000100004,durante,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,inyeccion,i
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,propofol,i
30,S0034-70942007000100004,RESULTADOS,o
30,S0034-70942007000100004,Lidocainafentanil,o
30,S0034-70942007000100004,70,o
30,S0034-70942007000100004,sin,o
30,S0034-70942007000100004,dolor,i
30,S0034-70942007000100004,y,o
30,S0034-70942007000100004,lidocaina,i
30,S0034-70942007000100004,68,o
30,S0034-70942007000100004,sin,o
30,S0034-70942007000100004,dolor,i
30,S0034-70942007000100004,fueron,o
30,S0034-70942007000100004,mas,o
30,S0034-70942007000100004,eficaces,o
30,S0034-70942007000100004,en,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,reduccion,o
30,S0034-70942007000100004,del,o
30,S0034-70942007000100004,dolor,i
30,S0034-70942007000100004,causado,o
30,S0034-70942007000100004,por,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,inyeccion,i
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,propofol,i
30,S0034-70942007000100004,que,o
30,S0034-70942007000100004,el,o
30,S0034-70942007000100004,paracetamol,i
30,S0034-70942007000100004,54,o
30,S0034-70942007000100004,sin,o
30,S0034-70942007000100004,dolor,i
30,S0034-70942007000100004,y,o
30,S0034-70942007000100004,el,o
30,S0034-70942007000100004,placebo,i
30,S0034-70942007000100004,36,o
30,S0034-70942007000100004,sin,o
30,S0034-70942007000100004,dolor,i
30,S0034-70942007000100004,p,o
30,S0034-70942007000100004,005,o
30,S0034-70942007000100004,La,o
30,S0034-70942007000100004,diferencia,o
30,S0034-70942007000100004,en,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,reduccion,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,incidencia,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,dolor,i
30,S0034-70942007000100004,causada,o
30,S0034-70942007000100004,por,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,inyeccion,i
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,propofol,i
30,S0034-70942007000100004,entre,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,lidocaina,i
30,S0034-70942007000100004,y,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,lidocainafentanil,o
30,S0034-70942007000100004,no,o
30,S0034-70942007000100004,fue,o
30,S0034-70942007000100004,estadisticamente,o
30,S0034-70942007000100004,significativa,o
30,S0034-70942007000100004,El,o
30,S0034-70942007000100004,paracetamol,i
30,S0034-70942007000100004,fue,o
30,S0034-70942007000100004,significativamente,o
30,S0034-70942007000100004,superior,o
30,S0034-70942007000100004,al,o
30,S0034-70942007000100004,placebo,i
30,S0034-70942007000100004,p,o
30,S0034-70942007000100004,005,o
30,S0034-70942007000100004,CONCLUSIONES,o
30,S0034-70942007000100004,El,o
30,S0034-70942007000100004,propofol,i
30,S0034-70942007000100004,es,o
30,S0034-70942007000100004,un,o
30,S0034-70942007000100004,anestesico,i
30,S0034-70942007000100004,ampliamente,o
30,S0034-70942007000100004,utilizado,o
30,S0034-70942007000100004,La,o
30,S0034-70942007000100004,lidocaina,i
30,S0034-70942007000100004,y,o
30,S0034-70942007000100004,lidocainafentanil,o
30,S0034-70942007000100004,administrados,o
30,S0034-70942007000100004,como,o
30,S0034-70942007000100004,tratamiento,i
30,S0034-70942007000100004,previo,o
30,S0034-70942007000100004,en,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,forma,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,retencion,i
30,S0034-70942007000100004,venosa,i
30,S0034-70942007000100004,durante,o
30,S0034-70942007000100004,60,o
30,S0034-70942007000100004,segundos,o
30,S0034-70942007000100004,antes,o
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,administracion,i
30,S0034-70942007000100004,del,o
30,S0034-70942007000100004,propofol,i
30,S0034-70942007000100004,redujeron,o
30,S0034-70942007000100004,significativamente,o
30,S0034-70942007000100004,el,o
30,S0034-70942007000100004,dolor,i
30,S0034-70942007000100004,causado,o
30,S0034-70942007000100004,por,o
30,S0034-70942007000100004,la,o
30,S0034-70942007000100004,inyeccion,i
30,S0034-70942007000100004,de,o
30,S0034-70942007000100004,propofol,i
30,S0034-70942007000100004,mientras,o
30,S0034-70942007000100004,que,o
30,S0034-70942007000100004,el,o
30,S0034-70942007000100004,paracetamol,i
30,S0034-70942007000100004,IV,o
30,S0034-70942007000100004,Perfalgan,i
30,S0034-70942007000100004,redujo,o
30,S0034-70942007000100004,discretamente,o
30,S0034-70942007000100004,ese,o
30,S0034-70942007000100004,mismo,o
30,S0034-70942007000100004,dolor,i
31,S0034-70942008000400003,Clonidina,i
31,S0034-70942008000400003,por,o
31,S0034-70942008000400003,via,o
31,S0034-70942008000400003,venosa,o
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,el,o
31,S0034-70942008000400003,preoperatorio,o
31,S0034-70942008000400003,del,o
31,S0034-70942008000400003,tratamiento,i
31,S0034-70942008000400003,quirurgico,i
31,S0034-70942008000400003,de,i
31,S0034-70942008000400003,catarata,i
31,S0034-70942008000400003,evaluacion,i
31,S0034-70942008000400003,del,o
31,S0034-70942008000400003,beneficio,o
31,S0034-70942008000400003,clinico,o
31,S0034-70942008000400003,JUSTIFICATIVA,o
31,S0034-70942008000400003,Y,o
31,S0034-70942008000400003,OBJETIVOS,o
31,S0034-70942008000400003,La,o
31,S0034-70942008000400003,clonidina,i
31,S0034-70942008000400003,ha,o
31,S0034-70942008000400003,sido,o
31,S0034-70942008000400003,utilizada,o
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,anestesia,i
31,S0034-70942008000400003,por,o
31,S0034-70942008000400003,añadir,o
31,S0034-70942008000400003,propiedades,o
31,S0034-70942008000400003,analgesicas,o
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,sedativas,o
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,por,o
31,S0034-70942008000400003,proporcionar,o
31,S0034-70942008000400003,una,o
31,S0034-70942008000400003,mayor,o
31,S0034-70942008000400003,estabilidad,o
31,S0034-70942008000400003,hemodinamica,o
31,S0034-70942008000400003,con,o
31,S0034-70942008000400003,reduccion,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,presion,i
31,S0034-70942008000400003,intraocular,i
31,S0034-70942008000400003,Este,o
31,S0034-70942008000400003,estudio,o
31,S0034-70942008000400003,evalua,o
31,S0034-70942008000400003,los,o
31,S0034-70942008000400003,efectos,o
31,S0034-70942008000400003,clinicos,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,clonidina,i
31,S0034-70942008000400003,25,o
31,S0034-70942008000400003,µgkg1,o
31,S0034-70942008000400003,por,o
31,S0034-70942008000400003,via,o
31,S0034-70942008000400003,venosa,o
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,presion,i
31,S0034-70942008000400003,Intraocular,i
31,S0034-70942008000400003,PIO,i
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,hemodinamica,o
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,recuperacion,o
31,S0034-70942008000400003,postanestesica,o
31,S0034-70942008000400003,del,o
31,S0034-70942008000400003,tratamiento,i
31,S0034-70942008000400003,quirurgico,i
31,S0034-70942008000400003,de,i
31,S0034-70942008000400003,catarata,i
31,S0034-70942008000400003,METODOS,o
31,S0034-70942008000400003,Se,o
31,S0034-70942008000400003,realizo,o
31,S0034-70942008000400003,un,o
31,S0034-70942008000400003,ensayo,o
31,S0034-70942008000400003,clinico,o
31,S0034-70942008000400003,a,o
31,S0034-70942008000400003,doble,o
31,S0034-70942008000400003,ciego,o
31,S0034-70942008000400003,controlado,o
31,S0034-70942008000400003,por,o
31,S0034-70942008000400003,placebo,i
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,con,o
31,S0034-70942008000400003,distribucion,o
31,S0034-70942008000400003,aleatoria,o
31,S0034-70942008000400003,que,o
31,S0034-70942008000400003,incluyo,o
31,S0034-70942008000400003,pacientes,o
31,S0034-70942008000400003,que,o
31,S0034-70942008000400003,fuesen,o
31,S0034-70942008000400003,realizar,o
31,S0034-70942008000400003,operacion,i
31,S0034-70942008000400003,de,i
31,S0034-70942008000400003,catarata,i
31,S0034-70942008000400003,bajo,o
31,S0034-70942008000400003,bloqueo,i
31,S0034-70942008000400003,peribulbar,i
31,S0034-70942008000400003,Despues,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,monitorizacion,i
31,S0034-70942008000400003,Momento,o
31,S0034-70942008000400003,0,o
31,S0034-70942008000400003,M0,o
31,S0034-70942008000400003,se,o
31,S0034-70942008000400003,realizaron,o
31,S0034-70942008000400003,las,o
31,S0034-70942008000400003,medidas,o
31,S0034-70942008000400003,iniciales,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,PIO,i
31,S0034-70942008000400003,presion,i
31,S0034-70942008000400003,arterial,i
31,S0034-70942008000400003,media,i
31,S0034-70942008000400003,PAM,i
31,S0034-70942008000400003,frecuencia,i
31,S0034-70942008000400003,cardiaca,i
31,S0034-70942008000400003,FC,i
31,S0034-70942008000400003,SpO2,i
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,el,o
31,S0034-70942008000400003,grado,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,sedacion,i
31,S0034-70942008000400003,Ramsay,o
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,entonces,o
31,S0034-70942008000400003,se,o
31,S0034-70942008000400003,administro,o
31,S0034-70942008000400003,el,o
31,S0034-70942008000400003,placebo,i
31,S0034-70942008000400003,Grupo,o
31,S0034-70942008000400003,P,o
31,S0034-70942008000400003,o,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,clonidina,i
31,S0034-70942008000400003,Grupo,o
31,S0034-70942008000400003,C,o
31,S0034-70942008000400003,por,o
31,S0034-70942008000400003,via,o
31,S0034-70942008000400003,venosa,o
31,S0034-70942008000400003,Treinta,o
31,S0034-70942008000400003,minutos,o
31,S0034-70942008000400003,despues,o
31,S0034-70942008000400003,Momento,o
31,S0034-70942008000400003,1,o
31,S0034-70942008000400003,M1,o
31,S0034-70942008000400003,se,o
31,S0034-70942008000400003,repetian,o
31,S0034-70942008000400003,las,o
31,S0034-70942008000400003,medidas,o
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,nuevamente,o
31,S0034-70942008000400003,al,o
31,S0034-70942008000400003,fin,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,operacion,i
31,S0034-70942008000400003,Momento,o
31,S0034-70942008000400003,2,o
31,S0034-70942008000400003,M2,o
31,S0034-70942008000400003,RESULTADOS,o
31,S0034-70942008000400003,Entre,o
31,S0034-70942008000400003,M0,o
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,M1,o
31,S0034-70942008000400003,hubo,o
31,S0034-70942008000400003,una,o
31,S0034-70942008000400003,disminucion,o
31,S0034-70942008000400003,diferente,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,PIO,i
31,S0034-70942008000400003,145,o
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,el,o
31,S0034-70942008000400003,Grupo,o
31,S0034-70942008000400003,C,o
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,525,o
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,el,o
31,S0034-70942008000400003,P,o
31,S0034-70942008000400003,p,o
31,S0034-70942008000400003,001,o
31,S0034-70942008000400003,manteniendo,o
31,S0034-70942008000400003,sus,o
31,S0034-70942008000400003,medias,o
31,S0034-70942008000400003,reducidas,o
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,M2,o
31,S0034-70942008000400003,La,o
31,S0034-70942008000400003,PAM,i
31,S0034-70942008000400003,del,o
31,S0034-70942008000400003,Grupo,o
31,S0034-70942008000400003,C,o
31,S0034-70942008000400003,se,o
31,S0034-70942008000400003,redujo,o
31,S0034-70942008000400003,un,o
31,S0034-70942008000400003,17,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,M0,o
31,S0034-70942008000400003,a,o
31,S0034-70942008000400003,M1,o
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,subio,o
31,S0034-70942008000400003,un,o
31,S0034-70942008000400003,35,o
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,el,o
31,S0034-70942008000400003,Grupo,o
31,S0034-70942008000400003,P,o
31,S0034-70942008000400003,p,o
31,S0034-70942008000400003,0001,o
31,S0034-70942008000400003,con,o
31,S0034-70942008000400003,una,o
31,S0034-70942008000400003,recuperacion,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,PAM,i
31,S0034-70942008000400003,del,o
31,S0034-70942008000400003,Grupo,o
31,S0034-70942008000400003,C,o
31,S0034-70942008000400003,hasta,o
31,S0034-70942008000400003,M2,o
31,S0034-70942008000400003,p,o
31,S0034-70942008000400003,017,o
31,S0034-70942008000400003,La,o
31,S0034-70942008000400003,FC,i
31,S0034-70942008000400003,disminuyo,o
31,S0034-70942008000400003,64,o
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,el,o
31,S0034-70942008000400003,Grupo,o
31,S0034-70942008000400003,C,o
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,1,o
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,el,o
31,S0034-70942008000400003,Grupo,o
31,S0034-70942008000400003,P,o
31,S0034-70942008000400003,p,o
31,S0034-70942008000400003,01,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,M0,o
31,S0034-70942008000400003,a,o
31,S0034-70942008000400003,M1,o
31,S0034-70942008000400003,Se,o
31,S0034-70942008000400003,registro,o
31,S0034-70942008000400003,un,o
31,S0034-70942008000400003,aumento,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,sedacion,i
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,el,o
31,S0034-70942008000400003,Grupo,o
31,S0034-70942008000400003,C,o
31,S0034-70942008000400003,con,o
31,S0034-70942008000400003,relacion,o
31,S0034-70942008000400003,al,o
31,S0034-70942008000400003,P,o
31,S0034-70942008000400003,p,o
31,S0034-70942008000400003,0001,o
31,S0034-70942008000400003,sin,o
31,S0034-70942008000400003,embargo,o
31,S0034-70942008000400003,sin,o
31,S0034-70942008000400003,que,o
31,S0034-70942008000400003,ocurriera,o
31,S0034-70942008000400003,depresion,i
31,S0034-70942008000400003,respiratoria,i
31,S0034-70942008000400003,El,o
31,S0034-70942008000400003,RR,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,hipertension,i
31,S0034-70942008000400003,arterial,i
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,el,o
31,S0034-70942008000400003,intraoperatorio,o
31,S0034-70942008000400003,del,o
31,S0034-70942008000400003,Grupo,o
31,S0034-70942008000400003,C,o
31,S0034-70942008000400003,fue,o
31,S0034-70942008000400003,0657,o
31,S0034-70942008000400003,IC95,o
31,S0034-70942008000400003,0517,o
31,S0034-70942008000400003,a,o
31,S0034-70942008000400003,0835,o
31,S0034-70942008000400003,p,o
31,S0034-70942008000400003,001,o
31,S0034-70942008000400003,No,o
31,S0034-70942008000400003,hubo,o
31,S0034-70942008000400003,diferencias,o
31,S0034-70942008000400003,con,o
31,S0034-70942008000400003,relacion,o
31,S0034-70942008000400003,a,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,incidencia,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,taquicardia,i
31,S0034-70942008000400003,hipoxemia,i
31,S0034-70942008000400003,hipotension,i
31,S0034-70942008000400003,arterial,i
31,S0034-70942008000400003,ni,o
31,S0034-70942008000400003,atraso,o
31,S0034-70942008000400003,del,o
31,S0034-70942008000400003,alta,i
31,S0034-70942008000400003,hospitalaria,i
31,S0034-70942008000400003,CONCLUSIONES,o
31,S0034-70942008000400003,La,o
31,S0034-70942008000400003,clonidina,i
31,S0034-70942008000400003,en,o
31,S0034-70942008000400003,las,o
31,S0034-70942008000400003,condiciones,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,este,o
31,S0034-70942008000400003,estudio,o
31,S0034-70942008000400003,fue,o
31,S0034-70942008000400003,un,o
31,S0034-70942008000400003,farmaco,i
31,S0034-70942008000400003,seguro,o
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,redujo,o
31,S0034-70942008000400003,la,o
31,S0034-70942008000400003,PIO,i
31,S0034-70942008000400003,y,o
31,S0034-70942008000400003,el,o
31,S0034-70942008000400003,riesgo,o
31,S0034-70942008000400003,de,o
31,S0034-70942008000400003,hipertension,i
31,S0034-70942008000400003,arterial,i
31,S0034-70942008000400003,intraoperatoria,o
31,S0034-70942008000400003,sin,o
31,S0034-70942008000400003,retardar,o
31,S0034-70942008000400003,el,o
31,S0034-70942008000400003,alta,i
31,S0034-70942008000400003,hospitalaria,i
32,S0034-70942010000200003,Anestesia,i
32,S0034-70942010000200003,espinal,i
32,S0034-70942010000200003,con,o
32,S0034-70942010000200003,10,o
32,S0034-70942010000200003,mg,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,bupivacaina,i
32,S0034-70942010000200003,hiperbarica,o
32,S0034-70942010000200003,asociada,o
32,S0034-70942010000200003,a,o
32,S0034-70942010000200003,5,o
32,S0034-70942010000200003,µg,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,sufentanil,i
32,S0034-70942010000200003,para,o
32,S0034-70942010000200003,cesarea,i
32,S0034-70942010000200003,estudio,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,diferentes,o
32,S0034-70942010000200003,volumenes,o
32,S0034-70942010000200003,JUSTIFICATIVA,o
32,S0034-70942010000200003,Y,o
32,S0034-70942010000200003,OBJETIVOS,o
32,S0034-70942010000200003,Diversos,o
32,S0034-70942010000200003,factores,o
32,S0034-70942010000200003,influyen,o
32,S0034-70942010000200003,en,o
32,S0034-70942010000200003,la,o
32,S0034-70942010000200003,dispersion,o
32,S0034-70942010000200003,cefalica,i
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,la,o
32,S0034-70942010000200003,solucion,i
32,S0034-70942010000200003,anestesica,i
32,S0034-70942010000200003,en,o
32,S0034-70942010000200003,el,o
32,S0034-70942010000200003,espacio,i
32,S0034-70942010000200003,subaracnoideo,i
32,S0034-70942010000200003,entre,o
32,S0034-70942010000200003,los,o
32,S0034-70942010000200003,cuales,o
32,S0034-70942010000200003,se,o
32,S0034-70942010000200003,destacan,o
32,S0034-70942010000200003,las,o
32,S0034-70942010000200003,alteraciones,o
32,S0034-70942010000200003,fisiologicas,o
32,S0034-70942010000200003,inherentes,o
32,S0034-70942010000200003,al,o
32,S0034-70942010000200003,embarazo,o
32,S0034-70942010000200003,baricidad,o
32,S0034-70942010000200003,dosis,o
32,S0034-70942010000200003,y,o
32,S0034-70942010000200003,volumen,o
32,S0034-70942010000200003,del,o
32,S0034-70942010000200003,anestesico,i
32,S0034-70942010000200003,local,i
32,S0034-70942010000200003,El,o
32,S0034-70942010000200003,objetivo,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,este,o
32,S0034-70942010000200003,estudio,o
32,S0034-70942010000200003,fue,o
32,S0034-70942010000200003,evaluar,i
32,S0034-70942010000200003,la,i
32,S0034-70942010000200003,efectividad,i
32,S0034-70942010000200003,y,o
32,S0034-70942010000200003,los,o
32,S0034-70942010000200003,efectos,i
32,S0034-70942010000200003,colaterales,i
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,diferentes,o
32,S0034-70942010000200003,volumenes,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,la,o
32,S0034-70942010000200003,asociacion,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,bupivacaina,i
32,S0034-70942010000200003,hiperbarica,o
32,S0034-70942010000200003,y,o
32,S0034-70942010000200003,sufentanil,i
32,S0034-70942010000200003,por,o
32,S0034-70942010000200003,via,o
32,S0034-70942010000200003,subaracnoidea,o
32,S0034-70942010000200003,en,o
32,S0034-70942010000200003,cesareas,i
32,S0034-70942010000200003,METODO,o
32,S0034-70942010000200003,Cuarenta,o
32,S0034-70942010000200003,pacientes,o
32,S0034-70942010000200003,ASA,o
32,S0034-70942010000200003,I,o
32,S0034-70942010000200003,y,o
32,S0034-70942010000200003,II,o
32,S0034-70942010000200003,sometidos,o
32,S0034-70942010000200003,a,o
32,S0034-70942010000200003,cesarea,i
32,S0034-70942010000200003,electiva,o
32,S0034-70942010000200003,bajo,o
32,S0034-70942010000200003,raquianestesia,i
32,S0034-70942010000200003,distribuidos,o
32,S0034-70942010000200003,en,o
32,S0034-70942010000200003,dos,o
32,S0034-70942010000200003,grupos,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,acuerdo,o
32,S0034-70942010000200003,con,o
32,S0034-70942010000200003,el,o
32,S0034-70942010000200003,volumen,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,la,o
32,S0034-70942010000200003,solucion,i
32,S0034-70942010000200003,anestesica,i
32,S0034-70942010000200003,usada,o
32,S0034-70942010000200003,Grupo,o
32,S0034-70942010000200003,I,o
32,S0034-70942010000200003,4,o
32,S0034-70942010000200003,mL,o
32,S0034-70942010000200003,y,o
32,S0034-70942010000200003,Grupo,o
32,S0034-70942010000200003,II,o
32,S0034-70942010000200003,3,o
32,S0034-70942010000200003,mL,o
32,S0034-70942010000200003,En,o
32,S0034-70942010000200003,los,o
32,S0034-70942010000200003,dos,o
32,S0034-70942010000200003,grupos,o
32,S0034-70942010000200003,el,o
32,S0034-70942010000200003,anestesico,i
32,S0034-70942010000200003,local,i
32,S0034-70942010000200003,empleado,o
32,S0034-70942010000200003,fue,o
32,S0034-70942010000200003,la,o
32,S0034-70942010000200003,bupivacaina,i
32,S0034-70942010000200003,hiperbarica,o
32,S0034-70942010000200003,10,o
32,S0034-70942010000200003,mg2,o
32,S0034-70942010000200003,mL,o
32,S0034-70942010000200003,asociada,o
32,S0034-70942010000200003,al,o
32,S0034-70942010000200003,sufentanil,i
32,S0034-70942010000200003,5,o
32,S0034-70942010000200003,µg1,o
32,S0034-70942010000200003,mL,o
32,S0034-70942010000200003,En,o
32,S0034-70942010000200003,el,o
32,S0034-70942010000200003,Grupo,o
32,S0034-70942010000200003,I,o
32,S0034-70942010000200003,para,o
32,S0034-70942010000200003,la,o
32,S0034-70942010000200003,obtencion,o
32,S0034-70942010000200003,del,o
32,S0034-70942010000200003,volumen,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,4,o
32,S0034-70942010000200003,mL,o
32,S0034-70942010000200003,se,o
32,S0034-70942010000200003,añadio,o
32,S0034-70942010000200003,1,o
32,S0034-70942010000200003,mL,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,solucion,i
32,S0034-70942010000200003,fisiologica,i
32,S0034-70942010000200003,a,o
32,S0034-70942010000200003,09,o
32,S0034-70942010000200003,Se,o
32,S0034-70942010000200003,evaluaron,o
32,S0034-70942010000200003,latencia,o
32,S0034-70942010000200003,del,o
32,S0034-70942010000200003,bloqueo,o
32,S0034-70942010000200003,nivel,o
32,S0034-70942010000200003,maximo,o
32,S0034-70942010000200003,del,o
32,S0034-70942010000200003,bloqueo,o
32,S0034-70942010000200003,sensitivo,o
32,S0034-70942010000200003,grado,o
32,S0034-70942010000200003,del,o
32,S0034-70942010000200003,bloqueo,o
32,S0034-70942010000200003,motor,o
32,S0034-70942010000200003,tiempo,o
32,S0034-70942010000200003,para,o
32,S0034-70942010000200003,regresion,o
32,S0034-70942010000200003,del,o
32,S0034-70942010000200003,bloqueo,o
32,S0034-70942010000200003,motor,o
32,S0034-70942010000200003,duracion,o
32,S0034-70942010000200003,total,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,la,o
32,S0034-70942010000200003,analgesia,i
32,S0034-70942010000200003,efectos,i
32,S0034-70942010000200003,adversos,i
32,S0034-70942010000200003,maternos,o
32,S0034-70942010000200003,y,o
32,S0034-70942010000200003,repercusiones,i
32,S0034-70942010000200003,neonatales,i
32,S0034-70942010000200003,RESULTADOS,o
32,S0034-70942010000200003,La,o
32,S0034-70942010000200003,latencia,o
32,S0034-70942010000200003,el,o
32,S0034-70942010000200003,nivel,o
32,S0034-70942010000200003,maximo,o
32,S0034-70942010000200003,del,o
32,S0034-70942010000200003,bloqueo,o
32,S0034-70942010000200003,sensitivo,o
32,S0034-70942010000200003,el,o
32,S0034-70942010000200003,grado,o
32,S0034-70942010000200003,y,o
32,S0034-70942010000200003,el,o
32,S0034-70942010000200003,tiempo,o
32,S0034-70942010000200003,para,o
32,S0034-70942010000200003,la,o
32,S0034-70942010000200003,regresion,o
32,S0034-70942010000200003,del,o
32,S0034-70942010000200003,bloqueo,o
32,S0034-70942010000200003,motor,o
32,S0034-70942010000200003,fueron,o
32,S0034-70942010000200003,similares,o
32,S0034-70942010000200003,en,o
32,S0034-70942010000200003,los,o
32,S0034-70942010000200003,dos,o
32,S0034-70942010000200003,grupos,o
32,S0034-70942010000200003,la,o
32,S0034-70942010000200003,duracion,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,la,o
32,S0034-70942010000200003,analgesia,i
32,S0034-70942010000200003,fue,o
32,S0034-70942010000200003,mayor,o
32,S0034-70942010000200003,en,o
32,S0034-70942010000200003,el,o
32,S0034-70942010000200003,Grupo,o
32,S0034-70942010000200003,I,o
32,S0034-70942010000200003,con,o
32,S0034-70942010000200003,una,o
32,S0034-70942010000200003,diferencia,o
32,S0034-70942010000200003,significativa,o
32,S0034-70942010000200003,con,o
32,S0034-70942010000200003,relacion,o
32,S0034-70942010000200003,al,o
32,S0034-70942010000200003,Grupo,o
32,S0034-70942010000200003,II,o
32,S0034-70942010000200003,Los,o
32,S0034-70942010000200003,efectos,i
32,S0034-70942010000200003,adversos,i
32,S0034-70942010000200003,se,o
32,S0034-70942010000200003,dieron,o
32,S0034-70942010000200003,a,o
32,S0034-70942010000200003,menudo,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,forma,o
32,S0034-70942010000200003,similar,o
32,S0034-70942010000200003,en,o
32,S0034-70942010000200003,los,o
32,S0034-70942010000200003,dos,o
32,S0034-70942010000200003,grupos,o
32,S0034-70942010000200003,Se,o
32,S0034-70942010000200003,registro,o
32,S0034-70942010000200003,la,o
32,S0034-70942010000200003,ausencia,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,las,o
32,S0034-70942010000200003,alteraciones,i
32,S0034-70942010000200003,cardiocirculatorias,i
32,S0034-70942010000200003,maternas,o
32,S0034-70942010000200003,y,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,las,o
32,S0034-70942010000200003,repercusiones,i
32,S0034-70942010000200003,neonatales,i
32,S0034-70942010000200003,CONCLUSIONES,o
32,S0034-70942010000200003,La,o
32,S0034-70942010000200003,bupivacaina,i
32,S0034-70942010000200003,hiperbarica,o
32,S0034-70942010000200003,en,o
32,S0034-70942010000200003,dosis,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,10,o
32,S0034-70942010000200003,mg,o
32,S0034-70942010000200003,asociada,o
32,S0034-70942010000200003,al,o
32,S0034-70942010000200003,sufentanil,i
32,S0034-70942010000200003,en,o
32,S0034-70942010000200003,dosis,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,5,o
32,S0034-70942010000200003,µg,o
32,S0034-70942010000200003,con,o
32,S0034-70942010000200003,un,o
32,S0034-70942010000200003,volumen,o
32,S0034-70942010000200003,de,o
32,S0034-70942010000200003,4,o
32,S0034-70942010000200003,mL,o
32,S0034-70942010000200003,fue,o
32,S0034-70942010000200003,mas,o
32,S0034-70942010000200003,eficaz,o
32,S0034-70942010000200003,que,o
32,S0034-70942010000200003,la,o
32,S0034-70942010000200003,misma,o
32,S0034-70942010000200003,asociacion,o
32,S0034-70942010000200003,en,o
32,S0034-70942010000200003,un,o
32,S0034-70942010000200003,menor,o
32,S0034-70942010000200003,volumen,o
32,S0034-70942010000200003,3,o
32,S0034-70942010000200003,mL,o
32,S0034-70942010000200003,proporcionando,o
32,S0034-70942010000200003,una,o
32,S0034-70942010000200003,mejor,o
32,S0034-70942010000200003,analgesia,i
32,S0034-70942010000200003,intra,o
32,S0034-70942010000200003,y,o
32,S0034-70942010000200003,postoperatoria,o
32,S0034-70942010000200003,sin,o
32,S0034-70942010000200003,repercusiones,o
32,S0034-70942010000200003,maternofetales,o
33,S0034-70942011000500003,Bloqueo,i
33,S0034-70942011000500003,de,i
33,S0034-70942011000500003,los,i
33,S0034-70942011000500003,nervios,i
33,S0034-70942011000500003,tibial,i
33,S0034-70942011000500003,y,i
33,S0034-70942011000500003,fibular,i
33,S0034-70942011000500003,comun,i
33,S0034-70942011000500003,en,o
33,S0034-70942011000500003,fosa,i
33,S0034-70942011000500003,poplitea,i
33,S0034-70942011000500003,con,o
33,S0034-70942011000500003,puncion,i
33,S0034-70942011000500003,unica,o
33,S0034-70942011000500003,utilizando,o
33,S0034-70942011000500003,el,o
33,S0034-70942011000500003,estimulador,o
33,S0034-70942011000500003,percutaneo,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,nervios,i
33,S0034-70942011000500003,consideraciones,o
33,S0034-70942011000500003,anatomicas,o
33,S0034-70942011000500003,y,o
33,S0034-70942011000500003,descripcion,i
33,S0034-70942011000500003,ultrasonografica,i
33,S0034-70942011000500003,JUSTIFICATIVA,o
33,S0034-70942011000500003,Y,o
33,S0034-70942011000500003,OBJETIVOS,o
33,S0034-70942011000500003,Las,o
33,S0034-70942011000500003,tecnicas,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,bloqueos,i
33,S0034-70942011000500003,de,i
33,S0034-70942011000500003,nervios,i
33,S0034-70942011000500003,perifericos,i
33,S0034-70942011000500003,ha,o
33,S0034-70942011000500003,venido,o
33,S0034-70942011000500003,obteniendo,o
33,S0034-70942011000500003,popularidad,o
33,S0034-70942011000500003,en,o
33,S0034-70942011000500003,las,o
33,S0034-70942011000500003,ultimas,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,los,o
33,S0034-70942011000500003,decadas,o
33,S0034-70942011000500003,y,o
33,S0034-70942011000500003,convirtiendose,o
33,S0034-70942011000500003,cada,o
33,S0034-70942011000500003,vez,o
33,S0034-70942011000500003,mas,o
33,S0034-70942011000500003,en,o
33,S0034-70942011000500003,una,o
33,S0034-70942011000500003,opcion,o
33,S0034-70942011000500003,anestesica,o
33,S0034-70942011000500003,para,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,cirugia,i
33,S0034-70942011000500003,de,i
33,S0034-70942011000500003,los,i
33,S0034-70942011000500003,miembros,i
33,S0034-70942011000500003,Este,o
33,S0034-70942011000500003,estudio,o
33,S0034-70942011000500003,propone,o
33,S0034-70942011000500003,una,o
33,S0034-70942011000500003,tecnica,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,abordaje,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,los,o
33,S0034-70942011000500003,nervios,i
33,S0034-70942011000500003,tibial,i
33,S0034-70942011000500003,y,i
33,S0034-70942011000500003,fibular,i
33,S0034-70942011000500003,comun,i
33,S0034-70942011000500003,en,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,fosa,i
33,S0034-70942011000500003,poplitea,i
33,S0034-70942011000500003,por,o
33,S0034-70942011000500003,puncion,i
33,S0034-70942011000500003,unica,o
33,S0034-70942011000500003,y,o
33,S0034-70942011000500003,utilizando,o
33,S0034-70942011000500003,el,o
33,S0034-70942011000500003,estimulador,o
33,S0034-70942011000500003,percutaneo,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,nervios,i
33,S0034-70942011000500003,considerando,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,correlacion,o
33,S0034-70942011000500003,con,o
33,S0034-70942011000500003,el,o
33,S0034-70942011000500003,estudio,i
33,S0034-70942011000500003,anatomico,i
33,S0034-70942011000500003,y,i
33,S0034-70942011000500003,ultrasonografico,i
33,S0034-70942011000500003,METODO,o
33,S0034-70942011000500003,Estudio,o
33,S0034-70942011000500003,prospectivo,o
33,S0034-70942011000500003,observacional,o
33,S0034-70942011000500003,y,o
33,S0034-70942011000500003,aleatorio,o
33,S0034-70942011000500003,realizado,o
33,S0034-70942011000500003,con,o
33,S0034-70942011000500003,28,o
33,S0034-70942011000500003,pacientes,o
33,S0034-70942011000500003,selecionados,o
33,S0034-70942011000500003,para,o
33,S0034-70942011000500003,cirugias,i
33,S0034-70942011000500003,en,i
33,S0034-70942011000500003,el,i
33,S0034-70942011000500003,pie,i
33,S0034-70942011000500003,Despues,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,localizacion,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,los,o
33,S0034-70942011000500003,nervios,i
33,S0034-70942011000500003,tibial,i
33,S0034-70942011000500003,y,i
33,S0034-70942011000500003,fibular,i
33,S0034-70942011000500003,comun,i
33,S0034-70942011000500003,a,o
33,S0034-70942011000500003,traves,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,estimulacion,i
33,S0034-70942011000500003,percutanea,i
33,S0034-70942011000500003,se,o
33,S0034-70942011000500003,realizo,o
33,S0034-70942011000500003,una,o
33,S0034-70942011000500003,puncion,i
33,S0034-70942011000500003,en,i
33,S0034-70942011000500003,el,i
33,S0034-70942011000500003,punto,i
33,S0034-70942011000500003,de,i
33,S0034-70942011000500003,estimulo,i
33,S0034-70942011000500003,del,i
33,S0034-70942011000500003,nervio,i
33,S0034-70942011000500003,tibial,i
33,S0034-70942011000500003,con,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,aguja,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,5,o
33,S0034-70942011000500003,cm,o
33,S0034-70942011000500003,BBraun,o
33,S0034-70942011000500003,Stimuplex,o
33,S0034-70942011000500003,50,o
33,S0034-70942011000500003,y,o
33,S0034-70942011000500003,fueron,o
33,S0034-70942011000500003,inyectados,i
33,S0034-70942011000500003,10,o
33,S0034-70942011000500003,mL,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,levobupivacaina,i
33,S0034-70942011000500003,La,o
33,S0034-70942011000500003,aguja,o
33,S0034-70942011000500003,se,o
33,S0034-70942011000500003,echo,o
33,S0034-70942011000500003,hacia,o
33,S0034-70942011000500003,atras,o
33,S0034-70942011000500003,y,o
33,S0034-70942011000500003,fue,o
33,S0034-70942011000500003,redirigida,o
33,S0034-70942011000500003,hacia,o
33,S0034-70942011000500003,el,o
33,S0034-70942011000500003,punto,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,estimulo,o
33,S0034-70942011000500003,del,o
33,S0034-70942011000500003,nervio,i
33,S0034-70942011000500003,fibular,i
33,S0034-70942011000500003,comun,i
33,S0034-70942011000500003,en,o
33,S0034-70942011000500003,busca,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,respuesta,o
33,S0034-70942011000500003,motora,o
33,S0034-70942011000500003,correspondiente,o
33,S0034-70942011000500003,inyectando,i
33,S0034-70942011000500003,10,o
33,S0034-70942011000500003,mL,o
33,S0034-70942011000500003,del,o
33,S0034-70942011000500003,anestesico,i
33,S0034-70942011000500003,Se,o
33,S0034-70942011000500003,realizo,o
33,S0034-70942011000500003,el,o
33,S0034-70942011000500003,estudio,i
33,S0034-70942011000500003,fotografico,i
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,region,i
33,S0034-70942011000500003,poplitea,i
33,S0034-70942011000500003,por,o
33,S0034-70942011000500003,ultrasonografia,i
33,S0034-70942011000500003,para,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,correlacion,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,anatomia,o
33,S0034-70942011000500003,con,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,tecnica,o
33,S0034-70942011000500003,utilizada,o
33,S0034-70942011000500003,RESULTADOS,o
33,S0034-70942011000500003,En,o
33,S0034-70942011000500003,todos,o
33,S0034-70942011000500003,los,o
33,S0034-70942011000500003,casos,o
33,S0034-70942011000500003,se,o
33,S0034-70942011000500003,obtuvo,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,anestesia,i
33,S0034-70942011000500003,adecuada,o
33,S0034-70942011000500003,El,o
33,S0034-70942011000500003,tiempo,o
33,S0034-70942011000500003,promedio,o
33,S0034-70942011000500003,para,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,localizacion,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,los,o
33,S0034-70942011000500003,nervios,i
33,S0034-70942011000500003,tibial,i
33,S0034-70942011000500003,y,i
33,S0034-70942011000500003,fibular,i
33,S0034-70942011000500003,comun,i
33,S0034-70942011000500003,utilizando,o
33,S0034-70942011000500003,el,o
33,S0034-70942011000500003,estimulador,o
33,S0034-70942011000500003,percutaneo,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,nervios,i
33,S0034-70942011000500003,fue,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,571,o
33,S0034-70942011000500003,y,o
33,S0034-70942011000500003,328,o
33,S0034-70942011000500003,segundos,o
33,S0034-70942011000500003,respectivamente,o
33,S0034-70942011000500003,y,o
33,S0034-70942011000500003,con,o
33,S0034-70942011000500003,el,o
33,S0034-70942011000500003,estimulador,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,nervios,i
33,S0034-70942011000500003,fue,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,222,o
33,S0034-70942011000500003,y,o
33,S0034-70942011000500003,179,o
33,S0034-70942011000500003,minutos,o
33,S0034-70942011000500003,La,o
33,S0034-70942011000500003,profundidad,o
33,S0034-70942011000500003,promedio,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,aguja,o
33,S0034-70942011000500003,para,o
33,S0034-70942011000500003,el,o
33,S0034-70942011000500003,nervio,i
33,S0034-70942011000500003,tibial,i
33,S0034-70942011000500003,fue,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,107,o
33,S0034-70942011000500003,mm,o
33,S0034-70942011000500003,CONCLUSIONES,o
33,S0034-70942011000500003,El,o
33,S0034-70942011000500003,abordaje,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,los,o
33,S0034-70942011000500003,nervios,i
33,S0034-70942011000500003,tibial,i
33,S0034-70942011000500003,y,i
33,S0034-70942011000500003,fibular,i
33,S0034-70942011000500003,comun,i
33,S0034-70942011000500003,con,o
33,S0034-70942011000500003,puncion,i
33,S0034-70942011000500003,unica,o
33,S0034-70942011000500003,en,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,fosa,i
33,S0034-70942011000500003,poplitea,i
33,S0034-70942011000500003,utilizando,o
33,S0034-70942011000500003,el,o
33,S0034-70942011000500003,estimulador,o
33,S0034-70942011000500003,percutaneo,o
33,S0034-70942011000500003,de,o
33,S0034-70942011000500003,nervios,i
33,S0034-70942011000500003,es,o
33,S0034-70942011000500003,una,o
33,S0034-70942011000500003,buena,o
33,S0034-70942011000500003,opcion,o
33,S0034-70942011000500003,para,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,anestesia,i
33,S0034-70942011000500003,y,o
33,S0034-70942011000500003,la,o
33,S0034-70942011000500003,analgesia,i
33,S0034-70942011000500003,en,o
33,S0034-70942011000500003,cirugias,i
33,S0034-70942011000500003,del,i
33,S0034-70942011000500003,pie,i
34,S0034-70942011000500006,Evaluacion,i
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,efecto,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,estimulacion,i
34,S0034-70942011000500006,nerviosa,i
34,S0034-70942011000500006,electrica,i
34,S0034-70942011000500006,transcutanea,i
34,S0034-70942011000500006,TENS,i
34,S0034-70942011000500006,para,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,analgesia,i
34,S0034-70942011000500006,despues,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,toracotomia,i
34,S0034-70942011000500006,JUSTIFICATIVA,o
34,S0034-70942011000500006,Y,o
34,S0034-70942011000500006,OBJETIVOS,o
34,S0034-70942011000500006,La,o
34,S0034-70942011000500006,estimulacion,i
34,S0034-70942011000500006,nerviosa,i
34,S0034-70942011000500006,electrica,i
34,S0034-70942011000500006,transcutanea,i
34,S0034-70942011000500006,TENS,i
34,S0034-70942011000500006,es,o
34,S0034-70942011000500006,una,o
34,S0034-70942011000500006,modalidad,o
34,S0034-70942011000500006,frecuentemente,o
34,S0034-70942011000500006,usada,o
34,S0034-70942011000500006,para,o
34,S0034-70942011000500006,el,o
34,S0034-70942011000500006,tratamiento,i
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,dolor,i
34,S0034-70942011000500006,musculoesqueletico,i
34,S0034-70942011000500006,pero,o
34,S0034-70942011000500006,tambien,o
34,S0034-70942011000500006,puede,o
34,S0034-70942011000500006,ser,o
34,S0034-70942011000500006,indicada,o
34,S0034-70942011000500006,en,o
34,S0034-70942011000500006,caso,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,analgesia,i
34,S0034-70942011000500006,postoperatoria,i
34,S0034-70942011000500006,El,o
34,S0034-70942011000500006,objetivo,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,este,o
34,S0034-70942011000500006,estudio,o
34,S0034-70942011000500006,fue,o
34,S0034-70942011000500006,evaluar,o
34,S0034-70942011000500006,el,o
34,S0034-70942011000500006,efecto,o
34,S0034-70942011000500006,analgesico,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,TENS,i
34,S0034-70942011000500006,despues,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,toracotomia,i
34,S0034-70942011000500006,METODO,o
34,S0034-70942011000500006,Se,o
34,S0034-70942011000500006,incluyeron,o
34,S0034-70942011000500006,30,o
34,S0034-70942011000500006,pacientes,o
34,S0034-70942011000500006,entre,o
34,S0034-70942011000500006,18,o
34,S0034-70942011000500006,y,o
34,S0034-70942011000500006,60,o
34,S0034-70942011000500006,años,o
34,S0034-70942011000500006,sometidos,o
34,S0034-70942011000500006,a,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,toracotomia,i
34,S0034-70942011000500006,para,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,reseccion,i
34,S0034-70942011000500006,de,i
34,S0034-70942011000500006,cancer,i
34,S0034-70942011000500006,pulmonar,i
34,S0034-70942011000500006,en,o
34,S0034-70942011000500006,el,o
34,S0034-70942011000500006,segundo,o
34,S0034-70942011000500006,dia,o
34,S0034-70942011000500006,despues,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,operacion,i
34,S0034-70942011000500006,Los,o
34,S0034-70942011000500006,pacientes,o
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,G1,o
34,S0034-70942011000500006,se,o
34,S0034-70942011000500006,sometieron,o
34,S0034-70942011000500006,al,o
34,S0034-70942011000500006,tratamiento,i
34,S0034-70942011000500006,con,i
34,S0034-70942011000500006,TENS,i
34,S0034-70942011000500006,en,o
34,S0034-70942011000500006,los,o
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,G2,o
34,S0034-70942011000500006,sin,o
34,S0034-70942011000500006,TENS,i
34,S0034-70942011000500006,se,o
34,S0034-70942011000500006,colocaron,o
34,S0034-70942011000500006,los,o
34,S0034-70942011000500006,electrodos,o
34,S0034-70942011000500006,pero,o
34,S0034-70942011000500006,el,o
34,S0034-70942011000500006,aparato,o
34,S0034-70942011000500006,no,o
34,S0034-70942011000500006,se,o
34,S0034-70942011000500006,encendio,o
34,S0034-70942011000500006,La,o
34,S0034-70942011000500006,TENS,i
34,S0034-70942011000500006,se,o
34,S0034-70942011000500006,mantuvo,o
34,S0034-70942011000500006,durante,o
34,S0034-70942011000500006,una,o
34,S0034-70942011000500006,hora,o
34,S0034-70942011000500006,La,o
34,S0034-70942011000500006,evaluacion,o
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,efecto,o
34,S0034-70942011000500006,analgesico,o
34,S0034-70942011000500006,se,o
34,S0034-70942011000500006,dio,o
34,S0034-70942011000500006,a,o
34,S0034-70942011000500006,traves,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,escala,i
34,S0034-70942011000500006,analogica,i
34,S0034-70942011000500006,visual,i
34,S0034-70942011000500006,en,o
34,S0034-70942011000500006,tres,o
34,S0034-70942011000500006,momentos,o
34,S0034-70942011000500006,antes,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,aplicacion,o
34,S0034-70942011000500006,M0,o
34,S0034-70942011000500006,inmediatamente,o
34,S0034-70942011000500006,despues,o
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,termino,o
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,procedimiento,i
34,S0034-70942011000500006,M1,o
34,S0034-70942011000500006,y,o
34,S0034-70942011000500006,una,o
34,S0034-70942011000500006,hora,o
34,S0034-70942011000500006,despues,o
34,S0034-70942011000500006,M2,o
34,S0034-70942011000500006,con,o
34,S0034-70942011000500006,el,o
34,S0034-70942011000500006,paciente,o
34,S0034-70942011000500006,en,o
34,S0034-70942011000500006,reposo,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,elevacion,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,los,o
34,S0034-70942011000500006,miembros,i
34,S0034-70942011000500006,superiores,i
34,S0034-70942011000500006,el,o
34,S0034-70942011000500006,cambio,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,decubito,o
34,S0034-70942011000500006,y,o
34,S0034-70942011000500006,con,o
34,S0034-70942011000500006,tos,i
34,S0034-70942011000500006,RESULTADOS,o
34,S0034-70942011000500006,La,o
34,S0034-70942011000500006,intensidad,o
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,dolor,i
34,S0034-70942011000500006,en,o
34,S0034-70942011000500006,el,o
34,S0034-70942011000500006,estado,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,reposo,o
34,S0034-70942011000500006,fue,o
34,S0034-70942011000500006,mas,o
34,S0034-70942011000500006,elevada,o
34,S0034-70942011000500006,en,o
34,S0034-70942011000500006,el,o
34,S0034-70942011000500006,G2,o
34,S0034-70942011000500006,inmediatamente,o
34,S0034-70942011000500006,despues,o
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,termino,o
34,S0034-70942011000500006,pero,o
34,S0034-70942011000500006,no,o
34,S0034-70942011000500006,una,o
34,S0034-70942011000500006,hora,o
34,S0034-70942011000500006,despues,o
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,procedimiento,i
34,S0034-70942011000500006,Con,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,elevacion,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,los,o
34,S0034-70942011000500006,miembros,i
34,S0034-70942011000500006,superiores,i
34,S0034-70942011000500006,el,o
34,S0034-70942011000500006,cambio,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,decubito,o
34,S0034-70942011000500006,y,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,tos,i
34,S0034-70942011000500006,no,o
34,S0034-70942011000500006,hubo,o
34,S0034-70942011000500006,diferencia,o
34,S0034-70942011000500006,entre,o
34,S0034-70942011000500006,los,o
34,S0034-70942011000500006,grupos,o
34,S0034-70942011000500006,CONCLUSIONES,o
34,S0034-70942011000500006,Con,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,aplicacion,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,TENS,i
34,S0034-70942011000500006,durante,o
34,S0034-70942011000500006,una,o
34,S0034-70942011000500006,hora,o
34,S0034-70942011000500006,en,o
34,S0034-70942011000500006,el,o
34,S0034-70942011000500006,segundo,o
34,S0034-70942011000500006,dia,o
34,S0034-70942011000500006,despues,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,toracotomia,i
34,S0034-70942011000500006,en,o
34,S0034-70942011000500006,pacientes,o
34,S0034-70942011000500006,que,o
34,S0034-70942011000500006,recibieron,o
34,S0034-70942011000500006,fentanil,i
34,S0034-70942011000500006,50,o
34,S0034-70942011000500006,µg,o
34,S0034-70942011000500006,asociada,o
34,S0034-70942011000500006,a,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,bupivacaina,i
34,S0034-70942011000500006,5,o
34,S0034-70942011000500006,mL,o
34,S0034-70942011000500006,en,o
34,S0034-70942011000500006,reposo,o
34,S0034-70942011000500006,se,o
34,S0034-70942011000500006,registro,o
34,S0034-70942011000500006,una,o
34,S0034-70942011000500006,reduccion,o
34,S0034-70942011000500006,en,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,intensidad,o
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,dolor,i
34,S0034-70942011000500006,inmediatamente,o
34,S0034-70942011000500006,despues,o
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,termino,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,aplicacion,o
34,S0034-70942011000500006,Pero,o
34,S0034-70942011000500006,con,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,elevacion,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,los,o
34,S0034-70942011000500006,miembros,i
34,S0034-70942011000500006,superiores,i
34,S0034-70942011000500006,el,o
34,S0034-70942011000500006,cambio,o
34,S0034-70942011000500006,de,o
34,S0034-70942011000500006,decubito,o
34,S0034-70942011000500006,y,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,tos,i
34,S0034-70942011000500006,no,o
34,S0034-70942011000500006,hubo,o
34,S0034-70942011000500006,reduccion,o
34,S0034-70942011000500006,en,o
34,S0034-70942011000500006,la,o
34,S0034-70942011000500006,intensidad,o
34,S0034-70942011000500006,del,o
34,S0034-70942011000500006,dolor,i
35,S0034-70942011000600001,Metadona,i
35,S0034-70942011000600001,y,o
35,S0034-70942011000600001,morfina,i
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,induccion,i
35,S0034-70942011000600001,de,i
35,S0034-70942011000600001,la,i
35,S0034-70942011000600001,anestesia,i
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,cirugia,i
35,S0034-70942011000600001,cardiaca,i
35,S0034-70942011000600001,repercusion,o
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,analgesia,i
35,S0034-70942011000600001,postoperatoria,i
35,S0034-70942011000600001,y,o
35,S0034-70942011000600001,prevalencia,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,nauseas,i
35,S0034-70942011000600001,y,i
35,S0034-70942011000600001,vomitos,i
35,S0034-70942011000600001,JUSTIFICATIVA,o
35,S0034-70942011000600001,Y,o
35,S0034-70942011000600001,OBJETIVOS,o
35,S0034-70942011000600001,El,o
35,S0034-70942011000600001,dolor,i
35,S0034-70942011000600001,es,o
35,S0034-70942011000600001,un,o
35,S0034-70942011000600001,factor,o
35,S0034-70942011000600001,agravante,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,morbimortalidad,o
35,S0034-70942011000600001,postoperatoria,o
35,S0034-70942011000600001,principalmente,o
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,las,o
35,S0034-70942011000600001,intervenciones,i
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,gran,o
35,S0034-70942011000600001,porte,o
35,S0034-70942011000600001,Los,o
35,S0034-70942011000600001,metodos,o
35,S0034-70942011000600001,para,o
35,S0034-70942011000600001,hacerle,o
35,S0034-70942011000600001,frente,o
35,S0034-70942011000600001,eficazmente,o
35,S0034-70942011000600001,se,o
35,S0034-70942011000600001,topan,o
35,S0034-70942011000600001,con,o
35,S0034-70942011000600001,los,o
35,S0034-70942011000600001,costes,o
35,S0034-70942011000600001,elevados,o
35,S0034-70942011000600001,y,o
35,S0034-70942011000600001,por,o
35,S0034-70942011000600001,eso,o
35,S0034-70942011000600001,no,o
35,S0034-70942011000600001,son,o
35,S0034-70942011000600001,accesibles,o
35,S0034-70942011000600001,a,o
35,S0034-70942011000600001,todos,o
35,S0034-70942011000600001,los,o
35,S0034-70942011000600001,servicios,o
35,S0034-70942011000600001,La,o
35,S0034-70942011000600001,opcion,o
35,S0034-70942011000600001,seria,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,utilizacion,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,un,o
35,S0034-70942011000600001,opioide,i
35,S0034-70942011000600001,con,o
35,S0034-70942011000600001,vida,o
35,S0034-70942011000600001,media,o
35,S0034-70942011000600001,larga,o
35,S0034-70942011000600001,como,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,metadona,i
35,S0034-70942011000600001,El,o
35,S0034-70942011000600001,objetivo,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,este,o
35,S0034-70942011000600001,trabajo,o
35,S0034-70942011000600001,fue,o
35,S0034-70942011000600001,comparar,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,demanda,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,analgesia,i
35,S0034-70942011000600001,postoperatoria,i
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,pacientes,o
35,S0034-70942011000600001,que,o
35,S0034-70942011000600001,recibieron,o
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,induccion,i
35,S0034-70942011000600001,de,i
35,S0034-70942011000600001,anestesia,i
35,S0034-70942011000600001,metadona,i
35,S0034-70942011000600001,o,o
35,S0034-70942011000600001,morfina,i
35,S0034-70942011000600001,o,o
35,S0034-70942011000600001,incluso,o
35,S0034-70942011000600001,placebo,i
35,S0034-70942011000600001,ademas,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,prevalencia,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,nauseas,i
35,S0034-70942011000600001,y,i
35,S0034-70942011000600001,vomitos,i
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,el,o
35,S0034-70942011000600001,postoperatorio,o
35,S0034-70942011000600001,METODO,o
35,S0034-70942011000600001,Cincuenta,o
35,S0034-70942011000600001,y,o
35,S0034-70942011000600001,cinco,o
35,S0034-70942011000600001,pacientes,o
35,S0034-70942011000600001,programados,o
35,S0034-70942011000600001,para,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,cirugia,i
35,S0034-70942011000600001,cardiaca,i
35,S0034-70942011000600001,fueron,o
35,S0034-70942011000600001,divididos,o
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,tres,o
35,S0034-70942011000600001,grupos,o
35,S0034-70942011000600001,que,o
35,S0034-70942011000600001,recibieron,o
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,induccion,i
35,S0034-70942011000600001,de,i
35,S0034-70942011000600001,la,i
35,S0034-70942011000600001,anestesia,i
35,S0034-70942011000600001,20,o
35,S0034-70942011000600001,mg,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,metadona,i
35,S0034-70942011000600001,o,o
35,S0034-70942011000600001,20,o
35,S0034-70942011000600001,mg,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,morfina,i
35,S0034-70942011000600001,o,o
35,S0034-70942011000600001,incluso,o
35,S0034-70942011000600001,placebo,i
35,S0034-70942011000600001,Al,o
35,S0034-70942011000600001,finalizar,o
35,S0034-70942011000600001,fueron,o
35,S0034-70942011000600001,derivados,i
35,S0034-70942011000600001,a,i
35,S0034-70942011000600001,la,i
35,S0034-70942011000600001,UCI,i
35,S0034-70942011000600001,donde,o
35,S0034-70942011000600001,se,o
35,S0034-70942011000600001,evaluaron,o
35,S0034-70942011000600001,los,o
35,S0034-70942011000600001,siguientes,o
35,S0034-70942011000600001,factores,o
35,S0034-70942011000600001,duracion,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,anestesia,i
35,S0034-70942011000600001,tiempo,o
35,S0034-70942011000600001,hasta,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,desentubacion,i
35,S0034-70942011000600001,tiempo,o
35,S0034-70942011000600001,hasta,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,necesidad,o
35,S0034-70942011000600001,del,o
35,S0034-70942011000600001,primer,o
35,S0034-70942011000600001,analgesico,i
35,S0034-70942011000600001,numero,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,dosis,o
35,S0034-70942011000600001,necesarias,o
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,24,o
35,S0034-70942011000600001,horas,o
35,S0034-70942011000600001,evaluacion,i
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,analgesia,i
35,S0034-70942011000600001,por,o
35,S0034-70942011000600001,el,o
35,S0034-70942011000600001,paciente,o
35,S0034-70942011000600001,y,o
35,S0034-70942011000600001,prevalencia,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,nauseasvomitos,o
35,S0034-70942011000600001,RESULTADOS,o
35,S0034-70942011000600001,No,o
35,S0034-70942011000600001,hubo,o
35,S0034-70942011000600001,ninguna,o
35,S0034-70942011000600001,diferencia,o
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,duracion,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,anestesia,i
35,S0034-70942011000600001,y,o
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,el,o
35,S0034-70942011000600001,plazo,o
35,S0034-70942011000600001,hasta,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,desentubacion,i
35,S0034-70942011000600001,La,o
35,S0034-70942011000600001,primera,o
35,S0034-70942011000600001,dosis,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,analgesico,i
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,aquellas,o
35,S0034-70942011000600001,que,o
35,S0034-70942011000600001,recibieron,o
35,S0034-70942011000600001,metadona,i
35,S0034-70942011000600001,fue,o
35,S0034-70942011000600001,administrada,o
35,S0034-70942011000600001,mas,o
35,S0034-70942011000600001,tarde,o
35,S0034-70942011000600001,que,o
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,los,o
35,S0034-70942011000600001,otros,o
35,S0034-70942011000600001,dos,o
35,S0034-70942011000600001,grupos,o
35,S0034-70942011000600001,La,o
35,S0034-70942011000600001,necesidad,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,analgesicos,i
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,el,o
35,S0034-70942011000600001,grupo,o
35,S0034-70942011000600001,metadona,i
35,S0034-70942011000600001,fue,o
35,S0034-70942011000600001,menor,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,calidad,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,analgesia,i
35,S0034-70942011000600001,fue,o
35,S0034-70942011000600001,mejor,o
35,S0034-70942011000600001,y,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,prevalencia,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,nauseas,i
35,S0034-70942011000600001,y,i
35,S0034-70942011000600001,vomitos,i
35,S0034-70942011000600001,tambien,o
35,S0034-70942011000600001,fue,o
35,S0034-70942011000600001,menor,o
35,S0034-70942011000600001,CONCLUSIONES,o
35,S0034-70942011000600001,La,o
35,S0034-70942011000600001,metadona,i
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,induccion,i
35,S0034-70942011000600001,de,i
35,S0034-70942011000600001,la,i
35,S0034-70942011000600001,anestesia,i
35,S0034-70942011000600001,fue,o
35,S0034-70942011000600001,eficiente,o
35,S0034-70942011000600001,para,o
35,S0034-70942011000600001,la,o
35,S0034-70942011000600001,analgesia,i
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,las,o
35,S0034-70942011000600001,cirugias,i
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,gran,o
35,S0034-70942011000600001,porte,o
35,S0034-70942011000600001,Hubo,o
35,S0034-70942011000600001,un,o
35,S0034-70942011000600001,menor,o
35,S0034-70942011000600001,aparecimiento,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,nauseas,i
35,S0034-70942011000600001,y,i
35,S0034-70942011000600001,vomitos,i
35,S0034-70942011000600001,tratandose,o
35,S0034-70942011000600001,por,o
35,S0034-70942011000600001,tanto,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,una,o
35,S0034-70942011000600001,opcion,o
35,S0034-70942011000600001,de,o
35,S0034-70942011000600001,bajo,o
35,S0034-70942011000600001,coste,o
35,S0034-70942011000600001,disponible,o
35,S0034-70942011000600001,en,o
35,S0034-70942011000600001,nuestro,o
35,S0034-70942011000600001,medio,o
35,S0034-70942011000600001,y,o
35,S0034-70942011000600001,que,o
35,S0034-70942011000600001,debe,o
35,S0034-70942011000600001,ser,o
35,S0034-70942011000600001,estimulada,o
36,S0034-70942012000400003,Evaluacion,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,la,i
36,S0034-70942012000400003,eficacia,i
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,analgesia,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,prevencion,i
36,S0034-70942012000400003,en,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,cirugia,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,extraccion,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,terceros,i
36,S0034-70942012000400003,molares,i
36,S0034-70942012000400003,incluidos,i
36,S0034-70942012000400003,JUSTIFICATIVA,o
36,S0034-70942012000400003,Y,o
36,S0034-70942012000400003,OBJETIVOS,o
36,S0034-70942012000400003,La,o
36,S0034-70942012000400003,literatura,o
36,S0034-70942012000400003,sobre,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,analgesia,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,prevencion,i
36,S0034-70942012000400003,es,o
36,S0034-70942012000400003,controversial,o
36,S0034-70942012000400003,La,o
36,S0034-70942012000400003,confiabilidad,o
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,los,o
36,S0034-70942012000400003,resultados,o
36,S0034-70942012000400003,y,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,dificultad,o
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,reproductibilidad,o
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,las,o
36,S0034-70942012000400003,investigaciones,o
36,S0034-70942012000400003,contribuyen,o
36,S0034-70942012000400003,para,o
36,S0034-70942012000400003,que,o
36,S0034-70942012000400003,el,o
36,S0034-70942012000400003,tema,o
36,S0034-70942012000400003,no,o
36,S0034-70942012000400003,quede,o
36,S0034-70942012000400003,clarificado,o
36,S0034-70942012000400003,en,o
36,S0034-70942012000400003,su,o
36,S0034-70942012000400003,totalidad,o
36,S0034-70942012000400003,El,o
36,S0034-70942012000400003,objetivo,o
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,este,o
36,S0034-70942012000400003,estudio,o
36,S0034-70942012000400003,es,o
36,S0034-70942012000400003,comprobar,i
36,S0034-70942012000400003,la,i
36,S0034-70942012000400003,eficacia,i
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,administracion,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,prevencion,i
36,S0034-70942012000400003,del,o
36,S0034-70942012000400003,Cetoprofeno,i
36,S0034-70942012000400003,150,o
36,S0034-70942012000400003,mg,o
36,S0034-70942012000400003,por,o
36,S0034-70942012000400003,via,o
36,S0034-70942012000400003,oral,o
36,S0034-70942012000400003,dos,o
36,S0034-70942012000400003,dias,o
36,S0034-70942012000400003,antes,o
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,cirugia,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,terceros,i
36,S0034-70942012000400003,molares,i
36,S0034-70942012000400003,comparando,o
36,S0034-70942012000400003,al,o
36,S0034-70942012000400003,mismo,o
36,S0034-70942012000400003,paciente,o
36,S0034-70942012000400003,con,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,administracion,i
36,S0034-70942012000400003,postoperatoria,i
36,S0034-70942012000400003,METODO,o
36,S0034-70942012000400003,Trece,o
36,S0034-70942012000400003,pacientes,o
36,S0034-70942012000400003,se,o
36,S0034-70942012000400003,sometieron,o
36,S0034-70942012000400003,a,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,cirugia,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,extraccion,i
36,S0034-70942012000400003,bilateral,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,terceros,i
36,S0034-70942012000400003,molares,i
36,S0034-70942012000400003,inferiores,i
36,S0034-70942012000400003,incluidos,i
36,S0034-70942012000400003,en,o
36,S0034-70942012000400003,dos,o
36,S0034-70942012000400003,procedimientos,i
36,S0034-70942012000400003,distintos,o
36,S0034-70942012000400003,De,i
36,S0034-70942012000400003,forma,i
36,S0034-70942012000400003,randomizada,i
36,S0034-70942012000400003,y,i
36,S0034-70942012000400003,doble,i
36,S0034-70942012000400003,ciega,i
36,S0034-70942012000400003,en,o
36,S0034-70942012000400003,un,o
36,S0034-70942012000400003,procedimiento,i
36,S0034-70942012000400003,se,o
36,S0034-70942012000400003,administro,o
36,S0034-70942012000400003,Cetoprofeno,i
36,S0034-70942012000400003,150,o
36,S0034-70942012000400003,mg,o
36,S0034-70942012000400003,por,o
36,S0034-70942012000400003,via,o
36,S0034-70942012000400003,oral,o
36,S0034-70942012000400003,a,o
36,S0034-70942012000400003,cada,o
36,S0034-70942012000400003,12,o
36,S0034-70942012000400003,horas,o
36,S0034-70942012000400003,dos,o
36,S0034-70942012000400003,dias,o
36,S0034-70942012000400003,antes,o
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,cirugia,i
36,S0034-70942012000400003,y,o
36,S0034-70942012000400003,despues,o
36,S0034-70942012000400003,del,o
36,S0034-70942012000400003,procedimiento,i
36,S0034-70942012000400003,continuamos,o
36,S0034-70942012000400003,con,o
36,S0034-70942012000400003,el,o
36,S0034-70942012000400003,mismo,o
36,S0034-70942012000400003,medicamento,i
36,S0034-70942012000400003,por,o
36,S0034-70942012000400003,tres,o
36,S0034-70942012000400003,dias,o
36,S0034-70942012000400003,mas,o
36,S0034-70942012000400003,Por,o
36,S0034-70942012000400003,otra,o
36,S0034-70942012000400003,parte,o
36,S0034-70942012000400003,fue,o
36,S0034-70942012000400003,utilizado,o
36,S0034-70942012000400003,un,o
36,S0034-70942012000400003,control,o
36,S0034-70942012000400003,placebo,i
36,S0034-70942012000400003,via,o
36,S0034-70942012000400003,oral,o
36,S0034-70942012000400003,a,o
36,S0034-70942012000400003,cada,o
36,S0034-70942012000400003,12,o
36,S0034-70942012000400003,horas,o
36,S0034-70942012000400003,dos,o
36,S0034-70942012000400003,dias,o
36,S0034-70942012000400003,antes,o
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,cirugia,i
36,S0034-70942012000400003,y,o
36,S0034-70942012000400003,despues,o
36,S0034-70942012000400003,del,o
36,S0034-70942012000400003,procedimiento,i
36,S0034-70942012000400003,se,o
36,S0034-70942012000400003,continuo,o
36,S0034-70942012000400003,con,o
36,S0034-70942012000400003,el,o
36,S0034-70942012000400003,Cetoprofeno,i
36,S0034-70942012000400003,150,o
36,S0034-70942012000400003,mg,o
36,S0034-70942012000400003,a,o
36,S0034-70942012000400003,cada,o
36,S0034-70942012000400003,12,o
36,S0034-70942012000400003,horas,o
36,S0034-70942012000400003,por,o
36,S0034-70942012000400003,tres,o
36,S0034-70942012000400003,dias,o
36,S0034-70942012000400003,mas,o
36,S0034-70942012000400003,El,o
36,S0034-70942012000400003,dolor,i
36,S0034-70942012000400003,del,i
36,S0034-70942012000400003,postoperatorio,i
36,S0034-70942012000400003,se,o
36,S0034-70942012000400003,evaluo,o
36,S0034-70942012000400003,por,o
36,S0034-70942012000400003,medio,o
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,escala,i
36,S0034-70942012000400003,visual,i
36,S0034-70942012000400003,analogica,i
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,escala,o
36,S0034-70942012000400003,nominal,o
36,S0034-70942012000400003,y,o
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,cantidad,o
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,consumo,o
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,analgesicos,i
36,S0034-70942012000400003,de,o
36,S0034-70942012000400003,rescate,i
36,S0034-70942012000400003,RESULTADOS,o
36,S0034-70942012000400003,No,o
36,S0034-70942012000400003,se,o
36,S0034-70942012000400003,observaron,o
36,S0034-70942012000400003,diferencias,o
36,S0034-70942012000400003,estadisticamente,o
36,S0034-70942012000400003,significativas,o
36,S0034-70942012000400003,en,o
36,S0034-70942012000400003,el,o
36,S0034-70942012000400003,dolor,i
36,S0034-70942012000400003,postoperatorio,i
36,S0034-70942012000400003,entre,o
36,S0034-70942012000400003,el,o
36,S0034-70942012000400003,tratamiento,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,prevencion,i
36,S0034-70942012000400003,y,o
36,S0034-70942012000400003,el,o
36,S0034-70942012000400003,control,o
36,S0034-70942012000400003,CONCLUSIONES,o
36,S0034-70942012000400003,En,o
36,S0034-70942012000400003,este,o
36,S0034-70942012000400003,modelo,o
36,S0034-70942012000400003,experimental,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,analgesia,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,prevencion,i
36,S0034-70942012000400003,no,o
36,S0034-70942012000400003,fue,o
36,S0034-70942012000400003,eficaz,o
36,S0034-70942012000400003,en,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,reducion,o
36,S0034-70942012000400003,del,o
36,S0034-70942012000400003,dolor,i
36,S0034-70942012000400003,postoperatorio,i
36,S0034-70942012000400003,en,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,cirugia,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,extraccion,i
36,S0034-70942012000400003,de,i
36,S0034-70942012000400003,terceros,i
36,S0034-70942012000400003,molares,i
36,S0034-70942012000400003,incluidos,i
36,S0034-70942012000400003,en,o
36,S0034-70942012000400003,comparacion,o
36,S0034-70942012000400003,con,o
36,S0034-70942012000400003,la,o
36,S0034-70942012000400003,administracion,i
36,S0034-70942012000400003,postoperatoria,i
36,S0034-70942012000400003,del,o
36,S0034-70942012000400003,mismo,o
36,S0034-70942012000400003,medicamento,i
37,S0034-70942013000300003,Influencia,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,los,o
37,S0034-70942013000300003,hipnoticos,i
37,S0034-70942013000300003,en,o
37,S0034-70942013000300003,el,o
37,S0034-70942013000300003,bloqueo,i
37,S0034-70942013000300003,neuromuscular,i
37,S0034-70942013000300003,producido,o
37,S0034-70942013000300003,por,o
37,S0034-70942013000300003,el,o
37,S0034-70942013000300003,cisatracurio,i
37,S0034-70942013000300003,uso,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,la,o
37,S0034-70942013000300003,aceleromiografia,i
37,S0034-70942013000300003,JUSTIFICATIVA,o
37,S0034-70942013000300003,Y,o
37,S0034-70942013000300003,OBJETIVOS,o
37,S0034-70942013000300003,Los,o
37,S0034-70942013000300003,efectos,o
37,S0034-70942013000300003,farmacodinamicos,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,los,o
37,S0034-70942013000300003,bloqueantes,i
37,S0034-70942013000300003,neuromusculares,i
37,S0034-70942013000300003,BNM,i
37,S0034-70942013000300003,pueden,o
37,S0034-70942013000300003,estar,o
37,S0034-70942013000300003,influenciados,o
37,S0034-70942013000300003,por,o
37,S0034-70942013000300003,diferentes,o
37,S0034-70942013000300003,farmacos,i
37,S0034-70942013000300003,entre,o
37,S0034-70942013000300003,ellos,o
37,S0034-70942013000300003,los,o
37,S0034-70942013000300003,hipnoticos,i
37,S0034-70942013000300003,El,o
37,S0034-70942013000300003,objetivo,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,este,o
37,S0034-70942013000300003,estudio,o
37,S0034-70942013000300003,fue,o
37,S0034-70942013000300003,evaluar,o
37,S0034-70942013000300003,la,o
37,S0034-70942013000300003,influencia,o
37,S0034-70942013000300003,del,o
37,S0034-70942013000300003,propofol,i
37,S0034-70942013000300003,y,o
37,S0034-70942013000300003,del,o
37,S0034-70942013000300003,etomidato,i
37,S0034-70942013000300003,sobre,o
37,S0034-70942013000300003,el,o
37,S0034-70942013000300003,bloqueo,i
37,S0034-70942013000300003,neuromuscular,i
37,S0034-70942013000300003,producido,o
37,S0034-70942013000300003,por,o
37,S0034-70942013000300003,el,o
37,S0034-70942013000300003,cisatracurio,i
37,S0034-70942013000300003,METODO,o
37,S0034-70942013000300003,Se,o
37,S0034-70942013000300003,incluyeron,o
37,S0034-70942013000300003,en,o
37,S0034-70942013000300003,el,o
37,S0034-70942013000300003,estudio,o
37,S0034-70942013000300003,60,o
37,S0034-70942013000300003,pacientes,o
37,S0034-70942013000300003,con,o
37,S0034-70942013000300003,ASA,o
37,S0034-70942013000300003,I,o
37,S0034-70942013000300003,y,o
37,S0034-70942013000300003,II,o
37,S0034-70942013000300003,sometidos,o
37,S0034-70942013000300003,a,o
37,S0034-70942013000300003,cirugias,i
37,S0034-70942013000300003,electivas,o
37,S0034-70942013000300003,bajo,o
37,S0034-70942013000300003,anestesia,i
37,S0034-70942013000300003,general,i
37,S0034-70942013000300003,distribuidos,i
37,S0034-70942013000300003,aleatoriamente,i
37,S0034-70942013000300003,en,o
37,S0034-70942013000300003,dos,o
37,S0034-70942013000300003,grupos,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,acuerdo,o
37,S0034-70942013000300003,con,o
37,S0034-70942013000300003,el,o
37,S0034-70942013000300003,hipnotico,i
37,S0034-70942013000300003,usado,o
37,S0034-70942013000300003,GI,o
37,S0034-70942013000300003,propofol,i
37,S0034-70942013000300003,y,o
37,S0034-70942013000300003,GII,o
37,S0034-70942013000300003,etomidato,i
37,S0034-70942013000300003,Las,o
37,S0034-70942013000300003,pacientes,o
37,S0034-70942013000300003,recibieron,o
37,S0034-70942013000300003,midazolam,i
37,S0034-70942013000300003,01,o
37,S0034-70942013000300003,mgkg1,o
37,S0034-70942013000300003,por,o
37,S0034-70942013000300003,via,o
37,S0034-70942013000300003,muscular,o
37,S0034-70942013000300003,como,o
37,S0034-70942013000300003,medicacion,i
37,S0034-70942013000300003,preanestesica,i
37,S0034-70942013000300003,la,o
37,S0034-70942013000300003,induccion,i
37,S0034-70942013000300003,fue,o
37,S0034-70942013000300003,con,o
37,S0034-70942013000300003,propofol,i
37,S0034-70942013000300003,25,o
37,S0034-70942013000300003,mgkg1,o
37,S0034-70942013000300003,o,o
37,S0034-70942013000300003,etomidato,i
37,S0034-70942013000300003,03,o
37,S0034-70942013000300003,mgkg1,o
37,S0034-70942013000300003,precedido,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,fentanilo,i
37,S0034-70942013000300003,250,o
37,S0034-70942013000300003,µg,o
37,S0034-70942013000300003,y,o
37,S0034-70942013000300003,seguido,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,cisatracurio,i
37,S0034-70942013000300003,01,o
37,S0034-70942013000300003,mgkg1,o
37,S0034-70942013000300003,Los,o
37,S0034-70942013000300003,pacientes,o
37,S0034-70942013000300003,fueron,o
37,S0034-70942013000300003,ventilados,i
37,S0034-70942013000300003,con,i
37,S0034-70942013000300003,oxigeno,i
37,S0034-70942013000300003,al,o
37,S0034-70942013000300003,100,o
37,S0034-70942013000300003,hasta,o
37,S0034-70942013000300003,la,o
37,S0034-70942013000300003,obtencion,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,la,o
37,S0034-70942013000300003,reduccion,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,un,o
37,S0034-70942013000300003,95,o
37,S0034-70942013000300003,o,o
37,S0034-70942013000300003,mas,o
37,S0034-70942013000300003,en,o
37,S0034-70942013000300003,la,o
37,S0034-70942013000300003,amplitud,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,la,o
37,S0034-70942013000300003,respuesta,o
37,S0034-70942013000300003,del,o
37,S0034-70942013000300003,aductor,i
37,S0034-70942013000300003,del,i
37,S0034-70942013000300003,pulgar,i
37,S0034-70942013000300003,cuando,o
37,S0034-70942013000300003,se,o
37,S0034-70942013000300003,hizo,o
37,S0034-70942013000300003,la,o
37,S0034-70942013000300003,laringoscopia,i
37,S0034-70942013000300003,y,o
37,S0034-70942013000300003,la,o
37,S0034-70942013000300003,intubacion,i
37,S0034-70942013000300003,traqueal,i
37,S0034-70942013000300003,La,o
37,S0034-70942013000300003,funcion,i
37,S0034-70942013000300003,neuromuscular,i
37,S0034-70942013000300003,fue,i
37,S0034-70942013000300003,monitorizada,i
37,S0034-70942013000300003,con,o
37,S0034-70942013000300003,aceleromiografia,i
37,S0034-70942013000300003,Se,o
37,S0034-70942013000300003,evaluaron,o
37,S0034-70942013000300003,el,o
37,S0034-70942013000300003,inicio,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,accion,o
37,S0034-70942013000300003,del,o
37,S0034-70942013000300003,cisatracurio,i
37,S0034-70942013000300003,las,o
37,S0034-70942013000300003,condiciones,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,intubacion,i
37,S0034-70942013000300003,traqueal,i
37,S0034-70942013000300003,y,o
37,S0034-70942013000300003,las,o
37,S0034-70942013000300003,repercusiones,o
37,S0034-70942013000300003,hemodinamicas,o
37,S0034-70942013000300003,RESULTADOS,o
37,S0034-70942013000300003,Los,o
37,S0034-70942013000300003,tiempos,o
37,S0034-70942013000300003,promedios,o
37,S0034-70942013000300003,y,o
37,S0034-70942013000300003,las,o
37,S0034-70942013000300003,desviaciones,o
37,S0034-70942013000300003,estandar,o
37,S0034-70942013000300003,para,o
37,S0034-70942013000300003,el,o
37,S0034-70942013000300003,inicio,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,accion,o
37,S0034-70942013000300003,del,o
37,S0034-70942013000300003,cisatracurio,i
37,S0034-70942013000300003,fueron,o
37,S0034-70942013000300003,GI,o
37,S0034-70942013000300003,866,o
37,S0034-70942013000300003,143,o
37,S0034-70942013000300003,y,o
37,S0034-70942013000300003,GII,o
37,S0034-70942013000300003,1169,o
37,S0034-70942013000300003,116,o
37,S0034-70942013000300003,con,o
37,S0034-70942013000300003,una,o
37,S0034-70942013000300003,diferencia,o
37,S0034-70942013000300003,significativa,o
37,S0034-70942013000300003,p,o
37,S0034-70942013000300003,00001,o
37,S0034-70942013000300003,Las,o
37,S0034-70942013000300003,condiciones,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,intubacion,i
37,S0034-70942013000300003,traqueal,i
37,S0034-70942013000300003,fueron,o
37,S0034-70942013000300003,aceptables,o
37,S0034-70942013000300003,en,o
37,S0034-70942013000300003,un,o
37,S0034-70942013000300003,100,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,los,o
37,S0034-70942013000300003,pacientes,o
37,S0034-70942013000300003,del,o
37,S0034-70942013000300003,GI,o
37,S0034-70942013000300003,y,o
37,S0034-70942013000300003,en,o
37,S0034-70942013000300003,533,o
37,S0034-70942013000300003,en,o
37,S0034-70942013000300003,el,o
37,S0034-70942013000300003,GII,o
37,S0034-70942013000300003,p,o
37,S0034-70942013000300003,00001,o
37,S0034-70942013000300003,CONCLUSIONES,o
37,S0034-70942013000300003,La,o
37,S0034-70942013000300003,instalacion,o
37,S0034-70942013000300003,del,o
37,S0034-70942013000300003,bloqueo,i
37,S0034-70942013000300003,neuromuscular,i
37,S0034-70942013000300003,con,o
37,S0034-70942013000300003,el,o
37,S0034-70942013000300003,cisatracurio,i
37,S0034-70942013000300003,fue,o
37,S0034-70942013000300003,mas,o
37,S0034-70942013000300003,rapida,o
37,S0034-70942013000300003,y,o
37,S0034-70942013000300003,las,o
37,S0034-70942013000300003,condiciones,o
37,S0034-70942013000300003,de,o
37,S0034-70942013000300003,intubacion,i
37,S0034-70942013000300003,traqueal,i
37,S0034-70942013000300003,fueron,o
37,S0034-70942013000300003,mejores,o
37,S0034-70942013000300003,en,o
37,S0034-70942013000300003,los,o
37,S0034-70942013000300003,pacientes,o
37,S0034-70942013000300003,que,o
37,S0034-70942013000300003,recibieron,o
37,S0034-70942013000300003,propofol,i
37,S0034-70942013000300003,con,o
37,S0034-70942013000300003,relacion,o
37,S0034-70942013000300003,al,o
37,S0034-70942013000300003,grupo,o
37,S0034-70942013000300003,que,o
37,S0034-70942013000300003,recibio,o
37,S0034-70942013000300003,etomidato,i
37,S0034-70942013000300003,sin,o
37,S0034-70942013000300003,repercusiones,o
37,S0034-70942013000300003,hemodinamicas,o
38,S0034-70942013000300004,Estudio,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,la,o
38,S0034-70942013000300004,lidocaina,i
38,S0034-70942013000300004,al,o
38,S0034-70942013000300004,05,o
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,en,o
38,S0034-70942013000300004,combinacion,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,lidocaina,i
38,S0034-70942013000300004,al,o
38,S0034-70942013000300004,025,o
38,S0034-70942013000300004,con,o
38,S0034-70942013000300004,fentanilo,i
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,vecuronio,i
38,S0034-70942013000300004,en,o
38,S0034-70942013000300004,anestesia,i
38,S0034-70942013000300004,regional,i
38,S0034-70942013000300004,intravenosa,i
38,S0034-70942013000300004,para,o
38,S0034-70942013000300004,cirugias,i
38,S0034-70942013000300004,de,i
38,S0034-70942013000300004,miembros,i
38,S0034-70942013000300004,superiores,i
38,S0034-70942013000300004,JUSTIFICATIVA,o
38,S0034-70942013000300004,Y,o
38,S0034-70942013000300004,OBJETIVOS,o
38,S0034-70942013000300004,La,o
38,S0034-70942013000300004,anestesia,i
38,S0034-70942013000300004,regional,i
38,S0034-70942013000300004,intravenosa,i
38,S0034-70942013000300004,ARIV,i
38,S0034-70942013000300004,para,o
38,S0034-70942013000300004,cirugias,i
38,S0034-70942013000300004,de,i
38,S0034-70942013000300004,miembros,i
38,S0034-70942013000300004,superiores,i
38,S0034-70942013000300004,con,o
38,S0034-70942013000300004,la,o
38,S0034-70942013000300004,tradicional,o
38,S0034-70942013000300004,dosis,o
38,S0034-70942013000300004,alta,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,lidocaina,i
38,S0034-70942013000300004,puede,o
38,S0034-70942013000300004,conllevar,o
38,S0034-70942013000300004,a,o
38,S0034-70942013000300004,efectos,i
38,S0034-70942013000300004,colaterales,i
38,S0034-70942013000300004,que,o
38,S0034-70942013000300004,amenazan,o
38,S0034-70942013000300004,la,o
38,S0034-70942013000300004,vida,o
38,S0034-70942013000300004,Para,o
38,S0034-70942013000300004,evitar,o
38,S0034-70942013000300004,esos,o
38,S0034-70942013000300004,efectos,i
38,S0034-70942013000300004,colaterales,i
38,S0034-70942013000300004,potencialmente,o
38,S0034-70942013000300004,amenazadores,o
38,S0034-70942013000300004,muchas,o
38,S0034-70942013000300004,tecnicas,o
38,S0034-70942013000300004,modificadas,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,ARIV,i
38,S0034-70942013000300004,fueron,o
38,S0034-70942013000300004,experimentadas,o
38,S0034-70942013000300004,con,o
38,S0034-70942013000300004,el,o
38,S0034-70942013000300004,uso,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,una,o
38,S0034-70942013000300004,dosis,o
38,S0034-70942013000300004,baja,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,lidocaina,i
38,S0034-70942013000300004,relajante,i
38,S0034-70942013000300004,muscular,i
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,opioide,i
38,S0034-70942013000300004,MATERIALES,o
38,S0034-70942013000300004,Y,o
38,S0034-70942013000300004,METODOS,o
38,S0034-70942013000300004,El,o
38,S0034-70942013000300004,presente,o
38,S0034-70942013000300004,estudio,o
38,S0034-70942013000300004,se,o
38,S0034-70942013000300004,hizo,o
38,S0034-70942013000300004,con,o
38,S0034-70942013000300004,60,o
38,S0034-70942013000300004,pacientes,o
38,S0034-70942013000300004,no,o
38,S0034-70942013000300004,medicados,i
38,S0034-70942013000300004,previamente,o
38,S0034-70942013000300004,con,o
38,S0034-70942013000300004,clasificacion,o
38,S0034-70942013000300004,ASA,o
38,S0034-70942013000300004,12,o
38,S0034-70942013000300004,para,o
38,S0034-70942013000300004,comparar,o
38,S0034-70942013000300004,las,o
38,S0034-70942013000300004,caracteristicas,o
38,S0034-70942013000300004,sensoriales,o
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,motoras,o
38,S0034-70942013000300004,los,o
38,S0034-70942013000300004,parametros,o
38,S0034-70942013000300004,cardiorrespiratorios,o
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,los,o
38,S0034-70942013000300004,efectos,i
38,S0034-70942013000300004,colaterales,i
38,S0034-70942013000300004,durante,o
38,S0034-70942013000300004,el,o
38,S0034-70942013000300004,periodo,o
38,S0034-70942013000300004,intraoperatorio,o
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,deflacion,i
38,S0034-70942013000300004,pos,i
38,S0034-70942013000300004,torniquete,i
38,S0034-70942013000300004,entre,o
38,S0034-70942013000300004,los,o
38,S0034-70942013000300004,pacientes,o
38,S0034-70942013000300004,que,o
38,S0034-70942013000300004,recibieron,o
38,S0034-70942013000300004,40,o
38,S0034-70942013000300004,mL,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,lidocaina,i
38,S0034-70942013000300004,al,o
38,S0034-70942013000300004,05,o
38,S0034-70942013000300004,sola,o
38,S0034-70942013000300004,n,o
38,S0034-70942013000300004,30,o
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,los,o
38,S0034-70942013000300004,que,o
38,S0034-70942013000300004,recibieron,o
38,S0034-70942013000300004,una,o
38,S0034-70942013000300004,combinacion,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,40,o
38,S0034-70942013000300004,mL,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,lidocaina,i
38,S0034-70942013000300004,al,o
38,S0034-70942013000300004,025,o
38,S0034-70942013000300004,con,o
38,S0034-70942013000300004,005,o
38,S0034-70942013000300004,mg,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,fentanilo,i
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,05,o
38,S0034-70942013000300004,mg,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,vecuronio,i
38,S0034-70942013000300004,n,o
38,S0034-70942013000300004,30,o
38,S0034-70942013000300004,en,o
38,S0034-70942013000300004,ARIV,i
38,S0034-70942013000300004,para,o
38,S0034-70942013000300004,cirugias,i
38,S0034-70942013000300004,ortopedicas,i
38,S0034-70942013000300004,de,i
38,S0034-70942013000300004,miembros,i
38,S0034-70942013000300004,superiores,i
38,S0034-70942013000300004,Los,o
38,S0034-70942013000300004,resultados,o
38,S0034-70942013000300004,se,o
38,S0034-70942013000300004,analizaron,o
38,S0034-70942013000300004,usando,o
38,S0034-70942013000300004,el,o
38,S0034-70942013000300004,teste,o
38,S0034-70942013000300004,t,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,Student,o
38,S0034-70942013000300004,pareado,o
38,S0034-70942013000300004,para,o
38,S0034-70942013000300004,identificar,o
38,S0034-70942013000300004,la,o
38,S0034-70942013000300004,significancia,o
38,S0034-70942013000300004,estadistica,o
38,S0034-70942013000300004,RESULTADO,o
38,S0034-70942013000300004,La,o
38,S0034-70942013000300004,diferencia,o
38,S0034-70942013000300004,entre,o
38,S0034-70942013000300004,los,o
38,S0034-70942013000300004,dos,o
38,S0034-70942013000300004,grupos,o
38,S0034-70942013000300004,con,o
38,S0034-70942013000300004,relacion,o
38,S0034-70942013000300004,al,o
38,S0034-70942013000300004,tiempo,o
38,S0034-70942013000300004,promedio,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,inicio,o
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,completo,o
38,S0034-70942013000300004,bloqueo,o
38,S0034-70942013000300004,sensitivo,o
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,motor,o
38,S0034-70942013000300004,fue,o
38,S0034-70942013000300004,estadisticamente,o
38,S0034-70942013000300004,significativo,o
38,S0034-70942013000300004,Sin,o
38,S0034-70942013000300004,embargo,o
38,S0034-70942013000300004,hubo,o
38,S0034-70942013000300004,un,o
38,S0034-70942013000300004,completo,o
38,S0034-70942013000300004,bloqueo,o
38,S0034-70942013000300004,sensitivo,o
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,motor,o
38,S0034-70942013000300004,en,o
38,S0034-70942013000300004,ambos,o
38,S0034-70942013000300004,grupos,o
38,S0034-70942013000300004,15,o
38,S0034-70942013000300004,minutos,o
38,S0034-70942013000300004,despues,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,la,o
38,S0034-70942013000300004,inyeccion,i
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,la,o
38,S0034-70942013000300004,solucion,i
38,S0034-70942013000300004,anestesica,i
38,S0034-70942013000300004,CONCLUSIONES,o
38,S0034-70942013000300004,Aunque,o
38,S0034-70942013000300004,la,o
38,S0034-70942013000300004,pequeña,o
38,S0034-70942013000300004,demora,o
38,S0034-70942013000300004,observada,o
38,S0034-70942013000300004,al,o
38,S0034-70942013000300004,inicio,o
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,durante,o
38,S0034-70942013000300004,la,o
38,S0034-70942013000300004,obtencion,o
38,S0034-70942013000300004,completa,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,los,o
38,S0034-70942013000300004,bloqueos,o
38,S0034-70942013000300004,sensitivo,o
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,motor,o
38,S0034-70942013000300004,teoricamente,o
38,S0034-70942013000300004,pueda,o
38,S0034-70942013000300004,atrasar,o
38,S0034-70942013000300004,el,o
38,S0034-70942013000300004,inicio,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,la,o
38,S0034-70942013000300004,operacion,i
38,S0034-70942013000300004,entre,o
38,S0034-70942013000300004,10,o
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,15,o
38,S0034-70942013000300004,minutos,o
38,S0034-70942013000300004,clinicamente,o
38,S0034-70942013000300004,ese,o
38,S0034-70942013000300004,tiempo,o
38,S0034-70942013000300004,se,o
38,S0034-70942013000300004,gastaria,o
38,S0034-70942013000300004,en,o
38,S0034-70942013000300004,la,o
38,S0034-70942013000300004,preparacion,o
38,S0034-70942013000300004,del,o
38,S0034-70942013000300004,campo,o
38,S0034-70942013000300004,quirurgico,o
38,S0034-70942013000300004,Por,o
38,S0034-70942013000300004,tanto,o
38,S0034-70942013000300004,esa,o
38,S0034-70942013000300004,combinacion,o
38,S0034-70942013000300004,puede,o
38,S0034-70942013000300004,ser,o
38,S0034-70942013000300004,usada,o
38,S0034-70942013000300004,con,o
38,S0034-70942013000300004,seguridad,o
38,S0034-70942013000300004,y,o
38,S0034-70942013000300004,eficacia,o
38,S0034-70942013000300004,en,o
38,S0034-70942013000300004,la,o
38,S0034-70942013000300004,anestesia,i
38,S0034-70942013000300004,regional,i
38,S0034-70942013000300004,intravenosa,i
38,S0034-70942013000300004,para,o
38,S0034-70942013000300004,las,o
38,S0034-70942013000300004,cirugias,i
38,S0034-70942013000300004,ortopedicas,i
38,S0034-70942013000300004,de,i
38,S0034-70942013000300004,miembros,i
38,S0034-70942013000300004,superiores,i
38,S0034-70942013000300004,con,o
38,S0034-70942013000300004,menor,o
38,S0034-70942013000300004,posibilidad,o
38,S0034-70942013000300004,de,o
38,S0034-70942013000300004,toxicidad,i
38,S0034-70942013000300004,anestesica,i
38,S0034-70942013000300004,local,i
39,S0034-70942013000300005,Efecto,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,administracion,i
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,solucion,i
39,S0034-70942013000300005,salina,i
39,S0034-70942013000300005,normal,i
39,S0034-70942013000300005,en,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,estabilidad,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,circulacion,o
39,S0034-70942013000300005,durante,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,induccion,i
39,S0034-70942013000300005,de,i
39,S0034-70942013000300005,anestesia,i
39,S0034-70942013000300005,general,i
39,S0034-70942013000300005,con,o
39,S0034-70942013000300005,propofol,i
39,S0034-70942013000300005,en,o
39,S0034-70942013000300005,estudio,i
39,S0034-70942013000300005,aleatorio,i
39,S0034-70942013000300005,y,i
39,S0034-70942013000300005,controlado,i
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,procedimientos,i
39,S0034-70942013000300005,ginecologicos,i
39,S0034-70942013000300005,JUSTIFICATIVA,o
39,S0034-70942013000300005,Y,o
39,S0034-70942013000300005,OBJETIVO,o
39,S0034-70942013000300005,Comparar,o
39,S0034-70942013000300005,el,o
39,S0034-70942013000300005,efecto,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,administracion,i
39,S0034-70942013000300005,profilactica,i
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,solucion,i
39,S0034-70942013000300005,salina,i
39,S0034-70942013000300005,normal,i
39,S0034-70942013000300005,con,o
39,S0034-70942013000300005,el,o
39,S0034-70942013000300005,efecto,o
39,S0034-70942013000300005,hipotensor,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,propofol,i
39,S0034-70942013000300005,en,o
39,S0034-70942013000300005,pacientes,o
39,S0034-70942013000300005,del,o
39,S0034-70942013000300005,sexo,o
39,S0034-70942013000300005,femenino,o
39,S0034-70942013000300005,programadas,o
39,S0034-70942013000300005,para,o
39,S0034-70942013000300005,procedimientos,i
39,S0034-70942013000300005,ginecologicos,i
39,S0034-70942013000300005,METODO,o
39,S0034-70942013000300005,Sesenta,o
39,S0034-70942013000300005,y,o
39,S0034-70942013000300005,nueve,o
39,S0034-70942013000300005,pacientes,o
39,S0034-70942013000300005,con,o
39,S0034-70942013000300005,ASA,o
39,S0034-70942013000300005,III,o
39,S0034-70942013000300005,fueron,o
39,S0034-70942013000300005,ubicados,i
39,S0034-70942013000300005,aleatoriamente,i
39,S0034-70942013000300005,en,o
39,S0034-70942013000300005,dos,o
39,S0034-70942013000300005,grupos,o
39,S0034-70942013000300005,El,o
39,S0034-70942013000300005,Grupo,o
39,S0034-70942013000300005,1,o
39,S0034-70942013000300005,recibio,o
39,S0034-70942013000300005,5,o
39,S0034-70942013000300005,mLkg1,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,solucion,i
39,S0034-70942013000300005,salina,i
39,S0034-70942013000300005,al,o
39,S0034-70942013000300005,09,o
39,S0034-70942013000300005,10,o
39,S0034-70942013000300005,minutos,o
39,S0034-70942013000300005,antes,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,induccion,i
39,S0034-70942013000300005,y,o
39,S0034-70942013000300005,el,o
39,S0034-70942013000300005,Grupo,o
39,S0034-70942013000300005,2,o
39,S0034-70942013000300005,no,o
39,S0034-70942013000300005,recibio,o
39,S0034-70942013000300005,nada,o
39,S0034-70942013000300005,La,o
39,S0034-70942013000300005,anestesia,i
39,S0034-70942013000300005,fue,o
39,S0034-70942013000300005,inducida,i
39,S0034-70942013000300005,con,o
39,S0034-70942013000300005,propofol,i
39,S0034-70942013000300005,y,o
39,S0034-70942013000300005,fentanilo,i
39,S0034-70942013000300005,y,o
39,S0034-70942013000300005,despues,o
39,S0034-70942013000300005,se,o
39,S0034-70942013000300005,mantuvo,o
39,S0034-70942013000300005,con,o
39,S0034-70942013000300005,propofol,i
39,S0034-70942013000300005,y,o
39,S0034-70942013000300005,remifentanilo,i
39,S0034-70942013000300005,Las,o
39,S0034-70942013000300005,variables,i
39,S0034-70942013000300005,hemodinamicas,i
39,S0034-70942013000300005,fueron,i
39,S0034-70942013000300005,mensuradas,i
39,S0034-70942013000300005,antes,o
39,S0034-70942013000300005,y,o
39,S0034-70942013000300005,despues,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,induccion,i
39,S0034-70942013000300005,de,i
39,S0034-70942013000300005,la,i
39,S0034-70942013000300005,anestesia,i
39,S0034-70942013000300005,general,i
39,S0034-70942013000300005,RESULTADOS,o
39,S0034-70942013000300005,Despues,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,induccion,i
39,S0034-70942013000300005,ambos,o
39,S0034-70942013000300005,grupos,o
39,S0034-70942013000300005,presentaron,o
39,S0034-70942013000300005,una,o
39,S0034-70942013000300005,caida,o
39,S0034-70942013000300005,significativa,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,presion,i
39,S0034-70942013000300005,arterial,i
39,S0034-70942013000300005,promedio,i
39,S0034-70942013000300005,p,o
39,S0034-70942013000300005,0001,o
39,S0034-70942013000300005,y,o
39,S0034-70942013000300005,una,o
39,S0034-70942013000300005,reduccion,o
39,S0034-70942013000300005,tambien,o
39,S0034-70942013000300005,significativa,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,frecuencia,i
39,S0034-70942013000300005,cardiaca,i
39,S0034-70942013000300005,p,o
39,S0034-70942013000300005,002,o
39,S0034-70942013000300005,en,o
39,S0034-70942013000300005,el,o
39,S0034-70942013000300005,grupo,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,estudio,o
39,S0034-70942013000300005,y,o
39,S0034-70942013000300005,p,o
39,S0034-70942013000300005,0001,o
39,S0034-70942013000300005,en,o
39,S0034-70942013000300005,el,o
39,S0034-70942013000300005,grupo,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,control,o
39,S0034-70942013000300005,La,o
39,S0034-70942013000300005,presion,i
39,S0034-70942013000300005,arterial,i
39,S0034-70942013000300005,promedio,i
39,S0034-70942013000300005,pre,o
39,S0034-70942013000300005,induccion,i
39,S0034-70942013000300005,tuvo,o
39,S0034-70942013000300005,una,o
39,S0034-70942013000300005,caida,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,mas,o
39,S0034-70942013000300005,del,o
39,S0034-70942013000300005,25,o
39,S0034-70942013000300005,en,o
39,S0034-70942013000300005,35,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,los,o
39,S0034-70942013000300005,pacientes,o
39,S0034-70942013000300005,del,o
39,S0034-70942013000300005,grupo,o
39,S0034-70942013000300005,control,o
39,S0034-70942013000300005,en,o
39,S0034-70942013000300005,comparacion,o
39,S0034-70942013000300005,con,o
39,S0034-70942013000300005,solamente,o
39,S0034-70942013000300005,un,o
39,S0034-70942013000300005,17,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,los,o
39,S0034-70942013000300005,pacientes,o
39,S0034-70942013000300005,que,o
39,S0034-70942013000300005,recibieron,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,solucion,i
39,S0034-70942013000300005,salina,i
39,S0034-70942013000300005,p,o
39,S0034-70942013000300005,004,o
39,S0034-70942013000300005,CONCLUSION,o
39,S0034-70942013000300005,La,o
39,S0034-70942013000300005,administracion,i
39,S0034-70942013000300005,profilactica,i
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,solucion,i
39,S0034-70942013000300005,salina,i
39,S0034-70942013000300005,normal,i
39,S0034-70942013000300005,puede,o
39,S0034-70942013000300005,disminuir,o
39,S0034-70942013000300005,el,o
39,S0034-70942013000300005,porcentaje,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,pacientes,o
39,S0034-70942013000300005,que,o
39,S0034-70942013000300005,presentan,o
39,S0034-70942013000300005,una,o
39,S0034-70942013000300005,caida,o
39,S0034-70942013000300005,significativa,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,presion,i
39,S0034-70942013000300005,arterial,i
39,S0034-70942013000300005,despues,o
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,induccion,i
39,S0034-70942013000300005,de,o
39,S0034-70942013000300005,propofol,i
39,S0034-70942013000300005,en,o
39,S0034-70942013000300005,la,o
39,S0034-70942013000300005,anestesia,i
39,S0034-70942013000300005,general,i
40,S0034-70942013000300008,Aplicacion,i
40,S0034-70942013000300008,del,i
40,S0034-70942013000300008,monitor,i
40,S0034-70942013000300008,Narcotrend,o
40,S0034-70942013000300008,para,o
40,S0034-70942013000300008,evaluar,i
40,S0034-70942013000300008,la,i
40,S0034-70942013000300008,profundidad,i
40,S0034-70942013000300008,de,i
40,S0034-70942013000300008,la,i
40,S0034-70942013000300008,anestesia,i
40,S0034-70942013000300008,en,o
40,S0034-70942013000300008,niños,o
40,S0034-70942013000300008,sometidos,o
40,S0034-70942013000300008,a,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,cirugia,i
40,S0034-70942013000300008,cardiaca,i
40,S0034-70942013000300008,estudio,i
40,S0034-70942013000300008,prospectivo,i
40,S0034-70942013000300008,y,i
40,S0034-70942013000300008,controlado,i
40,S0034-70942013000300008,JUSTIFICATIVA,o
40,S0034-70942013000300008,Y,o
40,S0034-70942013000300008,OBJETIVOS,o
40,S0034-70942013000300008,Investigar,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,eficacia,o
40,S0034-70942013000300008,clinica,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,seguridad,o
40,S0034-70942013000300008,y,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,viabilidad,o
40,S0034-70942013000300008,del,o
40,S0034-70942013000300008,monitor,o
40,S0034-70942013000300008,Narcotrend,o
40,S0034-70942013000300008,para,o
40,S0034-70942013000300008,evaluar,i
40,S0034-70942013000300008,la,i
40,S0034-70942013000300008,profundidad,i
40,S0034-70942013000300008,de,i
40,S0034-70942013000300008,la,i
40,S0034-70942013000300008,anestesia,i
40,S0034-70942013000300008,en,o
40,S0034-70942013000300008,niños,o
40,S0034-70942013000300008,con,o
40,S0034-70942013000300008,enfermedad,i
40,S0034-70942013000300008,cardiaca,i
40,S0034-70942013000300008,congenita,i
40,S0034-70942013000300008,ECC,i
40,S0034-70942013000300008,sometidos,o
40,S0034-70942013000300008,a,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,cirugia,i
40,S0034-70942013000300008,cardiaca,i
40,S0034-70942013000300008,METODOS,o
40,S0034-70942013000300008,Un,o
40,S0034-70942013000300008,total,o
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,80,o
40,S0034-70942013000300008,niños,o
40,S0034-70942013000300008,sometidos,o
40,S0034-70942013000300008,a,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,anestesia,i
40,S0034-70942013000300008,general,i
40,S0034-70942013000300008,en,o
40,S0034-70942013000300008,cirugia,i
40,S0034-70942013000300008,selectiva,o
40,S0034-70942013000300008,fueron,o
40,S0034-70942013000300008,seleccionados,i
40,S0034-70942013000300008,aleatoriamente,i
40,S0034-70942013000300008,Los,o
40,S0034-70942013000300008,niños,o
40,S0034-70942013000300008,fueron,o
40,S0034-70942013000300008,divididos,i
40,S0034-70942013000300008,en,i
40,S0034-70942013000300008,dos,i
40,S0034-70942013000300008,grupos,i
40,S0034-70942013000300008,de,i
40,S0034-70942013000300008,forma,i
40,S0034-70942013000300008,aleatoria,i
40,S0034-70942013000300008,N,o
40,S0034-70942013000300008,40,o
40,S0034-70942013000300008,por,o
40,S0034-70942013000300008,grupo,o
40,S0034-70942013000300008,En,o
40,S0034-70942013000300008,el,o
40,S0034-70942013000300008,grupo,o
40,S0034-70942013000300008,Narcotrend,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,profundidad,o
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,anestesia,i
40,S0034-70942013000300008,se,i
40,S0034-70942013000300008,monitorizo,i
40,S0034-70942013000300008,con,o
40,S0034-70942013000300008,el,o
40,S0034-70942013000300008,monitor,o
40,S0034-70942013000300008,Narcotrend,o
40,S0034-70942013000300008,En,o
40,S0034-70942013000300008,el,o
40,S0034-70942013000300008,grupo,o
40,S0034-70942013000300008,estandar,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,profundidad,o
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,anestesia,i
40,S0034-70942013000300008,fue,i
40,S0034-70942013000300008,controlada,i
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,acuerdo,o
40,S0034-70942013000300008,con,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,experiencia,o
40,S0034-70942013000300008,Se,o
40,S0034-70942013000300008,midieron,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,presion,i
40,S0034-70942013000300008,arterial,i
40,S0034-70942013000300008,promedio,i
40,S0034-70942013000300008,PAP,i
40,S0034-70942013000300008,y,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,frecuencia,i
40,S0034-70942013000300008,cardiaca,i
40,S0034-70942013000300008,FC,i
40,S0034-70942013000300008,Fueron,o
40,S0034-70942013000300008,registrados,o
40,S0034-70942013000300008,tambien,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,dosis,o
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,fentanilo,i
40,S0034-70942013000300008,y,o
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,relajante,i
40,S0034-70942013000300008,muscular,i
40,S0034-70942013000300008,junto,o
40,S0034-70942013000300008,con,o
40,S0034-70942013000300008,los,o
40,S0034-70942013000300008,tiempos,o
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,recuperacion,o
40,S0034-70942013000300008,y,o
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,desentubacion,i
40,S0034-70942013000300008,RESULTADOS,o
40,S0034-70942013000300008,En,o
40,S0034-70942013000300008,los,o
40,S0034-70942013000300008,dos,o
40,S0034-70942013000300008,grupos,o
40,S0034-70942013000300008,los,o
40,S0034-70942013000300008,signos,o
40,S0034-70942013000300008,vitales,o
40,S0034-70942013000300008,se,o
40,S0034-70942013000300008,mantuvieron,o
40,S0034-70942013000300008,estables,o
40,S0034-70942013000300008,durante,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,cirugia,i
40,S0034-70942013000300008,En,o
40,S0034-70942013000300008,el,o
40,S0034-70942013000300008,grupo,o
40,S0034-70942013000300008,Narcotrend,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,PAP,i
40,S0034-70942013000300008,y,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,FC,i
40,S0034-70942013000300008,fueron,o
40,S0034-70942013000300008,mas,o
40,S0034-70942013000300008,estables,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,dosis,o
40,S0034-70942013000300008,total,o
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,fentanilo,i
40,S0034-70942013000300008,y,o
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,relajante,i
40,S0034-70942013000300008,muscular,i
40,S0034-70942013000300008,significativamente,o
40,S0034-70942013000300008,menor,o
40,S0034-70942013000300008,y,o
40,S0034-70942013000300008,los,o
40,S0034-70942013000300008,tiempos,o
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,recuperacion,o
40,S0034-70942013000300008,y,o
40,S0034-70942013000300008,desentubacion,i
40,S0034-70942013000300008,ostensiblemente,o
40,S0034-70942013000300008,mas,o
40,S0034-70942013000300008,reducidos,o
40,S0034-70942013000300008,en,o
40,S0034-70942013000300008,comparacion,o
40,S0034-70942013000300008,con,o
40,S0034-70942013000300008,el,o
40,S0034-70942013000300008,grupo,o
40,S0034-70942013000300008,estandar,o
40,S0034-70942013000300008,CONCLUSIONES,o
40,S0034-70942013000300008,La,o
40,S0034-70942013000300008,aplicacion,i
40,S0034-70942013000300008,del,i
40,S0034-70942013000300008,monitor,i
40,S0034-70942013000300008,Narcotrend,o
40,S0034-70942013000300008,para,o
40,S0034-70942013000300008,medir,i
40,S0034-70942013000300008,la,i
40,S0034-70942013000300008,profundidad,i
40,S0034-70942013000300008,de,i
40,S0034-70942013000300008,la,i
40,S0034-70942013000300008,anestesia,i
40,S0034-70942013000300008,fue,o
40,S0034-70942013000300008,util,o
40,S0034-70942013000300008,en,o
40,S0034-70942013000300008,el,o
40,S0034-70942013000300008,control,i
40,S0034-70942013000300008,de,i
40,S0034-70942013000300008,la,i
40,S0034-70942013000300008,profundidad,i
40,S0034-70942013000300008,de,i
40,S0034-70942013000300008,la,i
40,S0034-70942013000300008,anestesia,i
40,S0034-70942013000300008,en,o
40,S0034-70942013000300008,niños,o
40,S0034-70942013000300008,con,o
40,S0034-70942013000300008,ECC,i
40,S0034-70942013000300008,que,o
40,S0034-70942013000300008,reciben,o
40,S0034-70942013000300008,anestesia,i
40,S0034-70942013000300008,intravenosa,i
40,S0034-70942013000300008,total,i
40,S0034-70942013000300008,en,o
40,S0034-70942013000300008,donde,o
40,S0034-70942013000300008,una,o
40,S0034-70942013000300008,pequeña,o
40,S0034-70942013000300008,cantidad,o
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,narcoticos,i
40,S0034-70942013000300008,puede,o
40,S0034-70942013000300008,alcanzar,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,anestesia,i
40,S0034-70942013000300008,ideal,o
40,S0034-70942013000300008,Ademas,o
40,S0034-70942013000300008,los,o
40,S0034-70942013000300008,tiempos,o
40,S0034-70942013000300008,de,o
40,S0034-70942013000300008,recuperacion,o
40,S0034-70942013000300008,y,o
40,S0034-70942013000300008,desentubacion,i
40,S0034-70942013000300008,fueron,o
40,S0034-70942013000300008,menores,o
40,S0034-70942013000300008,y,o
40,S0034-70942013000300008,el,o
40,S0034-70942013000300008,efecto,i
40,S0034-70942013000300008,secundario,i
40,S0034-70942013000300008,como,o
40,S0034-70942013000300008,la,o
40,S0034-70942013000300008,sensibilizacion,i
40,S0034-70942013000300008,intraoperatoria,o
40,S0034-70942013000300008,pudo,o
40,S0034-70942013000300008,ser,o
40,S0034-70942013000300008,evitado,o
41,S0034-70942013000400001,Comparacion,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,lornoxicam,i
41,S0034-70942013000400001,y,o
41,S0034-70942013000400001,fentanilo,i
41,S0034-70942013000400001,adicionados,o
41,S0034-70942013000400001,a,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,anestesia,i
41,S0034-70942013000400001,regional,i
41,S0034-70942013000400001,intravenosa,i
41,S0034-70942013000400001,JUSTIFICATIVA,o
41,S0034-70942013000400001,Y,o
41,S0034-70942013000400001,OBJETIVO,o
41,S0034-70942013000400001,Comparar,o
41,S0034-70942013000400001,los,o
41,S0034-70942013000400001,efectos,o
41,S0034-70942013000400001,analgesicos,i
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,los,o
41,S0034-70942013000400001,periodos,o
41,S0034-70942013000400001,intra,o
41,S0034-70942013000400001,y,o
41,S0034-70942013000400001,postoperatorio,o
41,S0034-70942013000400001,del,o
41,S0034-70942013000400001,lornoxicam,i
41,S0034-70942013000400001,y,o
41,S0034-70942013000400001,del,o
41,S0034-70942013000400001,fentanilo,i
41,S0034-70942013000400001,adicionados,o
41,S0034-70942013000400001,a,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,para,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,anestesia,i
41,S0034-70942013000400001,regional,i
41,S0034-70942013000400001,intravenosa,i
41,S0034-70942013000400001,ARIV,i
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,un,o
41,S0034-70942013000400001,grupo,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,pacientes,o
41,S0034-70942013000400001,sometidos,o
41,S0034-70942013000400001,a,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,cirugia,i
41,S0034-70942013000400001,de,i
41,S0034-70942013000400001,mano,i
41,S0034-70942013000400001,METODOS,o
41,S0034-70942013000400001,Estudio,o
41,S0034-70942013000400001,aleatorio,o
41,S0034-70942013000400001,doble,o
41,S0034-70942013000400001,ciego,o
41,S0034-70942013000400001,y,o
41,S0034-70942013000400001,controlado,o
41,S0034-70942013000400001,Fueron,o
41,S0034-70942013000400001,incluidos,o
41,S0034-70942013000400001,y,o
41,S0034-70942013000400001,aleatorizados,i
41,S0034-70942013000400001,por,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,equipo,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,investigacion,o
41,S0034-70942013000400001,45,o
41,S0034-70942013000400001,pacientes,o
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,tres,o
41,S0034-70942013000400001,grupos,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,Grupo,o
41,S0034-70942013000400001,I,o
41,S0034-70942013000400001,recibio,o
41,S0034-70942013000400001,3,o
41,S0034-70942013000400001,mgkg1,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,al,o
41,S0034-70942013000400001,2,o
41,S0034-70942013000400001,40,o
41,S0034-70942013000400001,mL,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,Grupo,o
41,S0034-70942013000400001,II,o
41,S0034-70942013000400001,recibio,o
41,S0034-70942013000400001,3,o
41,S0034-70942013000400001,mgkg1,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,38,o
41,S0034-70942013000400001,mL,o
41,S0034-70942013000400001,2,o
41,S0034-70942013000400001,mL,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,lornoxicam,i
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,Grupo,o
41,S0034-70942013000400001,III,o
41,S0034-70942013000400001,recibio,o
41,S0034-70942013000400001,3,o
41,S0034-70942013000400001,mgkg1,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,38,o
41,S0034-70942013000400001,mL,o
41,S0034-70942013000400001,2,o
41,S0034-70942013000400001,mL,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,fentanilo,i
41,S0034-70942013000400001,El,o
41,S0034-70942013000400001,resultado,o
41,S0034-70942013000400001,primario,o
41,S0034-70942013000400001,evaluado,o
41,S0034-70942013000400001,fue,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,tiempo,o
41,S0034-70942013000400001,hasta,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,primera,o
41,S0034-70942013000400001,necesidad,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,analgesicos,i
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,postoperatorio,o
41,S0034-70942013000400001,RESULTADOS,o
41,S0034-70942013000400001,El,o
41,S0034-70942013000400001,Lornoxicam,i
41,S0034-70942013000400001,adicionado,o
41,S0034-70942013000400001,a,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,ARIV,i
41,S0034-70942013000400001,aumento,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,tiempo,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,recuperacion,o
41,S0034-70942013000400001,del,o
41,S0034-70942013000400001,bloqueo,o
41,S0034-70942013000400001,sensorial,o
41,S0034-70942013000400001,sin,o
41,S0034-70942013000400001,aumentar,o
41,S0034-70942013000400001,los,o
41,S0034-70942013000400001,efectos,o
41,S0034-70942013000400001,colaterales,o
41,S0034-70942013000400001,y,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,tiempo,o
41,S0034-70942013000400001,hasta,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,primera,o
41,S0034-70942013000400001,necesidad,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,analgesicos,i
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,postoperatorio,o
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,comparacion,o
41,S0034-70942013000400001,con,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,sola,o
41,S0034-70942013000400001,p,o
41,S0034-70942013000400001,0001,o
41,S0034-70942013000400001,p,o
41,S0034-70942013000400001,0001,o
41,S0034-70942013000400001,respectivamente,o
41,S0034-70942013000400001,y,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,fentanilo,i
41,S0034-70942013000400001,adicionado,o
41,S0034-70942013000400001,a,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,p,o
41,S0034-70942013000400001,0001,o
41,S0034-70942013000400001,p,o
41,S0034-70942013000400001,0001,o
41,S0034-70942013000400001,respectivamente,o
41,S0034-70942013000400001,Ademas,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,eso,o
41,S0034-70942013000400001,tambien,o
41,S0034-70942013000400001,descubrimos,o
41,S0034-70942013000400001,que,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,fentanilo,i
41,S0034-70942013000400001,redujo,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,dolor,i
41,S0034-70942013000400001,ocasionado,o
41,S0034-70942013000400001,por,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,torniquete,o
41,S0034-70942013000400001,p,o
41,S0034-70942013000400001,001,o
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,comparacion,o
41,S0034-70942013000400001,con,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,pero,o
41,S0034-70942013000400001,mostro,o
41,S0034-70942013000400001,un,o
41,S0034-70942013000400001,efecto,o
41,S0034-70942013000400001,analgesico,o
41,S0034-70942013000400001,parecido,o
41,S0034-70942013000400001,con,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,del,o
41,S0034-70942013000400001,lornoxicam,i
41,S0034-70942013000400001,p,o
41,S0034-70942013000400001,005,o
41,S0034-70942013000400001,aunque,o
41,S0034-70942013000400001,las,o
41,S0034-70942013000400001,puntuaciones,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,escala,i
41,S0034-70942013000400001,visual,i
41,S0034-70942013000400001,analogica,i
41,S0034-70942013000400001,EVA,i
41,S0034-70942013000400001,relacionadas,o
41,S0034-70942013000400001,con,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,efecto,o
41,S0034-70942013000400001,ocasionado,o
41,S0034-70942013000400001,por,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,torniquete,o
41,S0034-70942013000400001,hayan,o
41,S0034-70942013000400001,sido,o
41,S0034-70942013000400001,menores,o
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,grupo,o
41,S0034-70942013000400001,fentanilo,i
41,S0034-70942013000400001,El,o
41,S0034-70942013000400001,Lornoxicam,i
41,S0034-70942013000400001,adicionado,o
41,S0034-70942013000400001,a,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,ARIV,i
41,S0034-70942013000400001,no,o
41,S0034-70942013000400001,fue,o
41,S0034-70942013000400001,superior,o
41,S0034-70942013000400001,a,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,sola,o
41,S0034-70942013000400001,para,o
41,S0034-70942013000400001,reducir,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,dolor,i
41,S0034-70942013000400001,ocasionado,o
41,S0034-70942013000400001,por,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,torniquete,o
41,S0034-70942013000400001,CONCLUSION,o
41,S0034-70942013000400001,Podemos,o
41,S0034-70942013000400001,decir,o
41,S0034-70942013000400001,que,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,adicion,o
41,S0034-70942013000400001,del,o
41,S0034-70942013000400001,fentanilo,i
41,S0034-70942013000400001,a,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,ARIV,i
41,S0034-70942013000400001,parece,o
41,S0034-70942013000400001,ser,o
41,S0034-70942013000400001,superior,o
41,S0034-70942013000400001,a,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,sola,o
41,S0034-70942013000400001,y,o
41,S0034-70942013000400001,al,o
41,S0034-70942013000400001,lornoxicam,i
41,S0034-70942013000400001,adicionado,o
41,S0034-70942013000400001,a,o
41,S0034-70942013000400001,la,o
41,S0034-70942013000400001,lidocaina,i
41,S0034-70942013000400001,para,o
41,S0034-70942013000400001,disminuir,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,dolor,i
41,S0034-70942013000400001,ocasionado,o
41,S0034-70942013000400001,por,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,torniquete,o
41,S0034-70942013000400001,a,o
41,S0034-70942013000400001,pesar,o
41,S0034-70942013000400001,de,o
41,S0034-70942013000400001,aumentar,o
41,S0034-70942013000400001,los,o
41,S0034-70942013000400001,efectos,i
41,S0034-70942013000400001,secundarios,i
41,S0034-70942013000400001,Sin,o
41,S0034-70942013000400001,embargo,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,lornoxicam,i
41,S0034-70942013000400001,no,o
41,S0034-70942013000400001,aumento,o
41,S0034-70942013000400001,los,o
41,S0034-70942013000400001,efectos,i
41,S0034-70942013000400001,secundarios,i
41,S0034-70942013000400001,proporcionando,o
41,S0034-70942013000400001,una,o
41,S0034-70942013000400001,analgesia,i
41,S0034-70942013000400001,en,o
41,S0034-70942013000400001,los,o
41,S0034-70942013000400001,periodos,o
41,S0034-70942013000400001,tanto,o
41,S0034-70942013000400001,intraoperatorio,o
41,S0034-70942013000400001,como,o
41,S0034-70942013000400001,postoperatorio,o
41,S0034-70942013000400001,Por,o
41,S0034-70942013000400001,tanto,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,lornoxicam,i
41,S0034-70942013000400001,puede,o
41,S0034-70942013000400001,ser,o
41,S0034-70942013000400001,mas,o
41,S0034-70942013000400001,adecuado,o
41,S0034-70942013000400001,para,o
41,S0034-70942013000400001,el,o
41,S0034-70942013000400001,uso,o
41,S0034-70942013000400001,clinico,o
42,S0034-70942013000500006,La,o
42,S0034-70942013000500006,asociacion,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,haloperidol,i
42,S0034-70942013000500006,dexametasona,i
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,ondansetron,i
42,S0034-70942013000500006,reduce,o
42,S0034-70942013000500006,la,o
42,S0034-70942013000500006,intensidad,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,nausea,i
42,S0034-70942013000500006,dolor,i
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,consumo,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,morfina,i
42,S0034-70942013000500006,despues,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,la,o
42,S0034-70942013000500006,gastrectomia,i
42,S0034-70942013000500006,vertical,i
42,S0034-70942013000500006,laparoscopica,i
42,S0034-70942013000500006,JUSTIFICATIVA,o
42,S0034-70942013000500006,Y,o
42,S0034-70942013000500006,OBJETIVOS,o
42,S0034-70942013000500006,La,o
42,S0034-70942013000500006,nausea,i
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,vomito,i
42,S0034-70942013000500006,postoperatorio,i
42,S0034-70942013000500006,NVPO,i
42,S0034-70942013000500006,ocurren,o
42,S0034-70942013000500006,a,o
42,S0034-70942013000500006,menudo,o
42,S0034-70942013000500006,despues,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,la,o
42,S0034-70942013000500006,cirugia,i
42,S0034-70942013000500006,bariatrica,i
42,S0034-70942013000500006,laparoscopica,i
42,S0034-70942013000500006,La,o
42,S0034-70942013000500006,asociacion,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,haloperidol,i
42,S0034-70942013000500006,dexametasona,i
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,ondansetron,i
42,S0034-70942013000500006,puede,o
42,S0034-70942013000500006,reducir,o
42,S0034-70942013000500006,esos,o
42,S0034-70942013000500006,eventos,i
42,S0034-70942013000500006,no,i
42,S0034-70942013000500006,deseados,i
42,S0034-70942013000500006,El,o
42,S0034-70942013000500006,objetivo,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,este,o
42,S0034-70942013000500006,estudio,o
42,S0034-70942013000500006,fue,o
42,S0034-70942013000500006,evaluar,o
42,S0034-70942013000500006,la,o
42,S0034-70942013000500006,intensidad,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,nausea,i
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,dolor,i
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,numero,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,episodios,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,vomito,i
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,consumo,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,morfina,i
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,postoperatorio,o
42,S0034-70942013000500006,PO,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,pacientes,o
42,S0034-70942013000500006,obesos,i
42,S0034-70942013000500006,sometidos,o
42,S0034-70942013000500006,a,o
42,S0034-70942013000500006,la,o
42,S0034-70942013000500006,gastrectomia,i
42,S0034-70942013000500006,vertical,i
42,S0034-70942013000500006,laparoscopica,i
42,S0034-70942013000500006,GVL,i
42,S0034-70942013000500006,METODO,o
42,S0034-70942013000500006,Estudio,o
42,S0034-70942013000500006,clinico,o
42,S0034-70942013000500006,aleatorizado,o
42,S0034-70942013000500006,controlado,o
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,doble,o
42,S0034-70942013000500006,ciego,o
42,S0034-70942013000500006,realizado,o
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,90,o
42,S0034-70942013000500006,pacientes,o
42,S0034-70942013000500006,con,o
42,S0034-70942013000500006,indice,i
42,S0034-70942013000500006,de,i
42,S0034-70942013000500006,masa,i
42,S0034-70942013000500006,corporal,i
42,S0034-70942013000500006,35,o
42,S0034-70942013000500006,Kgm2,o
42,S0034-70942013000500006,Los,o
42,S0034-70942013000500006,pacientes,o
42,S0034-70942013000500006,se,o
42,S0034-70942013000500006,distribuyeron,o
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,tres,o
42,S0034-70942013000500006,grupos,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,30,o
42,S0034-70942013000500006,para,o
42,S0034-70942013000500006,recibir,o
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,Grupo,o
42,S0034-70942013000500006,O,o
42,S0034-70942013000500006,ondansetron,i
42,S0034-70942013000500006,8,o
42,S0034-70942013000500006,mg,o
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,Grupo,o
42,S0034-70942013000500006,DO,o
42,S0034-70942013000500006,ondansetron,i
42,S0034-70942013000500006,8,o
42,S0034-70942013000500006,mg,o
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,dexametasona,i
42,S0034-70942013000500006,8,o
42,S0034-70942013000500006,mg,o
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,Grupo,o
42,S0034-70942013000500006,HDO,o
42,S0034-70942013000500006,ondansetron,i
42,S0034-70942013000500006,8,o
42,S0034-70942013000500006,mg,o
42,S0034-70942013000500006,dexametasona,i
42,S0034-70942013000500006,8,o
42,S0034-70942013000500006,mg,o
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,haloperidol,i
42,S0034-70942013000500006,2,o
42,S0034-70942013000500006,mg,o
42,S0034-70942013000500006,Fueron,o
42,S0034-70942013000500006,evaluados,o
42,S0034-70942013000500006,la,o
42,S0034-70942013000500006,intensidad,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,nausea,i
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,dolor,i
42,S0034-70942013000500006,por,o
42,S0034-70942013000500006,medio,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,la,o
42,S0034-70942013000500006,escala,i
42,S0034-70942013000500006,numerica,i
42,S0034-70942013000500006,verbal,i
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,numero,o
42,S0034-70942013000500006,acumulativo,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,episodios,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,vomito,i
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,consumo,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,morfina,i
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,periodo,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,02,o
42,S0034-70942013000500006,212,o
42,S0034-70942013000500006,1224,o
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,2436,o
42,S0034-70942013000500006,horas,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,PO,o
42,S0034-70942013000500006,RESULTADOS,o
42,S0034-70942013000500006,La,o
42,S0034-70942013000500006,intensidad,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,nausea,i
42,S0034-70942013000500006,fue,o
42,S0034-70942013000500006,menor,o
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,Grupo,o
42,S0034-70942013000500006,HDO,o
42,S0034-70942013000500006,comparado,o
42,S0034-70942013000500006,con,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,Grupo,o
42,S0034-70942013000500006,O,o
42,S0034-70942013000500006,p,o
42,S0034-70942013000500006,0001,o
42,S0034-70942013000500006,la,o
42,S0034-70942013000500006,intensidad,o
42,S0034-70942013000500006,del,o
42,S0034-70942013000500006,dolor,i
42,S0034-70942013000500006,fue,o
42,S0034-70942013000500006,menor,o
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,Grupo,o
42,S0034-70942013000500006,HDO,o
42,S0034-70942013000500006,comparado,o
42,S0034-70942013000500006,con,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,Grupo,o
42,S0034-70942013000500006,O,o
42,S0034-70942013000500006,p,o
42,S0034-70942013000500006,0046,o
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,consumo,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,morfina,i
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,Grupo,o
42,S0034-70942013000500006,HDO,o
42,S0034-70942013000500006,fue,o
42,S0034-70942013000500006,menor,o
42,S0034-70942013000500006,que,o
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,Grupo,o
42,S0034-70942013000500006,O,o
42,S0034-70942013000500006,p,o
42,S0034-70942013000500006,0037,o
42,S0034-70942013000500006,No,o
42,S0034-70942013000500006,hubo,o
42,S0034-70942013000500006,diferencia,o
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,numero,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,episodios,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,vomito,i
42,S0034-70942013000500006,entre,o
42,S0034-70942013000500006,los,o
42,S0034-70942013000500006,grupos,o
42,S0034-70942013000500006,p,o
42,S0034-70942013000500006,0052,o
42,S0034-70942013000500006,CONCLUSIONES,o
42,S0034-70942013000500006,La,o
42,S0034-70942013000500006,asociacion,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,haloperidol,i
42,S0034-70942013000500006,dexametasona,i
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,ondansetron,i
42,S0034-70942013000500006,genero,o
42,S0034-70942013000500006,una,o
42,S0034-70942013000500006,reduccion,o
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,la,o
42,S0034-70942013000500006,intensidad,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,la,o
42,S0034-70942013000500006,nausea,i
42,S0034-70942013000500006,del,o
42,S0034-70942013000500006,dolor,i
42,S0034-70942013000500006,y,o
42,S0034-70942013000500006,del,o
42,S0034-70942013000500006,consumo,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,morfina,i
42,S0034-70942013000500006,en,o
42,S0034-70942013000500006,el,o
42,S0034-70942013000500006,PO,o
42,S0034-70942013000500006,de,o
42,S0034-70942013000500006,pacientes,o
42,S0034-70942013000500006,obesos,i
42,S0034-70942013000500006,sometidos,o
42,S0034-70942013000500006,a,o
42,S0034-70942013000500006,la,o
42,S0034-70942013000500006,GVL,i
43,S0034-70942014000400247,Comparacion,o
43,S0034-70942014000400247,del,o
43,S0034-70942014000400247,esmolol,i
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,bolos,o
43,S0034-70942014000400247,e,o
43,S0034-70942014000400247,infusion,i
43,S0034-70942014000400247,continua,i
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,respuesta,o
43,S0034-70942014000400247,hemodinamica,o
43,S0034-70942014000400247,a,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,laringoscopia,i
43,S0034-70942014000400247,intubacion,i
43,S0034-70942014000400247,orotraqueal,i
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,esternotomia,i
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,cirugia,i
43,S0034-70942014000400247,de,i
43,S0034-70942014000400247,revascularizacion,i
43,S0034-70942014000400247,coronaria,i
43,S0034-70942014000400247,JUSTIFICACION,o
43,S0034-70942014000400247,Y,o
43,S0034-70942014000400247,OBJETIVO,o
43,S0034-70942014000400247,el,o
43,S0034-70942014000400247,objetivo,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,este,o
43,S0034-70942014000400247,estudio,o
43,S0034-70942014000400247,prospectivo,o
43,S0034-70942014000400247,aleatorizado,o
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,doble,o
43,S0034-70942014000400247,ciego,o
43,S0034-70942014000400247,fue,o
43,S0034-70942014000400247,investigar,o
43,S0034-70942014000400247,los,o
43,S0034-70942014000400247,efectos,o
43,S0034-70942014000400247,del,o
43,S0034-70942014000400247,diferente,o
43,S0034-70942014000400247,uso,o
43,S0034-70942014000400247,del,o
43,S0034-70942014000400247,esmolol,i
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,respuesta,o
43,S0034-70942014000400247,hemodinamica,o
43,S0034-70942014000400247,a,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,laringoscopia,i
43,S0034-70942014000400247,intubacion,i
43,S0034-70942014000400247,orotraqueal,i
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,esternotomia,i
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,cirugia,i
43,S0034-70942014000400247,de,i
43,S0034-70942014000400247,revascularizacion,i
43,S0034-70942014000400247,coronaria,i
43,S0034-70942014000400247,METODOS,o
43,S0034-70942014000400247,despues,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,obtener,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,aprobacion,o
43,S0034-70942014000400247,del,o
43,S0034-70942014000400247,Comite,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,Etica,o
43,S0034-70942014000400247,local,o
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,el,o
43,S0034-70942014000400247,consentimiento,i
43,S0034-70942014000400247,informado,i
43,S0034-70942014000400247,firmado,o
43,S0034-70942014000400247,por,o
43,S0034-70942014000400247,los,o
43,S0034-70942014000400247,pacientes,o
43,S0034-70942014000400247,45,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,ellos,o
43,S0034-70942014000400247,fueron,o
43,S0034-70942014000400247,aleatoriamente,i
43,S0034-70942014000400247,divididos,i
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,3,o
43,S0034-70942014000400247,grupos,o
43,S0034-70942014000400247,El,o
43,S0034-70942014000400247,grupo,o
43,S0034-70942014000400247,I,o
43,S0034-70942014000400247,infusion,i
43,S0034-70942014000400247,recibio,o
43,S0034-70942014000400247,05,o
43,S0034-70942014000400247,mgkgmin,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,esmolol,i
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,infusion,i
43,S0034-70942014000400247,desde,o
43,S0034-70942014000400247,10,o
43,S0034-70942014000400247,min,o
43,S0034-70942014000400247,antes,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,intubacion,i
43,S0034-70942014000400247,hasta,o
43,S0034-70942014000400247,5,o
43,S0034-70942014000400247,min,o
43,S0034-70942014000400247,despues,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,esternotomia,i
43,S0034-70942014000400247,el,o
43,S0034-70942014000400247,grupo,o
43,S0034-70942014000400247,B,o
43,S0034-70942014000400247,bolo,o
43,S0034-70942014000400247,que,o
43,S0034-70942014000400247,recibio,o
43,S0034-70942014000400247,15,o
43,S0034-70942014000400247,mgkg,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,esmolol,i
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,bolo,i
43,S0034-70942014000400247,iv,i
43,S0034-70942014000400247,a,o
43,S0034-70942014000400247,partir,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,2,o
43,S0034-70942014000400247,min,o
43,S0034-70942014000400247,antes,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,intubacion,i
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,esternotomia,i
43,S0034-70942014000400247,el,o
43,S0034-70942014000400247,grupo,o
43,S0034-70942014000400247,C,o
43,S0034-70942014000400247,control,o
43,S0034-70942014000400247,recibio,o
43,S0034-70942014000400247,NaCl,i
43,S0034-70942014000400247,al,o
43,S0034-70942014000400247,09,o
43,S0034-70942014000400247,Todos,o
43,S0034-70942014000400247,los,o
43,S0034-70942014000400247,parametros,o
43,S0034-70942014000400247,demograficos,o
43,S0034-70942014000400247,fueron,o
43,S0034-70942014000400247,registrados,o
43,S0034-70942014000400247,Los,o
43,S0034-70942014000400247,valores,i
43,S0034-70942014000400247,de,i
43,S0034-70942014000400247,frecuencia,i
43,S0034-70942014000400247,cardiaca,i
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,presion,i
43,S0034-70942014000400247,arterial,i
43,S0034-70942014000400247,fueron,o
43,S0034-70942014000400247,registrados,o
43,S0034-70942014000400247,ya,o
43,S0034-70942014000400247,antes,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,infusion,i
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,hasta,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,induccion,i
43,S0034-70942014000400247,de,i
43,S0034-70942014000400247,la,i
43,S0034-70942014000400247,anestesia,i
43,S0034-70942014000400247,cada,o
43,S0034-70942014000400247,minuto,o
43,S0034-70942014000400247,durante,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,intubacion,i
43,S0034-70942014000400247,endotraqueal,i
43,S0034-70942014000400247,cada,o
43,S0034-70942014000400247,minuto,o
43,S0034-70942014000400247,durante,o
43,S0034-70942014000400247,10,o
43,S0034-70942014000400247,min,o
43,S0034-70942014000400247,despues,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,intubacion,i
43,S0034-70942014000400247,endotraqueal,i
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,antes,o
43,S0034-70942014000400247,durante,o
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,despues,o
43,S0034-70942014000400247,de,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,esternotomia,i
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,el,o
43,S0034-70942014000400247,primer,o
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,quinto,o
43,S0034-70942014000400247,minutos,o
43,S0034-70942014000400247,RESULTADOS,o
43,S0034-70942014000400247,mientras,o
43,S0034-70942014000400247,que,o
43,S0034-70942014000400247,el,o
43,S0034-70942014000400247,area,o
43,S0034-70942014000400247,bajo,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,curva,o
43,S0034-70942014000400247,AUC,o
43,S0034-70942014000400247,presion,i
43,S0034-70942014000400247,arterial,i
43,S0034-70942014000400247,sistolica,i
43,S0034-70942014000400247,PAS,i
43,S0034-70942014000400247,tiempo,o
43,S0034-70942014000400247,fue,o
43,S0034-70942014000400247,mayor,o
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,los,o
43,S0034-70942014000400247,grupos,o
43,S0034-70942014000400247,B,o
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,C,o
43,S0034-70942014000400247,que,o
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,el,o
43,S0034-70942014000400247,grupo,o
43,S0034-70942014000400247,I,o
43,S0034-70942014000400247,el,o
43,S0034-70942014000400247,AUC,o
43,S0034-70942014000400247,PAS,i
43,S0034-70942014000400247,T,o
43,S0034-70942014000400247,int,o
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,T,o
43,S0034-70942014000400247,st,o
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,AUC,o
43,S0034-70942014000400247,PAS,i
43,S0034-70942014000400247,T,o
43,S0034-70942014000400247,2,o
43,S0034-70942014000400247,fueron,o
43,S0034-70942014000400247,mayores,o
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,los,o
43,S0034-70942014000400247,grupos,o
43,S0034-70942014000400247,B,o
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,C,o
43,S0034-70942014000400247,que,o
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,el,o
43,S0034-70942014000400247,grupo,o
43,S0034-70942014000400247,I,o
43,S0034-70942014000400247,p,o
43,S0034-70942014000400247,005,o
43,S0034-70942014000400247,Ademas,o
43,S0034-70942014000400247,el,o
43,S0034-70942014000400247,AUC,o
43,S0034-70942014000400247,frecuencia,i
43,S0034-70942014000400247,cardiaca,i
43,S0034-70942014000400247,T,o
43,S0034-70942014000400247,st,o
43,S0034-70942014000400247,fue,o
43,S0034-70942014000400247,menor,o
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,el,o
43,S0034-70942014000400247,grupo,o
43,S0034-70942014000400247,B,o
43,S0034-70942014000400247,que,o
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,el,o
43,S0034-70942014000400247,grupo,o
43,S0034-70942014000400247,C,o
43,S0034-70942014000400247,pero,o
43,S0034-70942014000400247,no,o
43,S0034-70942014000400247,hubo,o
43,S0034-70942014000400247,diferencia,o
43,S0034-70942014000400247,significativa,o
43,S0034-70942014000400247,entre,o
43,S0034-70942014000400247,los,o
43,S0034-70942014000400247,grupos,o
43,S0034-70942014000400247,B,o
43,S0034-70942014000400247,e,o
43,S0034-70942014000400247,I,o
43,S0034-70942014000400247,CONCLUSION,o
43,S0034-70942014000400247,este,o
43,S0034-70942014000400247,estudio,o
43,S0034-70942014000400247,destaca,o
43,S0034-70942014000400247,que,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,administracion,i
43,S0034-70942014000400247,del,o
43,S0034-70942014000400247,esmolol,i
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,infusion,i
43,S0034-70942014000400247,es,o
43,S0034-70942014000400247,mas,o
43,S0034-70942014000400247,eficaz,o
43,S0034-70942014000400247,que,o
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,bolos,o
43,S0034-70942014000400247,para,o
43,S0034-70942014000400247,controlar,i
43,S0034-70942014000400247,la,i
43,S0034-70942014000400247,PAS,i
43,S0034-70942014000400247,durante,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,intubacion,i
43,S0034-70942014000400247,endotraqueal,i
43,S0034-70942014000400247,y,o
43,S0034-70942014000400247,la,o
43,S0034-70942014000400247,esternotomia,i
43,S0034-70942014000400247,en,o
43,S0034-70942014000400247,cirugia,i
43,S0034-70942014000400247,de,i
43,S0034-70942014000400247,revascularizacion,i
43,S0034-70942014000400247,coronaria,i
44,S0034-70942014000400263,Comparacion,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,los,o
44,S0034-70942014000400263,efectos,o
44,S0034-70942014000400263,del,o
44,S0034-70942014000400263,remifentanilo,i
44,S0034-70942014000400263,y,o
44,S0034-70942014000400263,el,o
44,S0034-70942014000400263,remifentanilo,i
44,S0034-70942014000400263,mas,o
44,S0034-70942014000400263,lidocaina,i
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,intubacion,i
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,pacientes,o
44,S0034-70942014000400263,intelectualmente,i
44,S0034-70942014000400263,discapacitados,i
44,S0034-70942014000400263,JUSTIFICACION,o
44,S0034-70942014000400263,Y,o
44,S0034-70942014000400263,OBJETIVOS,o
44,S0034-70942014000400263,este,o
44,S0034-70942014000400263,es,o
44,S0034-70942014000400263,un,o
44,S0034-70942014000400263,estudio,o
44,S0034-70942014000400263,prospectivo,o
44,S0034-70942014000400263,aleatorizado,o
44,S0034-70942014000400263,y,o
44,S0034-70942014000400263,doble,o
44,S0034-70942014000400263,ciego,o
44,S0034-70942014000400263,Nuestro,o
44,S0034-70942014000400263,objetivo,o
44,S0034-70942014000400263,fue,o
44,S0034-70942014000400263,comparar,o
44,S0034-70942014000400263,las,o
44,S0034-70942014000400263,condiciones,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,intubacion,i
44,S0034-70942014000400263,endotraqueal,i
44,S0034-70942014000400263,y,o
44,S0034-70942014000400263,las,o
44,S0034-70942014000400263,respuestas,o
44,S0034-70942014000400263,hemodinamicas,o
44,S0034-70942014000400263,con,o
44,S0034-70942014000400263,el,o
44,S0034-70942014000400263,uso,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,remifentanilo,i
44,S0034-70942014000400263,o,o
44,S0034-70942014000400263,la,o
44,S0034-70942014000400263,combinacion,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,remifentanilo,i
44,S0034-70942014000400263,y,o
44,S0034-70942014000400263,lidocaina,i
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,induccion,i
44,S0034-70942014000400263,anestesica,i
44,S0034-70942014000400263,con,o
44,S0034-70942014000400263,sevoflurano,i
44,S0034-70942014000400263,sin,o
44,S0034-70942014000400263,agentes,i
44,S0034-70942014000400263,bloqueantes,i
44,S0034-70942014000400263,neuromusculares,i
44,S0034-70942014000400263,METODOS,o
44,S0034-70942014000400263,cincuenta,o
44,S0034-70942014000400263,pacientes,o
44,S0034-70942014000400263,intelectualmente,i
44,S0034-70942014000400263,discapacitados,i
44,S0034-70942014000400263,estado,o
44,S0034-70942014000400263,fisico,o
44,S0034-70942014000400263,ASA,o
44,S0034-70942014000400263,III,o
44,S0034-70942014000400263,sometidos,o
44,S0034-70942014000400263,a,o
44,S0034-70942014000400263,la,o
44,S0034-70942014000400263,extraccion,i
44,S0034-70942014000400263,dental,i
44,S0034-70942014000400263,bajo,o
44,S0034-70942014000400263,anestesia,i
44,S0034-70942014000400263,general,i
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,ambulatorio,o
44,S0034-70942014000400263,fueron,o
44,S0034-70942014000400263,incluidos,o
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,este,o
44,S0034-70942014000400263,estudio,o
44,S0034-70942014000400263,Los,o
44,S0034-70942014000400263,pacientes,o
44,S0034-70942014000400263,fueron,o
44,S0034-70942014000400263,aleatorizados,i
44,S0034-70942014000400263,para,o
44,S0034-70942014000400263,recibir,o
44,S0034-70942014000400263,2,o
44,S0034-70942014000400263,μgkg1,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,remifentanilo,i
44,S0034-70942014000400263,grupo,o
44,S0034-70942014000400263,1,o
44,S0034-70942014000400263,n,o
44,S0034-70942014000400263,25,o
44,S0034-70942014000400263,o,o
44,S0034-70942014000400263,una,o
44,S0034-70942014000400263,combinacion,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,2,o
44,S0034-70942014000400263,μgkg1,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,remifentanilo,i
44,S0034-70942014000400263,y,o
44,S0034-70942014000400263,1,o
44,S0034-70942014000400263,mgkg1,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,lidocaina,i
44,S0034-70942014000400263,grupo,o
44,S0034-70942014000400263,2,o
44,S0034-70942014000400263,n,o
44,S0034-70942014000400263,25,o
44,S0034-70942014000400263,Para,o
44,S0034-70942014000400263,evaluar,o
44,S0034-70942014000400263,las,o
44,S0034-70942014000400263,condiciones,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,intubacion,i
44,S0034-70942014000400263,se,o
44,S0034-70942014000400263,uso,o
44,S0034-70942014000400263,el,o
44,S0034-70942014000400263,sistema,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,puntuacion,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,HelboHansen,o
44,S0034-70942014000400263,En,o
44,S0034-70942014000400263,pacientes,o
44,S0034-70942014000400263,con,o
44,S0034-70942014000400263,2,o
44,S0034-70942014000400263,o,o
44,S0034-70942014000400263,menos,o
44,S0034-70942014000400263,puntos,o
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,todas,o
44,S0034-70942014000400263,las,o
44,S0034-70942014000400263,puntuaciones,o
44,S0034-70942014000400263,las,o
44,S0034-70942014000400263,condiciones,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,intubacion,i
44,S0034-70942014000400263,fueron,o
44,S0034-70942014000400263,consideradas,o
44,S0034-70942014000400263,aceptables,o
44,S0034-70942014000400263,sin,o
44,S0034-70942014000400263,embargo,o
44,S0034-70942014000400263,si,o
44,S0034-70942014000400263,cualquiera,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,las,o
44,S0034-70942014000400263,puntuaciones,o
44,S0034-70942014000400263,fuese,o
44,S0034-70942014000400263,superior,o
44,S0034-70942014000400263,a,o
44,S0034-70942014000400263,2,o
44,S0034-70942014000400263,las,o
44,S0034-70942014000400263,condiciones,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,intubacion,i
44,S0034-70942014000400263,serian,o
44,S0034-70942014000400263,consideradas,o
44,S0034-70942014000400263,inaceptables,o
44,S0034-70942014000400263,La,o
44,S0034-70942014000400263,presion,i
44,S0034-70942014000400263,arterial,i
44,S0034-70942014000400263,media,i
44,S0034-70942014000400263,frecuencia,i
44,S0034-70942014000400263,cardiaca,i
44,S0034-70942014000400263,y,o
44,S0034-70942014000400263,la,o
44,S0034-70942014000400263,saturacion,i
44,S0034-70942014000400263,periferica,i
44,S0034-70942014000400263,de,i
44,S0034-70942014000400263,oxigeno,i
44,S0034-70942014000400263,fueron,o
44,S0034-70942014000400263,registradas,o
44,S0034-70942014000400263,al,o
44,S0034-70942014000400263,inicio,o
44,S0034-70942014000400263,del,o
44,S0034-70942014000400263,estudio,o
44,S0034-70942014000400263,despues,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,la,o
44,S0034-70942014000400263,administracion,i
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,opiaceos,i
44,S0034-70942014000400263,antes,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,la,o
44,S0034-70942014000400263,intubacion,i
44,S0034-70942014000400263,y,o
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,los,o
44,S0034-70942014000400263,minutos,o
44,S0034-70942014000400263,1,o
44,S0034-70942014000400263,3,o
44,S0034-70942014000400263,y,o
44,S0034-70942014000400263,5,o
44,S0034-70942014000400263,despues,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,la,o
44,S0034-70942014000400263,intubacion,i
44,S0034-70942014000400263,RESULTADOS,o
44,S0034-70942014000400263,se,o
44,S0034-70942014000400263,obtuvieron,o
44,S0034-70942014000400263,parametros,o
44,S0034-70942014000400263,aceptables,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,intubacion,i
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,24,o
44,S0034-70942014000400263,pacientes,o
44,S0034-70942014000400263,del,o
44,S0034-70942014000400263,grupo,o
44,S0034-70942014000400263,1,o
44,S0034-70942014000400263,96,o
44,S0034-70942014000400263,y,o
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,23,o
44,S0034-70942014000400263,pacientes,o
44,S0034-70942014000400263,del,o
44,S0034-70942014000400263,grupo,o
44,S0034-70942014000400263,2,o
44,S0034-70942014000400263,92En,o
44,S0034-70942014000400263,las,o
44,S0034-70942014000400263,comparaciones,o
44,S0034-70942014000400263,intragrupo,o
44,S0034-70942014000400263,los,o
44,S0034-70942014000400263,valores,i
44,S0034-70942014000400263,de,i
44,S0034-70942014000400263,la,i
44,S0034-70942014000400263,frecuencia,i
44,S0034-70942014000400263,cardiaca,i
44,S0034-70942014000400263,y,o
44,S0034-70942014000400263,la,o
44,S0034-70942014000400263,presion,i
44,S0034-70942014000400263,arterial,i
44,S0034-70942014000400263,media,i
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,todos,o
44,S0034-70942014000400263,los,o
44,S0034-70942014000400263,momentos,o
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,ambos,o
44,S0034-70942014000400263,grupos,o
44,S0034-70942014000400263,arrojaron,o
44,S0034-70942014000400263,una,o
44,S0034-70942014000400263,reduccion,o
44,S0034-70942014000400263,significativa,o
44,S0034-70942014000400263,con,o
44,S0034-70942014000400263,relacion,o
44,S0034-70942014000400263,a,o
44,S0034-70942014000400263,los,o
44,S0034-70942014000400263,valores,o
44,S0034-70942014000400263,basales,o
44,S0034-70942014000400263,p,o
44,S0034-70942014000400263,0000,o
44,S0034-70942014000400263,CONCLUSION,o
44,S0034-70942014000400263,con,o
44,S0034-70942014000400263,la,o
44,S0034-70942014000400263,adicion,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,2,o
44,S0034-70942014000400263,μgkg,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,remifentanilo,i
44,S0034-70942014000400263,durante,o
44,S0034-70942014000400263,la,o
44,S0034-70942014000400263,induccion,i
44,S0034-70942014000400263,con,o
44,S0034-70942014000400263,sevoflurano,i
44,S0034-70942014000400263,pudimos,o
44,S0034-70942014000400263,obtener,o
44,S0034-70942014000400263,una,o
44,S0034-70942014000400263,intubacion,i
44,S0034-70942014000400263,endotraqueal,i
44,S0034-70942014000400263,exitosa,o
44,S0034-70942014000400263,sin,o
44,S0034-70942014000400263,usar,o
44,S0034-70942014000400263,relajantes,i
44,S0034-70942014000400263,musculares,i
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,pacientes,o
44,S0034-70942014000400263,intelectualmente,i
44,S0034-70942014000400263,discapacitados,i
44,S0034-70942014000400263,que,o
44,S0034-70942014000400263,se,o
44,S0034-70942014000400263,someten,o
44,S0034-70942014000400263,a,o
44,S0034-70942014000400263,extraccion,i
44,S0034-70942014000400263,dental,i
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,ambulatorio,o
44,S0034-70942014000400263,Tambien,o
44,S0034-70942014000400263,es,o
44,S0034-70942014000400263,importante,o
44,S0034-70942014000400263,resaltar,o
44,S0034-70942014000400263,que,o
44,S0034-70942014000400263,la,o
44,S0034-70942014000400263,adicion,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,1,o
44,S0034-70942014000400263,mgkg,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,lidocaina,i
44,S0034-70942014000400263,a,o
44,S0034-70942014000400263,2,o
44,S0034-70942014000400263,μgkg,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,remifentanilo,i
44,S0034-70942014000400263,no,o
44,S0034-70942014000400263,presenta,o
44,S0034-70942014000400263,ninguna,o
44,S0034-70942014000400263,mejoria,o
44,S0034-70942014000400263,adicional,o
44,S0034-70942014000400263,en,o
44,S0034-70942014000400263,los,o
44,S0034-70942014000400263,parametros,o
44,S0034-70942014000400263,de,o
44,S0034-70942014000400263,intubacion,i
45,S0034-70942014000500335,La,o
45,S0034-70942014000500335,adicion,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,75,o
45,S0034-70942014000500335,mg,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,pregabalina,i
45,S0034-70942014000500335,al,o
45,S0034-70942014000500335,regimen,i
45,S0034-70942014000500335,analgesico,i
45,S0034-70942014000500335,reduce,o
45,S0034-70942014000500335,puntuaciones,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,dolor,i
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,consumo,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,opiaceos,i
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,adultos,o
45,S0034-70942014000500335,despues,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,la,o
45,S0034-70942014000500335,nefrolitotomia,i
45,S0034-70942014000500335,percutanea,i
45,S0034-70942014000500335,Justificacion,o
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,objetivos,o
45,S0034-70942014000500335,La,o
45,S0034-70942014000500335,adicion,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,nuevos,o
45,S0034-70942014000500335,medicamentos,i
45,S0034-70942014000500335,adyuvantes,i
45,S0034-70942014000500335,como,o
45,S0034-70942014000500335,los,o
45,S0034-70942014000500335,gabapentinoides,i
45,S0034-70942014000500335,al,o
45,S0034-70942014000500335,regimen,i
45,S0034-70942014000500335,analgesico,i
45,S0034-70942014000500335,multimodal,i
45,S0034-70942014000500335,puede,o
45,S0034-70942014000500335,ser,o
45,S0034-70942014000500335,interesante,o
45,S0034-70942014000500335,para,o
45,S0034-70942014000500335,poder,o
45,S0034-70942014000500335,disminuir,o
45,S0034-70942014000500335,las,o
45,S0034-70942014000500335,puntuaciones,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,dolor,i
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,postoperatorio,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,consumo,o
45,S0034-70942014000500335,total,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,opiaceos,i
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,los,o
45,S0034-70942014000500335,efectos,i
45,S0034-70942014000500335,colaterales,i
45,S0034-70942014000500335,despues,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,la,o
45,S0034-70942014000500335,nefrolitotomia,i
45,S0034-70942014000500335,percutanea,i
45,S0034-70942014000500335,Nuestro,o
45,S0034-70942014000500335,objetivo,o
45,S0034-70942014000500335,fue,o
45,S0034-70942014000500335,evaluar,o
45,S0034-70942014000500335,durante,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,periodo,o
45,S0034-70942014000500335,postoperatorio,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,efecto,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,la,o
45,S0034-70942014000500335,pregabalina,i
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,las,o
45,S0034-70942014000500335,puntuaciones,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,dolor,i
45,S0034-70942014000500335,consumo,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,analgesicos,i
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,funciones,o
45,S0034-70942014000500335,renales,i
45,S0034-70942014000500335,expresadas,o
45,S0034-70942014000500335,por,o
45,S0034-70942014000500335,aclaramiento,i
45,S0034-70942014000500335,de,i
45,S0034-70942014000500335,creatinina,i
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,niveles,o
45,S0034-70942014000500335,sericos,i
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,cistatinaC,o
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,lipocalina,i
45,S0034-70942014000500335,asociada,i
45,S0034-70942014000500335,con,i
45,S0034-70942014000500335,la,i
45,S0034-70942014000500335,gelatinasa,i
45,S0034-70942014000500335,de,i
45,S0034-70942014000500335,neutrofilos,i
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,pacientes,o
45,S0034-70942014000500335,sometidos,o
45,S0034-70942014000500335,a,o
45,S0034-70942014000500335,la,o
45,S0034-70942014000500335,nefrolitotomia,i
45,S0034-70942014000500335,percutanea,i
45,S0034-70942014000500335,Metodos,o
45,S0034-70942014000500335,Sesenta,o
45,S0034-70942014000500335,pacientes,o
45,S0034-70942014000500335,sometidos,o
45,S0034-70942014000500335,a,o
45,S0034-70942014000500335,nefrolitotomia,i
45,S0034-70942014000500335,percutanea,i
45,S0034-70942014000500335,electiva,o
45,S0034-70942014000500335,fueron,o
45,S0034-70942014000500335,incluidos,o
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,estudio,o
45,S0034-70942014000500335,Los,o
45,S0034-70942014000500335,pacientes,o
45,S0034-70942014000500335,fueron,o
45,S0034-70942014000500335,aleatorizados,i
45,S0034-70942014000500335,para,o
45,S0034-70942014000500335,recibir,o
45,S0034-70942014000500335,pregabalina,i
45,S0034-70942014000500335,oral,o
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,dosis,o
45,S0034-70942014000500335,unica,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,75,o
45,S0034-70942014000500335,mg,o
45,S0034-70942014000500335,grupo,o
45,S0034-70942014000500335,pregabalina,i
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,grupo,o
45,S0034-70942014000500335,control,o
45,S0034-70942014000500335,Las,o
45,S0034-70942014000500335,puntuaciones,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,dolor,i
45,S0034-70942014000500335,medidas,o
45,S0034-70942014000500335,por,o
45,S0034-70942014000500335,la,o
45,S0034-70942014000500335,escala,i
45,S0034-70942014000500335,visual,i
45,S0034-70942014000500335,analogica,i
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,consumo,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,morfina,i
45,S0034-70942014000500335,intravenosa,o
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,las,o
45,S0034-70942014000500335,primeras,o
45,S0034-70942014000500335,24,o
45,S0034-70942014000500335,h,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,postoperatorio,o
45,S0034-70942014000500335,nivel,i
45,S0034-70942014000500335,serico,i
45,S0034-70942014000500335,de,i
45,S0034-70942014000500335,lipocalina,i
45,S0034-70942014000500335,asociada,i
45,S0034-70942014000500335,a,i
45,S0034-70942014000500335,la,i
45,S0034-70942014000500335,gelatinasa,i
45,S0034-70942014000500335,de,i
45,S0034-70942014000500335,neutrofilos,i
45,S0034-70942014000500335,niveles,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,cistatinaC,o
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,aclaramiento,i
45,S0034-70942014000500335,de,i
45,S0034-70942014000500335,creatinina,i
45,S0034-70942014000500335,fueron,o
45,S0034-70942014000500335,medidos,o
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,preoperatorio,o
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,la,o
45,S0034-70942014000500335,2a,o
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,24a,o
45,S0034-70942014000500335,horas,o
45,S0034-70942014000500335,del,o
45,S0034-70942014000500335,postoperatorio,o
45,S0034-70942014000500335,Resultados,o
45,S0034-70942014000500335,Las,o
45,S0034-70942014000500335,puntuaciones,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,la,o
45,S0034-70942014000500335,escala,i
45,S0034-70942014000500335,visual,i
45,S0034-70942014000500335,analogica,i
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,postoperatorio,o
45,S0034-70942014000500335,fueron,o
45,S0034-70942014000500335,significativamente,o
45,S0034-70942014000500335,menores,o
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,grupo,o
45,S0034-70942014000500335,pregabalina,i
45,S0034-70942014000500335,a,o
45,S0034-70942014000500335,los,o
45,S0034-70942014000500335,30,o
45,S0034-70942014000500335,min,o
45,S0034-70942014000500335,1,o
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,2,o
45,S0034-70942014000500335,h,o
45,S0034-70942014000500335,p,o
45,S0034-70942014000500335,0002,o
45,S0034-70942014000500335,p,o
45,S0034-70942014000500335,0001,o
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,p,o
45,S0034-70942014000500335,0027,o
45,S0034-70942014000500335,respectivamente,o
45,S0034-70942014000500335,El,o
45,S0034-70942014000500335,promedio,o
45,S0034-70942014000500335,del,o
45,S0034-70942014000500335,consumo,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,morfina,i
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,postoperatorio,o
45,S0034-70942014000500335,fue,o
45,S0034-70942014000500335,estadisticamente,o
45,S0034-70942014000500335,significativo,o
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,menor,o
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,todos,o
45,S0034-70942014000500335,los,o
45,S0034-70942014000500335,intervalos,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,tiempo,o
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,grupo,o
45,S0034-70942014000500335,pregabalina,i
45,S0034-70942014000500335,p,o
45,S0034-70942014000500335,0002,o
45,S0034-70942014000500335,p,o
45,S0034-70942014000500335,0001,o
45,S0034-70942014000500335,p,o
45,S0034-70942014000500335,0001,o
45,S0034-70942014000500335,p,o
45,S0034-70942014000500335,0001,o
45,S0034-70942014000500335,p,o
45,S0034-70942014000500335,0001,o
45,S0034-70942014000500335,respectivamente,o
45,S0034-70942014000500335,No,o
45,S0034-70942014000500335,hubo,o
45,S0034-70942014000500335,diferencia,o
45,S0034-70942014000500335,estadisticamente,o
45,S0034-70942014000500335,significativa,o
45,S0034-70942014000500335,entre,o
45,S0034-70942014000500335,los,o
45,S0034-70942014000500335,2,o
45,S0034-70942014000500335,grupos,o
45,S0034-70942014000500335,con,o
45,S0034-70942014000500335,relacion,o
45,S0034-70942014000500335,al,o
45,S0034-70942014000500335,aclaramiento,i
45,S0034-70942014000500335,de,i
45,S0034-70942014000500335,creatinina,i
45,S0034-70942014000500335,o,o
45,S0034-70942014000500335,cistatinaC,o
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,preoperatorio,o
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,la,o
45,S0034-70942014000500335,2a,o
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,24a,o
45,S0034-70942014000500335,horas,o
45,S0034-70942014000500335,del,o
45,S0034-70942014000500335,postoperatorio,o
45,S0034-70942014000500335,Los,o
45,S0034-70942014000500335,niveles,i
45,S0034-70942014000500335,de,i
45,S0034-70942014000500335,lipocalina,i
45,S0034-70942014000500335,asociada,i
45,S0034-70942014000500335,a,i
45,S0034-70942014000500335,la,i
45,S0034-70942014000500335,gelatinasa,i
45,S0034-70942014000500335,de,i
45,S0034-70942014000500335,neutrofilos,i
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,la,o
45,S0034-70942014000500335,24ahora,o
45,S0034-70942014000500335,del,o
45,S0034-70942014000500335,postoperatorio,o
45,S0034-70942014000500335,fueron,o
45,S0034-70942014000500335,significativamente,o
45,S0034-70942014000500335,menores,o
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,grupo,o
45,S0034-70942014000500335,pregabalina,i
45,S0034-70942014000500335,p,o
45,S0034-70942014000500335,0027,o
45,S0034-70942014000500335,Conclusiones,o
45,S0034-70942014000500335,La,o
45,S0034-70942014000500335,dosis,o
45,S0034-70942014000500335,unica,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,75,o
45,S0034-70942014000500335,mg,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,pregabalina,i
45,S0034-70942014000500335,oral,o
45,S0034-70942014000500335,administrada,i
45,S0034-70942014000500335,precozmente,i
45,S0034-70942014000500335,fue,o
45,S0034-70942014000500335,eficaz,o
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,la,o
45,S0034-70942014000500335,reduccion,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,las,o
45,S0034-70942014000500335,puntuaciones,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,dolor,i
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,postoperatorio,o
45,S0034-70942014000500335,inmediato,o
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,el,o
45,S0034-70942014000500335,consumo,o
45,S0034-70942014000500335,total,o
45,S0034-70942014000500335,de,o
45,S0034-70942014000500335,analgesicos,i
45,S0034-70942014000500335,en,o
45,S0034-70942014000500335,pacientes,o
45,S0034-70942014000500335,sometidos,o
45,S0034-70942014000500335,a,o
45,S0034-70942014000500335,nefrolitotomia,i
45,S0034-70942014000500335,percutanea,i
45,S0034-70942014000500335,sin,o
45,S0034-70942014000500335,causar,o
45,S0034-70942014000500335,inestabilidad,i
45,S0034-70942014000500335,hemodinamica,i
45,S0034-70942014000500335,y,o
45,S0034-70942014000500335,efectos,i
45,S0034-70942014000500335,colaterales,i
46,S0034-70942014000600377,Efectos,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,ketamina,i
46,S0034-70942014000600377,y,o
46,S0034-70942014000600377,el,o
46,S0034-70942014000600377,midazolam,i
46,S0034-70942014000600377,sobre,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,incidencia,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,agitacion,i
46,S0034-70942014000600377,postanestesia,i
46,S0034-70942014000600377,con,o
46,S0034-70942014000600377,sevoflurano,i
46,S0034-70942014000600377,en,o
46,S0034-70942014000600377,niños,o
46,S0034-70942014000600377,sometidos,o
46,S0034-70942014000600377,al,o
46,S0034-70942014000600377,bloqueo,i
46,S0034-70942014000600377,caudal,i
46,S0034-70942014000600377,estudio,i
46,S0034-70942014000600377,aleatorizado,i
46,S0034-70942014000600377,Introduccion,o
46,S0034-70942014000600377,y,o
46,S0034-70942014000600377,objetivos,o
46,S0034-70942014000600377,La,o
46,S0034-70942014000600377,incidencia,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,agitacion,i
46,S0034-70942014000600377,es,o
46,S0034-70942014000600377,un,o
46,S0034-70942014000600377,problema,i
46,S0034-70942014000600377,postanestesico,i
46,S0034-70942014000600377,frecuente,o
46,S0034-70942014000600377,en,o
46,S0034-70942014000600377,niños,o
46,S0034-70942014000600377,despues,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,anestesia,i
46,S0034-70942014000600377,con,o
46,S0034-70942014000600377,sevoflurano,i
46,S0034-70942014000600377,Nuestro,o
46,S0034-70942014000600377,objetivo,o
46,S0034-70942014000600377,fue,o
46,S0034-70942014000600377,comparar,o
46,S0034-70942014000600377,los,o
46,S0034-70942014000600377,efectos,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,ketamina,i
46,S0034-70942014000600377,y,o
46,S0034-70942014000600377,del,o
46,S0034-70942014000600377,midazolam,i
46,S0034-70942014000600377,administrados,i
46,S0034-70942014000600377,por,i
46,S0034-70942014000600377,via,i
46,S0034-70942014000600377,intravenosa,i
46,S0034-70942014000600377,antes,o
46,S0034-70942014000600377,del,o
46,S0034-70942014000600377,termino,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,cirugia,i
46,S0034-70942014000600377,para,o
46,S0034-70942014000600377,prevenir,i
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,incidencia,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,agitacion,i
46,S0034-70942014000600377,en,o
46,S0034-70942014000600377,niños,o
46,S0034-70942014000600377,sometidos,o
46,S0034-70942014000600377,al,o
46,S0034-70942014000600377,bloqueo,i
46,S0034-70942014000600377,caudal,i
46,S0034-70942014000600377,para,o
46,S0034-70942014000600377,alivio,o
46,S0034-70942014000600377,del,o
46,S0034-70942014000600377,dolor,i
46,S0034-70942014000600377,bajo,o
46,S0034-70942014000600377,anestesia,i
46,S0034-70942014000600377,con,o
46,S0034-70942014000600377,sevoflurano,i
46,S0034-70942014000600377,Metodos,o
46,S0034-70942014000600377,62,o
46,S0034-70942014000600377,pacientes,o
46,S0034-70942014000600377,pediatricos,o
46,S0034-70942014000600377,con,o
46,S0034-70942014000600377,edades,o
46,S0034-70942014000600377,entre,o
46,S0034-70942014000600377,2,o
46,S0034-70942014000600377,y,o
46,S0034-70942014000600377,7,o
46,S0034-70942014000600377,años,o
46,S0034-70942014000600377,estado,o
46,S0034-70942014000600377,fisico,o
46,S0034-70942014000600377,clasificado,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,acuerdo,o
46,S0034-70942014000600377,con,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,Sociedad,o
46,S0034-70942014000600377,Norteamericana,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,Anestesiologos,o
46,S0034-70942014000600377,ASA,o
46,S0034-70942014000600377,I,o
46,S0034-70942014000600377,programados,o
46,S0034-70942014000600377,para,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,correccion,i
46,S0034-70942014000600377,de,i
46,S0034-70942014000600377,hernia,i
46,S0034-70942014000600377,inguinal,i
46,S0034-70942014000600377,circuncision,i
46,S0034-70942014000600377,o,o
46,S0034-70942014000600377,orquidopexia,i
46,S0034-70942014000600377,fueron,o
46,S0034-70942014000600377,inscritos,o
46,S0034-70942014000600377,en,o
46,S0034-70942014000600377,el,o
46,S0034-70942014000600377,estudio,o
46,S0034-70942014000600377,La,o
46,S0034-70942014000600377,anestesia,i
46,S0034-70942014000600377,se,o
46,S0034-70942014000600377,indujo,i
46,S0034-70942014000600377,con,o
46,S0034-70942014000600377,sevoflurano,i
46,S0034-70942014000600377,al,o
46,S0034-70942014000600377,8,o
46,S0034-70942014000600377,en,o
46,S0034-70942014000600377,una,o
46,S0034-70942014000600377,mezcla,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,oxigeno,i
46,S0034-70942014000600377,al,o
46,S0034-70942014000600377,50,o
46,S0034-70942014000600377,y,o
46,S0034-70942014000600377,oxido,i
46,S0034-70942014000600377,nitroso,i
46,S0034-70942014000600377,al,o
46,S0034-70942014000600377,50,o
46,S0034-70942014000600377,Despues,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,alcanzar,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,profundidad,o
46,S0034-70942014000600377,adecuada,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,anestesia,i
46,S0034-70942014000600377,una,o
46,S0034-70942014000600377,mascarilla,o
46,S0034-70942014000600377,laringea,i
46,S0034-70942014000600377,se,o
46,S0034-70942014000600377,coloco,o
46,S0034-70942014000600377,y,o
46,S0034-70942014000600377,enseguida,o
46,S0034-70942014000600377,el,o
46,S0034-70942014000600377,bloqueo,i
46,S0034-70942014000600377,caudal,i
46,S0034-70942014000600377,se,o
46,S0034-70942014000600377,realizo,o
46,S0034-70942014000600377,con,o
46,S0034-70942014000600377,bupivacaina,i
46,S0034-70942014000600377,al,o
46,S0034-70942014000600377,025,o
46,S0034-70942014000600377,075,o
46,S0034-70942014000600377,ml,o
46,S0034-70942014000600377,kg1,o
46,S0034-70942014000600377,Al,o
46,S0034-70942014000600377,final,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,cirugia,i
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,ketamina,i
46,S0034-70942014000600377,025,o
46,S0034-70942014000600377,mg,o
46,S0034-70942014000600377,kg1,o
46,S0034-70942014000600377,el,o
46,S0034-70942014000600377,midazolam,i
46,S0034-70942014000600377,003,o
46,S0034-70942014000600377,mg,o
46,S0034-70942014000600377,kg1,o
46,S0034-70942014000600377,y,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,solucion,i
46,S0034-70942014000600377,salina,i
46,S0034-70942014000600377,fueron,o
46,S0034-70942014000600377,administrados,o
46,S0034-70942014000600377,a,o
46,S0034-70942014000600377,los,o
46,S0034-70942014000600377,grupos,o
46,S0034-70942014000600377,ketamina,i
46,S0034-70942014000600377,midazolam,i
46,S0034-70942014000600377,y,o
46,S0034-70942014000600377,control,o
46,S0034-70942014000600377,respectivamente,o
46,S0034-70942014000600377,La,o
46,S0034-70942014000600377,incidencia,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,agitacion,i
46,S0034-70942014000600377,se,o
46,S0034-70942014000600377,evaluo,o
46,S0034-70942014000600377,usando,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,escala,o
46,S0034-70942014000600377,Paediatric,o
46,S0034-70942014000600377,Anaesthesia,o
46,S0034-70942014000600377,Emergence,o
46,S0034-70942014000600377,Delirium,o
46,S0034-70942014000600377,y,o
46,S0034-70942014000600377,el,o
46,S0034-70942014000600377,dolor,i
46,S0034-70942014000600377,en,o
46,S0034-70942014000600377,el,o
46,S0034-70942014000600377,periodo,o
46,S0034-70942014000600377,postoperatorio,o
46,S0034-70942014000600377,se,o
46,S0034-70942014000600377,calculo,o
46,S0034-70942014000600377,con,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,escala,o
46,S0034-70942014000600377,modificada,o
46,S0034-70942014000600377,Childrens,o
46,S0034-70942014000600377,Hospital,o
46,S0034-70942014000600377,of,o
46,S0034-70942014000600377,Eastern,o
46,S0034-70942014000600377,Ontario,o
46,S0034-70942014000600377,Pain,o
46,S0034-70942014000600377,Scale,o
46,S0034-70942014000600377,Resultados,o
46,S0034-70942014000600377,y,o
46,S0034-70942014000600377,conclusiones,o
46,S0034-70942014000600377,Las,o
46,S0034-70942014000600377,puntuaciones,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,dolor,i
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,escala,o
46,S0034-70942014000600377,modificada,o
46,S0034-70942014000600377,Childrens,o
46,S0034-70942014000600377,Hospital,o
46,S0034-70942014000600377,of,o
46,S0034-70942014000600377,Eastern,o
46,S0034-70942014000600377,Ontario,o
46,S0034-70942014000600377,Pain,o
46,S0034-70942014000600377,Scale,o
46,S0034-70942014000600377,fueron,o
46,S0034-70942014000600377,mas,o
46,S0034-70942014000600377,elevadas,o
46,S0034-70942014000600377,en,o
46,S0034-70942014000600377,el,o
46,S0034-70942014000600377,grupo,o
46,S0034-70942014000600377,control,o
46,S0034-70942014000600377,que,o
46,S0034-70942014000600377,en,o
46,S0034-70942014000600377,los,o
46,S0034-70942014000600377,grupos,o
46,S0034-70942014000600377,ketamina,i
46,S0034-70942014000600377,y,o
46,S0034-70942014000600377,midazolam,i
46,S0034-70942014000600377,Las,o
46,S0034-70942014000600377,puntuaciones,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,Paediatric,o
46,S0034-70942014000600377,Anaesthesia,o
46,S0034-70942014000600377,Emergence,o
46,S0034-70942014000600377,Delirium,o
46,S0034-70942014000600377,fueron,o
46,S0034-70942014000600377,parecidas,o
46,S0034-70942014000600377,entre,o
46,S0034-70942014000600377,los,o
46,S0034-70942014000600377,grupos,o
46,S0034-70942014000600377,Las,o
46,S0034-70942014000600377,puntuaciones,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,esas,o
46,S0034-70942014000600377,2,o
46,S0034-70942014000600377,escalas,o
46,S0034-70942014000600377,arrojaron,o
46,S0034-70942014000600377,una,o
46,S0034-70942014000600377,reduccion,o
46,S0034-70942014000600377,significativa,o
46,S0034-70942014000600377,del,o
46,S0034-70942014000600377,tiempo,o
46,S0034-70942014000600377,en,o
46,S0034-70942014000600377,todos,o
46,S0034-70942014000600377,los,o
46,S0034-70942014000600377,grupos,o
46,S0034-70942014000600377,durante,o
46,S0034-70942014000600377,el,o
46,S0034-70942014000600377,seguimiento,i
46,S0034-70942014000600377,en,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,sala,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,recuperacion,o
46,S0034-70942014000600377,postanestesia,o
46,S0034-70942014000600377,El,o
46,S0034-70942014000600377,presente,o
46,S0034-70942014000600377,estudio,o
46,S0034-70942014000600377,trajo,o
46,S0034-70942014000600377,puntuaciones,o
46,S0034-70942014000600377,satisfactorias,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,escala,o
46,S0034-70942014000600377,Paediatric,o
46,S0034-70942014000600377,Anaesthesia,o
46,S0034-70942014000600377,Emergence,o
46,S0034-70942014000600377,Delirium,o
46,S0034-70942014000600377,que,o
46,S0034-70942014000600377,quedaron,o
46,S0034-70942014000600377,por,o
46,S0034-70942014000600377,debajo,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,10,o
46,S0034-70942014000600377,en,o
46,S0034-70942014000600377,todos,o
46,S0034-70942014000600377,los,o
46,S0034-70942014000600377,grupos,o
46,S0034-70942014000600377,Como,o
46,S0034-70942014000600377,conclusion,o
46,S0034-70942014000600377,tanto,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,ketamina,i
46,S0034-70942014000600377,como,o
46,S0034-70942014000600377,el,o
46,S0034-70942014000600377,midazolam,i
46,S0034-70942014000600377,adicionados,o
46,S0034-70942014000600377,al,o
46,S0034-70942014000600377,bloqueo,i
46,S0034-70942014000600377,caudal,i
46,S0034-70942014000600377,bajo,o
46,S0034-70942014000600377,anestesia,i
46,S0034-70942014000600377,con,o
46,S0034-70942014000600377,sevoflurano,i
46,S0034-70942014000600377,no,o
46,S0034-70942014000600377,mostraron,o
46,S0034-70942014000600377,efectos,o
46,S0034-70942014000600377,adicionales,o
46,S0034-70942014000600377,sobre,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,incidencia,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,agitacion,i
46,S0034-70942014000600377,Ademas,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,eso,o
46,S0034-70942014000600377,el,o
46,S0034-70942014000600377,alivio,o
46,S0034-70942014000600377,del,o
46,S0034-70942014000600377,dolor,i
46,S0034-70942014000600377,todavia,o
46,S0034-70942014000600377,parece,o
46,S0034-70942014000600377,ser,o
46,S0034-70942014000600377,el,o
46,S0034-70942014000600377,principal,o
46,S0034-70942014000600377,factor,o
46,S0034-70942014000600377,en,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,prevencion,i
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,incidencia,o
46,S0034-70942014000600377,de,o
46,S0034-70942014000600377,agitacion,i
46,S0034-70942014000600377,posterior,o
46,S0034-70942014000600377,a,o
46,S0034-70942014000600377,la,o
46,S0034-70942014000600377,anestesia,i
46,S0034-70942014000600377,con,o
46,S0034-70942014000600377,sevoflurano,i
47,S0034-70942015000200092,Efecto,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,lidocaina,i
47,S0034-70942015000200092,venosa,o
47,S0034-70942015000200092,intraoperatoria,o
47,S0034-70942015000200092,sobre,o
47,S0034-70942015000200092,el,o
47,S0034-70942015000200092,dolor,i
47,S0034-70942015000200092,e,o
47,S0034-70942015000200092,interleucina6,o
47,S0034-70942015000200092,plasmatica,i
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,pacientes,o
47,S0034-70942015000200092,sometidas,o
47,S0034-70942015000200092,a,o
47,S0034-70942015000200092,histerectomia,i
47,S0034-70942015000200092,JUSTIFICACION,o
47,S0034-70942015000200092,Y,o
47,S0034-70942015000200092,OBJETIVOS,o
47,S0034-70942015000200092,La,o
47,S0034-70942015000200092,interleucina6,o
47,S0034-70942015000200092,IL6,o
47,S0034-70942015000200092,es,o
47,S0034-70942015000200092,predictora,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,intensidad,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,el,o
47,S0034-70942015000200092,trauma,i
47,S0034-70942015000200092,El,o
47,S0034-70942015000200092,objetivo,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,este,o
47,S0034-70942015000200092,estudio,o
47,S0034-70942015000200092,fue,o
47,S0034-70942015000200092,evaluar,o
47,S0034-70942015000200092,el,o
47,S0034-70942015000200092,efecto,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,lidocaina,i
47,S0034-70942015000200092,por,o
47,S0034-70942015000200092,via,o
47,S0034-70942015000200092,venosa,o
47,S0034-70942015000200092,sobre,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,intensidad,o
47,S0034-70942015000200092,del,o
47,S0034-70942015000200092,dolor,i
47,S0034-70942015000200092,e,o
47,S0034-70942015000200092,IL6,o
47,S0034-70942015000200092,despues,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,histerectomia,i
47,S0034-70942015000200092,METODO,o
47,S0034-70942015000200092,El,o
47,S0034-70942015000200092,estudio,o
47,S0034-70942015000200092,fue,o
47,S0034-70942015000200092,prospectivo,o
47,S0034-70942015000200092,aleatorizado,o
47,S0034-70942015000200092,comparativo,o
47,S0034-70942015000200092,y,o
47,S0034-70942015000200092,doble,o
47,S0034-70942015000200092,ciego,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,40,o
47,S0034-70942015000200092,pacientes,o
47,S0034-70942015000200092,entre,o
47,S0034-70942015000200092,18,o
47,S0034-70942015000200092,y,o
47,S0034-70942015000200092,60,o
47,S0034-70942015000200092,años,o
47,S0034-70942015000200092,Fue,o
47,S0034-70942015000200092,administrada,o
47,S0034-70942015000200092,lidocaina,i
47,S0034-70942015000200092,2,o
47,S0034-70942015000200092,mgkg1h1,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,el,o
47,S0034-70942015000200092,G1,o
47,S0034-70942015000200092,o,o
47,S0034-70942015000200092,solucion,i
47,S0034-70942015000200092,salina,i
47,S0034-70942015000200092,al,o
47,S0034-70942015000200092,09,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,el,o
47,S0034-70942015000200092,G2,o
47,S0034-70942015000200092,durante,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,operacion,i
47,S0034-70942015000200092,La,o
47,S0034-70942015000200092,anestesia,i
47,S0034-70942015000200092,fue,o
47,S0034-70942015000200092,con,o
47,S0034-70942015000200092,O2isoflurano,o
47,S0034-70942015000200092,Se,o
47,S0034-70942015000200092,calculo,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,intensidad,o
47,S0034-70942015000200092,del,o
47,S0034-70942015000200092,dolor,i
47,S0034-70942015000200092,T0,o
47,S0034-70942015000200092,despertar,o
47,S0034-70942015000200092,y,o
47,S0034-70942015000200092,6,o
47,S0034-70942015000200092,12,o
47,S0034-70942015000200092,18,o
47,S0034-70942015000200092,y,o
47,S0034-70942015000200092,24,o
47,S0034-70942015000200092,h,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,primera,o
47,S0034-70942015000200092,solicitud,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,analgesico,i
47,S0034-70942015000200092,y,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,dosis,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,morfina,i
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,las,o
47,S0034-70942015000200092,primeras,o
47,S0034-70942015000200092,24,o
47,S0034-70942015000200092,h,o
47,S0034-70942015000200092,La,o
47,S0034-70942015000200092,IL6,o
47,S0034-70942015000200092,se,o
47,S0034-70942015000200092,midio,o
47,S0034-70942015000200092,antes,o
47,S0034-70942015000200092,del,o
47,S0034-70942015000200092,inicio,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,operacion,i
47,S0034-70942015000200092,T0,o
47,S0034-70942015000200092,despues,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,5,o
47,S0034-70942015000200092,h,o
47,S0034-70942015000200092,del,o
47,S0034-70942015000200092,inicio,o
47,S0034-70942015000200092,T5,o
47,S0034-70942015000200092,y,o
47,S0034-70942015000200092,24,o
47,S0034-70942015000200092,h,o
47,S0034-70942015000200092,despues,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,finalizada,o
47,S0034-70942015000200092,T24,o
47,S0034-70942015000200092,RESULTADOS,o
47,S0034-70942015000200092,No,o
47,S0034-70942015000200092,hubo,o
47,S0034-70942015000200092,diferencia,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,intensidad,o
47,S0034-70942015000200092,del,o
47,S0034-70942015000200092,dolor,i
47,S0034-70942015000200092,entre,o
47,S0034-70942015000200092,los,o
47,S0034-70942015000200092,grupos,o
47,S0034-70942015000200092,Hubo,o
47,S0034-70942015000200092,disminucion,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,intensidad,o
47,S0034-70942015000200092,del,o
47,S0034-70942015000200092,dolor,i
47,S0034-70942015000200092,entre,o
47,S0034-70942015000200092,T0,o
47,S0034-70942015000200092,y,o
47,S0034-70942015000200092,los,o
47,S0034-70942015000200092,otros,o
47,S0034-70942015000200092,momentos,o
47,S0034-70942015000200092,evaluados,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,el,o
47,S0034-70942015000200092,G1,o
47,S0034-70942015000200092,El,o
47,S0034-70942015000200092,tiempo,o
47,S0034-70942015000200092,para,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,primera,o
47,S0034-70942015000200092,complementacion,o
47,S0034-70942015000200092,fue,o
47,S0034-70942015000200092,mayor,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,el,o
47,S0034-70942015000200092,G2,o
47,S0034-70942015000200092,76,o
47,S0034-70942015000200092,1044,o
47,S0034-70942015000200092,min,o
47,S0034-70942015000200092,que,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,el,o
47,S0034-70942015000200092,G1,o
47,S0034-70942015000200092,267,o
47,S0034-70942015000200092,233,o
47,S0034-70942015000200092,min,o
47,S0034-70942015000200092,No,o
47,S0034-70942015000200092,hubo,o
47,S0034-70942015000200092,diferencia,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,las,o
47,S0034-70942015000200092,dosis,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,morfina,i
47,S0034-70942015000200092,complementaria,o
47,S0034-70942015000200092,entre,o
47,S0034-70942015000200092,G1,o
47,S0034-70942015000200092,235,o
47,S0034-70942015000200092,126,o
47,S0034-70942015000200092,mg,o
47,S0034-70942015000200092,y,o
47,S0034-70942015000200092,G2,o
47,S0034-70942015000200092,187,o
47,S0034-70942015000200092,113,o
47,S0034-70942015000200092,mg,o
47,S0034-70942015000200092,Hubo,o
47,S0034-70942015000200092,aumento,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,las,o
47,S0034-70942015000200092,concentraciones,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,IL6,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,los,o
47,S0034-70942015000200092,2,o
47,S0034-70942015000200092,grupos,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,T0,o
47,S0034-70942015000200092,para,o
47,S0034-70942015000200092,T5,o
47,S0034-70942015000200092,y,o
47,S0034-70942015000200092,T24,o
47,S0034-70942015000200092,No,o
47,S0034-70942015000200092,hubo,o
47,S0034-70942015000200092,diferencia,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,dosificacion,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,IL6,o
47,S0034-70942015000200092,entre,o
47,S0034-70942015000200092,los,o
47,S0034-70942015000200092,grupos,o
47,S0034-70942015000200092,La,o
47,S0034-70942015000200092,concentracion,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,lidocaina,i
47,S0034-70942015000200092,fue,o
47,S0034-70942015000200092,8565,o
47,S0034-70942015000200092,3641,o
47,S0034-70942015000200092,ngml1,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,T5,o
47,S0034-70942015000200092,y,o
47,S0034-70942015000200092,301,o
47,S0034-70942015000200092,142,o
47,S0034-70942015000200092,ngml1,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,T24,o
47,S0034-70942015000200092,CONCLUSION,o
47,S0034-70942015000200092,La,o
47,S0034-70942015000200092,lidocaina,i
47,S0034-70942015000200092,2,o
47,S0034-70942015000200092,mgkg1,o
47,S0034-70942015000200092,h1,o
47,S0034-70942015000200092,por,o
47,S0034-70942015000200092,via,o
47,S0034-70942015000200092,venosa,o
47,S0034-70942015000200092,no,o
47,S0034-70942015000200092,genero,o
47,S0034-70942015000200092,reduccion,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,la,o
47,S0034-70942015000200092,intensidad,o
47,S0034-70942015000200092,del,o
47,S0034-70942015000200092,dolor,i
47,S0034-70942015000200092,y,o
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,los,o
47,S0034-70942015000200092,niveles,o
47,S0034-70942015000200092,plasmaticos,i
47,S0034-70942015000200092,de,o
47,S0034-70942015000200092,IL6,o
47,S0034-70942015000200092,en,o
47,S0034-70942015000200092,pacientes,o
47,S0034-70942015000200092,sometidas,o
47,S0034-70942015000200092,a,o
47,S0034-70942015000200092,histerectomia,i
47,S0034-70942015000200092,abdominal,i
48,S0034-70942015000300207,Lidocaina,i
48,S0034-70942015000300207,intravenosa,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,el,o
48,S0034-70942015000300207,tratamiento,i
48,S0034-70942015000300207,del,i
48,S0034-70942015000300207,dolor,i
48,S0034-70942015000300207,posmastectomia,i
48,S0034-70942015000300207,ensayo,o
48,S0034-70942015000300207,clinico,o
48,S0034-70942015000300207,aleatorizado,o
48,S0034-70942015000300207,encubierto,o
48,S0034-70942015000300207,placebo,i
48,S0034-70942015000300207,controlado,o
48,S0034-70942015000300207,JUSTIFICACION,o
48,S0034-70942015000300207,Y,o
48,S0034-70942015000300207,OBJETIVO,o
48,S0034-70942015000300207,El,o
48,S0034-70942015000300207,tratamiento,i
48,S0034-70942015000300207,del,i
48,S0034-70942015000300207,dolor,i
48,S0034-70942015000300207,postoperatorio,i
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,la,o
48,S0034-70942015000300207,mastectomia,i
48,S0034-70942015000300207,continua,o
48,S0034-70942015000300207,siendo,o
48,S0034-70942015000300207,un,o
48,S0034-70942015000300207,gran,o
48,S0034-70942015000300207,reto,o
48,S0034-70942015000300207,a,o
48,S0034-70942015000300207,pesar,o
48,S0034-70942015000300207,del,o
48,S0034-70942015000300207,abordaje,o
48,S0034-70942015000300207,multimodal,o
48,S0034-70942015000300207,El,o
48,S0034-70942015000300207,objetivo,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,este,o
48,S0034-70942015000300207,estudio,o
48,S0034-70942015000300207,fue,o
48,S0034-70942015000300207,investigar,o
48,S0034-70942015000300207,el,o
48,S0034-70942015000300207,efecto,o
48,S0034-70942015000300207,analgesico,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,la,o
48,S0034-70942015000300207,lidocaina,i
48,S0034-70942015000300207,intravenosa,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,pacientes,o
48,S0034-70942015000300207,sometidas,o
48,S0034-70942015000300207,a,o
48,S0034-70942015000300207,mastectomia,i
48,S0034-70942015000300207,asi,o
48,S0034-70942015000300207,como,o
48,S0034-70942015000300207,el,o
48,S0034-70942015000300207,consumo,o
48,S0034-70942015000300207,postoperatorio,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,opiaceos,i
48,S0034-70942015000300207,METODOS,o
48,S0034-70942015000300207,Despues,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,la,o
48,S0034-70942015000300207,aprobacion,o
48,S0034-70942015000300207,por,o
48,S0034-70942015000300207,el,o
48,S0034-70942015000300207,Comite,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,Etica,o
48,S0034-70942015000300207,e,o
48,S0034-70942015000300207,Investigacion,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,seres,o
48,S0034-70942015000300207,humanos,o
48,S0034-70942015000300207,del,o
48,S0034-70942015000300207,Instituto,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,Medicina,o
48,S0034-70942015000300207,Integral,o
48,S0034-70942015000300207,Prof,o
48,S0034-70942015000300207,Fernando,o
48,S0034-70942015000300207,Figueira,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,Recife,o
48,S0034-70942015000300207,Pernambuco,o
48,S0034-70942015000300207,se,o
48,S0034-70942015000300207,realizo,o
48,S0034-70942015000300207,un,o
48,S0034-70942015000300207,ensayo,o
48,S0034-70942015000300207,clinico,o
48,S0034-70942015000300207,aleatorizado,o
48,S0034-70942015000300207,encubierto,o
48,S0034-70942015000300207,placebo,i
48,S0034-70942015000300207,controlado,o
48,S0034-70942015000300207,con,o
48,S0034-70942015000300207,lidocaina,i
48,S0034-70942015000300207,intravenosa,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,una,o
48,S0034-70942015000300207,dosis,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,3,o
48,S0034-70942015000300207,mgkg,o
48,S0034-70942015000300207,infundida,i
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,una,o
48,S0034-70942015000300207,hora,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,45,o
48,S0034-70942015000300207,mujeres,o
48,S0034-70942015000300207,sometidas,o
48,S0034-70942015000300207,a,o
48,S0034-70942015000300207,mastectomia,i
48,S0034-70942015000300207,bajo,o
48,S0034-70942015000300207,anestesia,i
48,S0034-70942015000300207,general,i
48,S0034-70942015000300207,Una,o
48,S0034-70942015000300207,paciente,o
48,S0034-70942015000300207,del,o
48,S0034-70942015000300207,grupo,o
48,S0034-70942015000300207,placebo,i
48,S0034-70942015000300207,fue,o
48,S0034-70942015000300207,excluida,o
48,S0034-70942015000300207,RESULTADOS,o
48,S0034-70942015000300207,Los,o
48,S0034-70942015000300207,grupos,o
48,S0034-70942015000300207,fueron,o
48,S0034-70942015000300207,similares,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,cuanto,o
48,S0034-70942015000300207,a,o
48,S0034-70942015000300207,la,o
48,S0034-70942015000300207,edad,o
48,S0034-70942015000300207,indice,i
48,S0034-70942015000300207,de,i
48,S0034-70942015000300207,masa,i
48,S0034-70942015000300207,corporal,i
48,S0034-70942015000300207,tipo,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,intervencion,i
48,S0034-70942015000300207,quirurgica,i
48,S0034-70942015000300207,y,o
48,S0034-70942015000300207,necesidad,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,opiaceos,i
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,el,o
48,S0034-70942015000300207,postoperatorio,o
48,S0034-70942015000300207,Solicitaron,o
48,S0034-70942015000300207,opiaceos,i
48,S0034-70942015000300207,222,o
48,S0034-70942015000300207,pacientes,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,los,o
48,S0034-70942015000300207,grupos,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,la,o
48,S0034-70942015000300207,lidocaina,i
48,S0034-70942015000300207,y,o
48,S0034-70942015000300207,322,o
48,S0034-70942015000300207,placebo,i
48,S0034-70942015000300207,p,o
48,S0034-70942015000300207,050,o
48,S0034-70942015000300207,Fue,o
48,S0034-70942015000300207,identificado,o
48,S0034-70942015000300207,el,o
48,S0034-70942015000300207,dolor,i
48,S0034-70942015000300207,al,o
48,S0034-70942015000300207,despertar,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,422,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,el,o
48,S0034-70942015000300207,grupo,o
48,S0034-70942015000300207,lidocaina,i
48,S0034-70942015000300207,y,o
48,S0034-70942015000300207,522,o
48,S0034-70942015000300207,p,o
48,S0034-70942015000300207,050,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,el,o
48,S0034-70942015000300207,grupo,o
48,S0034-70942015000300207,placebo,i
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,la,o
48,S0034-70942015000300207,sala,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,recuperacion,o
48,S0034-70942015000300207,postanestesica,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,1422,o
48,S0034-70942015000300207,y,o
48,S0034-70942015000300207,1222,o
48,S0034-70942015000300207,p,o
48,S0034-70942015000300207,037,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,los,o
48,S0034-70942015000300207,grupos,o
48,S0034-70942015000300207,lidocaina,i
48,S0034-70942015000300207,y,o
48,S0034-70942015000300207,placebo,i
48,S0034-70942015000300207,respectivamente,o
48,S0034-70942015000300207,Al,o
48,S0034-70942015000300207,calcular,o
48,S0034-70942015000300207,el,o
48,S0034-70942015000300207,dolor,i
48,S0034-70942015000300207,24,o
48,S0034-70942015000300207,h,o
48,S0034-70942015000300207,despues,o
48,S0034-70942015000300207,del,o
48,S0034-70942015000300207,procedimiento,i
48,S0034-70942015000300207,quirurgico,i
48,S0034-70942015000300207,322,o
48,S0034-70942015000300207,y,o
48,S0034-70942015000300207,222,o
48,S0034-70942015000300207,p,o
48,S0034-70942015000300207,050,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,las,o
48,S0034-70942015000300207,pacientes,o
48,S0034-70942015000300207,relataron,o
48,S0034-70942015000300207,dolor,i
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,ambos,o
48,S0034-70942015000300207,grupos,o
48,S0034-70942015000300207,respectivamente,o
48,S0034-70942015000300207,CONCLUSION,o
48,S0034-70942015000300207,La,o
48,S0034-70942015000300207,lidocaina,i
48,S0034-70942015000300207,intravenosa,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,una,o
48,S0034-70942015000300207,dosis,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,3,o
48,S0034-70942015000300207,mgkg,o
48,S0034-70942015000300207,administrada,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,un,o
48,S0034-70942015000300207,periodo,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,una,o
48,S0034-70942015000300207,hora,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,el,o
48,S0034-70942015000300207,transoperatorio,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,mastectomia,i
48,S0034-70942015000300207,no,o
48,S0034-70942015000300207,genero,o
48,S0034-70942015000300207,analgesia,i
48,S0034-70942015000300207,adicional,o
48,S0034-70942015000300207,con,o
48,S0034-70942015000300207,relacion,o
48,S0034-70942015000300207,al,o
48,S0034-70942015000300207,grupo,o
48,S0034-70942015000300207,placebo,i
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,las,o
48,S0034-70942015000300207,primeras,o
48,S0034-70942015000300207,24,o
48,S0034-70942015000300207,h,o
48,S0034-70942015000300207,y,o
48,S0034-70942015000300207,no,o
48,S0034-70942015000300207,disminuyo,o
48,S0034-70942015000300207,el,o
48,S0034-70942015000300207,consumo,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,opiaceos,i
48,S0034-70942015000300207,Sin,o
48,S0034-70942015000300207,embargo,o
48,S0034-70942015000300207,no,o
48,S0034-70942015000300207,puede,o
48,S0034-70942015000300207,ser,o
48,S0034-70942015000300207,descartado,o
48,S0034-70942015000300207,un,o
48,S0034-70942015000300207,efecto,o
48,S0034-70942015000300207,beneficioso,o
48,S0034-70942015000300207,de,o
48,S0034-70942015000300207,la,o
48,S0034-70942015000300207,lidocaina,i
48,S0034-70942015000300207,intravenosa,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,pacientes,o
48,S0034-70942015000300207,seleccionadas,o
48,S0034-70942015000300207,yo,o
48,S0034-70942015000300207,en,o
48,S0034-70942015000300207,otros,o
48,S0034-70942015000300207,regimenes,i
48,S0034-70942015000300207,terapeuticos,i
49,S0034-74932007000300003,Terapia,i
49,S0034-74932007000300003,neural,i
49,S0034-74932007000300003,como,o
49,S0034-74932007000300003,tratamiento,i
49,S0034-74932007000300003,contra,i
49,S0034-74932007000300003,el,i
49,S0034-74932007000300003,dolor,i
49,S0034-74932007000300003,en,o
49,S0034-74932007000300003,la,o
49,S0034-74932007000300003,displasia,i
49,S0034-74932007000300003,mamaria,i
49,S0034-74932007000300003,ciclica,o
49,S0034-74932007000300003,de,o
49,S0034-74932007000300003,grado,o
49,S0034-74932007000300003,II,o
49,S0034-74932007000300003,De,o
49,S0034-74932007000300003,enero,o
49,S0034-74932007000300003,a,o
49,S0034-74932007000300003,diciembre,o
49,S0034-74932007000300003,de,o
49,S0034-74932007000300003,2004,o
49,S0034-74932007000300003,se,o
49,S0034-74932007000300003,realizo,o
49,S0034-74932007000300003,un,o
49,S0034-74932007000300003,estudio,o
49,S0034-74932007000300003,experimental,o
49,S0034-74932007000300003,del,o
49,S0034-74932007000300003,tipo,o
49,S0034-74932007000300003,ensayo,o
49,S0034-74932007000300003,clinico,o
49,S0034-74932007000300003,de,o
49,S0034-74932007000300003,fase,o
49,S0034-74932007000300003,II,o
49,S0034-74932007000300003,controlado,o
49,S0034-74932007000300003,y,o
49,S0034-74932007000300003,monocentrico,o
49,S0034-74932007000300003,cuyo,o
49,S0034-74932007000300003,objetivo,o
49,S0034-74932007000300003,fue,o
49,S0034-74932007000300003,evaluar,i
49,S0034-74932007000300003,la,i
49,S0034-74932007000300003,eficacia,i
49,S0034-74932007000300003,de,o
49,S0034-74932007000300003,la,o
49,S0034-74932007000300003,terapia,i
49,S0034-74932007000300003,neural,i
49,S0034-74932007000300003,en,o
49,S0034-74932007000300003,el,o
49,S0034-74932007000300003,tratamiento,i
49,S0034-74932007000300003,del,i
49,S0034-74932007000300003,dolor,i
49,S0034-74932007000300003,como,o
49,S0034-74932007000300003,manifestacion,i
49,S0034-74932007000300003,de,o
49,S0034-74932007000300003,la,o
49,S0034-74932007000300003,displasia,i
49,S0034-74932007000300003,mamaria,i
49,S0034-74932007000300003,ciclica,o
49,S0034-74932007000300003,de,o
49,S0034-74932007000300003,grado,o
49,S0034-74932007000300003,II,o
49,S0034-74932007000300003,en,o
49,S0034-74932007000300003,comparacion,o
49,S0034-74932007000300003,con,o
49,S0034-74932007000300003,la,o
49,S0034-74932007000300003,terapeutica,i
49,S0034-74932007000300003,convencional,i
49,S0034-74932007000300003,Se,o
49,S0034-74932007000300003,estudiaron,o
49,S0034-74932007000300003,240,o
49,S0034-74932007000300003,pacientes,o
49,S0034-74932007000300003,que,o
49,S0034-74932007000300003,fueron,o
49,S0034-74932007000300003,divididos,o
49,S0034-74932007000300003,en,o
49,S0034-74932007000300003,4,o
49,S0034-74932007000300003,grupos,o
49,S0034-74932007000300003,segun,o
49,S0034-74932007000300003,el,o
49,S0034-74932007000300003,tipo,o
49,S0034-74932007000300003,de,o
49,S0034-74932007000300003,tratamiento,i
49,S0034-74932007000300003,con,o
49,S0034-74932007000300003,terapia,i
49,S0034-74932007000300003,neural,i
49,S0034-74932007000300003,grupo,o
49,S0034-74932007000300003,I,o
49,S0034-74932007000300003,con,o
49,S0034-74932007000300003,vitamina,i
49,S0034-74932007000300003,E,i
49,S0034-74932007000300003,grupo,o
49,S0034-74932007000300003,II,o
49,S0034-74932007000300003,con,o
49,S0034-74932007000300003,progesterona,i
49,S0034-74932007000300003,grupo,o
49,S0034-74932007000300003,III,o
49,S0034-74932007000300003,y,o
49,S0034-74932007000300003,con,o
49,S0034-74932007000300003,antiinflamatorios,i
49,S0034-74932007000300003,no,i
49,S0034-74932007000300003,esteroideos,i
49,S0034-74932007000300003,grupo,o
49,S0034-74932007000300003,IV,o
49,S0034-74932007000300003,Se,o
49,S0034-74932007000300003,observo,o
49,S0034-74932007000300003,mejoria,o
49,S0034-74932007000300003,del,o
49,S0034-74932007000300003,dolor,i
49,S0034-74932007000300003,en,o
49,S0034-74932007000300003,mas,o
49,S0034-74932007000300003,de,o
49,S0034-74932007000300003,60,o
49,S0034-74932007000300003,del,o
49,S0034-74932007000300003,grupo,o
49,S0034-74932007000300003,I,o
49,S0034-74932007000300003,y,o
49,S0034-74932007000300003,fue,o
49,S0034-74932007000300003,similar,o
49,S0034-74932007000300003,con,o
49,S0034-74932007000300003,el,o
49,S0034-74932007000300003,uso,o
49,S0034-74932007000300003,de,o
49,S0034-74932007000300003,la,o
49,S0034-74932007000300003,progesterona,i
49,S0034-74932007000300003,Con,o
49,S0034-74932007000300003,los,o
49,S0034-74932007000300003,antiinflamatorios,i
49,S0034-74932007000300003,no,i
49,S0034-74932007000300003,esteroideos,i
49,S0034-74932007000300003,y,o
49,S0034-74932007000300003,la,o
49,S0034-74932007000300003,vitamina,i
49,S0034-74932007000300003,E,i
49,S0034-74932007000300003,hubo,o
49,S0034-74932007000300003,diferencias,o
49,S0034-74932007000300003,significativas,o
49,S0034-74932007000300003,Se,o
49,S0034-74932007000300003,obtuvieron,o
49,S0034-74932007000300003,resultados,o
49,S0034-74932007000300003,satisfactorios,o
49,S0034-74932007000300003,con,o
49,S0034-74932007000300003,el,o
49,S0034-74932007000300003,empleo,o
49,S0034-74932007000300003,de,o
49,S0034-74932007000300003,la,o
49,S0034-74932007000300003,terapia,i
49,S0034-74932007000300003,neural,i
49,S0034-74932007000300003,con,o
49,S0034-74932007000300003,procaina,i
49,S0034-74932007000300003,al,o
49,S0034-74932007000300003,1,o
49,S0034-74932007000300003,por,o
49,S0034-74932007000300003,lo,o
49,S0034-74932007000300003,que,o
49,S0034-74932007000300003,pudimos,o
49,S0034-74932007000300003,considerarla,o
49,S0034-74932007000300003,eficaz,o
49,S0034-74932007000300003,en,o
49,S0034-74932007000300003,la,o
49,S0034-74932007000300003,terapeutica,i
49,S0034-74932007000300003,de,o
49,S0034-74932007000300003,esta,o
49,S0034-74932007000300003,manifestacion,i
50,S0034-75072006000300005,Uso,o
50,S0034-75072006000300005,del,o
50,S0034-75072006000300005,Inmunoferon,i
50,S0034-75072006000300005,en,o
50,S0034-75072006000300005,el,o
50,S0034-75072006000300005,tratamiento,i
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,la,o
50,S0034-75072006000300005,estomatitis,i
50,S0034-75072006000300005,aftosa,i
50,S0034-75072006000300005,recurrente,i
50,S0034-75072006000300005,en,o
50,S0034-75072006000300005,niños,o
50,S0034-75072006000300005,Se,o
50,S0034-75072006000300005,realizo,o
50,S0034-75072006000300005,un,o
50,S0034-75072006000300005,ensayo,o
50,S0034-75072006000300005,clinico,o
50,S0034-75072006000300005,terapeutico,o
50,S0034-75072006000300005,aleatorizado,o
50,S0034-75072006000300005,controlado,o
50,S0034-75072006000300005,fase,o
50,S0034-75072006000300005,III,o
50,S0034-75072006000300005,a,o
50,S0034-75072006000300005,40,o
50,S0034-75072006000300005,pacientes,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,1,o
50,S0034-75072006000300005,a,o
50,S0034-75072006000300005,18,o
50,S0034-75072006000300005,años,o
50,S0034-75072006000300005,con,o
50,S0034-75072006000300005,estomatitis,i
50,S0034-75072006000300005,aftosa,i
50,S0034-75072006000300005,recurrente,i
50,S0034-75072006000300005,que,o
50,S0034-75072006000300005,acudieron,o
50,S0034-75072006000300005,al,o
50,S0034-75072006000300005,Departamento,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,Periodoncia,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,la,o
50,S0034-75072006000300005,Facultad,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,Estomatologia,o
50,S0034-75072006000300005,del,o
50,S0034-75072006000300005,ISCMH,o
50,S0034-75072006000300005,y,o
50,S0034-75072006000300005,a,o
50,S0034-75072006000300005,la,o
50,S0034-75072006000300005,consulta,i
50,S0034-75072006000300005,externa,i
50,S0034-75072006000300005,del,o
50,S0034-75072006000300005,Hospital,o
50,S0034-75072006000300005,William,o
50,S0034-75072006000300005,Soler,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,septiembre,o
50,S0034-75072006000300005,del,o
50,S0034-75072006000300005,2003,o
50,S0034-75072006000300005,a,o
50,S0034-75072006000300005,septiembre,o
50,S0034-75072006000300005,del,o
50,S0034-75072006000300005,2004,o
50,S0034-75072006000300005,Se,o
50,S0034-75072006000300005,aleatorizaron,i
50,S0034-75072006000300005,en,o
50,S0034-75072006000300005,2,o
50,S0034-75072006000300005,grupos,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,tratamiento,i
50,S0034-75072006000300005,grupo,o
50,S0034-75072006000300005,A,o
50,S0034-75072006000300005,control,o
50,S0034-75072006000300005,vitaminas,i
50,S0034-75072006000300005,mas,o
50,S0034-75072006000300005,colutorios,i
50,S0034-75072006000300005,de,i
50,S0034-75072006000300005,clorhexidina,i
50,S0034-75072006000300005,y,o
50,S0034-75072006000300005,grupo,o
50,S0034-75072006000300005,B,o
50,S0034-75072006000300005,estudio,o
50,S0034-75072006000300005,tratamiento,i
50,S0034-75072006000300005,anterior,o
50,S0034-75072006000300005,mas,o
50,S0034-75072006000300005,Inmunoferon,i
50,S0034-75072006000300005,Las,o
50,S0034-75072006000300005,lesiones,i
50,S0034-75072006000300005,se,o
50,S0034-75072006000300005,clasificaron,o
50,S0034-75072006000300005,en,o
50,S0034-75072006000300005,menor,o
50,S0034-75072006000300005,mayor,o
50,S0034-75072006000300005,o,o
50,S0034-75072006000300005,herpetiforme,o
50,S0034-75072006000300005,La,o
50,S0034-75072006000300005,forma,o
50,S0034-75072006000300005,menor,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,la,o
50,S0034-75072006000300005,enfermedad,i
50,S0034-75072006000300005,fue,o
50,S0034-75072006000300005,la,o
50,S0034-75072006000300005,mas,o
50,S0034-75072006000300005,frecuente,o
50,S0034-75072006000300005,Los,o
50,S0034-75072006000300005,niños,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,mayor,o
50,S0034-75072006000300005,edad,o
50,S0034-75072006000300005,se,o
50,S0034-75072006000300005,correspondian,o
50,S0034-75072006000300005,con,o
50,S0034-75072006000300005,la,o
50,S0034-75072006000300005,forma,o
50,S0034-75072006000300005,mayor,o
50,S0034-75072006000300005,y,o
50,S0034-75072006000300005,los,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,menor,o
50,S0034-75072006000300005,edad,o
50,S0034-75072006000300005,con,o
50,S0034-75072006000300005,la,o
50,S0034-75072006000300005,variedad,o
50,S0034-75072006000300005,herpetiforme,o
50,S0034-75072006000300005,La,o
50,S0034-75072006000300005,duracion,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,la,o
50,S0034-75072006000300005,enfermedad,i
50,S0034-75072006000300005,disminuyo,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,105,o
50,S0034-75072006000300005,dias,o
50,S0034-75072006000300005,a,o
50,S0034-75072006000300005,62,o
50,S0034-75072006000300005,dias,o
50,S0034-75072006000300005,en,o
50,S0034-75072006000300005,el,o
50,S0034-75072006000300005,grupo,o
50,S0034-75072006000300005,estudio,o
50,S0034-75072006000300005,y,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,106,o
50,S0034-75072006000300005,a,o
50,S0034-75072006000300005,83,o
50,S0034-75072006000300005,en,o
50,S0034-75072006000300005,el,o
50,S0034-75072006000300005,control,o
50,S0034-75072006000300005,El,o
50,S0034-75072006000300005,421,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,los,o
50,S0034-75072006000300005,casos,o
50,S0034-75072006000300005,en,o
50,S0034-75072006000300005,el,o
50,S0034-75072006000300005,grupo,o
50,S0034-75072006000300005,A,o
50,S0034-75072006000300005,tuvo,o
50,S0034-75072006000300005,buena,o
50,S0034-75072006000300005,evolucion,o
50,S0034-75072006000300005,contra,o
50,S0034-75072006000300005,el,o
50,S0034-75072006000300005,737,o
50,S0034-75072006000300005,en,o
50,S0034-75072006000300005,el,o
50,S0034-75072006000300005,grupo,o
50,S0034-75072006000300005,B,o
50,S0034-75072006000300005,La,o
50,S0034-75072006000300005,forma,o
50,S0034-75072006000300005,mayor,o
50,S0034-75072006000300005,fue,o
50,S0034-75072006000300005,la,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,mejor,o
50,S0034-75072006000300005,evolucion,o
50,S0034-75072006000300005,y,o
50,S0034-75072006000300005,la,o
50,S0034-75072006000300005,posibilidad,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,mejoria,o
50,S0034-75072006000300005,clinica,o
50,S0034-75072006000300005,fue,o
50,S0034-75072006000300005,7,o
50,S0034-75072006000300005,veces,o
50,S0034-75072006000300005,mayor,o
50,S0034-75072006000300005,en,o
50,S0034-75072006000300005,el,o
50,S0034-75072006000300005,grupo,o
50,S0034-75072006000300005,B,o
50,S0034-75072006000300005,En,o
50,S0034-75072006000300005,general,o
50,S0034-75072006000300005,el,o
50,S0034-75072006000300005,porcentaje,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,pacientes,o
50,S0034-75072006000300005,que,o
50,S0034-75072006000300005,se,o
50,S0034-75072006000300005,agrupo,o
50,S0034-75072006000300005,en,o
50,S0034-75072006000300005,la,o
50,S0034-75072006000300005,categoria,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,recidiva,o
50,S0034-75072006000300005,por,o
50,S0034-75072006000300005,encima,o
50,S0034-75072006000300005,de,o
50,S0034-75072006000300005,los,o
50,S0034-75072006000300005,3,o
50,S0034-75072006000300005,meses,o
50,S0034-75072006000300005,fue,o
50,S0034-75072006000300005,muy,o
50,S0034-75072006000300005,superior,o
50,S0034-75072006000300005,en,o
50,S0034-75072006000300005,el,o
50,S0034-75072006000300005,grupo,o
50,S0034-75072006000300005,B,o
50,S0034-75072006000300005,con,o
50,S0034-75072006000300005,respecto,o
50,S0034-75072006000300005,al,o
50,S0034-75072006000300005,A,o
50,S0034-75072006000300005,579,o
50,S0034-75072006000300005,vs,o
50,S0034-75072006000300005,158,o
50,S0034-75072006000300005,No,o
50,S0034-75072006000300005,hubo,o
50,S0034-75072006000300005,reacciones,i
50,S0034-75072006000300005,adversas,i
50,S0034-75072006000300005,al,i
50,S0034-75072006000300005,medicamento,i
51,S0034-75072007000300001,Laser,o
51,S0034-75072007000300001,helioneon,o
51,S0034-75072007000300001,combinado,o
51,S0034-75072007000300001,con,o
51,S0034-75072007000300001,clorhexidina,i
51,S0034-75072007000300001,al,o
51,S0034-75072007000300001,02,o
51,S0034-75072007000300001,Efectos,o
51,S0034-75072007000300001,clinicos,o
51,S0034-75072007000300001,y,o
51,S0034-75072007000300001,microbiologicos,o
51,S0034-75072007000300001,en,o
51,S0034-75072007000300001,el,o
51,S0034-75072007000300001,tratamiento,i
51,S0034-75072007000300001,de,o
51,S0034-75072007000300001,la,o
51,S0034-75072007000300001,gingivitis,i
51,S0034-75072007000300001,cronica,i
51,S0034-75072007000300001,La,o
51,S0034-75072007000300001,gingivitis,i
51,S0034-75072007000300001,cronica,i
51,S0034-75072007000300001,constituye,o
51,S0034-75072007000300001,una,o
51,S0034-75072007000300001,de,o
51,S0034-75072007000300001,las,o
51,S0034-75072007000300001,formas,o
51,S0034-75072007000300001,mas,o
51,S0034-75072007000300001,frecuentes,o
51,S0034-75072007000300001,de,o
51,S0034-75072007000300001,enfermedad,i
51,S0034-75072007000300001,periodontal,i
51,S0034-75072007000300001,caracterizada,o
51,S0034-75072007000300001,por,o
51,S0034-75072007000300001,la,o
51,S0034-75072007000300001,inflamacion,i
51,S0034-75072007000300001,cronica,i
51,S0034-75072007000300001,de,i
51,S0034-75072007000300001,la,i
51,S0034-75072007000300001,encias,i
51,S0034-75072007000300001,tumefaccion,i
51,S0034-75072007000300001,enrojecimiento,i
51,S0034-75072007000300001,y,o
51,S0034-75072007000300001,sangramiento,i
51,S0034-75072007000300001,Su,o
51,S0034-75072007000300001,principal,o
51,S0034-75072007000300001,factor,o
51,S0034-75072007000300001,de,o
51,S0034-75072007000300001,riesgo,o
51,S0034-75072007000300001,lo,o
51,S0034-75072007000300001,constituye,o
51,S0034-75072007000300001,la,o
51,S0034-75072007000300001,microbiota,o
51,S0034-75072007000300001,del,o
51,S0034-75072007000300001,surco,i
51,S0034-75072007000300001,gingival,i
51,S0034-75072007000300001,que,o
51,S0034-75072007000300001,resulta,o
51,S0034-75072007000300001,necesario,o
51,S0034-75072007000300001,pero,o
51,S0034-75072007000300001,no,o
51,S0034-75072007000300001,suficiente,o
51,S0034-75072007000300001,para,o
51,S0034-75072007000300001,desencadenarla,o
51,S0034-75072007000300001,Se,o
51,S0034-75072007000300001,realizo,o
51,S0034-75072007000300001,un,o
51,S0034-75072007000300001,ensayo,o
51,S0034-75072007000300001,clinicoterapeutico,o
51,S0034-75072007000300001,fase,o
51,S0034-75072007000300001,II,o
51,S0034-75072007000300001,controlado,o
51,S0034-75072007000300001,aleatorizado,o
51,S0034-75072007000300001,y,o
51,S0034-75072007000300001,a,o
51,S0034-75072007000300001,simple,o
51,S0034-75072007000300001,ciegas,o
51,S0034-75072007000300001,para,o
51,S0034-75072007000300001,evaluar,o
51,S0034-75072007000300001,los,o
51,S0034-75072007000300001,efectos,o
51,S0034-75072007000300001,clinicos,o
51,S0034-75072007000300001,y,o
51,S0034-75072007000300001,microbiologicos,o
51,S0034-75072007000300001,del,o
51,S0034-75072007000300001,tratamiento,i
51,S0034-75072007000300001,combinado,i
51,S0034-75072007000300001,de,o
51,S0034-75072007000300001,la,o
51,S0034-75072007000300001,radiacion,o
51,S0034-75072007000300001,laser,o
51,S0034-75072007000300001,helioneon,o
51,S0034-75072007000300001,HeNe,o
51,S0034-75072007000300001,con,o
51,S0034-75072007000300001,la,o
51,S0034-75072007000300001,clorhexidina,i
51,S0034-75072007000300001,al,o
51,S0034-75072007000300001,02,o
51,S0034-75072007000300001,Todos,o
51,S0034-75072007000300001,los,o
51,S0034-75072007000300001,pacientes,o
51,S0034-75072007000300001,recibieron,o
51,S0034-75072007000300001,tratamiento,i
51,S0034-75072007000300001,inicial,o
51,S0034-75072007000300001,al,o
51,S0034-75072007000300001,mes,o
51,S0034-75072007000300001,de,o
51,S0034-75072007000300001,finalizado,o
51,S0034-75072007000300001,este,o
51,S0034-75072007000300001,se,o
51,S0034-75072007000300001,distribuyeron,i
51,S0034-75072007000300001,aleatoriamente,i
51,S0034-75072007000300001,en,o
51,S0034-75072007000300001,2,o
51,S0034-75072007000300001,grupos,o
51,S0034-75072007000300001,un,o
51,S0034-75072007000300001,grupo,o
51,S0034-75072007000300001,estudio,o
51,S0034-75072007000300001,que,o
51,S0034-75072007000300001,recibio,o
51,S0034-75072007000300001,la,o
51,S0034-75072007000300001,combinacion,o
51,S0034-75072007000300001,laserneon,o
51,S0034-75072007000300001,y,o
51,S0034-75072007000300001,clorhexidina,i
51,S0034-75072007000300001,al,o
51,S0034-75072007000300001,02,o
51,S0034-75072007000300001,y,o
51,S0034-75072007000300001,otro,o
51,S0034-75072007000300001,grupo,o
51,S0034-75072007000300001,control,o
51,S0034-75072007000300001,que,o
51,S0034-75072007000300001,solo,o
51,S0034-75072007000300001,recibio,o
51,S0034-75072007000300001,clorhexidina,i
51,S0034-75072007000300001,al,o
51,S0034-75072007000300001,02,o
51,S0034-75072007000300001,Se,o
51,S0034-75072007000300001,realizo,o
51,S0034-75072007000300001,una,o
51,S0034-75072007000300001,evaluacion,i
51,S0034-75072007000300001,a,o
51,S0034-75072007000300001,los,o
51,S0034-75072007000300001,15,o
51,S0034-75072007000300001,30,o
51,S0034-75072007000300001,y,o
51,S0034-75072007000300001,45,o
51,S0034-75072007000300001,dias,o
51,S0034-75072007000300001,con,o
51,S0034-75072007000300001,criterios,o
51,S0034-75072007000300001,de,o
51,S0034-75072007000300001,eficacia,o
51,S0034-75072007000300001,clinicos,o
51,S0034-75072007000300001,y,o
51,S0034-75072007000300001,microbiologicos,o
51,S0034-75072007000300001,Los,o
51,S0034-75072007000300001,resultados,o
51,S0034-75072007000300001,clinicos,o
51,S0034-75072007000300001,fueron,o
51,S0034-75072007000300001,satisfactorios,o
51,S0034-75072007000300001,en,o
51,S0034-75072007000300001,el,o
51,S0034-75072007000300001,grupo,o
51,S0034-75072007000300001,estudio,o
51,S0034-75072007000300001,con,o
51,S0034-75072007000300001,predominio,o
51,S0034-75072007000300001,de,o
51,S0034-75072007000300001,los,o
51,S0034-75072007000300001,morfotipos,o
51,S0034-75072007000300001,I,o
51,S0034-75072007000300001,caracterizados,o
51,S0034-75072007000300001,por,o
51,S0034-75072007000300001,cocos,o
51,S0034-75072007000300001,gramnegativos,o
51,S0034-75072007000300001,y,o
51,S0034-75072007000300001,positivos,o
51,S0034-75072007000300001,compatibles,o
51,S0034-75072007000300001,con,o
51,S0034-75072007000300001,un,o
51,S0034-75072007000300001,periodonto,i
51,S0034-75072007000300001,sano,o
51,S0034-75072007000300001,Los,o
51,S0034-75072007000300001,eventos,i
51,S0034-75072007000300001,adversos,i
51,S0034-75072007000300001,detectados,o
51,S0034-75072007000300001,con,o
51,S0034-75072007000300001,esta,o
51,S0034-75072007000300001,terapeutica,i
51,S0034-75072007000300001,fueron,o
51,S0034-75072007000300001,minimos,o
51,S0034-75072007000300001,todos,o
51,S0034-75072007000300001,relacionados,o
51,S0034-75072007000300001,con,o
51,S0034-75072007000300001,la,o
51,S0034-75072007000300001,somnolencia,i
52,S0034-75072007000300006,Pulpotomias,i
52,S0034-75072007000300006,de,i
52,S0034-75072007000300006,molares,i
52,S0034-75072007000300006,temporales,i
52,S0034-75072007000300006,en,o
52,S0034-75072007000300006,pulpas,i
52,S0034-75072007000300006,muertas,i
52,S0034-75072007000300006,con,o
52,S0034-75072007000300006,tintura,i
52,S0034-75072007000300006,de,i
52,S0034-75072007000300006,propoleos,i
52,S0034-75072007000300006,al,o
52,S0034-75072007000300006,10,o
52,S0034-75072007000300006,Se,o
52,S0034-75072007000300006,realizo,o
52,S0034-75072007000300006,un,o
52,S0034-75072007000300006,ensayo,i
52,S0034-75072007000300006,clinico,i
52,S0034-75072007000300006,fase,i
52,S0034-75072007000300006,II,i
52,S0034-75072007000300006,aleatorizado,i
52,S0034-75072007000300006,comparado,i
52,S0034-75072007000300006,en,o
52,S0034-75072007000300006,50,o
52,S0034-75072007000300006,niños,o
52,S0034-75072007000300006,de,o
52,S0034-75072007000300006,4,o
52,S0034-75072007000300006,a,o
52,S0034-75072007000300006,10,o
52,S0034-75072007000300006,años,o
52,S0034-75072007000300006,que,o
52,S0034-75072007000300006,presentaron,o
52,S0034-75072007000300006,molares,i
52,S0034-75072007000300006,temporales,i
52,S0034-75072007000300006,con,o
52,S0034-75072007000300006,muerte,i
52,S0034-75072007000300006,pulpar,i
52,S0034-75072007000300006,los,o
52,S0034-75072007000300006,cuales,o
52,S0034-75072007000300006,acudieron,o
52,S0034-75072007000300006,a,o
52,S0034-75072007000300006,la,o
52,S0034-75072007000300006,Clinica,o
52,S0034-75072007000300006,Estomatologica,o
52,S0034-75072007000300006,Provincial,o
52,S0034-75072007000300006,de,o
52,S0034-75072007000300006,Santiago,o
52,S0034-75072007000300006,de,o
52,S0034-75072007000300006,Cuba,o
52,S0034-75072007000300006,entre,o
52,S0034-75072007000300006,septiembre,o
52,S0034-75072007000300006,del,o
52,S0034-75072007000300006,2005,o
52,S0034-75072007000300006,y,o
52,S0034-75072007000300006,septiembre,o
52,S0034-75072007000300006,del,o
52,S0034-75072007000300006,2006,o
52,S0034-75072007000300006,con,o
52,S0034-75072007000300006,el,o
52,S0034-75072007000300006,objetivo,o
52,S0034-75072007000300006,de,o
52,S0034-75072007000300006,demostrar,o
52,S0034-75072007000300006,la,o
52,S0034-75072007000300006,eficacia,o
52,S0034-75072007000300006,de,o
52,S0034-75072007000300006,la,o
52,S0034-75072007000300006,tintura,i
52,S0034-75072007000300006,de,i
52,S0034-75072007000300006,propoleos,i
52,S0034-75072007000300006,al,o
52,S0034-75072007000300006,10,o
52,S0034-75072007000300006,en,o
52,S0034-75072007000300006,pulpotomias,i
52,S0034-75072007000300006,necropulpotomias,i
52,S0034-75072007000300006,Se,o
52,S0034-75072007000300006,conformaron,o
52,S0034-75072007000300006,2,o
52,S0034-75072007000300006,grupos,o
52,S0034-75072007000300006,de,o
52,S0034-75072007000300006,tratamientos,i
52,S0034-75072007000300006,de,o
52,S0034-75072007000300006,26,o
52,S0034-75072007000300006,pacientes,o
52,S0034-75072007000300006,cada,o
52,S0034-75072007000300006,uno,o
52,S0034-75072007000300006,en,o
52,S0034-75072007000300006,el,o
52,S0034-75072007000300006,grupo,o
52,S0034-75072007000300006,A,o
52,S0034-75072007000300006,se,o
52,S0034-75072007000300006,empleo,o
52,S0034-75072007000300006,tintura,i
52,S0034-75072007000300006,de,i
52,S0034-75072007000300006,propoleos,i
52,S0034-75072007000300006,al,o
52,S0034-75072007000300006,10,o
52,S0034-75072007000300006,y,o
52,S0034-75072007000300006,en,o
52,S0034-75072007000300006,el,o
52,S0034-75072007000300006,B,o
52,S0034-75072007000300006,el,o
52,S0034-75072007000300006,formocresol,i
52,S0034-75072007000300006,Los,o
52,S0034-75072007000300006,pacientes,o
52,S0034-75072007000300006,se,o
52,S0034-75072007000300006,evaluaron,o
52,S0034-75072007000300006,a,o
52,S0034-75072007000300006,los,o
52,S0034-75072007000300006,7,o
52,S0034-75072007000300006,15,o
52,S0034-75072007000300006,y,o
52,S0034-75072007000300006,30,o
52,S0034-75072007000300006,dias,o
52,S0034-75072007000300006,sin,o
52,S0034-75072007000300006,observarse,o
52,S0034-75072007000300006,diferencias,o
52,S0034-75072007000300006,ni,o
52,S0034-75072007000300006,reacciones,i
52,S0034-75072007000300006,adversas,i
52,S0034-75072007000300006,El,o
52,S0034-75072007000300006,grupo,o
52,S0034-75072007000300006,dentario,i
52,S0034-75072007000300006,mas,o
52,S0034-75072007000300006,tratado,i
52,S0034-75072007000300006,fue,o
52,S0034-75072007000300006,el,o
52,S0034-75072007000300006,constituido,o
52,S0034-75072007000300006,por,o
52,S0034-75072007000300006,los,o
52,S0034-75072007000300006,segundos,i
52,S0034-75072007000300006,molares,i
52,S0034-75072007000300006,temporales,i
52,S0034-75072007000300006,inferiores,i
52,S0034-75072007000300006,donde,o
52,S0034-75072007000300006,la,o
52,S0034-75072007000300006,tintura,i
52,S0034-75072007000300006,de,i
52,S0034-75072007000300006,propoleos,i
52,S0034-75072007000300006,al,o
52,S0034-75072007000300006,10,o
52,S0034-75072007000300006,en,o
52,S0034-75072007000300006,las,o
52,S0034-75072007000300006,pulpotomias,i
52,S0034-75072007000300006,resulto,o
52,S0034-75072007000300006,ser,o
52,S0034-75072007000300006,tan,o
52,S0034-75072007000300006,eficaz,o
52,S0034-75072007000300006,como,o
52,S0034-75072007000300006,el,o
52,S0034-75072007000300006,formocresol,i
52,S0034-75072007000300006,por,o
52,S0034-75072007000300006,lo,o
52,S0034-75072007000300006,que,o
52,S0034-75072007000300006,se,o
52,S0034-75072007000300006,recomienda,o
52,S0034-75072007000300006,incluir,o
52,S0034-75072007000300006,en,o
52,S0034-75072007000300006,tratamientos,i
52,S0034-75072007000300006,endodonticos,i
52,S0034-75072007000300006,esta,o
52,S0034-75072007000300006,nueva,o
52,S0034-75072007000300006,terapeutica,i
53,S0034-75072007000300008,Efectividad,o
53,S0034-75072007000300008,del,o
53,S0034-75072007000300008,uso,o
53,S0034-75072007000300008,del,o
53,S0034-75072007000300008,propoleo,i
53,S0034-75072007000300008,en,o
53,S0034-75072007000300008,el,o
53,S0034-75072007000300008,tratamiento,i
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,la,o
53,S0034-75072007000300008,estomatitis,i
53,S0034-75072007000300008,aftosa,i
53,S0034-75072007000300008,La,o
53,S0034-75072007000300008,estomatitis,i
53,S0034-75072007000300008,aftosa,i
53,S0034-75072007000300008,se,o
53,S0034-75072007000300008,considera,o
53,S0034-75072007000300008,como,o
53,S0034-75072007000300008,la,o
53,S0034-75072007000300008,mas,o
53,S0034-75072007000300008,frecuente,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,las,o
53,S0034-75072007000300008,lesiones,i
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,la,o
53,S0034-75072007000300008,mucosa,i
53,S0034-75072007000300008,bucal,i
53,S0034-75072007000300008,y,o
53,S0034-75072007000300008,afecta,o
53,S0034-75072007000300008,alrededor,o
53,S0034-75072007000300008,del,o
53,S0034-75072007000300008,20,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,la,o
53,S0034-75072007000300008,poblacion,o
53,S0034-75072007000300008,aunque,o
53,S0034-75072007000300008,en,o
53,S0034-75072007000300008,algunos,o
53,S0034-75072007000300008,estudios,o
53,S0034-75072007000300008,se,o
53,S0034-75072007000300008,han,o
53,S0034-75072007000300008,reportado,o
53,S0034-75072007000300008,cifras,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,hasta,o
53,S0034-75072007000300008,el,o
53,S0034-75072007000300008,60,o
53,S0034-75072007000300008,Se,o
53,S0034-75072007000300008,realiza,o
53,S0034-75072007000300008,este,o
53,S0034-75072007000300008,estudio,o
53,S0034-75072007000300008,con,o
53,S0034-75072007000300008,el,o
53,S0034-75072007000300008,objetivo,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,evaluar,i
53,S0034-75072007000300008,la,i
53,S0034-75072007000300008,efectividad,i
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,la,o
53,S0034-75072007000300008,tintura,i
53,S0034-75072007000300008,de,i
53,S0034-75072007000300008,propoleo,i
53,S0034-75072007000300008,al,o
53,S0034-75072007000300008,5,o
53,S0034-75072007000300008,en,o
53,S0034-75072007000300008,el,o
53,S0034-75072007000300008,tratamiento,i
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,la,o
53,S0034-75072007000300008,estomatitis,i
53,S0034-75072007000300008,aftosa,i
53,S0034-75072007000300008,Se,o
53,S0034-75072007000300008,realiza,o
53,S0034-75072007000300008,un,o
53,S0034-75072007000300008,ensayo,i
53,S0034-75072007000300008,clinico,i
53,S0034-75072007000300008,fase,i
53,S0034-75072007000300008,2,i
53,S0034-75072007000300008,aleatorizado,i
53,S0034-75072007000300008,y,o
53,S0034-75072007000300008,se,o
53,S0034-75072007000300008,conforman,o
53,S0034-75072007000300008,2,o
53,S0034-75072007000300008,grupos,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,pacientes,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,ambos,o
53,S0034-75072007000300008,sexos,o
53,S0034-75072007000300008,entre,o
53,S0034-75072007000300008,los,o
53,S0034-75072007000300008,12,o
53,S0034-75072007000300008,y,o
53,S0034-75072007000300008,44,o
53,S0034-75072007000300008,años,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,edad,o
53,S0034-75072007000300008,con,o
53,S0034-75072007000300008,diagnostico,i
53,S0034-75072007000300008,clinico,i
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,estomatitis,i
53,S0034-75072007000300008,aftosa,i
53,S0034-75072007000300008,Al,o
53,S0034-75072007000300008,grupo,o
53,S0034-75072007000300008,estudio,o
53,S0034-75072007000300008,se,o
53,S0034-75072007000300008,aplica,o
53,S0034-75072007000300008,el,o
53,S0034-75072007000300008,propoleo,i
53,S0034-75072007000300008,al,o
53,S0034-75072007000300008,5,o
53,S0034-75072007000300008,y,o
53,S0034-75072007000300008,al,o
53,S0034-75072007000300008,grupo,o
53,S0034-75072007000300008,control,o
53,S0034-75072007000300008,el,o
53,S0034-75072007000300008,tratamiento,i
53,S0034-75072007000300008,convencional,i
53,S0034-75072007000300008,comparando,o
53,S0034-75072007000300008,los,o
53,S0034-75072007000300008,resultados,o
53,S0034-75072007000300008,obtenidos,o
53,S0034-75072007000300008,en,o
53,S0034-75072007000300008,ambos,o
53,S0034-75072007000300008,tratamientos,i
53,S0034-75072007000300008,De,o
53,S0034-75072007000300008,estos,o
53,S0034-75072007000300008,resultados,o
53,S0034-75072007000300008,concluimos,o
53,S0034-75072007000300008,que,o
53,S0034-75072007000300008,con,o
53,S0034-75072007000300008,la,o
53,S0034-75072007000300008,aplicacion,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,un,o
53,S0034-75072007000300008,metodo,o
53,S0034-75072007000300008,rapido,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,bajo,o
53,S0034-75072007000300008,costo,o
53,S0034-75072007000300008,y,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,facil,o
53,S0034-75072007000300008,ejecucion,o
53,S0034-75072007000300008,se,o
53,S0034-75072007000300008,obtuvieron,o
53,S0034-75072007000300008,resultados,o
53,S0034-75072007000300008,altamente,o
53,S0034-75072007000300008,satisfactorios,o
53,S0034-75072007000300008,que,o
53,S0034-75072007000300008,corroboran,o
53,S0034-75072007000300008,la,o
53,S0034-75072007000300008,efectividad,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,la,o
53,S0034-75072007000300008,aplicacion,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,la,o
53,S0034-75072007000300008,tintura,i
53,S0034-75072007000300008,de,i
53,S0034-75072007000300008,propoleo,i
53,S0034-75072007000300008,al,o
53,S0034-75072007000300008,5,o
53,S0034-75072007000300008,en,o
53,S0034-75072007000300008,el,o
53,S0034-75072007000300008,tratamiento,i
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,la,o
53,S0034-75072007000300008,estomatitis,i
53,S0034-75072007000300008,aftosa,i
53,S0034-75072007000300008,Se,o
53,S0034-75072007000300008,logro,o
53,S0034-75072007000300008,una,o
53,S0034-75072007000300008,rapida,o
53,S0034-75072007000300008,incorporacion,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,los,o
53,S0034-75072007000300008,pacientes,o
53,S0034-75072007000300008,a,o
53,S0034-75072007000300008,sus,o
53,S0034-75072007000300008,actividades,o
53,S0034-75072007000300008,y,o
53,S0034-75072007000300008,el,o
53,S0034-75072007000300008,mejoramiento,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,la,o
53,S0034-75072007000300008,calidad,o
53,S0034-75072007000300008,de,o
53,S0034-75072007000300008,vida,o
54,S0034-75152013000100008,Enemas,i
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,factor,i
54,S0034-75152013000100008,de,i
54,S0034-75152013000100008,crecimiento,i
54,S0034-75152013000100008,epidermico,i
54,S0034-75152013000100008,para,o
54,S0034-75152013000100008,inducir,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,remision,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,colitis,i
54,S0034-75152013000100008,ulcerosa,i
54,S0034-75152013000100008,izquierda,o
54,S0034-75152013000100008,Introduccion,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,colitis,i
54,S0034-75152013000100008,ulcerosa,i
54,S0034-75152013000100008,es,o
54,S0034-75152013000100008,una,o
54,S0034-75152013000100008,enfermedad,i
54,S0034-75152013000100008,inflamatoria,i
54,S0034-75152013000100008,cronica,i
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,etiologia,o
54,S0034-75152013000100008,poco,o
54,S0034-75152013000100008,conocida,o
54,S0034-75152013000100008,que,o
54,S0034-75152013000100008,afecta,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,mucosa,i
54,S0034-75152013000100008,del,i
54,S0034-75152013000100008,colon,i
54,S0034-75152013000100008,El,o
54,S0034-75152013000100008,efecto,o
54,S0034-75152013000100008,positivo,o
54,S0034-75152013000100008,del,o
54,S0034-75152013000100008,factor,i
54,S0034-75152013000100008,de,i
54,S0034-75152013000100008,crecimiento,i
54,S0034-75152013000100008,epidermico,i
54,S0034-75152013000100008,fue,o
54,S0034-75152013000100008,reportado,o
54,S0034-75152013000100008,en,o
54,S0034-75152013000100008,estudio,o
54,S0034-75152013000100008,previo,o
54,S0034-75152013000100008,con,o
54,S0034-75152013000100008,uso,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,enema,i
54,S0034-75152013000100008,para,o
54,S0034-75152013000100008,tratamiento,i
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,manifestacion,i
54,S0034-75152013000100008,izquierda,o
54,S0034-75152013000100008,leve,o
54,S0034-75152013000100008,o,o
54,S0034-75152013000100008,moderada,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,enfermedad,i
54,S0034-75152013000100008,Este,o
54,S0034-75152013000100008,antecedente,o
54,S0034-75152013000100008,sirvio,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,base,o
54,S0034-75152013000100008,para,o
54,S0034-75152013000100008,evaluar,i
54,S0034-75152013000100008,la,i
54,S0034-75152013000100008,eficacia,i
54,S0034-75152013000100008,y,i
54,S0034-75152013000100008,perfil,i
54,S0034-75152013000100008,de,i
54,S0034-75152013000100008,seguridad,i
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,una,o
54,S0034-75152013000100008,solucion,i
54,S0034-75152013000100008,viscosa,i
54,S0034-75152013000100008,del,o
54,S0034-75152013000100008,producto,o
54,S0034-75152013000100008,Metodos,o
54,S0034-75152013000100008,fueron,o
54,S0034-75152013000100008,aleatorizados,i
54,S0034-75152013000100008,31,o
54,S0034-75152013000100008,pacientes,o
54,S0034-75152013000100008,hacia,o
54,S0034-75152013000100008,tres,o
54,S0034-75152013000100008,grupos,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,tratamiento,i
54,S0034-75152013000100008,diario,o
54,S0034-75152013000100008,durante,o
54,S0034-75152013000100008,14,o
54,S0034-75152013000100008,dias,o
54,S0034-75152013000100008,Doce,o
54,S0034-75152013000100008,recibieron,o
54,S0034-75152013000100008,enemas,i
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,10,o
54,S0034-75152013000100008,mg,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,factor,i
54,S0034-75152013000100008,de,i
54,S0034-75152013000100008,crecimiento,i
54,S0034-75152013000100008,epidermico,i
54,S0034-75152013000100008,en,o
54,S0034-75152013000100008,100,o
54,S0034-75152013000100008,mL,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,solucion,i
54,S0034-75152013000100008,viscosa,i
54,S0034-75152013000100008,mientras,o
54,S0034-75152013000100008,nueve,o
54,S0034-75152013000100008,fueron,o
54,S0034-75152013000100008,tratados,i
54,S0034-75152013000100008,con,o
54,S0034-75152013000100008,enemas,i
54,S0034-75152013000100008,placebo,i
54,S0034-75152013000100008,conteniendo,o
54,S0034-75152013000100008,solamente,o
54,S0034-75152013000100008,solucion,i
54,S0034-75152013000100008,viscosa,i
54,S0034-75152013000100008,Ambos,o
54,S0034-75152013000100008,grupos,o
54,S0034-75152013000100008,recibieron,o
54,S0034-75152013000100008,ademas,o
54,S0034-75152013000100008,12,o
54,S0034-75152013000100008,g,o
54,S0034-75152013000100008,diarios,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,mesalacina,i
54,S0034-75152013000100008,oral,o
54,S0034-75152013000100008,El,o
54,S0034-75152013000100008,tercer,o
54,S0034-75152013000100008,grupo,o
54,S0034-75152013000100008,incluyo,o
54,S0034-75152013000100008,10,o
54,S0034-75152013000100008,pacientes,o
54,S0034-75152013000100008,con,o
54,S0034-75152013000100008,mesalacina,i
54,S0034-75152013000100008,en,o
54,S0034-75152013000100008,enemas,i
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,3g,o
54,S0034-75152013000100008,100,o
54,S0034-75152013000100008,mL,o
54,S0034-75152013000100008,La,o
54,S0034-75152013000100008,variable,o
54,S0034-75152013000100008,principal,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,eficacia,o
54,S0034-75152013000100008,fue,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,respuesta,o
54,S0034-75152013000100008,clinica,o
54,S0034-75152013000100008,al,o
54,S0034-75152013000100008,finalizar,o
54,S0034-75152013000100008,las,o
54,S0034-75152013000100008,dos,o
54,S0034-75152013000100008,semanas,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,tratamiento,i
54,S0034-75152013000100008,definida,o
54,S0034-75152013000100008,como,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,disminucion,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,al,o
54,S0034-75152013000100008,menos,o
54,S0034-75152013000100008,tres,o
54,S0034-75152013000100008,puntos,o
54,S0034-75152013000100008,el,o
54,S0034-75152013000100008,indice,o
54,S0034-75152013000100008,basal,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,actividad,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,enfermedad,i
54,S0034-75152013000100008,acompañada,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,mejoria,o
54,S0034-75152013000100008,endoscopica,i
54,S0034-75152013000100008,o,o
54,S0034-75152013000100008,histologica,i
54,S0034-75152013000100008,Resultados,o
54,S0034-75152013000100008,se,o
54,S0034-75152013000100008,alcanzo,o
54,S0034-75152013000100008,remision,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,enfermedad,i
54,S0034-75152013000100008,en,o
54,S0034-75152013000100008,todos,o
54,S0034-75152013000100008,los,o
54,S0034-75152013000100008,pacientes,o
54,S0034-75152013000100008,que,o
54,S0034-75152013000100008,recibieron,o
54,S0034-75152013000100008,factor,i
54,S0034-75152013000100008,de,i
54,S0034-75152013000100008,crecimiento,i
54,S0034-75152013000100008,epidermico,i
54,S0034-75152013000100008,y,o
54,S0034-75152013000100008,en,o
54,S0034-75152013000100008,seis,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,los,o
54,S0034-75152013000100008,grupos,o
54,S0034-75152013000100008,mesalacina,i
54,S0034-75152013000100008,enema,i
54,S0034-75152013000100008,y,o
54,S0034-75152013000100008,placebo,i
54,S0034-75152013000100008,Todas,o
54,S0034-75152013000100008,las,o
54,S0034-75152013000100008,comparaciones,o
54,S0034-75152013000100008,entre,o
54,S0034-75152013000100008,grupos,o
54,S0034-75152013000100008,mostraron,o
54,S0034-75152013000100008,superioridad,o
54,S0034-75152013000100008,estadisticamente,o
54,S0034-75152013000100008,significativa,o
54,S0034-75152013000100008,para,o
54,S0034-75152013000100008,el,o
54,S0034-75152013000100008,factor,i
54,S0034-75152013000100008,de,i
54,S0034-75152013000100008,crecimiento,i
54,S0034-75152013000100008,epidermico,i
54,S0034-75152013000100008,unico,o
54,S0034-75152013000100008,producto,o
54,S0034-75152013000100008,que,o
54,S0034-75152013000100008,logro,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,reduccion,o
54,S0034-75152013000100008,significativa,o
54,S0034-75152013000100008,del,o
54,S0034-75152013000100008,indice,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,actividad,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,enfermedad,i
54,S0034-75152013000100008,y,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,presencia,o
54,S0034-75152013000100008,e,o
54,S0034-75152013000100008,intensidad,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,los,o
54,S0034-75152013000100008,sintomas,i
54,S0034-75152013000100008,digestivos,i
54,S0034-75152013000100008,en,o
54,S0034-75152013000100008,los,o
54,S0034-75152013000100008,pacientes,o
54,S0034-75152013000100008,luego,o
54,S0034-75152013000100008,del,o
54,S0034-75152013000100008,tratamiento,i
54,S0034-75152013000100008,Ningun,o
54,S0034-75152013000100008,evento,i
54,S0034-75152013000100008,adverso,i
54,S0034-75152013000100008,fue,o
54,S0034-75152013000100008,reportado,o
54,S0034-75152013000100008,Conclusiones,o
54,S0034-75152013000100008,estos,o
54,S0034-75152013000100008,resultados,o
54,S0034-75152013000100008,son,o
54,S0034-75152013000100008,consistentes,o
54,S0034-75152013000100008,con,o
54,S0034-75152013000100008,las,o
54,S0034-75152013000100008,anteriores,o
54,S0034-75152013000100008,evidencias,o
54,S0034-75152013000100008,moleculares,o
54,S0034-75152013000100008,y,o
54,S0034-75152013000100008,clinicas,o
54,S0034-75152013000100008,que,o
54,S0034-75152013000100008,señalan,o
54,S0034-75152013000100008,al,o
54,S0034-75152013000100008,factor,i
54,S0034-75152013000100008,de,i
54,S0034-75152013000100008,crecimiento,i
54,S0034-75152013000100008,epidermico,i
54,S0034-75152013000100008,capaz,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,reducir,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,actividad,o
54,S0034-75152013000100008,e,o
54,S0034-75152013000100008,inducir,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,remision,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,colitis,i
54,S0034-75152013000100008,ulcerosa,i
54,S0034-75152013000100008,Debe,o
54,S0034-75152013000100008,ser,o
54,S0034-75152013000100008,realizado,o
54,S0034-75152013000100008,un,o
54,S0034-75152013000100008,nuevo,o
54,S0034-75152013000100008,estudio,o
54,S0034-75152013000100008,en,o
54,S0034-75152013000100008,un,o
54,S0034-75152013000100008,numero,o
54,S0034-75152013000100008,mayor,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,pacientes,o
54,S0034-75152013000100008,para,o
54,S0034-75152013000100008,confirmar,o
54,S0034-75152013000100008,la,o
54,S0034-75152013000100008,eficacia,o
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,los,o
54,S0034-75152013000100008,enemas,i
54,S0034-75152013000100008,de,o
54,S0034-75152013000100008,factor,i
54,S0034-75152013000100008,de,i
54,S0034-75152013000100008,crecimiento,i
54,S0034-75152013000100008,epidermico,i
55,S0036-36342004000400008,Evaluacion,i
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,la,o
55,S0036-36342004000400008,nitazoxanida,i
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,dosis,o
55,S0036-36342004000400008,unica,o
55,S0036-36342004000400008,y,o
55,S0036-36342004000400008,por,o
55,S0036-36342004000400008,tres,o
55,S0036-36342004000400008,dias,o
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,parasitosis,i
55,S0036-36342004000400008,intestinal,i
55,S0036-36342004000400008,OBJETIVO,o
55,S0036-36342004000400008,Evaluar,i
55,S0036-36342004000400008,la,i
55,S0036-36342004000400008,utilidad,i
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,nitazoxanida,i
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,dosis,o
55,S0036-36342004000400008,habitual,o
55,S0036-36342004000400008,con,o
55,S0036-36342004000400008,esquema,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,tres,o
55,S0036-36342004000400008,dias,o
55,S0036-36342004000400008,y,o
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,dosis,o
55,S0036-36342004000400008,unica,o
55,S0036-36342004000400008,para,o
55,S0036-36342004000400008,la,o
55,S0036-36342004000400008,erradicacion,i
55,S0036-36342004000400008,masiva,i
55,S0036-36342004000400008,de,i
55,S0036-36342004000400008,parasitos,i
55,S0036-36342004000400008,intestinales,i
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,la,o
55,S0036-36342004000400008,poblacion,o
55,S0036-36342004000400008,pediatrica,o
55,S0036-36342004000400008,comparando,o
55,S0036-36342004000400008,su,o
55,S0036-36342004000400008,efecto,o
55,S0036-36342004000400008,con,o
55,S0036-36342004000400008,el,o
55,S0036-36342004000400008,del,o
55,S0036-36342004000400008,albendazol,i
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,dosis,o
55,S0036-36342004000400008,unica,o
55,S0036-36342004000400008,MATERIAL,o
55,S0036-36342004000400008,Y,o
55,S0036-36342004000400008,METODOS,o
55,S0036-36342004000400008,Se,o
55,S0036-36342004000400008,realizo,o
55,S0036-36342004000400008,un,o
55,S0036-36342004000400008,ensayo,i
55,S0036-36342004000400008,clinico,i
55,S0036-36342004000400008,aleatorizado,i
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,tres,o
55,S0036-36342004000400008,comunidades,o
55,S0036-36342004000400008,rurales,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,la,o
55,S0036-36342004000400008,region,o
55,S0036-36342004000400008,central,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,Mexico,o
55,S0036-36342004000400008,durante,o
55,S0036-36342004000400008,el,o
55,S0036-36342004000400008,periodo,o
55,S0036-36342004000400008,20012003,o
55,S0036-36342004000400008,para,o
55,S0036-36342004000400008,incluir,o
55,S0036-36342004000400008,tres,o
55,S0036-36342004000400008,posibles,o
55,S0036-36342004000400008,alternativas,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,tratamiento,i
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,786,o
55,S0036-36342004000400008,sujetos,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,entre,o
55,S0036-36342004000400008,5,o
55,S0036-36342004000400008,y,o
55,S0036-36342004000400008,11,o
55,S0036-36342004000400008,años,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,edad,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,los,o
55,S0036-36342004000400008,cuales,o
55,S0036-36342004000400008,92,o
55,S0036-36342004000400008,tuvieron,o
55,S0036-36342004000400008,un,o
55,S0036-36342004000400008,examen,i
55,S0036-36342004000400008,parasitologico,i
55,S0036-36342004000400008,positivo,o
55,S0036-36342004000400008,151,o
55,S0036-36342004000400008,El,o
55,S0036-36342004000400008,grupo,o
55,S0036-36342004000400008,1,o
55,S0036-36342004000400008,incluyo,o
55,S0036-36342004000400008,27,o
55,S0036-36342004000400008,pacientes,o
55,S0036-36342004000400008,que,o
55,S0036-36342004000400008,recibieron,o
55,S0036-36342004000400008,400,o
55,S0036-36342004000400008,mg,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,albendazol,i
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,dosis,o
55,S0036-36342004000400008,unica,o
55,S0036-36342004000400008,el,o
55,S0036-36342004000400008,grupo,o
55,S0036-36342004000400008,2,o
55,S0036-36342004000400008,incluyo,o
55,S0036-36342004000400008,34,o
55,S0036-36342004000400008,pacientes,o
55,S0036-36342004000400008,a,o
55,S0036-36342004000400008,quienes,o
55,S0036-36342004000400008,se,o
55,S0036-36342004000400008,administro,o
55,S0036-36342004000400008,nitazoxanida,i
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,dosis,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,15,o
55,S0036-36342004000400008,mgkgdia,o
55,S0036-36342004000400008,durante,o
55,S0036-36342004000400008,tres,o
55,S0036-36342004000400008,dias,o
55,S0036-36342004000400008,consecutivos,o
55,S0036-36342004000400008,y,o
55,S0036-36342004000400008,el,o
55,S0036-36342004000400008,grupo,o
55,S0036-36342004000400008,3,o
55,S0036-36342004000400008,incluyo,o
55,S0036-36342004000400008,31,o
55,S0036-36342004000400008,pacientes,o
55,S0036-36342004000400008,que,o
55,S0036-36342004000400008,recibieron,o
55,S0036-36342004000400008,12,o
55,S0036-36342004000400008,g,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,nitazoxanida,i
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,dosis,o
55,S0036-36342004000400008,unica,o
55,S0036-36342004000400008,Se,o
55,S0036-36342004000400008,evaluo,o
55,S0036-36342004000400008,diferencia,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,proporciones,o
55,S0036-36342004000400008,mediante,o
55,S0036-36342004000400008,prueba,o
55,S0036-36342004000400008,exacta,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,Fisher,o
55,S0036-36342004000400008,RESULTADOS,o
55,S0036-36342004000400008,No,o
55,S0036-36342004000400008,existieron,o
55,S0036-36342004000400008,diferencias,o
55,S0036-36342004000400008,estadisticamente,o
55,S0036-36342004000400008,significativas,o
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,la,o
55,S0036-36342004000400008,efectividad,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,los,o
55,S0036-36342004000400008,tres,o
55,S0036-36342004000400008,esquemas,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,tratamiento,i
55,S0036-36342004000400008,805,o
55,S0036-36342004000400008,con,o
55,S0036-36342004000400008,albendazol,i
55,S0036-36342004000400008,comparado,o
55,S0036-36342004000400008,con,o
55,S0036-36342004000400008,las,o
55,S0036-36342004000400008,dos,o
55,S0036-36342004000400008,alternativas,o
55,S0036-36342004000400008,adicionales,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,nitazoxanida,i
55,S0036-36342004000400008,676,o
55,S0036-36342004000400008,y,o
55,S0036-36342004000400008,71,o
55,S0036-36342004000400008,respectivamente,o
55,S0036-36342004000400008,Se,o
55,S0036-36342004000400008,observo,o
55,S0036-36342004000400008,una,o
55,S0036-36342004000400008,mayor,o
55,S0036-36342004000400008,prevalencia,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,efectos,i
55,S0036-36342004000400008,secundarios,i
55,S0036-36342004000400008,con,o
55,S0036-36342004000400008,nitazoxanida,i
55,S0036-36342004000400008,por,o
55,S0036-36342004000400008,kg,o
55,S0036-36342004000400008,dia,o
55,S0036-36342004000400008,265,o
55,S0036-36342004000400008,y,o
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,dosis,o
55,S0036-36342004000400008,unica,o
55,S0036-36342004000400008,322,o
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,comparacion,o
55,S0036-36342004000400008,con,o
55,S0036-36342004000400008,la,o
55,S0036-36342004000400008,dosis,o
55,S0036-36342004000400008,unica,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,albendazol,i
55,S0036-36342004000400008,74,o
55,S0036-36342004000400008,CONCLUSIONES,o
55,S0036-36342004000400008,Las,o
55,S0036-36342004000400008,evidencias,o
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,cuanto,o
55,S0036-36342004000400008,a,o
55,S0036-36342004000400008,la,o
55,S0036-36342004000400008,efectividad,o
55,S0036-36342004000400008,y,o
55,S0036-36342004000400008,elevada,o
55,S0036-36342004000400008,prevalencia,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,efectos,i
55,S0036-36342004000400008,secundarios,i
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,la,o
55,S0036-36342004000400008,nitazoxanida,i
55,S0036-36342004000400008,no,o
55,S0036-36342004000400008,justifican,o
55,S0036-36342004000400008,aun,o
55,S0036-36342004000400008,su,o
55,S0036-36342004000400008,utilizacion,o
55,S0036-36342004000400008,como,o
55,S0036-36342004000400008,quimiopreventivo,i
55,S0036-36342004000400008,masivo,o
55,S0036-36342004000400008,para,o
55,S0036-36342004000400008,el,o
55,S0036-36342004000400008,control,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,parasitosis,i
55,S0036-36342004000400008,intestinal,i
55,S0036-36342004000400008,en,o
55,S0036-36342004000400008,areas,o
55,S0036-36342004000400008,endemicas,o
55,S0036-36342004000400008,En,o
55,S0036-36342004000400008,paises,o
55,S0036-36342004000400008,con,o
55,S0036-36342004000400008,elevada,o
55,S0036-36342004000400008,prevalencia,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,parasitosis,i
55,S0036-36342004000400008,intestinal,i
55,S0036-36342004000400008,las,o
55,S0036-36342004000400008,medidas,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,prevencion,i
55,S0036-36342004000400008,primaria,i
55,S0036-36342004000400008,que,o
55,S0036-36342004000400008,continuan,o
55,S0036-36342004000400008,vigentes,o
55,S0036-36342004000400008,y,o
55,S0036-36342004000400008,que,o
55,S0036-36342004000400008,deben,o
55,S0036-36342004000400008,priorizarse,o
55,S0036-36342004000400008,estan,o
55,S0036-36342004000400008,relacionadas,o
55,S0036-36342004000400008,con,o
55,S0036-36342004000400008,sanidad,o
55,S0036-36342004000400008,publica,o
55,S0036-36342004000400008,introduccion,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,agua,i
55,S0036-36342004000400008,potable,o
55,S0036-36342004000400008,y,o
55,S0036-36342004000400008,drenaje,o
55,S0036-36342004000400008,cloracion,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,agua,i
55,S0036-36342004000400008,y,o
55,S0036-36342004000400008,manejo,o
55,S0036-36342004000400008,adecuado,o
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,excretas,i
55,S0036-36342004000400008,de,o
55,S0036-36342004000400008,animales,o
55,S0036-36342004000400008,domesticos,o
55,S0036-36342004000400008,asi,o
55,S0036-36342004000400008,como,o
55,S0036-36342004000400008,educacion,i
55,S0036-36342004000400008,para,i
55,S0036-36342004000400008,la,i
55,S0036-36342004000400008,salud,i
56,S0066-782X2009000300004,Combinacion,o
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,amlodipino,i
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,enalapril,i
56,S0066-782X2009000300004,en,o
56,S0066-782X2009000300004,pacientes,o
56,S0066-782X2009000300004,hipertensos,i
56,S0066-782X2009000300004,con,o
56,S0066-782X2009000300004,enfermedad,i
56,S0066-782X2009000300004,coronaria,i
56,S0066-782X2009000300004,FUNDAMENTO,o
56,S0066-782X2009000300004,Pacientes,o
56,S0066-782X2009000300004,pts,o
56,S0066-782X2009000300004,con,o
56,S0066-782X2009000300004,enfermedad,i
56,S0066-782X2009000300004,coronaria,i
56,S0066-782X2009000300004,EAC,i
56,S0066-782X2009000300004,estable,o
56,S0066-782X2009000300004,pueden,o
56,S0066-782X2009000300004,beneficiarse,o
56,S0066-782X2009000300004,con,o
56,S0066-782X2009000300004,una,o
56,S0066-782X2009000300004,menor,o
56,S0066-782X2009000300004,presion,i
56,S0066-782X2009000300004,arterial,i
56,S0066-782X2009000300004,PA,i
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,acuerdo,o
56,S0066-782X2009000300004,con,o
56,S0066-782X2009000300004,estudios,o
56,S0066-782X2009000300004,recientes,o
56,S0066-782X2009000300004,OBJETIVO,o
56,S0066-782X2009000300004,Evaluar,i
56,S0066-782X2009000300004,la,i
56,S0066-782X2009000300004,eficacia,i
56,S0066-782X2009000300004,y,i
56,S0066-782X2009000300004,la,i
56,S0066-782X2009000300004,tolerancia,i
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,la,o
56,S0066-782X2009000300004,combinacion,o
56,S0066-782X2009000300004,fija,o
56,S0066-782X2009000300004,amlodipino,i
56,S0066-782X2009000300004,enalapril,i
56,S0066-782X2009000300004,comparada,o
56,S0066-782X2009000300004,a,o
56,S0066-782X2009000300004,el,o
56,S0066-782X2009000300004,amlodipino,i
56,S0066-782X2009000300004,en,o
56,S0066-782X2009000300004,la,o
56,S0066-782X2009000300004,normalizacion,o
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,la,o
56,S0066-782X2009000300004,PA,i
56,S0066-782X2009000300004,diastolica,i
56,S0066-782X2009000300004,PAD,i
56,S0066-782X2009000300004,85,o
56,S0066-782X2009000300004,mmHg,o
56,S0066-782X2009000300004,en,o
56,S0066-782X2009000300004,pts,o
56,S0066-782X2009000300004,con,o
56,S0066-782X2009000300004,EAC,i
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,HAS,i
56,S0066-782X2009000300004,METODOS,o
56,S0066-782X2009000300004,Estudio,o
56,S0066-782X2009000300004,doble,o
56,S0066-782X2009000300004,ciego,o
56,S0066-782X2009000300004,randomizado,o
56,S0066-782X2009000300004,con,o
56,S0066-782X2009000300004,dos,o
56,S0066-782X2009000300004,grupos,o
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,pts,o
56,S0066-782X2009000300004,con,o
56,S0066-782X2009000300004,PAD,i
56,S0066-782X2009000300004,90,o
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,110,o
56,S0066-782X2009000300004,mmHg,o
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,EAC,i
56,S0066-782X2009000300004,Excluimos,o
56,S0066-782X2009000300004,a,o
56,S0066-782X2009000300004,los,o
56,S0066-782X2009000300004,pts,o
56,S0066-782X2009000300004,con,o
56,S0066-782X2009000300004,FEVI,i
56,S0066-782X2009000300004,40,o
56,S0066-782X2009000300004,sintomas,i
56,S0066-782X2009000300004,de,i
56,S0066-782X2009000300004,insuficiencia,i
56,S0066-782X2009000300004,cardiaca,i
56,S0066-782X2009000300004,o,o
56,S0066-782X2009000300004,angina,i
56,S0066-782X2009000300004,clase,o
56,S0066-782X2009000300004,III,o
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,IV,o
56,S0066-782X2009000300004,enfermedades,i
56,S0066-782X2009000300004,graves,o
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,PAD,i
56,S0066-782X2009000300004,110,o
56,S0066-782X2009000300004,mmHg,o
56,S0066-782X2009000300004,durante,o
56,S0066-782X2009000300004,el,o
56,S0066-782X2009000300004,washout,o
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,cuatro,o
56,S0066-782X2009000300004,semanas,o
56,S0066-782X2009000300004,en,o
56,S0066-782X2009000300004,uso,o
56,S0066-782X2009000300004,solo,o
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,atenolol,i
56,S0066-782X2009000300004,Despues,o
56,S0066-782X2009000300004,del,o
56,S0066-782X2009000300004,washout,o
56,S0066-782X2009000300004,randomizamos,i
56,S0066-782X2009000300004,para,o
56,S0066-782X2009000300004,combinacion,o
56,S0066-782X2009000300004,A,o
56,S0066-782X2009000300004,o,o
56,S0066-782X2009000300004,amlopidino,i
56,S0066-782X2009000300004,B,o
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,seguimos,o
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,cuatro,o
56,S0066-782X2009000300004,en,o
56,S0066-782X2009000300004,cuatro,o
56,S0066-782X2009000300004,semanas,o
56,S0066-782X2009000300004,hasta,o
56,S0066-782X2009000300004,98,o
56,S0066-782X2009000300004,dias,o
56,S0066-782X2009000300004,Las,o
56,S0066-782X2009000300004,dosis,o
56,S0066-782X2009000300004,mg,o
56,S0066-782X2009000300004,iniciales,o
56,S0066-782X2009000300004,fueron,o
56,S0066-782X2009000300004,respectivamente,o
56,S0066-782X2009000300004,A,o
56,S0066-782X2009000300004,2510,o
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,B,o
56,S0066-782X2009000300004,25,o
56,S0066-782X2009000300004,siendo,o
56,S0066-782X2009000300004,incrementadas,o
56,S0066-782X2009000300004,si,o
56,S0066-782X2009000300004,PAD,i
56,S0066-782X2009000300004,85mmHg,o
56,S0066-782X2009000300004,en,o
56,S0066-782X2009000300004,las,o
56,S0066-782X2009000300004,visitas,o
56,S0066-782X2009000300004,Estadistica,o
56,S0066-782X2009000300004,con,o
56,S0066-782X2009000300004,χ2,o
56,S0066-782X2009000300004,Fischer,o
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,analisis,o
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,varianza,o
56,S0066-782X2009000300004,para,o
56,S0066-782X2009000300004,p,o
56,S0066-782X2009000300004,005,o
56,S0066-782X2009000300004,RESULTADOS,o
56,S0066-782X2009000300004,De,o
56,S0066-782X2009000300004,un,o
56,S0066-782X2009000300004,total,o
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,110,o
56,S0066-782X2009000300004,pts,o
56,S0066-782X2009000300004,seleccionados,o
56,S0066-782X2009000300004,randomizamos,i
56,S0066-782X2009000300004,a,o
56,S0066-782X2009000300004,72,o
56,S0066-782X2009000300004,A,o
56,S0066-782X2009000300004,32,o
56,S0066-782X2009000300004,B,o
56,S0066-782X2009000300004,40,o
56,S0066-782X2009000300004,Las,o
56,S0066-782X2009000300004,reduccion,o
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,la,o
56,S0066-782X2009000300004,PAD,i
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,la,o
56,S0066-782X2009000300004,PA,i
56,S0066-782X2009000300004,sistolica,i
56,S0066-782X2009000300004,PAS,i
56,S0066-782X2009000300004,fueron,o
56,S0066-782X2009000300004,intensas,o
56,S0066-782X2009000300004,p,o
56,S0066-782X2009000300004,001,o
56,S0066-782X2009000300004,pero,o
56,S0066-782X2009000300004,sin,o
56,S0066-782X2009000300004,diferencias,o
56,S0066-782X2009000300004,entre,o
56,S0066-782X2009000300004,los,o
56,S0066-782X2009000300004,grupos,o
56,S0066-782X2009000300004,en,o
56,S0066-782X2009000300004,mmHg,o
56,S0066-782X2009000300004,PAS,i
56,S0066-782X2009000300004,A,o
56,S0066-782X2009000300004,1277,o
56,S0066-782X2009000300004,134,o
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,B,o
56,S0066-782X2009000300004,1253,o
56,S0066-782X2009000300004,126,o
56,S0066-782X2009000300004,p,o
56,S0066-782X2009000300004,045,o
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,PAD,i
56,S0066-782X2009000300004,A,o
56,S0066-782X2009000300004,745,o
56,S0066-782X2009000300004,67,o
56,S0066-782X2009000300004,mmHg,o
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,B,o
56,S0066-782X2009000300004,755,o
56,S0066-782X2009000300004,67,o
56,S0066-782X2009000300004,mmHg,o
56,S0066-782X2009000300004,p,o
56,S0066-782X2009000300004,032,o
56,S0066-782X2009000300004,Se,o
56,S0066-782X2009000300004,registro,o
56,S0066-782X2009000300004,menos,o
56,S0066-782X2009000300004,edema,i
56,S0066-782X2009000300004,de,i
56,S0066-782X2009000300004,miembros,i
56,S0066-782X2009000300004,inferiores,i
56,S0066-782X2009000300004,en,o
56,S0066-782X2009000300004,el,o
56,S0066-782X2009000300004,A,o
56,S0066-782X2009000300004,71,o
56,S0066-782X2009000300004,vs,o
56,S0066-782X2009000300004,306,o
56,S0066-782X2009000300004,p002,o
56,S0066-782X2009000300004,en,o
56,S0066-782X2009000300004,el,o
56,S0066-782X2009000300004,98º,o
56,S0066-782X2009000300004,dia,o
56,S0066-782X2009000300004,CONCLUSION,o
56,S0066-782X2009000300004,La,o
56,S0066-782X2009000300004,combinacion,o
56,S0066-782X2009000300004,fija,o
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,enalapril,i
56,S0066-782X2009000300004,con,o
56,S0066-782X2009000300004,amlodipino,i
56,S0066-782X2009000300004,tal,o
56,S0066-782X2009000300004,como,o
56,S0066-782X2009000300004,el,o
56,S0066-782X2009000300004,amlodipino,i
56,S0066-782X2009000300004,aislado,o
56,S0066-782X2009000300004,en,o
56,S0066-782X2009000300004,pts,o
56,S0066-782X2009000300004,con,o
56,S0066-782X2009000300004,EAC,i
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,HAS,i
56,S0066-782X2009000300004,estadios,o
56,S0066-782X2009000300004,I,o
56,S0066-782X2009000300004,y,o
56,S0066-782X2009000300004,II,o
56,S0066-782X2009000300004,fue,o
56,S0066-782X2009000300004,eficaz,o
56,S0066-782X2009000300004,en,o
56,S0066-782X2009000300004,la,o
56,S0066-782X2009000300004,normalizacion,o
56,S0066-782X2009000300004,de,o
56,S0066-782X2009000300004,la,o
56,S0066-782X2009000300004,presion,o
56,S0066-782X2009000300004,agregando,o
56,S0066-782X2009000300004,un,o
56,S0066-782X2009000300004,bloqueo,o
56,S0066-782X2009000300004,al,o
56,S0066-782X2009000300004,sistema,o
56,S0066-782X2009000300004,reninaangiotensina,o
57,S0066-782X2009000800010,Estudio,o
57,S0066-782X2009000800010,prospectivo,o
57,S0066-782X2009000800010,doble,o
57,S0066-782X2009000800010,ciego,o
57,S0066-782X2009000800010,y,o
57,S0066-782X2009000800010,cruzado,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,la,o
57,S0066-782X2009000800010,Camellia,o
57,S0066-782X2009000800010,sinensis,o
57,S0066-782X2009000800010,te,o
57,S0066-782X2009000800010,verde,o
57,S0066-782X2009000800010,en,o
57,S0066-782X2009000800010,las,o
57,S0066-782X2009000800010,dislipidemias,i
57,S0066-782X2009000800010,FUNDAMENTO,o
57,S0066-782X2009000800010,Estudios,i
57,S0066-782X2009000800010,epidemiologicos,i
57,S0066-782X2009000800010,establecieron,o
57,S0066-782X2009000800010,una,o
57,S0066-782X2009000800010,asociacion,o
57,S0066-782X2009000800010,entre,o
57,S0066-782X2009000800010,dislipidemias,i
57,S0066-782X2009000800010,y,o
57,S0066-782X2009000800010,aterosclerosis,i
57,S0066-782X2009000800010,La,o
57,S0066-782X2009000800010,terapia,i
57,S0066-782X2009000800010,nutricional,i
57,S0066-782X2009000800010,es,o
57,S0066-782X2009000800010,un,o
57,S0066-782X2009000800010,punto,o
57,S0066-782X2009000800010,central,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,la,o
57,S0066-782X2009000800010,estrategia,i
57,S0066-782X2009000800010,preventiva,i
57,S0066-782X2009000800010,en,o
57,S0066-782X2009000800010,individuos,o
57,S0066-782X2009000800010,que,o
57,S0066-782X2009000800010,presentan,o
57,S0066-782X2009000800010,factores,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,riesgo,o
57,S0066-782X2009000800010,para,o
57,S0066-782X2009000800010,enfermedad,i
57,S0066-782X2009000800010,aterosclerotica,i
57,S0066-782X2009000800010,OBJETIVO,o
57,S0066-782X2009000800010,Investigar,o
57,S0066-782X2009000800010,los,o
57,S0066-782X2009000800010,efectos,o
57,S0066-782X2009000800010,del,o
57,S0066-782X2009000800010,te,o
57,S0066-782X2009000800010,verde,o
57,S0066-782X2009000800010,Camellia,o
57,S0066-782X2009000800010,sinensis,o
57,S0066-782X2009000800010,en,o
57,S0066-782X2009000800010,pacientes,o
57,S0066-782X2009000800010,portadores,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,dislipidemias,i
57,S0066-782X2009000800010,METODOS,o
57,S0066-782X2009000800010,El,o
57,S0066-782X2009000800010,estudio,o
57,S0066-782X2009000800010,implico,o
57,S0066-782X2009000800010,a,o
57,S0066-782X2009000800010,33,o
57,S0066-782X2009000800010,pacientes,o
57,S0066-782X2009000800010,con,o
57,S0066-782X2009000800010,edad,o
57,S0066-782X2009000800010,entre,o
57,S0066-782X2009000800010,21,o
57,S0066-782X2009000800010,y,o
57,S0066-782X2009000800010,71,o
57,S0066-782X2009000800010,años,o
57,S0066-782X2009000800010,que,o
57,S0066-782X2009000800010,consumian,o
57,S0066-782X2009000800010,una,o
57,S0066-782X2009000800010,dieta,i
57,S0066-782X2009000800010,con,i
57,S0066-782X2009000800010,bajo,i
57,S0066-782X2009000800010,tenor,i
57,S0066-782X2009000800010,graso,i
57,S0066-782X2009000800010,el,o
57,S0066-782X2009000800010,25,o
57,S0066-782X2009000800010,al,o
57,S0066-782X2009000800010,35,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,las,o
57,S0066-782X2009000800010,calorias,o
57,S0066-782X2009000800010,totales,o
57,S0066-782X2009000800010,y,o
57,S0066-782X2009000800010,200mg,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,colesterol,i
57,S0066-782X2009000800010,por,o
57,S0066-782X2009000800010,dia,o
57,S0066-782X2009000800010,Se,o
57,S0066-782X2009000800010,randomizaron,i
57,S0066-782X2009000800010,para,o
57,S0066-782X2009000800010,dos,o
57,S0066-782X2009000800010,tratamientos,i
57,S0066-782X2009000800010,secuenciales,i
57,S0066-782X2009000800010,capsulas,o
57,S0066-782X2009000800010,conteniendo,o
57,S0066-782X2009000800010,250mg,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,extracto,i
57,S0066-782X2009000800010,seco,i
57,S0066-782X2009000800010,del,i
57,S0066-782X2009000800010,te,i
57,S0066-782X2009000800010,verde,i
57,S0066-782X2009000800010,o,o
57,S0066-782X2009000800010,placebo,i
57,S0066-782X2009000800010,administradas,o
57,S0066-782X2009000800010,por,o
57,S0066-782X2009000800010,un,o
57,S0066-782X2009000800010,periodo,o
57,S0066-782X2009000800010,total,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,16,o
57,S0066-782X2009000800010,semanas,o
57,S0066-782X2009000800010,habiendo,o
57,S0066-782X2009000800010,cada,o
57,S0066-782X2009000800010,paciente,o
57,S0066-782X2009000800010,utilizado,o
57,S0066-782X2009000800010,te,o
57,S0066-782X2009000800010,verde,o
57,S0066-782X2009000800010,Camellia,o
57,S0066-782X2009000800010,sinensis,o
57,S0066-782X2009000800010,por,o
57,S0066-782X2009000800010,ocho,o
57,S0066-782X2009000800010,semanas,o
57,S0066-782X2009000800010,y,o
57,S0066-782X2009000800010,placebo,i
57,S0066-782X2009000800010,en,o
57,S0066-782X2009000800010,igual,o
57,S0066-782X2009000800010,periodo,o
57,S0066-782X2009000800010,RESULTADOS,o
57,S0066-782X2009000800010,Los,o
57,S0066-782X2009000800010,valores,i
57,S0066-782X2009000800010,lipidicos,i
57,S0066-782X2009000800010,basales,o
57,S0066-782X2009000800010,mgdl,o
57,S0066-782X2009000800010,fueron,o
57,S0066-782X2009000800010,los,o
57,S0066-782X2009000800010,siguientes,o
57,S0066-782X2009000800010,HDLcolesterol,o
57,S0066-782X2009000800010,607,o
57,S0066-782X2009000800010,73,o
57,S0066-782X2009000800010,colesterol,i
57,S0066-782X2009000800010,total,i
57,S0066-782X2009000800010,255,o
57,S0066-782X2009000800010,309,o
57,S0066-782X2009000800010,LDLcolesterol,o
57,S0066-782X2009000800010,1588,o
57,S0066-782X2009000800010,290,o
57,S0066-782X2009000800010,trigliceridos,i
57,S0066-782X2009000800010,1690,o
57,S0066-782X2009000800010,613,o
57,S0066-782X2009000800010,y,o
57,S0066-782X2009000800010,ApoB,o
57,S0066-782X2009000800010,1202,o
57,S0066-782X2009000800010,189,o
57,S0066-782X2009000800010,Las,o
57,S0066-782X2009000800010,variaciones,o
57,S0066-782X2009000800010,lipidicas,i
57,S0066-782X2009000800010,promedios,o
57,S0066-782X2009000800010,provocadas,o
57,S0066-782X2009000800010,por,o
57,S0066-782X2009000800010,el,o
57,S0066-782X2009000800010,uso,o
57,S0066-782X2009000800010,del,o
57,S0066-782X2009000800010,te,o
57,S0066-782X2009000800010,verde,o
57,S0066-782X2009000800010,Camellia,o
57,S0066-782X2009000800010,sinensis,o
57,S0066-782X2009000800010,evidenciaron,o
57,S0066-782X2009000800010,una,o
57,S0066-782X2009000800010,reduccion,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,un,o
57,S0066-782X2009000800010,39,o
57,S0066-782X2009000800010,p,o
57,S0066-782X2009000800010,0006,o
57,S0066-782X2009000800010,en,o
57,S0066-782X2009000800010,las,o
57,S0066-782X2009000800010,concentraciones,i
57,S0066-782X2009000800010,del,i
57,S0066-782X2009000800010,colesterol,i
57,S0066-782X2009000800010,total,i
57,S0066-782X2009000800010,y,o
57,S0066-782X2009000800010,una,o
57,S0066-782X2009000800010,reduccion,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,un,o
57,S0066-782X2009000800010,45,o
57,S0066-782X2009000800010,p,o
57,S0066-782X2009000800010,0026,o
57,S0066-782X2009000800010,del,o
57,S0066-782X2009000800010,LDLcolesterol,o
57,S0066-782X2009000800010,La,o
57,S0066-782X2009000800010,ingestion,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,te,o
57,S0066-782X2009000800010,verde,o
57,S0066-782X2009000800010,no,o
57,S0066-782X2009000800010,influencio,o
57,S0066-782X2009000800010,significativamente,o
57,S0066-782X2009000800010,los,o
57,S0066-782X2009000800010,niveles,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,HDLcolesterol,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,los,o
57,S0066-782X2009000800010,trigliceridos,i
57,S0066-782X2009000800010,y,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,la,o
57,S0066-782X2009000800010,ApoB,o
57,S0066-782X2009000800010,Resultados,o
57,S0066-782X2009000800010,no,o
57,S0066-782X2009000800010,significativos,o
57,S0066-782X2009000800010,se,o
57,S0066-782X2009000800010,observaron,o
57,S0066-782X2009000800010,en,o
57,S0066-782X2009000800010,la,o
57,S0066-782X2009000800010,evaluacion,i
57,S0066-782X2009000800010,de,i
57,S0066-782X2009000800010,los,i
57,S0066-782X2009000800010,lipidos,i
57,S0066-782X2009000800010,sanguineos,i
57,S0066-782X2009000800010,colesterol,i
57,S0066-782X2009000800010,total,i
57,S0066-782X2009000800010,y,o
57,S0066-782X2009000800010,LDLcolesterol,o
57,S0066-782X2009000800010,con,o
57,S0066-782X2009000800010,el,o
57,S0066-782X2009000800010,empleo,o
57,S0066-782X2009000800010,del,o
57,S0066-782X2009000800010,placebo,i
57,S0066-782X2009000800010,CONCLUSION,o
57,S0066-782X2009000800010,Se,o
57,S0066-782X2009000800010,evidencio,o
57,S0066-782X2009000800010,el,o
57,S0066-782X2009000800010,efecto,o
57,S0066-782X2009000800010,benefico,o
57,S0066-782X2009000800010,del,o
57,S0066-782X2009000800010,te,o
57,S0066-782X2009000800010,verde,o
57,S0066-782X2009000800010,Camellia,o
57,S0066-782X2009000800010,sinensis,o
57,S0066-782X2009000800010,que,o
57,S0066-782X2009000800010,redujo,o
57,S0066-782X2009000800010,significativamente,o
57,S0066-782X2009000800010,en,o
57,S0066-782X2009000800010,ocho,o
57,S0066-782X2009000800010,semanas,o
57,S0066-782X2009000800010,los,o
57,S0066-782X2009000800010,niveles,i
57,S0066-782X2009000800010,de,i
57,S0066-782X2009000800010,colesterol,i
57,S0066-782X2009000800010,total,i
57,S0066-782X2009000800010,y,o
57,S0066-782X2009000800010,LDLcolesterol,o
57,S0066-782X2009000800010,en,o
57,S0066-782X2009000800010,ese,o
57,S0066-782X2009000800010,grupo,o
57,S0066-782X2009000800010,de,o
57,S0066-782X2009000800010,pacientes,o
58,S0066-782X2010000200017,Espirometria,i
58,S0066-782X2010000200017,incentivada,i
58,S0066-782X2010000200017,con,o
58,S0066-782X2010000200017,presion,i
58,S0066-782X2010000200017,positiva,i
58,S0066-782X2010000200017,espiratoria,i
58,S0066-782X2010000200017,es,o
58,S0066-782X2010000200017,beneficiosa,o
58,S0066-782X2010000200017,despues,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,revascularizacion,i
58,S0066-782X2010000200017,de,i
58,S0066-782X2010000200017,miocardio,i
58,S0066-782X2010000200017,FUNDAMENTO,o
58,S0066-782X2010000200017,Pacientes,o
58,S0066-782X2010000200017,que,o
58,S0066-782X2010000200017,son,o
58,S0066-782X2010000200017,sometidos,o
58,S0066-782X2010000200017,a,o
58,S0066-782X2010000200017,cirugia,i
58,S0066-782X2010000200017,de,i
58,S0066-782X2010000200017,revascularizacion,i
58,S0066-782X2010000200017,del,i
58,S0066-782X2010000200017,miocardio,i
58,S0066-782X2010000200017,CRM,i
58,S0066-782X2010000200017,presenta,o
58,S0066-782X2010000200017,mayor,o
58,S0066-782X2010000200017,riesgo,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,desarrollar,o
58,S0066-782X2010000200017,complicaciones,i
58,S0066-782X2010000200017,pulmonares,i
58,S0066-782X2010000200017,como,o
58,S0066-782X2010000200017,atelectasias,i
58,S0066-782X2010000200017,neumonia,i
58,S0066-782X2010000200017,y,o
58,S0066-782X2010000200017,derrame,i
58,S0066-782X2010000200017,pleural,i
58,S0066-782X2010000200017,Estas,o
58,S0066-782X2010000200017,complicaciones,i
58,S0066-782X2010000200017,pueden,o
58,S0066-782X2010000200017,aumentar,o
58,S0066-782X2010000200017,el,o
58,S0066-782X2010000200017,tiempo,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,internacion,i
58,S0066-782X2010000200017,hospitalaria,i
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,necesidad,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,recursos,o
58,S0066-782X2010000200017,financieros,o
58,S0066-782X2010000200017,y,o
58,S0066-782X2010000200017,tambien,o
58,S0066-782X2010000200017,se,o
58,S0066-782X2010000200017,asocian,o
58,S0066-782X2010000200017,con,o
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,reduccion,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,calidad,i
58,S0066-782X2010000200017,de,i
58,S0066-782X2010000200017,vida,i
58,S0066-782X2010000200017,y,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,capacidad,i
58,S0066-782X2010000200017,funcional,i
58,S0066-782X2010000200017,a,o
58,S0066-782X2010000200017,largo,o
58,S0066-782X2010000200017,plazo,o
58,S0066-782X2010000200017,OBJETIVO,o
58,S0066-782X2010000200017,Probar,o
58,S0066-782X2010000200017,si,o
58,S0066-782X2010000200017,el,o
58,S0066-782X2010000200017,uso,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,espirometria,i
58,S0066-782X2010000200017,incentivada,i
58,S0066-782X2010000200017,EI,o
58,S0066-782X2010000200017,asociada,o
58,S0066-782X2010000200017,con,o
58,S0066-782X2010000200017,presion,i
58,S0066-782X2010000200017,positiva,i
58,S0066-782X2010000200017,espiratoria,i
58,S0066-782X2010000200017,en,i
58,S0066-782X2010000200017,la,i
58,S0066-782X2010000200017,via,i
58,S0066-782X2010000200017,aerea,i
58,S0066-782X2010000200017,EPAP,i
58,S0066-782X2010000200017,despues,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,CRM,i
58,S0066-782X2010000200017,mejora,o
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,disnea,i
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,sensacion,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,esfuerzo,o
58,S0066-782X2010000200017,percibido,o
58,S0066-782X2010000200017,y,o
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,calidad,i
58,S0066-782X2010000200017,de,i
58,S0066-782X2010000200017,vida,i
58,S0066-782X2010000200017,18,o
58,S0066-782X2010000200017,meses,o
58,S0066-782X2010000200017,despues,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,CRM,i
58,S0066-782X2010000200017,METODOS,o
58,S0066-782X2010000200017,Dieciocho,o
58,S0066-782X2010000200017,pacientes,o
58,S0066-782X2010000200017,sometidos,o
58,S0066-782X2010000200017,a,o
58,S0066-782X2010000200017,CRM,i
58,S0066-782X2010000200017,fueron,o
58,S0066-782X2010000200017,aleatorizados,i
58,S0066-782X2010000200017,para,o
58,S0066-782X2010000200017,el,o
58,S0066-782X2010000200017,grupo,o
58,S0066-782X2010000200017,control,o
58,S0066-782X2010000200017,n8,o
58,S0066-782X2010000200017,o,o
58,S0066-782X2010000200017,para,o
58,S0066-782X2010000200017,el,o
58,S0066-782X2010000200017,grupo,o
58,S0066-782X2010000200017,EIEPAP,o
58,S0066-782X2010000200017,n8,o
58,S0066-782X2010000200017,El,o
58,S0066-782X2010000200017,protocolo,i
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,EIEPAP,o
58,S0066-782X2010000200017,se,o
58,S0066-782X2010000200017,realizo,o
58,S0066-782X2010000200017,en,o
58,S0066-782X2010000200017,el,o
58,S0066-782X2010000200017,periodo,o
58,S0066-782X2010000200017,postoperatorio,o
58,S0066-782X2010000200017,inmediato,o
58,S0066-782X2010000200017,y,o
58,S0066-782X2010000200017,durante,o
58,S0066-782X2010000200017,4,o
58,S0066-782X2010000200017,semanas,o
58,S0066-782X2010000200017,mas,o
58,S0066-782X2010000200017,en,o
58,S0066-782X2010000200017,domicilio,o
58,S0066-782X2010000200017,Dieciocho,o
58,S0066-782X2010000200017,meses,o
58,S0066-782X2010000200017,despues,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,CRM,i
58,S0066-782X2010000200017,se,o
58,S0066-782X2010000200017,evaluaron,o
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,fuerza,i
58,S0066-782X2010000200017,de,i
58,S0066-782X2010000200017,la,i
58,S0066-782X2010000200017,musculatura,i
58,S0066-782X2010000200017,respiratoria,i
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,capacidad,i
58,S0066-782X2010000200017,funcional,i
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,funcion,i
58,S0066-782X2010000200017,pulmonar,i
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,calidad,i
58,S0066-782X2010000200017,de,i
58,S0066-782X2010000200017,vida,i
58,S0066-782X2010000200017,y,o
58,S0066-782X2010000200017,el,o
58,S0066-782X2010000200017,nivel,i
58,S0066-782X2010000200017,de,i
58,S0066-782X2010000200017,actividad,i
58,S0066-782X2010000200017,fisica,i
58,S0066-782X2010000200017,RESULTADOS,o
58,S0066-782X2010000200017,Despues,o
58,S0066-782X2010000200017,del,o
58,S0066-782X2010000200017,test,i
58,S0066-782X2010000200017,de,i
58,S0066-782X2010000200017,caminata,i
58,S0066-782X2010000200017,de,i
58,S0066-782X2010000200017,seis,i
58,S0066-782X2010000200017,minutos,i
58,S0066-782X2010000200017,TC6,o
58,S0066-782X2010000200017,el,o
58,S0066-782X2010000200017,score,o
58,S0066-782X2010000200017,para,o
58,S0066-782X2010000200017,disnea,i
58,S0066-782X2010000200017,16,o
58,S0066-782X2010000200017,06,o
58,S0066-782X2010000200017,vs,o
58,S0066-782X2010000200017,06,o
58,S0066-782X2010000200017,03,o
58,S0066-782X2010000200017,P,o
58,S0066-782X2010000200017,005,o
58,S0066-782X2010000200017,y,o
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,sensacion,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,esfuerzo,o
58,S0066-782X2010000200017,134,o
58,S0066-782X2010000200017,12,o
58,S0066-782X2010000200017,vs,o
58,S0066-782X2010000200017,91,o
58,S0066-782X2010000200017,07,o
58,S0066-782X2010000200017,P,o
58,S0066-782X2010000200017,005,o
58,S0066-782X2010000200017,fueron,o
58,S0066-782X2010000200017,mayores,o
58,S0066-782X2010000200017,en,o
58,S0066-782X2010000200017,el,o
58,S0066-782X2010000200017,grupo,o
58,S0066-782X2010000200017,control,o
58,S0066-782X2010000200017,comparado,o
58,S0066-782X2010000200017,con,o
58,S0066-782X2010000200017,el,o
58,S0066-782X2010000200017,grupo,o
58,S0066-782X2010000200017,EIEPAP,o
58,S0066-782X2010000200017,En,o
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,evaluacion,i
58,S0066-782X2010000200017,de,i
58,S0066-782X2010000200017,la,i
58,S0066-782X2010000200017,calidad,i
58,S0066-782X2010000200017,de,i
58,S0066-782X2010000200017,vida,i
58,S0066-782X2010000200017,el,o
58,S0066-782X2010000200017,dominio,o
58,S0066-782X2010000200017,relacionado,o
58,S0066-782X2010000200017,con,o
58,S0066-782X2010000200017,las,o
58,S0066-782X2010000200017,limitaciones,o
58,S0066-782X2010000200017,en,o
58,S0066-782X2010000200017,los,o
58,S0066-782X2010000200017,aspectos,o
58,S0066-782X2010000200017,fisicos,o
58,S0066-782X2010000200017,fue,o
58,S0066-782X2010000200017,mejor,o
58,S0066-782X2010000200017,en,o
58,S0066-782X2010000200017,el,o
58,S0066-782X2010000200017,grupo,o
58,S0066-782X2010000200017,EIEPAP,o
58,S0066-782X2010000200017,937,o
58,S0066-782X2010000200017,41,o
58,S0066-782X2010000200017,vs,o
58,S0066-782X2010000200017,50,o
58,S0066-782X2010000200017,17,o
58,S0066-782X2010000200017,P,o
58,S0066-782X2010000200017,002,o
58,S0066-782X2010000200017,CONCLUSION,o
58,S0066-782X2010000200017,Pacientes,o
58,S0066-782X2010000200017,que,o
58,S0066-782X2010000200017,realizan,o
58,S0066-782X2010000200017,EIEPAP,o
58,S0066-782X2010000200017,presentan,o
58,S0066-782X2010000200017,menos,o
58,S0066-782X2010000200017,disnea,i
58,S0066-782X2010000200017,y,o
58,S0066-782X2010000200017,menor,o
58,S0066-782X2010000200017,sensacion,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,esfuerzo,o
58,S0066-782X2010000200017,despues,o
58,S0066-782X2010000200017,del,o
58,S0066-782X2010000200017,TC6,o
58,S0066-782X2010000200017,y,o
58,S0066-782X2010000200017,tambien,o
58,S0066-782X2010000200017,mejor,o
58,S0066-782X2010000200017,calidad,i
58,S0066-782X2010000200017,de,i
58,S0066-782X2010000200017,vida,i
58,S0066-782X2010000200017,18,o
58,S0066-782X2010000200017,meses,o
58,S0066-782X2010000200017,despues,o
58,S0066-782X2010000200017,de,o
58,S0066-782X2010000200017,la,o
58,S0066-782X2010000200017,CRM,i
59,S0066-782X2011000300008,Sedacion,i
59,S0066-782X2011000300008,con,o
59,S0066-782X2011000300008,sufentanil,i
59,S0066-782X2011000300008,y,o
59,S0066-782X2011000300008,clonidina,i
59,S0066-782X2011000300008,en,o
59,S0066-782X2011000300008,pacientes,o
59,S0066-782X2011000300008,sometidos,o
59,S0066-782X2011000300008,a,o
59,S0066-782X2011000300008,cateterismo,i
59,S0066-782X2011000300008,cardiaco,i
59,S0066-782X2011000300008,FUNDAMENTO,o
59,S0066-782X2011000300008,La,o
59,S0066-782X2011000300008,sedacion,i
59,S0066-782X2011000300008,para,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,realizacion,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,cateterismo,i
59,S0066-782X2011000300008,cardiaco,i
59,S0066-782X2011000300008,ha,o
59,S0066-782X2011000300008,sido,o
59,S0066-782X2011000300008,blanco,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,preocupacion,o
59,S0066-782X2011000300008,Benzodiazepinicos,i
59,S0066-782X2011000300008,agonistas,o
59,S0066-782X2011000300008,alfa2,o
59,S0066-782X2011000300008,adrenergicos,o
59,S0066-782X2011000300008,y,o
59,S0066-782X2011000300008,opioides,i
59,S0066-782X2011000300008,son,o
59,S0066-782X2011000300008,utilizados,o
59,S0066-782X2011000300008,para,o
59,S0066-782X2011000300008,ese,o
59,S0066-782X2011000300008,fin,o
59,S0066-782X2011000300008,entre,o
59,S0066-782X2011000300008,tanto,o
59,S0066-782X2011000300008,cada,o
59,S0066-782X2011000300008,uno,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,estos,o
59,S0066-782X2011000300008,medicamentos,i
59,S0066-782X2011000300008,posee,o
59,S0066-782X2011000300008,ventajas,o
59,S0066-782X2011000300008,y,o
59,S0066-782X2011000300008,desventajas,o
59,S0066-782X2011000300008,OBJETIVO,o
59,S0066-782X2011000300008,Evaluar,i
59,S0066-782X2011000300008,la,i
59,S0066-782X2011000300008,eficacia,i
59,S0066-782X2011000300008,del,o
59,S0066-782X2011000300008,sufentanil,i
59,S0066-782X2011000300008,y,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,clonidina,i
59,S0066-782X2011000300008,como,o
59,S0066-782X2011000300008,sedativos,i
59,S0066-782X2011000300008,en,o
59,S0066-782X2011000300008,pacientes,o
59,S0066-782X2011000300008,sometidos,o
59,S0066-782X2011000300008,a,o
59,S0066-782X2011000300008,cateterismo,i
59,S0066-782X2011000300008,cardiaco,i
59,S0066-782X2011000300008,observando,o
59,S0066-782X2011000300008,el,o
59,S0066-782X2011000300008,impacto,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,los,o
59,S0066-782X2011000300008,mismos,o
59,S0066-782X2011000300008,sobre,o
59,S0066-782X2011000300008,los,o
59,S0066-782X2011000300008,parametros,o
59,S0066-782X2011000300008,hemodinamicos,o
59,S0066-782X2011000300008,y,o
59,S0066-782X2011000300008,respiratorios,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,presencia,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,efectos,i
59,S0066-782X2011000300008,colaterales,i
59,S0066-782X2011000300008,ademas,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,satisfaccion,o
59,S0066-782X2011000300008,del,o
59,S0066-782X2011000300008,paciente,o
59,S0066-782X2011000300008,y,o
59,S0066-782X2011000300008,del,o
59,S0066-782X2011000300008,hemodinamista,o
59,S0066-782X2011000300008,con,o
59,S0066-782X2011000300008,el,o
59,S0066-782X2011000300008,examen,i
59,S0066-782X2011000300008,METODOS,o
59,S0066-782X2011000300008,Se,o
59,S0066-782X2011000300008,trata,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,un,o
59,S0066-782X2011000300008,ensayo,o
59,S0066-782X2011000300008,clinico,o
59,S0066-782X2011000300008,prospectivo,o
59,S0066-782X2011000300008,doble,o
59,S0066-782X2011000300008,ciego,o
59,S0066-782X2011000300008,randomizado,o
59,S0066-782X2011000300008,y,o
59,S0066-782X2011000300008,controlado,o
59,S0066-782X2011000300008,que,o
59,S0066-782X2011000300008,incluyo,o
59,S0066-782X2011000300008,60,o
59,S0066-782X2011000300008,pacientes,o
59,S0066-782X2011000300008,que,o
59,S0066-782X2011000300008,recibieron,o
59,S0066-782X2011000300008,01,o
59,S0066-782X2011000300008,µgkg,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,sufentanil,i
59,S0066-782X2011000300008,o,o
59,S0066-782X2011000300008,05,o
59,S0066-782X2011000300008,µgkg,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,clonidina,i
59,S0066-782X2011000300008,antes,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,realizacion,o
59,S0066-782X2011000300008,del,o
59,S0066-782X2011000300008,cateterismo,i
59,S0066-782X2011000300008,cardiaco,i
59,S0066-782X2011000300008,El,o
59,S0066-782X2011000300008,escore,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,sedacion,i
59,S0066-782X2011000300008,segun,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,escala,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,Ramsay,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,necesidad,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,utilizacion,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,midazolam,i
59,S0066-782X2011000300008,los,o
59,S0066-782X2011000300008,efectos,i
59,S0066-782X2011000300008,colaterales,i
59,S0066-782X2011000300008,los,o
59,S0066-782X2011000300008,parametros,o
59,S0066-782X2011000300008,hemodinamicos,o
59,S0066-782X2011000300008,y,o
59,S0066-782X2011000300008,respiratorios,o
59,S0066-782X2011000300008,fueron,o
59,S0066-782X2011000300008,registrados,o
59,S0066-782X2011000300008,siendo,o
59,S0066-782X2011000300008,los,o
59,S0066-782X2011000300008,datos,o
59,S0066-782X2011000300008,analizados,o
59,S0066-782X2011000300008,en,o
59,S0066-782X2011000300008,6,o
59,S0066-782X2011000300008,diferentes,o
59,S0066-782X2011000300008,momentos,o
59,S0066-782X2011000300008,RESULTADOS,o
59,S0066-782X2011000300008,El,o
59,S0066-782X2011000300008,comportamiento,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,presion,i
59,S0066-782X2011000300008,arterial,i
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,frecuencia,i
59,S0066-782X2011000300008,cardiaca,i
59,S0066-782X2011000300008,y,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,frecuencia,i
59,S0066-782X2011000300008,respiratoria,i
59,S0066-782X2011000300008,fue,o
59,S0066-782X2011000300008,semejante,o
59,S0066-782X2011000300008,en,o
59,S0066-782X2011000300008,los,o
59,S0066-782X2011000300008,dos,o
59,S0066-782X2011000300008,grupos,o
59,S0066-782X2011000300008,entre,o
59,S0066-782X2011000300008,tanto,o
59,S0066-782X2011000300008,en,o
59,S0066-782X2011000300008,el,o
59,S0066-782X2011000300008,momento,o
59,S0066-782X2011000300008,2,o
59,S0066-782X2011000300008,los,o
59,S0066-782X2011000300008,pacientes,o
59,S0066-782X2011000300008,del,o
59,S0066-782X2011000300008,grupo,o
59,S0066-782X2011000300008,sufentanil,i
59,S0066-782X2011000300008,Grupo,o
59,S0066-782X2011000300008,S,o
59,S0066-782X2011000300008,presentaron,o
59,S0066-782X2011000300008,menor,o
59,S0066-782X2011000300008,escore,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,sedacion,i
59,S0066-782X2011000300008,segun,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,escala,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,Ramsay,o
59,S0066-782X2011000300008,y,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,saturacion,i
59,S0066-782X2011000300008,periferica,i
59,S0066-782X2011000300008,de,i
59,S0066-782X2011000300008,la,i
59,S0066-782X2011000300008,oxihemoglobina,i
59,S0066-782X2011000300008,fue,o
59,S0066-782X2011000300008,menor,o
59,S0066-782X2011000300008,que,o
59,S0066-782X2011000300008,el,o
59,S0066-782X2011000300008,grupo,o
59,S0066-782X2011000300008,clonidina,i
59,S0066-782X2011000300008,Grupo,o
59,S0066-782X2011000300008,C,o
59,S0066-782X2011000300008,en,o
59,S0066-782X2011000300008,el,o
59,S0066-782X2011000300008,momento,o
59,S0066-782X2011000300008,6,o
59,S0066-782X2011000300008,Los,o
59,S0066-782X2011000300008,pacientes,o
59,S0066-782X2011000300008,del,o
59,S0066-782X2011000300008,Grupo,o
59,S0066-782X2011000300008,S,o
59,S0066-782X2011000300008,presentaron,o
59,S0066-782X2011000300008,mayor,o
59,S0066-782X2011000300008,incidencia,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,nausea,i
59,S0066-782X2011000300008,y,i
59,S0066-782X2011000300008,vomito,i
59,S0066-782X2011000300008,post,i
59,S0066-782X2011000300008,operatorio,i
59,S0066-782X2011000300008,que,o
59,S0066-782X2011000300008,los,o
59,S0066-782X2011000300008,pacientes,o
59,S0066-782X2011000300008,del,o
59,S0066-782X2011000300008,Grupo,o
59,S0066-782X2011000300008,C,o
59,S0066-782X2011000300008,La,o
59,S0066-782X2011000300008,satisfaccion,o
59,S0066-782X2011000300008,de,o
59,S0066-782X2011000300008,los,o
59,S0066-782X2011000300008,pacientes,o
59,S0066-782X2011000300008,fue,o
59,S0066-782X2011000300008,mayor,o
59,S0066-782X2011000300008,en,o
59,S0066-782X2011000300008,el,o
59,S0066-782X2011000300008,grupo,o
59,S0066-782X2011000300008,clonidina,i
59,S0066-782X2011000300008,Los,o
59,S0066-782X2011000300008,hemodinamistas,o
59,S0066-782X2011000300008,se,o
59,S0066-782X2011000300008,mostraron,o
59,S0066-782X2011000300008,satisfechos,o
59,S0066-782X2011000300008,en,o
59,S0066-782X2011000300008,los,o
59,S0066-782X2011000300008,dos,o
59,S0066-782X2011000300008,grupos,o
59,S0066-782X2011000300008,CONCLUSION,o
59,S0066-782X2011000300008,El,o
59,S0066-782X2011000300008,sufentanil,i
59,S0066-782X2011000300008,y,o
59,S0066-782X2011000300008,la,o
59,S0066-782X2011000300008,clonidina,i
59,S0066-782X2011000300008,fueron,o
59,S0066-782X2011000300008,efectivos,o
59,S0066-782X2011000300008,como,o
59,S0066-782X2011000300008,sedativos,i
59,S0066-782X2011000300008,en,o
59,S0066-782X2011000300008,pacientes,o
59,S0066-782X2011000300008,sometidos,o
59,S0066-782X2011000300008,a,o
59,S0066-782X2011000300008,cateterismo,i
59,S0066-782X2011000300008,cardiaco,i
60,S0066-782X2011000600010,Vitamina,i
60,S0066-782X2011000600010,C,i
60,S0066-782X2011000600010,restaura,o
60,S0066-782X2011000600010,presion,i
60,S0066-782X2011000600010,arterial,i
60,S0066-782X2011000600010,y,o
60,S0066-782X2011000600010,respuesta,o
60,S0066-782X2011000600010,vasodilatadora,o
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,antebrazo,i
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,niños,o
60,S0066-782X2011000600010,obesos,i
60,S0066-782X2011000600010,FUNDAMENTO,o
60,S0066-782X2011000600010,La,o
60,S0066-782X2011000600010,respuesta,o
60,S0066-782X2011000600010,vasodilatadora,o
60,S0066-782X2011000600010,periferica,o
60,S0066-782X2011000600010,tiene,o
60,S0066-782X2011000600010,un,o
60,S0066-782X2011000600010,papel,o
60,S0066-782X2011000600010,importante,o
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,fisiopatologia,o
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,obesidad,i
60,S0066-782X2011000600010,y,o
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,las,o
60,S0066-782X2011000600010,enfermedades,i
60,S0066-782X2011000600010,cardiacas,i
60,S0066-782X2011000600010,OBJETIVO,o
60,S0066-782X2011000600010,Evaluar,o
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,efecto,o
60,S0066-782X2011000600010,cronico,o
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,suplementacion,i
60,S0066-782X2011000600010,de,i
60,S0066-782X2011000600010,vitamina,i
60,S0066-782X2011000600010,C,i
60,S0066-782X2011000600010,VitC,i
60,S0066-782X2011000600010,sobre,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,presion,i
60,S0066-782X2011000600010,arterial,i
60,S0066-782X2011000600010,y,o
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,respuesta,o
60,S0066-782X2011000600010,vasodilatadora,o
60,S0066-782X2011000600010,al,o
60,S0066-782X2011000600010,estres,i
60,S0066-782X2011000600010,mental,i
60,S0066-782X2011000600010,METODOS,o
60,S0066-782X2011000600010,En,o
60,S0066-782X2011000600010,este,o
60,S0066-782X2011000600010,estudio,o
60,S0066-782X2011000600010,prospectivo,o
60,S0066-782X2011000600010,randomizado,o
60,S0066-782X2011000600010,y,o
60,S0066-782X2011000600010,doble,o
60,S0066-782X2011000600010,ciego,o
60,S0066-782X2011000600010,fueron,o
60,S0066-782X2011000600010,evaluados,o
60,S0066-782X2011000600010,niños,o
60,S0066-782X2011000600010,obesos,i
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,ambos,o
60,S0066-782X2011000600010,generos,o
60,S0066-782X2011000600010,con,o
60,S0066-782X2011000600010,edades,o
60,S0066-782X2011000600010,entre,o
60,S0066-782X2011000600010,8,o
60,S0066-782X2011000600010,y,o
60,S0066-782X2011000600010,12,o
60,S0066-782X2011000600010,años,o
60,S0066-782X2011000600010,divididos,o
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,2,o
60,S0066-782X2011000600010,grupos,o
60,S0066-782X2011000600010,1,o
60,S0066-782X2011000600010,grupo,o
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,niños,o
60,S0066-782X2011000600010,suplementados,i
60,S0066-782X2011000600010,con,o
60,S0066-782X2011000600010,500,o
60,S0066-782X2011000600010,mg,o
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,vitamina,i
60,S0066-782X2011000600010,C,i
60,S0066-782X2011000600010,n,o
60,S0066-782X2011000600010,11,o
60,S0066-782X2011000600010,y,o
60,S0066-782X2011000600010,2,o
60,S0066-782X2011000600010,substancia,i
60,S0066-782X2011000600010,placebo,i
60,S0066-782X2011000600010,n,o
60,S0066-782X2011000600010,10,o
60,S0066-782X2011000600010,durante,o
60,S0066-782X2011000600010,45,o
60,S0066-782X2011000600010,dias,o
60,S0066-782X2011000600010,Ocho,o
60,S0066-782X2011000600010,niños,o
60,S0066-782X2011000600010,eutroficos,o
60,S0066-782X2011000600010,pareados,o
60,S0066-782X2011000600010,por,o
60,S0066-782X2011000600010,edad,o
60,S0066-782X2011000600010,tambien,o
60,S0066-782X2011000600010,fueron,o
60,S0066-782X2011000600010,incluidos,o
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,estudio,o
60,S0066-782X2011000600010,Fueron,o
60,S0066-782X2011000600010,evaluados,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,presion,i
60,S0066-782X2011000600010,arterial,i
60,S0066-782X2011000600010,media,i
60,S0066-782X2011000600010,PAM,i
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,frecuencia,i
60,S0066-782X2011000600010,cardiaca,i
60,S0066-782X2011000600010,ECG,i
60,S0066-782X2011000600010,y,o
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,flujo,i
60,S0066-782X2011000600010,sanguineo,i
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,antebrazo,i
60,S0066-782X2011000600010,por,o
60,S0066-782X2011000600010,plestimografia,i
60,S0066-782X2011000600010,de,i
60,S0066-782X2011000600010,oclusion,i
60,S0066-782X2011000600010,venosa,i
60,S0066-782X2011000600010,La,o
60,S0066-782X2011000600010,conductancia,o
60,S0066-782X2011000600010,vascular,i
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,antebrazo,i
60,S0066-782X2011000600010,CVA,o
60,S0066-782X2011000600010,fue,o
60,S0066-782X2011000600010,obtenida,o
60,S0066-782X2011000600010,por,o
60,S0066-782X2011000600010,medio,o
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,relacion,o
60,S0066-782X2011000600010,entre,o
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,flujo,i
60,S0066-782X2011000600010,sanguineo,i
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,antebrazo,i
60,S0066-782X2011000600010,y,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,PAM,i
60,S0066-782X2011000600010,X100,o
60,S0066-782X2011000600010,RESULTADOS,o
60,S0066-782X2011000600010,Antes,o
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,intervencion,i
60,S0066-782X2011000600010,los,o
60,S0066-782X2011000600010,niños,o
60,S0066-782X2011000600010,obesos,i
60,S0066-782X2011000600010,presentaron,o
60,S0066-782X2011000600010,PAM,i
60,S0066-782X2011000600010,mayor,o
60,S0066-782X2011000600010,y,o
60,S0066-782X2011000600010,CVA,o
60,S0066-782X2011000600010,menor,o
60,S0066-782X2011000600010,cuando,o
60,S0066-782X2011000600010,fueron,o
60,S0066-782X2011000600010,comparados,o
60,S0066-782X2011000600010,con,o
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,Grupo,o
60,S0066-782X2011000600010,C,o
60,S0066-782X2011000600010,Post,o
60,S0066-782X2011000600010,intervencion,i
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,Grupo,o
60,S0066-782X2011000600010,VitC,i
60,S0066-782X2011000600010,presento,o
60,S0066-782X2011000600010,reduccion,o
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,PAM,i
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,reposo,o
60,S0066-782X2011000600010,81,o
60,S0066-782X2011000600010,2,o
60,S0066-782X2011000600010,vs,o
60,S0066-782X2011000600010,75,o
60,S0066-782X2011000600010,1,o
60,S0066-782X2011000600010,mmHg,o
60,S0066-782X2011000600010,p,o
60,S0066-782X2011000600010,001,o
60,S0066-782X2011000600010,mientras,o
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,Grupo,o
60,S0066-782X2011000600010,Placebo,i
60,S0066-782X2011000600010,no,o
60,S0066-782X2011000600010,hubo,o
60,S0066-782X2011000600010,alteracion,o
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,PAM,i
60,S0066-782X2011000600010,p,o
60,S0066-782X2011000600010,058,o
60,S0066-782X2011000600010,Adicionalmente,o
60,S0066-782X2011000600010,VitC,i
60,S0066-782X2011000600010,promovio,o
60,S0066-782X2011000600010,un,o
60,S0066-782X2011000600010,aumento,o
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,CVA,o
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,reposo,o
60,S0066-782X2011000600010,340,o
60,S0066-782X2011000600010,05,o
60,S0066-782X2011000600010,vs,o
60,S0066-782X2011000600010,509,o
60,S0066-782X2011000600010,06,o
60,S0066-782X2011000600010,un,o
60,S0066-782X2011000600010,p,o
60,S0066-782X2011000600010,004,o
60,S0066-782X2011000600010,y,o
60,S0066-782X2011000600010,durante,o
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,estres,i
60,S0066-782X2011000600010,mental,i
60,S0066-782X2011000600010,392,o
60,S0066-782X2011000600010,05,o
60,S0066-782X2011000600010,vs,o
60,S0066-782X2011000600010,668,o
60,S0066-782X2011000600010,09,o
60,S0066-782X2011000600010,un,o
60,S0066-782X2011000600010,p,o
60,S0066-782X2011000600010,003,o
60,S0066-782X2011000600010,Ademas,o
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,eso,o
60,S0066-782X2011000600010,post,o
60,S0066-782X2011000600010,suplementacion,i
60,S0066-782X2011000600010,con,i
60,S0066-782X2011000600010,VitC,i
60,S0066-782X2011000600010,los,o
60,S0066-782X2011000600010,niveles,o
60,S0066-782X2011000600010,de,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,CVA,o
60,S0066-782X2011000600010,fueron,o
60,S0066-782X2011000600010,estadisticamente,o
60,S0066-782X2011000600010,semejantes,o
60,S0066-782X2011000600010,a,o
60,S0066-782X2011000600010,los,o
60,S0066-782X2011000600010,del,o
60,S0066-782X2011000600010,Grupo,o
60,S0066-782X2011000600010,C,o
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,reposo,o
60,S0066-782X2011000600010,509,o
60,S0066-782X2011000600010,06,o
60,S0066-782X2011000600010,vs,o
60,S0066-782X2011000600010,582,o
60,S0066-782X2011000600010,04,o
60,S0066-782X2011000600010,un,o
60,S0066-782X2011000600010,p,o
60,S0066-782X2011000600010,005,o
60,S0066-782X2011000600010,y,o
60,S0066-782X2011000600010,durante,o
60,S0066-782X2011000600010,el,o
60,S0066-782X2011000600010,estres,i
60,S0066-782X2011000600010,mental,i
60,S0066-782X2011000600010,668,o
60,S0066-782X2011000600010,09,o
60,S0066-782X2011000600010,vs,o
60,S0066-782X2011000600010,735,o
60,S0066-782X2011000600010,05,o
60,S0066-782X2011000600010,un,o
60,S0066-782X2011000600010,p,o
60,S0066-782X2011000600010,005,o
60,S0066-782X2011000600010,CONCLUSION,o
60,S0066-782X2011000600010,Suplementacion,i
60,S0066-782X2011000600010,con,i
60,S0066-782X2011000600010,VitC,i
60,S0066-782X2011000600010,redujo,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,presion,i
60,S0066-782X2011000600010,arterial,i
60,S0066-782X2011000600010,y,o
60,S0066-782X2011000600010,restablecio,o
60,S0066-782X2011000600010,la,o
60,S0066-782X2011000600010,respuesta,o
60,S0066-782X2011000600010,vasodilatadora,o
60,S0066-782X2011000600010,periferica,o
60,S0066-782X2011000600010,en,o
60,S0066-782X2011000600010,niños,o
60,S0066-782X2011000600010,obesos,i
61,S0104-11692008000300007,Uso,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,vaselina,i
61,S0104-11692008000300007,liquida,o
61,S0104-11692008000300007,en,o
61,S0104-11692008000300007,la,o
61,S0104-11692008000300007,prevencion,i
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,laceracion,i
61,S0104-11692008000300007,perineal,i
61,S0104-11692008000300007,durante,o
61,S0104-11692008000300007,el,o
61,S0104-11692008000300007,parto,o
61,S0104-11692008000300007,La,o
61,S0104-11692008000300007,mayor,o
61,S0104-11692008000300007,parte,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,los,o
61,S0104-11692008000300007,nacimientos,o
61,S0104-11692008000300007,por,o
61,S0104-11692008000300007,via,o
61,S0104-11692008000300007,vaginal,i
61,S0104-11692008000300007,estan,o
61,S0104-11692008000300007,acompañados,o
61,S0104-11692008000300007,por,o
61,S0104-11692008000300007,laceraciones,i
61,S0104-11692008000300007,perineales,i
61,S0104-11692008000300007,Este,o
61,S0104-11692008000300007,es,o
61,S0104-11692008000300007,un,o
61,S0104-11692008000300007,estudio,i
61,S0104-11692008000300007,aleatorio,i
61,S0104-11692008000300007,realizado,o
61,S0104-11692008000300007,en,o
61,S0104-11692008000300007,una,o
61,S0104-11692008000300007,maternidad,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,la,o
61,S0104-11692008000300007,ciudad,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,San,o
61,S0104-11692008000300007,Pablo,o
61,S0104-11692008000300007,para,o
61,S0104-11692008000300007,evaluar,i
61,S0104-11692008000300007,la,i
61,S0104-11692008000300007,eficacia,i
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,la,o
61,S0104-11692008000300007,vaselina,i
61,S0104-11692008000300007,liquida,o
61,S0104-11692008000300007,en,o
61,S0104-11692008000300007,la,o
61,S0104-11692008000300007,reduccion,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,laceraciones,i
61,S0104-11692008000300007,perineales,i
61,S0104-11692008000300007,La,o
61,S0104-11692008000300007,muestra,o
61,S0104-11692008000300007,fue,o
61,S0104-11692008000300007,compuesta,o
61,S0104-11692008000300007,por,o
61,S0104-11692008000300007,38,o
61,S0104-11692008000300007,mujeres,o
61,S0104-11692008000300007,nuliparas,o
61,S0104-11692008000300007,organizadas,o
61,S0104-11692008000300007,en,o
61,S0104-11692008000300007,un,o
61,S0104-11692008000300007,grupo,o
61,S0104-11692008000300007,experimental,o
61,S0104-11692008000300007,y,o
61,S0104-11692008000300007,otro,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,control,o
61,S0104-11692008000300007,En,o
61,S0104-11692008000300007,el,o
61,S0104-11692008000300007,grupo,o
61,S0104-11692008000300007,experimental,o
61,S0104-11692008000300007,fue,o
61,S0104-11692008000300007,aplicado,o
61,S0104-11692008000300007,30,o
61,S0104-11692008000300007,ml,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,vaselina,i
61,S0104-11692008000300007,en,o
61,S0104-11692008000300007,la,o
61,S0104-11692008000300007,region,i
61,S0104-11692008000300007,perineal,i
61,S0104-11692008000300007,durante,o
61,S0104-11692008000300007,el,o
61,S0104-11692008000300007,periodo,o
61,S0104-11692008000300007,expulsivo,o
61,S0104-11692008000300007,Todas,o
61,S0104-11692008000300007,las,o
61,S0104-11692008000300007,parturientas,o
61,S0104-11692008000300007,realizaron,o
61,S0104-11692008000300007,pujos,o
61,S0104-11692008000300007,espontaneos,o
61,S0104-11692008000300007,y,o
61,S0104-11692008000300007,se,o
61,S0104-11692008000300007,mantuvieron,o
61,S0104-11692008000300007,en,o
61,S0104-11692008000300007,la,o
61,S0104-11692008000300007,posicion,o
61,S0104-11692008000300007,lateral,o
61,S0104-11692008000300007,izquierda,o
61,S0104-11692008000300007,La,o
61,S0104-11692008000300007,frecuencia,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,laceracion,i
61,S0104-11692008000300007,perineal,i
61,S0104-11692008000300007,fue,o
61,S0104-11692008000300007,semejante,o
61,S0104-11692008000300007,en,o
61,S0104-11692008000300007,ambos,o
61,S0104-11692008000300007,grupos,o
61,S0104-11692008000300007,experimental,o
61,S0104-11692008000300007,632,o
61,S0104-11692008000300007,y,o
61,S0104-11692008000300007,grupo,o
61,S0104-11692008000300007,control,o
61,S0104-11692008000300007,605,o
61,S0104-11692008000300007,La,o
61,S0104-11692008000300007,region,i
61,S0104-11692008000300007,posterior,i
61,S0104-11692008000300007,del,i
61,S0104-11692008000300007,perineo,i
61,S0104-11692008000300007,presento,o
61,S0104-11692008000300007,una,o
61,S0104-11692008000300007,alta,o
61,S0104-11692008000300007,frecuencia,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,trauma,i
61,S0104-11692008000300007,532,o
61,S0104-11692008000300007,De,o
61,S0104-11692008000300007,los,o
61,S0104-11692008000300007,casos,o
61,S0104-11692008000300007,totales,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,trauma,i
61,S0104-11692008000300007,perineal,i
61,S0104-11692008000300007,723,o
61,S0104-11692008000300007,fueron,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,laceracion,i
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,primer,o
61,S0104-11692008000300007,grado,o
61,S0104-11692008000300007,Se,o
61,S0104-11692008000300007,verifico,o
61,S0104-11692008000300007,que,o
61,S0104-11692008000300007,el,o
61,S0104-11692008000300007,uso,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,la,o
61,S0104-11692008000300007,vaselina,i
61,S0104-11692008000300007,en,o
61,S0104-11692008000300007,la,o
61,S0104-11692008000300007,region,i
61,S0104-11692008000300007,perineal,i
61,S0104-11692008000300007,no,o
61,S0104-11692008000300007,reduce,o
61,S0104-11692008000300007,la,o
61,S0104-11692008000300007,frecuencia,o
61,S0104-11692008000300007,o,o
61,S0104-11692008000300007,grado,o
61,S0104-11692008000300007,de,o
61,S0104-11692008000300007,las,o
61,S0104-11692008000300007,laceraciones,i
61,S0104-11692008000300007,durante,o
61,S0104-11692008000300007,el,o
61,S0104-11692008000300007,parto,o
62,S0104-11692012000400016,La,o
62,S0104-11692012000400016,aplicacion,i
62,S0104-11692012000400016,de,i
62,S0104-11692012000400016,microcorriente,i
62,S0104-11692012000400016,como,o
62,S0104-11692012000400016,tratamiento,i
62,S0104-11692012000400016,en,o
62,S0104-11692012000400016,las,o
62,S0104-11692012000400016,ulceras,i
62,S0104-11692012000400016,venosas,i
62,S0104-11692012000400016,un,o
62,S0104-11692012000400016,estudio,i
62,S0104-11692012000400016,piloto,i
62,S0104-11692012000400016,Este,o
62,S0104-11692012000400016,estudio,o
62,S0104-11692012000400016,objetivo,o
62,S0104-11692012000400016,evaluar,o
62,S0104-11692012000400016,el,o
62,S0104-11692012000400016,efecto,o
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,la,o
62,S0104-11692012000400016,estimulacion,i
62,S0104-11692012000400016,electrica,i
62,S0104-11692012000400016,por,i
62,S0104-11692012000400016,microcorriente,i
62,S0104-11692012000400016,sobre,o
62,S0104-11692012000400016,el,o
62,S0104-11692012000400016,dolor,i
62,S0104-11692012000400016,y,o
62,S0104-11692012000400016,el,o
62,S0104-11692012000400016,area,o
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,superficie,o
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,ulceras,i
62,S0104-11692012000400016,venosas,i
62,S0104-11692012000400016,En,o
62,S0104-11692012000400016,un,o
62,S0104-11692012000400016,estudio,i
62,S0104-11692012000400016,piloto,i
62,S0104-11692012000400016,para,o
62,S0104-11692012000400016,un,o
62,S0104-11692012000400016,ensayo,i
62,S0104-11692012000400016,clinico,i
62,S0104-11692012000400016,controlado,i
62,S0104-11692012000400016,simple,i
62,S0104-11692012000400016,ciego,i
62,S0104-11692012000400016,realizado,o
62,S0104-11692012000400016,en,o
62,S0104-11692012000400016,una,o
62,S0104-11692012000400016,clinica,o
62,S0104-11692012000400016,durante,o
62,S0104-11692012000400016,4,o
62,S0104-11692012000400016,semanas,o
62,S0104-11692012000400016,se,o
62,S0104-11692012000400016,dividieron,o
62,S0104-11692012000400016,14,o
62,S0104-11692012000400016,individuos,o
62,S0104-11692012000400016,629,o
62,S0104-11692012000400016,años,o
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,edad,o
62,S0104-11692012000400016,en,o
62,S0104-11692012000400016,dos,o
62,S0104-11692012000400016,grupos,o
62,S0104-11692012000400016,grupo,o
62,S0104-11692012000400016,microcorriente,i
62,S0104-11692012000400016,n8,o
62,S0104-11692012000400016,y,o
62,S0104-11692012000400016,grupo,o
62,S0104-11692012000400016,control,o
62,S0104-11692012000400016,n6,o
62,S0104-11692012000400016,Se,o
62,S0104-11692012000400016,evaluaron,o
62,S0104-11692012000400016,el,o
62,S0104-11692012000400016,dolor,i
62,S0104-11692012000400016,por,o
62,S0104-11692012000400016,medio,o
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,la,o
62,S0104-11692012000400016,Escala,i
62,S0104-11692012000400016,Visual,i
62,S0104-11692012000400016,Analogica,i
62,S0104-11692012000400016,y,o
62,S0104-11692012000400016,el,o
62,S0104-11692012000400016,area,o
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,superficie,o
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,la,o
62,S0104-11692012000400016,ulcera,i
62,S0104-11692012000400016,por,o
62,S0104-11692012000400016,medio,o
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,la,o
62,S0104-11692012000400016,Planimetria,i
62,S0104-11692012000400016,Hubo,o
62,S0104-11692012000400016,diferencia,o
62,S0104-11692012000400016,significativa,o
62,S0104-11692012000400016,entre,o
62,S0104-11692012000400016,los,o
62,S0104-11692012000400016,dos,o
62,S0104-11692012000400016,grupos,o
62,S0104-11692012000400016,con,o
62,S0104-11692012000400016,relacion,o
62,S0104-11692012000400016,al,o
62,S0104-11692012000400016,dolor,i
62,S0104-11692012000400016,grupo,o
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,microcorriente,i
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,85,o
62,S0104-11692012000400016,65975,o
62,S0104-11692012000400016,para,o
62,S0104-11692012000400016,35,o
62,S0104-11692012000400016,1475,o
62,S0104-11692012000400016,y,o
62,S0104-11692012000400016,grupo,o
62,S0104-11692012000400016,control,o
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,75,o
62,S0104-11692012000400016,57510,o
62,S0104-11692012000400016,para,o
62,S0104-11692012000400016,85,o
62,S0104-11692012000400016,5510,o
62,S0104-11692012000400016,p001,o
62,S0104-11692012000400016,No,o
62,S0104-11692012000400016,se,o
62,S0104-11692012000400016,verifico,o
62,S0104-11692012000400016,una,o
62,S0104-11692012000400016,diferencia,o
62,S0104-11692012000400016,significativa,o
62,S0104-11692012000400016,relacionada,o
62,S0104-11692012000400016,al,o
62,S0104-11692012000400016,area,o
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,superficie,o
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,la,o
62,S0104-11692012000400016,ulcera,i
62,S0104-11692012000400016,Planimetria,i
62,S0104-11692012000400016,con,o
62,S0104-11692012000400016,papel,o
62,S0104-11692012000400016,vegetal,o
62,S0104-11692012000400016,p041,o
62,S0104-11692012000400016,y,o
62,S0104-11692012000400016,por,o
62,S0104-11692012000400016,el,o
62,S0104-11692012000400016,software,o
62,S0104-11692012000400016,Image,o
62,S0104-11692012000400016,J,o
62,S0104-11692012000400016,p041,o
62,S0104-11692012000400016,Se,o
62,S0104-11692012000400016,concluye,o
62,S0104-11692012000400016,que,o
62,S0104-11692012000400016,la,o
62,S0104-11692012000400016,aplicacion,i
62,S0104-11692012000400016,de,i
62,S0104-11692012000400016,microcorriente,i
62,S0104-11692012000400016,mejora,o
62,S0104-11692012000400016,el,o
62,S0104-11692012000400016,cuadro,i
62,S0104-11692012000400016,algico,i
62,S0104-11692012000400016,de,o
62,S0104-11692012000400016,individuos,o
62,S0104-11692012000400016,con,o
62,S0104-11692012000400016,ulceras,i
62,S0104-11692012000400016,venosas,i
62,S0104-11692012000400016,Registro,o
62,S0104-11692012000400016,ClinicalTrialsgov,o
62,S0104-11692012000400016,NCT01372020,o
63,S0104-11692015000400571,Estudio,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,la,o
63,S0104-11692015000400571,Bota,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,Unna,o
63,S0104-11692015000400571,comparada,o
63,S0104-11692015000400571,al,o
63,S0104-11692015000400571,vendaje,i
63,S0104-11692015000400571,elastico,i
63,S0104-11692015000400571,en,o
63,S0104-11692015000400571,ulceras,i
63,S0104-11692015000400571,venosas,i
63,S0104-11692015000400571,ensayo,i
63,S0104-11692015000400571,clinico,i
63,S0104-11692015000400571,aleatorio,i
63,S0104-11692015000400571,Objetivo,o
63,S0104-11692015000400571,analizar,o
63,S0104-11692015000400571,el,o
63,S0104-11692015000400571,proceso,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,reparacion,i
63,S0104-11692015000400571,del,i
63,S0104-11692015000400571,tejido,i
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,pacientes,o
63,S0104-11692015000400571,con,o
63,S0104-11692015000400571,ulcera,i
63,S0104-11692015000400571,venosa,i
63,S0104-11692015000400571,que,o
63,S0104-11692015000400571,usan,o
63,S0104-11692015000400571,la,o
63,S0104-11692015000400571,terapia,i
63,S0104-11692015000400571,compresiva,i
63,S0104-11692015000400571,inelastica,i
63,S0104-11692015000400571,Bota,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,Unna,o
63,S0104-11692015000400571,en,o
63,S0104-11692015000400571,comparacion,o
63,S0104-11692015000400571,con,o
63,S0104-11692015000400571,el,o
63,S0104-11692015000400571,uso,i
63,S0104-11692015000400571,del,i
63,S0104-11692015000400571,vendaje,i
63,S0104-11692015000400571,elastico,i
63,S0104-11692015000400571,Metodo,o
63,S0104-11692015000400571,ensayo,i
63,S0104-11692015000400571,clinico,i
63,S0104-11692015000400571,controlado,i
63,S0104-11692015000400571,aleatorio,i
63,S0104-11692015000400571,en,o
63,S0104-11692015000400571,que,o
63,S0104-11692015000400571,los,o
63,S0104-11692015000400571,pacientes,o
63,S0104-11692015000400571,n18,o
63,S0104-11692015000400571,fueron,o
63,S0104-11692015000400571,designados,o
63,S0104-11692015000400571,en,o
63,S0104-11692015000400571,dos,o
63,S0104-11692015000400571,grupos,o
63,S0104-11692015000400571,los,o
63,S0104-11692015000400571,que,o
63,S0104-11692015000400571,utilizaban,i
63,S0104-11692015000400571,la,i
63,S0104-11692015000400571,Bota,i
63,S0104-11692015000400571,de,i
63,S0104-11692015000400571,Unna,i
63,S0104-11692015000400571,grupo,o
63,S0104-11692015000400571,B,o
63,S0104-11692015000400571,y,o
63,S0104-11692015000400571,los,o
63,S0104-11692015000400571,que,o
63,S0104-11692015000400571,utilizaban,i
63,S0104-11692015000400571,el,i
63,S0104-11692015000400571,vendaje,i
63,S0104-11692015000400571,elastico,i
63,S0104-11692015000400571,grupo,o
63,S0104-11692015000400571,A,o
63,S0104-11692015000400571,El,o
63,S0104-11692015000400571,tiempo,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,duracion,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,la,o
63,S0104-11692015000400571,investigacion,o
63,S0104-11692015000400571,fue,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,trece,o
63,S0104-11692015000400571,semanas,o
63,S0104-11692015000400571,Resultados,o
63,S0104-11692015000400571,se,o
63,S0104-11692015000400571,constato,o
63,S0104-11692015000400571,reduccion,o
63,S0104-11692015000400571,significativa,o
63,S0104-11692015000400571,al,o
63,S0104-11692015000400571,nivel,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,5,o
63,S0104-11692015000400571,en,o
63,S0104-11692015000400571,el,o
63,S0104-11692015000400571,area,o
63,S0104-11692015000400571,en,o
63,S0104-11692015000400571,centimetros,o
63,S0104-11692015000400571,cuadrados,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,las,o
63,S0104-11692015000400571,ulceras,i
63,S0104-11692015000400571,del,o
63,S0104-11692015000400571,grupo,o
63,S0104-11692015000400571,B,o
63,S0104-11692015000400571,p00001,o
63,S0104-11692015000400571,a,o
63,S0104-11692015000400571,lo,o
63,S0104-11692015000400571,largo,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,todo,o
63,S0104-11692015000400571,el,o
63,S0104-11692015000400571,tratamiento,i
63,S0104-11692015000400571,y,o
63,S0104-11692015000400571,tendencia,o
63,S0104-11692015000400571,del,o
63,S0104-11692015000400571,grupo,o
63,S0104-11692015000400571,A,o
63,S0104-11692015000400571,a,o
63,S0104-11692015000400571,la,o
63,S0104-11692015000400571,reduccion,o
63,S0104-11692015000400571,en,o
63,S0104-11692015000400571,el,o
63,S0104-11692015000400571,area,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,la,o
63,S0104-11692015000400571,ulcera,i
63,S0104-11692015000400571,en,o
63,S0104-11692015000400571,centimetros,o
63,S0104-11692015000400571,cuadrados,o
63,S0104-11692015000400571,p006,o
63,S0104-11692015000400571,solamente,o
63,S0104-11692015000400571,despues,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,la,o
63,S0104-11692015000400571,quinta,o
63,S0104-11692015000400571,semana,o
63,S0104-11692015000400571,Conclusion,o
63,S0104-11692015000400571,el,o
63,S0104-11692015000400571,tratamiento,i
63,S0104-11692015000400571,con,i
63,S0104-11692015000400571,la,i
63,S0104-11692015000400571,Bota,i
63,S0104-11692015000400571,de,i
63,S0104-11692015000400571,Unna,i
63,S0104-11692015000400571,presento,o
63,S0104-11692015000400571,mejor,o
63,S0104-11692015000400571,resultado,o
63,S0104-11692015000400571,en,o
63,S0104-11692015000400571,ulceras,i
63,S0104-11692015000400571,venosas,i
63,S0104-11692015000400571,con,o
63,S0104-11692015000400571,areas,o
63,S0104-11692015000400571,superiores,o
63,S0104-11692015000400571,a,o
63,S0104-11692015000400571,10cm²,o
63,S0104-11692015000400571,y,o
63,S0104-11692015000400571,el,o
63,S0104-11692015000400571,vendaje,i
63,S0104-11692015000400571,elastico,i
63,S0104-11692015000400571,con,o
63,S0104-11692015000400571,la,o
63,S0104-11692015000400571,gasa,o
63,S0104-11692015000400571,Petrolatumren,o
63,S0104-11692015000400571,ulceras,i
63,S0104-11692015000400571,venosas,i
63,S0104-11692015000400571,inferiores,i
63,S0104-11692015000400571,a,o
63,S0104-11692015000400571,10cm²,o
63,S0104-11692015000400571,Registro,o
63,S0104-11692015000400571,Brasileño,o
63,S0104-11692015000400571,de,o
63,S0104-11692015000400571,Ensayos,i
63,S0104-11692015000400571,Clinicos,i
63,S0104-11692015000400571,Trial,o
63,S0104-11692015000400571,req,o
63,S0104-11692015000400571,195,o
63,S0104-11692015000400571,y,o
63,S0104-11692015000400571,WHO,o
63,S0104-11692015000400571,UTN,o
63,S0104-11692015000400571,U111111225489,o
64,S0104-11692016000100435,Factores,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,riesgo,o
64,S0104-11692016000100435,para,o
64,S0104-11692016000100435,complicaciones,i
64,S0104-11692016000100435,en,i
64,S0104-11692016000100435,el,i
64,S0104-11692016000100435,cateter,i
64,S0104-11692016000100435,venoso,i
64,S0104-11692016000100435,periferico,i
64,S0104-11692016000100435,en,o
64,S0104-11692016000100435,adultos,o
64,S0104-11692016000100435,analisis,o
64,S0104-11692016000100435,secundario,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,ensayo,i
64,S0104-11692016000100435,clinico,i
64,S0104-11692016000100435,aleatorizado,i
64,S0104-11692016000100435,Objetivo,o
64,S0104-11692016000100435,analizar,o
64,S0104-11692016000100435,los,o
64,S0104-11692016000100435,factores,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,riesgo,o
64,S0104-11692016000100435,relacionados,o
64,S0104-11692016000100435,a,o
64,S0104-11692016000100435,la,o
64,S0104-11692016000100435,ocurrencia,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,complicaciones,i
64,S0104-11692016000100435,en,i
64,S0104-11692016000100435,el,i
64,S0104-11692016000100435,cateterismo,i
64,S0104-11692016000100435,venoso,i
64,S0104-11692016000100435,periferico,i
64,S0104-11692016000100435,Metodo,o
64,S0104-11692016000100435,analisis,o
64,S0104-11692016000100435,secundario,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,datos,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,un,o
64,S0104-11692016000100435,ensayo,i
64,S0104-11692016000100435,clinico,i
64,S0104-11692016000100435,aleatorizado,i
64,S0104-11692016000100435,en,o
64,S0104-11692016000100435,el,o
64,S0104-11692016000100435,cual,o
64,S0104-11692016000100435,169,o
64,S0104-11692016000100435,pacientes,o
64,S0104-11692016000100435,clinicos,o
64,S0104-11692016000100435,y,o
64,S0104-11692016000100435,quirurgicos,o
64,S0104-11692016000100435,fueron,o
64,S0104-11692016000100435,asignados,o
64,S0104-11692016000100435,al,o
64,S0104-11692016000100435,grupo,o
64,S0104-11692016000100435,que,o
64,S0104-11692016000100435,usaba,i
64,S0104-11692016000100435,cateter,i
64,S0104-11692016000100435,de,i
64,S0104-11692016000100435,seguridad,i
64,S0104-11692016000100435,completo,i
64,S0104-11692016000100435,n,o
64,S0104-11692016000100435,90,o
64,S0104-11692016000100435,y,o
64,S0104-11692016000100435,al,o
64,S0104-11692016000100435,grupo,o
64,S0104-11692016000100435,que,o
64,S0104-11692016000100435,utilizo,i
64,S0104-11692016000100435,cateter,i
64,S0104-11692016000100435,plastico,i
64,S0104-11692016000100435,sobre,i
64,S0104-11692016000100435,aguja,i
64,S0104-11692016000100435,tipo,o
64,S0104-11692016000100435,Abbocath,o
64,S0104-11692016000100435,n,o
64,S0104-11692016000100435,79,o
64,S0104-11692016000100435,tiempo,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,seguimiento,i
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,tres,o
64,S0104-11692016000100435,meses,o
64,S0104-11692016000100435,Resultados,o
64,S0104-11692016000100435,los,o
64,S0104-11692016000100435,factores,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,riesgo,o
64,S0104-11692016000100435,que,o
64,S0104-11692016000100435,aumentaron,o
64,S0104-11692016000100435,las,o
64,S0104-11692016000100435,probabilidades,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,desarrollar,o
64,S0104-11692016000100435,complicaciones,i
64,S0104-11692016000100435,fueron,o
64,S0104-11692016000100435,periodos,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,internacion,i
64,S0104-11692016000100435,comprendidos,o
64,S0104-11692016000100435,entre,o
64,S0104-11692016000100435,10,o
64,S0104-11692016000100435,y,o
64,S0104-11692016000100435,19,o
64,S0104-11692016000100435,dias,o
64,S0104-11692016000100435,p,o
64,S0104-11692016000100435,00483,o
64,S0104-11692016000100435,y,o
64,S0104-11692016000100435,entre,o
64,S0104-11692016000100435,20,o
64,S0104-11692016000100435,y,o
64,S0104-11692016000100435,29,o
64,S0104-11692016000100435,dias,o
64,S0104-11692016000100435,p,o
64,S0104-11692016000100435,00098,o
64,S0104-11692016000100435,uso,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,antimicrobianos,i
64,S0104-11692016000100435,p,o
64,S0104-11692016000100435,00288,o
64,S0104-11692016000100435,y,o
64,S0104-11692016000100435,uso,o
64,S0104-11692016000100435,soluciones,i
64,S0104-11692016000100435,y,o
64,S0104-11692016000100435,administracion,i
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,suero,i
64,S0104-11692016000100435,p,o
64,S0104-11692016000100435,00362,o
64,S0104-11692016000100435,El,o
64,S0104-11692016000100435,calibre,o
64,S0104-11692016000100435,20G,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,la,o
64,S0104-11692016000100435,aguja,o
64,S0104-11692016000100435,disminuyo,o
64,S0104-11692016000100435,los,o
64,S0104-11692016000100435,riesgos,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,ocurrencia,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,complicaciones,i
64,S0104-11692016000100435,p,o
64,S0104-11692016000100435,00153,o
64,S0104-11692016000100435,El,o
64,S0104-11692016000100435,analisis,o
64,S0104-11692016000100435,multiple,o
64,S0104-11692016000100435,apunto,o
64,S0104-11692016000100435,reduccion,o
64,S0104-11692016000100435,del,o
64,S0104-11692016000100435,riesgo,o
64,S0104-11692016000100435,para,o
64,S0104-11692016000100435,el,o
64,S0104-11692016000100435,calibre,o
64,S0104-11692016000100435,20G,o
64,S0104-11692016000100435,p,o
64,S0104-11692016000100435,00350,o
64,S0104-11692016000100435,aumento,o
64,S0104-11692016000100435,del,o
64,S0104-11692016000100435,riesgo,o
64,S0104-11692016000100435,para,o
64,S0104-11692016000100435,la,o
64,S0104-11692016000100435,infusion,i
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,soluciones,i
64,S0104-11692016000100435,administracion,i
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,suero,i
64,S0104-11692016000100435,p,o
64,S0104-11692016000100435,00351,o
64,S0104-11692016000100435,y,o
64,S0104-11692016000100435,administracion,i
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,corticosteroides,i
64,S0104-11692016000100435,p,o
64,S0104-11692016000100435,00214,o
64,S0104-11692016000100435,Conclusion,o
64,S0104-11692016000100435,los,o
64,S0104-11692016000100435,factores,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,riesgo,o
64,S0104-11692016000100435,relacionados,o
64,S0104-11692016000100435,a,o
64,S0104-11692016000100435,la,o
64,S0104-11692016000100435,ocurrencia,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,complicaciones,i
64,S0104-11692016000100435,en,i
64,S0104-11692016000100435,el,i
64,S0104-11692016000100435,cateterismo,i
64,S0104-11692016000100435,venoso,i
64,S0104-11692016000100435,periferico,i
64,S0104-11692016000100435,fueron,o
64,S0104-11692016000100435,el,o
64,S0104-11692016000100435,tiempo,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,internacion,i
64,S0104-11692016000100435,entre,o
64,S0104-11692016000100435,10,o
64,S0104-11692016000100435,y,o
64,S0104-11692016000100435,29,o
64,S0104-11692016000100435,dias,o
64,S0104-11692016000100435,la,o
64,S0104-11692016000100435,infusion,i
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,antimicrobianos,i
64,S0104-11692016000100435,soluciones,i
64,S0104-11692016000100435,administracion,i
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,suero,i
64,S0104-11692016000100435,y,o
64,S0104-11692016000100435,corticosteroides,i
64,S0104-11692016000100435,Se,o
64,S0104-11692016000100435,destaca,o
64,S0104-11692016000100435,el,o
64,S0104-11692016000100435,calibre,o
64,S0104-11692016000100435,20G,o
64,S0104-11692016000100435,como,o
64,S0104-11692016000100435,factor,o
64,S0104-11692016000100435,protector,o
64,S0104-11692016000100435,para,o
64,S0104-11692016000100435,el,o
64,S0104-11692016000100435,desarrollo,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,complicaciones,i
64,S0104-11692016000100435,cuando,o
64,S0104-11692016000100435,comparado,o
64,S0104-11692016000100435,al,o
64,S0104-11692016000100435,calibre,o
64,S0104-11692016000100435,22G,o
64,S0104-11692016000100435,Registro,o
64,S0104-11692016000100435,Brasileño,o
64,S0104-11692016000100435,de,o
64,S0104-11692016000100435,Ensayos,i
64,S0104-11692016000100435,Clinicos,i
64,S0104-11692016000100435,RBR46ZQR8,o
65,S0104-11692018000100389,Seguridad,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,una,o
65,S0104-11692018000100389,formulacion,o
65,S0104-11692018000100389,conteniendo,o
65,S0104-11692018000100389,microparticulas,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,quitosano,i
65,S0104-11692018000100389,con,o
65,S0104-11692018000100389,manzanilla,i
65,S0104-11692018000100389,ensayo,o
65,S0104-11692018000100389,clinico,o
65,S0104-11692018000100389,enmascarado,o
65,S0104-11692018000100389,y,o
65,S0104-11692018000100389,controlado,o
65,S0104-11692018000100389,Objetivo,o
65,S0104-11692018000100389,evaluar,i
65,S0104-11692018000100389,la,i
65,S0104-11692018000100389,seguridad,i
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,una,o
65,S0104-11692018000100389,formulacion,o
65,S0104-11692018000100389,topica,o
65,S0104-11692018000100389,conteniendo,o
65,S0104-11692018000100389,microparticulas,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,manzanilla,i
65,S0104-11692018000100389,revestidas,o
65,S0104-11692018000100389,con,o
65,S0104-11692018000100389,quitosano,i
65,S0104-11692018000100389,en,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,piel,i
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,participantes,o
65,S0104-11692018000100389,sanos,o
65,S0104-11692018000100389,Metodo,o
65,S0104-11692018000100389,ensayo,o
65,S0104-11692018000100389,clinico,o
65,S0104-11692018000100389,fase,o
65,S0104-11692018000100389,I,o
65,S0104-11692018000100389,enmascarado,o
65,S0104-11692018000100389,controlado,o
65,S0104-11692018000100389,no,o
65,S0104-11692018000100389,aleatorizado,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,dosis,o
65,S0104-11692018000100389,unica,o
65,S0104-11692018000100389,con,o
65,S0104-11692018000100389,controles,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,piel,i
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,base,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,formulacion,o
65,S0104-11692018000100389,y,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,formulacion,o
65,S0104-11692018000100389,con,o
65,S0104-11692018000100389,microparticulas,o
65,S0104-11692018000100389,Las,o
65,S0104-11692018000100389,variables,o
65,S0104-11692018000100389,analizadas,o
65,S0104-11692018000100389,fueron,o
65,S0104-11692018000100389,irritacion,i
65,S0104-11692018000100389,e,o
65,S0104-11692018000100389,hidratacion,o
65,S0104-11692018000100389,por,o
65,S0104-11692018000100389,medio,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,los,o
65,S0104-11692018000100389,tests,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,Wilcoxon,o
65,S0104-11692018000100389,y,o
65,S0104-11692018000100389,KruskallWallis,o
65,S0104-11692018000100389,Resultados,o
65,S0104-11692018000100389,iniciaron,o
65,S0104-11692018000100389,el,o
65,S0104-11692018000100389,estudio,o
65,S0104-11692018000100389,35,o
65,S0104-11692018000100389,participantes,o
65,S0104-11692018000100389,con,o
65,S0104-11692018000100389,edad,o
65,S0104-11692018000100389,media,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,263,o
65,S0104-11692018000100389,años,o
65,S0104-11692018000100389,De,o
65,S0104-11692018000100389,esos,o
65,S0104-11692018000100389,30,o
65,S0104-11692018000100389,8571,o
65,S0104-11692018000100389,eran,o
65,S0104-11692018000100389,del,o
65,S0104-11692018000100389,sexo,o
65,S0104-11692018000100389,femenino,o
65,S0104-11692018000100389,29,o
65,S0104-11692018000100389,8290,o
65,S0104-11692018000100389,blancos,o
65,S0104-11692018000100389,y,o
65,S0104-11692018000100389,32,o
65,S0104-11692018000100389,9140,o
65,S0104-11692018000100389,sin,o
65,S0104-11692018000100389,patologias,i
65,S0104-11692018000100389,previas,o
65,S0104-11692018000100389,Un,o
65,S0104-11692018000100389,participante,o
65,S0104-11692018000100389,fue,o
65,S0104-11692018000100389,descontinuado,o
65,S0104-11692018000100389,por,o
65,S0104-11692018000100389,referir,o
65,S0104-11692018000100389,eritema,i
65,S0104-11692018000100389,en,i
65,S0104-11692018000100389,el,i
65,S0104-11692018000100389,lugar,i
65,S0104-11692018000100389,de,i
65,S0104-11692018000100389,aplicacion,i
65,S0104-11692018000100389,y,o
65,S0104-11692018000100389,cuatro,o
65,S0104-11692018000100389,por,o
65,S0104-11692018000100389,no,o
65,S0104-11692018000100389,comparecer,o
65,S0104-11692018000100389,a,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,ultima,o
65,S0104-11692018000100389,evaluacion,i
65,S0104-11692018000100389,En,o
65,S0104-11692018000100389,los,o
65,S0104-11692018000100389,30,o
65,S0104-11692018000100389,participantes,o
65,S0104-11692018000100389,que,o
65,S0104-11692018000100389,finalizaron,o
65,S0104-11692018000100389,el,o
65,S0104-11692018000100389,estudio,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,formulacion,o
65,S0104-11692018000100389,test,o
65,S0104-11692018000100389,no,o
65,S0104-11692018000100389,causo,o
65,S0104-11692018000100389,eritema,i
65,S0104-11692018000100389,descamacion,i
65,S0104-11692018000100389,ardor,i
65,S0104-11692018000100389,prurito,i
65,S0104-11692018000100389,o,o
65,S0104-11692018000100389,dolor,i
65,S0104-11692018000100389,hubo,o
65,S0104-11692018000100389,mejora,o
65,S0104-11692018000100389,en,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,hidratacion,o
65,S0104-11692018000100389,cutanea,i
65,S0104-11692018000100389,en,o
65,S0104-11692018000100389,el,o
65,S0104-11692018000100389,lugar,i
65,S0104-11692018000100389,de,i
65,S0104-11692018000100389,aplicacion,i
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,formulacion,o
65,S0104-11692018000100389,con,o
65,S0104-11692018000100389,las,o
65,S0104-11692018000100389,microparticulas,o
65,S0104-11692018000100389,En,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,evaluacion,i
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,funcion,o
65,S0104-11692018000100389,barrera,o
65,S0104-11692018000100389,hubo,o
65,S0104-11692018000100389,aumento,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,perdida,o
65,S0104-11692018000100389,transepidermica,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,agua,i
65,S0104-11692018000100389,en,o
65,S0104-11692018000100389,todos,o
65,S0104-11692018000100389,los,o
65,S0104-11692018000100389,lugares,o
65,S0104-11692018000100389,Conclusion,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,formulacion,o
65,S0104-11692018000100389,con,o
65,S0104-11692018000100389,microparticulas,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,manzanilla,i
65,S0104-11692018000100389,es,o
65,S0104-11692018000100389,segura,o
65,S0104-11692018000100389,para,o
65,S0104-11692018000100389,el,o
65,S0104-11692018000100389,uso,o
65,S0104-11692018000100389,topico,o
65,S0104-11692018000100389,no,o
65,S0104-11692018000100389,provocando,o
65,S0104-11692018000100389,irritacion,i
65,S0104-11692018000100389,y,o
65,S0104-11692018000100389,mejorando,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,hidratacion,o
65,S0104-11692018000100389,cutanea,i
65,S0104-11692018000100389,a,o
65,S0104-11692018000100389,lo,o
65,S0104-11692018000100389,largo,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,cuatro,o
65,S0104-11692018000100389,semanas,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,uso,o
65,S0104-11692018000100389,Sus,o
65,S0104-11692018000100389,efectos,o
65,S0104-11692018000100389,en,o
65,S0104-11692018000100389,la,o
65,S0104-11692018000100389,funcion,o
65,S0104-11692018000100389,barrera,o
65,S0104-11692018000100389,deben,o
65,S0104-11692018000100389,ser,o
65,S0104-11692018000100389,mejor,o
65,S0104-11692018000100389,estudiados,o
65,S0104-11692018000100389,N,o
65,S0104-11692018000100389,RBR3h78kz,o
65,S0104-11692018000100389,en,o
65,S0104-11692018000100389,el,o
65,S0104-11692018000100389,Registro,o
65,S0104-11692018000100389,Brasilero,o
65,S0104-11692018000100389,de,o
65,S0104-11692018000100389,Ensayos,i
65,S0104-11692018000100389,Clinicos,i
65,S0104-11692018000100389,ReBEC,o
66,S0120-33472006000100002,Ensayo,o
66,S0120-33472006000100002,clinico,o
66,S0120-33472006000100002,doble,o
66,S0120-33472006000100002,ciego,o
66,S0120-33472006000100002,controlado,o
66,S0120-33472006000100002,para,o
66,S0120-33472006000100002,evaluar,i
66,S0120-33472006000100002,la,i
66,S0120-33472006000100002,efectividad,i
66,S0120-33472006000100002,analgesica,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,100,o
66,S0120-33472006000100002,microgramos,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,morfina,i
66,S0120-33472006000100002,intratecal,o
66,S0120-33472006000100002,en,o
66,S0120-33472006000100002,el,o
66,S0120-33472006000100002,control,i
66,S0120-33472006000100002,del,i
66,S0120-33472006000100002,dolor,i
66,S0120-33472006000100002,postoperatorio,i
66,S0120-33472006000100002,Antecedentes,o
66,S0120-33472006000100002,La,o
66,S0120-33472006000100002,morfina,i
66,S0120-33472006000100002,intratecal,o
66,S0120-33472006000100002,constituye,o
66,S0120-33472006000100002,una,o
66,S0120-33472006000100002,excelente,o
66,S0120-33472006000100002,alternativa,o
66,S0120-33472006000100002,para,o
66,S0120-33472006000100002,el,o
66,S0120-33472006000100002,manejo,o
66,S0120-33472006000100002,del,o
66,S0120-33472006000100002,dolor,i
66,S0120-33472006000100002,postoperatorio,i
66,S0120-33472006000100002,en,o
66,S0120-33472006000100002,cirugias,i
66,S0120-33472006000100002,con,o
66,S0120-33472006000100002,anestesia,i
66,S0120-33472006000100002,espinal,i
66,S0120-33472006000100002,La,o
66,S0120-33472006000100002,efectividad,o
66,S0120-33472006000100002,analgesica,o
66,S0120-33472006000100002,postoperatoria,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,100,o
66,S0120-33472006000100002,µg,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,morfina,i
66,S0120-33472006000100002,adicionados,o
66,S0120-33472006000100002,al,o
66,S0120-33472006000100002,anestesico,i
66,S0120-33472006000100002,local,i
66,S0120-33472006000100002,en,o
66,S0120-33472006000100002,anestesia,i
66,S0120-33472006000100002,espinal,i
66,S0120-33472006000100002,ha,o
66,S0120-33472006000100002,sido,o
66,S0120-33472006000100002,estudiada,o
66,S0120-33472006000100002,en,o
66,S0120-33472006000100002,cirugias,i
66,S0120-33472006000100002,de,i
66,S0120-33472006000100002,cesarea,i
66,S0120-33472006000100002,reseccion,i
66,S0120-33472006000100002,transuretral,i
66,S0120-33472006000100002,de,i
66,S0120-33472006000100002,prostata,i
66,S0120-33472006000100002,y,o
66,S0120-33472006000100002,reemplazos,i
66,S0120-33472006000100002,articulares,i
66,S0120-33472006000100002,El,o
66,S0120-33472006000100002,proposito,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,este,o
66,S0120-33472006000100002,estudio,o
66,S0120-33472006000100002,es,o
66,S0120-33472006000100002,valorar,i
66,S0120-33472006000100002,la,i
66,S0120-33472006000100002,efectividad,i
66,S0120-33472006000100002,analgesica,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,100,o
66,S0120-33472006000100002,µg,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,morfina,i
66,S0120-33472006000100002,intratecal,o
66,S0120-33472006000100002,en,o
66,S0120-33472006000100002,adultos,o
66,S0120-33472006000100002,jovenes,o
66,S0120-33472006000100002,sometidos,o
66,S0120-33472006000100002,a,o
66,S0120-33472006000100002,cirugia,i
66,S0120-33472006000100002,abdominal,i
66,S0120-33472006000100002,baja,i
66,S0120-33472006000100002,o,i
66,S0120-33472006000100002,de,i
66,S0120-33472006000100002,miembros,i
66,S0120-33472006000100002,inferiores,i
66,S0120-33472006000100002,Metodos,o
66,S0120-33472006000100002,Se,o
66,S0120-33472006000100002,realizo,o
66,S0120-33472006000100002,un,o
66,S0120-33472006000100002,ensayo,o
66,S0120-33472006000100002,clinico,o
66,S0120-33472006000100002,multicentrico,o
66,S0120-33472006000100002,doble,o
66,S0120-33472006000100002,ciego,o
66,S0120-33472006000100002,aleatorizado,o
66,S0120-33472006000100002,con,o
66,S0120-33472006000100002,140,o
66,S0120-33472006000100002,pacientes,o
66,S0120-33472006000100002,Setenta,o
66,S0120-33472006000100002,pacientes,o
66,S0120-33472006000100002,recibieron,o
66,S0120-33472006000100002,100,o
66,S0120-33472006000100002,microgramos,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,clorhidrato,i
66,S0120-33472006000100002,de,i
66,S0120-33472006000100002,morfina,i
66,S0120-33472006000100002,adicionados,o
66,S0120-33472006000100002,al,o
66,S0120-33472006000100002,anestesico,i
66,S0120-33472006000100002,local,i
66,S0120-33472006000100002,grupo,o
66,S0120-33472006000100002,experimental,o
66,S0120-33472006000100002,70,o
66,S0120-33472006000100002,pacientes,o
66,S0120-33472006000100002,no,o
66,S0120-33472006000100002,recibieron,o
66,S0120-33472006000100002,morfina,i
66,S0120-33472006000100002,intratecal,o
66,S0120-33472006000100002,grupo,o
66,S0120-33472006000100002,control,o
66,S0120-33472006000100002,La,o
66,S0120-33472006000100002,efectividad,o
66,S0120-33472006000100002,analgesica,o
66,S0120-33472006000100002,y,o
66,S0120-33472006000100002,los,o
66,S0120-33472006000100002,efectos,i
66,S0120-33472006000100002,secundarios,i
66,S0120-33472006000100002,fueron,o
66,S0120-33472006000100002,estudiados,o
66,S0120-33472006000100002,por,o
66,S0120-33472006000100002,un,o
66,S0120-33472006000100002,periodo,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,36,o
66,S0120-33472006000100002,horas,o
66,S0120-33472006000100002,despues,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,cirugia,i
66,S0120-33472006000100002,Resultados,o
66,S0120-33472006000100002,La,o
66,S0120-33472006000100002,dosis,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,morfina,i
66,S0120-33472006000100002,fue,o
66,S0120-33472006000100002,efectiva,o
66,S0120-33472006000100002,para,o
66,S0120-33472006000100002,el,o
66,S0120-33472006000100002,control,i
66,S0120-33472006000100002,del,i
66,S0120-33472006000100002,dolor,i
66,S0120-33472006000100002,en,o
66,S0120-33472006000100002,el,o
66,S0120-33472006000100002,postquirurgico,o
66,S0120-33472006000100002,El,o
66,S0120-33472006000100002,efecto,o
66,S0120-33472006000100002,analgesico,o
66,S0120-33472006000100002,se,o
66,S0120-33472006000100002,extendio,o
66,S0120-33472006000100002,en,o
66,S0120-33472006000100002,el,o
66,S0120-33472006000100002,grupo,o
66,S0120-33472006000100002,experimental,o
66,S0120-33472006000100002,a,o
66,S0120-33472006000100002,las,o
66,S0120-33472006000100002,35,o
66,S0120-33472006000100002,horas,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,seguimiento,i
66,S0120-33472006000100002,especialmente,o
66,S0120-33472006000100002,en,o
66,S0120-33472006000100002,el,o
66,S0120-33472006000100002,postoperatorio,o
66,S0120-33472006000100002,inmediato,o
66,S0120-33472006000100002,NNT2,o
66,S0120-33472006000100002,La,o
66,S0120-33472006000100002,incidencia,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,efectos,i
66,S0120-33472006000100002,secundarios,i
66,S0120-33472006000100002,fue,o
66,S0120-33472006000100002,prurito,i
66,S0120-33472006000100002,60,o
66,S0120-33472006000100002,NNH2,o
66,S0120-33472006000100002,nausea,i
66,S0120-33472006000100002,y,i
66,S0120-33472006000100002,vomito,i
66,S0120-33472006000100002,25,o
66,S0120-33472006000100002,NNH11,o
66,S0120-33472006000100002,retencion,i
66,S0120-33472006000100002,urinaria,i
66,S0120-33472006000100002,243,o
66,S0120-33472006000100002,NNH5,o
66,S0120-33472006000100002,y,o
66,S0120-33472006000100002,depresion,i
66,S0120-33472006000100002,respiratoria,i
66,S0120-33472006000100002,0,o
66,S0120-33472006000100002,No,o
66,S0120-33472006000100002,hubo,o
66,S0120-33472006000100002,diferencias,o
66,S0120-33472006000100002,en,o
66,S0120-33472006000100002,las,o
66,S0120-33472006000100002,caracteristicas,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,la,o
66,S0120-33472006000100002,anestesia,i
66,S0120-33472006000100002,ni,o
66,S0120-33472006000100002,en,o
66,S0120-33472006000100002,el,o
66,S0120-33472006000100002,comportamiento,o
66,S0120-33472006000100002,hemodinamico,o
66,S0120-33472006000100002,entre,o
66,S0120-33472006000100002,los,o
66,S0120-33472006000100002,dos,o
66,S0120-33472006000100002,grupos,o
66,S0120-33472006000100002,Conclusiones,o
66,S0120-33472006000100002,100,o
66,S0120-33472006000100002,microgramos,o
66,S0120-33472006000100002,de,o
66,S0120-33472006000100002,morfina,i
66,S0120-33472006000100002,son,o
66,S0120-33472006000100002,efectivos,o
66,S0120-33472006000100002,para,o
66,S0120-33472006000100002,aliviar,o
66,S0120-33472006000100002,el,o
66,S0120-33472006000100002,dolor,i
66,S0120-33472006000100002,postoperatorio,i
66,S0120-33472006000100002,en,o
66,S0120-33472006000100002,las,o
66,S0120-33472006000100002,primeras,o
66,S0120-33472006000100002,12,o
66,S0120-33472006000100002,horas,o
66,S0120-33472006000100002,Los,o
66,S0120-33472006000100002,efectos,i
66,S0120-33472006000100002,secundarios,i
66,S0120-33472006000100002,que,o
66,S0120-33472006000100002,se,o
66,S0120-33472006000100002,presentaron,o
66,S0120-33472006000100002,fueron,o
66,S0120-33472006000100002,tolerables,o
66,S0120-33472006000100002,y,o
66,S0120-33472006000100002,no,o
66,S0120-33472006000100002,requirieron,o
66,S0120-33472006000100002,tratamiento,i
66,S0120-33472006000100002,La,o
66,S0120-33472006000100002,muestra,o
66,S0120-33472006000100002,del,o
66,S0120-33472006000100002,estudio,o
66,S0120-33472006000100002,no,o
66,S0120-33472006000100002,fue,o
66,S0120-33472006000100002,suficiente,o
66,S0120-33472006000100002,para,o
66,S0120-33472006000100002,evaluar,o
66,S0120-33472006000100002,depresion,i
66,S0120-33472006000100002,respiratoria,i
67,S0120-33472007000400003,Estudio,i
67,S0120-33472007000400003,comparativo,i
67,S0120-33472007000400003,entre,o
67,S0120-33472007000400003,tramadol,i
67,S0120-33472007000400003,vs,o
67,S0120-33472007000400003,meperidina,i
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,cirugia,i
67,S0120-33472007000400003,de,i
67,S0120-33472007000400003,rodilla,i
67,S0120-33472007000400003,bajo,o
67,S0120-33472007000400003,anestesia,i
67,S0120-33472007000400003,regional,i
67,S0120-33472007000400003,Objetivo,o
67,S0120-33472007000400003,Evaluar,o
67,S0120-33472007000400003,el,o
67,S0120-33472007000400003,efecto,o
67,S0120-33472007000400003,analgesico,o
67,S0120-33472007000400003,del,o
67,S0120-33472007000400003,tramadol,i
67,S0120-33472007000400003,comparado,o
67,S0120-33472007000400003,con,o
67,S0120-33472007000400003,la,o
67,S0120-33472007000400003,meperidina,i
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,el,o
67,S0120-33472007000400003,postoperatorio,o
67,S0120-33472007000400003,de,o
67,S0120-33472007000400003,pacientes,o
67,S0120-33472007000400003,programados,o
67,S0120-33472007000400003,para,o
67,S0120-33472007000400003,cirugia,i
67,S0120-33472007000400003,de,i
67,S0120-33472007000400003,rodilla,i
67,S0120-33472007000400003,Materiales,o
67,S0120-33472007000400003,y,o
67,S0120-33472007000400003,metodos,o
67,S0120-33472007000400003,Se,o
67,S0120-33472007000400003,realizo,o
67,S0120-33472007000400003,un,o
67,S0120-33472007000400003,ensayo,o
67,S0120-33472007000400003,clinico,o
67,S0120-33472007000400003,controlado,o
67,S0120-33472007000400003,doble,o
67,S0120-33472007000400003,ciego,o
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,el,o
67,S0120-33472007000400003,hospital,o
67,S0120-33472007000400003,Guillermo,o
67,S0120-33472007000400003,Luis,o
67,S0120-33472007000400003,Fernandez,o
67,S0120-33472007000400003,HernandezBaquero,o
67,S0120-33472007000400003,Holguin,o
67,S0120-33472007000400003,Cuba,o
67,S0120-33472007000400003,de,o
67,S0120-33472007000400003,febrero,o
67,S0120-33472007000400003,a,o
67,S0120-33472007000400003,agosto,o
67,S0120-33472007000400003,de,o
67,S0120-33472007000400003,2007,o
67,S0120-33472007000400003,Se,o
67,S0120-33472007000400003,seleccionaron,o
67,S0120-33472007000400003,84,o
67,S0120-33472007000400003,pacientes,o
67,S0120-33472007000400003,los,o
67,S0120-33472007000400003,cuales,o
67,S0120-33472007000400003,se,o
67,S0120-33472007000400003,dividieron,i
67,S0120-33472007000400003,al,i
67,S0120-33472007000400003,azar,i
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,dos,o
67,S0120-33472007000400003,grupos,o
67,S0120-33472007000400003,de,o
67,S0120-33472007000400003,42,o
67,S0120-33472007000400003,pacientes,o
67,S0120-33472007000400003,cada,o
67,S0120-33472007000400003,uno,o
67,S0120-33472007000400003,aplicamos,o
67,S0120-33472007000400003,anestesia,i
67,S0120-33472007000400003,epidural,i
67,S0120-33472007000400003,lumbar,i
67,S0120-33472007000400003,y,o
67,S0120-33472007000400003,se,o
67,S0120-33472007000400003,coloco,i
67,S0120-33472007000400003,cateter,i
67,S0120-33472007000400003,El,o
67,S0120-33472007000400003,agente,i
67,S0120-33472007000400003,anestesico,i
67,S0120-33472007000400003,empleado,o
67,S0120-33472007000400003,fue,o
67,S0120-33472007000400003,mepivacaina,i
67,S0120-33472007000400003,al,o
67,S0120-33472007000400003,2,o
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,dosis,o
67,S0120-33472007000400003,de,o
67,S0120-33472007000400003,5,o
67,S0120-33472007000400003,mgkg,o
67,S0120-33472007000400003,A,o
67,S0120-33472007000400003,los,o
67,S0120-33472007000400003,10,o
67,S0120-33472007000400003,minutos,o
67,S0120-33472007000400003,se,o
67,S0120-33472007000400003,administraron,o
67,S0120-33472007000400003,100,o
67,S0120-33472007000400003,mg,o
67,S0120-33472007000400003,de,o
67,S0120-33472007000400003,tramadol,i
67,S0120-33472007000400003,por,o
67,S0120-33472007000400003,el,o
67,S0120-33472007000400003,cateter,o
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,los,o
67,S0120-33472007000400003,pacientes,o
67,S0120-33472007000400003,del,o
67,S0120-33472007000400003,grupo,o
67,S0120-33472007000400003,I,o
67,S0120-33472007000400003,y,o
67,S0120-33472007000400003,100,o
67,S0120-33472007000400003,mg,o
67,S0120-33472007000400003,de,o
67,S0120-33472007000400003,meperidina,i
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,el,o
67,S0120-33472007000400003,grupo,o
67,S0120-33472007000400003,II,o
67,S0120-33472007000400003,ambos,o
67,S0120-33472007000400003,disueltos,o
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,10,o
67,S0120-33472007000400003,ml,o
67,S0120-33472007000400003,de,o
67,S0120-33472007000400003,solucion,i
67,S0120-33472007000400003,salina,i
67,S0120-33472007000400003,fisiologica,i
67,S0120-33472007000400003,al,o
67,S0120-33472007000400003,09,o
67,S0120-33472007000400003,Se,o
67,S0120-33472007000400003,valoro,o
67,S0120-33472007000400003,la,o
67,S0120-33472007000400003,frecuencia,i
67,S0120-33472007000400003,cardiaca,i
67,S0120-33472007000400003,y,o
67,S0120-33472007000400003,la,o
67,S0120-33472007000400003,tension,i
67,S0120-33472007000400003,arterial,i
67,S0120-33472007000400003,media,i
67,S0120-33472007000400003,transoperatoria,o
67,S0120-33472007000400003,y,o
67,S0120-33472007000400003,postoperatoria,o
67,S0120-33472007000400003,La,o
67,S0120-33472007000400003,evaluacion,i
67,S0120-33472007000400003,del,i
67,S0120-33472007000400003,dolor,i
67,S0120-33472007000400003,se,o
67,S0120-33472007000400003,realizo,o
67,S0120-33472007000400003,con,o
67,S0120-33472007000400003,una,o
67,S0120-33472007000400003,escala,i
67,S0120-33472007000400003,visual,i
67,S0120-33472007000400003,analoga,i
67,S0120-33472007000400003,Las,o
67,S0120-33472007000400003,mediciones,o
67,S0120-33472007000400003,se,o
67,S0120-33472007000400003,realizaron,o
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,tres,o
67,S0120-33472007000400003,ocasiones,o
67,S0120-33472007000400003,recuperacion,o
67,S0120-33472007000400003,y,o
67,S0120-33472007000400003,a,o
67,S0120-33472007000400003,las,o
67,S0120-33472007000400003,2,o
67,S0120-33472007000400003,y,o
67,S0120-33472007000400003,4,o
67,S0120-33472007000400003,horas,o
67,S0120-33472007000400003,del,o
67,S0120-33472007000400003,postoperatorio,o
67,S0120-33472007000400003,Se,o
67,S0120-33472007000400003,registraron,o
67,S0120-33472007000400003,los,o
67,S0120-33472007000400003,efectos,i
67,S0120-33472007000400003,secundarios,i
67,S0120-33472007000400003,mas,o
67,S0120-33472007000400003,frecuentes,o
67,S0120-33472007000400003,Resultados,o
67,S0120-33472007000400003,La,o
67,S0120-33472007000400003,evaluacion,i
67,S0120-33472007000400003,a,o
67,S0120-33472007000400003,las,o
67,S0120-33472007000400003,4,o
67,S0120-33472007000400003,horas,o
67,S0120-33472007000400003,del,o
67,S0120-33472007000400003,postoperatorio,o
67,S0120-33472007000400003,reporto,o
67,S0120-33472007000400003,valores,o
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,la,o
67,S0120-33472007000400003,escala,i
67,S0120-33472007000400003,visual,i
67,S0120-33472007000400003,analoga,i
67,S0120-33472007000400003,por,o
67,S0120-33472007000400003,debajo,o
67,S0120-33472007000400003,de,o
67,S0120-33472007000400003,4,o
67,S0120-33472007000400003,para,o
67,S0120-33472007000400003,ambos,o
67,S0120-33472007000400003,grupos,o
67,S0120-33472007000400003,sin,o
67,S0120-33472007000400003,diferencia,o
67,S0120-33472007000400003,estadisticamente,o
67,S0120-33472007000400003,significativa,o
67,S0120-33472007000400003,p031,o
67,S0120-33472007000400003,Las,o
67,S0120-33472007000400003,nauseas,i
67,S0120-33472007000400003,fueron,o
67,S0120-33472007000400003,el,o
67,S0120-33472007000400003,efecto,i
67,S0120-33472007000400003,adverso,i
67,S0120-33472007000400003,mas,o
67,S0120-33472007000400003,frecuente,o
67,S0120-33472007000400003,166,o
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,el,o
67,S0120-33472007000400003,grupo,o
67,S0120-33472007000400003,I,o
67,S0120-33472007000400003,y,o
67,S0120-33472007000400003,285,o
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,el,o
67,S0120-33472007000400003,grupo,o
67,S0120-33472007000400003,II,o
67,S0120-33472007000400003,Conclusiones,o
67,S0120-33472007000400003,La,o
67,S0120-33472007000400003,analgesia,i
67,S0120-33472007000400003,epidural,i
67,S0120-33472007000400003,con,o
67,S0120-33472007000400003,tramadol,i
67,S0120-33472007000400003,y,o
67,S0120-33472007000400003,meperidina,i
67,S0120-33472007000400003,prolonga,o
67,S0120-33472007000400003,la,o
67,S0120-33472007000400003,analgesia,i
67,S0120-33472007000400003,en,o
67,S0120-33472007000400003,pacientes,o
67,S0120-33472007000400003,intervenidos,i
67,S0120-33472007000400003,de,o
67,S0120-33472007000400003,patologias,i
67,S0120-33472007000400003,de,i
67,S0120-33472007000400003,rodilla,i
68,S0120-33472008000300003,Irrigacion,i
68,S0120-33472008000300003,de,o
68,S0120-33472008000300003,anestesicos,i
68,S0120-33472008000300003,locales,i
68,S0120-33472008000300003,y,o
68,S0120-33472008000300003,dolor,i
68,S0120-33472008000300003,postoperatorio,i
68,S0120-33472008000300003,en,o
68,S0120-33472008000300003,pacientes,o
68,S0120-33472008000300003,sometidas,o
68,S0120-33472008000300003,a,o
68,S0120-33472008000300003,mamoplastia,i
68,S0120-33472008000300003,de,i
68,S0120-33472008000300003,aumento,i
68,S0120-33472008000300003,Objetivo,o
68,S0120-33472008000300003,Determinar,o
68,S0120-33472008000300003,si,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,irrigacion,i
68,S0120-33472008000300003,de,o
68,S0120-33472008000300003,anestesicos,i
68,S0120-33472008000300003,locales,i
68,S0120-33472008000300003,en,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,cavidad,i
68,S0120-33472008000300003,mamaria,i
68,S0120-33472008000300003,en,o
68,S0120-33472008000300003,pacientes,o
68,S0120-33472008000300003,sometidas,o
68,S0120-33472008000300003,a,o
68,S0120-33472008000300003,mamoplastia,i
68,S0120-33472008000300003,de,i
68,S0120-33472008000300003,aumento,i
68,S0120-33472008000300003,disminuye,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,necesidad,o
68,S0120-33472008000300003,de,o
68,S0120-33472008000300003,analgesia,i
68,S0120-33472008000300003,de,i
68,S0120-33472008000300003,rescate,i
68,S0120-33472008000300003,y,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,intensidad,o
68,S0120-33472008000300003,del,o
68,S0120-33472008000300003,dolor,i
68,S0120-33472008000300003,postoperatorio,i
68,S0120-33472008000300003,medido,o
68,S0120-33472008000300003,con,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,escala,i
68,S0120-33472008000300003,visual,i
68,S0120-33472008000300003,analoga,i
68,S0120-33472008000300003,Metodologia,o
68,S0120-33472008000300003,Estudio,i
68,S0120-33472008000300003,clinico,i
68,S0120-33472008000300003,cuasiexperimental,i
68,S0120-33472008000300003,controlado,i
68,S0120-33472008000300003,con,i
68,S0120-33472008000300003,placebo,i
68,S0120-33472008000300003,En,o
68,S0120-33472008000300003,el,o
68,S0120-33472008000300003,grupo,o
68,S0120-33472008000300003,de,o
68,S0120-33472008000300003,intervencion,i
68,S0120-33472008000300003,se,o
68,S0120-33472008000300003,irrigo,i
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,cavidad,i
68,S0120-33472008000300003,mamaria,i
68,S0120-33472008000300003,con,o
68,S0120-33472008000300003,una,o
68,S0120-33472008000300003,solucion,i
68,S0120-33472008000300003,de,i
68,S0120-33472008000300003,lidocaina,i
68,S0120-33472008000300003,al,o
68,S0120-33472008000300003,1,o
68,S0120-33472008000300003,con,o
68,S0120-33472008000300003,epinefrina,i
68,S0120-33472008000300003,7,o
68,S0120-33472008000300003,mgkg,o
68,S0120-33472008000300003,bupivacaina,i
68,S0120-33472008000300003,al,o
68,S0120-33472008000300003,05,o
68,S0120-33472008000300003,3,o
68,S0120-33472008000300003,mgkg,o
68,S0120-33472008000300003,y,o
68,S0120-33472008000300003,solucion,i
68,S0120-33472008000300003,salina,i
68,S0120-33472008000300003,En,o
68,S0120-33472008000300003,el,o
68,S0120-33472008000300003,grupo,o
68,S0120-33472008000300003,control,o
68,S0120-33472008000300003,se,o
68,S0120-33472008000300003,irrigo,i
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,cavidad,i
68,S0120-33472008000300003,mamaria,i
68,S0120-33472008000300003,con,o
68,S0120-33472008000300003,solucion,i
68,S0120-33472008000300003,salina,i
68,S0120-33472008000300003,La,o
68,S0120-33472008000300003,tecnica,i
68,S0120-33472008000300003,anestesica,i
68,S0120-33472008000300003,y,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,analgesia,i
68,S0120-33472008000300003,de,i
68,S0120-33472008000300003,transicion,i
68,S0120-33472008000300003,fueron,o
68,S0120-33472008000300003,estandarizadas,o
68,S0120-33472008000300003,Se,o
68,S0120-33472008000300003,registro,o
68,S0120-33472008000300003,el,o
68,S0120-33472008000300003,analgesico,i
68,S0120-33472008000300003,opiaceo,i
68,S0120-33472008000300003,morfina,i
68,S0120-33472008000300003,hidromorfona,i
68,S0120-33472008000300003,o,o
68,S0120-33472008000300003,meperidina,i
68,S0120-33472008000300003,y,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,dosis,o
68,S0120-33472008000300003,total,o
68,S0120-33472008000300003,requerida,o
68,S0120-33472008000300003,como,o
68,S0120-33472008000300003,analgesia,i
68,S0120-33472008000300003,de,i
68,S0120-33472008000300003,rescate,i
68,S0120-33472008000300003,durante,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,estancia,o
68,S0120-33472008000300003,en,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,unidad,o
68,S0120-33472008000300003,de,o
68,S0120-33472008000300003,cuidados,o
68,S0120-33472008000300003,postanestesicos,o
68,S0120-33472008000300003,UCPA,o
68,S0120-33472008000300003,Se,o
68,S0120-33472008000300003,registro,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,intensidad,o
68,S0120-33472008000300003,del,o
68,S0120-33472008000300003,dolor,i
68,S0120-33472008000300003,postoperatorio,i
68,S0120-33472008000300003,al,o
68,S0120-33472008000300003,recuperar,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,conciencia,o
68,S0120-33472008000300003,a,o
68,S0120-33472008000300003,los,o
68,S0120-33472008000300003,treinta,o
68,S0120-33472008000300003,minutos,o
68,S0120-33472008000300003,a,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,primera,o
68,S0120-33472008000300003,hora,o
68,S0120-33472008000300003,a,o
68,S0120-33472008000300003,las,o
68,S0120-33472008000300003,dos,o
68,S0120-33472008000300003,a,o
68,S0120-33472008000300003,las,o
68,S0120-33472008000300003,cinco,o
68,S0120-33472008000300003,y,o
68,S0120-33472008000300003,a,o
68,S0120-33472008000300003,las,o
68,S0120-33472008000300003,veinticuatro,o
68,S0120-33472008000300003,horas,o
68,S0120-33472008000300003,del,o
68,S0120-33472008000300003,postoperatorio,o
68,S0120-33472008000300003,Resultados,o
68,S0120-33472008000300003,Se,o
68,S0120-33472008000300003,encontro,o
68,S0120-33472008000300003,diferencia,o
68,S0120-33472008000300003,en,o
68,S0120-33472008000300003,el,o
68,S0120-33472008000300003,numero,o
68,S0120-33472008000300003,de,o
68,S0120-33472008000300003,pacientes,o
68,S0120-33472008000300003,que,o
68,S0120-33472008000300003,requirieron,o
68,S0120-33472008000300003,analgesia,i
68,S0120-33472008000300003,de,i
68,S0120-33472008000300003,rescate,i
68,S0120-33472008000300003,con,o
68,S0120-33472008000300003,morfina,i
68,S0120-33472008000300003,en,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,UCPA,o
68,S0120-33472008000300003,p001,o
68,S0120-33472008000300003,10,o
68,S0120-33472008000300003,en,o
68,S0120-33472008000300003,el,o
68,S0120-33472008000300003,grupo,o
68,S0120-33472008000300003,de,o
68,S0120-33472008000300003,intervencion,i
68,S0120-33472008000300003,versus,o
68,S0120-33472008000300003,50,o
68,S0120-33472008000300003,en,o
68,S0120-33472008000300003,el,o
68,S0120-33472008000300003,grupo,o
68,S0120-33472008000300003,control,o
68,S0120-33472008000300003,Tambien,o
68,S0120-33472008000300003,se,o
68,S0120-33472008000300003,encontro,o
68,S0120-33472008000300003,diferencia,o
68,S0120-33472008000300003,en,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,intensidad,o
68,S0120-33472008000300003,del,o
68,S0120-33472008000300003,dolor,i
68,S0120-33472008000300003,p001,o
68,S0120-33472008000300003,Conclusiones,o
68,S0120-33472008000300003,La,o
68,S0120-33472008000300003,irrigacion,i
68,S0120-33472008000300003,de,o
68,S0120-33472008000300003,anestesicos,i
68,S0120-33472008000300003,locales,i
68,S0120-33472008000300003,en,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,cavidad,i
68,S0120-33472008000300003,mamaria,i
68,S0120-33472008000300003,en,o
68,S0120-33472008000300003,pacientes,o
68,S0120-33472008000300003,sometidas,o
68,S0120-33472008000300003,a,o
68,S0120-33472008000300003,mamoplastia,i
68,S0120-33472008000300003,de,i
68,S0120-33472008000300003,aumento,i
68,S0120-33472008000300003,disminuye,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,necesidad,o
68,S0120-33472008000300003,de,o
68,S0120-33472008000300003,analgesia,i
68,S0120-33472008000300003,de,i
68,S0120-33472008000300003,rescate,i
68,S0120-33472008000300003,con,o
68,S0120-33472008000300003,opiaceos,i
68,S0120-33472008000300003,y,o
68,S0120-33472008000300003,la,o
68,S0120-33472008000300003,intensidad,o
68,S0120-33472008000300003,del,o
68,S0120-33472008000300003,dolor,i
68,S0120-33472008000300003,postoperatorio,i
69,S0120-33472010000200002,Eficacia,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,la,o
69,S0120-33472010000200002,asociacion,o
69,S0120-33472010000200002,dipironameperidina,o
69,S0120-33472010000200002,en,o
69,S0120-33472010000200002,disminuir,o
69,S0120-33472010000200002,la,o
69,S0120-33472010000200002,necesidad,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,opioide,i
69,S0120-33472010000200002,en,o
69,S0120-33472010000200002,dolor,i
69,S0120-33472010000200002,agudo,i
69,S0120-33472010000200002,posterior,o
69,S0120-33472010000200002,a,o
69,S0120-33472010000200002,cirugia,i
69,S0120-33472010000200002,abdominal,i
69,S0120-33472010000200002,Introduccion,o
69,S0120-33472010000200002,La,o
69,S0120-33472010000200002,principal,o
69,S0120-33472010000200002,preocupacion,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,los,o
69,S0120-33472010000200002,pacientes,o
69,S0120-33472010000200002,que,o
69,S0120-33472010000200002,van,o
69,S0120-33472010000200002,a,o
69,S0120-33472010000200002,ser,o
69,S0120-33472010000200002,intervenidos,i
69,S0120-33472010000200002,es,o
69,S0120-33472010000200002,el,o
69,S0120-33472010000200002,dolor,i
69,S0120-33472010000200002,agudo,i
69,S0120-33472010000200002,postoperatorio,i
69,S0120-33472010000200002,en,o
69,S0120-33472010000200002,cuyo,o
69,S0120-33472010000200002,manejo,o
69,S0120-33472010000200002,los,o
69,S0120-33472010000200002,opioides,i
69,S0120-33472010000200002,son,o
69,S0120-33472010000200002,los,o
69,S0120-33472010000200002,farmacos,i
69,S0120-33472010000200002,mas,o
69,S0120-33472010000200002,recomendados,o
69,S0120-33472010000200002,aunque,o
69,S0120-33472010000200002,sus,o
69,S0120-33472010000200002,efectos,i
69,S0120-33472010000200002,secundarios,i
69,S0120-33472010000200002,han,o
69,S0120-33472010000200002,limitado,o
69,S0120-33472010000200002,su,o
69,S0120-33472010000200002,uso,o
69,S0120-33472010000200002,En,o
69,S0120-33472010000200002,nuestro,o
69,S0120-33472010000200002,medio,o
69,S0120-33472010000200002,su,o
69,S0120-33472010000200002,manejo,o
69,S0120-33472010000200002,lo,o
69,S0120-33472010000200002,realizan,o
69,S0120-33472010000200002,los,o
69,S0120-33472010000200002,medicos,o
69,S0120-33472010000200002,generales,o
69,S0120-33472010000200002,o,o
69,S0120-33472010000200002,los,o
69,S0120-33472010000200002,cirujanos,o
69,S0120-33472010000200002,con,o
69,S0120-33472010000200002,uso,o
69,S0120-33472010000200002,prevalente,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,la,o
69,S0120-33472010000200002,dipirona,i
69,S0120-33472010000200002,y,o
69,S0120-33472010000200002,resultados,o
69,S0120-33472010000200002,suboptimos,o
69,S0120-33472010000200002,Una,o
69,S0120-33472010000200002,alternativa,o
69,S0120-33472010000200002,segura,o
69,S0120-33472010000200002,seria,o
69,S0120-33472010000200002,la,o
69,S0120-33472010000200002,adicion,o
69,S0120-33472010000200002,a,o
69,S0120-33472010000200002,la,o
69,S0120-33472010000200002,dipirona,i
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,meperidina,i
69,S0120-33472010000200002,obteniendose,o
69,S0120-33472010000200002,asi,o
69,S0120-33472010000200002,una,o
69,S0120-33472010000200002,adecuada,o
69,S0120-33472010000200002,alternativa,o
69,S0120-33472010000200002,para,o
69,S0120-33472010000200002,su,o
69,S0120-33472010000200002,manejo,o
69,S0120-33472010000200002,por,o
69,S0120-33472010000200002,parte,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,medicos,o
69,S0120-33472010000200002,no,o
69,S0120-33472010000200002,especialistas,o
69,S0120-33472010000200002,sin,o
69,S0120-33472010000200002,los,o
69,S0120-33472010000200002,efectos,i
69,S0120-33472010000200002,adversos,i
69,S0120-33472010000200002,Objetivo,o
69,S0120-33472010000200002,Determinar,o
69,S0120-33472010000200002,si,o
69,S0120-33472010000200002,la,o
69,S0120-33472010000200002,adicion,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,dipirona,i
69,S0120-33472010000200002,a,o
69,S0120-33472010000200002,la,o
69,S0120-33472010000200002,meperidina,i
69,S0120-33472010000200002,disminuye,o
69,S0120-33472010000200002,en,o
69,S0120-33472010000200002,50,o
69,S0120-33472010000200002,las,o
69,S0120-33472010000200002,necesidades,o
69,S0120-33472010000200002,del,o
69,S0120-33472010000200002,opioide,i
69,S0120-33472010000200002,en,o
69,S0120-33472010000200002,el,o
69,S0120-33472010000200002,manejo,o
69,S0120-33472010000200002,eficaz,o
69,S0120-33472010000200002,del,o
69,S0120-33472010000200002,dolor,i
69,S0120-33472010000200002,agudo,i
69,S0120-33472010000200002,postoperatorio,i
69,S0120-33472010000200002,Metodos,o
69,S0120-33472010000200002,Se,o
69,S0120-33472010000200002,llevo,o
69,S0120-33472010000200002,a,o
69,S0120-33472010000200002,cabo,o
69,S0120-33472010000200002,un,o
69,S0120-33472010000200002,ensayo,i
69,S0120-33472010000200002,clinico,i
69,S0120-33472010000200002,controlado,i
69,S0120-33472010000200002,con,o
69,S0120-33472010000200002,107,o
69,S0120-33472010000200002,pacientes,o
69,S0120-33472010000200002,distribuidos,o
69,S0120-33472010000200002,en,o
69,S0120-33472010000200002,dos,o
69,S0120-33472010000200002,grupos,o
69,S0120-33472010000200002,Se,o
69,S0120-33472010000200002,usaron,o
69,S0120-33472010000200002,dosis,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,05,o
69,S0120-33472010000200002,mgkg,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,meperidina,i
69,S0120-33472010000200002,mas,o
69,S0120-33472010000200002,25,o
69,S0120-33472010000200002,g,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,dipirona,i
69,S0120-33472010000200002,n,o
69,S0120-33472010000200002,57,o
69,S0120-33472010000200002,comparadas,o
69,S0120-33472010000200002,con,o
69,S0120-33472010000200002,la,o
69,S0120-33472010000200002,dosis,o
69,S0120-33472010000200002,usual,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,meperidina,i
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,1,o
69,S0120-33472010000200002,mgkg,o
69,S0120-33472010000200002,n,o
69,S0120-33472010000200002,50,o
69,S0120-33472010000200002,El,o
69,S0120-33472010000200002,dolor,i
69,S0120-33472010000200002,agudo,i
69,S0120-33472010000200002,postoperatorio,i
69,S0120-33472010000200002,se,o
69,S0120-33472010000200002,evaluo,o
69,S0120-33472010000200002,segun,o
69,S0120-33472010000200002,escala,i
69,S0120-33472010000200002,visual,i
69,S0120-33472010000200002,analoga,i
69,S0120-33472010000200002,Resultados,o
69,S0120-33472010000200002,La,o
69,S0120-33472010000200002,incidencia,o
69,S0120-33472010000200002,del,o
69,S0120-33472010000200002,dolor,i
69,S0120-33472010000200002,agudo,i
69,S0120-33472010000200002,postoperatorio,i
69,S0120-33472010000200002,fue,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,28,o
69,S0120-33472010000200002,en,o
69,S0120-33472010000200002,el,o
69,S0120-33472010000200002,grupo,o
69,S0120-33472010000200002,intervenido,i
69,S0120-33472010000200002,y,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,2632,o
69,S0120-33472010000200002,en,o
69,S0120-33472010000200002,el,o
69,S0120-33472010000200002,control,o
69,S0120-33472010000200002,El,o
69,S0120-33472010000200002,riesgo,o
69,S0120-33472010000200002,relativo,o
69,S0120-33472010000200002,RR,o
69,S0120-33472010000200002,fue,o
69,S0120-33472010000200002,mayor,o
69,S0120-33472010000200002,en,o
69,S0120-33472010000200002,el,o
69,S0120-33472010000200002,grupo,o
69,S0120-33472010000200002,intervenido,i
69,S0120-33472010000200002,RR,o
69,S0120-33472010000200002,106,o
69,S0120-33472010000200002,IC95,o
69,S0120-33472010000200002,057198,o
69,S0120-33472010000200002,sin,o
69,S0120-33472010000200002,diferencias,o
69,S0120-33472010000200002,entre,o
69,S0120-33472010000200002,ellos,o
69,S0120-33472010000200002,La,o
69,S0120-33472010000200002,incidencia,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,efectos,i
69,S0120-33472010000200002,secundarios,i
69,S0120-33472010000200002,presento,o
69,S0120-33472010000200002,mayores,o
69,S0120-33472010000200002,riesgos,o
69,S0120-33472010000200002,absolutos,o
69,S0120-33472010000200002,en,o
69,S0120-33472010000200002,el,o
69,S0120-33472010000200002,grupo,o
69,S0120-33472010000200002,control,o
69,S0120-33472010000200002,con,o
69,S0120-33472010000200002,una,o
69,S0120-33472010000200002,diferencia,o
69,S0120-33472010000200002,significativa,o
69,S0120-33472010000200002,p,o
69,S0120-33472010000200002,00055,o
69,S0120-33472010000200002,Conclusiones,o
69,S0120-33472010000200002,La,o
69,S0120-33472010000200002,mezcla,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,dipirona,i
69,S0120-33472010000200002,mas,o
69,S0120-33472010000200002,meperidina,i
69,S0120-33472010000200002,nos,o
69,S0120-33472010000200002,permite,o
69,S0120-33472010000200002,disminuir,o
69,S0120-33472010000200002,en,o
69,S0120-33472010000200002,50,o
69,S0120-33472010000200002,la,o
69,S0120-33472010000200002,necesidad,o
69,S0120-33472010000200002,de,o
69,S0120-33472010000200002,opioide,i
69,S0120-33472010000200002,con,o
69,S0120-33472010000200002,menos,o
69,S0120-33472010000200002,efectos,i
69,S0120-33472010000200002,adversos,i
69,S0120-33472010000200002,sin,o
69,S0120-33472010000200002,que,o
69,S0120-33472010000200002,el,o
69,S0120-33472010000200002,control,i
69,S0120-33472010000200002,del,i
69,S0120-33472010000200002,dolor,i
69,S0120-33472010000200002,agudo,i
69,S0120-33472010000200002,postoperatorio,i
69,S0120-33472010000200002,sea,o
69,S0120-33472010000200002,eficaz,o
70,S0120-41572006000300005,Malaria,i
70,S0120-41572006000300005,por,i
70,S0120-41572006000300005,Plasmodium,i
70,S0120-41572006000300005,vivax,i
70,S0120-41572006000300005,curacion,o
70,S0120-41572006000300005,del,o
70,S0120-41572006000300005,ataque,i
70,S0120-41572006000300005,agudo,i
70,S0120-41572006000300005,con,o
70,S0120-41572006000300005,tres,o
70,S0120-41572006000300005,dosis,o
70,S0120-41572006000300005,diferentes,o
70,S0120-41572006000300005,de,o
70,S0120-41572006000300005,primaquina,i
70,S0120-41572006000300005,y,o
70,S0120-41572006000300005,dosis,o
70,S0120-41572006000300005,fija,o
70,S0120-41572006000300005,de,o
70,S0120-41572006000300005,cloroquina,i
70,S0120-41572006000300005,Antioquia,o
70,S0120-41572006000300005,Colombia,o
70,S0120-41572006000300005,20032004,o
70,S0120-41572006000300005,Introduccion,o
70,S0120-41572006000300005,Cloroquina,i
70,S0120-41572006000300005,CQ,i
70,S0120-41572006000300005,y,o
70,S0120-41572006000300005,primaquina,i
70,S0120-41572006000300005,PQ,i
70,S0120-41572006000300005,se,o
70,S0120-41572006000300005,usan,o
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,Colombia,o
70,S0120-41572006000300005,para,o
70,S0120-41572006000300005,tratar,i
70,S0120-41572006000300005,la,o
70,S0120-41572006000300005,malaria,i
70,S0120-41572006000300005,vivax,i
70,S0120-41572006000300005,no,i
70,S0120-41572006000300005,complicada,i
70,S0120-41572006000300005,pero,o
70,S0120-41572006000300005,son,o
70,S0120-41572006000300005,escasas,o
70,S0120-41572006000300005,las,o
70,S0120-41572006000300005,evaluaciones,i
70,S0120-41572006000300005,de,i
70,S0120-41572006000300005,su,i
70,S0120-41572006000300005,eficacia,i
70,S0120-41572006000300005,Objetivos,o
70,S0120-41572006000300005,a,o
70,S0120-41572006000300005,investigar,o
70,S0120-41572006000300005,la,o
70,S0120-41572006000300005,clinica,o
70,S0120-41572006000300005,de,o
70,S0120-41572006000300005,la,o
70,S0120-41572006000300005,malaria,i
70,S0120-41572006000300005,vivax,i
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,dos,o
70,S0120-41572006000300005,zonas,o
70,S0120-41572006000300005,con,o
70,S0120-41572006000300005,muy,o
70,S0120-41572006000300005,diferente,o
70,S0120-41572006000300005,nivel,o
70,S0120-41572006000300005,endemico,o
70,S0120-41572006000300005,b,o
70,S0120-41572006000300005,evaluar,o
70,S0120-41572006000300005,la,o
70,S0120-41572006000300005,respuesta,o
70,S0120-41572006000300005,terapeutica,o
70,S0120-41572006000300005,antimalarica,o
70,S0120-41572006000300005,obtenida,o
70,S0120-41572006000300005,con,o
70,S0120-41572006000300005,el,o
70,S0120-41572006000300005,tratamiento,i
70,S0120-41572006000300005,estandar,i
70,S0120-41572006000300005,CQPQ,o
70,S0120-41572006000300005,tomadas,o
70,S0120-41572006000300005,simultaneamente,o
70,S0120-41572006000300005,c,o
70,S0120-41572006000300005,comparar,i
70,S0120-41572006000300005,la,i
70,S0120-41572006000300005,eficacia,i
70,S0120-41572006000300005,del,o
70,S0120-41572006000300005,tratamiento,i
70,S0120-41572006000300005,estandar,i
70,S0120-41572006000300005,y,o
70,S0120-41572006000300005,la,o
70,S0120-41572006000300005,de,o
70,S0120-41572006000300005,otros,o
70,S0120-41572006000300005,dos,o
70,S0120-41572006000300005,esquemas,o
70,S0120-41572006000300005,que,o
70,S0120-41572006000300005,conservan,o
70,S0120-41572006000300005,la,o
70,S0120-41572006000300005,dosis,o
70,S0120-41572006000300005,total,o
70,S0120-41572006000300005,de,o
70,S0120-41572006000300005,CQ,i
70,S0120-41572006000300005,pero,o
70,S0120-41572006000300005,varian,o
70,S0120-41572006000300005,la,o
70,S0120-41572006000300005,de,o
70,S0120-41572006000300005,PQ,i
70,S0120-41572006000300005,d,o
70,S0120-41572006000300005,identificar,o
70,S0120-41572006000300005,los,o
70,S0120-41572006000300005,efectos,i
70,S0120-41572006000300005,adversos,i
70,S0120-41572006000300005,ocurridos,o
70,S0120-41572006000300005,durante,o
70,S0120-41572006000300005,el,o
70,S0120-41572006000300005,tratamiento,i
70,S0120-41572006000300005,CQPQ,o
70,S0120-41572006000300005,Materiales,o
70,S0120-41572006000300005,y,o
70,S0120-41572006000300005,metodos,o
70,S0120-41572006000300005,Diseño,o
70,S0120-41572006000300005,aleatorio,o
70,S0120-41572006000300005,controlado,o
70,S0120-41572006000300005,no,o
70,S0120-41572006000300005,ciego,o
70,S0120-41572006000300005,tres,o
70,S0120-41572006000300005,grupos,o
70,S0120-41572006000300005,definidos,o
70,S0120-41572006000300005,segun,o
70,S0120-41572006000300005,dosis,o
70,S0120-41572006000300005,total,o
70,S0120-41572006000300005,de,o
70,S0120-41572006000300005,PQ,i
70,S0120-41572006000300005,45,o
70,S0120-41572006000300005,105,o
70,S0120-41572006000300005,y,o
70,S0120-41572006000300005,210,o
70,S0120-41572006000300005,mg,o
70,S0120-41572006000300005,Todos,o
70,S0120-41572006000300005,recibieron,o
70,S0120-41572006000300005,CQ,i
70,S0120-41572006000300005,1500,o
70,S0120-41572006000300005,mg,o
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,48,o
70,S0120-41572006000300005,horas,o
70,S0120-41572006000300005,y,o
70,S0120-41572006000300005,simultaneamente,o
70,S0120-41572006000300005,PQ,i
70,S0120-41572006000300005,Pacientes,o
70,S0120-41572006000300005,captados,o
70,S0120-41572006000300005,consecutivamente,o
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,Turbo,o
70,S0120-41572006000300005,y,o
70,S0120-41572006000300005,El,o
70,S0120-41572006000300005,Bagre,o
70,S0120-41572006000300005,Seguimiento,i
70,S0120-41572006000300005,durante,o
70,S0120-41572006000300005,28,o
70,S0120-41572006000300005,dias,o
70,S0120-41572006000300005,La,o
70,S0120-41572006000300005,respuesta,o
70,S0120-41572006000300005,terapeutica,o
70,S0120-41572006000300005,antimalarica,o
70,S0120-41572006000300005,clasificada,o
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,falla,o
70,S0120-41572006000300005,precoz,o
70,S0120-41572006000300005,falla,o
70,S0120-41572006000300005,tardia,o
70,S0120-41572006000300005,y,o
70,S0120-41572006000300005,respuesta,o
70,S0120-41572006000300005,adecuada,o
70,S0120-41572006000300005,Resultados,o
70,S0120-41572006000300005,Se,o
70,S0120-41572006000300005,trataron,i
70,S0120-41572006000300005,228,o
70,S0120-41572006000300005,pacientes,o
70,S0120-41572006000300005,y,o
70,S0120-41572006000300005,la,o
70,S0120-41572006000300005,respuesta,o
70,S0120-41572006000300005,terapeutica,o
70,S0120-41572006000300005,antimalarica,o
70,S0120-41572006000300005,se,o
70,S0120-41572006000300005,evaluo,o
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,210,o
70,S0120-41572006000300005,El,o
70,S0120-41572006000300005,cuadro,o
70,S0120-41572006000300005,clinico,o
70,S0120-41572006000300005,encontrado,o
70,S0120-41572006000300005,es,o
70,S0120-41572006000300005,similar,o
70,S0120-41572006000300005,al,o
70,S0120-41572006000300005,descrito,o
70,S0120-41572006000300005,por,o
70,S0120-41572006000300005,otros,o
70,S0120-41572006000300005,autores,o
70,S0120-41572006000300005,En,o
70,S0120-41572006000300005,todos,o
70,S0120-41572006000300005,los,o
70,S0120-41572006000300005,tres,o
70,S0120-41572006000300005,grupos,o
70,S0120-41572006000300005,la,o
70,S0120-41572006000300005,parasitemia,i
70,S0120-41572006000300005,se,o
70,S0120-41572006000300005,elimino,o
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,24,o
70,S0120-41572006000300005,horas,o
70,S0120-41572006000300005,de,o
70,S0120-41572006000300005,tratamiento,i
70,S0120-41572006000300005,con,o
70,S0120-41572006000300005,CQ,i
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,11,o
70,S0120-41572006000300005,de,o
70,S0120-41572006000300005,los,o
70,S0120-41572006000300005,pacientes,o
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,48,o
70,S0120-41572006000300005,horas,o
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,66,o
70,S0120-41572006000300005,y,o
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,72,o
70,S0120-41572006000300005,horas,o
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,97,o
70,S0120-41572006000300005,Todos,o
70,S0120-41572006000300005,los,o
70,S0120-41572006000300005,210,o
70,S0120-41572006000300005,pacientes,o
70,S0120-41572006000300005,respondieron,o
70,S0120-41572006000300005,adecuadamente,o
70,S0120-41572006000300005,al,o
70,S0120-41572006000300005,tratamiento,i
70,S0120-41572006000300005,CQPQ,o
70,S0120-41572006000300005,La,o
70,S0120-41572006000300005,dosis,o
70,S0120-41572006000300005,variable,o
70,S0120-41572006000300005,de,o
70,S0120-41572006000300005,PQ,i
70,S0120-41572006000300005,no,o
70,S0120-41572006000300005,afecto,o
70,S0120-41572006000300005,esta,o
70,S0120-41572006000300005,respuesta,o
70,S0120-41572006000300005,Conclusiones,o
70,S0120-41572006000300005,CQPQ,o
70,S0120-41572006000300005,debe,o
70,S0120-41572006000300005,conservarse,o
70,S0120-41572006000300005,como,o
70,S0120-41572006000300005,la,o
70,S0120-41572006000300005,primera,o
70,S0120-41572006000300005,opcion,o
70,S0120-41572006000300005,terapeutica,o
70,S0120-41572006000300005,y,o
70,S0120-41572006000300005,debe,o
70,S0120-41572006000300005,evaluarse,o
70,S0120-41572006000300005,en,o
70,S0120-41572006000300005,otras,o
70,S0120-41572006000300005,areas,o
70,S0120-41572006000300005,Se,o
70,S0120-41572006000300005,propone,o
70,S0120-41572006000300005,la,o
70,S0120-41572006000300005,administracion,i
70,S0120-41572006000300005,concomitante,i
70,S0120-41572006000300005,de,o
70,S0120-41572006000300005,CQ,i
70,S0120-41572006000300005,y,o
70,S0120-41572006000300005,PQ,i
71,S0120-41572006000500020,Eficacia,o
71,S0120-41572006000500020,y,o
71,S0120-41572006000500020,tolerancia,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,la,o
71,S0120-41572006000500020,pentamidina,i
71,S0120-41572006000500020,en,o
71,S0120-41572006000500020,el,o
71,S0120-41572006000500020,tratamiento,i
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,la,o
71,S0120-41572006000500020,leishmaniasis,i
71,S0120-41572006000500020,cutanea,i
71,S0120-41572006000500020,producida,o
71,S0120-41572006000500020,por,o
71,S0120-41572006000500020,Leishmania,o
71,S0120-41572006000500020,V,o
71,S0120-41572006000500020,panamensis,o
71,S0120-41572006000500020,en,o
71,S0120-41572006000500020,Colombia,o
71,S0120-41572006000500020,Introduccion,o
71,S0120-41572006000500020,El,o
71,S0120-41572006000500020,tratamiento,i
71,S0120-41572006000500020,de,i
71,S0120-41572006000500020,eleccion,i
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,la,o
71,S0120-41572006000500020,leishmaniasis,i
71,S0120-41572006000500020,cutanea,i
71,S0120-41572006000500020,es,o
71,S0120-41572006000500020,el,o
71,S0120-41572006000500020,antimonio,i
71,S0120-41572006000500020,pentavalente,i
71,S0120-41572006000500020,con,o
71,S0120-41572006000500020,una,o
71,S0120-41572006000500020,eficacia,o
71,S0120-41572006000500020,cercana,o
71,S0120-41572006000500020,al,o
71,S0120-41572006000500020,85,o
71,S0120-41572006000500020,sin,o
71,S0120-41572006000500020,embargo,o
71,S0120-41572006000500020,debido,o
71,S0120-41572006000500020,a,o
71,S0120-41572006000500020,los,o
71,S0120-41572006000500020,serios,o
71,S0120-41572006000500020,efectos,i
71,S0120-41572006000500020,adversos,i
71,S0120-41572006000500020,y,o
71,S0120-41572006000500020,a,o
71,S0120-41572006000500020,la,o
71,S0120-41572006000500020,aparicion,o
71,S0120-41572006000500020,cada,o
71,S0120-41572006000500020,vez,o
71,S0120-41572006000500020,mas,o
71,S0120-41572006000500020,frecuente,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,resistencia,o
71,S0120-41572006000500020,al,o
71,S0120-41572006000500020,tratamiento,i
71,S0120-41572006000500020,se,o
71,S0120-41572006000500020,hace,o
71,S0120-41572006000500020,necesaria,o
71,S0120-41572006000500020,la,o
71,S0120-41572006000500020,busqueda,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,alternativas,o
71,S0120-41572006000500020,terapeuticas,o
71,S0120-41572006000500020,Objetivo,o
71,S0120-41572006000500020,Evaluar,i
71,S0120-41572006000500020,la,i
71,S0120-41572006000500020,eficacia,i
71,S0120-41572006000500020,terapeutica,i
71,S0120-41572006000500020,y,i
71,S0120-41572006000500020,la,i
71,S0120-41572006000500020,tolerancia,i
71,S0120-41572006000500020,del,o
71,S0120-41572006000500020,isotianato,i
71,S0120-41572006000500020,de,i
71,S0120-41572006000500020,pentamidina,i
71,S0120-41572006000500020,con,o
71,S0120-41572006000500020,un,o
71,S0120-41572006000500020,ensayo,i
71,S0120-41572006000500020,clinico,i
71,S0120-41572006000500020,piloto,i
71,S0120-41572006000500020,con,o
71,S0120-41572006000500020,pacientes,o
71,S0120-41572006000500020,con,o
71,S0120-41572006000500020,leishmaniasis,i
71,S0120-41572006000500020,cutanea,i
71,S0120-41572006000500020,producida,o
71,S0120-41572006000500020,por,o
71,S0120-41572006000500020,L,o
71,S0120-41572006000500020,V,o
71,S0120-41572006000500020,panamensis,o
71,S0120-41572006000500020,en,o
71,S0120-41572006000500020,Colombia,o
71,S0120-41572006000500020,Materiales,o
71,S0120-41572006000500020,y,o
71,S0120-41572006000500020,metodos,o
71,S0120-41572006000500020,Se,o
71,S0120-41572006000500020,incluyeron,o
71,S0120-41572006000500020,en,o
71,S0120-41572006000500020,el,o
71,S0120-41572006000500020,estudio,o
71,S0120-41572006000500020,63,o
71,S0120-41572006000500020,pacientes,o
71,S0120-41572006000500020,los,o
71,S0120-41572006000500020,cuales,o
71,S0120-41572006000500020,fueron,o
71,S0120-41572006000500020,tratados,i
71,S0120-41572006000500020,por,i
71,S0120-41572006000500020,via,i
71,S0120-41572006000500020,intramuscular,i
71,S0120-41572006000500020,con,o
71,S0120-41572006000500020,4,o
71,S0120-41572006000500020,mg,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,isotianato,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,pentamidinakg,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,peso,o
71,S0120-41572006000500020,interdiario,o
71,S0120-41572006000500020,por,o
71,S0120-41572006000500020,cuatro,o
71,S0120-41572006000500020,dosis,o
71,S0120-41572006000500020,con,o
71,S0120-41572006000500020,seguimiento,i
71,S0120-41572006000500020,clinico,i
71,S0120-41572006000500020,por,o
71,S0120-41572006000500020,seis,o
71,S0120-41572006000500020,meses,o
71,S0120-41572006000500020,Resultados,o
71,S0120-41572006000500020,De,o
71,S0120-41572006000500020,los,o
71,S0120-41572006000500020,63,o
71,S0120-41572006000500020,paciente,o
71,S0120-41572006000500020,incluidos,o
71,S0120-41572006000500020,43,o
71,S0120-41572006000500020,fueron,o
71,S0120-41572006000500020,evaluados,o
71,S0120-41572006000500020,durante,o
71,S0120-41572006000500020,los,o
71,S0120-41572006000500020,seis,o
71,S0120-41572006000500020,meses,o
71,S0120-41572006000500020,del,o
71,S0120-41572006000500020,estudio,o
71,S0120-41572006000500020,y,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,estos,o
71,S0120-41572006000500020,37,o
71,S0120-41572006000500020,86,o
71,S0120-41572006000500020,presentaron,o
71,S0120-41572006000500020,curacion,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,todas,o
71,S0120-41572006000500020,sus,o
71,S0120-41572006000500020,lesiones,i
71,S0120-41572006000500020,mes,o
71,S0120-41572006000500020,y,o
71,S0120-41572006000500020,medio,o
71,S0120-41572006000500020,despues,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,terminar,o
71,S0120-41572006000500020,el,o
71,S0120-41572006000500020,tratamiento,i
71,S0120-41572006000500020,Cinco,o
71,S0120-41572006000500020,pacientes,o
71,S0120-41572006000500020,116,o
71,S0120-41572006000500020,fallaron,o
71,S0120-41572006000500020,al,o
71,S0120-41572006000500020,tratamiento,i
71,S0120-41572006000500020,por,o
71,S0120-41572006000500020,no,o
71,S0120-41572006000500020,cicatrizacion,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,las,o
71,S0120-41572006000500020,lesiones,i
71,S0120-41572006000500020,y,o
71,S0120-41572006000500020,uno,o
71,S0120-41572006000500020,presento,o
71,S0120-41572006000500020,recaida,o
71,S0120-41572006000500020,En,o
71,S0120-41572006000500020,general,o
71,S0120-41572006000500020,el,o
71,S0120-41572006000500020,tratamiento,i
71,S0120-41572006000500020,fue,o
71,S0120-41572006000500020,bien,o
71,S0120-41572006000500020,tolerado,o
71,S0120-41572006000500020,los,o
71,S0120-41572006000500020,efectos,i
71,S0120-41572006000500020,adversos,i
71,S0120-41572006000500020,principales,o
71,S0120-41572006000500020,fueron,o
71,S0120-41572006000500020,dolor,i
71,S0120-41572006000500020,y,o
71,S0120-41572006000500020,edema,i
71,S0120-41572006000500020,en,i
71,S0120-41572006000500020,el,i
71,S0120-41572006000500020,sitio,i
71,S0120-41572006000500020,de,i
71,S0120-41572006000500020,aplicacion,i
71,S0120-41572006000500020,mareo,i
71,S0120-41572006000500020,y,o
71,S0120-41572006000500020,fiebre,i
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,intensidad,o
71,S0120-41572006000500020,leve,o
71,S0120-41572006000500020,a,o
71,S0120-41572006000500020,moderada,o
71,S0120-41572006000500020,No,o
71,S0120-41572006000500020,se,o
71,S0120-41572006000500020,presentaron,o
71,S0120-41572006000500020,hipoglucemia,i
71,S0120-41572006000500020,hipotension,i
71,S0120-41572006000500020,ni,o
71,S0120-41572006000500020,diabetes,i
71,S0120-41572006000500020,Discusion,o
71,S0120-41572006000500020,Los,o
71,S0120-41572006000500020,resultados,o
71,S0120-41572006000500020,del,o
71,S0120-41572006000500020,presente,o
71,S0120-41572006000500020,estudio,o
71,S0120-41572006000500020,validan,o
71,S0120-41572006000500020,los,o
71,S0120-41572006000500020,hallazgos,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,eficacia,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,la,o
71,S0120-41572006000500020,pentamidina,i
71,S0120-41572006000500020,para,o
71,S0120-41572006000500020,el,o
71,S0120-41572006000500020,tratamiento,i
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,la,o
71,S0120-41572006000500020,leishmaniasis,i
71,S0120-41572006000500020,cutanea,i
71,S0120-41572006000500020,en,o
71,S0120-41572006000500020,Colombia,o
71,S0120-41572006000500020,y,o
71,S0120-41572006000500020,en,o
71,S0120-41572006000500020,Brasil,o
71,S0120-41572006000500020,Se,o
71,S0120-41572006000500020,destaca,o
71,S0120-41572006000500020,una,o
71,S0120-41572006000500020,baja,o
71,S0120-41572006000500020,frecuencia,o
71,S0120-41572006000500020,e,o
71,S0120-41572006000500020,intensidad,o
71,S0120-41572006000500020,de,o
71,S0120-41572006000500020,los,o
71,S0120-41572006000500020,efectos,i
71,S0120-41572006000500020,colaterales,i
71,S0120-41572006000500020,en,o
71,S0120-41572006000500020,la,o
71,S0120-41572006000500020,poblacion,o
71,S0120-41572006000500020,civil,o
71,S0120-41572006000500020,donde,o
71,S0120-41572006000500020,no,o
71,S0120-41572006000500020,se,o
71,S0120-41572006000500020,encontro,o
71,S0120-41572006000500020,ningun,o
71,S0120-41572006000500020,paciente,o
71,S0120-41572006000500020,con,o
71,S0120-41572006000500020,efectos,i
71,S0120-41572006000500020,secundarios,i
71,S0120-41572006000500020,serios,o
72,S0120-41572009000200015,Estudio,i
72,S0120-41572009000200015,piloto,i
72,S0120-41572009000200015,de,i
72,S0120-41572009000200015,la,i
72,S0120-41572009000200015,eficacia,i
72,S0120-41572009000200015,y,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,los,o
72,S0120-41572009000200015,efectos,o
72,S0120-41572009000200015,sobre,o
72,S0120-41572009000200015,los,o
72,S0120-41572009000200015,gametocitos,o
72,S0120-41572009000200015,del,o
72,S0120-41572009000200015,esquema,o
72,S0120-41572009000200015,artesunatomefloquinaprimaquina,o
72,S0120-41572009000200015,para,o
72,S0120-41572009000200015,la,o
72,S0120-41572009000200015,malaria,i
72,S0120-41572009000200015,por,i
72,S0120-41572009000200015,Plasmodium,i
72,S0120-41572009000200015,falciparum,i
72,S0120-41572009000200015,Introduccion,o
72,S0120-41572009000200015,El,o
72,S0120-41572009000200015,tratamiento,i
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,la,o
72,S0120-41572009000200015,malaria,i
72,S0120-41572009000200015,por,o
72,S0120-41572009000200015,P,o
72,S0120-41572009000200015,falciparum,o
72,S0120-41572009000200015,requiere,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,un,o
72,S0120-41572009000200015,esquema,o
72,S0120-41572009000200015,seguro,o
72,S0120-41572009000200015,eficaz,o
72,S0120-41572009000200015,y,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,impacto,o
72,S0120-41572009000200015,en,o
72,S0120-41572009000200015,la,o
72,S0120-41572009000200015,transmision,i
72,S0120-41572009000200015,En,o
72,S0120-41572009000200015,2006,o
72,S0120-41572009000200015,se,o
72,S0120-41572009000200015,implemento,o
72,S0120-41572009000200015,en,o
72,S0120-41572009000200015,Antioquia,o
72,S0120-41572009000200015,el,o
72,S0120-41572009000200015,esquema,o
72,S0120-41572009000200015,artesunatomefloquina,o
72,S0120-41572009000200015,y,o
72,S0120-41572009000200015,se,o
72,S0120-41572009000200015,adiciono,o
72,S0120-41572009000200015,primaquina,i
72,S0120-41572009000200015,para,o
72,S0120-41572009000200015,eliminar,o
72,S0120-41572009000200015,los,o
72,S0120-41572009000200015,gametocitos,o
72,S0120-41572009000200015,Objetivo,o
72,S0120-41572009000200015,Evaluar,i
72,S0120-41572009000200015,la,i
72,S0120-41572009000200015,eficacia,i
72,S0120-41572009000200015,y,o
72,S0120-41572009000200015,accion,o
72,S0120-41572009000200015,gametocida,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,los,o
72,S0120-41572009000200015,esquemas,o
72,S0120-41572009000200015,artesunatomefloquinaprimaquina,o
72,S0120-41572009000200015,y,o
72,S0120-41572009000200015,artesunatomefloquina,o
72,S0120-41572009000200015,en,o
72,S0120-41572009000200015,pacientes,o
72,S0120-41572009000200015,con,o
72,S0120-41572009000200015,malaria,i
72,S0120-41572009000200015,no,o
72,S0120-41572009000200015,complicada,o
72,S0120-41572009000200015,por,o
72,S0120-41572009000200015,P,o
72,S0120-41572009000200015,falciparum,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,Turbo,o
72,S0120-41572009000200015,Antioquia,o
72,S0120-41572009000200015,Materiales,o
72,S0120-41572009000200015,y,o
72,S0120-41572009000200015,metodos,o
72,S0120-41572009000200015,Ensayo,i
72,S0120-41572009000200015,clinico,i
72,S0120-41572009000200015,aleatorio,i
72,S0120-41572009000200015,los,o
72,S0120-41572009000200015,tratamientos,i
72,S0120-41572009000200015,se,o
72,S0120-41572009000200015,suministraron,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,forma,o
72,S0120-41572009000200015,supervisada,o
72,S0120-41572009000200015,y,o
72,S0120-41572009000200015,se,o
72,S0120-41572009000200015,realizo,o
72,S0120-41572009000200015,seguimiento,i
72,S0120-41572009000200015,clinicoparasitologico,o
72,S0120-41572009000200015,en,o
72,S0120-41572009000200015,los,o
72,S0120-41572009000200015,dias,o
72,S0120-41572009000200015,1,o
72,S0120-41572009000200015,2,o
72,S0120-41572009000200015,3,o
72,S0120-41572009000200015,7,o
72,S0120-41572009000200015,14,o
72,S0120-41572009000200015,21,o
72,S0120-41572009000200015,28,o
72,S0120-41572009000200015,35,o
72,S0120-41572009000200015,y,o
72,S0120-41572009000200015,42,o
72,S0120-41572009000200015,para,o
72,S0120-41572009000200015,evaluar,o
72,S0120-41572009000200015,la,o
72,S0120-41572009000200015,respuesta,o
72,S0120-41572009000200015,segun,o
72,S0120-41572009000200015,el,o
72,S0120-41572009000200015,protocolo,i
72,S0120-41572009000200015,OMS2003,o
72,S0120-41572009000200015,modificado,o
72,S0120-41572009000200015,Resultados,o
72,S0120-41572009000200015,Entre,o
72,S0120-41572009000200015,abril,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,2007,o
72,S0120-41572009000200015,y,o
72,S0120-41572009000200015,febrero,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,2008,o
72,S0120-41572009000200015,50,o
72,S0120-41572009000200015,pacientes,o
72,S0120-41572009000200015,fueron,o
72,S0120-41572009000200015,reclutados,o
72,S0120-41572009000200015,los,o
72,S0120-41572009000200015,resultados,o
72,S0120-41572009000200015,mostraron,o
72,S0120-41572009000200015,una,o
72,S0120-41572009000200015,eficacia,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,100,o
72,S0120-41572009000200015,IC95,o
72,S0120-41572009000200015,863100,o
72,S0120-41572009000200015,para,o
72,S0120-41572009000200015,el,o
72,S0120-41572009000200015,esquema,o
72,S0120-41572009000200015,artesunatomefloquina,o
72,S0120-41572009000200015,consin,o
72,S0120-41572009000200015,primaquina,i
72,S0120-41572009000200015,la,o
72,S0120-41572009000200015,parasitemia,i
72,S0120-41572009000200015,y,o
72,S0120-41572009000200015,la,o
72,S0120-41572009000200015,fiebre,i
72,S0120-41572009000200015,fueron,o
72,S0120-41572009000200015,eliminadas,o
72,S0120-41572009000200015,completamente,o
72,S0120-41572009000200015,al,o
72,S0120-41572009000200015,tercer,o
72,S0120-41572009000200015,dia,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,tratamiento,i
72,S0120-41572009000200015,en,o
72,S0120-41572009000200015,todos,o
72,S0120-41572009000200015,los,o
72,S0120-41572009000200015,pacientes,o
72,S0120-41572009000200015,La,o
72,S0120-41572009000200015,eliminacion,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,gametocitos,o
72,S0120-41572009000200015,fue,o
72,S0120-41572009000200015,mayor,o
72,S0120-41572009000200015,con,o
72,S0120-41572009000200015,el,o
72,S0120-41572009000200015,uso,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,primaquina,i
72,S0120-41572009000200015,al,o
72,S0120-41572009000200015,tercer,o
72,S0120-41572009000200015,dia,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,seguimiento,i
72,S0120-41572009000200015,el,o
72,S0120-41572009000200015,92,o
72,S0120-41572009000200015,IC95,o
72,S0120-41572009000200015,7499,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,los,o
72,S0120-41572009000200015,pacientes,o
72,S0120-41572009000200015,que,o
72,S0120-41572009000200015,recibieron,o
72,S0120-41572009000200015,primaquina,i
72,S0120-41572009000200015,no,o
72,S0120-41572009000200015,tuvieron,o
72,S0120-41572009000200015,gametocitos,o
72,S0120-41572009000200015,en,o
72,S0120-41572009000200015,comparacion,o
72,S0120-41572009000200015,con,o
72,S0120-41572009000200015,783,o
72,S0120-41572009000200015,IC95,o
72,S0120-41572009000200015,5993,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,pacientes,o
72,S0120-41572009000200015,del,o
72,S0120-41572009000200015,grupo,o
72,S0120-41572009000200015,artesunatomefloquina,o
72,S0120-41572009000200015,Ademas,o
72,S0120-41572009000200015,el,o
72,S0120-41572009000200015,esquema,o
72,S0120-41572009000200015,artesunatomefloquinaprimaquina,o
72,S0120-41572009000200015,elimino,o
72,S0120-41572009000200015,la,o
72,S0120-41572009000200015,gametocitemia,i
72,S0120-41572009000200015,una,o
72,S0120-41572009000200015,semana,o
72,S0120-41572009000200015,antes,o
72,S0120-41572009000200015,que,o
72,S0120-41572009000200015,el,o
72,S0120-41572009000200015,esquema,o
72,S0120-41572009000200015,sin,o
72,S0120-41572009000200015,primaquina,i
72,S0120-41572009000200015,Conclusion,o
72,S0120-41572009000200015,Se,o
72,S0120-41572009000200015,recomienda,o
72,S0120-41572009000200015,el,o
72,S0120-41572009000200015,uso,o
72,S0120-41572009000200015,del,o
72,S0120-41572009000200015,esquema,o
72,S0120-41572009000200015,artesunatomefloquina,o
72,S0120-41572009000200015,para,o
72,S0120-41572009000200015,la,o
72,S0120-41572009000200015,malaria,i
72,S0120-41572009000200015,por,o
72,S0120-41572009000200015,P,o
72,S0120-41572009000200015,falciparum,o
72,S0120-41572009000200015,por,o
72,S0120-41572009000200015,su,o
72,S0120-41572009000200015,alta,o
72,S0120-41572009000200015,eficacia,o
72,S0120-41572009000200015,y,o
72,S0120-41572009000200015,se,o
72,S0120-41572009000200015,sugieren,o
72,S0120-41572009000200015,futuras,o
72,S0120-41572009000200015,evaluaciones,i
72,S0120-41572009000200015,del,o
72,S0120-41572009000200015,beneficio,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,la,o
72,S0120-41572009000200015,PQ,i
72,S0120-41572009000200015,en,o
72,S0120-41572009000200015,la,o
72,S0120-41572009000200015,reduccion,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,la,o
72,S0120-41572009000200015,densidad,o
72,S0120-41572009000200015,y,o
72,S0120-41572009000200015,prevalencia,o
72,S0120-41572009000200015,de,o
72,S0120-41572009000200015,gametocitos,o
73,S0120-41572012000200011,Efecto,o
73,S0120-41572012000200011,del,o
73,S0120-41572012000200011,tratamiento,i
73,S0120-41572012000200011,periodontal,i
73,S0120-41572012000200011,sobre,o
73,S0120-41572012000200011,la,o
73,S0120-41572012000200011,microbiota,o
73,S0120-41572012000200011,subgingival,i
73,S0120-41572012000200011,en,o
73,S0120-41572012000200011,pacientes,o
73,S0120-41572012000200011,con,o
73,S0120-41572012000200011,preeclampsia,i
73,S0120-41572012000200011,Introduccion,o
73,S0120-41572012000200011,Pocos,o
73,S0120-41572012000200011,estudios,o
73,S0120-41572012000200011,han,o
73,S0120-41572012000200011,descrito,o
73,S0120-41572012000200011,la,o
73,S0120-41572012000200011,microbiota,o
73,S0120-41572012000200011,subgingival,i
73,S0120-41572012000200011,en,o
73,S0120-41572012000200011,mujeres,o
73,S0120-41572012000200011,embarazadas,o
73,S0120-41572012000200011,con,o
73,S0120-41572012000200011,preeclampsia,i
73,S0120-41572012000200011,leve,o
73,S0120-41572012000200011,Objetivo,o
73,S0120-41572012000200011,Identificar,o
73,S0120-41572012000200011,cambios,o
73,S0120-41572012000200011,periodontales,i
73,S0120-41572012000200011,y,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,la,o
73,S0120-41572012000200011,microbiota,o
73,S0120-41572012000200011,subgingival,i
73,S0120-41572012000200011,en,o
73,S0120-41572012000200011,mujeres,o
73,S0120-41572012000200011,embarazadas,o
73,S0120-41572012000200011,con,o
73,S0120-41572012000200011,preeclampsia,i
73,S0120-41572012000200011,despues,o
73,S0120-41572012000200011,del,o
73,S0120-41572012000200011,tratamiento,i
73,S0120-41572012000200011,periodontal,i
73,S0120-41572012000200011,Materiales,o
73,S0120-41572012000200011,y,o
73,S0120-41572012000200011,metodos,o
73,S0120-41572012000200011,En,o
73,S0120-41572012000200011,un,o
73,S0120-41572012000200011,analisis,o
73,S0120-41572012000200011,secundario,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,un,o
73,S0120-41572012000200011,ensayo,i
73,S0120-41572012000200011,clinico,i
73,S0120-41572012000200011,de,i
73,S0120-41572012000200011,asignacion,i
73,S0120-41572012000200011,aleatoria,i
73,S0120-41572012000200011,se,o
73,S0120-41572012000200011,estudiaron,o
73,S0120-41572012000200011,57,o
73,S0120-41572012000200011,pacientes,o
73,S0120-41572012000200011,con,o
73,S0120-41572012000200011,preeclampsia,i
73,S0120-41572012000200011,en,o
73,S0120-41572012000200011,el,o
73,S0120-41572012000200011,Hospital,o
73,S0120-41572012000200011,Universitario,o
73,S0120-41572012000200011,del,o
73,S0120-41572012000200011,Valle,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,Cali,o
73,S0120-41572012000200011,Se,o
73,S0120-41572012000200011,asignaron,i
73,S0120-41572012000200011,al,i
73,S0120-41572012000200011,azar,i
73,S0120-41572012000200011,31,o
73,S0120-41572012000200011,al,o
73,S0120-41572012000200011,grupo,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,intervencion,i
73,S0120-41572012000200011,periodontal,i
73,S0120-41572012000200011,detartraje,i
73,S0120-41572012000200011,y,o
73,S0120-41572012000200011,alisado,i
73,S0120-41572012000200011,subgingival,i
73,S0120-41572012000200011,ultrasonico,i
73,S0120-41572012000200011,y,i
73,S0120-41572012000200011,manual,i
73,S0120-41572012000200011,durante,o
73,S0120-41572012000200011,su,o
73,S0120-41572012000200011,embarazo,o
73,S0120-41572012000200011,y,o
73,S0120-41572012000200011,otras,o
73,S0120-41572012000200011,26,o
73,S0120-41572012000200011,al,o
73,S0120-41572012000200011,grupo,o
73,S0120-41572012000200011,control,o
73,S0120-41572012000200011,profilaxis,i
73,S0120-41572012000200011,supragingival,i
73,S0120-41572012000200011,Se,o
73,S0120-41572012000200011,determinaron,o
73,S0120-41572012000200011,los,o
73,S0120-41572012000200011,parametros,o
73,S0120-41572012000200011,clinicos,o
73,S0120-41572012000200011,periodontales,i
73,S0120-41572012000200011,y,o
73,S0120-41572012000200011,la,o
73,S0120-41572012000200011,microbiota,o
73,S0120-41572012000200011,subgingival,i
73,S0120-41572012000200011,a,o
73,S0120-41572012000200011,la,o
73,S0120-41572012000200011,inclusion,o
73,S0120-41572012000200011,al,o
73,S0120-41572012000200011,estudio,o
73,S0120-41572012000200011,y,o
73,S0120-41572012000200011,en,o
73,S0120-41572012000200011,el,o
73,S0120-41572012000200011,posparto,o
73,S0120-41572012000200011,Se,o
73,S0120-41572012000200011,evaluaron,o
73,S0120-41572012000200011,8,o
73,S0120-41572012000200011,bacterias,o
73,S0120-41572012000200011,periodontopaticas,o
73,S0120-41572012000200011,y,o
73,S0120-41572012000200011,2,o
73,S0120-41572012000200011,virus,o
73,S0120-41572012000200011,herpes,o
73,S0120-41572012000200011,por,o
73,S0120-41572012000200011,reaccion,i
73,S0120-41572012000200011,en,i
73,S0120-41572012000200011,cadena,i
73,S0120-41572012000200011,de,i
73,S0120-41572012000200011,la,i
73,S0120-41572012000200011,polimerasa,i
73,S0120-41572012000200011,Se,o
73,S0120-41572012000200011,usaron,o
73,S0120-41572012000200011,las,o
73,S0120-41572012000200011,pruebas,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,ji,o
73,S0120-41572012000200011,al,o
73,S0120-41572012000200011,cuadrado,o
73,S0120-41572012000200011,test,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,McNemar,o
73,S0120-41572012000200011,o,o
73,S0120-41572012000200011,t,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,Student,o
73,S0120-41572012000200011,con,o
73,S0120-41572012000200011,un,o
73,S0120-41572012000200011,nivel,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,significancia,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,p,o
73,S0120-41572012000200011,Resultados,o
73,S0120-41572012000200011,Los,o
73,S0120-41572012000200011,grupos,o
73,S0120-41572012000200011,fueron,o
73,S0120-41572012000200011,comparables,o
73,S0120-41572012000200011,en,o
73,S0120-41572012000200011,las,o
73,S0120-41572012000200011,variables,o
73,S0120-41572012000200011,clinicas,o
73,S0120-41572012000200011,y,o
73,S0120-41572012000200011,microbiologicas,o
73,S0120-41572012000200011,al,o
73,S0120-41572012000200011,inicio,o
73,S0120-41572012000200011,del,o
73,S0120-41572012000200011,estudio,o
73,S0120-41572012000200011,El,o
73,S0120-41572012000200011,tratamiento,i
73,S0120-41572012000200011,periodontal,i
73,S0120-41572012000200011,redujo,o
73,S0120-41572012000200011,el,o
73,S0120-41572012000200011,promedio,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,la,o
73,S0120-41572012000200011,profundidad,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,bolsa,i
73,S0120-41572012000200011,en,o
73,S0120-41572012000200011,el,o
73,S0120-41572012000200011,grupo,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,intervencion,i
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,244031,o
73,S0120-41572012000200011,a,o
73,S0120-41572012000200011,231024,o
73,S0120-41572012000200011,mm,o
73,S0120-41572012000200011,p0000,o
73,S0120-41572012000200011,y,o
73,S0120-41572012000200011,en,o
73,S0120-41572012000200011,el,o
73,S0120-41572012000200011,grupo,o
73,S0120-41572012000200011,control,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,258037,o
73,S0120-41572012000200011,a,o
73,S0120-41572012000200011,244039,o
73,S0120-41572012000200011,mm,o
73,S0120-41572012000200011,p0000y,o
73,S0120-41572012000200011,el,o
73,S0120-41572012000200011,indice,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,sangrado,i
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,16415,o
73,S0120-41572012000200011,a,o
73,S0120-41572012000200011,7907,o
73,S0120-41572012000200011,en,o
73,S0120-41572012000200011,el,o
73,S0120-41572012000200011,primero,o
73,S0120-41572012000200011,p0000,o
73,S0120-41572012000200011,y,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,17118,o
73,S0120-41572012000200011,a,o
73,S0120-41572012000200011,1009,o
73,S0120-41572012000200011,en,o
73,S0120-41572012000200011,el,o
73,S0120-41572012000200011,segundo,o
73,S0120-41572012000200011,p0002,o
73,S0120-41572012000200011,La,o
73,S0120-41572012000200011,frecuencia,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,deteccion,i
73,S0120-41572012000200011,de,i
73,S0120-41572012000200011,microorganismos,i
73,S0120-41572012000200011,no,o
73,S0120-41572012000200011,vario,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,manera,o
73,S0120-41572012000200011,significativa,o
73,S0120-41572012000200011,entre,o
73,S0120-41572012000200011,los,o
73,S0120-41572012000200011,grupos,o
73,S0120-41572012000200011,Conclusion,o
73,S0120-41572012000200011,El,o
73,S0120-41572012000200011,raspaje,i
73,S0120-41572012000200011,y,i
73,S0120-41572012000200011,alisado,i
73,S0120-41572012000200011,radicular,i
73,S0120-41572012000200011,asi,o
73,S0120-41572012000200011,como,o
73,S0120-41572012000200011,la,o
73,S0120-41572012000200011,profilaxis,i
73,S0120-41572012000200011,supragingival,i
73,S0120-41572012000200011,redujeron,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,manera,o
73,S0120-41572012000200011,significativa,o
73,S0120-41572012000200011,la,o
73,S0120-41572012000200011,profundidad,o
73,S0120-41572012000200011,a,o
73,S0120-41572012000200011,la,o
73,S0120-41572012000200011,sonda,o
73,S0120-41572012000200011,y,o
73,S0120-41572012000200011,el,o
73,S0120-41572012000200011,indice,o
73,S0120-41572012000200011,de,o
73,S0120-41572012000200011,sangrado,i
73,S0120-41572012000200011,gingival,i
73,S0120-41572012000200011,El,o
73,S0120-41572012000200011,tratamiento,i
73,S0120-41572012000200011,periodontal,i
73,S0120-41572012000200011,no,o
73,S0120-41572012000200011,fue,o
73,S0120-41572012000200011,mas,o
73,S0120-41572012000200011,efectivo,o
73,S0120-41572012000200011,que,o
73,S0120-41572012000200011,la,o
73,S0120-41572012000200011,profilaxis,i
73,S0120-41572012000200011,para,o
73,S0120-41572012000200011,reducir,o
73,S0120-41572012000200011,los,o
73,S0120-41572012000200011,organismos,o
73,S0120-41572012000200011,periodontopaticos,o
73,S0120-41572012000200011,o,o
73,S0120-41572012000200011,los,o
73,S0120-41572012000200011,virus,o
73,S0120-41572012000200011,herpes,o
74,S0120-99572013000200003,Estudio,i
74,S0120-99572013000200003,aleatorizado,i
74,S0120-99572013000200003,comparando,o
74,S0120-99572013000200003,una,o
74,S0120-99572013000200003,primera,o
74,S0120-99572013000200003,linea,o
74,S0120-99572013000200003,de,o
74,S0120-99572013000200003,terapia,i
74,S0120-99572013000200003,estandar,i
74,S0120-99572013000200003,contra,i
74,S0120-99572013000200003,Helicobacter,i
74,S0120-99572013000200003,pylori,i
74,S0120-99572013000200003,con,o
74,S0120-99572013000200003,claritromicina,i
74,S0120-99572013000200003,versus,o
74,S0120-99572013000200003,levofloxacina,i
74,S0120-99572013000200003,por,o
74,S0120-99572013000200003,10,o
74,S0120-99572013000200003,dias,o
74,S0120-99572013000200003,Antecedentes,o
74,S0120-99572013000200003,Hay,o
74,S0120-99572013000200003,una,o
74,S0120-99572013000200003,creciente,o
74,S0120-99572013000200003,evidencia,o
74,S0120-99572013000200003,de,o
74,S0120-99572013000200003,que,o
74,S0120-99572013000200003,la,o
74,S0120-99572013000200003,terapia,i
74,S0120-99572013000200003,triple,i
74,S0120-99572013000200003,estandar,i
74,S0120-99572013000200003,contra,o
74,S0120-99572013000200003,la,o
74,S0120-99572013000200003,infeccion,o
74,S0120-99572013000200003,por,o
74,S0120-99572013000200003,H,o
74,S0120-99572013000200003,pylori,o
74,S0120-99572013000200003,viene,o
74,S0120-99572013000200003,perdiendo,o
74,S0120-99572013000200003,efectividad,o
74,S0120-99572013000200003,clinica,o
74,S0120-99572013000200003,Una,o
74,S0120-99572013000200003,terapia,i
74,S0120-99572013000200003,triple,o
74,S0120-99572013000200003,con,o
74,S0120-99572013000200003,levofloxacina,i
74,S0120-99572013000200003,amoxicilina,i
74,S0120-99572013000200003,y,o
74,S0120-99572013000200003,un,o
74,S0120-99572013000200003,inhibidor,i
74,S0120-99572013000200003,de,i
74,S0120-99572013000200003,la,i
74,S0120-99572013000200003,bomba,i
74,S0120-99572013000200003,de,i
74,S0120-99572013000200003,protones,i
74,S0120-99572013000200003,es,o
74,S0120-99572013000200003,efectiva,o
74,S0120-99572013000200003,y,o
74,S0120-99572013000200003,bien,o
74,S0120-99572013000200003,tolerada,o
74,S0120-99572013000200003,e,o
74,S0120-99572013000200003,incluso,o
74,S0120-99572013000200003,este,o
74,S0120-99572013000200003,regimen,i
74,S0120-99572013000200003,se,o
74,S0120-99572013000200003,ha,o
74,S0120-99572013000200003,sugerido,o
74,S0120-99572013000200003,como,o
74,S0120-99572013000200003,una,o
74,S0120-99572013000200003,alternativa,o
74,S0120-99572013000200003,para,o
74,S0120-99572013000200003,la,o
74,S0120-99572013000200003,terapia,i
74,S0120-99572013000200003,de,i
74,S0120-99572013000200003,primera,i
74,S0120-99572013000200003,linea,i
74,S0120-99572013000200003,El,o
74,S0120-99572013000200003,proposito,o
74,S0120-99572013000200003,de,o
74,S0120-99572013000200003,este,o
74,S0120-99572013000200003,estudio,o
74,S0120-99572013000200003,aleatorizado,o
74,S0120-99572013000200003,multicentrico,o
74,S0120-99572013000200003,y,o
74,S0120-99572013000200003,controlado,o
74,S0120-99572013000200003,es,o
74,S0120-99572013000200003,comparar,o
74,S0120-99572013000200003,el,o
74,S0120-99572013000200003,exito,o
74,S0120-99572013000200003,en,o
74,S0120-99572013000200003,la,o
74,S0120-99572013000200003,erradicacion,i
74,S0120-99572013000200003,de,o
74,S0120-99572013000200003,dos,o
74,S0120-99572013000200003,lineas,o
74,S0120-99572013000200003,de,o
74,S0120-99572013000200003,terapia,i
74,S0120-99572013000200003,triples,o
74,S0120-99572013000200003,como,o
74,S0120-99572013000200003,son,o
74,S0120-99572013000200003,la,o
74,S0120-99572013000200003,claritromicina,i
74,S0120-99572013000200003,amoxicilina,i
74,S0120-99572013000200003,y,o
74,S0120-99572013000200003,omeprazol,i
74,S0120-99572013000200003,CAO,o
74,S0120-99572013000200003,versus,o
74,S0120-99572013000200003,levofloxacina,i
74,S0120-99572013000200003,amoxicilina,i
74,S0120-99572013000200003,y,o
74,S0120-99572013000200003,omeprazol,i
74,S0120-99572013000200003,LAO,o
74,S0120-99572013000200003,Materiales,o
74,S0120-99572013000200003,y,o
74,S0120-99572013000200003,metodos,o
74,S0120-99572013000200003,Un,o
74,S0120-99572013000200003,total,o
74,S0120-99572013000200003,de,o
74,S0120-99572013000200003,317,o
74,S0120-99572013000200003,pacientes,o
74,S0120-99572013000200003,con,o
74,S0120-99572013000200003,diagnostico,i
74,S0120-99572013000200003,por,i
74,S0120-99572013000200003,biopsia,i
74,S0120-99572013000200003,de,o
74,S0120-99572013000200003,infeccion,o
74,S0120-99572013000200003,por,o
74,S0120-99572013000200003,H,o
74,S0120-99572013000200003,pylori,o
74,S0120-99572013000200003,fueron,o
74,S0120-99572013000200003,aleatorizados,i
74,S0120-99572013000200003,a,o
74,S0120-99572013000200003,dos,o
74,S0120-99572013000200003,regimenes,i
74,S0120-99572013000200003,de,i
74,S0120-99572013000200003,terapia,i
74,S0120-99572013000200003,por,o
74,S0120-99572013000200003,10,o
74,S0120-99572013000200003,dias,o
74,S0120-99572013000200003,terapia,i
74,S0120-99572013000200003,estandar,i
74,S0120-99572013000200003,CAO,o
74,S0120-99572013000200003,n,o
74,S0120-99572013000200003,160,o
74,S0120-99572013000200003,o,o
74,S0120-99572013000200003,LAO,o
74,S0120-99572013000200003,n,o
74,S0120-99572013000200003,157,o
74,S0120-99572013000200003,La,o
74,S0120-99572013000200003,erradicacion,i
74,S0120-99572013000200003,fue,o
74,S0120-99572013000200003,evaluada,o
74,S0120-99572013000200003,por,o
74,S0120-99572013000200003,la,o
74,S0120-99572013000200003,prueba,i
74,S0120-99572013000200003,de,i
74,S0120-99572013000200003,aliento,i
74,S0120-99572013000200003,optimizada,o
74,S0120-99572013000200003,Los,o
74,S0120-99572013000200003,efectos,i
74,S0120-99572013000200003,adversos,i
74,S0120-99572013000200003,y,o
74,S0120-99572013000200003,la,o
74,S0120-99572013000200003,tolerancia,o
74,S0120-99572013000200003,tambien,o
74,S0120-99572013000200003,fueron,o
74,S0120-99572013000200003,evaluados,o
74,S0120-99572013000200003,Resultados,o
74,S0120-99572013000200003,El,o
74,S0120-99572013000200003,analisis,i
74,S0120-99572013000200003,por,i
74,S0120-99572013000200003,intencion,i
74,S0120-99572013000200003,de,i
74,S0120-99572013000200003,tratar,i
74,S0120-99572013000200003,fue,o
74,S0120-99572013000200003,CAO,o
74,S0120-99572013000200003,688,o
74,S0120-99572013000200003,110160,o
74,S0120-99572013000200003,y,o
74,S0120-99572013000200003,LAO,o
74,S0120-99572013000200003,841,o
74,S0120-99572013000200003,132157,o
74,S0120-99572013000200003,p,o
74,S0120-99572013000200003,00021,o
74,S0120-99572013000200003,Por,o
74,S0120-99572013000200003,protocolo,i
74,S0120-99572013000200003,las,o
74,S0120-99572013000200003,tasas,o
74,S0120-99572013000200003,de,o
74,S0120-99572013000200003,erradicacion,i
74,S0120-99572013000200003,fueron,o
74,S0120-99572013000200003,CAO,o
74,S0120-99572013000200003,719,o
74,S0120-99572013000200003,105146,o
74,S0120-99572013000200003,y,o
74,S0120-99572013000200003,LAO,o
74,S0120-99572013000200003,893,o
74,S0120-99572013000200003,125140,o
74,S0120-99572013000200003,P00004,o
74,S0120-99572013000200003,Hubo,o
74,S0120-99572013000200003,diferencias,o
74,S0120-99572013000200003,estadisticas,o
74,S0120-99572013000200003,en,o
74,S0120-99572013000200003,la,o
74,S0120-99572013000200003,efectividad,o
74,S0120-99572013000200003,entre,o
74,S0120-99572013000200003,los,o
74,S0120-99572013000200003,dos,o
74,S0120-99572013000200003,grupos,o
74,S0120-99572013000200003,de,o
74,S0120-99572013000200003,tratamiento,i
74,S0120-99572013000200003,Ademas,o
74,S0120-99572013000200003,no,o
74,S0120-99572013000200003,hubo,o
74,S0120-99572013000200003,diferencias,o
74,S0120-99572013000200003,en,o
74,S0120-99572013000200003,la,o
74,S0120-99572013000200003,tolerancia,o
74,S0120-99572013000200003,y,o
74,S0120-99572013000200003,los,o
74,S0120-99572013000200003,efectos,i
74,S0120-99572013000200003,adversos,i
74,S0120-99572013000200003,entre,o
74,S0120-99572013000200003,los,o
74,S0120-99572013000200003,dos,o
74,S0120-99572013000200003,grupos,o
74,S0120-99572013000200003,Conclusiones,o
74,S0120-99572013000200003,El,o
74,S0120-99572013000200003,tratamiento,i
74,S0120-99572013000200003,con,o
74,S0120-99572013000200003,una,o
74,S0120-99572013000200003,terapia,i
74,S0120-99572013000200003,estandar,i
74,S0120-99572013000200003,con,o
74,S0120-99572013000200003,base,o
74,S0120-99572013000200003,en,o
74,S0120-99572013000200003,levofloxacina,i
74,S0120-99572013000200003,para,o
74,S0120-99572013000200003,la,o
74,S0120-99572013000200003,infeccion,o
74,S0120-99572013000200003,por,o
74,S0120-99572013000200003,H,o
74,S0120-99572013000200003,pylori,o
74,S0120-99572013000200003,es,o
74,S0120-99572013000200003,una,o
74,S0120-99572013000200003,mejor,o
74,S0120-99572013000200003,alternativa,o
74,S0120-99572013000200003,para,o
74,S0120-99572013000200003,la,o
74,S0120-99572013000200003,erradicacion,i
74,S0120-99572013000200003,del,o
74,S0120-99572013000200003,H,o
74,S0120-99572013000200003,pylori,o
74,S0120-99572013000200003,sobre,o
74,S0120-99572013000200003,la,o
74,S0120-99572013000200003,triple,o
74,S0120-99572013000200003,terapia,i
74,S0120-99572013000200003,basada,o
74,S0120-99572013000200003,en,o
74,S0120-99572013000200003,claritromicina,i
74,S0120-99572013000200003,en,o
74,S0120-99572013000200003,el,o
74,S0120-99572013000200003,presente,o
74,S0120-99572013000200003,estudio,o
75,S0123-93922018000400199,Eficacia,o
75,S0123-93922018000400199,terapeutica,o
75,S0123-93922018000400199,seguridad,o
75,S0123-93922018000400199,y,o
75,S0123-93922018000400199,niveles,o
75,S0123-93922018000400199,plasmaticos,i
75,S0123-93922018000400199,del,o
75,S0123-93922018000400199,ArtemeterLumefantrine,o
75,S0123-93922018000400199,en,o
75,S0123-93922018000400199,pacientes,o
75,S0123-93922018000400199,con,o
75,S0123-93922018000400199,malaria,i
75,S0123-93922018000400199,falciparum,i
75,S0123-93922018000400199,no,o
75,S0123-93922018000400199,complicada,o
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,la,o
75,S0123-93922018000400199,region,o
75,S0123-93922018000400199,del,o
75,S0123-93922018000400199,Pacifico,o
75,S0123-93922018000400199,Colombiano,o
75,S0123-93922018000400199,Introduccion,o
75,S0123-93922018000400199,Son,o
75,S0123-93922018000400199,escasos,o
75,S0123-93922018000400199,los,o
75,S0123-93922018000400199,estudios,o
75,S0123-93922018000400199,en,o
75,S0123-93922018000400199,Colombia,o
75,S0123-93922018000400199,sobre,o
75,S0123-93922018000400199,eficacia,o
75,S0123-93922018000400199,del,o
75,S0123-93922018000400199,tratamiento,i
75,S0123-93922018000400199,para,o
75,S0123-93922018000400199,Plasmodium,o
75,S0123-93922018000400199,falciparum,o
75,S0123-93922018000400199,con,o
75,S0123-93922018000400199,la,o
75,S0123-93922018000400199,combinacion,o
75,S0123-93922018000400199,ArtemeterLumefantrina,o
75,S0123-93922018000400199,El,o
75,S0123-93922018000400199,objetivo,o
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,este,o
75,S0123-93922018000400199,estudio,o
75,S0123-93922018000400199,fue,o
75,S0123-93922018000400199,evaluar,i
75,S0123-93922018000400199,la,i
75,S0123-93922018000400199,eficacia,i
75,S0123-93922018000400199,terapeutica,i
75,S0123-93922018000400199,y,i
75,S0123-93922018000400199,el,i
75,S0123-93922018000400199,perfil,i
75,S0123-93922018000400199,de,i
75,S0123-93922018000400199,seguridad,i
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,este,o
75,S0123-93922018000400199,tratamiento,i
75,S0123-93922018000400199,combinado,i
75,S0123-93922018000400199,Metodos,o
75,S0123-93922018000400199,Se,o
75,S0123-93922018000400199,realizo,o
75,S0123-93922018000400199,un,o
75,S0123-93922018000400199,ensayo,i
75,S0123-93922018000400199,clinico,i
75,S0123-93922018000400199,en,o
75,S0123-93922018000400199,adultos,o
75,S0123-93922018000400199,con,o
75,S0123-93922018000400199,malaria,o
75,S0123-93922018000400199,por,o
75,S0123-93922018000400199,P,o
75,S0123-93922018000400199,falciparum,o
75,S0123-93922018000400199,no,o
75,S0123-93922018000400199,complicada,o
75,S0123-93922018000400199,utilizando,o
75,S0123-93922018000400199,el,o
75,S0123-93922018000400199,esquema,o
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,28,o
75,S0123-93922018000400199,dias,o
75,S0123-93922018000400199,recomendado,o
75,S0123-93922018000400199,por,o
75,S0123-93922018000400199,la,o
75,S0123-93922018000400199,Organizacion,o
75,S0123-93922018000400199,Mundial,o
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,la,o
75,S0123-93922018000400199,Salud,o
75,S0123-93922018000400199,OMS,o
75,S0123-93922018000400199,Los,o
75,S0123-93922018000400199,pacientes,o
75,S0123-93922018000400199,recibieron,o
75,S0123-93922018000400199,el,o
75,S0123-93922018000400199,tratamiento,i
75,S0123-93922018000400199,supervisado,o
75,S0123-93922018000400199,y,o
75,S0123-93922018000400199,el,o
75,S0123-93922018000400199,desenlace,o
75,S0123-93922018000400199,primario,o
75,S0123-93922018000400199,evaluado,o
75,S0123-93922018000400199,fue,o
75,S0123-93922018000400199,la,o
75,S0123-93922018000400199,respuesta,o
75,S0123-93922018000400199,clinica,o
75,S0123-93922018000400199,y,o
75,S0123-93922018000400199,parasitologica,o
75,S0123-93922018000400199,La,o
75,S0123-93922018000400199,seguridad,o
75,S0123-93922018000400199,fue,o
75,S0123-93922018000400199,evaluada,o
75,S0123-93922018000400199,a,o
75,S0123-93922018000400199,traves,o
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,vigilancia,i
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,efectos,i
75,S0123-93922018000400199,adversos,i
75,S0123-93922018000400199,y,o
75,S0123-93922018000400199,medicion,o
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,niveles,i
75,S0123-93922018000400199,plasmaticos,i
75,S0123-93922018000400199,del,i
75,S0123-93922018000400199,medicamento,i
75,S0123-93922018000400199,Resultados,o
75,S0123-93922018000400199,Se,o
75,S0123-93922018000400199,incluyeron,o
75,S0123-93922018000400199,88,o
75,S0123-93922018000400199,pacientes,o
75,S0123-93922018000400199,La,o
75,S0123-93922018000400199,tasa,o
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,curacion,o
75,S0123-93922018000400199,clinica,o
75,S0123-93922018000400199,y,o
75,S0123-93922018000400199,parasitologica,o
75,S0123-93922018000400199,fue,o
75,S0123-93922018000400199,del,o
75,S0123-93922018000400199,100,o
75,S0123-93922018000400199,en,o
75,S0123-93922018000400199,84,o
75,S0123-93922018000400199,pacientes,o
75,S0123-93922018000400199,que,o
75,S0123-93922018000400199,tuvieron,o
75,S0123-93922018000400199,examen,i
75,S0123-93922018000400199,de,i
75,S0123-93922018000400199,gota,i
75,S0123-93922018000400199,gruesa,i
75,S0123-93922018000400199,al,o
75,S0123-93922018000400199,dia,o
75,S0123-93922018000400199,28,o
75,S0123-93922018000400199,Hubo,o
75,S0123-93922018000400199,cuatro,o
75,S0123-93922018000400199,5,o
75,S0123-93922018000400199,fallas,o
75,S0123-93922018000400199,parasitologicas,o
75,S0123-93922018000400199,detectada,o
75,S0123-93922018000400199,por,o
75,S0123-93922018000400199,reaccion,i
75,S0123-93922018000400199,en,i
75,S0123-93922018000400199,cadena,i
75,S0123-93922018000400199,de,i
75,S0123-93922018000400199,polimerasa,i
75,S0123-93922018000400199,Discusion,o
75,S0123-93922018000400199,La,o
75,S0123-93922018000400199,eficacia,o
75,S0123-93922018000400199,terapeutica,o
75,S0123-93922018000400199,fue,o
75,S0123-93922018000400199,similar,o
75,S0123-93922018000400199,a,o
75,S0123-93922018000400199,la,o
75,S0123-93922018000400199,reportada,o
75,S0123-93922018000400199,en,o
75,S0123-93922018000400199,estudios,o
75,S0123-93922018000400199,previos,o
75,S0123-93922018000400199,con,o
75,S0123-93922018000400199,un,o
75,S0123-93922018000400199,ligero,o
75,S0123-93922018000400199,aumento,o
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,falla,o
75,S0123-93922018000400199,terapeutica,o
75,S0123-93922018000400199,Los,o
75,S0123-93922018000400199,niveles,o
75,S0123-93922018000400199,plasmaticos,i
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,los,o
75,S0123-93922018000400199,antimalaricos,i
75,S0123-93922018000400199,fueron,o
75,S0123-93922018000400199,adecuados,o
75,S0123-93922018000400199,y,o
75,S0123-93922018000400199,no,o
75,S0123-93922018000400199,relacionados,o
75,S0123-93922018000400199,con,o
75,S0123-93922018000400199,la,o
75,S0123-93922018000400199,falla,o
75,S0123-93922018000400199,terapeutica,o
75,S0123-93922018000400199,Conclusion,o
75,S0123-93922018000400199,El,o
75,S0123-93922018000400199,tratamiento,i
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,malaria,o
75,S0123-93922018000400199,por,o
75,S0123-93922018000400199,P,o
75,S0123-93922018000400199,falciparum,o
75,S0123-93922018000400199,no,o
75,S0123-93922018000400199,complicada,o
75,S0123-93922018000400199,con,o
75,S0123-93922018000400199,ArtemeterLumefantrina,o
75,S0123-93922018000400199,fue,o
75,S0123-93922018000400199,efectiva,o
75,S0123-93922018000400199,y,o
75,S0123-93922018000400199,segura,o
75,S0123-93922018000400199,en,o
75,S0123-93922018000400199,la,o
75,S0123-93922018000400199,poblacion,o
75,S0123-93922018000400199,estudiada,o
75,S0123-93922018000400199,Todos,o
75,S0123-93922018000400199,los,o
75,S0123-93922018000400199,pacientes,o
75,S0123-93922018000400199,alcanzaron,o
75,S0123-93922018000400199,niveles,o
75,S0123-93922018000400199,en,o
75,S0123-93922018000400199,plasma,i
75,S0123-93922018000400199,adecuados,o
75,S0123-93922018000400199,y,o
75,S0123-93922018000400199,no,o
75,S0123-93922018000400199,se,o
75,S0123-93922018000400199,encontro,o
75,S0123-93922018000400199,asociacion,o
75,S0123-93922018000400199,de,o
75,S0123-93922018000400199,falla,o
75,S0123-93922018000400199,terapeutica,o
75,S0123-93922018000400199,con,o
75,S0123-93922018000400199,bajos,o
75,S0123-93922018000400199,niveles,o
75,S0123-93922018000400199,en,o
75,S0123-93922018000400199,sangre,i
76,S0124-00642010000300010,Comparacion,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,dos,o
76,S0124-00642010000300010,metodos,i
76,S0124-00642010000300010,diagnosticos,i
76,S0124-00642010000300010,en,o
76,S0124-00642010000300010,tumores,i
76,S0124-00642010000300010,mamarios,i
76,S0124-00642010000300010,en,o
76,S0124-00642010000300010,un,o
76,S0124-00642010000300010,Centro,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,Cancerologia,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,Colima,o
76,S0124-00642010000300010,Mexico,o
76,S0124-00642010000300010,Objetivo,o
76,S0124-00642010000300010,Determinar,o
76,S0124-00642010000300010,la,o
76,S0124-00642010000300010,relacion,o
76,S0124-00642010000300010,entre,o
76,S0124-00642010000300010,los,o
76,S0124-00642010000300010,hallazgos,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,tumores,i
76,S0124-00642010000300010,mediante,o
76,S0124-00642010000300010,mamografia,i
76,S0124-00642010000300010,y,o
76,S0124-00642010000300010,el,o
76,S0124-00642010000300010,diagnostico,i
76,S0124-00642010000300010,histopatologico,i
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,los,o
76,S0124-00642010000300010,mismos,o
76,S0124-00642010000300010,Metodos,o
76,S0124-00642010000300010,Se,o
76,S0124-00642010000300010,realizo,o
76,S0124-00642010000300010,un,o
76,S0124-00642010000300010,estudio,i
76,S0124-00642010000300010,transversal,i
76,S0124-00642010000300010,descriptivo,i
76,S0124-00642010000300010,Participaron,o
76,S0124-00642010000300010,pacientes,o
76,S0124-00642010000300010,del,o
76,S0124-00642010000300010,Centro,o
76,S0124-00642010000300010,Estatal,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,Cancerologia,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,la,o
76,S0124-00642010000300010,ciudad,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,Colima,o
76,S0124-00642010000300010,Mexico,o
76,S0124-00642010000300010,Los,o
76,S0124-00642010000300010,criterios,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,inclusion,o
76,S0124-00642010000300010,fueron,o
76,S0124-00642010000300010,mujeres,o
76,S0124-00642010000300010,con,o
76,S0124-00642010000300010,mamografia,i
76,S0124-00642010000300010,y,o
76,S0124-00642010000300010,calificacion,o
76,S0124-00642010000300010,BIRADS,i
76,S0124-00642010000300010,mujeres,o
76,S0124-00642010000300010,con,o
76,S0124-00642010000300010,biopsia,i
76,S0124-00642010000300010,y,o
76,S0124-00642010000300010,diagnostico,i
76,S0124-00642010000300010,histopatologico,i
76,S0124-00642010000300010,mujeres,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,todas,o
76,S0124-00642010000300010,las,o
76,S0124-00642010000300010,edades,o
76,S0124-00642010000300010,todos,o
76,S0124-00642010000300010,los,o
76,S0124-00642010000300010,estadios,o
76,S0124-00642010000300010,clinicos,o
76,S0124-00642010000300010,y,o
76,S0124-00642010000300010,con,o
76,S0124-00642010000300010,expediente,o
76,S0124-00642010000300010,clinico,o
76,S0124-00642010000300010,completo,o
76,S0124-00642010000300010,Para,o
76,S0124-00642010000300010,la,o
76,S0124-00642010000300010,estadistica,o
76,S0124-00642010000300010,descriptiva,o
76,S0124-00642010000300010,se,o
76,S0124-00642010000300010,utilizaron,o
76,S0124-00642010000300010,las,o
76,S0124-00642010000300010,frecuencias,o
76,S0124-00642010000300010,porcentajes,o
76,S0124-00642010000300010,promedios,o
76,S0124-00642010000300010,y,o
76,S0124-00642010000300010,desviacion,o
76,S0124-00642010000300010,estandar,o
76,S0124-00642010000300010,Para,o
76,S0124-00642010000300010,la,o
76,S0124-00642010000300010,estadistica,o
76,S0124-00642010000300010,inferencial,o
76,S0124-00642010000300010,se,o
76,S0124-00642010000300010,utilizaron,o
76,S0124-00642010000300010,las,o
76,S0124-00642010000300010,pruebas,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,t,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,Student,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,chi,o
76,S0124-00642010000300010,cuadrada,o
76,S0124-00642010000300010,y,o
76,S0124-00642010000300010,el,o
76,S0124-00642010000300010,calculo,o
76,S0124-00642010000300010,del,o
76,S0124-00642010000300010,OR,o
76,S0124-00642010000300010,e,o
76,S0124-00642010000300010,IC,o
76,S0124-00642010000300010,95,o
76,S0124-00642010000300010,Las,o
76,S0124-00642010000300010,diferencias,o
76,S0124-00642010000300010,se,o
76,S0124-00642010000300010,consideran,o
76,S0124-00642010000300010,significativas,o
76,S0124-00642010000300010,cuando,o
76,S0124-00642010000300010,p005,o
76,S0124-00642010000300010,Resultados,o
76,S0124-00642010000300010,Al,o
76,S0124-00642010000300010,relacionar,o
76,S0124-00642010000300010,las,o
76,S0124-00642010000300010,categorias,o
76,S0124-00642010000300010,del,o
76,S0124-00642010000300010,BIRADS,i
76,S0124-00642010000300010,dependiendo,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,la,o
76,S0124-00642010000300010,probabilidad,o
76,S0124-00642010000300010,de,o
76,S0124-00642010000300010,benignidad,o
76,S0124-00642010000300010,BIRADS,i
76,S0124-00642010000300010,IIIIII,o
76,S0124-00642010000300010,o,o
76,S0124-00642010000300010,malignidad,i
76,S0124-00642010000300010,BIRADS,i
76,S0124-00642010000300010,IVV,o
76,S0124-00642010000300010,con,o
76,S0124-00642010000300010,los,o
76,S0124-00642010000300010,resultados,o
76,S0124-00642010000300010,histopatologicos,o
76,S0124-00642010000300010,benigno,o
76,S0124-00642010000300010,o,o
76,S0124-00642010000300010,maligno,o
76,S0124-00642010000300010,no,o
76,S0124-00642010000300010,se,o
76,S0124-00642010000300010,encontro,o
76,S0124-00642010000300010,relacion,o
76,S0124-00642010000300010,p00666,o
76,S0124-00642010000300010,En,o
76,S0124-00642010000300010,un,o
76,S0124-00642010000300010,analisis,o
76,S0124-00642010000300010,individual,o
76,S0124-00642010000300010,por,o
76,S0124-00642010000300010,categoria,o
76,S0124-00642010000300010,las,o
76,S0124-00642010000300010,relaciones,o
76,S0124-00642010000300010,significativas,o
76,S0124-00642010000300010,fueron,o
76,S0124-00642010000300010,categoria,o
76,S0124-00642010000300010,IV,o
76,S0124-00642010000300010,OR0024,o
76,S0124-00642010000300010,IC0005011,o
76,S0124-00642010000300010,p00007,o
76,S0124-00642010000300010,y,o
76,S0124-00642010000300010,categoria,o
76,S0124-00642010000300010,V,o
76,S0124-00642010000300010,OR405,o
76,S0124-00642010000300010,IC9031813,o
76,S0124-00642010000300010,p00002,o
76,S0124-00642010000300010,Conclusiones,o
76,S0124-00642010000300010,La,o
76,S0124-00642010000300010,clasificacion,o
76,S0124-00642010000300010,BIRADS,i
76,S0124-00642010000300010,I,o
76,S0124-00642010000300010,III,o
76,S0124-00642010000300010,y,o
76,S0124-00642010000300010,V,o
76,S0124-00642010000300010,tuvo,o
76,S0124-00642010000300010,relacion,o
76,S0124-00642010000300010,con,o
76,S0124-00642010000300010,el,o
76,S0124-00642010000300010,diagnostico,i
76,S0124-00642010000300010,histopatologico,i
76,S0124-00642010000300010,mientras,o
76,S0124-00642010000300010,que,o
76,S0124-00642010000300010,en,o
76,S0124-00642010000300010,el,o
76,S0124-00642010000300010,II,o
76,S0124-00642010000300010,y,o
76,S0124-00642010000300010,IV,o
76,S0124-00642010000300010,no,o
76,S0124-00642010000300010,hubo,o
76,S0124-00642010000300010,esta,o
76,S0124-00642010000300010,relacion,o
76,S0124-00642010000300010,Sin,o
76,S0124-00642010000300010,embargo,o
76,S0124-00642010000300010,los,o
76,S0124-00642010000300010,unicos,o
76,S0124-00642010000300010,resultados,o
76,S0124-00642010000300010,estadisticamente,o
76,S0124-00642010000300010,significativos,o
76,S0124-00642010000300010,se,o
76,S0124-00642010000300010,obtuvieron,o
76,S0124-00642010000300010,en,o
76,S0124-00642010000300010,las,o
76,S0124-00642010000300010,categorias,o
76,S0124-00642010000300010,IV,o
76,S0124-00642010000300010,y,o
76,S0124-00642010000300010,V,o
77,S0124-0064_PMID23250319,Curso,o
77,S0124-0064_PMID23250319,clinico,o
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,pronostico,o
77,S0124-0064_PMID23250319,a,o
77,S0124-0064_PMID23250319,un,o
77,S0124-0064_PMID23250319,año,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,una,o
77,S0124-0064_PMID23250319,cohorte,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,prematuros,i
77,S0124-0064_PMID23250319,dados,i
77,S0124-0064_PMID23250319,de,i
77,S0124-0064_PMID23250319,alta,i
77,S0124-0064_PMID23250319,con,o
77,S0124-0064_PMID23250319,oxigeno,i
77,S0124-0064_PMID23250319,domiciliario,i
77,S0124-0064_PMID23250319,en,o
77,S0124-0064_PMID23250319,Bogota,o
77,S0124-0064_PMID23250319,Colombia,o
77,S0124-0064_PMID23250319,Objetivo,o
77,S0124-0064_PMID23250319,Documentar,o
77,S0124-0064_PMID23250319,el,o
77,S0124-0064_PMID23250319,curso,o
77,S0124-0064_PMID23250319,clinico,o
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,pronostico,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,una,o
77,S0124-0064_PMID23250319,cohorte,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,niños,i
77,S0124-0064_PMID23250319,prematuros,i
77,S0124-0064_PMID23250319,dados,i
77,S0124-0064_PMID23250319,de,i
77,S0124-0064_PMID23250319,alta,i
77,S0124-0064_PMID23250319,con,o
77,S0124-0064_PMID23250319,oxigeno,i
77,S0124-0064_PMID23250319,domiciliario,i
77,S0124-0064_PMID23250319,en,o
77,S0124-0064_PMID23250319,Bogota,o
77,S0124-0064_PMID23250319,Colombia,o
77,S0124-0064_PMID23250319,Metodo,o
77,S0124-0064_PMID23250319,Cohorte,o
77,S0124-0064_PMID23250319,prospectiva,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,194,o
77,S0124-0064_PMID23250319,prematuros,i
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,34,o
77,S0124-0064_PMID23250319,o,o
77,S0124-0064_PMID23250319,menos,o
77,S0124-0064_PMID23250319,semanas,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,edad,o
77,S0124-0064_PMID23250319,gestacional,o
77,S0124-0064_PMID23250319,EG,o
77,S0124-0064_PMID23250319,al,o
77,S0124-0064_PMID23250319,nacer,o
77,S0124-0064_PMID23250319,egresados,i
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,12,o
77,S0124-0064_PMID23250319,unidades,o
77,S0124-0064_PMID23250319,neonatales,o
77,S0124-0064_PMID23250319,con,o
77,S0124-0064_PMID23250319,oxigeno,i
77,S0124-0064_PMID23250319,suplementario,i
77,S0124-0064_PMID23250319,seguidos,o
77,S0124-0064_PMID23250319,hasta,o
77,S0124-0064_PMID23250319,la,o
77,S0124-0064_PMID23250319,edad,o
77,S0124-0064_PMID23250319,corregida,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,12,o
77,S0124-0064_PMID23250319,meses,o
77,S0124-0064_PMID23250319,para,o
77,S0124-0064_PMID23250319,determinar,i
77,S0124-0064_PMID23250319,supervivencia,i
77,S0124-0064_PMID23250319,crecimiento,o
77,S0124-0064_PMID23250319,desarrollo,o
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,morbilidad,o
77,S0124-0064_PMID23250319,Resultados,o
77,S0124-0064_PMID23250319,49,o
77,S0124-0064_PMID23250319,niños,o
77,S0124-0064_PMID23250319,253,o
77,S0124-0064_PMID23250319,tenian,o
77,S0124-0064_PMID23250319,una,o
77,S0124-0064_PMID23250319,oxigenodependencia,i
77,S0124-0064_PMID23250319,leve,o
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,145,o
77,S0124-0064_PMID23250319,747,o
77,S0124-0064_PMID23250319,moderadasevera,o
77,S0124-0064_PMID23250319,Se,o
77,S0124-0064_PMID23250319,presentaron,o
77,S0124-0064_PMID23250319,3,o
77,S0124-0064_PMID23250319,muertes,i
77,S0124-0064_PMID23250319,15,o
77,S0124-0064_PMID23250319,el,o
77,S0124-0064_PMID23250319,estado,o
77,S0124-0064_PMID23250319,vital,o
77,S0124-0064_PMID23250319,a,o
77,S0124-0064_PMID23250319,40,o
77,S0124-0064_PMID23250319,semanas,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,EG,o
77,S0124-0064_PMID23250319,fue,o
77,S0124-0064_PMID23250319,conocido,o
77,S0124-0064_PMID23250319,en,o
77,S0124-0064_PMID23250319,169,o
77,S0124-0064_PMID23250319,pacientes,o
77,S0124-0064_PMID23250319,871,o
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,en,o
77,S0124-0064_PMID23250319,103,o
77,S0124-0064_PMID23250319,53,o
77,S0124-0064_PMID23250319,a,o
77,S0124-0064_PMID23250319,12,o
77,S0124-0064_PMID23250319,meses,o
77,S0124-0064_PMID23250319,La,o
77,S0124-0064_PMID23250319,lactancia,o
77,S0124-0064_PMID23250319,materna,o
77,S0124-0064_PMID23250319,fue,o
77,S0124-0064_PMID23250319,exitosa,o
77,S0124-0064_PMID23250319,en,o
77,S0124-0064_PMID23250319,147,o
77,S0124-0064_PMID23250319,758,o
77,S0124-0064_PMID23250319,niños,o
77,S0124-0064_PMID23250319,a,o
77,S0124-0064_PMID23250319,40,o
77,S0124-0064_PMID23250319,semanas,o
77,S0124-0064_PMID23250319,La,o
77,S0124-0064_PMID23250319,antropometria,i
77,S0124-0064_PMID23250319,al,o
77,S0124-0064_PMID23250319,año,o
77,S0124-0064_PMID23250319,fue,o
77,S0124-0064_PMID23250319,peso,o
77,S0124-0064_PMID23250319,8,o
77,S0124-0064_PMID23250319,991,o
77,S0124-0064_PMID23250319,g,o
77,S0124-0064_PMID23250319,talla,o
77,S0124-0064_PMID23250319,73,o
77,S0124-0064_PMID23250319,cm,o
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,perimetro,o
77,S0124-0064_PMID23250319,craneano,i
77,S0124-0064_PMID23250319,462,o
77,S0124-0064_PMID23250319,cm,o
77,S0124-0064_PMID23250319,A,o
77,S0124-0064_PMID23250319,las,o
77,S0124-0064_PMID23250319,40,o
77,S0124-0064_PMID23250319,semanas,o
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,a,o
77,S0124-0064_PMID23250319,3,o
77,S0124-0064_PMID23250319,meses,o
77,S0124-0064_PMID23250319,741,o
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,227,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,la,o
77,S0124-0064_PMID23250319,cohorte,o
77,S0124-0064_PMID23250319,aun,o
77,S0124-0064_PMID23250319,utilizaba,o
77,S0124-0064_PMID23250319,oxigeno,i
77,S0124-0064_PMID23250319,el,o
77,S0124-0064_PMID23250319,cual,o
77,S0124-0064_PMID23250319,fue,o
77,S0124-0064_PMID23250319,descontinuado,o
77,S0124-0064_PMID23250319,en,o
77,S0124-0064_PMID23250319,promedio,o
77,S0124-0064_PMID23250319,a,o
77,S0124-0064_PMID23250319,los109,o
77,S0124-0064_PMID23250319,dias,o
77,S0124-0064_PMID23250319,postnatales,o
77,S0124-0064_PMID23250319,El,o
77,S0124-0064_PMID23250319,568,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,los,o
77,S0124-0064_PMID23250319,niños,o
77,S0124-0064_PMID23250319,tuvo,o
77,S0124-0064_PMID23250319,al,o
77,S0124-0064_PMID23250319,menos,o
77,S0124-0064_PMID23250319,un,o
77,S0124-0064_PMID23250319,reingreso,i
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,47,o
77,S0124-0064_PMID23250319,por,o
77,S0124-0064_PMID23250319,patologias,i
77,S0124-0064_PMID23250319,respiratorias,i
77,S0124-0064_PMID23250319,Solo,o
77,S0124-0064_PMID23250319,se,o
77,S0124-0064_PMID23250319,tamizo,o
77,S0124-0064_PMID23250319,para,o
77,S0124-0064_PMID23250319,retinopatia,i
77,S0124-0064_PMID23250319,al,o
77,S0124-0064_PMID23250319,71,o
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,en,o
77,S0124-0064_PMID23250319,ellos,o
77,S0124-0064_PMID23250319,la,o
77,S0124-0064_PMID23250319,incidencia,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,retinopatia,i
77,S0124-0064_PMID23250319,de,i
77,S0124-0064_PMID23250319,la,i
77,S0124-0064_PMID23250319,prematurez,i
77,S0124-0064_PMID23250319,ROP,i
77,S0124-0064_PMID23250319,fue,o
77,S0124-0064_PMID23250319,38,o
77,S0124-0064_PMID23250319,con,o
77,S0124-0064_PMID23250319,3,o
77,S0124-0064_PMID23250319,cirugias,i
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,1,o
77,S0124-0064_PMID23250319,niño,o
77,S0124-0064_PMID23250319,ciego,i
77,S0124-0064_PMID23250319,Un,o
77,S0124-0064_PMID23250319,tamizado,i
77,S0124-0064_PMID23250319,neuropsicomotor,i
77,S0124-0064_PMID23250319,y,i
77,S0124-0064_PMID23250319,sensorial,i
77,S0124-0064_PMID23250319,se,o
77,S0124-0064_PMID23250319,realizo,o
77,S0124-0064_PMID23250319,solamente,o
77,S0124-0064_PMID23250319,en,o
77,S0124-0064_PMID23250319,19,o
77,S0124-0064_PMID23250319,encontrando,o
77,S0124-0064_PMID23250319,algun,o
77,S0124-0064_PMID23250319,tipo,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,alteracion,i
77,S0124-0064_PMID23250319,neuropsicomotriz,i
77,S0124-0064_PMID23250319,en,o
77,S0124-0064_PMID23250319,30,o
77,S0124-0064_PMID23250319,refractiva,o
77,S0124-0064_PMID23250319,en,o
77,S0124-0064_PMID23250319,40,o
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,auditiva,o
77,S0124-0064_PMID23250319,en,o
77,S0124-0064_PMID23250319,5,o
77,S0124-0064_PMID23250319,Conclusion,o
77,S0124-0064_PMID23250319,Mas,o
77,S0124-0064_PMID23250319,del,o
77,S0124-0064_PMID23250319,60,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,los,o
77,S0124-0064_PMID23250319,niños,o
77,S0124-0064_PMID23250319,oxigenodependientes,i
77,S0124-0064_PMID23250319,fueron,o
77,S0124-0064_PMID23250319,dados,i
77,S0124-0064_PMID23250319,de,i
77,S0124-0064_PMID23250319,alta,i
77,S0124-0064_PMID23250319,sin,o
77,S0124-0064_PMID23250319,plan,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,seguimiento,i
77,S0124-0064_PMID23250319,estructurado,o
77,S0124-0064_PMID23250319,El,o
77,S0124-0064_PMID23250319,problema,o
77,S0124-0064_PMID23250319,de,o
77,S0124-0064_PMID23250319,los,o
77,S0124-0064_PMID23250319,niños,o
77,S0124-0064_PMID23250319,oxigenodependientes,i
77,S0124-0064_PMID23250319,es,o
77,S0124-0064_PMID23250319,complejo,o
77,S0124-0064_PMID23250319,y,o
77,S0124-0064_PMID23250319,nuestros,o
77,S0124-0064_PMID23250319,datos,o
77,S0124-0064_PMID23250319,sugieren,o
77,S0124-0064_PMID23250319,un,o
77,S0124-0064_PMID23250319,gran,o
77,S0124-0064_PMID23250319,espacio,o
77,S0124-0064_PMID23250319,para,o
77,S0124-0064_PMID23250319,mejorar,o
77,S0124-0064_PMID23250319,el,o
77,S0124-0064_PMID23250319,seguimiento,i
78,S0187-53372013000400004,Ventilacion,i
78,S0187-53372013000400004,nasofaringea,i
78,S0187-53372013000400004,versus,o
78,S0187-53372013000400004,presion,i
78,S0187-53372013000400004,positiva,i
78,S0187-53372013000400004,continua,i
78,S0187-53372013000400004,de,i
78,S0187-53372013000400004,la,i
78,S0187-53372013000400004,via,i
78,S0187-53372013000400004,aerea,i
78,S0187-53372013000400004,nasal,i
78,S0187-53372013000400004,como,o
78,S0187-53372013000400004,metodo,i
78,S0187-53372013000400004,ventilatorio,i
78,S0187-53372013000400004,de,i
78,S0187-53372013000400004,rescate,i
78,S0187-53372013000400004,Reporte,o
78,S0187-53372013000400004,preliminar,o
78,S0187-53372013000400004,Objetivo,o
78,S0187-53372013000400004,Comparar,o
78,S0187-53372013000400004,la,o
78,S0187-53372013000400004,presion,i
78,S0187-53372013000400004,continua,i
78,S0187-53372013000400004,positiva,i
78,S0187-53372013000400004,de,i
78,S0187-53372013000400004,la,i
78,S0187-53372013000400004,via,i
78,S0187-53372013000400004,aerea,i
78,S0187-53372013000400004,nasal,i
78,S0187-53372013000400004,y,o
78,S0187-53372013000400004,la,o
78,S0187-53372013000400004,ventilacion,i
78,S0187-53372013000400004,nasofaringea,i
78,S0187-53372013000400004,Material,o
78,S0187-53372013000400004,y,o
78,S0187-53372013000400004,metodos,o
78,S0187-53372013000400004,Ensayo,i
78,S0187-53372013000400004,clinico,i
78,S0187-53372013000400004,aleatorizado,i
78,S0187-53372013000400004,que,o
78,S0187-53372013000400004,incluyo,o
78,S0187-53372013000400004,a,o
78,S0187-53372013000400004,todos,o
78,S0187-53372013000400004,los,o
78,S0187-53372013000400004,recien,i
78,S0187-53372013000400004,nacidos,i
78,S0187-53372013000400004,admitidos,i
78,S0187-53372013000400004,a,i
78,S0187-53372013000400004,la,i
78,S0187-53372013000400004,Unidad,i
78,S0187-53372013000400004,de,i
78,S0187-53372013000400004,Cuidados,i
78,S0187-53372013000400004,Intensivos,i
78,S0187-53372013000400004,Neonatales,o
78,S0187-53372013000400004,del,o
78,S0187-53372013000400004,INPer,o
78,S0187-53372013000400004,que,o
78,S0187-53372013000400004,presentaron,o
78,S0187-53372013000400004,dificultad,i
78,S0187-53372013000400004,respiratoria,i
78,S0187-53372013000400004,y,o
78,S0187-53372013000400004,requerian,o
78,S0187-53372013000400004,soporte,i
78,S0187-53372013000400004,ventilatorio,i
78,S0187-53372013000400004,Se,o
78,S0187-53372013000400004,incluyeron,o
78,S0187-53372013000400004,28,o
78,S0187-53372013000400004,individuos,o
78,S0187-53372013000400004,divididos,o
78,S0187-53372013000400004,en,o
78,S0187-53372013000400004,dos,o
78,S0187-53372013000400004,grupos,o
78,S0187-53372013000400004,el,o
78,S0187-53372013000400004,primero,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,12,o
78,S0187-53372013000400004,pacientes,o
78,S0187-53372013000400004,manejado,o
78,S0187-53372013000400004,con,o
78,S0187-53372013000400004,ventilacion,i
78,S0187-53372013000400004,nasofaringea,i
78,S0187-53372013000400004,y,o
78,S0187-53372013000400004,el,o
78,S0187-53372013000400004,segundo,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,16,o
78,S0187-53372013000400004,pacientes,o
78,S0187-53372013000400004,tratados,i
78,S0187-53372013000400004,con,i
78,S0187-53372013000400004,presion,i
78,S0187-53372013000400004,positiva,i
78,S0187-53372013000400004,continua,i
78,S0187-53372013000400004,de,i
78,S0187-53372013000400004,la,i
78,S0187-53372013000400004,via,i
78,S0187-53372013000400004,aerea,i
78,S0187-53372013000400004,nasal,i
78,S0187-53372013000400004,Criterios,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,inclusion,o
78,S0187-53372013000400004,Neonatos,i
78,S0187-53372013000400004,con,o
78,S0187-53372013000400004,dificultad,i
78,S0187-53372013000400004,respiratoria,i
78,S0187-53372013000400004,y,o
78,S0187-53372013000400004,automatismo,o
78,S0187-53372013000400004,respiratorio,o
78,S0187-53372013000400004,que,o
78,S0187-53372013000400004,requerian,o
78,S0187-53372013000400004,apoyo,i
78,S0187-53372013000400004,ventilatorio,i
78,S0187-53372013000400004,Criterios,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,exclusion,o
78,S0187-53372013000400004,Patologia,i
78,S0187-53372013000400004,nasal,i
78,S0187-53372013000400004,malformaciones,i
78,S0187-53372013000400004,congenitas,i
78,S0187-53372013000400004,mayores,o
78,S0187-53372013000400004,trastorno,i
78,S0187-53372013000400004,neuromuscular,i
78,S0187-53372013000400004,sindrome,i
78,S0187-53372013000400004,de,i
78,S0187-53372013000400004,fuga,i
78,S0187-53372013000400004,aerea,i
78,S0187-53372013000400004,y,o
78,S0187-53372013000400004,antecedente,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,cirugia,i
78,S0187-53372013000400004,o,o
78,S0187-53372013000400004,patologia,i
78,S0187-53372013000400004,de,i
78,S0187-53372013000400004,abdomen,i
78,S0187-53372013000400004,Variables,o
78,S0187-53372013000400004,edad,o
78,S0187-53372013000400004,gestacional,o
78,S0187-53372013000400004,peso,o
78,S0187-53372013000400004,dias,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,vida,o
78,S0187-53372013000400004,enfermedad,i
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,fondo,o
78,S0187-53372013000400004,metodo,i
78,S0187-53372013000400004,ventilatorio,i
78,S0187-53372013000400004,previo,o
78,S0187-53372013000400004,dias,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,aplicacion,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,la,o
78,S0187-53372013000400004,ventilacion,i
78,S0187-53372013000400004,indicacion,o
78,S0187-53372013000400004,del,o
78,S0187-53372013000400004,metodo,i
78,S0187-53372013000400004,de,i
78,S0187-53372013000400004,ventilacion,i
78,S0187-53372013000400004,complicaciones,i
78,S0187-53372013000400004,tasa,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,exito,o
78,S0187-53372013000400004,Se,o
78,S0187-53372013000400004,uso,o
78,S0187-53372013000400004,estadistica,o
78,S0187-53372013000400004,descriptiva,o
78,S0187-53372013000400004,y,o
78,S0187-53372013000400004,para,o
78,S0187-53372013000400004,la,o
78,S0187-53372013000400004,comparacion,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,los,o
78,S0187-53372013000400004,grupos,o
78,S0187-53372013000400004,χ2,o
78,S0187-53372013000400004,o,o
78,S0187-53372013000400004,U,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,MannWhitney,o
78,S0187-53372013000400004,Resultados,o
78,S0187-53372013000400004,En,o
78,S0187-53372013000400004,el,o
78,S0187-53372013000400004,grupo,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,ventilacion,i
78,S0187-53372013000400004,nasofaringea,i
78,S0187-53372013000400004,hubo,o
78,S0187-53372013000400004,nueve,o
78,S0187-53372013000400004,neonatos,i
78,S0187-53372013000400004,pretermino,i
78,S0187-53372013000400004,hipotroficos,i
78,S0187-53372013000400004,mientras,o
78,S0187-53372013000400004,que,o
78,S0187-53372013000400004,en,o
78,S0187-53372013000400004,el,o
78,S0187-53372013000400004,grupo,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,presion,i
78,S0187-53372013000400004,positiva,i
78,S0187-53372013000400004,continua,i
78,S0187-53372013000400004,de,i
78,S0187-53372013000400004,la,i
78,S0187-53372013000400004,via,i
78,S0187-53372013000400004,aerea,i
78,S0187-53372013000400004,nasal,i
78,S0187-53372013000400004,hubo,o
78,S0187-53372013000400004,seis,o
78,S0187-53372013000400004,neonatos,i
78,S0187-53372013000400004,pretermino,i
78,S0187-53372013000400004,hipotroficos,i
78,S0187-53372013000400004,Todos,o
78,S0187-53372013000400004,los,o
78,S0187-53372013000400004,neonatos,i
78,S0187-53372013000400004,ingresaron,o
78,S0187-53372013000400004,al,o
78,S0187-53372013000400004,estudio,o
78,S0187-53372013000400004,en,o
78,S0187-53372013000400004,fase,o
78,S0187-53372013000400004,I,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,ventilacion,i
78,S0187-53372013000400004,La,o
78,S0187-53372013000400004,indicacion,o
78,S0187-53372013000400004,predominante,o
78,S0187-53372013000400004,para,o
78,S0187-53372013000400004,la,o
78,S0187-53372013000400004,aplicacion,o
78,S0187-53372013000400004,del,o
78,S0187-53372013000400004,metodo,i
78,S0187-53372013000400004,de,i
78,S0187-53372013000400004,rescate,i
78,S0187-53372013000400004,en,o
78,S0187-53372013000400004,el,o
78,S0187-53372013000400004,grupo,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,ventilacion,i
78,S0187-53372013000400004,nasofaringea,i
78,S0187-53372013000400004,fue,o
78,S0187-53372013000400004,apnea,i
78,S0187-53372013000400004,y,o
78,S0187-53372013000400004,en,o
78,S0187-53372013000400004,el,o
78,S0187-53372013000400004,grupo,o
78,S0187-53372013000400004,de,o
78,S0187-53372013000400004,presion,i
78,S0187-53372013000400004,positiva,i
78,S0187-53372013000400004,continua,i
78,S0187-53372013000400004,de,i
78,S0187-53372013000400004,la,i
78,S0187-53372013000400004,via,i
78,S0187-53372013000400004,aerea,i
78,S0187-53372013000400004,nasal,i
78,S0187-53372013000400004,dificultad,i
78,S0187-53372013000400004,respiratoria,i
78,S0187-53372013000400004,La,o
78,S0187-53372013000400004,ventilacion,i
78,S0187-53372013000400004,nasofaringea,i
78,S0187-53372013000400004,fallo,o
78,S0187-53372013000400004,en,o
78,S0187-53372013000400004,cinco,o
78,S0187-53372013000400004,pacientes,o
78,S0187-53372013000400004,416,o
78,S0187-53372013000400004,y,o
78,S0187-53372013000400004,la,o
78,S0187-53372013000400004,presion,i
78,S0187-53372013000400004,positiva,i
78,S0187-53372013000400004,continua,i
78,S0187-53372013000400004,de,i
78,S0187-53372013000400004,la,i
78,S0187-53372013000400004,via,i
78,S0187-53372013000400004,aerea,i
78,S0187-53372013000400004,nasal,i
78,S0187-53372013000400004,en,o
78,S0187-53372013000400004,tres,o
78,S0187-53372013000400004,187,o
78,S0187-53372013000400004,sin,o
78,S0187-53372013000400004,haber,o
78,S0187-53372013000400004,diferencia,o
78,S0187-53372013000400004,estadistica,o
79,S0210-1238201324,Ropivacaina,i
79,S0210-1238201324,en,o
79,S0210-1238201324,bloqueos,i
79,S0210-1238201324,digitales,i
79,S0210-1238201324,del,i
79,S0210-1238201324,pie,i
79,S0210-1238201324,Ensayo,i
79,S0210-1238201324,clinico,i
79,S0210-1238201324,randomizado,i
79,S0210-1238201324,La,o
79,S0210-1238201324,Ropivacaina,i
79,S0210-1238201324,es,o
79,S0210-1238201324,un,o
79,S0210-1238201324,anestesico,i
79,S0210-1238201324,local,i
79,S0210-1238201324,tipo,o
79,S0210-1238201324,amida,i
79,S0210-1238201324,con,o
79,S0210-1238201324,larga,o
79,S0210-1238201324,duracion,o
79,S0210-1238201324,de,o
79,S0210-1238201324,su,o
79,S0210-1238201324,efecto,o
79,S0210-1238201324,Desde,o
79,S0210-1238201324,su,o
79,S0210-1238201324,introduccion,o
79,S0210-1238201324,en,o
79,S0210-1238201324,1996,o
79,S0210-1238201324,se,o
79,S0210-1238201324,ha,o
79,S0210-1238201324,utilizado,o
79,S0210-1238201324,para,o
79,S0210-1238201324,infiltraciones,i
79,S0210-1238201324,subcutaneas,o
79,S0210-1238201324,epidural,o
79,S0210-1238201324,intradural,o
79,S0210-1238201324,y,o
79,S0210-1238201324,bloqueos,i
79,S0210-1238201324,perifericos,i
79,S0210-1238201324,asi,o
79,S0210-1238201324,como,o
79,S0210-1238201324,para,o
79,S0210-1238201324,analgesia,i
79,S0210-1238201324,postquirurgica,i
79,S0210-1238201324,Sin,o
79,S0210-1238201324,embargo,o
79,S0210-1238201324,hay,o
79,S0210-1238201324,pocos,o
79,S0210-1238201324,estudios,o
79,S0210-1238201324,en,o
79,S0210-1238201324,los,o
79,S0210-1238201324,que,o
79,S0210-1238201324,se,o
79,S0210-1238201324,utiliza,o
79,S0210-1238201324,para,o
79,S0210-1238201324,bloqueos,i
79,S0210-1238201324,digitales,i
79,S0210-1238201324,En,o
79,S0210-1238201324,este,o
79,S0210-1238201324,estudio,o
79,S0210-1238201324,prospectivo,o
79,S0210-1238201324,randomizado,o
79,S0210-1238201324,y,o
79,S0210-1238201324,ciego,o
79,S0210-1238201324,simple,o
79,S0210-1238201324,se,o
79,S0210-1238201324,comparan,o
79,S0210-1238201324,los,o
79,S0210-1238201324,resultados,o
79,S0210-1238201324,obtenidos,o
79,S0210-1238201324,al,o
79,S0210-1238201324,realizar,o
79,S0210-1238201324,anestesia,i
79,S0210-1238201324,troncular,i
79,S0210-1238201324,de,o
79,S0210-1238201324,1o,i
79,S0210-1238201324,dedo,i
79,S0210-1238201324,administrando,o
79,S0210-1238201324,2,o
79,S0210-1238201324,ml,o
79,S0210-1238201324,de,o
79,S0210-1238201324,Mepivacaina,i
79,S0210-1238201324,al,o
79,S0210-1238201324,3,o
79,S0210-1238201324,y,o
79,S0210-1238201324,la,o
79,S0210-1238201324,combinacion,o
79,S0210-1238201324,de,o
79,S0210-1238201324,1,o
79,S0210-1238201324,ml,o
79,S0210-1238201324,de,o
79,S0210-1238201324,Mepivacaina,i
79,S0210-1238201324,al,o
79,S0210-1238201324,3,o
79,S0210-1238201324,1,o
79,S0210-1238201324,ml,o
79,S0210-1238201324,Ropivacaina,i
79,S0210-1238201324,al,o
79,S0210-1238201324,075,o
79,S0210-1238201324,Los,o
79,S0210-1238201324,objetivos,o
79,S0210-1238201324,principales,o
79,S0210-1238201324,del,o
79,S0210-1238201324,estudio,o
79,S0210-1238201324,son,o
79,S0210-1238201324,analizar,o
79,S0210-1238201324,si,o
79,S0210-1238201324,existen,o
79,S0210-1238201324,diferencias,o
79,S0210-1238201324,en,o
79,S0210-1238201324,la,o
79,S0210-1238201324,eficacia,o
79,S0210-1238201324,del,o
79,S0210-1238201324,tiempo,o
79,S0210-1238201324,de,o
79,S0210-1238201324,latencia,o
79,S0210-1238201324,y,o
79,S0210-1238201324,del,o
79,S0210-1238201324,control,o
79,S0210-1238201324,del,o
79,S0210-1238201324,dolor,o
79,S0210-1238201324,postquirurgico,o
79,S0210-1238201324,entre,o
79,S0210-1238201324,ambos,o
79,S0210-1238201324,grupos,o
79,S0210-1238201324,Desde,o
79,S0210-1238201324,Mayo,o
79,S0210-1238201324,de,o
79,S0210-1238201324,2011,o
79,S0210-1238201324,hasta,o
79,S0210-1238201324,Octubre,o
79,S0210-1238201324,de,o
79,S0210-1238201324,2011,o
79,S0210-1238201324,20,o
79,S0210-1238201324,pacientes,o
79,S0210-1238201324,ASA,o
79,S0210-1238201324,III,o
79,S0210-1238201324,sometidos,o
79,S0210-1238201324,a,o
79,S0210-1238201324,cirugia,i
79,S0210-1238201324,de,i
79,S0210-1238201324,matricectomia,i
79,S0210-1238201324,parcial,o
79,S0210-1238201324,mecanica,o
79,S0210-1238201324,bajo,o
79,S0210-1238201324,anestesia,i
79,S0210-1238201324,troncular,i
79,S0210-1238201324,de,o
79,S0210-1238201324,1o,i
79,S0210-1238201324,dedo,i
79,S0210-1238201324,fueron,o
79,S0210-1238201324,randomizados,i
79,S0210-1238201324,prospectivamente,i
79,S0210-1238201324,en,o
79,S0210-1238201324,2,o
79,S0210-1238201324,grupos,o
79,S0210-1238201324,Grupo,o
79,S0210-1238201324,A,o
79,S0210-1238201324,n10,o
79,S0210-1238201324,recibieron,o
79,S0210-1238201324,1,o
79,S0210-1238201324,ml,o
79,S0210-1238201324,de,o
79,S0210-1238201324,Mepivacaina,i
79,S0210-1238201324,al,o
79,S0210-1238201324,3,o
79,S0210-1238201324,1,o
79,S0210-1238201324,ml,o
79,S0210-1238201324,Ropivacaina,i
79,S0210-1238201324,al,o
79,S0210-1238201324,075,o
79,S0210-1238201324,y,o
79,S0210-1238201324,el,o
79,S0210-1238201324,grupo,o
79,S0210-1238201324,B,o
79,S0210-1238201324,n10,o
79,S0210-1238201324,2,o
79,S0210-1238201324,ml,o
79,S0210-1238201324,de,o
79,S0210-1238201324,Mepivacaina,i
79,S0210-1238201324,al,o
79,S0210-1238201324,3Se,o
79,S0210-1238201324,valoro,o
79,S0210-1238201324,el,o
79,S0210-1238201324,tiempo,o
79,S0210-1238201324,de,o
79,S0210-1238201324,latencia,o
79,S0210-1238201324,el,o
79,S0210-1238201324,dolor,o
79,S0210-1238201324,postquirurgico,o
79,S0210-1238201324,y,o
79,S0210-1238201324,la,o
79,S0210-1238201324,necesidad,o
79,S0210-1238201324,de,o
79,S0210-1238201324,utilizar,o
79,S0210-1238201324,analgesia,i
79,S0210-1238201324,de,i
79,S0210-1238201324,rescate,i
79,S0210-1238201324,No,o
79,S0210-1238201324,se,o
79,S0210-1238201324,contemplaron,o
79,S0210-1238201324,efectos,i
79,S0210-1238201324,adversos,i
79,S0210-1238201324,No,o
79,S0210-1238201324,se,o
79,S0210-1238201324,observaron,o
79,S0210-1238201324,diferencias,o
79,S0210-1238201324,significativas,o
79,S0210-1238201324,en,o
79,S0210-1238201324,la,o
79,S0210-1238201324,valoracion,o
79,S0210-1238201324,del,o
79,S0210-1238201324,tiempo,o
79,S0210-1238201324,de,o
79,S0210-1238201324,latencia,o
79,S0210-1238201324,ni,o
79,S0210-1238201324,en,o
79,S0210-1238201324,la,o
79,S0210-1238201324,analgesia,i
79,S0210-1238201324,postquirurgica,i
79,S0210-1238201324,A,o
79,S0210-1238201324,las,o
79,S0210-1238201324,2,o
79,S0210-1238201324,horas,o
79,S0210-1238201324,4,o
79,S0210-1238201324,horas,o
79,S0210-1238201324,y,o
79,S0210-1238201324,6,o
79,S0210-1238201324,horas,o
79,S0210-1238201324,posteriores,o
79,S0210-1238201324,a,o
79,S0210-1238201324,la,o
79,S0210-1238201324,intervencion,i
79,S0210-1238201324,se,o
79,S0210-1238201324,observo,o
79,S0210-1238201324,diferencias,o
79,S0210-1238201324,significativas,o
79,S0210-1238201324,p005,o
79,S0210-1238201324,en,o
79,S0210-1238201324,la,o
79,S0210-1238201324,escala,i
79,S0210-1238201324,visual,i
79,S0210-1238201324,analogica,i
79,S0210-1238201324,entre,o
79,S0210-1238201324,ambos,o
79,S0210-1238201324,grupos,o
79,S0210-1238201324,La,o
79,S0210-1238201324,Ropivacaina,i
79,S0210-1238201324,se,o
79,S0210-1238201324,puede,o
79,S0210-1238201324,utilizar,o
79,S0210-1238201324,como,o
79,S0210-1238201324,anestesico,i
79,S0210-1238201324,local,i
79,S0210-1238201324,en,o
79,S0210-1238201324,los,o
79,S0210-1238201324,bloqueos,i
79,S0210-1238201324,digitales,i
79,S0210-1238201324,para,o
79,S0210-1238201324,conseguir,o
79,S0210-1238201324,menor,o
79,S0210-1238201324,dolor,o
79,S0210-1238201324,postquirurgico,o
80,S0210-48062004001000008,Sobre,o
80,S0210-48062004001000008,la,o
80,S0210-48062004001000008,necesidad,o
80,S0210-48062004001000008,del,o
80,S0210-48062004001000008,rasurado,i
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,la,o
80,S0210-48062004001000008,region,i
80,S0210-48062004001000008,pubica,i
80,S0210-48062004001000008,en,o
80,S0210-48062004001000008,los,o
80,S0210-48062004001000008,pacientes,o
80,S0210-48062004001000008,que,o
80,S0210-48062004001000008,van,o
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,ser,o
80,S0210-48062004001000008,sometidos,o
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,cirugia,i
80,S0210-48062004001000008,urologica,i
80,S0210-48062004001000008,endoscopica,i
80,S0210-48062004001000008,OBJETIVO,o
80,S0210-48062004001000008,El,o
80,S0210-48062004001000008,objetivo,o
80,S0210-48062004001000008,del,o
80,S0210-48062004001000008,estudio,o
80,S0210-48062004001000008,es,o
80,S0210-48062004001000008,determinar,o
80,S0210-48062004001000008,mediante,o
80,S0210-48062004001000008,un,o
80,S0210-48062004001000008,ensayo,i
80,S0210-48062004001000008,clinico,i
80,S0210-48062004001000008,aleatorio,i
80,S0210-48062004001000008,controlado,i
80,S0210-48062004001000008,si,o
80,S0210-48062004001000008,se,o
80,S0210-48062004001000008,produce,o
80,S0210-48062004001000008,algun,o
80,S0210-48062004001000008,aumento,o
80,S0210-48062004001000008,en,o
80,S0210-48062004001000008,el,o
80,S0210-48062004001000008,numero,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,bacteriurias,i
80,S0210-48062004001000008,postoperatorias,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,un,o
80,S0210-48062004001000008,grupo,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,pacientes,o
80,S0210-48062004001000008,sometidos,o
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,cirugia,i
80,S0210-48062004001000008,urologica,i
80,S0210-48062004001000008,endoscopica,i
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,los,o
80,S0210-48062004001000008,que,o
80,S0210-48062004001000008,no,o
80,S0210-48062004001000008,se,o
80,S0210-48062004001000008,rasura,i
80,S0210-48062004001000008,la,o
80,S0210-48062004001000008,region,i
80,S0210-48062004001000008,pubica,i
80,S0210-48062004001000008,practica,o
80,S0210-48062004001000008,inhabitual,o
80,S0210-48062004001000008,en,o
80,S0210-48062004001000008,la,o
80,S0210-48062004001000008,preparacion,i
80,S0210-48062004001000008,quirurgica,i
80,S0210-48062004001000008,actual,o
80,S0210-48062004001000008,MATERIAL,o
80,S0210-48062004001000008,Y,o
80,S0210-48062004001000008,METODO,o
80,S0210-48062004001000008,El,o
80,S0210-48062004001000008,estudio,o
80,S0210-48062004001000008,se,o
80,S0210-48062004001000008,realizo,o
80,S0210-48062004001000008,distribuyendo,o
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,los,o
80,S0210-48062004001000008,pacientes,o
80,S0210-48062004001000008,que,o
80,S0210-48062004001000008,iban,o
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,ser,o
80,S0210-48062004001000008,intervenidos,i
80,S0210-48062004001000008,mediante,o
80,S0210-48062004001000008,cirugia,i
80,S0210-48062004001000008,urologica,i
80,S0210-48062004001000008,endoscopica,i
80,S0210-48062004001000008,de,i
80,S0210-48062004001000008,forma,i
80,S0210-48062004001000008,aleatoria,i
80,S0210-48062004001000008,en,o
80,S0210-48062004001000008,dos,o
80,S0210-48062004001000008,grupos,o
80,S0210-48062004001000008,A,o
80,S0210-48062004001000008,un,o
80,S0210-48062004001000008,grupo,o
80,S0210-48062004001000008,se,o
80,S0210-48062004001000008,le,o
80,S0210-48062004001000008,rasuro,i
80,S0210-48062004001000008,la,o
80,S0210-48062004001000008,region,i
80,S0210-48062004001000008,pubica,i
80,S0210-48062004001000008,segun,o
80,S0210-48062004001000008,las,o
80,S0210-48062004001000008,tecnicas,o
80,S0210-48062004001000008,habituales,o
80,S0210-48062004001000008,mientras,o
80,S0210-48062004001000008,que,o
80,S0210-48062004001000008,al,o
80,S0210-48062004001000008,otro,o
80,S0210-48062004001000008,grupo,o
80,S0210-48062004001000008,no,o
80,S0210-48062004001000008,se,o
80,S0210-48062004001000008,le,o
80,S0210-48062004001000008,rasuro,i
80,S0210-48062004001000008,dicha,o
80,S0210-48062004001000008,region,i
80,S0210-48062004001000008,el,o
80,S0210-48062004001000008,resto,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,la,o
80,S0210-48062004001000008,preparacion,o
80,S0210-48062004001000008,fue,o
80,S0210-48062004001000008,igual,o
80,S0210-48062004001000008,para,o
80,S0210-48062004001000008,ambos,o
80,S0210-48062004001000008,grupos,o
80,S0210-48062004001000008,Se,o
80,S0210-48062004001000008,recogieron,o
80,S0210-48062004001000008,muestras,i
80,S0210-48062004001000008,de,i
80,S0210-48062004001000008,orina,i
80,S0210-48062004001000008,para,o
80,S0210-48062004001000008,su,o
80,S0210-48062004001000008,cultivo,i
80,S0210-48062004001000008,antes,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,la,o
80,S0210-48062004001000008,administracion,i
80,S0210-48062004001000008,del,i
80,S0210-48062004001000008,antibiotico,i
80,S0210-48062004001000008,profilactico,i
80,S0210-48062004001000008,y,o
80,S0210-48062004001000008,se,o
80,S0210-48062004001000008,volvieron,o
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,tomar,o
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,la,o
80,S0210-48062004001000008,semana,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,retirar,i
80,S0210-48062004001000008,la,i
80,S0210-48062004001000008,sonda,i
80,S0210-48062004001000008,vesical,i
80,S0210-48062004001000008,ya,o
80,S0210-48062004001000008,sin,o
80,S0210-48062004001000008,tratamiento,i
80,S0210-48062004001000008,antibiotico,i
80,S0210-48062004001000008,Se,o
80,S0210-48062004001000008,presto,o
80,S0210-48062004001000008,especial,o
80,S0210-48062004001000008,atencion,o
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,las,o
80,S0210-48062004001000008,incidencias,o
80,S0210-48062004001000008,del,o
80,S0210-48062004001000008,postoperatorio,o
80,S0210-48062004001000008,sobre,o
80,S0210-48062004001000008,todo,o
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,las,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,naturaleza,o
80,S0210-48062004001000008,infecciosa,i
80,S0210-48062004001000008,RESULTADOS,o
80,S0210-48062004001000008,Se,o
80,S0210-48062004001000008,incluyeron,o
80,S0210-48062004001000008,un,o
80,S0210-48062004001000008,total,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,449,o
80,S0210-48062004001000008,pacientes,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,los,o
80,S0210-48062004001000008,cuales,o
80,S0210-48062004001000008,149,o
80,S0210-48062004001000008,fueron,o
80,S0210-48062004001000008,retirados,o
80,S0210-48062004001000008,del,o
80,S0210-48062004001000008,estudio,o
80,S0210-48062004001000008,por,o
80,S0210-48062004001000008,diferentes,o
80,S0210-48062004001000008,causas,o
80,S0210-48062004001000008,De,o
80,S0210-48062004001000008,estos,o
80,S0210-48062004001000008,149,o
80,S0210-48062004001000008,fueron,o
80,S0210-48062004001000008,rasurados,i
80,S0210-48062004001000008,y,o
80,S0210-48062004001000008,151,o
80,S0210-48062004001000008,no,o
80,S0210-48062004001000008,lo,o
80,S0210-48062004001000008,fueron,o
80,S0210-48062004001000008,En,o
80,S0210-48062004001000008,el,o
80,S0210-48062004001000008,grupo,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,pacientes,o
80,S0210-48062004001000008,no,o
80,S0210-48062004001000008,rasurados,i
80,S0210-48062004001000008,se,o
80,S0210-48062004001000008,observo,o
80,S0210-48062004001000008,una,o
80,S0210-48062004001000008,tasa,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,bacteriuria,i
80,S0210-48062004001000008,postoperatoria,o
80,S0210-48062004001000008,del,o
80,S0210-48062004001000008,195,o
80,S0210-48062004001000008,mientras,o
80,S0210-48062004001000008,que,o
80,S0210-48062004001000008,en,o
80,S0210-48062004001000008,el,o
80,S0210-48062004001000008,otro,o
80,S0210-48062004001000008,grupo,o
80,S0210-48062004001000008,fue,o
80,S0210-48062004001000008,del,o
80,S0210-48062004001000008,166,o
80,S0210-48062004001000008,no,o
80,S0210-48062004001000008,observandose,o
80,S0210-48062004001000008,diferencias,o
80,S0210-48062004001000008,estadisticamente,o
80,S0210-48062004001000008,significativas,o
80,S0210-48062004001000008,CONCLUSION,o
80,S0210-48062004001000008,La,o
80,S0210-48062004001000008,conclusion,o
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,la,o
80,S0210-48062004001000008,que,o
80,S0210-48062004001000008,se,o
80,S0210-48062004001000008,llego,o
80,S0210-48062004001000008,es,o
80,S0210-48062004001000008,que,o
80,S0210-48062004001000008,no,o
80,S0210-48062004001000008,se,o
80,S0210-48062004001000008,produce,o
80,S0210-48062004001000008,un,o
80,S0210-48062004001000008,aumento,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,bacteriurias,i
80,S0210-48062004001000008,postoperatorias,o
80,S0210-48062004001000008,en,o
80,S0210-48062004001000008,los,o
80,S0210-48062004001000008,pacientes,o
80,S0210-48062004001000008,sometidos,o
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,cirugia,i
80,S0210-48062004001000008,urologica,i
80,S0210-48062004001000008,endoscopica,i
80,S0210-48062004001000008,a,o
80,S0210-48062004001000008,los,o
80,S0210-48062004001000008,que,o
80,S0210-48062004001000008,no,o
80,S0210-48062004001000008,se,o
80,S0210-48062004001000008,les,o
80,S0210-48062004001000008,rasura,i
80,S0210-48062004001000008,la,o
80,S0210-48062004001000008,region,i
80,S0210-48062004001000008,pubica,i
80,S0210-48062004001000008,en,o
80,S0210-48062004001000008,comparacion,o
80,S0210-48062004001000008,con,o
80,S0210-48062004001000008,el,o
80,S0210-48062004001000008,grupo,o
80,S0210-48062004001000008,de,o
80,S0210-48062004001000008,pacientes,o
80,S0210-48062004001000008,que,o
80,S0210-48062004001000008,son,o
80,S0210-48062004001000008,rasurados,i
80,S0210-48062004001000008,con,o
80,S0210-48062004001000008,cuchillas,o
80,S0210-48062004001000008,desechables,o
81,S0210-48062005000600003,Infiltracion,i
81,S0210-48062005000600003,anestesica,i
81,S0210-48062005000600003,periprostatica,i
81,S0210-48062005000600003,para,o
81,S0210-48062005000600003,biopsia,i
81,S0210-48062005000600003,de,i
81,S0210-48062005000600003,prostata,i
81,S0210-48062005000600003,por,i
81,S0210-48062005000600003,puncion,i
81,S0210-48062005000600003,estudio,o
81,S0210-48062005000600003,randomizado,o
81,S0210-48062005000600003,doble,o
81,S0210-48062005000600003,ciego,o
81,S0210-48062005000600003,y,o
81,S0210-48062005000600003,controlado,o
81,S0210-48062005000600003,con,o
81,S0210-48062005000600003,placebo,o
81,S0210-48062005000600003,Estudio,o
81,S0210-48062005000600003,prospectivo,o
81,S0210-48062005000600003,randomizado,o
81,S0210-48062005000600003,doble,o
81,S0210-48062005000600003,ciego,o
81,S0210-48062005000600003,y,o
81,S0210-48062005000600003,controlado,o
81,S0210-48062005000600003,con,o
81,S0210-48062005000600003,placebo,o
81,S0210-48062005000600003,evaluando,i
81,S0210-48062005000600003,la,i
81,S0210-48062005000600003,efectividad,i
81,S0210-48062005000600003,de,o
81,S0210-48062005000600003,la,o
81,S0210-48062005000600003,infiltracion,i
81,S0210-48062005000600003,periprostatica,i
81,S0210-48062005000600003,de,o
81,S0210-48062005000600003,lidocaina,i
81,S0210-48062005000600003,en,o
81,S0210-48062005000600003,disminuir,o
81,S0210-48062005000600003,el,o
81,S0210-48062005000600003,dolor,i
81,S0210-48062005000600003,de,o
81,S0210-48062005000600003,la,o
81,S0210-48062005000600003,biopsia,i
81,S0210-48062005000600003,por,i
81,S0210-48062005000600003,puncion,i
81,S0210-48062005000600003,En,o
81,S0210-48062005000600003,un,o
81,S0210-48062005000600003,periodo,o
81,S0210-48062005000600003,de,o
81,S0210-48062005000600003,trece,o
81,S0210-48062005000600003,meses,o
81,S0210-48062005000600003,115,o
81,S0210-48062005000600003,pacientes,o
81,S0210-48062005000600003,fueron,o
81,S0210-48062005000600003,randomizados,i
81,S0210-48062005000600003,para,o
81,S0210-48062005000600003,recibir,o
81,S0210-48062005000600003,10,o
81,S0210-48062005000600003,ml,o
81,S0210-48062005000600003,de,o
81,S0210-48062005000600003,lidocaina,i
81,S0210-48062005000600003,al,o
81,S0210-48062005000600003,1,o
81,S0210-48062005000600003,n60,o
81,S0210-48062005000600003,o,o
81,S0210-48062005000600003,suero,i
81,S0210-48062005000600003,fisiologico,i
81,S0210-48062005000600003,n55,o
81,S0210-48062005000600003,Evaluando,i
81,S0210-48062005000600003,el,i
81,S0210-48062005000600003,dolor,i
81,S0210-48062005000600003,mediante,o
81,S0210-48062005000600003,escala,i
81,S0210-48062005000600003,visual,i
81,S0210-48062005000600003,analoga,i
81,S0210-48062005000600003,010,o
81,S0210-48062005000600003,el,o
81,S0210-48062005000600003,primer,o
81,S0210-48062005000600003,grupo,o
81,S0210-48062005000600003,refirio,o
81,S0210-48062005000600003,dolor,i
81,S0210-48062005000600003,promedio,o
81,S0210-48062005000600003,de,o
81,S0210-48062005000600003,383,o
81,S0210-48062005000600003,y,o
81,S0210-48062005000600003,el,o
81,S0210-48062005000600003,segundo,o
81,S0210-48062005000600003,de,o
81,S0210-48062005000600003,687,o
81,S0210-48062005000600003,siendo,o
81,S0210-48062005000600003,esta,o
81,S0210-48062005000600003,diferencia,o
81,S0210-48062005000600003,significativa,o
81,S0210-48062005000600003,p0005,o
81,S0210-48062005000600003,No,o
81,S0210-48062005000600003,hubo,o
81,S0210-48062005000600003,complicaciones,i
81,S0210-48062005000600003,derivadas,i
81,S0210-48062005000600003,del,i
81,S0210-48062005000600003,anestesico,i
81,S0210-48062005000600003,La,o
81,S0210-48062005000600003,infiltracion,i
81,S0210-48062005000600003,periprostatica,i
81,S0210-48062005000600003,es,o
81,S0210-48062005000600003,facil,o
81,S0210-48062005000600003,de,o
81,S0210-48062005000600003,realizar,o
81,S0210-48062005000600003,no,o
81,S0210-48062005000600003,presenta,o
81,S0210-48062005000600003,complicaciones,i
81,S0210-48062005000600003,y,o
81,S0210-48062005000600003,es,o
81,S0210-48062005000600003,efectiva,o
81,S0210-48062005000600003,en,o
81,S0210-48062005000600003,reducir,o
81,S0210-48062005000600003,el,o
81,S0210-48062005000600003,dolor,i
81,S0210-48062005000600003,del,o
81,S0210-48062005000600003,procedimiento,i
81,S0210-48062005000600003,Debiera,o
81,S0210-48062005000600003,ser,o
81,S0210-48062005000600003,usada,o
81,S0210-48062005000600003,en,o
81,S0210-48062005000600003,forma,o
81,S0210-48062005000600003,rutinaria,o
81,S0210-48062005000600003,durante,o
81,S0210-48062005000600003,biopsia,i
81,S0210-48062005000600003,por,i
81,S0210-48062005000600003,puncion,i
82,S0210-48062006000100011,Preferencia,o
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,Tadalafilo,i
82,S0210-48062006000100011,vs,o
82,S0210-48062006000100011,Sildenafilo,i
82,S0210-48062006000100011,en,o
82,S0210-48062006000100011,pacientes,o
82,S0210-48062006000100011,españoles,o
82,S0210-48062006000100011,con,o
82,S0210-48062006000100011,disfuncion,i
82,S0210-48062006000100011,erectil,i
82,S0210-48062006000100011,resultados,o
82,S0210-48062006000100011,procedentes,o
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,un,o
82,S0210-48062006000100011,estudio,i
82,S0210-48062006000100011,multicentrico,i
82,S0210-48062006000100011,internacional,i
82,S0210-48062006000100011,Fundamento,o
82,S0210-48062006000100011,y,o
82,S0210-48062006000100011,objetivo,o
82,S0210-48062006000100011,Comparar,o
82,S0210-48062006000100011,la,o
82,S0210-48062006000100011,preferencia,o
82,S0210-48062006000100011,por,o
82,S0210-48062006000100011,sildenafilo,i
82,S0210-48062006000100011,vs,o
82,S0210-48062006000100011,tadalafilo,i
82,S0210-48062006000100011,y,o
82,S0210-48062006000100011,por,o
82,S0210-48062006000100011,sus,o
82,S0210-48062006000100011,instrucciones,i
82,S0210-48062006000100011,de,i
82,S0210-48062006000100011,administracion,i
82,S0210-48062006000100011,en,o
82,S0210-48062006000100011,una,o
82,S0210-48062006000100011,cohorte,o
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,pacientes,o
82,S0210-48062006000100011,españoles,o
82,S0210-48062006000100011,con,o
82,S0210-48062006000100011,disfuncion,i
82,S0210-48062006000100011,erectil,i
82,S0210-48062006000100011,DE,i
82,S0210-48062006000100011,Material,o
82,S0210-48062006000100011,y,o
82,S0210-48062006000100011,metodo,o
82,S0210-48062006000100011,64,o
82,S0210-48062006000100011,pacientes,o
82,S0210-48062006000100011,españoles,o
82,S0210-48062006000100011,participantes,o
82,S0210-48062006000100011,en,o
82,S0210-48062006000100011,un,o
82,S0210-48062006000100011,estudio,o
82,S0210-48062006000100011,multicentrico,o
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,2,o
82,S0210-48062006000100011,periodos,o
82,S0210-48062006000100011,cruzado,o
82,S0210-48062006000100011,y,o
82,S0210-48062006000100011,dobleciego,o
82,S0210-48062006000100011,con,o
82,S0210-48062006000100011,265,o
82,S0210-48062006000100011,pacientes,o
82,S0210-48062006000100011,en,o
82,S0210-48062006000100011,total,o
82,S0210-48062006000100011,se,o
82,S0210-48062006000100011,distribuyeron,i
82,S0210-48062006000100011,aleatoriamente,i
82,S0210-48062006000100011,para,o
82,S0210-48062006000100011,recibir,o
82,S0210-48062006000100011,sildenafilo,i
82,S0210-48062006000100011,50,o
82,S0210-48062006000100011,mg,o
82,S0210-48062006000100011,o,o
82,S0210-48062006000100011,tadalafilo,i
82,S0210-48062006000100011,20,o
82,S0210-48062006000100011,mg,o
82,S0210-48062006000100011,a,o
82,S0210-48062006000100011,demanda,o
82,S0210-48062006000100011,durante,o
82,S0210-48062006000100011,12,o
82,S0210-48062006000100011,semanas,o
82,S0210-48062006000100011,tras,o
82,S0210-48062006000100011,lo,o
82,S0210-48062006000100011,cual,o
82,S0210-48062006000100011,se,o
82,S0210-48062006000100011,cruzaron,o
82,S0210-48062006000100011,para,o
82,S0210-48062006000100011,recibir,o
82,S0210-48062006000100011,el,o
82,S0210-48062006000100011,regimen,i
82,S0210-48062006000100011,alternativo,i
82,S0210-48062006000100011,otras,o
82,S0210-48062006000100011,12,o
82,S0210-48062006000100011,semanas,o
82,S0210-48062006000100011,para,o
82,S0210-48062006000100011,valorar,o
82,S0210-48062006000100011,la,o
82,S0210-48062006000100011,preferencia,o
82,S0210-48062006000100011,por,o
82,S0210-48062006000100011,uno,o
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,los,o
82,S0210-48062006000100011,dos,o
82,S0210-48062006000100011,tratamientos,i
82,S0210-48062006000100011,en,o
82,S0210-48062006000100011,una,o
82,S0210-48062006000100011,fase,o
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,extension,o
82,S0210-48062006000100011,del,o
82,S0210-48062006000100011,estudio,o
82,S0210-48062006000100011,Igualmente,o
82,S0210-48062006000100011,para,o
82,S0210-48062006000100011,valorar,o
82,S0210-48062006000100011,la,o
82,S0210-48062006000100011,preferencia,o
82,S0210-48062006000100011,por,o
82,S0210-48062006000100011,las,o
82,S0210-48062006000100011,respectivas,o
82,S0210-48062006000100011,instrucciones,i
82,S0210-48062006000100011,de,i
82,S0210-48062006000100011,administracion,i
82,S0210-48062006000100011,13,o
82,S0210-48062006000100011,pacientes,o
82,S0210-48062006000100011,se,o
82,S0210-48062006000100011,distribuyeron,o
82,S0210-48062006000100011,en,o
82,S0210-48062006000100011,2,o
82,S0210-48062006000100011,brazos,o
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,tratamiento,i
82,S0210-48062006000100011,con,o
82,S0210-48062006000100011,tadalafilo,i
82,S0210-48062006000100011,20,o
82,S0210-48062006000100011,mg,o
82,S0210-48062006000100011,uno,o
82,S0210-48062006000100011,con,o
82,S0210-48062006000100011,las,o
82,S0210-48062006000100011,instrucciones,i
82,S0210-48062006000100011,de,i
82,S0210-48062006000100011,administracion,i
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,sildenafilo,i
82,S0210-48062006000100011,S,o
82,S0210-48062006000100011,y,o
82,S0210-48062006000100011,otro,o
82,S0210-48062006000100011,con,o
82,S0210-48062006000100011,las,o
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,tadalafilo,i
82,S0210-48062006000100011,T,o
82,S0210-48062006000100011,Resultados,o
82,S0210-48062006000100011,De,o
82,S0210-48062006000100011,los,o
82,S0210-48062006000100011,56,o
82,S0210-48062006000100011,pacientes,o
82,S0210-48062006000100011,que,o
82,S0210-48062006000100011,finalizaron,o
82,S0210-48062006000100011,el,o
82,S0210-48062006000100011,estudio,o
82,S0210-48062006000100011,un,o
82,S0210-48062006000100011,70,o
82,S0210-48062006000100011,eligieron,o
82,S0210-48062006000100011,recibir,o
82,S0210-48062006000100011,tratamiento,i
82,S0210-48062006000100011,con,o
82,S0210-48062006000100011,tadalafilo,i
82,S0210-48062006000100011,frente,o
82,S0210-48062006000100011,a,o
82,S0210-48062006000100011,sildenafilo,i
82,S0210-48062006000100011,30,o
82,S0210-48062006000100011,en,o
82,S0210-48062006000100011,la,o
82,S0210-48062006000100011,extension,o
82,S0210-48062006000100011,p001,o
82,S0210-48062006000100011,Igualmente,o
82,S0210-48062006000100011,un,o
82,S0210-48062006000100011,73,o
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,los,o
82,S0210-48062006000100011,13,o
82,S0210-48062006000100011,que,o
82,S0210-48062006000100011,valoraron,o
82,S0210-48062006000100011,las,o
82,S0210-48062006000100011,instrucciones,i
82,S0210-48062006000100011,de,i
82,S0210-48062006000100011,administracion,i
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,ambos,o
82,S0210-48062006000100011,farmacos,i
82,S0210-48062006000100011,prefirieron,o
82,S0210-48062006000100011,las,o
82,S0210-48062006000100011,instrucciones,i
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,T,o
82,S0210-48062006000100011,p005,o
82,S0210-48062006000100011,La,o
82,S0210-48062006000100011,preferencia,o
82,S0210-48062006000100011,no,o
82,S0210-48062006000100011,vario,o
82,S0210-48062006000100011,con,o
82,S0210-48062006000100011,la,o
82,S0210-48062006000100011,edad,o
82,S0210-48062006000100011,enfermedades,i
82,S0210-48062006000100011,concomitantes,i
82,S0210-48062006000100011,o,o
82,S0210-48062006000100011,uso,o
82,S0210-48062006000100011,previo,o
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,sildenafilo,i
82,S0210-48062006000100011,Conclusiones,o
82,S0210-48062006000100011,En,o
82,S0210-48062006000100011,este,o
82,S0210-48062006000100011,estudio,o
82,S0210-48062006000100011,aproximadamente,o
82,S0210-48062006000100011,7,o
82,S0210-48062006000100011,de,o
82,S0210-48062006000100011,cada,o
82,S0210-48062006000100011,10,o
82,S0210-48062006000100011,pacientes,o
82,S0210-48062006000100011,prefirieron,o
82,S0210-48062006000100011,tadalafilo,i
82,S0210-48062006000100011,y,o
82,S0210-48062006000100011,sus,o
82,S0210-48062006000100011,instrucciones,i
82,S0210-48062006000100011,de,i
82,S0210-48062006000100011,administracion,i
82,S0210-48062006000100011,frente,o
82,S0210-48062006000100011,a,o
82,S0210-48062006000100011,sildenafilo,i
82,S0210-48062006000100011,como,o
82,S0210-48062006000100011,tratamiento,i
82,S0210-48062006000100011,para,o
82,S0210-48062006000100011,su,o
82,S0210-48062006000100011,DE,i
83,S0210-48062006000300009,Papel,o
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,las,o
83,S0210-48062006000300009,tiazidas,i
83,S0210-48062006000300009,en,o
83,S0210-48062006000300009,la,o
83,S0210-48062006000300009,profilaxis,i
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,la,o
83,S0210-48062006000300009,litiasis,i
83,S0210-48062006000300009,calcica,i
83,S0210-48062006000300009,recidivante,o
83,S0210-48062006000300009,Objetivo,o
83,S0210-48062006000300009,Demostrar,i
83,S0210-48062006000300009,la,i
83,S0210-48062006000300009,eficacia,i
83,S0210-48062006000300009,prolongada,o
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,las,o
83,S0210-48062006000300009,tiazidas,i
83,S0210-48062006000300009,en,o
83,S0210-48062006000300009,la,o
83,S0210-48062006000300009,profilaxis,i
83,S0210-48062006000300009,y,o
83,S0210-48062006000300009,tratamiento,i
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,las,o
83,S0210-48062006000300009,recidivas,o
83,S0210-48062006000300009,en,o
83,S0210-48062006000300009,pacientes,o
83,S0210-48062006000300009,con,o
83,S0210-48062006000300009,litiasis,i
83,S0210-48062006000300009,calcica,i
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,oxalato,i
83,S0210-48062006000300009,y,o
83,S0210-48062006000300009,fosfato,i
83,S0210-48062006000300009,calcico,i
83,S0210-48062006000300009,Metodos,o
83,S0210-48062006000300009,Se,o
83,S0210-48062006000300009,realiza,o
83,S0210-48062006000300009,un,o
83,S0210-48062006000300009,estudio,i
83,S0210-48062006000300009,prospectivo,i
83,S0210-48062006000300009,aleatorizado,i
83,S0210-48062006000300009,con,o
83,S0210-48062006000300009,un,o
83,S0210-48062006000300009,seguimiento,i
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,tres,o
83,S0210-48062006000300009,años,o
83,S0210-48062006000300009,en,o
83,S0210-48062006000300009,150,o
83,S0210-48062006000300009,pacientes,o
83,S0210-48062006000300009,diagnosticados,i
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,litiasis,i
83,S0210-48062006000300009,calcica,i
83,S0210-48062006000300009,recidivante,o
83,S0210-48062006000300009,Los,o
83,S0210-48062006000300009,pacientes,o
83,S0210-48062006000300009,se,o
83,S0210-48062006000300009,distribuyen,o
83,S0210-48062006000300009,en,o
83,S0210-48062006000300009,tres,o
83,S0210-48062006000300009,grupos,o
83,S0210-48062006000300009,A,o
83,S0210-48062006000300009,50,o
83,S0210-48062006000300009,casos,o
83,S0210-48062006000300009,sometidos,o
83,S0210-48062006000300009,a,o
83,S0210-48062006000300009,observacion,i
83,S0210-48062006000300009,sin,o
83,S0210-48062006000300009,tratamiento,i
83,S0210-48062006000300009,B,o
83,S0210-48062006000300009,50,o
83,S0210-48062006000300009,casos,o
83,S0210-48062006000300009,tratados,i
83,S0210-48062006000300009,con,o
83,S0210-48062006000300009,50,o
83,S0210-48062006000300009,mgdia,o
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,hidroclorotiazida,i
83,S0210-48062006000300009,y,o
83,S0210-48062006000300009,C,o
83,S0210-48062006000300009,50,o
83,S0210-48062006000300009,casos,o
83,S0210-48062006000300009,tratados,i
83,S0210-48062006000300009,con,o
83,S0210-48062006000300009,50,o
83,S0210-48062006000300009,mg,o
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,hidroclorotiazida,i
83,S0210-48062006000300009,y,o
83,S0210-48062006000300009,20,o
83,S0210-48062006000300009,mlEq,o
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,citrato,o
83,S0210-48062006000300009,potasicodia,o
83,S0210-48062006000300009,En,o
83,S0210-48062006000300009,cada,o
83,S0210-48062006000300009,grupo,o
83,S0210-48062006000300009,se,o
83,S0210-48062006000300009,realiza,o
83,S0210-48062006000300009,estudio,i
83,S0210-48062006000300009,renal,i
83,S0210-48062006000300009,con,o
83,S0210-48062006000300009,tecnicas,i
83,S0210-48062006000300009,de,i
83,S0210-48062006000300009,imagen,i
83,S0210-48062006000300009,y,o
83,S0210-48062006000300009,estudio,i
83,S0210-48062006000300009,metabolico,i
83,S0210-48062006000300009,urinario,i
83,S0210-48062006000300009,basal,o
83,S0210-48062006000300009,12,o
83,S0210-48062006000300009,24,o
83,S0210-48062006000300009,y,o
83,S0210-48062006000300009,36,o
83,S0210-48062006000300009,meses,o
83,S0210-48062006000300009,Resultados,o
83,S0210-48062006000300009,En,o
83,S0210-48062006000300009,los,o
83,S0210-48062006000300009,pacientes,o
83,S0210-48062006000300009,tratados,i
83,S0210-48062006000300009,con,o
83,S0210-48062006000300009,tiazidas,i
83,S0210-48062006000300009,Grupo,o
83,S0210-48062006000300009,B,o
83,S0210-48062006000300009,y,o
83,S0210-48062006000300009,C,o
83,S0210-48062006000300009,se,o
83,S0210-48062006000300009,obtiene,o
83,S0210-48062006000300009,una,o
83,S0210-48062006000300009,reduccion,o
83,S0210-48062006000300009,significativa,o
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,recidiva,i
83,S0210-48062006000300009,litiasica,i
83,S0210-48062006000300009,en,o
83,S0210-48062006000300009,relacion,o
83,S0210-48062006000300009,con,o
83,S0210-48062006000300009,el,o
83,S0210-48062006000300009,grupo,o
83,S0210-48062006000300009,control,o
83,S0210-48062006000300009,Grupo,o
83,S0210-48062006000300009,A,o
83,S0210-48062006000300009,La,o
83,S0210-48062006000300009,alteracion,i
83,S0210-48062006000300009,mas,o
83,S0210-48062006000300009,frecuente,o
83,S0210-48062006000300009,encontrada,o
83,S0210-48062006000300009,en,o
83,S0210-48062006000300009,el,o
83,S0210-48062006000300009,estudio,i
83,S0210-48062006000300009,metabolico,i
83,S0210-48062006000300009,fue,o
83,S0210-48062006000300009,hipercalciuria,i
83,S0210-48062006000300009,52,o
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,los,o
83,S0210-48062006000300009,casos,o
83,S0210-48062006000300009,el,o
83,S0210-48062006000300009,16,o
83,S0210-48062006000300009,presentan,o
83,S0210-48062006000300009,patron,o
83,S0210-48062006000300009,litogeno,o
83,S0210-48062006000300009,mixto,o
83,S0210-48062006000300009,El,o
83,S0210-48062006000300009,numero,o
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,recidivas,o
83,S0210-48062006000300009,y,o
83,S0210-48062006000300009,necesidad,o
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,nuevas,o
83,S0210-48062006000300009,sesiones,o
83,S0210-48062006000300009,de,o
83,S0210-48062006000300009,litotricia,i
83,S0210-48062006000300009,extracorporea,i
83,S0210-48062006000300009,en,o
83,S0210-48062006000300009,los,o
83,S0210-48062006000300009,pacientes,o
83,S0210-48062006000300009,con,o
83,S0210-48062006000300009,hipercalciuria,i
83,S0210-48062006000300009,tratados,i
83,S0210-48062006000300009,con,o
83,S0210-48062006000300009,tiazidas,i
83,S0210-48062006000300009,disminuye,o
83,S0210-48062006000300009,significativamente,o
83,S0210-48062006000300009,con,o
83,S0210-48062006000300009,respecto,o
83,S0210-48062006000300009,al,o
83,S0210-48062006000300009,Grupo,o
83,S0210-48062006000300009,A,o
83,S0210-48062006000300009,p0003,o
83,S0210-48062006000300009,Conclusiones,o
83,S0210-48062006000300009,Se,o
83,S0210-48062006000300009,observa,o
83,S0210-48062006000300009,una,o
83,S0210-48062006000300009,relacion,o
83,S0210-48062006000300009,significativa,o
83,S0210-48062006000300009,entre,o
83,S0210-48062006000300009,patron,o
83,S0210-48062006000300009,litogeno,o
83,S0210-48062006000300009,y,o
83,S0210-48062006000300009,recidiva,i
83,S0210-48062006000300009,litiasica,i
83,S0210-48062006000300009,Las,o
83,S0210-48062006000300009,tiazidas,i
83,S0210-48062006000300009,nos,o
83,S0210-48062006000300009,ayudan,o
83,S0210-48062006000300009,a,o
83,S0210-48062006000300009,controlar,o
83,S0210-48062006000300009,los,o
83,S0210-48062006000300009,factores,o
83,S0210-48062006000300009,litogenicos,o
83,S0210-48062006000300009,y,o
83,S0210-48062006000300009,las,o
83,S0210-48062006000300009,recidivas,o
83,S0210-48062006000300009,en,o
83,S0210-48062006000300009,pacientes,o
83,S0210-48062006000300009,con,o
83,S0210-48062006000300009,litiasis,i
83,S0210-48062006000300009,calcica,i
83,S0210-48062006000300009,Este,o
83,S0210-48062006000300009,efecto,o
83,S0210-48062006000300009,es,o
83,S0210-48062006000300009,prolongado,o
83,S0210-48062006000300009,y,o
83,S0210-48062006000300009,significativo,o
83,S0210-48062006000300009,en,o
83,S0210-48062006000300009,pacientes,o
83,S0210-48062006000300009,con,o
83,S0210-48062006000300009,hipercalciuria,i
84,S0210-48062006000400009,Uso,o
84,S0210-48062006000400009,de,o
84,S0210-48062006000400009,antagonistas,i
84,S0210-48062006000400009,del,i
84,S0210-48062006000400009,calcio,i
84,S0210-48062006000400009,en,o
84,S0210-48062006000400009,el,o
84,S0210-48062006000400009,tratamiento,i
84,S0210-48062006000400009,del,o
84,S0210-48062006000400009,sindrome,i
84,S0210-48062006000400009,uretral,i
84,S0210-48062006000400009,en,o
84,S0210-48062006000400009,las,o
84,S0210-48062006000400009,mujeres,o
84,S0210-48062006000400009,con,o
84,S0210-48062006000400009,urgencia,i
84,S0210-48062006000400009,e,i
84,S0210-48062006000400009,incontinencia,i
84,S0210-48062006000400009,urinaria,i
84,S0210-48062006000400009,Objetivo,o
84,S0210-48062006000400009,Se,o
84,S0210-48062006000400009,evalua,o
84,S0210-48062006000400009,la,o
84,S0210-48062006000400009,accion,o
84,S0210-48062006000400009,de,o
84,S0210-48062006000400009,los,o
84,S0210-48062006000400009,antagonistas,i
84,S0210-48062006000400009,del,i
84,S0210-48062006000400009,calcio,i
84,S0210-48062006000400009,en,o
84,S0210-48062006000400009,el,o
84,S0210-48062006000400009,Sindrome,i
84,S0210-48062006000400009,Uretral,i
84,S0210-48062006000400009,de,o
84,S0210-48062006000400009,la,o
84,S0210-48062006000400009,mujer,o
84,S0210-48062006000400009,incontinencia,i
84,S0210-48062006000400009,urgencia,i
84,S0210-48062006000400009,disuria,i
84,S0210-48062006000400009,Pacientes,o
84,S0210-48062006000400009,y,o
84,S0210-48062006000400009,Metodos,o
84,S0210-48062006000400009,En,o
84,S0210-48062006000400009,60,o
84,S0210-48062006000400009,pacientes,o
84,S0210-48062006000400009,de,o
84,S0210-48062006000400009,sexo,o
84,S0210-48062006000400009,femenino,o
84,S0210-48062006000400009,que,o
84,S0210-48062006000400009,acudieron,o
84,S0210-48062006000400009,con,o
84,S0210-48062006000400009,Sindrome,i
84,S0210-48062006000400009,Uretral,i
84,S0210-48062006000400009,Se,o
84,S0210-48062006000400009,utilizo,o
84,S0210-48062006000400009,la,o
84,S0210-48062006000400009,Cinarizina,i
84,S0210-48062006000400009,en,o
84,S0210-48062006000400009,20,o
84,S0210-48062006000400009,pacientes,o
84,S0210-48062006000400009,y,o
84,S0210-48062006000400009,la,o
84,S0210-48062006000400009,Flunarizina,i
84,S0210-48062006000400009,en,o
84,S0210-48062006000400009,20,o
84,S0210-48062006000400009,pacientes,o
84,S0210-48062006000400009,Y,o
84,S0210-48062006000400009,en,o
84,S0210-48062006000400009,20,o
84,S0210-48062006000400009,pacientes,o
84,S0210-48062006000400009,se,o
84,S0210-48062006000400009,utilizo,o
84,S0210-48062006000400009,placebo,i
84,S0210-48062006000400009,Resultados,o
84,S0210-48062006000400009,En,o
84,S0210-48062006000400009,las,o
84,S0210-48062006000400009,pacientes,o
84,S0210-48062006000400009,que,o
84,S0210-48062006000400009,recibieron,o
84,S0210-48062006000400009,Flunarizina,i
84,S0210-48062006000400009,como,o
84,S0210-48062006000400009,Cinarizina,i
84,S0210-48062006000400009,se,o
84,S0210-48062006000400009,observo,o
84,S0210-48062006000400009,una,o
84,S0210-48062006000400009,reduccion,o
84,S0210-48062006000400009,de,o
84,S0210-48062006000400009,la,o
84,S0210-48062006000400009,incontinencia,i
84,S0210-48062006000400009,de,i
84,S0210-48062006000400009,orina,i
84,S0210-48062006000400009,de,o
84,S0210-48062006000400009,la,o
84,S0210-48062006000400009,urgencia,i
84,S0210-48062006000400009,y,o
84,S0210-48062006000400009,de,o
84,S0210-48062006000400009,la,o
84,S0210-48062006000400009,disuria,i
84,S0210-48062006000400009,la,o
84,S0210-48062006000400009,miccion,o
84,S0210-48062006000400009,fue,o
84,S0210-48062006000400009,mas,o
84,S0210-48062006000400009,prolongada,o
84,S0210-48062006000400009,y,o
84,S0210-48062006000400009,mas,o
84,S0210-48062006000400009,facil,o
84,S0210-48062006000400009,el,o
84,S0210-48062006000400009,numero,o
84,S0210-48062006000400009,de,o
84,S0210-48062006000400009,las,o
84,S0210-48062006000400009,micciones,o
84,S0210-48062006000400009,se,o
84,S0210-48062006000400009,redujo,o
84,S0210-48062006000400009,al,o
84,S0210-48062006000400009,dia,o
84,S0210-48062006000400009,comparados,o
84,S0210-48062006000400009,con,o
84,S0210-48062006000400009,las,o
84,S0210-48062006000400009,pacientes,o
84,S0210-48062006000400009,tratadas,i
84,S0210-48062006000400009,con,i
84,S0210-48062006000400009,placebo,i
84,S0210-48062006000400009,Conclusiones,o
84,S0210-48062006000400009,Los,o
84,S0210-48062006000400009,antagonistas,i
84,S0210-48062006000400009,del,i
84,S0210-48062006000400009,calcio,i
84,S0210-48062006000400009,pueden,o
84,S0210-48062006000400009,ser,o
84,S0210-48062006000400009,utiles,o
84,S0210-48062006000400009,en,o
84,S0210-48062006000400009,aquellas,o
84,S0210-48062006000400009,pacientes,o
84,S0210-48062006000400009,con,o
84,S0210-48062006000400009,sindrome,i
84,S0210-48062006000400009,uretral,i
84,S0210-48062006000400009,en,o
84,S0210-48062006000400009,especial,o
84,S0210-48062006000400009,en,o
84,S0210-48062006000400009,las,o
84,S0210-48062006000400009,mujeres,o
84,S0210-48062006000400009,mayores,o
85,S0210-48062009000100011,Electroestimulacion,i
85,S0210-48062009000100011,del,o
85,S0210-48062009000100011,nervio,i
85,S0210-48062009000100011,tibial,i
85,S0210-48062009000100011,posterior,i
85,S0210-48062009000100011,para,o
85,S0210-48062009000100011,el,o
85,S0210-48062009000100011,tratamiento,i
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,la,o
85,S0210-48062009000100011,vejiga,i
85,S0210-48062009000100011,hiperactiva,i
85,S0210-48062009000100011,Estudio,i
85,S0210-48062009000100011,prospectivo,i
85,S0210-48062009000100011,y,i
85,S0210-48062009000100011,controlado,i
85,S0210-48062009000100011,Objetivo,o
85,S0210-48062009000100011,Evaluar,i
85,S0210-48062009000100011,la,i
85,S0210-48062009000100011,eficacia,i
85,S0210-48062009000100011,y,i
85,S0210-48062009000100011,el,i
85,S0210-48062009000100011,impacto,i
85,S0210-48062009000100011,en,i
85,S0210-48062009000100011,la,i
85,S0210-48062009000100011,calidad,i
85,S0210-48062009000100011,de,i
85,S0210-48062009000100011,vida,i
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,mujeres,o
85,S0210-48062009000100011,con,o
85,S0210-48062009000100011,sintomas,i
85,S0210-48062009000100011,clinicos,i
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,VH,i
85,S0210-48062009000100011,sometidas,o
85,S0210-48062009000100011,a,o
85,S0210-48062009000100011,estimulacion,i
85,S0210-48062009000100011,electrica,i
85,S0210-48062009000100011,percutanea,i
85,S0210-48062009000100011,del,o
85,S0210-48062009000100011,nervio,i
85,S0210-48062009000100011,tibial,i
85,S0210-48062009000100011,posterior,i
85,S0210-48062009000100011,Material,o
85,S0210-48062009000100011,y,o
85,S0210-48062009000100011,metodo,o
85,S0210-48062009000100011,Ensayo,o
85,S0210-48062009000100011,clinico,o
85,S0210-48062009000100011,randomizado,o
85,S0210-48062009000100011,controlado,o
85,S0210-48062009000100011,en,o
85,S0210-48062009000100011,37,o
85,S0210-48062009000100011,mujeres,o
85,S0210-48062009000100011,con,o
85,S0210-48062009000100011,sintomas,i
85,S0210-48062009000100011,clinicos,i
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,VH,i
85,S0210-48062009000100011,evaluadas,o
85,S0210-48062009000100011,en,o
85,S0210-48062009000100011,el,o
85,S0210-48062009000100011,Servicio,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,urologia,o
85,S0210-48062009000100011,femenina,o
85,S0210-48062009000100011,del,o
85,S0210-48062009000100011,Hospital,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,Clinicas,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,UNICAMP,o
85,S0210-48062009000100011,Las,o
85,S0210-48062009000100011,pacientes,o
85,S0210-48062009000100011,que,o
85,S0210-48062009000100011,presentaron,o
85,S0210-48062009000100011,los,o
85,S0210-48062009000100011,criterios,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,inclusion,o
85,S0210-48062009000100011,fueron,o
85,S0210-48062009000100011,distribuidas,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,forma,o
85,S0210-48062009000100011,aleatoria,o
85,S0210-48062009000100011,en,o
85,S0210-48062009000100011,dos,o
85,S0210-48062009000100011,grupos,o
85,S0210-48062009000100011,21,o
85,S0210-48062009000100011,pacientes,o
85,S0210-48062009000100011,en,o
85,S0210-48062009000100011,el,o
85,S0210-48062009000100011,grupo,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,tratamiento,i
85,S0210-48062009000100011,electroestimulacion,i
85,S0210-48062009000100011,percutanea,i
85,S0210-48062009000100011,del,o
85,S0210-48062009000100011,nervio,i
85,S0210-48062009000100011,tibial,i
85,S0210-48062009000100011,posterior,i
85,S0210-48062009000100011,y,o
85,S0210-48062009000100011,16,o
85,S0210-48062009000100011,pacientes,o
85,S0210-48062009000100011,en,o
85,S0210-48062009000100011,el,o
85,S0210-48062009000100011,grupo,o
85,S0210-48062009000100011,placebo,i
85,S0210-48062009000100011,solo,o
85,S0210-48062009000100011,colocacion,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,los,o
85,S0210-48062009000100011,electrodos,o
85,S0210-48062009000100011,sin,o
85,S0210-48062009000100011,el,o
85,S0210-48062009000100011,paso,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,corriente,o
85,S0210-48062009000100011,electrica,o
85,S0210-48062009000100011,Las,o
85,S0210-48062009000100011,mujeres,o
85,S0210-48062009000100011,fueron,o
85,S0210-48062009000100011,interrogadas,o
85,S0210-48062009000100011,sobre,o
85,S0210-48062009000100011,historia,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,sintomas,i
85,S0210-48062009000100011,cirugias,i
85,S0210-48062009000100011,previas,o
85,S0210-48062009000100011,presencia,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,sintomas,i
85,S0210-48062009000100011,menopausicos,i
85,S0210-48062009000100011,frecuencia,o
85,S0210-48062009000100011,urinaria,i
85,S0210-48062009000100011,urgencia,i
85,S0210-48062009000100011,miccional,i
85,S0210-48062009000100011,y,o
85,S0210-48062009000100011,nocturia,i
85,S0210-48062009000100011,demostrado,o
85,S0210-48062009000100011,mediante,o
85,S0210-48062009000100011,diario,o
85,S0210-48062009000100011,miccional,o
85,S0210-48062009000100011,durante,o
85,S0210-48062009000100011,tres,o
85,S0210-48062009000100011,dias,o
85,S0210-48062009000100011,Se,o
85,S0210-48062009000100011,respondio,o
85,S0210-48062009000100011,el,o
85,S0210-48062009000100011,cuestionario,i
85,S0210-48062009000100011,de,i
85,S0210-48062009000100011,calidad,i
85,S0210-48062009000100011,de,i
85,S0210-48062009000100011,vida,i
85,S0210-48062009000100011,Overactive,o
85,S0210-48062009000100011,Bladder,o
85,S0210-48062009000100011,Questionnaire,o
85,S0210-48062009000100011,OABq,o
85,S0210-48062009000100011,en,o
85,S0210-48062009000100011,el,o
85,S0210-48062009000100011,momento,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,la,o
85,S0210-48062009000100011,evaluacion,i
85,S0210-48062009000100011,inicial,o
85,S0210-48062009000100011,y,o
85,S0210-48062009000100011,final,o
85,S0210-48062009000100011,del,o
85,S0210-48062009000100011,tratamiento,i
85,S0210-48062009000100011,El,o
85,S0210-48062009000100011,tratamiento,i
85,S0210-48062009000100011,consistio,o
85,S0210-48062009000100011,en,o
85,S0210-48062009000100011,8,o
85,S0210-48062009000100011,sesiones,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,electroestimulacion,i
85,S0210-48062009000100011,dos,o
85,S0210-48062009000100011,veces,o
85,S0210-48062009000100011,por,o
85,S0210-48062009000100011,semana,o
85,S0210-48062009000100011,con,o
85,S0210-48062009000100011,duracion,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,30,o
85,S0210-48062009000100011,minutos,o
85,S0210-48062009000100011,cada,o
85,S0210-48062009000100011,sesion,o
85,S0210-48062009000100011,Resultados,o
85,S0210-48062009000100011,El,o
85,S0210-48062009000100011,trabajo,o
85,S0210-48062009000100011,mostro,o
85,S0210-48062009000100011,cambios,o
85,S0210-48062009000100011,significativos,o
85,S0210-48062009000100011,en,o
85,S0210-48062009000100011,los,o
85,S0210-48062009000100011,sintomas,i
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,frecuencia,o
85,S0210-48062009000100011,y,o
85,S0210-48062009000100011,nocturia,i
85,S0210-48062009000100011,en,o
85,S0210-48062009000100011,el,o
85,S0210-48062009000100011,grupo,o
85,S0210-48062009000100011,sometido,o
85,S0210-48062009000100011,a,o
85,S0210-48062009000100011,electroestimulacion,i
85,S0210-48062009000100011,del,o
85,S0210-48062009000100011,nervio,i
85,S0210-48062009000100011,tibial,i
85,S0210-48062009000100011,posterior,i
85,S0210-48062009000100011,P0003,o
85,S0210-48062009000100011,ep,o
85,S0210-48062009000100011,0001,o
85,S0210-48062009000100011,respectivamente,o
85,S0210-48062009000100011,La,o
85,S0210-48062009000100011,urgencia,i
85,S0210-48062009000100011,miccional,i
85,S0210-48062009000100011,y,o
85,S0210-48062009000100011,la,o
85,S0210-48062009000100011,calidad,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,vida,o
85,S0210-48062009000100011,mejoro,o
85,S0210-48062009000100011,en,o
85,S0210-48062009000100011,ambos,o
85,S0210-48062009000100011,grupos,o
85,S0210-48062009000100011,significativamente,o
85,S0210-48062009000100011,Conclusion,o
85,S0210-48062009000100011,la,o
85,S0210-48062009000100011,electroestimulacion,i
85,S0210-48062009000100011,del,o
85,S0210-48062009000100011,nervio,i
85,S0210-48062009000100011,tibial,i
85,S0210-48062009000100011,posterior,i
85,S0210-48062009000100011,demostro,o
85,S0210-48062009000100011,ser,o
85,S0210-48062009000100011,un,o
85,S0210-48062009000100011,tratamiento,i
85,S0210-48062009000100011,fisioterapeutico,i
85,S0210-48062009000100011,eficaz,o
85,S0210-48062009000100011,en,o
85,S0210-48062009000100011,el,o
85,S0210-48062009000100011,tratamiento,i
85,S0210-48062009000100011,de,i
85,S0210-48062009000100011,los,i
85,S0210-48062009000100011,sintomas,i
85,S0210-48062009000100011,clinicos,i
85,S0210-48062009000100011,y,o
85,S0210-48062009000100011,mejoria,o
85,S0210-48062009000100011,la,o
85,S0210-48062009000100011,calidad,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,vida,o
85,S0210-48062009000100011,de,o
85,S0210-48062009000100011,las,o
85,S0210-48062009000100011,mujeres,o
85,S0210-48062009000100011,con,o
85,S0210-48062009000100011,VH,i
86,S0210-48062009000200010,Procedimiento,i
86,S0210-48062009000200010,Cabestrillo,i
86,S0210-48062009000200010,Autologo,o
86,S0210-48062009000200010,versus,o
86,S0210-48062009000200010,Sintetico,o
86,S0210-48062009000200010,Tasa,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,exito,o
86,S0210-48062009000200010,y,o
86,S0210-48062009000200010,frecuencia,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,obstruccion,i
86,S0210-48062009000200010,del,i
86,S0210-48062009000200010,tracto,i
86,S0210-48062009000200010,urinario,i
86,S0210-48062009000200010,inferior,i
86,S0210-48062009000200010,Introduccion,o
86,S0210-48062009000200010,Disfuncion,i
86,S0210-48062009000200010,en,i
86,S0210-48062009000200010,el,i
86,S0210-48062009000200010,vaciamiento,i
86,S0210-48062009000200010,y,o
86,S0210-48062009000200010,retencion,i
86,S0210-48062009000200010,urinaria,i
86,S0210-48062009000200010,son,o
86,S0210-48062009000200010,complicaciones,i
86,S0210-48062009000200010,frecuentes,o
86,S0210-48062009000200010,del,o
86,S0210-48062009000200010,cabestrillo,o
86,S0210-48062009000200010,Recientemente,o
86,S0210-48062009000200010,se,o
86,S0210-48062009000200010,han,o
86,S0210-48062009000200010,incluido,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,el,o
86,S0210-48062009000200010,arsenal,o
86,S0210-48062009000200010,para,o
86,S0210-48062009000200010,el,o
86,S0210-48062009000200010,soporte,o
86,S0210-48062009000200010,suburetral,o
86,S0210-48062009000200010,suministros,o
86,S0210-48062009000200010,sinteticos,o
86,S0210-48062009000200010,tales,o
86,S0210-48062009000200010,como,o
86,S0210-48062009000200010,la,o
86,S0210-48062009000200010,malla,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,polipropilenol,i
86,S0210-48062009000200010,Metodos,o
86,S0210-48062009000200010,Se,o
86,S0210-48062009000200010,llevo,o
86,S0210-48062009000200010,a,o
86,S0210-48062009000200010,cabo,o
86,S0210-48062009000200010,un,o
86,S0210-48062009000200010,Estudio,i
86,S0210-48062009000200010,prospectivo,i
86,S0210-48062009000200010,no,i
86,S0210-48062009000200010,aleatorizado,i
86,S0210-48062009000200010,El,o
86,S0210-48062009000200010,procedimiento,i
86,S0210-48062009000200010,cabestrillo,i
86,S0210-48062009000200010,se,o
86,S0210-48062009000200010,realizo,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,436,o
86,S0210-48062009000200010,pacientes,o
86,S0210-48062009000200010,consecutivos,o
86,S0210-48062009000200010,con,o
86,S0210-48062009000200010,IUE,i
86,S0210-48062009000200010,Incontinencia,i
86,S0210-48062009000200010,Urinaria,i
86,S0210-48062009000200010,de,i
86,S0210-48062009000200010,Esfuerzo,i
86,S0210-48062009000200010,Las,o
86,S0210-48062009000200010,pacientes,o
86,S0210-48062009000200010,fueron,o
86,S0210-48062009000200010,divididas,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,grupos,o
86,S0210-48062009000200010,segun,o
86,S0210-48062009000200010,el,o
86,S0210-48062009000200010,tipo,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,malla,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,autologos,o
86,S0210-48062009000200010,210,o
86,S0210-48062009000200010,y,o
86,S0210-48062009000200010,226,o
86,S0210-48062009000200010,sinteticos,o
86,S0210-48062009000200010,Las,o
86,S0210-48062009000200010,pacientes,o
86,S0210-48062009000200010,fueron,o
86,S0210-48062009000200010,evaluadas,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,cuanto,o
86,S0210-48062009000200010,a,o
86,S0210-48062009000200010,condicion,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,vaciamiento,o
86,S0210-48062009000200010,continencia,o
86,S0210-48062009000200010,y,o
86,S0210-48062009000200010,satisfaccion,o
86,S0210-48062009000200010,Los,o
86,S0210-48062009000200010,resultados,o
86,S0210-48062009000200010,quirurgicos,o
86,S0210-48062009000200010,fueron,o
86,S0210-48062009000200010,evaluados,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,funcion,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,la,o
86,S0210-48062009000200010,clasificacion,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,Blaivas,o
86,S0210-48062009000200010,Se,o
86,S0210-48062009000200010,considero,o
86,S0210-48062009000200010,significativo,o
86,S0210-48062009000200010,p005,o
86,S0210-48062009000200010,Resultados,o
86,S0210-48062009000200010,La,o
86,S0210-48062009000200010,media,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,edad,o
86,S0210-48062009000200010,fue,o
86,S0210-48062009000200010,484,o
86,S0210-48062009000200010,años,o
86,S0210-48062009000200010,El,o
86,S0210-48062009000200010,tiempo,o
86,S0210-48062009000200010,medio,o
86,S0210-48062009000200010,operatorio,o
86,S0210-48062009000200010,para,o
86,S0210-48062009000200010,los,o
86,S0210-48062009000200010,Cabestrillo,i
86,S0210-48062009000200010,autologos,i
86,S0210-48062009000200010,fue,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,1076,o
86,S0210-48062009000200010,minutos,o
86,S0210-48062009000200010,frente,o
86,S0210-48062009000200010,a,o
86,S0210-48062009000200010,206,o
86,S0210-48062009000200010,min,o
86,S0210-48062009000200010,para,o
86,S0210-48062009000200010,el,o
86,S0210-48062009000200010,sintetico,o
86,S0210-48062009000200010,El,o
86,S0210-48062009000200010,promedio,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,hospitalizacion,i
86,S0210-48062009000200010,fue,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,36,o
86,S0210-48062009000200010,horas,o
86,S0210-48062009000200010,para,o
86,S0210-48062009000200010,autologos,o
86,S0210-48062009000200010,frente,o
86,S0210-48062009000200010,a,o
86,S0210-48062009000200010,24,o
86,S0210-48062009000200010,horas,o
86,S0210-48062009000200010,para,o
86,S0210-48062009000200010,los,o
86,S0210-48062009000200010,sinteticos,o
86,S0210-48062009000200010,y,o
86,S0210-48062009000200010,la,o
86,S0210-48062009000200010,media,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,seguimiento,i
86,S0210-48062009000200010,fue,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,25,o
86,S0210-48062009000200010,meses,o
86,S0210-48062009000200010,Se,o
86,S0210-48062009000200010,encontro,o
86,S0210-48062009000200010,871,o
86,S0210-48062009000200010,y,o
86,S0210-48062009000200010,929,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,las,o
86,S0210-48062009000200010,pacientes,o
86,S0210-48062009000200010,continentes,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,los,o
86,S0210-48062009000200010,grupos,o
86,S0210-48062009000200010,autologos,o
86,S0210-48062009000200010,y,o
86,S0210-48062009000200010,sinteticos,o
86,S0210-48062009000200010,respectivamente,o
86,S0210-48062009000200010,Fallo,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,el,o
86,S0210-48062009000200010,procedimiento,i
86,S0210-48062009000200010,se,o
86,S0210-48062009000200010,presento,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,un,o
86,S0210-48062009000200010,7,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,el,o
86,S0210-48062009000200010,grupo,o
86,S0210-48062009000200010,autologo,o
86,S0210-48062009000200010,y,o
86,S0210-48062009000200010,48,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,el,o
86,S0210-48062009000200010,sintetico,o
86,S0210-48062009000200010,p01961,o
86,S0210-48062009000200010,La,o
86,S0210-48062009000200010,tasa,o
86,S0210-48062009000200010,global,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,obstruccion,i
86,S0210-48062009000200010,del,i
86,S0210-48062009000200010,tracto,i
86,S0210-48062009000200010,urinario,i
86,S0210-48062009000200010,inferior,i
86,S0210-48062009000200010,fue,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,45,o
86,S0210-48062009000200010,20436,o
86,S0210-48062009000200010,cuando,o
86,S0210-48062009000200010,se,o
86,S0210-48062009000200010,analizo,o
86,S0210-48062009000200010,por,o
86,S0210-48062009000200010,grupos,o
86,S0210-48062009000200010,encontramos,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,el,o
86,S0210-48062009000200010,grupo,o
86,S0210-48062009000200010,autologo,o
86,S0210-48062009000200010,una,o
86,S0210-48062009000200010,tasa,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,85,o
86,S0210-48062009000200010,18210,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,comparacion,o
86,S0210-48062009000200010,con,o
86,S0210-48062009000200010,el,o
86,S0210-48062009000200010,09,o
86,S0210-48062009000200010,en,o
86,S0210-48062009000200010,el,o
86,S0210-48062009000200010,grupo,o
86,S0210-48062009000200010,sintetico,o
86,S0210-48062009000200010,2226,o
86,S0210-48062009000200010,p0000126,o
86,S0210-48062009000200010,Conclusiones,o
86,S0210-48062009000200010,Cabestrillos,i
86,S0210-48062009000200010,autologos,i
86,S0210-48062009000200010,y,i
86,S0210-48062009000200010,sinteticos,i
86,S0210-48062009000200010,presentan,o
86,S0210-48062009000200010,las,o
86,S0210-48062009000200010,tasas,o
86,S0210-48062009000200010,de,o
86,S0210-48062009000200010,exito,o
86,S0210-48062009000200010,comparables,o
86,S0210-48062009000200010,sin,o
86,S0210-48062009000200010,embargo,o
86,S0210-48062009000200010,la,o
86,S0210-48062009000200010,obstruccion,i
86,S0210-48062009000200010,del,i
86,S0210-48062009000200010,tracto,i
86,S0210-48062009000200010,urinario,i
86,S0210-48062009000200010,inferior,i
86,S0210-48062009000200010,fue,o
86,S0210-48062009000200010,mas,o
86,S0210-48062009000200010,comun,o
86,S0210-48062009000200010,entre,o
86,S0210-48062009000200010,las,o
86,S0210-48062009000200010,pacientes,o
86,S0210-48062009000200010,tratadas,i
86,S0210-48062009000200010,con,i
86,S0210-48062009000200010,fascias,i
86,S0210-48062009000200010,autologas,i
87,S0210-48062010000300010,Analisis,i
87,S0210-48062010000300010,de,i
87,S0210-48062010000300010,la,i
87,S0210-48062010000300010,utilidad,i
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,la,o
87,S0210-48062010000300010,preparacion,i
87,S0210-48062010000300010,intestinal,i
87,S0210-48062010000300010,en,o
87,S0210-48062010000300010,la,o
87,S0210-48062010000300010,prevencion,i
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,complicaciones,i
87,S0210-48062010000300010,postoperatorias,i
87,S0210-48062010000300010,en,o
87,S0210-48062010000300010,cirugia,i
87,S0210-48062010000300010,endoscopica,i
87,S0210-48062010000300010,Objetivos,o
87,S0210-48062010000300010,Determinar,o
87,S0210-48062010000300010,la,o
87,S0210-48062010000300010,relacion,o
87,S0210-48062010000300010,entre,o
87,S0210-48062010000300010,la,o
87,S0210-48062010000300010,preparacion,i
87,S0210-48062010000300010,mecanica,i
87,S0210-48062010000300010,intestinal,i
87,S0210-48062010000300010,previa,o
87,S0210-48062010000300010,a,o
87,S0210-48062010000300010,la,o
87,S0210-48062010000300010,cirugia,i
87,S0210-48062010000300010,endourologica,i
87,S0210-48062010000300010,y,o
87,S0210-48062010000300010,la,o
87,S0210-48062010000300010,existencia,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,complicaciones,i
87,S0210-48062010000300010,postoperatorias,i
87,S0210-48062010000300010,Material,o
87,S0210-48062010000300010,y,o
87,S0210-48062010000300010,metodos,o
87,S0210-48062010000300010,Diseñamos,o
87,S0210-48062010000300010,un,o
87,S0210-48062010000300010,estudio,i
87,S0210-48062010000300010,prospectivo,i
87,S0210-48062010000300010,y,i
87,S0210-48062010000300010,aleatorizado,i
87,S0210-48062010000300010,con,o
87,S0210-48062010000300010,162,o
87,S0210-48062010000300010,pacientes,o
87,S0210-48062010000300010,intervenidos,i
87,S0210-48062010000300010,mediante,o
87,S0210-48062010000300010,RTU,i
87,S0210-48062010000300010,vesical,i
87,S0210-48062010000300010,RTU,i
87,S0210-48062010000300010,prostatica,i
87,S0210-48062010000300010,y,o
87,S0210-48062010000300010,adenomectomia,i
87,S0210-48062010000300010,laser,i
87,S0210-48062010000300010,entre,o
87,S0210-48062010000300010,octubre,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,2008,o
87,S0210-48062010000300010,y,o
87,S0210-48062010000300010,febrero,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,2009,o
87,S0210-48062010000300010,sin,o
87,S0210-48062010000300010,excluir,o
87,S0210-48062010000300010,a,o
87,S0210-48062010000300010,ningun,o
87,S0210-48062010000300010,paciente,o
87,S0210-48062010000300010,A,o
87,S0210-48062010000300010,66,o
87,S0210-48062010000300010,pacientes,o
87,S0210-48062010000300010,se,o
87,S0210-48062010000300010,les,o
87,S0210-48062010000300010,administro,o
87,S0210-48062010000300010,un,o
87,S0210-48062010000300010,enema,i
87,S0210-48062010000300010,previo,o
87,S0210-48062010000300010,a,o
87,S0210-48062010000300010,la,o
87,S0210-48062010000300010,cirugia,i
87,S0210-48062010000300010,y,o
87,S0210-48062010000300010,a,o
87,S0210-48062010000300010,los,o
87,S0210-48062010000300010,restantes,o
87,S0210-48062010000300010,no,o
87,S0210-48062010000300010,Analizamos,o
87,S0210-48062010000300010,la,o
87,S0210-48062010000300010,incidencia,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,infeccion,i
87,S0210-48062010000300010,urinaria,i
87,S0210-48062010000300010,ITU,i
87,S0210-48062010000300010,fiebre,i
87,S0210-48062010000300010,retencion,i
87,S0210-48062010000300010,aguda,i
87,S0210-48062010000300010,de,i
87,S0210-48062010000300010,orina,i
87,S0210-48062010000300010,necesidad,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,enemas,i
87,S0210-48062010000300010,o,o
87,S0210-48062010000300010,laxantes,i
87,S0210-48062010000300010,durante,o
87,S0210-48062010000300010,el,o
87,S0210-48062010000300010,postoperatorio,o
87,S0210-48062010000300010,contaminacion,o
87,S0210-48062010000300010,del,o
87,S0210-48062010000300010,campo,o
87,S0210-48062010000300010,quirurgico,o
87,S0210-48062010000300010,y,o
87,S0210-48062010000300010,la,o
87,S0210-48062010000300010,estancia,o
87,S0210-48062010000300010,media,o
87,S0210-48062010000300010,Realizamos,o
87,S0210-48062010000300010,un,o
87,S0210-48062010000300010,analisis,i
87,S0210-48062010000300010,descriptivo,i
87,S0210-48062010000300010,comparacion,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,medias,o
87,S0210-48062010000300010,t,o
87,S0210-48062010000300010,test,o
87,S0210-48062010000300010,y,o
87,S0210-48062010000300010,chi,o
87,S0210-48062010000300010,cuadrado,o
87,S0210-48062010000300010,Resultados,o
87,S0210-48062010000300010,La,o
87,S0210-48062010000300010,edad,o
87,S0210-48062010000300010,media,o
87,S0210-48062010000300010,fue,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,705,o
87,S0210-48062010000300010,años,o
87,S0210-48062010000300010,DS1062,o
87,S0210-48062010000300010,y,o
87,S0210-48062010000300010,la,o
87,S0210-48062010000300010,estancia,o
87,S0210-48062010000300010,media,o
87,S0210-48062010000300010,fue,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,48,o
87,S0210-48062010000300010,dias,o
87,S0210-48062010000300010,DS39,o
87,S0210-48062010000300010,Un,o
87,S0210-48062010000300010,62,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,los,o
87,S0210-48062010000300010,pacientes,o
87,S0210-48062010000300010,tuvo,o
87,S0210-48062010000300010,ITU,i
87,S0210-48062010000300010,un,o
87,S0210-48062010000300010,31,o
87,S0210-48062010000300010,tuvo,o
87,S0210-48062010000300010,fiebre,i
87,S0210-48062010000300010,un,o
87,S0210-48062010000300010,12,o
87,S0210-48062010000300010,presento,o
87,S0210-48062010000300010,retencion,i
87,S0210-48062010000300010,aguda,i
87,S0210-48062010000300010,de,i
87,S0210-48062010000300010,orina,i
87,S0210-48062010000300010,y,o
87,S0210-48062010000300010,el,o
87,S0210-48062010000300010,154,o
87,S0210-48062010000300010,necesito,o
87,S0210-48062010000300010,enemas,i
87,S0210-48062010000300010,o,o
87,S0210-48062010000300010,laxantes,i
87,S0210-48062010000300010,Se,o
87,S0210-48062010000300010,recogio,o
87,S0210-48062010000300010,un,o
87,S0210-48062010000300010,caso,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,contaminacion,o
87,S0210-48062010000300010,con,o
87,S0210-48062010000300010,heces,i
87,S0210-48062010000300010,del,o
87,S0210-48062010000300010,campo,o
87,S0210-48062010000300010,quirurgico,o
87,S0210-48062010000300010,06,o
87,S0210-48062010000300010,No,o
87,S0210-48062010000300010,se,o
87,S0210-48062010000300010,encontraron,o
87,S0210-48062010000300010,diferencias,o
87,S0210-48062010000300010,estadisticamente,o
87,S0210-48062010000300010,significativas,o
87,S0210-48062010000300010,para,o
87,S0210-48062010000300010,las,o
87,S0210-48062010000300010,variables,o
87,S0210-48062010000300010,analizadas,o
87,S0210-48062010000300010,entre,o
87,S0210-48062010000300010,ambos,o
87,S0210-48062010000300010,grupos,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,estudio,o
87,S0210-48062010000300010,Conclusiones,o
87,S0210-48062010000300010,En,o
87,S0210-48062010000300010,nuestra,o
87,S0210-48062010000300010,serie,o
87,S0210-48062010000300010,la,o
87,S0210-48062010000300010,preparacion,i
87,S0210-48062010000300010,intestinal,i
87,S0210-48062010000300010,mediante,o
87,S0210-48062010000300010,el,o
87,S0210-48062010000300010,empleo,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,enemas,i
87,S0210-48062010000300010,no,o
87,S0210-48062010000300010,ha,o
87,S0210-48062010000300010,demostrado,o
87,S0210-48062010000300010,utilidad,o
87,S0210-48062010000300010,para,o
87,S0210-48062010000300010,disminuir,o
87,S0210-48062010000300010,complicaciones,i
87,S0210-48062010000300010,durante,o
87,S0210-48062010000300010,el,o
87,S0210-48062010000300010,postoperatorio,o
87,S0210-48062010000300010,de,o
87,S0210-48062010000300010,cirugia,i
87,S0210-48062010000300010,endourologica,i
88,S0210-48062011000400006,Debe,o
88,S0210-48062011000400006,emplearse,o
88,S0210-48062011000400006,de,o
88,S0210-48062011000400006,manera,o
88,S0210-48062011000400006,sistematica,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,cateterismo,i
88,S0210-48062011000400006,ureteral,i
88,S0210-48062011000400006,en,o
88,S0210-48062011000400006,los,o
88,S0210-48062011000400006,implantes,i
88,S0210-48062011000400006,renales,i
88,S0210-48062011000400006,Objetivo,o
88,S0210-48062011000400006,Evaluar,o
88,S0210-48062011000400006,si,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,uso,i
88,S0210-48062011000400006,sistematico,i
88,S0210-48062011000400006,de,i
88,S0210-48062011000400006,cateter,i
88,S0210-48062011000400006,ureteral,i
88,S0210-48062011000400006,doble,i
88,S0210-48062011000400006,J,i
88,S0210-48062011000400006,en,o
88,S0210-48062011000400006,las,o
88,S0210-48062011000400006,ureteroneocistostomias,i
88,S0210-48062011000400006,de,o
88,S0210-48062011000400006,los,o
88,S0210-48062011000400006,trasplantes,i
88,S0210-48062011000400006,renales,i
88,S0210-48062011000400006,reduce,o
88,S0210-48062011000400006,la,o
88,S0210-48062011000400006,tasa,o
88,S0210-48062011000400006,de,o
88,S0210-48062011000400006,complicaciones,i
88,S0210-48062011000400006,Material,o
88,S0210-48062011000400006,y,o
88,S0210-48062011000400006,metodos,o
88,S0210-48062011000400006,Estudio,i
88,S0210-48062011000400006,prospectivo,i
88,S0210-48062011000400006,comparativo,i
88,S0210-48062011000400006,no,i
88,S0210-48062011000400006,aleatorizado,i
88,S0210-48062011000400006,de,i
88,S0210-48062011000400006,grupos,i
88,S0210-48062011000400006,paralelos,i
88,S0210-48062011000400006,en,o
88,S0210-48062011000400006,194,o
88,S0210-48062011000400006,trasplantes,i
88,S0210-48062011000400006,renales,i
88,S0210-48062011000400006,Se,o
88,S0210-48062011000400006,establecieron,o
88,S0210-48062011000400006,dos,o
88,S0210-48062011000400006,grupos,o
88,S0210-48062011000400006,homogeneos,o
88,S0210-48062011000400006,111,o
88,S0210-48062011000400006,pacientes,o
88,S0210-48062011000400006,con,o
88,S0210-48062011000400006,cateter,o
88,S0210-48062011000400006,doble,o
88,S0210-48062011000400006,J,o
88,S0210-48062011000400006,y,o
88,S0210-48062011000400006,otro,o
88,S0210-48062011000400006,de,o
88,S0210-48062011000400006,83,o
88,S0210-48062011000400006,pacientes,o
88,S0210-48062011000400006,sin,o
88,S0210-48062011000400006,cateter,o
88,S0210-48062011000400006,Analizamos,o
88,S0210-48062011000400006,la,o
88,S0210-48062011000400006,incidencia,o
88,S0210-48062011000400006,de,o
88,S0210-48062011000400006,complicaciones,i
88,S0210-48062011000400006,entre,o
88,S0210-48062011000400006,ambos,o
88,S0210-48062011000400006,grupos,o
88,S0210-48062011000400006,mediante,o
88,S0210-48062011000400006,analisis,o
88,S0210-48062011000400006,univariante,o
88,S0210-48062011000400006,comparativo,o
88,S0210-48062011000400006,test,o
88,S0210-48062011000400006,de,o
88,S0210-48062011000400006,χ2,o
88,S0210-48062011000400006,y,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,analisis,o
88,S0210-48062011000400006,multivariante,o
88,S0210-48062011000400006,regresion,o
88,S0210-48062011000400006,logistica,o
88,S0210-48062011000400006,Resultados,o
88,S0210-48062011000400006,En,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,grupo,o
88,S0210-48062011000400006,con,o
88,S0210-48062011000400006,cateter,o
88,S0210-48062011000400006,las,o
88,S0210-48062011000400006,complicaciones,i
88,S0210-48062011000400006,globales,o
88,S0210-48062011000400006,aparecieron,o
88,S0210-48062011000400006,en,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,222,o
88,S0210-48062011000400006,frente,o
88,S0210-48062011000400006,al,o
88,S0210-48062011000400006,433,o
88,S0210-48062011000400006,del,o
88,S0210-48062011000400006,grupo,o
88,S0210-48062011000400006,sin,o
88,S0210-48062011000400006,cateter,o
88,S0210-48062011000400006,p004,o
88,S0210-48062011000400006,En,o
88,S0210-48062011000400006,funcion,o
88,S0210-48062011000400006,del,o
88,S0210-48062011000400006,reimplante,i
88,S0210-48062011000400006,ureteral,i
88,S0210-48062011000400006,aparecieron,o
88,S0210-48062011000400006,complicaciones,i
88,S0210-48062011000400006,en,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,3812,o
88,S0210-48062011000400006,del,o
88,S0210-48062011000400006,reimplante,i
88,S0210-48062011000400006,tipo,i
88,S0210-48062011000400006,Paquin,i
88,S0210-48062011000400006,frente,o
88,S0210-48062011000400006,al,o
88,S0210-48062011000400006,203,o
88,S0210-48062011000400006,en,o
88,S0210-48062011000400006,LichGregoir,o
88,S0210-48062011000400006,p009,o
88,S0210-48062011000400006,En,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,grupo,o
88,S0210-48062011000400006,con,o
88,S0210-48062011000400006,cateter,o
88,S0210-48062011000400006,se,o
88,S0210-48062011000400006,evidencio,o
88,S0210-48062011000400006,una,o
88,S0210-48062011000400006,09,o
88,S0210-48062011000400006,fistula,i
88,S0210-48062011000400006,urinaria,i
88,S0210-48062011000400006,frente,o
88,S0210-48062011000400006,a,o
88,S0210-48062011000400006,5,o
88,S0210-48062011000400006,6,o
88,S0210-48062011000400006,del,o
88,S0210-48062011000400006,grupo,o
88,S0210-48062011000400006,sin,o
88,S0210-48062011000400006,cateter,o
88,S0210-48062011000400006,p008,o
88,S0210-48062011000400006,y,o
88,S0210-48062011000400006,3,o
88,S0210-48062011000400006,27,o
88,S0210-48062011000400006,estenosis,i
88,S0210-48062011000400006,de,i
88,S0210-48062011000400006,la,i
88,S0210-48062011000400006,anastomosis,i
88,S0210-48062011000400006,ureterovesical,i
88,S0210-48062011000400006,en,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,grupo,o
88,S0210-48062011000400006,con,o
88,S0210-48062011000400006,cateter,o
88,S0210-48062011000400006,frente,o
88,S0210-48062011000400006,a,o
88,S0210-48062011000400006,7,o
88,S0210-48062011000400006,84,o
88,S0210-48062011000400006,del,o
88,S0210-48062011000400006,grupo,o
88,S0210-48062011000400006,sin,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,p013,o
88,S0210-48062011000400006,El,o
88,S0210-48062011000400006,analisis,o
88,S0210-48062011000400006,multivariante,o
88,S0210-48062011000400006,demostro,o
88,S0210-48062011000400006,que,o
88,S0210-48062011000400006,la,o
88,S0210-48062011000400006,no,o
88,S0210-48062011000400006,utilizacion,i
88,S0210-48062011000400006,de,i
88,S0210-48062011000400006,cateter,i
88,S0210-48062011000400006,aumenta,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,riesgo,o
88,S0210-48062011000400006,de,o
88,S0210-48062011000400006,sufrir,o
88,S0210-48062011000400006,complicaciones,i
88,S0210-48062011000400006,relacionadas,o
88,S0210-48062011000400006,con,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,reimplante,i
88,S0210-48062011000400006,OR,o
88,S0210-48062011000400006,255,o
88,S0210-48062011000400006,IC,o
88,S0210-48062011000400006,95,o
88,S0210-48062011000400006,137475,o
88,S0210-48062011000400006,El,o
88,S0210-48062011000400006,riesgo,o
88,S0210-48062011000400006,de,o
88,S0210-48062011000400006,fistula,i
88,S0210-48062011000400006,aumento,o
88,S0210-48062011000400006,significativamente,o
88,S0210-48062011000400006,al,o
88,S0210-48062011000400006,no,o
88,S0210-48062011000400006,colocar,i
88,S0210-48062011000400006,cateter,i
88,S0210-48062011000400006,OR,o
88,S0210-48062011000400006,919,o
88,S0210-48062011000400006,IC,o
88,S0210-48062011000400006,95,o
88,S0210-48062011000400006,101847,o
88,S0210-48062011000400006,No,o
88,S0210-48062011000400006,hubo,o
88,S0210-48062011000400006,diferencias,o
88,S0210-48062011000400006,entre,o
88,S0210-48062011000400006,ambos,o
88,S0210-48062011000400006,grupos,o
88,S0210-48062011000400006,en,o
88,S0210-48062011000400006,cuanto,o
88,S0210-48062011000400006,a,o
88,S0210-48062011000400006,las,o
88,S0210-48062011000400006,infecciones,i
88,S0210-48062011000400006,del,i
88,S0210-48062011000400006,tracto,i
88,S0210-48062011000400006,urinario,i
88,S0210-48062011000400006,produciendose,o
88,S0210-48062011000400006,tres,o
88,S0210-48062011000400006,27,o
88,S0210-48062011000400006,en,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,grupo,o
88,S0210-48062011000400006,con,o
88,S0210-48062011000400006,cateter,o
88,S0210-48062011000400006,y,o
88,S0210-48062011000400006,una,o
88,S0210-48062011000400006,12,o
88,S0210-48062011000400006,en,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,grupo,o
88,S0210-48062011000400006,sin,o
88,S0210-48062011000400006,cateter,o
88,S0210-48062011000400006,p063,o
88,S0210-48062011000400006,Conclusiones,o
88,S0210-48062011000400006,La,o
88,S0210-48062011000400006,colocacion,i
88,S0210-48062011000400006,de,i
88,S0210-48062011000400006,cateter,i
88,S0210-48062011000400006,doble,i
88,S0210-48062011000400006,J,i
88,S0210-48062011000400006,reduce,o
88,S0210-48062011000400006,las,o
88,S0210-48062011000400006,complicaciones,i
88,S0210-48062011000400006,relacionadas,o
88,S0210-48062011000400006,con,o
88,S0210-48062011000400006,el,o
88,S0210-48062011000400006,reimplante,i
88,S0210-48062011000400006,ureteral,i
88,S0210-48062011000400006,sin,o
88,S0210-48062011000400006,aumentar,o
88,S0210-48062011000400006,la,o
88,S0210-48062011000400006,morbilidad,o
88,S0210-48062011000400006,asociada,o
88,S0210-48062011000400006,a,o
88,S0210-48062011000400006,su,o
88,S0210-48062011000400006,uso,o
89,S0210-56912006000700002,Uso,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,epoprostenol,i
89,S0210-56912006000700002,aislado,o
89,S0210-56912006000700002,o,o
89,S0210-56912006000700002,asociado,o
89,S0210-56912006000700002,a,o
89,S0210-56912006000700002,heparina,i
89,S0210-56912006000700002,para,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,mantenimiento,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,la,o
89,S0210-56912006000700002,permeabilidad,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,los,o
89,S0210-56912006000700002,circuitos,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,tecnicas,i
89,S0210-56912006000700002,continuas,i
89,S0210-56912006000700002,de,i
89,S0210-56912006000700002,reemplazo,i
89,S0210-56912006000700002,renal,i
89,S0210-56912006000700002,Objetivo,o
89,S0210-56912006000700002,Actualmente,o
89,S0210-56912006000700002,no,o
89,S0210-56912006000700002,existe,o
89,S0210-56912006000700002,consenso,o
89,S0210-56912006000700002,sobre,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,mejor,o
89,S0210-56912006000700002,regimen,i
89,S0210-56912006000700002,anticoagulante,i
89,S0210-56912006000700002,para,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,mantenimiento,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,los,o
89,S0210-56912006000700002,circuitos,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,depuracion,i
89,S0210-56912006000700002,extrarrenal,i
89,S0210-56912006000700002,TCRR,o
89,S0210-56912006000700002,Presentamos,o
89,S0210-56912006000700002,nuestra,o
89,S0210-56912006000700002,experiencia,o
89,S0210-56912006000700002,con,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,uso,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,epoprostenol,i
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,forma,o
89,S0210-56912006000700002,aislada,o
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,pacientes,o
89,S0210-56912006000700002,con,o
89,S0210-56912006000700002,riesgo,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,sangrado,i
89,S0210-56912006000700002,o,o
89,S0210-56912006000700002,asociado,o
89,S0210-56912006000700002,a,o
89,S0210-56912006000700002,heparina,i
89,S0210-56912006000700002,no,i
89,S0210-56912006000700002,fraccionada,i
89,S0210-56912006000700002,HnF,i
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,pacientes,o
89,S0210-56912006000700002,con,o
89,S0210-56912006000700002,problemas,i
89,S0210-56912006000700002,de,i
89,S0210-56912006000700002,coagulacion,i
89,S0210-56912006000700002,precoz,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,los,o
89,S0210-56912006000700002,filtros,o
89,S0210-56912006000700002,Diseño,o
89,S0210-56912006000700002,Estudio,i
89,S0210-56912006000700002,prospectivo,i
89,S0210-56912006000700002,de,i
89,S0210-56912006000700002,cohortes,i
89,S0210-56912006000700002,sobre,o
89,S0210-56912006000700002,todos,o
89,S0210-56912006000700002,los,o
89,S0210-56912006000700002,filtros,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,TCRR,o
89,S0210-56912006000700002,usados,o
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,nuestro,o
89,S0210-56912006000700002,servicio,o
89,S0210-56912006000700002,desde,o
89,S0210-56912006000700002,1994,o
89,S0210-56912006000700002,Ambito,o
89,S0210-56912006000700002,Unidad,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,Cuidados,o
89,S0210-56912006000700002,Intensivos,o
89,S0210-56912006000700002,UCI,o
89,S0210-56912006000700002,polivalente,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,42,o
89,S0210-56912006000700002,camas,o
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,un,o
89,S0210-56912006000700002,hospital,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,tercer,o
89,S0210-56912006000700002,nivel,o
89,S0210-56912006000700002,Intervenciones,i
89,S0210-56912006000700002,La,o
89,S0210-56912006000700002,anticoagulacion,i
89,S0210-56912006000700002,se,o
89,S0210-56912006000700002,administro,o
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,perfusion,i
89,S0210-56912006000700002,prefiltro,o
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,dosis,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,57,o
89,S0210-56912006000700002,Ukghora,o
89,S0210-56912006000700002,para,o
89,S0210-56912006000700002,la,o
89,S0210-56912006000700002,HnF,i
89,S0210-56912006000700002,o,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,45,o
89,S0210-56912006000700002,ngkgmin,o
89,S0210-56912006000700002,para,o
89,S0210-56912006000700002,epoprostenol,i
89,S0210-56912006000700002,El,o
89,S0210-56912006000700002,uso,o
89,S0210-56912006000700002,combinado,o
89,S0210-56912006000700002,se,o
89,S0210-56912006000700002,realizo,o
89,S0210-56912006000700002,con,o
89,S0210-56912006000700002,igual,o
89,S0210-56912006000700002,dosis,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,epoprostenol,i
89,S0210-56912006000700002,y,o
89,S0210-56912006000700002,HnF,i
89,S0210-56912006000700002,a,o
89,S0210-56912006000700002,25,o
89,S0210-56912006000700002,Ukg,o
89,S0210-56912006000700002,hora,o
89,S0210-56912006000700002,Variables,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,interes,o
89,S0210-56912006000700002,principales,o
89,S0210-56912006000700002,Analizamos,o
89,S0210-56912006000700002,la,o
89,S0210-56912006000700002,duracion,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,cada,o
89,S0210-56912006000700002,filtro,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,motivo,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,retirada,o
89,S0210-56912006000700002,del,o
89,S0210-56912006000700002,filtro,o
89,S0210-56912006000700002,la,o
89,S0210-56912006000700002,existencia,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,coagulopatia,i
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,recuento,i
89,S0210-56912006000700002,plaquetario,i
89,S0210-56912006000700002,la,o
89,S0210-56912006000700002,aparicion,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,sangrado,i
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,anticoagulante,i
89,S0210-56912006000700002,usado,o
89,S0210-56912006000700002,y,o
89,S0210-56912006000700002,la,o
89,S0210-56912006000700002,dosis,o
89,S0210-56912006000700002,Resultados,o
89,S0210-56912006000700002,Analizamos,o
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,389,o
89,S0210-56912006000700002,pacientes,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,uso,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,2322,o
89,S0210-56912006000700002,filtros,o
89,S0210-56912006000700002,66957,o
89,S0210-56912006000700002,horas,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,los,o
89,S0210-56912006000700002,cuales,o
89,S0210-56912006000700002,un,o
89,S0210-56912006000700002,54,o
89,S0210-56912006000700002,presentaron,o
89,S0210-56912006000700002,coagulo,i
89,S0210-56912006000700002,Se,o
89,S0210-56912006000700002,uso,o
89,S0210-56912006000700002,HnF,i
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,74,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,los,o
89,S0210-56912006000700002,filtros,o
89,S0210-56912006000700002,durante,o
89,S0210-56912006000700002,una,o
89,S0210-56912006000700002,mediana,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,39,o
89,S0210-56912006000700002,horas,o
89,S0210-56912006000700002,rango,o
89,S0210-56912006000700002,intercuartil,o
89,S0210-56912006000700002,1975,o
89,S0210-56912006000700002,epoprostenol,i
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,6,o
89,S0210-56912006000700002,durante,o
89,S0210-56912006000700002,32,o
89,S0210-56912006000700002,horas,o
89,S0210-56912006000700002,rango,o
89,S0210-56912006000700002,intercuartil,o
89,S0210-56912006000700002,1748,o
89,S0210-56912006000700002,y,o
89,S0210-56912006000700002,terapia,i
89,S0210-56912006000700002,combinada,i
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,4,o
89,S0210-56912006000700002,durante,o
89,S0210-56912006000700002,27,o
89,S0210-56912006000700002,horas,o
89,S0210-56912006000700002,rango,o
89,S0210-56912006000700002,intercuartil,o
89,S0210-56912006000700002,1941,o
89,S0210-56912006000700002,En,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,grupo,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,epoprostenol,i
89,S0210-56912006000700002,detectamos,o
89,S0210-56912006000700002,un,o
89,S0210-56912006000700002,descenso,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,la,o
89,S0210-56912006000700002,tension,i
89,S0210-56912006000700002,arterial,i
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,solo,o
89,S0210-56912006000700002,dos,o
89,S0210-56912006000700002,filtros,o
89,S0210-56912006000700002,que,o
89,S0210-56912006000700002,se,o
89,S0210-56912006000700002,normalizo,o
89,S0210-56912006000700002,al,o
89,S0210-56912006000700002,disminuir,o
89,S0210-56912006000700002,la,o
89,S0210-56912006000700002,dosis,o
89,S0210-56912006000700002,Los,o
89,S0210-56912006000700002,filtros,o
89,S0210-56912006000700002,anticoagulados,o
89,S0210-56912006000700002,inicialmente,o
89,S0210-56912006000700002,con,o
89,S0210-56912006000700002,HnF,i
89,S0210-56912006000700002,mostraron,o
89,S0210-56912006000700002,una,o
89,S0210-56912006000700002,supervivencia,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,14,o
89,S0210-56912006000700002,horas,o
89,S0210-56912006000700002,como,o
89,S0210-56912006000700002,mediana,o
89,S0210-56912006000700002,frente,o
89,S0210-56912006000700002,a,o
89,S0210-56912006000700002,27,o
89,S0210-56912006000700002,horas,o
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,terapia,i
89,S0210-56912006000700002,combinada,i
89,S0210-56912006000700002,p,o
89,S0210-56912006000700002,0001,o
89,S0210-56912006000700002,En,o
89,S0210-56912006000700002,ausencia,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,coagulopatia,i
89,S0210-56912006000700002,o,o
89,S0210-56912006000700002,trombopenia,i
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,1170,o
89,S0210-56912006000700002,filtros,o
89,S0210-56912006000700002,tratados,i
89,S0210-56912006000700002,con,o
89,S0210-56912006000700002,HnF,i
89,S0210-56912006000700002,observamos,o
89,S0210-56912006000700002,un,o
89,S0210-56912006000700002,sangrado,i
89,S0210-56912006000700002,leve,o
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,8,o
89,S0210-56912006000700002,moderado,o
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,1,o
89,S0210-56912006000700002,y,o
89,S0210-56912006000700002,grave,o
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,1,o
89,S0210-56912006000700002,En,o
89,S0210-56912006000700002,66,o
89,S0210-56912006000700002,filtros,o
89,S0210-56912006000700002,con,o
89,S0210-56912006000700002,epoprostenol,i
89,S0210-56912006000700002,solo,o
89,S0210-56912006000700002,observamos,o
89,S0210-56912006000700002,sangrado,i
89,S0210-56912006000700002,leve,o
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,3,o
89,S0210-56912006000700002,Conclusiones,o
89,S0210-56912006000700002,En,o
89,S0210-56912006000700002,pacientes,o
89,S0210-56912006000700002,con,o
89,S0210-56912006000700002,riesgo,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,sangrado,i
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,epoprostenol,i
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,forma,o
89,S0210-56912006000700002,aislada,o
89,S0210-56912006000700002,proporciona,o
89,S0210-56912006000700002,una,o
89,S0210-56912006000700002,duracion,o
89,S0210-56912006000700002,similar,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,los,o
89,S0210-56912006000700002,filtros,o
89,S0210-56912006000700002,a,o
89,S0210-56912006000700002,la,o
89,S0210-56912006000700002,HnF,i
89,S0210-56912006000700002,disminuyendo,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,riesgo,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,sangrado,i
89,S0210-56912006000700002,En,o
89,S0210-56912006000700002,pacientes,o
89,S0210-56912006000700002,con,o
89,S0210-56912006000700002,coagulacion,i
89,S0210-56912006000700002,precoz,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,los,o
89,S0210-56912006000700002,filtros,o
89,S0210-56912006000700002,el,o
89,S0210-56912006000700002,uso,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,epoprostenol,i
89,S0210-56912006000700002,mas,o
89,S0210-56912006000700002,HnF,i
89,S0210-56912006000700002,en,o
89,S0210-56912006000700002,dosis,o
89,S0210-56912006000700002,bajas,o
89,S0210-56912006000700002,aumenta,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,forma,o
89,S0210-56912006000700002,significativa,o
89,S0210-56912006000700002,la,o
89,S0210-56912006000700002,duracion,o
89,S0210-56912006000700002,de,o
89,S0210-56912006000700002,los,o
89,S0210-56912006000700002,mismos,o
90,S0210-56912010000400001,Estudio,i
90,S0210-56912010000400001,aleatorizado,i
90,S0210-56912010000400001,sobre,o
90,S0210-56912010000400001,la,o
90,S0210-56912010000400001,posicion,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,electrodos,o
90,S0210-56912010000400001,en,o
90,S0210-56912010000400001,la,o
90,S0210-56912010000400001,cardioversion,i
90,S0210-56912010000400001,electrica,i
90,S0210-56912010000400001,electiva,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,la,o
90,S0210-56912010000400001,fibrilacion,i
90,S0210-56912010000400001,auricular,i
90,S0210-56912010000400001,A,o
90,S0210-56912010000400001,randomized,o
90,S0210-56912010000400001,study,o
90,S0210-56912010000400001,Objetivo,o
90,S0210-56912010000400001,Este,o
90,S0210-56912010000400001,estudio,o
90,S0210-56912010000400001,pretende,o
90,S0210-56912010000400001,averiguar,o
90,S0210-56912010000400001,cual,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,las,o
90,S0210-56912010000400001,2,o
90,S0210-56912010000400001,posiciones,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,electrodos,o
90,S0210-56912010000400001,anteroposterior,o
90,S0210-56912010000400001,AP,o
90,S0210-56912010000400001,izquierda,o
90,S0210-56912010000400001,o,o
90,S0210-56912010000400001,anteroapical,o
90,S0210-56912010000400001,AA,o
90,S0210-56912010000400001,se,o
90,S0210-56912010000400001,muestra,o
90,S0210-56912010000400001,mas,o
90,S0210-56912010000400001,eficaz,o
90,S0210-56912010000400001,en,o
90,S0210-56912010000400001,la,o
90,S0210-56912010000400001,cardioversion,i
90,S0210-56912010000400001,electrica,i
90,S0210-56912010000400001,CVE,i
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,la,o
90,S0210-56912010000400001,fibrilacion,i
90,S0210-56912010000400001,auricular,i
90,S0210-56912010000400001,FA,i
90,S0210-56912010000400001,Diseño,o
90,S0210-56912010000400001,Ensayo,i
90,S0210-56912010000400001,clinico,i
90,S0210-56912010000400001,con,i
90,S0210-56912010000400001,asignacion,i
90,S0210-56912010000400001,aleatorizada,i
90,S0210-56912010000400001,Ambito,o
90,S0210-56912010000400001,UCI,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,un,o
90,S0210-56912010000400001,hospital,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,segundo,o
90,S0210-56912010000400001,nivel,o
90,S0210-56912010000400001,Pacientes,o
90,S0210-56912010000400001,y,o
90,S0210-56912010000400001,metodos,o
90,S0210-56912010000400001,Pacientes,o
90,S0210-56912010000400001,ambulatorios,o
90,S0210-56912010000400001,en,o
90,S0210-56912010000400001,FA,i
90,S0210-56912010000400001,remitidos,i
90,S0210-56912010000400001,a,i
90,S0210-56912010000400001,la,i
90,S0210-56912010000400001,UCI,i
90,S0210-56912010000400001,para,o
90,S0210-56912010000400001,CVE,i
90,S0210-56912010000400001,mediante,o
90,S0210-56912010000400001,choques,i
90,S0210-56912010000400001,bifasicos,i
90,S0210-56912010000400001,Se,o
90,S0210-56912010000400001,comienza,o
90,S0210-56912010000400001,con,o
90,S0210-56912010000400001,la,o
90,S0210-56912010000400001,posicion,o
90,S0210-56912010000400001,correspondiente,o
90,S0210-56912010000400001,segun,o
90,S0210-56912010000400001,numeros,o
90,S0210-56912010000400001,aleatorizados,o
90,S0210-56912010000400001,y,o
90,S0210-56912010000400001,se,o
90,S0210-56912010000400001,administran,o
90,S0210-56912010000400001,hasta,o
90,S0210-56912010000400001,3,o
90,S0210-56912010000400001,choques,i
90,S0210-56912010000400001,150200200J,o
90,S0210-56912010000400001,y,o
90,S0210-56912010000400001,se,o
90,S0210-56912010000400001,cambia,o
90,S0210-56912010000400001,a,o
90,S0210-56912010000400001,la,o
90,S0210-56912010000400001,posicion,o
90,S0210-56912010000400001,alternativa,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,no,o
90,S0210-56912010000400001,haberse,o
90,S0210-56912010000400001,conseguido,o
90,S0210-56912010000400001,el,o
90,S0210-56912010000400001,ritmo,o
90,S0210-56912010000400001,sinusal,i
90,S0210-56912010000400001,RS,o
90,S0210-56912010000400001,hasta,o
90,S0210-56912010000400001,2,o
90,S0210-56912010000400001,choques,i
90,S0210-56912010000400001,mas,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,200J,o
90,S0210-56912010000400001,Se,o
90,S0210-56912010000400001,analizan,o
90,S0210-56912010000400001,y,o
90,S0210-56912010000400001,se,o
90,S0210-56912010000400001,comparan,o
90,S0210-56912010000400001,ambas,o
90,S0210-56912010000400001,posiciones,o
90,S0210-56912010000400001,asignadas,o
90,S0210-56912010000400001,y,o
90,S0210-56912010000400001,se,o
90,S0210-56912010000400001,determina,o
90,S0210-56912010000400001,cual,o
90,S0210-56912010000400001,consigue,o
90,S0210-56912010000400001,restaurar,i
90,S0210-56912010000400001,el,i
90,S0210-56912010000400001,RS,i
90,S0210-56912010000400001,con,o
90,S0210-56912010000400001,menor,o
90,S0210-56912010000400001,numero,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,choques,i
90,S0210-56912010000400001,y,o
90,S0210-56912010000400001,menor,o
90,S0210-56912010000400001,energia,o
90,S0210-56912010000400001,aplicada,o
90,S0210-56912010000400001,Resultados,o
90,S0210-56912010000400001,Se,o
90,S0210-56912010000400001,incluyen,o
90,S0210-56912010000400001,46,o
90,S0210-56912010000400001,pacientes,o
90,S0210-56912010000400001,en,o
90,S0210-56912010000400001,el,o
90,S0210-56912010000400001,grupo,o
90,S0210-56912010000400001,AA,o
90,S0210-56912010000400001,y,o
90,S0210-56912010000400001,45,o
90,S0210-56912010000400001,pacientes,o
90,S0210-56912010000400001,en,o
90,S0210-56912010000400001,el,o
90,S0210-56912010000400001,grupo,o
90,S0210-56912010000400001,AP,o
90,S0210-56912010000400001,y,o
90,S0210-56912010000400001,se,o
90,S0210-56912010000400001,consigue,o
90,S0210-56912010000400001,RS,o
90,S0210-56912010000400001,en,o
90,S0210-56912010000400001,el,o
90,S0210-56912010000400001,92,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,los,o
90,S0210-56912010000400001,casos,o
90,S0210-56912010000400001,si,o
90,S0210-56912010000400001,bien,o
90,S0210-56912010000400001,los,o
90,S0210-56912010000400001,pacientes,o
90,S0210-56912010000400001,del,o
90,S0210-56912010000400001,grupo,o
90,S0210-56912010000400001,AA,o
90,S0210-56912010000400001,precisaron,o
90,S0210-56912010000400001,significativamente,o
90,S0210-56912010000400001,menor,o
90,S0210-56912010000400001,numero,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,choques,i
90,S0210-56912010000400001,y,o
90,S0210-56912010000400001,menor,o
90,S0210-56912010000400001,energia,o
90,S0210-56912010000400001,1,o
90,S0210-56912010000400001,frente,o
90,S0210-56912010000400001,a,o
90,S0210-56912010000400001,2,o
90,S0210-56912010000400001,choques,i
90,S0210-56912010000400001,p0003,o
90,S0210-56912010000400001,y,o
90,S0210-56912010000400001,150,o
90,S0210-56912010000400001,frente,o
90,S0210-56912010000400001,a,o
90,S0210-56912010000400001,350J,o
90,S0210-56912010000400001,p0017,o
90,S0210-56912010000400001,Solamente,o
90,S0210-56912010000400001,un,o
90,S0210-56912010000400001,paciente,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,los,o
90,S0210-56912010000400001,5,o
90,S0210-56912010000400001,en,o
90,S0210-56912010000400001,los,o
90,S0210-56912010000400001,que,o
90,S0210-56912010000400001,fallo,o
90,S0210-56912010000400001,la,o
90,S0210-56912010000400001,posicion,o
90,S0210-56912010000400001,AA,o
90,S0210-56912010000400001,se,o
90,S0210-56912010000400001,revirtio,i
90,S0210-56912010000400001,a,i
90,S0210-56912010000400001,RS,i
90,S0210-56912010000400001,con,o
90,S0210-56912010000400001,la,o
90,S0210-56912010000400001,posicion,o
90,S0210-56912010000400001,AP,o
90,S0210-56912010000400001,mientras,o
90,S0210-56912010000400001,que,o
90,S0210-56912010000400001,10,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,los,o
90,S0210-56912010000400001,13,o
90,S0210-56912010000400001,pacientes,o
90,S0210-56912010000400001,no,o
90,S0210-56912010000400001,revertidos,i
90,S0210-56912010000400001,con,o
90,S0210-56912010000400001,electrodos,o
90,S0210-56912010000400001,AP,o
90,S0210-56912010000400001,lo,o
90,S0210-56912010000400001,fueron,o
90,S0210-56912010000400001,al,o
90,S0210-56912010000400001,cambiar,o
90,S0210-56912010000400001,a,o
90,S0210-56912010000400001,posicion,o
90,S0210-56912010000400001,AA,o
90,S0210-56912010000400001,p0038,o
90,S0210-56912010000400001,Conclusiones,o
90,S0210-56912010000400001,La,o
90,S0210-56912010000400001,posicion,o
90,S0210-56912010000400001,AA,o
90,S0210-56912010000400001,se,o
90,S0210-56912010000400001,muestra,o
90,S0210-56912010000400001,mas,o
90,S0210-56912010000400001,eficaz,o
90,S0210-56912010000400001,en,o
90,S0210-56912010000400001,la,o
90,S0210-56912010000400001,CVE,i
90,S0210-56912010000400001,electiva,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,la,o
90,S0210-56912010000400001,FA,i
90,S0210-56912010000400001,y,o
90,S0210-56912010000400001,se,o
90,S0210-56912010000400001,recomienda,o
90,S0210-56912010000400001,como,o
90,S0210-56912010000400001,de,o
90,S0210-56912010000400001,primera,o
90,S0210-56912010000400001,eleccion,o
91,S0210-56912010000600003,Tratamiento,i
91,S0210-56912010000600003,endovascular,i
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,trombolisis,i
91,S0210-56912010000600003,intraarterial,i
91,S0210-56912010000600003,en,o
91,S0210-56912010000600003,el,o
91,S0210-56912010000600003,ictus,i
91,S0210-56912010000600003,isquemico,i
91,S0210-56912010000600003,agudo,i
91,S0210-56912010000600003,Objetivo,o
91,S0210-56912010000600003,Analizar,i
91,S0210-56912010000600003,la,i
91,S0210-56912010000600003,eficacia,i
91,S0210-56912010000600003,y,i
91,S0210-56912010000600003,la,i
91,S0210-56912010000600003,seguridad,i
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,la,o
91,S0210-56912010000600003,trombolisis,i
91,S0210-56912010000600003,intraarterial,i
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,el,o
91,S0210-56912010000600003,tratamiento,i
91,S0210-56912010000600003,endovascular,i
91,S0210-56912010000600003,en,o
91,S0210-56912010000600003,pacientes,o
91,S0210-56912010000600003,con,o
91,S0210-56912010000600003,ictus,i
91,S0210-56912010000600003,isquemico,i
91,S0210-56912010000600003,agudo,i
91,S0210-56912010000600003,Diseño,o
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,ambito,o
91,S0210-56912010000600003,Estudio,i
91,S0210-56912010000600003,prospectivo,i
91,S0210-56912010000600003,observacional,i
91,S0210-56912010000600003,en,o
91,S0210-56912010000600003,una,o
91,S0210-56912010000600003,unidad,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,cuidados,o
91,S0210-56912010000600003,intensivos,o
91,S0210-56912010000600003,Pacientes,o
91,S0210-56912010000600003,Dieciseis,o
91,S0210-56912010000600003,pacientes,o
91,S0210-56912010000600003,recibieron,o
91,S0210-56912010000600003,tratamiento,i
91,S0210-56912010000600003,endovascular,i
91,S0210-56912010000600003,Se,o
91,S0210-56912010000600003,recogieron,o
91,S0210-56912010000600003,datos,o
91,S0210-56912010000600003,epidemiologicos,o
91,S0210-56912010000600003,localizacion,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,la,o
91,S0210-56912010000600003,oclusion,i
91,S0210-56912010000600003,arterial,i
91,S0210-56912010000600003,tiempo,o
91,S0210-56912010000600003,desde,o
91,S0210-56912010000600003,el,o
91,S0210-56912010000600003,ictus,i
91,S0210-56912010000600003,al,o
91,S0210-56912010000600003,tratamiento,i
91,S0210-56912010000600003,indicacion,o
91,S0210-56912010000600003,del,o
91,S0210-56912010000600003,tratamiento,i
91,S0210-56912010000600003,National,i
91,S0210-56912010000600003,Institutes,i
91,S0210-56912010000600003,of,i
91,S0210-56912010000600003,Health,i
91,S0210-56912010000600003,Stroke,i
91,S0210-56912010000600003,Scale,i
91,S0210-56912010000600003,al,o
91,S0210-56912010000600003,ingreso,i
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,al,o
91,S0210-56912010000600003,alta,i
91,S0210-56912010000600003,hospitalaria,i
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,complicaciones,i
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,evolucion,o
91,S0210-56912010000600003,funcional,o
91,S0210-56912010000600003,por,o
91,S0210-56912010000600003,escala,i
91,S0210-56912010000600003,de,i
91,S0210-56912010000600003,Rankin,i
91,S0210-56912010000600003,modificada,i
91,S0210-56912010000600003,realizada,o
91,S0210-56912010000600003,mediante,o
91,S0210-56912010000600003,una,o
91,S0210-56912010000600003,encuesta,i
91,S0210-56912010000600003,telefonica,i
91,S0210-56912010000600003,Resultados,o
91,S0210-56912010000600003,Diez,o
91,S0210-56912010000600003,varones,o
91,S0210-56912010000600003,con,o
91,S0210-56912010000600003,una,o
91,S0210-56912010000600003,edad,o
91,S0210-56912010000600003,media,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,59,o
91,S0210-56912010000600003,años,o
91,S0210-56912010000600003,2974,o
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,una,o
91,S0210-56912010000600003,estancia,o
91,S0210-56912010000600003,media,o
91,S0210-56912010000600003,en,o
91,S0210-56912010000600003,la,o
91,S0210-56912010000600003,unidad,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,cuidados,o
91,S0210-56912010000600003,intensivos,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,6,o
91,S0210-56912010000600003,dias,o
91,S0210-56912010000600003,133,o
91,S0210-56912010000600003,Siete,o
91,S0210-56912010000600003,pacientes,o
91,S0210-56912010000600003,requirieron,o
91,S0210-56912010000600003,ventilacion,i
91,S0210-56912010000600003,mecanica,i
91,S0210-56912010000600003,Indicacion,o
91,S0210-56912010000600003,del,o
91,S0210-56912010000600003,tratamiento,i
91,S0210-56912010000600003,4,o
91,S0210-56912010000600003,casos,o
91,S0210-56912010000600003,por,o
91,S0210-56912010000600003,fracaso,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,la,o
91,S0210-56912010000600003,trombolisis,i
91,S0210-56912010000600003,intravenosa,i
91,S0210-56912010000600003,5,o
91,S0210-56912010000600003,por,o
91,S0210-56912010000600003,oclusion,i
91,S0210-56912010000600003,de,i
91,S0210-56912010000600003,gran,i
91,S0210-56912010000600003,vaso,i
91,S0210-56912010000600003,2,o
91,S0210-56912010000600003,por,o
91,S0210-56912010000600003,estar,o
91,S0210-56912010000600003,fuera,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,la,o
91,S0210-56912010000600003,ventana,o
91,S0210-56912010000600003,terapeutica,o
91,S0210-56912010000600003,3,o
91,S0210-56912010000600003,por,o
91,S0210-56912010000600003,oclusion,i
91,S0210-56912010000600003,de,i
91,S0210-56912010000600003,la,i
91,S0210-56912010000600003,circulacion,i
91,S0210-56912010000600003,posterior,i
91,S0210-56912010000600003,uno,o
91,S0210-56912010000600003,por,o
91,S0210-56912010000600003,estar,o
91,S0210-56912010000600003,fuera,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,la,o
91,S0210-56912010000600003,ventana,o
91,S0210-56912010000600003,terapeutica,o
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,tener,o
91,S0210-56912010000600003,ademas,o
91,S0210-56912010000600003,una,o
91,S0210-56912010000600003,oclusion,i
91,S0210-56912010000600003,de,i
91,S0210-56912010000600003,gran,i
91,S0210-56912010000600003,vaso,i
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,uno,o
91,S0210-56912010000600003,por,o
91,S0210-56912010000600003,contraindicacion,o
91,S0210-56912010000600003,para,o
91,S0210-56912010000600003,la,o
91,S0210-56912010000600003,trombolisis,i
91,S0210-56912010000600003,intravenosa,i
91,S0210-56912010000600003,Localizacion,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,la,o
91,S0210-56912010000600003,oclusion,i
91,S0210-56912010000600003,3,o
91,S0210-56912010000600003,en,o
91,S0210-56912010000600003,la,o
91,S0210-56912010000600003,circulacion,o
91,S0210-56912010000600003,posterior,o
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,13,o
91,S0210-56912010000600003,en,o
91,S0210-56912010000600003,el,o
91,S0210-56912010000600003,territorio,i
91,S0210-56912010000600003,carotideo,i
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,sus,o
91,S0210-56912010000600003,ramas,i
91,S0210-56912010000600003,El,o
91,S0210-56912010000600003,fibrinolitico,i
91,S0210-56912010000600003,utilizado,o
91,S0210-56912010000600003,fue,o
91,S0210-56912010000600003,uroquinasa,i
91,S0210-56912010000600003,en,o
91,S0210-56912010000600003,dosis,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,100000600000,o
91,S0210-56912010000600003,UI,o
91,S0210-56912010000600003,Cuatro,o
91,S0210-56912010000600003,pacientes,o
91,S0210-56912010000600003,requirieron,o
91,S0210-56912010000600003,embolectomia,i
91,S0210-56912010000600003,mecanica,i
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,10,o
91,S0210-56912010000600003,implantacion,i
91,S0210-56912010000600003,de,i
91,S0210-56912010000600003,stent,i
91,S0210-56912010000600003,Se,o
91,S0210-56912010000600003,obtuvo,o
91,S0210-56912010000600003,recanalizacion,i
91,S0210-56912010000600003,completa,o
91,S0210-56912010000600003,en,o
91,S0210-56912010000600003,11,o
91,S0210-56912010000600003,pacientes,o
91,S0210-56912010000600003,69,o
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,parcial,o
91,S0210-56912010000600003,en,o
91,S0210-56912010000600003,4,o
91,S0210-56912010000600003,25,o
91,S0210-56912010000600003,Tres,o
91,S0210-56912010000600003,pacientes,o
91,S0210-56912010000600003,evolucionaron,o
91,S0210-56912010000600003,a,o
91,S0210-56912010000600003,muerte,i
91,S0210-56912010000600003,encefalica,i
91,S0210-56912010000600003,Seis,o
91,S0210-56912010000600003,pacientes,o
91,S0210-56912010000600003,46,o
91,S0210-56912010000600003,tuvieron,o
91,S0210-56912010000600003,una,o
91,S0210-56912010000600003,buena,o
91,S0210-56912010000600003,recuperacion,o
91,S0210-56912010000600003,escala,i
91,S0210-56912010000600003,de,i
91,S0210-56912010000600003,Rankin,i
91,S0210-56912010000600003,modificada,i
91,S0210-56912010000600003,2,o
91,S0210-56912010000600003,Como,o
91,S0210-56912010000600003,complicacion,i
91,S0210-56912010000600003,tecnica,o
91,S0210-56912010000600003,destaco,o
91,S0210-56912010000600003,un,o
91,S0210-56912010000600003,seudoaneurisma,i
91,S0210-56912010000600003,de,i
91,S0210-56912010000600003,la,i
91,S0210-56912010000600003,arteria,i
91,S0210-56912010000600003,femoral,i
91,S0210-56912010000600003,Conclusiones,o
91,S0210-56912010000600003,El,o
91,S0210-56912010000600003,tratamiento,i
91,S0210-56912010000600003,intraarterial,i
91,S0210-56912010000600003,obtiene,o
91,S0210-56912010000600003,altas,o
91,S0210-56912010000600003,tasas,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,recanalizacion,i
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,buenos,o
91,S0210-56912010000600003,resultados,o
91,S0210-56912010000600003,funcionales,o
91,S0210-56912010000600003,con,o
91,S0210-56912010000600003,escasas,o
91,S0210-56912010000600003,complicaciones,i
91,S0210-56912010000600003,Su,o
91,S0210-56912010000600003,uso,o
91,S0210-56912010000600003,estaria,o
91,S0210-56912010000600003,indicado,o
91,S0210-56912010000600003,en,o
91,S0210-56912010000600003,pacientes,o
91,S0210-56912010000600003,con,o
91,S0210-56912010000600003,afectacion,i
91,S0210-56912010000600003,neurologica,i
91,S0210-56912010000600003,importante,o
91,S0210-56912010000600003,National,i
91,S0210-56912010000600003,Institutes,i
91,S0210-56912010000600003,of,i
91,S0210-56912010000600003,Health,i
91,S0210-56912010000600003,Stroke,i
91,S0210-56912010000600003,Scale,i
91,S0210-56912010000600003,10,o
91,S0210-56912010000600003,tiempo,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,evolucion,o
91,S0210-56912010000600003,de,o
91,S0210-56912010000600003,36h,o
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,contraindicacion,o
91,S0210-56912010000600003,para,o
91,S0210-56912010000600003,la,o
91,S0210-56912010000600003,trombolisis,i
91,S0210-56912010000600003,intravenosa,i
91,S0210-56912010000600003,y,o
91,S0210-56912010000600003,la,o
91,S0210-56912010000600003,oclusion,i
91,S0210-56912010000600003,arterial,i
91,S0210-56912010000600003,proximal,i
92,S0210-56912010000700003,Ensayo,i
92,S0210-56912010000700003,de,i
92,S0210-56912010000700003,respiracion,i
92,S0210-56912010000700003,espontanea,i
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,pacientes,o
92,S0210-56912010000700003,con,o
92,S0210-56912010000700003,enfermedad,i
92,S0210-56912010000700003,pulmonar,i
92,S0210-56912010000700003,obstructiva,i
92,S0210-56912010000700003,cronica,i
92,S0210-56912010000700003,presion,i
92,S0210-56912010000700003,positiva,i
92,S0210-56912010000700003,continua,i
92,S0210-56912010000700003,de,i
92,S0210-56912010000700003,la,i
92,S0210-56912010000700003,via,i
92,S0210-56912010000700003,aerea,i
92,S0210-56912010000700003,CPAP,i
92,S0210-56912010000700003,versus,o
92,S0210-56912010000700003,Tubo,o
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,T,o
92,S0210-56912010000700003,Objetivo,o
92,S0210-56912010000700003,Determinar,o
92,S0210-56912010000700003,si,o
92,S0210-56912010000700003,el,o
92,S0210-56912010000700003,ensayo,i
92,S0210-56912010000700003,de,i
92,S0210-56912010000700003,respiracion,i
92,S0210-56912010000700003,espontanea,i
92,S0210-56912010000700003,con,o
92,S0210-56912010000700003,presion,i
92,S0210-56912010000700003,positiva,i
92,S0210-56912010000700003,continua,i
92,S0210-56912010000700003,de,i
92,S0210-56912010000700003,la,i
92,S0210-56912010000700003,via,i
92,S0210-56912010000700003,aerea,i
92,S0210-56912010000700003,CPAP,i
92,S0210-56912010000700003,es,o
92,S0210-56912010000700003,superior,o
92,S0210-56912010000700003,al,o
92,S0210-56912010000700003,ensayo,i
92,S0210-56912010000700003,con,i
92,S0210-56912010000700003,Tubo,i
92,S0210-56912010000700003,en,i
92,S0210-56912010000700003,T,i
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,pacientes,o
92,S0210-56912010000700003,con,o
92,S0210-56912010000700003,EPOC,i
92,S0210-56912010000700003,Diseño,o
92,S0210-56912010000700003,Ensayo,i
92,S0210-56912010000700003,clinico,i
92,S0210-56912010000700003,ciego,i
92,S0210-56912010000700003,con,i
92,S0210-56912010000700003,distribucion,i
92,S0210-56912010000700003,aleatoria,i
92,S0210-56912010000700003,Ambito,o
92,S0210-56912010000700003,Tres,o
92,S0210-56912010000700003,UCI,o
92,S0210-56912010000700003,medico,o
92,S0210-56912010000700003,quirurgicas,o
92,S0210-56912010000700003,Pacientes,o
92,S0210-56912010000700003,Muestra,i
92,S0210-56912010000700003,aleatoria,i
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,50,o
92,S0210-56912010000700003,pacientes,o
92,S0210-56912010000700003,con,o
92,S0210-56912010000700003,EPOC,i
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,ventilacion,i
92,S0210-56912010000700003,mecanica,i
92,S0210-56912010000700003,VM,i
92,S0210-56912010000700003,por,o
92,S0210-56912010000700003,mas,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,48,o
92,S0210-56912010000700003,horas,o
92,S0210-56912010000700003,con,o
92,S0210-56912010000700003,criterios,o
92,S0210-56912010000700003,para,o
92,S0210-56912010000700003,la,o
92,S0210-56912010000700003,liberacion,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,la,o
92,S0210-56912010000700003,VM,i
92,S0210-56912010000700003,resolucion,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,la,o
92,S0210-56912010000700003,exacerbacion,i
92,S0210-56912010000700003,del,i
92,S0210-56912010000700003,EPOC,i
92,S0210-56912010000700003,Glasgow,i
92,S0210-56912010000700003,10,o
92,S0210-56912010000700003,temperatura,i
92,S0210-56912010000700003,38oC,o
92,S0210-56912010000700003,cociente,o
92,S0210-56912010000700003,PaO2FiO2,o
92,S0210-56912010000700003,150con,o
92,S0210-56912010000700003,un,o
92,S0210-56912010000700003,PEEP,i
92,S0210-56912010000700003,5cm,o
92,S0210-56912010000700003,H2O,i
92,S0210-56912010000700003,y,o
92,S0210-56912010000700003,FiO2,i
92,S0210-56912010000700003,50,o
92,S0210-56912010000700003,Hb,i
92,S0210-56912010000700003,10gdl,o
92,S0210-56912010000700003,ninguna,o
92,S0210-56912010000700003,necesidad,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,vasoactivos,i
92,S0210-56912010000700003,excepto,o
92,S0210-56912010000700003,dopamina,i
92,S0210-56912010000700003,5μgkgmin,o
92,S0210-56912010000700003,o,o
92,S0210-56912010000700003,dobutamina,i
92,S0210-56912010000700003,5μgkgmin,o
92,S0210-56912010000700003,ni,o
92,S0210-56912010000700003,agentes,i
92,S0210-56912010000700003,sedantes,i
92,S0210-56912010000700003,y,o
92,S0210-56912010000700003,tos,i
92,S0210-56912010000700003,eficaz,o
92,S0210-56912010000700003,Intervencion,i
92,S0210-56912010000700003,Ensayo,i
92,S0210-56912010000700003,de,i
92,S0210-56912010000700003,respiracion,i
92,S0210-56912010000700003,espontanea,i
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,30min,o
92,S0210-56912010000700003,con,o
92,S0210-56912010000700003,sistema,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,Tubo,o
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,T,o
92,S0210-56912010000700003,o,o
92,S0210-56912010000700003,CPAP,i
92,S0210-56912010000700003,Variables,o
92,S0210-56912010000700003,Exito,o
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,la,o
92,S0210-56912010000700003,liberacion,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,la,o
92,S0210-56912010000700003,VM,i
92,S0210-56912010000700003,exito,o
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,el,o
92,S0210-56912010000700003,ensayo,i
92,S0210-56912010000700003,de,i
92,S0210-56912010000700003,respiracion,i
92,S0210-56912010000700003,espontanea,i
92,S0210-56912010000700003,reincubacion,i
92,S0210-56912010000700003,y,o
92,S0210-56912010000700003,PEEP,i
92,S0210-56912010000700003,intrinseca,i
92,S0210-56912010000700003,Resultados,o
92,S0210-56912010000700003,De,o
92,S0210-56912010000700003,los,o
92,S0210-56912010000700003,25,o
92,S0210-56912010000700003,pacientes,o
92,S0210-56912010000700003,asignados,o
92,S0210-56912010000700003,al,o
92,S0210-56912010000700003,grupo,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,Tubo,o
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,T,o
92,S0210-56912010000700003,18,o
92,S0210-56912010000700003,terminaron,o
92,S0210-56912010000700003,con,o
92,S0210-56912010000700003,exito,o
92,S0210-56912010000700003,el,o
92,S0210-56912010000700003,ensayo,i
92,S0210-56912010000700003,y,o
92,S0210-56912010000700003,fueron,o
92,S0210-56912010000700003,extubados,i
92,S0210-56912010000700003,3,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,ellos,o
92,S0210-56912010000700003,requirieron,o
92,S0210-56912010000700003,reintubacion,i
92,S0210-56912010000700003,De,o
92,S0210-56912010000700003,los,o
92,S0210-56912010000700003,25,o
92,S0210-56912010000700003,pacientes,o
92,S0210-56912010000700003,asignados,o
92,S0210-56912010000700003,al,o
92,S0210-56912010000700003,grupo,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,CPAP,i
92,S0210-56912010000700003,19,o
92,S0210-56912010000700003,fueron,o
92,S0210-56912010000700003,extubados,i
92,S0210-56912010000700003,y,o
92,S0210-56912010000700003,ninguno,o
92,S0210-56912010000700003,requirio,o
92,S0210-56912010000700003,reintubacion,i
92,S0210-56912010000700003,El,o
92,S0210-56912010000700003,exito,o
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,la,o
92,S0210-56912010000700003,liberacion,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,la,o
92,S0210-56912010000700003,VM,i
92,S0210-56912010000700003,fue,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,76,o
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,CPAP,i
92,S0210-56912010000700003,y,o
92,S0210-56912010000700003,60,o
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,Tubo,o
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,T,o
92,S0210-56912010000700003,riesgo,o
92,S0210-56912010000700003,relativo,o
92,S0210-56912010000700003,127,o
92,S0210-56912010000700003,intervalo,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,confianza,o
92,S0210-56912010000700003,del,o
92,S0210-56912010000700003,95,o
92,S0210-56912010000700003,086187,o
92,S0210-56912010000700003,Conclusion,o
92,S0210-56912010000700003,En,o
92,S0210-56912010000700003,una,o
92,S0210-56912010000700003,cohorte,o
92,S0210-56912010000700003,de,o
92,S0210-56912010000700003,pacientes,o
92,S0210-56912010000700003,con,o
92,S0210-56912010000700003,EPOC,i
92,S0210-56912010000700003,el,o
92,S0210-56912010000700003,ensayo,i
92,S0210-56912010000700003,de,i
92,S0210-56912010000700003,respiracion,i
92,S0210-56912010000700003,espontanea,i
92,S0210-56912010000700003,con,o
92,S0210-56912010000700003,CPAP,i
92,S0210-56912010000700003,tuvo,o
92,S0210-56912010000700003,una,o
92,S0210-56912010000700003,tendencia,o
92,S0210-56912010000700003,a,o
92,S0210-56912010000700003,mejor,o
92,S0210-56912010000700003,resultado,o
92,S0210-56912010000700003,que,o
92,S0210-56912010000700003,con,o
92,S0210-56912010000700003,Tubo,o
92,S0210-56912010000700003,en,o
92,S0210-56912010000700003,T,o
92,S0210-56912010000700003,pero,o
92,S0210-56912010000700003,esto,o
92,S0210-56912010000700003,necesita,o
92,S0210-56912010000700003,mayor,o
92,S0210-56912010000700003,investigacion,o
93,S0210-56912011000500005,El,o
93,S0210-56912011000500005,acido,i
93,S0210-56912011000500005,tranexamico,i
93,S0210-56912011000500005,disminuye,o
93,S0210-56912011000500005,la,o
93,S0210-56912011000500005,mortalidad,o
93,S0210-56912011000500005,del,o
93,S0210-56912011000500005,shock,i
93,S0210-56912011000500005,hemorragico,i
93,S0210-56912011000500005,traumatico,i
93,S0210-56912011000500005,Un,o
93,S0210-56912011000500005,estudio,o
93,S0210-56912011000500005,aleatorizado,o
93,S0210-56912011000500005,controlado,o
93,S0210-56912011000500005,con,o
93,S0210-56912011000500005,placebo,o
93,S0210-56912011000500005,y,o
93,S0210-56912011000500005,doble,o
93,S0210-56912011000500005,ciego,o
93,S0210-56912011000500005,el,o
93,S0210-56912011000500005,CRASH,o
93,S0210-56912011000500005,2,o
93,S0210-56912011000500005,ha,o
93,S0210-56912011000500005,concluido,o
93,S0210-56912011000500005,tras,o
93,S0210-56912011000500005,incluir,o
93,S0210-56912011000500005,a,o
93,S0210-56912011000500005,20211,o
93,S0210-56912011000500005,traumatizados,i
93,S0210-56912011000500005,que,o
93,S0210-56912011000500005,el,o
93,S0210-56912011000500005,acido,i
93,S0210-56912011000500005,tranexamico,i
93,S0210-56912011000500005,reduce,o
93,S0210-56912011000500005,significativamente,o
93,S0210-56912011000500005,la,o
93,S0210-56912011000500005,mortalidad,o
93,S0210-56912011000500005,tanto,o
93,S0210-56912011000500005,la,o
93,S0210-56912011000500005,global,o
93,S0210-56912011000500005,como,o
93,S0210-56912011000500005,la,o
93,S0210-56912011000500005,especificamente,o
93,S0210-56912011000500005,ligada,o
93,S0210-56912011000500005,a,o
93,S0210-56912011000500005,la,o
93,S0210-56912011000500005,perdida,i
93,S0210-56912011000500005,sanguinea,i
93,S0210-56912011000500005,severa,o
93,S0210-56912011000500005,Consideramos,o
93,S0210-56912011000500005,que,o
93,S0210-56912011000500005,este,o
93,S0210-56912011000500005,es,o
93,S0210-56912011000500005,un,o
93,S0210-56912011000500005,avance,o
93,S0210-56912011000500005,terapeutico,o
93,S0210-56912011000500005,significativo,o
93,S0210-56912011000500005,ya,o
93,S0210-56912011000500005,que,o
93,S0210-56912011000500005,por,o
93,S0210-56912011000500005,primera,o
93,S0210-56912011000500005,vez,o
93,S0210-56912011000500005,un,o
93,S0210-56912011000500005,farmaco,i
93,S0210-56912011000500005,se,o
93,S0210-56912011000500005,ha,o
93,S0210-56912011000500005,mostrado,o
93,S0210-56912011000500005,capaz,o
93,S0210-56912011000500005,de,o
93,S0210-56912011000500005,disminuir,o
93,S0210-56912011000500005,la,o
93,S0210-56912011000500005,letalidad,o
93,S0210-56912011000500005,del,o
93,S0210-56912011000500005,shock,i
93,S0210-56912011000500005,hemorragico,i
93,S0210-56912011000500005,traumatico,i
93,S0210-56912011000500005,Dados,o
93,S0210-56912011000500005,los,o
93,S0210-56912011000500005,resultados,o
93,S0210-56912011000500005,el,o
93,S0210-56912011000500005,elevado,o
93,S0210-56912011000500005,volumen,o
93,S0210-56912011000500005,de,o
93,S0210-56912011000500005,muertes,i
93,S0210-56912011000500005,por,o
93,S0210-56912011000500005,sangrado,i
93,S0210-56912011000500005,traumatico,i
93,S0210-56912011000500005,que,o
93,S0210-56912011000500005,se,o
93,S0210-56912011000500005,producen,o
93,S0210-56912011000500005,en,o
93,S0210-56912011000500005,el,o
93,S0210-56912011000500005,mundo,o
93,S0210-56912011000500005,y,o
93,S0210-56912011000500005,la,o
93,S0210-56912011000500005,eficiencia,o
93,S0210-56912011000500005,del,o
93,S0210-56912011000500005,tranexamico,i
93,S0210-56912011000500005,proponemos,o
93,S0210-56912011000500005,su,o
93,S0210-56912011000500005,uso,i
93,S0210-56912011000500005,compasivo,i
93,S0210-56912011000500005,hasta,o
93,S0210-56912011000500005,la,o
93,S0210-56912011000500005,inclusion,o
93,S0210-56912011000500005,de,o
93,S0210-56912011000500005,esta,o
93,S0210-56912011000500005,indicacion,o
93,S0210-56912011000500005,en,o
93,S0210-56912011000500005,la,o
93,S0210-56912011000500005,ficha,o
93,S0210-56912011000500005,tecnica,o
94,S0210-56912011000700003,Eficacia,o
94,S0210-56912011000700003,y,o
94,S0210-56912011000700003,seguridad,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,implantacion,i
94,S0210-56912011000700003,de,i
94,S0210-56912011000700003,marcapasos,i
94,S0210-56912011000700003,transvenosos,i
94,S0210-56912011000700003,transitorios,i
94,S0210-56912011000700003,en,o
94,S0210-56912011000700003,una,o
94,S0210-56912011000700003,unidad,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,cuidados,o
94,S0210-56912011000700003,intensivos,o
94,S0210-56912011000700003,Objetivo,o
94,S0210-56912011000700003,Analizar,o
94,S0210-56912011000700003,las,o
94,S0210-56912011000700003,caracteristicas,o
94,S0210-56912011000700003,clinicas,o
94,S0210-56912011000700003,indicaciones,o
94,S0210-56912011000700003,y,o
94,S0210-56912011000700003,morbimortalidad,o
94,S0210-56912011000700003,asociada,o
94,S0210-56912011000700003,a,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,implantacion,i
94,S0210-56912011000700003,de,i
94,S0210-56912011000700003,marcapasos,i
94,S0210-56912011000700003,transvenosos,i
94,S0210-56912011000700003,transitorios,i
94,S0210-56912011000700003,Diseño,o
94,S0210-56912011000700003,Estudio,i
94,S0210-56912011000700003,observacional,i
94,S0210-56912011000700003,y,i
94,S0210-56912011000700003,prospectivo,i
94,S0210-56912011000700003,Ambito,o
94,S0210-56912011000700003,Unidad,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,cuidados,o
94,S0210-56912011000700003,intensivos,o
94,S0210-56912011000700003,cardiologicos,o
94,S0210-56912011000700003,Pacientes,o
94,S0210-56912011000700003,Se,o
94,S0210-56912011000700003,implanto,i
94,S0210-56912011000700003,marcapasos,i
94,S0210-56912011000700003,transvenoso,i
94,S0210-56912011000700003,transitorio,i
94,S0210-56912011000700003,a,o
94,S0210-56912011000700003,182,o
94,S0210-56912011000700003,pacientes,o
94,S0210-56912011000700003,en,o
94,S0210-56912011000700003,un,o
94,S0210-56912011000700003,periodo,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,4,o
94,S0210-56912011000700003,años,o
94,S0210-56912011000700003,Variables,o
94,S0210-56912011000700003,recogidas,o
94,S0210-56912011000700003,Se,o
94,S0210-56912011000700003,registraron,o
94,S0210-56912011000700003,variables,o
94,S0210-56912011000700003,demograficas,o
94,S0210-56912011000700003,clinicas,o
94,S0210-56912011000700003,indicaciones,o
94,S0210-56912011000700003,via,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,acceso,o
94,S0210-56912011000700003,dias,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,estancia,o
94,S0210-56912011000700003,en,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,unidad,o
94,S0210-56912011000700003,y,o
94,S0210-56912011000700003,complicaciones,i
94,S0210-56912011000700003,Resultados,o
94,S0210-56912011000700003,El,o
94,S0210-56912011000700003,63,o
94,S0210-56912011000700003,eran,o
94,S0210-56912011000700003,hombres,o
94,S0210-56912011000700003,con,o
94,S0210-56912011000700003,una,o
94,S0210-56912011000700003,media,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,edad,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,7895,o
94,S0210-56912011000700003,años,o
94,S0210-56912011000700003,con,o
94,S0210-56912011000700003,bloqueo,i
94,S0210-56912011000700003,auriculoventricular,i
94,S0210-56912011000700003,sintomatico,i
94,S0210-56912011000700003,en,o
94,S0210-56912011000700003,un,o
94,S0210-56912011000700003,769,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,los,o
94,S0210-56912011000700003,casos,o
94,S0210-56912011000700003,La,o
94,S0210-56912011000700003,via,o
94,S0210-56912011000700003,venosa,i
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,abordaje,o
94,S0210-56912011000700003,habitual,o
94,S0210-56912011000700003,fue,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,femoral,i
94,S0210-56912011000700003,923,o
94,S0210-56912011000700003,El,o
94,S0210-56912011000700003,4011,o
94,S0210-56912011000700003,sufrio,o
94,S0210-56912011000700003,complicaciones,i
94,S0210-56912011000700003,siendo,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,mas,o
94,S0210-56912011000700003,frecuente,o
94,S0210-56912011000700003,el,o
94,S0210-56912011000700003,hematoma,i
94,S0210-56912011000700003,en,i
94,S0210-56912011000700003,la,i
94,S0210-56912011000700003,zona,i
94,S0210-56912011000700003,de,i
94,S0210-56912011000700003,puncion,i
94,S0210-56912011000700003,1319,o
94,S0210-56912011000700003,No,o
94,S0210-56912011000700003,hubo,o
94,S0210-56912011000700003,diferencias,o
94,S0210-56912011000700003,entre,o
94,S0210-56912011000700003,el,o
94,S0210-56912011000700003,profesional,o
94,S0210-56912011000700003,que,o
94,S0210-56912011000700003,implanto,i
94,S0210-56912011000700003,el,i
94,S0210-56912011000700003,marcapasos,i
94,S0210-56912011000700003,y,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,aparicion,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,complicaciones,i
94,S0210-56912011000700003,La,o
94,S0210-56912011000700003,agitacion,i
94,S0210-56912011000700003,psicomotriz,i
94,S0210-56912011000700003,se,o
94,S0210-56912011000700003,asocio,o
94,S0210-56912011000700003,a,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,existencia,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,hematoma,i
94,S0210-56912011000700003,en,i
94,S0210-56912011000700003,la,i
94,S0210-56912011000700003,zona,i
94,S0210-56912011000700003,de,i
94,S0210-56912011000700003,puncion,i
94,S0210-56912011000700003,p007,o
94,S0210-56912011000700003,y,o
94,S0210-56912011000700003,a,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,necesidad,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,movilizacion,o
94,S0210-56912011000700003,del,o
94,S0210-56912011000700003,cateter,o
94,S0210-56912011000700003,p0059,o
94,S0210-56912011000700003,Se,o
94,S0210-56912011000700003,identifico,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,via,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,insercion,i
94,S0210-56912011000700003,no,i
94,S0210-56912011000700003,femoral,i
94,S0210-56912011000700003,p0012,o
94,S0210-56912011000700003,OR016,o
94,S0210-56912011000700003,IC,o
94,S0210-56912011000700003,del,o
94,S0210-56912011000700003,95,o
94,S0210-56912011000700003,004066,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,agitacion,i
94,S0210-56912011000700003,p0006,o
94,S0210-56912011000700003,OR32,o
94,S0210-56912011000700003,IC,o
94,S0210-56912011000700003,del,o
94,S0210-56912011000700003,95,o
94,S0210-56912011000700003,1473,o
94,S0210-56912011000700003,y,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,presencia,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,factores,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,riesgo,i
94,S0210-56912011000700003,cardiovascular,i
94,S0210-56912011000700003,p0042,o
94,S0210-56912011000700003,OR5,o
94,S0210-56912011000700003,IC,o
94,S0210-56912011000700003,del,o
94,S0210-56912011000700003,95,o
94,S0210-56912011000700003,106142,o
94,S0210-56912011000700003,como,o
94,S0210-56912011000700003,predictores,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,complicaciones,i
94,S0210-56912011000700003,La,o
94,S0210-56912011000700003,realizacion,o
94,S0210-56912011000700003,del,o
94,S0210-56912011000700003,procedimiento,i
94,S0210-56912011000700003,por,o
94,S0210-56912011000700003,parte,o
94,S0210-56912011000700003,del,o
94,S0210-56912011000700003,personal,o
94,S0210-56912011000700003,especializado,o
94,S0210-56912011000700003,p00001,o
94,S0210-56912011000700003,y,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,presencia,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,complicaciones,i
94,S0210-56912011000700003,p005,o
94,S0210-56912011000700003,incrementaron,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,estancia,o
94,S0210-56912011000700003,en,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,unidad,o
94,S0210-56912011000700003,Conclusiones,o
94,S0210-56912011000700003,La,o
94,S0210-56912011000700003,presencia,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,agitacion,i
94,S0210-56912011000700003,los,o
94,S0210-56912011000700003,factores,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,riesgo,i
94,S0210-56912011000700003,cardiovascular,i
94,S0210-56912011000700003,y,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,insercion,i
94,S0210-56912011000700003,a,o
94,S0210-56912011000700003,traves,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,vena,i
94,S0210-56912011000700003,subclavia,i
94,S0210-56912011000700003,o,o
94,S0210-56912011000700003,yugular,i
94,S0210-56912011000700003,fueron,o
94,S0210-56912011000700003,predictores,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,complicaciones,i
94,S0210-56912011000700003,Estas,o
94,S0210-56912011000700003,no,o
94,S0210-56912011000700003,se,o
94,S0210-56912011000700003,relacionaron,o
94,S0210-56912011000700003,con,o
94,S0210-56912011000700003,el,o
94,S0210-56912011000700003,tipo,o
94,S0210-56912011000700003,de,o
94,S0210-56912011000700003,profesional,o
94,S0210-56912011000700003,implicado,o
94,S0210-56912011000700003,en,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,implantacion,i
94,S0210-56912011000700003,pero,o
94,S0210-56912011000700003,incrementaron,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,estancia,o
94,S0210-56912011000700003,en,o
94,S0210-56912011000700003,la,o
94,S0210-56912011000700003,unidad,o
95,S0211-699517300966,Efectos,o
95,S0211-699517300966,de,o
95,S0211-699517300966,la,o
95,S0211-699517300966,rotigotina,i
95,S0211-699517300966,sobre,o
95,S0211-699517300966,la,o
95,S0211-699517300966,sintomatologia,i
95,S0211-699517300966,calidad,o
95,S0211-699517300966,de,o
95,S0211-699517300966,vida,o
95,S0211-699517300966,e,o
95,S0211-699517300966,higiene,o
95,S0211-699517300966,de,o
95,S0211-699517300966,sueño,o
95,S0211-699517300966,en,o
95,S0211-699517300966,el,o
95,S0211-699517300966,sindrome,i
95,S0211-699517300966,de,i
95,S0211-699517300966,piernas,i
95,S0211-699517300966,inquietas,i
95,S0211-699517300966,en,o
95,S0211-699517300966,hemodialisis,i
95,S0211-699517300966,Introduccion,o
95,S0211-699517300966,El,o
95,S0211-699517300966,sindrome,i
95,S0211-699517300966,de,i
95,S0211-699517300966,piernas,i
95,S0211-699517300966,inquietas,i
95,S0211-699517300966,SPI,i
95,S0211-699517300966,es,o
95,S0211-699517300966,un,o
95,S0211-699517300966,trastorno,i
95,S0211-699517300966,neurologico,i
95,S0211-699517300966,caracterizado,o
95,S0211-699517300966,por,o
95,S0211-699517300966,una,o
95,S0211-699517300966,molesta,o
95,S0211-699517300966,sintomatologia,i
95,S0211-699517300966,asociado,o
95,S0211-699517300966,a,o
95,S0211-699517300966,deterioro,o
95,S0211-699517300966,de,o
95,S0211-699517300966,calidad,o
95,S0211-699517300966,de,o
95,S0211-699517300966,vida,o
95,S0211-699517300966,e,o
95,S0211-699517300966,higiene,o
95,S0211-699517300966,de,o
95,S0211-699517300966,sueño,o
95,S0211-699517300966,Rotigotina,i
95,S0211-699517300966,constituye,o
95,S0211-699517300966,una,o
95,S0211-699517300966,novedosa,o
95,S0211-699517300966,alternativa,o
95,S0211-699517300966,terapeutica,o
95,S0211-699517300966,si,o
95,S0211-699517300966,bien,o
95,S0211-699517300966,existen,o
95,S0211-699517300966,escasos,o
95,S0211-699517300966,estudios,o
95,S0211-699517300966,publicados,o
95,S0211-699517300966,sobre,o
95,S0211-699517300966,rotigotina,i
95,S0211-699517300966,en,o
95,S0211-699517300966,pacientes,o
95,S0211-699517300966,en,o
95,S0211-699517300966,hemodialisis,i
95,S0211-699517300966,HD,i
95,S0211-699517300966,con,o
95,S0211-699517300966,SPI,i
95,S0211-699517300966,Objetivos,o
95,S0211-699517300966,1,o
95,S0211-699517300966,Establecer,o
95,S0211-699517300966,la,o
95,S0211-699517300966,prevalencia,o
95,S0211-699517300966,de,o
95,S0211-699517300966,SPI,i
95,S0211-699517300966,en,o
95,S0211-699517300966,nuestra,o
95,S0211-699517300966,unidad,o
95,S0211-699517300966,de,o
95,S0211-699517300966,HD,i
95,S0211-699517300966,2,o
95,S0211-699517300966,Evaluar,i
95,S0211-699517300966,la,i
95,S0211-699517300966,eficacia,i
95,S0211-699517300966,y,i
95,S0211-699517300966,el,i
95,S0211-699517300966,perfil,i
95,S0211-699517300966,de,i
95,S0211-699517300966,seguridad,i
95,S0211-699517300966,asociado,o
95,S0211-699517300966,a,o
95,S0211-699517300966,rotigotina,i
95,S0211-699517300966,asi,o
95,S0211-699517300966,como,o
95,S0211-699517300966,su,o
95,S0211-699517300966,efecto,o
95,S0211-699517300966,sobre,o
95,S0211-699517300966,la,o
95,S0211-699517300966,sintomatologia,i
95,S0211-699517300966,calidad,o
95,S0211-699517300966,de,o
95,S0211-699517300966,vida,o
95,S0211-699517300966,e,o
95,S0211-699517300966,higiene,o
95,S0211-699517300966,del,o
95,S0211-699517300966,sueño,o
95,S0211-699517300966,en,o
95,S0211-699517300966,nuestra,o
95,S0211-699517300966,poblacion,o
95,S0211-699517300966,en,o
95,S0211-699517300966,HD,i
95,S0211-699517300966,con,o
95,S0211-699517300966,SPI,i
95,S0211-699517300966,Material,o
95,S0211-699517300966,y,o
95,S0211-699517300966,metodos,o
95,S0211-699517300966,Estudio,o
95,S0211-699517300966,unicentrico,o
95,S0211-699517300966,prospectivo,o
95,S0211-699517300966,de,o
95,S0211-699517300966,12,o
95,S0211-699517300966,semanas,o
95,S0211-699517300966,de,o
95,S0211-699517300966,duracion,o
95,S0211-699517300966,Dos,o
95,S0211-699517300966,fases,o
95,S0211-699517300966,6,o
95,S0211-699517300966,semanas,o
95,S0211-699517300966,fase,o
95,S0211-699517300966,1,o
95,S0211-699517300966,no,o
95,S0211-699517300966,tratamiento,i
95,S0211-699517300966,y,o
95,S0211-699517300966,fase,o
95,S0211-699517300966,2,o
95,S0211-699517300966,rotigotina,i
95,S0211-699517300966,Analizamos,o
95,S0211-699517300966,1,o
95,S0211-699517300966,Datos,o
95,S0211-699517300966,demograficos,o
95,S0211-699517300966,bioquimicos,o
95,S0211-699517300966,parametros,o
95,S0211-699517300966,de,o
95,S0211-699517300966,adecuacion,o
95,S0211-699517300966,de,o
95,S0211-699517300966,HD,i
95,S0211-699517300966,y,o
95,S0211-699517300966,tratamiento,i
95,S0211-699517300966,medico,i
95,S0211-699517300966,relacionado,o
95,S0211-699517300966,con,o
95,S0211-699517300966,SPI,i
95,S0211-699517300966,2,o
95,S0211-699517300966,Cuestionario,i
95,S0211-699517300966,sobre,o
95,S0211-699517300966,sintomas,i
95,S0211-699517300966,en,o
95,S0211-699517300966,extremidades,i
95,S0211-699517300966,inferiores,i
95,S0211-699517300966,QS,o
95,S0211-699517300966,3,o
95,S0211-699517300966,Escala,o
95,S0211-699517300966,de,o
95,S0211-699517300966,gravedad,o
95,S0211-699517300966,de,o
95,S0211-699517300966,los,o
95,S0211-699517300966,sintomas,i
95,S0211-699517300966,GRLS,o
95,S0211-699517300966,4,o
95,S0211-699517300966,Calidad,i
95,S0211-699517300966,de,i
95,S0211-699517300966,vida,i
95,S0211-699517300966,SPI,i
95,S0211-699517300966,John,o
95,S0211-699517300966,Hopkins,o
95,S0211-699517300966,RLSQoL,o
95,S0211-699517300966,JHQoL,o
95,S0211-699517300966,5,o
95,S0211-699517300966,Higiene,o
95,S0211-699517300966,del,o
95,S0211-699517300966,sueño,o
95,S0211-699517300966,Escala,o
95,S0211-699517300966,SCOPA,o
95,S0211-699517300966,Resultados,o
95,S0211-699517300966,Se,o
95,S0211-699517300966,incluyo,o
95,S0211-699517300966,a,o
95,S0211-699517300966,66,o
95,S0211-699517300966,pacientes,o
95,S0211-699517300966,en,o
95,S0211-699517300966,HD,i
95,S0211-699517300966,De,o
95,S0211-699517300966,ellos,o
95,S0211-699517300966,14,o
95,S0211-699517300966,con,o
95,S0211-699517300966,SPI,i
95,S0211-699517300966,el,o
95,S0211-699517300966,444,o
95,S0211-699517300966,eran,o
95,S0211-699517300966,hombres,o
95,S0211-699517300966,con,o
95,S0211-699517300966,70299,o
95,S0211-699517300966,años,o
95,S0211-699517300966,y,o
95,S0211-699517300966,11111608,o
95,S0211-699517300966,meses,o
95,S0211-699517300966,en,o
95,S0211-699517300966,HD,i
95,S0211-699517300966,El,o
95,S0211-699517300966,229,o
95,S0211-699517300966,con,o
95,S0211-699517300966,SPI,i
95,S0211-699517300966,Unicamente,o
95,S0211-699517300966,en,o
95,S0211-699517300966,la,o
95,S0211-699517300966,fase,o
95,S0211-699517300966,2,o
95,S0211-699517300966,observamos,o
95,S0211-699517300966,una,o
95,S0211-699517300966,mejoria,o
95,S0211-699517300966,significativa,o
95,S0211-699517300966,para,o
95,S0211-699517300966,QS,o
95,S0211-699517300966,1024,o
95,S0211-699517300966,vs,o
95,S0211-699517300966,5710,o
95,S0211-699517300966,GRLS,o
95,S0211-699517300966,214,o
95,S0211-699517300966,vs,o
95,S0211-699517300966,5746,o
95,S0211-699517300966,JHQoL,o
95,S0211-699517300966,22144,o
95,S0211-699517300966,vs,o
95,S0211-699517300966,4340,o
95,S0211-699517300966,y,o
95,S0211-699517300966,SCOPA,o
95,S0211-699517300966,1653,o
95,S0211-699517300966,vs,o
95,S0211-699517300966,6719,o
95,S0211-699517300966,Un,o
95,S0211-699517300966,777,o
95,S0211-699517300966,y,o
95,S0211-699517300966,un,o
95,S0211-699517300966,111,o
95,S0211-699517300966,presentaron,o
95,S0211-699517300966,remision,o
95,S0211-699517300966,parcial,o
95,S0211-699517300966,20,o
95,S0211-699517300966,y,o
95,S0211-699517300966,completa,o
95,S0211-699517300966,80,o
95,S0211-699517300966,respectivamente,o
95,S0211-699517300966,Un,o
95,S0211-699517300966,555,o
95,S0211-699517300966,alcanzo,o
95,S0211-699517300966,sintomatologia,i
95,S0211-699517300966,cero,o
95,S0211-699517300966,Un,o
95,S0211-699517300966,unico,o
95,S0211-699517300966,paciente,o
95,S0211-699517300966,presento,o
95,S0211-699517300966,intolerancia,i
95,S0211-699517300966,digestiva,i
95,S0211-699517300966,y,o
95,S0211-699517300966,ninguno,o
95,S0211-699517300966,augmentation,o
95,S0211-699517300966,efect,o
95,S0211-699517300966,No,o
95,S0211-699517300966,observamos,o
95,S0211-699517300966,cambios,o
95,S0211-699517300966,en,o
95,S0211-699517300966,datos,o
95,S0211-699517300966,bioquimicos,o
95,S0211-699517300966,adecuacion,o
95,S0211-699517300966,dialitica,i
95,S0211-699517300966,ni,o
95,S0211-699517300966,tratamiento,i
95,S0211-699517300966,medico,i
95,S0211-699517300966,El,o
95,S0211-699517300966,analisis,o
95,S0211-699517300966,intergrupos,o
95,S0211-699517300966,mostro,o
95,S0211-699517300966,una,o
95,S0211-699517300966,mejoria,o
95,S0211-699517300966,significativa,o
95,S0211-699517300966,en,o
95,S0211-699517300966,la,o
95,S0211-699517300966,fase,o
95,S0211-699517300966,2,o
95,S0211-699517300966,con,o
95,S0211-699517300966,relacion,o
95,S0211-699517300966,a,o
95,S0211-699517300966,QS,o
95,S0211-699517300966,GRLSS,o
95,S0211-699517300966,JHQoL,o
95,S0211-699517300966,y,o
95,S0211-699517300966,SCOPA,o
95,S0211-699517300966,Conclusiones,o
95,S0211-699517300966,En,o
95,S0211-699517300966,nuestro,o
95,S0211-699517300966,estudio,o
95,S0211-699517300966,el,o
95,S0211-699517300966,SPI,i
95,S0211-699517300966,uremico,i
95,S0211-699517300966,presento,o
95,S0211-699517300966,una,o
95,S0211-699517300966,prevalencia,o
95,S0211-699517300966,considerable,o
95,S0211-699517300966,Rotigotina,i
95,S0211-699517300966,mejoro,o
95,S0211-699517300966,la,o
95,S0211-699517300966,sintomatologia,i
95,S0211-699517300966,clinica,i
95,S0211-699517300966,la,o
95,S0211-699517300966,calidad,o
95,S0211-699517300966,de,o
95,S0211-699517300966,vida,o
95,S0211-699517300966,y,o
95,S0211-699517300966,la,o
95,S0211-699517300966,higiene,o
95,S0211-699517300966,de,o
95,S0211-699517300966,sueño,o
95,S0211-699517300966,en,o
95,S0211-699517300966,los,o
95,S0211-699517300966,pacientes,o
95,S0211-699517300966,con,o
95,S0211-699517300966,SPI,i
95,S0211-699517300966,en,o
95,S0211-699517300966,HD,i
95,S0211-699517300966,por,o
95,S0211-699517300966,lo,o
95,S0211-699517300966,que,o
95,S0211-699517300966,resulta,o
95,S0211-699517300966,ser,o
95,S0211-699517300966,un,o
95,S0211-699517300966,farmaco,i
95,S0211-699517300966,seguro,o
95,S0211-699517300966,con,o
95,S0211-699517300966,minimos,o
95,S0211-699517300966,efectos,i
95,S0211-699517300966,adversos,i
95,S0211-699517300966,y,o
95,S0211-699517300966,con,o
95,S0211-699517300966,cumplimento,o
95,S0211-699517300966,terapeutico,o
95,S0211-699517300966,completo,o
95,S0211-699517300966,No,o
95,S0211-699517300966,obstante,o
95,S0211-699517300966,serian,o
95,S0211-699517300966,necesarios,o
95,S0211-699517300966,futuros,o
95,S0211-699517300966,estudios,o
95,S0211-699517300966,para,o
95,S0211-699517300966,confirmar,o
95,S0211-699517300966,el,o
95,S0211-699517300966,beneficio,o
95,S0211-699517300966,de,o
95,S0211-699517300966,rotigotina,i
95,S0211-699517300966,en,o
95,S0211-699517300966,la,o
95,S0211-699517300966,poblacion,o
95,S0211-699517300966,en,o
95,S0211-699517300966,HD,i
95,S0211-699517300966,con,o
95,S0211-699517300966,SPI,i
96,S0211-699517301340,Evaluacion,i
96,S0211-699517301340,prospectiva,i
96,S0211-699517301340,del,o
96,S0211-699517301340,desarrollo,o
96,S0211-699517301340,de,o
96,S0211-699517301340,nefropatia,i
96,S0211-699517301340,inducida,i
96,S0211-699517301340,por,i
96,S0211-699517301340,contraste,i
96,S0211-699517301340,en,o
96,S0211-699517301340,pacientes,o
96,S0211-699517301340,con,o
96,S0211-699517301340,sindrome,i
96,S0211-699517301340,coronario,i
96,S0211-699517301340,agudo,i
96,S0211-699517301340,tratados,i
96,S0211-699517301340,con,o
96,S0211-699517301340,angiografia,i
96,S0211-699517301340,coronaria,i
96,S0211-699517301340,rotacional,i
96,S0211-699517301340,vs,o
96,S0211-699517301340,angiografia,i
96,S0211-699517301340,coronaria,i
96,S0211-699517301340,convencional,i
96,S0211-699517301340,Estudio,o
96,S0211-699517301340,CINERAMA,o
96,S0211-699517301340,Introduccion,o
96,S0211-699517301340,y,o
96,S0211-699517301340,objetivos,o
96,S0211-699517301340,La,o
96,S0211-699517301340,angiografia,i
96,S0211-699517301340,coronaria,i
96,S0211-699517301340,rotacional,i
96,S0211-699517301340,ACR,i
96,S0211-699517301340,permite,o
96,S0211-699517301340,reducir,o
96,S0211-699517301340,la,o
96,S0211-699517301340,cantidad,o
96,S0211-699517301340,de,o
96,S0211-699517301340,contraste,i
96,S0211-699517301340,administrado,o
96,S0211-699517301340,y,o
96,S0211-699517301340,puede,o
96,S0211-699517301340,prevenir,i
96,S0211-699517301340,el,o
96,S0211-699517301340,desarrollo,o
96,S0211-699517301340,de,o
96,S0211-699517301340,nefropatia,i
96,S0211-699517301340,inducida,i
96,S0211-699517301340,por,i
96,S0211-699517301340,contraste,i
96,S0211-699517301340,NIC,i
96,S0211-699517301340,durante,o
96,S0211-699517301340,los,o
96,S0211-699517301340,procedimientos,i
96,S0211-699517301340,coronarios,i
96,S0211-699517301340,invasivos,i
96,S0211-699517301340,El,o
96,S0211-699517301340,objetivo,o
96,S0211-699517301340,del,o
96,S0211-699517301340,estudio,o
96,S0211-699517301340,es,o
96,S0211-699517301340,evaluar,o
96,S0211-699517301340,el,o
96,S0211-699517301340,impacto,o
96,S0211-699517301340,de,o
96,S0211-699517301340,la,o
96,S0211-699517301340,ACR,i
96,S0211-699517301340,en,o
96,S0211-699517301340,la,o
96,S0211-699517301340,aparicion,o
96,S0211-699517301340,de,o
96,S0211-699517301340,NIC,i
96,S0211-699517301340,aumento,o
96,S0211-699517301340,de,o
96,S0211-699517301340,creatinina,i
96,S0211-699517301340,05mgdL,o
96,S0211-699517301340,o,o
96,S0211-699517301340,25,o
96,S0211-699517301340,tras,o
96,S0211-699517301340,un,o
96,S0211-699517301340,sindrome,i
96,S0211-699517301340,coronario,i
96,S0211-699517301340,agudo,i
96,S0211-699517301340,Metodos,o
96,S0211-699517301340,De,o
96,S0211-699517301340,abril,o
96,S0211-699517301340,a,o
96,S0211-699517301340,septiembre,o
96,S0211-699517301340,de,o
96,S0211-699517301340,2016,o
96,S0211-699517301340,se,o
96,S0211-699517301340,seleccionaron,o
96,S0211-699517301340,prospectivamente,o
96,S0211-699517301340,pacientes,o
96,S0211-699517301340,con,o
96,S0211-699517301340,sindrome,i
96,S0211-699517301340,coronario,i
96,S0211-699517301340,agudo,i
96,S0211-699517301340,remitidos,o
96,S0211-699517301340,para,o
96,S0211-699517301340,coronariografia,i
96,S0211-699517301340,diagnostica,i
96,S0211-699517301340,con,o
96,S0211-699517301340,posibilidad,o
96,S0211-699517301340,de,o
96,S0211-699517301340,angioplastia,i
96,S0211-699517301340,ad,o
96,S0211-699517301340,hoc,o
96,S0211-699517301340,que,o
96,S0211-699517301340,fueron,o
96,S0211-699517301340,estudiados,o
96,S0211-699517301340,con,o
96,S0211-699517301340,ACR,i
96,S0211-699517301340,o,o
96,S0211-699517301340,angiografia,i
96,S0211-699517301340,coronaria,i
96,S0211-699517301340,convencional,i
96,S0211-699517301340,ACC,i
96,S0211-699517301340,segun,o
96,S0211-699517301340,criterio,o
96,S0211-699517301340,del,o
96,S0211-699517301340,operador,o
96,S0211-699517301340,Se,o
96,S0211-699517301340,compararon,o
96,S0211-699517301340,la,o
96,S0211-699517301340,NIC,i
96,S0211-699517301340,variable,o
96,S0211-699517301340,de,o
96,S0211-699517301340,valoracion,i
96,S0211-699517301340,primaria,i
96,S0211-699517301340,variables,o
96,S0211-699517301340,analiticas,o
96,S0211-699517301340,angiograficas,i
96,S0211-699517301340,y,o
96,S0211-699517301340,clinicas,o
96,S0211-699517301340,Resultados,o
96,S0211-699517301340,De,o
96,S0211-699517301340,235,o
96,S0211-699517301340,pacientes,o
96,S0211-699517301340,reclutados,o
96,S0211-699517301340,116,o
96,S0211-699517301340,pacientes,o
96,S0211-699517301340,fueron,o
96,S0211-699517301340,estudiados,o
96,S0211-699517301340,con,o
96,S0211-699517301340,ACR,i
96,S0211-699517301340,y,o
96,S0211-699517301340,119,o
96,S0211-699517301340,pacientes,o
96,S0211-699517301340,con,o
96,S0211-699517301340,ACC,i
96,S0211-699517301340,El,o
96,S0211-699517301340,grupo,o
96,S0211-699517301340,de,o
96,S0211-699517301340,ACR,i
96,S0211-699517301340,presentaba,o
96,S0211-699517301340,mayor,o
96,S0211-699517301340,edad,o
96,S0211-699517301340,640118,o
96,S0211-699517301340,vs,o
96,S0211-699517301340,597121,o
96,S0211-699517301340,años,o
96,S0211-699517301340,p0006,o
96,S0211-699517301340,mas,o
96,S0211-699517301340,mujeres,o
96,S0211-699517301340,448,o
96,S0211-699517301340,vs,o
96,S0211-699517301340,176,o
96,S0211-699517301340,p0001,o
96,S0211-699517301340,y,o
96,S0211-699517301340,peor,o
96,S0211-699517301340,filtrado,i
96,S0211-699517301340,glomerular,i
96,S0211-699517301340,estimado,i
96,S0211-699517301340,7625,o
96,S0211-699517301340,vs,o
96,S0211-699517301340,8627,o
96,S0211-699517301340,mLmin173,o
96,S0211-699517301340,m2,o
96,S0211-699517301340,p0001,o
96,S0211-699517301340,con,o
96,S0211-699517301340,menos,o
96,S0211-699517301340,angioplastias,i
96,S0211-699517301340,p0001,o
96,S0211-699517301340,Asimismo,o
96,S0211-699517301340,el,o
96,S0211-699517301340,grupo,o
96,S0211-699517301340,de,o
96,S0211-699517301340,ACR,i
96,S0211-699517301340,recibio,o
96,S0211-699517301340,menos,o
96,S0211-699517301340,contraste,i
96,S0211-699517301340,11392,o
96,S0211-699517301340,vs,o
96,S0211-699517301340,169103,o
96,S0211-699517301340,mL,o
96,S0211-699517301340,p0001,o
96,S0211-699517301340,diferencias,o
96,S0211-699517301340,que,o
96,S0211-699517301340,se,o
96,S0211-699517301340,mantuvieron,o
96,S0211-699517301340,en,o
96,S0211-699517301340,los,o
96,S0211-699517301340,procedimientos,i
96,S0211-699517301340,diagnosticos,i
96,S0211-699517301340,5424,o
96,S0211-699517301340,vs,o
96,S0211-699517301340,8556,o
96,S0211-699517301340,mL,o
96,S0211-699517301340,p0001,o
96,S0211-699517301340,y,o
96,S0211-699517301340,diagnosticoterapeuticos,o
96,S0211-699517301340,17464,o
96,S0211-699517301340,vs,o
96,S0211-699517301340,20598,o
96,S0211-699517301340,mL,o
96,S0211-699517301340,p0049,o
96,S0211-699517301340,El,o
96,S0211-699517301340,grupo,o
96,S0211-699517301340,de,o
96,S0211-699517301340,ACR,i
96,S0211-699517301340,presento,o
96,S0211-699517301340,menos,o
96,S0211-699517301340,NIC,i
96,S0211-699517301340,43,o
96,S0211-699517301340,vs,o
96,S0211-699517301340,227,o
96,S0211-699517301340,p0001,o
96,S0211-699517301340,en,o
96,S0211-699517301340,el,o
96,S0211-699517301340,analisis,o
96,S0211-699517301340,de,o
96,S0211-699517301340,regresion,o
96,S0211-699517301340,se,o
96,S0211-699517301340,objetivo,o
96,S0211-699517301340,que,o
96,S0211-699517301340,continuaba,o
96,S0211-699517301340,relacionandose,o
96,S0211-699517301340,con,o
96,S0211-699517301340,menor,o
96,S0211-699517301340,desarrollo,o
96,S0211-699517301340,de,o
96,S0211-699517301340,NIC,i
96,S0211-699517301340,riesgo,o
96,S0211-699517301340,relativo,o
96,S0211-699517301340,ajustado,o
96,S0211-699517301340,0868,o
96,S0211-699517301340,IC,o
96,S0211-699517301340,95,o
96,S0211-699517301340,07940949,o
96,S0211-699517301340,p0002,o
96,S0211-699517301340,No,o
96,S0211-699517301340,hubo,o
96,S0211-699517301340,diferencias,o
96,S0211-699517301340,en,o
96,S0211-699517301340,las,o
96,S0211-699517301340,variables,o
96,S0211-699517301340,clinicas,o
96,S0211-699517301340,Conclusiones,o
96,S0211-699517301340,La,o
96,S0211-699517301340,ACR,i
96,S0211-699517301340,se,o
96,S0211-699517301340,asocio,o
96,S0211-699517301340,con,o
96,S0211-699517301340,menor,o
96,S0211-699517301340,administracion,i
96,S0211-699517301340,de,o
96,S0211-699517301340,contraste,i
96,S0211-699517301340,durante,o
96,S0211-699517301340,procedimientos,i
96,S0211-699517301340,coronarios,i
96,S0211-699517301340,invasivos,i
96,S0211-699517301340,tras,o
96,S0211-699517301340,un,o
96,S0211-699517301340,sindrome,i
96,S0211-699517301340,coronario,i
96,S0211-699517301340,agudo,i
96,S0211-699517301340,lo,o
96,S0211-699517301340,que,o
96,S0211-699517301340,resulto,o
96,S0211-699517301340,en,o
96,S0211-699517301340,una,o
96,S0211-699517301340,menor,o
96,S0211-699517301340,aparicion,o
96,S0211-699517301340,de,o
96,S0211-699517301340,NIC,i
97,S0211-699517301352,Cambios,i
97,S0211-699517301352,de,i
97,S0211-699517301352,la,i
97,S0211-699517301352,funcion,i
97,S0211-699517301352,renal,i
97,S0211-699517301352,tras,o
97,S0211-699517301352,la,o
97,S0211-699517301352,suspension,o
97,S0211-699517301352,de,o
97,S0211-699517301352,analogos,i
97,S0211-699517301352,de,i
97,S0211-699517301352,vitamina,i
97,S0211-699517301352,D,i
97,S0211-699517301352,en,o
97,S0211-699517301352,la,o
97,S0211-699517301352,enfermedad,i
97,S0211-699517301352,renal,i
97,S0211-699517301352,cronica,i
97,S0211-699517301352,avanzada,o
97,S0211-699517301352,Antecedentes,o
97,S0211-699517301352,En,o
97,S0211-699517301352,la,o
97,S0211-699517301352,practica,i
97,S0211-699517301352,clinica,i
97,S0211-699517301352,habitual,o
97,S0211-699517301352,la,o
97,S0211-699517301352,prescripcion,i
97,S0211-699517301352,de,o
97,S0211-699517301352,analogos,i
97,S0211-699517301352,de,i
97,S0211-699517301352,vitamina,i
97,S0211-699517301352,D,i
97,S0211-699517301352,AVD,o
97,S0211-699517301352,en,o
97,S0211-699517301352,la,o
97,S0211-699517301352,enfermedad,i
97,S0211-699517301352,renal,i
97,S0211-699517301352,cronica,i
97,S0211-699517301352,ERC,i
97,S0211-699517301352,se,o
97,S0211-699517301352,asocia,o
97,S0211-699517301352,con,o
97,S0211-699517301352,frecuencia,o
97,S0211-699517301352,a,o
97,S0211-699517301352,un,o
97,S0211-699517301352,descenso,o
97,S0211-699517301352,de,o
97,S0211-699517301352,la,o
97,S0211-699517301352,funcion,i
97,S0211-699517301352,renal,i
97,S0211-699517301352,estimada,i
97,S0211-699517301352,cuyo,o
97,S0211-699517301352,origen,o
97,S0211-699517301352,no,o
97,S0211-699517301352,es,o
97,S0211-699517301352,bien,o
97,S0211-699517301352,conocido,o
97,S0211-699517301352,Objetivos,o
97,S0211-699517301352,Analizar,o
97,S0211-699517301352,el,o
97,S0211-699517301352,efecto,o
97,S0211-699517301352,de,o
97,S0211-699517301352,la,o
97,S0211-699517301352,suspension,i
97,S0211-699517301352,de,i
97,S0211-699517301352,un,i
97,S0211-699517301352,tratamiento,i
97,S0211-699517301352,previo,o
97,S0211-699517301352,con,o
97,S0211-699517301352,AVD,o
97,S0211-699517301352,en,o
97,S0211-699517301352,ERC,i
97,S0211-699517301352,avanzada,o
97,S0211-699517301352,y,o
97,S0211-699517301352,determinar,o
97,S0211-699517301352,los,o
97,S0211-699517301352,factores,o
97,S0211-699517301352,asociados,o
97,S0211-699517301352,con,o
97,S0211-699517301352,los,o
97,S0211-699517301352,cambios,i
97,S0211-699517301352,de,i
97,S0211-699517301352,funcion,i
97,S0211-699517301352,renal,i
97,S0211-699517301352,Material,o
97,S0211-699517301352,y,o
97,S0211-699517301352,metodos,o
97,S0211-699517301352,Estudio,i
97,S0211-699517301352,de,i
97,S0211-699517301352,cohorte,i
97,S0211-699517301352,retrospectivo,i
97,S0211-699517301352,en,o
97,S0211-699517301352,pacientes,o
97,S0211-699517301352,adultos,o
97,S0211-699517301352,incidentes,o
97,S0211-699517301352,con,o
97,S0211-699517301352,ERC,i
97,S0211-699517301352,avanzada,o
97,S0211-699517301352,El,o
97,S0211-699517301352,subgrupo,o
97,S0211-699517301352,caso,o
97,S0211-699517301352,estaba,o
97,S0211-699517301352,siendo,o
97,S0211-699517301352,tratado,i
97,S0211-699517301352,con,i
97,S0211-699517301352,AVD,i
97,S0211-699517301352,y,o
97,S0211-699517301352,esta,o
97,S0211-699517301352,medicacion,i
97,S0211-699517301352,fue,o
97,S0211-699517301352,suspendida,o
97,S0211-699517301352,en,o
97,S0211-699517301352,la,o
97,S0211-699517301352,primera,o
97,S0211-699517301352,visita,o
97,S0211-699517301352,El,o
97,S0211-699517301352,subgrupo,o
97,S0211-699517301352,control,o
97,S0211-699517301352,no,o
97,S0211-699517301352,habia,o
97,S0211-699517301352,sido,o
97,S0211-699517301352,tratado,i
97,S0211-699517301352,con,i
97,S0211-699517301352,AVD,i
97,S0211-699517301352,y,o
97,S0211-699517301352,fueron,o
97,S0211-699517301352,elegidos,o
97,S0211-699517301352,por,o
97,S0211-699517301352,criterios,o
97,S0211-699517301352,de,o
97,S0211-699517301352,coincidencia,o
97,S0211-699517301352,para,o
97,S0211-699517301352,datos,o
97,S0211-699517301352,relevantes,o
97,S0211-699517301352,relacionados,o
97,S0211-699517301352,con,o
97,S0211-699517301352,la,o
97,S0211-699517301352,progresion,o
97,S0211-699517301352,de,o
97,S0211-699517301352,la,o
97,S0211-699517301352,ERC,i
97,S0211-699517301352,La,o
97,S0211-699517301352,variable,o
97,S0211-699517301352,de,o
97,S0211-699517301352,resultado,o
97,S0211-699517301352,principal,o
97,S0211-699517301352,fue,o
97,S0211-699517301352,el,o
97,S0211-699517301352,cambio,o
97,S0211-699517301352,de,o
97,S0211-699517301352,filtrado,i
97,S0211-699517301352,glomerular,i
97,S0211-699517301352,tanto,o
97,S0211-699517301352,el,o
97,S0211-699517301352,estimado,o
97,S0211-699517301352,FGMDRD,o
97,S0211-699517301352,como,o
97,S0211-699517301352,el,o
97,S0211-699517301352,medido,o
97,S0211-699517301352,media,o
97,S0211-699517301352,del,o
97,S0211-699517301352,aclaramiento,i
97,S0211-699517301352,de,i
97,S0211-699517301352,creatinina,i
97,S0211-699517301352,y,o
97,S0211-699517301352,urea,i
97,S0211-699517301352,con,o
97,S0211-699517301352,respecto,o
97,S0211-699517301352,al,o
97,S0211-699517301352,siguiente,o
97,S0211-699517301352,control,i
97,S0211-699517301352,analitico,i
97,S0211-699517301352,Parametros,o
97,S0211-699517301352,basales,o
97,S0211-699517301352,relacionados,o
97,S0211-699517301352,con,o
97,S0211-699517301352,el,o
97,S0211-699517301352,metabolismo,o
97,S0211-699517301352,mineral,i
97,S0211-699517301352,y,o
97,S0211-699517301352,la,o
97,S0211-699517301352,generacion,o
97,S0211-699517301352,de,o
97,S0211-699517301352,creatinina,i
97,S0211-699517301352,fueron,o
97,S0211-699517301352,analizados,o
97,S0211-699517301352,como,o
97,S0211-699517301352,determinantes,o
97,S0211-699517301352,potenciales,o
97,S0211-699517301352,de,o
97,S0211-699517301352,los,o
97,S0211-699517301352,cambios,i
97,S0211-699517301352,de,i
97,S0211-699517301352,la,i
97,S0211-699517301352,funcion,i
97,S0211-699517301352,renal,i
97,S0211-699517301352,Resultados,o
97,S0211-699517301352,Se,o
97,S0211-699517301352,incluyeron,o
97,S0211-699517301352,67,o
97,S0211-699517301352,pacientes,o
97,S0211-699517301352,casos,o
97,S0211-699517301352,y,o
97,S0211-699517301352,otros,o
97,S0211-699517301352,67,o
97,S0211-699517301352,controles,o
97,S0211-699517301352,El,o
97,S0211-699517301352,67,o
97,S0211-699517301352,de,o
97,S0211-699517301352,los,o
97,S0211-699517301352,casos,o
97,S0211-699517301352,mejoro,o
97,S0211-699517301352,la,o
97,S0211-699517301352,funcion,o
97,S0211-699517301352,renal,i
97,S0211-699517301352,mientras,o
97,S0211-699517301352,que,o
97,S0211-699517301352,el,o
97,S0211-699517301352,72,o
97,S0211-699517301352,de,o
97,S0211-699517301352,los,o
97,S0211-699517301352,controles,o
97,S0211-699517301352,empeoro,o
97,S0211-699517301352,p00001,o
97,S0211-699517301352,El,o
97,S0211-699517301352,cambio,o
97,S0211-699517301352,FGMDRD,o
97,S0211-699517301352,en,o
97,S0211-699517301352,casos,o
97,S0211-699517301352,y,o
97,S0211-699517301352,controles,o
97,S0211-699517301352,fue,o
97,S0211-699517301352,04550997,o
97,S0211-699517301352,vs,o
97,S0211-699517301352,04361103mlmin173,o
97,S0211-699517301352,m2mes,o
97,S0211-699517301352,p00001,o
97,S0211-699517301352,respectivamente,o
97,S0211-699517301352,La,o
97,S0211-699517301352,excrecion,i
97,S0211-699517301352,total,i
97,S0211-699517301352,de,i
97,S0211-699517301352,creatinina,i
97,S0211-699517301352,era,o
97,S0211-699517301352,ligeramente,o
97,S0211-699517301352,superior,o
97,S0211-699517301352,en,o
97,S0211-699517301352,los,o
97,S0211-699517301352,casos,o
97,S0211-699517301352,pero,o
97,S0211-699517301352,la,o
97,S0211-699517301352,diferencia,o
97,S0211-699517301352,con,o
97,S0211-699517301352,respecto,o
97,S0211-699517301352,a,o
97,S0211-699517301352,los,o
97,S0211-699517301352,controles,o
97,S0211-699517301352,no,o
97,S0211-699517301352,fue,o
97,S0211-699517301352,significativa,o
97,S0211-699517301352,Por,o
97,S0211-699517301352,regresion,o
97,S0211-699517301352,logistica,o
97,S0211-699517301352,y,o
97,S0211-699517301352,lineal,o
97,S0211-699517301352,multivariante,o
97,S0211-699517301352,el,o
97,S0211-699517301352,calcio,i
97,S0211-699517301352,serico,i
97,S0211-699517301352,total,i
97,S0211-699517301352,basal,i
97,S0211-699517301352,fue,o
97,S0211-699517301352,uno,o
97,S0211-699517301352,de,o
97,S0211-699517301352,los,o
97,S0211-699517301352,principales,o
97,S0211-699517301352,determinantes,o
97,S0211-699517301352,tanto,o
97,S0211-699517301352,de,o
97,S0211-699517301352,la,o
97,S0211-699517301352,recuperacion,o
97,S0211-699517301352,de,o
97,S0211-699517301352,la,o
97,S0211-699517301352,funcion,o
97,S0211-699517301352,renal,i
97,S0211-699517301352,odds,o
97,S0211-699517301352,ratio349,o
97,S0211-699517301352,p0001,o
97,S0211-699517301352,como,o
97,S0211-699517301352,de,o
97,S0211-699517301352,la,o
97,S0211-699517301352,magnitud,o
97,S0211-699517301352,de,o
97,S0211-699517301352,esta,o
97,S0211-699517301352,recuperacion,o
97,S0211-699517301352,beta0276,o
97,S0211-699517301352,p0001,o
97,S0211-699517301352,Conclusiones,o
97,S0211-699517301352,La,o
97,S0211-699517301352,suspension,i
97,S0211-699517301352,de,i
97,S0211-699517301352,AVD,i
97,S0211-699517301352,en,o
97,S0211-699517301352,pacientes,o
97,S0211-699517301352,con,o
97,S0211-699517301352,ERC,i
97,S0211-699517301352,se,o
97,S0211-699517301352,asocia,o
97,S0211-699517301352,con,o
97,S0211-699517301352,una,o
97,S0211-699517301352,mejoria,o
97,S0211-699517301352,significativa,o
97,S0211-699517301352,de,o
97,S0211-699517301352,la,o
97,S0211-699517301352,funcion,i
97,S0211-699517301352,renal,i
97,S0211-699517301352,estimada,i
97,S0211-699517301352,La,o
97,S0211-699517301352,magnitud,o
97,S0211-699517301352,de,o
97,S0211-699517301352,estos,o
97,S0211-699517301352,cambios,o
97,S0211-699517301352,se,o
97,S0211-699517301352,relaciona,o
97,S0211-699517301352,principalmente,o
97,S0211-699517301352,con,o
97,S0211-699517301352,la,o
97,S0211-699517301352,calcemia,i
97,S0211-699517301352,basal,i
98,S0211-699518300687,El,o
98,S0211-699518300687,modelo,o
98,S0211-699518300687,de,o
98,S0211-699518300687,control,o
98,S0211-699518300687,de,o
98,S0211-699518300687,anemia,i
98,S0211-699518300687,ayuda,o
98,S0211-699518300687,al,o
98,S0211-699518300687,nefrologo,o
98,S0211-699518300687,en,o
98,S0211-699518300687,la,o
98,S0211-699518300687,decision,o
98,S0211-699518300687,terapeutica,o
98,S0211-699518300687,para,o
98,S0211-699518300687,el,o
98,S0211-699518300687,manejo,o
98,S0211-699518300687,de,o
98,S0211-699518300687,la,o
98,S0211-699518300687,anemia,i
98,S0211-699518300687,Introduccion,o
98,S0211-699518300687,La,o
98,S0211-699518300687,anemia,i
98,S0211-699518300687,es,o
98,S0211-699518300687,frecuente,o
98,S0211-699518300687,en,o
98,S0211-699518300687,los,o
98,S0211-699518300687,pacientes,o
98,S0211-699518300687,en,o
98,S0211-699518300687,hemodialisis,i
98,S0211-699518300687,y,o
98,S0211-699518300687,su,o
98,S0211-699518300687,tratamiento,i
98,S0211-699518300687,con,o
98,S0211-699518300687,estimulantes,i
98,S0211-699518300687,de,i
98,S0211-699518300687,la,i
98,S0211-699518300687,eritropoyesis,i
98,S0211-699518300687,AEE,i
98,S0211-699518300687,resulta,o
98,S0211-699518300687,complejo,o
98,S0211-699518300687,debido,o
98,S0211-699518300687,a,o
98,S0211-699518300687,multiples,o
98,S0211-699518300687,factores,o
98,S0211-699518300687,Objetivos,o
98,S0211-699518300687,Valorar,o
98,S0211-699518300687,la,o
98,S0211-699518300687,utilidad,o
98,S0211-699518300687,del,o
98,S0211-699518300687,modelo,o
98,S0211-699518300687,de,o
98,S0211-699518300687,control,o
98,S0211-699518300687,de,o
98,S0211-699518300687,anemia,i
98,S0211-699518300687,MCA,o
98,S0211-699518300687,en,o
98,S0211-699518300687,el,o
98,S0211-699518300687,tratamiento,i
98,S0211-699518300687,de,o
98,S0211-699518300687,la,o
98,S0211-699518300687,anemia,i
98,S0211-699518300687,en,o
98,S0211-699518300687,hemodialisis,i
98,S0211-699518300687,Metodos,o
98,S0211-699518300687,El,o
98,S0211-699518300687,MCA,o
98,S0211-699518300687,es,o
98,S0211-699518300687,un,o
98,S0211-699518300687,software,o
98,S0211-699518300687,que,o
98,S0211-699518300687,predice,o
98,S0211-699518300687,la,o
98,S0211-699518300687,dosis,o
98,S0211-699518300687,optima,o
98,S0211-699518300687,de,o
98,S0211-699518300687,darbepoetina,i
98,S0211-699518300687,y,o
98,S0211-699518300687,hierro,i
98,S0211-699518300687,sacarosa,i
98,S0211-699518300687,para,o
98,S0211-699518300687,alcanzar,o
98,S0211-699518300687,niveles,i
98,S0211-699518300687,de,i
98,S0211-699518300687,hemoglobina,i
98,S0211-699518300687,Hb,i
98,S0211-699518300687,y,o
98,S0211-699518300687,ferritina,i
98,S0211-699518300687,deseados,o
98,S0211-699518300687,emitiendo,o
98,S0211-699518300687,sugerencias,o
98,S0211-699518300687,de,o
98,S0211-699518300687,prescripcion,i
98,S0211-699518300687,Estudio,o
98,S0211-699518300687,realizado,o
98,S0211-699518300687,en,o
98,S0211-699518300687,clinicas,o
98,S0211-699518300687,de,o
98,S0211-699518300687,dialisis,i
98,S0211-699518300687,de,o
98,S0211-699518300687,18,o
98,S0211-699518300687,meses,o
98,S0211-699518300687,de,o
98,S0211-699518300687,duracion,o
98,S0211-699518300687,en,o
98,S0211-699518300687,dos,o
98,S0211-699518300687,fases,o
98,S0211-699518300687,de,o
98,S0211-699518300687,intervencion,i
98,S0211-699518300687,FI,o
98,S0211-699518300687,con,o
98,S0211-699518300687,MCA,o
98,S0211-699518300687,FI1,o
98,S0211-699518300687,n213,o
98,S0211-699518300687,FI2,o
98,S0211-699518300687,n218,o
98,S0211-699518300687,separadas,o
98,S0211-699518300687,por,o
98,S0211-699518300687,una,o
98,S0211-699518300687,fase,o
98,S0211-699518300687,de,o
98,S0211-699518300687,control,o
98,S0211-699518300687,FC,o
98,S0211-699518300687,n219,o
98,S0211-699518300687,El,o
98,S0211-699518300687,resultado,o
98,S0211-699518300687,primario,o
98,S0211-699518300687,fue,o
98,S0211-699518300687,el,o
98,S0211-699518300687,porcentaje,o
98,S0211-699518300687,de,o
98,S0211-699518300687,Hb,i
98,S0211-699518300687,en,o
98,S0211-699518300687,rango,o
98,S0211-699518300687,y,o
98,S0211-699518300687,la,o
98,S0211-699518300687,mediana,o
98,S0211-699518300687,de,o
98,S0211-699518300687,dosis,o
98,S0211-699518300687,de,o
98,S0211-699518300687,AEE,i
98,S0211-699518300687,y,o
98,S0211-699518300687,los,o
98,S0211-699518300687,resultados,o
98,S0211-699518300687,secundarios,o
98,S0211-699518300687,fueron,o
98,S0211-699518300687,las,o
98,S0211-699518300687,transfusiones,i
98,S0211-699518300687,las,o
98,S0211-699518300687,hospitalizaciones,i
98,S0211-699518300687,o,o
98,S0211-699518300687,los,o
98,S0211-699518300687,acontecimientos,o
98,S0211-699518300687,cardiovasculares,i
98,S0211-699518300687,Analisis,o
98,S0211-699518300687,a,o
98,S0211-699518300687,nivel,o
98,S0211-699518300687,de,o
98,S0211-699518300687,clinica,o
98,S0211-699518300687,y,o
98,S0211-699518300687,de,o
98,S0211-699518300687,pacientes,o
98,S0211-699518300687,valorando,o
98,S0211-699518300687,la,o
98,S0211-699518300687,variabilidad,o
98,S0211-699518300687,de,o
98,S0211-699518300687,la,o
98,S0211-699518300687,Hb,i
98,S0211-699518300687,mediante,o
98,S0211-699518300687,la,o
98,S0211-699518300687,desviacion,o
98,S0211-699518300687,estandar,o
98,S0211-699518300687,DE,o
98,S0211-699518300687,de,o
98,S0211-699518300687,esta,o
98,S0211-699518300687,Tambien,o
98,S0211-699518300687,se,o
98,S0211-699518300687,analizaron,o
98,S0211-699518300687,pacientes,o
98,S0211-699518300687,con,o
98,S0211-699518300687,la,o
98,S0211-699518300687,mayoria,o
98,S0211-699518300687,de,o
98,S0211-699518300687,sugerencias,o
98,S0211-699518300687,confirmadas,o
98,S0211-699518300687,grupo,o
98,S0211-699518300687,MCA,o
98,S0211-699518300687,cumplidores,o
98,S0211-699518300687,Resultados,o
98,S0211-699518300687,El,o
98,S0211-699518300687,MCA,o
98,S0211-699518300687,aumento,o
98,S0211-699518300687,el,o
98,S0211-699518300687,porcentaje,o
98,S0211-699518300687,de,o
98,S0211-699518300687,Hb,i
98,S0211-699518300687,en,o
98,S0211-699518300687,rango,o
98,S0211-699518300687,809,o
98,S0211-699518300687,FI2,o
98,S0211-699518300687,frente,o
98,S0211-699518300687,a,o
98,S0211-699518300687,727,o
98,S0211-699518300687,en,o
98,S0211-699518300687,FC,o
98,S0211-699518300687,y,o
98,S0211-699518300687,redujo,o
98,S0211-699518300687,el,o
98,S0211-699518300687,consumo,o
98,S0211-699518300687,de,o
98,S0211-699518300687,darbepoetina,i
98,S0211-699518300687,FI1,o
98,S0211-699518300687,20,o
98,S0211-699518300687,70,o
98,S0211-699518300687,FC,o
98,S0211-699518300687,30,o
98,S0211-699518300687,80,o
98,S0211-699518300687,μg,o
98,S0211-699518300687,p0032,o
98,S0211-699518300687,con,o
98,S0211-699518300687,menor,o
98,S0211-699518300687,fluctuacion,o
98,S0211-699518300687,de,o
98,S0211-699518300687,la,o
98,S0211-699518300687,Hb,i
98,S0211-699518300687,091049,o
98,S0211-699518300687,en,o
98,S0211-699518300687,FC,o
98,S0211-699518300687,a,o
98,S0211-699518300687,082037gdl,o
98,S0211-699518300687,en,o
98,S0211-699518300687,FI2,o
98,S0211-699518300687,p005,o
98,S0211-699518300687,mejorando,o
98,S0211-699518300687,en,o
98,S0211-699518300687,el,o
98,S0211-699518300687,grupo,o
98,S0211-699518300687,MCA,o
98,S0211-699518300687,cumplidores,o
98,S0211-699518300687,En,o
98,S0211-699518300687,cuanto,o
98,S0211-699518300687,a,o
98,S0211-699518300687,los,o
98,S0211-699518300687,resultados,o
98,S0211-699518300687,secundarios,o
98,S0211-699518300687,descendieron,o
98,S0211-699518300687,con,o
98,S0211-699518300687,el,o
98,S0211-699518300687,uso,i
98,S0211-699518300687,del,i
98,S0211-699518300687,MCA,i
98,S0211-699518300687,Conclusiones,o
98,S0211-699518300687,El,o
98,S0211-699518300687,MCA,o
98,S0211-699518300687,ayuda,o
98,S0211-699518300687,a,o
98,S0211-699518300687,obtener,o
98,S0211-699518300687,mejores,o
98,S0211-699518300687,resultados,o
98,S0211-699518300687,de,o
98,S0211-699518300687,anemia,i
98,S0211-699518300687,en,o
98,S0211-699518300687,los,o
98,S0211-699518300687,pacientes,o
98,S0211-699518300687,en,o
98,S0211-699518300687,hemodialisis,i
98,S0211-699518300687,minimizando,o
98,S0211-699518300687,los,o
98,S0211-699518300687,riesgos,o
98,S0211-699518300687,del,o
98,S0211-699518300687,tratamiento,i
98,S0211-699518300687,con,o
98,S0211-699518300687,AEE,i
98,S0211-699518300687,y,o
98,S0211-699518300687,reduciendo,o
98,S0211-699518300687,costes,o
99,S0211-699518301425,Justificacion,o
99,S0211-699518301425,y,o
99,S0211-699518301425,diseño,o
99,S0211-699518301425,de,o
99,S0211-699518301425,DiPPI,o
99,S0211-699518301425,un,o
99,S0211-699518301425,ensayo,i
99,S0211-699518301425,controlado,i
99,S0211-699518301425,aleatorizado,i
99,S0211-699518301425,para,o
99,S0211-699518301425,evaluar,i
99,S0211-699518301425,la,i
99,S0211-699518301425,seguridad,i
99,S0211-699518301425,y,i
99,S0211-699518301425,la,i
99,S0211-699518301425,efectividad,i
99,S0211-699518301425,de,o
99,S0211-699518301425,la,o
99,S0211-699518301425,hemodialisis,i
99,S0211-699518301425,progresiva,i
99,S0211-699518301425,en,o
99,S0211-699518301425,pacientes,o
99,S0211-699518301425,incidentes,o
99,S0211-699518301425,Introduccion,o
99,S0211-699518301425,La,o
99,S0211-699518301425,hemodialisis,o
99,S0211-699518301425,HD,i
99,S0211-699518301425,progresiva,o
99,S0211-699518301425,es,o
99,S0211-699518301425,una,o
99,S0211-699518301425,modalidad,o
99,S0211-699518301425,de,o
99,S0211-699518301425,inicio,o
99,S0211-699518301425,del,o
99,S0211-699518301425,tratamiento,i
99,S0211-699518301425,renal,i
99,S0211-699518301425,sustitutivo,i
99,S0211-699518301425,adaptada,o
99,S0211-699518301425,a,o
99,S0211-699518301425,las,o
99,S0211-699518301425,necesidades,o
99,S0211-699518301425,individuales,o
99,S0211-699518301425,de,o
99,S0211-699518301425,cada,o
99,S0211-699518301425,paciente,o
99,S0211-699518301425,Esta,o
99,S0211-699518301425,condicionada,o
99,S0211-699518301425,fundamentalmente,o
99,S0211-699518301425,por,o
99,S0211-699518301425,la,o
99,S0211-699518301425,funcion,i
99,S0211-699518301425,renal,i
99,S0211-699518301425,residual,i
99,S0211-699518301425,FRR,i
99,S0211-699518301425,En,o
99,S0211-699518301425,ella,o
99,S0211-699518301425,la,o
99,S0211-699518301425,frecuencia,o
99,S0211-699518301425,de,o
99,S0211-699518301425,sesiones,o
99,S0211-699518301425,con,o
99,S0211-699518301425,las,o
99,S0211-699518301425,que,o
99,S0211-699518301425,el,o
99,S0211-699518301425,paciente,o
99,S0211-699518301425,inicia,o
99,S0211-699518301425,HD,i
99,S0211-699518301425,una,o
99,S0211-699518301425,o,o
99,S0211-699518301425,2,o
99,S0211-699518301425,sesiones,o
99,S0211-699518301425,por,o
99,S0211-699518301425,semana,o
99,S0211-699518301425,es,o
99,S0211-699518301425,menor,o
99,S0211-699518301425,que,o
99,S0211-699518301425,en,o
99,S0211-699518301425,la,o
99,S0211-699518301425,HD,i
99,S0211-699518301425,convencional,o
99,S0211-699518301425,3,o
99,S0211-699518301425,por,o
99,S0211-699518301425,semana,o
99,S0211-699518301425,Dicha,o
99,S0211-699518301425,frecuencia,o
99,S0211-699518301425,aumenta,o
99,S0211-699518301425,de,o
99,S0211-699518301425,una,o
99,S0211-699518301425,a,o
99,S0211-699518301425,2,o
99,S0211-699518301425,y,o
99,S0211-699518301425,de,o
99,S0211-699518301425,2,o
99,S0211-699518301425,a,o
99,S0211-699518301425,3,o
99,S0211-699518301425,con,o
99,S0211-699518301425,el,o
99,S0211-699518301425,declinar,o
99,S0211-699518301425,de,o
99,S0211-699518301425,la,o
99,S0211-699518301425,FRR,i
99,S0211-699518301425,Metodologiadiseño,o
99,S0211-699518301425,DiPPI,o
99,S0211-699518301425,es,o
99,S0211-699518301425,un,o
99,S0211-699518301425,estudio,o
99,S0211-699518301425,abierto,o
99,S0211-699518301425,multicentrico,o
99,S0211-699518301425,experimental,o
99,S0211-699518301425,aleatorizado,o
99,S0211-699518301425,11,o
99,S0211-699518301425,y,o
99,S0211-699518301425,controlado,o
99,S0211-699518301425,con,o
99,S0211-699518301425,procedimiento,o
99,S0211-699518301425,de,o
99,S0211-699518301425,practica,i
99,S0211-699518301425,clinica,i
99,S0211-699518301425,habitual,o
99,S0211-699518301425,de,o
99,S0211-699518301425,bajo,o
99,S0211-699518301425,nivel,o
99,S0211-699518301425,de,o
99,S0211-699518301425,intervencion,i
99,S0211-699518301425,y,o
99,S0211-699518301425,no,o
99,S0211-699518301425,comercial,o
99,S0211-699518301425,Incluye,o
99,S0211-699518301425,152,o
99,S0211-699518301425,pacientes,o
99,S0211-699518301425,mayores,o
99,S0211-699518301425,de,o
99,S0211-699518301425,18,o
99,S0211-699518301425,años,o
99,S0211-699518301425,con,o
99,S0211-699518301425,enfermedad,i
99,S0211-699518301425,renal,i
99,S0211-699518301425,cronica,i
99,S0211-699518301425,estadio,o
99,S0211-699518301425,5,o
99,S0211-699518301425,que,o
99,S0211-699518301425,inician,o
99,S0211-699518301425,HD,i
99,S0211-699518301425,como,o
99,S0211-699518301425,tratamiento,i
99,S0211-699518301425,renal,i
99,S0211-699518301425,sustitutivo,i
99,S0211-699518301425,y,o
99,S0211-699518301425,la,o
99,S0211-699518301425,FRR,i
99,S0211-699518301425,medida,o
99,S0211-699518301425,por,o
99,S0211-699518301425,aclaramiento,i
99,S0211-699518301425,renal,i
99,S0211-699518301425,de,i
99,S0211-699518301425,urea,i
99,S0211-699518301425,KrU,i
99,S0211-699518301425,es,o
99,S0211-699518301425,4mlmin173m2,o
99,S0211-699518301425,El,o
99,S0211-699518301425,estudio,o
99,S0211-699518301425,se,o
99,S0211-699518301425,basa,o
99,S0211-699518301425,en,o
99,S0211-699518301425,un,o
99,S0211-699518301425,grupo,o
99,S0211-699518301425,de,o
99,S0211-699518301425,intervencion,i
99,S0211-699518301425,con,o
99,S0211-699518301425,76,o
99,S0211-699518301425,pacientes,o
99,S0211-699518301425,que,o
99,S0211-699518301425,iniciaran,o
99,S0211-699518301425,HD,i
99,S0211-699518301425,con,o
99,S0211-699518301425,una,o
99,S0211-699518301425,sola,o
99,S0211-699518301425,sesion,o
99,S0211-699518301425,por,o
99,S0211-699518301425,semana,o
99,S0211-699518301425,modalidad,o
99,S0211-699518301425,progresiva,o
99,S0211-699518301425,y,o
99,S0211-699518301425,un,o
99,S0211-699518301425,grupo,o
99,S0211-699518301425,control,o
99,S0211-699518301425,con,o
99,S0211-699518301425,76,o
99,S0211-699518301425,pacientes,o
99,S0211-699518301425,que,o
99,S0211-699518301425,comenzaran,o
99,S0211-699518301425,con,o
99,S0211-699518301425,3,o
99,S0211-699518301425,sesiones,o
99,S0211-699518301425,por,o
99,S0211-699518301425,semana,o
99,S0211-699518301425,El,o
99,S0211-699518301425,objetivo,o
99,S0211-699518301425,primario,o
99,S0211-699518301425,es,o
99,S0211-699518301425,evaluar,i
99,S0211-699518301425,la,i
99,S0211-699518301425,supervivencia,i
99,S0211-699518301425,y,o
99,S0211-699518301425,los,o
99,S0211-699518301425,objetivos,o
99,S0211-699518301425,secundarios,o
99,S0211-699518301425,son,o
99,S0211-699518301425,la,o
99,S0211-699518301425,morbilidad,o
99,S0211-699518301425,hospitalizaciones,i
99,S0211-699518301425,los,o
99,S0211-699518301425,parametros,o
99,S0211-699518301425,clinicos,o
99,S0211-699518301425,habituales,o
99,S0211-699518301425,la,o
99,S0211-699518301425,calidad,o
99,S0211-699518301425,de,o
99,S0211-699518301425,vida,o
99,S0211-699518301425,y,o
99,S0211-699518301425,la,o
99,S0211-699518301425,eficiencia,o
99,S0211-699518301425,Discusion,o
99,S0211-699518301425,Este,o
99,S0211-699518301425,estudio,o
99,S0211-699518301425,permitira,o
99,S0211-699518301425,conocer,o
99,S0211-699518301425,con,o
99,S0211-699518301425,la,o
99,S0211-699518301425,maxima,o
99,S0211-699518301425,evidencia,o
99,S0211-699518301425,cientifica,o
99,S0211-699518301425,cuantas,o
99,S0211-699518301425,sesiones,o
99,S0211-699518301425,debe,o
99,S0211-699518301425,recibir,o
99,S0211-699518301425,un,o
99,S0211-699518301425,paciente,o
99,S0211-699518301425,al,o
99,S0211-699518301425,inicio,o
99,S0211-699518301425,del,o
99,S0211-699518301425,tratamiento,i
99,S0211-699518301425,con,i
99,S0211-699518301425,HD,i
99,S0211-699518301425,dependiendo,o
99,S0211-699518301425,de,o
99,S0211-699518301425,su,o
99,S0211-699518301425,FRR,i
99,S0211-699518301425,Registro,o
99,S0211-699518301425,Registrado,o
99,S0211-699518301425,en,o
99,S0211-699518301425,US,o
99,S0211-699518301425,National,o
99,S0211-699518301425,Institutes,o
99,S0211-699518301425,of,o
99,S0211-699518301425,Health,o
99,S0211-699518301425,ClinicalTrialsgov,o
99,S0211-699518301425,con,o
99,S0211-699518301425,numero,o
99,S0211-699518301425,NCT03239808,o
100,S0211-699518301541,Mejora,o
100,S0211-699518301541,la,o
100,S0211-699518301541,funcion,o
100,S0211-699518301541,renal,i
100,S0211-699518301541,tras,o
100,S0211-699518301541,la,o
100,S0211-699518301541,paratiroidectomia,i
100,S0211-699518301541,en,o
100,S0211-699518301541,el,o
100,S0211-699518301541,hiperparatirodismo,i
100,S0211-699518301541,primario,i
100,S0211-699518301541,Introduccion,o
100,S0211-699518301541,El,o
100,S0211-699518301541,hiperparatiroidismo,i
100,S0211-699518301541,primario,i
100,S0211-699518301541,HPTP,i
100,S0211-699518301541,es,o
100,S0211-699518301541,un,o
100,S0211-699518301541,trastorno,i
100,S0211-699518301541,endocrino,i
100,S0211-699518301541,frecuente,o
100,S0211-699518301541,caracterizado,o
100,S0211-699518301541,por,o
100,S0211-699518301541,hipercalcemia,i
100,S0211-699518301541,y,o
100,S0211-699518301541,elevacion,o
100,S0211-699518301541,de,o
100,S0211-699518301541,la,o
100,S0211-699518301541,parathormona,i
100,S0211-699518301541,La,o
100,S0211-699518301541,disminucion,o
100,S0211-699518301541,del,o
100,S0211-699518301541,filtrado,i
100,S0211-699518301541,glomerular,i
100,S0211-699518301541,60mlmin,o
100,S0211-699518301541,se,o
100,S0211-699518301541,mantiene,o
100,S0211-699518301541,en,o
100,S0211-699518301541,la,o
100,S0211-699518301541,guias,o
100,S0211-699518301541,como,o
100,S0211-699518301541,un,o
100,S0211-699518301541,criterio,o
100,S0211-699518301541,para,o
100,S0211-699518301541,la,o
100,S0211-699518301541,realizacion,o
100,S0211-699518301541,de,o
100,S0211-699518301541,la,o
100,S0211-699518301541,paratiroidectomia,i
100,S0211-699518301541,PTX,i
100,S0211-699518301541,en,o
100,S0211-699518301541,el,o
100,S0211-699518301541,HPTP,i
100,S0211-699518301541,asintomatico,i
100,S0211-699518301541,La,o
100,S0211-699518301541,influencia,o
100,S0211-699518301541,que,o
100,S0211-699518301541,tiene,o
100,S0211-699518301541,la,o
100,S0211-699518301541,PTX,i
100,S0211-699518301541,sobre,o
100,S0211-699518301541,la,o
100,S0211-699518301541,evolucion,o
100,S0211-699518301541,de,o
100,S0211-699518301541,la,o
100,S0211-699518301541,funcion,o
100,S0211-699518301541,renal,i
100,S0211-699518301541,es,o
100,S0211-699518301541,controvertida,o
100,S0211-699518301541,Objetivos,o
100,S0211-699518301541,Analizar,o
100,S0211-699518301541,las,o
100,S0211-699518301541,caracteristicas,o
100,S0211-699518301541,clinicas,o
100,S0211-699518301541,analiticas,o
100,S0211-699518301541,e,o
100,S0211-699518301541,histologicas,o
100,S0211-699518301541,de,o
100,S0211-699518301541,los,o
100,S0211-699518301541,pacientes,o
100,S0211-699518301541,intervenidos,i
100,S0211-699518301541,por,o
100,S0211-699518301541,HPTP,i
100,S0211-699518301541,asi,o
100,S0211-699518301541,como,o
100,S0211-699518301541,la,o
100,S0211-699518301541,evolucion,o
100,S0211-699518301541,de,o
100,S0211-699518301541,la,o
100,S0211-699518301541,funcion,o
100,S0211-699518301541,renal,i
100,S0211-699518301541,tras,o
100,S0211-699518301541,la,o
100,S0211-699518301541,PTX,i
100,S0211-699518301541,Material,o
100,S0211-699518301541,y,o
100,S0211-699518301541,metodos,o
100,S0211-699518301541,Estudio,i
100,S0211-699518301541,retrospectivo,i
100,S0211-699518301541,de,o
100,S0211-699518301541,297,o
100,S0211-699518301541,pacientes,o
100,S0211-699518301541,con,o
100,S0211-699518301541,HPTP,i
100,S0211-699518301541,remitidos,o
100,S0211-699518301541,a,o
100,S0211-699518301541,cirugia,i
100,S0211-699518301541,en,o
100,S0211-699518301541,un,o
100,S0211-699518301541,unico,o
100,S0211-699518301541,centro,o
100,S0211-699518301541,entre,o
100,S0211-699518301541,1998,o
100,S0211-699518301541,y,o
100,S0211-699518301541,2016,o
100,S0211-699518301541,Los,o
100,S0211-699518301541,parametros,i
100,S0211-699518301541,analiticos,i
100,S0211-699518301541,se,i
100,S0211-699518301541,determinaron,i
100,S0211-699518301541,en,o
100,S0211-699518301541,situacion,o
100,S0211-699518301541,basal,o
100,S0211-699518301541,a,o
100,S0211-699518301541,la,o
100,S0211-699518301541,semana,o
100,S0211-699518301541,y,o
100,S0211-699518301541,al,o
100,S0211-699518301541,año,o
100,S0211-699518301541,de,o
100,S0211-699518301541,la,o
100,S0211-699518301541,PTX,i
100,S0211-699518301541,Resultados,o
100,S0211-699518301541,La,o
100,S0211-699518301541,incidencia,o
100,S0211-699518301541,de,o
100,S0211-699518301541,PTX,i
100,S0211-699518301541,fue,o
100,S0211-699518301541,de,o
100,S0211-699518301541,38casosmillonaño,o
100,S0211-699518301541,La,o
100,S0211-699518301541,edad,o
100,S0211-699518301541,media,o
100,S0211-699518301541,fue,o
100,S0211-699518301541,6014,o
100,S0211-699518301541,años,o
100,S0211-699518301541,y,o
100,S0211-699518301541,el,o
100,S0211-699518301541,805,o
100,S0211-699518301541,de,o
100,S0211-699518301541,los,o
100,S0211-699518301541,pacientes,o
100,S0211-699518301541,eran,o
100,S0211-699518301541,mujeres,o
100,S0211-699518301541,El,o
100,S0211-699518301541,653,o
100,S0211-699518301541,estaban,o
100,S0211-699518301541,asintomaticos,i
100,S0211-699518301541,La,o
100,S0211-699518301541,nefrolitiasis,i
100,S0211-699518301541,fue,o
100,S0211-699518301541,el,o
100,S0211-699518301541,hallazgo,o
100,S0211-699518301541,clinico,o
100,S0211-699518301541,mas,o
100,S0211-699518301541,frecuente,o
100,S0211-699518301541,33,o
100,S0211-699518301541,seguido,o
100,S0211-699518301541,de,o
100,S0211-699518301541,la,o
100,S0211-699518301541,afectacion,i
100,S0211-699518301541,osea,i
100,S0211-699518301541,295,o
100,S0211-699518301541,Las,o
100,S0211-699518301541,indicaciones,o
100,S0211-699518301541,de,o
100,S0211-699518301541,PTX,i
100,S0211-699518301541,fueron,o
100,S0211-699518301541,sintomas,i
100,S0211-699518301541,clinicos,i
100,S0211-699518301541,347,o
100,S0211-699518301541,hipercalcemia112mgdl,o
100,S0211-699518301541,27,o
100,S0211-699518301541,litiasis,i
100,S0211-699518301541,renal,i
100,S0211-699518301541,13,o
100,S0211-699518301541,baja,i
100,S0211-699518301541,masa,i
100,S0211-699518301541,osea,i
100,S0211-699518301541,12,o
100,S0211-699518301541,edad50,o
100,S0211-699518301541,años,o
100,S0211-699518301541,11,o
100,S0211-699518301541,y,o
100,S0211-699518301541,disminucion,o
100,S0211-699518301541,del,o
100,S0211-699518301541,filtrado,i
100,S0211-699518301541,60mlmin,o
100,S0211-699518301541,23,o
100,S0211-699518301541,En,o
100,S0211-699518301541,el,o
100,S0211-699518301541,diagnostico,i
100,S0211-699518301541,de,o
100,S0211-699518301541,localizacion,o
100,S0211-699518301541,el,o
100,S0211-699518301541,spectMIBI,o
100,S0211-699518301541,presento,o
100,S0211-699518301541,una,o
100,S0211-699518301541,sensibilidad,o
100,S0211-699518301541,del,o
100,S0211-699518301541,92,o
100,S0211-699518301541,y,o
100,S0211-699518301541,la,o
100,S0211-699518301541,ecografia,i
100,S0211-699518301541,cervical,i
100,S0211-699518301541,del,o
100,S0211-699518301541,70,o
100,S0211-699518301541,El,o
100,S0211-699518301541,943,o
100,S0211-699518301541,de,o
100,S0211-699518301541,los,o
100,S0211-699518301541,casos,o
100,S0211-699518301541,de,o
100,S0211-699518301541,HPTP,i
100,S0211-699518301541,eran,o
100,S0211-699518301541,debidos,o
100,S0211-699518301541,a,o
100,S0211-699518301541,un,o
100,S0211-699518301541,adenoma,i
100,S0211-699518301541,paratiroideo,i
100,S0211-699518301541,Tras,o
100,S0211-699518301541,la,o
100,S0211-699518301541,PTX,i
100,S0211-699518301541,se,o
100,S0211-699518301541,objetivo,o
100,S0211-699518301541,normalizacion,o
100,S0211-699518301541,de,o
100,S0211-699518301541,los,o
100,S0211-699518301541,parametros,o
100,S0211-699518301541,relacionados,o
100,S0211-699518301541,con,o
100,S0211-699518301541,el,o
100,S0211-699518301541,HPTP,i
100,S0211-699518301541,Objetivamos,o
100,S0211-699518301541,un,o
100,S0211-699518301541,incremento,o
100,S0211-699518301541,significativo,o
100,S0211-699518301541,de,o
100,S0211-699518301541,la,o
100,S0211-699518301541,creatinina,i
100,S0211-699518301541,serica,i
100,S0211-699518301541,081,o
100,S0211-699518301541,vs,o
100,S0211-699518301541,085mgdl,o
100,S0211-699518301541,p0001,o
100,S0211-699518301541,desde,o
100,S0211-699518301541,la,o
100,S0211-699518301541,primera,o
100,S0211-699518301541,semana,o
100,S0211-699518301541,del,o
100,S0211-699518301541,postoperatorio,o
100,S0211-699518301541,y,o
100,S0211-699518301541,que,o
100,S0211-699518301541,se,o
100,S0211-699518301541,mantiene,o
100,S0211-699518301541,al,o
100,S0211-699518301541,año,o
100,S0211-699518301541,Cuando,o
100,S0211-699518301541,comparamos,o
100,S0211-699518301541,los,o
100,S0211-699518301541,pacientes,o
100,S0211-699518301541,segun,o
100,S0211-699518301541,el,o
100,S0211-699518301541,filtrado,i
100,S0211-699518301541,glomerular,i
100,S0211-699518301541,basal,o
100,S0211-699518301541,encontramos,o
100,S0211-699518301541,que,o
100,S0211-699518301541,el,o
100,S0211-699518301541,deterioro,i
100,S0211-699518301541,de,i
100,S0211-699518301541,la,i
100,S0211-699518301541,funcion,i
100,S0211-699518301541,renal,i
100,S0211-699518301541,solamente,o
100,S0211-699518301541,fue,o
100,S0211-699518301541,significativo,o
100,S0211-699518301541,en,o
100,S0211-699518301541,pacientes,o
100,S0211-699518301541,con,o
100,S0211-699518301541,filtrado,i
100,S0211-699518301541,glomerular,i
100,S0211-699518301541,60mlmin,o
100,S0211-699518301541,creatinina,i
100,S0211-699518301541,serica,i
100,S0211-699518301541,basal,o
100,S0211-699518301541,077mgdl,o
100,S0211-699518301541,vs,o
100,S0211-699518301541,creatinina,i
100,S0211-699518301541,serica,i
100,S0211-699518301541,al,o
100,S0211-699518301541,año,o
100,S0211-699518301541,081mgdl,o
100,S0211-699518301541,p0001,o
100,S0211-699518301541,Conclusiones,o
100,S0211-699518301541,El,o
100,S0211-699518301541,HPTP,i
100,S0211-699518301541,curso,o
100,S0211-699518301541,asintomatico,i
100,S0211-699518301541,en,o
100,S0211-699518301541,la,o
100,S0211-699518301541,mayoria,o
100,S0211-699518301541,de,o
100,S0211-699518301541,los,o
100,S0211-699518301541,pacientes,o
100,S0211-699518301541,intervenidos,i
100,S0211-699518301541,La,o
100,S0211-699518301541,hipercalcemia,i
100,S0211-699518301541,y,o
100,S0211-699518301541,la,o
100,S0211-699518301541,nefrolitiasis,i
100,S0211-699518301541,fueron,o
100,S0211-699518301541,las,o
100,S0211-699518301541,indicaciones,o
100,S0211-699518301541,mas,o
100,S0211-699518301541,frecuentes,o
100,S0211-699518301541,de,o
100,S0211-699518301541,paratiroidectomia,i
100,S0211-699518301541,en,o
100,S0211-699518301541,los,o
100,S0211-699518301541,pacientes,o
100,S0211-699518301541,asintomaticos,i
100,S0211-699518301541,El,o
100,S0211-699518301541,scanMIBI,o
100,S0211-699518301541,fue,o
100,S0211-699518301541,el,o
100,S0211-699518301541,metodo,o
100,S0211-699518301541,de,o
100,S0211-699518301541,localizacion,o
100,S0211-699518301541,mas,o
100,S0211-699518301541,util,o
100,S0211-699518301541,La,o
100,S0211-699518301541,curacion,i
100,S0211-699518301541,quirurgica,i
100,S0211-699518301541,del,o
100,S0211-699518301541,HPTP,i
100,S0211-699518301541,se,o
100,S0211-699518301541,sigue,o
100,S0211-699518301541,de,o
100,S0211-699518301541,un,o
100,S0211-699518301541,deterioro,i
100,S0211-699518301541,de,i
100,S0211-699518301541,la,i
100,S0211-699518301541,funcion,i
100,S0211-699518301541,renal,i
100,S0211-699518301541,que,o
100,S0211-699518301541,se,o
100,S0211-699518301541,mantiene,o
100,S0211-699518301541,desde,o
100,S0211-699518301541,la,o
100,S0211-699518301541,primera,o
100,S0211-699518301541,semana,o
100,S0211-699518301541,de,o
100,S0211-699518301541,la,o
100,S0211-699518301541,cirugia,i
101,S0211-699518302194,El,o
101,S0211-699518302194,uso,o
101,S0211-699518302194,de,o
101,S0211-699518302194,estatinas,i
101,S0211-699518302194,y,o
101,S0211-699518302194,antiagregantes,i
101,S0211-699518302194,se,o
101,S0211-699518302194,asocia,o
101,S0211-699518302194,con,o
101,S0211-699518302194,cambios,o
101,S0211-699518302194,en,o
101,S0211-699518302194,los,o
101,S0211-699518302194,marcadores,o
101,S0211-699518302194,de,o
101,S0211-699518302194,disfuncion,i
101,S0211-699518302194,endotelial,i
101,S0211-699518302194,en,o
101,S0211-699518302194,la,o
101,S0211-699518302194,enfermedad,i
101,S0211-699518302194,renal,i
101,S0211-699518302194,cronica,i
101,S0211-699518302194,Antecedentes,o
101,S0211-699518302194,y,o
101,S0211-699518302194,objetivos,o
101,S0211-699518302194,Los,o
101,S0211-699518302194,pacientes,o
101,S0211-699518302194,con,o
101,S0211-699518302194,insuficiencia,i
101,S0211-699518302194,renal,i
101,S0211-699518302194,cronica,i
101,S0211-699518302194,IRC,i
101,S0211-699518302194,corren,o
101,S0211-699518302194,mayor,o
101,S0211-699518302194,riesgo,o
101,S0211-699518302194,de,o
101,S0211-699518302194,desarrollar,o
101,S0211-699518302194,enfermedad,i
101,S0211-699518302194,cardiovascular,i
101,S0211-699518302194,En,o
101,S0211-699518302194,los,o
101,S0211-699518302194,pacientes,o
101,S0211-699518302194,con,o
101,S0211-699518302194,IRC,i
101,S0211-699518302194,los,o
101,S0211-699518302194,mecanismos,o
101,S0211-699518302194,implicados,o
101,S0211-699518302194,en,o
101,S0211-699518302194,la,o
101,S0211-699518302194,disfuncion,i
101,S0211-699518302194,endotelial,i
101,S0211-699518302194,y,o
101,S0211-699518302194,el,o
101,S0211-699518302194,papel,o
101,S0211-699518302194,de,o
101,S0211-699518302194,los,o
101,S0211-699518302194,diferentes,o
101,S0211-699518302194,farmacos,i
101,S0211-699518302194,utilizados,o
101,S0211-699518302194,en,o
101,S0211-699518302194,estos,o
101,S0211-699518302194,pacientes,o
101,S0211-699518302194,no,o
101,S0211-699518302194,se,o
101,S0211-699518302194,conocen,o
101,S0211-699518302194,por,o
101,S0211-699518302194,completo,o
101,S0211-699518302194,El,o
101,S0211-699518302194,objetivo,o
101,S0211-699518302194,de,o
101,S0211-699518302194,este,o
101,S0211-699518302194,articulo,o
101,S0211-699518302194,es,o
101,S0211-699518302194,analizar,o
101,S0211-699518302194,el,o
101,S0211-699518302194,efecto,o
101,S0211-699518302194,de,o
101,S0211-699518302194,las,o
101,S0211-699518302194,estatinas,i
101,S0211-699518302194,y,o
101,S0211-699518302194,los,o
101,S0211-699518302194,antiagregantes,i
101,S0211-699518302194,plaquetarios,i
101,S0211-699518302194,AP,i
101,S0211-699518302194,sobre,o
101,S0211-699518302194,las,o
101,S0211-699518302194,microvesiculas,i
101,S0211-699518302194,endoteliales,i
101,S0211-699518302194,MVE,i
101,S0211-699518302194,y,o
101,S0211-699518302194,otros,o
101,S0211-699518302194,marcadores,o
101,S0211-699518302194,de,o
101,S0211-699518302194,la,o
101,S0211-699518302194,disfuncion,i
101,S0211-699518302194,endotelial,i
101,S0211-699518302194,Enfoque,o
101,S0211-699518302194,experimental,o
101,S0211-699518302194,Estudio,i
101,S0211-699518302194,transversal,i
101,S0211-699518302194,con,o
101,S0211-699518302194,41,o
101,S0211-699518302194,pacientes,o
101,S0211-699518302194,con,o
101,S0211-699518302194,IRC,i
101,S0211-699518302194,3b4,o
101,S0211-699518302194,y,o
101,S0211-699518302194,8,o
101,S0211-699518302194,voluntarios,o
101,S0211-699518302194,sanos,o
101,S0211-699518302194,Se,o
101,S0211-699518302194,cuantificaron,o
101,S0211-699518302194,los,o
101,S0211-699518302194,niveles,i
101,S0211-699518302194,de,i
101,S0211-699518302194,MVE,i
101,S0211-699518302194,factor,i
101,S0211-699518302194,de,i
101,S0211-699518302194,crecimiento,i
101,S0211-699518302194,vascular,i
101,S0211-699518302194,endotelial,i
101,S0211-699518302194,FCVE,i
101,S0211-699518302194,y,o
101,S0211-699518302194,productos,i
101,S0211-699518302194,avanzados,i
101,S0211-699518302194,de,i
101,S0211-699518302194,oxidacion,i
101,S0211-699518302194,de,i
101,S0211-699518302194,proteinas,i
101,S0211-699518302194,AOPP,i
101,S0211-699518302194,por,o
101,S0211-699518302194,sus,o
101,S0211-699518302194,siglas,o
101,S0211-699518302194,en,o
101,S0211-699518302194,ingles,o
101,S0211-699518302194,en,o
101,S0211-699518302194,la,o
101,S0211-699518302194,circulacion,o
101,S0211-699518302194,y,o
101,S0211-699518302194,se,o
101,S0211-699518302194,evaluo,o
101,S0211-699518302194,la,o
101,S0211-699518302194,correlacion,o
101,S0211-699518302194,con,o
101,S0211-699518302194,diferentes,o
101,S0211-699518302194,variables,o
101,S0211-699518302194,de,o
101,S0211-699518302194,comorbilidad,i
101,S0211-699518302194,y,o
101,S0211-699518302194,estrategias,i
101,S0211-699518302194,terapeuticas,i
101,S0211-699518302194,Resultados,o
101,S0211-699518302194,Las,o
101,S0211-699518302194,MVE,i
101,S0211-699518302194,aumentaron,o
101,S0211-699518302194,en,o
101,S0211-699518302194,pacientes,o
101,S0211-699518302194,con,o
101,S0211-699518302194,IRC,i
101,S0211-699518302194,al,o
101,S0211-699518302194,comparar,o
101,S0211-699518302194,los,o
101,S0211-699518302194,niveles,o
101,S0211-699518302194,con,o
101,S0211-699518302194,los,o
101,S0211-699518302194,controles,o
101,S0211-699518302194,1711,o
101,S0211-699518302194,frente,o
101,S0211-699518302194,a,o
101,S0211-699518302194,683μl,o
101,S0211-699518302194,p,o
101,S0211-699518302194,0001,o
101,S0211-699518302194,Se,o
101,S0211-699518302194,observo,o
101,S0211-699518302194,una,o
101,S0211-699518302194,correlacion,o
101,S0211-699518302194,negativa,o
101,S0211-699518302194,entre,o
101,S0211-699518302194,la,o
101,S0211-699518302194,edad,o
101,S0211-699518302194,y,o
101,S0211-699518302194,las,o
101,S0211-699518302194,MVE,i
101,S0211-699518302194,Las,o
101,S0211-699518302194,estatinas,i
101,S0211-699518302194,y,o
101,S0211-699518302194,los,o
101,S0211-699518302194,AP,i
101,S0211-699518302194,se,o
101,S0211-699518302194,asociaron,o
101,S0211-699518302194,con,o
101,S0211-699518302194,una,o
101,S0211-699518302194,reduccion,o
101,S0211-699518302194,de,o
101,S0211-699518302194,los,o
101,S0211-699518302194,niveles,i
101,S0211-699518302194,de,i
101,S0211-699518302194,MVE,i
101,S0211-699518302194,y,o
101,S0211-699518302194,FCVE,i
101,S0211-699518302194,independientemente,o
101,S0211-699518302194,de,o
101,S0211-699518302194,los,o
101,S0211-699518302194,niveles,i
101,S0211-699518302194,sericos,i
101,S0211-699518302194,de,i
101,S0211-699518302194,colesterol,i
101,S0211-699518302194,total,i
101,S0211-699518302194,CT,i
101,S0211-699518302194,Los,o
101,S0211-699518302194,niveles,i
101,S0211-699518302194,de,i
101,S0211-699518302194,AOPP,i
101,S0211-699518302194,y,o
101,S0211-699518302194,FCVE,i
101,S0211-699518302194,no,o
101,S0211-699518302194,fueron,o
101,S0211-699518302194,diferentes,o
101,S0211-699518302194,entre,o
101,S0211-699518302194,los,o
101,S0211-699518302194,pacientes,o
101,S0211-699518302194,con,o
101,S0211-699518302194,IRC,i
101,S0211-699518302194,y,o
101,S0211-699518302194,los,o
101,S0211-699518302194,controles,o
101,S0211-699518302194,Conclusion,o
101,S0211-699518302194,La,o
101,S0211-699518302194,IRC,i
101,S0211-699518302194,se,o
101,S0211-699518302194,asocia,o
101,S0211-699518302194,con,o
101,S0211-699518302194,un,o
101,S0211-699518302194,cambio,o
101,S0211-699518302194,de,o
101,S0211-699518302194,los,o
101,S0211-699518302194,niveles,i
101,S0211-699518302194,de,i
101,S0211-699518302194,MVE,i
101,S0211-699518302194,FCVE,i
101,S0211-699518302194,y,o
101,S0211-699518302194,AOPP,i
101,S0211-699518302194,El,o
101,S0211-699518302194,tratamiento,i
101,S0211-699518302194,con,o
101,S0211-699518302194,estatinas,i
101,S0211-699518302194,y,o
101,S0211-699518302194,AP,i
101,S0211-699518302194,normaliza,o
101,S0211-699518302194,estos,o
101,S0211-699518302194,valores,o
101,S0211-699518302194,a,o
101,S0211-699518302194,casi,o
101,S0211-699518302194,los,o
101,S0211-699518302194,observados,o
101,S0211-699518302194,en,o
101,S0211-699518302194,los,o
101,S0211-699518302194,controles,o
101,S0211-699518302194,y,o
101,S0211-699518302194,este,o
101,S0211-699518302194,efecto,o
101,S0211-699518302194,es,o
101,S0211-699518302194,independiente,o
101,S0211-699518302194,del,o
101,S0211-699518302194,nivel,i
101,S0211-699518302194,de,i
101,S0211-699518302194,CT,i
101,S0211-699518302194,predominante,o
101,S0211-699518302194,Estos,o
101,S0211-699518302194,hallazgos,o
101,S0211-699518302194,explican,o
101,S0211-699518302194,la,o
101,S0211-699518302194,existencia,o
101,S0211-699518302194,de,o
101,S0211-699518302194,los,o
101,S0211-699518302194,efectos,o
101,S0211-699518302194,pleiotropicos,o
101,S0211-699518302194,de,o
101,S0211-699518302194,las,o
101,S0211-699518302194,estatinas,i
101,S0211-699518302194,y,o
101,S0211-699518302194,los,o
101,S0211-699518302194,AP,i
101,S0211-699518302194,que,o
101,S0211-699518302194,merecen,o
101,S0211-699518302194,estudios,o
101,S0211-699518302194,adicionales,o
102,S0211-699519300748,Valoracion,o
102,S0211-699519300748,de,o
102,S0211-699519300748,la,o
102,S0211-699519300748,influencia,o
102,S0211-699519300748,de,o
102,S0211-699519300748,la,o
102,S0211-699519300748,superficie,o
102,S0211-699519300748,de,o
102,S0211-699519300748,la,o
102,S0211-699519300748,membrana,i
102,S0211-699519300748,y,o
102,S0211-699519300748,el,o
102,S0211-699519300748,flujo,i
102,S0211-699519300748,sanguineo,i
102,S0211-699519300748,en,o
102,S0211-699519300748,dializadores,o
102,S0211-699519300748,de,o
102,S0211-699519300748,medio,o
102,S0211-699519300748,cutoff,o
102,S0211-699519300748,Introduccion,o
102,S0211-699519300748,Recientemente,o
102,S0211-699519300748,se,o
102,S0211-699519300748,ha,o
102,S0211-699519300748,incorporado,o
102,S0211-699519300748,a,o
102,S0211-699519300748,nuestras,o
102,S0211-699519300748,posibilidades,o
102,S0211-699519300748,terapeuticas,o
102,S0211-699519300748,una,o
102,S0211-699519300748,nueva,o
102,S0211-699519300748,clase,o
102,S0211-699519300748,de,o
102,S0211-699519300748,dializadores,o
102,S0211-699519300748,las,o
102,S0211-699519300748,membranas,o
102,S0211-699519300748,de,o
102,S0211-699519300748,medio,o
102,S0211-699519300748,cutoff,o
102,S0211-699519300748,MCO,o
102,S0211-699519300748,diseñadas,o
102,S0211-699519300748,para,o
102,S0211-699519300748,mejorar,o
102,S0211-699519300748,la,o
102,S0211-699519300748,permeabilidad,o
102,S0211-699519300748,y,o
102,S0211-699519300748,que,o
102,S0211-699519300748,podrian,o
102,S0211-699519300748,alcanzar,o
102,S0211-699519300748,una,o
102,S0211-699519300748,eficacia,o
102,S0211-699519300748,similar,o
102,S0211-699519300748,a,o
102,S0211-699519300748,la,o
102,S0211-699519300748,hemodiafiltracion,i
102,S0211-699519300748,Para,o
102,S0211-699519300748,aumentar,o
102,S0211-699519300748,el,o
102,S0211-699519300748,conocimiento,o
102,S0211-699519300748,sobre,o
102,S0211-699519300748,su,o
102,S0211-699519300748,uso,o
102,S0211-699519300748,el,o
102,S0211-699519300748,objetivo,o
102,S0211-699519300748,del,o
102,S0211-699519300748,estudio,o
102,S0211-699519300748,fue,o
102,S0211-699519300748,valorar,o
102,S0211-699519300748,en,o
102,S0211-699519300748,las,o
102,S0211-699519300748,membranas,o
102,S0211-699519300748,de,o
102,S0211-699519300748,MCO,o
102,S0211-699519300748,el,o
102,S0211-699519300748,efecto,o
102,S0211-699519300748,de,o
102,S0211-699519300748,la,o
102,S0211-699519300748,superficie,o
102,S0211-699519300748,y,o
102,S0211-699519300748,del,o
102,S0211-699519300748,flujo,i
102,S0211-699519300748,sanguineo,i
102,S0211-699519300748,Qb,o
102,S0211-699519300748,sobre,o
102,S0211-699519300748,la,o
102,S0211-699519300748,eficacia,o
102,S0211-699519300748,depurativa,o
102,S0211-699519300748,Material,o
102,S0211-699519300748,y,o
102,S0211-699519300748,metodos,o
102,S0211-699519300748,Se,o
102,S0211-699519300748,incluyo,o
102,S0211-699519300748,a,o
102,S0211-699519300748,19,o
102,S0211-699519300748,pacientes,o
102,S0211-699519300748,en,o
102,S0211-699519300748,programa,o
102,S0211-699519300748,de,o
102,S0211-699519300748,hemodialisis,i
102,S0211-699519300748,Cada,o
102,S0211-699519300748,paciente,o
102,S0211-699519300748,recibio,o
102,S0211-699519300748,6,o
102,S0211-699519300748,sesiones,o
102,S0211-699519300748,en,o
102,S0211-699519300748,las,o
102,S0211-699519300748,que,o
102,S0211-699519300748,se,o
102,S0211-699519300748,vario,o
102,S0211-699519300748,la,o
102,S0211-699519300748,superficie,o
102,S0211-699519300748,de,o
102,S0211-699519300748,membrana,i
102,S0211-699519300748,de,o
102,S0211-699519300748,17,o
102,S0211-699519300748,o,o
102,S0211-699519300748,20,o
102,S0211-699519300748,m2,o
102,S0211-699519300748,y,o
102,S0211-699519300748,el,o
102,S0211-699519300748,Qb,o
102,S0211-699519300748,300,o
102,S0211-699519300748,350,o
102,S0211-699519300748,400,o
102,S0211-699519300748,o,o
102,S0211-699519300748,450mLmin,o
102,S0211-699519300748,En,o
102,S0211-699519300748,cada,o
102,S0211-699519300748,sesion,o
102,S0211-699519300748,se,o
102,S0211-699519300748,determinaron,o
102,S0211-699519300748,diferentes,o
102,S0211-699519300748,solutos,i
102,S0211-699519300748,al,o
102,S0211-699519300748,inicio,o
102,S0211-699519300748,y,o
102,S0211-699519300748,al,o
102,S0211-699519300748,final,o
102,S0211-699519300748,de,o
102,S0211-699519300748,la,o
102,S0211-699519300748,dialisis,i
102,S0211-699519300748,Resultados,o
102,S0211-699519300748,El,o
102,S0211-699519300748,cambio,o
102,S0211-699519300748,de,o
102,S0211-699519300748,superficie,o
102,S0211-699519300748,del,o
102,S0211-699519300748,dializador,o
102,S0211-699519300748,no,o
102,S0211-699519300748,mostro,o
102,S0211-699519300748,diferencias,o
102,S0211-699519300748,significativas,o
102,S0211-699519300748,en,o
102,S0211-699519300748,la,o
102,S0211-699519300748,depuracion,i
102,S0211-699519300748,de,o
102,S0211-699519300748,pequeñas,o
102,S0211-699519300748,o,o
102,S0211-699519300748,grandes,o
102,S0211-699519300748,moleculas,o
102,S0211-699519300748,sin,o
102,S0211-699519300748,cambios,o
102,S0211-699519300748,en,o
102,S0211-699519300748,la,o
102,S0211-699519300748,perdida,o
102,S0211-699519300748,de,o
102,S0211-699519300748,albumina,i
102,S0211-699519300748,El,o
102,S0211-699519300748,aumento,o
102,S0211-699519300748,del,o
102,S0211-699519300748,Qb,o
102,S0211-699519300748,se,o
102,S0211-699519300748,acompaño,o
102,S0211-699519300748,de,o
102,S0211-699519300748,un,o
102,S0211-699519300748,aumento,o
102,S0211-699519300748,de,o
102,S0211-699519300748,depuracion,i
102,S0211-699519300748,de,o
102,S0211-699519300748,pequeñas,o
102,S0211-699519300748,moleculas,o
102,S0211-699519300748,sin,o
102,S0211-699519300748,mostrar,o
102,S0211-699519300748,diferencias,o
102,S0211-699519300748,en,o
102,S0211-699519300748,el,o
102,S0211-699519300748,porcentaje,o
102,S0211-699519300748,de,o
102,S0211-699519300748,reduccion,o
102,S0211-699519300748,de,o
102,S0211-699519300748,β2microglobulina,o
102,S0211-699519300748,mioglobina,i
102,S0211-699519300748,prolactina,i
102,S0211-699519300748,α1microglobulina,o
102,S0211-699519300748,y,o
102,S0211-699519300748,α1glicoproteina,o
102,S0211-699519300748,acida,o
102,S0211-699519300748,a,o
102,S0211-699519300748,excepcion,o
102,S0211-699519300748,de,o
102,S0211-699519300748,alguna,o
102,S0211-699519300748,comparacion,o
102,S0211-699519300748,con,o
102,S0211-699519300748,Qb,o
102,S0211-699519300748,450mLmin,o
102,S0211-699519300748,Tampoco,o
102,S0211-699519300748,se,o
102,S0211-699519300748,observaron,o
102,S0211-699519300748,diferencias,o
102,S0211-699519300748,en,o
102,S0211-699519300748,la,o
102,S0211-699519300748,perdida,o
102,S0211-699519300748,de,o
102,S0211-699519300748,albumina,i
102,S0211-699519300748,en,o
102,S0211-699519300748,el,o
102,S0211-699519300748,liquido,o
102,S0211-699519300748,de,o
102,S0211-699519300748,dialisis,i
102,S0211-699519300748,inferior,o
102,S0211-699519300748,a,o
102,S0211-699519300748,25,o
102,S0211-699519300748,g,o
102,S0211-699519300748,en,o
102,S0211-699519300748,todas,o
102,S0211-699519300748,las,o
102,S0211-699519300748,situaciones,o
102,S0211-699519300748,Conclusion,o
102,S0211-699519300748,El,o
102,S0211-699519300748,incremento,o
102,S0211-699519300748,de,o
102,S0211-699519300748,la,o
102,S0211-699519300748,superficie,o
102,S0211-699519300748,de,o
102,S0211-699519300748,17,o
102,S0211-699519300748,a,o
102,S0211-699519300748,20,o
102,S0211-699519300748,m2,o
102,S0211-699519300748,en,o
102,S0211-699519300748,el,o
102,S0211-699519300748,dializador,o
102,S0211-699519300748,de,o
102,S0211-699519300748,MCO,o
102,S0211-699519300748,no,o
102,S0211-699519300748,ha,o
102,S0211-699519300748,significado,o
102,S0211-699519300748,una,o
102,S0211-699519300748,mayor,o
102,S0211-699519300748,eficacia,o
102,S0211-699519300748,depurativa,o
102,S0211-699519300748,En,o
102,S0211-699519300748,estos,o
102,S0211-699519300748,dializadores,o
102,S0211-699519300748,el,o
102,S0211-699519300748,aumento,o
102,S0211-699519300748,del,o
102,S0211-699519300748,Qb,o
102,S0211-699519300748,no,o
102,S0211-699519300748,parece,o
102,S0211-699519300748,ser,o
102,S0211-699519300748,tan,o
102,S0211-699519300748,determinante,o
102,S0211-699519300748,como,o
102,S0211-699519300748,en,o
102,S0211-699519300748,la,o
102,S0211-699519300748,hemodiafiltracion,i
102,S0211-699519300748,a,o
102,S0211-699519300748,excepcion,o
102,S0211-699519300748,de,o
102,S0211-699519300748,la,o
102,S0211-699519300748,depuracion,i
102,S0211-699519300748,de,o
102,S0211-699519300748,pequeñas,o
102,S0211-699519300748,moleculas,o
103,S0211-699519301225,Progresion,o
103,S0211-699519301225,de,o
103,S0211-699519301225,la,o
103,S0211-699519301225,enfermedad,i
103,S0211-699519301225,renal,i
103,S0211-699519301225,cronica,i
103,S0211-699519301225,en,o
103,S0211-699519301225,pacientes,o
103,S0211-699519301225,con,o
103,S0211-699519301225,hipertension,i
103,S0211-699519301225,resistente,o
103,S0211-699519301225,sometidos,o
103,S0211-699519301225,a,o
103,S0211-699519301225,2,o
103,S0211-699519301225,estrategias,i
103,S0211-699519301225,terapeuticas,i
103,S0211-699519301225,intensificacion,o
103,S0211-699519301225,con,o
103,S0211-699519301225,diureticos,i
103,S0211-699519301225,de,i
103,S0211-699519301225,asa,i
103,S0211-699519301225,vs,o
103,S0211-699519301225,antagonistas,i
103,S0211-699519301225,de,i
103,S0211-699519301225,la,i
103,S0211-699519301225,aldosterona,i
103,S0211-699519301225,Introduccion,o
103,S0211-699519301225,En,o
103,S0211-699519301225,la,o
103,S0211-699519301225,actualidad,o
103,S0211-699519301225,existen,o
103,S0211-699519301225,pocos,o
103,S0211-699519301225,datos,o
103,S0211-699519301225,sobre,o
103,S0211-699519301225,la,o
103,S0211-699519301225,evolucion,o
103,S0211-699519301225,de,o
103,S0211-699519301225,la,o
103,S0211-699519301225,funcion,o
103,S0211-699519301225,renal,i
103,S0211-699519301225,en,o
103,S0211-699519301225,pacientes,o
103,S0211-699519301225,con,o
103,S0211-699519301225,hipertension,i
103,S0211-699519301225,arterial,i
103,S0211-699519301225,HTA,i
103,S0211-699519301225,resistente,o
103,S0211-699519301225,y,o
103,S0211-699519301225,enfermedad,i
103,S0211-699519301225,renal,i
103,S0211-699519301225,cronica,i
103,S0211-699519301225,ERC,i
103,S0211-699519301225,asi,o
103,S0211-699519301225,como,o
103,S0211-699519301225,de,o
103,S0211-699519301225,la,o
103,S0211-699519301225,influencia,o
103,S0211-699519301225,de,o
103,S0211-699519301225,diferentes,o
103,S0211-699519301225,tipos,o
103,S0211-699519301225,de,o
103,S0211-699519301225,tratamiento,i
103,S0211-699519301225,en,o
103,S0211-699519301225,dicha,o
103,S0211-699519301225,progresion,o
103,S0211-699519301225,Objetivo,o
103,S0211-699519301225,Evaluar,o
103,S0211-699519301225,la,o
103,S0211-699519301225,progresion,o
103,S0211-699519301225,de,o
103,S0211-699519301225,la,o
103,S0211-699519301225,ERC,i
103,S0211-699519301225,en,o
103,S0211-699519301225,pacientes,o
103,S0211-699519301225,con,o
103,S0211-699519301225,ERC,i
103,S0211-699519301225,e,o
103,S0211-699519301225,HTA,i
103,S0211-699519301225,resistente,o
103,S0211-699519301225,tratados,i
103,S0211-699519301225,mediante,o
103,S0211-699519301225,2,o
103,S0211-699519301225,estrategias,i
103,S0211-699519301225,terapeuticas,i
103,S0211-699519301225,diferentes,o
103,S0211-699519301225,tratamiento,i
103,S0211-699519301225,con,o
103,S0211-699519301225,espironolactona,i
103,S0211-699519301225,vs,o
103,S0211-699519301225,furosemida,i
103,S0211-699519301225,Metodos,o
103,S0211-699519301225,Incluimos,o
103,S0211-699519301225,a,o
103,S0211-699519301225,30,o
103,S0211-699519301225,pacientes,o
103,S0211-699519301225,21,o
103,S0211-699519301225,H,o
103,S0211-699519301225,9M,o
103,S0211-699519301225,con,o
103,S0211-699519301225,una,o
103,S0211-699519301225,edad,o
103,S0211-699519301225,media,o
103,S0211-699519301225,de,o
103,S0211-699519301225,66391,o
103,S0211-699519301225,años,o
103,S0211-699519301225,FGe,i
103,S0211-699519301225,558165mlmin173,o
103,S0211-699519301225,m2,o
103,S0211-699519301225,PAS,i
103,S0211-699519301225,162882,o
103,S0211-699519301225,y,o
103,S0211-699519301225,PAD,i
103,S0211-699519301225,90262mmHg,o
103,S0211-699519301225,15,o
103,S0211-699519301225,tratados,i
103,S0211-699519301225,con,o
103,S0211-699519301225,espironolactona,i
103,S0211-699519301225,y,o
103,S0211-699519301225,15,o
103,S0211-699519301225,con,o
103,S0211-699519301225,furosemida,i
103,S0211-699519301225,seguidos,i
103,S0211-699519301225,durante,o
103,S0211-699519301225,un,o
103,S0211-699519301225,tiempo,o
103,S0211-699519301225,medio,o
103,S0211-699519301225,de,o
103,S0211-699519301225,32,o
103,S0211-699519301225,meses,o
103,S0211-699519301225,2841,o
103,S0211-699519301225,Resultados,o
103,S0211-699519301225,El,o
103,S0211-699519301225,descenso,o
103,S0211-699519301225,medio,o
103,S0211-699519301225,anual,o
103,S0211-699519301225,del,o
103,S0211-699519301225,FGe,i
103,S0211-699519301225,fue,o
103,S0211-699519301225,de,o
103,S0211-699519301225,2854mlmin173,o
103,S0211-699519301225,m2,o
103,S0211-699519301225,En,o
103,S0211-699519301225,el,o
103,S0211-699519301225,grupo,o
103,S0211-699519301225,de,o
103,S0211-699519301225,espironolactona,i
103,S0211-699519301225,fue,o
103,S0211-699519301225,de,o
103,S0211-699519301225,2148mlmin173,o
103,S0211-699519301225,m2,o
103,S0211-699519301225,y,o
103,S0211-699519301225,en,o
103,S0211-699519301225,el,o
103,S0211-699519301225,de,o
103,S0211-699519301225,furosemida,i
103,S0211-699519301225,3256mlmin173,o
103,S0211-699519301225,m2,o
103,S0211-699519301225,p001,o
103,S0211-699519301225,En,o
103,S0211-699519301225,los,o
103,S0211-699519301225,pacientes,o
103,S0211-699519301225,con,o
103,S0211-699519301225,espironolactona,i
103,S0211-699519301225,la,o
103,S0211-699519301225,PAS,i
103,S0211-699519301225,disminuyo,o
103,S0211-699519301225,239mmHg,o
103,S0211-699519301225,vs,o
103,S0211-699519301225,163mmHg,o
103,S0211-699519301225,en,o
103,S0211-699519301225,el,o
103,S0211-699519301225,grupo,o
103,S0211-699519301225,de,o
103,S0211-699519301225,furosemida,i
103,S0211-699519301225,p001,o
103,S0211-699519301225,La,o
103,S0211-699519301225,PAD,i
103,S0211-699519301225,se,o
103,S0211-699519301225,redujo,o
103,S0211-699519301225,108mmHg,o
103,S0211-699519301225,y,o
103,S0211-699519301225,62mmHg,o
103,S0211-699519301225,respectivamente,o
103,S0211-699519301225,p001,o
103,S0211-699519301225,El,o
103,S0211-699519301225,tratamiento,i
103,S0211-699519301225,con,o
103,S0211-699519301225,espironolactona,i
103,S0211-699519301225,redujo,o
103,S0211-699519301225,la,o
103,S0211-699519301225,albuminuria,i
103,S0211-699519301225,de,o
103,S0211-699519301225,una,o
103,S0211-699519301225,mediana,o
103,S0211-699519301225,de,o
103,S0211-699519301225,210,o
103,S0211-699519301225,121385,o
103,S0211-699519301225,mgg,o
103,S0211-699519301225,a,o
103,S0211-699519301225,65,o
103,S0211-699519301225,45120,o
103,S0211-699519301225,mgg,o
103,S0211-699519301225,al,o
103,S0211-699519301225,final,o
103,S0211-699519301225,del,o
103,S0211-699519301225,seguimiento,i
103,S0211-699519301225,p001,o
103,S0211-699519301225,En,o
103,S0211-699519301225,el,o
103,S0211-699519301225,grupo,o
103,S0211-699519301225,de,o
103,S0211-699519301225,furosemida,i
103,S0211-699519301225,la,o
103,S0211-699519301225,albuminuria,i
103,S0211-699519301225,no,o
103,S0211-699519301225,descendio,o
103,S0211-699519301225,La,o
103,S0211-699519301225,progresion,o
103,S0211-699519301225,mas,o
103,S0211-699519301225,lenta,o
103,S0211-699519301225,en,o
103,S0211-699519301225,la,o
103,S0211-699519301225,enfermedad,i
103,S0211-699519301225,renal,i
103,S0211-699519301225,se,o
103,S0211-699519301225,asocio,o
103,S0211-699519301225,con,o
103,S0211-699519301225,una,o
103,S0211-699519301225,menor,o
103,S0211-699519301225,PAS,i
103,S0211-699519301225,p004,o
103,S0211-699519301225,mayor,o
103,S0211-699519301225,FGe,i
103,S0211-699519301225,basal,o
103,S0211-699519301225,p001,o
103,S0211-699519301225,menor,o
103,S0211-699519301225,albuminuria,i
103,S0211-699519301225,p001,o
103,S0211-699519301225,no,o
103,S0211-699519301225,tener,o
103,S0211-699519301225,diabetes,i
103,S0211-699519301225,mellitus,i
103,S0211-699519301225,p001,o
103,S0211-699519301225,y,o
103,S0211-699519301225,recibir,o
103,S0211-699519301225,tratamiento,i
103,S0211-699519301225,con,o
103,S0211-699519301225,espironolactona,i
103,S0211-699519301225,p002,o
103,S0211-699519301225,El,o
103,S0211-699519301225,tratamiento,i
103,S0211-699519301225,con,o
103,S0211-699519301225,espironolactona,i
103,S0211-699519301225,OR,o
103,S0211-699519301225,213,o
103,S0211-699519301225,IC,o
103,S0211-699519301225,189229,o
103,S0211-699519301225,y,o
103,S0211-699519301225,la,o
103,S0211-699519301225,menor,o
103,S0211-699519301225,albuminuria,i
103,S0211-699519301225,OR,o
103,S0211-699519301225,098,o
103,S0211-699519301225,IC,o
103,S0211-699519301225,097099,o
103,S0211-699519301225,mantienen,o
103,S0211-699519301225,su,o
103,S0211-699519301225,poder,o
103,S0211-699519301225,predictivo,o
103,S0211-699519301225,independiente,o
103,S0211-699519301225,en,o
103,S0211-699519301225,un,o
103,S0211-699519301225,modelo,o
103,S0211-699519301225,multivariante,o
103,S0211-699519301225,Conclusiones,o
103,S0211-699519301225,El,o
103,S0211-699519301225,tratamiento,i
103,S0211-699519301225,con,o
103,S0211-699519301225,espironolactona,i
103,S0211-699519301225,reduce,o
103,S0211-699519301225,mas,o
103,S0211-699519301225,la,o
103,S0211-699519301225,presion,i
103,S0211-699519301225,arterial,i
103,S0211-699519301225,y,o
103,S0211-699519301225,la,o
103,S0211-699519301225,albuminuria,i
103,S0211-699519301225,en,o
103,S0211-699519301225,pacientes,o
103,S0211-699519301225,con,o
103,S0211-699519301225,HTA,i
103,S0211-699519301225,resistente,o
103,S0211-699519301225,comparado,o
103,S0211-699519301225,con,o
103,S0211-699519301225,la,o
103,S0211-699519301225,furosemida,i
103,S0211-699519301225,y,o
103,S0211-699519301225,esto,o
103,S0211-699519301225,se,o
103,S0211-699519301225,asocia,o
103,S0211-699519301225,con,o
103,S0211-699519301225,una,o
103,S0211-699519301225,progresion,o
103,S0211-699519301225,mas,o
103,S0211-699519301225,lenta,o
103,S0211-699519301225,de,o
103,S0211-699519301225,la,o
103,S0211-699519301225,ERC,i
103,S0211-699519301225,a,o
103,S0211-699519301225,largo,o
103,S0211-699519301225,plazo,o
104,S0211-69952010000300014,Colocacion,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,cateter,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,dialisis,i
104,S0211-69952010000300014,peritoneal,i
104,S0211-69952010000300014,por,i
104,S0211-69952010000300014,laparoscopia,i
104,S0211-69952010000300014,descripcion,o
104,S0211-69952010000300014,y,o
104,S0211-69952010000300014,resultados,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,una,o
104,S0211-69952010000300014,tecnica,i
104,S0211-69952010000300014,propia,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,dos,i
104,S0211-69952010000300014,puertos,i
104,S0211-69952010000300014,Objetivo,o
104,S0211-69952010000300014,Estudiar,o
104,S0211-69952010000300014,la,o
104,S0211-69952010000300014,viabilidad,o
104,S0211-69952010000300014,la,o
104,S0211-69952010000300014,eficacia,o
104,S0211-69952010000300014,y,o
104,S0211-69952010000300014,la,o
104,S0211-69952010000300014,seguridad,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,nuestra,o
104,S0211-69952010000300014,tecnica,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,dos,i
104,S0211-69952010000300014,puertos,i
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,colocacion,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,cateter,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,dialisis,i
104,S0211-69952010000300014,peritoneal,i
104,S0211-69952010000300014,por,i
104,S0211-69952010000300014,laparoscopia,i
104,S0211-69952010000300014,Material,o
104,S0211-69952010000300014,y,o
104,S0211-69952010000300014,metodos,o
104,S0211-69952010000300014,Desde,o
104,S0211-69952010000300014,enero,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,2006,o
104,S0211-69952010000300014,a,o
104,S0211-69952010000300014,julio,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,2009,o
104,S0211-69952010000300014,51,o
104,S0211-69952010000300014,pacientes,o
104,S0211-69952010000300014,fueron,o
104,S0211-69952010000300014,sometidos,o
104,S0211-69952010000300014,a,o
104,S0211-69952010000300014,colocacion,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,cateter,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,dialisis,i
104,S0211-69952010000300014,peritoneal,i
104,S0211-69952010000300014,usando,o
104,S0211-69952010000300014,una,o
104,S0211-69952010000300014,nueva,o
104,S0211-69952010000300014,tecnica,o
104,S0211-69952010000300014,Todos,o
104,S0211-69952010000300014,los,o
104,S0211-69952010000300014,procedimientos,i
104,S0211-69952010000300014,se,o
104,S0211-69952010000300014,completaron,o
104,S0211-69952010000300014,laparoscopicamente,i
104,S0211-69952010000300014,usando,o
104,S0211-69952010000300014,dos,o
104,S0211-69952010000300014,puertos,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,12,o
104,S0211-69952010000300014,mm,o
104,S0211-69952010000300014,Nuestra,o
104,S0211-69952010000300014,tecnica,o
104,S0211-69952010000300014,se,o
104,S0211-69952010000300014,basa,o
104,S0211-69952010000300014,en,o
104,S0211-69952010000300014,la,o
104,S0211-69952010000300014,colocacion,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,un,i
104,S0211-69952010000300014,cateter,i
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,tipo,o
104,S0211-69952010000300014,OreopoulosZellerman,o
104,S0211-69952010000300014,sobre,o
104,S0211-69952010000300014,una,o
104,S0211-69952010000300014,guia,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,Guyon,o
104,S0211-69952010000300014,recta,o
104,S0211-69952010000300014,con,o
104,S0211-69952010000300014,punta,o
104,S0211-69952010000300014,atraumatica,o
104,S0211-69952010000300014,y,o
104,S0211-69952010000300014,garantiza,o
104,S0211-69952010000300014,la,o
104,S0211-69952010000300014,optima,o
104,S0211-69952010000300014,colocacion,i
104,S0211-69952010000300014,del,i
104,S0211-69952010000300014,cateter,i
104,S0211-69952010000300014,En,o
104,S0211-69952010000300014,caso,o
104,S0211-69952010000300014,necesario,o
104,S0211-69952010000300014,este,o
104,S0211-69952010000300014,se,o
104,S0211-69952010000300014,puede,o
104,S0211-69952010000300014,poner,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,nuevo,o
104,S0211-69952010000300014,mediante,o
104,S0211-69952010000300014,la,o
104,S0211-69952010000300014,recolocacion,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,la,i
104,S0211-69952010000300014,guia,i
104,S0211-69952010000300014,El,o
104,S0211-69952010000300014,seguimiento,i
104,S0211-69952010000300014,medio,o
104,S0211-69952010000300014,ha,o
104,S0211-69952010000300014,sido,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,25,o
104,S0211-69952010000300014,meses,o
104,S0211-69952010000300014,Resultados,o
104,S0211-69952010000300014,Tiempo,o
104,S0211-69952010000300014,quirurgico,o
104,S0211-69952010000300014,medio,o
104,S0211-69952010000300014,32,o
104,S0211-69952010000300014,minutos,o
104,S0211-69952010000300014,rango,o
104,S0211-69952010000300014,1555,o
104,S0211-69952010000300014,minutos,o
104,S0211-69952010000300014,Un,o
104,S0211-69952010000300014,paciente,o
104,S0211-69952010000300014,presento,o
104,S0211-69952010000300014,una,o
104,S0211-69952010000300014,obstruccion,i
104,S0211-69952010000300014,del,i
104,S0211-69952010000300014,cateter,i
104,S0211-69952010000300014,en,o
104,S0211-69952010000300014,el,o
104,S0211-69952010000300014,postoperatorio,o
104,S0211-69952010000300014,inmediato,o
104,S0211-69952010000300014,que,o
104,S0211-69952010000300014,requirio,o
104,S0211-69952010000300014,recolocacion,i
104,S0211-69952010000300014,quirurgica,i
104,S0211-69952010000300014,No,o
104,S0211-69952010000300014,se,o
104,S0211-69952010000300014,han,o
104,S0211-69952010000300014,producido,o
104,S0211-69952010000300014,otras,o
104,S0211-69952010000300014,complicaciones,i
104,S0211-69952010000300014,tecnicas,o
104,S0211-69952010000300014,durante,o
104,S0211-69952010000300014,la,o
104,S0211-69952010000300014,cirugia,i
104,S0211-69952010000300014,o,o
104,S0211-69952010000300014,el,o
104,S0211-69952010000300014,postoperatorio,o
104,S0211-69952010000300014,inmediato,o
104,S0211-69952010000300014,Media,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,tiempo,o
104,S0211-69952010000300014,al,o
104,S0211-69952010000300014,alta,o
104,S0211-69952010000300014,102,o
104,S0211-69952010000300014,22,o
104,S0211-69952010000300014,dias,o
104,S0211-69952010000300014,Tasa,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,obstruccion,i
104,S0211-69952010000300014,del,i
104,S0211-69952010000300014,cateter,i
104,S0211-69952010000300014,76,o
104,S0211-69952010000300014,Tasa,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,conversion,o
104,S0211-69952010000300014,a,o
104,S0211-69952010000300014,hemodialisis,i
104,S0211-69952010000300014,secundaria,o
104,S0211-69952010000300014,a,o
104,S0211-69952010000300014,peritonitis,i
104,S0211-69952010000300014,13,o
104,S0211-69952010000300014,Episodios,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,peritonitis,i
104,S0211-69952010000300014,por,o
104,S0211-69952010000300014,pacienteaño,o
104,S0211-69952010000300014,027,o
104,S0211-69952010000300014,Supervivencia,o
104,S0211-69952010000300014,del,o
104,S0211-69952010000300014,cateter,o
104,S0211-69952010000300014,a,o
104,S0211-69952010000300014,los,o
104,S0211-69952010000300014,6,o
104,S0211-69952010000300014,meses,o
104,S0211-69952010000300014,un,o
104,S0211-69952010000300014,año,o
104,S0211-69952010000300014,y,o
104,S0211-69952010000300014,5,o
104,S0211-69952010000300014,años,o
104,S0211-69952010000300014,94,o
104,S0211-69952010000300014,87,o
104,S0211-69952010000300014,y,o
104,S0211-69952010000300014,72,o
104,S0211-69952010000300014,respectivamente,o
104,S0211-69952010000300014,Tasa,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,migracion,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,cateter,i
104,S0211-69952010000300014,4,o
104,S0211-69952010000300014,No,o
104,S0211-69952010000300014,se,o
104,S0211-69952010000300014,han,o
104,S0211-69952010000300014,comentado,o
104,S0211-69952010000300014,casos,o
104,S0211-69952010000300014,de,o
104,S0211-69952010000300014,fistula,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,liquido,i
104,S0211-69952010000300014,peritoneal,i
104,S0211-69952010000300014,Conclusiones,o
104,S0211-69952010000300014,La,o
104,S0211-69952010000300014,tecnica,i
104,S0211-69952010000300014,de,i
104,S0211-69952010000300014,dos,i
104,S0211-69952010000300014,puertos,i
104,S0211-69952010000300014,descrita,o
104,S0211-69952010000300014,es,o
104,S0211-69952010000300014,un,o
104,S0211-69952010000300014,procedimiento,i
104,S0211-69952010000300014,sencillo,o
104,S0211-69952010000300014,y,o
104,S0211-69952010000300014,rapido,o
104,S0211-69952010000300014,con,o
104,S0211-69952010000300014,pocas,o
104,S0211-69952010000300014,complicaciones,i
104,S0211-69952010000300014,y,o
104,S0211-69952010000300014,alta,i
104,S0211-69952010000300014,hospitalaria,i
104,S0211-69952010000300014,inmediata,o
104,S0211-69952010000300014,Debido,o
104,S0211-69952010000300014,a,o
104,S0211-69952010000300014,su,o
104,S0211-69952010000300014,fiabilidad,o
104,S0211-69952010000300014,ofrece,o
104,S0211-69952010000300014,buenos,o
104,S0211-69952010000300014,resultados,o
104,S0211-69952010000300014,en,o
104,S0211-69952010000300014,la,o
104,S0211-69952010000300014,funcion,o
104,S0211-69952010000300014,del,o
104,S0211-69952010000300014,cateter,o
105,S0211-69952010000300018,Hemodialisis,i
105,S0211-69952010000300018,4,o
105,S0211-69952010000300018,dias,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,semana,o
105,S0211-69952010000300018,una,o
105,S0211-69952010000300018,alternativa,o
105,S0211-69952010000300018,eficaz,o
105,S0211-69952010000300018,en,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,control,i
105,S0211-69952010000300018,de,i
105,S0211-69952010000300018,la,i
105,S0211-69952010000300018,tension,i
105,S0211-69952010000300018,arterial,i
105,S0211-69952010000300018,y,o
105,S0211-69952010000300018,en,o
105,S0211-69952010000300018,alcanzar,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,peso,o
105,S0211-69952010000300018,objetivo,o
105,S0211-69952010000300018,posterior,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,dialisis,i
105,S0211-69952010000300018,Durante,o
105,S0211-69952010000300018,los,o
105,S0211-69952010000300018,ultimos,o
105,S0211-69952010000300018,años,o
105,S0211-69952010000300018,han,o
105,S0211-69952010000300018,sido,o
105,S0211-69952010000300018,abundantes,o
105,S0211-69952010000300018,las,o
105,S0211-69952010000300018,publicaciones,o
105,S0211-69952010000300018,sobre,o
105,S0211-69952010000300018,hemodialisis,i
105,S0211-69952010000300018,diaria,o
105,S0211-69952010000300018,que,o
105,S0211-69952010000300018,reflejan,o
105,S0211-69952010000300018,los,o
105,S0211-69952010000300018,beneficios,o
105,S0211-69952010000300018,que,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,aumento,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,frecuencia,o
105,S0211-69952010000300018,conlleva,o
105,S0211-69952010000300018,especialmente,o
105,S0211-69952010000300018,en,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,area,o
105,S0211-69952010000300018,cardiovascular,i
105,S0211-69952010000300018,y,o
105,S0211-69952010000300018,control,i
105,S0211-69952010000300018,de,i
105,S0211-69952010000300018,la,i
105,S0211-69952010000300018,tension,i
105,S0211-69952010000300018,arterial,i
105,S0211-69952010000300018,Sin,o
105,S0211-69952010000300018,embargo,o
105,S0211-69952010000300018,en,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,practica,i
105,S0211-69952010000300018,clinica,i
105,S0211-69952010000300018,muchas,o
105,S0211-69952010000300018,veces,o
105,S0211-69952010000300018,chocamos,o
105,S0211-69952010000300018,con,o
105,S0211-69952010000300018,enormes,o
105,S0211-69952010000300018,reticencias,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,los,o
105,S0211-69952010000300018,pacientes,o
105,S0211-69952010000300018,ante,o
105,S0211-69952010000300018,dicha,o
105,S0211-69952010000300018,tecnica,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,dialsis,i
105,S0211-69952010000300018,ya,o
105,S0211-69952010000300018,que,o
105,S0211-69952010000300018,perciben,o
105,S0211-69952010000300018,un,o
105,S0211-69952010000300018,empeoramiento,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,su,o
105,S0211-69952010000300018,calidad,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,vida,o
105,S0211-69952010000300018,al,o
105,S0211-69952010000300018,tener,o
105,S0211-69952010000300018,que,o
105,S0211-69952010000300018,acudir,o
105,S0211-69952010000300018,todos,o
105,S0211-69952010000300018,los,o
105,S0211-69952010000300018,dias,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,unidad,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,dialisis,i
105,S0211-69952010000300018,Ello,o
105,S0211-69952010000300018,se,o
105,S0211-69952010000300018,complica,o
105,S0211-69952010000300018,aun,o
105,S0211-69952010000300018,mas,o
105,S0211-69952010000300018,en,o
105,S0211-69952010000300018,areas,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,salud,o
105,S0211-69952010000300018,como,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,nuestra,o
105,S0211-69952010000300018,Segovia,o
105,S0211-69952010000300018,donde,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,50,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,poblacion,o
105,S0211-69952010000300018,habita,o
105,S0211-69952010000300018,en,o
105,S0211-69952010000300018,nucleos,o
105,S0211-69952010000300018,rurales,o
105,S0211-69952010000300018,debiendo,o
105,S0211-69952010000300018,sufrir,o
105,S0211-69952010000300018,en,o
105,S0211-69952010000300018,ocasiones,o
105,S0211-69952010000300018,viajes,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,mas,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,1,o
105,S0211-69952010000300018,hora,o
105,S0211-69952010000300018,En,o
105,S0211-69952010000300018,este,o
105,S0211-69952010000300018,sentido,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,aumento,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,frecuencia,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,dialisis,i
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,4,o
105,S0211-69952010000300018,dias,o
105,S0211-69952010000300018,podria,o
105,S0211-69952010000300018,producir,o
105,S0211-69952010000300018,algunos,o
105,S0211-69952010000300018,beneficios,o
105,S0211-69952010000300018,cardiovasculares,i
105,S0211-69952010000300018,con,o
105,S0211-69952010000300018,una,o
105,S0211-69952010000300018,mejor,o
105,S0211-69952010000300018,aceptacion,o
105,S0211-69952010000300018,por,o
105,S0211-69952010000300018,parte,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,los,o
105,S0211-69952010000300018,pacientes,o
105,S0211-69952010000300018,que,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,hemodialisis,i
105,S0211-69952010000300018,diaria,o
105,S0211-69952010000300018,Presentamos,o
105,S0211-69952010000300018,los,o
105,S0211-69952010000300018,datos,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,12,o
105,S0211-69952010000300018,pacientes,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,nuestra,o
105,S0211-69952010000300018,unidad,o
105,S0211-69952010000300018,que,o
105,S0211-69952010000300018,cambiaron,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,modalidad,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,4,o
105,S0211-69952010000300018,sesiones,o
105,S0211-69952010000300018,semanales,o
105,S0211-69952010000300018,durante,o
105,S0211-69952010000300018,los,o
105,S0211-69952010000300018,años,o
105,S0211-69952010000300018,2006,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,2008,o
105,S0211-69952010000300018,y,o
105,S0211-69952010000300018,fueron,o
105,S0211-69952010000300018,seguidos,i
105,S0211-69952010000300018,durante,o
105,S0211-69952010000300018,8,o
105,S0211-69952010000300018,meses,o
105,S0211-69952010000300018,La,o
105,S0211-69952010000300018,edad,o
105,S0211-69952010000300018,media,o
105,S0211-69952010000300018,era,o
105,S0211-69952010000300018,675,o
105,S0211-69952010000300018,años,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,flujo,o
105,S0211-69952010000300018,arterial,i
105,S0211-69952010000300018,medio,o
105,S0211-69952010000300018,35416,o
105,S0211-69952010000300018,mlmin,o
105,S0211-69952010000300018,y,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,del,o
105,S0211-69952010000300018,baño,i
105,S0211-69952010000300018,de,i
105,S0211-69952010000300018,dialisis,i
105,S0211-69952010000300018,66667,o
105,S0211-69952010000300018,mlmin,o
105,S0211-69952010000300018,Se,o
105,S0211-69952010000300018,utilizaron,o
105,S0211-69952010000300018,pruebas,o
105,S0211-69952010000300018,no,o
105,S0211-69952010000300018,parametricas,o
105,S0211-69952010000300018,para,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,analisis,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,los,o
105,S0211-69952010000300018,datos,o
105,S0211-69952010000300018,El,o
105,S0211-69952010000300018,aumento,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,frecuencia,o
105,S0211-69952010000300018,permitio,o
105,S0211-69952010000300018,un,o
105,S0211-69952010000300018,incremento,o
105,S0211-69952010000300018,significativo,o
105,S0211-69952010000300018,del,o
105,S0211-69952010000300018,tiempo,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,dialisis,i
105,S0211-69952010000300018,pasando,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,79875,o
105,S0211-69952010000300018,minutos,o
105,S0211-69952010000300018,semanales,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,96681,o
105,S0211-69952010000300018,Al,o
105,S0211-69952010000300018,analizar,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,dosis,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,dialisis,i
105,S0211-69952010000300018,tanto,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,EKR,o
105,S0211-69952010000300018,segun,o
105,S0211-69952010000300018,Casino,o
105,S0211-69952010000300018,y,o
105,S0211-69952010000300018,Lopez,o
105,S0211-69952010000300018,188,o
105,S0211-69952010000300018,frente,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,2164,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,PRU,i
105,S0211-69952010000300018,semanal,o
105,S0211-69952010000300018,23682,o
105,S0211-69952010000300018,frente,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,30548,o
105,S0211-69952010000300018,y,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,KT,o
105,S0211-69952010000300018,semanal,o
105,S0211-69952010000300018,19888,o
105,S0211-69952010000300018,frente,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,23831l,o
105,S0211-69952010000300018,mostraron,o
105,S0211-69952010000300018,un,o
105,S0211-69952010000300018,aumento,o
105,S0211-69952010000300018,en,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,dosis,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,dialisis,i
105,S0211-69952010000300018,recibida,o
105,S0211-69952010000300018,Las,o
105,S0211-69952010000300018,ganancias,i
105,S0211-69952010000300018,interdialisis,o
105,S0211-69952010000300018,disminuyeron,o
105,S0211-69952010000300018,significativamente,o
105,S0211-69952010000300018,261,o
105,S0211-69952010000300018,frente,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,152,o
105,S0211-69952010000300018,Kg,o
105,S0211-69952010000300018,asi,o
105,S0211-69952010000300018,como,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,ultrafiltracion,i
105,S0211-69952010000300018,horaria,i
105,S0211-69952010000300018,media,o
105,S0211-69952010000300018,durante,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,sesion,o
105,S0211-69952010000300018,600,o
105,S0211-69952010000300018,frente,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,375,o
105,S0211-69952010000300018,ml,o
105,S0211-69952010000300018,De,o
105,S0211-69952010000300018,igual,o
105,S0211-69952010000300018,manera,o
105,S0211-69952010000300018,se,o
105,S0211-69952010000300018,consiguio,o
105,S0211-69952010000300018,alcanzar,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,peso,i
105,S0211-69952010000300018,seco,i
105,S0211-69952010000300018,al,o
105,S0211-69952010000300018,final,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,las,o
105,S0211-69952010000300018,sesiones,o
105,S0211-69952010000300018,con,o
105,S0211-69952010000300018,un,o
105,S0211-69952010000300018,margen,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,300mg,o
105,S0211-69952010000300018,en,o
105,S0211-69952010000300018,un,o
105,S0211-69952010000300018,mayor,o
105,S0211-69952010000300018,numero,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,ocasiones,o
105,S0211-69952010000300018,5279,o
105,S0211-69952010000300018,frente,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,7609,o
105,S0211-69952010000300018,Los,o
105,S0211-69952010000300018,valores,i
105,S0211-69952010000300018,de,i
105,S0211-69952010000300018,tension,i
105,S0211-69952010000300018,arterial,i
105,S0211-69952010000300018,predialisis,o
105,S0211-69952010000300018,se,o
105,S0211-69952010000300018,redujeron,o
105,S0211-69952010000300018,significativamente,o
105,S0211-69952010000300018,14583,o
105,S0211-69952010000300018,7666,o
105,S0211-69952010000300018,frente,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,12501,o
105,S0211-69952010000300018,6727,o
105,S0211-69952010000300018,y,o
105,S0211-69952010000300018,en,o
105,S0211-69952010000300018,menor,o
105,S0211-69952010000300018,medida,o
105,S0211-69952010000300018,los,o
105,S0211-69952010000300018,valores,o
105,S0211-69952010000300018,postdialisis,o
105,S0211-69952010000300018,13541,o
105,S0211-69952010000300018,7375,o
105,S0211-69952010000300018,frente,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,11998,o
105,S0211-69952010000300018,vs,o
105,S0211-69952010000300018,6590,o
105,S0211-69952010000300018,y,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,numero,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,farmacos,i
105,S0211-69952010000300018,antihipertensivos,i
105,S0211-69952010000300018,disminuyo,o
105,S0211-69952010000300018,141,o
105,S0211-69952010000300018,frente,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,045,o
105,S0211-69952010000300018,tabla,o
105,S0211-69952010000300018,1,o
105,S0211-69952010000300018,No,o
105,S0211-69952010000300018,se,o
105,S0211-69952010000300018,observaron,o
105,S0211-69952010000300018,diferencias,o
105,S0211-69952010000300018,en,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,numero,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,hipotensiones,i
105,S0211-69952010000300018,o,o
105,S0211-69952010000300018,calambres,i
105,S0211-69952010000300018,intradialisis,o
105,S0211-69952010000300018,ni,o
105,S0211-69952010000300018,en,o
105,S0211-69952010000300018,los,o
105,S0211-69952010000300018,valores,i
105,S0211-69952010000300018,de,i
105,S0211-69952010000300018,albumina,i
105,S0211-69952010000300018,colesterol,i
105,S0211-69952010000300018,calcio,i
105,S0211-69952010000300018,fosforo,i
105,S0211-69952010000300018,PCR,i
105,S0211-69952010000300018,npcr,i
105,S0211-69952010000300018,peso,i
105,S0211-69952010000300018,seco,i
105,S0211-69952010000300018,o,o
105,S0211-69952010000300018,empleo,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,quelantes,i
105,S0211-69952010000300018,de,i
105,S0211-69952010000300018,fosforo,i
105,S0211-69952010000300018,En,o
105,S0211-69952010000300018,conclusion,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,aumento,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,frecuencia,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,4,o
105,S0211-69952010000300018,sesiones,o
105,S0211-69952010000300018,semanales,o
105,S0211-69952010000300018,nos,o
105,S0211-69952010000300018,permitio,o
105,S0211-69952010000300018,incrementar,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,tiempo,o
105,S0211-69952010000300018,semanal,o
105,S0211-69952010000300018,y,o
105,S0211-69952010000300018,consecuentemente,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,dosis,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,dialisis,i
105,S0211-69952010000300018,recibida,o
105,S0211-69952010000300018,La,o
105,S0211-69952010000300018,tension,i
105,S0211-69952010000300018,arterial,i
105,S0211-69952010000300018,se,i
105,S0211-69952010000300018,controlo,i
105,S0211-69952010000300018,mejor,o
105,S0211-69952010000300018,con,o
105,S0211-69952010000300018,necesidad,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,menos,o
105,S0211-69952010000300018,farmacos,i
105,S0211-69952010000300018,las,o
105,S0211-69952010000300018,ganancias,i
105,S0211-69952010000300018,interdialisis,o
105,S0211-69952010000300018,disminuyeron,o
105,S0211-69952010000300018,significativamente,o
105,S0211-69952010000300018,asi,o
105,S0211-69952010000300018,como,o
105,S0211-69952010000300018,la,o
105,S0211-69952010000300018,ultrafiltracion,i
105,S0211-69952010000300018,horaria,i
105,S0211-69952010000300018,y,o
105,S0211-69952010000300018,se,o
105,S0211-69952010000300018,alcanzo,o
105,S0211-69952010000300018,mas,o
105,S0211-69952010000300018,facilmente,o
105,S0211-69952010000300018,el,o
105,S0211-69952010000300018,peso,i
105,S0211-69952010000300018,seco,i
105,S0211-69952010000300018,prescrito,i
105,S0211-69952010000300018,con,o
105,S0211-69952010000300018,lo,o
105,S0211-69952010000300018,cual,o
105,S0211-69952010000300018,los,o
105,S0211-69952010000300018,enfermos,i
105,S0211-69952010000300018,que,o
105,S0211-69952010000300018,mas,o
105,S0211-69952010000300018,se,o
105,S0211-69952010000300018,pueden,o
105,S0211-69952010000300018,beneficiar,o
105,S0211-69952010000300018,del,o
105,S0211-69952010000300018,aumento,o
105,S0211-69952010000300018,a,o
105,S0211-69952010000300018,4,o
105,S0211-69952010000300018,sesiones,o
105,S0211-69952010000300018,semanales,o
105,S0211-69952010000300018,son,o
105,S0211-69952010000300018,aquellos,o
105,S0211-69952010000300018,con,o
105,S0211-69952010000300018,hipertension,i
105,S0211-69952010000300018,no,o
105,S0211-69952010000300018,controlada,o
105,S0211-69952010000300018,excesivas,o
105,S0211-69952010000300018,ganancias,i
105,S0211-69952010000300018,interdialisis,o
105,S0211-69952010000300018,o,o
105,S0211-69952010000300018,que,o
105,S0211-69952010000300018,precisen,o
105,S0211-69952010000300018,una,o
105,S0211-69952010000300018,mayor,o
105,S0211-69952010000300018,dosis,o
105,S0211-69952010000300018,de,o
105,S0211-69952010000300018,dialisis,i
106,S0211-69952011000300008,Eficacia,o
106,S0211-69952011000300008,y,o
106,S0211-69952011000300008,seguridad,o
106,S0211-69952011000300008,del,o
106,S0211-69952011000300008,tratamiento,i
106,S0211-69952011000300008,combinado,i
106,S0211-69952011000300008,con,o
106,S0211-69952011000300008,ciclosporina,i
106,S0211-69952011000300008,A,i
106,S0211-69952011000300008,y,o
106,S0211-69952011000300008,micofenolato,i
106,S0211-69952011000300008,de,i
106,S0211-69952011000300008,mofetilo,i
106,S0211-69952011000300008,en,o
106,S0211-69952011000300008,enfermos,i
106,S0211-69952011000300008,con,o
106,S0211-69952011000300008,glomeruloesclerosis,i
106,S0211-69952011000300008,segmentaria,i
106,S0211-69952011000300008,y,i
106,S0211-69952011000300008,focal,i
106,S0211-69952011000300008,ciclosporinaresistente,o
106,S0211-69952011000300008,Introduccion,o
106,S0211-69952011000300008,La,o
106,S0211-69952011000300008,asociacion,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,ciclosporina,i
106,S0211-69952011000300008,A,i
106,S0211-69952011000300008,CsA,i
106,S0211-69952011000300008,y,o
106,S0211-69952011000300008,micofenolato,i
106,S0211-69952011000300008,mofetil,i
106,S0211-69952011000300008,MMF,i
106,S0211-69952011000300008,tiene,o
106,S0211-69952011000300008,un,o
106,S0211-69952011000300008,efecto,o
106,S0211-69952011000300008,inmunosupresor,o
106,S0211-69952011000300008,sinergico,o
106,S0211-69952011000300008,y,o
106,S0211-69952011000300008,en,o
106,S0211-69952011000300008,consecuencia,o
106,S0211-69952011000300008,podria,o
106,S0211-69952011000300008,inducir,o
106,S0211-69952011000300008,una,o
106,S0211-69952011000300008,remision,o
106,S0211-69952011000300008,del,o
106,S0211-69952011000300008,sindrome,i
106,S0211-69952011000300008,nefrotico,i
106,S0211-69952011000300008,en,o
106,S0211-69952011000300008,enfermos,i
106,S0211-69952011000300008,con,o
106,S0211-69952011000300008,glomeruloesclerosis,i
106,S0211-69952011000300008,segmentaria,i
106,S0211-69952011000300008,y,i
106,S0211-69952011000300008,focal,i
106,S0211-69952011000300008,resistente,o
106,S0211-69952011000300008,a,o
106,S0211-69952011000300008,esteroides,i
106,S0211-69952011000300008,y,o
106,S0211-69952011000300008,a,o
106,S0211-69952011000300008,CsA,i
106,S0211-69952011000300008,Objetivo,o
106,S0211-69952011000300008,Analizar,i
106,S0211-69952011000300008,la,i
106,S0211-69952011000300008,eficacia,i
106,S0211-69952011000300008,y,i
106,S0211-69952011000300008,el,i
106,S0211-69952011000300008,perfil,i
106,S0211-69952011000300008,de,i
106,S0211-69952011000300008,seguridad,i
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,la,o
106,S0211-69952011000300008,asociacion,o
106,S0211-69952011000300008,CsA,i
106,S0211-69952011000300008,y,o
106,S0211-69952011000300008,MMF,i
106,S0211-69952011000300008,en,o
106,S0211-69952011000300008,enfermos,i
106,S0211-69952011000300008,con,o
106,S0211-69952011000300008,GSF,i
106,S0211-69952011000300008,resistente,o
106,S0211-69952011000300008,a,o
106,S0211-69952011000300008,ciclosporina,i
106,S0211-69952011000300008,A,i
106,S0211-69952011000300008,Pacientes,o
106,S0211-69952011000300008,y,o
106,S0211-69952011000300008,metodo,o
106,S0211-69952011000300008,27,o
106,S0211-69952011000300008,enfermos,i
106,S0211-69952011000300008,con,o
106,S0211-69952011000300008,GSF,i
106,S0211-69952011000300008,resistente,o
106,S0211-69952011000300008,a,o
106,S0211-69952011000300008,CsA,i
106,S0211-69952011000300008,recibieron,o
106,S0211-69952011000300008,tratamiento,i
106,S0211-69952011000300008,con,o
106,S0211-69952011000300008,CsA,i
106,S0211-69952011000300008,4,o
106,S0211-69952011000300008,mgkgdia,o
106,S0211-69952011000300008,asociada,o
106,S0211-69952011000300008,a,o
106,S0211-69952011000300008,MMF,i
106,S0211-69952011000300008,2,o
106,S0211-69952011000300008,gdia,o
106,S0211-69952011000300008,durante,o
106,S0211-69952011000300008,12,o
106,S0211-69952011000300008,meses,o
106,S0211-69952011000300008,El,o
106,S0211-69952011000300008,seguimiento,i
106,S0211-69952011000300008,total,o
106,S0211-69952011000300008,fue,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,5,o
106,S0211-69952011000300008,años,o
106,S0211-69952011000300008,Como,o
106,S0211-69952011000300008,medida,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,resultado,o
106,S0211-69952011000300008,se,o
106,S0211-69952011000300008,considero,o
106,S0211-69952011000300008,la,o
106,S0211-69952011000300008,proporcion,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,enfermos,i
106,S0211-69952011000300008,con,o
106,S0211-69952011000300008,remision,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,la,o
106,S0211-69952011000300008,proteinuria,i
106,S0211-69952011000300008,y,o
106,S0211-69952011000300008,la,o
106,S0211-69952011000300008,evolucion,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,la,o
106,S0211-69952011000300008,funcion,i
106,S0211-69952011000300008,renal,i
106,S0211-69952011000300008,a,o
106,S0211-69952011000300008,los,o
106,S0211-69952011000300008,5,o
106,S0211-69952011000300008,años,o
106,S0211-69952011000300008,Resultados,o
106,S0211-69952011000300008,Al,o
106,S0211-69952011000300008,finalizar,o
106,S0211-69952011000300008,el,o
106,S0211-69952011000300008,periodo,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,tratamiento,i
106,S0211-69952011000300008,ningun,o
106,S0211-69952011000300008,paciente,o
106,S0211-69952011000300008,presento,o
106,S0211-69952011000300008,remision,o
106,S0211-69952011000300008,completa,o
106,S0211-69952011000300008,4,o
106,S0211-69952011000300008,pacientes,o
106,S0211-69952011000300008,148,o
106,S0211-69952011000300008,presentaron,o
106,S0211-69952011000300008,reduccion,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,proteinuria,i
106,S0211-69952011000300008,a,o
106,S0211-69952011000300008,valores,o
106,S0211-69952011000300008,35,o
106,S0211-69952011000300008,gdia,o
106,S0211-69952011000300008,Estos,o
106,S0211-69952011000300008,enfermos,i
106,S0211-69952011000300008,presentaban,o
106,S0211-69952011000300008,proteinuria,i
106,S0211-69952011000300008,basal,o
106,S0211-69952011000300008,562,o
106,S0211-69952011000300008,219,o
106,S0211-69952011000300008,frente,o
106,S0211-69952011000300008,a,o
106,S0211-69952011000300008,81,o
106,S0211-69952011000300008,296,o
106,S0211-69952011000300008,gdia,o
106,S0211-69952011000300008,p,o
106,S0211-69952011000300008,0042,o
106,S0211-69952011000300008,y,o
106,S0211-69952011000300008,pendientes,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,FG,i
106,S0211-69952011000300008,008,o
106,S0211-69952011000300008,012,o
106,S0211-69952011000300008,frente,o
106,S0211-69952011000300008,a,o
106,S0211-69952011000300008,069,o
106,S0211-69952011000300008,038,o
106,S0211-69952011000300008,p,o
106,S0211-69952011000300008,0003,o
106,S0211-69952011000300008,significativamente,o
106,S0211-69952011000300008,inferiores,o
106,S0211-69952011000300008,y,o
106,S0211-69952011000300008,mayor,o
106,S0211-69952011000300008,funcion,i
106,S0211-69952011000300008,renal,i
106,S0211-69952011000300008,basal,o
106,S0211-69952011000300008,996,o
106,S0211-69952011000300008,129,o
106,S0211-69952011000300008,frente,o
106,S0211-69952011000300008,a,o
106,S0211-69952011000300008,8505,o
106,S0211-69952011000300008,155,o
106,S0211-69952011000300008,mlmin,o
106,S0211-69952011000300008,p,o
106,S0211-69952011000300008,0003,o
106,S0211-69952011000300008,Dieciseis,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,los,o
106,S0211-69952011000300008,27,o
106,S0211-69952011000300008,enfermos,i
106,S0211-69952011000300008,592,o
106,S0211-69952011000300008,presentaron,o
106,S0211-69952011000300008,una,o
106,S0211-69952011000300008,enfermedad,i
106,S0211-69952011000300008,renal,i
106,S0211-69952011000300008,progresiva,o
106,S0211-69952011000300008,o,o
106,S0211-69952011000300008,estadio,o
106,S0211-69952011000300008,V,o
106,S0211-69952011000300008,al,o
106,S0211-69952011000300008,final,o
106,S0211-69952011000300008,del,o
106,S0211-69952011000300008,periodo,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,seguimiento,i
106,S0211-69952011000300008,Se,o
106,S0211-69952011000300008,apreciaron,o
106,S0211-69952011000300008,efectos,i
106,S0211-69952011000300008,adversos,i
106,S0211-69952011000300008,gastrointestinales,i
106,S0211-69952011000300008,en,o
106,S0211-69952011000300008,el,o
106,S0211-69952011000300008,333,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,los,o
106,S0211-69952011000300008,enfermos,i
106,S0211-69952011000300008,y,o
106,S0211-69952011000300008,nefrotoxicidad,i
106,S0211-69952011000300008,aguda,o
106,S0211-69952011000300008,transitoria,o
106,S0211-69952011000300008,en,o
106,S0211-69952011000300008,el,o
106,S0211-69952011000300008,148,o
106,S0211-69952011000300008,El,o
106,S0211-69952011000300008,222,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,los,o
106,S0211-69952011000300008,enfermos,i
106,S0211-69952011000300008,preciso,o
106,S0211-69952011000300008,un,o
106,S0211-69952011000300008,incremento,o
106,S0211-69952011000300008,en,o
106,S0211-69952011000300008,la,o
106,S0211-69952011000300008,dosis,o
106,S0211-69952011000300008,yo,o
106,S0211-69952011000300008,numero,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,hipotensores,i
106,S0211-69952011000300008,durante,o
106,S0211-69952011000300008,los,o
106,S0211-69952011000300008,12,o
106,S0211-69952011000300008,meses,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,tratamiento,i
106,S0211-69952011000300008,Conclusiones,o
106,S0211-69952011000300008,En,o
106,S0211-69952011000300008,enfermos,i
106,S0211-69952011000300008,con,o
106,S0211-69952011000300008,GSF,i
106,S0211-69952011000300008,resistente,o
106,S0211-69952011000300008,a,o
106,S0211-69952011000300008,ciclosporina,i
106,S0211-69952011000300008,el,o
106,S0211-69952011000300008,tratamiento,i
106,S0211-69952011000300008,con,o
106,S0211-69952011000300008,asociacion,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,CsA,i
106,S0211-69952011000300008,y,o
106,S0211-69952011000300008,MMF,i
106,S0211-69952011000300008,durante,o
106,S0211-69952011000300008,12,o
106,S0211-69952011000300008,meses,o
106,S0211-69952011000300008,aunque,o
106,S0211-69952011000300008,puede,o
106,S0211-69952011000300008,inducir,o
106,S0211-69952011000300008,reducciones,o
106,S0211-69952011000300008,parciales,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,la,o
106,S0211-69952011000300008,proteinuria,i
106,S0211-69952011000300008,no,o
106,S0211-69952011000300008,modifica,o
106,S0211-69952011000300008,significativamente,o
106,S0211-69952011000300008,el,o
106,S0211-69952011000300008,curso,o
106,S0211-69952011000300008,evolutivo,o
106,S0211-69952011000300008,de,o
106,S0211-69952011000300008,la,o
106,S0211-69952011000300008,funcion,i
106,S0211-69952011000300008,renal,i
107,S0211-69952011000300009,Efectos,o
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,la,o
107,S0211-69952011000300009,rapamicina,i
107,S0211-69952011000300009,en,o
107,S0211-69952011000300009,los,o
107,S0211-69952011000300009,angiomiolipomas,i
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,pacientes,o
107,S0211-69952011000300009,con,o
107,S0211-69952011000300009,esclerosis,i
107,S0211-69952011000300009,tuberosa,i
107,S0211-69952011000300009,Introduccion,o
107,S0211-69952011000300009,La,o
107,S0211-69952011000300009,esclerosis,i
107,S0211-69952011000300009,tuberosa,i
107,S0211-69952011000300009,ET,i
107,S0211-69952011000300009,es,o
107,S0211-69952011000300009,una,o
107,S0211-69952011000300009,enfermedad,i
107,S0211-69952011000300009,sistemica,i
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,herencia,o
107,S0211-69952011000300009,autosomica,i
107,S0211-69952011000300009,dominante,o
107,S0211-69952011000300009,ocasionada,o
107,S0211-69952011000300009,por,o
107,S0211-69952011000300009,mutaciones,i
107,S0211-69952011000300009,en,o
107,S0211-69952011000300009,dos,o
107,S0211-69952011000300009,genes,o
107,S0211-69952011000300009,TSC1,o
107,S0211-69952011000300009,y,o
107,S0211-69952011000300009,TSC2,o
107,S0211-69952011000300009,que,o
107,S0211-69952011000300009,causan,o
107,S0211-69952011000300009,la,o
107,S0211-69952011000300009,aparicion,o
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,tumores,i
107,S0211-69952011000300009,angiolipomas,i
107,S0211-69952011000300009,AML,i
107,S0211-69952011000300009,angiofibromas,i
107,S0211-69952011000300009,astrocitomas,i
107,S0211-69952011000300009,etc,o
107,S0211-69952011000300009,La,o
107,S0211-69952011000300009,proliferacion,o
107,S0211-69952011000300009,inadecuada,o
107,S0211-69952011000300009,y,o
107,S0211-69952011000300009,constante,o
107,S0211-69952011000300009,que,o
107,S0211-69952011000300009,existe,o
107,S0211-69952011000300009,en,o
107,S0211-69952011000300009,la,o
107,S0211-69952011000300009,ET,i
107,S0211-69952011000300009,puede,o
107,S0211-69952011000300009,ser,o
107,S0211-69952011000300009,bloqueada,o
107,S0211-69952011000300009,por,o
107,S0211-69952011000300009,inhibidores,i
107,S0211-69952011000300009,de,i
107,S0211-69952011000300009,la,i
107,S0211-69952011000300009,kinasa,i
107,S0211-69952011000300009,mTOR,i
107,S0211-69952011000300009,mammalian,i
107,S0211-69952011000300009,target,i
107,S0211-69952011000300009,of,i
107,S0211-69952011000300009,rapamycin,i
107,S0211-69952011000300009,como,o
107,S0211-69952011000300009,la,o
107,S0211-69952011000300009,rapamicina,i
107,S0211-69952011000300009,Material,o
107,S0211-69952011000300009,y,o
107,S0211-69952011000300009,metodos,o
107,S0211-69952011000300009,Se,o
107,S0211-69952011000300009,han,o
107,S0211-69952011000300009,incluido,o
107,S0211-69952011000300009,17,o
107,S0211-69952011000300009,pacientes,o
107,S0211-69952011000300009,afectados,o
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,ET,i
107,S0211-69952011000300009,y,o
107,S0211-69952011000300009,al,o
107,S0211-69952011000300009,menos,o
107,S0211-69952011000300009,un,o
107,S0211-69952011000300009,AML,i
107,S0211-69952011000300009,mayor,o
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,2,o
107,S0211-69952011000300009,cm,o
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,diametro,o
107,S0211-69952011000300009,diagnosticado,i
107,S0211-69952011000300009,por,o
107,S0211-69952011000300009,resonancia,i
107,S0211-69952011000300009,magnetica,i
107,S0211-69952011000300009,RM,i
107,S0211-69952011000300009,Han,o
107,S0211-69952011000300009,recibido,o
107,S0211-69952011000300009,tratamiento,i
107,S0211-69952011000300009,con,o
107,S0211-69952011000300009,rapamicina,i
107,S0211-69952011000300009,durante,o
107,S0211-69952011000300009,12,o
107,S0211-69952011000300009,meses,o
107,S0211-69952011000300009,Los,o
107,S0211-69952011000300009,niveles,o
107,S0211-69952011000300009,plasmaticos,i
107,S0211-69952011000300009,se,o
107,S0211-69952011000300009,han,o
107,S0211-69952011000300009,mantenido,o
107,S0211-69952011000300009,entre,o
107,S0211-69952011000300009,4,o
107,S0211-69952011000300009,y,o
107,S0211-69952011000300009,8,o
107,S0211-69952011000300009,ngdl,o
107,S0211-69952011000300009,El,o
107,S0211-69952011000300009,tamaño,o
107,S0211-69952011000300009,del,o
107,S0211-69952011000300009,AML,i
107,S0211-69952011000300009,se,o
107,S0211-69952011000300009,ha,o
107,S0211-69952011000300009,monitorizado,i
107,S0211-69952011000300009,semestralmente,o
107,S0211-69952011000300009,mediante,o
107,S0211-69952011000300009,RM,i
107,S0211-69952011000300009,abdominal,i
107,S0211-69952011000300009,Resultados,o
107,S0211-69952011000300009,A,o
107,S0211-69952011000300009,los,o
107,S0211-69952011000300009,12,o
107,S0211-69952011000300009,meses,o
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,la,o
107,S0211-69952011000300009,inclusion,o
107,S0211-69952011000300009,con,o
107,S0211-69952011000300009,la,o
107,S0211-69952011000300009,RM,i
107,S0211-69952011000300009,se,o
107,S0211-69952011000300009,ha,o
107,S0211-69952011000300009,objetivado,o
107,S0211-69952011000300009,una,o
107,S0211-69952011000300009,disminucion,o
107,S0211-69952011000300009,del,o
107,S0211-69952011000300009,tamaño,o
107,S0211-69952011000300009,del,o
107,S0211-69952011000300009,AML,i
107,S0211-69952011000300009,en,o
107,S0211-69952011000300009,todos,o
107,S0211-69952011000300009,los,o
107,S0211-69952011000300009,pacientes,o
107,S0211-69952011000300009,incluidos,o
107,S0211-69952011000300009,mostrando,o
107,S0211-69952011000300009,una,o
107,S0211-69952011000300009,reduccion,o
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,al,o
107,S0211-69952011000300009,menos,o
107,S0211-69952011000300009,un,o
107,S0211-69952011000300009,50,o
107,S0211-69952011000300009,en,o
107,S0211-69952011000300009,el,o
107,S0211-69952011000300009,824,o
107,S0211-69952011000300009,1417,o
107,S0211-69952011000300009,intervalo,o
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,confianza,o
107,S0211-69952011000300009,IC,o
107,S0211-69952011000300009,95,o
107,S0211-69952011000300009,5657,o
107,S0211-69952011000300009,9620,o
107,S0211-69952011000300009,El,o
107,S0211-69952011000300009,porcentaje,o
107,S0211-69952011000300009,medio,o
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,reduccion,o
107,S0211-69952011000300009,fue,o
107,S0211-69952011000300009,del,o
107,S0211-69952011000300009,663,o
107,S0211-69952011000300009,IC95,o
107,S0211-69952011000300009,569,o
107,S0211-69952011000300009,756,o
107,S0211-69952011000300009,p,o
107,S0211-69952011000300009,00001,o
107,S0211-69952011000300009,Los,o
107,S0211-69952011000300009,principales,o
107,S0211-69952011000300009,efectos,i
107,S0211-69952011000300009,secundarios,i
107,S0211-69952011000300009,observados,o
107,S0211-69952011000300009,han,o
107,S0211-69952011000300009,sido,o
107,S0211-69952011000300009,aftas,i
107,S0211-69952011000300009,orales,i
107,S0211-69952011000300009,517,o
107,S0211-69952011000300009,hipertrigliceridemia,i
107,S0211-69952011000300009,317,o
107,S0211-69952011000300009,microcitosis,i
107,S0211-69952011000300009,e,o
107,S0211-69952011000300009,hipocromia,i
107,S0211-69952011000300009,317,o
107,S0211-69952011000300009,diarrea,i
107,S0211-69952011000300009,217,o
107,S0211-69952011000300009,acne,i
107,S0211-69952011000300009,117,o
107,S0211-69952011000300009,pielonefritis,i
107,S0211-69952011000300009,aguda,i
107,S0211-69952011000300009,117,o
107,S0211-69952011000300009,y,o
107,S0211-69952011000300009,proteinuria,i
107,S0211-69952011000300009,117,o
107,S0211-69952011000300009,Conclusiones,o
107,S0211-69952011000300009,Los,o
107,S0211-69952011000300009,datos,o
107,S0211-69952011000300009,clinicos,o
107,S0211-69952011000300009,preliminares,o
107,S0211-69952011000300009,sugieren,o
107,S0211-69952011000300009,que,o
107,S0211-69952011000300009,la,o
107,S0211-69952011000300009,rapamicina,i
107,S0211-69952011000300009,puede,o
107,S0211-69952011000300009,desempeñar,o
107,S0211-69952011000300009,un,o
107,S0211-69952011000300009,papel,o
107,S0211-69952011000300009,beneficioso,o
107,S0211-69952011000300009,en,o
107,S0211-69952011000300009,el,o
107,S0211-69952011000300009,tratamiento,i
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,la,o
107,S0211-69952011000300009,ET,i
107,S0211-69952011000300009,Nuestra,o
107,S0211-69952011000300009,experiencia,o
107,S0211-69952011000300009,en,o
107,S0211-69952011000300009,17,o
107,S0211-69952011000300009,pacientes,o
107,S0211-69952011000300009,tratados,i
107,S0211-69952011000300009,durante,o
107,S0211-69952011000300009,12,o
107,S0211-69952011000300009,meses,o
107,S0211-69952011000300009,demuestra,o
107,S0211-69952011000300009,seguridad,o
107,S0211-69952011000300009,y,o
107,S0211-69952011000300009,eficacia,o
107,S0211-69952011000300009,en,o
107,S0211-69952011000300009,la,o
107,S0211-69952011000300009,reduccion,o
107,S0211-69952011000300009,de,o
107,S0211-69952011000300009,AML,i
108,S0211-69952012000100014,Efecto,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,DDVAP,i
108,S0211-69952012000100014,intranasal,o
108,S0211-69952012000100014,en,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,prevencion,i
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,hipotension,i
108,S0211-69952012000100014,durante,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,hemodialisis,i
108,S0211-69952012000100014,Introduccion,o
108,S0211-69952012000100014,La,o
108,S0211-69952012000100014,aparicion,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,hipotension,i
108,S0211-69952012000100014,intradialitica,i
108,S0211-69952012000100014,durante,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,hemodialisis,i
108,S0211-69952012000100014,HD,i
108,S0211-69952012000100014,en,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,que,o
108,S0211-69952012000100014,el,o
108,S0211-69952012000100014,objetivo,o
108,S0211-69952012000100014,principal,o
108,S0211-69952012000100014,es,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,eliminacion,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,fluidos,o
108,S0211-69952012000100014,contribuye,o
108,S0211-69952012000100014,a,o
108,S0211-69952012000100014,una,o
108,S0211-69952012000100014,morbilidad,o
108,S0211-69952012000100014,excesiva,o
108,S0211-69952012000100014,que,o
108,S0211-69952012000100014,se,o
108,S0211-69952012000100014,asocia,o
108,S0211-69952012000100014,con,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,dialisis,i
108,S0211-69952012000100014,Materiales,o
108,S0211-69952012000100014,y,o
108,S0211-69952012000100014,metodos,o
108,S0211-69952012000100014,Mediante,o
108,S0211-69952012000100014,un,o
108,S0211-69952012000100014,ensayo,i
108,S0211-69952012000100014,clinico,i
108,S0211-69952012000100014,doble,i
108,S0211-69952012000100014,ciego,i
108,S0211-69952012000100014,comparamos,o
108,S0211-69952012000100014,los,o
108,S0211-69952012000100014,posibles,o
108,S0211-69952012000100014,efectos,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,DDAVP,i
108,S0211-69952012000100014,intranasal,o
108,S0211-69952012000100014,con,o
108,S0211-69952012000100014,los,o
108,S0211-69952012000100014,del,o
108,S0211-69952012000100014,agua,i
108,S0211-69952012000100014,destilada,i
108,S0211-69952012000100014,intranasal,o
108,S0211-69952012000100014,como,o
108,S0211-69952012000100014,placebo,i
108,S0211-69952012000100014,en,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,prevencion,i
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,hipotension,i
108,S0211-69952012000100014,intradialitica,i
108,S0211-69952012000100014,HID,i
108,S0211-69952012000100014,en,o
108,S0211-69952012000100014,pacientes,o
108,S0211-69952012000100014,con,o
108,S0211-69952012000100014,HID,i
108,S0211-69952012000100014,sintomatica,i
108,S0211-69952012000100014,diagnosticada,i
108,S0211-69952012000100014,Durante,o
108,S0211-69952012000100014,el,o
108,S0211-69952012000100014,primer,o
108,S0211-69952012000100014,mes,o
108,S0211-69952012000100014,del,o
108,S0211-69952012000100014,estudio,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,pulverizacion,i
108,S0211-69952012000100014,nasal,i
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,agua,i
108,S0211-69952012000100014,destilada,i
108,S0211-69952012000100014,se,o
108,S0211-69952012000100014,realizaba,o
108,S0211-69952012000100014,30,o
108,S0211-69952012000100014,minutos,o
108,S0211-69952012000100014,antes,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,todas,o
108,S0211-69952012000100014,las,o
108,S0211-69952012000100014,sesiones,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,HD,i
108,S0211-69952012000100014,grupo,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,placebo,i
108,S0211-69952012000100014,grupo,o
108,S0211-69952012000100014,1,o
108,S0211-69952012000100014,y,o
108,S0211-69952012000100014,luego,o
108,S0211-69952012000100014,tras,o
108,S0211-69952012000100014,un,o
108,S0211-69952012000100014,periodo,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,reposo,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,30,o
108,S0211-69952012000100014,dias,o
108,S0211-69952012000100014,utilizamos,o
108,S0211-69952012000100014,DDVAP,i
108,S0211-69952012000100014,intranasal,o
108,S0211-69952012000100014,30,o
108,S0211-69952012000100014,minutos,o
108,S0211-69952012000100014,antes,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,las,o
108,S0211-69952012000100014,sesiones,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,HD,i
108,S0211-69952012000100014,grupo,o
108,S0211-69952012000100014,vasopresina,i
108,S0211-69952012000100014,grupo,o
108,S0211-69952012000100014,2,o
108,S0211-69952012000100014,La,o
108,S0211-69952012000100014,presion,i
108,S0211-69952012000100014,arterial,i
108,S0211-69952012000100014,se,o
108,S0211-69952012000100014,media,o
108,S0211-69952012000100014,justo,o
108,S0211-69952012000100014,antes,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,HD,i
108,S0211-69952012000100014,dos,o
108,S0211-69952012000100014,horas,o
108,S0211-69952012000100014,despues,o
108,S0211-69952012000100014,y,o
108,S0211-69952012000100014,una,o
108,S0211-69952012000100014,vez,o
108,S0211-69952012000100014,finalizada,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,HD,i
108,S0211-69952012000100014,Se,o
108,S0211-69952012000100014,definio,o
108,S0211-69952012000100014,como,o
108,S0211-69952012000100014,episodio,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,hipotension,i
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,caida,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,presion,i
108,S0211-69952012000100014,arterial,i
108,S0211-69952012000100014,sistolica,i
108,S0211-69952012000100014,del,o
108,S0211-69952012000100014,mas,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,10,o
108,S0211-69952012000100014,mmHg,o
108,S0211-69952012000100014,Resultados,o
108,S0211-69952012000100014,Se,o
108,S0211-69952012000100014,incluyo,o
108,S0211-69952012000100014,en,o
108,S0211-69952012000100014,el,o
108,S0211-69952012000100014,estudio,o
108,S0211-69952012000100014,un,o
108,S0211-69952012000100014,total,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,17,o
108,S0211-69952012000100014,pacientes,o
108,S0211-69952012000100014,nueve,o
108,S0211-69952012000100014,hombres,o
108,S0211-69952012000100014,y,o
108,S0211-69952012000100014,ocho,o
108,S0211-69952012000100014,mujeres,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,475,o
108,S0211-69952012000100014,años,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,edad,o
108,S0211-69952012000100014,media,o
108,S0211-69952012000100014,con,o
108,S0211-69952012000100014,HID,i
108,S0211-69952012000100014,sintomatica,i
108,S0211-69952012000100014,diagnosticada,i
108,S0211-69952012000100014,En,o
108,S0211-69952012000100014,ambos,o
108,S0211-69952012000100014,grupos,o
108,S0211-69952012000100014,el,o
108,S0211-69952012000100014,tipo,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,membranas,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,dialisis,i
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,media,o
108,S0211-69952012000100014,del,o
108,S0211-69952012000100014,flujo,i
108,S0211-69952012000100014,sanguineo,i
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,tasa,o
108,S0211-69952012000100014,del,o
108,S0211-69952012000100014,flujo,o
108,S0211-69952012000100014,dializado,i
108,S0211-69952012000100014,y,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,tasa,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,ultrafiltracion,i
108,S0211-69952012000100014,eran,o
108,S0211-69952012000100014,los,o
108,S0211-69952012000100014,mismos,o
108,S0211-69952012000100014,Ambos,o
108,S0211-69952012000100014,grupos,o
108,S0211-69952012000100014,se,o
108,S0211-69952012000100014,sometieron,o
108,S0211-69952012000100014,a,o
108,S0211-69952012000100014,204,o
108,S0211-69952012000100014,sesiones,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,HD,i
108,S0211-69952012000100014,17,o
108,S0211-69952012000100014,x,o
108,S0211-69952012000100014,12,o
108,S0211-69952012000100014,Los,o
108,S0211-69952012000100014,episodios,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,hipotension,i
108,S0211-69952012000100014,sucedieron,o
108,S0211-69952012000100014,en,o
108,S0211-69952012000100014,18,o
108,S0211-69952012000100014,ocasiones,o
108,S0211-69952012000100014,882,o
108,S0211-69952012000100014,en,o
108,S0211-69952012000100014,el,o
108,S0211-69952012000100014,grupo,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,vasopresina,i
108,S0211-69952012000100014,en,o
108,S0211-69952012000100014,comparacion,o
108,S0211-69952012000100014,con,o
108,S0211-69952012000100014,las,o
108,S0211-69952012000100014,125,o
108,S0211-69952012000100014,ocasiones,o
108,S0211-69952012000100014,6127,o
108,S0211-69952012000100014,del,o
108,S0211-69952012000100014,grupo,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,placebo,i
108,S0211-69952012000100014,y,o
108,S0211-69952012000100014,hubo,o
108,S0211-69952012000100014,una,o
108,S0211-69952012000100014,relacion,o
108,S0211-69952012000100014,significativa,o
108,S0211-69952012000100014,entre,o
108,S0211-69952012000100014,ellos,o
108,S0211-69952012000100014,p00001,o
108,S0211-69952012000100014,Ademas,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,presion,i
108,S0211-69952012000100014,arterial,i
108,S0211-69952012000100014,media,i
108,S0211-69952012000100014,en,o
108,S0211-69952012000100014,el,o
108,S0211-69952012000100014,grupo,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,vasopresina,i
108,S0211-69952012000100014,era,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,8077,o
108,S0211-69952012000100014,y,o
108,S0211-69952012000100014,en,o
108,S0211-69952012000100014,el,o
108,S0211-69952012000100014,grupo,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,placebo,i
108,S0211-69952012000100014,era,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,7392,o
108,S0211-69952012000100014,e,o
108,S0211-69952012000100014,igualmente,o
108,S0211-69952012000100014,se,o
108,S0211-69952012000100014,observo,o
108,S0211-69952012000100014,una,o
108,S0211-69952012000100014,asociacion,o
108,S0211-69952012000100014,significativa,o
108,S0211-69952012000100014,p00001,o
108,S0211-69952012000100014,La,o
108,S0211-69952012000100014,media,o
108,S0211-69952012000100014,Ktv,o
108,S0211-69952012000100014,en,o
108,S0211-69952012000100014,el,o
108,S0211-69952012000100014,grupo,o
108,S0211-69952012000100014,1,o
108,S0211-69952012000100014,y,o
108,S0211-69952012000100014,el,o
108,S0211-69952012000100014,2,o
108,S0211-69952012000100014,fue,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,129,o
108,S0211-69952012000100014,y,o
108,S0211-69952012000100014,128,o
108,S0211-69952012000100014,sin,o
108,S0211-69952012000100014,diferencias,o
108,S0211-69952012000100014,entre,o
108,S0211-69952012000100014,ellos,o
108,S0211-69952012000100014,p0896,o
108,S0211-69952012000100014,Conclusion,o
108,S0211-69952012000100014,Estos,o
108,S0211-69952012000100014,resultados,o
108,S0211-69952012000100014,indican,o
108,S0211-69952012000100014,que,o
108,S0211-69952012000100014,en,o
108,S0211-69952012000100014,comparacion,o
108,S0211-69952012000100014,con,o
108,S0211-69952012000100014,el,o
108,S0211-69952012000100014,placebo,i
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,vasopresina,i
108,S0211-69952012000100014,esta,o
108,S0211-69952012000100014,relacionada,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,forma,o
108,S0211-69952012000100014,significativa,o
108,S0211-69952012000100014,con,o
108,S0211-69952012000100014,una,o
108,S0211-69952012000100014,menor,o
108,S0211-69952012000100014,incidencia,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,los,o
108,S0211-69952012000100014,episodios,o
108,S0211-69952012000100014,de,o
108,S0211-69952012000100014,hipotension,i
108,S0211-69952012000100014,intradialitica,i
108,S0211-69952012000100014,durante,o
108,S0211-69952012000100014,la,o
108,S0211-69952012000100014,hemodialisis,i
109,S0211-69952012000200010,Efectos,o
109,S0211-69952012000200010,renoprotectores,o
109,S0211-69952012000200010,a,o
109,S0211-69952012000200010,largo,o
109,S0211-69952012000200010,plazo,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,dosis,o
109,S0211-69952012000200010,altas,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,irbesartan,i
109,S0211-69952012000200010,en,o
109,S0211-69952012000200010,la,o
109,S0211-69952012000200010,nefropatia,i
109,S0211-69952012000200010,diabetica,i
109,S0211-69952012000200010,establecida,o
109,S0211-69952012000200010,Antecedentes,o
109,S0211-69952012000200010,Hipoteticamente,o
109,S0211-69952012000200010,la,o
109,S0211-69952012000200010,utilizacion,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,dosis,o
109,S0211-69952012000200010,altas,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,antagonistas,i
109,S0211-69952012000200010,del,i
109,S0211-69952012000200010,receptor,i
109,S0211-69952012000200010,AT1,i
109,S0211-69952012000200010,de,i
109,S0211-69952012000200010,angiotensina,i
109,S0211-69952012000200010,II,i
109,S0211-69952012000200010,al,o
109,S0211-69952012000200010,bloquear,o
109,S0211-69952012000200010,mas,o
109,S0211-69952012000200010,el,o
109,S0211-69952012000200010,receptor,i
109,S0211-69952012000200010,AT1,i
109,S0211-69952012000200010,deberia,o
109,S0211-69952012000200010,producir,o
109,S0211-69952012000200010,mayores,o
109,S0211-69952012000200010,beneficios,o
109,S0211-69952012000200010,que,o
109,S0211-69952012000200010,el,o
109,S0211-69952012000200010,uso,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,dosis,o
109,S0211-69952012000200010,convencionales,o
109,S0211-69952012000200010,Objetivo,o
109,S0211-69952012000200010,Evaluar,o
109,S0211-69952012000200010,los,o
109,S0211-69952012000200010,efectos,o
109,S0211-69952012000200010,sobre,o
109,S0211-69952012000200010,proteinuria,i
109,S0211-69952012000200010,y,o
109,S0211-69952012000200010,funcion,o
109,S0211-69952012000200010,renal,i
109,S0211-69952012000200010,con,o
109,S0211-69952012000200010,dosis,o
109,S0211-69952012000200010,ultraaltas,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,irbesartan,i
109,S0211-69952012000200010,en,o
109,S0211-69952012000200010,la,o
109,S0211-69952012000200010,nefropatia,i
109,S0211-69952012000200010,diabetica,i
109,S0211-69952012000200010,establecida,o
109,S0211-69952012000200010,Material,o
109,S0211-69952012000200010,y,o
109,S0211-69952012000200010,metodo,o
109,S0211-69952012000200010,Estudio,i
109,S0211-69952012000200010,prospectivo,i
109,S0211-69952012000200010,de,i
109,S0211-69952012000200010,intervencion,i
109,S0211-69952012000200010,no,i
109,S0211-69952012000200010,controlado,i
109,S0211-69952012000200010,ni,i
109,S0211-69952012000200010,aleatorizado,i
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,3,o
109,S0211-69952012000200010,años,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,seguimiento,i
109,S0211-69952012000200010,utilizando,o
109,S0211-69952012000200010,un,o
109,S0211-69952012000200010,tratamiento,i
109,S0211-69952012000200010,multifactorial,i
109,S0211-69952012000200010,basado,o
109,S0211-69952012000200010,en,o
109,S0211-69952012000200010,600,o
109,S0211-69952012000200010,mg,o
109,S0211-69952012000200010,diarios,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,irbesartan,i
109,S0211-69952012000200010,Se,o
109,S0211-69952012000200010,analizan,o
109,S0211-69952012000200010,variables,o
109,S0211-69952012000200010,demograficas,o
109,S0211-69952012000200010,antropometricas,i
109,S0211-69952012000200010,y,o
109,S0211-69952012000200010,analiticas,i
109,S0211-69952012000200010,al,o
109,S0211-69952012000200010,inicio,o
109,S0211-69952012000200010,y,o
109,S0211-69952012000200010,final,o
109,S0211-69952012000200010,del,o
109,S0211-69952012000200010,estudio,o
109,S0211-69952012000200010,Se,o
109,S0211-69952012000200010,incluyeron,o
109,S0211-69952012000200010,40,o
109,S0211-69952012000200010,pacientes,o
109,S0211-69952012000200010,75,o
109,S0211-69952012000200010,con,o
109,S0211-69952012000200010,diabetes,i
109,S0211-69952012000200010,tipo,i
109,S0211-69952012000200010,2,i
109,S0211-69952012000200010,con,o
109,S0211-69952012000200010,promedio,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,edad,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,571,o
109,S0211-69952012000200010,10,o
109,S0211-69952012000200010,años,o
109,S0211-69952012000200010,29,o
109,S0211-69952012000200010,725,o
109,S0211-69952012000200010,hombres,o
109,S0211-69952012000200010,con,o
109,S0211-69952012000200010,indice,i
109,S0211-69952012000200010,de,i
109,S0211-69952012000200010,masa,i
109,S0211-69952012000200010,corporal,i
109,S0211-69952012000200010,IMC,i
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,307,o
109,S0211-69952012000200010,5,o
109,S0211-69952012000200010,kgm2,o
109,S0211-69952012000200010,Resultados,o
109,S0211-69952012000200010,La,o
109,S0211-69952012000200010,presion,i
109,S0211-69952012000200010,arterial,i
109,S0211-69952012000200010,sistolica,i
109,S0211-69952012000200010,1576,o
109,S0211-69952012000200010,27,o
109,S0211-69952012000200010,vs,o
109,S0211-69952012000200010,1301,o
109,S0211-69952012000200010,14,o
109,S0211-69952012000200010,y,o
109,S0211-69952012000200010,diastolica,o
109,S0211-69952012000200010,888,o
109,S0211-69952012000200010,10,o
109,S0211-69952012000200010,vs,o
109,S0211-69952012000200010,762,o
109,S0211-69952012000200010,8,o
109,S0211-69952012000200010,mmHg,o
109,S0211-69952012000200010,se,o
109,S0211-69952012000200010,redujeron,o
109,S0211-69952012000200010,significativamente,o
109,S0211-69952012000200010,p,o
109,S0211-69952012000200010,0001,o
109,S0211-69952012000200010,al,o
109,S0211-69952012000200010,final,o
109,S0211-69952012000200010,del,o
109,S0211-69952012000200010,estudio,o
109,S0211-69952012000200010,El,o
109,S0211-69952012000200010,perfil,i
109,S0211-69952012000200010,lipidico,i
109,S0211-69952012000200010,mejoro,o
109,S0211-69952012000200010,significativamente,o
109,S0211-69952012000200010,La,o
109,S0211-69952012000200010,kaliemia,i
109,S0211-69952012000200010,no,o
109,S0211-69952012000200010,se,o
109,S0211-69952012000200010,modifico,o
109,S0211-69952012000200010,La,o
109,S0211-69952012000200010,creatinina,i
109,S0211-69952012000200010,solo,o
109,S0211-69952012000200010,aumento,o
109,S0211-69952012000200010,017,o
109,S0211-69952012000200010,mgdl,o
109,S0211-69952012000200010,aunque,o
109,S0211-69952012000200010,fue,o
109,S0211-69952012000200010,significativo,o
109,S0211-69952012000200010,p,o
109,S0211-69952012000200010,005,o
109,S0211-69952012000200010,y,o
109,S0211-69952012000200010,el,o
109,S0211-69952012000200010,filtrado,i
109,S0211-69952012000200010,glomerular,i
109,S0211-69952012000200010,estimado,i
109,S0211-69952012000200010,se,o
109,S0211-69952012000200010,redujo,o
109,S0211-69952012000200010,698,o
109,S0211-69952012000200010,297,o
109,S0211-69952012000200010,vs,o
109,S0211-69952012000200010,6025,o
109,S0211-69952012000200010,230,o
109,S0211-69952012000200010,mlminm2,o
109,S0211-69952012000200010,p,o
109,S0211-69952012000200010,005,o
109,S0211-69952012000200010,La,o
109,S0211-69952012000200010,proteinuria,i
109,S0211-69952012000200010,se,o
109,S0211-69952012000200010,redujo,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,24,o
109,S0211-69952012000200010,199,o
109,S0211-69952012000200010,a,o
109,S0211-69952012000200010,098,o
109,S0211-69952012000200010,118,o
109,S0211-69952012000200010,g24,o
109,S0211-69952012000200010,h,o
109,S0211-69952012000200010,p,o
109,S0211-69952012000200010,0001,o
109,S0211-69952012000200010,La,o
109,S0211-69952012000200010,reduccion,o
109,S0211-69952012000200010,promedio,o
109,S0211-69952012000200010,fue,o
109,S0211-69952012000200010,592,o
109,S0211-69952012000200010,y,o
109,S0211-69952012000200010,el,o
109,S0211-69952012000200010,25,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,los,o
109,S0211-69952012000200010,pacientes,o
109,S0211-69952012000200010,se,o
109,S0211-69952012000200010,hizo,o
109,S0211-69952012000200010,normoalbuminurico,o
109,S0211-69952012000200010,Salvo,o
109,S0211-69952012000200010,IMC,i
109,S0211-69952012000200010,y,o
109,S0211-69952012000200010,hemoglobina,i
109,S0211-69952012000200010,glucosilada,i
109,S0211-69952012000200010,todos,o
109,S0211-69952012000200010,los,o
109,S0211-69952012000200010,objetivos,o
109,S0211-69952012000200010,recomendados,o
109,S0211-69952012000200010,por,o
109,S0211-69952012000200010,la,o
109,S0211-69952012000200010,American,o
109,S0211-69952012000200010,Diabetes,o
109,S0211-69952012000200010,Association,o
109,S0211-69952012000200010,se,o
109,S0211-69952012000200010,alcanzaron,o
109,S0211-69952012000200010,Ningun,o
109,S0211-69952012000200010,paciente,o
109,S0211-69952012000200010,abandono,o
109,S0211-69952012000200010,el,o
109,S0211-69952012000200010,estudio,o
109,S0211-69952012000200010,por,o
109,S0211-69952012000200010,efectos,i
109,S0211-69952012000200010,secundarios,i
109,S0211-69952012000200010,Conclusion,o
109,S0211-69952012000200010,El,o
109,S0211-69952012000200010,tratamiento,i
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,la,o
109,S0211-69952012000200010,nefropatia,i
109,S0211-69952012000200010,diabetica,i
109,S0211-69952012000200010,establecida,o
109,S0211-69952012000200010,con,o
109,S0211-69952012000200010,dosis,o
109,S0211-69952012000200010,ultraaltas,o
109,S0211-69952012000200010,de,o
109,S0211-69952012000200010,irbesartan,i
109,S0211-69952012000200010,se,o
109,S0211-69952012000200010,mostro,o
109,S0211-69952012000200010,muy,o
109,S0211-69952012000200010,eficaz,o
109,S0211-69952012000200010,y,o
109,S0211-69952012000200010,seguro,o
109,S0211-69952012000200010,en,o
109,S0211-69952012000200010,reducir,o
109,S0211-69952012000200010,la,o
109,S0211-69952012000200010,proteinuria,i
109,S0211-69952012000200010,y,o
109,S0211-69952012000200010,retardar,o
109,S0211-69952012000200010,la,o
109,S0211-69952012000200010,progresion,o
109,S0211-69952012000200010,hacia,o
109,S0211-69952012000200010,la,o
109,S0211-69952012000200010,insuficiencia,i
109,S0211-69952012000200010,renal,i
109,S0211-69952012000200010,cronica,i
109,S0211-69952012000200010,terminal,i
110,S0211-69952012000500008,Uso,o
110,S0211-69952012000500008,del,o
110,S0211-69952012000500008,sirolimus,i
110,S0211-69952012000500008,en,o
110,S0211-69952012000500008,pacientes,o
110,S0211-69952012000500008,con,o
110,S0211-69952012000500008,sindrome,i
110,S0211-69952012000500008,nefrotico,i
110,S0211-69952012000500008,corticoresistente,o
110,S0211-69952012000500008,primario,o
110,S0211-69952012000500008,La,o
110,S0211-69952012000500008,persistencia,o
110,S0211-69952012000500008,de,o
110,S0211-69952012000500008,la,o
110,S0211-69952012000500008,proteinuria,i
110,S0211-69952012000500008,nefrotica,i
110,S0211-69952012000500008,favorece,o
110,S0211-69952012000500008,la,o
110,S0211-69952012000500008,progresion,o
110,S0211-69952012000500008,hacia,o
110,S0211-69952012000500008,la,o
110,S0211-69952012000500008,insuficiencia,i
110,S0211-69952012000500008,renal,i
110,S0211-69952012000500008,Hemos,o
110,S0211-69952012000500008,diseñado,o
110,S0211-69952012000500008,un,o
110,S0211-69952012000500008,protocolo,i
110,S0211-69952012000500008,terapeutico,i
110,S0211-69952012000500008,con,o
110,S0211-69952012000500008,sirolimus,i
110,S0211-69952012000500008,para,o
110,S0211-69952012000500008,ese,o
110,S0211-69952012000500008,grupo,o
110,S0211-69952012000500008,de,o
110,S0211-69952012000500008,pacientes,o
110,S0211-69952012000500008,implementando,o
110,S0211-69952012000500008,un,o
110,S0211-69952012000500008,estudio,o
110,S0211-69952012000500008,clinico,o
110,S0211-69952012000500008,prospectivo,o
110,S0211-69952012000500008,intervencionista,o
110,S0211-69952012000500008,y,o
110,S0211-69952012000500008,no,o
110,S0211-69952012000500008,aleatorizado,o
110,S0211-69952012000500008,sobre,o
110,S0211-69952012000500008,una,o
110,S0211-69952012000500008,cohorte,o
110,S0211-69952012000500008,de,o
110,S0211-69952012000500008,13,o
110,S0211-69952012000500008,pacientes,o
110,S0211-69952012000500008,con,o
110,S0211-69952012000500008,una,o
110,S0211-69952012000500008,edad,o
110,S0211-69952012000500008,media,o
110,S0211-69952012000500008,de,o
110,S0211-69952012000500008,10,o
110,S0211-69952012000500008,años,o
110,S0211-69952012000500008,todos,o
110,S0211-69952012000500008,con,o
110,S0211-69952012000500008,sindrome,i
110,S0211-69952012000500008,nefrotico,i
110,S0211-69952012000500008,corticoresistente,o
110,S0211-69952012000500008,primario,o
110,S0211-69952012000500008,y,o
110,S0211-69952012000500008,glomerulosclerosis,i
110,S0211-69952012000500008,focal,i
110,S0211-69952012000500008,y,i
110,S0211-69952012000500008,segmentaria,i
110,S0211-69952012000500008,resistentes,o
110,S0211-69952012000500008,tambien,o
110,S0211-69952012000500008,a,o
110,S0211-69952012000500008,la,o
110,S0211-69952012000500008,ciclofosfamida,i
110,S0211-69952012000500008,a,o
110,S0211-69952012000500008,los,o
110,S0211-69952012000500008,inhibidores,i
110,S0211-69952012000500008,de,i
110,S0211-69952012000500008,la,i
110,S0211-69952012000500008,calcineurina,i
110,S0211-69952012000500008,y,o
110,S0211-69952012000500008,al,o
110,S0211-69952012000500008,empleo,o
110,S0211-69952012000500008,de,o
110,S0211-69952012000500008,enalapril,i
110,S0211-69952012000500008,y,o
110,S0211-69952012000500008,losartan,i
110,S0211-69952012000500008,La,o
110,S0211-69952012000500008,dosis,o
110,S0211-69952012000500008,media,o
110,S0211-69952012000500008,empleada,o
110,S0211-69952012000500008,de,o
110,S0211-69952012000500008,sirolimus,i
110,S0211-69952012000500008,fue,o
110,S0211-69952012000500008,de,o
110,S0211-69952012000500008,36,o
110,S0211-69952012000500008,mgm2dia,o
110,S0211-69952012000500008,y,o
110,S0211-69952012000500008,el,o
110,S0211-69952012000500008,tratamiento,i
110,S0211-69952012000500008,duro,o
110,S0211-69952012000500008,12,o
110,S0211-69952012000500008,meses,o
110,S0211-69952012000500008,Evaluamos,i
110,S0211-69952012000500008,la,i
110,S0211-69952012000500008,eficacia,i
110,S0211-69952012000500008,terapeutica,i
110,S0211-69952012000500008,acorde,o
110,S0211-69952012000500008,a,o
110,S0211-69952012000500008,la,o
110,S0211-69952012000500008,reduccion,o
110,S0211-69952012000500008,de,o
110,S0211-69952012000500008,la,o
110,S0211-69952012000500008,proteinuria,i
110,S0211-69952012000500008,respuesta,o
110,S0211-69952012000500008,total,o
110,S0211-69952012000500008,parcial,o
110,S0211-69952012000500008,y,o
110,S0211-69952012000500008,ausente,o
110,S0211-69952012000500008,y,o
110,S0211-69952012000500008,tambien,o
110,S0211-69952012000500008,fueron,o
110,S0211-69952012000500008,evaluadas,o
110,S0211-69952012000500008,la,o
110,S0211-69952012000500008,severidad,o
110,S0211-69952012000500008,del,o
110,S0211-69952012000500008,daño,i
110,S0211-69952012000500008,histologico,i
110,S0211-69952012000500008,pretratamiento,o
110,S0211-69952012000500008,y,o
110,S0211-69952012000500008,el,o
110,S0211-69952012000500008,tiempo,o
110,S0211-69952012000500008,previo,o
110,S0211-69952012000500008,transcurrido,o
110,S0211-69952012000500008,hasta,o
110,S0211-69952012000500008,recibir,o
110,S0211-69952012000500008,el,o
110,S0211-69952012000500008,sirolimus,i
110,S0211-69952012000500008,Nueve,o
110,S0211-69952012000500008,de,o
110,S0211-69952012000500008,los,o
110,S0211-69952012000500008,trece,o
110,S0211-69952012000500008,pacientes,o
110,S0211-69952012000500008,tuvieron,o
110,S0211-69952012000500008,remision,o
110,S0211-69952012000500008,parcial,o
110,S0211-69952012000500008,o,o
110,S0211-69952012000500008,total,o
110,S0211-69952012000500008,del,o
110,S0211-69952012000500008,sindrome,i
110,S0211-69952012000500008,nefrotico,i
110,S0211-69952012000500008,y,o
110,S0211-69952012000500008,el,o
110,S0211-69952012000500008,tiempo,o
110,S0211-69952012000500008,medio,o
110,S0211-69952012000500008,previo,o
110,S0211-69952012000500008,transcurrido,o
110,S0211-69952012000500008,y,o
110,S0211-69952012000500008,la,o
110,S0211-69952012000500008,severidad,o
110,S0211-69952012000500008,del,o
110,S0211-69952012000500008,daño,i
110,S0211-69952012000500008,histologico,i
110,S0211-69952012000500008,influyeron,o
110,S0211-69952012000500008,en,o
110,S0211-69952012000500008,el,o
110,S0211-69952012000500008,tipo,o
110,S0211-69952012000500008,de,o
110,S0211-69952012000500008,respuesta,o
110,S0211-69952012000500008,Consideramos,o
110,S0211-69952012000500008,que,o
110,S0211-69952012000500008,el,o
110,S0211-69952012000500008,sirolimus,i
110,S0211-69952012000500008,es,o
110,S0211-69952012000500008,una,o
110,S0211-69952012000500008,opcion,o
110,S0211-69952012000500008,valida,o
110,S0211-69952012000500008,de,o
110,S0211-69952012000500008,tratamiento,i
110,S0211-69952012000500008,para,o
110,S0211-69952012000500008,los,o
110,S0211-69952012000500008,pacientes,o
110,S0211-69952012000500008,con,o
110,S0211-69952012000500008,sindrome,i
110,S0211-69952012000500008,nefrotico,i
110,S0211-69952012000500008,corticoresistente,o
110,S0211-69952012000500008,aunque,o
110,S0211-69952012000500008,probablemente,o
110,S0211-69952012000500008,sea,o
110,S0211-69952012000500008,necesario,o
110,S0211-69952012000500008,un,o
110,S0211-69952012000500008,inicio,o
110,S0211-69952012000500008,terapeutico,o
110,S0211-69952012000500008,mas,o
110,S0211-69952012000500008,precoz,o
111,S0211-69952012000500009,Tratamiento,i
111,S0211-69952012000500009,eficaz,o
111,S0211-69952012000500009,de,o
111,S0211-69952012000500009,la,o
111,S0211-69952012000500009,arteriolopatia,i
111,S0211-69952012000500009,uremica,i
111,S0211-69952012000500009,calcificante,i
111,S0211-69952012000500009,con,o
111,S0211-69952012000500009,bifosfonatos,i
111,S0211-69952012000500009,Antecedentes,o
111,S0211-69952012000500009,y,o
111,S0211-69952012000500009,objetivos,o
111,S0211-69952012000500009,La,o
111,S0211-69952012000500009,arteriolopatia,i
111,S0211-69952012000500009,uremica,i
111,S0211-69952012000500009,calcificante,i
111,S0211-69952012000500009,CUA,i
111,S0211-69952012000500009,o,o
111,S0211-69952012000500009,calcifilaxis,i
111,S0211-69952012000500009,es,o
111,S0211-69952012000500009,una,o
111,S0211-69952012000500009,enfermedad,i
111,S0211-69952012000500009,rara,i
111,S0211-69952012000500009,pero,o
111,S0211-69952012000500009,potencialmente,o
111,S0211-69952012000500009,mortal,o
111,S0211-69952012000500009,que,o
111,S0211-69952012000500009,afecta,o
111,S0211-69952012000500009,casi,o
111,S0211-69952012000500009,exclusivamente,o
111,S0211-69952012000500009,a,o
111,S0211-69952012000500009,pacientes,o
111,S0211-69952012000500009,con,o
111,S0211-69952012000500009,enfermedad,i
111,S0211-69952012000500009,renal,i
111,S0211-69952012000500009,cronica,i
111,S0211-69952012000500009,Para,o
111,S0211-69952012000500009,su,o
111,S0211-69952012000500009,tratamiento,i
111,S0211-69952012000500009,se,o
111,S0211-69952012000500009,han,o
111,S0211-69952012000500009,empleado,o
111,S0211-69952012000500009,diferentes,o
111,S0211-69952012000500009,alternativas,o
111,S0211-69952012000500009,con,o
111,S0211-69952012000500009,resultados,o
111,S0211-69952012000500009,irregulares,o
111,S0211-69952012000500009,siendo,o
111,S0211-69952012000500009,los,o
111,S0211-69952012000500009,bifosfonatos,i
111,S0211-69952012000500009,una,o
111,S0211-69952012000500009,de,o
111,S0211-69952012000500009,ellas,o
111,S0211-69952012000500009,Desde,o
111,S0211-69952012000500009,2002,o
111,S0211-69952012000500009,iniciamos,o
111,S0211-69952012000500009,en,o
111,S0211-69952012000500009,nuestra,o
111,S0211-69952012000500009,Unidad,o
111,S0211-69952012000500009,el,o
111,S0211-69952012000500009,tratamiento,i
111,S0211-69952012000500009,con,o
111,S0211-69952012000500009,bifosfonatos,i
111,S0211-69952012000500009,en,o
111,S0211-69952012000500009,todos,o
111,S0211-69952012000500009,los,o
111,S0211-69952012000500009,pacientes,o
111,S0211-69952012000500009,con,o
111,S0211-69952012000500009,diagnostico,i
111,S0211-69952012000500009,de,o
111,S0211-69952012000500009,CUA,i
111,S0211-69952012000500009,Material,o
111,S0211-69952012000500009,y,o
111,S0211-69952012000500009,metodos,o
111,S0211-69952012000500009,Se,o
111,S0211-69952012000500009,recogieron,o
111,S0211-69952012000500009,prospectivamente,o
111,S0211-69952012000500009,entre,o
111,S0211-69952012000500009,2002,o
111,S0211-69952012000500009,y,o
111,S0211-69952012000500009,2010,o
111,S0211-69952012000500009,ocho,o
111,S0211-69952012000500009,pacientes,o
111,S0211-69952012000500009,cuatro,o
111,S0211-69952012000500009,hombres,o
111,S0211-69952012000500009,cinco,o
111,S0211-69952012000500009,en,o
111,S0211-69952012000500009,dialisis,i
111,S0211-69952012000500009,y,o
111,S0211-69952012000500009,tres,o
111,S0211-69952012000500009,con,o
111,S0211-69952012000500009,trasplante,i
111,S0211-69952012000500009,renal,i
111,S0211-69952012000500009,funcionante,o
111,S0211-69952012000500009,con,o
111,S0211-69952012000500009,CUA,i
111,S0211-69952012000500009,tratados,i
111,S0211-69952012000500009,con,o
111,S0211-69952012000500009,bifosfonatos,i
111,S0211-69952012000500009,El,o
111,S0211-69952012000500009,diagnostico,i
111,S0211-69952012000500009,se,o
111,S0211-69952012000500009,realizo,o
111,S0211-69952012000500009,por,o
111,S0211-69952012000500009,sospecha,o
111,S0211-69952012000500009,clinica,o
111,S0211-69952012000500009,y,o
111,S0211-69952012000500009,biopsia,i
111,S0211-69952012000500009,de,o
111,S0211-69952012000500009,confirmacion,o
111,S0211-69952012000500009,Cinco,o
111,S0211-69952012000500009,pacientes,o
111,S0211-69952012000500009,con,o
111,S0211-69952012000500009,antecedentes,o
111,S0211-69952012000500009,de,o
111,S0211-69952012000500009,producto,o
111,S0211-69952012000500009,calciofosforo,o
111,S0211-69952012000500009,elevado,o
111,S0211-69952012000500009,seis,o
111,S0211-69952012000500009,con,o
111,S0211-69952012000500009,antecedentes,o
111,S0211-69952012000500009,de,o
111,S0211-69952012000500009,hormona,i
111,S0211-69952012000500009,paratiroidea,i
111,S0211-69952012000500009,elevada,o
111,S0211-69952012000500009,800,o
111,S0211-69952012000500009,pgml,o
111,S0211-69952012000500009,cuatro,o
111,S0211-69952012000500009,paratiroidectomizados,i
111,S0211-69952012000500009,cinco,o
111,S0211-69952012000500009,con,o
111,S0211-69952012000500009,elevada,o
111,S0211-69952012000500009,dosis,o
111,S0211-69952012000500009,acumulada,o
111,S0211-69952012000500009,de,o
111,S0211-69952012000500009,esteroides,i
111,S0211-69952012000500009,y,o
111,S0211-69952012000500009,seis,o
111,S0211-69952012000500009,recibiendo,o
111,S0211-69952012000500009,dicumarinicos,i
111,S0211-69952012000500009,Ningun,o
111,S0211-69952012000500009,paciente,o
111,S0211-69952012000500009,presentaba,o
111,S0211-69952012000500009,obesidad,i
111,S0211-69952012000500009,ni,o
111,S0211-69952012000500009,diabetes,i
111,S0211-69952012000500009,mellitus,i
111,S0211-69952012000500009,Resultados,o
111,S0211-69952012000500009,En,o
111,S0211-69952012000500009,todos,o
111,S0211-69952012000500009,los,o
111,S0211-69952012000500009,casos,o
111,S0211-69952012000500009,se,o
111,S0211-69952012000500009,constato,o
111,S0211-69952012000500009,disminucion,o
111,S0211-69952012000500009,de,o
111,S0211-69952012000500009,sintomatologia,i
111,S0211-69952012000500009,dolor,i
111,S0211-69952012000500009,a,o
111,S0211-69952012000500009,los,o
111,S0211-69952012000500009,pocos,o
111,S0211-69952012000500009,dias,o
111,S0211-69952012000500009,y,o
111,S0211-69952012000500009,regresion,o
111,S0211-69952012000500009,de,o
111,S0211-69952012000500009,las,o
111,S0211-69952012000500009,lesiones,i
111,S0211-69952012000500009,entre,o
111,S0211-69952012000500009,2,o
111,S0211-69952012000500009,a,o
111,S0211-69952012000500009,4,o
111,S0211-69952012000500009,semanas,o
111,S0211-69952012000500009,tras,o
111,S0211-69952012000500009,iniciar,o
111,S0211-69952012000500009,los,o
111,S0211-69952012000500009,bifosfonatos,i
111,S0211-69952012000500009,sin,o
111,S0211-69952012000500009,cambios,o
111,S0211-69952012000500009,en,o
111,S0211-69952012000500009,los,o
111,S0211-69952012000500009,valores,i
111,S0211-69952012000500009,sericos,i
111,S0211-69952012000500009,de,i
111,S0211-69952012000500009,calcio,i
111,S0211-69952012000500009,y,o
111,S0211-69952012000500009,fosforo,i
111,S0211-69952012000500009,La,o
111,S0211-69952012000500009,mejoria,o
111,S0211-69952012000500009,fue,o
111,S0211-69952012000500009,mas,o
111,S0211-69952012000500009,rapida,o
111,S0211-69952012000500009,en,o
111,S0211-69952012000500009,los,o
111,S0211-69952012000500009,que,o
111,S0211-69952012000500009,recibieron,o
111,S0211-69952012000500009,ibandronato,i
111,S0211-69952012000500009,intravenoso,o
111,S0211-69952012000500009,Todos,o
111,S0211-69952012000500009,se,o
111,S0211-69952012000500009,mantuvieron,o
111,S0211-69952012000500009,en,o
111,S0211-69952012000500009,tratamiento,i
111,S0211-69952012000500009,con,o
111,S0211-69952012000500009,bifosfonatos,i
111,S0211-69952012000500009,durante,o
111,S0211-69952012000500009,al,o
111,S0211-69952012000500009,menos,o
111,S0211-69952012000500009,6,o
111,S0211-69952012000500009,meses,o
111,S0211-69952012000500009,hasta,o
111,S0211-69952012000500009,que,o
111,S0211-69952012000500009,las,o
111,S0211-69952012000500009,heridas,i
111,S0211-69952012000500009,se,o
111,S0211-69952012000500009,curaron,o
111,S0211-69952012000500009,completamente,o
111,S0211-69952012000500009,No,o
111,S0211-69952012000500009,se,o
111,S0211-69952012000500009,han,o
111,S0211-69952012000500009,observado,o
111,S0211-69952012000500009,recurrencias,o
111,S0211-69952012000500009,tras,o
111,S0211-69952012000500009,un,o
111,S0211-69952012000500009,seguimiento,i
111,S0211-69952012000500009,de,o
111,S0211-69952012000500009,entre,o
111,S0211-69952012000500009,1,o
111,S0211-69952012000500009,y,o
111,S0211-69952012000500009,9,o
111,S0211-69952012000500009,años,o
111,S0211-69952012000500009,La,o
111,S0211-69952012000500009,funcion,o
111,S0211-69952012000500009,renal,i
111,S0211-69952012000500009,se,o
111,S0211-69952012000500009,mantuvo,o
111,S0211-69952012000500009,estable,o
111,S0211-69952012000500009,en,o
111,S0211-69952012000500009,los,o
111,S0211-69952012000500009,pacientes,o
111,S0211-69952012000500009,trasplantados,i
111,S0211-69952012000500009,El,o
111,S0211-69952012000500009,tratamiento,i
111,S0211-69952012000500009,fue,o
111,S0211-69952012000500009,bien,o
111,S0211-69952012000500009,tolerado,o
111,S0211-69952012000500009,y,o
111,S0211-69952012000500009,no,o
111,S0211-69952012000500009,se,o
111,S0211-69952012000500009,observaron,o
111,S0211-69952012000500009,efectos,i
111,S0211-69952012000500009,adversos,i
111,S0211-69952012000500009,Conclusiones,o
111,S0211-69952012000500009,Los,o
111,S0211-69952012000500009,bifosfonatos,i
111,S0211-69952012000500009,podrian,o
111,S0211-69952012000500009,constituir,o
111,S0211-69952012000500009,una,o
111,S0211-69952012000500009,alternativa,o
111,S0211-69952012000500009,nueva,o
111,S0211-69952012000500009,y,o
111,S0211-69952012000500009,atractiva,o
111,S0211-69952012000500009,para,o
111,S0211-69952012000500009,el,o
111,S0211-69952012000500009,tratamiento,i
111,S0211-69952012000500009,de,o
111,S0211-69952012000500009,la,o
111,S0211-69952012000500009,CUA,i
112,S0211-69952012000500022,Microalbuminuria,i
112,S0211-69952012000500022,otro,o
112,S0211-69952012000500022,uso,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,paricalcitol,i
112,S0211-69952012000500022,Nuestra,o
112,S0211-69952012000500022,experiencia,o
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,enfermedad,i
112,S0211-69952012000500022,renal,i
112,S0211-69952012000500022,cronica,i
112,S0211-69952012000500022,avanzada,o
112,S0211-69952012000500022,La,o
112,S0211-69952012000500022,presencia,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,albuminuria,i
112,S0211-69952012000500022,aumenta,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,riesgo,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,progresion,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,insuficiencia,i
112,S0211-69952012000500022,renal,i
112,S0211-69952012000500022,IR,i
112,S0211-69952012000500022,incluso,o
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,estadios,o
112,S0211-69952012000500022,avanzados,o
112,S0211-69952012000500022,Los,o
112,S0211-69952012000500022,inhibidores,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,sistema,o
112,S0211-69952012000500022,reninaangiotensinaaldosterona,o
112,S0211-69952012000500022,SRAA,i
112,S0211-69952012000500022,constituyen,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,principal,o
112,S0211-69952012000500022,herramienta,o
112,S0211-69952012000500022,disponible,o
112,S0211-69952012000500022,para,o
112,S0211-69952012000500022,disminuir,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,albuminuria,i
112,S0211-69952012000500022,y,o
112,S0211-69952012000500022,frenar,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,progresion,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,IR,i
112,S0211-69952012000500022,aunque,o
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,muchas,o
112,S0211-69952012000500022,ocasiones,o
112,S0211-69952012000500022,sean,o
112,S0211-69952012000500022,insuficientes,o
112,S0211-69952012000500022,Recientemente,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,paricalcitol,i
112,S0211-69952012000500022,ha,o
112,S0211-69952012000500022,demostrado,o
112,S0211-69952012000500022,ser,o
112,S0211-69952012000500022,capaz,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,reducir,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,albuminuria,i
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,ciertos,o
112,S0211-69952012000500022,grupos,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,pacientes,o
112,S0211-69952012000500022,El,o
112,S0211-69952012000500022,objetivo,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,este,o
112,S0211-69952012000500022,estudio,o
112,S0211-69952012000500022,fue,o
112,S0211-69952012000500022,determinar,i
112,S0211-69952012000500022,la,i
112,S0211-69952012000500022,utilidad,i
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,paricalcitol,i
112,S0211-69952012000500022,para,o
112,S0211-69952012000500022,reducir,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,albuminuria,i
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,pacientes,o
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,IR,i
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,grado,o
112,S0211-69952012000500022,45,o
112,S0211-69952012000500022,Metodos,o
112,S0211-69952012000500022,Se,o
112,S0211-69952012000500022,incluyeron,o
112,S0211-69952012000500022,todos,o
112,S0211-69952012000500022,los,o
112,S0211-69952012000500022,pacientes,o
112,S0211-69952012000500022,remitidos,o
112,S0211-69952012000500022,a,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,consulta,i
112,S0211-69952012000500022,predialisis,o
112,S0211-69952012000500022,Se,o
112,S0211-69952012000500022,les,o
112,S0211-69952012000500022,administro,o
112,S0211-69952012000500022,paricalcitol,i
112,S0211-69952012000500022,dosis,o
112,S0211-69952012000500022,inicial,o
112,S0211-69952012000500022,media,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,1,o
112,S0211-69952012000500022,03,o
112,S0211-69952012000500022,μgdia,o
112,S0211-69952012000500022,por,o
112,S0211-69952012000500022,via,o
112,S0211-69952012000500022,oral,o
112,S0211-69952012000500022,ajustada,o
112,S0211-69952012000500022,a,o
112,S0211-69952012000500022,parametros,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,metabolismo,o
112,S0211-69952012000500022,calciofosforo,o
112,S0211-69952012000500022,Se,o
112,S0211-69952012000500022,efectuo,o
112,S0211-69952012000500022,seguimiento,i
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,al,o
112,S0211-69952012000500022,menos,o
112,S0211-69952012000500022,6,o
112,S0211-69952012000500022,meses,o
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,3,o
112,S0211-69952012000500022,consultas,i
112,S0211-69952012000500022,cada,o
112,S0211-69952012000500022,2,o
112,S0211-69952012000500022,meses,o
112,S0211-69952012000500022,registrandose,o
112,S0211-69952012000500022,variables,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,metabolismo,o
112,S0211-69952012000500022,calciofosforo,o
112,S0211-69952012000500022,MDRD,i
112,S0211-69952012000500022,y,o
112,S0211-69952012000500022,albuminuria,i
112,S0211-69952012000500022,El,o
112,S0211-69952012000500022,tratamiento,i
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,inhibidores,i
112,S0211-69952012000500022,del,i
112,S0211-69952012000500022,SRAA,i
112,S0211-69952012000500022,e,o
112,S0211-69952012000500022,hidroferol,i
112,S0211-69952012000500022,se,o
112,S0211-69952012000500022,mantuvo,o
112,S0211-69952012000500022,sin,o
112,S0211-69952012000500022,cambios,o
112,S0211-69952012000500022,Estadistica,o
112,S0211-69952012000500022,se,o
112,S0211-69952012000500022,empleo,o
112,S0211-69952012000500022,analisis,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,varianza,o
112,S0211-69952012000500022,para,o
112,S0211-69952012000500022,comparacion,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,medias,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,variables,o
112,S0211-69952012000500022,cuantitativas,o
112,S0211-69952012000500022,test,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,Wilcoxon,o
112,S0211-69952012000500022,para,o
112,S0211-69952012000500022,comparacion,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,medianas,o
112,S0211-69952012000500022,y,o
112,S0211-69952012000500022,test,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,χ2,o
112,S0211-69952012000500022,para,o
112,S0211-69952012000500022,comparacion,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,porcentajes,o
112,S0211-69952012000500022,entre,o
112,S0211-69952012000500022,variables,o
112,S0211-69952012000500022,Resultados,o
112,S0211-69952012000500022,Se,o
112,S0211-69952012000500022,incluyeron,o
112,S0211-69952012000500022,40,o
112,S0211-69952012000500022,pacientes,o
112,S0211-69952012000500022,67,o
112,S0211-69952012000500022,varones,o
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,seguimiento,i
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,135235,o
112,S0211-69952012000500022,dias,o
112,S0211-69952012000500022,El,o
112,S0211-69952012000500022,975,o
112,S0211-69952012000500022,eran,o
112,S0211-69952012000500022,hipertensos,i
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,35,o
112,S0211-69952012000500022,diabeticos,i
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,MDRD,i
112,S0211-69952012000500022,basal,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,195,o
112,S0211-69952012000500022,3,o
112,S0211-69952012000500022,mlmin,o
112,S0211-69952012000500022,La,o
112,S0211-69952012000500022,excrecion,i
112,S0211-69952012000500022,urinaria,i
112,S0211-69952012000500022,media,i
112,S0211-69952012000500022,de,i
112,S0211-69952012000500022,albumina,i
112,S0211-69952012000500022,UACR,i
112,S0211-69952012000500022,fue,o
112,S0211-69952012000500022,1932,o
112,S0211-69952012000500022,1641,o
112,S0211-69952012000500022,mgg,o
112,S0211-69952012000500022,Los,o
112,S0211-69952012000500022,parametros,o
112,S0211-69952012000500022,iniciales,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,metabolismo,o
112,S0211-69952012000500022,calciofosforo,o
112,S0211-69952012000500022,fueron,o
112,S0211-69952012000500022,calcio,i
112,S0211-69952012000500022,88,o
112,S0211-69952012000500022,05,o
112,S0211-69952012000500022,mgdl,o
112,S0211-69952012000500022,fosforo,i
112,S0211-69952012000500022,45,o
112,S0211-69952012000500022,05,o
112,S0211-69952012000500022,y,o
112,S0211-69952012000500022,paratohormona,i
112,S0211-69952012000500022,intacta,i
112,S0211-69952012000500022,PTHi,i
112,S0211-69952012000500022,473,o
112,S0211-69952012000500022,143,o
112,S0211-69952012000500022,pgml,o
112,S0211-69952012000500022,Al,o
112,S0211-69952012000500022,inicio,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,seguimiento,i
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,25,o
112,S0211-69952012000500022,recibian,o
112,S0211-69952012000500022,inhibidores,i
112,S0211-69952012000500022,de,i
112,S0211-69952012000500022,la,i
112,S0211-69952012000500022,enzima,i
112,S0211-69952012000500022,conversora,i
112,S0211-69952012000500022,de,i
112,S0211-69952012000500022,angiotensina,i
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,425,o
112,S0211-69952012000500022,antagonistas,i
112,S0211-69952012000500022,de,i
112,S0211-69952012000500022,los,i
112,S0211-69952012000500022,receptores,i
112,S0211-69952012000500022,de,i
112,S0211-69952012000500022,angiotensina,i
112,S0211-69952012000500022,II,i
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,55,o
112,S0211-69952012000500022,hidroferol,i
112,S0211-69952012000500022,y,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,125,o
112,S0211-69952012000500022,calcitriol,i
112,S0211-69952012000500022,Durante,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,seguimiento,i
112,S0211-69952012000500022,se,o
112,S0211-69952012000500022,observo,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,descenso,o
112,S0211-69952012000500022,significativo,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,MDRD,i
112,S0211-69952012000500022,195,o
112,S0211-69952012000500022,3,o
112,S0211-69952012000500022,vs,o
112,S0211-69952012000500022,173,o
112,S0211-69952012000500022,34mlmin,o
112,S0211-69952012000500022,p,o
112,S0211-69952012000500022,0003,o
112,S0211-69952012000500022,Hubo,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,descenso,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,PTHi,i
112,S0211-69952012000500022,y,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,aumento,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,calcio,i
112,S0211-69952012000500022,ambos,o
112,S0211-69952012000500022,significativos,o
112,S0211-69952012000500022,473,o
112,S0211-69952012000500022,143,o
112,S0211-69952012000500022,vs,o
112,S0211-69952012000500022,197,o
112,S0211-69952012000500022,88,o
112,S0211-69952012000500022,pgml,o
112,S0211-69952012000500022,y,o
112,S0211-69952012000500022,884,o
112,S0211-69952012000500022,05,o
112,S0211-69952012000500022,vs,o
112,S0211-69952012000500022,9,o
112,S0211-69952012000500022,04,o
112,S0211-69952012000500022,mgdl,o
112,S0211-69952012000500022,p,o
112,S0211-69952012000500022,000,o
112,S0211-69952012000500022,y,o
112,S0211-69952012000500022,p,o
112,S0211-69952012000500022,001,o
112,S0211-69952012000500022,respectivamente,o
112,S0211-69952012000500022,Se,o
112,S0211-69952012000500022,demostro,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,aumento,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,fosforo,i
112,S0211-69952012000500022,que,o
112,S0211-69952012000500022,no,o
112,S0211-69952012000500022,alcanzo,o
112,S0211-69952012000500022,significacion,o
112,S0211-69952012000500022,estadistica,o
112,S0211-69952012000500022,45,o
112,S0211-69952012000500022,05,o
112,S0211-69952012000500022,vs,o
112,S0211-69952012000500022,48,o
112,S0211-69952012000500022,06,o
112,S0211-69952012000500022,mgdl,o
112,S0211-69952012000500022,p,o
112,S0211-69952012000500022,01,o
112,S0211-69952012000500022,La,o
112,S0211-69952012000500022,UACR,i
112,S0211-69952012000500022,disminuyo,o
112,S0211-69952012000500022,durante,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,estudio,o
112,S0211-69952012000500022,desde,o
112,S0211-69952012000500022,1932,o
112,S0211-69952012000500022,1641,o
112,S0211-69952012000500022,mgg,o
112,S0211-69952012000500022,al,o
112,S0211-69952012000500022,inicio,o
112,S0211-69952012000500022,hasta,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,valor,o
112,S0211-69952012000500022,medio,o
112,S0211-69952012000500022,final,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,1417,o
112,S0211-69952012000500022,1284,o
112,S0211-69952012000500022,mgg,o
112,S0211-69952012000500022,que,o
112,S0211-69952012000500022,supone,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,descenso,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,27,o
112,S0211-69952012000500022,p,o
112,S0211-69952012000500022,01,o
112,S0211-69952012000500022,En,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,grupo,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,pacientes,o
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,mayor,o
112,S0211-69952012000500022,UACR,i
112,S0211-69952012000500022,al,o
112,S0211-69952012000500022,inicio,o
112,S0211-69952012000500022,3000,o
112,S0211-69952012000500022,mgg,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,descenso,o
112,S0211-69952012000500022,fue,o
112,S0211-69952012000500022,significativo,o
112,S0211-69952012000500022,4258,o
112,S0211-69952012000500022,944,o
112,S0211-69952012000500022,vs,o
112,S0211-69952012000500022,2786,o
112,S0211-69952012000500022,1630,o
112,S0211-69952012000500022,p,o
112,S0211-69952012000500022,003,o
112,S0211-69952012000500022,Se,o
112,S0211-69952012000500022,observo,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,aumento,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,los,o
112,S0211-69952012000500022,pacientes,o
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,normalizacion,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,albuminuria,i
112,S0211-69952012000500022,y,o
112,S0211-69952012000500022,disminucion,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,aquellos,o
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,albuminurias,i
112,S0211-69952012000500022,mayores,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,3000,o
112,S0211-69952012000500022,mgg,o
112,S0211-69952012000500022,La,o
112,S0211-69952012000500022,UACR,i
112,S0211-69952012000500022,no,o
112,S0211-69952012000500022,se,o
112,S0211-69952012000500022,correlaciono,o
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,tratamiento,i
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,inhibidores,i
112,S0211-69952012000500022,del,i
112,S0211-69952012000500022,SRAA,i
112,S0211-69952012000500022,hidroferol,i
112,S0211-69952012000500022,ni,o
112,S0211-69952012000500022,calcitriol,i
112,S0211-69952012000500022,En,o
112,S0211-69952012000500022,ningun,o
112,S0211-69952012000500022,paciente,o
112,S0211-69952012000500022,fue,o
112,S0211-69952012000500022,necesario,o
112,S0211-69952012000500022,suspender,i
112,S0211-69952012000500022,el,i
112,S0211-69952012000500022,tratamiento,i
112,S0211-69952012000500022,por,o
112,S0211-69952012000500022,alteraciones,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,metabolismo,o
112,S0211-69952012000500022,calciofosforo,o
112,S0211-69952012000500022,o,o
112,S0211-69952012000500022,efectos,i
112,S0211-69952012000500022,secundarios,i
112,S0211-69952012000500022,aunque,o
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,17,o
112,S0211-69952012000500022,fue,o
112,S0211-69952012000500022,necesario,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,ajuste,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,dosis,o
112,S0211-69952012000500022,En,o
112,S0211-69952012000500022,este,o
112,S0211-69952012000500022,estudio,o
112,S0211-69952012000500022,se,o
112,S0211-69952012000500022,demuestra,o
112,S0211-69952012000500022,que,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,tratamiento,i
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,paricalcitol,i
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,este,o
112,S0211-69952012000500022,grupo,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,pacientes,o
112,S0211-69952012000500022,ademas,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,permitir,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,mejor,o
112,S0211-69952012000500022,control,i
112,S0211-69952012000500022,del,i
112,S0211-69952012000500022,metabolismo,i
112,S0211-69952012000500022,oseo,i
112,S0211-69952012000500022,se,o
112,S0211-69952012000500022,asocia,o
112,S0211-69952012000500022,a,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,descenso,o
112,S0211-69952012000500022,significativo,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,UACR,i
112,S0211-69952012000500022,lograndose,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,mayor,o
112,S0211-69952012000500022,numero,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,pacientes,o
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,normalizacion,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,excrecion,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,albumina,i
112,S0211-69952012000500022,El,o
112,S0211-69952012000500022,efecto,o
112,S0211-69952012000500022,fue,o
112,S0211-69952012000500022,mayor,o
112,S0211-69952012000500022,y,o
112,S0211-69952012000500022,significativo,o
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,los,o
112,S0211-69952012000500022,pacientes,o
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,mayor,o
112,S0211-69952012000500022,excrecion,o
112,S0211-69952012000500022,inicial,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,albumina,i
112,S0211-69952012000500022,que,o
112,S0211-69952012000500022,constituyen,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,grupo,o
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,mayor,o
112,S0211-69952012000500022,riesgo,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,progresion,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,IR,i
112,S0211-69952012000500022,El,o
112,S0211-69952012000500022,numero,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,pacientes,o
112,S0211-69952012000500022,puede,o
112,S0211-69952012000500022,haber,o
112,S0211-69952012000500022,resultado,o
112,S0211-69952012000500022,insuficiente,o
112,S0211-69952012000500022,para,o
112,S0211-69952012000500022,demostrar,o
112,S0211-69952012000500022,una,o
112,S0211-69952012000500022,mayor,o
112,S0211-69952012000500022,significacion,o
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,efecto,o
112,S0211-69952012000500022,antiproteinurico,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,tratamiento,i
112,S0211-69952012000500022,Por,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,mismo,o
112,S0211-69952012000500022,motivo,o
112,S0211-69952012000500022,posiblemente,o
112,S0211-69952012000500022,no,o
112,S0211-69952012000500022,se,o
112,S0211-69952012000500022,observo,o
112,S0211-69952012000500022,un,o
112,S0211-69952012000500022,control,o
112,S0211-69952012000500022,significativo,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,deterioro,i
112,S0211-69952012000500022,de,i
112,S0211-69952012000500022,funcion,i
112,S0211-69952012000500022,renal,i
112,S0211-69952012000500022,Aunque,o
112,S0211-69952012000500022,no,o
112,S0211-69952012000500022,ha,o
112,S0211-69952012000500022,sido,o
112,S0211-69952012000500022,objeto,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,este,o
112,S0211-69952012000500022,estudio,o
112,S0211-69952012000500022,debe,o
112,S0211-69952012000500022,tenerse,o
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,cuenta,o
112,S0211-69952012000500022,tambien,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,descenso,o
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,riesgo,i
112,S0211-69952012000500022,cardiovascular,i
112,S0211-69952012000500022,que,o
112,S0211-69952012000500022,se,o
112,S0211-69952012000500022,asocia,o
112,S0211-69952012000500022,a,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,disminucion,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,UACR,i
112,S0211-69952012000500022,Conclusion,o
112,S0211-69952012000500022,El,o
112,S0211-69952012000500022,paricalcitol,i
112,S0211-69952012000500022,puede,o
112,S0211-69952012000500022,ser,o
112,S0211-69952012000500022,eficaz,o
112,S0211-69952012000500022,para,o
112,S0211-69952012000500022,frenar,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,proteinuria,i
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,pacientes,o
112,S0211-69952012000500022,con,o
112,S0211-69952012000500022,IR,i
112,S0211-69952012000500022,cronica,i
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,grado,o
112,S0211-69952012000500022,45,o
112,S0211-69952012000500022,ademas,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,su,o
112,S0211-69952012000500022,eficacia,o
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,el,o
112,S0211-69952012000500022,control,o
112,S0211-69952012000500022,del,o
112,S0211-69952012000500022,hiperparatiroidismo,i
112,S0211-69952012000500022,secundario,i
112,S0211-69952012000500022,Su,o
112,S0211-69952012000500022,eficacia,o
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,prevencion,i
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,progresion,o
112,S0211-69952012000500022,de,o
112,S0211-69952012000500022,la,o
112,S0211-69952012000500022,IR,i
112,S0211-69952012000500022,necesita,o
112,S0211-69952012000500022,confirmarse,o
112,S0211-69952012000500022,en,o
112,S0211-69952012000500022,otros,o
112,S0211-69952012000500022,estudios,o
113,S0211-69952013000100008,Tratamiento,i
113,S0211-69952013000100008,doble,o
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,calcifediol,i
113,S0211-69952013000100008,asociado,o
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,paricalcitol,i
113,S0211-69952013000100008,y,o
113,S0211-69952013000100008,biomarcadores,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,riesgo,i
113,S0211-69952013000100008,cardiovascular,i
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,hemodialisis,i
113,S0211-69952013000100008,Introduccion,o
113,S0211-69952013000100008,El,o
113,S0211-69952013000100008,deficit,i
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,25hidroxivitamina,o
113,S0211-69952013000100008,D,o
113,S0211-69952013000100008,25OHD,i
113,S0211-69952013000100008,asociado,o
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,un,o
113,S0211-69952013000100008,hiperparatiroidismo,i
113,S0211-69952013000100008,secundario,i
113,S0211-69952013000100008,son,o
113,S0211-69952013000100008,hallazgos,o
113,S0211-69952013000100008,frecuentes,o
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,pacientes,o
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,enfermedad,i
113,S0211-69952013000100008,renal,i
113,S0211-69952013000100008,cronica,i
113,S0211-69952013000100008,ERC,i
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,hemodialisis,i
113,S0211-69952013000100008,HD,i
113,S0211-69952013000100008,Estos,o
113,S0211-69952013000100008,hechos,o
113,S0211-69952013000100008,se,o
113,S0211-69952013000100008,asocian,o
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,un,o
113,S0211-69952013000100008,incremento,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,la,o
113,S0211-69952013000100008,morbimortalidad,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,origen,o
113,S0211-69952013000100008,cardiovascular,i
113,S0211-69952013000100008,CV,i
113,S0211-69952013000100008,Niveles,o
113,S0211-69952013000100008,sericos,i
113,S0211-69952013000100008,adecuados,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,25OHD,i
113,S0211-69952013000100008,asi,o
113,S0211-69952013000100008,como,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,uso,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,activadores,i
113,S0211-69952013000100008,selectivos,i
113,S0211-69952013000100008,del,i
113,S0211-69952013000100008,receptor,i
113,S0211-69952013000100008,de,i
113,S0211-69952013000100008,vitamina,i
113,S0211-69952013000100008,D,i
113,S0211-69952013000100008,AsRVD,i
113,S0211-69952013000100008,han,o
113,S0211-69952013000100008,demostrado,o
113,S0211-69952013000100008,tener,o
113,S0211-69952013000100008,efectos,o
113,S0211-69952013000100008,beneficiosos,o
113,S0211-69952013000100008,sobre,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,metabolismo,o
113,S0211-69952013000100008,oseomineral,o
113,S0211-69952013000100008,y,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,riesgo,i
113,S0211-69952013000100008,CV,i
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,manera,o
113,S0211-69952013000100008,independiente,o
113,S0211-69952013000100008,Actualmente,o
113,S0211-69952013000100008,aun,o
113,S0211-69952013000100008,existe,o
113,S0211-69952013000100008,controversia,o
113,S0211-69952013000100008,respecto,o
113,S0211-69952013000100008,al,o
113,S0211-69952013000100008,tipo,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,suplementacion,i
113,S0211-69952013000100008,que,o
113,S0211-69952013000100008,precisan,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,pacientes,o
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,ERC,i
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,HD,i
113,S0211-69952013000100008,Objetivo,o
113,S0211-69952013000100008,El,o
113,S0211-69952013000100008,objetivo,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,nuestro,o
113,S0211-69952013000100008,estudio,o
113,S0211-69952013000100008,fue,o
113,S0211-69952013000100008,evaluar,o
113,S0211-69952013000100008,si,o
113,S0211-69952013000100008,existe,o
113,S0211-69952013000100008,beneficio,o
113,S0211-69952013000100008,alguno,o
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,tratamiento,i
113,S0211-69952013000100008,combinado,i
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,25OHD,i
113,S0211-69952013000100008,calcifediol,i
113,S0211-69952013000100008,oral,o
113,S0211-69952013000100008,y,o
113,S0211-69952013000100008,AsRVD,i
113,S0211-69952013000100008,paricalcitol,i
113,S0211-69952013000100008,oral,o
113,S0211-69952013000100008,sobre,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,metabolismo,o
113,S0211-69952013000100008,oseomineral,o
113,S0211-69952013000100008,y,o
113,S0211-69952013000100008,marcadores,i
113,S0211-69952013000100008,inflamatorios,i
113,S0211-69952013000100008,respecto,o
113,S0211-69952013000100008,al,o
113,S0211-69952013000100008,tratamiento,i
113,S0211-69952013000100008,unico,o
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,cada,o
113,S0211-69952013000100008,uno,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,ellos,o
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,un,o
113,S0211-69952013000100008,grupo,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,pacientes,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,HD,i
113,S0211-69952013000100008,Material,o
113,S0211-69952013000100008,y,o
113,S0211-69952013000100008,metodos,o
113,S0211-69952013000100008,Realizamos,o
113,S0211-69952013000100008,un,o
113,S0211-69952013000100008,estudio,i
113,S0211-69952013000100008,prospectivo,i
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,6,o
113,S0211-69952013000100008,meses,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,duracion,o
113,S0211-69952013000100008,sobre,o
113,S0211-69952013000100008,26,o
113,S0211-69952013000100008,pacientes,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,nuestra,o
113,S0211-69952013000100008,unidad,o
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,HD,i
113,S0211-69952013000100008,Aleatorizamos,i
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,pacientes,o
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,dos,o
113,S0211-69952013000100008,grupos,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,grupo,o
113,S0211-69952013000100008,1,o
113,S0211-69952013000100008,G1,o
113,S0211-69952013000100008,recibio,o
113,S0211-69952013000100008,tratamiento,i
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,paricalcitol,i
113,S0211-69952013000100008,oral,o
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,dosis,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,1,o
113,S0211-69952013000100008,μgdia,o
113,S0211-69952013000100008,El,o
113,S0211-69952013000100008,grupo,o
113,S0211-69952013000100008,2,o
113,S0211-69952013000100008,G2,o
113,S0211-69952013000100008,fue,o
113,S0211-69952013000100008,tratado,i
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,calcifediol,i
113,S0211-69952013000100008,1,o
113,S0211-69952013000100008,ampollasem,o
113,S0211-69952013000100008,0266,o
113,S0211-69952013000100008,mgsem,o
113,S0211-69952013000100008,16000,o
113,S0211-69952013000100008,U,o
113,S0211-69952013000100008,por,o
113,S0211-69952013000100008,via,o
113,S0211-69952013000100008,oral,o
113,S0211-69952013000100008,Trascurridos,o
113,S0211-69952013000100008,3,o
113,S0211-69952013000100008,meses,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,tratamiento,i
113,S0211-69952013000100008,al,o
113,S0211-69952013000100008,G1,o
113,S0211-69952013000100008,se,o
113,S0211-69952013000100008,le,o
113,S0211-69952013000100008,añadio,o
113,S0211-69952013000100008,calcifediol,i
113,S0211-69952013000100008,y,o
113,S0211-69952013000100008,al,o
113,S0211-69952013000100008,G2,o
113,S0211-69952013000100008,paricalcitol,i
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,las,o
113,S0211-69952013000100008,mismas,o
113,S0211-69952013000100008,dosis,o
113,S0211-69952013000100008,manteniendo,o
113,S0211-69952013000100008,dichos,o
113,S0211-69952013000100008,tratamientos,i
113,S0211-69952013000100008,durante,o
113,S0211-69952013000100008,3,o
113,S0211-69952013000100008,meses,o
113,S0211-69952013000100008,mas,o
113,S0211-69952013000100008,hasta,o
113,S0211-69952013000100008,completar,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,6,o
113,S0211-69952013000100008,meses,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,seguimiento,i
113,S0211-69952013000100008,Las,o
113,S0211-69952013000100008,determinaciones,i
113,S0211-69952013000100008,analiticas,i
113,S0211-69952013000100008,se,o
113,S0211-69952013000100008,llevaron,o
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,cabo,o
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,meses,o
113,S0211-69952013000100008,0,o
113,S0211-69952013000100008,3,o
113,S0211-69952013000100008,y,o
113,S0211-69952013000100008,6,o
113,S0211-69952013000100008,midiendose,o
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,todos,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,pacientes,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,marcadores,i
113,S0211-69952013000100008,sericos,i
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,25OHD,i
113,S0211-69952013000100008,calcio,i
113,S0211-69952013000100008,fosforo,i
113,S0211-69952013000100008,y,o
113,S0211-69952013000100008,hormona,i
113,S0211-69952013000100008,paratiroidea,i
113,S0211-69952013000100008,PTH,i
113,S0211-69952013000100008,como,o
113,S0211-69952013000100008,marcadores,i
113,S0211-69952013000100008,de,i
113,S0211-69952013000100008,remodelado,i
113,S0211-69952013000100008,oseo,i
113,S0211-69952013000100008,se,o
113,S0211-69952013000100008,midio,o
113,S0211-69952013000100008,la,o
113,S0211-69952013000100008,fosfatasa,i
113,S0211-69952013000100008,alcalina,i
113,S0211-69952013000100008,propeptido,i
113,S0211-69952013000100008,aminoterminal,i
113,S0211-69952013000100008,del,i
113,S0211-69952013000100008,procolageno,i
113,S0211-69952013000100008,tipo,i
113,S0211-69952013000100008,1,i
113,S0211-69952013000100008,Pinp1,i
113,S0211-69952013000100008,y,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,telopeptido,o
113,S0211-69952013000100008,carboxiloterminal,o
113,S0211-69952013000100008,del,o
113,S0211-69952013000100008,colageno,o
113,S0211-69952013000100008,tipo,o
113,S0211-69952013000100008,I,o
113,S0211-69952013000100008,Cross,o
113,S0211-69952013000100008,Laps,o
113,S0211-69952013000100008,marcadores,i
113,S0211-69952013000100008,inflamatorios,i
113,S0211-69952013000100008,interleuquina,i
113,S0211-69952013000100008,8,i
113,S0211-69952013000100008,IL8,o
113,S0211-69952013000100008,Asimismo,o
113,S0211-69952013000100008,se,o
113,S0211-69952013000100008,recogieron,o
113,S0211-69952013000100008,datos,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,niveles,i
113,S0211-69952013000100008,de,i
113,S0211-69952013000100008,insulina,i
113,S0211-69952013000100008,glucosa,i
113,S0211-69952013000100008,hemoglobina,i
113,S0211-69952013000100008,agentes,i
113,S0211-69952013000100008,eritropoyeticos,i
113,S0211-69952013000100008,AEE,i
113,S0211-69952013000100008,e,o
113,S0211-69952013000100008,indices,i
113,S0211-69952013000100008,de,i
113,S0211-69952013000100008,resistencia,i
113,S0211-69952013000100008,a,i
113,S0211-69952013000100008,la,i
113,S0211-69952013000100008,eritropoyetina,i
113,S0211-69952013000100008,y,o
113,S0211-69952013000100008,HOMA,i
113,S0211-69952013000100008,homeostasis,i
113,S0211-69952013000100008,model,i
113,S0211-69952013000100008,assessment,i
113,S0211-69952013000100008,Resultados,o
113,S0211-69952013000100008,Se,o
113,S0211-69952013000100008,detecta,o
113,S0211-69952013000100008,un,o
113,S0211-69952013000100008,deficit,i
113,S0211-69952013000100008,de,i
113,S0211-69952013000100008,25OHD,i
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,todos,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,pacientes,o
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,estudio,o
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,una,o
113,S0211-69952013000100008,media,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,1367,o
113,S0211-69952013000100008,481,o
113,S0211-69952013000100008,ngml,o
113,S0211-69952013000100008,La,o
113,S0211-69952013000100008,suplementacion,i
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,calcifediol,i
113,S0211-69952013000100008,oral,o
113,S0211-69952013000100008,aislado,o
113,S0211-69952013000100008,corrige,o
113,S0211-69952013000100008,este,o
113,S0211-69952013000100008,deficit,i
113,S0211-69952013000100008,sin,o
113,S0211-69952013000100008,evidencia,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,toxicidad,i
113,S0211-69952013000100008,3536,o
113,S0211-69952013000100008,3368,o
113,S0211-69952013000100008,ngml,o
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,G1,o
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,6,o
113,S0211-69952013000100008,meses,o
113,S0211-69952013000100008,y,o
113,S0211-69952013000100008,5921,o
113,S0211-69952013000100008,2650,o
113,S0211-69952013000100008,ngml,o
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,G2,o
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,3,o
113,S0211-69952013000100008,meses,o
113,S0211-69952013000100008,El,o
113,S0211-69952013000100008,tratamiento,i
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,paricalcitol,i
113,S0211-69952013000100008,reduce,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,forma,o
113,S0211-69952013000100008,significativa,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,niveles,i
113,S0211-69952013000100008,de,i
113,S0211-69952013000100008,PTH,i
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,G1,o
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,3,o
113,S0211-69952013000100008,meses,o
113,S0211-69952013000100008,p,o
113,S0211-69952013000100008,0039,o
113,S0211-69952013000100008,no,o
113,S0211-69952013000100008,observandose,o
113,S0211-69952013000100008,esta,o
113,S0211-69952013000100008,significacion,o
113,S0211-69952013000100008,aunque,o
113,S0211-69952013000100008,si,o
113,S0211-69952013000100008,descenso,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,la,o
113,S0211-69952013000100008,PTH,i
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,G2,o
113,S0211-69952013000100008,tras,o
113,S0211-69952013000100008,su,o
113,S0211-69952013000100008,introduccion,o
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,partir,o
113,S0211-69952013000100008,del,o
113,S0211-69952013000100008,tercer,o
113,S0211-69952013000100008,mes,o
113,S0211-69952013000100008,Asimismo,o
113,S0211-69952013000100008,observamos,o
113,S0211-69952013000100008,una,o
113,S0211-69952013000100008,disminucion,o
113,S0211-69952013000100008,del,o
113,S0211-69952013000100008,marcador,i
113,S0211-69952013000100008,oseo,i
113,S0211-69952013000100008,Pinp1,i
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,paricalcitol,i
113,S0211-69952013000100008,sin,o
113,S0211-69952013000100008,otros,o
113,S0211-69952013000100008,cambios,o
113,S0211-69952013000100008,apuntando,o
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,un,o
113,S0211-69952013000100008,posible,o
113,S0211-69952013000100008,efecto,o
113,S0211-69952013000100008,directo,o
113,S0211-69952013000100008,sobre,o
113,S0211-69952013000100008,las,o
113,S0211-69952013000100008,celulas,i
113,S0211-69952013000100008,oseas,i
113,S0211-69952013000100008,p,o
113,S0211-69952013000100008,0001,o
113,S0211-69952013000100008,Tanto,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,tratamiento,i
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,calcifediol,i
113,S0211-69952013000100008,como,o
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,paricalcitol,i
113,S0211-69952013000100008,producen,o
113,S0211-69952013000100008,una,o
113,S0211-69952013000100008,significativa,o
113,S0211-69952013000100008,disminucion,o
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,niveles,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,IL8,o
113,S0211-69952013000100008,p,o
113,S0211-69952013000100008,0001,o
113,S0211-69952013000100008,conocido,o
113,S0211-69952013000100008,marcador,i
113,S0211-69952013000100008,inflamatorio,i
113,S0211-69952013000100008,llamando,o
113,S0211-69952013000100008,la,o
113,S0211-69952013000100008,atencion,o
113,S0211-69952013000100008,una,o
113,S0211-69952013000100008,tendencia,o
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,mejor,o
113,S0211-69952013000100008,respuesta,o
113,S0211-69952013000100008,a,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,AEE,i
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,posible,o
113,S0211-69952013000100008,relacion,o
113,S0211-69952013000100008,con,o
113,S0211-69952013000100008,este,o
113,S0211-69952013000100008,descenso,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,la,o
113,S0211-69952013000100008,inflamacion,i
113,S0211-69952013000100008,El,o
113,S0211-69952013000100008,indice,i
113,S0211-69952013000100008,HOMA,i
113,S0211-69952013000100008,no,o
113,S0211-69952013000100008,cambio,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,forma,o
113,S0211-69952013000100008,significativa,o
113,S0211-69952013000100008,Conclusion,o
113,S0211-69952013000100008,Con,o
113,S0211-69952013000100008,nuestros,o
113,S0211-69952013000100008,resultados,o
113,S0211-69952013000100008,no,o
113,S0211-69952013000100008,podemos,o
113,S0211-69952013000100008,concluir,o
113,S0211-69952013000100008,que,o
113,S0211-69952013000100008,la,o
113,S0211-69952013000100008,asociacion,o
113,S0211-69952013000100008,calcifediolparicalcitol,o
113,S0211-69952013000100008,produzca,o
113,S0211-69952013000100008,ventajas,o
113,S0211-69952013000100008,sobre,o
113,S0211-69952013000100008,el,o
113,S0211-69952013000100008,efecto,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,cada,o
113,S0211-69952013000100008,uno,o
113,S0211-69952013000100008,de,o
113,S0211-69952013000100008,ellos,o
113,S0211-69952013000100008,por,o
113,S0211-69952013000100008,separado,o
113,S0211-69952013000100008,en,o
113,S0211-69952013000100008,los,o
113,S0211-69952013000100008,marcadores,i
113,S0211-69952013000100008,medidos,o
113,S0211-69952013000100008,Paricalcitol,i
113,S0211-69952013000100008,ademas,o
113,S0211-69952013000100008,por,o
113,S0211-69952013000100008,si,o
113,S0211-69952013000100008,solo,o
113,S0211-69952013000100008,parece,o
113,S0211-69952013000100008,tener,o
113,S0211-69952013000100008,efecto,o
113,S0211-69952013000100008,directo,o
113,S0211-69952013000100008,sobre,o
113,S0211-69952013000100008,la,o
113,S0211-69952013000100008,remodelacion,o
113,S0211-69952013000100008,osea,i
114,S0211-69952013000700005,Comparacion,o
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,la,o
114,S0211-69952013000700005,eficacia,o
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,dos,o
114,S0211-69952013000700005,modalidades,o
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,hemodiafiltracion,i
114,S0211-69952013000700005,en,i
114,S0211-69952013000700005,linea,i
114,S0211-69952013000700005,mixta,o
114,S0211-69952013000700005,frente,o
114,S0211-69952013000700005,a,o
114,S0211-69952013000700005,posdilucional,o
114,S0211-69952013000700005,Introduccion,o
114,S0211-69952013000700005,La,o
114,S0211-69952013000700005,hemodiafiltracion,i
114,S0211-69952013000700005,HDF,i
114,S0211-69952013000700005,con,o
114,S0211-69952013000700005,altos,o
114,S0211-69952013000700005,volumenes,o
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,reinfusion,i
114,S0211-69952013000700005,es,o
114,S0211-69952013000700005,la,o
114,S0211-69952013000700005,tecnica,o
114,S0211-69952013000700005,mas,o
114,S0211-69952013000700005,eficaz,o
114,S0211-69952013000700005,en,o
114,S0211-69952013000700005,la,o
114,S0211-69952013000700005,depuracion,i
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,toxinas,i
114,S0211-69952013000700005,uremicas,i
114,S0211-69952013000700005,Existen,o
114,S0211-69952013000700005,distintas,o
114,S0211-69952013000700005,modalidades,o
114,S0211-69952013000700005,dependiendo,o
114,S0211-69952013000700005,del,o
114,S0211-69952013000700005,lugar,o
114,S0211-69952013000700005,donde,o
114,S0211-69952013000700005,se,o
114,S0211-69952013000700005,administra,o
114,S0211-69952013000700005,el,o
114,S0211-69952013000700005,volumen,o
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,sustitucion,o
114,S0211-69952013000700005,en,o
114,S0211-69952013000700005,el,o
114,S0211-69952013000700005,circuito,o
114,S0211-69952013000700005,extracorporeo,o
114,S0211-69952013000700005,predilucional,o
114,S0211-69952013000700005,mixta,o
114,S0211-69952013000700005,o,o
114,S0211-69952013000700005,middilucional,o
114,S0211-69952013000700005,y,o
114,S0211-69952013000700005,posdilucional,o
114,S0211-69952013000700005,en,o
114,S0211-69952013000700005,las,o
114,S0211-69952013000700005,que,o
114,S0211-69952013000700005,la,o
114,S0211-69952013000700005,infusion,i
114,S0211-69952013000700005,se,o
114,S0211-69952013000700005,realiza,o
114,S0211-69952013000700005,pre,o
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,forma,o
114,S0211-69952013000700005,simultanea,o
114,S0211-69952013000700005,pre,o
114,S0211-69952013000700005,y,o
114,S0211-69952013000700005,pos,o
114,S0211-69952013000700005,y,o
114,S0211-69952013000700005,posdilucional,o
114,S0211-69952013000700005,respectivamente,o
114,S0211-69952013000700005,Objetivo,o
114,S0211-69952013000700005,Comparar,o
114,S0211-69952013000700005,la,o
114,S0211-69952013000700005,depuracion,i
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,moleculas,i
114,S0211-69952013000700005,pequeñas,i
114,S0211-69952013000700005,medianas,o
114,S0211-69952013000700005,y,o
114,S0211-69952013000700005,unidas,o
114,S0211-69952013000700005,a,o
114,S0211-69952013000700005,proteinas,i
114,S0211-69952013000700005,y,o
114,S0211-69952013000700005,el,o
114,S0211-69952013000700005,volumen,o
114,S0211-69952013000700005,convectivo,o
114,S0211-69952013000700005,administrado,o
114,S0211-69952013000700005,en,o
114,S0211-69952013000700005,HDF,i
114,S0211-69952013000700005,en,i
114,S0211-69952013000700005,linea,i
114,S0211-69952013000700005,HDFOL,o
114,S0211-69952013000700005,con,o
114,S0211-69952013000700005,infusion,i
114,S0211-69952013000700005,posdilucional,i
114,S0211-69952013000700005,y,i
114,S0211-69952013000700005,mixta,i
114,S0211-69952013000700005,preposdilucional,o
114,S0211-69952013000700005,Material,o
114,S0211-69952013000700005,y,o
114,S0211-69952013000700005,metodos,o
114,S0211-69952013000700005,Estudio,o
114,S0211-69952013000700005,prospectivo,o
114,S0211-69952013000700005,aleatorizado,o
114,S0211-69952013000700005,y,o
114,S0211-69952013000700005,cruzado,o
114,S0211-69952013000700005,comparando,o
114,S0211-69952013000700005,HDFOL,o
114,S0211-69952013000700005,posdilucional,o
114,S0211-69952013000700005,y,o
114,S0211-69952013000700005,mixta,o
114,S0211-69952013000700005,Los,o
114,S0211-69952013000700005,pacientes,o
114,S0211-69952013000700005,n,o
114,S0211-69952013000700005,8,o
114,S0211-69952013000700005,fueron,o
114,S0211-69952013000700005,asignados,i
114,S0211-69952013000700005,aleatoriamente,i
114,S0211-69952013000700005,para,o
114,S0211-69952013000700005,recibir,o
114,S0211-69952013000700005,6,o
114,S0211-69952013000700005,sesiones,o
114,S0211-69952013000700005,en,o
114,S0211-69952013000700005,cada,o
114,S0211-69952013000700005,tecnica,o
114,S0211-69952013000700005,Se,o
114,S0211-69952013000700005,realizaron,o
114,S0211-69952013000700005,89,o
114,S0211-69952013000700005,sesiones,o
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,las,o
114,S0211-69952013000700005,cuales,o
114,S0211-69952013000700005,68,o
114,S0211-69952013000700005,fueron,o
114,S0211-69952013000700005,a,o
114,S0211-69952013000700005,tiempo,o
114,S0211-69952013000700005,programado,o
114,S0211-69952013000700005,TP,o
114,S0211-69952013000700005,y,o
114,S0211-69952013000700005,21,o
114,S0211-69952013000700005,a,o
114,S0211-69952013000700005,tiempo,o
114,S0211-69952013000700005,efectivo,o
114,S0211-69952013000700005,TE,o
114,S0211-69952013000700005,Se,o
114,S0211-69952013000700005,determinaron,o
114,S0211-69952013000700005,los,o
114,S0211-69952013000700005,porcentajes,o
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,reduccion,o
114,S0211-69952013000700005,RR,o
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,distintas,o
114,S0211-69952013000700005,sustancias,o
114,S0211-69952013000700005,y,o
114,S0211-69952013000700005,los,o
114,S0211-69952013000700005,volumenes,o
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,infusion,i
114,S0211-69952013000700005,El,o
114,S0211-69952013000700005,estudio,o
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,los,o
114,S0211-69952013000700005,RR,o
114,S0211-69952013000700005,se,o
114,S0211-69952013000700005,realizo,o
114,S0211-69952013000700005,con,o
114,S0211-69952013000700005,TE,o
114,S0211-69952013000700005,Resultados,o
114,S0211-69952013000700005,El,o
114,S0211-69952013000700005,KT,o
114,S0211-69952013000700005,obtenido,o
114,S0211-69952013000700005,fue,o
114,S0211-69952013000700005,mayor,o
114,S0211-69952013000700005,con,o
114,S0211-69952013000700005,HDFOL,o
114,S0211-69952013000700005,posdilucional,o
114,S0211-69952013000700005,68,o
114,S0211-69952013000700005,81,o
114,S0211-69952013000700005,frente,o
114,S0211-69952013000700005,a,o
114,S0211-69952013000700005,649,o
114,S0211-69952013000700005,88,o
114,S0211-69952013000700005,litros,o
114,S0211-69952013000700005,p,o
114,S0211-69952013000700005,0009,o
114,S0211-69952013000700005,cuando,o
114,S0211-69952013000700005,los,o
114,S0211-69952013000700005,pacientes,o
114,S0211-69952013000700005,se,o
114,S0211-69952013000700005,dializaron,i
114,S0211-69952013000700005,a,o
114,S0211-69952013000700005,TP,o
114,S0211-69952013000700005,Esta,o
114,S0211-69952013000700005,diferencia,o
114,S0211-69952013000700005,desaparecia,o
114,S0211-69952013000700005,cuando,o
114,S0211-69952013000700005,la,o
114,S0211-69952013000700005,dialisis,i
114,S0211-69952013000700005,se,o
114,S0211-69952013000700005,realizaba,o
114,S0211-69952013000700005,a,o
114,S0211-69952013000700005,TE,o
114,S0211-69952013000700005,La,o
114,S0211-69952013000700005,diferencia,o
114,S0211-69952013000700005,entre,o
114,S0211-69952013000700005,el,o
114,S0211-69952013000700005,TPTE,o
114,S0211-69952013000700005,fue,o
114,S0211-69952013000700005,mayor,o
114,S0211-69952013000700005,en,o
114,S0211-69952013000700005,la,o
114,S0211-69952013000700005,HDF,i
114,S0211-69952013000700005,mixta,i
114,S0211-69952013000700005,con,o
114,S0211-69952013000700005,respecto,o
114,S0211-69952013000700005,a,o
114,S0211-69952013000700005,la,o
114,S0211-69952013000700005,HDF,i
114,S0211-69952013000700005,posdilucional,i
114,S0211-69952013000700005,103,o
114,S0211-69952013000700005,74,o
114,S0211-69952013000700005,frente,o
114,S0211-69952013000700005,a,o
114,S0211-69952013000700005,65,o
114,S0211-69952013000700005,31,o
114,S0211-69952013000700005,minutos,o
114,S0211-69952013000700005,p,o
114,S0211-69952013000700005,002,o
114,S0211-69952013000700005,No,o
114,S0211-69952013000700005,encontramos,o
114,S0211-69952013000700005,diferencias,o
114,S0211-69952013000700005,en,o
114,S0211-69952013000700005,los,o
114,S0211-69952013000700005,RR,o
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,las,o
114,S0211-69952013000700005,sustancias,o
114,S0211-69952013000700005,analizadas,o
114,S0211-69952013000700005,Conclusion,o
114,S0211-69952013000700005,La,o
114,S0211-69952013000700005,HDFOL,o
114,S0211-69952013000700005,mixta,o
114,S0211-69952013000700005,no,o
114,S0211-69952013000700005,es,o
114,S0211-69952013000700005,inferior,o
114,S0211-69952013000700005,a,o
114,S0211-69952013000700005,la,o
114,S0211-69952013000700005,posdilucional,o
114,S0211-69952013000700005,ni,o
114,S0211-69952013000700005,en,o
114,S0211-69952013000700005,la,o
114,S0211-69952013000700005,depuracion,i
114,S0211-69952013000700005,de,o
114,S0211-69952013000700005,moleculas,i
114,S0211-69952013000700005,pequeñas,i
114,S0211-69952013000700005,y,o
114,S0211-69952013000700005,medianas,o
114,S0211-69952013000700005,ni,o
114,S0211-69952013000700005,en,o
114,S0211-69952013000700005,las,o
114,S0211-69952013000700005,unidas,o
114,S0211-69952013000700005,a,o
114,S0211-69952013000700005,proteinas,i
114,S0211-69952013000700005,a,o
114,S0211-69952013000700005,igual,o
114,S0211-69952013000700005,TE,o
115,S0211-69952015000100007,Endurecimiento,i
115,S0211-69952015000100007,arterial,i
115,S0211-69952015000100007,en,o
115,S0211-69952015000100007,el,o
115,S0211-69952015000100007,trasplante,i
115,S0211-69952015000100007,renal,i
115,S0211-69952015000100007,estudio,o
115,S0211-69952015000100007,casocontrol,o
115,S0211-69952015000100007,en,o
115,S0211-69952015000100007,un,o
115,S0211-69952015000100007,unico,o
115,S0211-69952015000100007,centro,o
115,S0211-69952015000100007,para,o
115,S0211-69952015000100007,la,o
115,S0211-69952015000100007,comparacion,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,un,o
115,S0211-69952015000100007,tratamiento,i
115,S0211-69952015000100007,inmunosupresor,i
115,S0211-69952015000100007,con,o
115,S0211-69952015000100007,belatacept,i
115,S0211-69952015000100007,frente,o
115,S0211-69952015000100007,a,o
115,S0211-69952015000100007,uno,o
115,S0211-69952015000100007,con,o
115,S0211-69952015000100007,inhibidores,i
115,S0211-69952015000100007,de,i
115,S0211-69952015000100007,la,i
115,S0211-69952015000100007,calcineurina,i
115,S0211-69952015000100007,Actualmente,o
115,S0211-69952015000100007,el,o
115,S0211-69952015000100007,endurecimiento,i
115,S0211-69952015000100007,arterial,i
115,S0211-69952015000100007,se,o
115,S0211-69952015000100007,considera,o
115,S0211-69952015000100007,un,o
115,S0211-69952015000100007,buen,o
115,S0211-69952015000100007,indicador,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,mortalidad,o
115,S0211-69952015000100007,cardiovascular,i
115,S0211-69952015000100007,tanto,o
115,S0211-69952015000100007,en,o
115,S0211-69952015000100007,la,o
115,S0211-69952015000100007,poblacion,o
115,S0211-69952015000100007,general,o
115,S0211-69952015000100007,como,o
115,S0211-69952015000100007,en,o
115,S0211-69952015000100007,receptores,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,trasplantes,i
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,renales,i
115,S0211-69952015000100007,Para,o
115,S0211-69952015000100007,cuantificarlo,o
115,S0211-69952015000100007,el,o
115,S0211-69952015000100007,metodo,o
115,S0211-69952015000100007,mas,o
115,S0211-69952015000100007,empleado,o
115,S0211-69952015000100007,es,o
115,S0211-69952015000100007,la,o
115,S0211-69952015000100007,medicion,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,la,o
115,S0211-69952015000100007,velocidad,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,onda,o
115,S0211-69952015000100007,del,o
115,S0211-69952015000100007,pulso,o
115,S0211-69952015000100007,carotidofemoral,o
115,S0211-69952015000100007,VOPcf,i
115,S0211-69952015000100007,El,o
115,S0211-69952015000100007,objetivo,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,este,o
115,S0211-69952015000100007,estudio,o
115,S0211-69952015000100007,es,o
115,S0211-69952015000100007,analizar,o
115,S0211-69952015000100007,si,o
115,S0211-69952015000100007,un,o
115,S0211-69952015000100007,tratamiento,i
115,S0211-69952015000100007,inmunosupresor,i
115,S0211-69952015000100007,con,o
115,S0211-69952015000100007,belatacept,i
115,S0211-69952015000100007,sin,o
115,S0211-69952015000100007,inhibidores,i
115,S0211-69952015000100007,de,i
115,S0211-69952015000100007,la,i
115,S0211-69952015000100007,calcineurina,i
115,S0211-69952015000100007,ICN,i
115,S0211-69952015000100007,se,o
115,S0211-69952015000100007,asocia,o
115,S0211-69952015000100007,a,o
115,S0211-69952015000100007,una,o
115,S0211-69952015000100007,VOPcf,i
115,S0211-69952015000100007,como,o
115,S0211-69952015000100007,marcador,o
115,S0211-69952015000100007,alternativo,o
115,S0211-69952015000100007,del,o
115,S0211-69952015000100007,endurecimiento,i
115,S0211-69952015000100007,arterial,i
115,S0211-69952015000100007,menor,o
115,S0211-69952015000100007,que,o
115,S0211-69952015000100007,la,o
115,S0211-69952015000100007,asociada,o
115,S0211-69952015000100007,a,o
115,S0211-69952015000100007,un,o
115,S0211-69952015000100007,tratamiento,i
115,S0211-69952015000100007,con,o
115,S0211-69952015000100007,ICN,i
115,S0211-69952015000100007,Se,o
115,S0211-69952015000100007,trata,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,un,o
115,S0211-69952015000100007,estudio,o
115,S0211-69952015000100007,retrospectivo,o
115,S0211-69952015000100007,casocontrol,o
115,S0211-69952015000100007,en,o
115,S0211-69952015000100007,el,o
115,S0211-69952015000100007,que,o
115,S0211-69952015000100007,incluimos,o
115,S0211-69952015000100007,todos,o
115,S0211-69952015000100007,los,o
115,S0211-69952015000100007,casos,o
115,S0211-69952015000100007,que,o
115,S0211-69952015000100007,recibieron,o
115,S0211-69952015000100007,un,o
115,S0211-69952015000100007,tratamiento,i
115,S0211-69952015000100007,inmunosupresor,i
115,S0211-69952015000100007,de,i
115,S0211-69952015000100007,mantenimiento,i
115,S0211-69952015000100007,con,o
115,S0211-69952015000100007,belatacept,i
115,S0211-69952015000100007,en,o
115,S0211-69952015000100007,nuestro,o
115,S0211-69952015000100007,centro,o
115,S0211-69952015000100007,n20,o
115,S0211-69952015000100007,Para,o
115,S0211-69952015000100007,estos,o
115,S0211-69952015000100007,seleccionamos,o
115,S0211-69952015000100007,un,o
115,S0211-69952015000100007,grupo,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,controles,o
115,S0211-69952015000100007,adecuado,o
115,S0211-69952015000100007,n20,o
115,S0211-69952015000100007,que,o
115,S0211-69952015000100007,habia,o
115,S0211-69952015000100007,recibido,o
115,S0211-69952015000100007,un,o
115,S0211-69952015000100007,tratamiento,i
115,S0211-69952015000100007,con,o
115,S0211-69952015000100007,ICN,i
115,S0211-69952015000100007,y,o
115,S0211-69952015000100007,con,o
115,S0211-69952015000100007,identicos,o
115,S0211-69952015000100007,factores,o
115,S0211-69952015000100007,clave,o
115,S0211-69952015000100007,asociados,o
115,S0211-69952015000100007,al,o
115,S0211-69952015000100007,endurecimiento,i
115,S0211-69952015000100007,arterial,i
115,S0211-69952015000100007,Tras,o
115,S0211-69952015000100007,el,o
115,S0211-69952015000100007,seguimiento,i
115,S0211-69952015000100007,llevado,o
115,S0211-69952015000100007,a,o
115,S0211-69952015000100007,cabo,o
115,S0211-69952015000100007,durante,o
115,S0211-69952015000100007,los,o
115,S0211-69952015000100007,5,o
115,S0211-69952015000100007,años,o
115,S0211-69952015000100007,posteriores,o
115,S0211-69952015000100007,al,o
115,S0211-69952015000100007,trasplante,i
115,S0211-69952015000100007,la,o
115,S0211-69952015000100007,prevalencia,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,pacientes,o
115,S0211-69952015000100007,con,o
115,S0211-69952015000100007,una,o
115,S0211-69952015000100007,VOPcf,i
115,S0211-69952015000100007,superior,o
115,S0211-69952015000100007,a,o
115,S0211-69952015000100007,81,o
115,S0211-69952015000100007,ms,o
115,S0211-69952015000100007,se,o
115,S0211-69952015000100007,habia,o
115,S0211-69952015000100007,reducido,o
115,S0211-69952015000100007,en,o
115,S0211-69952015000100007,el,o
115,S0211-69952015000100007,grupo,o
115,S0211-69952015000100007,al,o
115,S0211-69952015000100007,que,o
115,S0211-69952015000100007,se,o
115,S0211-69952015000100007,le,o
115,S0211-69952015000100007,administro,o
115,S0211-69952015000100007,belatacept,i
115,S0211-69952015000100007,50,o
115,S0211-69952015000100007,en,o
115,S0211-69952015000100007,el,o
115,S0211-69952015000100007,grupo,o
115,S0211-69952015000100007,BLC,i
115,S0211-69952015000100007,frente,o
115,S0211-69952015000100007,al,o
115,S0211-69952015000100007,25,o
115,S0211-69952015000100007,en,o
115,S0211-69952015000100007,el,o
115,S0211-69952015000100007,grupo,o
115,S0211-69952015000100007,ICN,i
115,S0211-69952015000100007,p,o
115,S0211-69952015000100007,008,o
115,S0211-69952015000100007,El,o
115,S0211-69952015000100007,analisis,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,regresion,o
115,S0211-69952015000100007,logistica,o
115,S0211-69952015000100007,multivariante,o
115,S0211-69952015000100007,revelo,o
115,S0211-69952015000100007,que,o
115,S0211-69952015000100007,el,o
115,S0211-69952015000100007,riesgo,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,presentar,o
115,S0211-69952015000100007,una,o
115,S0211-69952015000100007,VOPcf,i
115,S0211-69952015000100007,alta,o
115,S0211-69952015000100007,se,o
115,S0211-69952015000100007,encontraba,o
115,S0211-69952015000100007,correlacionado,o
115,S0211-69952015000100007,con,o
115,S0211-69952015000100007,la,o
115,S0211-69952015000100007,edad,o
115,S0211-69952015000100007,OR,o
115,S0211-69952015000100007,124,o
115,S0211-69952015000100007,p,o
115,S0211-69952015000100007,003,o
115,S0211-69952015000100007,y,o
115,S0211-69952015000100007,el,o
115,S0211-69952015000100007,indice,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,resistencia,o
115,S0211-69952015000100007,renal,i
115,S0211-69952015000100007,OR,o
115,S0211-69952015000100007,125,o
115,S0211-69952015000100007,p,o
115,S0211-69952015000100007,005,o
115,S0211-69952015000100007,El,o
115,S0211-69952015000100007,tratamiento,i
115,S0211-69952015000100007,con,o
115,S0211-69952015000100007,belatacept,i
115,S0211-69952015000100007,se,o
115,S0211-69952015000100007,asocio,o
115,S0211-69952015000100007,a,o
115,S0211-69952015000100007,una,o
115,S0211-69952015000100007,reduccion,o
115,S0211-69952015000100007,significativa,o
115,S0211-69952015000100007,del,o
115,S0211-69952015000100007,riesgo,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,aumentar,o
115,S0211-69952015000100007,la,o
115,S0211-69952015000100007,VOPcf,i
115,S0211-69952015000100007,OR,o
115,S0211-69952015000100007,0008,o
115,S0211-69952015000100007,p,o
115,S0211-69952015000100007,0045,o
115,S0211-69952015000100007,La,o
115,S0211-69952015000100007,inmunosupresion,i
115,S0211-69952015000100007,de,i
115,S0211-69952015000100007,mantenimiento,i
115,S0211-69952015000100007,con,o
115,S0211-69952015000100007,belatacept,i
115,S0211-69952015000100007,podria,o
115,S0211-69952015000100007,favorecer,o
115,S0211-69952015000100007,la,o
115,S0211-69952015000100007,tasa,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,supervivencia,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,receptores,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,trasplantes,i
115,S0211-69952015000100007,renales,i
115,S0211-69952015000100007,gracias,o
115,S0211-69952015000100007,a,o
115,S0211-69952015000100007,la,o
115,S0211-69952015000100007,disminucion,o
115,S0211-69952015000100007,de,o
115,S0211-69952015000100007,los,o
115,S0211-69952015000100007,eventos,i
115,S0211-69952015000100007,cardiovasculares,i
115,S0211-69952015000100007,relacionados,o
115,S0211-69952015000100007,con,o
115,S0211-69952015000100007,el,o
115,S0211-69952015000100007,endurecimiento,i
115,S0211-69952015000100007,arterial,i
116,S0211-69952015000200009,Klotho,i
116,S0211-69952015000200009,urinario,i
116,S0211-69952015000200009,determinado,o
116,S0211-69952015000200009,por,o
116,S0211-69952015000200009,ELISA,i
116,S0211-69952015000200009,como,o
116,S0211-69952015000200009,biomarcador,o
116,S0211-69952015000200009,precoz,o
116,S0211-69952015000200009,de,o
116,S0211-69952015000200009,fracaso,i
116,S0211-69952015000200009,renal,i
116,S0211-69952015000200009,agudo,i
116,S0211-69952015000200009,en,o
116,S0211-69952015000200009,pacientes,o
116,S0211-69952015000200009,sometidos,o
116,S0211-69952015000200009,a,o
116,S0211-69952015000200009,cirugia,i
116,S0211-69952015000200009,cardiaca,i
116,S0211-69952015000200009,o,o
116,S0211-69952015000200009,angiografia,i
116,S0211-69952015000200009,coronaria,i
116,S0211-69952015000200009,Introduccion,o
116,S0211-69952015000200009,y,o
116,S0211-69952015000200009,objetivos,o
116,S0211-69952015000200009,El,o
116,S0211-69952015000200009,fracaso,i
116,S0211-69952015000200009,renal,i
116,S0211-69952015000200009,agudo,i
116,S0211-69952015000200009,FRA,i
116,S0211-69952015000200009,es,o
116,S0211-69952015000200009,una,o
116,S0211-69952015000200009,complicacion,i
116,S0211-69952015000200009,frecuente,o
116,S0211-69952015000200009,tras,o
116,S0211-69952015000200009,la,o
116,S0211-69952015000200009,cirugia,i
116,S0211-69952015000200009,cardiaca,i
116,S0211-69952015000200009,y,o
116,S0211-69952015000200009,las,o
116,S0211-69952015000200009,intervenciones,i
116,S0211-69952015000200009,percutaneas,i
116,S0211-69952015000200009,coronarias,i
116,S0211-69952015000200009,cuya,o
116,S0211-69952015000200009,aparicion,o
116,S0211-69952015000200009,empeora,o
116,S0211-69952015000200009,el,o
116,S0211-69952015000200009,pronostico,o
116,S0211-69952015000200009,de,o
116,S0211-69952015000200009,manera,o
116,S0211-69952015000200009,marcada,o
116,S0211-69952015000200009,En,o
116,S0211-69952015000200009,los,o
116,S0211-69952015000200009,ultimos,o
116,S0211-69952015000200009,años,o
116,S0211-69952015000200009,se,o
116,S0211-69952015000200009,han,o
116,S0211-69952015000200009,identificado,o
116,S0211-69952015000200009,nuevos,o
116,S0211-69952015000200009,biomarcadores,o
116,S0211-69952015000200009,precoces,o
116,S0211-69952015000200009,de,o
116,S0211-69952015000200009,FRA,i
116,S0211-69952015000200009,pero,o
116,S0211-69952015000200009,aun,o
116,S0211-69952015000200009,quedan,o
116,S0211-69952015000200009,muchos,o
116,S0211-69952015000200009,aspectos,o
116,S0211-69952015000200009,importantes,o
116,S0211-69952015000200009,por,o
116,S0211-69952015000200009,resolver,o
116,S0211-69952015000200009,Klotho,i
116,S0211-69952015000200009,es,o
116,S0211-69952015000200009,una,o
116,S0211-69952015000200009,proteina,i
116,S0211-69952015000200009,pleiotropica,i
116,S0211-69952015000200009,que,o
116,S0211-69952015000200009,actua,o
116,S0211-69952015000200009,como,o
116,S0211-69952015000200009,un,o
116,S0211-69952015000200009,factor,o
116,S0211-69952015000200009,paracrino,o
116,S0211-69952015000200009,y,o
116,S0211-69952015000200009,endocrino,o
116,S0211-69952015000200009,en,o
116,S0211-69952015000200009,multiples,o
116,S0211-69952015000200009,organos,i
116,S0211-69952015000200009,En,o
116,S0211-69952015000200009,diversos,o
116,S0211-69952015000200009,modelos,o
116,S0211-69952015000200009,animales,o
116,S0211-69952015000200009,de,o
116,S0211-69952015000200009,FRA,i
116,S0211-69952015000200009,se,o
116,S0211-69952015000200009,ha,o
116,S0211-69952015000200009,demostrado,o
116,S0211-69952015000200009,niveles,o
116,S0211-69952015000200009,disminuidos,o
116,S0211-69952015000200009,de,o
116,S0211-69952015000200009,Klotho,i
116,S0211-69952015000200009,renal,i
116,S0211-69952015000200009,No,o
116,S0211-69952015000200009,se,o
116,S0211-69952015000200009,ha,o
116,S0211-69952015000200009,publicado,o
116,S0211-69952015000200009,ningun,o
116,S0211-69952015000200009,estudio,o
116,S0211-69952015000200009,en,o
116,S0211-69952015000200009,el,o
116,S0211-69952015000200009,que,o
116,S0211-69952015000200009,se,o
116,S0211-69952015000200009,haya,o
116,S0211-69952015000200009,probado,o
116,S0211-69952015000200009,Klotho,i
116,S0211-69952015000200009,como,o
116,S0211-69952015000200009,marcador,o
116,S0211-69952015000200009,precoz,o
116,S0211-69952015000200009,de,o
116,S0211-69952015000200009,FRA,i
116,S0211-69952015000200009,en,o
116,S0211-69952015000200009,humanos,o
116,S0211-69952015000200009,El,o
116,S0211-69952015000200009,objetivo,o
116,S0211-69952015000200009,de,o
116,S0211-69952015000200009,este,o
116,S0211-69952015000200009,trabajo,o
116,S0211-69952015000200009,es,o
116,S0211-69952015000200009,investigar,o
116,S0211-69952015000200009,la,o
116,S0211-69952015000200009,utilidad,o
116,S0211-69952015000200009,de,o
116,S0211-69952015000200009,la,o
116,S0211-69952015000200009,determinacion,i
116,S0211-69952015000200009,de,i
116,S0211-69952015000200009,Klotho,i
116,S0211-69952015000200009,en,i
116,S0211-69952015000200009,orina,i
116,S0211-69952015000200009,para,o
116,S0211-69952015000200009,el,o
116,S0211-69952015000200009,diagnostico,i
116,S0211-69952015000200009,precoz,i
116,S0211-69952015000200009,del,o
116,S0211-69952015000200009,FRA,i
116,S0211-69952015000200009,en,o
116,S0211-69952015000200009,pacientes,o
116,S0211-69952015000200009,con,o
116,S0211-69952015000200009,sindrome,i
116,S0211-69952015000200009,coronario,i
116,S0211-69952015000200009,agudo,i
116,S0211-69952015000200009,o,o
116,S0211-69952015000200009,fallo,i
116,S0211-69952015000200009,cardiaco,i
116,S0211-69952015000200009,sometidos,o
116,S0211-69952015000200009,a,o
116,S0211-69952015000200009,cirugia,i
116,S0211-69952015000200009,cardiaca,i
116,S0211-69952015000200009,o,o
116,S0211-69952015000200009,angiografia,i
116,S0211-69952015000200009,coronaria,i
116,S0211-69952015000200009,Metodos,o
116,S0211-69952015000200009,Se,o
116,S0211-69952015000200009,midio,o
116,S0211-69952015000200009,Klotho,i
116,S0211-69952015000200009,urinario,i
116,S0211-69952015000200009,12,o
116,S0211-69952015000200009,horas,o
116,S0211-69952015000200009,tras,o
116,S0211-69952015000200009,la,o
116,S0211-69952015000200009,intervencion,i
116,S0211-69952015000200009,en,o
116,S0211-69952015000200009,60,o
116,S0211-69952015000200009,pacientes,o
116,S0211-69952015000200009,ingresados,i
116,S0211-69952015000200009,en,i
116,S0211-69952015000200009,la,i
116,S0211-69952015000200009,unidad,i
116,S0211-69952015000200009,de,i
116,S0211-69952015000200009,cuidados,i
116,S0211-69952015000200009,intensivos,i
116,S0211-69952015000200009,por,o
116,S0211-69952015000200009,sindrome,i
116,S0211-69952015000200009,coronario,i
116,S0211-69952015000200009,agudo,i
116,S0211-69952015000200009,o,o
116,S0211-69952015000200009,fallo,i
116,S0211-69952015000200009,cardiaco,i
116,S0211-69952015000200009,secundarios,o
116,S0211-69952015000200009,a,o
116,S0211-69952015000200009,enfermedad,i
116,S0211-69952015000200009,coronaria,i
116,S0211-69952015000200009,o,i
116,S0211-69952015000200009,valvular,i
116,S0211-69952015000200009,y,o
116,S0211-69952015000200009,a,o
116,S0211-69952015000200009,los,o
116,S0211-69952015000200009,que,o
116,S0211-69952015000200009,se,o
116,S0211-69952015000200009,realizo,o
116,S0211-69952015000200009,angiografia,i
116,S0211-69952015000200009,coronaria,i
116,S0211-69952015000200009,30,o
116,S0211-69952015000200009,pacientes,o
116,S0211-69952015000200009,o,o
116,S0211-69952015000200009,cirugia,i
116,S0211-69952015000200009,cardiaca,i
116,S0211-69952015000200009,de,i
116,S0211-69952015000200009,recambio,i
116,S0211-69952015000200009,valvular,i
116,S0211-69952015000200009,o,o
116,S0211-69952015000200009,bypass,i
116,S0211-69952015000200009,30,o
116,S0211-69952015000200009,pacientes,o
116,S0211-69952015000200009,El,o
116,S0211-69952015000200009,criterio,o
116,S0211-69952015000200009,de,o
116,S0211-69952015000200009,valoracion,o
116,S0211-69952015000200009,primario,o
116,S0211-69952015000200009,fue,o
116,S0211-69952015000200009,la,o
116,S0211-69952015000200009,aparicion,o
116,S0211-69952015000200009,de,o
116,S0211-69952015000200009,FRA,i
116,S0211-69952015000200009,segun,o
116,S0211-69952015000200009,la,o
116,S0211-69952015000200009,clasificacion,o
116,S0211-69952015000200009,RIFLE,o
116,S0211-69952015000200009,Los,o
116,S0211-69952015000200009,niveles,i
116,S0211-69952015000200009,de,i
116,S0211-69952015000200009,Klotho,i
116,S0211-69952015000200009,humano,o
116,S0211-69952015000200009,se,o
116,S0211-69952015000200009,midieron,o
116,S0211-69952015000200009,utilizando,o
116,S0211-69952015000200009,un,o
116,S0211-69952015000200009,ensayo,i
116,S0211-69952015000200009,ELISA,i
116,S0211-69952015000200009,Resultados,o
116,S0211-69952015000200009,No,o
116,S0211-69952015000200009,encontramos,o
116,S0211-69952015000200009,diferencias,o
116,S0211-69952015000200009,en,o
116,S0211-69952015000200009,los,o
116,S0211-69952015000200009,niveles,i
116,S0211-69952015000200009,de,i
116,S0211-69952015000200009,Klotho,i
116,S0211-69952015000200009,en,i
116,S0211-69952015000200009,orina,i
116,S0211-69952015000200009,entre,o
116,S0211-69952015000200009,los,o
116,S0211-69952015000200009,pacientes,o
116,S0211-69952015000200009,que,o
116,S0211-69952015000200009,desarrollaron,o
116,S0211-69952015000200009,FRA,i
116,S0211-69952015000200009,y,o
116,S0211-69952015000200009,aquellos,o
116,S0211-69952015000200009,que,o
116,S0211-69952015000200009,no,o
116,S0211-69952015000200009,Ademas,o
116,S0211-69952015000200009,no,o
116,S0211-69952015000200009,habia,o
116,S0211-69952015000200009,correlacion,o
116,S0211-69952015000200009,significativa,o
116,S0211-69952015000200009,entre,o
116,S0211-69952015000200009,niveles,i
116,S0211-69952015000200009,de,i
116,S0211-69952015000200009,klotho,i
116,S0211-69952015000200009,en,i
116,S0211-69952015000200009,orina,i
116,S0211-69952015000200009,y,o
116,S0211-69952015000200009,presencia,o
116,S0211-69952015000200009,de,o
116,S0211-69952015000200009,FRA,i
116,S0211-69952015000200009,Conclusion,o
116,S0211-69952015000200009,Klotho,i
116,S0211-69952015000200009,urinario,i
116,S0211-69952015000200009,medido,o
116,S0211-69952015000200009,por,o
116,S0211-69952015000200009,ELISA,i
116,S0211-69952015000200009,no,o
116,S0211-69952015000200009,parece,o
116,S0211-69952015000200009,ser,o
116,S0211-69952015000200009,un,o
116,S0211-69952015000200009,buen,o
116,S0211-69952015000200009,candidato,o
116,S0211-69952015000200009,para,o
116,S0211-69952015000200009,ser,o
116,S0211-69952015000200009,usado,o
116,S0211-69952015000200009,como,o
116,S0211-69952015000200009,biomarcador,o
116,S0211-69952015000200009,precoz,o
116,S0211-69952015000200009,de,o
116,S0211-69952015000200009,FRA,i
117,S0211-69952015000500002,Sesion,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,hemodialisis,i
117,S0211-69952015000500002,la,o
117,S0211-69952015000500002,tormenta,o
117,S0211-69952015000500002,perfecta,o
117,S0211-69952015000500002,para,o
117,S0211-69952015000500002,la,o
117,S0211-69952015000500002,calcificacion,i
117,S0211-69952015000500002,vascular,i
117,S0211-69952015000500002,Introduccion,o
117,S0211-69952015000500002,La,o
117,S0211-69952015000500002,calcificacion,i
117,S0211-69952015000500002,vascular,i
117,S0211-69952015000500002,CV,i
117,S0211-69952015000500002,asociada,o
117,S0211-69952015000500002,a,o
117,S0211-69952015000500002,la,o
117,S0211-69952015000500002,enfermedad,i
117,S0211-69952015000500002,renal,i
117,S0211-69952015000500002,cronica,i
117,S0211-69952015000500002,ERC,i
117,S0211-69952015000500002,es,o
117,S0211-69952015000500002,un,o
117,S0211-69952015000500002,fenomeno,o
117,S0211-69952015000500002,estrechamente,o
117,S0211-69952015000500002,ligado,o
117,S0211-69952015000500002,a,o
117,S0211-69952015000500002,las,o
117,S0211-69952015000500002,alteraciones,i
117,S0211-69952015000500002,en,i
117,S0211-69952015000500002,el,i
117,S0211-69952015000500002,metabolismo,i
117,S0211-69952015000500002,mineral,i
117,S0211-69952015000500002,oseo,i
117,S0211-69952015000500002,Existen,o
117,S0211-69952015000500002,muchos,o
117,S0211-69952015000500002,factores,o
117,S0211-69952015000500002,implicados,o
117,S0211-69952015000500002,entre,o
117,S0211-69952015000500002,ellos,o
117,S0211-69952015000500002,los,o
117,S0211-69952015000500002,farmacos,i
117,S0211-69952015000500002,empleados,o
117,S0211-69952015000500002,en,o
117,S0211-69952015000500002,el,o
117,S0211-69952015000500002,tratamiento,i
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,la,o
117,S0211-69952015000500002,ERC,i
117,S0211-69952015000500002,Algunos,o
117,S0211-69952015000500002,estudios,i
117,S0211-69952015000500002,in,i
117,S0211-69952015000500002,vitro,i
117,S0211-69952015000500002,señalan,o
117,S0211-69952015000500002,que,o
117,S0211-69952015000500002,las,o
117,S0211-69952015000500002,alteraciones,o
117,S0211-69952015000500002,electroliticas,i
117,S0211-69952015000500002,y,o
117,S0211-69952015000500002,acidobasicas,o
117,S0211-69952015000500002,que,o
117,S0211-69952015000500002,tienen,o
117,S0211-69952015000500002,lugar,o
117,S0211-69952015000500002,durante,o
117,S0211-69952015000500002,la,o
117,S0211-69952015000500002,sesion,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,hemodialisis,i
117,S0211-69952015000500002,HD,i
117,S0211-69952015000500002,pueden,o
117,S0211-69952015000500002,jugar,o
117,S0211-69952015000500002,un,o
117,S0211-69952015000500002,papel,o
117,S0211-69952015000500002,clave,o
117,S0211-69952015000500002,en,o
117,S0211-69952015000500002,el,o
117,S0211-69952015000500002,proceso,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,CV,i
117,S0211-69952015000500002,Metodos,o
117,S0211-69952015000500002,Analizamos,o
117,S0211-69952015000500002,las,o
117,S0211-69952015000500002,alteraciones,o
117,S0211-69952015000500002,electroliticas,i
117,S0211-69952015000500002,y,o
117,S0211-69952015000500002,acidobasicas,o
117,S0211-69952015000500002,que,o
117,S0211-69952015000500002,tienen,o
117,S0211-69952015000500002,lugar,o
117,S0211-69952015000500002,durante,o
117,S0211-69952015000500002,la,o
117,S0211-69952015000500002,sesion,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,HD,i
117,S0211-69952015000500002,en,o
117,S0211-69952015000500002,26,o
117,S0211-69952015000500002,pacientes,o
117,S0211-69952015000500002,empleando,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,forma,o
117,S0211-69952015000500002,aleatorizada,i
117,S0211-69952015000500002,concentraciones,i
117,S0211-69952015000500002,de,i
117,S0211-69952015000500002,calcio,i
117,S0211-69952015000500002,en,o
117,S0211-69952015000500002,el,o
117,S0211-69952015000500002,liquido,i
117,S0211-69952015000500002,de,i
117,S0211-69952015000500002,dialisis,i
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,125,o
117,S0211-69952015000500002,o,o
117,S0211-69952015000500002,15,o
117,S0211-69952015000500002,mM,o
117,S0211-69952015000500002,Resultados,o
117,S0211-69952015000500002,En,o
117,S0211-69952015000500002,todos,o
117,S0211-69952015000500002,los,o
117,S0211-69952015000500002,pacientes,o
117,S0211-69952015000500002,independientemente,o
117,S0211-69952015000500002,del,o
117,S0211-69952015000500002,baño,i
117,S0211-69952015000500002,de,i
117,S0211-69952015000500002,calcio,i
117,S0211-69952015000500002,empleado,o
117,S0211-69952015000500002,se,o
117,S0211-69952015000500002,produce,o
117,S0211-69952015000500002,una,o
117,S0211-69952015000500002,ganancia,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,calcio,i
117,S0211-69952015000500002,En,o
117,S0211-69952015000500002,el,o
117,S0211-69952015000500002,grupo,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,pacientes,o
117,S0211-69952015000500002,dializados,i
117,S0211-69952015000500002,con,o
117,S0211-69952015000500002,baño,i
117,S0211-69952015000500002,de,i
117,S0211-69952015000500002,calcio,i
117,S0211-69952015000500002,15,o
117,S0211-69952015000500002,mM,o
117,S0211-69952015000500002,el,o
117,S0211-69952015000500002,100,o
117,S0211-69952015000500002,finaliza,o
117,S0211-69952015000500002,la,o
117,S0211-69952015000500002,sesion,o
117,S0211-69952015000500002,con,o
117,S0211-69952015000500002,valores,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,calcio,i
117,S0211-69952015000500002,serico,i
117,S0211-69952015000500002,13,o
117,S0211-69952015000500002,mM,o
117,S0211-69952015000500002,mientras,o
117,S0211-69952015000500002,que,o
117,S0211-69952015000500002,en,o
117,S0211-69952015000500002,el,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,125,o
117,S0211-69952015000500002,mM,o
117,S0211-69952015000500002,esto,o
117,S0211-69952015000500002,solo,o
117,S0211-69952015000500002,ocurre,o
117,S0211-69952015000500002,en,o
117,S0211-69952015000500002,el,o
117,S0211-69952015000500002,15,o
117,S0211-69952015000500002,Al,o
117,S0211-69952015000500002,inicio,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,la,o
117,S0211-69952015000500002,sesion,o
117,S0211-69952015000500002,esta,o
117,S0211-69952015000500002,ganancia,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,calcio,i
117,S0211-69952015000500002,coincide,o
117,S0211-69952015000500002,con,o
117,S0211-69952015000500002,niveles,i
117,S0211-69952015000500002,de,i
117,S0211-69952015000500002,fosforo,i
117,S0211-69952015000500002,aun,o
117,S0211-69952015000500002,no,o
117,S0211-69952015000500002,controlado,o
117,S0211-69952015000500002,Ademas,o
117,S0211-69952015000500002,en,o
117,S0211-69952015000500002,todos,o
117,S0211-69952015000500002,los,o
117,S0211-69952015000500002,pacientes,o
117,S0211-69952015000500002,se,o
117,S0211-69952015000500002,observa,o
117,S0211-69952015000500002,una,o
117,S0211-69952015000500002,alcalinizacion,o
117,S0211-69952015000500002,progresiva,o
117,S0211-69952015000500002,el,o
117,S0211-69952015000500002,50,o
117,S0211-69952015000500002,finaliza,o
117,S0211-69952015000500002,la,o
117,S0211-69952015000500002,sesion,o
117,S0211-69952015000500002,con,o
117,S0211-69952015000500002,cifras,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,bicarbonato,i
117,S0211-69952015000500002,30,o
117,S0211-69952015000500002,mM,o
117,S0211-69952015000500002,y,o
117,S0211-69952015000500002,el,o
117,S0211-69952015000500002,23,o
117,S0211-69952015000500002,con,o
117,S0211-69952015000500002,pH,i
117,S0211-69952015000500002,75,o
117,S0211-69952015000500002,Conclusiones,o
117,S0211-69952015000500002,Durante,o
117,S0211-69952015000500002,la,o
117,S0211-69952015000500002,sesion,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,HD,i
117,S0211-69952015000500002,se,o
117,S0211-69952015000500002,producen,o
117,S0211-69952015000500002,cambios,o
117,S0211-69952015000500002,electroliticos,i
117,S0211-69952015000500002,y,o
117,S0211-69952015000500002,acidobasicos,o
117,S0211-69952015000500002,inductores,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,CV,i
117,S0211-69952015000500002,ganancia,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,calcio,i
117,S0211-69952015000500002,y,o
117,S0211-69952015000500002,alcalinizacion,o
117,S0211-69952015000500002,en,o
117,S0211-69952015000500002,presencia,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,fosforo,i
117,S0211-69952015000500002,serico,i
117,S0211-69952015000500002,inicialmente,o
117,S0211-69952015000500002,elevado,o
117,S0211-69952015000500002,Son,o
117,S0211-69952015000500002,necesarios,o
117,S0211-69952015000500002,estudios,o
117,S0211-69952015000500002,con,o
117,S0211-69952015000500002,modelos,o
117,S0211-69952015000500002,cineticos,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,ganancia,o
117,S0211-69952015000500002,de,o
117,S0211-69952015000500002,calcio,i
117,S0211-69952015000500002,y,o
117,S0211-69952015000500002,alcalinizacion,o
117,S0211-69952015000500002,diferentes,o
117,S0211-69952015000500002,a,o
117,S0211-69952015000500002,los,o
117,S0211-69952015000500002,actuales,o
118,S0211-69952016000200156,Reanalisis,o
118,S0211-69952016000200156,del,o
118,S0211-69952016000200156,estudio,o
118,S0211-69952016000200156,ESHOL,o
118,S0211-69952016000200156,mortalidad,o
118,S0211-69952016000200156,por,o
118,S0211-69952016000200156,todas,o
118,S0211-69952016000200156,las,o
118,S0211-69952016000200156,causas,o
118,S0211-69952016000200156,considerando,o
118,S0211-69952016000200156,riesgos,o
118,S0211-69952016000200156,de,o
118,S0211-69952016000200156,competicion,o
118,S0211-69952016000200156,y,o
118,S0211-69952016000200156,tiempodependientes,o
118,S0211-69952016000200156,para,o
118,S0211-69952016000200156,trasplante,i
118,S0211-69952016000200156,renal,i
118,S0211-69952016000200156,Introduccion,o
118,S0211-69952016000200156,El,o
118,S0211-69952016000200156,estudio,o
118,S0211-69952016000200156,ESHOL,o
118,S0211-69952016000200156,ha,o
118,S0211-69952016000200156,demostrado,o
118,S0211-69952016000200156,que,o
118,S0211-69952016000200156,la,o
118,S0211-69952016000200156,hemodiafiltracion,o
118,S0211-69952016000200156,on,o
118,S0211-69952016000200156,line,o
118,S0211-69952016000200156,HDFOL,o
118,S0211-69952016000200156,posdilucion,o
118,S0211-69952016000200156,reduce,o
118,S0211-69952016000200156,la,o
118,S0211-69952016000200156,mortalidad,o
118,S0211-69952016000200156,por,o
118,S0211-69952016000200156,todas,o
118,S0211-69952016000200156,las,o
118,S0211-69952016000200156,causas,o
118,S0211-69952016000200156,respecto,o
118,S0211-69952016000200156,a,o
118,S0211-69952016000200156,la,o
118,S0211-69952016000200156,hemodialisis,i
118,S0211-69952016000200156,HD,i
118,S0211-69952016000200156,en,o
118,S0211-69952016000200156,pacientes,o
118,S0211-69952016000200156,prevalentes,o
118,S0211-69952016000200156,Sin,o
118,S0211-69952016000200156,embargo,o
118,S0211-69952016000200156,durante,o
118,S0211-69952016000200156,el,o
118,S0211-69952016000200156,periodo,o
118,S0211-69952016000200156,de,o
118,S0211-69952016000200156,observacion,i
118,S0211-69952016000200156,355,o
118,S0211-69952016000200156,pacientes,o
118,S0211-69952016000200156,finalizaron,o
118,S0211-69952016000200156,prematuramente,o
118,S0211-69952016000200156,el,o
118,S0211-69952016000200156,estudio,o
118,S0211-69952016000200156,de,o
118,S0211-69952016000200156,acuerdo,o
118,S0211-69952016000200156,con,o
118,S0211-69952016000200156,el,o
118,S0211-69952016000200156,diseño,o
118,S0211-69952016000200156,del,o
118,S0211-69952016000200156,mismo,o
118,S0211-69952016000200156,Estos,o
118,S0211-69952016000200156,pacientes,o
118,S0211-69952016000200156,fueron,o
118,S0211-69952016000200156,censurados,o
118,S0211-69952016000200156,en,o
118,S0211-69952016000200156,el,o
118,S0211-69952016000200156,momento,o
118,S0211-69952016000200156,de,o
118,S0211-69952016000200156,la,o
118,S0211-69952016000200156,finalizacion,o
118,S0211-69952016000200156,prematura,o
118,S0211-69952016000200156,Objetivos,o
118,S0211-69952016000200156,El,o
118,S0211-69952016000200156,objetivo,o
118,S0211-69952016000200156,de,o
118,S0211-69952016000200156,este,o
118,S0211-69952016000200156,estudio,o
118,S0211-69952016000200156,fue,o
118,S0211-69952016000200156,investigar,o
118,S0211-69952016000200156,los,o
118,S0211-69952016000200156,eventos,o
118,S0211-69952016000200156,de,o
118,S0211-69952016000200156,los,o
118,S0211-69952016000200156,pacientes,o
118,S0211-69952016000200156,que,o
118,S0211-69952016000200156,abandonaron,o
118,S0211-69952016000200156,el,o
118,S0211-69952016000200156,estudio,o
118,S0211-69952016000200156,Metodos,o
118,S0211-69952016000200156,Reanalizar,i
118,S0211-69952016000200156,los,i
118,S0211-69952016000200156,datos,i
118,S0211-69952016000200156,de,i
118,S0211-69952016000200156,supervivencia,i
118,S0211-69952016000200156,utilizando,o
118,S0211-69952016000200156,la,o
118,S0211-69952016000200156,poblacion,o
118,S0211-69952016000200156,por,o
118,S0211-69952016000200156,intencion,o
118,S0211-69952016000200156,de,o
118,S0211-69952016000200156,tratar,o
118,S0211-69952016000200156,en,o
118,S0211-69952016000200156,los,o
118,S0211-69952016000200156,3,o
118,S0211-69952016000200156,años,o
118,S0211-69952016000200156,de,o
118,S0211-69952016000200156,seguimiento,i
118,S0211-69952016000200156,Los,o
118,S0211-69952016000200156,datos,o
118,S0211-69952016000200156,fueron,o
118,S0211-69952016000200156,analizados,o
118,S0211-69952016000200156,considerando,o
118,S0211-69952016000200156,tambien,o
118,S0211-69952016000200156,el,o
118,S0211-69952016000200156,trasplante,i
118,S0211-69952016000200156,renal,i
118,S0211-69952016000200156,como,o
118,S0211-69952016000200156,evento,o
118,S0211-69952016000200156,competitivo,o
118,S0211-69952016000200156,de,o
118,S0211-69952016000200156,la,o
118,S0211-69952016000200156,muerte,i
118,S0211-69952016000200156,del,o
118,S0211-69952016000200156,paciente,o
118,S0211-69952016000200156,Resultados,o
118,S0211-69952016000200156,Durante,o
118,S0211-69952016000200156,el,o
118,S0211-69952016000200156,seguimiento,i
118,S0211-69952016000200156,207,o
118,S0211-69952016000200156,pacientes,o
118,S0211-69952016000200156,fallecieron,i
118,S0211-69952016000200156,durante,o
118,S0211-69952016000200156,el,o
118,S0211-69952016000200156,tratamiento,i
118,S0211-69952016000200156,y,o
118,S0211-69952016000200156,47,o
118,S0211-69952016000200156,despues,o
118,S0211-69952016000200156,de,o
118,S0211-69952016000200156,abandonar,o
118,S0211-69952016000200156,el,o
118,S0211-69952016000200156,estudio,o
118,S0211-69952016000200156,Comparados,o
118,S0211-69952016000200156,con,o
118,S0211-69952016000200156,aquellos,o
118,S0211-69952016000200156,pacientes,o
118,S0211-69952016000200156,que,o
118,S0211-69952016000200156,se,o
118,S0211-69952016000200156,mantuvieron,o
118,S0211-69952016000200156,en,o
118,S0211-69952016000200156,HD,i
118,S0211-69952016000200156,los,o
118,S0211-69952016000200156,que,o
118,S0211-69952016000200156,fueron,o
118,S0211-69952016000200156,aleatorizados,i
118,S0211-69952016000200156,a,o
118,S0211-69952016000200156,HDFOL,o
118,S0211-69952016000200156,tuvieron,o
118,S0211-69952016000200156,una,o
118,S0211-69952016000200156,mortalidad,o
118,S0211-69952016000200156,total,o
118,S0211-69952016000200156,menor,o
118,S0211-69952016000200156,124,o
118,S0211-69952016000200156,vs,o
118,S0211-69952016000200156,946,o
118,S0211-69952016000200156,por,o
118,S0211-69952016000200156,100pacientesaño,o
118,S0211-69952016000200156,hazard,o
118,S0211-69952016000200156,ratio,o
118,S0211-69952016000200156,HR,o
118,S0211-69952016000200156,e,o
118,S0211-69952016000200156,IC,o
118,S0211-69952016000200156,95,o
118,S0211-69952016000200156,076,o
118,S0211-69952016000200156,059098,o
118,S0211-69952016000200156,p,o
118,S0211-69952016000200156,0031,o
118,S0211-69952016000200156,La,o
118,S0211-69952016000200156,mortalidad,o
118,S0211-69952016000200156,total,o
118,S0211-69952016000200156,por,o
118,S0211-69952016000200156,todas,o
118,S0211-69952016000200156,las,o
118,S0211-69952016000200156,causas,o
118,S0211-69952016000200156,teniendo,o
118,S0211-69952016000200156,en,o
118,S0211-69952016000200156,consideracion,o
118,S0211-69952016000200156,el,o
118,S0211-69952016000200156,riesgo,o
118,S0211-69952016000200156,competitivo,o
118,S0211-69952016000200156,del,o
118,S0211-69952016000200156,trasplante,i
118,S0211-69952016000200156,renal,i
118,S0211-69952016000200156,y,o
118,S0211-69952016000200156,tiempodependiente,o
118,S0211-69952016000200156,mostro,o
118,S0211-69952016000200156,en,o
118,S0211-69952016000200156,el,o
118,S0211-69952016000200156,analisis,o
118,S0211-69952016000200156,de,o
118,S0211-69952016000200156,Cox,o
118,S0211-69952016000200156,tiempodependiente,o
118,S0211-69952016000200156,resultados,o
118,S0211-69952016000200156,similares,o
118,S0211-69952016000200156,al,o
118,S0211-69952016000200156,analisis,o
118,S0211-69952016000200156,principal,o
118,S0211-69952016000200156,con,o
118,S0211-69952016000200156,un,o
118,S0211-69952016000200156,HR,o
118,S0211-69952016000200156,de,o
118,S0211-69952016000200156,077,o
118,S0211-69952016000200156,060099,o
118,S0211-69952016000200156,p,o
118,S0211-69952016000200156,0043,o
118,S0211-69952016000200156,Conclusiones,o
118,S0211-69952016000200156,Los,o
118,S0211-69952016000200156,resultados,o
118,S0211-69952016000200156,del,o
118,S0211-69952016000200156,reanalisis,o
118,S0211-69952016000200156,del,o
118,S0211-69952016000200156,estudio,o
118,S0211-69952016000200156,ESHOL,o
118,S0211-69952016000200156,se,o
118,S0211-69952016000200156,confirman,o
118,S0211-69952016000200156,cuando,o
118,S0211-69952016000200156,se,o
118,S0211-69952016000200156,aplica,o
118,S0211-69952016000200156,el,o
118,S0211-69952016000200156,analisis,i
118,S0211-69952016000200156,en,i
118,S0211-69952016000200156,la,i
118,S0211-69952016000200156,poblacion,i
118,S0211-69952016000200156,por,i
118,S0211-69952016000200156,intencion,i
118,S0211-69952016000200156,de,i
118,S0211-69952016000200156,tratar,i
118,S0211-69952016000200156,sin,o
118,S0211-69952016000200156,censurar,o
118,S0211-69952016000200156,ninguna,o
118,S0211-69952016000200156,observacion,i
118,S0211-69952016000200156,y,o
118,S0211-69952016000200156,considerando,o
118,S0211-69952016000200156,la,o
118,S0211-69952016000200156,mortalidad,o
118,S0211-69952016000200156,por,o
118,S0211-69952016000200156,todas,o
118,S0211-69952016000200156,las,o
118,S0211-69952016000200156,causas,o
118,S0211-69952016000200156,dependiente,o
118,S0211-69952016000200156,del,o
118,S0211-69952016000200156,tiempo,o
118,S0211-69952016000200156,y,o
118,S0211-69952016000200156,del,o
118,S0211-69952016000200156,riesgo,o
118,S0211-69952016000200156,competitivo,o
118,S0211-69952016000200156,del,o
118,S0211-69952016000200156,trasplante,i
118,S0211-69952016000200156,renal,i
119,S0211-69952017000600622,Perfil,o
119,S0211-69952017000600622,antiinflamatorio,o
119,S0211-69952017000600622,del,o
119,S0211-69952017000600622,paricalcitol,i
119,S0211-69952017000600622,en,o
119,S0211-69952017000600622,el,o
119,S0211-69952017000600622,receptor,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,trasplante,i
119,S0211-69952017000600622,renal,i
119,S0211-69952017000600622,Antecedentes,o
119,S0211-69952017000600622,y,o
119,S0211-69952017000600622,objetivos,o
119,S0211-69952017000600622,El,o
119,S0211-69952017000600622,paricalcitol,i
119,S0211-69952017000600622,un,o
119,S0211-69952017000600622,activador,i
119,S0211-69952017000600622,selectivo,i
119,S0211-69952017000600622,del,i
119,S0211-69952017000600622,receptor,i
119,S0211-69952017000600622,de,i
119,S0211-69952017000600622,la,i
119,S0211-69952017000600622,vitamina,i
119,S0211-69952017000600622,D,i
119,S0211-69952017000600622,se,o
119,S0211-69952017000600622,utiliza,o
119,S0211-69952017000600622,en,o
119,S0211-69952017000600622,el,o
119,S0211-69952017000600622,tratamiento,i
119,S0211-69952017000600622,del,o
119,S0211-69952017000600622,hiperparatiroidismo,i
119,S0211-69952017000600622,secundario,i
119,S0211-69952017000600622,en,o
119,S0211-69952017000600622,el,o
119,S0211-69952017000600622,receptor,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,trasplante,i
119,S0211-69952017000600622,renal,i
119,S0211-69952017000600622,Estudios,o
119,S0211-69952017000600622,tanto,o
119,S0211-69952017000600622,clinicos,o
119,S0211-69952017000600622,como,o
119,S0211-69952017000600622,experimentales,o
119,S0211-69952017000600622,realizados,o
119,S0211-69952017000600622,en,o
119,S0211-69952017000600622,pacientes,o
119,S0211-69952017000600622,renales,i
119,S0211-69952017000600622,no,o
119,S0211-69952017000600622,trasplantados,i
119,S0211-69952017000600622,muestran,o
119,S0211-69952017000600622,propiedades,o
119,S0211-69952017000600622,antiinflamatorias,o
119,S0211-69952017000600622,para,o
119,S0211-69952017000600622,esta,o
119,S0211-69952017000600622,molecula,o
119,S0211-69952017000600622,En,o
119,S0211-69952017000600622,este,o
119,S0211-69952017000600622,estudio,i
119,S0211-69952017000600622,exploratorio,i
119,S0211-69952017000600622,hemos,o
119,S0211-69952017000600622,evaluado,o
119,S0211-69952017000600622,el,o
119,S0211-69952017000600622,perfil,o
119,S0211-69952017000600622,antiinflamatorio,o
119,S0211-69952017000600622,del,o
119,S0211-69952017000600622,paricalcitol,i
119,S0211-69952017000600622,en,o
119,S0211-69952017000600622,receptores,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,trasplante,i
119,S0211-69952017000600622,renal,i
119,S0211-69952017000600622,Metodos,o
119,S0211-69952017000600622,Treinta,o
119,S0211-69952017000600622,y,o
119,S0211-69952017000600622,un,o
119,S0211-69952017000600622,pacientes,o
119,S0211-69952017000600622,trasplantados,i
119,S0211-69952017000600622,con,o
119,S0211-69952017000600622,hiperparatiroidismo,i
119,S0211-69952017000600622,secundario,i
119,S0211-69952017000600622,completaron,o
119,S0211-69952017000600622,3,o
119,S0211-69952017000600622,meses,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,terapia,i
119,S0211-69952017000600622,con,o
119,S0211-69952017000600622,paricalcitol,i
119,S0211-69952017000600622,oral,o
119,S0211-69952017000600622,1,o
119,S0211-69952017000600622,μgdia,o
119,S0211-69952017000600622,Se,o
119,S0211-69952017000600622,determinaron,o
119,S0211-69952017000600622,las,o
119,S0211-69952017000600622,concentraciones,i
119,S0211-69952017000600622,sericas,i
119,S0211-69952017000600622,y,o
119,S0211-69952017000600622,los,o
119,S0211-69952017000600622,niveles,i
119,S0211-69952017000600622,de,i
119,S0211-69952017000600622,expresion,i
119,S0211-69952017000600622,genica,i
119,S0211-69952017000600622,de,i
119,S0211-69952017000600622,citocinas,i
119,S0211-69952017000600622,inflamatorias,o
119,S0211-69952017000600622,en,o
119,S0211-69952017000600622,celulas,i
119,S0211-69952017000600622,mononucleares,i
119,S0211-69952017000600622,de,i
119,S0211-69952017000600622,sangre,i
119,S0211-69952017000600622,periferica,i
119,S0211-69952017000600622,al,o
119,S0211-69952017000600622,inicio,o
119,S0211-69952017000600622,y,o
119,S0211-69952017000600622,al,o
119,S0211-69952017000600622,final,o
119,S0211-69952017000600622,del,o
119,S0211-69952017000600622,estudio,o
119,S0211-69952017000600622,Resultados,o
119,S0211-69952017000600622,El,o
119,S0211-69952017000600622,paricalcitol,i
119,S0211-69952017000600622,provoco,o
119,S0211-69952017000600622,una,o
119,S0211-69952017000600622,disminucion,o
119,S0211-69952017000600622,significativa,o
119,S0211-69952017000600622,en,o
119,S0211-69952017000600622,los,o
119,S0211-69952017000600622,niveles,i
119,S0211-69952017000600622,de,i
119,S0211-69952017000600622,hormona,i
119,S0211-69952017000600622,paratiroidea,i
119,S0211-69952017000600622,sin,o
119,S0211-69952017000600622,cambios,o
119,S0211-69952017000600622,en,o
119,S0211-69952017000600622,los,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,calcio,i
119,S0211-69952017000600622,y,o
119,S0211-69952017000600622,fosforo,i
119,S0211-69952017000600622,Ademas,o
119,S0211-69952017000600622,indujo,o
119,S0211-69952017000600622,una,o
119,S0211-69952017000600622,reduccion,o
119,S0211-69952017000600622,en,o
119,S0211-69952017000600622,las,o
119,S0211-69952017000600622,concentraciones,i
119,S0211-69952017000600622,sericas,i
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,la,o
119,S0211-69952017000600622,interleucina,o
119,S0211-69952017000600622,IL6,o
119,S0211-69952017000600622,y,o
119,S0211-69952017000600622,del,o
119,S0211-69952017000600622,factor,i
119,S0211-69952017000600622,de,i
119,S0211-69952017000600622,necrosis,i
119,S0211-69952017000600622,tumoral,i
119,S0211-69952017000600622,alfa,i
119,S0211-69952017000600622,TNFα,o
119,S0211-69952017000600622,con,o
119,S0211-69952017000600622,reducciones,o
119,S0211-69952017000600622,porcentuales,o
119,S0211-69952017000600622,respecto,o
119,S0211-69952017000600622,al,o
119,S0211-69952017000600622,estado,o
119,S0211-69952017000600622,basal,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,un,o
119,S0211-69952017000600622,29,o
119,S0211-69952017000600622,p,o
119,S0211-69952017000600622,005,o
119,S0211-69952017000600622,y,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,un,o
119,S0211-69952017000600622,95,o
119,S0211-69952017000600622,p,o
119,S0211-69952017000600622,005,o
119,S0211-69952017000600622,respectivamente,o
119,S0211-69952017000600622,Los,o
119,S0211-69952017000600622,niveles,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,expresion,o
119,S0211-69952017000600622,genica,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,la,o
119,S0211-69952017000600622,IL6,o
119,S0211-69952017000600622,y,o
119,S0211-69952017000600622,del,o
119,S0211-69952017000600622,TNFα,o
119,S0211-69952017000600622,en,o
119,S0211-69952017000600622,celulas,i
119,S0211-69952017000600622,mononucleares,i
119,S0211-69952017000600622,de,i
119,S0211-69952017000600622,sangre,i
119,S0211-69952017000600622,periferica,i
119,S0211-69952017000600622,experimentaron,o
119,S0211-69952017000600622,un,o
119,S0211-69952017000600622,descenso,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,un,o
119,S0211-69952017000600622,141,o
119,S0211-69952017000600622,p,o
119,S0211-69952017000600622,0001,o
119,S0211-69952017000600622,y,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,un,o
119,S0211-69952017000600622,341,o
119,S0211-69952017000600622,p,o
119,S0211-69952017000600622,0001,o
119,S0211-69952017000600622,respectivamente,o
119,S0211-69952017000600622,La,o
119,S0211-69952017000600622,proporcion,o
119,S0211-69952017000600622,entre,o
119,S0211-69952017000600622,las,o
119,S0211-69952017000600622,citocinas,i
119,S0211-69952017000600622,proinflamatorias,o
119,S0211-69952017000600622,TNFα,o
119,S0211-69952017000600622,e,o
119,S0211-69952017000600622,IL6,o
119,S0211-69952017000600622,y,o
119,S0211-69952017000600622,la,o
119,S0211-69952017000600622,antiinflamatoria,o
119,S0211-69952017000600622,IL10,o
119,S0211-69952017000600622,tanto,o
119,S0211-69952017000600622,para,o
119,S0211-69952017000600622,los,o
119,S0211-69952017000600622,niveles,o
119,S0211-69952017000600622,sericos,i
119,S0211-69952017000600622,como,o
119,S0211-69952017000600622,para,o
119,S0211-69952017000600622,los,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,expresion,o
119,S0211-69952017000600622,genica,o
119,S0211-69952017000600622,tambien,o
119,S0211-69952017000600622,disminuyo,o
119,S0211-69952017000600622,significativamente,o
119,S0211-69952017000600622,Conclusiones,o
119,S0211-69952017000600622,La,o
119,S0211-69952017000600622,administracion,i
119,S0211-69952017000600622,del,o
119,S0211-69952017000600622,paricalcitol,i
119,S0211-69952017000600622,a,o
119,S0211-69952017000600622,receptores,o
119,S0211-69952017000600622,de,o
119,S0211-69952017000600622,trasplante,i
119,S0211-69952017000600622,renal,i
119,S0211-69952017000600622,se,o
119,S0211-69952017000600622,asocia,o
119,S0211-69952017000600622,con,o
119,S0211-69952017000600622,efectos,o
119,S0211-69952017000600622,beneficiosos,o
119,S0211-69952017000600622,sobre,o
119,S0211-69952017000600622,su,o
119,S0211-69952017000600622,estado,i
119,S0211-69952017000600622,inflamatorio,i
119,S0211-69952017000600622,lo,o
119,S0211-69952017000600622,que,o
119,S0211-69952017000600622,podria,o
119,S0211-69952017000600622,asociarse,o
119,S0211-69952017000600622,a,o
119,S0211-69952017000600622,un,o
119,S0211-69952017000600622,potencial,o
119,S0211-69952017000600622,beneficio,o
119,S0211-69952017000600622,clinico,o
120,S0212-16112004000700041,Ensayo,i
120,S0212-16112004000700041,randomizado,i
120,S0212-16112004000700041,eficacia,o
120,S0212-16112004000700041,de,o
120,S0212-16112004000700041,una,o
120,S0212-16112004000700041,formula,i
120,S0212-16112004000700041,enriquecida,i
120,S0212-16112004000700041,en,i
120,S0212-16112004000700041,acidos,i
120,S0212-16112004000700041,w3,i
120,S0212-16112004000700041,vs,o
120,S0212-16112004000700041,una,o
120,S0212-16112004000700041,formula,i
120,S0212-16112004000700041,enriquecida,i
120,S0212-16112004000700041,en,i
120,S0212-16112004000700041,arginina,i
120,S0212-16112004000700041,en,o
120,S0212-16112004000700041,pacientes,o
120,S0212-16112004000700041,ambulatorios,o
120,S0212-16112004000700041,con,o
120,S0212-16112004000700041,tumores,i
120,S0212-16112004000700041,de,i
120,S0212-16112004000700041,cabeza,i
120,S0212-16112004000700041,y,i
120,S0212-16112004000700041,cuello,i
120,S0212-16112004000700041,Introduccion,o
120,S0212-16112004000700041,Los,o
120,S0212-16112004000700041,pacientes,o
120,S0212-16112004000700041,con,o
120,S0212-16112004000700041,tumores,i
120,S0212-16112004000700041,de,i
120,S0212-16112004000700041,cabeza,i
120,S0212-16112004000700041,y,i
120,S0212-16112004000700041,cuello,i
120,S0212-16112004000700041,sometidos,o
120,S0212-16112004000700041,a,o
120,S0212-16112004000700041,cirugia,i
120,S0212-16112004000700041,resectiva,i
120,S0212-16112004000700041,presentan,o
120,S0212-16112004000700041,desnutricion,i
120,S0212-16112004000700041,y,o
120,S0212-16112004000700041,una,o
120,S0212-16112004000700041,elevada,o
120,S0212-16112004000700041,prevalencia,o
120,S0212-16112004000700041,de,o
120,S0212-16112004000700041,complicaciones,i
120,S0212-16112004000700041,ambulatorias,i
120,S0212-16112004000700041,Objetivo,o
120,S0212-16112004000700041,El,o
120,S0212-16112004000700041,principal,o
120,S0212-16112004000700041,objetivo,o
120,S0212-16112004000700041,fue,o
120,S0212-16112004000700041,investigar,o
120,S0212-16112004000700041,si,o
120,S0212-16112004000700041,la,o
120,S0212-16112004000700041,suplementacion,i
120,S0212-16112004000700041,oral,i
120,S0212-16112004000700041,ambulatoria,i
120,S0212-16112004000700041,en,o
120,S0212-16112004000700041,pacientes,o
120,S0212-16112004000700041,con,o
120,S0212-16112004000700041,cirugia,i
120,S0212-16112004000700041,por,i
120,S0212-16112004000700041,tumores,i
120,S0212-16112004000700041,de,i
120,S0212-16112004000700041,cabeza,i
120,S0212-16112004000700041,y,i
120,S0212-16112004000700041,cuello,i
120,S0212-16112004000700041,usando,o
120,S0212-16112004000700041,una,o
120,S0212-16112004000700041,formula,i
120,S0212-16112004000700041,enriquecida,i
120,S0212-16112004000700041,en,i
120,S0212-16112004000700041,omega,i
120,S0212-16112004000700041,3,i
120,S0212-16112004000700041,frente,o
120,S0212-16112004000700041,a,o
120,S0212-16112004000700041,una,o
120,S0212-16112004000700041,formula,i
120,S0212-16112004000700041,enriquecida,i
120,S0212-16112004000700041,en,i
120,S0212-16112004000700041,arginina,i
120,S0212-16112004000700041,mejoraba,o
120,S0212-16112004000700041,variables,o
120,S0212-16112004000700041,clinicas,o
120,S0212-16112004000700041,yo,o
120,S0212-16112004000700041,bioquimicas,o
120,S0212-16112004000700041,Diseño,o
120,S0212-16112004000700041,Se,o
120,S0212-16112004000700041,randomizaron,i
120,S0212-16112004000700041,un,o
120,S0212-16112004000700041,total,o
120,S0212-16112004000700041,de,o
120,S0212-16112004000700041,73,o
120,S0212-16112004000700041,pacientes,o
120,S0212-16112004000700041,postquirurgicos,o
120,S0212-16112004000700041,con,o
120,S0212-16112004000700041,tumores,i
120,S0212-16112004000700041,de,i
120,S0212-16112004000700041,cabeza,i
120,S0212-16112004000700041,y,i
120,S0212-16112004000700041,cuello,i
120,S0212-16112004000700041,El,o
120,S0212-16112004000700041,grupo,o
120,S0212-16112004000700041,1,o
120,S0212-16112004000700041,recibio,o
120,S0212-16112004000700041,dos,o
120,S0212-16112004000700041,botes,o
120,S0212-16112004000700041,de,o
120,S0212-16112004000700041,una,o
120,S0212-16112004000700041,formula,i
120,S0212-16112004000700041,enriquecida,i
120,S0212-16112004000700041,en,i
120,S0212-16112004000700041,w3,i
120,S0212-16112004000700041,ratio,o
120,S0212-16112004000700041,w6w3,o
120,S0212-16112004000700041,027,o
120,S0212-16112004000700041,grupo,o
120,S0212-16112004000700041,I,o
120,S0212-16112004000700041,y,o
120,S0212-16112004000700041,el,o
120,S0212-16112004000700041,grupo,o
120,S0212-16112004000700041,II,o
120,S0212-16112004000700041,dos,o
120,S0212-16112004000700041,botes,o
120,S0212-16112004000700041,de,o
120,S0212-16112004000700041,una,o
120,S0212-16112004000700041,formula,i
120,S0212-16112004000700041,enriquecida,i
120,S0212-16112004000700041,en,i
120,S0212-16112004000700041,arginina,i
120,S0212-16112004000700041,37,o
120,S0212-16112004000700041,gbote,o
120,S0212-16112004000700041,y,o
120,S0212-16112004000700041,una,o
120,S0212-16112004000700041,ratio,o
120,S0212-16112004000700041,w6w3,o
120,S0212-16112004000700041,09,o
120,S0212-16112004000700041,Resultados,o
120,S0212-16112004000700041,En,o
120,S0212-16112004000700041,ambos,o
120,S0212-16112004000700041,grupos,o
120,S0212-16112004000700041,mejoraron,o
120,S0212-16112004000700041,la,o
120,S0212-16112004000700041,albumina,i
120,S0212-16112004000700041,prealbumina,i
120,S0212-16112004000700041,y,o
120,S0212-16112004000700041,transferrina,i
120,S0212-16112004000700041,sin,o
120,S0212-16112004000700041,diferencias,o
120,S0212-16112004000700041,significativas,o
120,S0212-16112004000700041,intergrupo,o
120,S0212-16112004000700041,Solo,o
120,S0212-16112004000700041,existieron,o
120,S0212-16112004000700041,diferencias,o
120,S0212-16112004000700041,significativas,o
120,S0212-16112004000700041,en,o
120,S0212-16112004000700041,el,o
120,S0212-16112004000700041,peso,o
120,S0212-16112004000700041,del,o
120,S0212-16112004000700041,grupo,o
120,S0212-16112004000700041,I,o
120,S0212-16112004000700041,655,o
120,S0212-16112004000700041,115,o
120,S0212-16112004000700041,kg,o
120,S0212-16112004000700041,vs,o
120,S0212-16112004000700041,704,o
120,S0212-16112004000700041,111,o
120,S0212-16112004000700041,kg,o
120,S0212-16112004000700041,p,o
120,S0212-16112004000700041,005,o
120,S0212-16112004000700041,con,o
120,S0212-16112004000700041,un,o
120,S0212-16112004000700041,incremento,o
120,S0212-16112004000700041,significativo,o
120,S0212-16112004000700041,de,o
120,S0212-16112004000700041,la,o
120,S0212-16112004000700041,masa,o
120,S0212-16112004000700041,grasa,i
120,S0212-16112004000700041,154,o
120,S0212-16112004000700041,66,o
120,S0212-16112004000700041,kg,o
120,S0212-16112004000700041,vs,o
120,S0212-16112004000700041,181,o
120,S0212-16112004000700041,84,o
120,S0212-16112004000700041,kg,o
120,S0212-16112004000700041,p,o
120,S0212-16112004000700041,005,o
120,S0212-16112004000700041,Las,o
120,S0212-16112004000700041,complicaciones,i
120,S0212-16112004000700041,infecciosas,i
120,S0212-16112004000700041,postoperatorias,i
120,S0212-16112004000700041,fueron,o
120,S0212-16112004000700041,superiores,o
120,S0212-16112004000700041,en,o
120,S0212-16112004000700041,el,o
120,S0212-16112004000700041,grupo,o
120,S0212-16112004000700041,II,o
120,S0212-16112004000700041,0,o
120,S0212-16112004000700041,grupo,o
120,S0212-16112004000700041,I,o
120,S0212-16112004000700041,y,o
120,S0212-16112004000700041,857,o
120,S0212-16112004000700041,grupo,o
120,S0212-16112004000700041,II,o
120,S0212-16112004000700041,p,o
120,S0212-16112004000700041,005,o
120,S0212-16112004000700041,No,o
120,S0212-16112004000700041,se,o
120,S0212-16112004000700041,detectaron,o
120,S0212-16112004000700041,diferencias,o
120,S0212-16112004000700041,significativas,o
120,S0212-16112004000700041,en,o
120,S0212-16112004000700041,las,o
120,S0212-16112004000700041,complicaciones,i
120,S0212-16112004000700041,de,i
120,S0212-16112004000700041,la,i
120,S0212-16112004000700041,herida,i
120,S0212-16112004000700041,quirurgica,i
120,S0212-16112004000700041,ni,o
120,S0212-16112004000700041,en,o
120,S0212-16112004000700041,los,o
120,S0212-16112004000700041,efectos,i
120,S0212-16112004000700041,secundarios,i
120,S0212-16112004000700041,Conclusiones,o
120,S0212-16112004000700041,A,o
120,S0212-16112004000700041,la,o
120,S0212-16112004000700041,dosis,o
120,S0212-16112004000700041,utilizada,o
120,S0212-16112004000700041,la,o
120,S0212-16112004000700041,formula,i
120,S0212-16112004000700041,enriquecida,i
120,S0212-16112004000700041,en,i
120,S0212-16112004000700041,w3,i
120,S0212-16112004000700041,mejora,o
120,S0212-16112004000700041,la,o
120,S0212-16112004000700041,masa,o
120,S0212-16112004000700041,grasa,i
120,S0212-16112004000700041,y,o
120,S0212-16112004000700041,las,o
120,S0212-16112004000700041,proteinas,i
120,S0212-16112004000700041,sericas,i
120,S0212-16112004000700041,en,o
120,S0212-16112004000700041,pacientes,o
120,S0212-16112004000700041,postquirurgicos,o
120,S0212-16112004000700041,ambulatorios,o
120,S0212-16112004000700041,con,o
120,S0212-16112004000700041,tumor,i
120,S0212-16112004000700041,de,i
120,S0212-16112004000700041,cabeza,i
120,S0212-16112004000700041,y,i
120,S0212-16112004000700041,cuello,i
121,S0212-16112008000100003,Efecto,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,la,o
121,S0212-16112008000100003,ingesta,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,un,o
121,S0212-16112008000100003,preparado,i
121,S0212-16112008000100003,lacteo,i
121,S0212-16112008000100003,con,o
121,S0212-16112008000100003,fibra,i
121,S0212-16112008000100003,dietetica,i
121,S0212-16112008000100003,sobre,o
121,S0212-16112008000100003,el,o
121,S0212-16112008000100003,estreñimiento,i
121,S0212-16112008000100003,cronico,i
121,S0212-16112008000100003,primario,i
121,S0212-16112008000100003,idiopatico,i
121,S0212-16112008000100003,Objetivo,o
121,S0212-16112008000100003,Determinar,o
121,S0212-16112008000100003,si,o
121,S0212-16112008000100003,la,o
121,S0212-16112008000100003,administracion,i
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,un,o
121,S0212-16112008000100003,preparado,i
121,S0212-16112008000100003,lacteo,i
121,S0212-16112008000100003,enriquecido,o
121,S0212-16112008000100003,con,o
121,S0212-16112008000100003,un,o
121,S0212-16112008000100003,suplemento,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,fibra,i
121,S0212-16112008000100003,soluble,o
121,S0212-16112008000100003,Naturfibrainulina,o
121,S0212-16112008000100003,y,o
121,S0212-16112008000100003,maltodextrina,i
121,S0212-16112008000100003,resistente,o
121,S0212-16112008000100003,a,o
121,S0212-16112008000100003,la,o
121,S0212-16112008000100003,digestion,o
121,S0212-16112008000100003,Fibersol,o
121,S0212-16112008000100003,2,o
121,S0212-16112008000100003,afecta,o
121,S0212-16112008000100003,a,o
121,S0212-16112008000100003,la,o
121,S0212-16112008000100003,sintomatologia,i
121,S0212-16112008000100003,en,o
121,S0212-16112008000100003,el,o
121,S0212-16112008000100003,estreñimiento,i
121,S0212-16112008000100003,cronico,i
121,S0212-16112008000100003,primario,i
121,S0212-16112008000100003,idiopatico,i
121,S0212-16112008000100003,Ambito,o
121,S0212-16112008000100003,Sujetos,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,ambos,o
121,S0212-16112008000100003,sexos,o
121,S0212-16112008000100003,con,o
121,S0212-16112008000100003,estreñimiento,i
121,S0212-16112008000100003,segun,o
121,S0212-16112008000100003,los,o
121,S0212-16112008000100003,criterios,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,Roma,o
121,S0212-16112008000100003,II,o
121,S0212-16112008000100003,Sujetos,o
121,S0212-16112008000100003,Se,o
121,S0212-16112008000100003,trata,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,un,o
121,S0212-16112008000100003,ensayo,i
121,S0212-16112008000100003,clinico,i
121,S0212-16112008000100003,doble,i
121,S0212-16112008000100003,ciego,i
121,S0212-16112008000100003,aleatorizado,i
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,intervencion,i
121,S0212-16112008000100003,dietetica,i
121,S0212-16112008000100003,realizado,o
121,S0212-16112008000100003,en,o
121,S0212-16112008000100003,32,o
121,S0212-16112008000100003,individuos,o
121,S0212-16112008000100003,con,o
121,S0212-16112008000100003,estreñimiento,i
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,ambos,o
121,S0212-16112008000100003,sexos,o
121,S0212-16112008000100003,hombres,o
121,S0212-16112008000100003,4,o
121,S0212-16112008000100003,mujeres,o
121,S0212-16112008000100003,28,o
121,S0212-16112008000100003,y,o
121,S0212-16112008000100003,con,o
121,S0212-16112008000100003,una,o
121,S0212-16112008000100003,edad,o
121,S0212-16112008000100003,media,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,47,o
121,S0212-16112008000100003,15,o
121,S0212-16112008000100003,años,o
121,S0212-16112008000100003,Los,o
121,S0212-16112008000100003,32,o
121,S0212-16112008000100003,individuos,o
121,S0212-16112008000100003,que,o
121,S0212-16112008000100003,formaban,o
121,S0212-16112008000100003,la,o
121,S0212-16112008000100003,muestra,o
121,S0212-16112008000100003,se,o
121,S0212-16112008000100003,dividieron,i
121,S0212-16112008000100003,al,i
121,S0212-16112008000100003,azar,i
121,S0212-16112008000100003,en,o
121,S0212-16112008000100003,dos,o
121,S0212-16112008000100003,grupos,o
121,S0212-16112008000100003,homogeneos,o
121,S0212-16112008000100003,Intervenciones,i
121,S0212-16112008000100003,A,o
121,S0212-16112008000100003,cada,o
121,S0212-16112008000100003,grupo,o
121,S0212-16112008000100003,se,o
121,S0212-16112008000100003,le,o
121,S0212-16112008000100003,asigno,o
121,S0212-16112008000100003,un,o
121,S0212-16112008000100003,tipo,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,leche,o
121,S0212-16112008000100003,A,o
121,S0212-16112008000100003,o,o
121,S0212-16112008000100003,B,o
121,S0212-16112008000100003,una,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,ellas,o
121,S0212-16112008000100003,era,o
121,S0212-16112008000100003,leche,o
121,S0212-16112008000100003,semidesnatada,o
121,S0212-16112008000100003,enriquecida,o
121,S0212-16112008000100003,con,o
121,S0212-16112008000100003,fibra,i
121,S0212-16112008000100003,A,o
121,S0212-16112008000100003,y,o
121,S0212-16112008000100003,la,o
121,S0212-16112008000100003,otra,o
121,S0212-16112008000100003,leche,o
121,S0212-16112008000100003,semidesnatada,o
121,S0212-16112008000100003,B,o
121,S0212-16112008000100003,Los,o
121,S0212-16112008000100003,sujetos,o
121,S0212-16112008000100003,tomaron,o
121,S0212-16112008000100003,medio,o
121,S0212-16112008000100003,litro,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,leche,o
121,S0212-16112008000100003,diario,o
121,S0212-16112008000100003,durante,o
121,S0212-16112008000100003,20,o
121,S0212-16112008000100003,dias,o
121,S0212-16112008000100003,lo,o
121,S0212-16112008000100003,que,o
121,S0212-16112008000100003,supone,o
121,S0212-16112008000100003,que,o
121,S0212-16112008000100003,aquellos,o
121,S0212-16112008000100003,que,o
121,S0212-16112008000100003,tomaron,o
121,S0212-16112008000100003,la,o
121,S0212-16112008000100003,leche,o
121,S0212-16112008000100003,enriquecida,o
121,S0212-16112008000100003,ingirieron,o
121,S0212-16112008000100003,20,o
121,S0212-16112008000100003,gramos,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,fibra,i
121,S0212-16112008000100003,al,o
121,S0212-16112008000100003,dia,o
121,S0212-16112008000100003,Resultados,o
121,S0212-16112008000100003,Los,o
121,S0212-16112008000100003,individuos,o
121,S0212-16112008000100003,que,o
121,S0212-16112008000100003,presentaban,o
121,S0212-16112008000100003,esfuerzo,i
121,S0212-16112008000100003,deposicional,i
121,S0212-16112008000100003,p,o
121,S0212-16112008000100003,0001,o
121,S0212-16112008000100003,sensacion,i
121,S0212-16112008000100003,de,i
121,S0212-16112008000100003,evacuacion,i
121,S0212-16112008000100003,incompleta,i
121,S0212-16112008000100003,p,o
121,S0212-16112008000100003,0001,o
121,S0212-16112008000100003,sensacion,i
121,S0212-16112008000100003,de,i
121,S0212-16112008000100003,obstruccion,i
121,S0212-16112008000100003,en,i
121,S0212-16112008000100003,la,i
121,S0212-16112008000100003,evacuacion,i
121,S0212-16112008000100003,p,o
121,S0212-16112008000100003,0001,o
121,S0212-16112008000100003,y,o
121,S0212-16112008000100003,numero,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,dias,o
121,S0212-16112008000100003,entre,o
121,S0212-16112008000100003,deposiciones,o
121,S0212-16112008000100003,disminuyeron,o
121,S0212-16112008000100003,significativamente,o
121,S0212-16112008000100003,tras,o
121,S0212-16112008000100003,la,o
121,S0212-16112008000100003,ingesta,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,leche,o
121,S0212-16112008000100003,con,o
121,S0212-16112008000100003,fibra,i
121,S0212-16112008000100003,Conclusiones,o
121,S0212-16112008000100003,La,o
121,S0212-16112008000100003,ingesta,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,un,o
121,S0212-16112008000100003,preparado,i
121,S0212-16112008000100003,lacteo,i
121,S0212-16112008000100003,con,o
121,S0212-16112008000100003,un,o
121,S0212-16112008000100003,suplemento,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,fibra,i
121,S0212-16112008000100003,que,o
121,S0212-16112008000100003,contiene,o
121,S0212-16112008000100003,20,o
121,S0212-16112008000100003,gramos,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,fibra,i
121,S0212-16112008000100003,soluble,o
121,S0212-16112008000100003,inulina,i
121,S0212-16112008000100003,y,o
121,S0212-16112008000100003,maltodextrina,i
121,S0212-16112008000100003,resistente,o
121,S0212-16112008000100003,a,o
121,S0212-16112008000100003,la,o
121,S0212-16112008000100003,digestion,o
121,S0212-16112008000100003,mejora,o
121,S0212-16112008000100003,la,o
121,S0212-16112008000100003,situacion,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,estreñimiento,i
121,S0212-16112008000100003,cronico,i
121,S0212-16112008000100003,primario,i
121,S0212-16112008000100003,idiopatico,i
121,S0212-16112008000100003,en,o
121,S0212-16112008000100003,base,o
121,S0212-16112008000100003,a,o
121,S0212-16112008000100003,los,o
121,S0212-16112008000100003,criterios,o
121,S0212-16112008000100003,de,o
121,S0212-16112008000100003,Roma,o
121,S0212-16112008000100003,II,o
122,S0212-16112008000200011,Efecto,o
122,S0212-16112008000200011,de,o
122,S0212-16112008000200011,la,o
122,S0212-16112008000200011,dieta,i
122,S0212-16112008000200011,con,i
122,S0212-16112008000200011,restriccion,i
122,S0212-16112008000200011,proteica,i
122,S0212-16112008000200011,en,o
122,S0212-16112008000200011,la,o
122,S0212-16112008000200011,funcion,o
122,S0212-16112008000200011,renal,i
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,el,o
122,S0212-16112008000200011,control,o
122,S0212-16112008000200011,metabolico,o
122,S0212-16112008000200011,de,o
122,S0212-16112008000200011,pacientes,o
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,diabetes,i
122,S0212-16112008000200011,tipo,i
122,S0212-16112008000200011,2,i
122,S0212-16112008000200011,ensayo,i
122,S0212-16112008000200011,clinico,i
122,S0212-16112008000200011,de,i
122,S0212-16112008000200011,distribucion,i
122,S0212-16112008000200011,aleatoria,i
122,S0212-16112008000200011,Objetivo,o
122,S0212-16112008000200011,Valorar,o
122,S0212-16112008000200011,el,o
122,S0212-16112008000200011,efecto,o
122,S0212-16112008000200011,de,o
122,S0212-16112008000200011,una,o
122,S0212-16112008000200011,dieta,i
122,S0212-16112008000200011,baja,i
122,S0212-16112008000200011,en,i
122,S0212-16112008000200011,proteinas,i
122,S0212-16112008000200011,DBP,i
122,S0212-16112008000200011,sobre,o
122,S0212-16112008000200011,la,o
122,S0212-16112008000200011,funcion,o
122,S0212-16112008000200011,renal,i
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,el,o
122,S0212-16112008000200011,control,o
122,S0212-16112008000200011,metabolico,o
122,S0212-16112008000200011,en,o
122,S0212-16112008000200011,tres,o
122,S0212-16112008000200011,subgrupos,o
122,S0212-16112008000200011,de,o
122,S0212-16112008000200011,pacientes,o
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,diabetes,i
122,S0212-16112008000200011,tipo,i
122,S0212-16112008000200011,2,i
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,sin,o
122,S0212-16112008000200011,nefropatia,i
122,S0212-16112008000200011,Diseño,o
122,S0212-16112008000200011,del,o
122,S0212-16112008000200011,estudio,o
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,metodos,o
122,S0212-16112008000200011,Ensayo,i
122,S0212-16112008000200011,clinico,i
122,S0212-16112008000200011,de,i
122,S0212-16112008000200011,distribucion,i
122,S0212-16112008000200011,aleatoria,i
122,S0212-16112008000200011,en,o
122,S0212-16112008000200011,60,o
122,S0212-16112008000200011,pacientes,o
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,diabetes,i
122,S0212-16112008000200011,tipo,i
122,S0212-16112008000200011,2,i
122,S0212-16112008000200011,en,o
122,S0212-16112008000200011,atencion,i
122,S0212-16112008000200011,primaria,i
122,S0212-16112008000200011,19,o
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,normoalbuminuria,o
122,S0212-16112008000200011,22,o
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,microalbuminuria,i
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,19,o
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,macroalbuminuria,i
122,S0212-16112008000200011,Todos,o
122,S0212-16112008000200011,los,o
122,S0212-16112008000200011,pacientes,o
122,S0212-16112008000200011,pasaron,o
122,S0212-16112008000200011,una,o
122,S0212-16112008000200011,fase,o
122,S0212-16112008000200011,de,o
122,S0212-16112008000200011,preintervencion,o
122,S0212-16112008000200011,durante,o
122,S0212-16112008000200011,3,o
122,S0212-16112008000200011,meses,o
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,se,o
122,S0212-16112008000200011,anoto,o
122,S0212-16112008000200011,los,o
122,S0212-16112008000200011,porcentajes,o
122,S0212-16112008000200011,de,o
122,S0212-16112008000200011,ingesta,o
122,S0212-16112008000200011,calorica,o
122,S0212-16112008000200011,diaria,o
122,S0212-16112008000200011,pej,o
122,S0212-16112008000200011,carbohidratos,i
122,S0212-16112008000200011,50,o
122,S0212-16112008000200011,grasas,i
122,S0212-16112008000200011,30,o
122,S0212-16112008000200011,proteinas,i
122,S0212-16112008000200011,20,o
122,S0212-16112008000200011,Despues,o
122,S0212-16112008000200011,de,o
122,S0212-16112008000200011,este,o
122,S0212-16112008000200011,periodo,o
122,S0212-16112008000200011,de,o
122,S0212-16112008000200011,lavado,o
122,S0212-16112008000200011,fueron,o
122,S0212-16112008000200011,distribuidos,i
122,S0212-16112008000200011,de,i
122,S0212-16112008000200011,forma,i
122,S0212-16112008000200011,aleatoria,i
122,S0212-16112008000200011,para,o
122,S0212-16112008000200011,recibir,o
122,S0212-16112008000200011,o,o
122,S0212-16112008000200011,bien,o
122,S0212-16112008000200011,una,o
122,S0212-16112008000200011,DBP,i
122,S0212-16112008000200011,0608,o
122,S0212-16112008000200011,gkg,o
122,S0212-16112008000200011,al,o
122,S0212-16112008000200011,dia,o
122,S0212-16112008000200011,o,o
122,S0212-16112008000200011,una,o
122,S0212-16112008000200011,dieta,i
122,S0212-16112008000200011,normoproteica,i
122,S0212-16112008000200011,DNP,i
122,S0212-16112008000200011,1012,o
122,S0212-16112008000200011,gkg,o
122,S0212-16112008000200011,al,o
122,S0212-16112008000200011,dia,o
122,S0212-16112008000200011,durante,o
122,S0212-16112008000200011,un,o
122,S0212-16112008000200011,periodo,o
122,S0212-16112008000200011,de,o
122,S0212-16112008000200011,4,o
122,S0212-16112008000200011,meses,o
122,S0212-16112008000200011,Veintinueve,o
122,S0212-16112008000200011,pacientes,o
122,S0212-16112008000200011,recibieron,o
122,S0212-16112008000200011,DBP,i
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,31,o
122,S0212-16112008000200011,DNP,i
122,S0212-16112008000200011,Las,o
122,S0212-16112008000200011,principales,o
122,S0212-16112008000200011,variables,o
122,S0212-16112008000200011,de,o
122,S0212-16112008000200011,desenlace,o
122,S0212-16112008000200011,fueron,o
122,S0212-16112008000200011,las,o
122,S0212-16112008000200011,medidas,i
122,S0212-16112008000200011,de,i
122,S0212-16112008000200011,funcion,i
122,S0212-16112008000200011,renal,i
122,S0212-16112008000200011,EAU,i
122,S0212-16112008000200011,creatinina,i
122,S0212-16112008000200011,serica,i
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,TFG,i
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,el,o
122,S0212-16112008000200011,control,i
122,S0212-16112008000200011,glucemico,i
122,S0212-16112008000200011,glucemia,i
122,S0212-16112008000200011,en,i
122,S0212-16112008000200011,ayunas,i
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,hemoglobina,i
122,S0212-16112008000200011,A1,i
122,S0212-16112008000200011,c,i
122,S0212-16112008000200011,glucosilada,i
122,S0212-16112008000200011,Resultados,o
122,S0212-16112008000200011,La,o
122,S0212-16112008000200011,funcion,o
122,S0212-16112008000200011,renal,i
122,S0212-16112008000200011,mejoro,o
122,S0212-16112008000200011,en,o
122,S0212-16112008000200011,los,o
122,S0212-16112008000200011,pacientes,o
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,macroalbuminuria,i
122,S0212-16112008000200011,que,o
122,S0212-16112008000200011,realizaron,o
122,S0212-16112008000200011,la,o
122,S0212-16112008000200011,DBP,i
122,S0212-16112008000200011,la,o
122,S0212-16112008000200011,EAU,i
122,S0212-16112008000200011,disminuyo,o
122,S0212-16112008000200011,de,o
122,S0212-16112008000200011,12807,o
122,S0212-16112008000200011,11397,o
122,S0212-16112008000200011,a,o
122,S0212-16112008000200011,4444,o
122,S0212-16112008000200011,3298,o
122,S0212-16112008000200011,mg24,o
122,S0212-16112008000200011,h,o
122,S0212-16112008000200011,p,o
122,S0212-16112008000200011,005,o
122,S0212-16112008000200011,la,o
122,S0212-16112008000200011,TFG,i
122,S0212-16112008000200011,aumento,o
122,S0212-16112008000200011,563,o
122,S0212-16112008000200011,290,o
122,S0212-16112008000200011,742,o
122,S0212-16112008000200011,404,o
122,S0212-16112008000200011,mlmin,o
122,S0212-16112008000200011,p,o
122,S0212-16112008000200011,005,o
122,S0212-16112008000200011,En,o
122,S0212-16112008000200011,los,o
122,S0212-16112008000200011,pacientes,o
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,normo,o
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,microalbuminuria,i
122,S0212-16112008000200011,no,o
122,S0212-16112008000200011,hubo,o
122,S0212-16112008000200011,cambios,o
122,S0212-16112008000200011,significativos,o
122,S0212-16112008000200011,en,o
122,S0212-16112008000200011,la,o
122,S0212-16112008000200011,EAU,i
122,S0212-16112008000200011,o,o
122,S0212-16112008000200011,TFG,i
122,S0212-16112008000200011,tras,o
122,S0212-16112008000200011,cualquiera,o
122,S0212-16112008000200011,de,o
122,S0212-16112008000200011,las,o
122,S0212-16112008000200011,dietas,i
122,S0212-16112008000200011,La,o
122,S0212-16112008000200011,HbA1c,i
122,S0212-16112008000200011,disminuyo,o
122,S0212-16112008000200011,significativamente,o
122,S0212-16112008000200011,en,o
122,S0212-16112008000200011,los,o
122,S0212-16112008000200011,pacientes,o
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,microalbuminuria,i
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,ambas,o
122,S0212-16112008000200011,dietas,i
122,S0212-16112008000200011,DBP,i
122,S0212-16112008000200011,82,o
122,S0212-16112008000200011,1672,o
122,S0212-16112008000200011,18,o
122,S0212-16112008000200011,p,o
122,S0212-16112008000200011,005,o
122,S0212-16112008000200011,DNP,i
122,S0212-16112008000200011,88,o
122,S0212-16112008000200011,1971,o
122,S0212-16112008000200011,08,o
122,S0212-16112008000200011,p,o
122,S0212-16112008000200011,005,o
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,en,o
122,S0212-16112008000200011,los,o
122,S0212-16112008000200011,pacientes,o
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,macroalbuminuria,i
122,S0212-16112008000200011,que,o
122,S0212-16112008000200011,siguieron,o
122,S0212-16112008000200011,la,o
122,S0212-16112008000200011,DNP,i
122,S0212-16112008000200011,81,o
122,S0212-16112008000200011,1869,o
122,S0212-16112008000200011,16,o
122,S0212-16112008000200011,p,o
122,S0212-16112008000200011,005,o
122,S0212-16112008000200011,Conclusiones,o
122,S0212-16112008000200011,Una,o
122,S0212-16112008000200011,dieta,i
122,S0212-16112008000200011,con,i
122,S0212-16112008000200011,restriccion,i
122,S0212-16112008000200011,proteica,i
122,S0212-16112008000200011,moderada,o
122,S0212-16112008000200011,mejora,o
122,S0212-16112008000200011,la,o
122,S0212-16112008000200011,funcion,o
122,S0212-16112008000200011,renal,i
122,S0212-16112008000200011,en,o
122,S0212-16112008000200011,pacientes,o
122,S0212-16112008000200011,con,o
122,S0212-16112008000200011,diabetes,i
122,S0212-16112008000200011,tipo,i
122,S0212-16112008000200011,2,i
122,S0212-16112008000200011,y,o
122,S0212-16112008000200011,macroalbuminuria,i
123,S0212-16112008000800011,Efectos,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,la,o
123,S0212-16112008000800011,suplementacion,i
123,S0212-16112008000800011,dietetica,i
123,S0212-16112008000800011,con,i
123,S0212-16112008000800011,hongos,i
123,S0212-16112008000800011,medicinales,i
123,S0212-16112008000800011,en,o
123,S0212-16112008000800011,la,o
123,S0212-16112008000800011,glicemia,i
123,S0212-16112008000800011,de,i
123,S0212-16112008000800011,ayuno,i
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,enfermos,i
123,S0212-16112008000800011,con,o
123,S0212-16112008000800011,cancer,i
123,S0212-16112008000800011,colorrectal,i
123,S0212-16112008000800011,ensayo,o
123,S0212-16112008000800011,clinico,o
123,S0212-16112008000800011,aleatorizado,o
123,S0212-16112008000800011,dobleciego,o
123,S0212-16112008000800011,placebocontrolado,o
123,S0212-16112008000800011,Introduccion,o
123,S0212-16112008000800011,El,o
123,S0212-16112008000800011,objetivo,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,este,o
123,S0212-16112008000800011,estudio,o
123,S0212-16112008000800011,fue,o
123,S0212-16112008000800011,evaluar,o
123,S0212-16112008000800011,los,o
123,S0212-16112008000800011,efectos,o
123,S0212-16112008000800011,en,o
123,S0212-16112008000800011,la,o
123,S0212-16112008000800011,glicemia,i
123,S0212-16112008000800011,de,i
123,S0212-16112008000800011,ayuno,i
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,los,o
123,S0212-16112008000800011,enfermos,i
123,S0212-16112008000800011,con,o
123,S0212-16112008000800011,cancer,i
123,S0212-16112008000800011,colorrectal,i
123,S0212-16112008000800011,en,o
123,S0212-16112008000800011,fase,o
123,S0212-16112008000800011,postoperatoria,o
123,S0212-16112008000800011,con,o
123,S0212-16112008000800011,suplementacion,i
123,S0212-16112008000800011,dietetica,i
123,S0212-16112008000800011,con,i
123,S0212-16112008000800011,hongos,i
123,S0212-16112008000800011,medicinales,i
123,S0212-16112008000800011,Agaricus,i
123,S0212-16112008000800011,sylvaticus,i
123,S0212-16112008000800011,Ambito,o
123,S0212-16112008000800011,Ambulatorio,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,Proctologia,o
123,S0212-16112008000800011,del,o
123,S0212-16112008000800011,Hospital,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,Base,o
123,S0212-16112008000800011,do,o
123,S0212-16112008000800011,Distrito,o
123,S0212-16112008000800011,FederalBrasil,o
123,S0212-16112008000800011,Sujetos,o
123,S0212-16112008000800011,Cincuenta,o
123,S0212-16112008000800011,y,o
123,S0212-16112008000800011,seis,o
123,S0212-16112008000800011,enfermos,i
123,S0212-16112008000800011,con,o
123,S0212-16112008000800011,cancer,i
123,S0212-16112008000800011,colorrectal,i
123,S0212-16112008000800011,en,o
123,S0212-16112008000800011,la,o
123,S0212-16112008000800011,fase,o
123,S0212-16112008000800011,postoperatoria,o
123,S0212-16112008000800011,estadio,o
123,S0212-16112008000800011,I,o
123,S0212-16112008000800011,II,o
123,S0212-16112008000800011,y,o
123,S0212-16112008000800011,III,o
123,S0212-16112008000800011,siguiendo,o
123,S0212-16112008000800011,criterios,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,inclusion,o
123,S0212-16112008000800011,y,o
123,S0212-16112008000800011,exclusion,o
123,S0212-16112008000800011,Intervenciones,i
123,S0212-16112008000800011,Todos,o
123,S0212-16112008000800011,los,o
123,S0212-16112008000800011,enfermos,i
123,S0212-16112008000800011,fueron,o
123,S0212-16112008000800011,aleatorizados,i
123,S0212-16112008000800011,en,o
123,S0212-16112008000800011,dos,o
123,S0212-16112008000800011,grupos,o
123,S0212-16112008000800011,suplementado,i
123,S0212-16112008000800011,con,i
123,S0212-16112008000800011,hongos,i
123,S0212-16112008000800011,Agaricus,i
123,S0212-16112008000800011,sylvaticus,i
123,S0212-16112008000800011,30,o
123,S0212-16112008000800011,mgkgdia,o
123,S0212-16112008000800011,y,o
123,S0212-16112008000800011,placebo,i
123,S0212-16112008000800011,por,o
123,S0212-16112008000800011,seis,o
123,S0212-16112008000800011,meses,o
123,S0212-16112008000800011,Enfermos,i
123,S0212-16112008000800011,fueron,o
123,S0212-16112008000800011,divididos,o
123,S0212-16112008000800011,siguiendo,o
123,S0212-16112008000800011,el,o
123,S0212-16112008000800011,Indice,i
123,S0212-16112008000800011,de,i
123,S0212-16112008000800011,Masa,i
123,S0212-16112008000800011,Corporal,i
123,S0212-16112008000800011,IMC,i
123,S0212-16112008000800011,sexo,o
123,S0212-16112008000800011,y,o
123,S0212-16112008000800011,estadio,o
123,S0212-16112008000800011,Tres,o
123,S0212-16112008000800011,evaluaciones,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,glicemia,i
123,S0212-16112008000800011,de,i
123,S0212-16112008000800011,ayuno,i
123,S0212-16112008000800011,en,o
123,S0212-16112008000800011,el,o
123,S0212-16112008000800011,tratamiento,i
123,S0212-16112008000800011,Resultados,o
123,S0212-16112008000800011,Los,o
123,S0212-16112008000800011,enfermos,i
123,S0212-16112008000800011,presentaban,o
123,S0212-16112008000800011,IMC,i
123,S0212-16112008000800011,promedio,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,2465,o
123,S0212-16112008000800011,kgm2,o
123,S0212-16112008000800011,mujeres,o
123,S0212-16112008000800011,571,o
123,S0212-16112008000800011,y,o
123,S0212-16112008000800011,hombres,o
123,S0212-16112008000800011,429,o
123,S0212-16112008000800011,El,o
123,S0212-16112008000800011,grupo,o
123,S0212-16112008000800011,placebo,i
123,S0212-16112008000800011,edad,o
123,S0212-16112008000800011,5914,o
123,S0212-16112008000800011,1295,o
123,S0212-16112008000800011,años,o
123,S0212-16112008000800011,tenia,o
123,S0212-16112008000800011,glicemia,i
123,S0212-16112008000800011,inicial,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,9436,o
123,S0212-16112008000800011,1534,o
123,S0212-16112008000800011,mgdL,o
123,S0212-16112008000800011,despues,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,tres,o
123,S0212-16112008000800011,meses,o
123,S0212-16112008000800011,9812,o
123,S0212-16112008000800011,1554,o
123,S0212-16112008000800011,mgdL,o
123,S0212-16112008000800011,p,o
123,S0212-16112008000800011,003,o
123,S0212-16112008000800011,y,o
123,S0212-16112008000800011,en,o
123,S0212-16112008000800011,el,o
123,S0212-16112008000800011,sexto,o
123,S0212-16112008000800011,mes,o
123,S0212-16112008000800011,presento,o
123,S0212-16112008000800011,aumento,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,9852,o
123,S0212-16112008000800011,903,o
123,S0212-16112008000800011,mgdL,o
123,S0212-16112008000800011,p,o
123,S0212-16112008000800011,001,o
123,S0212-16112008000800011,El,o
123,S0212-16112008000800011,grupo,o
123,S0212-16112008000800011,suplementado,i
123,S0212-16112008000800011,edad,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,5634,o
123,S0212-16112008000800011,1553,o
123,S0212-16112008000800011,años,o
123,S0212-16112008000800011,tenia,o
123,S0212-16112008000800011,glicemia,i
123,S0212-16112008000800011,inicial,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,9592,o
123,S0212-16112008000800011,1164,o
123,S0212-16112008000800011,mgdL,o
123,S0212-16112008000800011,despues,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,tres,o
123,S0212-16112008000800011,meses,o
123,S0212-16112008000800011,9488,o
123,S0212-16112008000800011,1224,o
123,S0212-16112008000800011,mgdL,o
123,S0212-16112008000800011,p,o
123,S0212-16112008000800011,065,o
123,S0212-16112008000800011,y,o
123,S0212-16112008000800011,en,o
123,S0212-16112008000800011,el,o
123,S0212-16112008000800011,sexto,o
123,S0212-16112008000800011,mes,o
123,S0212-16112008000800011,reduccion,o
123,S0212-16112008000800011,significativa,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,9286,o
123,S0212-16112008000800011,682,o
123,S0212-16112008000800011,mgdL,o
123,S0212-16112008000800011,p,o
123,S0212-16112008000800011,001,o
123,S0212-16112008000800011,Conclusion,o
123,S0212-16112008000800011,Resultados,o
123,S0212-16112008000800011,sugieren,o
123,S0212-16112008000800011,que,o
123,S0212-16112008000800011,la,o
123,S0212-16112008000800011,suplementacion,i
123,S0212-16112008000800011,dietetica,i
123,S0212-16112008000800011,con,i
123,S0212-16112008000800011,hongos,i
123,S0212-16112008000800011,Agaricus,i
123,S0212-16112008000800011,sylvaticus,i
123,S0212-16112008000800011,puede,o
123,S0212-16112008000800011,reducir,o
123,S0212-16112008000800011,la,o
123,S0212-16112008000800011,glicemia,i
123,S0212-16112008000800011,de,i
123,S0212-16112008000800011,ayuno,i
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,los,o
123,S0212-16112008000800011,enfermos,i
123,S0212-16112008000800011,con,o
123,S0212-16112008000800011,cancer,i
123,S0212-16112008000800011,colorrectal,i
123,S0212-16112008000800011,en,o
123,S0212-16112008000800011,la,o
123,S0212-16112008000800011,fase,o
123,S0212-16112008000800011,postoperatoria,o
123,S0212-16112008000800011,presentando,o
123,S0212-16112008000800011,efectos,o
123,S0212-16112008000800011,beneficos,o
123,S0212-16112008000800011,en,o
123,S0212-16112008000800011,el,o
123,S0212-16112008000800011,prognostico,o
123,S0212-16112008000800011,de,o
123,S0212-16112008000800011,los,o
123,S0212-16112008000800011,enfermos,i
124,S0212-16112010000100008,Ensayo,i
124,S0212-16112010000100008,clinico,i
124,S0212-16112010000100008,aleatorizado,i
124,S0212-16112010000100008,con,o
124,S0212-16112010000100008,una,o
124,S0212-16112010000100008,galleta,o
124,S0212-16112010000100008,enriquecida,o
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,inulina,i
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,el,o
124,S0212-16112010000100008,patron,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,riesgo,i
124,S0212-16112010000100008,cardiovascular,i
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,pacientes,o
124,S0212-16112010000100008,obesos,i
124,S0212-16112010000100008,Introduccion,o
124,S0212-16112010000100008,La,o
124,S0212-16112010000100008,inulina,i
124,S0212-16112010000100008,es,o
124,S0212-16112010000100008,un,o
124,S0212-16112010000100008,prebiotico,i
124,S0212-16112010000100008,con,o
124,S0212-16112010000100008,potenciales,o
124,S0212-16112010000100008,efectos,o
124,S0212-16112010000100008,beneficiosos,o
124,S0212-16112010000100008,a,o
124,S0212-16112010000100008,nivel,o
124,S0212-16112010000100008,cardiovascular,i
124,S0212-16112010000100008,El,o
124,S0212-16112010000100008,objetivo,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,nuestro,o
124,S0212-16112010000100008,trabajo,o
124,S0212-16112010000100008,es,o
124,S0212-16112010000100008,evaluar,o
124,S0212-16112010000100008,la,o
124,S0212-16112010000100008,respuesta,o
124,S0212-16112010000100008,del,o
124,S0212-16112010000100008,perfil,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,riesgo,i
124,S0212-16112010000100008,cardiovascular,i
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,pacientes,o
124,S0212-16112010000100008,obesos,i
124,S0212-16112010000100008,tras,o
124,S0212-16112010000100008,la,o
124,S0212-16112010000100008,inclusion,o
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,la,o
124,S0212-16112010000100008,dieta,i
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,una,o
124,S0212-16112010000100008,galleta,o
124,S0212-16112010000100008,enriquecida,o
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,inulina,i
124,S0212-16112010000100008,Material,o
124,S0212-16112010000100008,y,o
124,S0212-16112010000100008,metodos,o
124,S0212-16112010000100008,Un,o
124,S0212-16112010000100008,total,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,34,o
124,S0212-16112010000100008,pacientes,o
124,S0212-16112010000100008,fueron,o
124,S0212-16112010000100008,randomizados,i
124,S0212-16112010000100008,a,o
124,S0212-16112010000100008,una,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,las,o
124,S0212-16112010000100008,siguientes,o
124,S0212-16112010000100008,ramas,o
124,S0212-16112010000100008,galleta,o
124,S0212-16112010000100008,I,o
124,S0212-16112010000100008,enriquecida,o
124,S0212-16112010000100008,con,o
124,S0212-16112010000100008,inulina,i
124,S0212-16112010000100008,ver,o
124,S0212-16112010000100008,tabla,o
124,S0212-16112010000100008,I,o
124,S0212-16112010000100008,y,o
124,S0212-16112010000100008,galleta,o
124,S0212-16112010000100008,II,o
124,S0212-16112010000100008,galleta,o
124,S0212-16112010000100008,control,o
124,S0212-16112010000100008,ver,o
124,S0212-16112010000100008,tabla,o
124,S0212-16112010000100008,I,o
124,S0212-16112010000100008,Gullon,o
124,S0212-16112010000100008,SL,o
124,S0212-16112010000100008,Cada,o
124,S0212-16112010000100008,paciente,o
124,S0212-16112010000100008,recibio,o
124,S0212-16112010000100008,un,o
124,S0212-16112010000100008,total,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,8,o
124,S0212-16112010000100008,galletas,o
124,S0212-16112010000100008,al,o
124,S0212-16112010000100008,dia,o
124,S0212-16112010000100008,total,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,68,o
124,S0212-16112010000100008,gramos,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,producto,o
124,S0212-16112010000100008,Antes,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,iniciar,o
124,S0212-16112010000100008,el,o
124,S0212-16112010000100008,tratamiento,i
124,S0212-16112010000100008,y,o
124,S0212-16112010000100008,al,o
124,S0212-16112010000100008,mes,o
124,S0212-16112010000100008,se,o
124,S0212-16112010000100008,realizouna,o
124,S0212-16112010000100008,valoracion,i
124,S0212-16112010000100008,nutricional,i
124,S0212-16112010000100008,y,o
124,S0212-16112010000100008,analitica,i
124,S0212-16112010000100008,Resultados,o
124,S0212-16112010000100008,Finalizaron,o
124,S0212-16112010000100008,un,o
124,S0212-16112010000100008,total,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,15,o
124,S0212-16112010000100008,pacientes,o
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,cada,o
124,S0212-16112010000100008,grupo,o
124,S0212-16112010000100008,En,o
124,S0212-16112010000100008,el,o
124,S0212-16112010000100008,grupo,o
124,S0212-16112010000100008,I,o
124,S0212-16112010000100008,se,o
124,S0212-16112010000100008,produjo,o
124,S0212-16112010000100008,un,o
124,S0212-16112010000100008,aumento,o
124,S0212-16112010000100008,significativo,o
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,la,o
124,S0212-16112010000100008,ingesta,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,fibra,i
124,S0212-16112010000100008,soluble,o
124,S0212-16112010000100008,inulina,i
124,S0212-16112010000100008,Se,o
124,S0212-16112010000100008,detecto,o
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,los,o
124,S0212-16112010000100008,pacientes,o
124,S0212-16112010000100008,con,o
124,S0212-16112010000100008,las,o
124,S0212-16112010000100008,galletas,o
124,S0212-16112010000100008,enriquecidas,o
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,inulina,i
124,S0212-16112010000100008,una,o
124,S0212-16112010000100008,disminucion,o
124,S0212-16112010000100008,significativa,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,los,o
124,S0212-16112010000100008,niveles,i
124,S0212-16112010000100008,de,i
124,S0212-16112010000100008,colesterol,i
124,S0212-16112010000100008,total,i
124,S0212-16112010000100008,2231,o
124,S0212-16112010000100008,453,o
124,S0212-16112010000100008,mgdl,o
124,S0212-16112010000100008,vs,o
124,S0212-16112010000100008,2088,o
124,S0212-16112010000100008,331,o
124,S0212-16112010000100008,mgdl,o
124,S0212-16112010000100008,p,o
124,S0212-16112010000100008,005,o
124,S0212-16112010000100008,y,o
124,S0212-16112010000100008,LDL,i
124,S0212-16112010000100008,colesterol,i
124,S0212-16112010000100008,1429,o
124,S0212-16112010000100008,392,o
124,S0212-16112010000100008,mgdl,o
124,S0212-16112010000100008,vs,o
124,S0212-16112010000100008,1314,o
124,S0212-16112010000100008,286,o
124,S0212-16112010000100008,mgdl,o
124,S0212-16112010000100008,p,o
124,S0212-16112010000100008,005,o
124,S0212-16112010000100008,Tambien,o
124,S0212-16112010000100008,se,o
124,S0212-16112010000100008,detecto,o
124,S0212-16112010000100008,una,o
124,S0212-16112010000100008,disminucion,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,los,o
124,S0212-16112010000100008,niveles,i
124,S0212-16112010000100008,de,i
124,S0212-16112010000100008,insulina,i
124,S0212-16112010000100008,y,o
124,S0212-16112010000100008,resistencia,i
124,S0212-16112010000100008,a,i
124,S0212-16112010000100008,la,i
124,S0212-16112010000100008,insulina,i
124,S0212-16112010000100008,HOMA,i
124,S0212-16112010000100008,pero,o
124,S0212-16112010000100008,sin,o
124,S0212-16112010000100008,alcanzar,o
124,S0212-16112010000100008,la,o
124,S0212-16112010000100008,significacion,o
124,S0212-16112010000100008,estadistica,o
124,S0212-16112010000100008,No,o
124,S0212-16112010000100008,existieron,o
124,S0212-16112010000100008,diferencias,o
124,S0212-16112010000100008,estadisticamente,o
124,S0212-16112010000100008,significativas,o
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,las,o
124,S0212-16112010000100008,variables,o
124,S0212-16112010000100008,antropometricas,o
124,S0212-16112010000100008,El,o
124,S0212-16112010000100008,aumento,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,la,o
124,S0212-16112010000100008,ingesta,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,fibra,i
124,S0212-16112010000100008,soluble,o
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,los,o
124,S0212-16112010000100008,pacientes,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,grupo,o
124,S0212-16112010000100008,I,o
124,S0212-16112010000100008,no,o
124,S0212-16112010000100008,supuso,o
124,S0212-16112010000100008,ningun,o
124,S0212-16112010000100008,efecto,i
124,S0212-16112010000100008,secundario,i
124,S0212-16112010000100008,a,i
124,S0212-16112010000100008,nivel,i
124,S0212-16112010000100008,gastrointestinal,i
124,S0212-16112010000100008,Conclusion,o
124,S0212-16112010000100008,El,o
124,S0212-16112010000100008,aumento,o
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,la,o
124,S0212-16112010000100008,ingesta,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,3,o
124,S0212-16112010000100008,gramos,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,inulina,i
124,S0212-16112010000100008,proveniente,o
124,S0212-16112010000100008,de,o
124,S0212-16112010000100008,una,o
124,S0212-16112010000100008,galleta,o
124,S0212-16112010000100008,enriquecida,o
124,S0212-16112010000100008,reduce,o
124,S0212-16112010000100008,los,o
124,S0212-16112010000100008,niveles,i
124,S0212-16112010000100008,de,i
124,S0212-16112010000100008,colesterol,i
124,S0212-16112010000100008,LDL,i
124,S0212-16112010000100008,en,o
124,S0212-16112010000100008,pacientes,o
124,S0212-16112010000100008,obesos,i
125,S0212-16112010000200012,Efectos,o
125,S0212-16112010000200012,de,o
125,S0212-16112010000200012,telmisartan,i
125,S0212-16112010000200012,vs,o
125,S0212-16112010000200012,olmesartan,i
125,S0212-16112010000200012,sobre,o
125,S0212-16112010000200012,parametros,o
125,S0212-16112010000200012,antropometricos,i
125,S0212-16112010000200012,resistencia,i
125,S0212-16112010000200012,a,i
125,S0212-16112010000200012,la,i
125,S0212-16112010000200012,insulina,i
125,S0212-16112010000200012,y,o
125,S0212-16112010000200012,adipocitoquinas,i
125,S0212-16112010000200012,en,o
125,S0212-16112010000200012,pacientes,o
125,S0212-16112010000200012,hipertensos,i
125,S0212-16112010000200012,obesos,i
125,S0212-16112010000200012,Introduccion,o
125,S0212-16112010000200012,La,o
125,S0212-16112010000200012,angiotensina,i
125,S0212-16112010000200012,II,i
125,S0212-16112010000200012,puede,o
125,S0212-16112010000200012,regular,o
125,S0212-16112010000200012,la,o
125,S0212-16112010000200012,produccion,o
125,S0212-16112010000200012,de,o
125,S0212-16112010000200012,adipocitoquinas,i
125,S0212-16112010000200012,El,o
125,S0212-16112010000200012,objetivo,o
125,S0212-16112010000200012,de,o
125,S0212-16112010000200012,nuestro,o
125,S0212-16112010000200012,trabajo,o
125,S0212-16112010000200012,fue,o
125,S0212-16112010000200012,evaluar,o
125,S0212-16112010000200012,el,o
125,S0212-16112010000200012,efecto,o
125,S0212-16112010000200012,sobre,o
125,S0212-16112010000200012,parametros,i
125,S0212-16112010000200012,bioquimicos,i
125,S0212-16112010000200012,del,o
125,S0212-16112010000200012,tratamiento,i
125,S0212-16112010000200012,con,o
125,S0212-16112010000200012,telmisartan,i
125,S0212-16112010000200012,versus,o
125,S0212-16112010000200012,olmesartan,i
125,S0212-16112010000200012,en,o
125,S0212-16112010000200012,pacientes,o
125,S0212-16112010000200012,obesos,i
125,S0212-16112010000200012,hipertensos,i
125,S0212-16112010000200012,Pacientes,o
125,S0212-16112010000200012,Se,o
125,S0212-16112010000200012,analizo,o
125,S0212-16112010000200012,una,o
125,S0212-16112010000200012,muestra,o
125,S0212-16112010000200012,de,o
125,S0212-16112010000200012,65,o
125,S0212-16112010000200012,pacientes,o
125,S0212-16112010000200012,con,o
125,S0212-16112010000200012,hipertension,i
125,S0212-16112010000200012,moderada,o
125,S0212-16112010000200012,severa,o
125,S0212-16112010000200012,y,o
125,S0212-16112010000200012,obesidad,i
125,S0212-16112010000200012,mediante,o
125,S0212-16112010000200012,un,o
125,S0212-16112010000200012,ensayo,i
125,S0212-16112010000200012,clinico,i
125,S0212-16112010000200012,randomizado,i
125,S0212-16112010000200012,Los,o
125,S0212-16112010000200012,pacientes,o
125,S0212-16112010000200012,fueron,o
125,S0212-16112010000200012,randomizados,i
125,S0212-16112010000200012,en,o
125,S0212-16112010000200012,dos,o
125,S0212-16112010000200012,ramas,o
125,S0212-16112010000200012,telmisartan,i
125,S0212-16112010000200012,80,o
125,S0212-16112010000200012,mgdia,o
125,S0212-16112010000200012,u,o
125,S0212-16112010000200012,olmesartan,i
125,S0212-16112010000200012,40,o
125,S0212-16112010000200012,mgdia,o
125,S0212-16112010000200012,durante,o
125,S0212-16112010000200012,3,o
125,S0212-16112010000200012,meses,o
125,S0212-16112010000200012,Se,o
125,S0212-16112010000200012,determinaron,o
125,S0212-16112010000200012,en,o
125,S0212-16112010000200012,el,o
125,S0212-16112010000200012,tiempo,o
125,S0212-16112010000200012,basal,o
125,S0212-16112010000200012,y,o
125,S0212-16112010000200012,tras,o
125,S0212-16112010000200012,3,o
125,S0212-16112010000200012,meses,o
125,S0212-16112010000200012,los,o
125,S0212-16112010000200012,siguientes,o
125,S0212-16112010000200012,parametros,o
125,S0212-16112010000200012,peso,o
125,S0212-16112010000200012,indice,i
125,S0212-16112010000200012,de,i
125,S0212-16112010000200012,masa,i
125,S0212-16112010000200012,corporal,i
125,S0212-16112010000200012,presion,i
125,S0212-16112010000200012,arterial,i
125,S0212-16112010000200012,glucosa,i
125,S0212-16112010000200012,insulina,i
125,S0212-16112010000200012,colesterol,i
125,S0212-16112010000200012,total,i
125,S0212-16112010000200012,LDLcolesterol,o
125,S0212-16112010000200012,HDLcolesteroltrigliceridos,o
125,S0212-16112010000200012,HOMA,i
125,S0212-16112010000200012,QUICKI,i
125,S0212-16112010000200012,leptina,i
125,S0212-16112010000200012,y,o
125,S0212-16112010000200012,adiponectina,i
125,S0212-16112010000200012,Resultados,o
125,S0212-16112010000200012,Los,o
125,S0212-16112010000200012,pacientes,o
125,S0212-16112010000200012,que,o
125,S0212-16112010000200012,recibieron,o
125,S0212-16112010000200012,telmisartan,i
125,S0212-16112010000200012,tuvieron,o
125,S0212-16112010000200012,una,o
125,S0212-16112010000200012,disminucion,o
125,S0212-16112010000200012,significativa,o
125,S0212-16112010000200012,de,o
125,S0212-16112010000200012,los,o
125,S0212-16112010000200012,niveles,i
125,S0212-16112010000200012,de,i
125,S0212-16112010000200012,glucosa,i
125,S0212-16112010000200012,1053,o
125,S0212-16112010000200012,mgdl,o
125,S0212-16112010000200012,CI,o
125,S0212-16112010000200012,95,o
125,S0212-16112010000200012,26185,o
125,S0212-16112010000200012,insulina,i
125,S0212-16112010000200012,251,o
125,S0212-16112010000200012,mUIL,o
125,S0212-16112010000200012,CI,o
125,S0212-16112010000200012,95,o
125,S0212-16112010000200012,207717,o
125,S0212-16112010000200012,y,o
125,S0212-16112010000200012,HOMA,i
125,S0212-16112010000200012,108,o
125,S0212-16112010000200012,CI,o
125,S0212-16112010000200012,95,o
125,S0212-16112010000200012,039255,o
125,S0212-16112010000200012,Los,o
125,S0212-16112010000200012,pacientes,o
125,S0212-16112010000200012,tratados,i
125,S0212-16112010000200012,con,o
125,S0212-16112010000200012,olmesartan,i
125,S0212-16112010000200012,presentaron,o
125,S0212-16112010000200012,una,o
125,S0212-16112010000200012,disminucion,o
125,S0212-16112010000200012,significativa,o
125,S0212-16112010000200012,de,o
125,S0212-16112010000200012,colesterol,i
125,S0212-16112010000200012,202,o
125,S0212-16112010000200012,mgdl,o
125,S0212-16112010000200012,CI,o
125,S0212-16112010000200012,95,o
125,S0212-16112010000200012,58349,o
125,S0212-16112010000200012,y,o
125,S0212-16112010000200012,LDL,i
125,S0212-16112010000200012,colesterol,i
125,S0212-16112010000200012,226,o
125,S0212-16112010000200012,mgdl,o
125,S0212-16112010000200012,CI,o
125,S0212-16112010000200012,95,o
125,S0212-16112010000200012,97356,o
125,S0212-16112010000200012,Solo,o
125,S0212-16112010000200012,los,o
125,S0212-16112010000200012,niveles,i
125,S0212-16112010000200012,de,i
125,S0212-16112010000200012,leptina,i
125,S0212-16112010000200012,disminuyeron,o
125,S0212-16112010000200012,de,o
125,S0212-16112010000200012,manera,o
125,S0212-16112010000200012,significativa,o
125,S0212-16112010000200012,con,o
125,S0212-16112010000200012,telmisartan,i
125,S0212-16112010000200012,739,o
125,S0212-16112010000200012,ngml,o
125,S0212-16112010000200012,CI,o
125,S0212-16112010000200012,95,o
125,S0212-16112010000200012,1471331,o
125,S0212-16112010000200012,Conclusion,o
125,S0212-16112010000200012,Telmisartan,i
125,S0212-16112010000200012,mejora,o
125,S0212-16112010000200012,los,o
125,S0212-16112010000200012,niveles,i
125,S0212-16112010000200012,de,i
125,S0212-16112010000200012,presion,i
125,S0212-16112010000200012,arterial,i
125,S0212-16112010000200012,glucosa,i
125,S0212-16112010000200012,insulina,i
125,S0212-16112010000200012,HOMA,i
125,S0212-16112010000200012,y,o
125,S0212-16112010000200012,leptina,i
125,S0212-16112010000200012,en,o
125,S0212-16112010000200012,pacientes,o
125,S0212-16112010000200012,hipertensos,i
125,S0212-16112010000200012,obesos,i
125,S0212-16112010000200012,Olmesartan,i
125,S0212-16112010000200012,mejoro,o
125,S0212-16112010000200012,los,o
125,S0212-16112010000200012,niveles,i
125,S0212-16112010000200012,de,i
125,S0212-16112010000200012,presion,i
125,S0212-16112010000200012,arterial,i
125,S0212-16112010000200012,y,o
125,S0212-16112010000200012,el,o
125,S0212-16112010000200012,perfil,i
125,S0212-16112010000200012,lipidico,i
126,S0212-16112010000500018,Apoyo,i
126,S0212-16112010000500018,nutricional,i
126,S0212-16112010000500018,perioperatorio,o
126,S0212-16112010000500018,en,o
126,S0212-16112010000500018,pacientes,o
126,S0212-16112010000500018,con,o
126,S0212-16112010000500018,neoplasia,i
126,S0212-16112010000500018,colorrectal,i
126,S0212-16112010000500018,Objetivos,o
126,S0212-16112010000500018,La,o
126,S0212-16112010000500018,desnutricion,i
126,S0212-16112010000500018,se,o
126,S0212-16112010000500018,asocia,o
126,S0212-16112010000500018,con,o
126,S0212-16112010000500018,elevadas,o
126,S0212-16112010000500018,tasas,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,morbimortalidad,o
126,S0212-16112010000500018,postoperatoria,o
126,S0212-16112010000500018,Nos,o
126,S0212-16112010000500018,proponemos,o
126,S0212-16112010000500018,evaluar,i
126,S0212-16112010000500018,la,i
126,S0212-16112010000500018,efectividad,i
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,un,o
126,S0212-16112010000500018,programa,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,apoyo,i
126,S0212-16112010000500018,nutricional,i
126,S0212-16112010000500018,perioperatorio,o
126,S0212-16112010000500018,entre,o
126,S0212-16112010000500018,pacientes,o
126,S0212-16112010000500018,sometidos,o
126,S0212-16112010000500018,a,o
126,S0212-16112010000500018,cirugia,i
126,S0212-16112010000500018,mayor,i
126,S0212-16112010000500018,oncologica,i
126,S0212-16112010000500018,Metodos,o
126,S0212-16112010000500018,Estudio,i
126,S0212-16112010000500018,prospectivo,i
126,S0212-16112010000500018,aleatorizado,i
126,S0212-16112010000500018,sobre,o
126,S0212-16112010000500018,una,o
126,S0212-16112010000500018,muestra,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,pacientes,o
126,S0212-16112010000500018,intervenidos,i
126,S0212-16112010000500018,por,o
126,S0212-16112010000500018,neoplasia,i
126,S0212-16112010000500018,del,i
126,S0212-16112010000500018,tubo,i
126,S0212-16112010000500018,digestivo,i
126,S0212-16112010000500018,bajo,i
126,S0212-16112010000500018,durante,o
126,S0212-16112010000500018,un,o
126,S0212-16112010000500018,periodo,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,3,o
126,S0212-16112010000500018,años,o
126,S0212-16112010000500018,Se,o
126,S0212-16112010000500018,realizo,o
126,S0212-16112010000500018,una,o
126,S0212-16112010000500018,valoracion,i
126,S0212-16112010000500018,nutricional,i
126,S0212-16112010000500018,y,o
126,S0212-16112010000500018,se,o
126,S0212-16112010000500018,administro,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,forma,o
126,S0212-16112010000500018,perioperatoria,o
126,S0212-16112010000500018,una,o
126,S0212-16112010000500018,formula,i
126,S0212-16112010000500018,enteral,i
126,S0212-16112010000500018,inmunomoduladora,i
126,S0212-16112010000500018,a,o
126,S0212-16112010000500018,un,o
126,S0212-16112010000500018,grupo,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,pacientes,o
126,S0212-16112010000500018,malnutridos,i
126,S0212-16112010000500018,DS,o
126,S0212-16112010000500018,mientras,o
126,S0212-16112010000500018,que,o
126,S0212-16112010000500018,otro,o
126,S0212-16112010000500018,grupo,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,pacientes,o
126,S0212-16112010000500018,malnutridos,i
126,S0212-16112010000500018,DNS,o
126,S0212-16112010000500018,y,o
126,S0212-16112010000500018,los,o
126,S0212-16112010000500018,normonutridos,o
126,S0212-16112010000500018,recibieron,o
126,S0212-16112010000500018,solo,o
126,S0212-16112010000500018,consejo,i
126,S0212-16112010000500018,dietetico,i
126,S0212-16112010000500018,antes,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,la,o
126,S0212-16112010000500018,cirugia,i
126,S0212-16112010000500018,Las,o
126,S0212-16112010000500018,variables,o
126,S0212-16112010000500018,estudiadas,o
126,S0212-16112010000500018,fueron,o
126,S0212-16112010000500018,edad,o
126,S0212-16112010000500018,sexo,o
126,S0212-16112010000500018,tipo,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,neoplasia,i
126,S0212-16112010000500018,y,o
126,S0212-16112010000500018,estancia,o
126,S0212-16112010000500018,hospitalaria,o
126,S0212-16112010000500018,Tambien,o
126,S0212-16112010000500018,se,o
126,S0212-16112010000500018,recogieron,o
126,S0212-16112010000500018,la,o
126,S0212-16112010000500018,situacion,o
126,S0212-16112010000500018,nutricional,o
126,S0212-16112010000500018,mortalidad,o
126,S0212-16112010000500018,complicaciones,i
126,S0212-16112010000500018,postoperatorias,i
126,S0212-16112010000500018,y,o
126,S0212-16112010000500018,alteraciones,i
126,S0212-16112010000500018,gastrointestinales,i
126,S0212-16112010000500018,Para,o
126,S0212-16112010000500018,el,o
126,S0212-16112010000500018,analisis,o
126,S0212-16112010000500018,estadistico,o
126,S0212-16112010000500018,realizamos,o
126,S0212-16112010000500018,un,o
126,S0212-16112010000500018,estudio,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,frecuencias,o
126,S0212-16112010000500018,y,o
126,S0212-16112010000500018,aplicamos,o
126,S0212-16112010000500018,el,o
126,S0212-16112010000500018,test,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,Chicuadrado,o
126,S0212-16112010000500018,en,o
126,S0212-16112010000500018,las,o
126,S0212-16112010000500018,variables,o
126,S0212-16112010000500018,cualitativas,o
126,S0212-16112010000500018,Para,o
126,S0212-16112010000500018,las,o
126,S0212-16112010000500018,cuantitativas,o
126,S0212-16112010000500018,usamos,o
126,S0212-16112010000500018,la,o
126,S0212-16112010000500018,ANOVA,o
126,S0212-16112010000500018,y,o
126,S0212-16112010000500018,el,o
126,S0212-16112010000500018,test,o
126,S0212-16112010000500018,Posthoc,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,Tukey,o
126,S0212-16112010000500018,Se,o
126,S0212-16112010000500018,consideraron,o
126,S0212-16112010000500018,significativos,o
126,S0212-16112010000500018,aquellos,o
126,S0212-16112010000500018,valores,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,p,o
126,S0212-16112010000500018,005,o
126,S0212-16112010000500018,Resultados,o
126,S0212-16112010000500018,Estudio,o
126,S0212-16112010000500018,sobre,o
126,S0212-16112010000500018,82,o
126,S0212-16112010000500018,pacientes,o
126,S0212-16112010000500018,divididos,o
126,S0212-16112010000500018,en,o
126,S0212-16112010000500018,3,o
126,S0212-16112010000500018,grupos,o
126,S0212-16112010000500018,estadisticamente,o
126,S0212-16112010000500018,comparables,o
126,S0212-16112010000500018,entre,o
126,S0212-16112010000500018,si,o
126,S0212-16112010000500018,Se,o
126,S0212-16112010000500018,encontraron,o
126,S0212-16112010000500018,diferencias,o
126,S0212-16112010000500018,estadisticamente,o
126,S0212-16112010000500018,significativas,o
126,S0212-16112010000500018,en,o
126,S0212-16112010000500018,la,o
126,S0212-16112010000500018,incidencia,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,complicaciones,i
126,S0212-16112010000500018,gastrointestinales,i
126,S0212-16112010000500018,estancia,o
126,S0212-16112010000500018,hospitalaria,o
126,S0212-16112010000500018,p0001,o
126,S0212-16112010000500018,y,o
126,S0212-16112010000500018,mortalidad,o
126,S0212-16112010000500018,p0004,o
126,S0212-16112010000500018,entre,o
126,S0212-16112010000500018,los,o
126,S0212-16112010000500018,dos,o
126,S0212-16112010000500018,grupos,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,pacientes,o
126,S0212-16112010000500018,malnutridos,i
126,S0212-16112010000500018,Conclusiones,o
126,S0212-16112010000500018,Se,o
126,S0212-16112010000500018,ha,o
126,S0212-16112010000500018,demostrado,o
126,S0212-16112010000500018,una,o
126,S0212-16112010000500018,mejor,o
126,S0212-16112010000500018,evolucion,o
126,S0212-16112010000500018,tras,o
126,S0212-16112010000500018,la,o
126,S0212-16112010000500018,cirugia,i
126,S0212-16112010000500018,en,o
126,S0212-16112010000500018,el,o
126,S0212-16112010000500018,grupo,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,pacientes,o
126,S0212-16112010000500018,normonutridos,o
126,S0212-16112010000500018,y,o
126,S0212-16112010000500018,el,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,DS,o
126,S0212-16112010000500018,Se,o
126,S0212-16112010000500018,observaron,o
126,S0212-16112010000500018,en,o
126,S0212-16112010000500018,estos,o
126,S0212-16112010000500018,pacientes,o
126,S0212-16112010000500018,una,o
126,S0212-16112010000500018,menor,o
126,S0212-16112010000500018,ingresacidencia,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,complicaciones,i
126,S0212-16112010000500018,gastrointestinales,i
126,S0212-16112010000500018,acortamiento,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,la,o
126,S0212-16112010000500018,estancia,o
126,S0212-16112010000500018,hospitalaria,o
126,S0212-16112010000500018,y,o
126,S0212-16112010000500018,disminucion,o
126,S0212-16112010000500018,de,o
126,S0212-16112010000500018,la,o
126,S0212-16112010000500018,morbimortalidad,o
126,S0212-16112010000500018,con,o
126,S0212-16112010000500018,diferencias,o
126,S0212-16112010000500018,estadisticamente,o
126,S0212-16112010000500018,significativas,o
126,S0212-16112010000500018,respecto,o
126,S0212-16112010000500018,al,o
126,S0212-16112010000500018,grupo,o
126,S0212-16112010000500018,DNS,o
127,S0212-16112010000600008,Efectos,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,una,o
127,S0212-16112010000600008,dietaformula,o
127,S0212-16112010000600008,normocalorica,o
127,S0212-16112010000600008,e,o
127,S0212-16112010000600008,hiperproteica,o
127,S0212-16112010000600008,Vegestart,o
127,S0212-16112010000600008,complet,o
127,S0212-16112010000600008,vs,o
127,S0212-16112010000600008,dieta,i
127,S0212-16112010000600008,normal,i
127,S0212-16112010000600008,baja,i
127,S0212-16112010000600008,en,i
127,S0212-16112010000600008,calorias,i
127,S0212-16112010000600008,en,o
127,S0212-16112010000600008,pacientes,o
127,S0212-16112010000600008,con,o
127,S0212-16112010000600008,obesidad,i
127,S0212-16112010000600008,morbida,i
127,S0212-16112010000600008,como,o
127,S0212-16112010000600008,preparacion,o
127,S0212-16112010000600008,a,o
127,S0212-16112010000600008,cirugia,i
127,S0212-16112010000600008,bariatrica,i
127,S0212-16112010000600008,bypass,i
127,S0212-16112010000600008,gastrico,i
127,S0212-16112010000600008,laparoscopico,i
127,S0212-16112010000600008,de,i
127,S0212-16112010000600008,una,i
127,S0212-16112010000600008,anastomosis,i
127,S0212-16112010000600008,estudio,i
127,S0212-16112010000600008,prospectivo,i
127,S0212-16112010000600008,doble,i
127,S0212-16112010000600008,ciego,i
127,S0212-16112010000600008,aleatorizado,i
127,S0212-16112010000600008,Objetivos,o
127,S0212-16112010000600008,La,o
127,S0212-16112010000600008,cirugia,i
127,S0212-16112010000600008,bariatrica,i
127,S0212-16112010000600008,es,o
127,S0212-16112010000600008,considerada,o
127,S0212-16112010000600008,la,o
127,S0212-16112010000600008,unica,o
127,S0212-16112010000600008,alternativa,o
127,S0212-16112010000600008,terapeutica,o
127,S0212-16112010000600008,para,o
127,S0212-16112010000600008,el,o
127,S0212-16112010000600008,control,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,la,o
127,S0212-16112010000600008,obesidad,i
127,S0212-16112010000600008,morbida,i
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,sus,o
127,S0212-16112010000600008,comorbilidades,o
127,S0212-16112010000600008,Dada,o
127,S0212-16112010000600008,la,o
127,S0212-16112010000600008,complejidad,o
127,S0212-16112010000600008,gravedad,o
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,dificultades,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,estos,o
127,S0212-16112010000600008,pacientes,o
127,S0212-16112010000600008,todo,o
127,S0212-16112010000600008,lo,o
127,S0212-16112010000600008,que,o
127,S0212-16112010000600008,hagamos,o
127,S0212-16112010000600008,para,o
127,S0212-16112010000600008,disminuir,o
127,S0212-16112010000600008,los,o
127,S0212-16112010000600008,riesgos,o
127,S0212-16112010000600008,perioperatorios,o
127,S0212-16112010000600008,debe,o
127,S0212-16112010000600008,ser,o
127,S0212-16112010000600008,considerado,o
127,S0212-16112010000600008,como,o
127,S0212-16112010000600008,muy,o
127,S0212-16112010000600008,beneficioso,o
127,S0212-16112010000600008,para,o
127,S0212-16112010000600008,ellos,o
127,S0212-16112010000600008,De,o
127,S0212-16112010000600008,este,o
127,S0212-16112010000600008,modo,o
127,S0212-16112010000600008,consideramos,o
127,S0212-16112010000600008,que,o
127,S0212-16112010000600008,una,o
127,S0212-16112010000600008,disminucion,o
127,S0212-16112010000600008,como,o
127,S0212-16112010000600008,minimo,o
127,S0212-16112010000600008,del,o
127,S0212-16112010000600008,10,o
127,S0212-16112010000600008,en,o
127,S0212-16112010000600008,el,o
127,S0212-16112010000600008,exceso,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,peso,o
127,S0212-16112010000600008,en,o
127,S0212-16112010000600008,los,o
127,S0212-16112010000600008,Obesos,i
127,S0212-16112010000600008,Morbidos,i
127,S0212-16112010000600008,OM,i
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,un,o
127,S0212-16112010000600008,20,o
127,S0212-16112010000600008,en,o
127,S0212-16112010000600008,los,o
127,S0212-16112010000600008,SuperObesos,o
127,S0212-16112010000600008,SO,o
127,S0212-16112010000600008,antes,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,la,o
127,S0212-16112010000600008,cirugia,i
127,S0212-16112010000600008,puede,o
127,S0212-16112010000600008,mejorar,o
127,S0212-16112010000600008,los,o
127,S0212-16112010000600008,resultados,o
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,disminuir,o
127,S0212-16112010000600008,la,o
127,S0212-16112010000600008,morbimortalidad,o
127,S0212-16112010000600008,del,o
127,S0212-16112010000600008,procedimiento,i
127,S0212-16112010000600008,El,o
127,S0212-16112010000600008,objetivo,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,nuestro,o
127,S0212-16112010000600008,estudio,o
127,S0212-16112010000600008,es,o
127,S0212-16112010000600008,demostrar,i
127,S0212-16112010000600008,la,i
127,S0212-16112010000600008,eficiencia,i
127,S0212-16112010000600008,y,i
127,S0212-16112010000600008,tolerancia,i
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,una,o
127,S0212-16112010000600008,dietaformula,o
127,S0212-16112010000600008,hiperproteica,o
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,normocalorica,o
127,S0212-16112010000600008,como,o
127,S0212-16112010000600008,preparacion,o
127,S0212-16112010000600008,preoperatoria,o
127,S0212-16112010000600008,comparandola,o
127,S0212-16112010000600008,con,o
127,S0212-16112010000600008,una,o
127,S0212-16112010000600008,dieta,i
127,S0212-16112010000600008,hipocalorica,i
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,comida,o
127,S0212-16112010000600008,habitual,o
127,S0212-16112010000600008,Metodos,o
127,S0212-16112010000600008,De,o
127,S0212-16112010000600008,forma,o
127,S0212-16112010000600008,prospectiva,o
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,aleatorizada,i
127,S0212-16112010000600008,se,o
127,S0212-16112010000600008,estudiaron,o
127,S0212-16112010000600008,120,o
127,S0212-16112010000600008,pacientes,o
127,S0212-16112010000600008,divididos,o
127,S0212-16112010000600008,en,o
127,S0212-16112010000600008,dos,o
127,S0212-16112010000600008,grupos,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,60,o
127,S0212-16112010000600008,cada,o
127,S0212-16112010000600008,uno,o
127,S0212-16112010000600008,Las,o
127,S0212-16112010000600008,dietas,i
127,S0212-16112010000600008,se,o
127,S0212-16112010000600008,administraron,o
127,S0212-16112010000600008,20,o
127,S0212-16112010000600008,dias,o
127,S0212-16112010000600008,previos,o
127,S0212-16112010000600008,a,o
127,S0212-16112010000600008,la,o
127,S0212-16112010000600008,cirugia,i
127,S0212-16112010000600008,Al,o
127,S0212-16112010000600008,primer,o
127,S0212-16112010000600008,grupo,o
127,S0212-16112010000600008,A,o
127,S0212-16112010000600008,se,o
127,S0212-16112010000600008,le,o
127,S0212-16112010000600008,aplico,o
127,S0212-16112010000600008,una,o
127,S0212-16112010000600008,dietaformula,o
127,S0212-16112010000600008,hiperproteica,o
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,normocalorica,o
127,S0212-16112010000600008,en,o
127,S0212-16112010000600008,bricks,o
127,S0212-16112010000600008,conteniendo,o
127,S0212-16112010000600008,200,o
127,S0212-16112010000600008,kcal,o
127,S0212-16112010000600008,cada,o
127,S0212-16112010000600008,6,o
127,S0212-16112010000600008,horas,o
127,S0212-16112010000600008,durante,o
127,S0212-16112010000600008,los,o
127,S0212-16112010000600008,primeros,o
127,S0212-16112010000600008,12,o
127,S0212-16112010000600008,dias,o
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,al,o
127,S0212-16112010000600008,segundo,o
127,S0212-16112010000600008,grupo,o
127,S0212-16112010000600008,B,o
127,S0212-16112010000600008,una,o
127,S0212-16112010000600008,dieta,i
127,S0212-16112010000600008,hiperproteica,i
127,S0212-16112010000600008,normal,i
127,S0212-16112010000600008,sin,i
127,S0212-16112010000600008,carbohidratos,i
127,S0212-16112010000600008,o,i
127,S0212-16112010000600008,grasas,i
127,S0212-16112010000600008,Los,o
127,S0212-16112010000600008,ultimos,o
127,S0212-16112010000600008,8,o
127,S0212-16112010000600008,dias,o
127,S0212-16112010000600008,previos,o
127,S0212-16112010000600008,a,o
127,S0212-16112010000600008,la,o
127,S0212-16112010000600008,cirugia,i
127,S0212-16112010000600008,se,o
127,S0212-16112010000600008,dieron,o
127,S0212-16112010000600008,solamente,o
127,S0212-16112010000600008,liquidos,o
127,S0212-16112010000600008,claros,o
127,S0212-16112010000600008,en,o
127,S0212-16112010000600008,ambos,o
127,S0212-16112010000600008,grupos,o
127,S0212-16112010000600008,El,o
127,S0212-16112010000600008,analisis,i
127,S0212-16112010000600008,se,i
127,S0212-16112010000600008,efectuo,i
127,S0212-16112010000600008,sobre,i
127,S0212-16112010000600008,la,i
127,S0212-16112010000600008,evolucion,i
127,S0212-16112010000600008,del,i
127,S0212-16112010000600008,peso,i
127,S0212-16112010000600008,del,o
127,S0212-16112010000600008,IMC,i
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,la,o
127,S0212-16112010000600008,presion,i
127,S0212-16112010000600008,arterial,i
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,los,o
127,S0212-16112010000600008,niveles,i
127,S0212-16112010000600008,de,i
127,S0212-16112010000600008,glucemia,i
127,S0212-16112010000600008,asi,o
127,S0212-16112010000600008,como,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,la,o
127,S0212-16112010000600008,tolerancia,o
127,S0212-16112010000600008,al,o
127,S0212-16112010000600008,procedimiento,i
127,S0212-16112010000600008,Resultados,o
127,S0212-16112010000600008,El,o
127,S0212-16112010000600008,estudio,o
127,S0212-16112010000600008,demostro,o
127,S0212-16112010000600008,que,o
127,S0212-16112010000600008,los,o
127,S0212-16112010000600008,pacientes,o
127,S0212-16112010000600008,pertenecientes,o
127,S0212-16112010000600008,al,o
127,S0212-16112010000600008,grupo,o
127,S0212-16112010000600008,A,o
127,S0212-16112010000600008,mejoraron,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,forma,o
127,S0212-16112010000600008,estadisticamente,o
127,S0212-16112010000600008,significativa,o
127,S0212-16112010000600008,tanto,o
127,S0212-16112010000600008,en,o
127,S0212-16112010000600008,la,o
127,S0212-16112010000600008,perdida,i
127,S0212-16112010000600008,de,i
127,S0212-16112010000600008,peso,i
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,del,o
127,S0212-16112010000600008,IMC,i
127,S0212-16112010000600008,como,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,las,o
127,S0212-16112010000600008,comorbilidades,o
127,S0212-16112010000600008,estudiadas,o
127,S0212-16112010000600008,frente,o
127,S0212-16112010000600008,a,o
127,S0212-16112010000600008,los,o
127,S0212-16112010000600008,pacientes,o
127,S0212-16112010000600008,que,o
127,S0212-16112010000600008,integraron,o
127,S0212-16112010000600008,el,o
127,S0212-16112010000600008,grupo,o
127,S0212-16112010000600008,B,o
127,S0212-16112010000600008,Aunque,o
127,S0212-16112010000600008,en,o
127,S0212-16112010000600008,todo,o
127,S0212-16112010000600008,el,o
127,S0212-16112010000600008,conjunto,o
127,S0212-16112010000600008,ambos,o
127,S0212-16112010000600008,grupos,o
127,S0212-16112010000600008,obtuvieron,o
127,S0212-16112010000600008,perdida,i
127,S0212-16112010000600008,de,i
127,S0212-16112010000600008,peso,i
127,S0212-16112010000600008,preoperatoria,o
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,mejoria,o
127,S0212-16112010000600008,en,o
127,S0212-16112010000600008,sus,o
127,S0212-16112010000600008,comorbilidades,o
127,S0212-16112010000600008,Conclusiones,o
127,S0212-16112010000600008,Una,o
127,S0212-16112010000600008,preparacion,o
127,S0212-16112010000600008,adecuada,o
127,S0212-16112010000600008,para,o
127,S0212-16112010000600008,los,o
127,S0212-16112010000600008,pacientes,o
127,S0212-16112010000600008,que,o
127,S0212-16112010000600008,vayan,o
127,S0212-16112010000600008,a,o
127,S0212-16112010000600008,ser,o
127,S0212-16112010000600008,sometidos,o
127,S0212-16112010000600008,a,o
127,S0212-16112010000600008,cirugia,i
127,S0212-16112010000600008,bariatrica,i
127,S0212-16112010000600008,puede,o
127,S0212-16112010000600008,mejorar,o
127,S0212-16112010000600008,los,o
127,S0212-16112010000600008,resultados,o
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,minimizar,o
127,S0212-16112010000600008,los,o
127,S0212-16112010000600008,posibles,o
127,S0212-16112010000600008,efectos,i
127,S0212-16112010000600008,indeseables,i
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,la,o
127,S0212-16112010000600008,misma,o
127,S0212-16112010000600008,Una,o
127,S0212-16112010000600008,dietaformula,o
127,S0212-16112010000600008,del,o
127,S0212-16112010000600008,tipo,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,la,o
127,S0212-16112010000600008,ensayada,o
127,S0212-16112010000600008,en,o
127,S0212-16112010000600008,nuestro,o
127,S0212-16112010000600008,estudio,o
127,S0212-16112010000600008,alcanza,o
127,S0212-16112010000600008,los,o
127,S0212-16112010000600008,objetivos,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,perdida,i
127,S0212-16112010000600008,de,i
127,S0212-16112010000600008,peso,i
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,reduccion,o
127,S0212-16112010000600008,o,o
127,S0212-16112010000600008,control,o
127,S0212-16112010000600008,de,o
127,S0212-16112010000600008,las,o
127,S0212-16112010000600008,comorbilidades,o
127,S0212-16112010000600008,en,o
127,S0212-16112010000600008,mejor,o
127,S0212-16112010000600008,proporcion,o
127,S0212-16112010000600008,que,o
127,S0212-16112010000600008,las,o
127,S0212-16112010000600008,dietas,i
127,S0212-16112010000600008,hipocaloricas,i
127,S0212-16112010000600008,habituales,o
127,S0212-16112010000600008,mejorando,o
127,S0212-16112010000600008,el,o
127,S0212-16112010000600008,riesgo,i
127,S0212-16112010000600008,cardiovascular,i
127,S0212-16112010000600008,y,o
127,S0212-16112010000600008,facilitando,o
127,S0212-16112010000600008,todo,o
127,S0212-16112010000600008,el,o
127,S0212-16112010000600008,proceso,i
127,S0212-16112010000600008,quirurgico,i
128,S0212-16112011000300017,Las,o
128,S0212-16112011000300017,variaciones,o
128,S0212-16112011000300017,de,o
128,S0212-16112011000300017,la,o
128,S0212-16112011000300017,glucosa,i
128,S0212-16112011000300017,aguda,o
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,individuos,o
128,S0212-16112011000300017,con,o
128,S0212-16112011000300017,diabetes,i
128,S0212-16112011000300017,tipo,i
128,S0212-16112011000300017,2,i
128,S0212-16112011000300017,causada,o
128,S0212-16112011000300017,por,o
128,S0212-16112011000300017,las,o
128,S0212-16112011000300017,dietas,i
128,S0212-16112011000300017,de,i
128,S0212-16112011000300017,bajo,i
128,S0212-16112011000300017,y,i
128,S0212-16112011000300017,alto,i
128,S0212-16112011000300017,indice,i
128,S0212-16112011000300017,glucemico,i
128,S0212-16112011000300017,Introduccion,o
128,S0212-16112011000300017,Dietas,i
128,S0212-16112011000300017,de,i
128,S0212-16112011000300017,bajo,i
128,S0212-16112011000300017,indice,i
128,S0212-16112011000300017,glucemico,i
128,S0212-16112011000300017,pueden,o
128,S0212-16112011000300017,mejorar,o
128,S0212-16112011000300017,el,o
128,S0212-16112011000300017,control,i
128,S0212-16112011000300017,glucemico,i
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,la,o
128,S0212-16112011000300017,diabetes,i
128,S0212-16112011000300017,tipo,i
128,S0212-16112011000300017,2,i
128,S0212-16112011000300017,pero,o
128,S0212-16112011000300017,sigue,o
128,S0212-16112011000300017,el,o
128,S0212-16112011000300017,debate,o
128,S0212-16112011000300017,sobre,o
128,S0212-16112011000300017,su,o
128,S0212-16112011000300017,eficacia,o
128,S0212-16112011000300017,Objetivos,o
128,S0212-16112011000300017,Evaluar,o
128,S0212-16112011000300017,los,o
128,S0212-16112011000300017,efectos,o
128,S0212-16112011000300017,de,o
128,S0212-16112011000300017,las,o
128,S0212-16112011000300017,dietas,i
128,S0212-16112011000300017,bajas,i
128,S0212-16112011000300017,en,i
128,S0212-16112011000300017,el,i
128,S0212-16112011000300017,indice,i
128,S0212-16112011000300017,glucemico,i
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,el,o
128,S0212-16112011000300017,control,i
128,S0212-16112011000300017,glucemico,i
128,S0212-16112011000300017,agudo,o
128,S0212-16112011000300017,2,o
128,S0212-16112011000300017,dias,o
128,S0212-16112011000300017,por,o
128,S0212-16112011000300017,la,o
128,S0212-16112011000300017,medicion,i
128,S0212-16112011000300017,de,i
128,S0212-16112011000300017,glucosa,i
128,S0212-16112011000300017,en,i
128,S0212-16112011000300017,sangre,i
128,S0212-16112011000300017,capilar,i
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,pacientes,o
128,S0212-16112011000300017,con,o
128,S0212-16112011000300017,diabetes,i
128,S0212-16112011000300017,tipo,i
128,S0212-16112011000300017,2,i
128,S0212-16112011000300017,Metodos,o
128,S0212-16112011000300017,Se,o
128,S0212-16112011000300017,realizo,o
128,S0212-16112011000300017,un,o
128,S0212-16112011000300017,ensayo,i
128,S0212-16112011000300017,clinico,i
128,S0212-16112011000300017,cruzado,i
128,S0212-16112011000300017,y,i
128,S0212-16112011000300017,aleatorizado,i
128,S0212-16112011000300017,con,o
128,S0212-16112011000300017,12,o
128,S0212-16112011000300017,pacientes,o
128,S0212-16112011000300017,diabeticos,i
128,S0212-16112011000300017,tipo,i
128,S0212-16112011000300017,2,i
128,S0212-16112011000300017,Fueron,o
128,S0212-16112011000300017,divididos,o
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,2,o
128,S0212-16112011000300017,grupos,o
128,S0212-16112011000300017,dietas,i
128,S0212-16112011000300017,de,i
128,S0212-16112011000300017,bajo,i
128,S0212-16112011000300017,y,i
128,S0212-16112011000300017,alto,i
128,S0212-16112011000300017,indice,i
128,S0212-16112011000300017,glucemico,i
128,S0212-16112011000300017,BIG,o
128,S0212-16112011000300017,y,o
128,S0212-16112011000300017,AIG,o
128,S0212-16112011000300017,Las,o
128,S0212-16112011000300017,dietas,i
128,S0212-16112011000300017,fueron,o
128,S0212-16112011000300017,consumidas,o
128,S0212-16112011000300017,por,o
128,S0212-16112011000300017,2,o
128,S0212-16112011000300017,dias,o
128,S0212-16112011000300017,consecutivos,o
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,2,o
128,S0212-16112011000300017,semanas,o
128,S0212-16112011000300017,distintas,o
128,S0212-16112011000300017,Para,o
128,S0212-16112011000300017,el,o
128,S0212-16112011000300017,grupo,o
128,S0212-16112011000300017,1,o
128,S0212-16112011000300017,fue,o
128,S0212-16112011000300017,administrado,o
128,S0212-16112011000300017,la,o
128,S0212-16112011000300017,dieta,i
128,S0212-16112011000300017,BIG,i
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,la,o
128,S0212-16112011000300017,semana,o
128,S0212-16112011000300017,1,o
128,S0212-16112011000300017,seguida,o
128,S0212-16112011000300017,de,o
128,S0212-16112011000300017,la,o
128,S0212-16112011000300017,dieta,i
128,S0212-16112011000300017,AIG,i
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,la,o
128,S0212-16112011000300017,semana,o
128,S0212-16112011000300017,2,o
128,S0212-16112011000300017,En,o
128,S0212-16112011000300017,contrario,o
128,S0212-16112011000300017,se,o
128,S0212-16112011000300017,dio,o
128,S0212-16112011000300017,para,o
128,S0212-16112011000300017,el,o
128,S0212-16112011000300017,grupo,o
128,S0212-16112011000300017,2,o
128,S0212-16112011000300017,Se,o
128,S0212-16112011000300017,recomendo,o
128,S0212-16112011000300017,a,o
128,S0212-16112011000300017,los,o
128,S0212-16112011000300017,pacientes,o
128,S0212-16112011000300017,que,o
128,S0212-16112011000300017,mantuviesen,o
128,S0212-16112011000300017,la,o
128,S0212-16112011000300017,medicacion,i
128,S0212-16112011000300017,y,o
128,S0212-16112011000300017,el,o
128,S0212-16112011000300017,estilo,o
128,S0212-16112011000300017,de,o
128,S0212-16112011000300017,vida,o
128,S0212-16112011000300017,estables,o
128,S0212-16112011000300017,Se,o
128,S0212-16112011000300017,midio,o
128,S0212-16112011000300017,y,o
128,S0212-16112011000300017,registro,o
128,S0212-16112011000300017,la,o
128,S0212-16112011000300017,glucemia,i
128,S0212-16112011000300017,capilar,i
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,2,o
128,S0212-16112011000300017,dias,o
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,ayunas,o
128,S0212-16112011000300017,antes,o
128,S0212-16112011000300017,y,o
128,S0212-16112011000300017,despues,o
128,S0212-16112011000300017,2,o
128,S0212-16112011000300017,h,o
128,S0212-16112011000300017,del,o
128,S0212-16112011000300017,almuerzo,o
128,S0212-16112011000300017,y,o
128,S0212-16112011000300017,antes,o
128,S0212-16112011000300017,de,o
128,S0212-16112011000300017,la,o
128,S0212-16112011000300017,cena,o
128,S0212-16112011000300017,y,o
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,ayuno,o
128,S0212-16112011000300017,del,o
128,S0212-16112011000300017,dia,o
128,S0212-16112011000300017,3,o
128,S0212-16112011000300017,Durante,o
128,S0212-16112011000300017,los,o
128,S0212-16112011000300017,dias,o
128,S0212-16112011000300017,del,o
128,S0212-16112011000300017,estudio,o
128,S0212-16112011000300017,se,o
128,S0212-16112011000300017,hicieron,o
128,S0212-16112011000300017,un,o
128,S0212-16112011000300017,registro,o
128,S0212-16112011000300017,de,o
128,S0212-16112011000300017,los,o
128,S0212-16112011000300017,alimentos,o
128,S0212-16112011000300017,y,o
128,S0212-16112011000300017,el,o
128,S0212-16112011000300017,conteo,o
128,S0212-16112011000300017,de,o
128,S0212-16112011000300017,carbohidratos,i
128,S0212-16112011000300017,Para,o
128,S0212-16112011000300017,el,o
128,S0212-16112011000300017,tratamiento,o
128,S0212-16112011000300017,estadistico,o
128,S0212-16112011000300017,p,o
128,S0212-16112011000300017,005,o
128,S0212-16112011000300017,se,o
128,S0212-16112011000300017,utilizo,o
128,S0212-16112011000300017,el,o
128,S0212-16112011000300017,programa,o
128,S0212-16112011000300017,SigmaStat,o
128,S0212-16112011000300017,version,o
128,S0212-16112011000300017,203,o
128,S0212-16112011000300017,Resultados,o
128,S0212-16112011000300017,y,o
128,S0212-16112011000300017,discusion,o
128,S0212-16112011000300017,La,o
128,S0212-16112011000300017,ingesta,o
128,S0212-16112011000300017,de,o
128,S0212-16112011000300017,carbohidratos,i
128,S0212-16112011000300017,fue,o
128,S0212-16112011000300017,menor,o
128,S0212-16112011000300017,p,o
128,S0212-16112011000300017,001,o
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,el,o
128,S0212-16112011000300017,BIG,o
128,S0212-16112011000300017,sugiriendo,o
128,S0212-16112011000300017,que,o
128,S0212-16112011000300017,la,o
128,S0212-16112011000300017,utilizacion,o
128,S0212-16112011000300017,de,o
128,S0212-16112011000300017,esta,o
128,S0212-16112011000300017,dieta,i
128,S0212-16112011000300017,reduce,o
128,S0212-16112011000300017,la,o
128,S0212-16112011000300017,ingesta,o
128,S0212-16112011000300017,de,o
128,S0212-16112011000300017,carbohidratos,i
128,S0212-16112011000300017,siendo,o
128,S0212-16112011000300017,favorable,o
128,S0212-16112011000300017,para,o
128,S0212-16112011000300017,los,o
128,S0212-16112011000300017,diabeticos,i
128,S0212-16112011000300017,La,o
128,S0212-16112011000300017,media,o
128,S0212-16112011000300017,de,o
128,S0212-16112011000300017,glucosa,i
128,S0212-16112011000300017,en,i
128,S0212-16112011000300017,sangre,i
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,el,o
128,S0212-16112011000300017,primer,o
128,S0212-16112011000300017,dia,o
128,S0212-16112011000300017,fue,o
128,S0212-16112011000300017,inferior,o
128,S0212-16112011000300017,en,o
128,S0212-16112011000300017,el,o
128,S0212-16112011000300017,grupo,o
128,S0212-16112011000300017,BIG,o
128,S0212-16112011000300017,p,o
128,S0212-16112011000300017,005,o
129,S0212-16112011000400024,Ensayo,i
129,S0212-16112011000400024,clinico,i
129,S0212-16112011000400024,aletorizado,i
129,S0212-16112011000400024,doble,i
129,S0212-16112011000400024,ciego,i
129,S0212-16112011000400024,controlado,i
129,S0212-16112011000400024,con,i
129,S0212-16112011000400024,placebo,i
129,S0212-16112011000400024,con,o
129,S0212-16112011000400024,una,o
129,S0212-16112011000400024,galleta,o
129,S0212-16112011000400024,enriquecida,o
129,S0212-16112011000400024,en,o
129,S0212-16112011000400024,acido,i
129,S0212-16112011000400024,alfa,i
129,S0212-16112011000400024,linoleico,i
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,prebioticos,i
129,S0212-16112011000400024,en,o
129,S0212-16112011000400024,el,o
129,S0212-16112011000400024,patron,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,riesgo,i
129,S0212-16112011000400024,cardiovascular,i
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,pacientes,o
129,S0212-16112011000400024,obesos,i
129,S0212-16112011000400024,Introduccion,o
129,S0212-16112011000400024,La,o
129,S0212-16112011000400024,inulina,i
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,los,o
129,S0212-16112011000400024,FOS,i
129,S0212-16112011000400024,son,o
129,S0212-16112011000400024,prebioticos,i
129,S0212-16112011000400024,con,o
129,S0212-16112011000400024,potenciales,o
129,S0212-16112011000400024,efectos,o
129,S0212-16112011000400024,beneficiosos,o
129,S0212-16112011000400024,a,o
129,S0212-16112011000400024,nivel,o
129,S0212-16112011000400024,cardiovascular,i
129,S0212-16112011000400024,El,o
129,S0212-16112011000400024,acido,i
129,S0212-16112011000400024,alfa,i
129,S0212-16112011000400024,linolenico,i
129,S0212-16112011000400024,ALA,i
129,S0212-16112011000400024,es,o
129,S0212-16112011000400024,el,o
129,S0212-16112011000400024,precursor,o
129,S0212-16112011000400024,del,o
129,S0212-16112011000400024,acido,i
129,S0212-16112011000400024,eicosapentaenoico,i
129,S0212-16112011000400024,20,o
129,S0212-16112011000400024,5n3,o
129,S0212-16112011000400024,presentando,o
129,S0212-16112011000400024,propiedades,o
129,S0212-16112011000400024,antinflamatorias,o
129,S0212-16112011000400024,El,o
129,S0212-16112011000400024,objetivo,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,nuestro,o
129,S0212-16112011000400024,trabajo,o
129,S0212-16112011000400024,es,o
129,S0212-16112011000400024,evaluar,o
129,S0212-16112011000400024,la,o
129,S0212-16112011000400024,respuesta,o
129,S0212-16112011000400024,del,o
129,S0212-16112011000400024,perfil,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,riesgo,i
129,S0212-16112011000400024,cardiovascular,i
129,S0212-16112011000400024,en,o
129,S0212-16112011000400024,pacientes,o
129,S0212-16112011000400024,obesos,i
129,S0212-16112011000400024,tras,o
129,S0212-16112011000400024,la,o
129,S0212-16112011000400024,inclusion,o
129,S0212-16112011000400024,en,o
129,S0212-16112011000400024,la,o
129,S0212-16112011000400024,dieta,i
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,una,o
129,S0212-16112011000400024,galleta,o
129,S0212-16112011000400024,enriquecida,o
129,S0212-16112011000400024,en,o
129,S0212-16112011000400024,inulina,i
129,S0212-16112011000400024,FOS,i
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,ALA,i
129,S0212-16112011000400024,Material,o
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,metodos,o
129,S0212-16112011000400024,Un,o
129,S0212-16112011000400024,total,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,36,o
129,S0212-16112011000400024,pacientes,o
129,S0212-16112011000400024,fueron,o
129,S0212-16112011000400024,randomizados,i
129,S0212-16112011000400024,a,o
129,S0212-16112011000400024,una,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,las,o
129,S0212-16112011000400024,siguientes,o
129,S0212-16112011000400024,ramas,o
129,S0212-16112011000400024,galleta,o
129,S0212-16112011000400024,I,o
129,S0212-16112011000400024,enriquecida,o
129,S0212-16112011000400024,con,o
129,S0212-16112011000400024,inulina,i
129,S0212-16112011000400024,FOS,i
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,ALA,i
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,galleta,o
129,S0212-16112011000400024,II,o
129,S0212-16112011000400024,galleta,o
129,S0212-16112011000400024,control,o
129,S0212-16112011000400024,Gullon,o
129,S0212-16112011000400024,SL,o
129,S0212-16112011000400024,Cada,o
129,S0212-16112011000400024,paciente,o
129,S0212-16112011000400024,recibio,o
129,S0212-16112011000400024,un,o
129,S0212-16112011000400024,total,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,2,o
129,S0212-16112011000400024,galletas,o
129,S0212-16112011000400024,al,o
129,S0212-16112011000400024,dia,o
129,S0212-16112011000400024,70,o
129,S0212-16112011000400024,gramos,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,producto,o
129,S0212-16112011000400024,Antes,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,iniciar,o
129,S0212-16112011000400024,el,o
129,S0212-16112011000400024,tratamiento,i
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,al,o
129,S0212-16112011000400024,mes,o
129,S0212-16112011000400024,se,o
129,S0212-16112011000400024,realizo,o
129,S0212-16112011000400024,una,o
129,S0212-16112011000400024,valoracion,i
129,S0212-16112011000400024,nutricional,i
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,analitica,i
129,S0212-16112011000400024,Resultados,o
129,S0212-16112011000400024,Finalizaron,o
129,S0212-16112011000400024,el,o
129,S0212-16112011000400024,protocolo,i
129,S0212-16112011000400024,un,o
129,S0212-16112011000400024,total,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,15,o
129,S0212-16112011000400024,pacientes,o
129,S0212-16112011000400024,en,o
129,S0212-16112011000400024,cada,o
129,S0212-16112011000400024,grupo,o
129,S0212-16112011000400024,En,o
129,S0212-16112011000400024,el,o
129,S0212-16112011000400024,grupo,o
129,S0212-16112011000400024,I,o
129,S0212-16112011000400024,se,o
129,S0212-16112011000400024,produjo,o
129,S0212-16112011000400024,un,o
129,S0212-16112011000400024,aumento,o
129,S0212-16112011000400024,significativo,o
129,S0212-16112011000400024,en,o
129,S0212-16112011000400024,la,o
129,S0212-16112011000400024,ingesta,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,fibra,i
129,S0212-16112011000400024,soluble,o
129,S0212-16112011000400024,23,o
129,S0212-16112011000400024,08,o
129,S0212-16112011000400024,gdia,o
129,S0212-16112011000400024,vs,o
129,S0212-16112011000400024,77,o
129,S0212-16112011000400024,08,o
129,S0212-16112011000400024,gdia,o
129,S0212-16112011000400024,p,o
129,S0212-16112011000400024,005,o
129,S0212-16112011000400024,inulina,i
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,FOS,i
129,S0212-16112011000400024,asi,o
129,S0212-16112011000400024,como,o
129,S0212-16112011000400024,ALA,i
129,S0212-16112011000400024,06,o
129,S0212-16112011000400024,05,o
129,S0212-16112011000400024,gdia,o
129,S0212-16112011000400024,vs,o
129,S0212-16112011000400024,38,o
129,S0212-16112011000400024,05,o
129,S0212-16112011000400024,gdia,o
129,S0212-16112011000400024,p,o
129,S0212-16112011000400024,005,o
129,S0212-16112011000400024,Se,o
129,S0212-16112011000400024,detecto,o
129,S0212-16112011000400024,en,o
129,S0212-16112011000400024,los,o
129,S0212-16112011000400024,pacientes,o
129,S0212-16112011000400024,varones,o
129,S0212-16112011000400024,que,o
129,S0212-16112011000400024,recibieron,o
129,S0212-16112011000400024,las,o
129,S0212-16112011000400024,galletas,o
129,S0212-16112011000400024,enriquecidas,o
129,S0212-16112011000400024,una,o
129,S0212-16112011000400024,disminucion,o
129,S0212-16112011000400024,significativa,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,los,o
129,S0212-16112011000400024,niveles,i
129,S0212-16112011000400024,de,i
129,S0212-16112011000400024,colesterol,i
129,S0212-16112011000400024,total,i
129,S0212-16112011000400024,2381,o
129,S0212-16112011000400024,453,o
129,S0212-16112011000400024,mgdl,o
129,S0212-16112011000400024,vs,o
129,S0212-16112011000400024,2105,o
129,S0212-16112011000400024,381,o
129,S0212-16112011000400024,mgdl,o
129,S0212-16112011000400024,p,o
129,S0212-16112011000400024,005,o
129,S0212-16112011000400024,LDL,i
129,S0212-16112011000400024,colesterol,i
129,S0212-16112011000400024,1536,o
129,S0212-16112011000400024,232,o
129,S0212-16112011000400024,mgdl,o
129,S0212-16112011000400024,vs,o
129,S0212-16112011000400024,1271,o
129,S0212-16112011000400024,279,o
129,S0212-16112011000400024,mgdl,o
129,S0212-16112011000400024,p,o
129,S0212-16112011000400024,005,o
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,proteina,i
129,S0212-16112011000400024,C,i
129,S0212-16112011000400024,reactiva,i
129,S0212-16112011000400024,66,o
129,S0212-16112011000400024,14,o
129,S0212-16112011000400024,mgdl,o
129,S0212-16112011000400024,vs,o
129,S0212-16112011000400024,44718,o
129,S0212-16112011000400024,mgdl,o
129,S0212-16112011000400024,p,o
129,S0212-16112011000400024,005,o
129,S0212-16112011000400024,No,o
129,S0212-16112011000400024,existieron,o
129,S0212-16112011000400024,diferencias,o
129,S0212-16112011000400024,estadisticamente,o
129,S0212-16112011000400024,significativas,o
129,S0212-16112011000400024,en,o
129,S0212-16112011000400024,las,o
129,S0212-16112011000400024,variables,o
129,S0212-16112011000400024,antropometricas,o
129,S0212-16112011000400024,El,o
129,S0212-16112011000400024,aumento,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,la,o
129,S0212-16112011000400024,ingesta,o
129,S0212-16112011000400024,dietetica,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,fibra,i
129,S0212-16112011000400024,soluble,o
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,ALA,i
129,S0212-16112011000400024,en,o
129,S0212-16112011000400024,los,o
129,S0212-16112011000400024,pacientes,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,grupo,o
129,S0212-16112011000400024,I,o
129,S0212-16112011000400024,no,o
129,S0212-16112011000400024,supuso,o
129,S0212-16112011000400024,ningun,o
129,S0212-16112011000400024,efecto,i
129,S0212-16112011000400024,secundario,i
129,S0212-16112011000400024,a,i
129,S0212-16112011000400024,nivel,i
129,S0212-16112011000400024,gastrointestinal,i
129,S0212-16112011000400024,Conclusion,o
129,S0212-16112011000400024,El,o
129,S0212-16112011000400024,aumento,o
129,S0212-16112011000400024,en,o
129,S0212-16112011000400024,la,o
129,S0212-16112011000400024,ingesta,o
129,S0212-16112011000400024,con,o
129,S0212-16112011000400024,una,o
129,S0212-16112011000400024,galleta,o
129,S0212-16112011000400024,enriquecida,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,2,o
129,S0212-16112011000400024,gramos,o
129,S0212-16112011000400024,al,o
129,S0212-16112011000400024,dia,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,inulina,i
129,S0212-16112011000400024,31,o
129,S0212-16112011000400024,gramos,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,FOS,i
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,32,o
129,S0212-16112011000400024,gramos,o
129,S0212-16112011000400024,de,o
129,S0212-16112011000400024,ALA,i
129,S0212-16112011000400024,mejora,o
129,S0212-16112011000400024,en,o
129,S0212-16112011000400024,los,o
129,S0212-16112011000400024,pacientes,o
129,S0212-16112011000400024,obesos,i
129,S0212-16112011000400024,varones,o
129,S0212-16112011000400024,los,o
129,S0212-16112011000400024,niveles,i
129,S0212-16112011000400024,de,i
129,S0212-16112011000400024,colesterol,i
129,S0212-16112011000400024,total,i
129,S0212-16112011000400024,LDL,i
129,S0212-16112011000400024,colesterol,i
129,S0212-16112011000400024,y,o
129,S0212-16112011000400024,proteina,i
129,S0212-16112011000400024,C,i
129,S0212-16112011000400024,reactiva,i
130,S0212-16112012000100014,Beneficios,o
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,microbiota,o
130,S0212-16112012000100014,intestinal,i
130,S0212-16112012000100014,despues,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,suplementacion,i
130,S0212-16112012000100014,con,o
130,S0212-16112012000100014,inulina,i
130,S0212-16112012000100014,y,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,goma,i
130,S0212-16112012000100014,guar,i
130,S0212-16112012000100014,parcialmente,i
130,S0212-16112012000100014,hidrolizada,i
130,S0212-16112012000100014,un,o
130,S0212-16112012000100014,ensayo,i
130,S0212-16112012000100014,clinico,i
130,S0212-16112012000100014,aleatorizado,i
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,mujeres,o
130,S0212-16112012000100014,con,o
130,S0212-16112012000100014,estreñimiento,i
130,S0212-16112012000100014,Introduccion,o
130,S0212-16112012000100014,Los,o
130,S0212-16112012000100014,prebioticos,i
130,S0212-16112012000100014,influyen,o
130,S0212-16112012000100014,positivamente,o
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,composicion,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,microbiota,o
130,S0212-16112012000100014,intestinal,i
130,S0212-16112012000100014,mejorando,o
130,S0212-16112012000100014,asi,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,funcion,o
130,S0212-16112012000100014,intestinal,i
130,S0212-16112012000100014,Estas,o
130,S0212-16112012000100014,propiedades,o
130,S0212-16112012000100014,pueden,o
130,S0212-16112012000100014,ser,o
130,S0212-16112012000100014,utiles,o
130,S0212-16112012000100014,para,o
130,S0212-16112012000100014,el,o
130,S0212-16112012000100014,tratamiento,i
130,S0212-16112012000100014,del,o
130,S0212-16112012000100014,estreñimiento,i
130,S0212-16112012000100014,Objetivos,o
130,S0212-16112012000100014,Este,o
130,S0212-16112012000100014,estudio,o
130,S0212-16112012000100014,evaluo,i
130,S0212-16112012000100014,la,i
130,S0212-16112012000100014,tolerancia,i
130,S0212-16112012000100014,y,i
130,S0212-16112012000100014,la,i
130,S0212-16112012000100014,eficacia,i
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,una,o
130,S0212-16112012000100014,mezcla,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,prebiotico,i
130,S0212-16112012000100014,inulina,i
130,S0212-16112012000100014,con,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,goma,i
130,S0212-16112012000100014,guar,i
130,S0212-16112012000100014,parcialmente,i
130,S0212-16112012000100014,hidrolizada,i
130,S0212-16112012000100014,IPHGG,o
130,S0212-16112012000100014,para,o
130,S0212-16112012000100014,el,o
130,S0212-16112012000100014,tratamiento,i
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,mujeres,o
130,S0212-16112012000100014,con,o
130,S0212-16112012000100014,estreñimiento,i
130,S0212-16112012000100014,asi,o
130,S0212-16112012000100014,como,o
130,S0212-16112012000100014,su,o
130,S0212-16112012000100014,influencia,o
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,composicion,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,microbiota,o
130,S0212-16112012000100014,intestinal,i
130,S0212-16112012000100014,y,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,produccion,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,acidos,i
130,S0212-16112012000100014,grasos,i
130,S0212-16112012000100014,de,i
130,S0212-16112012000100014,cadena,i
130,S0212-16112012000100014,corta,i
130,S0212-16112012000100014,Metodos,o
130,S0212-16112012000100014,Nuestro,o
130,S0212-16112012000100014,estudio,o
130,S0212-16112012000100014,conto,o
130,S0212-16112012000100014,con,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,participacion,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,60,o
130,S0212-16112012000100014,mujeres,o
130,S0212-16112012000100014,voluntarias,o
130,S0212-16112012000100014,con,o
130,S0212-16112012000100014,estreñimiento,i
130,S0212-16112012000100014,y,o
130,S0212-16112012000100014,profesionales,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,salud,o
130,S0212-16112012000100014,Las,o
130,S0212-16112012000100014,participantes,o
130,S0212-16112012000100014,informaron,o
130,S0212-16112012000100014,tener,o
130,S0212-16112012000100014,menos,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,tres,o
130,S0212-16112012000100014,evacuaciones,o
130,S0212-16112012000100014,por,o
130,S0212-16112012000100014,semana,o
130,S0212-16112012000100014,y,o
130,S0212-16112012000100014,fueron,o
130,S0212-16112012000100014,asignadas,i
130,S0212-16112012000100014,aleatoriamente,i
130,S0212-16112012000100014,a,o
130,S0212-16112012000100014,tratamiento,i
130,S0212-16112012000100014,con,o
130,S0212-16112012000100014,prebioticos,i
130,S0212-16112012000100014,o,o
130,S0212-16112012000100014,placebo,i
130,S0212-16112012000100014,El,o
130,S0212-16112012000100014,tratamiento,i
130,S0212-16112012000100014,consistio,o
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,3,o
130,S0212-16112012000100014,semanas,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,suplementacion,i
130,S0212-16112012000100014,con,o
130,S0212-16112012000100014,15,o
130,S0212-16112012000100014,g,o
130,S0212-16112012000100014,d,o
130,S0212-16112012000100014,IPHGG,o
130,S0212-16112012000100014,grupo,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,fibras,i
130,S0212-16112012000100014,o,o
130,S0212-16112012000100014,maltodextrina,i
130,S0212-16112012000100014,grupo,o
130,S0212-16112012000100014,placebo,i
130,S0212-16112012000100014,Malestar,i
130,S0212-16112012000100014,abdominal,i
130,S0212-16112012000100014,flatulencia,i
130,S0212-16112012000100014,consistencia,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,las,o
130,S0212-16112012000100014,heces,i
130,S0212-16112012000100014,y,o
130,S0212-16112012000100014,los,o
130,S0212-16112012000100014,movimientos,o
130,S0212-16112012000100014,intestinales,i
130,S0212-16112012000100014,se,o
130,S0212-16112012000100014,evaluaron,o
130,S0212-16112012000100014,mediante,o
130,S0212-16112012000100014,un,o
130,S0212-16112012000100014,cuestionario,i
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,registro,o
130,S0212-16112012000100014,diario,o
130,S0212-16112012000100014,y,o
130,S0212-16112012000100014,una,o
130,S0212-16112012000100014,entrevista,i
130,S0212-16112012000100014,semanal,o
130,S0212-16112012000100014,Cambios,o
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,poblacion,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,bacterias,o
130,S0212-16112012000100014,fecales,i
130,S0212-16112012000100014,y,o
130,S0212-16112012000100014,los,o
130,S0212-16112012000100014,acidos,i
130,S0212-16112012000100014,grasos,i
130,S0212-16112012000100014,de,i
130,S0212-16112012000100014,cadena,i
130,S0212-16112012000100014,corta,i
130,S0212-16112012000100014,fueron,o
130,S0212-16112012000100014,evaluados,o
130,S0212-16112012000100014,por,o
130,S0212-16112012000100014,PCR,i
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,tiempo,o
130,S0212-16112012000100014,real,o
130,S0212-16112012000100014,y,o
130,S0212-16112012000100014,cromatografia,i
130,S0212-16112012000100014,de,i
130,S0212-16112012000100014,gases,i
130,S0212-16112012000100014,respectivamente,o
130,S0212-16112012000100014,Resultados,o
130,S0212-16112012000100014,Hubo,o
130,S0212-16112012000100014,un,o
130,S0212-16112012000100014,aumento,o
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,frecuencia,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,las,o
130,S0212-16112012000100014,evacuaciones,o
130,S0212-16112012000100014,intestinales,i
130,S0212-16112012000100014,por,o
130,S0212-16112012000100014,semana,o
130,S0212-16112012000100014,y,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,satisfaccion,o
130,S0212-16112012000100014,del,o
130,S0212-16112012000100014,paciente,o
130,S0212-16112012000100014,tanto,o
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,fibra,i
130,S0212-16112012000100014,y,o
130,S0212-16112012000100014,el,o
130,S0212-16112012000100014,grupo,o
130,S0212-16112012000100014,placebo,i
130,S0212-16112012000100014,sin,o
130,S0212-16112012000100014,diferencias,o
130,S0212-16112012000100014,significativas,o
130,S0212-16112012000100014,El,o
130,S0212-16112012000100014,total,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,Clostridium,o
130,S0212-16112012000100014,sp,o
130,S0212-16112012000100014,disminuyo,o
130,S0212-16112012000100014,significativamente,o
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,el,o
130,S0212-16112012000100014,grupo,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,fibras,i
130,S0212-16112012000100014,p,o
130,S0212-16112012000100014,0046,o
130,S0212-16112012000100014,y,o
130,S0212-16112012000100014,aumento,o
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,el,o
130,S0212-16112012000100014,grupo,o
130,S0212-16112012000100014,placebo,i
130,S0212-16112012000100014,p,o
130,S0212-16112012000100014,0047,o
130,S0212-16112012000100014,No,o
130,S0212-16112012000100014,hubo,o
130,S0212-16112012000100014,cambios,o
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,el,o
130,S0212-16112012000100014,perfil,o
130,S0212-16112012000100014,fecal,i
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,acidos,i
130,S0212-16112012000100014,grasos,i
130,S0212-16112012000100014,de,i
130,S0212-16112012000100014,cadena,i
130,S0212-16112012000100014,corta,i
130,S0212-16112012000100014,Conclusiones,o
130,S0212-16112012000100014,El,o
130,S0212-16112012000100014,consumo,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,IPHGG,o
130,S0212-16112012000100014,ha,o
130,S0212-16112012000100014,producido,o
130,S0212-16112012000100014,resultados,o
130,S0212-16112012000100014,clinicos,o
130,S0212-16112012000100014,comparables,o
130,S0212-16112012000100014,a,o
130,S0212-16112012000100014,placebo,i
130,S0212-16112012000100014,en,o
130,S0212-16112012000100014,mujeres,o
130,S0212-16112012000100014,con,o
130,S0212-16112012000100014,estreñimiento,i
130,S0212-16112012000100014,pero,o
130,S0212-16112012000100014,ofrecio,o
130,S0212-16112012000100014,otros,o
130,S0212-16112012000100014,efectos,o
130,S0212-16112012000100014,protectores,o
130,S0212-16112012000100014,sobre,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,microbiota,o
130,S0212-16112012000100014,intestinal,i
130,S0212-16112012000100014,al,o
130,S0212-16112012000100014,disminuir,o
130,S0212-16112012000100014,la,o
130,S0212-16112012000100014,cantidad,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,bacterias,o
130,S0212-16112012000100014,patologicas,o
130,S0212-16112012000100014,de,o
130,S0212-16112012000100014,lo,o
130,S0212-16112012000100014,genero,o
130,S0212-16112012000100014,Clostridium,o
131,S0212-16112012000200014,Orientacion,i
131,S0212-16112012000200014,nutricional,i
131,S0212-16112012000200014,conocimiento,o
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,calidad,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,dieta,i
131,S0212-16112012000200014,en,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,insuficiencia,i
131,S0212-16112012000200014,cardiaca,i
131,S0212-16112012000200014,ensayo,i
131,S0212-16112012000200014,aleatorizado,i
131,S0212-16112012000200014,Introduccion,o
131,S0212-16112012000200014,Medidas,i
131,S0212-16112012000200014,no,i
131,S0212-16112012000200014,farmacologicas,i
131,S0212-16112012000200014,se,o
131,S0212-16112012000200014,recomiendan,o
131,S0212-16112012000200014,en,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,insuficiencia,i
131,S0212-16112012000200014,cardiaca,i
131,S0212-16112012000200014,Sin,o
131,S0212-16112012000200014,embargo,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,mayoria,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,los,o
131,S0212-16112012000200014,estudios,o
131,S0212-16112012000200014,evalua,o
131,S0212-16112012000200014,dietas,i
131,S0212-16112012000200014,restrictas,i
131,S0212-16112012000200014,en,i
131,S0212-16112012000200014,sodio,i
131,S0212-16112012000200014,mientras,o
131,S0212-16112012000200014,que,o
131,S0212-16112012000200014,poco,o
131,S0212-16112012000200014,se,o
131,S0212-16112012000200014,sabe,o
131,S0212-16112012000200014,sobre,o
131,S0212-16112012000200014,el,o
131,S0212-16112012000200014,efecto,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,intervenciones,i
131,S0212-16112012000200014,para,o
131,S0212-16112012000200014,mejorar,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,adherencia,o
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,el,o
131,S0212-16112012000200014,conocimiento,o
131,S0212-16112012000200014,sobre,o
131,S0212-16112012000200014,dieta,i
131,S0212-16112012000200014,Objetivo,o
131,S0212-16112012000200014,Evaluar,o
131,S0212-16112012000200014,si,o
131,S0212-16112012000200014,una,o
131,S0212-16112012000200014,orientacion,i
131,S0212-16112012000200014,nutricional,i
131,S0212-16112012000200014,puede,o
131,S0212-16112012000200014,modificar,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,adherencia,o
131,S0212-16112012000200014,a,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,dieta,i
131,S0212-16112012000200014,conocimiento,o
131,S0212-16112012000200014,nutricional,o
131,S0212-16112012000200014,antropometria,i
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,calidad,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,vida,o
131,S0212-16112012000200014,en,o
131,S0212-16112012000200014,pacientes,o
131,S0212-16112012000200014,con,o
131,S0212-16112012000200014,insuficiencia,i
131,S0212-16112012000200014,cardiaca,i
131,S0212-16112012000200014,Metodos,o
131,S0212-16112012000200014,46,o
131,S0212-16112012000200014,pacientes,o
131,S0212-16112012000200014,fueron,o
131,S0212-16112012000200014,aleatorizados,i
131,S0212-16112012000200014,al,o
131,S0212-16112012000200014,grupo,o
131,S0212-16112012000200014,control,o
131,S0212-16112012000200014,o,o
131,S0212-16112012000200014,intervencion,i
131,S0212-16112012000200014,Ambos,o
131,S0212-16112012000200014,recibieron,o
131,S0212-16112012000200014,el,o
131,S0212-16112012000200014,tratamiento,i
131,S0212-16112012000200014,habitual,o
131,S0212-16112012000200014,del,o
131,S0212-16112012000200014,equipo,o
131,S0212-16112012000200014,el,o
131,S0212-16112012000200014,grupo,o
131,S0212-16112012000200014,intervencion,i
131,S0212-16112012000200014,recibio,o
131,S0212-16112012000200014,ademas,o
131,S0212-16112012000200014,orientacion,i
131,S0212-16112012000200014,sobre,i
131,S0212-16112012000200014,la,i
131,S0212-16112012000200014,dieta,i
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,su,o
131,S0212-16112012000200014,relacion,o
131,S0212-16112012000200014,con,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,enfermedad,i
131,S0212-16112012000200014,fuentes,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,alimentos,o
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,reduccion,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,las,o
131,S0212-16112012000200014,grasas,i
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,sodio,i
131,S0212-16112012000200014,Ambos,o
131,S0212-16112012000200014,los,o
131,S0212-16112012000200014,grupos,o
131,S0212-16112012000200014,fueron,o
131,S0212-16112012000200014,evaluados,o
131,S0212-16112012000200014,al,o
131,S0212-16112012000200014,principio,o
131,S0212-16112012000200014,del,o
131,S0212-16112012000200014,estudio,o
131,S0212-16112012000200014,6,o
131,S0212-16112012000200014,semanas,o
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,6,o
131,S0212-16112012000200014,meses,o
131,S0212-16112012000200014,Evaluaciones,i
131,S0212-16112012000200014,incluian,o
131,S0212-16112012000200014,antropometria,i
131,S0212-16112012000200014,sodio,i
131,S0212-16112012000200014,en,i
131,S0212-16112012000200014,la,i
131,S0212-16112012000200014,orina,i
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,24,o
131,S0212-16112012000200014,h,o
131,S0212-16112012000200014,el,o
131,S0212-16112012000200014,recordatorio,o
131,S0212-16112012000200014,alimenticio,o
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,los,o
131,S0212-16112012000200014,cuestionarios,i
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,conocimiento,o
131,S0212-16112012000200014,nutricional,o
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,calidad,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,vida,o
131,S0212-16112012000200014,Resultados,o
131,S0212-16112012000200014,La,o
131,S0212-16112012000200014,media,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,edad,o
131,S0212-16112012000200014,fue,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,58,o
131,S0212-16112012000200014,10,o
131,S0212-16112012000200014,años,o
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,70,o
131,S0212-16112012000200014,eran,o
131,S0212-16112012000200014,hombres,o
131,S0212-16112012000200014,Despues,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,6,o
131,S0212-16112012000200014,meses,o
131,S0212-16112012000200014,el,o
131,S0212-16112012000200014,conocimiento,o
131,S0212-16112012000200014,nutricional,o
131,S0212-16112012000200014,del,o
131,S0212-16112012000200014,grupo,o
131,S0212-16112012000200014,intervencion,i
131,S0212-16112012000200014,aumento,o
131,S0212-16112012000200014,en,o
131,S0212-16112012000200014,comparacion,o
131,S0212-16112012000200014,al,o
131,S0212-16112012000200014,grupo,o
131,S0212-16112012000200014,control,o
131,S0212-16112012000200014,p,o
131,S0212-16112012000200014,005,o
131,S0212-16112012000200014,La,o
131,S0212-16112012000200014,ingestion,o
131,S0212-16112012000200014,calorica,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,grasa,i
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,del,o
131,S0212-16112012000200014,sodio,i
131,S0212-16112012000200014,reduciran,o
131,S0212-16112012000200014,en,o
131,S0212-16112012000200014,grupo,o
131,S0212-16112012000200014,intervencion,i
131,S0212-16112012000200014,comparado,o
131,S0212-16112012000200014,con,o
131,S0212-16112012000200014,el,o
131,S0212-16112012000200014,grupo,o
131,S0212-16112012000200014,control,o
131,S0212-16112012000200014,p,o
131,S0212-16112012000200014,005,o
131,S0212-16112012000200014,No,o
131,S0212-16112012000200014,hubo,o
131,S0212-16112012000200014,diferencias,o
131,S0212-16112012000200014,significativas,o
131,S0212-16112012000200014,en,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,calidad,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,vida,o
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,antropometria,i
131,S0212-16112012000200014,Conclusiones,o
131,S0212-16112012000200014,La,o
131,S0212-16112012000200014,orientacion,i
131,S0212-16112012000200014,nutricional,i
131,S0212-16112012000200014,fue,o
131,S0212-16112012000200014,efectiva,o
131,S0212-16112012000200014,en,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,modificacion,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,1,o
131,S0212-16112012000200014,conocimiento,o
131,S0212-16112012000200014,nutricional,o
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,2,o
131,S0212-16112012000200014,calidad,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,dieta,i
131,S0212-16112012000200014,en,o
131,S0212-16112012000200014,pacientes,o
131,S0212-16112012000200014,con,o
131,S0212-16112012000200014,insuficiencia,i
131,S0212-16112012000200014,cardiaca,i
131,S0212-16112012000200014,Mas,o
131,S0212-16112012000200014,estudios,o
131,S0212-16112012000200014,que,o
131,S0212-16112012000200014,evaluan,o
131,S0212-16112012000200014,los,o
131,S0212-16112012000200014,beneficios,o
131,S0212-16112012000200014,en,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,calidad,o
131,S0212-16112012000200014,de,o
131,S0212-16112012000200014,la,o
131,S0212-16112012000200014,vida,o
131,S0212-16112012000200014,y,o
131,S0212-16112012000200014,pronostico,o
131,S0212-16112012000200014,son,o
131,S0212-16112012000200014,necesarios,o
132,S0212-16112012000600016,Efecto,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,una,o
132,S0212-16112012000600016,mezcla,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,inulina,i
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,fructooligosacarido,o
132,S0212-16112012000600016,sobre,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,microflora,o
132,S0212-16112012000600016,intestinal,i
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,lactobacillus,o
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,bifidobacterium,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,pacientes,o
132,S0212-16112012000600016,que,o
132,S0212-16112012000600016,reciben,o
132,S0212-16112012000600016,radioterapia,i
132,S0212-16112012000600016,un,o
132,S0212-16112012000600016,ensayo,o
132,S0212-16112012000600016,aleatorio,o
132,S0212-16112012000600016,a,o
132,S0212-16112012000600016,doble,o
132,S0212-16112012000600016,ciego,o
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,controlado,o
132,S0212-16112012000600016,con,o
132,S0212-16112012000600016,placebo,i
132,S0212-16112012000600016,Antecedentes,o
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,objetivos,o
132,S0212-16112012000600016,Se,o
132,S0212-16112012000600016,desconoce,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,patogenia,i
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,enteritis,i
132,S0212-16112012000600016,tras,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,radioterapia,i
132,S0212-16112012000600016,abdominal,i
132,S0212-16112012000600016,si,o
132,S0212-16112012000600016,bien,o
132,S0212-16112012000600016,podrian,o
132,S0212-16112012000600016,estar,o
132,S0212-16112012000600016,implicados,o
132,S0212-16112012000600016,cambios,o
132,S0212-16112012000600016,en,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,microflora,o
132,S0212-16112012000600016,fecal,i
132,S0212-16112012000600016,Diversos,o
132,S0212-16112012000600016,estudios,o
132,S0212-16112012000600016,han,o
132,S0212-16112012000600016,demostrado,o
132,S0212-16112012000600016,que,o
132,S0212-16112012000600016,los,o
132,S0212-16112012000600016,Lactobacillus,o
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,Bifidobacterium,o
132,S0212-16112012000600016,confieren,o
132,S0212-16112012000600016,beneficios,o
132,S0212-16112012000600016,al,o
132,S0212-16112012000600016,huesped,o
132,S0212-16112012000600016,Los,o
132,S0212-16112012000600016,prebioticos,i
132,S0212-16112012000600016,estimulan,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,proliferacion,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,Lactobacillus,o
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,Bifidobacterium,o
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,esto,o
132,S0212-16112012000600016,podria,o
132,S0212-16112012000600016,tener,o
132,S0212-16112012000600016,efectos,o
132,S0212-16112012000600016,positivos,o
132,S0212-16112012000600016,sobre,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,mucosa,i
132,S0212-16112012000600016,intestinal,i
132,S0212-16112012000600016,durante,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,radioterapia,i
132,S0212-16112012000600016,abdominal,i
132,S0212-16112012000600016,Metodos,o
132,S0212-16112012000600016,Realizamos,o
132,S0212-16112012000600016,un,o
132,S0212-16112012000600016,estudio,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,distribucion,o
132,S0212-16112012000600016,aleatoria,o
132,S0212-16112012000600016,a,o
132,S0212-16112012000600016,doble,o
132,S0212-16112012000600016,ciego,o
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,controlado,o
132,S0212-16112012000600016,con,o
132,S0212-16112012000600016,placebo,i
132,S0212-16112012000600016,que,o
132,S0212-16112012000600016,incluyo,o
132,S0212-16112012000600016,a,o
132,S0212-16112012000600016,31,o
132,S0212-16112012000600016,pacientes,o
132,S0212-16112012000600016,con,o
132,S0212-16112012000600016,cancer,i
132,S0212-16112012000600016,ginecologico,i
132,S0212-16112012000600016,que,o
132,S0212-16112012000600016,recibieron,o
132,S0212-16112012000600016,radioterapia,i
132,S0212-16112012000600016,29,o
132,S0212-16112012000600016,sesiones,o
132,S0212-16112012000600016,522,o
132,S0212-16112012000600016,Gy,o
132,S0212-16112012000600016,tras,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,cirugia,i
132,S0212-16112012000600016,Se,o
132,S0212-16112012000600016,distribuyo,i
132,S0212-16112012000600016,al,i
132,S0212-16112012000600016,azar,i
132,S0212-16112012000600016,a,o
132,S0212-16112012000600016,las,o
132,S0212-16112012000600016,pacientes,o
132,S0212-16112012000600016,en,o
132,S0212-16112012000600016,dos,o
132,S0212-16112012000600016,grupos,o
132,S0212-16112012000600016,prebiotico,i
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,placebo,i
132,S0212-16112012000600016,El,o
132,S0212-16112012000600016,primer,o
132,S0212-16112012000600016,grupo,o
132,S0212-16112012000600016,recibio,o
132,S0212-16112012000600016,una,o
132,S0212-16112012000600016,mezcla,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,fibra,i
132,S0212-16112012000600016,50,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,inulina,i
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,50,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,fructooligosacarido,o
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,el,o
132,S0212-16112012000600016,segundo,o
132,S0212-16112012000600016,6,o
132,S0212-16112012000600016,g,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,maltodextrina,i
132,S0212-16112012000600016,dos,o
132,S0212-16112012000600016,veces,o
132,S0212-16112012000600016,al,o
132,S0212-16112012000600016,dia,o
132,S0212-16112012000600016,desde,o
132,S0212-16112012000600016,una,o
132,S0212-16112012000600016,semana,o
132,S0212-16112012000600016,antes,o
132,S0212-16112012000600016,hasta,o
132,S0212-16112012000600016,3,o
132,S0212-16112012000600016,semanas,o
132,S0212-16112012000600016,despues,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,radioterapia,i
132,S0212-16112012000600016,Se,o
132,S0212-16112012000600016,determinaron,o
132,S0212-16112012000600016,los,o
132,S0212-16112012000600016,recuentos,i
132,S0212-16112012000600016,de,i
132,S0212-16112012000600016,Lactobacillus,i
132,S0212-16112012000600016,y,i
132,S0212-16112012000600016,Bifidobacterium,i
132,S0212-16112012000600016,en,o
132,S0212-16112012000600016,muestras,i
132,S0212-16112012000600016,fecales,i
132,S0212-16112012000600016,dia,o
132,S0212-16112012000600016,7,o
132,S0212-16112012000600016,antes,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,radioterapia,i
132,S0212-16112012000600016,dia,o
132,S0212-16112012000600016,15,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,radioterapia,i
132,S0212-16112012000600016,al,o
132,S0212-16112012000600016,final,o
132,S0212-16112012000600016,del,o
132,S0212-16112012000600016,tratamiento,i
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,tres,o
132,S0212-16112012000600016,semanas,o
132,S0212-16112012000600016,despues,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,radioterapia,i
132,S0212-16112012000600016,mediante,o
132,S0212-16112012000600016,un,o
132,S0212-16112012000600016,cultivo,i
132,S0212-16112012000600016,en,o
132,S0212-16112012000600016,medios,o
132,S0212-16112012000600016,seleccionados,o
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,con,o
132,S0212-16112012000600016,hibridacion,i
132,S0212-16112012000600016,in,i
132,S0212-16112012000600016,situ,i
132,S0212-16112012000600016,fluorescente,i
132,S0212-16112012000600016,FISH,i
132,S0212-16112012000600016,con,o
132,S0212-16112012000600016,sondas,i
132,S0212-16112012000600016,especificas,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,especie,o
132,S0212-16112012000600016,Los,o
132,S0212-16112012000600016,recuentos,i
132,S0212-16112012000600016,bacterianos,i
132,S0212-16112012000600016,con,o
132,S0212-16112012000600016,FISH,i
132,S0212-16112012000600016,fueron,o
132,S0212-16112012000600016,significativamente,o
132,S0212-16112012000600016,superiores,o
132,S0212-16112012000600016,que,o
132,S0212-16112012000600016,por,o
132,S0212-16112012000600016,el,o
132,S0212-16112012000600016,metodo,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,cultivo,i
132,S0212-16112012000600016,Resultados,o
132,S0212-16112012000600016,No,o
132,S0212-16112012000600016,hubo,o
132,S0212-16112012000600016,diferencias,o
132,S0212-16112012000600016,en,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,microflora,o
132,S0212-16112012000600016,basal,o
132,S0212-16112012000600016,entre,o
132,S0212-16112012000600016,los,o
132,S0212-16112012000600016,grupos,o
132,S0212-16112012000600016,Al,o
132,S0212-16112012000600016,final,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,radioterapia,i
132,S0212-16112012000600016,observamos,o
132,S0212-16112012000600016,un,o
132,S0212-16112012000600016,descenso,o
132,S0212-16112012000600016,estadisticamente,o
132,S0212-16112012000600016,significativo,o
132,S0212-16112012000600016,en,o
132,S0212-16112012000600016,los,o
132,S0212-16112012000600016,recuentos,i
132,S0212-16112012000600016,de,i
132,S0212-16112012000600016,Lactobacillus,i
132,S0212-16112012000600016,y,i
132,S0212-16112012000600016,Bifidobacterium,i
132,S0212-16112012000600016,en,o
132,S0212-16112012000600016,ambos,o
132,S0212-16112012000600016,grupos,o
132,S0212-16112012000600016,Mediante,o
132,S0212-16112012000600016,el,o
132,S0212-16112012000600016,analisis,i
132,S0212-16112012000600016,de,i
132,S0212-16112012000600016,los,i
132,S0212-16112012000600016,cultivos,i
132,S0212-16112012000600016,observamos,o
132,S0212-16112012000600016,un,o
132,S0212-16112012000600016,mayor,o
132,S0212-16112012000600016,recuento,i
132,S0212-16112012000600016,de,i
132,S0212-16112012000600016,Lactobacillus,i
132,S0212-16112012000600016,y,i
132,S0212-16112012000600016,Bifidobacterium,i
132,S0212-16112012000600016,a,o
132,S0212-16112012000600016,las,o
132,S0212-16112012000600016,tres,o
132,S0212-16112012000600016,semanas,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,finalizar,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,radioterapia,i
132,S0212-16112012000600016,en,o
132,S0212-16112012000600016,el,o
132,S0212-16112012000600016,grupo,o
132,S0212-16112012000600016,con,o
132,S0212-16112012000600016,prebiotico,i
132,S0212-16112012000600016,56,o
132,S0212-16112012000600016,frente,o
132,S0212-16112012000600016,a,o
132,S0212-16112012000600016,63,o
132,S0212-16112012000600016,p,o
132,S0212-16112012000600016,004,o
132,S0212-16112012000600016,and,o
132,S0212-16112012000600016,55,o
132,S0212-16112012000600016,frente,o
132,S0212-16112012000600016,a,o
132,S0212-16112012000600016,6,o
132,S0212-16112012000600016,log,o
132,S0212-16112012000600016,ufcg,o
132,S0212-16112012000600016,p,o
132,S0212-16112012000600016,003,o
132,S0212-16112012000600016,Conclusiones,o
132,S0212-16112012000600016,La,o
132,S0212-16112012000600016,radioterapia,i
132,S0212-16112012000600016,abdominal,i
132,S0212-16112012000600016,afecta,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,forma,o
132,S0212-16112012000600016,negativa,o
132,S0212-16112012000600016,los,o
132,S0212-16112012000600016,recuentos,i
132,S0212-16112012000600016,de,i
132,S0212-16112012000600016,Lactobacillus,i
132,S0212-16112012000600016,y,i
132,S0212-16112012000600016,Bifidobacterium,i
132,S0212-16112012000600016,La,o
132,S0212-16112012000600016,mezcla,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,prebioticos,i
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,inulina,i
132,S0212-16112012000600016,y,o
132,S0212-16112012000600016,fructooligosacarido,o
132,S0212-16112012000600016,puede,o
132,S0212-16112012000600016,mejorar,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,recuperacion,o
132,S0212-16112012000600016,de,o
132,S0212-16112012000600016,ambas,o
132,S0212-16112012000600016,especies,o
132,S0212-16112012000600016,tras,o
132,S0212-16112012000600016,la,o
132,S0212-16112012000600016,radioterapia,i
132,S0212-16112012000600016,Registrado,o
132,S0212-16112012000600016,en,o
132,S0212-16112012000600016,el,o
132,S0212-16112012000600016,ClinicalTrialsgov,o
132,S0212-16112012000600016,con,o
132,S0212-16112012000600016,el,o
132,S0212-16112012000600016,identificador,o
132,S0212-16112012000600016,num,o
132,S0212-16112012000600016,NCT01549782,o
133,S0212-16112012000600040,Efectividad,o
133,S0212-16112012000600040,a,o
133,S0212-16112012000600040,un,o
133,S0212-16112012000600040,año,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,dos,o
133,S0212-16112012000600040,dietas,i
133,S0212-16112012000600040,hipocaloricas,i
133,S0212-16112012000600040,con,o
133,S0212-16112012000600040,diferente,o
133,S0212-16112012000600040,proporcion,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,proteinas,i
133,S0212-16112012000600040,y,o
133,S0212-16112012000600040,carbohidratos,i
133,S0212-16112012000600040,en,o
133,S0212-16112012000600040,la,o
133,S0212-16112012000600040,perdida,i
133,S0212-16112012000600040,de,i
133,S0212-16112012000600040,peso,i
133,S0212-16112012000600040,y,o
133,S0212-16112012000600040,en,o
133,S0212-16112012000600040,la,o
133,S0212-16112012000600040,resistencia,i
133,S0212-16112012000600040,a,i
133,S0212-16112012000600040,la,i
133,S0212-16112012000600040,insulina,i
133,S0212-16112012000600040,Introduccion,o
133,S0212-16112012000600040,El,o
133,S0212-16112012000600040,mantenimiento,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,la,o
133,S0212-16112012000600040,perdida,i
133,S0212-16112012000600040,de,i
133,S0212-16112012000600040,peso,i
133,S0212-16112012000600040,puede,o
133,S0212-16112012000600040,estar,o
133,S0212-16112012000600040,influido,o
133,S0212-16112012000600040,por,o
133,S0212-16112012000600040,la,o
133,S0212-16112012000600040,distribucion,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,macronutrientes,o
133,S0212-16112012000600040,en,o
133,S0212-16112012000600040,la,o
133,S0212-16112012000600040,dieta,i
133,S0212-16112012000600040,y,o
133,S0212-16112012000600040,la,o
133,S0212-16112012000600040,sensibilidad,o
133,S0212-16112012000600040,a,o
133,S0212-16112012000600040,la,o
133,S0212-16112012000600040,insulina,i
133,S0212-16112012000600040,Objetivo,o
133,S0212-16112012000600040,El,o
133,S0212-16112012000600040,objetivo,o
133,S0212-16112012000600040,del,o
133,S0212-16112012000600040,estudio,o
133,S0212-16112012000600040,fue,o
133,S0212-16112012000600040,evaluar,o
133,S0212-16112012000600040,el,o
133,S0212-16112012000600040,efecto,o
133,S0212-16112012000600040,a,o
133,S0212-16112012000600040,largo,o
133,S0212-16112012000600040,plazo,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,dos,o
133,S0212-16112012000600040,dietas,i
133,S0212-16112012000600040,hipocaloricas,i
133,S0212-16112012000600040,con,o
133,S0212-16112012000600040,diferente,o
133,S0212-16112012000600040,distribucion,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,proteinas,i
133,S0212-16112012000600040,y,o
133,S0212-16112012000600040,carbohidratos,i
133,S0212-16112012000600040,HCO,i
133,S0212-16112012000600040,en,o
133,S0212-16112012000600040,individuos,o
133,S0212-16112012000600040,con,o
133,S0212-16112012000600040,sobrepeso,i
133,S0212-16112012000600040,y,o
133,S0212-16112012000600040,obesos,i
133,S0212-16112012000600040,ya,o
133,S0212-16112012000600040,fuese,o
133,S0212-16112012000600040,con,o
133,S0212-16112012000600040,resistencia,i
133,S0212-16112012000600040,a,i
133,S0212-16112012000600040,la,i
133,S0212-16112012000600040,insulina,i
133,S0212-16112012000600040,IR,i
133,S0212-16112012000600040,o,o
133,S0212-16112012000600040,sin,o
133,S0212-16112012000600040,resistencia,i
133,S0212-16112012000600040,a,i
133,S0212-16112012000600040,la,i
133,S0212-16112012000600040,insulina,i
133,S0212-16112012000600040,IS,o
133,S0212-16112012000600040,Metodologia,o
133,S0212-16112012000600040,Estudio,o
133,S0212-16112012000600040,prospectivo,o
133,S0212-16112012000600040,aleatorizado,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,intervencion,o
133,S0212-16112012000600040,clinica,o
133,S0212-16112012000600040,Cuarenta,o
133,S0212-16112012000600040,pacientes,o
133,S0212-16112012000600040,fueron,o
133,S0212-16112012000600040,clasificados,o
133,S0212-16112012000600040,como,o
133,S0212-16112012000600040,IR,i
133,S0212-16112012000600040,IS,o
133,S0212-16112012000600040,despues,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,una,o
133,S0212-16112012000600040,prueba,i
133,S0212-16112012000600040,de,i
133,S0212-16112012000600040,tolerancia,i
133,S0212-16112012000600040,oral,i
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,75,o
133,S0212-16112012000600040,g,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,glucosa,i
133,S0212-16112012000600040,y,o
133,S0212-16112012000600040,luego,o
133,S0212-16112012000600040,asignados,i
133,S0212-16112012000600040,al,i
133,S0212-16112012000600040,azar,i
133,S0212-16112012000600040,a,o
133,S0212-16112012000600040,una,o
133,S0212-16112012000600040,dieta,i
133,S0212-16112012000600040,con,o
133,S0212-16112012000600040,40,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,HCO,i
133,S0212-16112012000600040,30,o
133,S0212-16112012000600040,proteina,i
133,S0212-16112012000600040,30,o
133,S0212-16112012000600040,grasa,i
133,S0212-16112012000600040,dieta,i
133,S0212-16112012000600040,A,o
133,S0212-16112012000600040,o,o
133,S0212-16112012000600040,el,o
133,S0212-16112012000600040,55,o
133,S0212-16112012000600040,HCO,i
133,S0212-16112012000600040,15,o
133,S0212-16112012000600040,proteina,i
133,S0212-16112012000600040,30,o
133,S0212-16112012000600040,grasa,i
133,S0212-16112012000600040,dieta,i
133,S0212-16112012000600040,B,o
133,S0212-16112012000600040,Resultados,o
133,S0212-16112012000600040,Tras,o
133,S0212-16112012000600040,un,o
133,S0212-16112012000600040,año,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,seguimiento,i
133,S0212-16112012000600040,no,o
133,S0212-16112012000600040,se,o
133,S0212-16112012000600040,observaron,o
133,S0212-16112012000600040,diferencias,o
133,S0212-16112012000600040,en,o
133,S0212-16112012000600040,la,o
133,S0212-16112012000600040,perdida,i
133,S0212-16112012000600040,de,i
133,S0212-16112012000600040,peso,i
133,S0212-16112012000600040,entre,o
133,S0212-16112012000600040,las,o
133,S0212-16112012000600040,dietas,i
133,S0212-16112012000600040,A,o
133,S0212-16112012000600040,y,o
133,S0212-16112012000600040,B,o
133,S0212-16112012000600040,en,o
133,S0212-16112012000600040,cada,o
133,S0212-16112012000600040,grupo,o
133,S0212-16112012000600040,pero,o
133,S0212-16112012000600040,el,o
133,S0212-16112012000600040,grupo,o
133,S0212-16112012000600040,IS,o
133,S0212-16112012000600040,mantuvo,o
133,S0212-16112012000600040,la,o
133,S0212-16112012000600040,perdida,i
133,S0212-16112012000600040,de,i
133,S0212-16112012000600040,peso,i
133,S0212-16112012000600040,mejor,o
133,S0212-16112012000600040,que,o
133,S0212-16112012000600040,el,o
133,S0212-16112012000600040,grupo,o
133,S0212-16112012000600040,IR,i
133,S0212-16112012000600040,57,o
133,S0212-16112012000600040,39,o
133,S0212-16112012000600040,vs,o
133,S0212-16112012000600040,06,o
133,S0212-16112012000600040,41,o
133,S0212-16112012000600040,p,o
133,S0212-16112012000600040,004,o
133,S0212-16112012000600040,No,o
133,S0212-16112012000600040,se,o
133,S0212-16112012000600040,encontraron,o
133,S0212-16112012000600040,diferencias,o
133,S0212-16112012000600040,en,o
133,S0212-16112012000600040,ninguno,o
133,S0212-16112012000600040,en,o
133,S0212-16112012000600040,el,o
133,S0212-16112012000600040,Homeostasis,i
133,S0212-16112012000600040,Model,i
133,S0212-16112012000600040,Assessment,i
133,S0212-16112012000600040,HOMA,i
133,S0212-16112012000600040,u,o
133,S0212-16112012000600040,otros,o
133,S0212-16112012000600040,parametros,o
133,S0212-16112012000600040,metabolicos,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,glucosa,i
133,S0212-16112012000600040,excepto,o
133,S0212-16112012000600040,en,o
133,S0212-16112012000600040,una,o
133,S0212-16112012000600040,insulina,i
133,S0212-16112012000600040,inferior,o
133,S0212-16112012000600040,a,o
133,S0212-16112012000600040,los,o
133,S0212-16112012000600040,120,o
133,S0212-16112012000600040,minutos,o
133,S0212-16112012000600040,con,o
133,S0212-16112012000600040,la,o
133,S0212-16112012000600040,dieta,i
133,S0212-16112012000600040,A,o
133,S0212-16112012000600040,2140,o
133,S0212-16112012000600040,830,o
133,S0212-16112012000600040,vs,o
133,S0212-16112012000600040,7140,o
133,S0212-16112012000600040,1711,o
133,S0212-16112012000600040,p,o
133,S0212-16112012000600040,002,o
133,S0212-16112012000600040,Conclusiones,o
133,S0212-16112012000600040,Las,o
133,S0212-16112012000600040,dietas,i
133,S0212-16112012000600040,hipocaloricas,i
133,S0212-16112012000600040,con,o
133,S0212-16112012000600040,diferentes,o
133,S0212-16112012000600040,proporciones,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,proteinas,i
133,S0212-16112012000600040,y,o
133,S0212-16112012000600040,carbohidratos,i
133,S0212-16112012000600040,produjeron,o
133,S0212-16112012000600040,cambios,o
133,S0212-16112012000600040,similares,o
133,S0212-16112012000600040,en,o
133,S0212-16112012000600040,el,o
133,S0212-16112012000600040,peso,o
133,S0212-16112012000600040,La,o
133,S0212-16112012000600040,resistencia,i
133,S0212-16112012000600040,a,i
133,S0212-16112012000600040,la,i
133,S0212-16112012000600040,insulina,i
133,S0212-16112012000600040,puede,o
133,S0212-16112012000600040,jugar,o
133,S0212-16112012000600040,un,o
133,S0212-16112012000600040,papel,o
133,S0212-16112012000600040,negativo,o
133,S0212-16112012000600040,en,o
133,S0212-16112012000600040,el,o
133,S0212-16112012000600040,mantenimiento,o
133,S0212-16112012000600040,de,o
133,S0212-16112012000600040,la,o
133,S0212-16112012000600040,perdida,i
133,S0212-16112012000600040,de,i
133,S0212-16112012000600040,peso,i
134,S0212-16112013000100010,Ensayo,i
134,S0212-16112013000100010,clinico,i
134,S0212-16112013000100010,randomizado,i
134,S0212-16112013000100010,controlado,i
134,S0212-16112013000100010,con,i
134,S0212-16112013000100010,placebo,i
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,una,o
134,S0212-16112013000100010,galleta,o
134,S0212-16112013000100010,enriquecida,o
134,S0212-16112013000100010,en,o
134,S0212-16112013000100010,FOS,i
134,S0212-16112013000100010,efecto,o
134,S0212-16112013000100010,sobre,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,saciedad,o
134,S0212-16112013000100010,y,o
134,S0212-16112013000100010,factores,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,riesgo,i
134,S0212-16112013000100010,cardiovascular,i
134,S0212-16112013000100010,en,o
134,S0212-16112013000100010,pacientes,o
134,S0212-16112013000100010,obesos,i
134,S0212-16112013000100010,Introduccion,o
134,S0212-16112013000100010,Es,o
134,S0212-16112013000100010,importante,o
134,S0212-16112013000100010,evaluar,o
134,S0212-16112013000100010,el,o
134,S0212-16112013000100010,papel,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,los,o
134,S0212-16112013000100010,alimentos,o
134,S0212-16112013000100010,tipo,o
134,S0212-16112013000100010,snacks,o
134,S0212-16112013000100010,sobre,o
134,S0212-16112013000100010,el,o
134,S0212-16112013000100010,apetito,o
134,S0212-16112013000100010,El,o
134,S0212-16112013000100010,objetivo,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,este,o
134,S0212-16112013000100010,trabajo,o
134,S0212-16112013000100010,fue,o
134,S0212-16112013000100010,evaluar,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,respuesta,o
134,S0212-16112013000100010,en,o
134,S0212-16112013000100010,terminos,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,saciedad,o
134,S0212-16112013000100010,y,o
134,S0212-16112013000100010,el,o
134,S0212-16112013000100010,efecto,o
134,S0212-16112013000100010,sobre,o
134,S0212-16112013000100010,factores,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,riesgo,i
134,S0212-16112013000100010,cardiovascular,i
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,dos,o
134,S0212-16112013000100010,galletas,o
134,S0212-16112013000100010,diferentes,o
134,S0212-16112013000100010,Material,o
134,S0212-16112013000100010,y,o
134,S0212-16112013000100010,Metodos,o
134,S0212-16112013000100010,Se,o
134,S0212-16112013000100010,randomizaron,i
134,S0212-16112013000100010,38,o
134,S0212-16112013000100010,pacientes,o
134,S0212-16112013000100010,grupo,o
134,S0212-16112013000100010,I,o
134,S0212-16112013000100010,galleta,o
134,S0212-16112013000100010,enriquecida,o
134,S0212-16112013000100010,en,o
134,S0212-16112013000100010,FOS,i
134,S0212-16112013000100010,n19,o
134,S0212-16112013000100010,y,o
134,S0212-16112013000100010,grupo,o
134,S0212-16112013000100010,II,o
134,S0212-16112013000100010,galleta,o
134,S0212-16112013000100010,control,o
134,S0212-16112013000100010,n19,o
134,S0212-16112013000100010,Antes,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,intervencion,i
134,S0212-16112013000100010,nutricional,i
134,S0212-16112013000100010,y,o
134,S0212-16112013000100010,tras,o
134,S0212-16112013000100010,un,o
134,S0212-16112013000100010,mes,o
134,S0212-16112013000100010,a,o
134,S0212-16112013000100010,los,o
134,S0212-16112013000100010,pacientes,o
134,S0212-16112013000100010,se,o
134,S0212-16112013000100010,les,o
134,S0212-16112013000100010,valoro,i
134,S0212-16112013000100010,la,i
134,S0212-16112013000100010,saciedad,i
134,S0212-16112013000100010,con,o
134,S0212-16112013000100010,un,o
134,S0212-16112013000100010,test,i
134,S0212-16112013000100010,de,i
134,S0212-16112013000100010,prueba,i
134,S0212-16112013000100010,con,o
134,S0212-16112013000100010,5,o
134,S0212-16112013000100010,galletas,o
134,S0212-16112013000100010,Resultados,o
134,S0212-16112013000100010,Tras,o
134,S0212-16112013000100010,el,o
134,S0212-16112013000100010,test,i
134,S0212-16112013000100010,de,i
134,S0212-16112013000100010,prueba,i
134,S0212-16112013000100010,el,o
134,S0212-16112013000100010,area,o
134,S0212-16112013000100010,bajo,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,curva,o
134,S0212-16112013000100010,del,o
134,S0212-16112013000100010,test,i
134,S0212-16112013000100010,de,i
134,S0212-16112013000100010,saciedad,i
134,S0212-16112013000100010,fue,o
134,S0212-16112013000100010,mayor,o
134,S0212-16112013000100010,con,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,galleta,o
134,S0212-16112013000100010,saciante,o
134,S0212-16112013000100010,que,o
134,S0212-16112013000100010,con,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,galleta,o
134,S0212-16112013000100010,control,o
134,S0212-16112013000100010,detectandose,o
134,S0212-16112013000100010,el,o
134,S0212-16112013000100010,mismo,o
134,S0212-16112013000100010,resultado,o
134,S0212-16112013000100010,con,o
134,S0212-16112013000100010,el,o
134,S0212-16112013000100010,test,i
134,S0212-16112013000100010,tras,o
134,S0212-16112013000100010,1,o
134,S0212-16112013000100010,mes,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,ingerir,o
134,S0212-16112013000100010,las,o
134,S0212-16112013000100010,galletas,o
134,S0212-16112013000100010,Analizando,o
134,S0212-16112013000100010,los,o
134,S0212-16112013000100010,diferentes,o
134,S0212-16112013000100010,tiempos,o
134,S0212-16112013000100010,el,o
134,S0212-16112013000100010,score,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,saciedad,o
134,S0212-16112013000100010,mostro,o
134,S0212-16112013000100010,una,o
134,S0212-16112013000100010,puntuacion,o
134,S0212-16112013000100010,superior,o
134,S0212-16112013000100010,en,o
134,S0212-16112013000100010,los,o
134,S0212-16112013000100010,tiempos,o
134,S0212-16112013000100010,20,o
134,S0212-16112013000100010,y,o
134,S0212-16112013000100010,40,o
134,S0212-16112013000100010,minutos,o
134,S0212-16112013000100010,frente,o
134,S0212-16112013000100010,al,o
134,S0212-16112013000100010,valor,o
134,S0212-16112013000100010,basal,o
134,S0212-16112013000100010,tiempo,o
134,S0212-16112013000100010,0,o
134,S0212-16112013000100010,tras,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,ingesta,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,galleta,o
134,S0212-16112013000100010,saciante,o
134,S0212-16112013000100010,comparado,o
134,S0212-16112013000100010,con,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,galleta,o
134,S0212-16112013000100010,control,o
134,S0212-16112013000100010,Los,o
134,S0212-16112013000100010,valores,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,saciedad,o
134,S0212-16112013000100010,en,o
134,S0212-16112013000100010,los,o
134,S0212-16112013000100010,tiempos,o
134,S0212-16112013000100010,20,o
134,S0212-16112013000100010,minutos,o
134,S0212-16112013000100010,y,o
134,S0212-16112013000100010,40,o
134,S0212-16112013000100010,minutos,o
134,S0212-16112013000100010,fueron,o
134,S0212-16112013000100010,superiores,o
134,S0212-16112013000100010,que,o
134,S0212-16112013000100010,los,o
134,S0212-16112013000100010,que,o
134,S0212-16112013000100010,presento,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,galleta,o
134,S0212-16112013000100010,control,o
134,S0212-16112013000100010,Este,o
134,S0212-16112013000100010,resultado,o
134,S0212-16112013000100010,fue,o
134,S0212-16112013000100010,similar,o
134,S0212-16112013000100010,al,o
134,S0212-16112013000100010,realizar,o
134,S0212-16112013000100010,el,o
134,S0212-16112013000100010,test,i
134,S0212-16112013000100010,tras,o
134,S0212-16112013000100010,1,o
134,S0212-16112013000100010,mes,o
134,S0212-16112013000100010,tomando,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,galleta,o
134,S0212-16112013000100010,saciante,o
134,S0212-16112013000100010,Los,o
134,S0212-16112013000100010,resultados,o
134,S0212-16112013000100010,fueron,o
134,S0212-16112013000100010,similares,o
134,S0212-16112013000100010,al,o
134,S0212-16112013000100010,utilizar,o
134,S0212-16112013000100010,una,o
134,S0212-16112013000100010,escala,o
134,S0212-16112013000100010,visual,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,saciedad,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,100,o
134,S0212-16112013000100010,mm,o
134,S0212-16112013000100010,con,o
134,S0212-16112013000100010,5,o
134,S0212-16112013000100010,cuestiones,o
134,S0212-16112013000100010,No,o
134,S0212-16112013000100010,se,o
134,S0212-16112013000100010,detectaron,o
134,S0212-16112013000100010,efectos,o
134,S0212-16112013000100010,sobre,o
134,S0212-16112013000100010,los,o
134,S0212-16112013000100010,factores,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,riesgo,i
134,S0212-16112013000100010,cardiovascular,i
134,S0212-16112013000100010,tras,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,intervencion,i
134,S0212-16112013000100010,nutricional,i
134,S0212-16112013000100010,ni,o
134,S0212-16112013000100010,sobre,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,ingesta,o
134,S0212-16112013000100010,dietetica,o
134,S0212-16112013000100010,global,o
134,S0212-16112013000100010,Conclusion,o
134,S0212-16112013000100010,La,o
134,S0212-16112013000100010,galleta,o
134,S0212-16112013000100010,enriquecida,o
134,S0212-16112013000100010,en,o
134,S0212-16112013000100010,FOS,i
134,S0212-16112013000100010,produce,o
134,S0212-16112013000100010,mayores,o
134,S0212-16112013000100010,niveles,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,saciedad,o
134,S0212-16112013000100010,que,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,galleta,o
134,S0212-16112013000100010,control,o
134,S0212-16112013000100010,Sin,o
134,S0212-16112013000100010,embargo,o
134,S0212-16112013000100010,no,o
134,S0212-16112013000100010,existieron,o
134,S0212-16112013000100010,efectos,o
134,S0212-16112013000100010,sobre,o
134,S0212-16112013000100010,los,o
134,S0212-16112013000100010,factores,o
134,S0212-16112013000100010,de,o
134,S0212-16112013000100010,riesgo,i
134,S0212-16112013000100010,cardiovascular,i
134,S0212-16112013000100010,ni,o
134,S0212-16112013000100010,la,o
134,S0212-16112013000100010,ingesta,o
134,S0212-16112013000100010,dietetica,o
134,S0212-16112013000100010,global,o
135,S0212-16112014000300018,Efecto,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,lactobacillus,o
135,S0212-16112014000300018,casei,o
135,S0212-16112014000300018,shirota,o
135,S0212-16112014000300018,sobre,o
135,S0212-16112014000300018,concentraciones,i
135,S0212-16112014000300018,de,i
135,S0212-16112014000300018,urea,i
135,S0212-16112014000300018,en,o
135,S0212-16112014000300018,la,o
135,S0212-16112014000300018,enfermedad,i
135,S0212-16112014000300018,renal,i
135,S0212-16112014000300018,cronica,i
135,S0212-16112014000300018,Introduccion,o
135,S0212-16112014000300018,Los,o
135,S0212-16112014000300018,pacientes,o
135,S0212-16112014000300018,con,o
135,S0212-16112014000300018,enfermedad,i
135,S0212-16112014000300018,renal,i
135,S0212-16112014000300018,cronica,i
135,S0212-16112014000300018,ERC,i
135,S0212-16112014000300018,muestran,o
135,S0212-16112014000300018,un,o
135,S0212-16112014000300018,aumento,o
135,S0212-16112014000300018,a,o
135,S0212-16112014000300018,nivel,o
135,S0212-16112014000300018,intestinal,i
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,bacterias,o
135,S0212-16112014000300018,aerobicas,o
135,S0212-16112014000300018,que,o
135,S0212-16112014000300018,generan,o
135,S0212-16112014000300018,toxinas,i
135,S0212-16112014000300018,uremicas,i
135,S0212-16112014000300018,y,o
135,S0212-16112014000300018,disminucion,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,bacterias,o
135,S0212-16112014000300018,anaerobicas,o
135,S0212-16112014000300018,como,o
135,S0212-16112014000300018,bifidobacterias,o
135,S0212-16112014000300018,y,o
135,S0212-16112014000300018,lactobacilos,o
135,S0212-16112014000300018,Estas,o
135,S0212-16112014000300018,ultimas,o
135,S0212-16112014000300018,se,o
135,S0212-16112014000300018,pueden,o
135,S0212-16112014000300018,utilizar,o
135,S0212-16112014000300018,como,o
135,S0212-16112014000300018,probioticos,o
135,S0212-16112014000300018,El,o
135,S0212-16112014000300018,probiotico,o
135,S0212-16112014000300018,con,o
135,S0212-16112014000300018,mayor,o
135,S0212-16112014000300018,disponibilidad,o
135,S0212-16112014000300018,en,o
135,S0212-16112014000300018,Mexico,o
135,S0212-16112014000300018,es,o
135,S0212-16112014000300018,el,o
135,S0212-16112014000300018,lactobacillus,o
135,S0212-16112014000300018,casei,o
135,S0212-16112014000300018,shirota,o
135,S0212-16112014000300018,LcS,o
135,S0212-16112014000300018,actualmente,o
135,S0212-16112014000300018,no,o
135,S0212-16112014000300018,se,o
135,S0212-16112014000300018,conoce,o
135,S0212-16112014000300018,que,o
135,S0212-16112014000300018,dosis,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,LcS,o
135,S0212-16112014000300018,puede,o
135,S0212-16112014000300018,generar,o
135,S0212-16112014000300018,un,o
135,S0212-16112014000300018,beneficio,o
135,S0212-16112014000300018,para,o
135,S0212-16112014000300018,el,o
135,S0212-16112014000300018,paciente,o
135,S0212-16112014000300018,con,o
135,S0212-16112014000300018,ERC,i
135,S0212-16112014000300018,Objetivo,o
135,S0212-16112014000300018,Determinar,o
135,S0212-16112014000300018,el,o
135,S0212-16112014000300018,efecto,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,2,o
135,S0212-16112014000300018,dosis,o
135,S0212-16112014000300018,diferentes,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,LcS,o
135,S0212-16112014000300018,para,o
135,S0212-16112014000300018,disminuir,o
135,S0212-16112014000300018,al,o
135,S0212-16112014000300018,menos,o
135,S0212-16112014000300018,10,o
135,S0212-16112014000300018,las,o
135,S0212-16112014000300018,concentraciones,i
135,S0212-16112014000300018,de,i
135,S0212-16112014000300018,urea,i
135,S0212-16112014000300018,en,o
135,S0212-16112014000300018,pacientes,o
135,S0212-16112014000300018,con,o
135,S0212-16112014000300018,ERC,i
135,S0212-16112014000300018,estadios,o
135,S0212-16112014000300018,KDOQI,o
135,S0212-16112014000300018,3,o
135,S0212-16112014000300018,y,o
135,S0212-16112014000300018,4,o
135,S0212-16112014000300018,Metodos,o
135,S0212-16112014000300018,Ensayo,i
135,S0212-16112014000300018,clinico,i
135,S0212-16112014000300018,controlado,i
135,S0212-16112014000300018,con,i
135,S0212-16112014000300018,asignacion,i
135,S0212-16112014000300018,aleatoria,i
135,S0212-16112014000300018,en,o
135,S0212-16112014000300018,el,o
135,S0212-16112014000300018,cual,o
135,S0212-16112014000300018,se,o
135,S0212-16112014000300018,incluyeron,o
135,S0212-16112014000300018,pacientes,o
135,S0212-16112014000300018,ambulatorios,o
135,S0212-16112014000300018,con,o
135,S0212-16112014000300018,ERC,i
135,S0212-16112014000300018,del,o
135,S0212-16112014000300018,Instituto,o
135,S0212-16112014000300018,Nacional,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,Ciencias,o
135,S0212-16112014000300018,Medica,o
135,S0212-16112014000300018,y,o
135,S0212-16112014000300018,Nutricion,o
135,S0212-16112014000300018,Salvador,o
135,S0212-16112014000300018,Zubiran,o
135,S0212-16112014000300018,Se,o
135,S0212-16112014000300018,asigno,o
135,S0212-16112014000300018,a,o
135,S0212-16112014000300018,los,o
135,S0212-16112014000300018,pacientes,o
135,S0212-16112014000300018,a,o
135,S0212-16112014000300018,uno,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,los,o
135,S0212-16112014000300018,dos,o
135,S0212-16112014000300018,grupos,o
135,S0212-16112014000300018,grupo,o
135,S0212-16112014000300018,A,o
135,S0212-16112014000300018,8,o
135,S0212-16112014000300018,x,o
135,S0212-16112014000300018,109,o
135,S0212-16112014000300018,unidades,o
135,S0212-16112014000300018,formadoras,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,colonias,o
135,S0212-16112014000300018,UFC,o
135,S0212-16112014000300018,y,o
135,S0212-16112014000300018,grupo,o
135,S0212-16112014000300018,B,o
135,S0212-16112014000300018,16,o
135,S0212-16112014000300018,x,o
135,S0212-16112014000300018,109,o
135,S0212-16112014000300018,UFC,o
135,S0212-16112014000300018,El,o
135,S0212-16112014000300018,seguimiento,i
135,S0212-16112014000300018,fue,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,ocho,o
135,S0212-16112014000300018,semanas,o
135,S0212-16112014000300018,obteniendose,o
135,S0212-16112014000300018,una,o
135,S0212-16112014000300018,muestra,i
135,S0212-16112014000300018,de,i
135,S0212-16112014000300018,sangre,i
135,S0212-16112014000300018,basal,o
135,S0212-16112014000300018,y,o
135,S0212-16112014000300018,otra,o
135,S0212-16112014000300018,final,o
135,S0212-16112014000300018,para,o
135,S0212-16112014000300018,conocer,o
135,S0212-16112014000300018,concentraciones,i
135,S0212-16112014000300018,de,i
135,S0212-16112014000300018,urea,i
135,S0212-16112014000300018,y,o
135,S0212-16112014000300018,creatinina,i
135,S0212-16112014000300018,Ambos,o
135,S0212-16112014000300018,grupos,o
135,S0212-16112014000300018,consumieron,o
135,S0212-16112014000300018,una,o
135,S0212-16112014000300018,dieta,i
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,30,o
135,S0212-16112014000300018,kcalkgpeso,o
135,S0212-16112014000300018,y,o
135,S0212-16112014000300018,08,o
135,S0212-16112014000300018,gkgpeso,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,proteina,i
135,S0212-16112014000300018,se,o
135,S0212-16112014000300018,realizo,o
135,S0212-16112014000300018,un,o
135,S0212-16112014000300018,diario,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,alimentacion,o
135,S0212-16112014000300018,para,o
135,S0212-16112014000300018,evaluar,o
135,S0212-16112014000300018,el,o
135,S0212-16112014000300018,cumplimiento,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,la,o
135,S0212-16112014000300018,dieta,i
135,S0212-16112014000300018,y,o
135,S0212-16112014000300018,del,o
135,S0212-16112014000300018,tratamiento,i
135,S0212-16112014000300018,del,i
135,S0212-16112014000300018,LcS,i
135,S0212-16112014000300018,Resultados,o
135,S0212-16112014000300018,Se,o
135,S0212-16112014000300018,evaluaron,o
135,S0212-16112014000300018,30,o
135,S0212-16112014000300018,pacientes,o
135,S0212-16112014000300018,Al,o
135,S0212-16112014000300018,analizar,o
135,S0212-16112014000300018,el,o
135,S0212-16112014000300018,porcentaje,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,cambio,o
135,S0212-16112014000300018,entre,o
135,S0212-16112014000300018,las,o
135,S0212-16112014000300018,diferentes,o
135,S0212-16112014000300018,dosis,o
135,S0212-16112014000300018,se,o
135,S0212-16112014000300018,encontro,o
135,S0212-16112014000300018,una,o
135,S0212-16112014000300018,disminucion,o
135,S0212-16112014000300018,mayor,o
135,S0212-16112014000300018,al,o
135,S0212-16112014000300018,10,o
135,S0212-16112014000300018,en,o
135,S0212-16112014000300018,urea,i
135,S0212-16112014000300018,sanguinea,i
135,S0212-16112014000300018,en,o
135,S0212-16112014000300018,pacientes,o
135,S0212-16112014000300018,con,o
135,S0212-16112014000300018,la,o
135,S0212-16112014000300018,dosis,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,16,o
135,S0212-16112014000300018,x,o
135,S0212-16112014000300018,109,o
135,S0212-16112014000300018,con,o
135,S0212-16112014000300018,respecto,o
135,S0212-16112014000300018,a,o
135,S0212-16112014000300018,su,o
135,S0212-16112014000300018,medicion,o
135,S0212-16112014000300018,basal,o
135,S0212-16112014000300018,Conclusion,o
135,S0212-16112014000300018,Existe,o
135,S0212-16112014000300018,una,o
135,S0212-16112014000300018,disminucion,o
135,S0212-16112014000300018,10,o
135,S0212-16112014000300018,de,o
135,S0212-16112014000300018,la,o
135,S0212-16112014000300018,concentracion,i
135,S0212-16112014000300018,serica,i
135,S0212-16112014000300018,de,i
135,S0212-16112014000300018,urea,i
135,S0212-16112014000300018,con,o
135,S0212-16112014000300018,el,o
135,S0212-16112014000300018,LcS,o
135,S0212-16112014000300018,en,o
135,S0212-16112014000300018,pacientes,o
135,S0212-16112014000300018,con,o
135,S0212-16112014000300018,ERC,i
135,S0212-16112014000300018,3,o
135,S0212-16112014000300018,y,o
135,S0212-16112014000300018,4,o
136,S0212-16112014000300030,Ingesta,o
136,S0212-16112014000300030,segura,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,un,o
136,S0212-16112014000300030,suplemento,o
136,S0212-16112014000300030,oral,o
136,S0212-16112014000300030,que,o
136,S0212-16112014000300030,contiene,o
136,S0212-16112014000300030,hidratos,i
136,S0212-16112014000300030,de,i
136,S0212-16112014000300030,carbono,i
136,S0212-16112014000300030,y,o
136,S0212-16112014000300030,proteinas,i
136,S0212-16112014000300030,de,i
136,S0212-16112014000300030,suero,i
136,S0212-16112014000300030,de,i
136,S0212-16112014000300030,leche,i
136,S0212-16112014000300030,poco,o
136,S0212-16112014000300030,antes,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,sedacion,i
136,S0212-16112014000300030,para,o
136,S0212-16112014000300030,endoscopia,i
136,S0212-16112014000300030,un,o
136,S0212-16112014000300030,ensayo,i
136,S0212-16112014000300030,doble,i
136,S0212-16112014000300030,ciego,i
136,S0212-16112014000300030,y,i
136,S0212-16112014000300030,aleatorizado,i
136,S0212-16112014000300030,Objetivo,o
136,S0212-16112014000300030,Investigar,i
136,S0212-16112014000300030,el,i
136,S0212-16112014000300030,vaciado,i
136,S0212-16112014000300030,gastrico,i
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,un,o
136,S0212-16112014000300030,suplemento,o
136,S0212-16112014000300030,oral,o
136,S0212-16112014000300030,que,o
136,S0212-16112014000300030,contiene,o
136,S0212-16112014000300030,hidratos,i
136,S0212-16112014000300030,de,i
136,S0212-16112014000300030,carbono,i
136,S0212-16112014000300030,mas,o
136,S0212-16112014000300030,proteinas,i
136,S0212-16112014000300030,de,i
136,S0212-16112014000300030,suero,i
136,S0212-16112014000300030,de,i
136,S0212-16112014000300030,leche,i
136,S0212-16112014000300030,tomado,o
136,S0212-16112014000300030,antes,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,la,o
136,S0212-16112014000300030,sedacion,i
136,S0212-16112014000300030,para,o
136,S0212-16112014000300030,endoscopia,i
136,S0212-16112014000300030,Metodo,o
136,S0212-16112014000300030,Se,o
136,S0212-16112014000300030,trata,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,un,o
136,S0212-16112014000300030,estudio,i
136,S0212-16112014000300030,doble,i
136,S0212-16112014000300030,ciego,i
136,S0212-16112014000300030,aleatorizado,i
136,S0212-16112014000300030,que,o
136,S0212-16112014000300030,incluyo,o
136,S0212-16112014000300030,pacientes,o
136,S0212-16112014000300030,adultos,o
136,S0212-16112014000300030,1865,o
136,S0212-16112014000300030,años,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,edad,o
136,S0212-16112014000300030,por,o
136,S0212-16112014000300030,presentar,o
136,S0212-16112014000300030,epigastralgia,i
136,S0212-16112014000300030,y,o
136,S0212-16112014000300030,que,o
136,S0212-16112014000300030,eran,o
136,S0212-16112014000300030,candidatos,o
136,S0212-16112014000300030,a,o
136,S0212-16112014000300030,gastroscopia,i
136,S0212-16112014000300030,electiva,o
136,S0212-16112014000300030,Despues,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,una,o
136,S0212-16112014000300030,noche,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,ayuno,o
136,S0212-16112014000300030,los,o
136,S0212-16112014000300030,pacientes,o
136,S0212-16112014000300030,fueron,o
136,S0212-16112014000300030,asignados,i
136,S0212-16112014000300030,aleatoriamente,i
136,S0212-16112014000300030,para,o
136,S0212-16112014000300030,tomar,o
136,S0212-16112014000300030,200,o
136,S0212-16112014000300030,ml,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,un,o
136,S0212-16112014000300030,suplemento,i
136,S0212-16112014000300030,nutricional,i
136,S0212-16112014000300030,oral,o
136,S0212-16112014000300030,que,o
136,S0212-16112014000300030,contiene,o
136,S0212-16112014000300030,maltodextrina,i
136,S0212-16112014000300030,y,o
136,S0212-16112014000300030,proteina,i
136,S0212-16112014000300030,de,i
136,S0212-16112014000300030,suero,i
136,S0212-16112014000300030,de,i
136,S0212-16112014000300030,leche,i
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,150,o
136,S0212-16112014000300030,a,o
136,S0212-16112014000300030,210,o
136,S0212-16112014000300030,minutos,o
136,S0212-16112014000300030,antes,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,la,o
136,S0212-16112014000300030,sedacion,i
136,S0212-16112014000300030,para,o
136,S0212-16112014000300030,gastroscopia,i
136,S0212-16112014000300030,grupo,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,intervencion,i
136,S0212-16112014000300030,n,o
136,S0212-16112014000300030,12,o
136,S0212-16112014000300030,o,o
136,S0212-16112014000300030,continuar,o
136,S0212-16112014000300030,en,o
136,S0212-16112014000300030,ayuno,o
136,S0212-16112014000300030,para,o
136,S0212-16112014000300030,el,o
136,S0212-16112014000300030,procedimiento,i
136,S0212-16112014000300030,endoscopico,i
136,S0212-16112014000300030,grupo,o
136,S0212-16112014000300030,control,o
136,S0212-16112014000300030,n,o
136,S0212-16112014000300030,12,o
136,S0212-16112014000300030,El,o
136,S0212-16112014000300030,volumen,i
136,S0212-16112014000300030,gastrico,i
136,S0212-16112014000300030,residual,i
136,S0212-16112014000300030,RGV,i
136,S0212-16112014000300030,aspirado,o
136,S0212-16112014000300030,y,o
136,S0212-16112014000300030,medido,o
136,S0212-16112014000300030,durante,o
136,S0212-16112014000300030,el,o
136,S0212-16112014000300030,examen,i
136,S0212-16112014000300030,fue,o
136,S0212-16112014000300030,la,o
136,S0212-16112014000300030,variable,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,evaluacion,i
136,S0212-16112014000300030,principal,o
136,S0212-16112014000300030,del,o
136,S0212-16112014000300030,estudio,o
136,S0212-16112014000300030,Resultados,o
136,S0212-16112014000300030,No,o
136,S0212-16112014000300030,hubo,o
136,S0212-16112014000300030,complicaciones,i
136,S0212-16112014000300030,durante,o
136,S0212-16112014000300030,los,o
136,S0212-16112014000300030,examenes,i
136,S0212-16112014000300030,El,o
136,S0212-16112014000300030,tiempo,o
136,S0212-16112014000300030,medio,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,ayuno,o
136,S0212-16112014000300030,rango,o
136,S0212-16112014000300030,fue,o
136,S0212-16112014000300030,mayor,o
136,S0212-16112014000300030,P,o
136,S0212-16112014000300030,0001,o
136,S0212-16112014000300030,en,o
136,S0212-16112014000300030,el,o
136,S0212-16112014000300030,grupo,o
136,S0212-16112014000300030,control,o
136,S0212-16112014000300030,770,o
136,S0212-16112014000300030,min,o
136,S0212-16112014000300030,660,o
136,S0212-16112014000300030,917,o
136,S0212-16112014000300030,min,o
136,S0212-16112014000300030,que,o
136,S0212-16112014000300030,en,o
136,S0212-16112014000300030,el,o
136,S0212-16112014000300030,grupo,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,estudio,o
136,S0212-16112014000300030,175,o
136,S0212-16112014000300030,min,o
136,S0212-16112014000300030,150210,o
136,S0212-16112014000300030,min,o
136,S0212-16112014000300030,El,o
136,S0212-16112014000300030,RGV,i
136,S0212-16112014000300030,mediana,o
136,S0212-16112014000300030,y,o
136,S0212-16112014000300030,rango,o
136,S0212-16112014000300030,fue,o
136,S0212-16112014000300030,similar,o
136,S0212-16112014000300030,entre,o
136,S0212-16112014000300030,los,o
136,S0212-16112014000300030,dos,o
136,S0212-16112014000300030,grupos,o
136,S0212-16112014000300030,grupo,o
136,S0212-16112014000300030,control,o
136,S0212-16112014000300030,25,o
136,S0212-16112014000300030,1070,o
136,S0212-16112014000300030,ml,o
136,S0212-16112014000300030,y,o
136,S0212-16112014000300030,grupo,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,intervencion,i
136,S0212-16112014000300030,10,o
136,S0212-16112014000300030,0100,o
136,S0212-16112014000300030,ml,o
136,S0212-16112014000300030,p,o
136,S0212-16112014000300030,032,o
136,S0212-16112014000300030,Conclusion,o
136,S0212-16112014000300030,El,o
136,S0212-16112014000300030,vaciado,o
136,S0212-16112014000300030,gastrico,i
136,S0212-16112014000300030,150210,o
136,S0212-16112014000300030,minutos,o
136,S0212-16112014000300030,despues,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,la,o
136,S0212-16112014000300030,ingestion,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,un,o
136,S0212-16112014000300030,suplemento,o
136,S0212-16112014000300030,oral,o
136,S0212-16112014000300030,que,o
136,S0212-16112014000300030,contiene,o
136,S0212-16112014000300030,hidratos,i
136,S0212-16112014000300030,de,i
136,S0212-16112014000300030,carbono,i
136,S0212-16112014000300030,y,o
136,S0212-16112014000300030,proteina,i
136,S0212-16112014000300030,de,i
136,S0212-16112014000300030,suero,i
136,S0212-16112014000300030,de,i
136,S0212-16112014000300030,leche,i
136,S0212-16112014000300030,es,o
136,S0212-16112014000300030,similar,o
136,S0212-16112014000300030,al,o
136,S0212-16112014000300030,ayuno,o
136,S0212-16112014000300030,tradicional,o
136,S0212-16112014000300030,durante,o
136,S0212-16112014000300030,toda,o
136,S0212-16112014000300030,la,o
136,S0212-16112014000300030,noche,o
136,S0212-16112014000300030,Aunque,o
136,S0212-16112014000300030,limitado,o
136,S0212-16112014000300030,por,o
136,S0212-16112014000300030,el,o
136,S0212-16112014000300030,numero,o
136,S0212-16112014000300030,de,o
136,S0212-16112014000300030,casos,o
136,S0212-16112014000300030,la,o
136,S0212-16112014000300030,sedacion,i
136,S0212-16112014000300030,para,o
136,S0212-16112014000300030,procedimiento,i
136,S0212-16112014000300030,endoscopico,i
136,S0212-16112014000300030,es,o
136,S0212-16112014000300030,segura,o
136,S0212-16112014000300030,con,o
136,S0212-16112014000300030,este,o
136,S0212-16112014000300030,protocolo,i
136,S0212-16112014000300030,de,i
136,S0212-16112014000300030,ayuno,i
137,S0212-16112014000600017,Efecto,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,metoclopramida,i
137,S0212-16112014000600017,sobre,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,tolerancia,o
137,S0212-16112014000600017,enteral,i
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,neumonia,i
137,S0212-16112014000600017,asociada,i
137,S0212-16112014000600017,a,i
137,S0212-16112014000600017,ventilacion,i
137,S0212-16112014000600017,mecanica,i
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,pacientes,o
137,S0212-16112014000600017,neurocriticos,o
137,S0212-16112014000600017,Introduccion,o
137,S0212-16112014000600017,El,o
137,S0212-16112014000600017,uso,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,procineticos,i
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,paciente,o
137,S0212-16112014000600017,critico,o
137,S0212-16112014000600017,con,o
137,S0212-16112014000600017,nutricion,i
137,S0212-16112014000600017,enteral,i
137,S0212-16112014000600017,tienen,o
137,S0212-16112014000600017,como,o
137,S0212-16112014000600017,objetivo,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,reducir,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,aumento,o
137,S0212-16112014000600017,del,o
137,S0212-16112014000600017,residuo,o
137,S0212-16112014000600017,gastrico,i
137,S0212-16112014000600017,RG,o
137,S0212-16112014000600017,Analizamos,o
137,S0212-16112014000600017,su,o
137,S0212-16112014000600017,eficacia,o
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,mejoria,o
137,S0212-16112014000600017,del,o
137,S0212-16112014000600017,aporte,o
137,S0212-16112014000600017,enteral,i
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,sobre,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,reduccion,o
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,incidencia,o
137,S0212-16112014000600017,complicaciones,i
137,S0212-16112014000600017,gastrointestinales,i
137,S0212-16112014000600017,CGI,o
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,neumonia,i
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,pacientes,o
137,S0212-16112014000600017,criticos,o
137,S0212-16112014000600017,con,o
137,S0212-16112014000600017,lesion,i
137,S0212-16112014000600017,neurologica,i
137,S0212-16112014000600017,Objetivos,o
137,S0212-16112014000600017,Medir,o
137,S0212-16112014000600017,los,o
137,S0212-16112014000600017,efectos,o
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,administracion,i
137,S0212-16112014000600017,metoclopramida,i
137,S0212-16112014000600017,MCG,o
137,S0212-16112014000600017,durante,o
137,S0212-16112014000600017,los,o
137,S0212-16112014000600017,primeros,o
137,S0212-16112014000600017,cinco,o
137,S0212-16112014000600017,dias,o
137,S0212-16112014000600017,con,o
137,S0212-16112014000600017,nutricion,i
137,S0212-16112014000600017,enteral,i
137,S0212-16112014000600017,versus,o
137,S0212-16112014000600017,control,o
137,S0212-16112014000600017,GC,o
137,S0212-16112014000600017,sobre,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,volumen,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,dieta,i
137,S0212-16112014000600017,enteral,i
137,S0212-16112014000600017,administrada,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,numero,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,complicaciones,i
137,S0212-16112014000600017,gastrointestinales,i
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,incidencia,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,neumonia,i
137,S0212-16112014000600017,asociada,i
137,S0212-16112014000600017,a,i
137,S0212-16112014000600017,ventilacion,i
137,S0212-16112014000600017,mecanica,i
137,S0212-16112014000600017,NAVM,i
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,enfermos,o
137,S0212-16112014000600017,neurocriticos,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,etiologia,o
137,S0212-16112014000600017,traumatica,i
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,vascular,i
137,S0212-16112014000600017,Metodos,o
137,S0212-16112014000600017,De,o
137,S0212-16112014000600017,los,o
137,S0212-16112014000600017,150,o
137,S0212-16112014000600017,pacientes,o
137,S0212-16112014000600017,NC,o
137,S0212-16112014000600017,ingresados,i
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,forma,o
137,S0212-16112014000600017,consecutiva,o
137,S0212-16112014000600017,109,o
137,S0212-16112014000600017,fueron,o
137,S0212-16112014000600017,aleatorizados,i
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,dos,o
137,S0212-16112014000600017,grupos,o
137,S0212-16112014000600017,58,o
137,S0212-16112014000600017,MCG,o
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,51,o
137,S0212-16112014000600017,GC,o
137,S0212-16112014000600017,Los,o
137,S0212-16112014000600017,objetivos,o
137,S0212-16112014000600017,primarios,o
137,S0212-16112014000600017,fueron,o
137,S0212-16112014000600017,nutridonales,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,volumen,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,dieta,i
137,S0212-16112014000600017,administrada,o
137,S0212-16112014000600017,VDA,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,volumen,o
137,S0212-16112014000600017,eficaz,o
137,S0212-16112014000600017,VEM,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,numero,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,complicaciones,i
137,S0212-16112014000600017,gastrointestinales,i
137,S0212-16112014000600017,CGI,o
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,tasa,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,suspension,o
137,S0212-16112014000600017,temporal,o
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,definitiva,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,dieta,i
137,S0212-16112014000600017,Infecciosos,i
137,S0212-16112014000600017,incidencia,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,neumonia,i
137,S0212-16112014000600017,asociada,i
137,S0212-16112014000600017,a,i
137,S0212-16112014000600017,ventilacion,i
137,S0212-16112014000600017,mecanica,i
137,S0212-16112014000600017,NAVM,i
137,S0212-16112014000600017,Fueron,o
137,S0212-16112014000600017,objetivos,o
137,S0212-16112014000600017,secundarios,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,duracion,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,ventilacion,i
137,S0212-16112014000600017,mecanica,i
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,estancia,o
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,UCI,o
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,hospitalaria,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,secuela,i
137,S0212-16112014000600017,neurologica,i
137,S0212-16112014000600017,grave,o
137,S0212-16112014000600017,al,o
137,S0212-16112014000600017,alta,o
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,mortalidad,o
137,S0212-16112014000600017,a,o
137,S0212-16112014000600017,los,o
137,S0212-16112014000600017,30,o
137,S0212-16112014000600017,dias,o
137,S0212-16112014000600017,Resultados,o
137,S0212-16112014000600017,No,o
137,S0212-16112014000600017,se,o
137,S0212-16112014000600017,observaron,o
137,S0212-16112014000600017,diferencias,o
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,los,o
137,S0212-16112014000600017,parametros,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,gravedad,o
137,S0212-16112014000600017,entre,o
137,S0212-16112014000600017,grupos,o
137,S0212-16112014000600017,al,o
137,S0212-16112014000600017,ingreso,i
137,S0212-16112014000600017,Un,o
137,S0212-16112014000600017,incremento,o
137,S0212-16112014000600017,significativo,o
137,S0212-16112014000600017,fue,o
137,S0212-16112014000600017,observado,o
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,analisis,o
137,S0212-16112014000600017,global,o
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,a,o
137,S0212-16112014000600017,los,o
137,S0212-16112014000600017,cinco,o
137,S0212-16112014000600017,dias,o
137,S0212-16112014000600017,p,o
137,S0212-16112014000600017,003,o
137,S0212-16112014000600017,del,o
137,S0212-16112014000600017,VEM,o
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,grupo,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,MCG,o
137,S0212-16112014000600017,Los,o
137,S0212-16112014000600017,valores,o
137,S0212-16112014000600017,del,o
137,S0212-16112014000600017,VDA,o
137,S0212-16112014000600017,global,o
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,durante,o
137,S0212-16112014000600017,las,o
137,S0212-16112014000600017,dos,o
137,S0212-16112014000600017,fases,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,estudio,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,numero,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,CGI,o
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,numero,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,suspensiones,o
137,S0212-16112014000600017,parciales,o
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,definitivas,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,dieta,i
137,S0212-16112014000600017,o,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,numero,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,NAVM,i
137,S0212-16112014000600017,fueron,o
137,S0212-16112014000600017,similares,o
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,ambos,o
137,S0212-16112014000600017,grupos,o
137,S0212-16112014000600017,no,o
137,S0212-16112014000600017,significativos,o
137,S0212-16112014000600017,Tampoco,o
137,S0212-16112014000600017,se,o
137,S0212-16112014000600017,observaron,o
137,S0212-16112014000600017,diferencias,o
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,los,o
137,S0212-16112014000600017,diferentes,o
137,S0212-16112014000600017,objetivos,o
137,S0212-16112014000600017,secundarios,o
137,S0212-16112014000600017,Conclusion,o
137,S0212-16112014000600017,El,o
137,S0212-16112014000600017,uso,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,metoclopramida,i
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,enfermo,i
137,S0212-16112014000600017,neurocritico,i
137,S0212-16112014000600017,no,o
137,S0212-16112014000600017,es,o
137,S0212-16112014000600017,eficaz,o
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,la,o
137,S0212-16112014000600017,disminucion,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,las,o
137,S0212-16112014000600017,CGI,o
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,las,o
137,S0212-16112014000600017,dosis,o
137,S0212-16112014000600017,y,o
137,S0212-16112014000600017,tiempo,o
137,S0212-16112014000600017,de,o
137,S0212-16112014000600017,tratamiento,i
137,S0212-16112014000600017,reflejados,o
137,S0212-16112014000600017,en,o
137,S0212-16112014000600017,el,o
137,S0212-16112014000600017,estudio,o
138,S0212-16112014001200013,Impacto,o
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,la,o
138,S0212-16112014001200013,carne,o
138,S0212-16112014001200013,funcional,o
138,S0212-16112014001200013,cocinada,o
138,S0212-16112014001200013,enriquecida,o
138,S0212-16112014001200013,con,o
138,S0212-16112014001200013,acidos,i
138,S0212-16112014001200013,grasos,i
138,S0212-16112014001200013,omega,i
138,S0212-16112014001200013,3,i
138,S0212-16112014001200013,y,o
138,S0212-16112014001200013,extracto,i
138,S0212-16112014001200013,de,i
138,S0212-16112014001200013,romero,i
138,S0212-16112014001200013,sobre,o
138,S0212-16112014001200013,el,o
138,S0212-16112014001200013,estado,i
138,S0212-16112014001200013,inflamatorio,i
138,S0212-16112014001200013,y,i
138,S0212-16112014001200013,oxidativo,i
138,S0212-16112014001200013,un,o
138,S0212-16112014001200013,estudio,o
138,S0212-16112014001200013,aleatorizado,o
138,S0212-16112014001200013,cruzado,o
138,S0212-16112014001200013,y,o
138,S0212-16112014001200013,doble,o
138,S0212-16112014001200013,ciego,o
138,S0212-16112014001200013,Objetivos,o
138,S0212-16112014001200013,La,o
138,S0212-16112014001200013,ingesta,o
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,omega3,o
138,S0212-16112014001200013,se,o
138,S0212-16112014001200013,ha,o
138,S0212-16112014001200013,asociado,o
138,S0212-16112014001200013,con,o
138,S0212-16112014001200013,efectos,o
138,S0212-16112014001200013,antinflamatorios,o
138,S0212-16112014001200013,relacionados,o
138,S0212-16112014001200013,con,o
138,S0212-16112014001200013,la,o
138,S0212-16112014001200013,prevencion,i
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,la,o
138,S0212-16112014001200013,enfermedad,i
138,S0212-16112014001200013,cardiovascular,i
138,S0212-16112014001200013,ECV,i
138,S0212-16112014001200013,Desarrollar,o
138,S0212-16112014001200013,productos,o
138,S0212-16112014001200013,carnicos,o
138,S0212-16112014001200013,funcionales,o
138,S0212-16112014001200013,podria,o
138,S0212-16112014001200013,ser,o
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,gran,o
138,S0212-16112014001200013,interes,o
138,S0212-16112014001200013,para,o
138,S0212-16112014001200013,la,o
138,S0212-16112014001200013,poblacion,o
138,S0212-16112014001200013,El,o
138,S0212-16112014001200013,objetivo,o
138,S0212-16112014001200013,del,o
138,S0212-16112014001200013,presente,o
138,S0212-16112014001200013,estudio,o
138,S0212-16112014001200013,fue,o
138,S0212-16112014001200013,evaluar,o
138,S0212-16112014001200013,el,o
138,S0212-16112014001200013,efecto,o
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,una,o
138,S0212-16112014001200013,carne,o
138,S0212-16112014001200013,funcional,o
138,S0212-16112014001200013,con,o
138,S0212-16112014001200013,omega3,o
138,S0212-16112014001200013,y,o
138,S0212-16112014001200013,extracto,i
138,S0212-16112014001200013,de,i
138,S0212-16112014001200013,romero,i
138,S0212-16112014001200013,sobre,o
138,S0212-16112014001200013,marcadores,i
138,S0212-16112014001200013,de,i
138,S0212-16112014001200013,inflamacion,i
138,S0212-16112014001200013,y,i
138,S0212-16112014001200013,oxidacion,i
138,S0212-16112014001200013,en,o
138,S0212-16112014001200013,personas,o
138,S0212-16112014001200013,con,o
138,S0212-16112014001200013,riesgo,i
138,S0212-16112014001200013,cardiovascular,i
138,S0212-16112014001200013,Pacientes,o
138,S0212-16112014001200013,y,o
138,S0212-16112014001200013,metodos,o
138,S0212-16112014001200013,Se,o
138,S0212-16112014001200013,diseño,o
138,S0212-16112014001200013,un,o
138,S0212-16112014001200013,ensayo,o
138,S0212-16112014001200013,clinico,o
138,S0212-16112014001200013,cruzado,o
138,S0212-16112014001200013,y,o
138,S0212-16112014001200013,dobleciego,o
138,S0212-16112014001200013,para,o
138,S0212-16112014001200013,estudiar,o
138,S0212-16112014001200013,el,o
138,S0212-16112014001200013,efecto,o
138,S0212-16112014001200013,del,o
138,S0212-16112014001200013,consumo,i
138,S0212-16112014001200013,de,i
138,S0212-16112014001200013,un,i
138,S0212-16112014001200013,producto,i
138,S0212-16112014001200013,carnico,i
138,S0212-16112014001200013,funcional,i
138,S0212-16112014001200013,sobre,o
138,S0212-16112014001200013,marcadores,i
138,S0212-16112014001200013,de,i
138,S0212-16112014001200013,inflamacion,i
138,S0212-16112014001200013,y,i
138,S0212-16112014001200013,oxidacion,i
138,S0212-16112014001200013,Se,o
138,S0212-16112014001200013,incluyeron,o
138,S0212-16112014001200013,43,o
138,S0212-16112014001200013,voluntarios,o
138,S0212-16112014001200013,con,o
138,S0212-16112014001200013,al,o
138,S0212-16112014001200013,menos,o
138,S0212-16112014001200013,2,o
138,S0212-16112014001200013,parametros,o
138,S0212-16112014001200013,del,o
138,S0212-16112014001200013,perfil,i
138,S0212-16112014001200013,lipidico,i
138,S0212-16112014001200013,alterado,o
138,S0212-16112014001200013,indicando,o
138,S0212-16112014001200013,riesgo,o
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,ECV,i
138,S0212-16112014001200013,Fueron,o
138,S0212-16112014001200013,asignados,i
138,S0212-16112014001200013,aleatoriamente,i
138,S0212-16112014001200013,en,o
138,S0212-16112014001200013,2,o
138,S0212-16112014001200013,grupos,o
138,S0212-16112014001200013,que,o
138,S0212-16112014001200013,consumieron,o
138,S0212-16112014001200013,en,o
138,S0212-16112014001200013,cruzado,o
138,S0212-16112014001200013,carne,o
138,S0212-16112014001200013,funcional,o
138,S0212-16112014001200013,CF,o
138,S0212-16112014001200013,o,o
138,S0212-16112014001200013,carne,o
138,S0212-16112014001200013,control,o
138,S0212-16112014001200013,CC,o
138,S0212-16112014001200013,durante,o
138,S0212-16112014001200013,12,o
138,S0212-16112014001200013,semanas,o
138,S0212-16112014001200013,con,o
138,S0212-16112014001200013,un,o
138,S0212-16112014001200013,periodo,o
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,lavado,o
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,4,o
138,S0212-16112014001200013,semanas,o
138,S0212-16112014001200013,entre,o
138,S0212-16112014001200013,ellos,o
138,S0212-16112014001200013,Al,o
138,S0212-16112014001200013,finalizar,o
138,S0212-16112014001200013,el,o
138,S0212-16112014001200013,estudio,o
138,S0212-16112014001200013,se,o
138,S0212-16112014001200013,evaluo,o
138,S0212-16112014001200013,perfil,i
138,S0212-16112014001200013,lipidico,i
138,S0212-16112014001200013,marcadores,i
138,S0212-16112014001200013,de,i
138,S0212-16112014001200013,inflamacion,i
138,S0212-16112014001200013,PCR,i
138,S0212-16112014001200013,PAI1,o
138,S0212-16112014001200013,TNFalpha,o
138,S0212-16112014001200013,IL6,o
138,S0212-16112014001200013,fibrinogeno,i
138,S0212-16112014001200013,y,o
138,S0212-16112014001200013,marcadores,i
138,S0212-16112014001200013,de,i
138,S0212-16112014001200013,oxidacion,i
138,S0212-16112014001200013,TBARS,i
138,S0212-16112014001200013,FRAP,i
138,S0212-16112014001200013,8isoPGF2α,o
138,S0212-16112014001200013,Resultados,o
138,S0212-16112014001200013,Completaron,o
138,S0212-16112014001200013,el,o
138,S0212-16112014001200013,estudio,o
138,S0212-16112014001200013,33,o
138,S0212-16112014001200013,personas,o
138,S0212-16112014001200013,24,o
138,S0212-16112014001200013,mujeres,o
138,S0212-16112014001200013,con,o
138,S0212-16112014001200013,edad,o
138,S0212-16112014001200013,media,o
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,50788,o
138,S0212-16112014001200013,años,o
138,S0212-16112014001200013,Tras,o
138,S0212-16112014001200013,consumir,o
138,S0212-16112014001200013,CF,o
138,S0212-16112014001200013,durante,o
138,S0212-16112014001200013,12,o
138,S0212-16112014001200013,semanas,o
138,S0212-16112014001200013,se,o
138,S0212-16112014001200013,observo,o
138,S0212-16112014001200013,una,o
138,S0212-16112014001200013,disminucion,o
138,S0212-16112014001200013,significativa,o
138,S0212-16112014001200013,del,o
138,S0212-16112014001200013,PAI1,o
138,S0212-16112014001200013,fibrinogeno,i
138,S0212-16112014001200013,y,o
138,S0212-16112014001200013,8isoPGF2α,o
138,S0212-16112014001200013,mientras,o
138,S0212-16112014001200013,que,o
138,S0212-16112014001200013,el,o
138,S0212-16112014001200013,FRAP,i
138,S0212-16112014001200013,incremento,o
138,S0212-16112014001200013,significativamente,o
138,S0212-16112014001200013,Sin,o
138,S0212-16112014001200013,embargo,o
138,S0212-16112014001200013,con,o
138,S0212-16112014001200013,CC,o
138,S0212-16112014001200013,incremento,o
138,S0212-16112014001200013,PAI1,o
138,S0212-16112014001200013,y,o
138,S0212-16112014001200013,disminuyo,o
138,S0212-16112014001200013,FRAP,i
138,S0212-16112014001200013,significativamente,o
138,S0212-16112014001200013,Ademas,o
138,S0212-16112014001200013,se,o
138,S0212-16112014001200013,observaron,o
138,S0212-16112014001200013,diferencias,o
138,S0212-16112014001200013,significativas,o
138,S0212-16112014001200013,entre,o
138,S0212-16112014001200013,los,o
138,S0212-16112014001200013,cambios,o
138,S0212-16112014001200013,producidos,o
138,S0212-16112014001200013,tras,o
138,S0212-16112014001200013,consumir,o
138,S0212-16112014001200013,uno,o
138,S0212-16112014001200013,u,o
138,S0212-16112014001200013,otro,o
138,S0212-16112014001200013,producto,o
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,los,o
138,S0212-16112014001200013,marcadores,o
138,S0212-16112014001200013,PAI1,o
138,S0212-16112014001200013,FRAP,i
138,S0212-16112014001200013,y,o
138,S0212-16112014001200013,8isoPGF2α,o
138,S0212-16112014001200013,Al,o
138,S0212-16112014001200013,final,o
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,cada,o
138,S0212-16112014001200013,intervencion,i
138,S0212-16112014001200013,no,o
138,S0212-16112014001200013,se,o
138,S0212-16112014001200013,observaron,o
138,S0212-16112014001200013,cambios,o
138,S0212-16112014001200013,en,o
138,S0212-16112014001200013,variables,o
138,S0212-16112014001200013,antropometricas,o
138,S0212-16112014001200013,ni,o
138,S0212-16112014001200013,efectos,i
138,S0212-16112014001200013,adversos,i
138,S0212-16112014001200013,Conclusiones,o
138,S0212-16112014001200013,El,o
138,S0212-16112014001200013,consumo,i
138,S0212-16112014001200013,de,i
138,S0212-16112014001200013,CF,i
138,S0212-16112014001200013,con,o
138,S0212-16112014001200013,omega3,o
138,S0212-16112014001200013,y,o
138,S0212-16112014001200013,extracto,i
138,S0212-16112014001200013,de,i
138,S0212-16112014001200013,romero,i
138,S0212-16112014001200013,mejora,o
138,S0212-16112014001200013,el,o
138,S0212-16112014001200013,estado,i
138,S0212-16112014001200013,inflamatorio,i
138,S0212-16112014001200013,y,i
138,S0212-16112014001200013,oxidativo,i
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,personas,o
138,S0212-16112014001200013,con,o
138,S0212-16112014001200013,al,o
138,S0212-16112014001200013,menos,o
138,S0212-16112014001200013,2,o
138,S0212-16112014001200013,parametros,o
138,S0212-16112014001200013,del,o
138,S0212-16112014001200013,perfil,i
138,S0212-16112014001200013,lipidico,i
138,S0212-16112014001200013,alterado,o
138,S0212-16112014001200013,La,o
138,S0212-16112014001200013,inclusion,o
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,estas,o
138,S0212-16112014001200013,CF,o
138,S0212-16112014001200013,en,o
138,S0212-16112014001200013,una,o
138,S0212-16112014001200013,dieta,i
138,S0212-16112014001200013,equilibrada,i
138,S0212-16112014001200013,podria,o
138,S0212-16112014001200013,ser,o
138,S0212-16112014001200013,una,o
138,S0212-16112014001200013,opcion,o
138,S0212-16112014001200013,mas,o
138,S0212-16112014001200013,para,o
138,S0212-16112014001200013,mantener,o
138,S0212-16112014001200013,un,o
138,S0212-16112014001200013,estilo,o
138,S0212-16112014001200013,de,o
138,S0212-16112014001200013,vida,o
138,S0212-16112014001200013,saludable,o
138,S0212-16112014001200013,ClinicalTrialsgov,o
138,S0212-16112014001200013,NCT0199088,o
139,S0212-16112015000200046,Efecto,o
139,S0212-16112015000200046,del,o
139,S0212-16112015000200046,acido,i
139,S0212-16112015000200046,lipoico,i
139,S0212-16112015000200046,en,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,recuento,i
139,S0212-16112015000200046,de,i
139,S0212-16112015000200046,sangre,i
139,S0212-16112015000200046,y,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,metabolismo,o
139,S0212-16112015000200046,de,o
139,S0212-16112015000200046,hierro,i
139,S0212-16112015000200046,en,o
139,S0212-16112015000200046,pacientes,o
139,S0212-16112015000200046,hipertensos,i
139,S0212-16112015000200046,Introduccion,o
139,S0212-16112015000200046,El,o
139,S0212-16112015000200046,Acido,o
139,S0212-16112015000200046,αLipoico,o
139,S0212-16112015000200046,ALA,i
139,S0212-16112015000200046,ha,o
139,S0212-16112015000200046,sido,o
139,S0212-16112015000200046,utilizado,o
139,S0212-16112015000200046,como,o
139,S0212-16112015000200046,recurso,i
139,S0212-16112015000200046,terapeutico,i
139,S0212-16112015000200046,para,o
139,S0212-16112015000200046,reducir,o
139,S0212-16112015000200046,daño,i
139,S0212-16112015000200046,oxidativo,i
139,S0212-16112015000200046,en,o
139,S0212-16112015000200046,la,o
139,S0212-16112015000200046,Hipertension,i
139,S0212-16112015000200046,Arterial,i
139,S0212-16112015000200046,Sistemica,i
139,S0212-16112015000200046,HAS,i
139,S0212-16112015000200046,pero,o
139,S0212-16112015000200046,aun,o
139,S0212-16112015000200046,no,o
139,S0212-16112015000200046,existen,o
139,S0212-16112015000200046,estudios,i
139,S0212-16112015000200046,in,i
139,S0212-16112015000200046,vivo,i
139,S0212-16112015000200046,que,o
139,S0212-16112015000200046,reporten,o
139,S0212-16112015000200046,sobre,o
139,S0212-16112015000200046,su,o
139,S0212-16112015000200046,mecanismo,o
139,S0212-16112015000200046,de,o
139,S0212-16112015000200046,accion,o
139,S0212-16112015000200046,en,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,metabolismo,o
139,S0212-16112015000200046,del,o
139,S0212-16112015000200046,hierro,i
139,S0212-16112015000200046,Objetivo,o
139,S0212-16112015000200046,Evaluar,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,efecto,o
139,S0212-16112015000200046,antioxidante,o
139,S0212-16112015000200046,del,o
139,S0212-16112015000200046,acido,o
139,S0212-16112015000200046,AlfaLipoico,o
139,S0212-16112015000200046,sobre,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,hemograma,i
139,S0212-16112015000200046,y,o
139,S0212-16112015000200046,metabolismo,o
139,S0212-16112015000200046,del,o
139,S0212-16112015000200046,hierro,i
139,S0212-16112015000200046,en,o
139,S0212-16112015000200046,individuos,o
139,S0212-16112015000200046,hipertensos,i
139,S0212-16112015000200046,con,o
139,S0212-16112015000200046,o,o
139,S0212-16112015000200046,sin,o
139,S0212-16112015000200046,anemia,i
139,S0212-16112015000200046,Metodos,o
139,S0212-16112015000200046,Estudio,o
139,S0212-16112015000200046,clinico,o
139,S0212-16112015000200046,dobleciego,o
139,S0212-16112015000200046,randomizado,o
139,S0212-16112015000200046,y,o
139,S0212-16112015000200046,controlado,o
139,S0212-16112015000200046,con,o
139,S0212-16112015000200046,placebo,i
139,S0212-16112015000200046,La,o
139,S0212-16112015000200046,muestra,o
139,S0212-16112015000200046,fue,o
139,S0212-16112015000200046,constituida,o
139,S0212-16112015000200046,por,o
139,S0212-16112015000200046,60,o
139,S0212-16112015000200046,individuos,o
139,S0212-16112015000200046,hipertensos,i
139,S0212-16112015000200046,distribuidos,i
139,S0212-16112015000200046,aleatoriamente,i
139,S0212-16112015000200046,en,o
139,S0212-16112015000200046,grupo,o
139,S0212-16112015000200046,tratamiento,i
139,S0212-16112015000200046,n,o
139,S0212-16112015000200046,32,o
139,S0212-16112015000200046,que,o
139,S0212-16112015000200046,recibio,o
139,S0212-16112015000200046,600,o
139,S0212-16112015000200046,mgdia,o
139,S0212-16112015000200046,del,o
139,S0212-16112015000200046,ALA,i
139,S0212-16112015000200046,por,o
139,S0212-16112015000200046,doce,o
139,S0212-16112015000200046,semanas,o
139,S0212-16112015000200046,y,o
139,S0212-16112015000200046,grupo,o
139,S0212-16112015000200046,control,o
139,S0212-16112015000200046,n,o
139,S0212-16112015000200046,28,o
139,S0212-16112015000200046,que,o
139,S0212-16112015000200046,recibio,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,placebo,i
139,S0212-16112015000200046,por,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,mismo,o
139,S0212-16112015000200046,periodo,o
139,S0212-16112015000200046,Fueron,o
139,S0212-16112015000200046,analizados,o
139,S0212-16112015000200046,antes,o
139,S0212-16112015000200046,y,o
139,S0212-16112015000200046,despues,o
139,S0212-16112015000200046,de,o
139,S0212-16112015000200046,la,o
139,S0212-16112015000200046,intervencion,i
139,S0212-16112015000200046,los,o
139,S0212-16112015000200046,parametros,o
139,S0212-16112015000200046,del,o
139,S0212-16112015000200046,hemograma,i
139,S0212-16112015000200046,Hierro,i
139,S0212-16112015000200046,Serico,i
139,S0212-16112015000200046,Ferritina,i
139,S0212-16112015000200046,Capacidad,i
139,S0212-16112015000200046,Latente,i
139,S0212-16112015000200046,de,i
139,S0212-16112015000200046,Enlace,i
139,S0212-16112015000200046,del,i
139,S0212-16112015000200046,hierro,i
139,S0212-16112015000200046,Capacidad,i
139,S0212-16112015000200046,Total,i
139,S0212-16112015000200046,de,i
139,S0212-16112015000200046,Enlace,i
139,S0212-16112015000200046,del,i
139,S0212-16112015000200046,Hierro,i
139,S0212-16112015000200046,Indice,i
139,S0212-16112015000200046,de,i
139,S0212-16112015000200046,Saturacion,i
139,S0212-16112015000200046,de,i
139,S0212-16112015000200046,la,i
139,S0212-16112015000200046,Transferrina,i
139,S0212-16112015000200046,ISI,o
139,S0212-16112015000200046,y,o
139,S0212-16112015000200046,Transferrina,i
139,S0212-16112015000200046,Para,o
139,S0212-16112015000200046,evaluar,o
139,S0212-16112015000200046,las,o
139,S0212-16112015000200046,alteraciones,i
139,S0212-16112015000200046,entre,o
139,S0212-16112015000200046,los,o
139,S0212-16112015000200046,grupos,o
139,S0212-16112015000200046,se,o
139,S0212-16112015000200046,utilizo,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,teste,o
139,S0212-16112015000200046,t,o
139,S0212-16112015000200046,de,o
139,S0212-16112015000200046,Student,o
139,S0212-16112015000200046,y,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,analisis,o
139,S0212-16112015000200046,de,o
139,S0212-16112015000200046,varianza,o
139,S0212-16112015000200046,ANOVA,o
139,S0212-16112015000200046,adoptandose,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,nivel,o
139,S0212-16112015000200046,de,o
139,S0212-16112015000200046,significacion,o
139,S0212-16112015000200046,de,o
139,S0212-16112015000200046,5,o
139,S0212-16112015000200046,Resultados,o
139,S0212-16112015000200046,Despues,o
139,S0212-16112015000200046,de,o
139,S0212-16112015000200046,la,o
139,S0212-16112015000200046,intervencion,i
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,suplemento,o
139,S0212-16112015000200046,con,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,ALA,i
139,S0212-16112015000200046,demostro,o
139,S0212-16112015000200046,una,o
139,S0212-16112015000200046,asociacion,o
139,S0212-16112015000200046,estadisticamente,o
139,S0212-16112015000200046,significativa,o
139,S0212-16112015000200046,p,o
139,S0212-16112015000200046,005,o
139,S0212-16112015000200046,con,o
139,S0212-16112015000200046,la,o
139,S0212-16112015000200046,reduccion,i
139,S0212-16112015000200046,de,i
139,S0212-16112015000200046,los,i
139,S0212-16112015000200046,leucocitos,i
139,S0212-16112015000200046,totales,o
139,S0212-16112015000200046,aumento,i
139,S0212-16112015000200046,del,i
139,S0212-16112015000200046,numero,i
139,S0212-16112015000200046,de,i
139,S0212-16112015000200046,neutrofilos,i
139,S0212-16112015000200046,y,o
139,S0212-16112015000200046,reducciones,o
139,S0212-16112015000200046,en,o
139,S0212-16112015000200046,los,o
139,S0212-16112015000200046,niveles,i
139,S0212-16112015000200046,de,i
139,S0212-16112015000200046,Hierro,i
139,S0212-16112015000200046,Serico,i
139,S0212-16112015000200046,e,o
139,S0212-16112015000200046,ISI,o
139,S0212-16112015000200046,Conclusion,o
139,S0212-16112015000200046,La,o
139,S0212-16112015000200046,administracion,i
139,S0212-16112015000200046,oral,i
139,S0212-16112015000200046,del,o
139,S0212-16112015000200046,ALA,i
139,S0212-16112015000200046,como,o
139,S0212-16112015000200046,un,o
139,S0212-16112015000200046,adyuvante,i
139,S0212-16112015000200046,terapeutico,o
139,S0212-16112015000200046,altera,o
139,S0212-16112015000200046,la,o
139,S0212-16112015000200046,respuesta,o
139,S0212-16112015000200046,hematologica,o
139,S0212-16112015000200046,del,o
139,S0212-16112015000200046,leucograma,i
139,S0212-16112015000200046,y,o
139,S0212-16112015000200046,reduce,o
139,S0212-16112015000200046,la,o
139,S0212-16112015000200046,absorcion,o
139,S0212-16112015000200046,del,o
139,S0212-16112015000200046,hierro,i
139,S0212-16112015000200046,Cabe,o
139,S0212-16112015000200046,señalar,o
139,S0212-16112015000200046,que,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,mecanismo,o
139,S0212-16112015000200046,de,o
139,S0212-16112015000200046,quelacion,o
139,S0212-16112015000200046,de,o
139,S0212-16112015000200046,metales,i
139,S0212-16112015000200046,por,o
139,S0212-16112015000200046,el,o
139,S0212-16112015000200046,acido,i
139,S0212-16112015000200046,lipoico,i
139,S0212-16112015000200046,puede,o
139,S0212-16112015000200046,ser,o
139,S0212-16112015000200046,responsable,o
139,S0212-16112015000200046,de,o
139,S0212-16112015000200046,estos,o
139,S0212-16112015000200046,cambios,o
139,S0212-16112015000200046,y,o
139,S0212-16112015000200046,en,o
139,S0212-16112015000200046,consecuencia,o
139,S0212-16112015000200046,podria,o
139,S0212-16112015000200046,desencadenar,o
139,S0212-16112015000200046,una,o
139,S0212-16112015000200046,condicion,o
139,S0212-16112015000200046,de,o
139,S0212-16112015000200046,anemia,i
139,S0212-16112015000200046,ferropenica,i
139,S0212-16112015000200046,en,o
139,S0212-16112015000200046,individuos,o
139,S0212-16112015000200046,hipertensos,i
140,S0212-16112015000400032,Efectos,i
140,S0212-16112015000400032,tisulares,i
140,S0212-16112015000400032,de,o
140,S0212-16112015000400032,la,o
140,S0212-16112015000400032,glutamina,i
140,S0212-16112015000400032,en,o
140,S0212-16112015000400032,pacientes,o
140,S0212-16112015000400032,con,o
140,S0212-16112015000400032,cancer,i
140,S0212-16112015000400032,de,i
140,S0212-16112015000400032,recto,i
140,S0212-16112015000400032,tratados,i
140,S0212-16112015000400032,con,i
140,S0212-16112015000400032,quimiorradioterapia,i
140,S0212-16112015000400032,preoperatoria,o
140,S0212-16112015000400032,Introduccion,o
140,S0212-16112015000400032,El,o
140,S0212-16112015000400032,objetivo,o
140,S0212-16112015000400032,fue,o
140,S0212-16112015000400032,evaluar,o
140,S0212-16112015000400032,los,o
140,S0212-16112015000400032,efectos,o
140,S0212-16112015000400032,de,o
140,S0212-16112015000400032,la,o
140,S0212-16112015000400032,administracion,i
140,S0212-16112015000400032,de,o
140,S0212-16112015000400032,glutamina,i
140,S0212-16112015000400032,sobre,o
140,S0212-16112015000400032,la,o
140,S0212-16112015000400032,regresion,o
140,S0212-16112015000400032,tumoral,i
140,S0212-16112015000400032,y,o
140,S0212-16112015000400032,sobre,o
140,S0212-16112015000400032,el,o
140,S0212-16112015000400032,tejido,i
140,S0212-16112015000400032,sano,o
140,S0212-16112015000400032,en,o
140,S0212-16112015000400032,pacientes,o
140,S0212-16112015000400032,con,o
140,S0212-16112015000400032,cancer,i
140,S0212-16112015000400032,rectal,i
140,S0212-16112015000400032,que,o
140,S0212-16112015000400032,recibieron,o
140,S0212-16112015000400032,quimiorradioterapia,i
140,S0212-16112015000400032,Material,o
140,S0212-16112015000400032,y,o
140,S0212-16112015000400032,metodos,o
140,S0212-16112015000400032,Se,o
140,S0212-16112015000400032,incluyo,o
140,S0212-16112015000400032,10,o
140,S0212-16112015000400032,pacientes,o
140,S0212-16112015000400032,con,o
140,S0212-16112015000400032,cancer,i
140,S0212-16112015000400032,rectal,i
140,S0212-16112015000400032,operado,i
140,S0212-16112015000400032,despues,o
140,S0212-16112015000400032,de,o
140,S0212-16112015000400032,quimiorradioterapia,i
140,S0212-16112015000400032,un,o
140,S0212-16112015000400032,subgrupo,o
140,S0212-16112015000400032,de,o
140,S0212-16112015000400032,un,o
140,S0212-16112015000400032,ensayo,i
140,S0212-16112015000400032,clinico,i
140,S0212-16112015000400032,que,o
140,S0212-16112015000400032,comparo,o
140,S0212-16112015000400032,glutamina,i
140,S0212-16112015000400032,con,o
140,S0212-16112015000400032,placebo,i
140,S0212-16112015000400032,en,o
140,S0212-16112015000400032,la,o
140,S0212-16112015000400032,prevencion,i
140,S0212-16112015000400032,de,o
140,S0212-16112015000400032,enteritis,i
140,S0212-16112015000400032,aguda,i
140,S0212-16112015000400032,Un,o
140,S0212-16112015000400032,patologo,o
140,S0212-16112015000400032,experto,o
140,S0212-16112015000400032,analizo,i
140,S0212-16112015000400032,las,i
140,S0212-16112015000400032,muestras,i
140,S0212-16112015000400032,de,i
140,S0212-16112015000400032,tumor,i
140,S0212-16112015000400032,y,i
140,S0212-16112015000400032,tejido,i
140,S0212-16112015000400032,sano,i
140,S0212-16112015000400032,buscando,o
140,S0212-16112015000400032,datos,o
140,S0212-16112015000400032,de,o
140,S0212-16112015000400032,regresion,o
140,S0212-16112015000400032,tumoral,i
140,S0212-16112015000400032,mucifagos,i
140,S0212-16112015000400032,y,o
140,S0212-16112015000400032,daño,i
140,S0212-16112015000400032,por,i
140,S0212-16112015000400032,radiacion,i
140,S0212-16112015000400032,Resultados,o
140,S0212-16112015000400032,No,o
140,S0212-16112015000400032,hubo,o
140,S0212-16112015000400032,diferencias,o
140,S0212-16112015000400032,entre,o
140,S0212-16112015000400032,placebo,i
140,S0212-16112015000400032,y,o
140,S0212-16112015000400032,glutamina,i
140,S0212-16112015000400032,en,o
140,S0212-16112015000400032,el,o
140,S0212-16112015000400032,grado,o
140,S0212-16112015000400032,de,o
140,S0212-16112015000400032,regresion,o
140,S0212-16112015000400032,tumoral,i
140,S0212-16112015000400032,Todos,o
140,S0212-16112015000400032,los,o
140,S0212-16112015000400032,pacientes,o
140,S0212-16112015000400032,con,o
140,S0212-16112015000400032,glutamina,i
140,S0212-16112015000400032,presentaron,o
140,S0212-16112015000400032,mucifagos,i
140,S0212-16112015000400032,frente,o
140,S0212-16112015000400032,al,o
140,S0212-16112015000400032,286,o
140,S0212-16112015000400032,con,o
140,S0212-16112015000400032,placebo,i
140,S0212-16112015000400032,p,o
140,S0212-16112015000400032,0038,o
140,S0212-16112015000400032,El,o
140,S0212-16112015000400032,daño,i
140,S0212-16112015000400032,sobre,i
140,S0212-16112015000400032,tejido,i
140,S0212-16112015000400032,sano,i
140,S0212-16112015000400032,fue,o
140,S0212-16112015000400032,similar,o
140,S0212-16112015000400032,en,o
140,S0212-16112015000400032,los,o
140,S0212-16112015000400032,pacientes,o
140,S0212-16112015000400032,con,o
140,S0212-16112015000400032,glutamina,i
140,S0212-16112015000400032,y,o
140,S0212-16112015000400032,placebo,i
140,S0212-16112015000400032,y,o
140,S0212-16112015000400032,entre,o
140,S0212-16112015000400032,aquellos,o
140,S0212-16112015000400032,con,o
140,S0212-16112015000400032,y,o
140,S0212-16112015000400032,sin,o
140,S0212-16112015000400032,enteritis,i
140,S0212-16112015000400032,Conclusion,o
140,S0212-16112015000400032,La,o
140,S0212-16112015000400032,glutamina,i
140,S0212-16112015000400032,no,o
140,S0212-16112015000400032,ejerce,o
140,S0212-16112015000400032,un,o
140,S0212-16112015000400032,efecto,o
140,S0212-16112015000400032,protector,o
140,S0212-16112015000400032,frente,o
140,S0212-16112015000400032,a,o
140,S0212-16112015000400032,la,o
140,S0212-16112015000400032,quimiorradioterapia,i
140,S0212-16112015000400032,sobre,o
140,S0212-16112015000400032,el,o
140,S0212-16112015000400032,tumor,i
140,S0212-16112015000400032,o,o
140,S0212-16112015000400032,el,o
140,S0212-16112015000400032,tejido,i
140,S0212-16112015000400032,rectal,i
140,S0212-16112015000400032,sano,o
141,S0212-16112015000500025,Comportamiento,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,cifras,i
141,S0212-16112015000500025,de,i
141,S0212-16112015000500025,glucemia,i
141,S0212-16112015000500025,con,o
141,S0212-16112015000500025,la,o
141,S0212-16112015000500025,administracion,i
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,los,o
141,S0212-16112015000500025,micronutrientes,i
141,S0212-16112015000500025,vitamina,i
141,S0212-16112015000500025,D3,i
141,S0212-16112015000500025,y,o
141,S0212-16112015000500025,calcio,i
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,pacientes,o
141,S0212-16112015000500025,no,o
141,S0212-16112015000500025,diabeticos,i
141,S0212-16112015000500025,con,i
141,S0212-16112015000500025,hiperglucemia,i
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,una,o
141,S0212-16112015000500025,unidad,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,cuidado,o
141,S0212-16112015000500025,intensivo,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,adultos,o
141,S0212-16112015000500025,La,o
141,S0212-16112015000500025,hiperglucemia,i
141,S0212-16112015000500025,sin,o
141,S0212-16112015000500025,antecedentes,o
141,S0212-16112015000500025,previos,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,diabetes,i
141,S0212-16112015000500025,mellitus,i
141,S0212-16112015000500025,DM,i
141,S0212-16112015000500025,se,o
141,S0212-16112015000500025,observa,o
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,un,o
141,S0212-16112015000500025,alto,o
141,S0212-16112015000500025,porcentaje,o
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,pacientes,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,unidades,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,cuidado,o
141,S0212-16112015000500025,intensivo,o
141,S0212-16112015000500025,UCI,o
141,S0212-16112015000500025,Objetivo,o
141,S0212-16112015000500025,Determinar,o
141,S0212-16112015000500025,el,o
141,S0212-16112015000500025,comportamiento,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,cifras,i
141,S0212-16112015000500025,de,i
141,S0212-16112015000500025,glucemia,i
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,pacientes,o
141,S0212-16112015000500025,no,o
141,S0212-16112015000500025,diabeticos,i
141,S0212-16112015000500025,con,i
141,S0212-16112015000500025,hiperglucemia,i
141,S0212-16112015000500025,mediante,o
141,S0212-16112015000500025,la,o
141,S0212-16112015000500025,administracion,i
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,2,o
141,S0212-16112015000500025,micronutrientes,i
141,S0212-16112015000500025,Metodologia,o
141,S0212-16112015000500025,se,o
141,S0212-16112015000500025,realizo,o
141,S0212-16112015000500025,un,o
141,S0212-16112015000500025,ensayo,i
141,S0212-16112015000500025,clinico,i
141,S0212-16112015000500025,a,o
141,S0212-16112015000500025,32,o
141,S0212-16112015000500025,pacientes,o
141,S0212-16112015000500025,16,o
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,el,o
141,S0212-16112015000500025,grupo,o
141,S0212-16112015000500025,a,o
141,S0212-16112015000500025,intervenir,i
141,S0212-16112015000500025,y,o
141,S0212-16112015000500025,16,o
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,el,o
141,S0212-16112015000500025,grupo,o
141,S0212-16112015000500025,control,o
141,S0212-16112015000500025,Al,o
141,S0212-16112015000500025,grupo,o
141,S0212-16112015000500025,intervenido,i
141,S0212-16112015000500025,se,o
141,S0212-16112015000500025,le,o
141,S0212-16112015000500025,administro,o
141,S0212-16112015000500025,desde,o
141,S0212-16112015000500025,su,o
141,S0212-16112015000500025,ingreso,i
141,S0212-16112015000500025,los,o
141,S0212-16112015000500025,micronutrientes,i
141,S0212-16112015000500025,vitamina,i
141,S0212-16112015000500025,D3,i
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,dosis,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,1000,o
141,S0212-16112015000500025,unidades,o
141,S0212-16112015000500025,internacionales,o
141,S0212-16112015000500025,UI,o
141,S0212-16112015000500025,y,o
141,S0212-16112015000500025,calcio,i
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,dosis,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,1000,o
141,S0212-16112015000500025,mg,o
141,S0212-16112015000500025,cada,o
141,S0212-16112015000500025,24,o
141,S0212-16112015000500025,horas,o
141,S0212-16112015000500025,por,o
141,S0212-16112015000500025,un,o
141,S0212-16112015000500025,periodo,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,72,o
141,S0212-16112015000500025,horas,o
141,S0212-16112015000500025,Resultados,o
141,S0212-16112015000500025,no,o
141,S0212-16112015000500025,se,o
141,S0212-16112015000500025,observaron,o
141,S0212-16112015000500025,diferencias,o
141,S0212-16112015000500025,estadisticamente,o
141,S0212-16112015000500025,significativas,o
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,la,o
141,S0212-16112015000500025,glucemia,i
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,ingreso,i
141,S0212-16112015000500025,entre,o
141,S0212-16112015000500025,los,o
141,S0212-16112015000500025,grupos,o
141,S0212-16112015000500025,intervenidos,i
141,S0212-16112015000500025,y,o
141,S0212-16112015000500025,control,o
141,S0212-16112015000500025,1526,o
141,S0212-16112015000500025,y,o
141,S0212-16112015000500025,1533,o
141,S0212-16112015000500025,mgdl,o
141,S0212-16112015000500025,respectivamente,o
141,S0212-16112015000500025,p,o
141,S0212-16112015000500025,0922,o
141,S0212-16112015000500025,sin,o
141,S0212-16112015000500025,embargo,o
141,S0212-16112015000500025,a,o
141,S0212-16112015000500025,las,o
141,S0212-16112015000500025,72,o
141,S0212-16112015000500025,horas,o
141,S0212-16112015000500025,el,o
141,S0212-16112015000500025,comportamiento,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,las,o
141,S0212-16112015000500025,glucemias,i
141,S0212-16112015000500025,disminuyo,o
141,S0212-16112015000500025,significativamente,o
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,el,o
141,S0212-16112015000500025,grupo,o
141,S0212-16112015000500025,intervenido,i
141,S0212-16112015000500025,comparado,o
141,S0212-16112015000500025,con,o
141,S0212-16112015000500025,el,o
141,S0212-16112015000500025,grupo,o
141,S0212-16112015000500025,control,o
141,S0212-16112015000500025,9841,o
141,S0212-16112015000500025,y,o
141,S0212-16112015000500025,14166,o
141,S0212-16112015000500025,mgdl,o
141,S0212-16112015000500025,respectivamente,o
141,S0212-16112015000500025,p,o
141,S0212-16112015000500025,0000,o
141,S0212-16112015000500025,Asi,o
141,S0212-16112015000500025,mismo,o
141,S0212-16112015000500025,se,o
141,S0212-16112015000500025,evidencio,o
141,S0212-16112015000500025,que,o
141,S0212-16112015000500025,la,o
141,S0212-16112015000500025,intervencion,i
141,S0212-16112015000500025,con,o
141,S0212-16112015000500025,vitamina,i
141,S0212-16112015000500025,D3,i
141,S0212-16112015000500025,y,o
141,S0212-16112015000500025,Calcio,i
141,S0212-16112015000500025,redujo,o
141,S0212-16112015000500025,el,o
141,S0212-16112015000500025,riesgo,o
141,S0212-16112015000500025,47,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,desarrollo,o
141,S0212-16112015000500025,del,o
141,S0212-16112015000500025,evento,i
141,S0212-16112015000500025,indeseado,i
141,S0212-16112015000500025,glucemia,i
141,S0212-16112015000500025,100,o
141,S0212-16112015000500025,mgdl,o
141,S0212-16112015000500025,mostrando,o
141,S0212-16112015000500025,que,o
141,S0212-16112015000500025,se,o
141,S0212-16112015000500025,deben,o
141,S0212-16112015000500025,tratar,i
141,S0212-16112015000500025,229,o
141,S0212-16112015000500025,pacientes,o
141,S0212-16112015000500025,para,o
141,S0212-16112015000500025,disminuir,o
141,S0212-16112015000500025,el,o
141,S0212-16112015000500025,evento,i
141,S0212-16112015000500025,indeseable,i
141,S0212-16112015000500025,NNT,o
141,S0212-16112015000500025,Conclusion,o
141,S0212-16112015000500025,la,o
141,S0212-16112015000500025,utilizacion,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,los,o
141,S0212-16112015000500025,micronutrientes,i
141,S0212-16112015000500025,analizados,o
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,pacientes,o
141,S0212-16112015000500025,criticos,o
141,S0212-16112015000500025,sin,o
141,S0212-16112015000500025,diagnostico,i
141,S0212-16112015000500025,previo,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,diabetes,i
141,S0212-16112015000500025,requiere,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,mas,o
141,S0212-16112015000500025,investigaciones,o
141,S0212-16112015000500025,que,o
141,S0212-16112015000500025,contemplen,o
141,S0212-16112015000500025,las,o
141,S0212-16112015000500025,limitaciones,o
141,S0212-16112015000500025,aqui,o
141,S0212-16112015000500025,planteadas,o
141,S0212-16112015000500025,Dada,o
141,S0212-16112015000500025,la,o
141,S0212-16112015000500025,poca,o
141,S0212-16112015000500025,literatura,o
141,S0212-16112015000500025,encontrada,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,estudios,o
141,S0212-16112015000500025,similares,o
141,S0212-16112015000500025,esta,o
141,S0212-16112015000500025,investigacion,o
141,S0212-16112015000500025,proporcionaria,o
141,S0212-16112015000500025,otra,o
141,S0212-16112015000500025,alternativa,o
141,S0212-16112015000500025,en,o
141,S0212-16112015000500025,la,o
141,S0212-16112015000500025,disminucion,o
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,la,o
141,S0212-16112015000500025,hiperglucemia,i
141,S0212-16112015000500025,de,o
141,S0212-16112015000500025,estos,o
141,S0212-16112015000500025,pacientes,o
142,S0212-16112015000800032,Efectos,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,un,o
142,S0212-16112015000800032,suplemento,i
142,S0212-16112015000800032,nutricional,i
142,S0212-16112015000800032,en,o
142,S0212-16112015000800032,la,o
142,S0212-16112015000800032,incidencia,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,infecciones,i
142,S0212-16112015000800032,respiratorias,i
142,S0212-16112015000800032,agudas,i
142,S0212-16112015000800032,en,o
142,S0212-16112015000800032,adultos,o
142,S0212-16112015000800032,susceptibles,o
142,S0212-16112015000800032,un,o
142,S0212-16112015000800032,ensayo,i
142,S0212-16112015000800032,clinico,i
142,S0212-16112015000800032,controlado,i
142,S0212-16112015000800032,Introduccion,o
142,S0212-16112015000800032,aunque,o
142,S0212-16112015000800032,la,o
142,S0212-16112015000800032,suplementacion,i
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,micronutrientes,i
142,S0212-16112015000800032,especificos,o
142,S0212-16112015000800032,puede,o
142,S0212-16112015000800032,mejorar,o
142,S0212-16112015000800032,determinados,o
142,S0212-16112015000800032,factores,o
142,S0212-16112015000800032,inmunologicos,o
142,S0212-16112015000800032,han,o
142,S0212-16112015000800032,sido,o
142,S0212-16112015000800032,publicados,o
142,S0212-16112015000800032,pocos,o
142,S0212-16112015000800032,estudios,o
142,S0212-16112015000800032,sobre,o
142,S0212-16112015000800032,la,o
142,S0212-16112015000800032,combinacion,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,micronutrientes,i
142,S0212-16112015000800032,con,o
142,S0212-16112015000800032,extractos,i
142,S0212-16112015000800032,herbales,i
142,S0212-16112015000800032,y,o
142,S0212-16112015000800032,la,o
142,S0212-16112015000800032,incidencia,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,infecciones,i
142,S0212-16112015000800032,respiratorias,i
142,S0212-16112015000800032,agudas,i
142,S0212-16112015000800032,ARI,o
142,S0212-16112015000800032,Objetivos,o
142,S0212-16112015000800032,evaluar,o
142,S0212-16112015000800032,el,o
142,S0212-16112015000800032,efecto,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,un,o
142,S0212-16112015000800032,suplemento,i
142,S0212-16112015000800032,alimenticio,i
142,S0212-16112015000800032,con,o
142,S0212-16112015000800032,micronutrientes,i
142,S0212-16112015000800032,y,o
142,S0212-16112015000800032,extractos,i
142,S0212-16112015000800032,herbales,i
142,S0212-16112015000800032,en,o
142,S0212-16112015000800032,la,o
142,S0212-16112015000800032,incidencia,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,ARI,o
142,S0212-16112015000800032,en,o
142,S0212-16112015000800032,adultos,o
142,S0212-16112015000800032,susceptibles,o
142,S0212-16112015000800032,en,o
142,S0212-16112015000800032,eneroabril,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,2012,o
142,S0212-16112015000800032,Metodos,o
142,S0212-16112015000800032,se,o
142,S0212-16112015000800032,realizo,o
142,S0212-16112015000800032,un,o
142,S0212-16112015000800032,ensayo,o
142,S0212-16112015000800032,clinico,o
142,S0212-16112015000800032,paralelo,o
142,S0212-16112015000800032,aleatorizado,o
142,S0212-16112015000800032,doble,o
142,S0212-16112015000800032,ciego,o
142,S0212-16112015000800032,controlado,o
142,S0212-16112015000800032,con,o
142,S0212-16112015000800032,placebo,i
142,S0212-16112015000800032,Se,o
142,S0212-16112015000800032,incluyeron,o
142,S0212-16112015000800032,adultos,o
142,S0212-16112015000800032,susceptibles,o
142,S0212-16112015000800032,a,o
142,S0212-16112015000800032,ARI,o
142,S0212-16112015000800032,sanos,o
142,S0212-16112015000800032,en,o
142,S0212-16112015000800032,el,o
142,S0212-16112015000800032,momento,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,la,o
142,S0212-16112015000800032,evaluacion,i
142,S0212-16112015000800032,que,o
142,S0212-16112015000800032,firmaron,o
142,S0212-16112015000800032,un,o
142,S0212-16112015000800032,consentimiento,i
142,S0212-16112015000800032,informado,i
142,S0212-16112015000800032,y,o
142,S0212-16112015000800032,que,o
142,S0212-16112015000800032,no,o
142,S0212-16112015000800032,tomaban,o
142,S0212-16112015000800032,medicamentos,i
142,S0212-16112015000800032,Completaron,o
142,S0212-16112015000800032,una,o
142,S0212-16112015000800032,historia,o
142,S0212-16112015000800032,clinica,o
142,S0212-16112015000800032,y,o
142,S0212-16112015000800032,se,o
142,S0212-16112015000800032,evaluo,o
142,S0212-16112015000800032,peso,o
142,S0212-16112015000800032,talla,o
142,S0212-16112015000800032,signos,o
142,S0212-16112015000800032,vitales,o
142,S0212-16112015000800032,y,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,laboratorio,o
142,S0212-16112015000800032,Se,o
142,S0212-16112015000800032,asignaron,i
142,S0212-16112015000800032,aleatoriamente,i
142,S0212-16112015000800032,para,o
142,S0212-16112015000800032,consumir,o
142,S0212-16112015000800032,durante,o
142,S0212-16112015000800032,90,o
142,S0212-16112015000800032,dias,o
142,S0212-16112015000800032,el,o
142,S0212-16112015000800032,suplemento,o
142,S0212-16112015000800032,o,o
142,S0212-16112015000800032,un,o
142,S0212-16112015000800032,placebo,i
142,S0212-16112015000800032,Los,o
142,S0212-16112015000800032,sujetos,o
142,S0212-16112015000800032,registraron,o
142,S0212-16112015000800032,diariamente,o
142,S0212-16112015000800032,si,o
142,S0212-16112015000800032,presentaban,o
142,S0212-16112015000800032,o,o
142,S0212-16112015000800032,no,o
142,S0212-16112015000800032,sintomas,i
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,ARI,o
142,S0212-16112015000800032,en,o
142,S0212-16112015000800032,un,o
142,S0212-16112015000800032,diario,o
142,S0212-16112015000800032,En,o
142,S0212-16112015000800032,caso,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,enfermedad,i
142,S0212-16112015000800032,se,o
142,S0212-16112015000800032,lo,o
142,S0212-16112015000800032,notificaron,o
142,S0212-16112015000800032,a,o
142,S0212-16112015000800032,los,o
142,S0212-16112015000800032,investigadores,o
142,S0212-16112015000800032,y,o
142,S0212-16112015000800032,el,o
142,S0212-16112015000800032,medico,o
142,S0212-16112015000800032,responsable,o
142,S0212-16112015000800032,confirmo,o
142,S0212-16112015000800032,la,o
142,S0212-16112015000800032,presencia,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,infeccion,i
142,S0212-16112015000800032,Se,o
142,S0212-16112015000800032,utilizo,o
142,S0212-16112015000800032,la,o
142,S0212-16112015000800032,prueba,o
142,S0212-16112015000800032,exacta,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,Fisher,o
142,S0212-16112015000800032,para,o
142,S0212-16112015000800032,comparar,o
142,S0212-16112015000800032,la,o
142,S0212-16112015000800032,proporcion,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,enfermos,i
142,S0212-16112015000800032,entre,o
142,S0212-16112015000800032,los,o
142,S0212-16112015000800032,grupos,o
142,S0212-16112015000800032,y,o
142,S0212-16112015000800032,se,o
142,S0212-16112015000800032,calculo,o
142,S0212-16112015000800032,el,o
142,S0212-16112015000800032,riesgo,o
142,S0212-16112015000800032,relativo,o
142,S0212-16112015000800032,y,o
142,S0212-16112015000800032,la,o
142,S0212-16112015000800032,diferencia,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,riesgos,o
142,S0212-16112015000800032,p005,o
142,S0212-16112015000800032,significativa,o
142,S0212-16112015000800032,Resultados,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,59,o
142,S0212-16112015000800032,sujetos,o
142,S0212-16112015000800032,incluidos,o
142,S0212-16112015000800032,45,o
142,S0212-16112015000800032,25,o
142,S0212-16112015000800032,mujeres,o
142,S0212-16112015000800032,completaron,o
142,S0212-16112015000800032,el,o
142,S0212-16112015000800032,estudio,o
142,S0212-16112015000800032,21,o
142,S0212-16112015000800032,del,o
142,S0212-16112015000800032,grupo,o
142,S0212-16112015000800032,suplementado,i
142,S0212-16112015000800032,y,o
142,S0212-16112015000800032,24,o
142,S0212-16112015000800032,del,o
142,S0212-16112015000800032,placebo,i
142,S0212-16112015000800032,No,o
142,S0212-16112015000800032,hubo,o
142,S0212-16112015000800032,diferencias,o
142,S0212-16112015000800032,significativas,o
142,S0212-16112015000800032,al,o
142,S0212-16112015000800032,inicio,o
142,S0212-16112015000800032,entre,o
142,S0212-16112015000800032,grupos,o
142,S0212-16112015000800032,Al,o
142,S0212-16112015000800032,finalizar,o
142,S0212-16112015000800032,la,o
142,S0212-16112015000800032,intervencion,i
142,S0212-16112015000800032,el,o
142,S0212-16112015000800032,grupo,o
142,S0212-16112015000800032,suplementado,i
142,S0212-16112015000800032,tuvo,o
142,S0212-16112015000800032,una,o
142,S0212-16112015000800032,menor,o
142,S0212-16112015000800032,incidencia,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,ARI,o
142,S0212-16112015000800032,en,o
142,S0212-16112015000800032,comparacion,o
142,S0212-16112015000800032,con,o
142,S0212-16112015000800032,el,o
142,S0212-16112015000800032,placebo,i
142,S0212-16112015000800032,571,o
142,S0212-16112015000800032,vs,o
142,S0212-16112015000800032,917,o
142,S0212-16112015000800032,p,o
142,S0212-16112015000800032,0013,o
142,S0212-16112015000800032,RR,o
142,S0212-16112015000800032,062,o
142,S0212-16112015000800032,IC95,o
142,S0212-16112015000800032,042,o
142,S0212-16112015000800032,092,o
142,S0212-16112015000800032,Discusion,o
142,S0212-16112015000800032,en,o
142,S0212-16112015000800032,conclusion,o
142,S0212-16112015000800032,el,o
142,S0212-16112015000800032,consumo,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,un,o
142,S0212-16112015000800032,suplemento,o
142,S0212-16112015000800032,a,o
142,S0212-16112015000800032,base,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,micronutrientes,i
142,S0212-16112015000800032,y,o
142,S0212-16112015000800032,extractos,i
142,S0212-16112015000800032,herbales,i
142,S0212-16112015000800032,puede,o
142,S0212-16112015000800032,disminuir,o
142,S0212-16112015000800032,la,o
142,S0212-16112015000800032,incidencia,o
142,S0212-16112015000800032,de,o
142,S0212-16112015000800032,ARI,o
142,S0212-16112015000800032,en,o
142,S0212-16112015000800032,adultos,o
142,S0212-16112015000800032,susceptibles,o
143,S0212-16112016000200007,Efectos,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,la,o
143,S0212-16112016000200007,administracion,i
143,S0212-16112016000200007,de,i
143,S0212-16112016000200007,calostro,i
143,S0212-16112016000200007,orofaringeo,i
143,S0212-16112016000200007,en,o
143,S0212-16112016000200007,recien,i
143,S0212-16112016000200007,nacidos,i
143,S0212-16112016000200007,prematuros,i
143,S0212-16112016000200007,sobre,o
143,S0212-16112016000200007,los,o
143,S0212-16112016000200007,niveles,i
143,S0212-16112016000200007,de,i
143,S0212-16112016000200007,inmunoglobulina,i
143,S0212-16112016000200007,A,i
143,S0212-16112016000200007,Introduccion,o
143,S0212-16112016000200007,el,o
143,S0212-16112016000200007,recien,i
143,S0212-16112016000200007,nacido,i
143,S0212-16112016000200007,prematuro,i
143,S0212-16112016000200007,de,i
143,S0212-16112016000200007,muy,i
143,S0212-16112016000200007,bajo,i
143,S0212-16112016000200007,peso,i
143,S0212-16112016000200007,RNMBP,i
143,S0212-16112016000200007,es,o
143,S0212-16112016000200007,inmunologicamente,o
143,S0212-16112016000200007,inmaduro,o
143,S0212-16112016000200007,y,o
143,S0212-16112016000200007,ademas,o
143,S0212-16112016000200007,presenta,o
143,S0212-16112016000200007,una,o
143,S0212-16112016000200007,alteracion,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,las,o
143,S0212-16112016000200007,barreras,o
143,S0212-16112016000200007,naturales,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,defensa,o
143,S0212-16112016000200007,Objetivo,o
143,S0212-16112016000200007,evaluar,o
143,S0212-16112016000200007,los,o
143,S0212-16112016000200007,efectos,o
143,S0212-16112016000200007,que,o
143,S0212-16112016000200007,pueda,o
143,S0212-16112016000200007,tener,o
143,S0212-16112016000200007,la,o
143,S0212-16112016000200007,administracion,i
143,S0212-16112016000200007,de,i
143,S0212-16112016000200007,calostro,i
143,S0212-16112016000200007,orofaringeo,i
143,S0212-16112016000200007,administrado,o
143,S0212-16112016000200007,durante,o
143,S0212-16112016000200007,los,o
143,S0212-16112016000200007,primeros,o
143,S0212-16112016000200007,15,o
143,S0212-16112016000200007,dias,o
143,S0212-16112016000200007,posnatales,o
143,S0212-16112016000200007,sobre,o
143,S0212-16112016000200007,los,o
143,S0212-16112016000200007,niveles,i
143,S0212-16112016000200007,de,i
143,S0212-16112016000200007,inmunoglobulina,i
143,S0212-16112016000200007,A,i
143,S0212-16112016000200007,IgA,i
143,S0212-16112016000200007,serica,i
143,S0212-16112016000200007,en,o
143,S0212-16112016000200007,recien,i
143,S0212-16112016000200007,nacidos,i
143,S0212-16112016000200007,prematuros,i
143,S0212-16112016000200007,de,i
143,S0212-16112016000200007,muy,i
143,S0212-16112016000200007,bajo,i
143,S0212-16112016000200007,peso,i
143,S0212-16112016000200007,durante,o
143,S0212-16112016000200007,el,o
143,S0212-16112016000200007,primer,o
143,S0212-16112016000200007,mes,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,vida,o
143,S0212-16112016000200007,Material,o
143,S0212-16112016000200007,y,o
143,S0212-16112016000200007,metodos,o
143,S0212-16112016000200007,se,o
143,S0212-16112016000200007,desarrollo,o
143,S0212-16112016000200007,un,o
143,S0212-16112016000200007,estudio,i
143,S0212-16112016000200007,de,i
143,S0212-16112016000200007,intervencion,i
143,S0212-16112016000200007,no,i
143,S0212-16112016000200007,aleatorizado,i
143,S0212-16112016000200007,con,i
143,S0212-16112016000200007,grupo,i
143,S0212-16112016000200007,control,i
143,S0212-16112016000200007,en,o
143,S0212-16112016000200007,el,o
143,S0212-16112016000200007,que,o
143,S0212-16112016000200007,se,o
143,S0212-16112016000200007,incluyeron,o
143,S0212-16112016000200007,38,o
143,S0212-16112016000200007,recien,i
143,S0212-16112016000200007,nacidos,i
143,S0212-16112016000200007,con,o
143,S0212-16112016000200007,32,o
143,S0212-16112016000200007,6,o
143,S0212-16112016000200007,semanas,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,gestacion,o
143,S0212-16112016000200007,yo,o
143,S0212-16112016000200007,menores,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,1500,o
143,S0212-16112016000200007,g,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,peso,o
143,S0212-16112016000200007,Los,o
143,S0212-16112016000200007,sujetos,o
143,S0212-16112016000200007,recibieron,o
143,S0212-16112016000200007,02,o
143,S0212-16112016000200007,ml,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,calostro,i
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,su,o
143,S0212-16112016000200007,madre,o
143,S0212-16112016000200007,cada,o
143,S0212-16112016000200007,4,o
143,S0212-16112016000200007,h,o
143,S0212-16112016000200007,iniciandose,o
143,S0212-16112016000200007,el,o
143,S0212-16112016000200007,procedimiento,i
143,S0212-16112016000200007,en,o
143,S0212-16112016000200007,las,o
143,S0212-16112016000200007,primeras,o
143,S0212-16112016000200007,24,o
143,S0212-16112016000200007,h,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,vida,o
143,S0212-16112016000200007,hasta,o
143,S0212-16112016000200007,el,o
143,S0212-16112016000200007,15o,o
143,S0212-16112016000200007,dia,o
143,S0212-16112016000200007,postnatal,o
143,S0212-16112016000200007,Se,o
143,S0212-16112016000200007,midieron,o
143,S0212-16112016000200007,los,o
143,S0212-16112016000200007,niveles,i
143,S0212-16112016000200007,de,i
143,S0212-16112016000200007,IgA,i
143,S0212-16112016000200007,en,i
143,S0212-16112016000200007,la,i
143,S0212-16112016000200007,sangre,i
143,S0212-16112016000200007,al,o
143,S0212-16112016000200007,nacimiento,o
143,S0212-16112016000200007,3er,o
143,S0212-16112016000200007,15o,o
143,S0212-16112016000200007,y,o
143,S0212-16112016000200007,30o,o
143,S0212-16112016000200007,dias,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,vida,o
143,S0212-16112016000200007,Se,o
143,S0212-16112016000200007,registraron,o
143,S0212-16112016000200007,datos,o
143,S0212-16112016000200007,perinatales,o
143,S0212-16112016000200007,al,o
143,S0212-16112016000200007,nacimiento,o
143,S0212-16112016000200007,y,o
143,S0212-16112016000200007,durante,o
143,S0212-16112016000200007,el,o
143,S0212-16112016000200007,periodo,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,seguimiento,i
143,S0212-16112016000200007,Resultados,o
143,S0212-16112016000200007,IgA,i
143,S0212-16112016000200007,serica,i
143,S0212-16112016000200007,aumento,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,forma,o
143,S0212-16112016000200007,estadisticamente,o
143,S0212-16112016000200007,significativa,o
143,S0212-16112016000200007,en,o
143,S0212-16112016000200007,el,o
143,S0212-16112016000200007,grupo,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,intervencion,i
143,S0212-16112016000200007,M1,o
143,S0212-16112016000200007,1584,o
143,S0212-16112016000200007,µgml,o
143,S0212-16112016000200007,M2,o
143,S0212-16112016000200007,2007,o
143,S0212-16112016000200007,µgml,o
143,S0212-16112016000200007,M3,o
143,S0212-16112016000200007,2365,o
143,S0212-16112016000200007,µgml,o
143,S0212-16112016000200007,M4,o
143,S0212-16112016000200007,3034,o
143,S0212-16112016000200007,µgml,o
143,S0212-16112016000200007,p,o
143,S0212-16112016000200007,0001,o
143,S0212-16112016000200007,y,o
143,S0212-16112016000200007,en,o
143,S0212-16112016000200007,el,o
143,S0212-16112016000200007,grupo,o
143,S0212-16112016000200007,control,o
143,S0212-16112016000200007,M1,o
143,S0212-16112016000200007,1248,o
143,S0212-16112016000200007,µgml,o
143,S0212-16112016000200007,M2,o
143,S0212-16112016000200007,1648,o
143,S0212-16112016000200007,µgml,o
143,S0212-16112016000200007,p,o
143,S0212-16112016000200007,0018,o
143,S0212-16112016000200007,M3,o
143,S0212-16112016000200007,1941,o
143,S0212-16112016000200007,µgml,o
143,S0212-16112016000200007,M4,o
143,S0212-16112016000200007,2248,o
143,S0212-16112016000200007,µgml,o
143,S0212-16112016000200007,p,o
143,S0212-16112016000200007,0001,o
143,S0212-16112016000200007,Al,o
143,S0212-16112016000200007,mes,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,vida,o
143,S0212-16112016000200007,los,o
143,S0212-16112016000200007,niveles,i
143,S0212-16112016000200007,de,i
143,S0212-16112016000200007,IgA,i
143,S0212-16112016000200007,serica,i
143,S0212-16112016000200007,fueron,o
143,S0212-16112016000200007,significativamente,o
143,S0212-16112016000200007,mayores,o
143,S0212-16112016000200007,en,o
143,S0212-16112016000200007,el,o
143,S0212-16112016000200007,grupo,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,intervencion,i
143,S0212-16112016000200007,que,o
143,S0212-16112016000200007,en,o
143,S0212-16112016000200007,el,o
143,S0212-16112016000200007,grupo,o
143,S0212-16112016000200007,control,o
143,S0212-16112016000200007,p,o
143,S0212-16112016000200007,0026,o
143,S0212-16112016000200007,Conclusiones,o
143,S0212-16112016000200007,este,o
143,S0212-16112016000200007,estudio,o
143,S0212-16112016000200007,sugiere,o
143,S0212-16112016000200007,que,o
143,S0212-16112016000200007,la,o
143,S0212-16112016000200007,administracion,i
143,S0212-16112016000200007,de,i
143,S0212-16112016000200007,calostro,i
143,S0212-16112016000200007,orofaringeo,i
143,S0212-16112016000200007,favoreceria,o
143,S0212-16112016000200007,el,o
143,S0212-16112016000200007,desarrollo,o
143,S0212-16112016000200007,del,o
143,S0212-16112016000200007,sistema,i
143,S0212-16112016000200007,inmunologico,i
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,los,o
143,S0212-16112016000200007,recien,i
143,S0212-16112016000200007,nacidos,i
143,S0212-16112016000200007,prematuros,i
143,S0212-16112016000200007,y,o
143,S0212-16112016000200007,RNMBP,i
143,S0212-16112016000200007,a,o
143,S0212-16112016000200007,traves,o
143,S0212-16112016000200007,del,o
143,S0212-16112016000200007,aumento,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,IgA,i
143,S0212-16112016000200007,al,o
143,S0212-16112016000200007,mes,o
143,S0212-16112016000200007,de,o
143,S0212-16112016000200007,vida,o
144,S0212-16112017000200352,Influencia,o
144,S0212-16112017000200352,del,o
144,S0212-16112017000200352,aceite,i
144,S0212-16112017000200352,de,i
144,S0212-16112017000200352,coco,i
144,S0212-16112017000200352,en,o
144,S0212-16112017000200352,enfermos,i
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,alzheimer,i
144,S0212-16112017000200352,a,o
144,S0212-16112017000200352,nivel,o
144,S0212-16112017000200352,cognitivo,o
144,S0212-16112017000200352,Introduccion,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,enfermedad,i
144,S0212-16112017000200352,de,i
144,S0212-16112017000200352,Alzheimer,i
144,S0212-16112017000200352,es,o
144,S0212-16112017000200352,a,o
144,S0212-16112017000200352,dia,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,hoy,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,demencia,i
144,S0212-16112017000200352,neurodegenerativa,i
144,S0212-16112017000200352,con,o
144,S0212-16112017000200352,mayor,o
144,S0212-16112017000200352,prevalencia,o
144,S0212-16112017000200352,en,o
144,S0212-16112017000200352,el,o
144,S0212-16112017000200352,primer,o
144,S0212-16112017000200352,mundo,o
144,S0212-16112017000200352,Este,o
144,S0212-16112017000200352,hecho,o
144,S0212-16112017000200352,unido,o
144,S0212-16112017000200352,a,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,falta,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,tratamiento,i
144,S0212-16112017000200352,farmacologico,i
144,S0212-16112017000200352,que,o
144,S0212-16112017000200352,cure,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,enfermedad,i
144,S0212-16112017000200352,hace,o
144,S0212-16112017000200352,que,o
144,S0212-16112017000200352,se,o
144,S0212-16112017000200352,estudien,o
144,S0212-16112017000200352,nuevas,o
144,S0212-16112017000200352,estrategias,i
144,S0212-16112017000200352,terapeuticas,i
144,S0212-16112017000200352,no,i
144,S0212-16112017000200352,farmacologicas,i
144,S0212-16112017000200352,como,o
144,S0212-16112017000200352,es,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,administracion,i
144,S0212-16112017000200352,de,i
144,S0212-16112017000200352,nutrientes,i
144,S0212-16112017000200352,En,o
144,S0212-16112017000200352,este,o
144,S0212-16112017000200352,sentido,o
144,S0212-16112017000200352,destaca,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,posible,o
144,S0212-16112017000200352,influencia,o
144,S0212-16112017000200352,del,o
144,S0212-16112017000200352,aceite,i
144,S0212-16112017000200352,de,i
144,S0212-16112017000200352,coco,i
144,S0212-16112017000200352,como,o
144,S0212-16112017000200352,fuente,o
144,S0212-16112017000200352,energetica,o
144,S0212-16112017000200352,alternativa,o
144,S0212-16112017000200352,capaz,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,frenar,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,muerte,i
144,S0212-16112017000200352,neuronal,i
144,S0212-16112017000200352,que,o
144,S0212-16112017000200352,se,o
144,S0212-16112017000200352,produce,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,modo,o
144,S0212-16112017000200352,progresivo,o
144,S0212-16112017000200352,en,o
144,S0212-16112017000200352,esta,o
144,S0212-16112017000200352,enfermedad,i
144,S0212-16112017000200352,Objetivos,o
144,S0212-16112017000200352,valorar,o
144,S0212-16112017000200352,el,o
144,S0212-16112017000200352,impacto,o
144,S0212-16112017000200352,del,o
144,S0212-16112017000200352,aceite,i
144,S0212-16112017000200352,de,i
144,S0212-16112017000200352,coco,i
144,S0212-16112017000200352,a,o
144,S0212-16112017000200352,nivel,o
144,S0212-16112017000200352,cognitivo,o
144,S0212-16112017000200352,en,o
144,S0212-16112017000200352,pacientes,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,alzheimer,i
144,S0212-16112017000200352,y,o
144,S0212-16112017000200352,concretamente,o
144,S0212-16112017000200352,en,o
144,S0212-16112017000200352,las,o
144,S0212-16112017000200352,areas,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,orientacion,o
144,S0212-16112017000200352,lenguajeconstruccion,o
144,S0212-16112017000200352,fijacion,o
144,S0212-16112017000200352,calculoconcentracion,o
144,S0212-16112017000200352,y,o
144,S0212-16112017000200352,memoria,o
144,S0212-16112017000200352,Metodos,o
144,S0212-16112017000200352,estudio,o
144,S0212-16112017000200352,prospectivo,o
144,S0212-16112017000200352,longitudinal,o
144,S0212-16112017000200352,cualitativo,o
144,S0212-16112017000200352,analitico,o
144,S0212-16112017000200352,y,o
144,S0212-16112017000200352,experimental,o
144,S0212-16112017000200352,a,o
144,S0212-16112017000200352,traves,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,un,o
144,S0212-16112017000200352,ensayo,i
144,S0212-16112017000200352,clinico,i
144,S0212-16112017000200352,donde,o
144,S0212-16112017000200352,se,o
144,S0212-16112017000200352,seleccionaron,o
144,S0212-16112017000200352,a,o
144,S0212-16112017000200352,44,o
144,S0212-16112017000200352,pacientes,o
144,S0212-16112017000200352,con,o
144,S0212-16112017000200352,alzheimer,i
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,zona,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,Ribera,o
144,S0212-16112017000200352,Comunidad,o
144,S0212-16112017000200352,Valenciana,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,los,o
144,S0212-16112017000200352,cuales,o
144,S0212-16112017000200352,a,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,mitad,o
144,S0212-16112017000200352,se,o
144,S0212-16112017000200352,le,o
144,S0212-16112017000200352,administro,o
144,S0212-16112017000200352,durante,o
144,S0212-16112017000200352,21,o
144,S0212-16112017000200352,dias,o
144,S0212-16112017000200352,40,o
144,S0212-16112017000200352,ml,o
144,S0212-16112017000200352,diarios,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,aceite,i
144,S0212-16112017000200352,de,i
144,S0212-16112017000200352,coco,i
144,S0212-16112017000200352,repartidos,o
144,S0212-16112017000200352,entre,o
144,S0212-16112017000200352,desayuno,o
144,S0212-16112017000200352,20,o
144,S0212-16112017000200352,ml,o
144,S0212-16112017000200352,y,o
144,S0212-16112017000200352,comida,o
144,S0212-16112017000200352,20,o
144,S0212-16112017000200352,ml,o
144,S0212-16112017000200352,Antes,o
144,S0212-16112017000200352,y,o
144,S0212-16112017000200352,despues,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,administracion,i
144,S0212-16112017000200352,del,o
144,S0212-16112017000200352,aceite,i
144,S0212-16112017000200352,se,o
144,S0212-16112017000200352,les,o
144,S0212-16112017000200352,valoro,o
144,S0212-16112017000200352,a,o
144,S0212-16112017000200352,traves,o
144,S0212-16112017000200352,del,o
144,S0212-16112017000200352,test,o
144,S0212-16112017000200352,cognitivo,o
144,S0212-16112017000200352,MiniExamen,o
144,S0212-16112017000200352,Cognoscitivo,o
144,S0212-16112017000200352,para,o
144,S0212-16112017000200352,determinar,o
144,S0212-16112017000200352,los,o
144,S0212-16112017000200352,posibles,o
144,S0212-16112017000200352,cambios,o
144,S0212-16112017000200352,Resultados,o
144,S0212-16112017000200352,en,o
144,S0212-16112017000200352,los,o
144,S0212-16112017000200352,enfermos,i
144,S0212-16112017000200352,que,o
144,S0212-16112017000200352,tomaron,o
144,S0212-16112017000200352,el,o
144,S0212-16112017000200352,aceite,i
144,S0212-16112017000200352,de,i
144,S0212-16112017000200352,coco,i
144,S0212-16112017000200352,se,o
144,S0212-16112017000200352,observo,o
144,S0212-16112017000200352,una,o
144,S0212-16112017000200352,mejora,o
144,S0212-16112017000200352,cognitiva,o
144,S0212-16112017000200352,tras,o
144,S0212-16112017000200352,finalizar,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,intervencion,i
144,S0212-16112017000200352,siendo,o
144,S0212-16112017000200352,estadisticamente,o
144,S0212-16112017000200352,significativa,o
144,S0212-16112017000200352,en,o
144,S0212-16112017000200352,las,o
144,S0212-16112017000200352,areas,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,orientacion,o
144,S0212-16112017000200352,y,o
144,S0212-16112017000200352,lenguajeconstruccion,o
144,S0212-16112017000200352,Conclusiones,o
144,S0212-16112017000200352,el,o
144,S0212-16112017000200352,aceite,i
144,S0212-16112017000200352,de,i
144,S0212-16112017000200352,coco,i
144,S0212-16112017000200352,parece,o
144,S0212-16112017000200352,mejorar,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,capacidad,o
144,S0212-16112017000200352,cognitiva,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,los,o
144,S0212-16112017000200352,enfermos,i
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,alzheimer,i
144,S0212-16112017000200352,variando,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,intensidad,o
144,S0212-16112017000200352,de,o
144,S0212-16112017000200352,la,o
144,S0212-16112017000200352,misma,o
144,S0212-16112017000200352,en,o
144,S0212-16112017000200352,funcion,o
144,S0212-16112017000200352,del,o
144,S0212-16112017000200352,area,o
144,S0212-16112017000200352,cognitiva,o
145,S0212-16112017000300532,Indice,i
145,S0212-16112017000300532,glicemico,i
145,S0212-16112017000300532,carga,i
145,S0212-16112017000300532,glicemica,i
145,S0212-16112017000300532,e,o
145,S0212-16112017000300532,insulina,i
145,S0212-16112017000300532,posprandial,o
145,S0212-16112017000300532,a,o
145,S0212-16112017000300532,dos,o
145,S0212-16112017000300532,formulas,i
145,S0212-16112017000300532,isoglucidicas,i
145,S0212-16112017000300532,con,o
145,S0212-16112017000300532,distintos,o
145,S0212-16112017000300532,edulcorantes,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,fibra,o
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,adultos,o
145,S0212-16112017000300532,sanos,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,diabeticos,i
145,S0212-16112017000300532,tipo,i
145,S0212-16112017000300532,2,i
145,S0212-16112017000300532,Objetivo,o
145,S0212-16112017000300532,el,o
145,S0212-16112017000300532,objetivo,o
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,este,o
145,S0212-16112017000300532,estudio,o
145,S0212-16112017000300532,fue,o
145,S0212-16112017000300532,comparar,o
145,S0212-16112017000300532,el,o
145,S0212-16112017000300532,indice,i
145,S0212-16112017000300532,glicemico,i
145,S0212-16112017000300532,IG,o
145,S0212-16112017000300532,la,o
145,S0212-16112017000300532,carga,i
145,S0212-16112017000300532,glicemica,i
145,S0212-16112017000300532,CG,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,la,o
145,S0212-16112017000300532,insulina,i
145,S0212-16112017000300532,posprandial,o
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,dos,o
145,S0212-16112017000300532,formulas,i
145,S0212-16112017000300532,isoglucidicas,i
145,S0212-16112017000300532,con,o
145,S0212-16112017000300532,distintos,o
145,S0212-16112017000300532,edulcorantes,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,fibra,o
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,adultos,o
145,S0212-16112017000300532,sanos,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,diabeticos,i
145,S0212-16112017000300532,tipo,i
145,S0212-16112017000300532,2,i
145,S0212-16112017000300532,DM2,i
145,S0212-16112017000300532,Metodologia,o
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,este,o
145,S0212-16112017000300532,estudio,o
145,S0212-16112017000300532,aleatorizado,o
145,S0212-16112017000300532,cruzado,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,doble,o
145,S0212-16112017000300532,ciego,o
145,S0212-16112017000300532,once,o
145,S0212-16112017000300532,sujetos,o
145,S0212-16112017000300532,sanos,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,seis,o
145,S0212-16112017000300532,diabeticos,i
145,S0212-16112017000300532,consumieron,o
145,S0212-16112017000300532,dos,o
145,S0212-16112017000300532,formulas,i
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,cuatro,o
145,S0212-16112017000300532,ocasiones,o
145,S0212-16112017000300532,Glucerna,o
145,S0212-16112017000300532,SRr,o
145,S0212-16112017000300532,Laboratorios,o
145,S0212-16112017000300532,Abbott,o
145,S0212-16112017000300532,CA,o
145,S0212-16112017000300532,FG,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,Enterex,o
145,S0212-16112017000300532,Diabeticr,o
145,S0212-16112017000300532,Victus,o
145,S0212-16112017000300532,CA,o
145,S0212-16112017000300532,FE,o
145,S0212-16112017000300532,edulcoradas,o
145,S0212-16112017000300532,con,o
145,S0212-16112017000300532,fructosa,i
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,sucralosa,i
145,S0212-16112017000300532,respectivamente,o
145,S0212-16112017000300532,con,o
145,S0212-16112017000300532,distintas,o
145,S0212-16112017000300532,fuentes,o
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,fibra,o
145,S0212-16112017000300532,ademas,o
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,solucion,i
145,S0212-16112017000300532,glucosada,i
145,S0212-16112017000300532,SG,i
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,una,o
145,S0212-16112017000300532,ocasion,o
145,S0212-16112017000300532,Se,o
145,S0212-16112017000300532,obtuvieron,o
145,S0212-16112017000300532,muestras,i
145,S0212-16112017000300532,de,i
145,S0212-16112017000300532,sangre,i
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,ambos,o
145,S0212-16112017000300532,grupos,o
145,S0212-16112017000300532,a,o
145,S0212-16112017000300532,los,o
145,S0212-16112017000300532,tiempos,o
145,S0212-16112017000300532,0,o
145,S0212-16112017000300532,15,o
145,S0212-16112017000300532,30,o
145,S0212-16112017000300532,45,o
145,S0212-16112017000300532,60,o
145,S0212-16112017000300532,90,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,120,o
145,S0212-16112017000300532,minutos,o
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,los,o
145,S0212-16112017000300532,diabeticos,i
145,S0212-16112017000300532,se,o
145,S0212-16112017000300532,adiciono,o
145,S0212-16112017000300532,el,o
145,S0212-16112017000300532,minuto,o
145,S0212-16112017000300532,150,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,180,o
145,S0212-16112017000300532,para,o
145,S0212-16112017000300532,medicion,i
145,S0212-16112017000300532,de,i
145,S0212-16112017000300532,glicemias,i
145,S0212-16112017000300532,e,o
145,S0212-16112017000300532,insulina,i
145,S0212-16112017000300532,basalposprandial,o
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,dos,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,tres,o
145,S0212-16112017000300532,horas,o
145,S0212-16112017000300532,Resultados,o
145,S0212-16112017000300532,el,o
145,S0212-16112017000300532,area,o
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,incremento,o
145,S0212-16112017000300532,bajo,o
145,S0212-16112017000300532,la,o
145,S0212-16112017000300532,curva,o
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,glucosa,i
145,S0212-16112017000300532,IAUC,o
145,S0212-16112017000300532,fue,o
145,S0212-16112017000300532,menor,o
145,S0212-16112017000300532,para,o
145,S0212-16112017000300532,las,o
145,S0212-16112017000300532,formulas,i
145,S0212-16112017000300532,que,o
145,S0212-16112017000300532,para,o
145,S0212-16112017000300532,SG,i
145,S0212-16112017000300532,En,o
145,S0212-16112017000300532,sanos,o
145,S0212-16112017000300532,fue,o
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,12857,o
145,S0212-16112017000300532,422,o
145,S0212-16112017000300532,para,o
145,S0212-16112017000300532,FE,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,11601,o
145,S0212-16112017000300532,272,o
145,S0212-16112017000300532,para,o
145,S0212-16112017000300532,FG,o
145,S0212-16112017000300532,p,o
145,S0212-16112017000300532,0014,o
145,S0212-16112017000300532,En,o
145,S0212-16112017000300532,diabeticos,i
145,S0212-16112017000300532,resulto,o
145,S0212-16112017000300532,mas,o
145,S0212-16112017000300532,disminuida,o
145,S0212-16112017000300532,para,o
145,S0212-16112017000300532,FG,o
145,S0212-16112017000300532,28656,o
145,S0212-16112017000300532,123,o
145,S0212-16112017000300532,comparada,o
145,S0212-16112017000300532,con,o
145,S0212-16112017000300532,FE,o
145,S0212-16112017000300532,29855,o
145,S0212-16112017000300532,496,o
145,S0212-16112017000300532,p,o
145,S0212-16112017000300532,001,o
145,S0212-16112017000300532,El,o
145,S0212-16112017000300532,IG,o
145,S0212-16112017000300532,resulto,o
145,S0212-16112017000300532,5807,o
145,S0212-16112017000300532,84,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,607,o
145,S0212-16112017000300532,2,o
145,S0212-16112017000300532,para,o
145,S0212-16112017000300532,FG,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,FE,o
145,S0212-16112017000300532,respectivamente,o
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,controles,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,6516,o
145,S0212-16112017000300532,02,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,6806,o
145,S0212-16112017000300532,1,o
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,diabeticos,i
145,S0212-16112017000300532,sin,o
145,S0212-16112017000300532,diferencias,o
145,S0212-16112017000300532,igualmente,o
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,la,o
145,S0212-16112017000300532,insulina,i
145,S0212-16112017000300532,posprandial,o
145,S0212-16112017000300532,Conclusiones,o
145,S0212-16112017000300532,el,o
145,S0212-16112017000300532,IG,o
145,S0212-16112017000300532,y,o
145,S0212-16112017000300532,la,o
145,S0212-16112017000300532,CG,o
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,ambas,o
145,S0212-16112017000300532,formulas,i
145,S0212-16112017000300532,resultaron,o
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,un,o
145,S0212-16112017000300532,valor,o
145,S0212-16112017000300532,intermedio,o
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,los,o
145,S0212-16112017000300532,dos,o
145,S0212-16112017000300532,grupos,o
145,S0212-16112017000300532,con,o
145,S0212-16112017000300532,perfil,i
145,S0212-16112017000300532,glicemico,i
145,S0212-16112017000300532,inferior,o
145,S0212-16112017000300532,al,o
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,SG,i
145,S0212-16112017000300532,No,o
145,S0212-16112017000300532,se,o
145,S0212-16112017000300532,observaron,o
145,S0212-16112017000300532,diferencias,o
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,el,o
145,S0212-16112017000300532,comportamiento,o
145,S0212-16112017000300532,insulinico,i
145,S0212-16112017000300532,evidenciando,o
145,S0212-16112017000300532,que,o
145,S0212-16112017000300532,la,o
145,S0212-16112017000300532,velocidad,o
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,absorcion,o
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,los,o
145,S0212-16112017000300532,carbohidratos,i
145,S0212-16112017000300532,de,o
145,S0212-16112017000300532,estas,o
145,S0212-16112017000300532,formulas,i
145,S0212-16112017000300532,es,o
145,S0212-16112017000300532,prolongada,o
145,S0212-16112017000300532,con,o
145,S0212-16112017000300532,impacto,o
145,S0212-16112017000300532,glicemico,o
145,S0212-16112017000300532,menor,o
145,S0212-16112017000300532,que,o
145,S0212-16112017000300532,el,o
145,S0212-16112017000300532,producto,o
145,S0212-16112017000300532,patron,o
145,S0212-16112017000300532,lo,o
145,S0212-16112017000300532,que,o
145,S0212-16112017000300532,sugiere,o
145,S0212-16112017000300532,que,o
145,S0212-16112017000300532,es,o
145,S0212-16112017000300532,aceptable,o
145,S0212-16112017000300532,su,o
145,S0212-16112017000300532,indicacion,o
145,S0212-16112017000300532,en,o
145,S0212-16112017000300532,el,o
145,S0212-16112017000300532,diabetico,i
146,S0212-16112017000900028,Rol,o
146,S0212-16112017000900028,de,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,estevia,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,Lcarnitina,o
146,S0212-16112017000900028,sobre,o
146,S0212-16112017000900028,el,o
146,S0212-16112017000900028,impacto,o
146,S0212-16112017000900028,glicemico,o
146,S0212-16112017000900028,de,o
146,S0212-16112017000900028,un,o
146,S0212-16112017000900028,suplemento,i
146,S0212-16112017000900028,nutricional,i
146,S0212-16112017000900028,en,o
146,S0212-16112017000900028,adultos,o
146,S0212-16112017000900028,Actualmente,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,industria,o
146,S0212-16112017000900028,alimentaria,o
146,S0212-16112017000900028,ha,o
146,S0212-16112017000900028,generado,o
146,S0212-16112017000900028,interes,o
146,S0212-16112017000900028,en,o
146,S0212-16112017000900028,edulcorantes,o
146,S0212-16112017000900028,no,o
146,S0212-16112017000900028,nutritivos,o
146,S0212-16112017000900028,por,o
146,S0212-16112017000900028,ejemplo,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,estevia,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,en,o
146,S0212-16112017000900028,componentes,o
146,S0212-16112017000900028,especiales,o
146,S0212-16112017000900028,como,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,Lcarnitina,o
146,S0212-16112017000900028,utilizados,o
146,S0212-16112017000900028,en,o
146,S0212-16112017000900028,formulaciones,o
146,S0212-16112017000900028,de,o
146,S0212-16112017000900028,suplementos,i
146,S0212-16112017000900028,nutricionales,i
146,S0212-16112017000900028,para,o
146,S0212-16112017000900028,el,o
146,S0212-16112017000900028,control,i
146,S0212-16112017000900028,glicemico,i
146,S0212-16112017000900028,especificos,o
146,S0212-16112017000900028,para,o
146,S0212-16112017000900028,diabeticos,i
146,S0212-16112017000900028,El,o
146,S0212-16112017000900028,presente,o
146,S0212-16112017000900028,estudio,o
146,S0212-16112017000900028,evaluo,o
146,S0212-16112017000900028,el,o
146,S0212-16112017000900028,efecto,o
146,S0212-16112017000900028,de,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,estevia,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,Lcarnitina,o
146,S0212-16112017000900028,sobre,o
146,S0212-16112017000900028,el,o
146,S0212-16112017000900028,indice,o
146,S0212-16112017000900028,glicemico,o
146,S0212-16112017000900028,IG,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,carga,o
146,S0212-16112017000900028,glicemica,o
146,S0212-16112017000900028,CG,o
146,S0212-16112017000900028,de,o
146,S0212-16112017000900028,un,o
146,S0212-16112017000900028,suplemento,i
146,S0212-16112017000900028,nutricional,i
146,S0212-16112017000900028,en,o
146,S0212-16112017000900028,19,o
146,S0212-16112017000900028,sujetos,o
146,S0212-16112017000900028,sanos,o
146,S0212-16112017000900028,9,o
146,S0212-16112017000900028,hombres,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,10,o
146,S0212-16112017000900028,mujeres,o
146,S0212-16112017000900028,quienes,o
146,S0212-16112017000900028,completaron,o
146,S0212-16112017000900028,aleatoriamente,i
146,S0212-16112017000900028,3,o
146,S0212-16112017000900028,pruebas,i
146,S0212-16112017000900028,de,i
146,S0212-16112017000900028,consumo,i
146,S0212-16112017000900028,1,o
146,S0212-16112017000900028,para,o
146,S0212-16112017000900028,el,o
146,S0212-16112017000900028,suplemento,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,1,o
146,S0212-16112017000900028,para,o
146,S0212-16112017000900028,cada,o
146,S0212-16112017000900028,producto,o
146,S0212-16112017000900028,de,o
146,S0212-16112017000900028,referencia,o
146,S0212-16112017000900028,solucion,i
146,S0212-16112017000900028,glucosada,i
146,S0212-16112017000900028,SG,i
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,pan,o
146,S0212-16112017000900028,blanco,o
146,S0212-16112017000900028,PB,o
146,S0212-16112017000900028,obteniendo,o
146,S0212-16112017000900028,muestras,i
146,S0212-16112017000900028,de,i
146,S0212-16112017000900028,sangre,i
146,S0212-16112017000900028,a,o
146,S0212-16112017000900028,los,o
146,S0212-16112017000900028,tiempos,o
146,S0212-16112017000900028,0,o
146,S0212-16112017000900028,15,o
146,S0212-16112017000900028,30,o
146,S0212-16112017000900028,45,o
146,S0212-16112017000900028,60,o
146,S0212-16112017000900028,90,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,120,o
146,S0212-16112017000900028,min,o
146,S0212-16112017000900028,para,o
146,S0212-16112017000900028,medicion,i
146,S0212-16112017000900028,de,i
146,S0212-16112017000900028,glicemias,i
146,S0212-16112017000900028,e,o
146,S0212-16112017000900028,insulina,i
146,S0212-16112017000900028,basal,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,postprandial,o
146,S0212-16112017000900028,El,o
146,S0212-16112017000900028,area,o
146,S0212-16112017000900028,de,o
146,S0212-16112017000900028,incremento,o
146,S0212-16112017000900028,bajo,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,curva,o
146,S0212-16112017000900028,de,o
146,S0212-16112017000900028,glucosa,i
146,S0212-16112017000900028,IAUC,o
146,S0212-16112017000900028,fue,o
146,S0212-16112017000900028,menor,o
146,S0212-16112017000900028,para,o
146,S0212-16112017000900028,el,o
146,S0212-16112017000900028,suplemento,o
146,S0212-16112017000900028,1177873,o
146,S0212-16112017000900028,que,o
146,S0212-16112017000900028,para,o
146,S0212-16112017000900028,los,o
146,S0212-16112017000900028,productos,o
146,S0212-16112017000900028,de,o
146,S0212-16112017000900028,referencia,o
146,S0212-16112017000900028,SG,i
146,S0212-16112017000900028,1372406,o
146,S0212-16112017000900028,PB,o
146,S0212-16112017000900028,1315356,o
146,S0212-16112017000900028,α,o
146,S0212-16112017000900028,p,o
146,S0212-16112017000900028,0005,o
146,S0212-16112017000900028,El,o
146,S0212-16112017000900028,IG,o
146,S0212-16112017000900028,62,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,CG,o
146,S0212-16112017000900028,16,o
146,S0212-16112017000900028,resultaron,o
146,S0212-16112017000900028,intermedios,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,mas,o
146,S0212-16112017000900028,bajos,o
146,S0212-16112017000900028,que,o
146,S0212-16112017000900028,el,o
146,S0212-16112017000900028,del,o
146,S0212-16112017000900028,pan,o
146,S0212-16112017000900028,blanco,o
146,S0212-16112017000900028,IG,o
146,S0212-16112017000900028,69,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,CG,o
146,S0212-16112017000900028,18,o
146,S0212-16112017000900028,sin,o
146,S0212-16112017000900028,diferencias,o
146,S0212-16112017000900028,en,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,insulina,i
146,S0212-16112017000900028,postprandial,o
146,S0212-16112017000900028,Esto,o
146,S0212-16112017000900028,demuestra,o
146,S0212-16112017000900028,que,o
146,S0212-16112017000900028,este,o
146,S0212-16112017000900028,suplemento,i
146,S0212-16112017000900028,nutricional,i
146,S0212-16112017000900028,formulado,o
146,S0212-16112017000900028,con,o
146,S0212-16112017000900028,estevia,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,Lcarnitina,o
146,S0212-16112017000900028,es,o
146,S0212-16112017000900028,capaz,o
146,S0212-16112017000900028,de,o
146,S0212-16112017000900028,prolongar,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,respuesta,o
146,S0212-16112017000900028,glicemica,o
146,S0212-16112017000900028,sin,o
146,S0212-16112017000900028,aumentar,o
146,S0212-16112017000900028,los,o
146,S0212-16112017000900028,requerimientos,o
146,S0212-16112017000900028,insulinicos,i
146,S0212-16112017000900028,en,o
146,S0212-16112017000900028,sujetos,o
146,S0212-16112017000900028,sanos,o
146,S0212-16112017000900028,Se,o
146,S0212-16112017000900028,requieren,o
146,S0212-16112017000900028,estudios,o
146,S0212-16112017000900028,especificos,o
146,S0212-16112017000900028,en,o
146,S0212-16112017000900028,diabeticos,i
146,S0212-16112017000900028,para,o
146,S0212-16112017000900028,validar,o
146,S0212-16112017000900028,si,o
146,S0212-16112017000900028,el,o
146,S0212-16112017000900028,impacto,o
146,S0212-16112017000900028,glicemico,o
146,S0212-16112017000900028,es,o
146,S0212-16112017000900028,menor,o
146,S0212-16112017000900028,que,o
146,S0212-16112017000900028,el,o
146,S0212-16112017000900028,producto,o
146,S0212-16112017000900028,patron,o
146,S0212-16112017000900028,La,o
146,S0212-16112017000900028,presencia,o
146,S0212-16112017000900028,de,o
146,S0212-16112017000900028,otros,o
146,S0212-16112017000900028,nutrientes,o
146,S0212-16112017000900028,en,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,formula,i
146,S0212-16112017000900028,influyentes,o
146,S0212-16112017000900028,en,o
146,S0212-16112017000900028,estos,o
146,S0212-16112017000900028,indicadores,o
146,S0212-16112017000900028,no,o
146,S0212-16112017000900028,permite,o
146,S0212-16112017000900028,inferir,o
146,S0212-16112017000900028,que,o
146,S0212-16112017000900028,los,o
146,S0212-16112017000900028,resultados,o
146,S0212-16112017000900028,se,o
146,S0212-16112017000900028,deban,o
146,S0212-16112017000900028,unicamente,o
146,S0212-16112017000900028,al,o
146,S0212-16112017000900028,tipo,o
146,S0212-16112017000900028,de,o
146,S0212-16112017000900028,endulzante,o
146,S0212-16112017000900028,utilizado,o
146,S0212-16112017000900028,y,o
146,S0212-16112017000900028,a,o
146,S0212-16112017000900028,la,o
146,S0212-16112017000900028,Lcarnitina,o
147,S0212-16112018000100162,Efecto,o
147,S0212-16112018000100162,del,o
147,S0212-16112018000100162,aceite,i
147,S0212-16112018000100162,de,i
147,S0212-16112018000100162,pescado,i
147,S0212-16112018000100162,en,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,actividad,o
147,S0212-16112018000100162,hidrolitica,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,ATPasa,i
147,S0212-16112018000100162,y,o
147,S0212-16112018000100162,en,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,fluidez,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,membrana,i
147,S0212-16112018000100162,mitocondrial,i
147,S0212-16112018000100162,en,o
147,S0212-16112018000100162,pacientes,o
147,S0212-16112018000100162,con,o
147,S0212-16112018000100162,esclerosis,i
147,S0212-16112018000100162,multiple,i
147,S0212-16112018000100162,remitenterecurrente,o
147,S0212-16112018000100162,tratados,i
147,S0212-16112018000100162,con,o
147,S0212-16112018000100162,interferon,o
147,S0212-16112018000100162,beta,o
147,S0212-16112018000100162,1b,o
147,S0212-16112018000100162,Introduccion,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,esclerosis,i
147,S0212-16112018000100162,multiple,i
147,S0212-16112018000100162,EM,i
147,S0212-16112018000100162,es,o
147,S0212-16112018000100162,una,o
147,S0212-16112018000100162,enfermedad,i
147,S0212-16112018000100162,inflamatoria,i
147,S0212-16112018000100162,del,i
147,S0212-16112018000100162,sistema,i
147,S0212-16112018000100162,nervioso,i
147,S0212-16112018000100162,central,i
147,S0212-16112018000100162,asociada,o
147,S0212-16112018000100162,con,o
147,S0212-16112018000100162,estres,i
147,S0212-16112018000100162,oxidativo,i
147,S0212-16112018000100162,EO,i
147,S0212-16112018000100162,y,o
147,S0212-16112018000100162,alteraciones,i
147,S0212-16112018000100162,mitocondriales,i
147,S0212-16112018000100162,El,o
147,S0212-16112018000100162,aceite,i
147,S0212-16112018000100162,de,i
147,S0212-16112018000100162,pescado,i
147,S0212-16112018000100162,tiene,o
147,S0212-16112018000100162,efectos,o
147,S0212-16112018000100162,neuroprotectores,o
147,S0212-16112018000100162,antioxidantes,o
147,S0212-16112018000100162,y,o
147,S0212-16112018000100162,antiinflamatorios,o
147,S0212-16112018000100162,en,o
147,S0212-16112018000100162,pacientes,o
147,S0212-16112018000100162,con,o
147,S0212-16112018000100162,EM,i
147,S0212-16112018000100162,remitenterecurrente,o
147,S0212-16112018000100162,EMRR,o
147,S0212-16112018000100162,Objetivo,o
147,S0212-16112018000100162,evaluar,o
147,S0212-16112018000100162,los,o
147,S0212-16112018000100162,cambios,o
147,S0212-16112018000100162,en,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,actividad,o
147,S0212-16112018000100162,hidrolitica,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,ATPasa,i
147,S0212-16112018000100162,y,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,fluidez,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,membrana,i
147,S0212-16112018000100162,mitocondrial,i
147,S0212-16112018000100162,en,o
147,S0212-16112018000100162,pacientes,o
147,S0212-16112018000100162,con,o
147,S0212-16112018000100162,EMRR,o
147,S0212-16112018000100162,que,o
147,S0212-16112018000100162,reciben,o
147,S0212-16112018000100162,aceite,i
147,S0212-16112018000100162,de,i
147,S0212-16112018000100162,pescado,i
147,S0212-16112018000100162,o,o
147,S0212-16112018000100162,aceite,i
147,S0212-16112018000100162,de,i
147,S0212-16112018000100162,oliva,i
147,S0212-16112018000100162,como,o
147,S0212-16112018000100162,suplemento,o
147,S0212-16112018000100162,alimenticio,o
147,S0212-16112018000100162,Metodos,o
147,S0212-16112018000100162,ensayo,o
147,S0212-16112018000100162,clinico,o
147,S0212-16112018000100162,controlado,o
147,S0212-16112018000100162,aleatorizado,o
147,S0212-16112018000100162,doble,o
147,S0212-16112018000100162,ciego,o
147,S0212-16112018000100162,Los,o
147,S0212-16112018000100162,pacientes,o
147,S0212-16112018000100162,consumieron,o
147,S0212-16112018000100162,aceite,i
147,S0212-16112018000100162,de,i
147,S0212-16112018000100162,pescado,i
147,S0212-16112018000100162,o,o
147,S0212-16112018000100162,aceite,i
147,S0212-16112018000100162,de,i
147,S0212-16112018000100162,oliva,i
147,S0212-16112018000100162,durante,o
147,S0212-16112018000100162,un,o
147,S0212-16112018000100162,año,o
147,S0212-16112018000100162,Se,o
147,S0212-16112018000100162,cuantifico,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,actividad,o
147,S0212-16112018000100162,hidrolitica,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,ATPasa,i
147,S0212-16112018000100162,y,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,fluidez,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,membrana,i
147,S0212-16112018000100162,mitocondrial,i
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,plaquetas,i
147,S0212-16112018000100162,Resultados,o
147,S0212-16112018000100162,en,o
147,S0212-16112018000100162,pacientes,o
147,S0212-16112018000100162,con,o
147,S0212-16112018000100162,EMRR,o
147,S0212-16112018000100162,hay,o
147,S0212-16112018000100162,una,o
147,S0212-16112018000100162,disminucion,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,fluidez,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,las,o
147,S0212-16112018000100162,membranas,i
147,S0212-16112018000100162,mitocondriales,i
147,S0212-16112018000100162,y,o
147,S0212-16112018000100162,un,o
147,S0212-16112018000100162,incremento,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,actividad,o
147,S0212-16112018000100162,hidrolitica,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,ATPasa,i
147,S0212-16112018000100162,en,o
147,S0212-16112018000100162,comparacion,o
147,S0212-16112018000100162,con,o
147,S0212-16112018000100162,controles,o
147,S0212-16112018000100162,sanos,o
147,S0212-16112018000100162,Despues,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,6,o
147,S0212-16112018000100162,y,o
147,S0212-16112018000100162,9,o
147,S0212-16112018000100162,meses,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,tratamiento,i
147,S0212-16112018000100162,con,o
147,S0212-16112018000100162,aceite,i
147,S0212-16112018000100162,de,i
147,S0212-16112018000100162,oliva,i
147,S0212-16112018000100162,y,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,aceite,i
147,S0212-16112018000100162,de,i
147,S0212-16112018000100162,pescado,i
147,S0212-16112018000100162,respectivamente,o
147,S0212-16112018000100162,los,o
147,S0212-16112018000100162,valores,o
147,S0212-16112018000100162,se,o
147,S0212-16112018000100162,normalizaron,o
147,S0212-16112018000100162,y,o
147,S0212-16112018000100162,se,o
147,S0212-16112018000100162,mantuvieron,o
147,S0212-16112018000100162,asi,o
147,S0212-16112018000100162,hasta,o
147,S0212-16112018000100162,el,o
147,S0212-16112018000100162,fin,o
147,S0212-16112018000100162,del,o
147,S0212-16112018000100162,estudio,o
147,S0212-16112018000100162,Conclusion,o
147,S0212-16112018000100162,el,o
147,S0212-16112018000100162,consumo,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,aceite,i
147,S0212-16112018000100162,de,i
147,S0212-16112018000100162,pescado,i
147,S0212-16112018000100162,y,o
147,S0212-16112018000100162,aceite,i
147,S0212-16112018000100162,de,i
147,S0212-16112018000100162,oliva,i
147,S0212-16112018000100162,incrementan,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,fluidez,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,membrana,i
147,S0212-16112018000100162,y,o
147,S0212-16112018000100162,disminuye,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,actividad,o
147,S0212-16112018000100162,catabolica,o
147,S0212-16112018000100162,de,o
147,S0212-16112018000100162,la,o
147,S0212-16112018000100162,ATP,i
147,S0212-16112018000100162,sintasa,i
147,S0212-16112018000100162,en,o
147,S0212-16112018000100162,pacientes,o
147,S0212-16112018000100162,con,o
147,S0212-16112018000100162,EMRR,o
148,S0212-16112018000200392,Efectos,o
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,dieta,o
148,S0212-16112018000200392,lactovegetariana,o
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,ejercicios,i
148,S0212-16112018000200392,de,i
148,S0212-16112018000200392,estabilizacion,i
148,S0212-16112018000200392,del,i
148,S0212-16112018000200392,core,i
148,S0212-16112018000200392,sobre,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,composicion,o
148,S0212-16112018000200392,corporal,i
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,el,o
148,S0212-16112018000200392,dolor,i
148,S0212-16112018000200392,en,o
148,S0212-16112018000200392,mujeres,o
148,S0212-16112018000200392,con,o
148,S0212-16112018000200392,fibromialgia,i
148,S0212-16112018000200392,ensayo,i
148,S0212-16112018000200392,controlado,i
148,S0212-16112018000200392,aleatorizado,i
148,S0212-16112018000200392,Introduccion,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,fibromialgia,i
148,S0212-16112018000200392,es,o
148,S0212-16112018000200392,una,o
148,S0212-16112018000200392,enfermedad,i
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,origen,o
148,S0212-16112018000200392,desconocido,o
148,S0212-16112018000200392,caracterizada,o
148,S0212-16112018000200392,por,o
148,S0212-16112018000200392,dolor,i
148,S0212-16112018000200392,muscular,i
148,S0212-16112018000200392,cronico,i
148,S0212-16112018000200392,La,o
148,S0212-16112018000200392,falta,o
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,conocimientos,o
148,S0212-16112018000200392,sobre,o
148,S0212-16112018000200392,esta,o
148,S0212-16112018000200392,enfermedad,i
148,S0212-16112018000200392,es,o
148,S0212-16112018000200392,una,o
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,las,o
148,S0212-16112018000200392,principales,o
148,S0212-16112018000200392,causas,o
148,S0212-16112018000200392,por,o
148,S0212-16112018000200392,las,o
148,S0212-16112018000200392,que,o
148,S0212-16112018000200392,resulta,o
148,S0212-16112018000200392,complejo,o
148,S0212-16112018000200392,realizar,o
148,S0212-16112018000200392,un,o
148,S0212-16112018000200392,diagnostico,i
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,tratamiento,i
148,S0212-16112018000200392,adecuados,o
148,S0212-16112018000200392,Objetivo,o
148,S0212-16112018000200392,el,o
148,S0212-16112018000200392,objetivo,o
148,S0212-16112018000200392,principal,o
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,este,o
148,S0212-16112018000200392,estudio,o
148,S0212-16112018000200392,fue,o
148,S0212-16112018000200392,conocer,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,eficacia,o
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,un,o
148,S0212-16112018000200392,tratamiento,i
148,S0212-16112018000200392,de,i
148,S0212-16112018000200392,fisioterapia,i
148,S0212-16112018000200392,combinado,o
148,S0212-16112018000200392,con,o
148,S0212-16112018000200392,una,o
148,S0212-16112018000200392,intervencion,i
148,S0212-16112018000200392,dieteticonutricional,o
148,S0212-16112018000200392,lactovegetariana,o
148,S0212-16112018000200392,sobre,o
148,S0212-16112018000200392,el,o
148,S0212-16112018000200392,dolor,i
148,S0212-16112018000200392,bajo,i
148,S0212-16112018000200392,de,i
148,S0212-16112018000200392,espalda,i
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,composicion,o
148,S0212-16112018000200392,corporal,i
148,S0212-16112018000200392,en,o
148,S0212-16112018000200392,mujeres,o
148,S0212-16112018000200392,con,o
148,S0212-16112018000200392,fibromialgia,i
148,S0212-16112018000200392,Metodos,o
148,S0212-16112018000200392,en,o
148,S0212-16112018000200392,el,o
148,S0212-16112018000200392,estudio,o
148,S0212-16112018000200392,participaron,o
148,S0212-16112018000200392,21,o
148,S0212-16112018000200392,mujeres,o
148,S0212-16112018000200392,que,o
148,S0212-16112018000200392,fueron,o
148,S0212-16112018000200392,divididas,i
148,S0212-16112018000200392,aleatoriamente,i
148,S0212-16112018000200392,en,o
148,S0212-16112018000200392,3,o
148,S0212-16112018000200392,grupos,o
148,S0212-16112018000200392,A,o
148,S0212-16112018000200392,ejercicios,i
148,S0212-16112018000200392,estabilizacion,i
148,S0212-16112018000200392,core,i
148,S0212-16112018000200392,dieta,o
148,S0212-16112018000200392,lactovegetariana,o
148,S0212-16112018000200392,B,o
148,S0212-16112018000200392,placebo,i
148,S0212-16112018000200392,dieta,o
148,S0212-16112018000200392,lactovegetariana,o
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,C,o
148,S0212-16112018000200392,control,o
148,S0212-16112018000200392,La,o
148,S0212-16112018000200392,intervencion,i
148,S0212-16112018000200392,tuvo,o
148,S0212-16112018000200392,una,o
148,S0212-16112018000200392,duracion,o
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,4,o
148,S0212-16112018000200392,semanas,o
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,se,o
148,S0212-16112018000200392,realizaron,o
148,S0212-16112018000200392,evaluaciones,i
148,S0212-16112018000200392,del,i
148,S0212-16112018000200392,dolor,i
148,S0212-16112018000200392,escala,i
148,S0212-16112018000200392,EVA,i
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,composicion,o
148,S0212-16112018000200392,corporal,i
148,S0212-16112018000200392,bioimpedancia,i
148,S0212-16112018000200392,al,o
148,S0212-16112018000200392,inicio,o
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,final,o
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,intervencion,i
148,S0212-16112018000200392,Resultados,o
148,S0212-16112018000200392,el,o
148,S0212-16112018000200392,grupo,o
148,S0212-16112018000200392,A,o
148,S0212-16112018000200392,mostro,o
148,S0212-16112018000200392,cambios,o
148,S0212-16112018000200392,significativos,o
148,S0212-16112018000200392,en,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,reduccion,o
148,S0212-16112018000200392,del,o
148,S0212-16112018000200392,dolor,i
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,composicion,o
148,S0212-16112018000200392,corporal,i
148,S0212-16112018000200392,al,o
148,S0212-16112018000200392,final,o
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,intervencion,i
148,S0212-16112018000200392,aumentando,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,masa,o
148,S0212-16112018000200392,muscular,i
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,disminuyendo,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,masa,o
148,S0212-16112018000200392,grasa,i
148,S0212-16112018000200392,Ademas,o
148,S0212-16112018000200392,este,o
148,S0212-16112018000200392,grupo,o
148,S0212-16112018000200392,mejoro,o
148,S0212-16112018000200392,significativamente,o
148,S0212-16112018000200392,los,o
148,S0212-16112018000200392,resultados,o
148,S0212-16112018000200392,en,o
148,S0212-16112018000200392,comparacion,o
148,S0212-16112018000200392,con,o
148,S0212-16112018000200392,los,o
148,S0212-16112018000200392,grupos,o
148,S0212-16112018000200392,B,o
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,C,o
148,S0212-16112018000200392,Las,o
148,S0212-16112018000200392,correlaciones,o
148,S0212-16112018000200392,realizadas,o
148,S0212-16112018000200392,mostraron,o
148,S0212-16112018000200392,una,o
148,S0212-16112018000200392,relacion,o
148,S0212-16112018000200392,entre,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,masa,o
148,S0212-16112018000200392,muscular,i
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,disminucion,o
148,S0212-16112018000200392,del,o
148,S0212-16112018000200392,dolor,i
148,S0212-16112018000200392,referido,o
148,S0212-16112018000200392,al,o
148,S0212-16112018000200392,final,o
148,S0212-16112018000200392,del,o
148,S0212-16112018000200392,estudio,o
148,S0212-16112018000200392,en,o
148,S0212-16112018000200392,las,o
148,S0212-16112018000200392,pacientes,o
148,S0212-16112018000200392,del,o
148,S0212-16112018000200392,grupo,o
148,S0212-16112018000200392,A,o
148,S0212-16112018000200392,Conclusiones,o
148,S0212-16112018000200392,un,o
148,S0212-16112018000200392,programa,i
148,S0212-16112018000200392,de,i
148,S0212-16112018000200392,intervencion,i
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,4,o
148,S0212-16112018000200392,semanas,o
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,duracion,o
148,S0212-16112018000200392,en,o
148,S0212-16112018000200392,el,o
148,S0212-16112018000200392,que,o
148,S0212-16112018000200392,se,o
148,S0212-16112018000200392,combina,o
148,S0212-16112018000200392,ejercicios,i
148,S0212-16112018000200392,de,i
148,S0212-16112018000200392,estabilizacion,i
148,S0212-16112018000200392,de,i
148,S0212-16112018000200392,core,i
148,S0212-16112018000200392,mas,o
148,S0212-16112018000200392,dieta,o
148,S0212-16112018000200392,lactovegetariana,o
148,S0212-16112018000200392,en,o
148,S0212-16112018000200392,pacientes,o
148,S0212-16112018000200392,con,o
148,S0212-16112018000200392,fibromialgia,i
148,S0212-16112018000200392,que,o
148,S0212-16112018000200392,presentan,o
148,S0212-16112018000200392,dolor,i
148,S0212-16112018000200392,bajo,i
148,S0212-16112018000200392,de,i
148,S0212-16112018000200392,espalda,i
148,S0212-16112018000200392,contribuye,o
148,S0212-16112018000200392,a,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,reduccion,o
148,S0212-16112018000200392,del,o
148,S0212-16112018000200392,dolor,i
148,S0212-16112018000200392,y,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,mejora,o
148,S0212-16112018000200392,de,o
148,S0212-16112018000200392,la,o
148,S0212-16112018000200392,composicion,o
148,S0212-16112018000200392,corporal,i
149,S0212-71992001000700004,Estudio,i
149,S0212-71992001000700004,comparativo,i
149,S0212-71992001000700004,en,o
149,S0212-71992001000700004,la,o
149,S0212-71992001000700004,erradicacion,i
149,S0212-71992001000700004,del,i
149,S0212-71992001000700004,Helicobacter,i
149,S0212-71992001000700004,pylori,i
149,S0212-71992001000700004,ranitidinacitrato,o
149,S0212-71992001000700004,bismuto,o
149,S0212-71992001000700004,frente,o
149,S0212-71992001000700004,omeprazol,i
149,S0212-71992001000700004,mas,o
149,S0212-71992001000700004,dos,o
149,S0212-71992001000700004,antibioticos,i
149,S0212-71992001000700004,durante,o
149,S0212-71992001000700004,7,o
149,S0212-71992001000700004,dias,o
149,S0212-71992001000700004,Objetivos,o
149,S0212-71992001000700004,Comparar,i
149,S0212-71992001000700004,la,i
149,S0212-71992001000700004,eficacia,i
149,S0212-71992001000700004,en,o
149,S0212-71992001000700004,la,o
149,S0212-71992001000700004,erradicacion,i
149,S0212-71992001000700004,del,i
149,S0212-71992001000700004,Helicobacter,i
149,S0212-71992001000700004,pylori,i
149,S0212-71992001000700004,con,o
149,S0212-71992001000700004,ranitidinacitrato,o
149,S0212-71992001000700004,bismuto,o
149,S0212-71992001000700004,RB,o
149,S0212-71992001000700004,frente,o
149,S0212-71992001000700004,al,o
149,S0212-71992001000700004,tratamiento,i
149,S0212-71992001000700004,clasico,o
149,S0212-71992001000700004,con,o
149,S0212-71992001000700004,omeprazol,i
149,S0212-71992001000700004,Material,o
149,S0212-71992001000700004,y,o
149,S0212-71992001000700004,metodos,o
149,S0212-71992001000700004,Se,o
149,S0212-71992001000700004,estudiaron,i
149,S0212-71992001000700004,de,i
149,S0212-71992001000700004,forma,i
149,S0212-71992001000700004,prospectiva,i
149,S0212-71992001000700004,y,i
149,S0212-71992001000700004,randomizada,i
149,S0212-71992001000700004,la,i
149,S0212-71992001000700004,eficacia,i
149,S0212-71992001000700004,de,o
149,S0212-71992001000700004,erradicacion,i
149,S0212-71992001000700004,en,o
149,S0212-71992001000700004,200,o
149,S0212-71992001000700004,pacientes,o
149,S0212-71992001000700004,consecutivos,o
149,S0212-71992001000700004,con,o
149,S0212-71992001000700004,dos,o
149,S0212-71992001000700004,pautas,i
149,S0212-71992001000700004,de,i
149,S0212-71992001000700004,tratamiento,i
149,S0212-71992001000700004,OCA7,o
149,S0212-71992001000700004,omeprazol,i
149,S0212-71992001000700004,20,o
149,S0212-71992001000700004,mg12,o
149,S0212-71992001000700004,horas,o
149,S0212-71992001000700004,amoxicilina,i
149,S0212-71992001000700004,1g12,o
149,S0212-71992001000700004,horas,o
149,S0212-71992001000700004,claritromicina,i
149,S0212-71992001000700004,500,o
149,S0212-71992001000700004,mg12,o
149,S0212-71992001000700004,horas,o
149,S0212-71992001000700004,durante,o
149,S0212-71992001000700004,7,o
149,S0212-71992001000700004,dias,o
149,S0212-71992001000700004,y,o
149,S0212-71992001000700004,RBCA7,o
149,S0212-71992001000700004,RB,o
149,S0212-71992001000700004,400,o
149,S0212-71992001000700004,mg12,o
149,S0212-71992001000700004,horas,o
149,S0212-71992001000700004,amoxicilina,i
149,S0212-71992001000700004,1g12,o
149,S0212-71992001000700004,horas,o
149,S0212-71992001000700004,claritromicina,i
149,S0212-71992001000700004,500,o
149,S0212-71992001000700004,mg12,o
149,S0212-71992001000700004,horas,o
149,S0212-71992001000700004,durante,o
149,S0212-71992001000700004,7,o
149,S0212-71992001000700004,dias,o
149,S0212-71992001000700004,La,o
149,S0212-71992001000700004,erradicacion,i
149,S0212-71992001000700004,se,o
149,S0212-71992001000700004,valoro,o
149,S0212-71992001000700004,con,o
149,S0212-71992001000700004,el,o
149,S0212-71992001000700004,test,i
149,S0212-71992001000700004,del,i
149,S0212-71992001000700004,aliento,i
149,S0212-71992001000700004,al,o
149,S0212-71992001000700004,menos,o
149,S0212-71992001000700004,4,o
149,S0212-71992001000700004,semanas,o
149,S0212-71992001000700004,de,o
149,S0212-71992001000700004,finalizar,o
149,S0212-71992001000700004,el,o
149,S0212-71992001000700004,tratamiento,i
149,S0212-71992001000700004,Resultados,o
149,S0212-71992001000700004,112,o
149,S0212-71992001000700004,hombres,o
149,S0212-71992001000700004,y,o
149,S0212-71992001000700004,88,o
149,S0212-71992001000700004,mujeres,o
149,S0212-71992001000700004,con,o
149,S0212-71992001000700004,una,o
149,S0212-71992001000700004,media,o
149,S0212-71992001000700004,de,o
149,S0212-71992001000700004,edad,o
149,S0212-71992001000700004,de,o
149,S0212-71992001000700004,48,o
149,S0212-71992001000700004,años,o
149,S0212-71992001000700004,1882,o
149,S0212-71992001000700004,años,o
149,S0212-71992001000700004,100,o
149,S0212-71992001000700004,pacientes,o
149,S0212-71992001000700004,eran,o
149,S0212-71992001000700004,randomizados,i
149,S0212-71992001000700004,a,o
149,S0212-71992001000700004,OCA7,o
149,S0212-71992001000700004,y,o
149,S0212-71992001000700004,100,o
149,S0212-71992001000700004,pacientes,o
149,S0212-71992001000700004,a,o
149,S0212-71992001000700004,RBCA7,o
149,S0212-71992001000700004,En,o
149,S0212-71992001000700004,total,o
149,S0212-71992001000700004,186,o
149,S0212-71992001000700004,pacientes,o
149,S0212-71992001000700004,completaban,o
149,S0212-71992001000700004,todo,o
149,S0212-71992001000700004,el,o
149,S0212-71992001000700004,estudio,o
149,S0212-71992001000700004,La,o
149,S0212-71992001000700004,tasa,o
149,S0212-71992001000700004,de,o
149,S0212-71992001000700004,erradicacion,i
149,S0212-71992001000700004,por,o
149,S0212-71992001000700004,intencion,o
149,S0212-71992001000700004,a,o
149,S0212-71992001000700004,tratar,o
149,S0212-71992001000700004,en,o
149,S0212-71992001000700004,el,o
149,S0212-71992001000700004,grupo,o
149,S0212-71992001000700004,OCA7,o
149,S0212-71992001000700004,fue,o
149,S0212-71992001000700004,del,o
149,S0212-71992001000700004,72,o
149,S0212-71992001000700004,y,o
149,S0212-71992001000700004,del,o
149,S0212-71992001000700004,grupo,o
149,S0212-71992001000700004,RBCA7,o
149,S0212-71992001000700004,del,o
149,S0212-71992001000700004,73,o
149,S0212-71992001000700004,La,o
149,S0212-71992001000700004,tasa,o
149,S0212-71992001000700004,de,o
149,S0212-71992001000700004,erradicacion,i
149,S0212-71992001000700004,por,o
149,S0212-71992001000700004,protocolo,i
149,S0212-71992001000700004,en,o
149,S0212-71992001000700004,el,o
149,S0212-71992001000700004,grupo,o
149,S0212-71992001000700004,OCA7,o
149,S0212-71992001000700004,fue,o
149,S0212-71992001000700004,del,o
149,S0212-71992001000700004,78,o
149,S0212-71992001000700004,y,o
149,S0212-71992001000700004,del,o
149,S0212-71992001000700004,grupo,o
149,S0212-71992001000700004,RBCA7,o
149,S0212-71992001000700004,del,o
149,S0212-71992001000700004,77,o
149,S0212-71992001000700004,p03,o
149,S0212-71992001000700004,Cinco,o
149,S0212-71992001000700004,pacientes,o
149,S0212-71992001000700004,del,o
149,S0212-71992001000700004,grupo,o
149,S0212-71992001000700004,OCA7,o
149,S0212-71992001000700004,y,o
149,S0212-71992001000700004,9,o
149,S0212-71992001000700004,pacientes,o
149,S0212-71992001000700004,del,o
149,S0212-71992001000700004,grupo,o
149,S0212-71992001000700004,RBCA7,o
149,S0212-71992001000700004,relataron,o
149,S0212-71992001000700004,efectos,i
149,S0212-71992001000700004,secundarios,i
149,S0212-71992001000700004,3,o
149,S0212-71992001000700004,de,o
149,S0212-71992001000700004,estos,o
149,S0212-71992001000700004,ultimos,o
149,S0212-71992001000700004,suspendieron,i
149,S0212-71992001000700004,el,i
149,S0212-71992001000700004,tratamiento,i
149,S0212-71992001000700004,por,o
149,S0212-71992001000700004,diarrea,i
149,S0212-71992001000700004,Conclusiones,o
149,S0212-71992001000700004,Ranitidina,i
149,S0212-71992001000700004,citrato,i
149,S0212-71992001000700004,bismuto,i
149,S0212-71992001000700004,mas,o
149,S0212-71992001000700004,dos,o
149,S0212-71992001000700004,antibioticos,i
149,S0212-71992001000700004,es,o
149,S0212-71992001000700004,tan,o
149,S0212-71992001000700004,eficaz,o
149,S0212-71992001000700004,y,o
149,S0212-71992001000700004,segura,o
149,S0212-71992001000700004,como,o
149,S0212-71992001000700004,el,o
149,S0212-71992001000700004,tratamiento,i
149,S0212-71992001000700004,clasico,o
149,S0212-71992001000700004,con,o
149,S0212-71992001000700004,omeprazol,i
149,S0212-71992001000700004,en,o
149,S0212-71992001000700004,la,o
149,S0212-71992001000700004,erradicacion,i
149,S0212-71992001000700004,del,i
149,S0212-71992001000700004,Helicobacter,i
149,S0212-71992001000700004,pylori,i
150,S0212-71992005001000008,Respuesta,o
150,S0212-71992005001000008,al,o
150,S0212-71992005001000008,tratamiento,i
150,S0212-71992005001000008,con,o
150,S0212-71992005001000008,lamivudina,i
150,S0212-71992005001000008,en,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,con,o
150,S0212-71992005001000008,hepatitis,i
150,S0212-71992005001000008,cronica,i
150,S0212-71992005001000008,por,i
150,S0212-71992005001000008,virus,i
150,S0212-71992005001000008,B,i
150,S0212-71992005001000008,Objetivo,o
150,S0212-71992005001000008,Descripcion,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,la,o
150,S0212-71992005001000008,respuesta,o
150,S0212-71992005001000008,bioquimica,o
150,S0212-71992005001000008,y,o
150,S0212-71992005001000008,virologica,o
150,S0212-71992005001000008,en,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,HBeAg,i
150,S0212-71992005001000008,positivo,o
150,S0212-71992005001000008,y,o
150,S0212-71992005001000008,negativo,o
150,S0212-71992005001000008,tratados,i
150,S0212-71992005001000008,con,o
150,S0212-71992005001000008,lamivudina,i
150,S0212-71992005001000008,Como,o
150,S0212-71992005001000008,objetivo,o
150,S0212-71992005001000008,secundario,o
150,S0212-71992005001000008,se,o
150,S0212-71992005001000008,valoro,o
150,S0212-71992005001000008,las,o
150,S0212-71992005001000008,modificaciones,i
150,S0212-71992005001000008,en,i
150,S0212-71992005001000008,la,i
150,S0212-71992005001000008,funcion,i
150,S0212-71992005001000008,renal,i
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,los,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,tratados,i
150,S0212-71992005001000008,con,o
150,S0212-71992005001000008,este,o
150,S0212-71992005001000008,farmaco,i
150,S0212-71992005001000008,Metodo,o
150,S0212-71992005001000008,Se,o
150,S0212-71992005001000008,estudio,i
150,S0212-71992005001000008,de,i
150,S0212-71992005001000008,forma,i
150,S0212-71992005001000008,retrospectiva,i
150,S0212-71992005001000008,a,o
150,S0212-71992005001000008,treinta,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,con,o
150,S0212-71992005001000008,hepatitis,i
150,S0212-71992005001000008,cronica,i
150,S0212-71992005001000008,por,i
150,S0212-71992005001000008,virus,i
150,S0212-71992005001000008,B,i
150,S0212-71992005001000008,que,o
150,S0212-71992005001000008,habian,o
150,S0212-71992005001000008,realizado,o
150,S0212-71992005001000008,tratamiento,i
150,S0212-71992005001000008,con,o
150,S0212-71992005001000008,lamivudina,i
150,S0212-71992005001000008,entre,o
150,S0212-71992005001000008,noviembre,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,1999,o
150,S0212-71992005001000008,y,o
150,S0212-71992005001000008,marzo,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,2004,o
150,S0212-71992005001000008,en,o
150,S0212-71992005001000008,la,o
150,S0212-71992005001000008,Unidad,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,Digestivo,o
150,S0212-71992005001000008,del,o
150,S0212-71992005001000008,Complejo,o
150,S0212-71992005001000008,Hospitalario,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,Ciudad,o
150,S0212-71992005001000008,Real,o
150,S0212-71992005001000008,Resultados,o
150,S0212-71992005001000008,Se,o
150,S0212-71992005001000008,incluyeron,o
150,S0212-71992005001000008,finalmente,o
150,S0212-71992005001000008,29,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,los,o
150,S0212-71992005001000008,cuales,o
150,S0212-71992005001000008,8,o
150,S0212-71992005001000008,eran,o
150,S0212-71992005001000008,HBeAg,i
150,S0212-71992005001000008,positivo,o
150,S0212-71992005001000008,y,o
150,S0212-71992005001000008,21,o
150,S0212-71992005001000008,HBeAg,i
150,S0212-71992005001000008,negativo,o
150,S0212-71992005001000008,La,o
150,S0212-71992005001000008,media,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,duracion,o
150,S0212-71992005001000008,del,o
150,S0212-71992005001000008,tratamiento,i
150,S0212-71992005001000008,con,o
150,S0212-71992005001000008,lamivudina,i
150,S0212-71992005001000008,fue,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,237,o
150,S0212-71992005001000008,meses,o
150,S0212-71992005001000008,346,o
150,S0212-71992005001000008,Siete,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,habian,o
150,S0212-71992005001000008,recibido,o
150,S0212-71992005001000008,tratamiento,i
150,S0212-71992005001000008,previo,o
150,S0212-71992005001000008,con,o
150,S0212-71992005001000008,IFN,i
150,S0212-71992005001000008,En,o
150,S0212-71992005001000008,ocho,o
150,S0212-71992005001000008,casos,o
150,S0212-71992005001000008,se,o
150,S0212-71992005001000008,inicio,o
150,S0212-71992005001000008,tratamiento,i
150,S0212-71992005001000008,posterior,o
150,S0212-71992005001000008,con,o
150,S0212-71992005001000008,adefovir,i
150,S0212-71992005001000008,Ninguno,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,los,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,del,o
150,S0212-71992005001000008,estudio,o
150,S0212-71992005001000008,negativizo,o
150,S0212-71992005001000008,el,o
150,S0212-71992005001000008,HBsAg,i
150,S0212-71992005001000008,Entre,o
150,S0212-71992005001000008,los,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,HBeAg,i
150,S0212-71992005001000008,positivo,o
150,S0212-71992005001000008,un,o
150,S0212-71992005001000008,50,o
150,S0212-71992005001000008,presenta,o
150,S0212-71992005001000008,actualmente,o
150,S0212-71992005001000008,valores,o
150,S0212-71992005001000008,negativos,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,ADN,i
150,S0212-71992005001000008,y,o
150,S0212-71992005001000008,un,o
150,S0212-71992005001000008,25,o
150,S0212-71992005001000008,ha,o
150,S0212-71992005001000008,negativizado,o
150,S0212-71992005001000008,el,o
150,S0212-71992005001000008,HBeAg,i
150,S0212-71992005001000008,aunque,o
150,S0212-71992005001000008,sin,o
150,S0212-71992005001000008,seroconversion,o
150,S0212-71992005001000008,antiHBe,o
150,S0212-71992005001000008,Entre,o
150,S0212-71992005001000008,los,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,HBeAg,i
150,S0212-71992005001000008,negativo,o
150,S0212-71992005001000008,un,o
150,S0212-71992005001000008,76,o
150,S0212-71992005001000008,han,o
150,S0212-71992005001000008,disminuido,o
150,S0212-71992005001000008,o,o
150,S0212-71992005001000008,negativizado,o
150,S0212-71992005001000008,el,o
150,S0212-71992005001000008,ADN,i
150,S0212-71992005001000008,Observamos,o
150,S0212-71992005001000008,aparicion,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,mutantes,i
150,S0212-71992005001000008,a,o
150,S0212-71992005001000008,la,o
150,S0212-71992005001000008,lamivudina,i
150,S0212-71992005001000008,en,o
150,S0212-71992005001000008,un,o
150,S0212-71992005001000008,50,o
150,S0212-71992005001000008,y,o
150,S0212-71992005001000008,19,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,los,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,HBeAg,i
150,S0212-71992005001000008,positivo,o
150,S0212-71992005001000008,y,o
150,S0212-71992005001000008,negativo,o
150,S0212-71992005001000008,respectivamente,o
150,S0212-71992005001000008,siendo,o
150,S0212-71992005001000008,la,o
150,S0212-71992005001000008,duracion,o
150,S0212-71992005001000008,media,o
150,S0212-71992005001000008,del,o
150,S0212-71992005001000008,tratamiento,i
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,dos,o
150,S0212-71992005001000008,años,o
150,S0212-71992005001000008,Los,o
150,S0212-71992005001000008,niveles,i
150,S0212-71992005001000008,de,i
150,S0212-71992005001000008,ADN,i
150,S0212-71992005001000008,viral,o
150,S0212-71992005001000008,negativos,o
150,S0212-71992005001000008,se,o
150,S0212-71992005001000008,asociaron,o
150,S0212-71992005001000008,en,o
150,S0212-71992005001000008,todos,o
150,S0212-71992005001000008,los,o
150,S0212-71992005001000008,casos,o
150,S0212-71992005001000008,con,o
150,S0212-71992005001000008,niveles,o
150,S0212-71992005001000008,normales,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,transaminasas,i
150,S0212-71992005001000008,Los,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,no,o
150,S0212-71992005001000008,sufrieron,o
150,S0212-71992005001000008,modificaciones,i
150,S0212-71992005001000008,en,i
150,S0212-71992005001000008,la,i
150,S0212-71992005001000008,funcion,i
150,S0212-71992005001000008,renal,i
150,S0212-71992005001000008,Conclusion,o
150,S0212-71992005001000008,La,o
150,S0212-71992005001000008,respuesta,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,nuestros,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,a,o
150,S0212-71992005001000008,la,o
150,S0212-71992005001000008,lamivudina,i
150,S0212-71992005001000008,es,o
150,S0212-71992005001000008,similar,o
150,S0212-71992005001000008,a,o
150,S0212-71992005001000008,la,o
150,S0212-71992005001000008,descrita,o
150,S0212-71992005001000008,en,o
150,S0212-71992005001000008,la,o
150,S0212-71992005001000008,literatura,o
150,S0212-71992005001000008,excepto,o
150,S0212-71992005001000008,en,o
150,S0212-71992005001000008,la,o
150,S0212-71992005001000008,tasa,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,seroconversion,o
150,S0212-71992005001000008,antiHBe,o
150,S0212-71992005001000008,que,o
150,S0212-71992005001000008,en,o
150,S0212-71992005001000008,nuestro,o
150,S0212-71992005001000008,caso,o
150,S0212-71992005001000008,ha,o
150,S0212-71992005001000008,sido,o
150,S0212-71992005001000008,nula,o
150,S0212-71992005001000008,y,o
150,S0212-71992005001000008,en,o
150,S0212-71992005001000008,el,o
150,S0212-71992005001000008,porcentaje,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,aparicion,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,mutantes,i
150,S0212-71992005001000008,a,o
150,S0212-71992005001000008,la,o
150,S0212-71992005001000008,lamivudina,i
150,S0212-71992005001000008,en,o
150,S0212-71992005001000008,los,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,HBeAg,i
150,S0212-71992005001000008,negativo,o
150,S0212-71992005001000008,que,o
150,S0212-71992005001000008,en,o
150,S0212-71992005001000008,nuestro,o
150,S0212-71992005001000008,estudio,o
150,S0212-71992005001000008,ha,o
150,S0212-71992005001000008,sido,o
150,S0212-71992005001000008,menor,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,la,o
150,S0212-71992005001000008,esperada,o
150,S0212-71992005001000008,19,o
150,S0212-71992005001000008,25,o
150,S0212-71992005001000008,referido,o
150,S0212-71992005001000008,a,o
150,S0212-71992005001000008,pacientes,o
150,S0212-71992005001000008,con,o
150,S0212-71992005001000008,mas,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,un,o
150,S0212-71992005001000008,año,o
150,S0212-71992005001000008,de,o
150,S0212-71992005001000008,tratamiento,i
151,S0213-12852003000600003,Efectos,o
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,los,o
151,S0213-12852003000600003,diferentes,o
151,S0213-12852003000600003,colutorios,i
151,S0213-12852003000600003,para,o
151,S0213-12852003000600003,el,o
151,S0213-12852003000600003,tratamiento,i
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,la,o
151,S0213-12852003000600003,halitosis,i
151,S0213-12852003000600003,oral,i
151,S0213-12852003000600003,Objetivo,o
151,S0213-12852003000600003,La,o
151,S0213-12852003000600003,halitosis,i
151,S0213-12852003000600003,intraoral,i
151,S0213-12852003000600003,se,o
151,S0213-12852003000600003,define,o
151,S0213-12852003000600003,como,o
151,S0213-12852003000600003,olor,o
151,S0213-12852003000600003,desagradable,o
151,S0213-12852003000600003,u,o
151,S0213-12852003000600003,ofensivo,o
151,S0213-12852003000600003,que,o
151,S0213-12852003000600003,procede,o
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,la,o
151,S0213-12852003000600003,cavidad,i
151,S0213-12852003000600003,oral,i
151,S0213-12852003000600003,La,o
151,S0213-12852003000600003,conexion,o
151,S0213-12852003000600003,entre,o
151,S0213-12852003000600003,mal,i
151,S0213-12852003000600003,aliento,i
151,S0213-12852003000600003,y,o
151,S0213-12852003000600003,compuestos,i
151,S0213-12852003000600003,volatiles,i
151,S0213-12852003000600003,sulfurados,i
151,S0213-12852003000600003,CVS,i
151,S0213-12852003000600003,fue,o
151,S0213-12852003000600003,establecida,o
151,S0213-12852003000600003,por,o
151,S0213-12852003000600003,Tonzetich,o
151,S0213-12852003000600003,1977,o
151,S0213-12852003000600003,Los,o
151,S0213-12852003000600003,diversos,o
151,S0213-12852003000600003,productos,o
151,S0213-12852003000600003,utilizados,o
151,S0213-12852003000600003,para,o
151,S0213-12852003000600003,el,o
151,S0213-12852003000600003,tratamiento,i
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,la,o
151,S0213-12852003000600003,halitosis,i
151,S0213-12852003000600003,tienen,o
151,S0213-12852003000600003,distintos,o
151,S0213-12852003000600003,objetivos,o
151,S0213-12852003000600003,enmascarar,i
151,S0213-12852003000600003,antibacteriano,i
151,S0213-12852003000600003,convertir,o
151,S0213-12852003000600003,las,o
151,S0213-12852003000600003,formas,o
151,S0213-12852003000600003,volatiles,o
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,los,o
151,S0213-12852003000600003,CVS,i
151,S0213-12852003000600003,en,o
151,S0213-12852003000600003,no,o
151,S0213-12852003000600003,volatiles,o
151,S0213-12852003000600003,o,o
151,S0213-12852003000600003,la,o
151,S0213-12852003000600003,suma,o
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,los,o
151,S0213-12852003000600003,estos,o
151,S0213-12852003000600003,dos,o
151,S0213-12852003000600003,ultimos,o
151,S0213-12852003000600003,El,o
151,S0213-12852003000600003,objetivo,o
151,S0213-12852003000600003,es,o
151,S0213-12852003000600003,comparar,i
151,S0213-12852003000600003,la,i
151,S0213-12852003000600003,eficacia,i
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,los,o
151,S0213-12852003000600003,distintos,o
151,S0213-12852003000600003,tratamientos,i
151,S0213-12852003000600003,Material,o
151,S0213-12852003000600003,y,o
151,S0213-12852003000600003,metodo,o
151,S0213-12852003000600003,Se,o
151,S0213-12852003000600003,realizo,o
151,S0213-12852003000600003,un,o
151,S0213-12852003000600003,estudio,o
151,S0213-12852003000600003,piloto,o
151,S0213-12852003000600003,doble,o
151,S0213-12852003000600003,ciego,o
151,S0213-12852003000600003,controlado,o
151,S0213-12852003000600003,se,o
151,S0213-12852003000600003,llevo,o
151,S0213-12852003000600003,a,o
151,S0213-12852003000600003,cabo,o
151,S0213-12852003000600003,en,o
151,S0213-12852003000600003,40,o
151,S0213-12852003000600003,sujetos,o
151,S0213-12852003000600003,voluntarios,o
151,S0213-12852003000600003,diagnosticados,i
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,halitosis,i
151,S0213-12852003000600003,intraoral,i
151,S0213-12852003000600003,repartidos,o
151,S0213-12852003000600003,distribuidos,i
151,S0213-12852003000600003,de,i
151,S0213-12852003000600003,forma,i
151,S0213-12852003000600003,aleatoria,i
151,S0213-12852003000600003,en,o
151,S0213-12852003000600003,4,o
151,S0213-12852003000600003,grupos,o
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,10,o
151,S0213-12852003000600003,sujetos,o
151,S0213-12852003000600003,asignandole,o
151,S0213-12852003000600003,a,o
151,S0213-12852003000600003,cada,o
151,S0213-12852003000600003,grupo,o
151,S0213-12852003000600003,un,o
151,S0213-12852003000600003,tratamiento,i
151,S0213-12852003000600003,diferente,o
151,S0213-12852003000600003,A,o
151,S0213-12852003000600003,triclosan,i
151,S0213-12852003000600003,fluorurosodico,i
151,S0213-12852003000600003,cloruro,i
151,S0213-12852003000600003,de,i
151,S0213-12852003000600003,zinc,i
151,S0213-12852003000600003,alcohol,i
151,S0213-12852003000600003,B,o
151,S0213-12852003000600003,triclosan,i
151,S0213-12852003000600003,fluorurosodico,i
151,S0213-12852003000600003,cloruro,i
151,S0213-12852003000600003,de,i
151,S0213-12852003000600003,zinc,i
151,S0213-12852003000600003,fue,o
151,S0213-12852003000600003,C,o
151,S0213-12852003000600003,lactato,i
151,S0213-12852003000600003,de,i
151,S0213-12852003000600003,zinc,i
151,S0213-12852003000600003,014,o
151,S0213-12852003000600003,chorhexidina,i
151,S0213-12852003000600003,005,o
151,S0213-12852003000600003,clorururo,i
151,S0213-12852003000600003,de,i
151,S0213-12852003000600003,cetilpiridino,i
151,S0213-12852003000600003,005,o
151,S0213-12852003000600003,y,o
151,S0213-12852003000600003,D,o
151,S0213-12852003000600003,con,o
151,S0213-12852003000600003,medicacion,i
151,S0213-12852003000600003,placebo,i
151,S0213-12852003000600003,El,o
151,S0213-12852003000600003,tratamiento,i
151,S0213-12852003000600003,lo,o
151,S0213-12852003000600003,realizo,o
151,S0213-12852003000600003,10ml,o
151,S0213-12852003000600003,2,o
151,S0213-12852003000600003,veces,o
151,S0213-12852003000600003,dia,o
151,S0213-12852003000600003,durante,o
151,S0213-12852003000600003,3,o
151,S0213-12852003000600003,semanas,o
151,S0213-12852003000600003,Los,o
151,S0213-12852003000600003,resultados,o
151,S0213-12852003000600003,se,o
151,S0213-12852003000600003,valoraron,o
151,S0213-12852003000600003,el,o
151,S0213-12852003000600003,nivel,i
151,S0213-12852003000600003,de,i
151,S0213-12852003000600003,CVS,i
151,S0213-12852003000600003,mediante,o
151,S0213-12852003000600003,Halimeter,o
151,S0213-12852003000600003,ppb,o
151,S0213-12852003000600003,Resultados,o
151,S0213-12852003000600003,No,o
151,S0213-12852003000600003,encontramos,o
151,S0213-12852003000600003,en,o
151,S0213-12852003000600003,este,o
151,S0213-12852003000600003,estudio,o
151,S0213-12852003000600003,diferencias,o
151,S0213-12852003000600003,estadisticas,o
151,S0213-12852003000600003,significativas,o
151,S0213-12852003000600003,p04932,o
151,S0213-12852003000600003,en,o
151,S0213-12852003000600003,la,o
151,S0213-12852003000600003,variable,o
151,S0213-12852003000600003,CVS,i
151,S0213-12852003000600003,medida,o
151,S0213-12852003000600003,mediante,o
151,S0213-12852003000600003,el,o
151,S0213-12852003000600003,halimeter,o
151,S0213-12852003000600003,Los,o
151,S0213-12852003000600003,valores,o
151,S0213-12852003000600003,comparativos,o
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,p,o
151,S0213-12852003000600003,en,o
151,S0213-12852003000600003,los,o
151,S0213-12852003000600003,4,o
151,S0213-12852003000600003,tratamientos,i
151,S0213-12852003000600003,ninguno,o
151,S0213-12852003000600003,fue,o
151,S0213-12852003000600003,menor,o
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,p001,o
151,S0213-12852003000600003,Conclusiones,o
151,S0213-12852003000600003,Este,o
151,S0213-12852003000600003,protocolo,i
151,S0213-12852003000600003,no,o
151,S0213-12852003000600003,ha,o
151,S0213-12852003000600003,mostrado,o
151,S0213-12852003000600003,la,o
151,S0213-12852003000600003,eficacia,o
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,ninguno,o
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,los,o
151,S0213-12852003000600003,4,o
151,S0213-12852003000600003,tratamientos,i
151,S0213-12852003000600003,empleados,o
151,S0213-12852003000600003,en,o
151,S0213-12852003000600003,la,o
151,S0213-12852003000600003,disminucion,o
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,VSC,i
151,S0213-12852003000600003,a,o
151,S0213-12852003000600003,corto,o
151,S0213-12852003000600003,plazo,o
151,S0213-12852003000600003,de,o
151,S0213-12852003000600003,la,o
151,S0213-12852003000600003,halitosis,i
151,S0213-12852003000600003,oral,i
152,S0300-90412018000400233,Validez,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,la,o
152,S0300-90412018000400233,glucemia,i
152,S0300-90412018000400233,en,i
152,S0300-90412018000400233,ayuno,i
152,S0300-90412018000400233,como,o
152,S0300-90412018000400233,prueba,i
152,S0300-90412018000400233,diagnostica,i
152,S0300-90412018000400233,para,o
152,S0300-90412018000400233,diabetes,i
152,S0300-90412018000400233,gestacional,i
152,S0300-90412018000400233,durante,o
152,S0300-90412018000400233,el,o
152,S0300-90412018000400233,primer,o
152,S0300-90412018000400233,trimestre,o
152,S0300-90412018000400233,del,o
152,S0300-90412018000400233,embarazo,o
152,S0300-90412018000400233,Objetivo,o
152,S0300-90412018000400233,Determinar,o
152,S0300-90412018000400233,la,o
152,S0300-90412018000400233,validez,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,la,o
152,S0300-90412018000400233,glucemia,i
152,S0300-90412018000400233,en,i
152,S0300-90412018000400233,ayuno,i
152,S0300-90412018000400233,como,o
152,S0300-90412018000400233,valor,o
152,S0300-90412018000400233,unico,o
152,S0300-90412018000400233,para,o
152,S0300-90412018000400233,establecer,o
152,S0300-90412018000400233,el,o
152,S0300-90412018000400233,diagnostico,i
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,diabetes,i
152,S0300-90412018000400233,gestacional,i
152,S0300-90412018000400233,en,o
152,S0300-90412018000400233,el,o
152,S0300-90412018000400233,primer,o
152,S0300-90412018000400233,trimestre,o
152,S0300-90412018000400233,del,o
152,S0300-90412018000400233,embarazo,o
152,S0300-90412018000400233,Calcular,o
152,S0300-90412018000400233,la,o
152,S0300-90412018000400233,sensibilidad,o
152,S0300-90412018000400233,especificidad,o
152,S0300-90412018000400233,valor,o
152,S0300-90412018000400233,predictivo,o
152,S0300-90412018000400233,positivo,o
152,S0300-90412018000400233,y,o
152,S0300-90412018000400233,negativo,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,esta,o
152,S0300-90412018000400233,prueba,i
152,S0300-90412018000400233,comparandola,o
152,S0300-90412018000400233,con,o
152,S0300-90412018000400233,el,o
152,S0300-90412018000400233,patron,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,referencia,o
152,S0300-90412018000400233,curva,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,tolerancia,i
152,S0300-90412018000400233,a,i
152,S0300-90412018000400233,la,i
152,S0300-90412018000400233,glucosa,i
152,S0300-90412018000400233,Materiales,o
152,S0300-90412018000400233,y,o
152,S0300-90412018000400233,metodos,o
152,S0300-90412018000400233,Estudio,o
152,S0300-90412018000400233,observacional,o
152,S0300-90412018000400233,retrospectivo,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,casos,o
152,S0300-90412018000400233,y,o
152,S0300-90412018000400233,controles,o
152,S0300-90412018000400233,efectuado,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,2014,o
152,S0300-90412018000400233,a,o
152,S0300-90412018000400233,2017,o
152,S0300-90412018000400233,En,o
152,S0300-90412018000400233,el,o
152,S0300-90412018000400233,grupo,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,casos,o
152,S0300-90412018000400233,se,o
152,S0300-90412018000400233,incluyeron,o
152,S0300-90412018000400233,pacientes,o
152,S0300-90412018000400233,con,o
152,S0300-90412018000400233,diagnostico,i
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,diabetes,i
152,S0300-90412018000400233,gestacional,i
152,S0300-90412018000400233,establecido,o
152,S0300-90412018000400233,entre,o
152,S0300-90412018000400233,las,o
152,S0300-90412018000400233,semanas,o
152,S0300-90412018000400233,24,o
152,S0300-90412018000400233,a,o
152,S0300-90412018000400233,28,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,embarazo,o
152,S0300-90412018000400233,mediante,o
152,S0300-90412018000400233,una,o
152,S0300-90412018000400233,curva,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,tolerancia,i
152,S0300-90412018000400233,a,i
152,S0300-90412018000400233,la,i
152,S0300-90412018000400233,glucosa,i
152,S0300-90412018000400233,Para,o
152,S0300-90412018000400233,obtener,o
152,S0300-90412018000400233,el,o
152,S0300-90412018000400233,grupo,o
152,S0300-90412018000400233,control,o
152,S0300-90412018000400233,con,o
152,S0300-90412018000400233,resultado,o
152,S0300-90412018000400233,negativo,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,la,o
152,S0300-90412018000400233,curva,o
152,S0300-90412018000400233,se,o
152,S0300-90412018000400233,hizo,o
152,S0300-90412018000400233,un,o
152,S0300-90412018000400233,muestreo,i
152,S0300-90412018000400233,aleatorio,i
152,S0300-90412018000400233,El,o
152,S0300-90412018000400233,analisis,o
152,S0300-90412018000400233,estadistico,o
152,S0300-90412018000400233,se,o
152,S0300-90412018000400233,efectuo,o
152,S0300-90412018000400233,con,o
152,S0300-90412018000400233,SPSS,o
152,S0300-90412018000400233,Statistics,o
152,S0300-90412018000400233,Para,o
152,S0300-90412018000400233,la,o
152,S0300-90412018000400233,validez,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,la,o
152,S0300-90412018000400233,prueba,i
152,S0300-90412018000400233,se,o
152,S0300-90412018000400233,calculo,o
152,S0300-90412018000400233,la,o
152,S0300-90412018000400233,sensibilidad,o
152,S0300-90412018000400233,especificidad,o
152,S0300-90412018000400233,valores,o
152,S0300-90412018000400233,predictivos,o
152,S0300-90412018000400233,positivo,o
152,S0300-90412018000400233,y,o
152,S0300-90412018000400233,negativo,o
152,S0300-90412018000400233,Resultados,o
152,S0300-90412018000400233,En,o
152,S0300-90412018000400233,el,o
152,S0300-90412018000400233,grupo,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,casos,o
152,S0300-90412018000400233,se,o
152,S0300-90412018000400233,obtuvieron,o
152,S0300-90412018000400233,204,o
152,S0300-90412018000400233,pacientes,o
152,S0300-90412018000400233,681,o
152,S0300-90412018000400233,con,o
152,S0300-90412018000400233,glucemia,i
152,S0300-90412018000400233,en,i
152,S0300-90412018000400233,ayuno,i
152,S0300-90412018000400233,92,o
152,S0300-90412018000400233,mgdL,o
152,S0300-90412018000400233,y,o
152,S0300-90412018000400233,319,o
152,S0300-90412018000400233,con,o
152,S0300-90412018000400233,valores,o
152,S0300-90412018000400233,normales,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,glucosa,i
152,S0300-90412018000400233,en,o
152,S0300-90412018000400233,el,o
152,S0300-90412018000400233,primer,o
152,S0300-90412018000400233,trimestre,o
152,S0300-90412018000400233,del,o
152,S0300-90412018000400233,embarazo,o
152,S0300-90412018000400233,El,o
152,S0300-90412018000400233,50,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,las,o
152,S0300-90412018000400233,pacientes,o
152,S0300-90412018000400233,con,o
152,S0300-90412018000400233,sobrepeso,i
152,S0300-90412018000400233,y,o
152,S0300-90412018000400233,100,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,las,o
152,S0300-90412018000400233,pacientes,o
152,S0300-90412018000400233,con,o
152,S0300-90412018000400233,obesidad,i
152,S0300-90412018000400233,tuvieron,o
152,S0300-90412018000400233,glucemias,i
152,S0300-90412018000400233,92,o
152,S0300-90412018000400233,mgdL,o
152,S0300-90412018000400233,En,o
152,S0300-90412018000400233,el,o
152,S0300-90412018000400233,grupo,o
152,S0300-90412018000400233,control,o
152,S0300-90412018000400233,n,o
152,S0300-90412018000400233,204,o
152,S0300-90412018000400233,solo,o
152,S0300-90412018000400233,53,o
152,S0300-90412018000400233,tuvo,o
152,S0300-90412018000400233,valores,o
152,S0300-90412018000400233,92mgdL,o
152,S0300-90412018000400233,La,o
152,S0300-90412018000400233,razon,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,momios,o
152,S0300-90412018000400233,para,o
152,S0300-90412018000400233,diabetes,i
152,S0300-90412018000400233,gestacional,i
152,S0300-90412018000400233,con,o
152,S0300-90412018000400233,este,o
152,S0300-90412018000400233,valor,i
152,S0300-90412018000400233,de,i
152,S0300-90412018000400233,glucosa,i
152,S0300-90412018000400233,en,o
152,S0300-90412018000400233,el,o
152,S0300-90412018000400233,primer,o
152,S0300-90412018000400233,trimestre,o
152,S0300-90412018000400233,fue,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,375,o
152,S0300-90412018000400233,IC95,o
152,S0300-90412018000400233,191737,o
152,S0300-90412018000400233,La,o
152,S0300-90412018000400233,sensibilidad,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,la,o
152,S0300-90412018000400233,prueba,i
152,S0300-90412018000400233,fue,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,68,o
152,S0300-90412018000400233,y,o
152,S0300-90412018000400233,la,o
152,S0300-90412018000400233,especificidad,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,95,o
152,S0300-90412018000400233,Valor,o
152,S0300-90412018000400233,predictivo,o
152,S0300-90412018000400233,positivo,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,93,o
152,S0300-90412018000400233,y,o
152,S0300-90412018000400233,valor,o
152,S0300-90412018000400233,predictivo,o
152,S0300-90412018000400233,negativo,o
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,75,o
152,S0300-90412018000400233,Conclusiones,o
152,S0300-90412018000400233,El,o
152,S0300-90412018000400233,valor,i
152,S0300-90412018000400233,de,i
152,S0300-90412018000400233,la,i
152,S0300-90412018000400233,glucosa,i
152,S0300-90412018000400233,en,i
152,S0300-90412018000400233,ayuno,i
152,S0300-90412018000400233,como,o
152,S0300-90412018000400233,unica,o
152,S0300-90412018000400233,prueba,i
152,S0300-90412018000400233,diagnostica,i
152,S0300-90412018000400233,de,o
152,S0300-90412018000400233,diabetes,i
152,S0300-90412018000400233,gestacional,i
152,S0300-90412018000400233,durante,o
152,S0300-90412018000400233,el,o
152,S0300-90412018000400233,primer,o
152,S0300-90412018000400233,trimestre,o
152,S0300-90412018000400233,tiene,o
152,S0300-90412018000400233,sensibilidad,o
152,S0300-90412018000400233,aceptable,o
152,S0300-90412018000400233,y,o
152,S0300-90412018000400233,buena,o
152,S0300-90412018000400233,especificidad,o
152,S0300-90412018000400233,en,o
152,S0300-90412018000400233,cualquier,o
152,S0300-90412018000400233,paciente,o
152,S0300-90412018000400233,con,o
152,S0300-90412018000400233,sobrepeso,i
152,S0300-90412018000400233,u,o
152,S0300-90412018000400233,obesidad,i
153,S0325-00752008000500004,Prevencion,i
153,S0325-00752008000500004,del,o
153,S0325-00752008000500004,dolor,i
153,S0325-00752008000500004,en,o
153,S0325-00752008000500004,recien,i
153,S0325-00752008000500004,nacidos,i
153,S0325-00752008000500004,de,i
153,S0325-00752008000500004,termino,i
153,S0325-00752008000500004,estudio,i
153,S0325-00752008000500004,aleatorizado,i
153,S0325-00752008000500004,sobre,o
153,S0325-00752008000500004,tres,o
153,S0325-00752008000500004,metodos,o
153,S0325-00752008000500004,Introduccion,o
153,S0325-00752008000500004,Por,o
153,S0325-00752008000500004,norma,o
153,S0325-00752008000500004,legal,o
153,S0325-00752008000500004,a,o
153,S0325-00752008000500004,todos,o
153,S0325-00752008000500004,los,o
153,S0325-00752008000500004,recien,i
153,S0325-00752008000500004,nacidos,i
153,S0325-00752008000500004,se,o
153,S0325-00752008000500004,les,o
153,S0325-00752008000500004,debe,o
153,S0325-00752008000500004,extraer,i
153,S0325-00752008000500004,sangre,i
153,S0325-00752008000500004,durante,o
153,S0325-00752008000500004,los,o
153,S0325-00752008000500004,primeros,o
153,S0325-00752008000500004,dias,o
153,S0325-00752008000500004,de,o
153,S0325-00752008000500004,vida,o
153,S0325-00752008000500004,para,o
153,S0325-00752008000500004,la,o
153,S0325-00752008000500004,pesquisa,i
153,S0325-00752008000500004,neonatal,i
153,S0325-00752008000500004,de,o
153,S0325-00752008000500004,hipotiroidismo,i
153,S0325-00752008000500004,congenito,i
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,fenilcetonuria,i
153,S0325-00752008000500004,El,o
153,S0325-00752008000500004,procedimiento,i
153,S0325-00752008000500004,de,i
153,S0325-00752008000500004,extraccion,i
153,S0325-00752008000500004,supone,o
153,S0325-00752008000500004,cierto,o
153,S0325-00752008000500004,dolor,i
153,S0325-00752008000500004,para,o
153,S0325-00752008000500004,el,o
153,S0325-00752008000500004,neonato,i
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,aun,o
153,S0325-00752008000500004,no,o
153,S0325-00752008000500004,existe,o
153,S0325-00752008000500004,un,o
153,S0325-00752008000500004,metodo,o
153,S0325-00752008000500004,sencillo,o
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,eficaz,o
153,S0325-00752008000500004,para,o
153,S0325-00752008000500004,disminuirlo,o
153,S0325-00752008000500004,Objetivos,o
153,S0325-00752008000500004,Evaluar,o
153,S0325-00752008000500004,si,o
153,S0325-00752008000500004,la,o
153,S0325-00752008000500004,administracion,i
153,S0325-00752008000500004,de,o
153,S0325-00752008000500004,glucosa,i
153,S0325-00752008000500004,paracetamol,i
153,S0325-00752008000500004,o,o
153,S0325-00752008000500004,EMLA,i
153,S0325-00752008000500004,disminuyen,o
153,S0325-00752008000500004,individualmente,o
153,S0325-00752008000500004,el,o
153,S0325-00752008000500004,dolor,i
153,S0325-00752008000500004,en,o
153,S0325-00752008000500004,recien,i
153,S0325-00752008000500004,nacidos,i
153,S0325-00752008000500004,provocado,o
153,S0325-00752008000500004,por,o
153,S0325-00752008000500004,puncion,i
153,S0325-00752008000500004,de,i
153,S0325-00752008000500004,talon,i
153,S0325-00752008000500004,en,o
153,S0325-00752008000500004,un,o
153,S0325-00752008000500004,ambiente,o
153,S0325-00752008000500004,ambulatorio,o
153,S0325-00752008000500004,Material,o
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,metodos,o
153,S0325-00752008000500004,Estudio,o
153,S0325-00752008000500004,prospectivo,o
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,aleatorizado,o
153,S0325-00752008000500004,a,o
153,S0325-00752008000500004,doble,o
153,S0325-00752008000500004,ciego,o
153,S0325-00752008000500004,en,o
153,S0325-00752008000500004,el,o
153,S0325-00752008000500004,cual,o
153,S0325-00752008000500004,setenta,o
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,seis,o
153,S0325-00752008000500004,recien,i
153,S0325-00752008000500004,nacidos,i
153,S0325-00752008000500004,de,i
153,S0325-00752008000500004,termino,i
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,sanos,o
153,S0325-00752008000500004,fueron,o
153,S0325-00752008000500004,asignados,o
153,S0325-00752008000500004,a,o
153,S0325-00752008000500004,recibir,o
153,S0325-00752008000500004,placebo,i
153,S0325-00752008000500004,glucosa,i
153,S0325-00752008000500004,por,o
153,S0325-00752008000500004,via,o
153,S0325-00752008000500004,oral,o
153,S0325-00752008000500004,EMLA,i
153,S0325-00752008000500004,en,o
153,S0325-00752008000500004,talon,i
153,S0325-00752008000500004,o,o
153,S0325-00752008000500004,paracetamol,i
153,S0325-00752008000500004,por,o
153,S0325-00752008000500004,via,o
153,S0325-00752008000500004,oral,o
153,S0325-00752008000500004,Se,o
153,S0325-00752008000500004,realizo,o
153,S0325-00752008000500004,puncion,i
153,S0325-00752008000500004,de,i
153,S0325-00752008000500004,talon,i
153,S0325-00752008000500004,para,o
153,S0325-00752008000500004,extraer,i
153,S0325-00752008000500004,sangre,i
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,dos,o
153,S0325-00752008000500004,observadores,o
153,S0325-00752008000500004,independientes,o
153,S0325-00752008000500004,midieron,i
153,S0325-00752008000500004,el,i
153,S0325-00752008000500004,dolor,i
153,S0325-00752008000500004,con,o
153,S0325-00752008000500004,dos,o
153,S0325-00752008000500004,escalas,o
153,S0325-00752008000500004,NIPS,o
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,PIPP,o
153,S0325-00752008000500004,La,o
153,S0325-00752008000500004,variable,o
153,S0325-00752008000500004,de,o
153,S0325-00752008000500004,resultado,o
153,S0325-00752008000500004,fue,o
153,S0325-00752008000500004,la,o
153,S0325-00752008000500004,cantidad,o
153,S0325-00752008000500004,de,o
153,S0325-00752008000500004,niños,o
153,S0325-00752008000500004,con,o
153,S0325-00752008000500004,valores,i
153,S0325-00752008000500004,de,i
153,S0325-00752008000500004,dolor,i
153,S0325-00752008000500004,por,o
153,S0325-00752008000500004,debajo,o
153,S0325-00752008000500004,de,o
153,S0325-00752008000500004,las,o
153,S0325-00752008000500004,cifras,o
153,S0325-00752008000500004,consideradas,o
153,S0325-00752008000500004,dolor,i
153,S0325-00752008000500004,moderado,o
153,S0325-00752008000500004,en,o
153,S0325-00752008000500004,cada,o
153,S0325-00752008000500004,grupo,o
153,S0325-00752008000500004,Resultados,o
153,S0325-00752008000500004,NIPS,o
153,S0325-00752008000500004,4,o
153,S0325-00752008000500004,placebo,i
153,S0325-00752008000500004,919,o
153,S0325-00752008000500004,47,o
153,S0325-00752008000500004,glucosa,i
153,S0325-00752008000500004,1619,o
153,S0325-00752008000500004,84,o
153,S0325-00752008000500004,paracetamol,i
153,S0325-00752008000500004,819,o
153,S0325-00752008000500004,42,o
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,EMLA,i
153,S0325-00752008000500004,1219,o
153,S0325-00752008000500004,63,o
153,S0325-00752008000500004,PIPP,o
153,S0325-00752008000500004,8,o
153,S0325-00752008000500004,placebo,i
153,S0325-00752008000500004,919,o
153,S0325-00752008000500004,47,o
153,S0325-00752008000500004,glucosa,i
153,S0325-00752008000500004,1219,o
153,S0325-00752008000500004,63,o
153,S0325-00752008000500004,paracetamol,i
153,S0325-00752008000500004,519,o
153,S0325-00752008000500004,26,o
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,EMLA,i
153,S0325-00752008000500004,819,o
153,S0325-00752008000500004,42,o
153,S0325-00752008000500004,Con,o
153,S0325-00752008000500004,el,o
153,S0325-00752008000500004,uso,o
153,S0325-00752008000500004,de,o
153,S0325-00752008000500004,glucosa,i
153,S0325-00752008000500004,oral,o
153,S0325-00752008000500004,encontramos,o
153,S0325-00752008000500004,RAR,o
153,S0325-00752008000500004,037,o
153,S0325-00752008000500004,IC,o
153,S0325-00752008000500004,95,o
153,S0325-00752008000500004,009064,o
153,S0325-00752008000500004,RRR,o
153,S0325-00752008000500004,44,o
153,S0325-00752008000500004,IC,o
153,S0325-00752008000500004,95,o
153,S0325-00752008000500004,667,o
153,S0325-00752008000500004,NNT,o
153,S0325-00752008000500004,27,o
153,S0325-00752008000500004,IC,o
153,S0325-00752008000500004,95,o
153,S0325-00752008000500004,1511,o
153,S0325-00752008000500004,Conclusiones,o
153,S0325-00752008000500004,Con,o
153,S0325-00752008000500004,el,o
153,S0325-00752008000500004,uso,o
153,S0325-00752008000500004,de,o
153,S0325-00752008000500004,la,o
153,S0325-00752008000500004,solucion,i
153,S0325-00752008000500004,glucosada,i
153,S0325-00752008000500004,por,o
153,S0325-00752008000500004,via,o
153,S0325-00752008000500004,oral,o
153,S0325-00752008000500004,se,o
153,S0325-00752008000500004,obtuvieron,o
153,S0325-00752008000500004,los,o
153,S0325-00752008000500004,mejores,o
153,S0325-00752008000500004,resultados,o
153,S0325-00752008000500004,Solo,o
153,S0325-00752008000500004,con,o
153,S0325-00752008000500004,una,o
153,S0325-00752008000500004,de,o
153,S0325-00752008000500004,las,o
153,S0325-00752008000500004,escalas,o
153,S0325-00752008000500004,utilizadas,o
153,S0325-00752008000500004,fueron,o
153,S0325-00752008000500004,estadisticamente,o
153,S0325-00752008000500004,significativos,o
153,S0325-00752008000500004,Con,o
153,S0325-00752008000500004,paracetamol,i
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,EMLA,i
153,S0325-00752008000500004,no,o
153,S0325-00752008000500004,observamos,o
153,S0325-00752008000500004,disminucion,o
153,S0325-00752008000500004,del,o
153,S0325-00752008000500004,dolor,i
153,S0325-00752008000500004,Deberan,o
153,S0325-00752008000500004,considerarse,o
153,S0325-00752008000500004,otros,o
153,S0325-00752008000500004,metodos,o
153,S0325-00752008000500004,complementarios,o
153,S0325-00752008000500004,y,o
153,S0325-00752008000500004,combinados,o
153,S0325-00752008000500004,junto,o
153,S0325-00752008000500004,con,o
153,S0325-00752008000500004,la,o
153,S0325-00752008000500004,glucosa,i
153,S0325-00752008000500004,para,o
153,S0325-00752008000500004,aliviar,o
153,S0325-00752008000500004,esta,o
153,S0325-00752008000500004,experiencia,i
153,S0325-00752008000500004,dolorosa,i
153,S0325-00752008000500004,a,o
153,S0325-00752008000500004,miles,o
153,S0325-00752008000500004,de,o
153,S0325-00752008000500004,niños,o
153,S0325-00752008000500004,diariamente,o
154,S0325-00752009000200007,Levosimendan,i
154,S0325-00752009000200007,un,o
154,S0325-00752009000200007,nuevo,o
154,S0325-00752009000200007,agente,i
154,S0325-00752009000200007,inotropico,i
154,S0325-00752009000200007,experiencia,o
154,S0325-00752009000200007,en,o
154,S0325-00752009000200007,niños,o
154,S0325-00752009000200007,con,o
154,S0325-00752009000200007,fallo,i
154,S0325-00752009000200007,cardiaco,i
154,S0325-00752009000200007,agudo,i
154,S0325-00752009000200007,Introduccion,o
154,S0325-00752009000200007,El,o
154,S0325-00752009000200007,sindrome,i
154,S0325-00752009000200007,de,i
154,S0325-00752009000200007,bajo,i
154,S0325-00752009000200007,gasto,i
154,S0325-00752009000200007,cardiaco,i
154,S0325-00752009000200007,ocurre,o
154,S0325-00752009000200007,frecuentemente,o
154,S0325-00752009000200007,en,o
154,S0325-00752009000200007,el,o
154,S0325-00752009000200007,posoperatorio,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,pacientes,o
154,S0325-00752009000200007,con,o
154,S0325-00752009000200007,cirugia,i
154,S0325-00752009000200007,cardiaca,i
154,S0325-00752009000200007,Las,o
154,S0325-00752009000200007,catecolaminas,i
154,S0325-00752009000200007,utilizadas,o
154,S0325-00752009000200007,como,o
154,S0325-00752009000200007,inotropicos,i
154,S0325-00752009000200007,pueden,o
154,S0325-00752009000200007,provocar,o
154,S0325-00752009000200007,efectos,i
154,S0325-00752009000200007,adversos,i
154,S0325-00752009000200007,potencialmente,o
154,S0325-00752009000200007,deletereos,o
154,S0325-00752009000200007,El,o
154,S0325-00752009000200007,levosimendan,i
154,S0325-00752009000200007,es,o
154,S0325-00752009000200007,un,o
154,S0325-00752009000200007,nuevo,o
154,S0325-00752009000200007,farmaco,i
154,S0325-00752009000200007,inotropico,i
154,S0325-00752009000200007,no,i
154,S0325-00752009000200007,adrenergico,i
154,S0325-00752009000200007,con,o
154,S0325-00752009000200007,posibles,o
154,S0325-00752009000200007,beneficios,o
154,S0325-00752009000200007,en,o
154,S0325-00752009000200007,esta,o
154,S0325-00752009000200007,poblacion,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,pacientes,o
154,S0325-00752009000200007,Este,o
154,S0325-00752009000200007,estudio,o
154,S0325-00752009000200007,evaluo,i
154,S0325-00752009000200007,la,i
154,S0325-00752009000200007,seguridad,i
154,S0325-00752009000200007,y,i
154,S0325-00752009000200007,eficacia,i
154,S0325-00752009000200007,del,o
154,S0325-00752009000200007,levosimendan,i
154,S0325-00752009000200007,en,o
154,S0325-00752009000200007,niños,o
154,S0325-00752009000200007,con,o
154,S0325-00752009000200007,bajo,o
154,S0325-00752009000200007,gasto,o
154,S0325-00752009000200007,posoperatorio,o
154,S0325-00752009000200007,Poblacion,o
154,S0325-00752009000200007,material,o
154,S0325-00752009000200007,y,o
154,S0325-00752009000200007,metodos,o
154,S0325-00752009000200007,Estudio,o
154,S0325-00752009000200007,prospectivo,o
154,S0325-00752009000200007,abierto,o
154,S0325-00752009000200007,no,o
154,S0325-00752009000200007,controlado,o
154,S0325-00752009000200007,realizado,o
154,S0325-00752009000200007,en,o
154,S0325-00752009000200007,la,o
154,S0325-00752009000200007,Unidad,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,Recuperacion,o
154,S0325-00752009000200007,Cardiovascular,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,un,o
154,S0325-00752009000200007,hospital,o
154,S0325-00752009000200007,pediatrico,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,alta,o
154,S0325-00752009000200007,complejidad,o
154,S0325-00752009000200007,Se,o
154,S0325-00752009000200007,administro,o
154,S0325-00752009000200007,levosimendan,i
154,S0325-00752009000200007,como,o
154,S0325-00752009000200007,uso,o
154,S0325-00752009000200007,compasivo,o
154,S0325-00752009000200007,a,o
154,S0325-00752009000200007,todos,o
154,S0325-00752009000200007,los,o
154,S0325-00752009000200007,pacientes,o
154,S0325-00752009000200007,con,o
154,S0325-00752009000200007,bajo,o
154,S0325-00752009000200007,gasto,o
154,S0325-00752009000200007,posoperatorio,o
154,S0325-00752009000200007,refractario,o
154,S0325-00752009000200007,al,o
154,S0325-00752009000200007,tratamiento,i
154,S0325-00752009000200007,convencional,i
154,S0325-00752009000200007,Se,o
154,S0325-00752009000200007,administro,o
154,S0325-00752009000200007,una,o
154,S0325-00752009000200007,dosis,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,carga,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,6,o
154,S0325-00752009000200007,μgkg,o
154,S0325-00752009000200007,EV,o
154,S0325-00752009000200007,seguido,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,01,o
154,S0325-00752009000200007,μgkgmin,o
154,S0325-00752009000200007,por,o
154,S0325-00752009000200007,24,o
154,S0325-00752009000200007,h,o
154,S0325-00752009000200007,La,o
154,S0325-00752009000200007,variable,o
154,S0325-00752009000200007,primaria,o
154,S0325-00752009000200007,predeterminada,o
154,S0325-00752009000200007,fue,o
154,S0325-00752009000200007,el,o
154,S0325-00752009000200007,impacto,o
154,S0325-00752009000200007,clinico,o
154,S0325-00752009000200007,del,o
154,S0325-00752009000200007,levosimendan,i
154,S0325-00752009000200007,sobre,o
154,S0325-00752009000200007,el,o
154,S0325-00752009000200007,gasto,o
154,S0325-00752009000200007,cardiaco,i
154,S0325-00752009000200007,Dos,o
154,S0325-00752009000200007,observadores,o
154,S0325-00752009000200007,independientes,o
154,S0325-00752009000200007,realizaron,o
154,S0325-00752009000200007,la,o
154,S0325-00752009000200007,evaluacion,i
154,S0325-00752009000200007,clinica,i
154,S0325-00752009000200007,del,i
154,S0325-00752009000200007,gasto,i
154,S0325-00752009000200007,cardiaco,i
154,S0325-00752009000200007,Se,o
154,S0325-00752009000200007,analizo,i
154,S0325-00752009000200007,la,i
154,S0325-00752009000200007,funcion,i
154,S0325-00752009000200007,cardiaca,i
154,S0325-00752009000200007,por,o
154,S0325-00752009000200007,ecocardiografia,i
154,S0325-00752009000200007,y,o
154,S0325-00752009000200007,variables,o
154,S0325-00752009000200007,clinicas,o
154,S0325-00752009000200007,bioquimicas,o
154,S0325-00752009000200007,y,o
154,S0325-00752009000200007,hemodinamicas,o
154,S0325-00752009000200007,antes,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,la,o
154,S0325-00752009000200007,infusion,i
154,S0325-00752009000200007,y,o
154,S0325-00752009000200007,despues,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,ella,o
154,S0325-00752009000200007,Resultados,o
154,S0325-00752009000200007,Se,o
154,S0325-00752009000200007,administro,o
154,S0325-00752009000200007,levosimendan,i
154,S0325-00752009000200007,a,o
154,S0325-00752009000200007,14,o
154,S0325-00752009000200007,pacientes,o
154,S0325-00752009000200007,en,o
154,S0325-00752009000200007,18,o
154,S0325-00752009000200007,oportunidades,o
154,S0325-00752009000200007,La,o
154,S0325-00752009000200007,mediana,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,edad,o
154,S0325-00752009000200007,fue,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,275,o
154,S0325-00752009000200007,meses,o
154,S0325-00752009000200007,r,o
154,S0325-00752009000200007,016197,o
154,S0325-00752009000200007,y,o
154,S0325-00752009000200007,el,o
154,S0325-00752009000200007,peso,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,111,o
154,S0325-00752009000200007,kg,o
154,S0325-00752009000200007,r,o
154,S0325-00752009000200007,29848,o
154,S0325-00752009000200007,En,o
154,S0325-00752009000200007,918,o
154,S0325-00752009000200007,intervenciones,i
154,S0325-00752009000200007,50,o
154,S0325-00752009000200007,p,o
154,S0325-00752009000200007,0004,o
154,S0325-00752009000200007,se,o
154,S0325-00752009000200007,observo,o
154,S0325-00752009000200007,una,o
154,S0325-00752009000200007,mejoria,o
154,S0325-00752009000200007,en,o
154,S0325-00752009000200007,el,o
154,S0325-00752009000200007,gasto,o
154,S0325-00752009000200007,cardiaco,i
154,S0325-00752009000200007,El,o
154,S0325-00752009000200007,puntaje,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,inotropicos,i
154,S0325-00752009000200007,disminuyo,o
154,S0325-00752009000200007,121,o
154,S0325-00752009000200007,contra,o
154,S0325-00752009000200007,61,o
154,S0325-00752009000200007,p,o
154,S0325-00752009000200007,001,o
154,S0325-00752009000200007,la,o
154,S0325-00752009000200007,SvO2,i
154,S0325-00752009000200007,mejoro,o
154,S0325-00752009000200007,695,o
154,S0325-00752009000200007,114,o
154,S0325-00752009000200007,contra,o
154,S0325-00752009000200007,76,o
154,S0325-00752009000200007,929,o
154,S0325-00752009000200007,p,o
154,S0325-00752009000200007,003,o
154,S0325-00752009000200007,y,o
154,S0325-00752009000200007,la,o
154,S0325-00752009000200007,AVDO2,o
154,S0325-00752009000200007,disminuyo,o
154,S0325-00752009000200007,2678,o
154,S0325-00752009000200007,115,o
154,S0325-00752009000200007,contra,o
154,S0325-00752009000200007,2081,o
154,S0325-00752009000200007,772,o
154,S0325-00752009000200007,p,o
154,S0325-00752009000200007,0029,o
154,S0325-00752009000200007,No,o
154,S0325-00752009000200007,se,o
154,S0325-00752009000200007,identificaron,o
154,S0325-00752009000200007,efectos,i
154,S0325-00752009000200007,adversos,i
154,S0325-00752009000200007,Cuatro,o
154,S0325-00752009000200007,pacientes,o
154,S0325-00752009000200007,fallecieron,i
154,S0325-00752009000200007,ninguno,o
154,S0325-00752009000200007,en,o
154,S0325-00752009000200007,relacion,o
154,S0325-00752009000200007,con,o
154,S0325-00752009000200007,la,o
154,S0325-00752009000200007,administracion,i
154,S0325-00752009000200007,del,i
154,S0325-00752009000200007,farmaco,i
154,S0325-00752009000200007,Conclusiones,o
154,S0325-00752009000200007,En,o
154,S0325-00752009000200007,el,o
154,S0325-00752009000200007,50,o
154,S0325-00752009000200007,de,o
154,S0325-00752009000200007,las,o
154,S0325-00752009000200007,intervenciones,i
154,S0325-00752009000200007,se,o
154,S0325-00752009000200007,observo,o
154,S0325-00752009000200007,mejoria,o
154,S0325-00752009000200007,en,o
154,S0325-00752009000200007,el,o
154,S0325-00752009000200007,gasto,o
154,S0325-00752009000200007,cardiaco,i
154,S0325-00752009000200007,No,o
154,S0325-00752009000200007,se,o
154,S0325-00752009000200007,detectaron,o
154,S0325-00752009000200007,efectos,i
154,S0325-00752009000200007,adversos,i
154,S0325-00752009000200007,atribuibles,o
154,S0325-00752009000200007,al,o
154,S0325-00752009000200007,farmaco,i
155,S0325-00752009000500007,Tratamiento,i
155,S0325-00752009000500007,con,o
155,S0325-00752009000500007,hormona,i
155,S0325-00752009000500007,de,i
155,S0325-00752009000500007,crecimiento,i
155,S0325-00752009000500007,en,o
155,S0325-00752009000500007,niños,o
155,S0325-00752009000500007,menores,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,6,o
155,S0325-00752009000500007,años,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,edad,o
155,S0325-00752009000500007,con,o
155,S0325-00752009000500007,talla,i
155,S0325-00752009000500007,baja,i
155,S0325-00752009000500007,nacidos,o
155,S0325-00752009000500007,pequeños,i
155,S0325-00752009000500007,para,i
155,S0325-00752009000500007,la,i
155,S0325-00752009000500007,edad,i
155,S0325-00752009000500007,gestacional,i
155,S0325-00752009000500007,Introduccion,o
155,S0325-00752009000500007,Un,o
155,S0325-00752009000500007,10,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,los,o
155,S0325-00752009000500007,niños,o
155,S0325-00752009000500007,nacidos,o
155,S0325-00752009000500007,pequeños,i
155,S0325-00752009000500007,para,i
155,S0325-00752009000500007,la,i
155,S0325-00752009000500007,edad,i
155,S0325-00752009000500007,gestacional,i
155,S0325-00752009000500007,no,o
155,S0325-00752009000500007,presentan,o
155,S0325-00752009000500007,un,o
155,S0325-00752009000500007,crecimiento,o
155,S0325-00752009000500007,compensador,o
155,S0325-00752009000500007,y,o
155,S0325-00752009000500007,permanecen,o
155,S0325-00752009000500007,bajos,o
155,S0325-00752009000500007,El,o
155,S0325-00752009000500007,tratamiento,i
155,S0325-00752009000500007,con,o
155,S0325-00752009000500007,hormona,i
155,S0325-00752009000500007,de,i
155,S0325-00752009000500007,crecimiento,i
155,S0325-00752009000500007,aprobado,o
155,S0325-00752009000500007,en,o
155,S0325-00752009000500007,los,o
155,S0325-00752009000500007,paises,o
155,S0325-00752009000500007,desarrollados,o
155,S0325-00752009000500007,ha,o
155,S0325-00752009000500007,demostrado,o
155,S0325-00752009000500007,su,o
155,S0325-00752009000500007,eficacia,o
155,S0325-00752009000500007,en,o
155,S0325-00752009000500007,estos,o
155,S0325-00752009000500007,niños,o
155,S0325-00752009000500007,Objetivo,o
155,S0325-00752009000500007,Determinar,i
155,S0325-00752009000500007,la,i
155,S0325-00752009000500007,eficacia,i
155,S0325-00752009000500007,y,i
155,S0325-00752009000500007,la,i
155,S0325-00752009000500007,seguridad,i
155,S0325-00752009000500007,del,o
155,S0325-00752009000500007,tratamiento,i
155,S0325-00752009000500007,con,o
155,S0325-00752009000500007,hormona,i
155,S0325-00752009000500007,de,i
155,S0325-00752009000500007,crecimiento,i
155,S0325-00752009000500007,durante,o
155,S0325-00752009000500007,dos,o
155,S0325-00752009000500007,años,o
155,S0325-00752009000500007,en,o
155,S0325-00752009000500007,niños,o
155,S0325-00752009000500007,nacidos,o
155,S0325-00752009000500007,pequeños,i
155,S0325-00752009000500007,para,i
155,S0325-00752009000500007,la,i
155,S0325-00752009000500007,edad,i
155,S0325-00752009000500007,gestacional,i
155,S0325-00752009000500007,sin,o
155,S0325-00752009000500007,deficiencia,i
155,S0325-00752009000500007,de,i
155,S0325-00752009000500007,hormona,i
155,S0325-00752009000500007,de,i
155,S0325-00752009000500007,crecimiento,i
155,S0325-00752009000500007,Material,o
155,S0325-00752009000500007,y,o
155,S0325-00752009000500007,metodos,o
155,S0325-00752009000500007,Se,o
155,S0325-00752009000500007,trataron,i
155,S0325-00752009000500007,14,o
155,S0325-00752009000500007,niños,o
155,S0325-00752009000500007,menores,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,6,o
155,S0325-00752009000500007,años,o
155,S0325-00752009000500007,con,o
155,S0325-00752009000500007,hormona,i
155,S0325-00752009000500007,de,i
155,S0325-00752009000500007,crecimiento,i
155,S0325-00752009000500007,a,o
155,S0325-00752009000500007,10,o
155,S0325-00752009000500007,UIkgsemana,o
155,S0325-00752009000500007,Resultados,o
155,S0325-00752009000500007,Se,o
155,S0325-00752009000500007,observo,o
155,S0325-00752009000500007,un,o
155,S0325-00752009000500007,aumento,o
155,S0325-00752009000500007,significativo,o
155,S0325-00752009000500007,en,o
155,S0325-00752009000500007,la,o
155,S0325-00752009000500007,velocidad,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,crecimiento,o
155,S0325-00752009000500007,media,o
155,S0325-00752009000500007,DE,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,54,o
155,S0325-00752009000500007,17,o
155,S0325-00752009000500007,cmaño,o
155,S0325-00752009000500007,a,o
155,S0325-00752009000500007,98,o
155,S0325-00752009000500007,15,o
155,S0325-00752009000500007,cmaño,o
155,S0325-00752009000500007,y,o
155,S0325-00752009000500007,76,o
155,S0325-00752009000500007,15,o
155,S0325-00752009000500007,cmaño,o
155,S0325-00752009000500007,durante,o
155,S0325-00752009000500007,el,o
155,S0325-00752009000500007,primer,o
155,S0325-00752009000500007,y,o
155,S0325-00752009000500007,segundo,o
155,S0325-00752009000500007,años,o
155,S0325-00752009000500007,respectivamente,o
155,S0325-00752009000500007,p,o
155,S0325-00752009000500007,000058,o
155,S0325-00752009000500007,Ello,o
155,S0325-00752009000500007,resulto,o
155,S0325-00752009000500007,en,o
155,S0325-00752009000500007,una,o
155,S0325-00752009000500007,mejoria,o
155,S0325-00752009000500007,significativa,o
155,S0325-00752009000500007,en,o
155,S0325-00752009000500007,el,o
155,S0325-00752009000500007,puntaje,o
155,S0325-00752009000500007,z,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,talla,o
155,S0325-00752009000500007,media,o
155,S0325-00752009000500007,DE,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,279,o
155,S0325-00752009000500007,03,o
155,S0325-00752009000500007,a,o
155,S0325-00752009000500007,127,o
155,S0325-00752009000500007,05,o
155,S0325-00752009000500007,en,o
155,S0325-00752009000500007,2,o
155,S0325-00752009000500007,años,o
155,S0325-00752009000500007,p,o
155,S0325-00752009000500007,00001,o
155,S0325-00752009000500007,Se,o
155,S0325-00752009000500007,observo,o
155,S0325-00752009000500007,un,o
155,S0325-00752009000500007,incremento,o
155,S0325-00752009000500007,significativo,o
155,S0325-00752009000500007,en,o
155,S0325-00752009000500007,las,o
155,S0325-00752009000500007,concentraciones,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,IGFI,o
155,S0325-00752009000500007,y,o
155,S0325-00752009000500007,su,o
155,S0325-00752009000500007,proteina,i
155,S0325-00752009000500007,transportadora,i
155,S0325-00752009000500007,BP3,i
155,S0325-00752009000500007,a,o
155,S0325-00752009000500007,los,o
155,S0325-00752009000500007,12,o
155,S0325-00752009000500007,y,o
155,S0325-00752009000500007,24,o
155,S0325-00752009000500007,meses,o
155,S0325-00752009000500007,del,o
155,S0325-00752009000500007,tratamiento,i
155,S0325-00752009000500007,Las,o
155,S0325-00752009000500007,concentraciones,i
155,S0325-00752009000500007,de,i
155,S0325-00752009000500007,glucosa,i
155,S0325-00752009000500007,e,o
155,S0325-00752009000500007,insulina,i
155,S0325-00752009000500007,aumentaron,o
155,S0325-00752009000500007,significativamente,o
155,S0325-00752009000500007,durante,o
155,S0325-00752009000500007,el,o
155,S0325-00752009000500007,estudio,o
155,S0325-00752009000500007,ANOVA,o
155,S0325-00752009000500007,p,o
155,S0325-00752009000500007,00006,o
155,S0325-00752009000500007,y,o
155,S0325-00752009000500007,p,o
155,S0325-00752009000500007,0036,o
155,S0325-00752009000500007,respectivamente,o
155,S0325-00752009000500007,Dos,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,los,o
155,S0325-00752009000500007,indices,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,sensibilidad,o
155,S0325-00752009000500007,a,o
155,S0325-00752009000500007,la,o
155,S0325-00752009000500007,insulina,i
155,S0325-00752009000500007,utilizados,o
155,S0325-00752009000500007,revelaron,o
155,S0325-00752009000500007,una,o
155,S0325-00752009000500007,leve,o
155,S0325-00752009000500007,alteracion,i
155,S0325-00752009000500007,en,i
155,S0325-00752009000500007,la,i
155,S0325-00752009000500007,sensibilidad,i
155,S0325-00752009000500007,a,i
155,S0325-00752009000500007,la,i
155,S0325-00752009000500007,insulina,i
155,S0325-00752009000500007,Conclusiones,o
155,S0325-00752009000500007,El,o
155,S0325-00752009000500007,tratamiento,i
155,S0325-00752009000500007,durante,o
155,S0325-00752009000500007,2,o
155,S0325-00752009000500007,años,o
155,S0325-00752009000500007,con,o
155,S0325-00752009000500007,hormona,i
155,S0325-00752009000500007,del,i
155,S0325-00752009000500007,crecimiento,i
155,S0325-00752009000500007,produjo,o
155,S0325-00752009000500007,un,o
155,S0325-00752009000500007,aumento,o
155,S0325-00752009000500007,significativo,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,la,o
155,S0325-00752009000500007,talla,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,los,o
155,S0325-00752009000500007,pacientes,o
155,S0325-00752009000500007,nacidos,o
155,S0325-00752009000500007,pequeños,i
155,S0325-00752009000500007,para,i
155,S0325-00752009000500007,la,i
155,S0325-00752009000500007,edad,i
155,S0325-00752009000500007,gestacional,i
155,S0325-00752009000500007,y,o
155,S0325-00752009000500007,permitio,o
155,S0325-00752009000500007,alcanzar,o
155,S0325-00752009000500007,una,o
155,S0325-00752009000500007,talla,o
155,S0325-00752009000500007,dentro,o
155,S0325-00752009000500007,de,o
155,S0325-00752009000500007,los,o
155,S0325-00752009000500007,limites,o
155,S0325-00752009000500007,normales,o
155,S0325-00752009000500007,No,o
155,S0325-00752009000500007,se,o
155,S0325-00752009000500007,informaron,o
155,S0325-00752009000500007,episodios,i
155,S0325-00752009000500007,adversos,i
155,S0325-00752009000500007,mayores,o
155,S0325-00752009000500007,durante,o
155,S0325-00752009000500007,el,o
155,S0325-00752009000500007,tratamiento,i
156,S0325-00752012000400003,Salbutamol,i
156,S0325-00752012000400003,original,o
156,S0325-00752012000400003,contra,o
156,S0325-00752012000400003,salbutamol,i
156,S0325-00752012000400003,similar,o
156,S0325-00752012000400003,en,o
156,S0325-00752012000400003,niños,o
156,S0325-00752012000400003,con,o
156,S0325-00752012000400003,crisis,i
156,S0325-00752012000400003,de,i
156,S0325-00752012000400003,asma,i
156,S0325-00752012000400003,Estudio,o
156,S0325-00752012000400003,aleatorizado,o
156,S0325-00752012000400003,controlado,o
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,doble,o
156,S0325-00752012000400003,ciego,o
156,S0325-00752012000400003,Introduccion,o
156,S0325-00752012000400003,Existe,o
156,S0325-00752012000400003,evidencia,o
156,S0325-00752012000400003,clinica,o
156,S0325-00752012000400003,que,o
156,S0325-00752012000400003,sugiere,o
156,S0325-00752012000400003,que,o
156,S0325-00752012000400003,el,o
156,S0325-00752012000400003,salbutamol,i
156,S0325-00752012000400003,original,o
156,S0325-00752012000400003,seria,o
156,S0325-00752012000400003,mas,o
156,S0325-00752012000400003,eficaz,o
156,S0325-00752012000400003,que,o
156,S0325-00752012000400003,el,o
156,S0325-00752012000400003,salbutamol,i
156,S0325-00752012000400003,similar,o
156,S0325-00752012000400003,para,o
156,S0325-00752012000400003,revertir,o
156,S0325-00752012000400003,los,o
156,S0325-00752012000400003,sintomas,i
156,S0325-00752012000400003,en,o
156,S0325-00752012000400003,el,o
156,S0325-00752012000400003,episodio,i
156,S0325-00752012000400003,agudo,i
156,S0325-00752012000400003,de,i
156,S0325-00752012000400003,asma,i
156,S0325-00752012000400003,Objetivo,o
156,S0325-00752012000400003,Evaluar,o
156,S0325-00752012000400003,la,o
156,S0325-00752012000400003,respuesta,o
156,S0325-00752012000400003,broncodilatadora,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,ambas,o
156,S0325-00752012000400003,especialidades,i
156,S0325-00752012000400003,farmaceuticas,i
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,salbutamol,i
156,S0325-00752012000400003,en,o
156,S0325-00752012000400003,niños,o
156,S0325-00752012000400003,con,o
156,S0325-00752012000400003,asma,i
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,establecer,o
156,S0325-00752012000400003,mediante,o
156,S0325-00752012000400003,el,o
156,S0325-00752012000400003,volumen,i
156,S0325-00752012000400003,espiratorio,i
156,S0325-00752012000400003,forzado,i
156,S0325-00752012000400003,si,o
156,S0325-00752012000400003,difiere,o
156,S0325-00752012000400003,entre,o
156,S0325-00752012000400003,los,o
156,S0325-00752012000400003,grupos,o
156,S0325-00752012000400003,tratados,i
156,S0325-00752012000400003,con,o
156,S0325-00752012000400003,salbutamol,i
156,S0325-00752012000400003,original,o
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,similar,o
156,S0325-00752012000400003,Diseño,o
156,S0325-00752012000400003,Estudio,o
156,S0325-00752012000400003,prospectivo,o
156,S0325-00752012000400003,aleatorizado,o
156,S0325-00752012000400003,controlado,o
156,S0325-00752012000400003,a,o
156,S0325-00752012000400003,doble,o
156,S0325-00752012000400003,ciego,o
156,S0325-00752012000400003,Material,o
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,metodos,o
156,S0325-00752012000400003,Se,o
156,S0325-00752012000400003,incluyeron,o
156,S0325-00752012000400003,126,o
156,S0325-00752012000400003,niños,o
156,S0325-00752012000400003,63,o
156,S0325-00752012000400003,varones,o
156,S0325-00752012000400003,edad,o
156,S0325-00752012000400003,918,o
156,S0325-00752012000400003,283,o
156,S0325-00752012000400003,años,o
156,S0325-00752012000400003,que,o
156,S0325-00752012000400003,recibieron,o
156,S0325-00752012000400003,una,o
156,S0325-00752012000400003,dosis,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,20,o
156,S0325-00752012000400003,gotas,o
156,S0325-00752012000400003,5,o
156,S0325-00752012000400003,mg,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,salbutamol,i
156,S0325-00752012000400003,original,o
156,S0325-00752012000400003,o,o
156,S0325-00752012000400003,similar,o
156,S0325-00752012000400003,en,o
156,S0325-00752012000400003,solucion,o
156,S0325-00752012000400003,para,o
156,S0325-00752012000400003,nebulizar,i
156,S0325-00752012000400003,diluida,o
156,S0325-00752012000400003,en,o
156,S0325-00752012000400003,2,o
156,S0325-00752012000400003,ml,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,solucion,i
156,S0325-00752012000400003,fisiologica,i
156,S0325-00752012000400003,por,o
156,S0325-00752012000400003,unica,o
156,S0325-00752012000400003,vez,o
156,S0325-00752012000400003,Se,o
156,S0325-00752012000400003,comparo,o
156,S0325-00752012000400003,el,o
156,S0325-00752012000400003,volumen,i
156,S0325-00752012000400003,espiratorio,i
156,S0325-00752012000400003,forzado,i
156,S0325-00752012000400003,prebroncodilatador,o
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,posbroncodilatador,o
156,S0325-00752012000400003,intragrupos,o
156,S0325-00752012000400003,e,o
156,S0325-00752012000400003,intergrupos,o
156,S0325-00752012000400003,al,o
156,S0325-00752012000400003,inicio,o
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,a,o
156,S0325-00752012000400003,los,o
156,S0325-00752012000400003,30,o
156,S0325-00752012000400003,minutos,o
156,S0325-00752012000400003,Se,o
156,S0325-00752012000400003,determino,o
156,S0325-00752012000400003,el,o
156,S0325-00752012000400003,peso,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,las,o
156,S0325-00752012000400003,gotas,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,salbutamol,i
156,S0325-00752012000400003,por,o
156,S0325-00752012000400003,gravimetria,i
156,S0325-00752012000400003,la,o
156,S0325-00752012000400003,concentracion,o
156,S0325-00752012000400003,por,o
156,S0325-00752012000400003,cromatografia,i
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,el,o
156,S0325-00752012000400003,numero,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,gotas,o
156,S0325-00752012000400003,por,o
156,S0325-00752012000400003,envase,o
156,S0325-00752012000400003,Resultados,o
156,S0325-00752012000400003,La,o
156,S0325-00752012000400003,respuesta,o
156,S0325-00752012000400003,broncodilatadora,o
156,S0325-00752012000400003,entre,o
156,S0325-00752012000400003,el,o
156,S0325-00752012000400003,volumen,i
156,S0325-00752012000400003,espiratorio,i
156,S0325-00752012000400003,forzado,i
156,S0325-00752012000400003,prebroncodilatador,o
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,posbroncodilatador,o
156,S0325-00752012000400003,fue,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,225,o
156,S0325-00752012000400003,ml,o
156,S0325-00752012000400003,IC,o
156,S0325-00752012000400003,95,o
156,S0325-00752012000400003,164286,o
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,224,o
156,S0325-00752012000400003,ml,o
156,S0325-00752012000400003,IC,o
156,S0325-00752012000400003,95,o
156,S0325-00752012000400003,163284,o
156,S0325-00752012000400003,para,o
156,S0325-00752012000400003,salbutamol,i
156,S0325-00752012000400003,original,o
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,similar,o
156,S0325-00752012000400003,respectivamente,o
156,S0325-00752012000400003,p,o
156,S0325-00752012000400003,0001,o
156,S0325-00752012000400003,El,o
156,S0325-00752012000400003,delta,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,la,o
156,S0325-00752012000400003,diferencia,o
156,S0325-00752012000400003,fue,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,13,o
156,S0325-00752012000400003,ml,o
156,S0325-00752012000400003,IC,o
156,S0325-00752012000400003,95,o
156,S0325-00752012000400003,8683,o
156,S0325-00752012000400003,p,o
156,S0325-00752012000400003,097,o
156,S0325-00752012000400003,La,o
156,S0325-00752012000400003,media,o
156,S0325-00752012000400003,desvio,o
156,S0325-00752012000400003,estandar,o
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,porcentaje,o
156,S0325-00752012000400003,del,o
156,S0325-00752012000400003,coeficiente,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,variacion,o
156,S0325-00752012000400003,del,o
156,S0325-00752012000400003,peso,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,las,o
156,S0325-00752012000400003,gotas,o
156,S0325-00752012000400003,fue,o
156,S0325-00752012000400003,de,o
156,S0325-00752012000400003,36475,o
156,S0325-00752012000400003,mg,o
156,S0325-00752012000400003,601,o
156,S0325-00752012000400003,165,o
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,54388,o
156,S0325-00752012000400003,mg,o
156,S0325-00752012000400003,5609,o
156,S0325-00752012000400003,1031,o
156,S0325-00752012000400003,p,o
156,S0325-00752012000400003,0001,o
156,S0325-00752012000400003,para,o
156,S0325-00752012000400003,salbutamol,i
156,S0325-00752012000400003,original,o
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,similar,o
156,S0325-00752012000400003,respectivamente,o
156,S0325-00752012000400003,Conclusion,o
156,S0325-00752012000400003,No,o
156,S0325-00752012000400003,hubo,o
156,S0325-00752012000400003,diferencias,o
156,S0325-00752012000400003,en,o
156,S0325-00752012000400003,la,o
156,S0325-00752012000400003,respuesta,o
156,S0325-00752012000400003,broncodilatadora,o
156,S0325-00752012000400003,medida,o
156,S0325-00752012000400003,por,o
156,S0325-00752012000400003,el,o
156,S0325-00752012000400003,VEF1,i
156,S0325-00752012000400003,entre,o
156,S0325-00752012000400003,salbutamol,i
156,S0325-00752012000400003,original,o
156,S0325-00752012000400003,y,o
156,S0325-00752012000400003,similar,o
157,S0325-00752012000400004,Eficacia,o
157,S0325-00752012000400004,del,o
157,S0325-00752012000400004,sulfato,i
157,S0325-00752012000400004,de,i
157,S0325-00752012000400004,magnesio,i
157,S0325-00752012000400004,como,o
157,S0325-00752012000400004,tratamiento,i
157,S0325-00752012000400004,inicial,o
157,S0325-00752012000400004,del,o
157,S0325-00752012000400004,asma,i
157,S0325-00752012000400004,aguda,i
157,S0325-00752012000400004,grave,o
157,S0325-00752012000400004,pediatrica,o
157,S0325-00752012000400004,Estudio,i
157,S0325-00752012000400004,aleatorizado,i
157,S0325-00752012000400004,y,i
157,S0325-00752012000400004,controlado,i
157,S0325-00752012000400004,Introduccion,o
157,S0325-00752012000400004,El,o
157,S0325-00752012000400004,sulfato,i
157,S0325-00752012000400004,de,i
157,S0325-00752012000400004,magnesio,i
157,S0325-00752012000400004,es,o
157,S0325-00752012000400004,un,o
157,S0325-00752012000400004,antagonista,i
157,S0325-00752012000400004,del,i
157,S0325-00752012000400004,calcio,i
157,S0325-00752012000400004,que,o
157,S0325-00752012000400004,inhibe,o
157,S0325-00752012000400004,la,o
157,S0325-00752012000400004,contraccion,o
157,S0325-00752012000400004,del,o
157,S0325-00752012000400004,musculo,i
157,S0325-00752012000400004,liso,i
157,S0325-00752012000400004,bronquial,i
157,S0325-00752012000400004,y,o
157,S0325-00752012000400004,favorece,o
157,S0325-00752012000400004,la,o
157,S0325-00752012000400004,broncodilatacion,o
157,S0325-00752012000400004,Se,o
157,S0325-00752012000400004,utiliza,o
157,S0325-00752012000400004,en,o
157,S0325-00752012000400004,el,o
157,S0325-00752012000400004,manejo,o
157,S0325-00752012000400004,del,o
157,S0325-00752012000400004,asma,i
157,S0325-00752012000400004,aguda,i
157,S0325-00752012000400004,grave,o
157,S0325-00752012000400004,en,o
157,S0325-00752012000400004,pediatria,o
157,S0325-00752012000400004,no,o
157,S0325-00752012000400004,obstante,o
157,S0325-00752012000400004,haber,o
157,S0325-00752012000400004,sido,o
157,S0325-00752012000400004,la,o
157,S0325-00752012000400004,mayoria,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,los,o
157,S0325-00752012000400004,estudios,o
157,S0325-00752012000400004,desarrollados,o
157,S0325-00752012000400004,en,o
157,S0325-00752012000400004,adultos,o
157,S0325-00752012000400004,Objetivo,o
157,S0325-00752012000400004,Evaluar,i
157,S0325-00752012000400004,la,i
157,S0325-00752012000400004,eficacia,i
157,S0325-00752012000400004,del,o
157,S0325-00752012000400004,sulfato,i
157,S0325-00752012000400004,de,i
157,S0325-00752012000400004,magnesio,i
157,S0325-00752012000400004,endovenoso,o
157,S0325-00752012000400004,para,o
157,S0325-00752012000400004,exacerbaciones,i
157,S0325-00752012000400004,graves,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,pacientes,o
157,S0325-00752012000400004,asmaticos,i
157,S0325-00752012000400004,pediatricos,o
157,S0325-00752012000400004,Poblacion,o
157,S0325-00752012000400004,y,o
157,S0325-00752012000400004,metodos,o
157,S0325-00752012000400004,Se,o
157,S0325-00752012000400004,realizo,o
157,S0325-00752012000400004,un,o
157,S0325-00752012000400004,estudio,o
157,S0325-00752012000400004,clinico,o
157,S0325-00752012000400004,controlado,o
157,S0325-00752012000400004,y,o
157,S0325-00752012000400004,aleatorizado,o
157,S0325-00752012000400004,entre,o
157,S0325-00752012000400004,marzo,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,2006,o
157,S0325-00752012000400004,y,o
157,S0325-00752012000400004,marzo,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,2011,o
157,S0325-00752012000400004,en,o
157,S0325-00752012000400004,el,o
157,S0325-00752012000400004,Hospital,o
157,S0325-00752012000400004,Universitario,o
157,S0325-00752012000400004,Austral,o
157,S0325-00752012000400004,Los,o
157,S0325-00752012000400004,pacientes,o
157,S0325-00752012000400004,con,o
157,S0325-00752012000400004,asma,i
157,S0325-00752012000400004,aguda,i
157,S0325-00752012000400004,grave,o
157,S0325-00752012000400004,admitidos,o
157,S0325-00752012000400004,en,o
157,S0325-00752012000400004,Emergencias,o
157,S0325-00752012000400004,se,o
157,S0325-00752012000400004,aleatorizaron,i
157,S0325-00752012000400004,en,o
157,S0325-00752012000400004,dos,o
157,S0325-00752012000400004,grupos,o
157,S0325-00752012000400004,Grupo,o
157,S0325-00752012000400004,A,o
157,S0325-00752012000400004,protocolo,i
157,S0325-00752012000400004,inicial,i
157,S0325-00752012000400004,estandar,i
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,exacerbacion,i
157,S0325-00752012000400004,asmatica,i
157,S0325-00752012000400004,aguda,i
157,S0325-00752012000400004,grave,o
157,S0325-00752012000400004,Grupo,o
157,S0325-00752012000400004,B,o
157,S0325-00752012000400004,protocolo,i
157,S0325-00752012000400004,de,i
157,S0325-00752012000400004,intervencion,i
157,S0325-00752012000400004,con,o
157,S0325-00752012000400004,sulfato,i
157,S0325-00752012000400004,de,i
157,S0325-00752012000400004,magnesio,i
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,exacerbacion,i
157,S0325-00752012000400004,asmatica,i
157,S0325-00752012000400004,aguda,i
157,S0325-00752012000400004,grave,o
157,S0325-00752012000400004,La,o
157,S0325-00752012000400004,variable,o
157,S0325-00752012000400004,principal,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,resultado,o
157,S0325-00752012000400004,fue,o
157,S0325-00752012000400004,la,o
157,S0325-00752012000400004,necesidad,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,soporte,i
157,S0325-00752012000400004,invasivo,i
157,S0325-00752012000400004,o,i
157,S0325-00752012000400004,no,i
157,S0325-00752012000400004,invasivo,i
157,S0325-00752012000400004,ventilatorio,i
157,S0325-00752012000400004,mecanico,i
157,S0325-00752012000400004,Resultados,o
157,S0325-00752012000400004,Se,o
157,S0325-00752012000400004,analizaron,o
157,S0325-00752012000400004,143,o
157,S0325-00752012000400004,pacientes,o
157,S0325-00752012000400004,aleatorizados,i
157,S0325-00752012000400004,en,o
157,S0325-00752012000400004,2,o
157,S0325-00752012000400004,grupos,o
157,S0325-00752012000400004,El,o
157,S0325-00752012000400004,grupo,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,intervencion,i
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,76,o
157,S0325-00752012000400004,pacientes,o
157,S0325-00752012000400004,que,o
157,S0325-00752012000400004,recibieron,o
157,S0325-00752012000400004,tratamiento,i
157,S0325-00752012000400004,con,o
157,S0325-00752012000400004,sulfato,i
157,S0325-00752012000400004,de,i
157,S0325-00752012000400004,magnesio,i
157,S0325-00752012000400004,dentro,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,la,o
157,S0325-00752012000400004,primera,o
157,S0325-00752012000400004,hora,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,iniciado,o
157,S0325-00752012000400004,el,o
157,S0325-00752012000400004,tratamiento,i
157,S0325-00752012000400004,de,i
157,S0325-00752012000400004,rescate,i
157,S0325-00752012000400004,en,o
157,S0325-00752012000400004,el,o
157,S0325-00752012000400004,hospital,o
157,S0325-00752012000400004,y,o
157,S0325-00752012000400004,el,o
157,S0325-00752012000400004,grupo,o
157,S0325-00752012000400004,control,o
157,S0325-00752012000400004,testigo,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,67,o
157,S0325-00752012000400004,pacientes,o
157,S0325-00752012000400004,que,o
157,S0325-00752012000400004,no,o
157,S0325-00752012000400004,recibieron,o
157,S0325-00752012000400004,tratamiento,i
157,S0325-00752012000400004,con,o
157,S0325-00752012000400004,sulfato,i
157,S0325-00752012000400004,de,i
157,S0325-00752012000400004,magnesio,i
157,S0325-00752012000400004,El,o
157,S0325-00752012000400004,33,o
157,S0325-00752012000400004,n,o
157,S0325-00752012000400004,22,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,los,o
157,S0325-00752012000400004,pacientes,o
157,S0325-00752012000400004,del,o
157,S0325-00752012000400004,grupo,o
157,S0325-00752012000400004,control,o
157,S0325-00752012000400004,requirio,o
157,S0325-00752012000400004,asistencia,i
157,S0325-00752012000400004,ventilatoria,i
157,S0325-00752012000400004,mecanica,i
157,S0325-00752012000400004,en,o
157,S0325-00752012000400004,comparacion,o
157,S0325-00752012000400004,con,o
157,S0325-00752012000400004,solo,o
157,S0325-00752012000400004,4,o
157,S0325-00752012000400004,5,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,los,o
157,S0325-00752012000400004,pacientes,o
157,S0325-00752012000400004,del,o
157,S0325-00752012000400004,grupo,o
157,S0325-00752012000400004,intervencion,i
157,S0325-00752012000400004,p,o
157,S0325-00752012000400004,0001,o
157,S0325-00752012000400004,Conclusiones,o
157,S0325-00752012000400004,El,o
157,S0325-00752012000400004,uso,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,sulfato,i
157,S0325-00752012000400004,de,i
157,S0325-00752012000400004,magnesio,i
157,S0325-00752012000400004,en,o
157,S0325-00752012000400004,infusion,i
157,S0325-00752012000400004,endovenosa,i
157,S0325-00752012000400004,en,o
157,S0325-00752012000400004,la,o
157,S0325-00752012000400004,primera,o
157,S0325-00752012000400004,hora,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,ingreso,i
157,S0325-00752012000400004,del,o
157,S0325-00752012000400004,paciente,o
157,S0325-00752012000400004,con,o
157,S0325-00752012000400004,asma,i
157,S0325-00752012000400004,aguda,i
157,S0325-00752012000400004,grave,o
157,S0325-00752012000400004,redujo,o
157,S0325-00752012000400004,significativamente,o
157,S0325-00752012000400004,el,o
157,S0325-00752012000400004,porcentaje,o
157,S0325-00752012000400004,de,o
157,S0325-00752012000400004,niños,o
157,S0325-00752012000400004,que,o
157,S0325-00752012000400004,requirieron,o
157,S0325-00752012000400004,asistencia,i
157,S0325-00752012000400004,ventilatoria,i
157,S0325-00752012000400004,mecanica,i
158,S0325-00752013000400005,Ensayo,i
158,S0325-00752013000400005,clinico,i
158,S0325-00752013000400005,aleatorizado,i
158,S0325-00752013000400005,sobre,o
158,S0325-00752013000400005,la,o
158,S0325-00752013000400005,administracion,i
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,una,o
158,S0325-00752013000400005,solucion,i
158,S0325-00752013000400005,de,i
158,S0325-00752013000400005,mantenimiento,i
158,S0325-00752013000400005,intravenosa,i
158,S0325-00752013000400005,hipotonica,i
158,S0325-00752013000400005,comparada,o
158,S0325-00752013000400005,contra,o
158,S0325-00752013000400005,una,o
158,S0325-00752013000400005,isotonica,o
158,S0325-00752013000400005,en,o
158,S0325-00752013000400005,pacientes,o
158,S0325-00752013000400005,pediatricos,o
158,S0325-00752013000400005,criticos,o
158,S0325-00752013000400005,a,o
158,S0325-00752013000400005,randomized,o
158,S0325-00752013000400005,control,o
158,S0325-00752013000400005,trial,o
158,S0325-00752013000400005,Introduccion,o
158,S0325-00752013000400005,Las,o
158,S0325-00752013000400005,soluciones,i
158,S0325-00752013000400005,hipotonicas,i
158,S0325-00752013000400005,se,o
158,S0325-00752013000400005,han,o
158,S0325-00752013000400005,vinculado,o
158,S0325-00752013000400005,a,o
158,S0325-00752013000400005,la,o
158,S0325-00752013000400005,produccion,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,hiponatremia,i
158,S0325-00752013000400005,iatrogenica,i
158,S0325-00752013000400005,Objetivos,o
158,S0325-00752013000400005,Evaluar,o
158,S0325-00752013000400005,las,o
158,S0325-00752013000400005,variaciones,o
158,S0325-00752013000400005,en,o
158,S0325-00752013000400005,el,o
158,S0325-00752013000400005,sodio,i
158,S0325-00752013000400005,serico,i
158,S0325-00752013000400005,NaS,o
158,S0325-00752013000400005,tras,o
158,S0325-00752013000400005,la,o
158,S0325-00752013000400005,administracion,i
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,una,o
158,S0325-00752013000400005,solucion,i
158,S0325-00752013000400005,de,i
158,S0325-00752013000400005,mantenimiento,i
158,S0325-00752013000400005,intravenosa,i
158,S0325-00752013000400005,isotonica,i
158,S0325-00752013000400005,NaCl,i
158,S0325-00752013000400005,al,o
158,S0325-00752013000400005,09,o
158,S0325-00752013000400005,en,o
158,S0325-00752013000400005,dextrosa,i
158,S0325-00752013000400005,al,o
158,S0325-00752013000400005,5,o
158,S0325-00752013000400005,en,o
158,S0325-00752013000400005,comparacion,o
158,S0325-00752013000400005,con,o
158,S0325-00752013000400005,una,o
158,S0325-00752013000400005,solucion,i
158,S0325-00752013000400005,de,i
158,S0325-00752013000400005,mantenimiento,i
158,S0325-00752013000400005,hipotonica,i
158,S0325-00752013000400005,NaCl,i
158,S0325-00752013000400005,al,o
158,S0325-00752013000400005,045,o
158,S0325-00752013000400005,en,o
158,S0325-00752013000400005,dextrosa,i
158,S0325-00752013000400005,al,o
158,S0325-00752013000400005,5,o
158,S0325-00752013000400005,Material,o
158,S0325-00752013000400005,y,o
158,S0325-00752013000400005,metodos,o
158,S0325-00752013000400005,Ensayo,i
158,S0325-00752013000400005,clinico,i
158,S0325-00752013000400005,aleatorizado,i
158,S0325-00752013000400005,doble,o
158,S0325-00752013000400005,ciego,o
158,S0325-00752013000400005,y,o
158,S0325-00752013000400005,controlado,o
158,S0325-00752013000400005,Se,o
158,S0325-00752013000400005,enrolaron,o
158,S0325-00752013000400005,pacientes,o
158,S0325-00752013000400005,pediatricos,o
158,S0325-00752013000400005,con,o
158,S0325-00752013000400005,una,o
158,S0325-00752013000400005,estadia,o
158,S0325-00752013000400005,esperada,o
158,S0325-00752013000400005,en,o
158,S0325-00752013000400005,la,o
158,S0325-00752013000400005,unidad,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,cuidados,o
158,S0325-00752013000400005,intensivos,o
158,S0325-00752013000400005,mayor,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,24,o
158,S0325-00752013000400005,horas,o
158,S0325-00752013000400005,NaS,o
158,S0325-00752013000400005,normal,o
158,S0325-00752013000400005,y,o
158,S0325-00752013000400005,liquidos,o
158,S0325-00752013000400005,intravenosos,o
158,S0325-00752013000400005,80,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,los,o
158,S0325-00752013000400005,liquidos,o
158,S0325-00752013000400005,totales,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,mantenimiento,o
158,S0325-00752013000400005,La,o
158,S0325-00752013000400005,concentracion,i
158,S0325-00752013000400005,serica,i
158,S0325-00752013000400005,de,i
158,S0325-00752013000400005,Na,i
158,S0325-00752013000400005,se,o
158,S0325-00752013000400005,midio,o
158,S0325-00752013000400005,antes,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,colocar,o
158,S0325-00752013000400005,la,o
158,S0325-00752013000400005,solucion,i
158,S0325-00752013000400005,de,i
158,S0325-00752013000400005,mantenimiento,i
158,S0325-00752013000400005,y,o
158,S0325-00752013000400005,al,o
158,S0325-00752013000400005,reducir,o
158,S0325-00752013000400005,la,o
158,S0325-00752013000400005,administracion,i
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,esta,o
158,S0325-00752013000400005,a,o
158,S0325-00752013000400005,80,o
158,S0325-00752013000400005,del,o
158,S0325-00752013000400005,total,o
158,S0325-00752013000400005,del,o
158,S0325-00752013000400005,aporte,o
158,S0325-00752013000400005,Resultados,o
158,S0325-00752013000400005,Se,o
158,S0325-00752013000400005,incorporaron,o
158,S0325-00752013000400005,63,o
158,S0325-00752013000400005,pacientes,o
158,S0325-00752013000400005,que,o
158,S0325-00752013000400005,fueron,o
158,S0325-00752013000400005,asignados,i
158,S0325-00752013000400005,en,i
158,S0325-00752013000400005,forma,i
158,S0325-00752013000400005,aleatoria,i
158,S0325-00752013000400005,a,o
158,S0325-00752013000400005,recibir,o
158,S0325-00752013000400005,una,o
158,S0325-00752013000400005,solucion,i
158,S0325-00752013000400005,de,i
158,S0325-00752013000400005,mantenimiento,i
158,S0325-00752013000400005,hipotonica,i
158,S0325-00752013000400005,n,o
158,S0325-00752013000400005,32,o
158,S0325-00752013000400005,o,o
158,S0325-00752013000400005,isotonica,o
158,S0325-00752013000400005,n,o
158,S0325-00752013000400005,31,o
158,S0325-00752013000400005,Las,o
158,S0325-00752013000400005,caracteristicas,o
158,S0325-00752013000400005,basales,o
158,S0325-00752013000400005,fueron,o
158,S0325-00752013000400005,similares,o
158,S0325-00752013000400005,en,o
158,S0325-00752013000400005,ambos,o
158,S0325-00752013000400005,grupos,o
158,S0325-00752013000400005,No,o
158,S0325-00752013000400005,hubo,o
158,S0325-00752013000400005,diferencias,o
158,S0325-00752013000400005,con,o
158,S0325-00752013000400005,respecto,o
158,S0325-00752013000400005,a,o
158,S0325-00752013000400005,la,o
158,S0325-00752013000400005,cantidad,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,solucion,i
158,S0325-00752013000400005,administrada,o
158,S0325-00752013000400005,grupo,o
158,S0325-00752013000400005,hipotonico,o
158,S0325-00752013000400005,865,o
158,S0325-00752013000400005,853,o
158,S0325-00752013000400005,ml,o
158,S0325-00752013000400005,grupo,o
158,S0325-00752013000400005,isotonico,o
158,S0325-00752013000400005,778,o
158,S0325-00752013000400005,649,o
158,S0325-00752013000400005,ml,o
158,S0325-00752013000400005,p,o
158,S0325-00752013000400005,0654,o
158,S0325-00752013000400005,o,o
158,S0325-00752013000400005,el,o
158,S0325-00752013000400005,tiempo,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,infusion,i
158,S0325-00752013000400005,grupo,o
158,S0325-00752013000400005,hipotonico,o
158,S0325-00752013000400005,24,o
158,S0325-00752013000400005,108,o
158,S0325-00752013000400005,horas,o
158,S0325-00752013000400005,grupo,o
158,S0325-00752013000400005,isotonico,o
158,S0325-00752013000400005,276,o
158,S0325-00752013000400005,128,o
158,S0325-00752013000400005,horas,o
158,S0325-00752013000400005,p,o
158,S0325-00752013000400005,0231,o
158,S0325-00752013000400005,Se,o
158,S0325-00752013000400005,encontro,o
158,S0325-00752013000400005,una,o
158,S0325-00752013000400005,diferencia,o
158,S0325-00752013000400005,en,o
158,S0325-00752013000400005,el,o
158,S0325-00752013000400005,NaS,o
158,S0325-00752013000400005,luego,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,la,o
158,S0325-00752013000400005,administracion,i
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,las,o
158,S0325-00752013000400005,soluciones,i
158,S0325-00752013000400005,de,i
158,S0325-00752013000400005,mantenimiento,i
158,S0325-00752013000400005,grupo,o
158,S0325-00752013000400005,hipotonico,o
158,S0325-00752013000400005,1378,o
158,S0325-00752013000400005,43,o
158,S0325-00752013000400005,mmolL,o
158,S0325-00752013000400005,grupo,o
158,S0325-00752013000400005,isotonico,o
158,S0325-00752013000400005,1400,o
158,S0325-00752013000400005,41,o
158,S0325-00752013000400005,mmolL,o
158,S0325-00752013000400005,p,o
158,S0325-00752013000400005,004,o
158,S0325-00752013000400005,Ninguna,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,las,o
158,S0325-00752013000400005,dos,o
158,S0325-00752013000400005,soluciones,i
158,S0325-00752013000400005,de,i
158,S0325-00752013000400005,mantenimiento,i
158,S0325-00752013000400005,aumento,o
158,S0325-00752013000400005,el,o
158,S0325-00752013000400005,riesgo,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,hiponatremia,i
158,S0325-00752013000400005,Na,i
158,S0325-00752013000400005,145,o
158,S0325-00752013000400005,mmolL,o
158,S0325-00752013000400005,Conclusiones,o
158,S0325-00752013000400005,Ambas,o
158,S0325-00752013000400005,soluciones,i
158,S0325-00752013000400005,de,i
158,S0325-00752013000400005,mantenimiento,i
158,S0325-00752013000400005,en,o
158,S0325-00752013000400005,24,o
158,S0325-00752013000400005,horas,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,infusion,i
158,S0325-00752013000400005,no,o
158,S0325-00752013000400005,aumentaron,o
158,S0325-00752013000400005,el,o
158,S0325-00752013000400005,riesgo,o
158,S0325-00752013000400005,de,o
158,S0325-00752013000400005,producir,o
158,S0325-00752013000400005,hiponatremia,i
158,S0325-00752013000400005,iatrogenica,i
159,S0325-00752015000500004,Eficacia,o
159,S0325-00752015000500004,y,o
159,S0325-00752015000500004,seguridad,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,una,o
159,S0325-00752015000500004,regla,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,decision,o
159,S0325-00752015000500004,para,o
159,S0325-00752015000500004,orientar,o
159,S0325-00752015000500004,el,o
159,S0325-00752015000500004,tratamiento,i
159,S0325-00752015000500004,en,o
159,S0325-00752015000500004,niños,o
159,S0325-00752015000500004,con,o
159,S0325-00752015000500004,neumonia,i
159,S0325-00752015000500004,vacunados,i
159,S0325-00752015000500004,contra,i
159,S0325-00752015000500004,neumococo,i
159,S0325-00752015000500004,Un,o
159,S0325-00752015000500004,ensayo,i
159,S0325-00752015000500004,clinico,i
159,S0325-00752015000500004,controlado,i
159,S0325-00752015000500004,Introduccion,o
159,S0325-00752015000500004,A,o
159,S0325-00752015000500004,pesar,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,que,o
159,S0325-00752015000500004,la,o
159,S0325-00752015000500004,mayoria,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,las,o
159,S0325-00752015000500004,neumonias,i
159,S0325-00752015000500004,en,o
159,S0325-00752015000500004,menores,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,5,o
159,S0325-00752015000500004,años,o
159,S0325-00752015000500004,son,o
159,S0325-00752015000500004,virales,o
159,S0325-00752015000500004,en,o
159,S0325-00752015000500004,la,o
159,S0325-00752015000500004,practica,o
159,S0325-00752015000500004,diaria,o
159,S0325-00752015000500004,frecuentemente,o
159,S0325-00752015000500004,son,o
159,S0325-00752015000500004,tratadas,i
159,S0325-00752015000500004,con,o
159,S0325-00752015000500004,antibioticos,i
159,S0325-00752015000500004,Una,o
159,S0325-00752015000500004,regla,o
159,S0325-00752015000500004,clinica,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,decision,o
159,S0325-00752015000500004,BPS,o
159,S0325-00752015000500004,Bacterial,o
159,S0325-00752015000500004,Pneumonia,o
159,S0325-00752015000500004,Score,o
159,S0325-00752015000500004,demostro,o
159,S0325-00752015000500004,ser,o
159,S0325-00752015000500004,eficaz,o
159,S0325-00752015000500004,para,o
159,S0325-00752015000500004,identificar,o
159,S0325-00752015000500004,que,o
159,S0325-00752015000500004,niños,o
159,S0325-00752015000500004,con,o
159,S0325-00752015000500004,neumonia,i
159,S0325-00752015000500004,requerian,o
159,S0325-00752015000500004,antibioticos,i
159,S0325-00752015000500004,pero,o
159,S0325-00752015000500004,su,o
159,S0325-00752015000500004,desempeño,o
159,S0325-00752015000500004,no,o
159,S0325-00752015000500004,ha,o
159,S0325-00752015000500004,sido,o
159,S0325-00752015000500004,evaluado,o
159,S0325-00752015000500004,en,o
159,S0325-00752015000500004,la,o
159,S0325-00752015000500004,poblacion,o
159,S0325-00752015000500004,vacunada,i
159,S0325-00752015000500004,contra,i
159,S0325-00752015000500004,neumococo,i
159,S0325-00752015000500004,El,o
159,S0325-00752015000500004,objetivo,o
159,S0325-00752015000500004,fue,o
159,S0325-00752015000500004,evaluar,o
159,S0325-00752015000500004,si,o
159,S0325-00752015000500004,el,o
159,S0325-00752015000500004,empleo,o
159,S0325-00752015000500004,del,o
159,S0325-00752015000500004,BPS,o
159,S0325-00752015000500004,permitia,o
159,S0325-00752015000500004,un,o
159,S0325-00752015000500004,menor,o
159,S0325-00752015000500004,uso,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,antibioticos,i
159,S0325-00752015000500004,comparado,o
159,S0325-00752015000500004,con,o
159,S0325-00752015000500004,el,o
159,S0325-00752015000500004,manejo,o
159,S0325-00752015000500004,habitual,o
159,S0325-00752015000500004,en,o
159,S0325-00752015000500004,niños,o
159,S0325-00752015000500004,con,o
159,S0325-00752015000500004,neumonia,i
159,S0325-00752015000500004,adquirida,i
159,S0325-00752015000500004,en,i
159,S0325-00752015000500004,la,i
159,S0325-00752015000500004,comunidad,i
159,S0325-00752015000500004,que,o
159,S0325-00752015000500004,recibieron,o
159,S0325-00752015000500004,vacunacion,i
159,S0325-00752015000500004,antineumococcica,i
159,S0325-00752015000500004,Material,o
159,S0325-00752015000500004,y,o
159,S0325-00752015000500004,metodo,o
159,S0325-00752015000500004,Ensayo,o
159,S0325-00752015000500004,clinico,o
159,S0325-00752015000500004,controlado,o
159,S0325-00752015000500004,aleatorizado,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,grupos,o
159,S0325-00752015000500004,paralelos,o
159,S0325-00752015000500004,con,o
159,S0325-00752015000500004,enmascaramiento,o
159,S0325-00752015000500004,parcial,o
159,S0325-00752015000500004,que,o
159,S0325-00752015000500004,compara,o
159,S0325-00752015000500004,dos,o
159,S0325-00752015000500004,metodos,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,manejo,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,niños,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,360,o
159,S0325-00752015000500004,meses,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,edad,o
159,S0325-00752015000500004,asistidos,i
159,S0325-00752015000500004,ambulatoriamente,i
159,S0325-00752015000500004,por,o
159,S0325-00752015000500004,neumonia,i
159,S0325-00752015000500004,que,o
159,S0325-00752015000500004,hubieran,o
159,S0325-00752015000500004,recibido,o
159,S0325-00752015000500004,vacuna,i
159,S0325-00752015000500004,antineumococcica,i
159,S0325-00752015000500004,conjugada,i
159,S0325-00752015000500004,El,o
159,S0325-00752015000500004,Grupo,o
159,S0325-00752015000500004,BPS,o
159,S0325-00752015000500004,recibio,o
159,S0325-00752015000500004,antibioticos,i
159,S0325-00752015000500004,con,o
159,S0325-00752015000500004,BPS,o
159,S0325-00752015000500004,4,o
159,S0325-00752015000500004,puntos,o
159,S0325-00752015000500004,el,o
159,S0325-00752015000500004,grupo,o
159,S0325-00752015000500004,control,o
159,S0325-00752015000500004,recibio,o
159,S0325-00752015000500004,antibioticos,i
159,S0325-00752015000500004,segun,o
159,S0325-00752015000500004,criterio,o
159,S0325-00752015000500004,del,o
159,S0325-00752015000500004,medico,o
159,S0325-00752015000500004,tratante,o
159,S0325-00752015000500004,El,o
159,S0325-00752015000500004,tamaño,o
159,S0325-00752015000500004,muestral,o
159,S0325-00752015000500004,calculado,o
159,S0325-00752015000500004,contemplo,o
159,S0325-00752015000500004,al,o
159,S0325-00752015000500004,menos,o
159,S0325-00752015000500004,30,o
159,S0325-00752015000500004,pacientes,o
159,S0325-00752015000500004,por,o
159,S0325-00752015000500004,grupo,o
159,S0325-00752015000500004,Se,o
159,S0325-00752015000500004,comparo,o
159,S0325-00752015000500004,la,o
159,S0325-00752015000500004,proporcion,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,uso,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,antibioticos,i
159,S0325-00752015000500004,y,o
159,S0325-00752015000500004,la,o
159,S0325-00752015000500004,evolucion,o
159,S0325-00752015000500004,clinica,o
159,S0325-00752015000500004,en,o
159,S0325-00752015000500004,ambos,o
159,S0325-00752015000500004,grupos,o
159,S0325-00752015000500004,Resultados,o
159,S0325-00752015000500004,Se,o
159,S0325-00752015000500004,incluyeron,o
159,S0325-00752015000500004,65,o
159,S0325-00752015000500004,pacientes,o
159,S0325-00752015000500004,33,o
159,S0325-00752015000500004,en,o
159,S0325-00752015000500004,el,o
159,S0325-00752015000500004,grupo,o
159,S0325-00752015000500004,BPS,o
159,S0325-00752015000500004,y,o
159,S0325-00752015000500004,32,o
159,S0325-00752015000500004,en,o
159,S0325-00752015000500004,el,o
159,S0325-00752015000500004,grupo,o
159,S0325-00752015000500004,control,o
159,S0325-00752015000500004,con,o
159,S0325-00752015000500004,edad,o
159,S0325-00752015000500004,promedio,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,175,o
159,S0325-00752015000500004,meses,o
159,S0325-00752015000500004,El,o
159,S0325-00752015000500004,empleo,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,antibioticos,i
159,S0325-00752015000500004,fue,o
159,S0325-00752015000500004,significativamente,o
159,S0325-00752015000500004,mayor,o
159,S0325-00752015000500004,en,o
159,S0325-00752015000500004,el,o
159,S0325-00752015000500004,grupo,o
159,S0325-00752015000500004,control,o
159,S0325-00752015000500004,que,o
159,S0325-00752015000500004,en,o
159,S0325-00752015000500004,el,o
159,S0325-00752015000500004,grupo,o
159,S0325-00752015000500004,BPS,o
159,S0325-00752015000500004,2132,o
159,S0325-00752015000500004,vs,o
159,S0325-00752015000500004,933,o
159,S0325-00752015000500004,OR,o
159,S0325-00752015000500004,509,o
159,S0325-00752015000500004,IC,o
159,S0325-00752015000500004,95,o
159,S0325-00752015000500004,1571685,o
159,S0325-00752015000500004,p,o
159,S0325-00752015000500004,0001,o
159,S0325-00752015000500004,Se,o
159,S0325-00752015000500004,observo,o
159,S0325-00752015000500004,una,o
159,S0325-00752015000500004,mala,o
159,S0325-00752015000500004,evolucion,o
159,S0325-00752015000500004,en,o
159,S0325-00752015000500004,7,o
159,S0325-00752015000500004,pacientes,o
159,S0325-00752015000500004,3,o
159,S0325-00752015000500004,del,o
159,S0325-00752015000500004,grupo,o
159,S0325-00752015000500004,BPS,o
159,S0325-00752015000500004,y,o
159,S0325-00752015000500004,4,o
159,S0325-00752015000500004,del,o
159,S0325-00752015000500004,grupo,o
159,S0325-00752015000500004,control,o
159,S0325-00752015000500004,Conclusion,o
159,S0325-00752015000500004,El,o
159,S0325-00752015000500004,empleo,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,BPS,o
159,S0325-00752015000500004,permitio,o
159,S0325-00752015000500004,un,o
159,S0325-00752015000500004,menor,o
159,S0325-00752015000500004,uso,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,antibioticos,i
159,S0325-00752015000500004,para,o
159,S0325-00752015000500004,el,o
159,S0325-00752015000500004,manejo,o
159,S0325-00752015000500004,inicial,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,pacientes,o
159,S0325-00752015000500004,con,o
159,S0325-00752015000500004,neumonia,i
159,S0325-00752015000500004,vacunados,i
159,S0325-00752015000500004,contra,i
159,S0325-00752015000500004,neumococo,i
159,S0325-00752015000500004,sin,o
159,S0325-00752015000500004,aumentar,o
159,S0325-00752015000500004,el,o
159,S0325-00752015000500004,riesgo,o
159,S0325-00752015000500004,de,o
159,S0325-00752015000500004,mala,o
159,S0325-00752015000500004,evolucion,o
160,S0325-00752018000200003,Las,o
160,S0325-00752018000200003,infecciones,i
160,S0325-00752018000200003,asociadas,i
160,S0325-00752018000200003,a,i
160,S0325-00752018000200003,cateteres,i
160,S0325-00752018000200003,IAC,i
160,S0325-00752018000200003,conllevan,o
160,S0325-00752018000200003,elevada,o
160,S0325-00752018000200003,morbimortalidad,o
160,S0325-00752018000200003,con,o
160,S0325-00752018000200003,el,o
160,S0325-00752018000200003,aumento,o
160,S0325-00752018000200003,del,o
160,S0325-00752018000200003,uso,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,recursos,o
160,S0325-00752018000200003,hospitalarios,o
160,S0325-00752018000200003,Objetivo,o
160,S0325-00752018000200003,Describir,o
160,S0325-00752018000200003,los,o
160,S0325-00752018000200003,resultados,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,un,o
160,S0325-00752018000200003,programa,o
160,S0325-00752018000200003,para,o
160,S0325-00752018000200003,disminuir,o
160,S0325-00752018000200003,la,o
160,S0325-00752018000200003,tasa,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,IAC,i
160,S0325-00752018000200003,en,o
160,S0325-00752018000200003,las,o
160,S0325-00752018000200003,unidades,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,cuidados,o
160,S0325-00752018000200003,intensivos,o
160,S0325-00752018000200003,pediatricos,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,Argentina,o
160,S0325-00752018000200003,Poblacion,o
160,S0325-00752018000200003,y,o
160,S0325-00752018000200003,metodos,o
160,S0325-00752018000200003,Estudio,o
160,S0325-00752018000200003,colaborativo,o
160,S0325-00752018000200003,multicentrico,o
160,S0325-00752018000200003,clinicoepidemiologico,o
160,S0325-00752018000200003,cuasi,o
160,S0325-00752018000200003,experimental,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,intervencion,o
160,S0325-00752018000200003,antes,o
160,S0325-00752018000200003,y,o
160,S0325-00752018000200003,despues,o
160,S0325-00752018000200003,Se,o
160,S0325-00752018000200003,incluyen,o
160,S0325-00752018000200003,niños,o
160,S0325-00752018000200003,con,o
160,S0325-00752018000200003,cateter,o
160,S0325-00752018000200003,venoso,i
160,S0325-00752018000200003,central,o
160,S0325-00752018000200003,internados,i
160,S0325-00752018000200003,en,o
160,S0325-00752018000200003,9,o
160,S0325-00752018000200003,unidades,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,cuidados,o
160,S0325-00752018000200003,intensivos,o
160,S0325-00752018000200003,pediatricos,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,la,o
160,S0325-00752018000200003,Ciudad,o
160,S0325-00752018000200003,Autonoma,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,Buenos,o
160,S0325-00752018000200003,Aires,o
160,S0325-00752018000200003,conurbano,o
160,S0325-00752018000200003,y,o
160,S0325-00752018000200003,otras,o
160,S0325-00752018000200003,provincias,o
160,S0325-00752018000200003,desde,o
160,S0325-00752018000200003,junio,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,2011,o
160,S0325-00752018000200003,a,o
160,S0325-00752018000200003,abril,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,2012,o
160,S0325-00752018000200003,Se,o
160,S0325-00752018000200003,implemento,o
160,S0325-00752018000200003,un,o
160,S0325-00752018000200003,paquete,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,medidas,o
160,S0325-00752018000200003,basado,o
160,S0325-00752018000200003,en,o
160,S0325-00752018000200003,la,o
160,S0325-00752018000200003,educacion,i
160,S0325-00752018000200003,del,i
160,S0325-00752018000200003,personal,i
160,S0325-00752018000200003,de,i
160,S0325-00752018000200003,salud,i
160,S0325-00752018000200003,para,o
160,S0325-00752018000200003,insercion,i
160,S0325-00752018000200003,de,i
160,S0325-00752018000200003,cateteres,i
160,S0325-00752018000200003,e,o
160,S0325-00752018000200003,higiene,i
160,S0325-00752018000200003,de,i
160,S0325-00752018000200003,manos,i
160,S0325-00752018000200003,y,o
160,S0325-00752018000200003,uso,i
160,S0325-00752018000200003,de,i
160,S0325-00752018000200003,listas,i
160,S0325-00752018000200003,de,i
160,S0325-00752018000200003,verificacion,i
160,S0325-00752018000200003,con,o
160,S0325-00752018000200003,monitoreo,i
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,las,o
160,S0325-00752018000200003,medidas,o
160,S0325-00752018000200003,implementadas,o
160,S0325-00752018000200003,Se,o
160,S0325-00752018000200003,compararon,o
160,S0325-00752018000200003,el,o
160,S0325-00752018000200003,numero,o
160,S0325-00752018000200003,y,o
160,S0325-00752018000200003,la,o
160,S0325-00752018000200003,tasa,o
160,S0325-00752018000200003,anual,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,IAC,i
160,S0325-00752018000200003,y,o
160,S0325-00752018000200003,la,o
160,S0325-00752018000200003,tasa,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,uso,i
160,S0325-00752018000200003,de,i
160,S0325-00752018000200003,cateter,i
160,S0325-00752018000200003,venoso,i
160,S0325-00752018000200003,central,i
160,S0325-00752018000200003,previa,o
160,S0325-00752018000200003,y,o
160,S0325-00752018000200003,posterior,o
160,S0325-00752018000200003,a,o
160,S0325-00752018000200003,la,o
160,S0325-00752018000200003,implementacion,i
160,S0325-00752018000200003,del,i
160,S0325-00752018000200003,programa,i
160,S0325-00752018000200003,Stata,o
160,S0325-00752018000200003,80,o
160,S0325-00752018000200003,Resultados,o
160,S0325-00752018000200003,El,o
160,S0325-00752018000200003,total,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,IAC,i
160,S0325-00752018000200003,preintervencion,o
160,S0325-00752018000200003,fue,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,117,o
160,S0325-00752018000200003,vs,o
160,S0325-00752018000200003,74,o
160,S0325-00752018000200003,en,o
160,S0325-00752018000200003,el,o
160,S0325-00752018000200003,pos,o
160,S0325-00752018000200003,La,o
160,S0325-00752018000200003,tasa,o
160,S0325-00752018000200003,previa,o
160,S0325-00752018000200003,fue,o
160,S0325-00752018000200003,861000,o
160,S0325-00752018000200003,dias,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,uso,o
160,S0325-00752018000200003,y,o
160,S0325-00752018000200003,la,o
160,S0325-00752018000200003,posintervencion,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,581000,o
160,S0325-00752018000200003,dias,o
160,S0325-00752018000200003,RR,o
160,S0325-00752018000200003,082,o
160,S0325-00752018000200003,IC,o
160,S0325-00752018000200003,95,o
160,S0325-00752018000200003,068098,o
160,S0325-00752018000200003,p,o
160,S0325-00752018000200003,0015,o
160,S0325-00752018000200003,La,o
160,S0325-00752018000200003,tasa,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,uso,i
160,S0325-00752018000200003,de,i
160,S0325-00752018000200003,cateter,i
160,S0325-00752018000200003,venoso,i
160,S0325-00752018000200003,central,i
160,S0325-00752018000200003,se,o
160,S0325-00752018000200003,redujo,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,54,o
160,S0325-00752018000200003,a,o
160,S0325-00752018000200003,49,o
160,S0325-00752018000200003,diferencia,o
160,S0325-00752018000200003,no,o
160,S0325-00752018000200003,significativa,o
160,S0325-00752018000200003,Conclusiones,o
160,S0325-00752018000200003,El,o
160,S0325-00752018000200003,programa,o
160,S0325-00752018000200003,logro,o
160,S0325-00752018000200003,un,o
160,S0325-00752018000200003,descenso,o
160,S0325-00752018000200003,significativo,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,las,o
160,S0325-00752018000200003,tasas,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,IAC,i
160,S0325-00752018000200003,A,o
160,S0325-00752018000200003,partir,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,el,o
160,S0325-00752018000200003,se,o
160,S0325-00752018000200003,implemento,o
160,S0325-00752018000200003,la,o
160,S0325-00752018000200003,vigilancia,i
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,las,o
160,S0325-00752018000200003,IAC,i
160,S0325-00752018000200003,en,o
160,S0325-00752018000200003,todas,o
160,S0325-00752018000200003,las,o
160,S0325-00752018000200003,unidades,o
160,S0325-00752018000200003,de,o
160,S0325-00752018000200003,cuidados,o
160,S0325-00752018000200003,intensivos,o
160,S0325-00752018000200003,pediatricos,o
160,S0325-00752018000200003,participantes,o
160,S0325-00752018000200003,La,o
160,S0325-00752018000200003,educacion,i
160,S0325-00752018000200003,y,o
160,S0325-00752018000200003,la,o
160,S0325-00752018000200003,vigilancia,i
160,S0325-00752018000200003,continua,i
160,S0325-00752018000200003,son,o
160,S0325-00752018000200003,necesarias,o
160,S0325-00752018000200003,para,o
160,S0325-00752018000200003,mantener,o
160,S0325-00752018000200003,y,o
160,S0325-00752018000200003,mejorar,o
160,S0325-00752018000200003,los,o
160,S0325-00752018000200003,resultados,o
160,S0325-00752018000200003,alcanzados,o
161,S0325-00752018000500004,Caracteristicas,o
161,S0325-00752018000500004,posoperatorias,o
161,S0325-00752018000500004,de,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,faringoplastia,i
161,S0325-00752018000500004,combinada,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,amigdalectomia,i
161,S0325-00752018000500004,en,o
161,S0325-00752018000500004,comparacion,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,amigdalectomia,i
161,S0325-00752018000500004,en,o
161,S0325-00752018000500004,niños,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,sindrome,i
161,S0325-00752018000500004,obstructivo,i
161,S0325-00752018000500004,de,i
161,S0325-00752018000500004,apnea,i
161,S0325-00752018000500004,del,i
161,S0325-00752018000500004,sueño,i
161,S0325-00752018000500004,Objetivo,o
161,S0325-00752018000500004,Identificar,o
161,S0325-00752018000500004,las,o
161,S0325-00752018000500004,ventajas,o
161,S0325-00752018000500004,posoperatorias,o
161,S0325-00752018000500004,de,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,amigdalectomia,i
161,S0325-00752018000500004,en,o
161,S0325-00752018000500004,conjunto,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,faringoplastia,i
161,S0325-00752018000500004,en,o
161,S0325-00752018000500004,comparacion,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,amigdalectomia,i
161,S0325-00752018000500004,sola,o
161,S0325-00752018000500004,en,o
161,S0325-00752018000500004,niños,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,apnea,i
161,S0325-00752018000500004,obstructiva,i
161,S0325-00752018000500004,del,i
161,S0325-00752018000500004,sueño,i
161,S0325-00752018000500004,Metodos,o
161,S0325-00752018000500004,En,o
161,S0325-00752018000500004,un,o
161,S0325-00752018000500004,estudio,i
161,S0325-00752018000500004,prospectivo,i
161,S0325-00752018000500004,observacional,i
161,S0325-00752018000500004,los,o
161,S0325-00752018000500004,pacientes,o
161,S0325-00752018000500004,que,o
161,S0325-00752018000500004,cumplian,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,los,o
161,S0325-00752018000500004,criterios,o
161,S0325-00752018000500004,del,o
161,S0325-00752018000500004,estudio,o
161,S0325-00752018000500004,fueron,o
161,S0325-00752018000500004,asignados,i
161,S0325-00752018000500004,aleatoriamente,i
161,S0325-00752018000500004,a,o
161,S0325-00752018000500004,dos,o
161,S0325-00752018000500004,grupos,o
161,S0325-00752018000500004,el,o
161,S0325-00752018000500004,grupo,o
161,S0325-00752018000500004,de,o
161,S0325-00752018000500004,amigdalectomia,i
161,S0325-00752018000500004,y,o
161,S0325-00752018000500004,faringoplastia,i
161,S0325-00752018000500004,y,o
161,S0325-00752018000500004,el,o
161,S0325-00752018000500004,grupo,o
161,S0325-00752018000500004,de,o
161,S0325-00752018000500004,solo,o
161,S0325-00752018000500004,amigdalectomia,i
161,S0325-00752018000500004,En,o
161,S0325-00752018000500004,ambos,o
161,S0325-00752018000500004,grupos,o
161,S0325-00752018000500004,tambien,o
161,S0325-00752018000500004,se,o
161,S0325-00752018000500004,practico,o
161,S0325-00752018000500004,adenoidectomia,i
161,S0325-00752018000500004,a,o
161,S0325-00752018000500004,los,o
161,S0325-00752018000500004,pacientes,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,vegetaciones,i
161,S0325-00752018000500004,Se,o
161,S0325-00752018000500004,compararon,o
161,S0325-00752018000500004,los,o
161,S0325-00752018000500004,procesos,o
161,S0325-00752018000500004,de,o
161,S0325-00752018000500004,cicatrizacion,o
161,S0325-00752018000500004,en,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,herida,i
161,S0325-00752018000500004,faringea,i
161,S0325-00752018000500004,y,o
161,S0325-00752018000500004,las,o
161,S0325-00752018000500004,proporciones,o
161,S0325-00752018000500004,hemorragicas,i
161,S0325-00752018000500004,Ademas,o
161,S0325-00752018000500004,se,o
161,S0325-00752018000500004,evaluo,i
161,S0325-00752018000500004,la,i
161,S0325-00752018000500004,funcion,i
161,S0325-00752018000500004,velofaringea,i
161,S0325-00752018000500004,posoperatoria,o
161,S0325-00752018000500004,Resultados,o
161,S0325-00752018000500004,La,o
161,S0325-00752018000500004,faringoplastia,i
161,S0325-00752018000500004,junto,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,amigdalectomia,i
161,S0325-00752018000500004,se,o
161,S0325-00752018000500004,practico,o
161,S0325-00752018000500004,en,o
161,S0325-00752018000500004,328,o
161,S0325-00752018000500004,niños,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,apnea,i
161,S0325-00752018000500004,obstructiva,i
161,S0325-00752018000500004,del,i
161,S0325-00752018000500004,sueño,i
161,S0325-00752018000500004,debido,o
161,S0325-00752018000500004,a,o
161,S0325-00752018000500004,hipertrofia,i
161,S0325-00752018000500004,amigdalina,i
161,S0325-00752018000500004,y,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,amigdalectomia,i
161,S0325-00752018000500004,sola,o
161,S0325-00752018000500004,en,o
161,S0325-00752018000500004,275,o
161,S0325-00752018000500004,niños,o
161,S0325-00752018000500004,Estas,o
161,S0325-00752018000500004,cohortes,o
161,S0325-00752018000500004,no,o
161,S0325-00752018000500004,mostraban,o
161,S0325-00752018000500004,diferencias,o
161,S0325-00752018000500004,demograficas,o
161,S0325-00752018000500004,significativas,o
161,S0325-00752018000500004,Por,o
161,S0325-00752018000500004,otro,o
161,S0325-00752018000500004,lado,o
161,S0325-00752018000500004,se,o
161,S0325-00752018000500004,encontro,o
161,S0325-00752018000500004,que,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,perdida,i
161,S0325-00752018000500004,de,i
161,S0325-00752018000500004,sangre,i
161,S0325-00752018000500004,fue,o
161,S0325-00752018000500004,significativamente,o
161,S0325-00752018000500004,menor,o
161,S0325-00752018000500004,en,o
161,S0325-00752018000500004,el,o
161,S0325-00752018000500004,grupo,o
161,S0325-00752018000500004,que,o
161,S0325-00752018000500004,recibio,o
161,S0325-00752018000500004,amigdalectomia,i
161,S0325-00752018000500004,y,o
161,S0325-00752018000500004,faringoplastia,i
161,S0325-00752018000500004,p,o
161,S0325-00752018000500004,001,o
161,S0325-00752018000500004,y,o
161,S0325-00752018000500004,el,o
161,S0325-00752018000500004,proceso,o
161,S0325-00752018000500004,de,o
161,S0325-00752018000500004,cicatrizacion,o
161,S0325-00752018000500004,fue,o
161,S0325-00752018000500004,notablemente,o
161,S0325-00752018000500004,mas,o
161,S0325-00752018000500004,breve,o
161,S0325-00752018000500004,La,o
161,S0325-00752018000500004,funcion,o
161,S0325-00752018000500004,velofaringea,o
161,S0325-00752018000500004,posoperatoria,o
161,S0325-00752018000500004,no,o
161,S0325-00752018000500004,resulto,o
161,S0325-00752018000500004,afectada,o
161,S0325-00752018000500004,Conclusiones,o
161,S0325-00752018000500004,En,o
161,S0325-00752018000500004,comparacion,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,amigdalectomia,i
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,amigdalectomia,i
161,S0325-00752018000500004,junto,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,faringoplastia,i
161,S0325-00752018000500004,redujeron,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,duracion,o
161,S0325-00752018000500004,del,o
161,S0325-00752018000500004,proceso,o
161,S0325-00752018000500004,de,o
161,S0325-00752018000500004,cicatrizacion,o
161,S0325-00752018000500004,y,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,perdida,i
161,S0325-00752018000500004,de,i
161,S0325-00752018000500004,sangre,i
161,S0325-00752018000500004,no,o
161,S0325-00752018000500004,obstante,o
161,S0325-00752018000500004,las,o
161,S0325-00752018000500004,complicaciones,i
161,S0325-00752018000500004,posoperatorias,i
161,S0325-00752018000500004,no,o
161,S0325-00752018000500004,aumentaron,o
161,S0325-00752018000500004,En,o
161,S0325-00752018000500004,nuestra,o
161,S0325-00752018000500004,opinion,o
161,S0325-00752018000500004,la,o
161,S0325-00752018000500004,combinacion,o
161,S0325-00752018000500004,de,o
161,S0325-00752018000500004,faringoplastia,i
161,S0325-00752018000500004,y,o
161,S0325-00752018000500004,amigdalectomia,i
161,S0325-00752018000500004,reune,o
161,S0325-00752018000500004,un,o
161,S0325-00752018000500004,gran,o
161,S0325-00752018000500004,potencial,o
161,S0325-00752018000500004,en,o
161,S0325-00752018000500004,el,o
161,S0325-00752018000500004,tratamiento,i
161,S0325-00752018000500004,de,o
161,S0325-00752018000500004,los,o
161,S0325-00752018000500004,niños,o
161,S0325-00752018000500004,con,o
161,S0325-00752018000500004,apnea,i
161,S0325-00752018000500004,obstructiva,i
161,S0325-00752018000500004,del,i
161,S0325-00752018000500004,sueño,i
162,S0365-66912003000500004,Anestesia,i
162,S0365-66912003000500004,topica,i
162,S0365-66912003000500004,versus,o
162,S0365-66912003000500004,anestesia,i
162,S0365-66912003000500004,de,i
162,S0365-66912003000500004,contacto,i
162,S0365-66912003000500004,en,o
162,S0365-66912003000500004,la,o
162,S0365-66912003000500004,trabeculectomia,i
162,S0365-66912003000500004,convencional,o
162,S0365-66912003000500004,Estudio,i
162,S0365-66912003000500004,prospectivo,i
162,S0365-66912003000500004,aleatorizado,i
162,S0365-66912003000500004,Objetivo,o
162,S0365-66912003000500004,Comparar,o
162,S0365-66912003000500004,los,o
162,S0365-66912003000500004,niveles,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,anestesia,i
162,S0365-66912003000500004,confort,o
162,S0365-66912003000500004,y,o
162,S0365-66912003000500004,seguridad,o
162,S0365-66912003000500004,para,o
162,S0365-66912003000500004,el,o
162,S0365-66912003000500004,paciente,o
162,S0365-66912003000500004,entre,o
162,S0365-66912003000500004,la,o
162,S0365-66912003000500004,anestesia,i
162,S0365-66912003000500004,topica,i
162,S0365-66912003000500004,simple,o
162,S0365-66912003000500004,y,o
162,S0365-66912003000500004,la,o
162,S0365-66912003000500004,aplicacion,o
162,S0365-66912003000500004,del,o
162,S0365-66912003000500004,mismo,o
162,S0365-66912003000500004,agente,i
162,S0365-66912003000500004,anestesico,i
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,forma,o
162,S0365-66912003000500004,prolongada,o
162,S0365-66912003000500004,utilizando,o
162,S0365-66912003000500004,un,o
162,S0365-66912003000500004,vehiculo,i
162,S0365-66912003000500004,poroso,o
162,S0365-66912003000500004,o,o
162,S0365-66912003000500004,anestesia,i
162,S0365-66912003000500004,de,i
162,S0365-66912003000500004,contacto,i
162,S0365-66912003000500004,Metodos,o
162,S0365-66912003000500004,Se,o
162,S0365-66912003000500004,incluyeron,o
162,S0365-66912003000500004,un,o
162,S0365-66912003000500004,total,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,50,o
162,S0365-66912003000500004,pacientes,o
162,S0365-66912003000500004,programados,o
162,S0365-66912003000500004,para,o
162,S0365-66912003000500004,trabeculectomia,i
162,S0365-66912003000500004,simple,o
162,S0365-66912003000500004,con,o
162,S0365-66912003000500004,o,o
162,S0365-66912003000500004,sin,o
162,S0365-66912003000500004,antimitoticos,i
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,forma,o
162,S0365-66912003000500004,consecutiva,o
162,S0365-66912003000500004,La,o
162,S0365-66912003000500004,mitad,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,ellos,o
162,S0365-66912003000500004,se,o
162,S0365-66912003000500004,asignaron,o
162,S0365-66912003000500004,de,i
162,S0365-66912003000500004,forma,i
162,S0365-66912003000500004,aleatoria,i
162,S0365-66912003000500004,al,o
162,S0365-66912003000500004,grupo,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,anestesia,i
162,S0365-66912003000500004,topica,i
162,S0365-66912003000500004,y,o
162,S0365-66912003000500004,la,o
162,S0365-66912003000500004,otra,o
162,S0365-66912003000500004,mitad,o
162,S0365-66912003000500004,al,o
162,S0365-66912003000500004,grupo,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,anestesia,i
162,S0365-66912003000500004,de,i
162,S0365-66912003000500004,contacto,i
162,S0365-66912003000500004,Se,o
162,S0365-66912003000500004,valoraron,i
162,S0365-66912003000500004,el,i
162,S0365-66912003000500004,nivel,i
162,S0365-66912003000500004,de,i
162,S0365-66912003000500004,dolor,i
162,S0365-66912003000500004,o,i
162,S0365-66912003000500004,molestia,i
162,S0365-66912003000500004,en,o
162,S0365-66912003000500004,los,o
162,S0365-66912003000500004,diferentes,o
162,S0365-66912003000500004,momentos,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,la,o
162,S0365-66912003000500004,cirugia,i
162,S0365-66912003000500004,con,o
162,S0365-66912003000500004,una,o
162,S0365-66912003000500004,escala,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,0,o
162,S0365-66912003000500004,a,o
162,S0365-66912003000500004,5,o
162,S0365-66912003000500004,el,o
162,S0365-66912003000500004,nivel,i
162,S0365-66912003000500004,de,i
162,S0365-66912003000500004,stress,i
162,S0365-66912003000500004,del,o
162,S0365-66912003000500004,cirujano,o
162,S0365-66912003000500004,y,o
162,S0365-66912003000500004,las,o
162,S0365-66912003000500004,complicaciones,i
162,S0365-66912003000500004,Resultados,o
162,S0365-66912003000500004,Se,o
162,S0365-66912003000500004,encontraron,o
162,S0365-66912003000500004,diferencias,o
162,S0365-66912003000500004,significativas,o
162,S0365-66912003000500004,entre,o
162,S0365-66912003000500004,ambos,o
162,S0365-66912003000500004,grupos,o
162,S0365-66912003000500004,relativas,o
162,S0365-66912003000500004,al,o
162,S0365-66912003000500004,nivel,i
162,S0365-66912003000500004,de,i
162,S0365-66912003000500004,dolor,i
162,S0365-66912003000500004,durante,o
162,S0365-66912003000500004,y,o
162,S0365-66912003000500004,tras,o
162,S0365-66912003000500004,la,o
162,S0365-66912003000500004,cirugia,i
162,S0365-66912003000500004,y,o
162,S0365-66912003000500004,al,o
162,S0365-66912003000500004,nivel,i
162,S0365-66912003000500004,de,i
162,S0365-66912003000500004,stress,i
162,S0365-66912003000500004,del,o
162,S0365-66912003000500004,cirujano,o
162,S0365-66912003000500004,La,o
162,S0365-66912003000500004,necesidad,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,sedacion,i
162,S0365-66912003000500004,y,o
162,S0365-66912003000500004,reconversion,o
162,S0365-66912003000500004,anestesica,o
162,S0365-66912003000500004,fue,o
162,S0365-66912003000500004,mayor,o
162,S0365-66912003000500004,en,o
162,S0365-66912003000500004,el,o
162,S0365-66912003000500004,grupo,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,anestesia,i
162,S0365-66912003000500004,topica,i
162,S0365-66912003000500004,simple,o
162,S0365-66912003000500004,Conclusiones,o
162,S0365-66912003000500004,La,o
162,S0365-66912003000500004,anestesia,i
162,S0365-66912003000500004,topica,i
162,S0365-66912003000500004,presenta,o
162,S0365-66912003000500004,unos,o
162,S0365-66912003000500004,aceptables,o
162,S0365-66912003000500004,niveles,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,anestesia,i
162,S0365-66912003000500004,en,o
162,S0365-66912003000500004,la,o
162,S0365-66912003000500004,trabeculectomia,i
162,S0365-66912003000500004,a,o
162,S0365-66912003000500004,pesar,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,ello,o
162,S0365-66912003000500004,las,o
162,S0365-66912003000500004,diferencias,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,niveles,i
162,S0365-66912003000500004,de,i
162,S0365-66912003000500004,dolor,i
162,S0365-66912003000500004,entre,o
162,S0365-66912003000500004,la,o
162,S0365-66912003000500004,anestesia,i
162,S0365-66912003000500004,topica,i
162,S0365-66912003000500004,simple,o
162,S0365-66912003000500004,y,o
162,S0365-66912003000500004,la,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,contacto,o
162,S0365-66912003000500004,son,o
162,S0365-66912003000500004,evidentes,o
162,S0365-66912003000500004,tanto,o
162,S0365-66912003000500004,en,o
162,S0365-66912003000500004,el,o
162,S0365-66912003000500004,momento,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,la,o
162,S0365-66912003000500004,cirugia,i
162,S0365-66912003000500004,como,o
162,S0365-66912003000500004,tras,o
162,S0365-66912003000500004,la,o
162,S0365-66912003000500004,misma,o
162,S0365-66912003000500004,siendo,o
162,S0365-66912003000500004,la,o
162,S0365-66912003000500004,anestesia,i
162,S0365-66912003000500004,de,i
162,S0365-66912003000500004,contacto,i
162,S0365-66912003000500004,una,o
162,S0365-66912003000500004,alternativa,o
162,S0365-66912003000500004,valida,o
162,S0365-66912003000500004,y,o
162,S0365-66912003000500004,aplicable,o
162,S0365-66912003000500004,en,o
162,S0365-66912003000500004,una,o
162,S0365-66912003000500004,amplio,o
162,S0365-66912003000500004,rango,o
162,S0365-66912003000500004,de,o
162,S0365-66912003000500004,pacientes,o
162,S0365-66912003000500004,sometidos,o
162,S0365-66912003000500004,a,o
162,S0365-66912003000500004,cirugia,i
162,S0365-66912003000500004,de,i
162,S0365-66912003000500004,glaucoma,i
163,S0365-66912003001200006,Estudio,i
163,S0365-66912003001200006,clinico,i
163,S0365-66912003001200006,comparativo,i
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,los,o
163,S0365-66912003001200006,resultados,o
163,S0365-66912003001200006,visuales,o
163,S0365-66912003001200006,en,o
163,S0365-66912003001200006,dos,o
163,S0365-66912003001200006,lentes,o
163,S0365-66912003001200006,intraoculares,o
163,S0365-66912003001200006,bifocales,o
163,S0365-66912003001200006,Introduccion,o
163,S0365-66912003001200006,Comparar,o
163,S0365-66912003001200006,los,o
163,S0365-66912003001200006,resultados,o
163,S0365-66912003001200006,visuales,o
163,S0365-66912003001200006,tras,o
163,S0365-66912003001200006,cirugia,i
163,S0365-66912003001200006,de,i
163,S0365-66912003001200006,cataratas,i
163,S0365-66912003001200006,con,o
163,S0365-66912003001200006,implante,o
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,dos,o
163,S0365-66912003001200006,tipos,o
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,lentes,o
163,S0365-66912003001200006,intraoculares,o
163,S0365-66912003001200006,LIO,o
163,S0365-66912003001200006,bifocales,o
163,S0365-66912003001200006,el,o
163,S0365-66912003001200006,modelo,o
163,S0365-66912003001200006,811E,o
163,S0365-66912003001200006,Pharmacia,o
163,S0365-66912003001200006,y,o
163,S0365-66912003001200006,el,o
163,S0365-66912003001200006,modelo,o
163,S0365-66912003001200006,MF4,o
163,S0365-66912003001200006,Ioltech,o
163,S0365-66912003001200006,Metodos,o
163,S0365-66912003001200006,Para,o
163,S0365-66912003001200006,ello,o
163,S0365-66912003001200006,realizamos,o
163,S0365-66912003001200006,un,o
163,S0365-66912003001200006,estudio,i
163,S0365-66912003001200006,prospectivo,i
163,S0365-66912003001200006,en,o
163,S0365-66912003001200006,99,o
163,S0365-66912003001200006,pacientes,o
163,S0365-66912003001200006,intervenidos,i
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,cataratas,i
163,S0365-66912003001200006,mediante,o
163,S0365-66912003001200006,facoemulsificacion,i
163,S0365-66912003001200006,con,o
163,S0365-66912003001200006,posterior,o
163,S0365-66912003001200006,implante,i
163,S0365-66912003001200006,de,i
163,S0365-66912003001200006,LIO,i
163,S0365-66912003001200006,bifocales,i
163,S0365-66912003001200006,En,o
163,S0365-66912003001200006,47,o
163,S0365-66912003001200006,pacientes,o
163,S0365-66912003001200006,se,o
163,S0365-66912003001200006,implanto,i
163,S0365-66912003001200006,el,o
163,S0365-66912003001200006,modelo,o
163,S0365-66912003001200006,811E,o
163,S0365-66912003001200006,y,o
163,S0365-66912003001200006,en,o
163,S0365-66912003001200006,52,o
163,S0365-66912003001200006,pacientes,o
163,S0365-66912003001200006,se,o
163,S0365-66912003001200006,implanto,i
163,S0365-66912003001200006,el,o
163,S0365-66912003001200006,modelo,o
163,S0365-66912003001200006,MF4,o
163,S0365-66912003001200006,Se,o
163,S0365-66912003001200006,valoraron,i
163,S0365-66912003001200006,agudezas,i
163,S0365-66912003001200006,visuales,i
163,S0365-66912003001200006,AV,i
163,S0365-66912003001200006,lejos,o
163,S0365-66912003001200006,y,o
163,S0365-66912003001200006,cerca,o
163,S0365-66912003001200006,y,o
163,S0365-66912003001200006,refraccion,i
163,S0365-66912003001200006,postoperatoria,o
163,S0365-66912003001200006,tras,o
163,S0365-66912003001200006,un,o
163,S0365-66912003001200006,periodo,o
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,seguimiento,i
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,6,o
163,S0365-66912003001200006,meses,o
163,S0365-66912003001200006,La,o
163,S0365-66912003001200006,satisfaccion,o
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,los,o
163,S0365-66912003001200006,pacientes,o
163,S0365-66912003001200006,se,o
163,S0365-66912003001200006,evaluo,o
163,S0365-66912003001200006,mediante,o
163,S0365-66912003001200006,un,o
163,S0365-66912003001200006,cuestionario,i
163,S0365-66912003001200006,Resultados,o
163,S0365-66912003001200006,No,o
163,S0365-66912003001200006,se,o
163,S0365-66912003001200006,observaron,o
163,S0365-66912003001200006,diferencias,o
163,S0365-66912003001200006,entre,o
163,S0365-66912003001200006,ambos,o
163,S0365-66912003001200006,tipos,o
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,lentes,o
163,S0365-66912003001200006,al,o
163,S0365-66912003001200006,valorar,i
163,S0365-66912003001200006,la,i
163,S0365-66912003001200006,AV,i
163,S0365-66912003001200006,para,o
163,S0365-66912003001200006,lejos,o
163,S0365-66912003001200006,sin,o
163,S0365-66912003001200006,correccion,o
163,S0365-66912003001200006,siendo,o
163,S0365-66912003001200006,063,o
163,S0365-66912003001200006,DE,o
163,S0365-66912003001200006,02,o
163,S0365-66912003001200006,para,o
163,S0365-66912003001200006,la,o
163,S0365-66912003001200006,811E,o
163,S0365-66912003001200006,y,o
163,S0365-66912003001200006,058,o
163,S0365-66912003001200006,DE,o
163,S0365-66912003001200006,016,o
163,S0365-66912003001200006,para,o
163,S0365-66912003001200006,la,o
163,S0365-66912003001200006,MF4,o
163,S0365-66912003001200006,p017,o
163,S0365-66912003001200006,Por,o
163,S0365-66912003001200006,el,o
163,S0365-66912003001200006,contrario,o
163,S0365-66912003001200006,se,o
163,S0365-66912003001200006,observaron,o
163,S0365-66912003001200006,diferencias,o
163,S0365-66912003001200006,significativas,o
163,S0365-66912003001200006,al,o
163,S0365-66912003001200006,valorar,i
163,S0365-66912003001200006,la,i
163,S0365-66912003001200006,AV,i
163,S0365-66912003001200006,media,o
163,S0365-66912003001200006,para,o
163,S0365-66912003001200006,lejos,o
163,S0365-66912003001200006,con,o
163,S0365-66912003001200006,correccion,o
163,S0365-66912003001200006,siendo,o
163,S0365-66912003001200006,086,o
163,S0365-66912003001200006,DE,o
163,S0365-66912003001200006,01,o
163,S0365-66912003001200006,para,o
163,S0365-66912003001200006,la,o
163,S0365-66912003001200006,811E,o
163,S0365-66912003001200006,y,o
163,S0365-66912003001200006,077,o
163,S0365-66912003001200006,DE,o
163,S0365-66912003001200006,012,o
163,S0365-66912003001200006,para,o
163,S0365-66912003001200006,la,o
163,S0365-66912003001200006,MF4,o
163,S0365-66912003001200006,p001,o
163,S0365-66912003001200006,y,o
163,S0365-66912003001200006,la,o
163,S0365-66912003001200006,AV,i
163,S0365-66912003001200006,media,o
163,S0365-66912003001200006,para,o
163,S0365-66912003001200006,cerca,o
163,S0365-66912003001200006,sin,o
163,S0365-66912003001200006,correccion,o
163,S0365-66912003001200006,siendo,o
163,S0365-66912003001200006,J200,o
163,S0365-66912003001200006,DE,o
163,S0365-66912003001200006,116,o
163,S0365-66912003001200006,para,o
163,S0365-66912003001200006,la,o
163,S0365-66912003001200006,811E,o
163,S0365-66912003001200006,y,o
163,S0365-66912003001200006,J248,o
163,S0365-66912003001200006,DE,o
163,S0365-66912003001200006,083,o
163,S0365-66912003001200006,para,o
163,S0365-66912003001200006,la,o
163,S0365-66912003001200006,MF4,o
163,S0365-66912003001200006,p0021,o
163,S0365-66912003001200006,El,o
163,S0365-66912003001200006,porcentaje,o
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,satisfaccion,o
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,los,o
163,S0365-66912003001200006,pacientes,o
163,S0365-66912003001200006,fue,o
163,S0365-66912003001200006,similar,o
163,S0365-66912003001200006,en,o
163,S0365-66912003001200006,ambos,o
163,S0365-66912003001200006,tipos,o
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,LIOs,o
163,S0365-66912003001200006,siendo,o
163,S0365-66912003001200006,respectivamente,o
163,S0365-66912003001200006,del,o
163,S0365-66912003001200006,78,o
163,S0365-66912003001200006,811E,o
163,S0365-66912003001200006,y,o
163,S0365-66912003001200006,del,o
163,S0365-66912003001200006,734,o
163,S0365-66912003001200006,MF4,o
163,S0365-66912003001200006,Conclusiones,o
163,S0365-66912003001200006,Nuestros,o
163,S0365-66912003001200006,resultados,o
163,S0365-66912003001200006,muestran,o
163,S0365-66912003001200006,una,o
163,S0365-66912003001200006,superioridad,o
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,las,o
163,S0365-66912003001200006,lentes,o
163,S0365-66912003001200006,difractivas,o
163,S0365-66912003001200006,bifocales,o
163,S0365-66912003001200006,sobre,o
163,S0365-66912003001200006,las,o
163,S0365-66912003001200006,lentes,o
163,S0365-66912003001200006,refractivas,o
163,S0365-66912003001200006,bifocales,o
163,S0365-66912003001200006,en,o
163,S0365-66912003001200006,la,o
163,S0365-66912003001200006,agudeza,i
163,S0365-66912003001200006,visual,i
163,S0365-66912003001200006,corregida,i
163,S0365-66912003001200006,para,o
163,S0365-66912003001200006,lejos,o
163,S0365-66912003001200006,y,o
163,S0365-66912003001200006,en,o
163,S0365-66912003001200006,la,o
163,S0365-66912003001200006,agudeza,i
163,S0365-66912003001200006,visual,i
163,S0365-66912003001200006,de,i
163,S0365-66912003001200006,cerca,i
163,S0365-66912003001200006,con,o
163,S0365-66912003001200006,la,o
163,S0365-66912003001200006,correccion,o
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,lejos,o
163,S0365-66912003001200006,Las,o
163,S0365-66912003001200006,complicaciones,i
163,S0365-66912003001200006,postoperatorias,i
163,S0365-66912003001200006,y,o
163,S0365-66912003001200006,el,o
163,S0365-66912003001200006,grado,o
163,S0365-66912003001200006,de,o
163,S0365-66912003001200006,satisfaccion,o
163,S0365-66912003001200006,fueron,o
163,S0365-66912003001200006,similares,o
163,S0365-66912003001200006,para,o
163,S0365-66912003001200006,ambos,o
163,S0365-66912003001200006,modelos,o
164,S0365-66912005000200004,Influencia,o
164,S0365-66912005000200004,de,o
164,S0365-66912005000200004,la,o
164,S0365-66912005000200004,aberracion,i
164,S0365-66912005000200004,esferica,i
164,S0365-66912005000200004,en,o
164,S0365-66912005000200004,la,o
164,S0365-66912005000200004,funcion,o
164,S0365-66912005000200004,visual,o
164,S0365-66912005000200004,tras,o
164,S0365-66912005000200004,cirugia,i
164,S0365-66912005000200004,de,i
164,S0365-66912005000200004,catarata,i
164,S0365-66912005000200004,ensayo,i
164,S0365-66912005000200004,prospectivo,i
164,S0365-66912005000200004,aleatorio,i
164,S0365-66912005000200004,Proposito,o
164,S0365-66912005000200004,Comparar,o
164,S0365-66912005000200004,los,o
164,S0365-66912005000200004,resultados,o
164,S0365-66912005000200004,obtenidos,o
164,S0365-66912005000200004,tras,o
164,S0365-66912005000200004,la,o
164,S0365-66912005000200004,implantacion,i
164,S0365-66912005000200004,de,i
164,S0365-66912005000200004,una,i
164,S0365-66912005000200004,lente,i
164,S0365-66912005000200004,con,o
164,S0365-66912005000200004,optica,o
164,S0365-66912005000200004,prolata,o
164,S0365-66912005000200004,modificada,o
164,S0365-66912005000200004,Tecnis,o
164,S0365-66912005000200004,Z9000,o
164,S0365-66912005000200004,con,o
164,S0365-66912005000200004,los,o
164,S0365-66912005000200004,de,o
164,S0365-66912005000200004,una,o
164,S0365-66912005000200004,lente,o
164,S0365-66912005000200004,plegable,o
164,S0365-66912005000200004,acrilica,i
164,S0365-66912005000200004,convencional,o
164,S0365-66912005000200004,Acrysof,o
164,S0365-66912005000200004,SA60,o
164,S0365-66912005000200004,AT,o
164,S0365-66912005000200004,en,o
164,S0365-66912005000200004,cuanto,o
164,S0365-66912005000200004,a,o
164,S0365-66912005000200004,agudeza,i
164,S0365-66912005000200004,visual,i
164,S0365-66912005000200004,y,o
164,S0365-66912005000200004,sensibilidad,i
164,S0365-66912005000200004,al,i
164,S0365-66912005000200004,contraste,i
164,S0365-66912005000200004,Metodos,o
164,S0365-66912005000200004,En,o
164,S0365-66912005000200004,este,o
164,S0365-66912005000200004,estudio,i
164,S0365-66912005000200004,prospectivo,i
164,S0365-66912005000200004,64,o
164,S0365-66912005000200004,pacientes,o
164,S0365-66912005000200004,fueron,o
164,S0365-66912005000200004,aleatorizados,i
164,S0365-66912005000200004,para,o
164,S0365-66912005000200004,recibir,o
164,S0365-66912005000200004,en,o
164,S0365-66912005000200004,sus,o
164,S0365-66912005000200004,dos,o
164,S0365-66912005000200004,ojos,i
164,S0365-66912005000200004,el,o
164,S0365-66912005000200004,mismo,o
164,S0365-66912005000200004,tipo,o
164,S0365-66912005000200004,de,o
164,S0365-66912005000200004,lente,o
164,S0365-66912005000200004,intraocular,o
164,S0365-66912005000200004,32,o
164,S0365-66912005000200004,Tecnis,o
164,S0365-66912005000200004,Z9000,o
164,S0365-66912005000200004,y,o
164,S0365-66912005000200004,32,o
164,S0365-66912005000200004,Acrysof,o
164,S0365-66912005000200004,SA60AT,o
164,S0365-66912005000200004,La,o
164,S0365-66912005000200004,agudeza,i
164,S0365-66912005000200004,visual,i
164,S0365-66912005000200004,y,o
164,S0365-66912005000200004,sensibilidad,i
164,S0365-66912005000200004,al,i
164,S0365-66912005000200004,contraste,i
164,S0365-66912005000200004,se,o
164,S0365-66912005000200004,evaluo,o
164,S0365-66912005000200004,monocular,o
164,S0365-66912005000200004,y,o
164,S0365-66912005000200004,binocularmente,o
164,S0365-66912005000200004,en,o
164,S0365-66912005000200004,todos,o
164,S0365-66912005000200004,ellos,o
164,S0365-66912005000200004,antes,o
164,S0365-66912005000200004,de,o
164,S0365-66912005000200004,la,o
164,S0365-66912005000200004,cirugia,i
164,S0365-66912005000200004,y,o
164,S0365-66912005000200004,a,o
164,S0365-66912005000200004,los,o
164,S0365-66912005000200004,tres,o
164,S0365-66912005000200004,meses,o
164,S0365-66912005000200004,de,o
164,S0365-66912005000200004,evolucion,o
164,S0365-66912005000200004,Resultados,o
164,S0365-66912005000200004,La,o
164,S0365-66912005000200004,agudeza,i
164,S0365-66912005000200004,visual,i
164,S0365-66912005000200004,monocular,o
164,S0365-66912005000200004,fue,o
164,S0365-66912005000200004,mejor,o
164,S0365-66912005000200004,en,o
164,S0365-66912005000200004,el,o
164,S0365-66912005000200004,grupo,o
164,S0365-66912005000200004,Tecnis,o
164,S0365-66912005000200004,085,o
164,S0365-66912005000200004,que,o
164,S0365-66912005000200004,en,o
164,S0365-66912005000200004,el,o
164,S0365-66912005000200004,Acrysof,o
164,S0365-66912005000200004,078,o
164,S0365-66912005000200004,p001,o
164,S0365-66912005000200004,En,o
164,S0365-66912005000200004,condiciones,o
164,S0365-66912005000200004,de,o
164,S0365-66912005000200004,binocularidad,o
164,S0365-66912005000200004,tambien,o
164,S0365-66912005000200004,resulto,o
164,S0365-66912005000200004,superior,o
164,S0365-66912005000200004,la,o
164,S0365-66912005000200004,AV,o
164,S0365-66912005000200004,en,o
164,S0365-66912005000200004,el,o
164,S0365-66912005000200004,grupo,o
164,S0365-66912005000200004,Tecnis,o
164,S0365-66912005000200004,095,o
164,S0365-66912005000200004,que,o
164,S0365-66912005000200004,en,o
164,S0365-66912005000200004,el,o
164,S0365-66912005000200004,Acrysof,o
164,S0365-66912005000200004,086,o
164,S0365-66912005000200004,p002,o
164,S0365-66912005000200004,La,o
164,S0365-66912005000200004,sensibilidad,i
164,S0365-66912005000200004,media,i
164,S0365-66912005000200004,al,i
164,S0365-66912005000200004,contraste,i
164,S0365-66912005000200004,tambien,o
164,S0365-66912005000200004,es,o
164,S0365-66912005000200004,superior,o
164,S0365-66912005000200004,para,o
164,S0365-66912005000200004,el,o
164,S0365-66912005000200004,grupo,o
164,S0365-66912005000200004,Tecnis,o
164,S0365-66912005000200004,tanto,o
164,S0365-66912005000200004,monocular,o
164,S0365-66912005000200004,como,o
164,S0365-66912005000200004,binocularmente,o
164,S0365-66912005000200004,pero,o
164,S0365-66912005000200004,no,o
164,S0365-66912005000200004,alcanza,o
164,S0365-66912005000200004,significacion,o
164,S0365-66912005000200004,estadistica,o
164,S0365-66912005000200004,Conclusion,o
164,S0365-66912005000200004,En,o
164,S0365-66912005000200004,ambos,o
164,S0365-66912005000200004,grupos,o
164,S0365-66912005000200004,se,o
164,S0365-66912005000200004,produjo,o
164,S0365-66912005000200004,una,o
164,S0365-66912005000200004,mejoria,o
164,S0365-66912005000200004,de,o
164,S0365-66912005000200004,la,o
164,S0365-66912005000200004,agudeza,i
164,S0365-66912005000200004,visual,i
164,S0365-66912005000200004,y,o
164,S0365-66912005000200004,sensibilidad,i
164,S0365-66912005000200004,al,i
164,S0365-66912005000200004,contraste,i
164,S0365-66912005000200004,despues,o
164,S0365-66912005000200004,de,o
164,S0365-66912005000200004,la,o
164,S0365-66912005000200004,cirugia,i
164,S0365-66912005000200004,de,i
164,S0365-66912005000200004,catarata,i
164,S0365-66912005000200004,pero,o
164,S0365-66912005000200004,el,o
164,S0365-66912005000200004,implante,o
164,S0365-66912005000200004,Tecnis,o
164,S0365-66912005000200004,se,o
164,S0365-66912005000200004,asocio,o
164,S0365-66912005000200004,con,o
164,S0365-66912005000200004,una,o
164,S0365-66912005000200004,agudeza,i
164,S0365-66912005000200004,visual,i
164,S0365-66912005000200004,significativamente,o
164,S0365-66912005000200004,mejor,o
164,S0365-66912005000200004,tanto,o
164,S0365-66912005000200004,monocular,o
164,S0365-66912005000200004,como,o
164,S0365-66912005000200004,binocularmente,o
164,S0365-66912005000200004,Los,o
164,S0365-66912005000200004,valores,o
164,S0365-66912005000200004,medios,o
164,S0365-66912005000200004,de,o
164,S0365-66912005000200004,sensibilidad,i
164,S0365-66912005000200004,al,i
164,S0365-66912005000200004,contraste,i
164,S0365-66912005000200004,son,o
164,S0365-66912005000200004,superiores,o
164,S0365-66912005000200004,en,o
164,S0365-66912005000200004,el,o
164,S0365-66912005000200004,grupo,o
164,S0365-66912005000200004,Tecnis,o
164,S0365-66912005000200004,pero,o
164,S0365-66912005000200004,la,o
164,S0365-66912005000200004,diferencia,o
164,S0365-66912005000200004,no,o
164,S0365-66912005000200004,es,o
164,S0365-66912005000200004,estadisticamente,o
164,S0365-66912005000200004,significativa,o
165,S0365-66912006001000005,Resultados,o
165,S0365-66912006001000005,de,o
165,S0365-66912006001000005,la,o
165,S0365-66912006001000005,cirugia,i
165,S0365-66912006001000005,del,i
165,S0365-66912006001000005,agujero,i
165,S0365-66912006001000005,macular,i
165,S0365-66912006001000005,con,o
165,S0365-66912006001000005,diferentes,o
165,S0365-66912006001000005,tecnicas,o
165,S0365-66912006001000005,de,o
165,S0365-66912006001000005,tratamiento,i
165,S0365-66912006001000005,Objetivo,o
165,S0365-66912006001000005,Comparar,o
165,S0365-66912006001000005,la,o
165,S0365-66912006001000005,efectividad,o
165,S0365-66912006001000005,eficiencia,o
165,S0365-66912006001000005,y,o
165,S0365-66912006001000005,complicaciones,i
165,S0365-66912006001000005,de,o
165,S0365-66912006001000005,las,o
165,S0365-66912006001000005,tres,o
165,S0365-66912006001000005,tecnicas,i
165,S0365-66912006001000005,quirurgicas,i
165,S0365-66912006001000005,empleadas,o
165,S0365-66912006001000005,en,o
165,S0365-66912006001000005,el,o
165,S0365-66912006001000005,tratamiento,i
165,S0365-66912006001000005,del,o
165,S0365-66912006001000005,agujero,i
165,S0365-66912006001000005,macular,i
165,S0365-66912006001000005,en,o
165,S0365-66912006001000005,el,o
165,S0365-66912006001000005,periodo,o
165,S0365-66912006001000005,19982004,o
165,S0365-66912006001000005,en,o
165,S0365-66912006001000005,nuestro,o
165,S0365-66912006001000005,centro,o
165,S0365-66912006001000005,Metodos,o
165,S0365-66912006001000005,Estudio,o
165,S0365-66912006001000005,retrospectivo,o
165,S0365-66912006001000005,comparativo,o
165,S0365-66912006001000005,intervencionista,o
165,S0365-66912006001000005,y,o
165,S0365-66912006001000005,no,o
165,S0365-66912006001000005,aleatorizado,o
165,S0365-66912006001000005,de,o
165,S0365-66912006001000005,131,o
165,S0365-66912006001000005,ojos,i
165,S0365-66912006001000005,con,o
165,S0365-66912006001000005,agujero,i
165,S0365-66912006001000005,macular,i
165,S0365-66912006001000005,idiopatico,o
165,S0365-66912006001000005,en,o
165,S0365-66912006001000005,estadio,o
165,S0365-66912006001000005,III,o
165,S0365-66912006001000005,y,o
165,S0365-66912006001000005,IV,o
165,S0365-66912006001000005,operados,i
165,S0365-66912006001000005,con,o
165,S0365-66912006001000005,tres,o
165,S0365-66912006001000005,tecnicas,o
165,S0365-66912006001000005,En,o
165,S0365-66912006001000005,25,o
165,S0365-66912006001000005,ojos,i
165,S0365-66912006001000005,se,o
165,S0365-66912006001000005,realizo,o
165,S0365-66912006001000005,vitrectomia,i
165,S0365-66912006001000005,simple,i
165,S0365-66912006001000005,grupo,o
165,S0365-66912006001000005,1,o
165,S0365-66912006001000005,en,o
165,S0365-66912006001000005,19,o
165,S0365-66912006001000005,ojos,i
165,S0365-66912006001000005,se,o
165,S0365-66912006001000005,asocio,o
165,S0365-66912006001000005,rexis,i
165,S0365-66912006001000005,de,i
165,S0365-66912006001000005,la,i
165,S0365-66912006001000005,membrana,i
165,S0365-66912006001000005,limitante,i
165,S0365-66912006001000005,interna,i
165,S0365-66912006001000005,MLI,i
165,S0365-66912006001000005,grupo,o
165,S0365-66912006001000005,2,o
165,S0365-66912006001000005,y,o
165,S0365-66912006001000005,en,o
165,S0365-66912006001000005,87,o
165,S0365-66912006001000005,ojos,i
165,S0365-66912006001000005,esta,o
165,S0365-66912006001000005,rexis,i
165,S0365-66912006001000005,se,o
165,S0365-66912006001000005,llevo,o
165,S0365-66912006001000005,a,o
165,S0365-66912006001000005,cabo,o
165,S0365-66912006001000005,previa,o
165,S0365-66912006001000005,tincion,i
165,S0365-66912006001000005,con,o
165,S0365-66912006001000005,verde,i
165,S0365-66912006001000005,de,i
165,S0365-66912006001000005,indocianina,i
165,S0365-66912006001000005,ICG,i
165,S0365-66912006001000005,grupo,o
165,S0365-66912006001000005,3,o
165,S0365-66912006001000005,Las,o
165,S0365-66912006001000005,concentraciones,o
165,S0365-66912006001000005,de,o
165,S0365-66912006001000005,ICG,i
165,S0365-66912006001000005,empleadas,o
165,S0365-66912006001000005,fueron,o
165,S0365-66912006001000005,del,o
165,S0365-66912006001000005,5,o
165,S0365-66912006001000005,25,o
165,S0365-66912006001000005,y,o
165,S0365-66912006001000005,05,o
165,S0365-66912006001000005,Se,o
165,S0365-66912006001000005,compararon,o
165,S0365-66912006001000005,la,o
165,S0365-66912006001000005,recuperacion,o
165,S0365-66912006001000005,anatomica,o
165,S0365-66912006001000005,y,o
165,S0365-66912006001000005,funcional,o
165,S0365-66912006001000005,y,o
165,S0365-66912006001000005,las,o
165,S0365-66912006001000005,complicaciones,i
165,S0365-66912006001000005,en,o
165,S0365-66912006001000005,los,o
165,S0365-66912006001000005,distintos,o
165,S0365-66912006001000005,grupos,o
165,S0365-66912006001000005,Resultados,o
165,S0365-66912006001000005,El,o
165,S0365-66912006001000005,884,o
165,S0365-66912006001000005,114,o
165,S0365-66912006001000005,ojos,i
165,S0365-66912006001000005,lograron,o
165,S0365-66912006001000005,la,o
165,S0365-66912006001000005,resolucion,o
165,S0365-66912006001000005,anatomica,o
165,S0365-66912006001000005,siendo,o
165,S0365-66912006001000005,superior,o
165,S0365-66912006001000005,en,o
165,S0365-66912006001000005,el,o
165,S0365-66912006001000005,grupo,o
165,S0365-66912006001000005,3,o
165,S0365-66912006001000005,906,o
165,S0365-66912006001000005,La,o
165,S0365-66912006001000005,recuperacion,o
165,S0365-66912006001000005,funcional,o
165,S0365-66912006001000005,se,o
165,S0365-66912006001000005,consiguio,o
165,S0365-66912006001000005,en,o
165,S0365-66912006001000005,el,o
165,S0365-66912006001000005,636,o
165,S0365-66912006001000005,En,o
165,S0365-66912006001000005,ambos,o
165,S0365-66912006001000005,casos,o
165,S0365-66912006001000005,no,o
165,S0365-66912006001000005,existieron,o
165,S0365-66912006001000005,diferencias,o
165,S0365-66912006001000005,entre,o
165,S0365-66912006001000005,grupos,o
165,S0365-66912006001000005,Las,o
165,S0365-66912006001000005,complicaciones,i
165,S0365-66912006001000005,mas,o
165,S0365-66912006001000005,importantes,o
165,S0365-66912006001000005,fueron,o
165,S0365-66912006001000005,cataratas,i
165,S0365-66912006001000005,postcirugia,o
165,S0365-66912006001000005,519,o
165,S0365-66912006001000005,aumento,o
165,S0365-66912006001000005,de,o
165,S0365-66912006001000005,PIO,i
165,S0365-66912006001000005,372,o
165,S0365-66912006001000005,desprendimientos,i
165,S0365-66912006001000005,de,i
165,S0365-66912006001000005,retina,i
165,S0365-66912006001000005,78,o
165,S0365-66912006001000005,y,o
165,S0365-66912006001000005,alteraciones,i
165,S0365-66912006001000005,del,i
165,S0365-66912006001000005,epitelio,i
165,S0365-66912006001000005,pigmentario,i
165,S0365-66912006001000005,7,o
165,S0365-66912006001000005,Esta,o
165,S0365-66912006001000005,ultima,o
165,S0365-66912006001000005,se,o
165,S0365-66912006001000005,relaciono,o
165,S0365-66912006001000005,con,o
165,S0365-66912006001000005,el,o
165,S0365-66912006001000005,uso,o
165,S0365-66912006001000005,de,o
165,S0365-66912006001000005,ICG,i
165,S0365-66912006001000005,p005,o
165,S0365-66912006001000005,sin,o
165,S0365-66912006001000005,encontrarse,o
165,S0365-66912006001000005,diferencias,o
165,S0365-66912006001000005,en,o
165,S0365-66912006001000005,las,o
165,S0365-66912006001000005,concentraciones,o
165,S0365-66912006001000005,empleadas,o
165,S0365-66912006001000005,El,o
165,S0365-66912006001000005,tamaño,o
165,S0365-66912006001000005,del,o
165,S0365-66912006001000005,agujero,o
165,S0365-66912006001000005,tuvo,o
165,S0365-66912006001000005,una,o
165,S0365-66912006001000005,correlacion,o
165,S0365-66912006001000005,inversa,o
165,S0365-66912006001000005,con,o
165,S0365-66912006001000005,la,o
165,S0365-66912006001000005,agudeza,i
165,S0365-66912006001000005,visual,i
165,S0365-66912006001000005,AV,i
165,S0365-66912006001000005,inicial,o
165,S0365-66912006001000005,y,o
165,S0365-66912006001000005,postquirurgica,o
165,S0365-66912006001000005,La,o
165,S0365-66912006001000005,presencia,o
165,S0365-66912006001000005,de,o
165,S0365-66912006001000005,membrana,i
165,S0365-66912006001000005,epirretiniana,i
165,S0365-66912006001000005,se,o
165,S0365-66912006001000005,asocio,o
165,S0365-66912006001000005,a,o
165,S0365-66912006001000005,mejores,o
165,S0365-66912006001000005,AV,i
165,S0365-66912006001000005,y,o
165,S0365-66912006001000005,a,o
165,S0365-66912006001000005,un,o
165,S0365-66912006001000005,mayor,o
165,S0365-66912006001000005,exito,o
165,S0365-66912006001000005,anatomico,o
165,S0365-66912006001000005,Conclusiones,o
165,S0365-66912006001000005,En,o
165,S0365-66912006001000005,nuestra,o
165,S0365-66912006001000005,experiencia,o
165,S0365-66912006001000005,la,o
165,S0365-66912006001000005,cirugia,i
165,S0365-66912006001000005,mejora,o
165,S0365-66912006001000005,la,o
165,S0365-66912006001000005,AV,i
165,S0365-66912006001000005,siendo,o
165,S0365-66912006001000005,mas,o
165,S0365-66912006001000005,efectiva,o
165,S0365-66912006001000005,si,o
165,S0365-66912006001000005,se,o
165,S0365-66912006001000005,asocia,o
165,S0365-66912006001000005,ICG,i
165,S0365-66912006001000005,para,o
165,S0365-66912006001000005,la,o
165,S0365-66912006001000005,rexis,i
165,S0365-66912006001000005,de,i
165,S0365-66912006001000005,la,i
165,S0365-66912006001000005,MLI,i
165,S0365-66912006001000005,Sin,o
165,S0365-66912006001000005,embargo,o
165,S0365-66912006001000005,esta,o
165,S0365-66912006001000005,tincion,i
165,S0365-66912006001000005,podria,o
165,S0365-66912006001000005,estar,o
165,S0365-66912006001000005,relacionada,o
165,S0365-66912006001000005,con,o
165,S0365-66912006001000005,las,o
165,S0365-66912006001000005,alteraciones,i
165,S0365-66912006001000005,del,i
165,S0365-66912006001000005,EPR,i
165,S0365-66912006001000005,encontradas,o
166,S0365-66912007000500007,Anestesia,i
166,S0365-66912007000500007,topica,i
166,S0365-66912007000500007,mas,i
166,S0365-66912007000500007,subconjuntival,i
166,S0365-66912007000500007,versus,o
166,S0365-66912007000500007,retrobulbar,o
166,S0365-66912007000500007,en,o
166,S0365-66912007000500007,la,o
166,S0365-66912007000500007,esclerectomia,i
166,S0365-66912007000500007,profunda,i
166,S0365-66912007000500007,no,o
166,S0365-66912007000500007,penetrante,o
166,S0365-66912007000500007,Objetivo,o
166,S0365-66912007000500007,Comparar,i
166,S0365-66912007000500007,la,i
166,S0365-66912007000500007,eficacia,i
166,S0365-66912007000500007,y,i
166,S0365-66912007000500007,seguridad,i
166,S0365-66912007000500007,de,o
166,S0365-66912007000500007,la,o
166,S0365-66912007000500007,anestesia,o
166,S0365-66912007000500007,topicasubconjuntival,o
166,S0365-66912007000500007,con,o
166,S0365-66912007000500007,la,o
166,S0365-66912007000500007,retrobulbar,o
166,S0365-66912007000500007,en,o
166,S0365-66912007000500007,la,o
166,S0365-66912007000500007,escleroctomia,i
166,S0365-66912007000500007,profunda,i
166,S0365-66912007000500007,no,o
166,S0365-66912007000500007,penetrante,o
166,S0365-66912007000500007,suplementada,i
166,S0365-66912007000500007,con,o
166,S0365-66912007000500007,5FU,o
166,S0365-66912007000500007,Metodo,o
166,S0365-66912007000500007,Se,o
166,S0365-66912007000500007,realizo,o
166,S0365-66912007000500007,un,o
166,S0365-66912007000500007,estudio,i
166,S0365-66912007000500007,prospectivo,i
166,S0365-66912007000500007,y,i
166,S0365-66912007000500007,aleatorizado,i
166,S0365-66912007000500007,de,o
166,S0365-66912007000500007,30,o
166,S0365-66912007000500007,pacientes,o
166,S0365-66912007000500007,consecutivos,o
166,S0365-66912007000500007,a,o
166,S0365-66912007000500007,los,o
166,S0365-66912007000500007,que,o
166,S0365-66912007000500007,se,o
166,S0365-66912007000500007,les,o
166,S0365-66912007000500007,practico,o
166,S0365-66912007000500007,anestesia,o
166,S0365-66912007000500007,topicasubconjuntival,o
166,S0365-66912007000500007,n14,o
166,S0365-66912007000500007,o,o
166,S0365-66912007000500007,retrobulbar,o
166,S0365-66912007000500007,n16,o
166,S0365-66912007000500007,Se,o
166,S0365-66912007000500007,evaluaron,o
166,S0365-66912007000500007,las,o
166,S0365-66912007000500007,condiciones,o
166,S0365-66912007000500007,operatorias,o
166,S0365-66912007000500007,el,o
166,S0365-66912007000500007,confort,o
166,S0365-66912007000500007,del,o
166,S0365-66912007000500007,paciente,o
166,S0365-66912007000500007,el,o
166,S0365-66912007000500007,dolor,i
166,S0365-66912007000500007,postoperatorio,i
166,S0365-66912007000500007,el,o
166,S0365-66912007000500007,dolor,i
166,S0365-66912007000500007,total,o
166,S0365-66912007000500007,y,o
166,S0365-66912007000500007,el,o
166,S0365-66912007000500007,resultado,o
166,S0365-66912007000500007,quirurgico,o
166,S0365-66912007000500007,en,o
166,S0365-66912007000500007,cuanto,o
166,S0365-66912007000500007,a,o
166,S0365-66912007000500007,bajada,o
166,S0365-66912007000500007,de,o
166,S0365-66912007000500007,presion,i
166,S0365-66912007000500007,intraocular,i
166,S0365-66912007000500007,Resultados,o
166,S0365-66912007000500007,No,o
166,S0365-66912007000500007,hubo,o
166,S0365-66912007000500007,diferencias,o
166,S0365-66912007000500007,en,o
166,S0365-66912007000500007,las,o
166,S0365-66912007000500007,condiciones,o
166,S0365-66912007000500007,quirurgicas,o
166,S0365-66912007000500007,entre,o
166,S0365-66912007000500007,ambos,o
166,S0365-66912007000500007,grupos,o
166,S0365-66912007000500007,El,o
166,S0365-66912007000500007,grupo,o
166,S0365-66912007000500007,con,o
166,S0365-66912007000500007,anestesia,i
166,S0365-66912007000500007,retrobulbar,i
166,S0365-66912007000500007,refirio,o
166,S0365-66912007000500007,mas,o
166,S0365-66912007000500007,dolor,i
166,S0365-66912007000500007,durante,o
166,S0365-66912007000500007,la,o
166,S0365-66912007000500007,aplicacion,o
166,S0365-66912007000500007,del,o
166,S0365-66912007000500007,anestesico,i
166,S0365-66912007000500007,P,o
166,S0365-66912007000500007,000,o
166,S0365-66912007000500007,El,o
166,S0365-66912007000500007,grupo,o
166,S0365-66912007000500007,con,o
166,S0365-66912007000500007,anestesia,o
166,S0365-66912007000500007,topicasubconjuntival,o
166,S0365-66912007000500007,refirio,o
166,S0365-66912007000500007,mas,o
166,S0365-66912007000500007,disconfort,i
166,S0365-66912007000500007,intraoperatoriamente,o
166,S0365-66912007000500007,P000,o
166,S0365-66912007000500007,Sin,o
166,S0365-66912007000500007,embargo,o
166,S0365-66912007000500007,esto,o
166,S0365-66912007000500007,no,o
166,S0365-66912007000500007,represento,o
166,S0365-66912007000500007,un,o
166,S0365-66912007000500007,problema,o
166,S0365-66912007000500007,para,o
166,S0365-66912007000500007,el,o
166,S0365-66912007000500007,cirujano,o
166,S0365-66912007000500007,No,o
166,S0365-66912007000500007,hubo,o
166,S0365-66912007000500007,diferencias,o
166,S0365-66912007000500007,en,o
166,S0365-66912007000500007,el,o
166,S0365-66912007000500007,dolor,i
166,S0365-66912007000500007,postoperatorio,i
166,S0365-66912007000500007,entre,o
166,S0365-66912007000500007,ambos,o
166,S0365-66912007000500007,grupos,o
166,S0365-66912007000500007,No,o
166,S0365-66912007000500007,hubo,o
166,S0365-66912007000500007,diferencias,o
166,S0365-66912007000500007,estadisticamente,o
166,S0365-66912007000500007,significativas,o
166,S0365-66912007000500007,en,o
166,S0365-66912007000500007,cuanto,o
166,S0365-66912007000500007,al,o
166,S0365-66912007000500007,dolor,i
166,S0365-66912007000500007,total,o
166,S0365-66912007000500007,No,o
166,S0365-66912007000500007,hubo,o
166,S0365-66912007000500007,diferencia,o
166,S0365-66912007000500007,en,o
166,S0365-66912007000500007,cuanto,o
166,S0365-66912007000500007,al,o
166,S0365-66912007000500007,exito,o
166,S0365-66912007000500007,quirurgico,o
166,S0365-66912007000500007,entre,o
166,S0365-66912007000500007,ambos,o
166,S0365-66912007000500007,grupos,o
166,S0365-66912007000500007,Conclusiones,o
166,S0365-66912007000500007,La,o
166,S0365-66912007000500007,anestesia,o
166,S0365-66912007000500007,topicasubconjuntival,o
166,S0365-66912007000500007,es,o
166,S0365-66912007000500007,una,o
166,S0365-66912007000500007,alternativa,o
166,S0365-66912007000500007,segura,o
166,S0365-66912007000500007,y,o
166,S0365-66912007000500007,efectiva,o
166,S0365-66912007000500007,para,o
166,S0365-66912007000500007,la,o
166,S0365-66912007000500007,escleroctomia,i
166,S0365-66912007000500007,no,o
166,S0365-66912007000500007,penetrante,o
166,S0365-66912007000500007,suplementada,i
166,S0365-66912007000500007,con,o
166,S0365-66912007000500007,5FU,o
167,S0365-66912007000700004,Correlacion,o
167,S0365-66912007000700004,entre,o
167,S0365-66912007000700004,los,o
167,S0365-66912007000700004,indices,o
167,S0365-66912007000700004,globales,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,la,o
167,S0365-66912007000700004,perimetria,i
167,S0365-66912007000700004,automatizada,i
167,S0365-66912007000700004,convencional,o
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,los,o
167,S0365-66912007000700004,parametros,o
167,S0365-66912007000700004,topograficos,o
167,S0365-66912007000700004,papilares,i
167,S0365-66912007000700004,Heidelberg,o
167,S0365-66912007000700004,Retina,o
167,S0365-66912007000700004,Tomograph,o
167,S0365-66912007000700004,II,o
167,S0365-66912007000700004,Objetivo,o
167,S0365-66912007000700004,Correlacionar,o
167,S0365-66912007000700004,los,o
167,S0365-66912007000700004,parametros,o
167,S0365-66912007000700004,estructurales,o
167,S0365-66912007000700004,del,o
167,S0365-66912007000700004,nervio,i
167,S0365-66912007000700004,optico,i
167,S0365-66912007000700004,obtenidos,o
167,S0365-66912007000700004,mediante,o
167,S0365-66912007000700004,Heidelberg,o
167,S0365-66912007000700004,Retina,o
167,S0365-66912007000700004,Tomograph,o
167,S0365-66912007000700004,II,o
167,S0365-66912007000700004,HRT,o
167,S0365-66912007000700004,con,o
167,S0365-66912007000700004,los,o
167,S0365-66912007000700004,indices,o
167,S0365-66912007000700004,perimetricos,i
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,la,o
167,S0365-66912007000700004,perimetria,i
167,S0365-66912007000700004,automatizada,i
167,S0365-66912007000700004,convencional,o
167,S0365-66912007000700004,Metodos,o
167,S0365-66912007000700004,Se,o
167,S0365-66912007000700004,incluyeron,o
167,S0365-66912007000700004,101,o
167,S0365-66912007000700004,sujetos,o
167,S0365-66912007000700004,normales,o
167,S0365-66912007000700004,247,o
167,S0365-66912007000700004,hipertensos,i
167,S0365-66912007000700004,oculares,i
167,S0365-66912007000700004,presion,o
167,S0365-66912007000700004,intraocular,o
167,S0365-66912007000700004,PIO,i
167,S0365-66912007000700004,elevada,o
167,S0365-66912007000700004,con,o
167,S0365-66912007000700004,perimetria,i
167,S0365-66912007000700004,automatizada,i
167,S0365-66912007000700004,convencional,o
167,S0365-66912007000700004,normal,o
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,102,o
167,S0365-66912007000700004,sujetos,o
167,S0365-66912007000700004,glaucomatosos,i
167,S0365-66912007000700004,PIO,i
167,S0365-66912007000700004,21,o
167,S0365-66912007000700004,mmHg,o
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,perimetria,i
167,S0365-66912007000700004,automatizada,i
167,S0365-66912007000700004,convencional,o
167,S0365-66912007000700004,alterada,o
167,S0365-66912007000700004,Solo,o
167,S0365-66912007000700004,se,o
167,S0365-66912007000700004,incluyo,o
167,S0365-66912007000700004,un,o
167,S0365-66912007000700004,ojo,i
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,cada,o
167,S0365-66912007000700004,sujeto,o
167,S0365-66912007000700004,para,o
167,S0365-66912007000700004,el,o
167,S0365-66912007000700004,analisis,o
167,S0365-66912007000700004,La,o
167,S0365-66912007000700004,perimetria,i
167,S0365-66912007000700004,automatizada,i
167,S0365-66912007000700004,se,o
167,S0365-66912007000700004,realizo,o
167,S0365-66912007000700004,mediante,o
167,S0365-66912007000700004,un,o
167,S0365-66912007000700004,perimetro,o
167,S0365-66912007000700004,Humphrey,o
167,S0365-66912007000700004,Field,o
167,S0365-66912007000700004,Analyzer,o
167,S0365-66912007000700004,umbral,o
167,S0365-66912007000700004,completo,o
167,S0365-66912007000700004,242,o
167,S0365-66912007000700004,El,o
167,S0365-66912007000700004,estudio,i
167,S0365-66912007000700004,papilar,i
167,S0365-66912007000700004,se,o
167,S0365-66912007000700004,realizo,o
167,S0365-66912007000700004,mediante,o
167,S0365-66912007000700004,laser,i
167,S0365-66912007000700004,confocal,i
167,S0365-66912007000700004,de,i
167,S0365-66912007000700004,barrido,i
167,S0365-66912007000700004,Heidelberg,o
167,S0365-66912007000700004,Retina,o
167,S0365-66912007000700004,Tomograph,o
167,S0365-66912007000700004,HRT,o
167,S0365-66912007000700004,II,o
167,S0365-66912007000700004,Se,o
167,S0365-66912007000700004,realizo,o
167,S0365-66912007000700004,un,o
167,S0365-66912007000700004,estudio,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,los,o
167,S0365-66912007000700004,coeficientes,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,correlacion,o
167,S0365-66912007000700004,Pearson,o
167,S0365-66912007000700004,entre,o
167,S0365-66912007000700004,los,o
167,S0365-66912007000700004,parametros,o
167,S0365-66912007000700004,topograficos,o
167,S0365-66912007000700004,papilares,i
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,los,o
167,S0365-66912007000700004,indices,o
167,S0365-66912007000700004,perimetricos,i
167,S0365-66912007000700004,en,o
167,S0365-66912007000700004,el,o
167,S0365-66912007000700004,total,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,sujetos,o
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,en,o
167,S0365-66912007000700004,cada,o
167,S0365-66912007000700004,uno,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,los,o
167,S0365-66912007000700004,grupos,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,estudio,o
167,S0365-66912007000700004,ya,o
167,S0365-66912007000700004,que,o
167,S0365-66912007000700004,las,o
167,S0365-66912007000700004,muestras,o
167,S0365-66912007000700004,presentaban,o
167,S0365-66912007000700004,una,o
167,S0365-66912007000700004,distribucion,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,sus,o
167,S0365-66912007000700004,valores,o
167,S0365-66912007000700004,ajustada,o
167,S0365-66912007000700004,a,o
167,S0365-66912007000700004,la,o
167,S0365-66912007000700004,normalidad,o
167,S0365-66912007000700004,Resultados,o
167,S0365-66912007000700004,Se,o
167,S0365-66912007000700004,observaron,o
167,S0365-66912007000700004,correlaciones,o
167,S0365-66912007000700004,significativas,o
167,S0365-66912007000700004,entre,o
167,S0365-66912007000700004,varios,o
167,S0365-66912007000700004,parametros,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,la,o
167,S0365-66912007000700004,cabeza,i
167,S0365-66912007000700004,del,i
167,S0365-66912007000700004,nervio,i
167,S0365-66912007000700004,optico,i
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,los,o
167,S0365-66912007000700004,indices,o
167,S0365-66912007000700004,globales,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,la,o
167,S0365-66912007000700004,perimetria,i
167,S0365-66912007000700004,automatizada,i
167,S0365-66912007000700004,convencional,o
167,S0365-66912007000700004,En,o
167,S0365-66912007000700004,el,o
167,S0365-66912007000700004,total,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,sujetos,o
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,en,o
167,S0365-66912007000700004,el,o
167,S0365-66912007000700004,grupo,o
167,S0365-66912007000700004,glaucoma,i
167,S0365-66912007000700004,las,o
167,S0365-66912007000700004,correlaciones,o
167,S0365-66912007000700004,mas,o
167,S0365-66912007000700004,fuertes,o
167,S0365-66912007000700004,con,o
167,S0365-66912007000700004,los,o
167,S0365-66912007000700004,indices,o
167,S0365-66912007000700004,del,o
167,S0365-66912007000700004,campo,o
167,S0365-66912007000700004,visual,o
167,S0365-66912007000700004,se,o
167,S0365-66912007000700004,obtuvieron,o
167,S0365-66912007000700004,con,o
167,S0365-66912007000700004,el,o
167,S0365-66912007000700004,area,o
167,S0365-66912007000700004,total,o
167,S0365-66912007000700004,r032,o
167,S0365-66912007000700004,p414x1011,o
167,S0365-66912007000700004,glaucoma,i
167,S0365-66912007000700004,r028,o
167,S0365-66912007000700004,p0004,o
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,volumen,o
167,S0365-66912007000700004,del,o
167,S0365-66912007000700004,anillo,i
167,S0365-66912007000700004,neurorretiniano,i
167,S0365-66912007000700004,total,o
167,S0365-66912007000700004,r026,o
167,S0365-66912007000700004,p155x107,o
167,S0365-66912007000700004,glaucoma,i
167,S0365-66912007000700004,r026,o
167,S0365-66912007000700004,p0006,o
167,S0365-66912007000700004,el,o
167,S0365-66912007000700004,cociente,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,area,o
167,S0365-66912007000700004,excavaciondisco,o
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,anillodisco,o
167,S0365-66912007000700004,el,o
167,S0365-66912007000700004,indice,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,morfologia,o
167,S0365-66912007000700004,papilar,i
167,S0365-66912007000700004,el,o
167,S0365-66912007000700004,area,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,corte,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,la,o
167,S0365-66912007000700004,capa,i
167,S0365-66912007000700004,de,i
167,S0365-66912007000700004,fibras,i
167,S0365-66912007000700004,nerviosas,i
167,S0365-66912007000700004,de,i
167,S0365-66912007000700004,la,i
167,S0365-66912007000700004,retina,i
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,las,o
167,S0365-66912007000700004,funciones,o
167,S0365-66912007000700004,discriminantes,o
167,S0365-66912007000700004,FSM,o
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,RB,o
167,S0365-66912007000700004,El,o
167,S0365-66912007000700004,grupo,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,hipertension,i
167,S0365-66912007000700004,ocular,i
167,S0365-66912007000700004,obtuvo,o
167,S0365-66912007000700004,pocas,o
167,S0365-66912007000700004,correlaciones,o
167,S0365-66912007000700004,significativas,o
167,S0365-66912007000700004,Conclusiones,o
167,S0365-66912007000700004,Las,o
167,S0365-66912007000700004,correlaciones,o
167,S0365-66912007000700004,observadas,o
167,S0365-66912007000700004,entre,o
167,S0365-66912007000700004,la,o
167,S0365-66912007000700004,perimetria,i
167,S0365-66912007000700004,automatizada,i
167,S0365-66912007000700004,convencional,o
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,HRT,o
167,S0365-66912007000700004,II,o
167,S0365-66912007000700004,permiten,o
167,S0365-66912007000700004,mejorar,o
167,S0365-66912007000700004,el,o
167,S0365-66912007000700004,conocimiento,o
167,S0365-66912007000700004,del,o
167,S0365-66912007000700004,daño,i
167,S0365-66912007000700004,glaucomatoso,i
167,S0365-66912007000700004,y,o
167,S0365-66912007000700004,facilitan,o
167,S0365-66912007000700004,la,o
167,S0365-66912007000700004,toma,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,decisiones,o
167,S0365-66912007000700004,con,o
167,S0365-66912007000700004,los,o
167,S0365-66912007000700004,resultados,o
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,todas,o
167,S0365-66912007000700004,las,o
167,S0365-66912007000700004,pruebas,i
167,S0365-66912007000700004,de,o
167,S0365-66912007000700004,las,o
167,S0365-66912007000700004,que,o
167,S0365-66912007000700004,disponemos,o
167,S0365-66912007000700004,en,o
167,S0365-66912007000700004,la,o
167,S0365-66912007000700004,actualidad,o
168,S0365-66912007000800007,Estudio,i
168,S0365-66912007000800007,prospectivo,i
168,S0365-66912007000800007,randomizado,i
168,S0365-66912007000800007,comparando,o
168,S0365-66912007000800007,Discovisc,i
168,S0365-66912007000800007,versus,o
168,S0365-66912007000800007,Healon,i
168,S0365-66912007000800007,en,o
168,S0365-66912007000800007,facoemulsificacion,i
168,S0365-66912007000800007,Proposito,o
168,S0365-66912007000800007,Comparar,o
168,S0365-66912007000800007,el,o
168,S0365-66912007000800007,comportamiento,o
168,S0365-66912007000800007,de,o
168,S0365-66912007000800007,ambos,o
168,S0365-66912007000800007,viscoelasticos,i
168,S0365-66912007000800007,intraoperatoriamente,o
168,S0365-66912007000800007,Metodo,o
168,S0365-66912007000800007,Estudio,i
168,S0365-66912007000800007,prospectivo,i
168,S0365-66912007000800007,aleatorio,i
168,S0365-66912007000800007,en,o
168,S0365-66912007000800007,el,o
168,S0365-66912007000800007,que,o
168,S0365-66912007000800007,se,o
168,S0365-66912007000800007,incluyen,o
168,S0365-66912007000800007,35,o
168,S0365-66912007000800007,pacientes,o
168,S0365-66912007000800007,con,o
168,S0365-66912007000800007,catarata,i
168,S0365-66912007000800007,intervenidos,i
168,S0365-66912007000800007,mediante,o
168,S0365-66912007000800007,facoemulsificacion,i
168,S0365-66912007000800007,ultrasonica,i
168,S0365-66912007000800007,e,o
168,S0365-66912007000800007,implantacion,i
168,S0365-66912007000800007,de,i
168,S0365-66912007000800007,lente,i
168,S0365-66912007000800007,intraocular,i
168,S0365-66912007000800007,En,o
168,S0365-66912007000800007,el,o
168,S0365-66912007000800007,grupo,o
168,S0365-66912007000800007,A,o
168,S0365-66912007000800007,se,o
168,S0365-66912007000800007,incluyeron,o
168,S0365-66912007000800007,17,o
168,S0365-66912007000800007,pacientes,o
168,S0365-66912007000800007,en,o
168,S0365-66912007000800007,los,o
168,S0365-66912007000800007,que,o
168,S0365-66912007000800007,se,o
168,S0365-66912007000800007,utilizo,o
168,S0365-66912007000800007,Healon,i
168,S0365-66912007000800007,hialuronato,i
168,S0365-66912007000800007,sodico,i
168,S0365-66912007000800007,1,o
168,S0365-66912007000800007,y,o
168,S0365-66912007000800007,en,o
168,S0365-66912007000800007,el,o
168,S0365-66912007000800007,grupo,o
168,S0365-66912007000800007,B,o
168,S0365-66912007000800007,18,o
168,S0365-66912007000800007,pacientes,o
168,S0365-66912007000800007,en,o
168,S0365-66912007000800007,los,o
168,S0365-66912007000800007,que,o
168,S0365-66912007000800007,se,o
168,S0365-66912007000800007,utilizo,o
168,S0365-66912007000800007,DisCoVisc,i
168,S0365-66912007000800007,acido,i
168,S0365-66912007000800007,hialuronico,i
168,S0365-66912007000800007,al,o
168,S0365-66912007000800007,16,o
168,S0365-66912007000800007,y,o
168,S0365-66912007000800007,condroitin,i
168,S0365-66912007000800007,sulfato,i
168,S0365-66912007000800007,al,o
168,S0365-66912007000800007,4,o
168,S0365-66912007000800007,Tras,o
168,S0365-66912007000800007,la,o
168,S0365-66912007000800007,intervencion,i
168,S0365-66912007000800007,el,o
168,S0365-66912007000800007,cirujano,o
168,S0365-66912007000800007,relleno,i
168,S0365-66912007000800007,un,i
168,S0365-66912007000800007,cuestionario,i
168,S0365-66912007000800007,sobre,o
168,S0365-66912007000800007,el,o
168,S0365-66912007000800007,comportamiento,o
168,S0365-66912007000800007,de,o
168,S0365-66912007000800007,los,o
168,S0365-66912007000800007,viscoelasticos,i
168,S0365-66912007000800007,en,o
168,S0365-66912007000800007,cada,o
168,S0365-66912007000800007,momento,o
168,S0365-66912007000800007,de,o
168,S0365-66912007000800007,la,o
168,S0365-66912007000800007,cirugia,i
168,S0365-66912007000800007,Resultados,o
168,S0365-66912007000800007,El,o
168,S0365-66912007000800007,DisCoVisc,i
168,S0365-66912007000800007,se,o
168,S0365-66912007000800007,ha,o
168,S0365-66912007000800007,comportado,o
168,S0365-66912007000800007,como,o
168,S0365-66912007000800007,dispersivo,o
168,S0365-66912007000800007,y,o
168,S0365-66912007000800007,cohesivo,o
168,S0365-66912007000800007,durante,o
168,S0365-66912007000800007,la,o
168,S0365-66912007000800007,capsulorrexis,i
168,S0365-66912007000800007,la,o
168,S0365-66912007000800007,facoemulsificacion,i
168,S0365-66912007000800007,y,o
168,S0365-66912007000800007,la,o
168,S0365-66912007000800007,aspiracion,i
168,S0365-66912007000800007,del,o
168,S0365-66912007000800007,viscoelastico,i
168,S0365-66912007000800007,mientras,o
168,S0365-66912007000800007,el,o
168,S0365-66912007000800007,Healon,i
168,S0365-66912007000800007,ha,o
168,S0365-66912007000800007,demostrado,o
168,S0365-66912007000800007,ser,o
168,S0365-66912007000800007,una,o
168,S0365-66912007000800007,sustancia,o
168,S0365-66912007000800007,cohesiva,o
168,S0365-66912007000800007,en,o
168,S0365-66912007000800007,dichas,o
168,S0365-66912007000800007,fases,o
168,S0365-66912007000800007,El,o
168,S0365-66912007000800007,DisCoVisc,i
168,S0365-66912007000800007,permite,o
168,S0365-66912007000800007,una,o
168,S0365-66912007000800007,mejor,o
168,S0365-66912007000800007,visualizacion,o
168,S0365-66912007000800007,y,o
168,S0365-66912007000800007,transparencia,o
168,S0365-66912007000800007,durante,o
168,S0365-66912007000800007,todos,o
168,S0365-66912007000800007,los,o
168,S0365-66912007000800007,pasos,o
168,S0365-66912007000800007,quirurgicos,o
168,S0365-66912007000800007,y,o
168,S0365-66912007000800007,mantiene,o
168,S0365-66912007000800007,mejor,o
168,S0365-66912007000800007,el,o
168,S0365-66912007000800007,el,o
168,S0365-66912007000800007,espacio,i
168,S0365-66912007000800007,capsular,i
168,S0365-66912007000800007,durante,o
168,S0365-66912007000800007,la,o
168,S0365-66912007000800007,implantacion,i
168,S0365-66912007000800007,de,i
168,S0365-66912007000800007,la,i
168,S0365-66912007000800007,lente,i
168,S0365-66912007000800007,intraocular,i
168,S0365-66912007000800007,La,o
168,S0365-66912007000800007,aspiracion,i
168,S0365-66912007000800007,del,o
168,S0365-66912007000800007,viscoelastico,i
168,S0365-66912007000800007,ha,o
168,S0365-66912007000800007,resultado,o
168,S0365-66912007000800007,ser,o
168,S0365-66912007000800007,mas,o
168,S0365-66912007000800007,facil,o
168,S0365-66912007000800007,utilizando,o
168,S0365-66912007000800007,Healon,i
168,S0365-66912007000800007,Conclusiones,o
168,S0365-66912007000800007,El,o
168,S0365-66912007000800007,DisCoVisc,i
168,S0365-66912007000800007,es,o
168,S0365-66912007000800007,un,o
168,S0365-66912007000800007,nuevo,o
168,S0365-66912007000800007,viscoelastico,i
168,S0365-66912007000800007,que,o
168,S0365-66912007000800007,presenta,o
168,S0365-66912007000800007,propiedades,o
168,S0365-66912007000800007,dispersivas,o
168,S0365-66912007000800007,y,o
168,S0365-66912007000800007,cohesivas,o
168,S0365-66912007000800007,evitando,o
168,S0365-66912007000800007,la,o
168,S0365-66912007000800007,utilizacion,o
168,S0365-66912007000800007,de,o
168,S0365-66912007000800007,dos,o
168,S0365-66912007000800007,viscoelasticos,i
168,S0365-66912007000800007,uno,o
168,S0365-66912007000800007,cohesivo,o
168,S0365-66912007000800007,y,o
168,S0365-66912007000800007,otro,o
168,S0365-66912007000800007,dispersivo,o
168,S0365-66912007000800007,para,o
168,S0365-66912007000800007,adaptarse,o
168,S0365-66912007000800007,a,o
168,S0365-66912007000800007,las,o
168,S0365-66912007000800007,necesidades,o
168,S0365-66912007000800007,de,o
168,S0365-66912007000800007,todos,o
168,S0365-66912007000800007,los,o
168,S0365-66912007000800007,pasos,o
168,S0365-66912007000800007,de,o
168,S0365-66912007000800007,la,o
168,S0365-66912007000800007,facoemulsificacion,i
168,S0365-66912007000800007,Ha,o
168,S0365-66912007000800007,demostrado,o
168,S0365-66912007000800007,ofrecer,o
168,S0365-66912007000800007,mayor,o
168,S0365-66912007000800007,transparencia,o
168,S0365-66912007000800007,en,o
168,S0365-66912007000800007,la,o
168,S0365-66912007000800007,cirugia,i
168,S0365-66912007000800007,con,o
168,S0365-66912007000800007,respecto,o
168,S0365-66912007000800007,al,o
168,S0365-66912007000800007,Healon,i
168,S0365-66912007000800007,y,o
168,S0365-66912007000800007,un,o
168,S0365-66912007000800007,mejor,o
168,S0365-66912007000800007,mantenimiento,o
168,S0365-66912007000800007,de,o
168,S0365-66912007000800007,la,o
168,S0365-66912007000800007,camara,i
168,S0365-66912007000800007,anterior,i
168,S0365-66912007000800007,en,o
168,S0365-66912007000800007,todas,o
168,S0365-66912007000800007,las,o
168,S0365-66912007000800007,fases,o
168,S0365-66912007000800007,de,o
168,S0365-66912007000800007,la,o
168,S0365-66912007000800007,cirugia,i
168,S0365-66912007000800007,La,o
168,S0365-66912007000800007,aspiracion,i
168,S0365-66912007000800007,del,o
168,S0365-66912007000800007,Healon,i
168,S0365-66912007000800007,se,o
168,S0365-66912007000800007,realizo,o
168,S0365-66912007000800007,con,o
168,S0365-66912007000800007,mayor,o
168,S0365-66912007000800007,sencillez,o
168,S0365-66912007000800007,por,o
168,S0365-66912007000800007,su,o
168,S0365-66912007000800007,caracter,o
168,S0365-66912007000800007,cohesivo,o
169,S0365-66912009000400003,Cirugia,i
169,S0365-66912009000400003,del,i
169,S0365-66912009000400003,pterigion,i
169,S0365-66912009000400003,estudio,i
169,S0365-66912009000400003,comparativo,i
169,S0365-66912009000400003,entre,o
169,S0365-66912009000400003,autoinjerto,i
169,S0365-66912009000400003,conjuntival,i
169,S0365-66912009000400003,con,o
169,S0365-66912009000400003,sutura,i
169,S0365-66912009000400003,y,o
169,S0365-66912009000400003,con,o
169,S0365-66912009000400003,adhesivo,i
169,S0365-66912009000400003,tisular,i
169,S0365-66912009000400003,Objetivo,o
169,S0365-66912009000400003,Comparar,o
169,S0365-66912009000400003,la,o
169,S0365-66912009000400003,tasa,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,recurrencias,o
169,S0365-66912009000400003,complicaciones,i
169,S0365-66912009000400003,y,o
169,S0365-66912009000400003,hallazgos,o
169,S0365-66912009000400003,biomicroscopicos,o
169,S0365-66912009000400003,despues,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,cirugia,i
169,S0365-66912009000400003,de,i
169,S0365-66912009000400003,pterigion,i
169,S0365-66912009000400003,con,o
169,S0365-66912009000400003,autoinjerto,i
169,S0365-66912009000400003,conjuntival,i
169,S0365-66912009000400003,usando,o
169,S0365-66912009000400003,adhesivo,i
169,S0365-66912009000400003,tisular,i
169,S0365-66912009000400003,Tissucol,i
169,S0365-66912009000400003,Duo,o
169,S0365-66912009000400003,Baxter,o
169,S0365-66912009000400003,AG,o
169,S0365-66912009000400003,Viena,o
169,S0365-66912009000400003,Austria,o
169,S0365-66912009000400003,o,o
169,S0365-66912009000400003,sutura,i
169,S0365-66912009000400003,seda,i
169,S0365-66912009000400003,70,o
169,S0365-66912009000400003,Material,o
169,S0365-66912009000400003,y,o
169,S0365-66912009000400003,metodos,o
169,S0365-66912009000400003,Se,o
169,S0365-66912009000400003,han,o
169,S0365-66912009000400003,incluido,o
169,S0365-66912009000400003,en,o
169,S0365-66912009000400003,el,o
169,S0365-66912009000400003,estudio,o
169,S0365-66912009000400003,pacientes,o
169,S0365-66912009000400003,con,o
169,S0365-66912009000400003,pterigion,i
169,S0365-66912009000400003,nasal,i
169,S0365-66912009000400003,en,o
169,S0365-66912009000400003,dos,o
169,S0365-66912009000400003,grupos,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,cirugia,i
169,S0365-66912009000400003,de,i
169,S0365-66912009000400003,autoinjerto,i
169,S0365-66912009000400003,conjuntival,i
169,S0365-66912009000400003,en,o
169,S0365-66912009000400003,9,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,ellos,o
169,S0365-66912009000400003,el,o
169,S0365-66912009000400003,injerto,i
169,S0365-66912009000400003,se,o
169,S0365-66912009000400003,sutura,i
169,S0365-66912009000400003,a,o
169,S0365-66912009000400003,conjuntiva,i
169,S0365-66912009000400003,y,o
169,S0365-66912009000400003,en,o
169,S0365-66912009000400003,8,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,ellos,o
169,S0365-66912009000400003,se,o
169,S0365-66912009000400003,fija,i
169,S0365-66912009000400003,con,o
169,S0365-66912009000400003,adhesivo,i
169,S0365-66912009000400003,tisular,i
169,S0365-66912009000400003,Resultados,o
169,S0365-66912009000400003,Se,o
169,S0365-66912009000400003,intervinieron,i
169,S0365-66912009000400003,17,o
169,S0365-66912009000400003,ojos,i
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,17,o
169,S0365-66912009000400003,pacientes,o
169,S0365-66912009000400003,412,o
169,S0365-66912009000400003,mujeres,o
169,S0365-66912009000400003,y,o
169,S0365-66912009000400003,588,o
169,S0365-66912009000400003,hombres,o
169,S0365-66912009000400003,con,o
169,S0365-66912009000400003,edad,o
169,S0365-66912009000400003,media,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,598,o
169,S0365-66912009000400003,años,o
169,S0365-66912009000400003,5,o
169,S0365-66912009000400003,ojos,i
169,S0365-66912009000400003,presentaban,o
169,S0365-66912009000400003,recurrencia,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,reseccion,i
169,S0365-66912009000400003,simple,i
169,S0365-66912009000400003,y,o
169,S0365-66912009000400003,12,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,ellos,o
169,S0365-66912009000400003,presentaban,o
169,S0365-66912009000400003,pterigion,i
169,S0365-66912009000400003,primario,o
169,S0365-66912009000400003,El,o
169,S0365-66912009000400003,tamaño,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,la,o
169,S0365-66912009000400003,invasion,i
169,S0365-66912009000400003,corneal,i
169,S0365-66912009000400003,oscilo,o
169,S0365-66912009000400003,entre,o
169,S0365-66912009000400003,2,o
169,S0365-66912009000400003,y,o
169,S0365-66912009000400003,4,o
169,S0365-66912009000400003,mm,o
169,S0365-66912009000400003,333,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,los,o
169,S0365-66912009000400003,pacientes,o
169,S0365-66912009000400003,del,o
169,S0365-66912009000400003,grupo,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,sutura,i
169,S0365-66912009000400003,presentaron,o
169,S0365-66912009000400003,molestias,i
169,S0365-66912009000400003,despues,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,la,o
169,S0365-66912009000400003,cirugia,i
169,S0365-66912009000400003,frente,o
169,S0365-66912009000400003,a,o
169,S0365-66912009000400003,ninguno,o
169,S0365-66912009000400003,en,o
169,S0365-66912009000400003,el,o
169,S0365-66912009000400003,grupo,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,adhesivo,i
169,S0365-66912009000400003,444,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,los,o
169,S0365-66912009000400003,pacientes,o
169,S0365-66912009000400003,presentaron,o
169,S0365-66912009000400003,inflamacion,i
169,S0365-66912009000400003,tras,o
169,S0365-66912009000400003,la,o
169,S0365-66912009000400003,cirugia,i
169,S0365-66912009000400003,frente,o
169,S0365-66912009000400003,a,o
169,S0365-66912009000400003,ninguno,o
169,S0365-66912009000400003,en,o
169,S0365-66912009000400003,el,o
169,S0365-66912009000400003,grupo,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,sutura,i
169,S0365-66912009000400003,En,o
169,S0365-66912009000400003,uno,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,los,o
169,S0365-66912009000400003,pacientes,o
169,S0365-66912009000400003,del,o
169,S0365-66912009000400003,grupo,o
169,S0365-66912009000400003,del,o
169,S0365-66912009000400003,adhesivo,i
169,S0365-66912009000400003,se,o
169,S0365-66912009000400003,produjo,o
169,S0365-66912009000400003,una,o
169,S0365-66912009000400003,perdida,i
169,S0365-66912009000400003,del,i
169,S0365-66912009000400003,injerto,i
169,S0365-66912009000400003,causando,o
169,S0365-66912009000400003,una,o
169,S0365-66912009000400003,posterior,o
169,S0365-66912009000400003,recidiva,o
169,S0365-66912009000400003,del,o
169,S0365-66912009000400003,pterigion,i
169,S0365-66912009000400003,Conclusiones,o
169,S0365-66912009000400003,El,o
169,S0365-66912009000400003,uso,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,adhesivo,i
169,S0365-66912009000400003,tisular,i
169,S0365-66912009000400003,reduce,o
169,S0365-66912009000400003,los,o
169,S0365-66912009000400003,sintomas,i
169,S0365-66912009000400003,postquirurgicos,o
169,S0365-66912009000400003,asi,o
169,S0365-66912009000400003,como,o
169,S0365-66912009000400003,la,o
169,S0365-66912009000400003,inflamacion,i
169,S0365-66912009000400003,y,o
169,S0365-66912009000400003,el,o
169,S0365-66912009000400003,disconfort,i
169,S0365-66912009000400003,La,o
169,S0365-66912009000400003,tasa,o
169,S0365-66912009000400003,de,o
169,S0365-66912009000400003,recurrencias,o
169,S0365-66912009000400003,parece,o
169,S0365-66912009000400003,ser,o
169,S0365-66912009000400003,similar,o
169,S0365-66912009000400003,con,o
169,S0365-66912009000400003,los,o
169,S0365-66912009000400003,dos,o
169,S0365-66912009000400003,procedimientos,i
170,S0365-66912009000500003,Estudio,o
170,S0365-66912009000500003,de,o
170,S0365-66912009000500003,prevalencia,o
170,S0365-66912009000500003,de,o
170,S0365-66912009000500003,retinopatia,i
170,S0365-66912009000500003,diabetica,i
170,S0365-66912009000500003,en,o
170,S0365-66912009000500003,pacientes,o
170,S0365-66912009000500003,diabeticos,i
170,S0365-66912009000500003,mediante,o
170,S0365-66912009000500003,retinografo,o
170,S0365-66912009000500003,no,o
170,S0365-66912009000500003,midriatico,i
170,S0365-66912009000500003,Objetivo,o
170,S0365-66912009000500003,Conocer,o
170,S0365-66912009000500003,la,o
170,S0365-66912009000500003,prevalencia,o
170,S0365-66912009000500003,y,o
170,S0365-66912009000500003,gravedad,o
170,S0365-66912009000500003,de,o
170,S0365-66912009000500003,la,o
170,S0365-66912009000500003,retinopatia,i
170,S0365-66912009000500003,diabetica,i
170,S0365-66912009000500003,RD,i
170,S0365-66912009000500003,en,o
170,S0365-66912009000500003,una,o
170,S0365-66912009000500003,muestra,o
170,S0365-66912009000500003,poblacional,o
170,S0365-66912009000500003,de,o
170,S0365-66912009000500003,pacientes,o
170,S0365-66912009000500003,diabeticos,i
170,S0365-66912009000500003,del,o
170,S0365-66912009000500003,area,o
170,S0365-66912009000500003,sanitaria,o
170,S0365-66912009000500003,3,o
170,S0365-66912009000500003,mediante,o
170,S0365-66912009000500003,el,o
170,S0365-66912009000500003,empleo,i
170,S0365-66912009000500003,de,i
170,S0365-66912009000500003,camaras,i
170,S0365-66912009000500003,no,i
170,S0365-66912009000500003,midriaticas,i
170,S0365-66912009000500003,CNM,o
170,S0365-66912009000500003,y,o
170,S0365-66912009000500003,telemedicina,i
170,S0365-66912009000500003,Metodos,o
170,S0365-66912009000500003,Se,o
170,S0365-66912009000500003,incluyeron,o
170,S0365-66912009000500003,todos,o
170,S0365-66912009000500003,los,o
170,S0365-66912009000500003,pacientes,o
170,S0365-66912009000500003,que,o
170,S0365-66912009000500003,acudieron,o
170,S0365-66912009000500003,a,o
170,S0365-66912009000500003,revision,i
170,S0365-66912009000500003,de,i
170,S0365-66912009000500003,fondo,i
170,S0365-66912009000500003,de,i
170,S0365-66912009000500003,ojo,i
170,S0365-66912009000500003,en,o
170,S0365-66912009000500003,el,o
170,S0365-66912009000500003,area,o
170,S0365-66912009000500003,sanitaria,o
170,S0365-66912009000500003,3,o
170,S0365-66912009000500003,de,o
170,S0365-66912009000500003,la,o
170,S0365-66912009000500003,comunidad,o
170,S0365-66912009000500003,de,o
170,S0365-66912009000500003,Madrid,o
170,S0365-66912009000500003,por,o
170,S0365-66912009000500003,presentar,o
170,S0365-66912009000500003,diabetes,i
170,S0365-66912009000500003,mellitus,i
170,S0365-66912009000500003,tipo,i
170,S0365-66912009000500003,1,i
170,S0365-66912009000500003,DM1,i
170,S0365-66912009000500003,diabetes,i
170,S0365-66912009000500003,mellitus,i
170,S0365-66912009000500003,tipo,i
170,S0365-66912009000500003,no,i
170,S0365-66912009000500003,insulinodependientes,i
170,S0365-66912009000500003,DM2NID,i
170,S0365-66912009000500003,y,o
170,S0365-66912009000500003,diabetes,i
170,S0365-66912009000500003,tipo,i
170,S0365-66912009000500003,2,i
170,S0365-66912009000500003,en,i
170,S0365-66912009000500003,tratamiento,i
170,S0365-66912009000500003,con,i
170,S0365-66912009000500003,insulina,i
170,S0365-66912009000500003,DM2ID,i
170,S0365-66912009000500003,Se,o
170,S0365-66912009000500003,realizaron,o
170,S0365-66912009000500003,retinografias,i
170,S0365-66912009000500003,en,o
170,S0365-66912009000500003,tres,o
170,S0365-66912009000500003,campos,o
170,S0365-66912009000500003,de,o
170,S0365-66912009000500003,los,o
170,S0365-66912009000500003,dos,o
170,S0365-66912009000500003,ojos,i
170,S0365-66912009000500003,que,o
170,S0365-66912009000500003,fueron,o
170,S0365-66912009000500003,valoradas,o
170,S0365-66912009000500003,por,o
170,S0365-66912009000500003,un,o
170,S0365-66912009000500003,oftalmologo,o
170,S0365-66912009000500003,en,o
170,S0365-66912009000500003,el,o
170,S0365-66912009000500003,hospital,o
170,S0365-66912009000500003,Se,o
170,S0365-66912009000500003,valoro,o
170,S0365-66912009000500003,la,o
170,S0365-66912009000500003,presencia,o
170,S0365-66912009000500003,de,o
170,S0365-66912009000500003,retinopatia,i
170,S0365-66912009000500003,diabetica,i
170,S0365-66912009000500003,y,o
170,S0365-66912009000500003,su,o
170,S0365-66912009000500003,gravedad,o
170,S0365-66912009000500003,Resultados,o
170,S0365-66912009000500003,En,o
170,S0365-66912009000500003,el,o
170,S0365-66912009000500003,79,o
170,S0365-66912009000500003,de,o
170,S0365-66912009000500003,los,o
170,S0365-66912009000500003,casos,o
170,S0365-66912009000500003,la,o
170,S0365-66912009000500003,exploracion,i
170,S0365-66912009000500003,no,o
170,S0365-66912009000500003,mostro,o
170,S0365-66912009000500003,signos,i
170,S0365-66912009000500003,de,i
170,S0365-66912009000500003,RD,i
170,S0365-66912009000500003,en,o
170,S0365-66912009000500003,el,o
170,S0365-66912009000500003,9,o
170,S0365-66912009000500003,RD,i
170,S0365-66912009000500003,no,i
170,S0365-66912009000500003,proliferativa,i
170,S0365-66912009000500003,leve,o
170,S0365-66912009000500003,en,o
170,S0365-66912009000500003,el,o
170,S0365-66912009000500003,9,o
170,S0365-66912009000500003,RD,i
170,S0365-66912009000500003,no,i
170,S0365-66912009000500003,proliferante,i
170,S0365-66912009000500003,moderada,o
170,S0365-66912009000500003,en,o
170,S0365-66912009000500003,el,o
170,S0365-66912009000500003,1,o
170,S0365-66912009000500003,RD,i
170,S0365-66912009000500003,no,i
170,S0365-66912009000500003,proliferante,i
170,S0365-66912009000500003,severa,o
170,S0365-66912009000500003,Esto,o
170,S0365-66912009000500003,arroja,o
170,S0365-66912009000500003,una,o
170,S0365-66912009000500003,prevalencia,o
170,S0365-66912009000500003,aproximada,o
170,S0365-66912009000500003,del,o
170,S0365-66912009000500003,21,o
170,S0365-66912009000500003,de,o
170,S0365-66912009000500003,RD,i
170,S0365-66912009000500003,en,o
170,S0365-66912009000500003,la,o
170,S0365-66912009000500003,poblacion,o
170,S0365-66912009000500003,diabetica,i
170,S0365-66912009000500003,del,o
170,S0365-66912009000500003,area,o
170,S0365-66912009000500003,3,o
170,S0365-66912009000500003,El,o
170,S0365-66912009000500003,12,o
170,S0365-66912009000500003,de,o
170,S0365-66912009000500003,las,o
170,S0365-66912009000500003,retinografias,i
170,S0365-66912009000500003,fueron,o
170,S0365-66912009000500003,no,o
170,S0365-66912009000500003,valorables,o
170,S0365-66912009000500003,necesitando,o
170,S0365-66912009000500003,exploracion,i
170,S0365-66912009000500003,por,o
170,S0365-66912009000500003,un,o
170,S0365-66912009000500003,oftalmologo,o
170,S0365-66912009000500003,Conclusiones,o
170,S0365-66912009000500003,El,o
170,S0365-66912009000500003,uso,i
170,S0365-66912009000500003,de,i
170,S0365-66912009000500003,camaras,i
170,S0365-66912009000500003,no,i
170,S0365-66912009000500003,midriaticas,i
170,S0365-66912009000500003,y,o
170,S0365-66912009000500003,telemedicina,i
170,S0365-66912009000500003,es,o
170,S0365-66912009000500003,un,o
170,S0365-66912009000500003,metodo,o
170,S0365-66912009000500003,adecuado,o
170,S0365-66912009000500003,para,o
170,S0365-66912009000500003,el,o
170,S0365-66912009000500003,cribado,i
170,S0365-66912009000500003,de,i
170,S0365-66912009000500003,la,i
170,S0365-66912009000500003,RD,i
170,S0365-66912009000500003,que,o
170,S0365-66912009000500003,en,o
170,S0365-66912009000500003,la,o
170,S0365-66912009000500003,poblacion,o
170,S0365-66912009000500003,afecta,o
170,S0365-66912009000500003,de,o
170,S0365-66912009000500003,diabetes,i
170,S0365-66912009000500003,mellitus,i
171,S0365-66912009000500004,Queratoplastia,i
171,S0365-66912009000500004,endotelial,i
171,S0365-66912009000500004,de,i
171,S0365-66912009000500004,membrana,i
171,S0365-66912009000500004,de,i
171,S0365-66912009000500004,Descemet,i
171,S0365-66912009000500004,DMEK,i
171,S0365-66912009000500004,resultados,o
171,S0365-66912009000500004,a,o
171,S0365-66912009000500004,dos,o
171,S0365-66912009000500004,años,o
171,S0365-66912009000500004,Objetivo,o
171,S0365-66912009000500004,Describir,o
171,S0365-66912009000500004,los,o
171,S0365-66912009000500004,resultados,o
171,S0365-66912009000500004,dos,o
171,S0365-66912009000500004,años,o
171,S0365-66912009000500004,despues,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,realizar,o
171,S0365-66912009000500004,una,o
171,S0365-66912009000500004,queratoplastia,i
171,S0365-66912009000500004,endotelial,i
171,S0365-66912009000500004,de,i
171,S0365-66912009000500004,membrana,i
171,S0365-66912009000500004,de,i
171,S0365-66912009000500004,Descemet,i
171,S0365-66912009000500004,DMEK,i
171,S0365-66912009000500004,Descemet,o
171,S0365-66912009000500004,membrane,o
171,S0365-66912009000500004,endothelial,o
171,S0365-66912009000500004,keratoplasty,o
171,S0365-66912009000500004,para,o
171,S0365-66912009000500004,el,o
171,S0365-66912009000500004,tratamiento,i
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,alteraciones,i
171,S0365-66912009000500004,del,i
171,S0365-66912009000500004,endotelio,i
171,S0365-66912009000500004,corneal,i
171,S0365-66912009000500004,Metodos,o
171,S0365-66912009000500004,Estudio,i
171,S0365-66912009000500004,clinico,i
171,S0365-66912009000500004,prospectivo,i
171,S0365-66912009000500004,no,i
171,S0365-66912009000500004,randomizado,i
171,S0365-66912009000500004,En,o
171,S0365-66912009000500004,10,o
171,S0365-66912009000500004,pacientes,o
171,S0365-66912009000500004,con,o
171,S0365-66912009000500004,distrofia,i
171,S0365-66912009000500004,endotelial,i
171,S0365-66912009000500004,de,i
171,S0365-66912009000500004,Fuchs,i
171,S0365-66912009000500004,o,o
171,S0365-66912009000500004,queratopatia,i
171,S0365-66912009000500004,bullosa,i
171,S0365-66912009000500004,se,o
171,S0365-66912009000500004,practico,o
171,S0365-66912009000500004,una,o
171,S0365-66912009000500004,DMEK,i
171,S0365-66912009000500004,A,o
171,S0365-66912009000500004,traves,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,una,o
171,S0365-66912009000500004,incision,i
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,35,o
171,S0365-66912009000500004,mm,o
171,S0365-66912009000500004,en,o
171,S0365-66912009000500004,cornea,i
171,S0365-66912009000500004,clara,i
171,S0365-66912009000500004,la,o
171,S0365-66912009000500004,membrana,i
171,S0365-66912009000500004,de,i
171,S0365-66912009000500004,Descemet,i
171,S0365-66912009000500004,MD,i
171,S0365-66912009000500004,del,o
171,S0365-66912009000500004,receptor,o
171,S0365-66912009000500004,fue,o
171,S0365-66912009000500004,desprendida,o
171,S0365-66912009000500004,del,o
171,S0365-66912009000500004,estroma,i
171,S0365-66912009000500004,posterior,i
171,S0365-66912009000500004,en,o
171,S0365-66912009000500004,presencia,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,aire,o
171,S0365-66912009000500004,Un,o
171,S0365-66912009000500004,disco,i
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,9,o
171,S0365-66912009000500004,mm,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,diametro,o
171,S0365-66912009000500004,enrollado,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,MD,i
171,S0365-66912009000500004,donante,o
171,S0365-66912009000500004,preservada,o
171,S0365-66912009000500004,fue,o
171,S0365-66912009000500004,insertado,o
171,S0365-66912009000500004,en,o
171,S0365-66912009000500004,la,o
171,S0365-66912009000500004,camara,i
171,S0365-66912009000500004,anterior,i
171,S0365-66912009000500004,del,o
171,S0365-66912009000500004,receptor,o
171,S0365-66912009000500004,posicionado,o
171,S0365-66912009000500004,en,o
171,S0365-66912009000500004,contacto,o
171,S0365-66912009000500004,con,o
171,S0365-66912009000500004,el,o
171,S0365-66912009000500004,estroma,i
171,S0365-66912009000500004,posterior,i
171,S0365-66912009000500004,corneal,i
171,S0365-66912009000500004,y,o
171,S0365-66912009000500004,asegurado,o
171,S0365-66912009000500004,en,o
171,S0365-66912009000500004,su,o
171,S0365-66912009000500004,posicion,o
171,S0365-66912009000500004,mediante,o
171,S0365-66912009000500004,el,o
171,S0365-66912009000500004,llenado,o
171,S0365-66912009000500004,completo,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,la,o
171,S0365-66912009000500004,camara,i
171,S0365-66912009000500004,anterior,i
171,S0365-66912009000500004,con,o
171,S0365-66912009000500004,aire,o
171,S0365-66912009000500004,durante,o
171,S0365-66912009000500004,30,o
171,S0365-66912009000500004,minutos,o
171,S0365-66912009000500004,Resultados,o
171,S0365-66912009000500004,Tres,o
171,S0365-66912009000500004,ojos,i
171,S0365-66912009000500004,mostraron,o
171,S0365-66912009000500004,un,o
171,S0365-66912009000500004,desprendimiento,i
171,S0365-66912009000500004,completo,i
171,S0365-66912009000500004,del,i
171,S0365-66912009000500004,tejido,i
171,S0365-66912009000500004,donante,i
171,S0365-66912009000500004,por,o
171,S0365-66912009000500004,lo,o
171,S0365-66912009000500004,que,o
171,S0365-66912009000500004,fueron,o
171,S0365-66912009000500004,sometidos,o
171,S0365-66912009000500004,posteriormente,o
171,S0365-66912009000500004,a,o
171,S0365-66912009000500004,una,o
171,S0365-66912009000500004,queratoplastia,o
171,S0365-66912009000500004,endotelial,i
171,S0365-66912009000500004,con,o
171,S0365-66912009000500004,pelado,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,la,o
171,S0365-66912009000500004,MD,i
171,S0365-66912009000500004,DSEK,i
171,S0365-66912009000500004,Descemet,o
171,S0365-66912009000500004,stripping,o
171,S0365-66912009000500004,endothelial,o
171,S0365-66912009000500004,keratoplasty,o
171,S0365-66912009000500004,En,o
171,S0365-66912009000500004,los,o
171,S0365-66912009000500004,siete,o
171,S0365-66912009000500004,ojos,i
171,S0365-66912009000500004,restantes,o
171,S0365-66912009000500004,se,o
171,S0365-66912009000500004,observo,o
171,S0365-66912009000500004,una,o
171,S0365-66912009000500004,agudeza,i
171,S0365-66912009000500004,visual,i
171,S0365-66912009000500004,mejor,i
171,S0365-66912009000500004,corregida,i
171,S0365-66912009000500004,AVMC,i
171,S0365-66912009000500004,a,o
171,S0365-66912009000500004,07,o
171,S0365-66912009000500004,en,o
171,S0365-66912009000500004,3,o
171,S0365-66912009000500004,ojos,i
171,S0365-66912009000500004,43,o
171,S0365-66912009000500004,en,o
171,S0365-66912009000500004,el,o
171,S0365-66912009000500004,primer,o
171,S0365-66912009000500004,mes,o
171,S0365-66912009000500004,en,o
171,S0365-66912009000500004,5,o
171,S0365-66912009000500004,ojos,i
171,S0365-66912009000500004,71,o
171,S0365-66912009000500004,a,o
171,S0365-66912009000500004,los,o
171,S0365-66912009000500004,seis,o
171,S0365-66912009000500004,meses,o
171,S0365-66912009000500004,y,o
171,S0365-66912009000500004,en,o
171,S0365-66912009000500004,seis,o
171,S0365-66912009000500004,ojos,i
171,S0365-66912009000500004,86,o
171,S0365-66912009000500004,al,o
171,S0365-66912009000500004,primer,o
171,S0365-66912009000500004,y,o
171,S0365-66912009000500004,segundo,o
171,S0365-66912009000500004,años,o
171,S0365-66912009000500004,A,o
171,S0365-66912009000500004,los,o
171,S0365-66912009000500004,seis,o
171,S0365-66912009000500004,meses,o
171,S0365-66912009000500004,la,o
171,S0365-66912009000500004,densidad,o
171,S0365-66912009000500004,celular,i
171,S0365-66912009000500004,endotelial,i
171,S0365-66912009000500004,media,o
171,S0365-66912009000500004,fue,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,2039,o
171,S0365-66912009000500004,DS,o
171,S0365-66912009000500004,373,o
171,S0365-66912009000500004,celmm2,o
171,S0365-66912009000500004,n7,o
171,S0365-66912009000500004,al,o
171,S0365-66912009000500004,año,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,1925,o
171,S0365-66912009000500004,DS,o
171,S0365-66912009000500004,267,o
171,S0365-66912009000500004,celmm2,o
171,S0365-66912009000500004,n7,o
171,S0365-66912009000500004,y,o
171,S0365-66912009000500004,a,o
171,S0365-66912009000500004,los,o
171,S0365-66912009000500004,2,o
171,S0365-66912009000500004,años,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,1730,o
171,S0365-66912009000500004,DS,o
171,S0365-66912009000500004,400,o
171,S0365-66912009000500004,celmm2,o
171,S0365-66912009000500004,n6,o
171,S0365-66912009000500004,Conclusion,o
171,S0365-66912009000500004,DMEK,i
171,S0365-66912009000500004,podria,o
171,S0365-66912009000500004,proporcionar,o
171,S0365-66912009000500004,una,o
171,S0365-66912009000500004,recuperacion,o
171,S0365-66912009000500004,rapida,o
171,S0365-66912009000500004,y,o
171,S0365-66912009000500004,casi,o
171,S0365-66912009000500004,completa,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,la,o
171,S0365-66912009000500004,vision,o
171,S0365-66912009000500004,Debido,o
171,S0365-66912009000500004,a,o
171,S0365-66912009000500004,que,o
171,S0365-66912009000500004,el,o
171,S0365-66912009000500004,tejido,i
171,S0365-66912009000500004,donante,i
171,S0365-66912009000500004,puede,o
171,S0365-66912009000500004,ser,o
171,S0365-66912009000500004,obtenido,o
171,S0365-66912009000500004,a,o
171,S0365-66912009000500004,partir,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,anillos,o
171,S0365-66912009000500004,corneoesclerales,o
171,S0365-66912009000500004,donantes,o
171,S0365-66912009000500004,el,o
171,S0365-66912009000500004,procedimiento,i
171,S0365-66912009000500004,podria,o
171,S0365-66912009000500004,ser,o
171,S0365-66912009000500004,facilmente,o
171,S0365-66912009000500004,accesible,o
171,S0365-66912009000500004,para,o
171,S0365-66912009000500004,la,o
171,S0365-66912009000500004,mayoria,o
171,S0365-66912009000500004,de,o
171,S0365-66912009000500004,los,o
171,S0365-66912009000500004,cirujanos,o
171,S0365-66912009000500004,corneales,i
172,S0365-66912009000600005,Dexametasona,i
172,S0365-66912009000600005,al,o
172,S0365-66912009000600005,01,o
172,S0365-66912009000600005,versus,o
172,S0365-66912009000600005,Rimexolona,i
172,S0365-66912009000600005,al,o
172,S0365-66912009000600005,1,o
172,S0365-66912009000600005,Estudio,i
172,S0365-66912009000600005,comparativo,i
172,S0365-66912009000600005,en,o
172,S0365-66912009000600005,el,o
172,S0365-66912009000600005,postoperatorio,o
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,cirugia,i
172,S0365-66912009000600005,de,i
172,S0365-66912009000600005,cataratas,i
172,S0365-66912009000600005,Objetivo,o
172,S0365-66912009000600005,Comparar,i
172,S0365-66912009000600005,la,i
172,S0365-66912009000600005,eficacia,i
172,S0365-66912009000600005,y,o
172,S0365-66912009000600005,los,o
172,S0365-66912009000600005,efectos,i
172,S0365-66912009000600005,secundarios,i
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,rimexolona,i
172,S0365-66912009000600005,1,o
172,S0365-66912009000600005,y,o
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,dexametasona,i
172,S0365-66912009000600005,01,o
172,S0365-66912009000600005,en,o
172,S0365-66912009000600005,el,o
172,S0365-66912009000600005,tratamiento,i
172,S0365-66912009000600005,postoperatorio,i
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,cirugia,i
172,S0365-66912009000600005,de,i
172,S0365-66912009000600005,catarata,i
172,S0365-66912009000600005,Material,o
172,S0365-66912009000600005,y,o
172,S0365-66912009000600005,metodos,o
172,S0365-66912009000600005,Estudio,i
172,S0365-66912009000600005,de,i
172,S0365-66912009000600005,cohortes,i
172,S0365-66912009000600005,prospectivo,i
172,S0365-66912009000600005,en,o
172,S0365-66912009000600005,el,o
172,S0365-66912009000600005,que,o
172,S0365-66912009000600005,se,o
172,S0365-66912009000600005,ha,o
172,S0365-66912009000600005,seleccionado,o
172,S0365-66912009000600005,una,o
172,S0365-66912009000600005,muestra,o
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,37,o
172,S0365-66912009000600005,pacientes,o
172,S0365-66912009000600005,intervenidos,i
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,cataratas,i
172,S0365-66912009000600005,mediante,o
172,S0365-66912009000600005,facoemulsificacion,i
172,S0365-66912009000600005,sin,o
172,S0365-66912009000600005,complicaciones,i
172,S0365-66912009000600005,intraoperatorias,i
172,S0365-66912009000600005,en,o
172,S0365-66912009000600005,el,o
172,S0365-66912009000600005,Hospital,o
172,S0365-66912009000600005,Clinico,o
172,S0365-66912009000600005,San,o
172,S0365-66912009000600005,Carlos,o
172,S0365-66912009000600005,y,o
172,S0365-66912009000600005,se,o
172,S0365-66912009000600005,han,o
172,S0365-66912009000600005,dividido,o
172,S0365-66912009000600005,en,o
172,S0365-66912009000600005,dos,o
172,S0365-66912009000600005,grupos,o
172,S0365-66912009000600005,El,o
172,S0365-66912009000600005,grupo,o
172,S0365-66912009000600005,DEX,i
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,19,o
172,S0365-66912009000600005,pacientes,o
172,S0365-66912009000600005,se,o
172,S0365-66912009000600005,trato,o
172,S0365-66912009000600005,con,o
172,S0365-66912009000600005,dexametasona,i
172,S0365-66912009000600005,al,o
172,S0365-66912009000600005,01,o
172,S0365-66912009000600005,topica,o
172,S0365-66912009000600005,como,o
172,S0365-66912009000600005,tratamiento,i
172,S0365-66912009000600005,antiinflamatorio,i
172,S0365-66912009000600005,y,o
172,S0365-66912009000600005,el,o
172,S0365-66912009000600005,grupo,o
172,S0365-66912009000600005,RIMEX,o
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,18,o
172,S0365-66912009000600005,pacientes,o
172,S0365-66912009000600005,se,o
172,S0365-66912009000600005,trato,o
172,S0365-66912009000600005,con,o
172,S0365-66912009000600005,rimexolona,i
172,S0365-66912009000600005,1,o
172,S0365-66912009000600005,topica,o
172,S0365-66912009000600005,siguiendo,o
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,misma,o
172,S0365-66912009000600005,pauta,i
172,S0365-66912009000600005,en,o
172,S0365-66912009000600005,ambos,o
172,S0365-66912009000600005,casos,o
172,S0365-66912009000600005,En,o
172,S0365-66912009000600005,todos,o
172,S0365-66912009000600005,los,o
172,S0365-66912009000600005,pacientes,o
172,S0365-66912009000600005,se,o
172,S0365-66912009000600005,han,o
172,S0365-66912009000600005,estudiado,i
172,S0365-66912009000600005,la,i
172,S0365-66912009000600005,agudeza,i
172,S0365-66912009000600005,visual,i
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,hiperemia,i
172,S0365-66912009000600005,conjuntival,i
172,S0365-66912009000600005,las,o
172,S0365-66912009000600005,celulas,i
172,S0365-66912009000600005,en,i
172,S0365-66912009000600005,camara,i
172,S0365-66912009000600005,anterior,i
172,S0365-66912009000600005,el,o
172,S0365-66912009000600005,flare,o
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,presion,i
172,S0365-66912009000600005,intraocular,i
172,S0365-66912009000600005,el,o
172,S0365-66912009000600005,grosor,o
172,S0365-66912009000600005,corneal,i
172,S0365-66912009000600005,y,o
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,presencia,o
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,edema,i
172,S0365-66912009000600005,macular,i
172,S0365-66912009000600005,a,o
172,S0365-66912009000600005,las,o
172,S0365-66912009000600005,24,o
172,S0365-66912009000600005,horas,o
172,S0365-66912009000600005,y,o
172,S0365-66912009000600005,al,o
172,S0365-66912009000600005,mes,o
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,cirugia,i
172,S0365-66912009000600005,Resultados,o
172,S0365-66912009000600005,Al,o
172,S0365-66912009000600005,comparar,o
172,S0365-66912009000600005,ambos,o
172,S0365-66912009000600005,farmacos,i
172,S0365-66912009000600005,mediante,o
172,S0365-66912009000600005,el,o
172,S0365-66912009000600005,test,o
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,medidas,o
172,S0365-66912009000600005,repetidas,o
172,S0365-66912009000600005,a,o
172,S0365-66912009000600005,las,o
172,S0365-66912009000600005,24,o
172,S0365-66912009000600005,horas,o
172,S0365-66912009000600005,y,o
172,S0365-66912009000600005,al,o
172,S0365-66912009000600005,mes,o
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,cirugia,i
172,S0365-66912009000600005,se,o
172,S0365-66912009000600005,obtuvieron,o
172,S0365-66912009000600005,diferencias,o
172,S0365-66912009000600005,estadisticamente,o
172,S0365-66912009000600005,significativas,o
172,S0365-66912009000600005,en,o
172,S0365-66912009000600005,el,o
172,S0365-66912009000600005,tyndall,o
172,S0365-66912009000600005,p,o
172,S0365-66912009000600005,0001,o
172,S0365-66912009000600005,y,o
172,S0365-66912009000600005,en,o
172,S0365-66912009000600005,el,o
172,S0365-66912009000600005,flare,o
172,S0365-66912009000600005,p,o
172,S0365-66912009000600005,0034,o
172,S0365-66912009000600005,siendo,o
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,reduccion,o
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,estos,o
172,S0365-66912009000600005,parametros,o
172,S0365-66912009000600005,mayor,o
172,S0365-66912009000600005,en,o
172,S0365-66912009000600005,el,o
172,S0365-66912009000600005,grupo,o
172,S0365-66912009000600005,dexametasona,i
172,S0365-66912009000600005,mientras,o
172,S0365-66912009000600005,que,o
172,S0365-66912009000600005,no,o
172,S0365-66912009000600005,se,o
172,S0365-66912009000600005,observaron,o
172,S0365-66912009000600005,cambios,o
172,S0365-66912009000600005,significativos,o
172,S0365-66912009000600005,en,o
172,S0365-66912009000600005,el,o
172,S0365-66912009000600005,resto,o
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,los,o
172,S0365-66912009000600005,parametros,o
172,S0365-66912009000600005,evaluados,o
172,S0365-66912009000600005,Conclusiones,o
172,S0365-66912009000600005,La,o
172,S0365-66912009000600005,Rimexolona,i
172,S0365-66912009000600005,ha,o
172,S0365-66912009000600005,resultado,o
172,S0365-66912009000600005,ser,o
172,S0365-66912009000600005,un,o
172,S0365-66912009000600005,farmaco,i
172,S0365-66912009000600005,util,o
172,S0365-66912009000600005,y,o
172,S0365-66912009000600005,seguro,o
172,S0365-66912009000600005,al,o
172,S0365-66912009000600005,igual,o
172,S0365-66912009000600005,que,o
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,dexametasona,i
172,S0365-66912009000600005,como,o
172,S0365-66912009000600005,tratamiento,i
172,S0365-66912009000600005,postoperatorio,i
172,S0365-66912009000600005,de,o
172,S0365-66912009000600005,la,o
172,S0365-66912009000600005,cirugia,i
172,S0365-66912009000600005,de,i
172,S0365-66912009000600005,catarata,i
173,S0365-66912009001200003,Tratamiento,i
173,S0365-66912009001200003,Focal,i
173,S0365-66912009001200003,Macular,i
173,S0365-66912009001200003,guiado,o
173,S0365-66912009001200003,por,o
173,S0365-66912009001200003,el,o
173,S0365-66912009001200003,mapa,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,grosor,o
173,S0365-66912009001200003,retiniano,i
173,S0365-66912009001200003,del,o
173,S0365-66912009001200003,HDOCT,o
173,S0365-66912009001200003,Cirrus,o
173,S0365-66912009001200003,versus,o
173,S0365-66912009001200003,Angiografia,i
173,S0365-66912009001200003,Fluoresceinica,i
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,las,o
173,S0365-66912009001200003,Oclusiones,i
173,S0365-66912009001200003,Venosas,i
173,S0365-66912009001200003,de,i
173,S0365-66912009001200003,la,i
173,S0365-66912009001200003,Retina,i
173,S0365-66912009001200003,La,o
173,S0365-66912009001200003,fotocoagulacion,i
173,S0365-66912009001200003,macular,i
173,S0365-66912009001200003,sigue,o
173,S0365-66912009001200003,siendo,o
173,S0365-66912009001200003,el,o
173,S0365-66912009001200003,tratamiento,i
173,S0365-66912009001200003,de,i
173,S0365-66912009001200003,eleccion,i
173,S0365-66912009001200003,del,o
173,S0365-66912009001200003,edema,i
173,S0365-66912009001200003,macular,i
173,S0365-66912009001200003,asociado,o
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,patologia,i
173,S0365-66912009001200003,vascular,i
173,S0365-66912009001200003,de,i
173,S0365-66912009001200003,la,i
173,S0365-66912009001200003,retina,i
173,S0365-66912009001200003,1,o
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,forma,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,rejilla,o
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,las,o
173,S0365-66912009001200003,formas,o
173,S0365-66912009001200003,difusas,o
173,S0365-66912009001200003,y,o
173,S0365-66912009001200003,focal,o
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,las,o
173,S0365-66912009001200003,localizadas,o
173,S0365-66912009001200003,La,o
173,S0365-66912009001200003,angiografia,i
173,S0365-66912009001200003,con,i
173,S0365-66912009001200003,fluoresceina,i
173,S0365-66912009001200003,AFG,i
173,S0365-66912009001200003,es,o
173,S0365-66912009001200003,la,o
173,S0365-66912009001200003,prueba,i
173,S0365-66912009001200003,de,i
173,S0365-66912009001200003,imagen,i
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,referencia,o
173,S0365-66912009001200003,para,o
173,S0365-66912009001200003,localizar,o
173,S0365-66912009001200003,los,o
173,S0365-66912009001200003,puntos,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,fuga,o
173,S0365-66912009001200003,y,o
173,S0365-66912009001200003,con,o
173,S0365-66912009001200003,ello,o
173,S0365-66912009001200003,guiar,o
173,S0365-66912009001200003,con,o
173,S0365-66912009001200003,precision,o
173,S0365-66912009001200003,el,o
173,S0365-66912009001200003,tratamiento,i
173,S0365-66912009001200003,con,i
173,S0365-66912009001200003,laser,i
173,S0365-66912009001200003,de,i
173,S0365-66912009001200003,la,i
173,S0365-66912009001200003,macula,i
173,S0365-66912009001200003,2,o
173,S0365-66912009001200003,Se,o
173,S0365-66912009001200003,trata,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,una,o
173,S0365-66912009001200003,exploracion,i
173,S0365-66912009001200003,bien,o
173,S0365-66912009001200003,tolerada,o
173,S0365-66912009001200003,pero,o
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,la,o
173,S0365-66912009001200003,que,o
173,S0365-66912009001200003,existe,o
173,S0365-66912009001200003,hasta,o
173,S0365-66912009001200003,un,o
173,S0365-66912009001200003,10,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,reacciones,i
173,S0365-66912009001200003,adversas,i
173,S0365-66912009001200003,nauseas,i
173,S0365-66912009001200003,y,i
173,S0365-66912009001200003,vomitos,i
173,S0365-66912009001200003,las,o
173,S0365-66912009001200003,mas,o
173,S0365-66912009001200003,frecuentes,o
173,S0365-66912009001200003,edema,i
173,S0365-66912009001200003,pulmonar,i
173,S0365-66912009001200003,infarto,i
173,S0365-66912009001200003,de,i
173,S0365-66912009001200003,miocardio,i
173,S0365-66912009001200003,o,o
173,S0365-66912009001200003,shock,i
173,S0365-66912009001200003,anafilactico,i
173,S0365-66912009001200003,3,o
173,S0365-66912009001200003,ademas,o
173,S0365-66912009001200003,hay,o
173,S0365-66912009001200003,que,o
173,S0365-66912009001200003,considerar,o
173,S0365-66912009001200003,las,o
173,S0365-66912009001200003,dificultades,o
173,S0365-66912009001200003,ocasionales,o
173,S0365-66912009001200003,para,o
173,S0365-66912009001200003,encontrar,o
173,S0365-66912009001200003,una,o
173,S0365-66912009001200003,via,o
173,S0365-66912009001200003,periferica,o
173,S0365-66912009001200003,accesible,o
173,S0365-66912009001200003,y,o
173,S0365-66912009001200003,el,o
173,S0365-66912009001200003,tiempo,o
173,S0365-66912009001200003,que,o
173,S0365-66912009001200003,requiere,o
173,S0365-66912009001200003,para,o
173,S0365-66912009001200003,su,o
173,S0365-66912009001200003,realizacion,o
173,S0365-66912009001200003,Los,o
173,S0365-66912009001200003,nuevos,o
173,S0365-66912009001200003,sistemas,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,tomografia,i
173,S0365-66912009001200003,de,i
173,S0365-66912009001200003,coherencia,i
173,S0365-66912009001200003,optica,i
173,S0365-66912009001200003,de,i
173,S0365-66912009001200003,alta,i
173,S0365-66912009001200003,definicion,i
173,S0365-66912009001200003,basados,o
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,la,o
173,S0365-66912009001200003,tecnologia,o
173,S0365-66912009001200003,espectral,o
173,S0365-66912009001200003,HDOCT,o
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,diferencia,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,los,o
173,S0365-66912009001200003,tomografos,o
173,S0365-66912009001200003,convencionales,o
173,S0365-66912009001200003,OCT,i
173,S0365-66912009001200003,Stratus,o
173,S0365-66912009001200003,Carl,o
173,S0365-66912009001200003,Zeiss,o
173,S0365-66912009001200003,Meditec,o
173,S0365-66912009001200003,permiten,o
173,S0365-66912009001200003,obtener,o
173,S0365-66912009001200003,un,o
173,S0365-66912009001200003,mapa,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,grosor,o
173,S0365-66912009001200003,macular,i
173,S0365-66912009001200003,con,o
173,S0365-66912009001200003,una,o
173,S0365-66912009001200003,resolucion,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,2,o
173,S0365-66912009001200003,micras,o
173,S0365-66912009001200003,codificado,o
173,S0365-66912009001200003,con,o
173,S0365-66912009001200003,una,o
173,S0365-66912009001200003,escala,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,colores,o
173,S0365-66912009001200003,superpuesto,o
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,una,o
173,S0365-66912009001200003,retinografia,i
173,S0365-66912009001200003,De,o
173,S0365-66912009001200003,esta,o
173,S0365-66912009001200003,manera,o
173,S0365-66912009001200003,es,o
173,S0365-66912009001200003,posible,o
173,S0365-66912009001200003,no,o
173,S0365-66912009001200003,solo,o
173,S0365-66912009001200003,cuantificar,o
173,S0365-66912009001200003,las,o
173,S0365-66912009001200003,micras,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,edema,i
173,S0365-66912009001200003,sino,o
173,S0365-66912009001200003,localizar,o
173,S0365-66912009001200003,con,o
173,S0365-66912009001200003,gran,o
173,S0365-66912009001200003,precision,o
173,S0365-66912009001200003,topografica,o
173,S0365-66912009001200003,las,o
173,S0365-66912009001200003,areas,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,engrosamiento,o
173,S0365-66912009001200003,macular,i
173,S0365-66912009001200003,y,o
173,S0365-66912009001200003,con,o
173,S0365-66912009001200003,ello,o
173,S0365-66912009001200003,se,o
173,S0365-66912009001200003,podria,o
173,S0365-66912009001200003,constituir,o
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,una,o
173,S0365-66912009001200003,alternativa,o
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,la,o
173,S0365-66912009001200003,AFG,i
173,S0365-66912009001200003,En,o
173,S0365-66912009001200003,un,o
173,S0365-66912009001200003,estudio,i
173,S0365-66912009001200003,piloto,i
173,S0365-66912009001200003,hemos,o
173,S0365-66912009001200003,valorado,i
173,S0365-66912009001200003,la,i
173,S0365-66912009001200003,eficacia,i
173,S0365-66912009001200003,y,i
173,S0365-66912009001200003,rentabilidad,i
173,S0365-66912009001200003,del,o
173,S0365-66912009001200003,mapa,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,grosor,o
173,S0365-66912009001200003,macular,i
173,S0365-66912009001200003,del,o
173,S0365-66912009001200003,HDOCT,o
173,S0365-66912009001200003,Cirrus,o
173,S0365-66912009001200003,Carl,o
173,S0365-66912009001200003,Zeiss,o
173,S0365-66912009001200003,Meditec,o
173,S0365-66912009001200003,como,o
173,S0365-66912009001200003,guia,o
173,S0365-66912009001200003,del,o
173,S0365-66912009001200003,tratamiento,i
173,S0365-66912009001200003,focal,i
173,S0365-66912009001200003,macular,i
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,pacientes,o
173,S0365-66912009001200003,con,o
173,S0365-66912009001200003,edema,i
173,S0365-66912009001200003,macular,i
173,S0365-66912009001200003,secundario,o
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,oclusion,i
173,S0365-66912009001200003,de,i
173,S0365-66912009001200003,rama,i
173,S0365-66912009001200003,venosa,i
173,S0365-66912009001200003,retiniana,i
173,S0365-66912009001200003,ORVR,i
173,S0365-66912009001200003,Un,o
173,S0365-66912009001200003,total,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,10,o
173,S0365-66912009001200003,ojos,i
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,10,o
173,S0365-66912009001200003,pacientes,o
173,S0365-66912009001200003,con,o
173,S0365-66912009001200003,ORVR,i
173,S0365-66912009001200003,fueron,o
173,S0365-66912009001200003,asignados,i
173,S0365-66912009001200003,de,i
173,S0365-66912009001200003,manera,i
173,S0365-66912009001200003,aleatoria,i
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,recibir,o
173,S0365-66912009001200003,tratamiento,i
173,S0365-66912009001200003,con,i
173,S0365-66912009001200003,laser,i
173,S0365-66912009001200003,guiado,o
173,S0365-66912009001200003,por,o
173,S0365-66912009001200003,AFG,i
173,S0365-66912009001200003,n5,o
173,S0365-66912009001200003,o,o
173,S0365-66912009001200003,por,o
173,S0365-66912009001200003,HDOCT,o
173,S0365-66912009001200003,n5,o
173,S0365-66912009001200003,Se,o
173,S0365-66912009001200003,evaluaron,o
173,S0365-66912009001200003,los,o
173,S0365-66912009001200003,resultados,o
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,los,o
173,S0365-66912009001200003,3,o
173,S0365-66912009001200003,meses,o
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,terminos,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,reduccion,o
173,S0365-66912009001200003,del,o
173,S0365-66912009001200003,grosor,o
173,S0365-66912009001200003,macular,i
173,S0365-66912009001200003,central,o
173,S0365-66912009001200003,Central,o
173,S0365-66912009001200003,Subfield,o
173,S0365-66912009001200003,Thickness,o
173,S0365-66912009001200003,CST,o
173,S0365-66912009001200003,y,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,mejoria,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,la,o
173,S0365-66912009001200003,agudeza,o
173,S0365-66912009001200003,visual,o
173,S0365-66912009001200003,Mejor,i
173,S0365-66912009001200003,Agudeza,i
173,S0365-66912009001200003,Visual,i
173,S0365-66912009001200003,Corregida,i
173,S0365-66912009001200003,MAVC,i
173,S0365-66912009001200003,Los,o
173,S0365-66912009001200003,casos,o
173,S0365-66912009001200003,que,o
173,S0365-66912009001200003,recibieron,o
173,S0365-66912009001200003,la,o
173,S0365-66912009001200003,fotocoagulacion,i
173,S0365-66912009001200003,focal,i
173,S0365-66912009001200003,guiada,o
173,S0365-66912009001200003,mediante,o
173,S0365-66912009001200003,AFG,i
173,S0365-66912009001200003,mostraron,o
173,S0365-66912009001200003,una,o
173,S0365-66912009001200003,reduccion,o
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,el,o
173,S0365-66912009001200003,CST,o
173,S0365-66912009001200003,medio,o
173,S0365-66912009001200003,desde,o
173,S0365-66912009001200003,5005,o
173,S0365-66912009001200003,1068,o
173,S0365-66912009001200003,micras,o
173,S0365-66912009001200003,iniciales,o
173,S0365-66912009001200003,hasta,o
173,S0365-66912009001200003,3343,o
173,S0365-66912009001200003,652,o
173,S0365-66912009001200003,micras,o
173,S0365-66912009001200003,con,o
173,S0365-66912009001200003,un,o
173,S0365-66912009001200003,incremento,o
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,la,o
173,S0365-66912009001200003,MAVC,i
173,S0365-66912009001200003,media,o
173,S0365-66912009001200003,desde,o
173,S0365-66912009001200003,018,o
173,S0365-66912009001200003,016,o
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,030,o
173,S0365-66912009001200003,024,o
173,S0365-66912009001200003,El,o
173,S0365-66912009001200003,grupo,o
173,S0365-66912009001200003,que,o
173,S0365-66912009001200003,recibio,o
173,S0365-66912009001200003,el,o
173,S0365-66912009001200003,tratamiento,i
173,S0365-66912009001200003,guiado,o
173,S0365-66912009001200003,por,o
173,S0365-66912009001200003,HDOCT,o
173,S0365-66912009001200003,mostro,o
173,S0365-66912009001200003,una,o
173,S0365-66912009001200003,reduccion,o
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,el,o
173,S0365-66912009001200003,CST,o
173,S0365-66912009001200003,medio,o
173,S0365-66912009001200003,desde,o
173,S0365-66912009001200003,5591,o
173,S0365-66912009001200003,2176,o
173,S0365-66912009001200003,micras,o
173,S0365-66912009001200003,iniciales,o
173,S0365-66912009001200003,hasta,o
173,S0365-66912009001200003,3235,o
173,S0365-66912009001200003,1001,o
173,S0365-66912009001200003,con,o
173,S0365-66912009001200003,una,o
173,S0365-66912009001200003,mejoria,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,la,o
173,S0365-66912009001200003,MAVC,i
173,S0365-66912009001200003,desde,o
173,S0365-66912009001200003,019,o
173,S0365-66912009001200003,016,o
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,033,o
173,S0365-66912009001200003,028,o
173,S0365-66912009001200003,No,o
173,S0365-66912009001200003,se,o
173,S0365-66912009001200003,objetivaron,o
173,S0365-66912009001200003,diferencias,o
173,S0365-66912009001200003,estadisticamente,o
173,S0365-66912009001200003,significativas,o
173,S0365-66912009001200003,en,o
173,S0365-66912009001200003,ninguno,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,los,o
173,S0365-66912009001200003,parametros,o
173,S0365-66912009001200003,del,o
173,S0365-66912009001200003,estudio,o
173,S0365-66912009001200003,entre,o
173,S0365-66912009001200003,los,o
173,S0365-66912009001200003,dos,o
173,S0365-66912009001200003,grupos,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,tratamiento,i
173,S0365-66912009001200003,p072,o
173,S0365-66912009001200003,para,o
173,S0365-66912009001200003,CST,o
173,S0365-66912009001200003,y,o
173,S0365-66912009001200003,p091,o
173,S0365-66912009001200003,para,o
173,S0365-66912009001200003,MAVC,i
173,S0365-66912009001200003,En,o
173,S0365-66912009001200003,conclusion,o
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,pesar,o
173,S0365-66912009001200003,del,o
173,S0365-66912009001200003,reducido,o
173,S0365-66912009001200003,tamaño,o
173,S0365-66912009001200003,muestral,o
173,S0365-66912009001200003,y,o
173,S0365-66912009001200003,del,o
173,S0365-66912009001200003,corto,o
173,S0365-66912009001200003,periodo,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,seguimiento,i
173,S0365-66912009001200003,los,o
173,S0365-66912009001200003,resultados,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,este,o
173,S0365-66912009001200003,estudio,o
173,S0365-66912009001200003,permiten,o
173,S0365-66912009001200003,sugerir,o
173,S0365-66912009001200003,que,o
173,S0365-66912009001200003,el,o
173,S0365-66912009001200003,tratamiento,i
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,los,o
173,S0365-66912009001200003,edemas,i
173,S0365-66912009001200003,maculares,i
173,S0365-66912009001200003,secundarios,o
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,retinopatias,i
173,S0365-66912009001200003,vasculares,i
173,S0365-66912009001200003,mediante,o
173,S0365-66912009001200003,la,o
173,S0365-66912009001200003,fotocoagulacion,i
173,S0365-66912009001200003,macular,i
173,S0365-66912009001200003,guiada,o
173,S0365-66912009001200003,exclusivamente,o
173,S0365-66912009001200003,por,o
173,S0365-66912009001200003,la,o
173,S0365-66912009001200003,imagen,o
173,S0365-66912009001200003,del,o
173,S0365-66912009001200003,HDOCT,o
173,S0365-66912009001200003,Cirrus,o
173,S0365-66912009001200003,es,o
173,S0365-66912009001200003,una,o
173,S0365-66912009001200003,alternativa,o
173,S0365-66912009001200003,eficaz,o
173,S0365-66912009001200003,y,o
173,S0365-66912009001200003,comparable,o
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,la,o
173,S0365-66912009001200003,AFG,i
173,S0365-66912009001200003,que,o
173,S0365-66912009001200003,evita,o
173,S0365-66912009001200003,exponer,o
173,S0365-66912009001200003,al,o
173,S0365-66912009001200003,paciente,o
173,S0365-66912009001200003,a,o
173,S0365-66912009001200003,una,o
173,S0365-66912009001200003,prueba,i
173,S0365-66912009001200003,invasiva,i
173,S0365-66912009001200003,y,o
173,S0365-66912009001200003,no,o
173,S0365-66912009001200003,exenta,o
173,S0365-66912009001200003,de,o
173,S0365-66912009001200003,riesgos,o
174,S0365-66912010000400002,Evaluacion,i
174,S0365-66912010000400002,mediante,o
174,S0365-66912010000400002,ecografia,i
174,S0365-66912010000400002,doppler,i
174,S0365-66912010000400002,color,i
174,S0365-66912010000400002,del,o
174,S0365-66912010000400002,efecto,o
174,S0365-66912010000400002,de,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,combinacion,o
174,S0365-66912010000400002,fija,o
174,S0365-66912010000400002,bimatoprosttimolol,o
174,S0365-66912010000400002,sobre,o
174,S0365-66912010000400002,el,o
174,S0365-66912010000400002,flujo,i
174,S0365-66912010000400002,sanguineo,i
174,S0365-66912010000400002,ocular,i
174,S0365-66912010000400002,en,o
174,S0365-66912010000400002,pacientes,o
174,S0365-66912010000400002,con,o
174,S0365-66912010000400002,hipertension,i
174,S0365-66912010000400002,ocular,i
174,S0365-66912010000400002,Estudio,o
174,S0365-66912010000400002,preliminar,o
174,S0365-66912010000400002,Objetivo,o
174,S0365-66912010000400002,Evaluar,o
174,S0365-66912010000400002,el,o
174,S0365-66912010000400002,efecto,o
174,S0365-66912010000400002,de,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,administracion,i
174,S0365-66912010000400002,topica,i
174,S0365-66912010000400002,de,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,combinacion,o
174,S0365-66912010000400002,fija,o
174,S0365-66912010000400002,bimatoprost,i
174,S0365-66912010000400002,03,o
174,S0365-66912010000400002,mgmlmaleato,o
174,S0365-66912010000400002,de,o
174,S0365-66912010000400002,timolol,i
174,S0365-66912010000400002,5,o
174,S0365-66912010000400002,mgml,o
174,S0365-66912010000400002,sobre,o
174,S0365-66912010000400002,el,o
174,S0365-66912010000400002,flujo,i
174,S0365-66912010000400002,sanguineo,i
174,S0365-66912010000400002,retrobulbar,i
174,S0365-66912010000400002,en,o
174,S0365-66912010000400002,pacientes,o
174,S0365-66912010000400002,con,o
174,S0365-66912010000400002,hipertension,i
174,S0365-66912010000400002,ocular,i
174,S0365-66912010000400002,HTO,i
174,S0365-66912010000400002,Pacientes,o
174,S0365-66912010000400002,y,o
174,S0365-66912010000400002,metodos,o
174,S0365-66912010000400002,Veinte,o
174,S0365-66912010000400002,pacientes,o
174,S0365-66912010000400002,con,o
174,S0365-66912010000400002,HTO,i
174,S0365-66912010000400002,fueron,o
174,S0365-66912010000400002,incluidos,o
174,S0365-66912010000400002,en,o
174,S0365-66912010000400002,este,o
174,S0365-66912010000400002,estudio,o
174,S0365-66912010000400002,prospectivo,o
174,S0365-66912010000400002,doble,o
174,S0365-66912010000400002,ciego,o
174,S0365-66912010000400002,y,o
174,S0365-66912010000400002,aleatorizados,i
174,S0365-66912010000400002,a,o
174,S0365-66912010000400002,recibir,o
174,S0365-66912010000400002,tratamiento,i
174,S0365-66912010000400002,con,o
174,S0365-66912010000400002,bimatoprosttimolol,o
174,S0365-66912010000400002,o,o
174,S0365-66912010000400002,placebo,i
174,S0365-66912010000400002,durante,o
174,S0365-66912010000400002,12,o
174,S0365-66912010000400002,semanas,o
174,S0365-66912010000400002,Las,o
174,S0365-66912010000400002,pruebas,i
174,S0365-66912010000400002,se,o
174,S0365-66912010000400002,llevaron,o
174,S0365-66912010000400002,a,o
174,S0365-66912010000400002,cabo,o
174,S0365-66912010000400002,en,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,primera,o
174,S0365-66912010000400002,visita,o
174,S0365-66912010000400002,y,o
174,S0365-66912010000400002,a,o
174,S0365-66912010000400002,las,o
174,S0365-66912010000400002,12,o
174,S0365-66912010000400002,semanas,o
174,S0365-66912010000400002,Se,o
174,S0365-66912010000400002,registraron,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,agudeza,i
174,S0365-66912010000400002,visual,i
174,S0365-66912010000400002,presion,i
174,S0365-66912010000400002,intraocular,i
174,S0365-66912010000400002,PIO,i
174,S0365-66912010000400002,examen,i
174,S0365-66912010000400002,en,i
174,S0365-66912010000400002,lampara,i
174,S0365-66912010000400002,de,i
174,S0365-66912010000400002,hendidura,i
174,S0365-66912010000400002,perimetria,i
174,S0365-66912010000400002,estatica,i
174,S0365-66912010000400002,automatica,i
174,S0365-66912010000400002,presion,i
174,S0365-66912010000400002,arterial,i
174,S0365-66912010000400002,sistemica,i
174,S0365-66912010000400002,y,o
174,S0365-66912010000400002,frecuencia,i
174,S0365-66912010000400002,cardiaca,i
174,S0365-66912010000400002,Mediante,o
174,S0365-66912010000400002,ecografia,i
174,S0365-66912010000400002,doppler,i
174,S0365-66912010000400002,color,i
174,S0365-66912010000400002,EDC,i
174,S0365-66912010000400002,se,o
174,S0365-66912010000400002,midieron,o
174,S0365-66912010000400002,los,o
174,S0365-66912010000400002,parametros,o
174,S0365-66912010000400002,del,o
174,S0365-66912010000400002,flujo,i
174,S0365-66912010000400002,sanguineo,i
174,S0365-66912010000400002,retrobulbar,i
174,S0365-66912010000400002,de,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,arteria,i
174,S0365-66912010000400002,oftalmica,i
174,S0365-66912010000400002,AO,i
174,S0365-66912010000400002,y,o
174,S0365-66912010000400002,arteria,i
174,S0365-66912010000400002,central,i
174,S0365-66912010000400002,de,i
174,S0365-66912010000400002,la,i
174,S0365-66912010000400002,retina,i
174,S0365-66912010000400002,ACR,i
174,S0365-66912010000400002,Resultados,o
174,S0365-66912010000400002,La,o
174,S0365-66912010000400002,combinacion,o
174,S0365-66912010000400002,fija,o
174,S0365-66912010000400002,bimatoprosttimolol,o
174,S0365-66912010000400002,redujo,o
174,S0365-66912010000400002,significativamente,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,PIO,i
174,S0365-66912010000400002,p,o
174,S0365-66912010000400002,00001,o
174,S0365-66912010000400002,ademas,o
174,S0365-66912010000400002,de,o
174,S0365-66912010000400002,conseguir,o
174,S0365-66912010000400002,un,o
174,S0365-66912010000400002,incremento,o
174,S0365-66912010000400002,significativo,o
174,S0365-66912010000400002,de,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,velocidad,i
174,S0365-66912010000400002,diastolica,i
174,S0365-66912010000400002,final,i
174,S0365-66912010000400002,VDF,i
174,S0365-66912010000400002,en,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,ACR,i
174,S0365-66912010000400002,p,o
174,S0365-66912010000400002,003,o
174,S0365-66912010000400002,En,o
174,S0365-66912010000400002,el,o
174,S0365-66912010000400002,grupo,o
174,S0365-66912010000400002,de,o
174,S0365-66912010000400002,pacientes,o
174,S0365-66912010000400002,tratados,i
174,S0365-66912010000400002,con,o
174,S0365-66912010000400002,bimatoprosttimolol,o
174,S0365-66912010000400002,se,o
174,S0365-66912010000400002,observo,o
174,S0365-66912010000400002,una,o
174,S0365-66912010000400002,correlacion,o
174,S0365-66912010000400002,estadisticamente,o
174,S0365-66912010000400002,significativa,o
174,S0365-66912010000400002,entre,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,PIO,i
174,S0365-66912010000400002,y,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,VDF,i
174,S0365-66912010000400002,a,o
174,S0365-66912010000400002,las,o
174,S0365-66912010000400002,12,o
174,S0365-66912010000400002,semanas,o
174,S0365-66912010000400002,de,o
174,S0365-66912010000400002,tratamiento,i
174,S0365-66912010000400002,r,o
174,S0365-66912010000400002,0511,o
174,S0365-66912010000400002,p,o
174,S0365-66912010000400002,0045,o
174,S0365-66912010000400002,No,o
174,S0365-66912010000400002,hubo,o
174,S0365-66912010000400002,cambios,o
174,S0365-66912010000400002,significativos,o
174,S0365-66912010000400002,en,o
174,S0365-66912010000400002,las,o
174,S0365-66912010000400002,presiones,i
174,S0365-66912010000400002,arteriales,i
174,S0365-66912010000400002,sistolica,i
174,S0365-66912010000400002,p,o
174,S0365-66912010000400002,054,o
174,S0365-66912010000400002,y,o
174,S0365-66912010000400002,diastolica,o
174,S0365-66912010000400002,p,o
174,S0365-66912010000400002,067,o
174,S0365-66912010000400002,ni,o
174,S0365-66912010000400002,en,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,frecuencia,i
174,S0365-66912010000400002,cardiaca,i
174,S0365-66912010000400002,p,o
174,S0365-66912010000400002,010,o
174,S0365-66912010000400002,durante,o
174,S0365-66912010000400002,el,o
174,S0365-66912010000400002,periodo,o
174,S0365-66912010000400002,de,o
174,S0365-66912010000400002,tratamiento,i
174,S0365-66912010000400002,Conclusiones,o
174,S0365-66912010000400002,La,o
174,S0365-66912010000400002,combinacion,o
174,S0365-66912010000400002,fija,o
174,S0365-66912010000400002,bimatoprosttimolol,o
174,S0365-66912010000400002,redujo,o
174,S0365-66912010000400002,significativamente,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,PIO,i
174,S0365-66912010000400002,en,o
174,S0365-66912010000400002,pacientes,o
174,S0365-66912010000400002,con,o
174,S0365-66912010000400002,HTO,i
174,S0365-66912010000400002,El,o
174,S0365-66912010000400002,unico,o
174,S0365-66912010000400002,cambio,o
174,S0365-66912010000400002,observado,o
174,S0365-66912010000400002,en,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,hemodinamica,o
174,S0365-66912010000400002,retrobulbar,i
174,S0365-66912010000400002,fue,o
174,S0365-66912010000400002,un,o
174,S0365-66912010000400002,incremento,o
174,S0365-66912010000400002,de,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,VDF,i
174,S0365-66912010000400002,en,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,ACR,i
174,S0365-66912010000400002,probablemente,o
174,S0365-66912010000400002,relacionado,o
174,S0365-66912010000400002,con,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,reduccion,o
174,S0365-66912010000400002,de,o
174,S0365-66912010000400002,la,o
174,S0365-66912010000400002,PIO,i
175,S0365-66912010000800003,Estudio,i
175,S0365-66912010000800003,comparativo,i
175,S0365-66912010000800003,entre,o
175,S0365-66912010000800003,cirugia,i
175,S0365-66912010000800003,de,i
175,S0365-66912010000800003,catarata,i
175,S0365-66912010000800003,por,i
175,S0365-66912010000800003,microincision,i
175,S0365-66912010000800003,coaxial,i
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,facoemulsificacion,i
175,S0365-66912010000800003,estandar,o
175,S0365-66912010000800003,Objetivo,o
175,S0365-66912010000800003,Analizar,o
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,comparar,o
175,S0365-66912010000800003,cuantitativamente,o
175,S0365-66912010000800003,los,o
175,S0365-66912010000800003,resultados,o
175,S0365-66912010000800003,obtenidos,o
175,S0365-66912010000800003,tras,o
175,S0365-66912010000800003,la,o
175,S0365-66912010000800003,cirugia,i
175,S0365-66912010000800003,de,i
175,S0365-66912010000800003,catarata,i
175,S0365-66912010000800003,por,i
175,S0365-66912010000800003,microincision,i
175,S0365-66912010000800003,coaxial,i
175,S0365-66912010000800003,CCMIC,o
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,la,o
175,S0365-66912010000800003,facoemulsificacion,i
175,S0365-66912010000800003,convencional,o
175,S0365-66912010000800003,valorando,o
175,S0365-66912010000800003,el,o
175,S0365-66912010000800003,astigmatismo,i
175,S0365-66912010000800003,inducido,o
175,S0365-66912010000800003,la,o
175,S0365-66912010000800003,densidad,o
175,S0365-66912010000800003,de,o
175,S0365-66912010000800003,celulas,i
175,S0365-66912010000800003,endoteliales,i
175,S0365-66912010000800003,el,o
175,S0365-66912010000800003,espesor,o
175,S0365-66912010000800003,corneal,i
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,el,o
175,S0365-66912010000800003,espesor,o
175,S0365-66912010000800003,foveal,i
175,S0365-66912010000800003,en,o
175,S0365-66912010000800003,el,o
175,S0365-66912010000800003,pre,o
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,en,o
175,S0365-66912010000800003,el,o
175,S0365-66912010000800003,postoperatorio,o
175,S0365-66912010000800003,Metodo,o
175,S0365-66912010000800003,Estudio,i
175,S0365-66912010000800003,prospectivo,i
175,S0365-66912010000800003,y,i
175,S0365-66912010000800003,aleatorizado,i
175,S0365-66912010000800003,incluyendo,o
175,S0365-66912010000800003,74,o
175,S0365-66912010000800003,ojos,i
175,S0365-66912010000800003,de,o
175,S0365-66912010000800003,37,o
175,S0365-66912010000800003,pacientes,o
175,S0365-66912010000800003,con,o
175,S0365-66912010000800003,una,o
175,S0365-66912010000800003,edad,o
175,S0365-66912010000800003,media,o
175,S0365-66912010000800003,de,o
175,S0365-66912010000800003,7297755,o
175,S0365-66912010000800003,años,o
175,S0365-66912010000800003,Todos,o
175,S0365-66912010000800003,ellos,o
175,S0365-66912010000800003,fueron,o
175,S0365-66912010000800003,intervenidos,i
175,S0365-66912010000800003,mediante,o
175,S0365-66912010000800003,facoemulsificacion,i
175,S0365-66912010000800003,convencional,o
175,S0365-66912010000800003,en,o
175,S0365-66912010000800003,un,o
175,S0365-66912010000800003,ojo,i
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,CCMIC,o
175,S0365-66912010000800003,en,o
175,S0365-66912010000800003,el,o
175,S0365-66912010000800003,ojo,i
175,S0365-66912010000800003,contralateral,i
175,S0365-66912010000800003,Las,o
175,S0365-66912010000800003,variables,o
175,S0365-66912010000800003,estudiadas,o
175,S0365-66912010000800003,fueron,o
175,S0365-66912010000800003,el,o
175,S0365-66912010000800003,astigmatismo,i
175,S0365-66912010000800003,refractivo,o
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,topografico,o
175,S0365-66912010000800003,la,o
175,S0365-66912010000800003,densidad,o
175,S0365-66912010000800003,de,o
175,S0365-66912010000800003,celulas,i
175,S0365-66912010000800003,endoteliales,i
175,S0365-66912010000800003,el,o
175,S0365-66912010000800003,espesor,o
175,S0365-66912010000800003,corneal,i
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,el,o
175,S0365-66912010000800003,espesor,o
175,S0365-66912010000800003,foveal,i
175,S0365-66912010000800003,estableciendo,o
175,S0365-66912010000800003,los,o
175,S0365-66912010000800003,controles,i
175,S0365-66912010000800003,al,o
175,S0365-66912010000800003,dia,o
175,S0365-66912010000800003,siguiente,o
175,S0365-66912010000800003,a,o
175,S0365-66912010000800003,la,o
175,S0365-66912010000800003,semana,o
175,S0365-66912010000800003,al,o
175,S0365-66912010000800003,mes,o
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,a,o
175,S0365-66912010000800003,los,o
175,S0365-66912010000800003,3,o
175,S0365-66912010000800003,meses,o
175,S0365-66912010000800003,de,o
175,S0365-66912010000800003,la,o
175,S0365-66912010000800003,cirugia,i
175,S0365-66912010000800003,Resultados,o
175,S0365-66912010000800003,Las,o
175,S0365-66912010000800003,variaciones,o
175,S0365-66912010000800003,entre,o
175,S0365-66912010000800003,el,o
175,S0365-66912010000800003,pre,o
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,el,o
175,S0365-66912010000800003,postoperatorio,o
175,S0365-66912010000800003,de,o
175,S0365-66912010000800003,las,o
175,S0365-66912010000800003,diferentes,o
175,S0365-66912010000800003,variables,o
175,S0365-66912010000800003,estudiadas,o
175,S0365-66912010000800003,no,o
175,S0365-66912010000800003,han,o
175,S0365-66912010000800003,mostrado,o
175,S0365-66912010000800003,diferencias,o
175,S0365-66912010000800003,estadisticamente,o
175,S0365-66912010000800003,significativas,o
175,S0365-66912010000800003,entre,o
175,S0365-66912010000800003,ambas,o
175,S0365-66912010000800003,modalidades,o
175,S0365-66912010000800003,quirurgicas,o
175,S0365-66912010000800003,p005,o
175,S0365-66912010000800003,Conclusiones,o
175,S0365-66912010000800003,La,o
175,S0365-66912010000800003,CCMIC,o
175,S0365-66912010000800003,es,o
175,S0365-66912010000800003,una,o
175,S0365-66912010000800003,tecnica,o
175,S0365-66912010000800003,efectiva,o
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,segura,o
175,S0365-66912010000800003,que,o
175,S0365-66912010000800003,ofrece,o
175,S0365-66912010000800003,una,o
175,S0365-66912010000800003,excelente,o
175,S0365-66912010000800003,alternativa,o
175,S0365-66912010000800003,para,o
175,S0365-66912010000800003,la,o
175,S0365-66912010000800003,extraccion,i
175,S0365-66912010000800003,de,i
175,S0365-66912010000800003,la,i
175,S0365-66912010000800003,catarata,i
175,S0365-66912010000800003,con,o
175,S0365-66912010000800003,una,o
175,S0365-66912010000800003,disminucion,o
175,S0365-66912010000800003,en,o
175,S0365-66912010000800003,el,o
175,S0365-66912010000800003,tamaño,o
175,S0365-66912010000800003,de,o
175,S0365-66912010000800003,la,o
175,S0365-66912010000800003,incision,i
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,resultados,o
175,S0365-66912010000800003,postoperatorios,o
175,S0365-66912010000800003,comparables,o
175,S0365-66912010000800003,con,o
175,S0365-66912010000800003,la,o
175,S0365-66912010000800003,tecnica,i
175,S0365-66912010000800003,estandar,i
175,S0365-66912010000800003,Se,o
175,S0365-66912010000800003,requieren,o
175,S0365-66912010000800003,estudios,i
175,S0365-66912010000800003,prospectivos,i
175,S0365-66912010000800003,con,o
175,S0365-66912010000800003,mayor,o
175,S0365-66912010000800003,numero,o
175,S0365-66912010000800003,de,o
175,S0365-66912010000800003,pacientes,o
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,seguimiento,i
175,S0365-66912010000800003,mas,o
175,S0365-66912010000800003,largo,o
175,S0365-66912010000800003,para,o
175,S0365-66912010000800003,establecer,o
175,S0365-66912010000800003,si,o
175,S0365-66912010000800003,realmente,o
175,S0365-66912010000800003,existen,o
175,S0365-66912010000800003,diferencias,o
175,S0365-66912010000800003,estadisticamente,o
175,S0365-66912010000800003,significativas,o
175,S0365-66912010000800003,y,o
175,S0365-66912010000800003,clinicamente,o
175,S0365-66912010000800003,relevantes,o
175,S0365-66912010000800003,entre,o
175,S0365-66912010000800003,ambas,o
175,S0365-66912010000800003,tecnicas,o
176,S0365-66912011000200002,Efecto,o
176,S0365-66912011000200002,de,o
176,S0365-66912011000200002,Combigan,i
176,S0365-66912011000200002,versus,o
176,S0365-66912011000200002,placebo,i
176,S0365-66912011000200002,en,o
176,S0365-66912011000200002,el,o
176,S0365-66912011000200002,flujo,i
176,S0365-66912011000200002,sanguineo,i
176,S0365-66912011000200002,ocular,i
176,S0365-66912011000200002,en,o
176,S0365-66912011000200002,pacientes,o
176,S0365-66912011000200002,hipertensos,i
176,S0365-66912011000200002,oculares,i
176,S0365-66912011000200002,Proposito,o
176,S0365-66912011000200002,Estudiar,o
176,S0365-66912011000200002,los,o
176,S0365-66912011000200002,cambios,o
176,S0365-66912011000200002,hemodinamicos,o
176,S0365-66912011000200002,retrobulbares,i
176,S0365-66912011000200002,mediante,o
176,S0365-66912011000200002,ecografia,i
176,S0365-66912011000200002,doppler,i
176,S0365-66912011000200002,color,i
176,S0365-66912011000200002,en,o
176,S0365-66912011000200002,pacientes,o
176,S0365-66912011000200002,hipertensos,i
176,S0365-66912011000200002,oculares,i
176,S0365-66912011000200002,HTO,i
176,S0365-66912011000200002,en,o
176,S0365-66912011000200002,tratamiento,i
176,S0365-66912011000200002,con,o
176,S0365-66912011000200002,Combigan,i
176,S0365-66912011000200002,versus,o
176,S0365-66912011000200002,placebo,i
176,S0365-66912011000200002,Metodo,o
176,S0365-66912011000200002,Treinta,o
176,S0365-66912011000200002,pacientes,o
176,S0365-66912011000200002,randomizados,i
176,S0365-66912011000200002,en,o
176,S0365-66912011000200002,2,o
176,S0365-66912011000200002,grupos,o
176,S0365-66912011000200002,paralelos,o
176,S0365-66912011000200002,fueron,o
176,S0365-66912011000200002,incluidos,o
176,S0365-66912011000200002,en,o
176,S0365-66912011000200002,un,o
176,S0365-66912011000200002,estudio,i
176,S0365-66912011000200002,prospectivo,i
176,S0365-66912011000200002,y,i
176,S0365-66912011000200002,a,i
176,S0365-66912011000200002,doble,i
176,S0365-66912011000200002,ciego,i
176,S0365-66912011000200002,quince,o
176,S0365-66912011000200002,de,o
176,S0365-66912011000200002,ellos,o
176,S0365-66912011000200002,en,o
176,S0365-66912011000200002,tratamiento,i
176,S0365-66912011000200002,con,o
176,S0365-66912011000200002,Combigan,i
176,S0365-66912011000200002,y,o
176,S0365-66912011000200002,quince,o
176,S0365-66912011000200002,en,o
176,S0365-66912011000200002,tratamiento,i
176,S0365-66912011000200002,con,i
176,S0365-66912011000200002,placebo,i
176,S0365-66912011000200002,durante,o
176,S0365-66912011000200002,un,o
176,S0365-66912011000200002,periodo,o
176,S0365-66912011000200002,de,o
176,S0365-66912011000200002,3,o
176,S0365-66912011000200002,meses,o
176,S0365-66912011000200002,Se,o
176,S0365-66912011000200002,obtuvieron,o
176,S0365-66912011000200002,medidas,o
176,S0365-66912011000200002,de,o
176,S0365-66912011000200002,la,o
176,S0365-66912011000200002,presion,i
176,S0365-66912011000200002,intraocular,i
176,S0365-66912011000200002,PIO,i
176,S0365-66912011000200002,y,o
176,S0365-66912011000200002,del,o
176,S0365-66912011000200002,flujo,i
176,S0365-66912011000200002,sanguineo,i
176,S0365-66912011000200002,a,o
176,S0365-66912011000200002,nivel,o
176,S0365-66912011000200002,de,o
176,S0365-66912011000200002,la,o
176,S0365-66912011000200002,arteria,i
176,S0365-66912011000200002,central,i
176,S0365-66912011000200002,de,i
176,S0365-66912011000200002,la,i
176,S0365-66912011000200002,retina,i
176,S0365-66912011000200002,ACR,i
176,S0365-66912011000200002,y,o
176,S0365-66912011000200002,la,o
176,S0365-66912011000200002,arteria,i
176,S0365-66912011000200002,oftamica,i
176,S0365-66912011000200002,en,o
176,S0365-66912011000200002,el,o
176,S0365-66912011000200002,momento,o
176,S0365-66912011000200002,basal,o
176,S0365-66912011000200002,y,o
176,S0365-66912011000200002,a,o
176,S0365-66912011000200002,los,o
176,S0365-66912011000200002,3,o
176,S0365-66912011000200002,meses,o
176,S0365-66912011000200002,Resultados,o
176,S0365-66912011000200002,Combigan,i
176,S0365-66912011000200002,redujo,o
176,S0365-66912011000200002,significativamente,o
176,S0365-66912011000200002,la,o
176,S0365-66912011000200002,PIO,i
176,S0365-66912011000200002,tras,o
176,S0365-66912011000200002,tres,o
176,S0365-66912011000200002,meses,o
176,S0365-66912011000200002,de,o
176,S0365-66912011000200002,tratamiento,i
176,S0365-66912011000200002,p0001,o
176,S0365-66912011000200002,Los,o
176,S0365-66912011000200002,parametros,o
176,S0365-66912011000200002,hemodinamicos,o
176,S0365-66912011000200002,basales,o
176,S0365-66912011000200002,fueron,o
176,S0365-66912011000200002,similares,o
176,S0365-66912011000200002,entre,o
176,S0365-66912011000200002,los,o
176,S0365-66912011000200002,grupos,o
176,S0365-66912011000200002,placebo,i
176,S0365-66912011000200002,y,o
176,S0365-66912011000200002,tratamiento,i
176,S0365-66912011000200002,Los,o
176,S0365-66912011000200002,pacientes,o
176,S0365-66912011000200002,tratados,i
176,S0365-66912011000200002,con,o
176,S0365-66912011000200002,Combigan,i
176,S0365-66912011000200002,mostraron,o
176,S0365-66912011000200002,un,o
176,S0365-66912011000200002,descenso,o
176,S0365-66912011000200002,estadisticamente,o
176,S0365-66912011000200002,significativo,o
176,S0365-66912011000200002,del,o
176,S0365-66912011000200002,indice,o
176,S0365-66912011000200002,de,o
176,S0365-66912011000200002,resistencia,o
176,S0365-66912011000200002,de,o
176,S0365-66912011000200002,la,o
176,S0365-66912011000200002,ACR,i
176,S0365-66912011000200002,p0007,o
176,S0365-66912011000200002,Conclusiones,o
176,S0365-66912011000200002,Los,o
176,S0365-66912011000200002,pacientes,o
176,S0365-66912011000200002,tratados,i
176,S0365-66912011000200002,durante,o
176,S0365-66912011000200002,3,o
176,S0365-66912011000200002,meses,o
176,S0365-66912011000200002,con,o
176,S0365-66912011000200002,Combigan,i
176,S0365-66912011000200002,mostraron,o
176,S0365-66912011000200002,un,o
176,S0365-66912011000200002,descenso,o
176,S0365-66912011000200002,estadisticamente,o
176,S0365-66912011000200002,significativo,o
176,S0365-66912011000200002,del,o
176,S0365-66912011000200002,indice,o
176,S0365-66912011000200002,de,o
176,S0365-66912011000200002,resistenciade,o
176,S0365-66912011000200002,la,o
176,S0365-66912011000200002,ACR,i
176,S0365-66912011000200002,que,o
176,S0365-66912011000200002,podria,o
176,S0365-66912011000200002,explicarse,o
176,S0365-66912011000200002,por,o
176,S0365-66912011000200002,el,o
176,S0365-66912011000200002,descenso,o
176,S0365-66912011000200002,de,o
176,S0365-66912011000200002,PIO,i
177,S0365-66912011001100004,Efecto,o
177,S0365-66912011001100004,del,o
177,S0365-66912011001100004,cerclaje,i
177,S0365-66912011001100004,escleral,i
177,S0365-66912011001100004,en,o
177,S0365-66912011001100004,la,o
177,S0365-66912011001100004,cirugia,i
177,S0365-66912011001100004,vitreoretiniana,o
177,S0365-66912011001100004,sobre,o
177,S0365-66912011001100004,la,o
177,S0365-66912011001100004,morfologia,o
177,S0365-66912011001100004,y,o
177,S0365-66912011001100004,biomecanica,o
177,S0365-66912011001100004,de,o
177,S0365-66912011001100004,la,o
177,S0365-66912011001100004,cornea,i
177,S0365-66912011001100004,Objetivo,o
177,S0365-66912011001100004,Valorar,o
177,S0365-66912011001100004,los,o
177,S0365-66912011001100004,efectos,o
177,S0365-66912011001100004,del,o
177,S0365-66912011001100004,cerclaje,i
177,S0365-66912011001100004,escleral,i
177,S0365-66912011001100004,en,o
177,S0365-66912011001100004,cirugia,i
177,S0365-66912011001100004,vitreoretiniana,o
177,S0365-66912011001100004,sobre,o
177,S0365-66912011001100004,la,o
177,S0365-66912011001100004,biomecanica,o
177,S0365-66912011001100004,y,o
177,S0365-66912011001100004,morfologia,o
177,S0365-66912011001100004,del,o
177,S0365-66912011001100004,segmento,o
177,S0365-66912011001100004,anterior,o
177,S0365-66912011001100004,Metodos,o
177,S0365-66912011001100004,Estudio,i
177,S0365-66912011001100004,prospectivo,i
177,S0365-66912011001100004,15,o
177,S0365-66912011001100004,ojos,i
177,S0365-66912011001100004,con,o
177,S0365-66912011001100004,desprendimiento,i
177,S0365-66912011001100004,de,i
177,S0365-66912011001100004,retina,i
177,S0365-66912011001100004,DR,i
177,S0365-66912011001100004,sometidos,o
177,S0365-66912011001100004,a,o
177,S0365-66912011001100004,vitrectomia,i
177,S0365-66912011001100004,pars,i
177,S0365-66912011001100004,plana,i
177,S0365-66912011001100004,VPP,i
177,S0365-66912011001100004,mas,o
177,S0365-66912011001100004,implante,i
177,S0365-66912011001100004,de,i
177,S0365-66912011001100004,cerclaje,i
177,S0365-66912011001100004,escleral,i
177,S0365-66912011001100004,grupo,o
177,S0365-66912011001100004,1,o
177,S0365-66912011001100004,y,o
177,S0365-66912011001100004,12,o
177,S0365-66912011001100004,ojos,i
177,S0365-66912011001100004,con,o
177,S0365-66912011001100004,hemorragia,i
177,S0365-66912011001100004,vitrea,i
177,S0365-66912011001100004,sometidos,o
177,S0365-66912011001100004,a,o
177,S0365-66912011001100004,VPP,i
177,S0365-66912011001100004,aislada,o
177,S0365-66912011001100004,grupo,o
177,S0365-66912011001100004,2,o
177,S0365-66912011001100004,Se,o
177,S0365-66912011001100004,compararon,o
177,S0365-66912011001100004,pre,o
177,S0365-66912011001100004,y,o
177,S0365-66912011001100004,postoperatoriamente,o
177,S0365-66912011001100004,las,o
177,S0365-66912011001100004,propiedades,o
177,S0365-66912011001100004,biomecanicas,o
177,S0365-66912011001100004,corneales,i
177,S0365-66912011001100004,mediante,o
177,S0365-66912011001100004,Ocular,o
177,S0365-66912011001100004,Response,o
177,S0365-66912011001100004,Analyzer,o
177,S0365-66912011001100004,ORA,o
177,S0365-66912011001100004,histeresis,i
177,S0365-66912011001100004,corneal,i
177,S0365-66912011001100004,CH,i
177,S0365-66912011001100004,y,o
177,S0365-66912011001100004,factor,i
177,S0365-66912011001100004,de,i
177,S0365-66912011001100004,resistencia,i
177,S0365-66912011001100004,corneal,i
177,S0365-66912011001100004,CRF,i
177,S0365-66912011001100004,ademas,o
177,S0365-66912011001100004,de,o
177,S0365-66912011001100004,presion,i
177,S0365-66912011001100004,intraocular,i
177,S0365-66912011001100004,Goldmann,o
177,S0365-66912011001100004,PIOg,o
177,S0365-66912011001100004,y,o
177,S0365-66912011001100004,presion,i
177,S0365-66912011001100004,intraocular,i
177,S0365-66912011001100004,compensada,o
177,S0365-66912011001100004,PIOcc,o
177,S0365-66912011001100004,Se,o
177,S0365-66912011001100004,investigo,o
177,S0365-66912011001100004,su,o
177,S0365-66912011001100004,relacion,o
177,S0365-66912011001100004,con,o
177,S0365-66912011001100004,4,o
177,S0365-66912011001100004,parametros,o
177,S0365-66912011001100004,morfologicos,o
177,S0365-66912011001100004,obtenidos,o
177,S0365-66912011001100004,con,o
177,S0365-66912011001100004,Orbscan,o
177,S0365-66912011001100004,IIz,o
177,S0365-66912011001100004,potencia,o
177,S0365-66912011001100004,media,o
177,S0365-66912011001100004,de,o
177,S0365-66912011001100004,K,o
177,S0365-66912011001100004,Mean,o
177,S0365-66912011001100004,power,o
177,S0365-66912011001100004,desviacion,o
177,S0365-66912011001100004,estandar,o
177,S0365-66912011001100004,DE,o
177,S0365-66912011001100004,minimo,o
177,S0365-66912011001100004,espesor,o
177,S0365-66912011001100004,corneal,i
177,S0365-66912011001100004,Thinnest,o
177,S0365-66912011001100004,y,o
177,S0365-66912011001100004,profundidad,o
177,S0365-66912011001100004,de,o
177,S0365-66912011001100004,camara,i
177,S0365-66912011001100004,anterior,i
177,S0365-66912011001100004,ACD,o
177,S0365-66912011001100004,Resultados,o
177,S0365-66912011001100004,CH,i
177,S0365-66912011001100004,descendio,o
177,S0365-66912011001100004,de,o
177,S0365-66912011001100004,10217mmHg,o
177,S0365-66912011001100004,a,o
177,S0365-66912011001100004,7611,o
177,S0365-66912011001100004,en,o
177,S0365-66912011001100004,el,o
177,S0365-66912011001100004,grupo,o
177,S0365-66912011001100004,1,o
177,S0365-66912011001100004,p0003,o
177,S0365-66912011001100004,pero,o
177,S0365-66912011001100004,no,o
177,S0365-66912011001100004,en,o
177,S0365-66912011001100004,el,o
177,S0365-66912011001100004,grupo,o
177,S0365-66912011001100004,2,o
177,S0365-66912011001100004,9832,o
177,S0365-66912011001100004,vs,o
177,S0365-66912011001100004,9627,o
177,S0365-66912011001100004,p0465,o
177,S0365-66912011001100004,No,o
177,S0365-66912011001100004,hubo,o
177,S0365-66912011001100004,cambios,o
177,S0365-66912011001100004,en,o
177,S0365-66912011001100004,el,o
177,S0365-66912011001100004,CRF,i
177,S0365-66912011001100004,tras,o
177,S0365-66912011001100004,la,o
177,S0365-66912011001100004,cirugia,i
177,S0365-66912011001100004,PIOg,o
177,S0365-66912011001100004,y,o
177,S0365-66912011001100004,PIOcc,o
177,S0365-66912011001100004,aumentaron,o
177,S0365-66912011001100004,significativamente,o
177,S0365-66912011001100004,en,o
177,S0365-66912011001100004,el,o
177,S0365-66912011001100004,grupo,o
177,S0365-66912011001100004,1,o
177,S0365-66912011001100004,p0019,o
177,S0365-66912011001100004,y,o
177,S0365-66912011001100004,p0010,o
177,S0365-66912011001100004,respectivamente,o
177,S0365-66912011001100004,pero,o
177,S0365-66912011001100004,no,o
177,S0365-66912011001100004,en,o
177,S0365-66912011001100004,el,o
177,S0365-66912011001100004,grupo,o
177,S0365-66912011001100004,2,o
177,S0365-66912011001100004,p0715,o
177,S0365-66912011001100004,y,o
177,S0365-66912011001100004,p0273,o
177,S0365-66912011001100004,No,o
177,S0365-66912011001100004,hubo,o
177,S0365-66912011001100004,cambios,o
177,S0365-66912011001100004,significativos,o
177,S0365-66912011001100004,en,o
177,S0365-66912011001100004,los,o
177,S0365-66912011001100004,parametros,o
177,S0365-66912011001100004,topograficos,o
177,S0365-66912011001100004,en,o
177,S0365-66912011001100004,ambos,o
177,S0365-66912011001100004,grupos,o
177,S0365-66912011001100004,p,o
177,S0365-66912011001100004,005,o
177,S0365-66912011001100004,Test,o
177,S0365-66912011001100004,de,o
177,S0365-66912011001100004,Wilcoxon,o
177,S0365-66912011001100004,Conclusiones,o
177,S0365-66912011001100004,El,o
177,S0365-66912011001100004,cerclaje,i
177,S0365-66912011001100004,escleral,i
177,S0365-66912011001100004,en,o
177,S0365-66912011001100004,la,o
177,S0365-66912011001100004,cirugia,i
177,S0365-66912011001100004,del,i
177,S0365-66912011001100004,DR,i
177,S0365-66912011001100004,no,o
177,S0365-66912011001100004,modifica,o
177,S0365-66912011001100004,significativamente,o
177,S0365-66912011001100004,la,o
177,S0365-66912011001100004,morfologia,o
177,S0365-66912011001100004,del,o
177,S0365-66912011001100004,segmento,o
177,S0365-66912011001100004,anterior,o
177,S0365-66912011001100004,luego,o
177,S0365-66912011001100004,la,o
177,S0365-66912011001100004,miopizacion,i
177,S0365-66912011001100004,generada,o
177,S0365-66912011001100004,se,o
177,S0365-66912011001100004,deberia,o
177,S0365-66912011001100004,exclusivamente,o
177,S0365-66912011001100004,a,o
177,S0365-66912011001100004,la,o
177,S0365-66912011001100004,elongacion,o
177,S0365-66912011001100004,axial,o
177,S0365-66912011001100004,del,o
177,S0365-66912011001100004,segmento,o
177,S0365-66912011001100004,posterior,o
177,S0365-66912011001100004,La,o
177,S0365-66912011001100004,biomecanica,o
177,S0365-66912011001100004,corneal,i
177,S0365-66912011001100004,si,o
177,S0365-66912011001100004,se,o
177,S0365-66912011001100004,altera,o
177,S0365-66912011001100004,disminuyendo,o
177,S0365-66912011001100004,la,o
177,S0365-66912011001100004,CH,i
177,S0365-66912011001100004,Se,o
177,S0365-66912011001100004,aporta,o
177,S0365-66912011001100004,un,o
177,S0365-66912011001100004,argumento,o
177,S0365-66912011001100004,mas,o
177,S0365-66912011001100004,a,o
177,S0365-66912011001100004,favor,o
177,S0365-66912011001100004,de,o
177,S0365-66912011001100004,la,o
177,S0365-66912011001100004,VPP,i
177,S0365-66912011001100004,aislada,o
177,S0365-66912011001100004,en,o
177,S0365-66912011001100004,estas,o
177,S0365-66912011001100004,cirugias,i
177,S0365-66912011001100004,que,o
177,S0365-66912011001100004,supondria,o
177,S0365-66912011001100004,una,o
177,S0365-66912011001100004,tecnica,o
177,S0365-66912011001100004,menos,o
177,S0365-66912011001100004,agresiva,o
177,S0365-66912011001100004,quirurgicamente,o
178,S0370-41062001000100013,Evaluacion,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,la,o
178,S0370-41062001000100013,quimioprofilaxis,i
178,S0370-41062001000100013,con,o
178,S0370-41062001000100013,zidovudine,i
178,S0370-41062001000100013,a,o
178,S0370-41062001000100013,la,o
178,S0370-41062001000100013,mujer,o
178,S0370-41062001000100013,embarazada,o
178,S0370-41062001000100013,VIH,o
178,S0370-41062001000100013,y,o
178,S0370-41062001000100013,su,o
178,S0370-41062001000100013,hijo,o
178,S0370-41062001000100013,Uruguay,o
178,S0370-41062001000100013,En,o
178,S0370-41062001000100013,1994,o
178,S0370-41062001000100013,se,o
178,S0370-41062001000100013,publicaron,o
178,S0370-41062001000100013,los,o
178,S0370-41062001000100013,resultados,o
178,S0370-41062001000100013,del,o
178,S0370-41062001000100013,protocolo,i
178,S0370-41062001000100013,ACTG,o
178,S0370-41062001000100013,076,o
178,S0370-41062001000100013,sobre,o
178,S0370-41062001000100013,quimioprofilaxis,i
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,con,o
178,S0370-41062001000100013,zidovudine,i
178,S0370-41062001000100013,AZT,i
178,S0370-41062001000100013,para,o
178,S0370-41062001000100013,reducir,o
178,S0370-41062001000100013,la,o
178,S0370-41062001000100013,transmision,i
178,S0370-41062001000100013,vertical,i
178,S0370-41062001000100013,del,i
178,S0370-41062001000100013,VIH,i
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,grupo,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,madres,o
178,S0370-41062001000100013,que,o
178,S0370-41062001000100013,recibio,o
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,con,o
178,S0370-41062001000100013,AZT,i
178,S0370-41062001000100013,tuvo,o
178,S0370-41062001000100013,un,o
178,S0370-41062001000100013,porcentaje,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,transmision,i
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,84,o
178,S0370-41062001000100013,comparado,o
178,S0370-41062001000100013,con,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,242,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,los,o
178,S0370-41062001000100013,que,o
178,S0370-41062001000100013,recibian,o
178,S0370-41062001000100013,placebo,i
178,S0370-41062001000100013,Objetivo,o
178,S0370-41062001000100013,El,o
178,S0370-41062001000100013,objetivo,o
178,S0370-41062001000100013,del,o
178,S0370-41062001000100013,presente,o
178,S0370-41062001000100013,trabajo,o
178,S0370-41062001000100013,fue,o
178,S0370-41062001000100013,evaluar,o
178,S0370-41062001000100013,la,o
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,con,o
178,S0370-41062001000100013,AZT,i
178,S0370-41062001000100013,y,o
178,S0370-41062001000100013,los,o
178,S0370-41062001000100013,resultados,o
178,S0370-41062001000100013,obtenidos,o
178,S0370-41062001000100013,Material,o
178,S0370-41062001000100013,y,o
178,S0370-41062001000100013,metodos,o
178,S0370-41062001000100013,se,o
178,S0370-41062001000100013,analizaron,i
178,S0370-41062001000100013,en,i
178,S0370-41062001000100013,forma,i
178,S0370-41062001000100013,retrospectiva,i
178,S0370-41062001000100013,los,o
178,S0370-41062001000100013,datos,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,304,o
178,S0370-41062001000100013,binomios,o
178,S0370-41062001000100013,madrehijo,o
178,S0370-41062001000100013,captados,o
178,S0370-41062001000100013,en,o
178,S0370-41062001000100013,la,o
178,S0370-41062001000100013,Policlinica,o
178,S0370-41062001000100013,maternoinfantil,o
178,S0370-41062001000100013,del,o
178,S0370-41062001000100013,CHPR,o
178,S0370-41062001000100013,desde,o
178,S0370-41062001000100013,junio,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,1990,o
178,S0370-41062001000100013,al,o
178,S0370-41062001000100013,31,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,diciembre,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,1998,o
178,S0370-41062001000100013,Se,o
178,S0370-41062001000100013,definio,o
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,completa,o
178,S0370-41062001000100013,cuando,o
178,S0370-41062001000100013,la,o
178,S0370-41062001000100013,mujer,o
178,S0370-41062001000100013,VIH,o
178,S0370-41062001000100013,embarazada,o
178,S0370-41062001000100013,recibio,o
178,S0370-41062001000100013,AZT,i
178,S0370-41062001000100013,via,o
178,S0370-41062001000100013,oral,o
178,S0370-41062001000100013,durante,o
178,S0370-41062001000100013,un,o
178,S0370-41062001000100013,mes,o
178,S0370-41062001000100013,o,o
178,S0370-41062001000100013,mas,o
178,S0370-41062001000100013,antes,o
178,S0370-41062001000100013,del,o
178,S0370-41062001000100013,nacimiento,o
178,S0370-41062001000100013,endovenoso,o
178,S0370-41062001000100013,durante,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,trabajo,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,parto,o
178,S0370-41062001000100013,y,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,recien,i
178,S0370-41062001000100013,nacido,i
178,S0370-41062001000100013,via,o
178,S0370-41062001000100013,oral,o
178,S0370-41062001000100013,las,o
178,S0370-41062001000100013,primeras,o
178,S0370-41062001000100013,6,o
178,S0370-41062001000100013,semanas,o
178,S0370-41062001000100013,Se,o
178,S0370-41062001000100013,definio,o
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,incompleta,o
178,S0370-41062001000100013,cuando,o
178,S0370-41062001000100013,faltaron,o
178,S0370-41062001000100013,una,o
178,S0370-41062001000100013,o,o
178,S0370-41062001000100013,dos,o
178,S0370-41062001000100013,fases,o
178,S0370-41062001000100013,del,o
178,S0370-41062001000100013,tratamiento,i
178,S0370-41062001000100013,Los,o
178,S0370-41062001000100013,niños,o
178,S0370-41062001000100013,fueron,o
178,S0370-41062001000100013,clasificados,o
178,S0370-41062001000100013,como,o
178,S0370-41062001000100013,serorrevertidos,o
178,S0370-41062001000100013,S,o
178,S0370-41062001000100013,infectados,i
178,S0370-41062001000100013,I,o
178,S0370-41062001000100013,o,o
178,S0370-41062001000100013,perinatalmente,o
178,S0370-41062001000100013,expuestos,o
178,S0370-41062001000100013,E,o
178,S0370-41062001000100013,segun,o
178,S0370-41062001000100013,criterios,o
178,S0370-41062001000100013,del,o
178,S0370-41062001000100013,CDC,o
178,S0370-41062001000100013,Resultados,o
178,S0370-41062001000100013,hasta,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,31121994,o
178,S0370-41062001000100013,se,o
178,S0370-41062001000100013,estudiaron,o
178,S0370-41062001000100013,116,o
178,S0370-41062001000100013,binomios,o
178,S0370-41062001000100013,madrehijo,o
178,S0370-41062001000100013,y,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,porcentaje,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,transmision,i
178,S0370-41062001000100013,vertical,i
178,S0370-41062001000100013,fue,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,284,o
178,S0370-41062001000100013,En,o
178,S0370-41062001000100013,1995,o
178,S0370-41062001000100013,en,o
178,S0370-41062001000100013,31,o
178,S0370-41062001000100013,binomios,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,porcentaje,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,transmision,i
178,S0370-41062001000100013,fue,o
178,S0370-41062001000100013,2903,o
178,S0370-41062001000100013,ningun,o
178,S0370-41062001000100013,binomio,o
178,S0370-41062001000100013,recibio,o
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,completa,o
178,S0370-41062001000100013,y,o
178,S0370-41062001000100013,5,o
178,S0370-41062001000100013,156,o
178,S0370-41062001000100013,lo,o
178,S0370-41062001000100013,recibieron,o
178,S0370-41062001000100013,incompleta,o
178,S0370-41062001000100013,En,o
178,S0370-41062001000100013,1996,o
178,S0370-41062001000100013,en,o
178,S0370-41062001000100013,60,o
178,S0370-41062001000100013,binomios,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,porcentaje,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,transmision,i
178,S0370-41062001000100013,fue,o
178,S0370-41062001000100013,316,o
178,S0370-41062001000100013,7,o
178,S0370-41062001000100013,116,o
178,S0370-41062001000100013,recibieron,o
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,completa,o
178,S0370-41062001000100013,y,o
178,S0370-41062001000100013,22,o
178,S0370-41062001000100013,36,o
178,S0370-41062001000100013,incompleta,o
178,S0370-41062001000100013,En,o
178,S0370-41062001000100013,1997,o
178,S0370-41062001000100013,en,o
178,S0370-41062001000100013,50,o
178,S0370-41062001000100013,binomios,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,porcentaje,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,transmision,i
178,S0370-41062001000100013,fue,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,12,o
178,S0370-41062001000100013,26,o
178,S0370-41062001000100013,529,o
178,S0370-41062001000100013,recibieron,o
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,completa,o
178,S0370-41062001000100013,y,o
178,S0370-41062001000100013,16,o
178,S0370-41062001000100013,313,o
178,S0370-41062001000100013,incompleta,o
178,S0370-41062001000100013,En,o
178,S0370-41062001000100013,1998,o
178,S0370-41062001000100013,en,o
178,S0370-41062001000100013,47,o
178,S0370-41062001000100013,binomios,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,porcentaje,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,transmision,i
178,S0370-41062001000100013,fue,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,85,o
178,S0370-41062001000100013,recibieron,o
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,completa,o
178,S0370-41062001000100013,31,o
178,S0370-41062001000100013,65,o
178,S0370-41062001000100013,e,o
178,S0370-41062001000100013,incompleta,o
178,S0370-41062001000100013,14,o
178,S0370-41062001000100013,2978,o
178,S0370-41062001000100013,Analizados,o
178,S0370-41062001000100013,desde,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,111995,o
178,S0370-41062001000100013,recibieron,o
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,completa,o
178,S0370-41062001000100013,64,o
178,S0370-41062001000100013,binomios,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,porcentaje,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,transmision,i
178,S0370-41062001000100013,fue,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,625,o
178,S0370-41062001000100013,Recibieron,o
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,incompleta,o
178,S0370-41062001000100013,57,o
178,S0370-41062001000100013,binomios,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,porcentaje,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,transmision,i
178,S0370-41062001000100013,fue,o
178,S0370-41062001000100013,87,o
178,S0370-41062001000100013,El,o
178,S0370-41062001000100013,porcentaje,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,transmision,i
178,S0370-41062001000100013,en,o
178,S0370-41062001000100013,los,o
178,S0370-41062001000100013,binomios,o
178,S0370-41062001000100013,que,o
178,S0370-41062001000100013,no,o
178,S0370-41062001000100013,recibieron,o
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,fue,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,432,o
178,S0370-41062001000100013,Conclusiones,o
178,S0370-41062001000100013,a,o
178,S0370-41062001000100013,partir,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,1995,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,numero,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,binomios,o
178,S0370-41062001000100013,madrehijo,o
178,S0370-41062001000100013,que,o
178,S0370-41062001000100013,recibieron,o
178,S0370-41062001000100013,QP,i
178,S0370-41062001000100013,con,o
178,S0370-41062001000100013,AZT,i
178,S0370-41062001000100013,ha,o
178,S0370-41062001000100013,ido,o
178,S0370-41062001000100013,en,o
178,S0370-41062001000100013,aumento,o
178,S0370-41062001000100013,progresivo,o
178,S0370-41062001000100013,con,o
178,S0370-41062001000100013,un,o
178,S0370-41062001000100013,impacto,o
178,S0370-41062001000100013,favorable,o
178,S0370-41062001000100013,al,o
178,S0370-41062001000100013,disminuir,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,numero,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,niños,o
178,S0370-41062001000100013,infectados,i
178,S0370-41062001000100013,La,o
178,S0370-41062001000100013,campaña,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,prevencion,i
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,la,o
178,S0370-41062001000100013,transmision,i
178,S0370-41062001000100013,vertical,i
178,S0370-41062001000100013,del,i
178,S0370-41062001000100013,VIH,i
178,S0370-41062001000100013,en,o
178,S0370-41062001000100013,Uruguay,o
178,S0370-41062001000100013,demostro,o
178,S0370-41062001000100013,resultados,o
178,S0370-41062001000100013,importantes,o
178,S0370-41062001000100013,Una,o
178,S0370-41062001000100013,adecuada,o
178,S0370-41062001000100013,relacion,o
178,S0370-41062001000100013,costobeneficio,o
178,S0370-41062001000100013,y,o
178,S0370-41062001000100013,la,o
178,S0370-41062001000100013,disminucion,o
178,S0370-41062001000100013,del,o
178,S0370-41062001000100013,numero,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,niños,o
178,S0370-41062001000100013,infectados,i
178,S0370-41062001000100013,debe,o
178,S0370-41062001000100013,ser,o
178,S0370-41062001000100013,la,o
178,S0370-41062001000100013,meta,o
178,S0370-41062001000100013,para,o
178,S0370-41062001000100013,el,o
178,S0370-41062001000100013,100,o
178,S0370-41062001000100013,de,o
178,S0370-41062001000100013,los,o
178,S0370-41062001000100013,binomios,o
178,S0370-41062001000100013,madrehijo,o
179,S0370-41062002000100005,Factor,i
179,S0370-41062002000100005,estimulante,i
179,S0370-41062002000100005,de,i
179,S0370-41062002000100005,colonias,i
179,S0370-41062002000100005,granulociticas,i
179,S0370-41062002000100005,en,o
179,S0370-41062002000100005,prevencion,i
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,sepsis,i
179,S0370-41062002000100005,nosocomial,i
179,S0370-41062002000100005,del,o
179,S0370-41062002000100005,prematuro,i
179,S0370-41062002000100005,estudio,o
179,S0370-41062002000100005,doble,o
179,S0370-41062002000100005,ciego,o
179,S0370-41062002000100005,randomizado,o
179,S0370-41062002000100005,controlado,o
179,S0370-41062002000100005,El,o
179,S0370-41062002000100005,recien,i
179,S0370-41062002000100005,nacido,i
179,S0370-41062002000100005,presenta,o
179,S0370-41062002000100005,con,o
179,S0370-41062002000100005,frecuencia,o
179,S0370-41062002000100005,infecciones,i
179,S0370-41062002000100005,bacterianas,i
179,S0370-41062002000100005,severas,o
179,S0370-41062002000100005,que,o
179,S0370-41062002000100005,pueden,o
179,S0370-41062002000100005,o,o
179,S0370-41062002000100005,no,o
179,S0370-41062002000100005,acompañarse,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,neutropenia,i
179,S0370-41062002000100005,las,o
179,S0370-41062002000100005,que,o
179,S0370-41062002000100005,se,o
179,S0370-41062002000100005,ven,o
179,S0370-41062002000100005,favorecidas,o
179,S0370-41062002000100005,por,o
179,S0370-41062002000100005,una,o
179,S0370-41062002000100005,insuficiencia,o
179,S0370-41062002000100005,cualitativa,o
179,S0370-41062002000100005,y,o
179,S0370-41062002000100005,cuantitativa,o
179,S0370-41062002000100005,del,o
179,S0370-41062002000100005,sistema,i
179,S0370-41062002000100005,fagocitico,i
179,S0370-41062002000100005,neutrofilo,i
179,S0370-41062002000100005,en,o
179,S0370-41062002000100005,esta,o
179,S0370-41062002000100005,etapa,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,la,o
179,S0370-41062002000100005,vida,o
179,S0370-41062002000100005,Lo,o
179,S0370-41062002000100005,anterior,o
179,S0370-41062002000100005,se,o
179,S0370-41062002000100005,acentua,o
179,S0370-41062002000100005,aun,o
179,S0370-41062002000100005,mas,o
179,S0370-41062002000100005,en,o
179,S0370-41062002000100005,el,o
179,S0370-41062002000100005,prematuro,i
179,S0370-41062002000100005,lo,o
179,S0370-41062002000100005,que,o
179,S0370-41062002000100005,contribuye,o
179,S0370-41062002000100005,a,o
179,S0370-41062002000100005,altas,o
179,S0370-41062002000100005,tasas,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,morbimortalidad,o
179,S0370-41062002000100005,por,o
179,S0370-41062002000100005,infeccion,i
179,S0370-41062002000100005,Publicaciones,o
179,S0370-41062002000100005,recientes,o
179,S0370-41062002000100005,sugieren,o
179,S0370-41062002000100005,la,o
179,S0370-41062002000100005,utilidad,o
179,S0370-41062002000100005,del,o
179,S0370-41062002000100005,factor,i
179,S0370-41062002000100005,estimulante,i
179,S0370-41062002000100005,de,i
179,S0370-41062002000100005,colonias,i
179,S0370-41062002000100005,granulociticas,i
179,S0370-41062002000100005,rHGCF,o
179,S0370-41062002000100005,El,o
179,S0370-41062002000100005,objetivo,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,nuestro,o
179,S0370-41062002000100005,estudio,o
179,S0370-41062002000100005,fue,o
179,S0370-41062002000100005,la,o
179,S0370-41062002000100005,evaluacion,i
179,S0370-41062002000100005,prospectiva,i
179,S0370-41062002000100005,del,o
179,S0370-41062002000100005,uso,o
179,S0370-41062002000100005,precoz,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,rHGCSF,o
179,S0370-41062002000100005,en,o
179,S0370-41062002000100005,prevencion,i
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,sepsis,i
179,S0370-41062002000100005,nosocomial,i
179,S0370-41062002000100005,Pacientes,o
179,S0370-41062002000100005,y,o
179,S0370-41062002000100005,Metodos,o
179,S0370-41062002000100005,Se,o
179,S0370-41062002000100005,estudiaron,o
179,S0370-41062002000100005,68,o
179,S0370-41062002000100005,recien,i
179,S0370-41062002000100005,nacidos,i
179,S0370-41062002000100005,pretermino,i
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,menos,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,32,o
179,S0370-41062002000100005,semanas,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,edad,o
179,S0370-41062002000100005,gestacional,o
179,S0370-41062002000100005,y,o
179,S0370-41062002000100005,peso,o
179,S0370-41062002000100005,inferior,o
179,S0370-41062002000100005,a,o
179,S0370-41062002000100005,1,o
179,S0370-41062002000100005,500,o
179,S0370-41062002000100005,g,o
179,S0370-41062002000100005,libres,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,infeccion,i
179,S0370-41062002000100005,clinica,i
179,S0370-41062002000100005,34,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,ellos,o
179,S0370-41062002000100005,fueron,o
179,S0370-41062002000100005,asignados,o
179,S0370-41062002000100005,a,o
179,S0370-41062002000100005,tratamiento,i
179,S0370-41062002000100005,diario,o
179,S0370-41062002000100005,por,o
179,S0370-41062002000100005,un,o
179,S0370-41062002000100005,periodo,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,15,o
179,S0370-41062002000100005,dias,o
179,S0370-41062002000100005,con,o
179,S0370-41062002000100005,rHGCSF,o
179,S0370-41062002000100005,desde,o
179,S0370-41062002000100005,antes,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,las,o
179,S0370-41062002000100005,72,o
179,S0370-41062002000100005,horas,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,vida,o
179,S0370-41062002000100005,la,o
179,S0370-41062002000100005,asignacion,o
179,S0370-41062002000100005,se,o
179,S0370-41062002000100005,realizo,o
179,S0370-41062002000100005,en,i
179,S0370-41062002000100005,forma,i
179,S0370-41062002000100005,ciega,i
179,S0370-41062002000100005,y,i
179,S0370-41062002000100005,randomizada,i
179,S0370-41062002000100005,por,o
179,S0370-41062002000100005,tablas,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,numeros,o
179,S0370-41062002000100005,al,i
179,S0370-41062002000100005,azar,i
179,S0370-41062002000100005,Resultados,o
179,S0370-41062002000100005,la,o
179,S0370-41062002000100005,morbilidad,o
179,S0370-41062002000100005,infecciosa,i
179,S0370-41062002000100005,tanto,o
179,S0370-41062002000100005,sospechada,o
179,S0370-41062002000100005,como,o
179,S0370-41062002000100005,confirmada,o
179,S0370-41062002000100005,no,o
179,S0370-41062002000100005,mostro,o
179,S0370-41062002000100005,diferencias,o
179,S0370-41062002000100005,entre,o
179,S0370-41062002000100005,ambos,o
179,S0370-41062002000100005,grupos,o
179,S0370-41062002000100005,a,o
179,S0370-41062002000100005,pesar,o
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,lograr,o
179,S0370-41062002000100005,una,o
179,S0370-41062002000100005,neutrofilia,o
179,S0370-41062002000100005,significativa,o
179,S0370-41062002000100005,Conclusion,o
179,S0370-41062002000100005,En,o
179,S0370-41062002000100005,este,o
179,S0370-41062002000100005,estudio,o
179,S0370-41062002000100005,rHGCF,o
179,S0370-41062002000100005,no,o
179,S0370-41062002000100005,demostro,o
179,S0370-41062002000100005,ser,o
179,S0370-41062002000100005,util,o
179,S0370-41062002000100005,en,o
179,S0370-41062002000100005,la,o
179,S0370-41062002000100005,prevencion,i
179,S0370-41062002000100005,de,o
179,S0370-41062002000100005,sepsis,i
179,S0370-41062002000100005,de,i
179,S0370-41062002000100005,origen,i
179,S0370-41062002000100005,intrahospitalario,i
180,S0370-41062008000400015,Respuesta,o
180,S0370-41062008000400015,broncodilatadora,o
180,S0370-41062008000400015,del,o
180,S0370-41062008000400015,salbutamol,i
180,S0370-41062008000400015,administrado,o
180,S0370-41062008000400015,como,o
180,S0370-41062008000400015,aerosol,o
180,S0370-41062008000400015,presurizado,o
180,S0370-41062008000400015,mediante,o
180,S0370-41062008000400015,aerocamaras,o
180,S0370-41062008000400015,con,o
180,S0370-41062008000400015,valvulas,o
180,S0370-41062008000400015,o,o
180,S0370-41062008000400015,espaciadores,o
180,S0370-41062008000400015,no,o
180,S0370-41062008000400015,valvulados,o
180,S0370-41062008000400015,Introduccion,o
180,S0370-41062008000400015,Los,o
180,S0370-41062008000400015,medicamentos,i
180,S0370-41062008000400015,para,o
180,S0370-41062008000400015,tratar,i
180,S0370-41062008000400015,asma,i
180,S0370-41062008000400015,utilizan,o
180,S0370-41062008000400015,fundamentalmente,o
180,S0370-41062008000400015,la,o
180,S0370-41062008000400015,via,o
180,S0370-41062008000400015,inhalatoria,o
180,S0370-41062008000400015,La,o
180,S0370-41062008000400015,utilidad,o
180,S0370-41062008000400015,de,o
180,S0370-41062008000400015,los,o
180,S0370-41062008000400015,espaciadores,o
180,S0370-41062008000400015,con,o
180,S0370-41062008000400015,valvulas,o
180,S0370-41062008000400015,aerocamaras,o
180,S0370-41062008000400015,esta,o
180,S0370-41062008000400015,demostrada,o
180,S0370-41062008000400015,sin,o
180,S0370-41062008000400015,embargo,o
180,S0370-41062008000400015,recientemente,o
180,S0370-41062008000400015,se,o
180,S0370-41062008000400015,ha,o
180,S0370-41062008000400015,propuesto,o
180,S0370-41062008000400015,como,o
180,S0370-41062008000400015,una,o
180,S0370-41062008000400015,alternativa,o
180,S0370-41062008000400015,mas,o
180,S0370-41062008000400015,economica,o
180,S0370-41062008000400015,el,o
180,S0370-41062008000400015,uso,o
180,S0370-41062008000400015,de,o
180,S0370-41062008000400015,espaciadores,o
180,S0370-41062008000400015,sin,o
180,S0370-41062008000400015,valvulas,o
180,S0370-41062008000400015,La,o
180,S0370-41062008000400015,eficacia,o
180,S0370-41062008000400015,clinica,o
180,S0370-41062008000400015,de,o
180,S0370-41062008000400015,estos,o
180,S0370-41062008000400015,no,o
180,S0370-41062008000400015,se,o
180,S0370-41062008000400015,ha,o
180,S0370-41062008000400015,demostrado,o
180,S0370-41062008000400015,hasta,o
180,S0370-41062008000400015,el,o
180,S0370-41062008000400015,momento,o
180,S0370-41062008000400015,Objetivo,o
180,S0370-41062008000400015,Comparar,o
180,S0370-41062008000400015,la,o
180,S0370-41062008000400015,respuesta,o
180,S0370-41062008000400015,broncodilatadora,o
180,S0370-41062008000400015,de,o
180,S0370-41062008000400015,un,o
180,S0370-41062008000400015,inhalador,o
180,S0370-41062008000400015,de,o
180,S0370-41062008000400015,dosis,o
180,S0370-41062008000400015,medida,o
180,S0370-41062008000400015,IDM,o
180,S0370-41062008000400015,de,o
180,S0370-41062008000400015,salbutamol,i
180,S0370-41062008000400015,administrado,o
180,S0370-41062008000400015,a,o
180,S0370-41062008000400015,traves,o
180,S0370-41062008000400015,de,o
180,S0370-41062008000400015,una,o
180,S0370-41062008000400015,aerocamara,o
180,S0370-41062008000400015,contra,o
180,S0370-41062008000400015,un,o
180,S0370-41062008000400015,espaciador,o
180,S0370-41062008000400015,sin,o
180,S0370-41062008000400015,valvulas,o
180,S0370-41062008000400015,Poblacion,o
180,S0370-41062008000400015,material,o
180,S0370-41062008000400015,y,o
180,S0370-41062008000400015,metodos,o
180,S0370-41062008000400015,Estudio,o
180,S0370-41062008000400015,experimental,o
180,S0370-41062008000400015,prospectivo,o
180,S0370-41062008000400015,aleatorizado,o
180,S0370-41062008000400015,simple,o
180,S0370-41062008000400015,ciego,o
180,S0370-41062008000400015,de,o
180,S0370-41062008000400015,grupos,o
180,S0370-41062008000400015,paralelos,o
180,S0370-41062008000400015,Se,o
180,S0370-41062008000400015,incluyeron,o
180,S0370-41062008000400015,34,o
180,S0370-41062008000400015,pacientes,o
180,S0370-41062008000400015,616,o
180,S0370-41062008000400015,años,o
180,S0370-41062008000400015,con,o
180,S0370-41062008000400015,asma,i
180,S0370-41062008000400015,que,o
180,S0370-41062008000400015,presentaban,o
180,S0370-41062008000400015,obstruccion,i
180,S0370-41062008000400015,bronquial,i
180,S0370-41062008000400015,leve,o
180,S0370-41062008000400015,o,o
180,S0370-41062008000400015,moderada,o
180,S0370-41062008000400015,volumen,i
180,S0370-41062008000400015,respiratorio,i
180,S0370-41062008000400015,forzado,i
180,S0370-41062008000400015,entre,o
180,S0370-41062008000400015,50,o
180,S0370-41062008000400015,y,o
180,S0370-41062008000400015,79,o
180,S0370-41062008000400015,del,o
180,S0370-41062008000400015,valor,o
180,S0370-41062008000400015,predictivo,o
180,S0370-41062008000400015,sin,o
180,S0370-41062008000400015,haber,o
180,S0370-41062008000400015,recibido,o
180,S0370-41062008000400015,broncodilatadores,i
180,S0370-41062008000400015,recientemente,o
180,S0370-41062008000400015,Luego,o
180,S0370-41062008000400015,de,o
180,S0370-41062008000400015,una,o
180,S0370-41062008000400015,espirometria,i
180,S0370-41062008000400015,inicial,o
180,S0370-41062008000400015,se,o
180,S0370-41062008000400015,asignaron,o
180,S0370-41062008000400015,para,o
180,S0370-41062008000400015,recibir,o
180,S0370-41062008000400015,100,o
180,S0370-41062008000400015,mg,o
180,S0370-41062008000400015,de,o
180,S0370-41062008000400015,salbutamol,i
180,S0370-41062008000400015,aerosol,o
180,S0370-41062008000400015,presurizado,o
180,S0370-41062008000400015,mediante,o
180,S0370-41062008000400015,una,o
180,S0370-41062008000400015,aerocamara,o
180,S0370-41062008000400015,con,o
180,S0370-41062008000400015,valvulas,o
180,S0370-41062008000400015,Aerochamber,o
180,S0370-41062008000400015,o,o
180,S0370-41062008000400015,un,o
180,S0370-41062008000400015,espaciador,o
180,S0370-41062008000400015,sin,o
180,S0370-41062008000400015,valvulas,o
180,S0370-41062008000400015,Aeromed,o
180,S0370-41062008000400015,Se,o
180,S0370-41062008000400015,determino,o
180,S0370-41062008000400015,la,o
180,S0370-41062008000400015,respuesta,o
180,S0370-41062008000400015,broncodilatadora,o
180,S0370-41062008000400015,del,o
180,S0370-41062008000400015,volumen,i
180,S0370-41062008000400015,respiratorio,i
180,S0370-41062008000400015,forzado,i
180,S0370-41062008000400015,y,o
180,S0370-41062008000400015,del,o
180,S0370-41062008000400015,FMF,i
180,S0370-41062008000400015,a,o
180,S0370-41062008000400015,los,o
180,S0370-41062008000400015,30,o
180,S0370-41062008000400015,minutos,o
180,S0370-41062008000400015,Resultados,o
180,S0370-41062008000400015,En,o
180,S0370-41062008000400015,el,o
180,S0370-41062008000400015,grupo,o
180,S0370-41062008000400015,tratado,i
180,S0370-41062008000400015,con,i
180,S0370-41062008000400015,aerocamara,i
180,S0370-41062008000400015,ingresaron,i
180,S0370-41062008000400015,17,o
180,S0370-41062008000400015,pacientes,o
180,S0370-41062008000400015,12,o
180,S0370-41062008000400015,varones,o
180,S0370-41062008000400015,volumen,i
180,S0370-41062008000400015,respiratorio,i
180,S0370-41062008000400015,forzado,i
180,S0370-41062008000400015,basal,o
180,S0370-41062008000400015,67,o
180,S0370-41062008000400015,10,o
180,S0370-41062008000400015,y,o
180,S0370-41062008000400015,en,o
180,S0370-41062008000400015,el,o
180,S0370-41062008000400015,grupo,o
180,S0370-41062008000400015,con,o
180,S0370-41062008000400015,espaciador,o
180,S0370-41062008000400015,sin,o
180,S0370-41062008000400015,valvulas,o
180,S0370-41062008000400015,ingresaron,i
180,S0370-41062008000400015,17,o
180,S0370-41062008000400015,pacientes,o
180,S0370-41062008000400015,13,o
180,S0370-41062008000400015,varones,o
180,S0370-41062008000400015,volumen,i
180,S0370-41062008000400015,respiratorio,i
180,S0370-41062008000400015,forzado,i
180,S0370-41062008000400015,basal,o
180,S0370-41062008000400015,67,o
180,S0370-41062008000400015,6,o
180,S0370-41062008000400015,La,o
180,S0370-41062008000400015,variacion,o
180,S0370-41062008000400015,del,o
180,S0370-41062008000400015,FEV1,i
180,S0370-41062008000400015,fue,o
180,S0370-41062008000400015,26,o
180,S0370-41062008000400015,14,o
180,S0370-41062008000400015,contra,o
180,S0370-41062008000400015,16,o
180,S0370-41062008000400015,5,o
180,S0370-41062008000400015,p,o
180,S0370-41062008000400015,0017,o
180,S0370-41062008000400015,y,o
180,S0370-41062008000400015,la,o
180,S0370-41062008000400015,variacion,o
180,S0370-41062008000400015,del,o
180,S0370-41062008000400015,FMF,i
180,S0370-41062008000400015,fue,o
180,S0370-41062008000400015,92,o
180,S0370-41062008000400015,48,o
180,S0370-41062008000400015,contra,o
180,S0370-41062008000400015,5829,o
180,S0370-41062008000400015,p,o
180,S0370-41062008000400015,0018,o
180,S0370-41062008000400015,para,o
180,S0370-41062008000400015,aerocamaras,o
180,S0370-41062008000400015,y,o
180,S0370-41062008000400015,espaciadores,o
180,S0370-41062008000400015,sin,o
180,S0370-41062008000400015,valvulas,o
180,S0370-41062008000400015,respectivamente,o
180,S0370-41062008000400015,ANOVA,o
180,S0370-41062008000400015,Conclusion,o
180,S0370-41062008000400015,El,o
180,S0370-41062008000400015,aerosol,o
180,S0370-41062008000400015,presurizado,o
180,S0370-41062008000400015,de,o
180,S0370-41062008000400015,salbutamol,i
180,S0370-41062008000400015,administrado,o
180,S0370-41062008000400015,a,o
180,S0370-41062008000400015,traves,o
180,S0370-41062008000400015,de,o
180,S0370-41062008000400015,aerocamaras,o
180,S0370-41062008000400015,con,o
180,S0370-41062008000400015,valvulas,o
180,S0370-41062008000400015,produce,o
180,S0370-41062008000400015,una,o
180,S0370-41062008000400015,respuesta,o
180,S0370-41062008000400015,broncodilatadora,o
180,S0370-41062008000400015,mayor,o
180,S0370-41062008000400015,que,o
180,S0370-41062008000400015,con,o
180,S0370-41062008000400015,espaciadores,o
180,S0370-41062008000400015,sin,o
180,S0370-41062008000400015,valvulas,o
180,S0370-41062008000400015,en,o
180,S0370-41062008000400015,niños,o
180,S0370-41062008000400015,con,o
180,S0370-41062008000400015,asma,i
181,S0370-41062012000100012,Efecto,o
181,S0370-41062012000100012,del,o
181,S0370-41062012000100012,clampeo,i
181,S0370-41062012000100012,demorado,i
181,S0370-41062012000100012,del,i
181,S0370-41062012000100012,cordon,i
181,S0370-41062012000100012,umbilical,i
181,S0370-41062012000100012,en,o
181,S0370-41062012000100012,la,o
181,S0370-41062012000100012,ferritina,i
181,S0370-41062012000100012,serica,i
181,S0370-41062012000100012,a,o
181,S0370-41062012000100012,los,o
181,S0370-41062012000100012,seis,o
181,S0370-41062012000100012,meses,o
181,S0370-41062012000100012,de,o
181,S0370-41062012000100012,vida,o
181,S0370-41062012000100012,Estudio,i
181,S0370-41062012000100012,clinico,i
181,S0370-41062012000100012,controlado,i
181,S0370-41062012000100012,aleatorizados,i
181,S0370-41062012000100012,Introduccion,o
181,S0370-41062012000100012,El,o
181,S0370-41062012000100012,clampeo,i
181,S0370-41062012000100012,demorado,i
181,S0370-41062012000100012,del,i
181,S0370-41062012000100012,cordon,i
181,S0370-41062012000100012,umbilical,i
181,S0370-41062012000100012,aumentaria,o
181,S0370-41062012000100012,el,o
181,S0370-41062012000100012,deposito,o
181,S0370-41062012000100012,de,o
181,S0370-41062012000100012,hierro,i
181,S0370-41062012000100012,en,o
181,S0370-41062012000100012,lactantes,o
181,S0370-41062012000100012,Para,o
181,S0370-41062012000100012,comprobar,o
181,S0370-41062012000100012,esta,o
181,S0370-41062012000100012,hipotesis,o
181,S0370-41062012000100012,medimos,o
181,S0370-41062012000100012,la,o
181,S0370-41062012000100012,ferritina,i
181,S0370-41062012000100012,serica,i
181,S0370-41062012000100012,a,o
181,S0370-41062012000100012,los,o
181,S0370-41062012000100012,seis,o
181,S0370-41062012000100012,meses,o
181,S0370-41062012000100012,de,o
181,S0370-41062012000100012,vida,o
181,S0370-41062012000100012,en,o
181,S0370-41062012000100012,niños,o
181,S0370-41062012000100012,nacidos,o
181,S0370-41062012000100012,a,o
181,S0370-41062012000100012,termino,o
181,S0370-41062012000100012,participantes,o
181,S0370-41062012000100012,en,o
181,S0370-41062012000100012,un,o
181,S0370-41062012000100012,estudio,i
181,S0370-41062012000100012,controlado,i
181,S0370-41062012000100012,aleatorizado,i
181,S0370-41062012000100012,que,o
181,S0370-41062012000100012,evaluo,o
181,S0370-41062012000100012,el,o
181,S0370-41062012000100012,efecto,o
181,S0370-41062012000100012,del,o
181,S0370-41062012000100012,tiempo,o
181,S0370-41062012000100012,de,o
181,S0370-41062012000100012,clampeo,i
181,S0370-41062012000100012,del,i
181,S0370-41062012000100012,cordon,i
181,S0370-41062012000100012,en,o
181,S0370-41062012000100012,el,o
181,S0370-41062012000100012,hematocrito,i
181,S0370-41062012000100012,venoso,i
181,S0370-41062012000100012,y,o
181,S0370-41062012000100012,la,o
181,S0370-41062012000100012,evolucion,o
181,S0370-41062012000100012,neonatal,o
181,S0370-41062012000100012,Metodos,o
181,S0370-41062012000100012,De,o
181,S0370-41062012000100012,276,o
181,S0370-41062012000100012,neonatos,i
181,S0370-41062012000100012,incluidos,o
181,S0370-41062012000100012,en,o
181,S0370-41062012000100012,el,o
181,S0370-41062012000100012,estudio,o
181,S0370-41062012000100012,original,o
181,S0370-41062012000100012,255,o
181,S0370-41062012000100012,924,o
181,S0370-41062012000100012,fueron,o
181,S0370-41062012000100012,seguidos,i
181,S0370-41062012000100012,seis,o
181,S0370-41062012000100012,meses,o
181,S0370-41062012000100012,86,o
181,S0370-41062012000100012,tuvieron,o
181,S0370-41062012000100012,clampeo,i
181,S0370-41062012000100012,temprano,o
181,S0370-41062012000100012,83,o
181,S0370-41062012000100012,al,o
181,S0370-41062012000100012,minuto,o
181,S0370-41062012000100012,y,o
181,S0370-41062012000100012,83,o
181,S0370-41062012000100012,al,o
181,S0370-41062012000100012,tercer,o
181,S0370-41062012000100012,minuto,o
181,S0370-41062012000100012,La,o
181,S0370-41062012000100012,variable,o
181,S0370-41062012000100012,principal,o
181,S0370-41062012000100012,de,o
181,S0370-41062012000100012,resultado,o
181,S0370-41062012000100012,fue,o
181,S0370-41062012000100012,la,o
181,S0370-41062012000100012,concentracion,i
181,S0370-41062012000100012,de,i
181,S0370-41062012000100012,ferritina,i
181,S0370-41062012000100012,serica,i
181,S0370-41062012000100012,a,o
181,S0370-41062012000100012,los,o
181,S0370-41062012000100012,seis,o
181,S0370-41062012000100012,meses,o
181,S0370-41062012000100012,Resultados,o
181,S0370-41062012000100012,Las,o
181,S0370-41062012000100012,caracteristicas,o
181,S0370-41062012000100012,de,o
181,S0370-41062012000100012,los,o
181,S0370-41062012000100012,grupos,o
181,S0370-41062012000100012,de,o
181,S0370-41062012000100012,madres,o
181,S0370-41062012000100012,y,o
181,S0370-41062012000100012,niños,o
181,S0370-41062012000100012,fueron,o
181,S0370-41062012000100012,similares,o
181,S0370-41062012000100012,La,o
181,S0370-41062012000100012,ferritina,i
181,S0370-41062012000100012,fue,o
181,S0370-41062012000100012,significativamente,o
181,S0370-41062012000100012,mas,o
181,S0370-41062012000100012,alta,o
181,S0370-41062012000100012,en,o
181,S0370-41062012000100012,los,o
181,S0370-41062012000100012,niños,o
181,S0370-41062012000100012,con,o
181,S0370-41062012000100012,clampeo,i
181,S0370-41062012000100012,al,o
181,S0370-41062012000100012,tercer,o
181,S0370-41062012000100012,minuto,o
181,S0370-41062012000100012,332,o
181,S0370-41062012000100012,μgL,o
181,S0370-41062012000100012,que,o
181,S0370-41062012000100012,en,o
181,S0370-41062012000100012,los,o
181,S0370-41062012000100012,de,o
181,S0370-41062012000100012,clampeo,i
181,S0370-41062012000100012,temprano,o
181,S0370-41062012000100012,209,o
181,S0370-41062012000100012,μgL,o
181,S0370-41062012000100012,diferencia,o
181,S0370-41062012000100012,de,o
181,S0370-41062012000100012,medias,o
181,S0370-41062012000100012,geometrica,o
181,S0370-41062012000100012,16,o
181,S0370-41062012000100012,IC,o
181,S0370-41062012000100012,95,o
181,S0370-41062012000100012,1221,o
181,S0370-41062012000100012,No,o
181,S0370-41062012000100012,hubo,o
181,S0370-41062012000100012,diferencia,o
181,S0370-41062012000100012,significativa,o
181,S0370-41062012000100012,entre,o
181,S0370-41062012000100012,clampeo,i
181,S0370-41062012000100012,al,o
181,S0370-41062012000100012,minuto,o
181,S0370-41062012000100012,255,o
181,S0370-41062012000100012,μgL,o
181,S0370-41062012000100012,y,o
181,S0370-41062012000100012,clampeo,i
181,S0370-41062012000100012,temprano,o
181,S0370-41062012000100012,Tampoco,o
181,S0370-41062012000100012,hubo,o
181,S0370-41062012000100012,diferencia,o
181,S0370-41062012000100012,en,o
181,S0370-41062012000100012,los,o
181,S0370-41062012000100012,valores,o
181,S0370-41062012000100012,medios,o
181,S0370-41062012000100012,de,o
181,S0370-41062012000100012,hemoglobina,i
181,S0370-41062012000100012,entre,o
181,S0370-41062012000100012,los,o
181,S0370-41062012000100012,grupos,o
181,S0370-41062012000100012,temprano,o
181,S0370-41062012000100012,106,o
181,S0370-41062012000100012,gdl,o
181,S0370-41062012000100012,DE111,o
181,S0370-41062012000100012,al,o
181,S0370-41062012000100012,minuto,o
181,S0370-41062012000100012,108,o
181,S0370-41062012000100012,gdl,o
181,S0370-41062012000100012,DE,o
181,S0370-41062012000100012,086,o
181,S0370-41062012000100012,y,o
181,S0370-41062012000100012,tres,o
181,S0370-41062012000100012,minutos,o
181,S0370-41062012000100012,107,o
181,S0370-41062012000100012,gdl,o
181,S0370-41062012000100012,DE,o
181,S0370-41062012000100012,097,o
181,S0370-41062012000100012,respectivamente,o
181,S0370-41062012000100012,La,o
181,S0370-41062012000100012,prevalencia,o
181,S0370-41062012000100012,de,o
181,S0370-41062012000100012,anemia,i
181,S0370-41062012000100012,ferropenica,i
181,S0370-41062012000100012,fue,o
181,S0370-41062012000100012,tres,o
181,S0370-41062012000100012,veces,o
181,S0370-41062012000100012,mayor,o
181,S0370-41062012000100012,en,o
181,S0370-41062012000100012,niños,o
181,S0370-41062012000100012,con,o
181,S0370-41062012000100012,clampeo,i
181,S0370-41062012000100012,temprano,o
181,S0370-41062012000100012,7,o
181,S0370-41062012000100012,en,o
181,S0370-41062012000100012,comparacion,o
181,S0370-41062012000100012,con,o
181,S0370-41062012000100012,los,o
181,S0370-41062012000100012,del,o
181,S0370-41062012000100012,tercer,o
181,S0370-41062012000100012,minuto,o
181,S0370-41062012000100012,24,o
181,S0370-41062012000100012,diferencias,o
181,S0370-41062012000100012,no,o
181,S0370-41062012000100012,significativas,o
181,S0370-41062012000100012,RR,o
181,S0370-41062012000100012,030,o
181,S0370-41062012000100012,IC,o
181,S0370-41062012000100012,95,o
181,S0370-41062012000100012,010160,o
181,S0370-41062012000100012,Conclusion,o
181,S0370-41062012000100012,En,o
181,S0370-41062012000100012,niños,o
181,S0370-41062012000100012,nacidos,o
181,S0370-41062012000100012,a,o
181,S0370-41062012000100012,termino,o
181,S0370-41062012000100012,el,o
181,S0370-41062012000100012,clampeo,i
181,S0370-41062012000100012,del,i
181,S0370-41062012000100012,cordon,i
181,S0370-41062012000100012,umbilical,i
181,S0370-41062012000100012,a,o
181,S0370-41062012000100012,los,o
181,S0370-41062012000100012,tres,o
181,S0370-41062012000100012,minutos,o
181,S0370-41062012000100012,del,o
181,S0370-41062012000100012,nacimiento,o
181,S0370-41062012000100012,aumento,o
181,S0370-41062012000100012,significativamente,o
181,S0370-41062012000100012,las,o
181,S0370-41062012000100012,concentraciones,i
181,S0370-41062012000100012,de,i
181,S0370-41062012000100012,ferritina,i
181,S0370-41062012000100012,a,o
181,S0370-41062012000100012,los,o
181,S0370-41062012000100012,seis,o
181,S0370-41062012000100012,meses,o
181,S0370-41062012000100012,de,o
181,S0370-41062012000100012,edad,o
181,S0370-41062012000100012,No,o
181,S0370-41062012000100012,hubo,o
181,S0370-41062012000100012,diferencias,o
181,S0370-41062012000100012,significativas,o
181,S0370-41062012000100012,en,o
181,S0370-41062012000100012,los,o
181,S0370-41062012000100012,niveles,i
181,S0370-41062012000100012,de,i
181,S0370-41062012000100012,hemoglobina,i
182,S0370-41062015000600003,Efecto,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,la,o
182,S0370-41062015000600003,suplementacion,i
182,S0370-41062015000600003,con,i
182,S0370-41062015000600003,vitamina,i
182,S0370-41062015000600003,D,i
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,monodosis,o
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,niños,o
182,S0370-41062015000600003,con,o
182,S0370-41062015000600003,paralisis,i
182,S0370-41062015000600003,cerebral,i
182,S0370-41062015000600003,Estudio,i
182,S0370-41062015000600003,preliminar,i
182,S0370-41062015000600003,controlado,i
182,S0370-41062015000600003,y,i
182,S0370-41062015000600003,aleatorizado,i
182,S0370-41062015000600003,Introduccion,o
182,S0370-41062015000600003,Los,o
182,S0370-41062015000600003,niños,o
182,S0370-41062015000600003,con,o
182,S0370-41062015000600003,paralisis,i
182,S0370-41062015000600003,cerebral,i
182,S0370-41062015000600003,PC,i
182,S0370-41062015000600003,tienen,o
182,S0370-41062015000600003,mayor,o
182,S0370-41062015000600003,riesgo,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,deficiencia,i
182,S0370-41062015000600003,de,i
182,S0370-41062015000600003,vitamina,i
182,S0370-41062015000600003,D,i
182,S0370-41062015000600003,VD,i
182,S0370-41062015000600003,Aunque,o
182,S0370-41062015000600003,existen,o
182,S0370-41062015000600003,bastantes,o
182,S0370-41062015000600003,estudios,o
182,S0370-41062015000600003,sobre,o
182,S0370-41062015000600003,VD,i
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,PC,i
182,S0370-41062015000600003,hay,o
182,S0370-41062015000600003,limitada,o
182,S0370-41062015000600003,informacion,o
182,S0370-41062015000600003,sobre,o
182,S0370-41062015000600003,suplementacion,i
182,S0370-41062015000600003,con,i
182,S0370-41062015000600003,VD,i
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,estos,o
182,S0370-41062015000600003,pacientes,o
182,S0370-41062015000600003,Objetivo,o
182,S0370-41062015000600003,Evaluar,o
182,S0370-41062015000600003,el,o
182,S0370-41062015000600003,efecto,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,la,o
182,S0370-41062015000600003,suplementacion,i
182,S0370-41062015000600003,con,i
182,S0370-41062015000600003,VD,i
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,monodosis,o
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,las,o
182,S0370-41062015000600003,concentraciones,o
182,S0370-41062015000600003,plasmaticas,i
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,25hidroxivitaminaD,o
182,S0370-41062015000600003,25OHD,i
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,niños,o
182,S0370-41062015000600003,con,o
182,S0370-41062015000600003,PC,i
182,S0370-41062015000600003,Pacientes,o
182,S0370-41062015000600003,y,o
182,S0370-41062015000600003,metodo,o
182,S0370-41062015000600003,Estudio,o
182,S0370-41062015000600003,controlado,o
182,S0370-41062015000600003,prospectivo,o
182,S0370-41062015000600003,y,o
182,S0370-41062015000600003,aleatorizado,o
182,S0370-41062015000600003,Se,o
182,S0370-41062015000600003,estudiaron,o
182,S0370-41062015000600003,30,o
182,S0370-41062015000600003,niños,o
182,S0370-41062015000600003,chilenos,o
182,S0370-41062015000600003,19,o
182,S0370-41062015000600003,varones,o
182,S0370-41062015000600003,con,o
182,S0370-41062015000600003,PC,i
182,S0370-41062015000600003,mediana,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,edad,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,99,o
182,S0370-41062015000600003,años,o
182,S0370-41062015000600003,62135,o
182,S0370-41062015000600003,Se,o
182,S0370-41062015000600003,registraron,i
182,S0370-41062015000600003,las,i
182,S0370-41062015000600003,variables,i
182,S0370-41062015000600003,clinicas,i
182,S0370-41062015000600003,y,i
182,S0370-41062015000600003,bioquimicas,i
182,S0370-41062015000600003,incluyendo,o
182,S0370-41062015000600003,25OHD,i
182,S0370-41062015000600003,tiempo,o
182,S0370-41062015000600003,0,o
182,S0370-41062015000600003,y,o
182,S0370-41062015000600003,8,o
182,S0370-41062015000600003,semanas,o
182,S0370-41062015000600003,El,o
182,S0370-41062015000600003,grupo,o
182,S0370-41062015000600003,suplementado,i
182,S0370-41062015000600003,S,o
182,S0370-41062015000600003,recibio,o
182,S0370-41062015000600003,100000,o
182,S0370-41062015000600003,UI,o
182,S0370-41062015000600003,D3,i
182,S0370-41062015000600003,oral,o
182,S0370-41062015000600003,tiempo,o
182,S0370-41062015000600003,0,o
182,S0370-41062015000600003,comparado,o
182,S0370-41062015000600003,con,o
182,S0370-41062015000600003,el,o
182,S0370-41062015000600003,grupo,o
182,S0370-41062015000600003,placebo,i
182,S0370-41062015000600003,P,o
182,S0370-41062015000600003,Resultados,o
182,S0370-41062015000600003,Entre,o
182,S0370-41062015000600003,las,o
182,S0370-41062015000600003,caracteristicas,o
182,S0370-41062015000600003,clinicas,o
182,S0370-41062015000600003,destaca,o
182,S0370-41062015000600003,gastrostomizados,i
182,S0370-41062015000600003,60,o
182,S0370-41062015000600003,desnutricion,i
182,S0370-41062015000600003,30,o
182,S0370-41062015000600003,postracion,i
182,S0370-41062015000600003,933,o
182,S0370-41062015000600003,uso,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,antiepilepticos,i
182,S0370-41062015000600003,70,o
182,S0370-41062015000600003,y,o
182,S0370-41062015000600003,uso,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,antiepilepticos,i
182,S0370-41062015000600003,inductores,o
182,S0370-41062015000600003,del,o
182,S0370-41062015000600003,metabolismo,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,VD,i
182,S0370-41062015000600003,433,o
182,S0370-41062015000600003,Las,o
182,S0370-41062015000600003,mediciones,i
182,S0370-41062015000600003,basales,i
182,S0370-41062015000600003,de,i
182,S0370-41062015000600003,variables,i
182,S0370-41062015000600003,bioquimicas,i
182,S0370-41062015000600003,fueron,o
182,S0370-41062015000600003,normales,o
182,S0370-41062015000600003,La,o
182,S0370-41062015000600003,25OHD,i
182,S0370-41062015000600003,fue,o
182,S0370-41062015000600003,insuficiente,o
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,430,o
182,S0370-41062015000600003,y,o
182,S0370-41062015000600003,deficiente,o
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,630,o
182,S0370-41062015000600003,No,o
182,S0370-41062015000600003,hubo,o
182,S0370-41062015000600003,asociacion,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,25OHD,i
182,S0370-41062015000600003,con,o
182,S0370-41062015000600003,las,o
182,S0370-41062015000600003,variables,o
182,S0370-41062015000600003,estudiadas,o
182,S0370-41062015000600003,Completaron,o
182,S0370-41062015000600003,el,o
182,S0370-41062015000600003,estudio,o
182,S0370-41062015000600003,8,o
182,S0370-41062015000600003,pacientes,o
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,el,o
182,S0370-41062015000600003,grupo,o
182,S0370-41062015000600003,S,o
182,S0370-41062015000600003,y,o
182,S0370-41062015000600003,10,o
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,el,o
182,S0370-41062015000600003,P,o
182,S0370-41062015000600003,En,o
182,S0370-41062015000600003,ambos,o
182,S0370-41062015000600003,grupos,o
182,S0370-41062015000600003,no,o
182,S0370-41062015000600003,se,o
182,S0370-41062015000600003,observaron,o
182,S0370-41062015000600003,diferencias,o
182,S0370-41062015000600003,significativas,o
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,las,o
182,S0370-41062015000600003,variables,o
182,S0370-41062015000600003,basales,o
182,S0370-41062015000600003,A,o
182,S0370-41062015000600003,las,o
182,S0370-41062015000600003,8,o
182,S0370-41062015000600003,semanas,o
182,S0370-41062015000600003,la,o
182,S0370-41062015000600003,calcemia,i
182,S0370-41062015000600003,la,o
182,S0370-41062015000600003,fosfemia,i
182,S0370-41062015000600003,y,o
182,S0370-41062015000600003,la,o
182,S0370-41062015000600003,fosfatasa,i
182,S0370-41062015000600003,alcalina,i
182,S0370-41062015000600003,fueron,o
182,S0370-41062015000600003,normales,o
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,ambos,o
182,S0370-41062015000600003,grupos,o
182,S0370-41062015000600003,la,o
182,S0370-41062015000600003,25OHD,i
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,el,o
182,S0370-41062015000600003,grupo,o
182,S0370-41062015000600003,P,o
182,S0370-41062015000600003,fue,o
182,S0370-41062015000600003,normal,o
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,610,o
182,S0370-41062015000600003,e,o
182,S0370-41062015000600003,insuficiente,o
182,S0370-41062015000600003,deficiente,o
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,410,o
182,S0370-41062015000600003,y,o
182,S0370-41062015000600003,normal,o
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,88,o
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,el,o
182,S0370-41062015000600003,grupo,o
182,S0370-41062015000600003,S,o
182,S0370-41062015000600003,test,o
182,S0370-41062015000600003,exacto,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,Fisher,o
182,S0370-41062015000600003,p,o
182,S0370-41062015000600003,007,o
182,S0370-41062015000600003,Conclusiones,o
182,S0370-41062015000600003,Una,o
182,S0370-41062015000600003,monodosis,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,100000,o
182,S0370-41062015000600003,UI,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,VD,i
182,S0370-41062015000600003,podria,o
182,S0370-41062015000600003,normalizar,o
182,S0370-41062015000600003,las,o
182,S0370-41062015000600003,concentraciones,o
182,S0370-41062015000600003,de,o
182,S0370-41062015000600003,25OHD,i
182,S0370-41062015000600003,en,o
182,S0370-41062015000600003,niños,o
182,S0370-41062015000600003,con,o
182,S0370-41062015000600003,PC,i
182,S0370-41062015000600003,Se,o
182,S0370-41062015000600003,necesitan,o
182,S0370-41062015000600003,mas,o
182,S0370-41062015000600003,estudios,o
182,S0370-41062015000600003,para,o
182,S0370-41062015000600003,confirmar,o
182,S0370-41062015000600003,estos,o
182,S0370-41062015000600003,resultados,o
183,S0370-41062019000600642,Oxigenoterapia,i
183,S0370-41062019000600642,por,i
183,S0370-41062019000600642,canula,i
183,S0370-41062019000600642,nasal,i
183,S0370-41062019000600642,de,i
183,S0370-41062019000600642,alto,i
183,S0370-41062019000600642,flujo,i
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,pacientes,o
183,S0370-41062019000600642,con,o
183,S0370-41062019000600642,crisis,i
183,S0370-41062019000600642,asmatica,i
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,un,o
183,S0370-41062019000600642,departamento,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,emergencia,o
183,S0370-41062019000600642,pediatrica,o
183,S0370-41062019000600642,Introduccion,o
183,S0370-41062019000600642,Pocos,o
183,S0370-41062019000600642,estudios,o
183,S0370-41062019000600642,son,o
183,S0370-41062019000600642,concluyentes,o
183,S0370-41062019000600642,sobre,o
183,S0370-41062019000600642,la,o
183,S0370-41062019000600642,utilidad,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,la,o
183,S0370-41062019000600642,Oxigenoterapia,i
183,S0370-41062019000600642,por,i
183,S0370-41062019000600642,Canula,i
183,S0370-41062019000600642,Nasal,i
183,S0370-41062019000600642,de,i
183,S0370-41062019000600642,Alto,i
183,S0370-41062019000600642,Flujo,i
183,S0370-41062019000600642,CNAF,i
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,pacientes,o
183,S0370-41062019000600642,con,o
183,S0370-41062019000600642,crisis,i
183,S0370-41062019000600642,asmatica,i
183,S0370-41062019000600642,Objetivo,o
183,S0370-41062019000600642,Determinar,o
183,S0370-41062019000600642,la,o
183,S0370-41062019000600642,eficacia,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,la,o
183,S0370-41062019000600642,CNAF,i
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,niños,o
183,S0370-41062019000600642,mayores,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,2,o
183,S0370-41062019000600642,años,o
183,S0370-41062019000600642,con,o
183,S0370-41062019000600642,crisis,i
183,S0370-41062019000600642,asmatica,i
183,S0370-41062019000600642,severa,o
183,S0370-41062019000600642,y,o
183,S0370-41062019000600642,moderada,o
183,S0370-41062019000600642,que,o
183,S0370-41062019000600642,no,o
183,S0370-41062019000600642,responde,o
183,S0370-41062019000600642,al,o
183,S0370-41062019000600642,tratamiento,i
183,S0370-41062019000600642,inicial,o
183,S0370-41062019000600642,Pacientes,o
183,S0370-41062019000600642,y,o
183,S0370-41062019000600642,Metodo,o
183,S0370-41062019000600642,Ensayo,i
183,S0370-41062019000600642,clinico,i
183,S0370-41062019000600642,randomizado,i
183,S0370-41062019000600642,controlado,i
183,S0370-41062019000600642,abierto,i
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,pacientes,o
183,S0370-41062019000600642,con,o
183,S0370-41062019000600642,exacerbacion,i
183,S0370-41062019000600642,asmatica,i
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,un,o
183,S0370-41062019000600642,Departamento,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,Emergencia,o
183,S0370-41062019000600642,Pediatrica,o
183,S0370-41062019000600642,Se,o
183,S0370-41062019000600642,excluyo,o
183,S0370-41062019000600642,crisis,i
183,S0370-41062019000600642,mediadas,o
183,S0370-41062019000600642,por,o
183,S0370-41062019000600642,infecciones,i
183,S0370-41062019000600642,y,o
183,S0370-41062019000600642,comorbilidad,i
183,S0370-41062019000600642,Los,o
183,S0370-41062019000600642,pacientes,o
183,S0370-41062019000600642,fueron,o
183,S0370-41062019000600642,aleatorizados,i
183,S0370-41062019000600642,Grupo,o
183,S0370-41062019000600642,1,o
183,S0370-41062019000600642,CNAF,i
183,S0370-41062019000600642,n,o
183,S0370-41062019000600642,32,o
183,S0370-41062019000600642,y,o
183,S0370-41062019000600642,Grupo,o
183,S0370-41062019000600642,2,o
183,S0370-41062019000600642,Oxigenoterapia,i
183,S0370-41062019000600642,Convencional,o
183,S0370-41062019000600642,n,o
183,S0370-41062019000600642,33,o
183,S0370-41062019000600642,Ambos,o
183,S0370-41062019000600642,grupos,o
183,S0370-41062019000600642,recibieron,o
183,S0370-41062019000600642,el,o
183,S0370-41062019000600642,tratamiento,i
183,S0370-41062019000600642,farmacologico,i
183,S0370-41062019000600642,habitual,o
183,S0370-41062019000600642,El,o
183,S0370-41062019000600642,primer,o
183,S0370-41062019000600642,punto,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,corte,o
183,S0370-41062019000600642,fue,o
183,S0370-41062019000600642,el,o
183,S0370-41062019000600642,descenso,o
183,S0370-41062019000600642,del,o
183,S0370-41062019000600642,PIS,o
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,mas,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,2,o
183,S0370-41062019000600642,puntos,o
183,S0370-41062019000600642,a,o
183,S0370-41062019000600642,las,o
183,S0370-41062019000600642,2,o
183,S0370-41062019000600642,horas,o
183,S0370-41062019000600642,del,o
183,S0370-41062019000600642,tratamiento,i
183,S0370-41062019000600642,los,o
183,S0370-41062019000600642,puntos,o
183,S0370-41062019000600642,secundarios,o
183,S0370-41062019000600642,descenso,o
183,S0370-41062019000600642,del,o
183,S0370-41062019000600642,PIS,o
183,S0370-41062019000600642,a,o
183,S0370-41062019000600642,las,o
183,S0370-41062019000600642,6,o
183,S0370-41062019000600642,horas,o
183,S0370-41062019000600642,tiempo,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,permanencia,o
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,la,o
183,S0370-41062019000600642,emergencia,o
183,S0370-41062019000600642,e,o
183,S0370-41062019000600642,ingreso,i
183,S0370-41062019000600642,a,i
183,S0370-41062019000600642,UCIP,i
183,S0370-41062019000600642,Resultados,o
183,S0370-41062019000600642,Las,o
183,S0370-41062019000600642,caracteristicas,o
183,S0370-41062019000600642,basales,o
183,S0370-41062019000600642,fueron,o
183,S0370-41062019000600642,similares,o
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,ambos,o
183,S0370-41062019000600642,grupos,o
183,S0370-41062019000600642,La,o
183,S0370-41062019000600642,proporcion,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,sujetos,o
183,S0370-41062019000600642,con,o
183,S0370-41062019000600642,disminucion,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,mas,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,dos,o
183,S0370-41062019000600642,puntos,o
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,el,o
183,S0370-41062019000600642,PIS,o
183,S0370-41062019000600642,a,o
183,S0370-41062019000600642,las,o
183,S0370-41062019000600642,2,o
183,S0370-41062019000600642,horas,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,tratamiento,i
183,S0370-41062019000600642,Grupo,o
183,S0370-41062019000600642,1,o
183,S0370-41062019000600642,437,o
183,S0370-41062019000600642,IC,o
183,S0370-41062019000600642,95,o
183,S0370-41062019000600642,2860,o
183,S0370-41062019000600642,vs,o
183,S0370-41062019000600642,Grupo,o
183,S0370-41062019000600642,2,o
183,S0370-41062019000600642,484,o
183,S0370-41062019000600642,IC,o
183,S0370-41062019000600642,95,o
183,S0370-41062019000600642,3264,o
183,S0370-41062019000600642,p,o
183,S0370-41062019000600642,0447,o
183,S0370-41062019000600642,La,o
183,S0370-41062019000600642,estadia,o
183,S0370-41062019000600642,media,o
183,S0370-41062019000600642,fue,o
183,S0370-41062019000600642,248,o
183,S0370-41062019000600642,123,o
183,S0370-41062019000600642,horas,o
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,el,o
183,S0370-41062019000600642,Grupo1,o
183,S0370-41062019000600642,vs,o
183,S0370-41062019000600642,24,o
183,S0370-41062019000600642,148,o
183,S0370-41062019000600642,horas,o
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,el,o
183,S0370-41062019000600642,Grupo2,o
183,S0370-41062019000600642,IC,o
183,S0370-41062019000600642,95,o
183,S0370-41062019000600642,756596,o
183,S0370-41062019000600642,p,o
183,S0370-41062019000600642,037,o
183,S0370-41062019000600642,No,o
183,S0370-41062019000600642,encontramos,o
183,S0370-41062019000600642,diferencias,o
183,S0370-41062019000600642,del,o
183,S0370-41062019000600642,score,o
183,S0370-41062019000600642,y,o
183,S0370-41062019000600642,puntaje,o
183,S0370-41062019000600642,del,o
183,S0370-41062019000600642,esfuerzo,o
183,S0370-41062019000600642,respiratorio,o
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,mediciones,o
183,S0370-41062019000600642,cada,o
183,S0370-41062019000600642,2,o
183,S0370-41062019000600642,horas,o
183,S0370-41062019000600642,Ningun,o
183,S0370-41062019000600642,paciente,o
183,S0370-41062019000600642,ingreso,i
183,S0370-41062019000600642,a,i
183,S0370-41062019000600642,cuidados,i
183,S0370-41062019000600642,intensivos,i
183,S0370-41062019000600642,Conclusiones,o
183,S0370-41062019000600642,La,o
183,S0370-41062019000600642,incorporacion,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,la,o
183,S0370-41062019000600642,CNAF,i
183,S0370-41062019000600642,al,o
183,S0370-41062019000600642,tratamiento,i
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,pacientes,o
183,S0370-41062019000600642,con,o
183,S0370-41062019000600642,crisis,i
183,S0370-41062019000600642,asmatica,i
183,S0370-41062019000600642,no,o
183,S0370-41062019000600642,presento,o
183,S0370-41062019000600642,beneficios,o
183,S0370-41062019000600642,clinicos,o
183,S0370-41062019000600642,ni,o
183,S0370-41062019000600642,disminuyo,o
183,S0370-41062019000600642,el,o
183,S0370-41062019000600642,tiempo,o
183,S0370-41062019000600642,de,o
183,S0370-41062019000600642,estadia,o
183,S0370-41062019000600642,en,o
183,S0370-41062019000600642,el,o
183,S0370-41062019000600642,DEP,o
184,S0375-090615000543,Evaluacion,i
184,S0375-090615000543,clinica,i
184,S0375-090615000543,y,o
184,S0375-090615000543,de,o
184,S0375-090615000543,la,o
184,S0375-090615000543,calidad,i
184,S0375-090615000543,de,i
184,S0375-090615000543,vida,i
184,S0375-090615000543,relacionada,i
184,S0375-090615000543,con,i
184,S0375-090615000543,la,i
184,S0375-090615000543,salud,i
184,S0375-090615000543,en,o
184,S0375-090615000543,pacientes,o
184,S0375-090615000543,con,o
184,S0375-090615000543,dolor,i
184,S0375-090615000543,toracico,i
184,S0375-090615000543,no,i
184,S0375-090615000543,cardiaco,i
184,S0375-090615000543,Introduccion,o
184,S0375-090615000543,El,o
184,S0375-090615000543,dolor,i
184,S0375-090615000543,toracico,i
184,S0375-090615000543,no,i
184,S0375-090615000543,cardiaco,i
184,S0375-090615000543,DTNC,i
184,S0375-090615000543,se,o
184,S0375-090615000543,relaciona,o
184,S0375-090615000543,principalmente,o
184,S0375-090615000543,con,o
184,S0375-090615000543,enfermedades,i
184,S0375-090615000543,del,i
184,S0375-090615000543,esofago,i
184,S0375-090615000543,y,o
184,S0375-090615000543,aunque,o
184,S0375-090615000543,se,o
184,S0375-090615000543,considera,o
184,S0375-090615000543,una,o
184,S0375-090615000543,condicion,o
184,S0375-090615000543,comun,o
184,S0375-090615000543,en,o
184,S0375-090615000543,Mexico,o
184,S0375-090615000543,la,o
184,S0375-090615000543,informacion,o
184,S0375-090615000543,aun,o
184,S0375-090615000543,es,o
184,S0375-090615000543,escasa,o
184,S0375-090615000543,Objetivo,o
184,S0375-090615000543,Evaluar,i
184,S0375-090615000543,las,i
184,S0375-090615000543,caracteristicas,i
184,S0375-090615000543,clinicas,i
184,S0375-090615000543,y,o
184,S0375-090615000543,la,o
184,S0375-090615000543,calidad,i
184,S0375-090615000543,de,i
184,S0375-090615000543,vida,i
184,S0375-090615000543,relacionada,i
184,S0375-090615000543,con,i
184,S0375-090615000543,salud,i
184,S0375-090615000543,en,o
184,S0375-090615000543,pacientes,o
184,S0375-090615000543,con,o
184,S0375-090615000543,DTNC,i
184,S0375-090615000543,de,o
184,S0375-090615000543,presunto,o
184,S0375-090615000543,origen,o
184,S0375-090615000543,esofagico,i
184,S0375-090615000543,Material,o
184,S0375-090615000543,y,o
184,S0375-090615000543,metodos,o
184,S0375-090615000543,Se,o
184,S0375-090615000543,incluyeron,o
184,S0375-090615000543,en,o
184,S0375-090615000543,el,o
184,S0375-090615000543,estudio,o
184,S0375-090615000543,pacientes,o
184,S0375-090615000543,con,o
184,S0375-090615000543,DTNC,i
184,S0375-090615000543,de,o
184,S0375-090615000543,presunto,o
184,S0375-090615000543,origen,o
184,S0375-090615000543,esofagico,i
184,S0375-090615000543,sin,o
184,S0375-090615000543,tratamiento,i
184,S0375-090615000543,previo,o
184,S0375-090615000543,Se,o
184,S0375-090615000543,evaluaron,o
184,S0375-090615000543,los,o
184,S0375-090615000543,sintomas,i
184,S0375-090615000543,asociados,o
184,S0375-090615000543,se,o
184,S0375-090615000543,realizo,o
184,S0375-090615000543,endoscopia,i
184,S0375-090615000543,alta,i
184,S0375-090615000543,y,o
184,S0375-090615000543,monitorizacion,i
184,S0375-090615000543,de,i
184,S0375-090615000543,pH,i
184,S0375-090615000543,esofagico,i
184,S0375-090615000543,de,o
184,S0375-090615000543,24,o
184,S0375-090615000543,h,o
184,S0375-090615000543,para,o
184,S0375-090615000543,establecer,o
184,S0375-090615000543,el,o
184,S0375-090615000543,diagnostico,i
184,S0375-090615000543,de,o
184,S0375-090615000543,enfermedad,i
184,S0375-090615000543,por,i
184,S0375-090615000543,reflujo,i
184,S0375-090615000543,gastroesofagico,i
184,S0375-090615000543,y,o
184,S0375-090615000543,para,o
184,S0375-090615000543,descartar,o
184,S0375-090615000543,trastornos,i
184,S0375-090615000543,en,i
184,S0375-090615000543,la,i
184,S0375-090615000543,motilidad,i
184,S0375-090615000543,esofagica,i
184,S0375-090615000543,se,o
184,S0375-090615000543,llevo,o
184,S0375-090615000543,a,o
184,S0375-090615000543,cabo,o
184,S0375-090615000543,manometria,i
184,S0375-090615000543,esofagica,i
184,S0375-090615000543,Se,o
184,S0375-090615000543,aplico,o
184,S0375-090615000543,el,o
184,S0375-090615000543,cuestionario,o
184,S0375-090615000543,de,o
184,S0375-090615000543,calidad,i
184,S0375-090615000543,de,i
184,S0375-090615000543,vida,i
184,S0375-090615000543,SF36,o
184,S0375-090615000543,y,o
184,S0375-090615000543,los,o
184,S0375-090615000543,resultados,o
184,S0375-090615000543,se,o
184,S0375-090615000543,compararon,o
184,S0375-090615000543,con,o
184,S0375-090615000543,un,o
184,S0375-090615000543,grupo,o
184,S0375-090615000543,control,o
184,S0375-090615000543,de,o
184,S0375-090615000543,sanos,o
184,S0375-090615000543,Resultados,o
184,S0375-090615000543,Se,o
184,S0375-090615000543,incluyeron,o
184,S0375-090615000543,33,o
184,S0375-090615000543,pacientes,o
184,S0375-090615000543,el,o
184,S0375-090615000543,61,o
184,S0375-090615000543,mujeres,o
184,S0375-090615000543,y,o
184,S0375-090615000543,la,o
184,S0375-090615000543,edad,o
184,S0375-090615000543,promedio,o
184,S0375-090615000543,fue,o
184,S0375-090615000543,461,o
184,S0375-090615000543,116,o
184,S0375-090615000543,años,o
184,S0375-090615000543,Las,o
184,S0375-090615000543,causas,o
184,S0375-090615000543,de,o
184,S0375-090615000543,DTNC,i
184,S0375-090615000543,fueron,o
184,S0375-090615000543,enfermedad,i
184,S0375-090615000543,por,i
184,S0375-090615000543,reflujo,i
184,S0375-090615000543,gastroesofagico,i
184,S0375-090615000543,48,o
184,S0375-090615000543,acalasia,i
184,S0375-090615000543,34,o
184,S0375-090615000543,y,o
184,S0375-090615000543,dolor,i
184,S0375-090615000543,toracico,i
184,S0375-090615000543,funcional,o
184,S0375-090615000543,18,o
184,S0375-090615000543,El,o
184,S0375-090615000543,tiempo,o
184,S0375-090615000543,promedio,o
184,S0375-090615000543,de,o
184,S0375-090615000543,progresion,i
184,S0375-090615000543,del,i
184,S0375-090615000543,dolor,i
184,S0375-090615000543,toracico,i
184,S0375-090615000543,fue,o
184,S0375-090615000543,24,o
184,S0375-090615000543,2240,o
184,S0375-090615000543,meses,o
184,S0375-090615000543,con,o
184,S0375-090615000543,3,o
184,S0375-090615000543,eventossemana,o
184,S0375-090615000543,en,o
184,S0375-090615000543,el,o
184,S0375-090615000543,52,o
184,S0375-090615000543,Los,o
184,S0375-090615000543,sintomas,i
184,S0375-090615000543,acompañantes,o
184,S0375-090615000543,mas,o
184,S0375-090615000543,frecuentes,o
184,S0375-090615000543,fueron,o
184,S0375-090615000543,regurgitaciones,i
184,S0375-090615000543,81,o
184,S0375-090615000543,disfagia,i
184,S0375-090615000543,72,o
184,S0375-090615000543,y,o
184,S0375-090615000543,pirosis,i
184,S0375-090615000543,66,o
184,S0375-090615000543,Los,o
184,S0375-090615000543,pacientes,o
184,S0375-090615000543,con,o
184,S0375-090615000543,DTNC,i
184,S0375-090615000543,muestran,o
184,S0375-090615000543,deterioro,o
184,S0375-090615000543,en,o
184,S0375-090615000543,su,o
184,S0375-090615000543,calidad,i
184,S0375-090615000543,de,i
184,S0375-090615000543,vida,i
184,S0375-090615000543,comparado,o
184,S0375-090615000543,con,o
184,S0375-090615000543,el,o
184,S0375-090615000543,grupo,o
184,S0375-090615000543,control,o
184,S0375-090615000543,independientemente,o
184,S0375-090615000543,de,o
184,S0375-090615000543,la,o
184,S0375-090615000543,etiologia,o
184,S0375-090615000543,del,o
184,S0375-090615000543,dolor,i
184,S0375-090615000543,toracico,i
184,S0375-090615000543,Los,o
184,S0375-090615000543,dominios,o
184,S0375-090615000543,mas,o
184,S0375-090615000543,afectados,o
184,S0375-090615000543,son,o
184,S0375-090615000543,la,o
184,S0375-090615000543,percepcion,o
184,S0375-090615000543,general,o
184,S0375-090615000543,de,o
184,S0375-090615000543,salud,o
184,S0375-090615000543,problemas,i
184,S0375-090615000543,emocionales,i
184,S0375-090615000543,y,o
184,S0375-090615000543,la,o
184,S0375-090615000543,subescala,o
184,S0375-090615000543,de,o
184,S0375-090615000543,salud,o
184,S0375-090615000543,mental,o
184,S0375-090615000543,sin,o
184,S0375-090615000543,diferencia,o
184,S0375-090615000543,estadistica,o
184,S0375-090615000543,significativa,o
184,S0375-090615000543,P,o
184,S0375-090615000543,005,o
184,S0375-090615000543,Conclusiones,o
184,S0375-090615000543,En,o
184,S0375-090615000543,nuestra,o
184,S0375-090615000543,poblacion,o
184,S0375-090615000543,los,o
184,S0375-090615000543,pacientes,o
184,S0375-090615000543,con,o
184,S0375-090615000543,DTNC,i
184,S0375-090615000543,muestran,o
184,S0375-090615000543,deterioro,o
184,S0375-090615000543,en,o
184,S0375-090615000543,su,o
184,S0375-090615000543,calidad,i
184,S0375-090615000543,de,i
184,S0375-090615000543,vida,i
184,S0375-090615000543,independientemente,o
184,S0375-090615000543,de,o
184,S0375-090615000543,la,o
184,S0375-090615000543,etiologia,o
184,S0375-090615000543,frecuencia,o
184,S0375-090615000543,y,o
184,S0375-090615000543,sintomas,i
184,S0375-090615000543,que,o
184,S0375-090615000543,acompañan,o
184,S0375-090615000543,al,o
184,S0375-090615000543,dolor,i
184,S0375-090615000543,toracico,i
185,S0375-090616000100,Diltiazem,i
185,S0375-090616000100,topico,o
185,S0375-090616000100,en,o
185,S0375-090616000100,el,o
185,S0375-090616000100,dolor,i
185,S0375-090616000100,postoperatorio,i
185,S0375-090616000100,de,o
185,S0375-090616000100,hemorroidectomia,i
185,S0375-090616000100,con,i
185,S0375-090616000100,tecnica,i
185,S0375-090616000100,cerrada,i
185,S0375-090616000100,Antecedentes,o
185,S0375-090616000100,El,o
185,S0375-090616000100,espasmo,i
185,S0375-090616000100,del,i
185,S0375-090616000100,esfinter,i
185,S0375-090616000100,anal,i
185,S0375-090616000100,contribuye,o
185,S0375-090616000100,a,o
185,S0375-090616000100,la,o
185,S0375-090616000100,aparicion,o
185,S0375-090616000100,del,o
185,S0375-090616000100,dolor,i
185,S0375-090616000100,postoperatorio,i
185,S0375-090616000100,despues,o
185,S0375-090616000100,de,o
185,S0375-090616000100,una,o
185,S0375-090616000100,hemorroidectomia,i
185,S0375-090616000100,Objetivo,o
185,S0375-090616000100,Determinar,i
185,S0375-090616000100,la,i
185,S0375-090616000100,eficacia,i
185,S0375-090616000100,del,o
185,S0375-090616000100,diltiazem,i
185,S0375-090616000100,topico,o
185,S0375-090616000100,en,o
185,S0375-090616000100,el,o
185,S0375-090616000100,control,i
185,S0375-090616000100,del,i
185,S0375-090616000100,dolor,i
185,S0375-090616000100,postoperatorio,i
185,S0375-090616000100,de,o
185,S0375-090616000100,hemorroidectomia,i
185,S0375-090616000100,Material,o
185,S0375-090616000100,y,o
185,S0375-090616000100,metodos,o
185,S0375-090616000100,Se,o
185,S0375-090616000100,realizo,o
185,S0375-090616000100,un,o
185,S0375-090616000100,estudio,o
185,S0375-090616000100,aleatorizado,o
185,S0375-090616000100,prospectivo,o
185,S0375-090616000100,experimental,o
185,S0375-090616000100,doble,o
185,S0375-090616000100,ciego,o
185,S0375-090616000100,en,o
185,S0375-090616000100,2,o
185,S0375-090616000100,grupos,o
185,S0375-090616000100,de,o
185,S0375-090616000100,pacientes,o
185,S0375-090616000100,en,o
185,S0375-090616000100,el,o
185,S0375-090616000100,postoperatorio,o
185,S0375-090616000100,de,o
185,S0375-090616000100,hemorroidectomia,i
185,S0375-090616000100,con,i
185,S0375-090616000100,tecnica,i
185,S0375-090616000100,cerrada,i
185,S0375-090616000100,Cada,o
185,S0375-090616000100,grupo,o
185,S0375-090616000100,incluyo,o
185,S0375-090616000100,a,o
185,S0375-090616000100,17,o
185,S0375-090616000100,pacientes,o
185,S0375-090616000100,el,o
185,S0375-090616000100,grupo,o
185,S0375-090616000100,A,o
185,S0375-090616000100,recibio,o
185,S0375-090616000100,diltiazem,i
185,S0375-090616000100,topico,o
185,S0375-090616000100,en,o
185,S0375-090616000100,la,o
185,S0375-090616000100,region,i
185,S0375-090616000100,anal,i
185,S0375-090616000100,3,o
185,S0375-090616000100,veces,o
185,S0375-090616000100,al,o
185,S0375-090616000100,dia,o
185,S0375-090616000100,y,o
185,S0375-090616000100,el,o
185,S0375-090616000100,grupo,o
185,S0375-090616000100,B,o
185,S0375-090616000100,recibio,o
185,S0375-090616000100,un,o
185,S0375-090616000100,placebo,i
185,S0375-090616000100,En,o
185,S0375-090616000100,ambos,o
185,S0375-090616000100,grupos,o
185,S0375-090616000100,se,o
185,S0375-090616000100,administro,o
185,S0375-090616000100,ketorolaco,i
185,S0375-090616000100,por,o
185,S0375-090616000100,via,o
185,S0375-090616000100,oral,o
185,S0375-090616000100,como,o
185,S0375-090616000100,terapia,i
185,S0375-090616000100,de,i
185,S0375-090616000100,rescate,i
185,S0375-090616000100,Resultados,o
185,S0375-090616000100,En,o
185,S0375-090616000100,el,o
185,S0375-090616000100,grupo,o
185,S0375-090616000100,A,o
185,S0375-090616000100,el,o
185,S0375-090616000100,promedio,o
185,S0375-090616000100,de,o
185,S0375-090616000100,calificacion,o
185,S0375-090616000100,de,o
185,S0375-090616000100,la,o
185,S0375-090616000100,escala,i
185,S0375-090616000100,analoga,i
185,S0375-090616000100,visual,i
185,S0375-090616000100,fue,o
185,S0375-090616000100,de,o
185,S0375-090616000100,297,o
185,S0375-090616000100,118,o
185,S0375-090616000100,cm,o
185,S0375-090616000100,a,o
185,S0375-090616000100,las,o
185,S0375-090616000100,24,o
185,S0375-090616000100,h,o
185,S0375-090616000100,151,o
185,S0375-090616000100,118,o
185,S0375-090616000100,cm,o
185,S0375-090616000100,a,o
185,S0375-090616000100,las,o
185,S0375-090616000100,48,o
185,S0375-090616000100,h,o
185,S0375-090616000100,y,o
185,S0375-090616000100,084,o
185,S0375-090616000100,092,o
185,S0375-090616000100,cm,o
185,S0375-090616000100,a,o
185,S0375-090616000100,las,o
185,S0375-090616000100,72,o
185,S0375-090616000100,h,o
185,S0375-090616000100,En,o
185,S0375-090616000100,el,o
185,S0375-090616000100,grupo,o
185,S0375-090616000100,B,o
185,S0375-090616000100,fue,o
185,S0375-090616000100,de,o
185,S0375-090616000100,682,o
185,S0375-090616000100,19,o
185,S0375-090616000100,cm,o
185,S0375-090616000100,a,o
185,S0375-090616000100,las,o
185,S0375-090616000100,24,o
185,S0375-090616000100,h,o
185,S0375-090616000100,53,o
185,S0375-090616000100,166,o
185,S0375-090616000100,cm,o
185,S0375-090616000100,a,o
185,S0375-090616000100,las,o
185,S0375-090616000100,48,o
185,S0375-090616000100,h,o
185,S0375-090616000100,y,o
185,S0375-090616000100,432,o
185,S0375-090616000100,213,o
185,S0375-090616000100,cm,o
185,S0375-090616000100,a,o
185,S0375-090616000100,las,o
185,S0375-090616000100,72,o
185,S0375-090616000100,h,o
185,S0375-090616000100,p,o
185,S0375-090616000100,0001,o
185,S0375-090616000100,IC,o
185,S0375-090616000100,del,o
185,S0375-090616000100,95,o
185,S0375-090616000100,El,o
185,S0375-090616000100,promedio,o
185,S0375-090616000100,de,o
185,S0375-090616000100,numero,o
185,S0375-090616000100,de,o
185,S0375-090616000100,dosis,o
185,S0375-090616000100,de,o
185,S0375-090616000100,analgesico,i
185,S0375-090616000100,en,o
185,S0375-090616000100,el,o
185,S0375-090616000100,grupo,o
185,S0375-090616000100,A,o
185,S0375-090616000100,fue,o
185,S0375-090616000100,de,o
185,S0375-090616000100,241,o
185,S0375-090616000100,087,o
185,S0375-090616000100,a,o
185,S0375-090616000100,las,o
185,S0375-090616000100,24,o
185,S0375-090616000100,h,o
185,S0375-090616000100,111,o
185,S0375-090616000100,085,o
185,S0375-090616000100,a,o
185,S0375-090616000100,las,o
185,S0375-090616000100,48,o
185,S0375-090616000100,h,o
185,S0375-090616000100,y,o
185,S0375-090616000100,094,o
185,S0375-090616000100,096,o
185,S0375-090616000100,a,o
185,S0375-090616000100,las,o
185,S0375-090616000100,72,o
185,S0375-090616000100,h,o
185,S0375-090616000100,En,o
185,S0375-090616000100,el,o
185,S0375-090616000100,grupo,o
185,S0375-090616000100,B,o
185,S0375-090616000100,fue,o
185,S0375-090616000100,de,o
185,S0375-090616000100,382,o
185,S0375-090616000100,052,o
185,S0375-090616000100,dosis,o
185,S0375-090616000100,a,o
185,S0375-090616000100,las,o
185,S0375-090616000100,24,o
185,S0375-090616000100,h,o
185,S0375-090616000100,364,o
185,S0375-090616000100,070,o
185,S0375-090616000100,dosis,o
185,S0375-090616000100,a,o
185,S0375-090616000100,las,o
185,S0375-090616000100,48,o
185,S0375-090616000100,h,o
185,S0375-090616000100,y,o
185,S0375-090616000100,288,o
185,S0375-090616000100,126,o
185,S0375-090616000100,a,o
185,S0375-090616000100,las,o
185,S0375-090616000100,72,o
185,S0375-090616000100,h,o
185,S0375-090616000100,p,o
185,S0375-090616000100,0001,o
185,S0375-090616000100,IC,o
185,S0375-090616000100,del,o
185,S0375-090616000100,95,o
185,S0375-090616000100,Conclusiones,o
185,S0375-090616000100,En,o
185,S0375-090616000100,este,o
185,S0375-090616000100,estudio,o
185,S0375-090616000100,el,o
185,S0375-090616000100,diltiazem,i
185,S0375-090616000100,administrado,i
185,S0375-090616000100,por,i
185,S0375-090616000100,via,i
185,S0375-090616000100,topica,i
185,S0375-090616000100,disminuyo,o
185,S0375-090616000100,el,o
185,S0375-090616000100,dolor,i
185,S0375-090616000100,en,o
185,S0375-090616000100,los,o
185,S0375-090616000100,pacientes,o
185,S0375-090616000100,postoperados,o
185,S0375-090616000100,de,o
185,S0375-090616000100,hemorroidectomia,i
185,S0375-090616000100,con,i
185,S0375-090616000100,tecnica,i
185,S0375-090616000100,cerrada,i
185,S0375-090616000100,de,o
185,S0375-090616000100,manera,o
185,S0375-090616000100,estadisticamente,o
185,S0375-090616000100,significativa,o
186,S0375-090616300283,Efectos,o
186,S0375-090616300283,de,o
186,S0375-090616300283,la,o
186,S0375-090616300283,melatonina,i
186,S0375-090616300283,en,o
186,S0375-090616300283,la,o
186,S0375-090616300283,respuesta,i
186,S0375-090616300283,inflamatoria,i
186,S0375-090616300283,aguda,i
186,S0375-090616300283,asociada,o
186,S0375-090616300283,con,o
186,S0375-090616300283,la,o
186,S0375-090616300283,colangiopancreatografia,i
186,S0375-090616300283,retrograda,i
186,S0375-090616300283,endoscopica,i
186,S0375-090616300283,un,o
186,S0375-090616300283,ensayo,i
186,S0375-090616300283,clinico,i
186,S0375-090616300283,aleatorizado,o
186,S0375-090616300283,doble,o
186,S0375-090616300283,ciego,o
186,S0375-090616300283,y,o
186,S0375-090616300283,controlado,o
186,S0375-090616300283,con,o
186,S0375-090616300283,placebo,i
186,S0375-090616300283,Introduccion,o
186,S0375-090616300283,La,o
186,S0375-090616300283,colangiopancreatografia,i
186,S0375-090616300283,retrograda,i
186,S0375-090616300283,endoscopica,i
186,S0375-090616300283,CPRE,i
186,S0375-090616300283,esta,o
186,S0375-090616300283,asociada,o
186,S0375-090616300283,con,o
186,S0375-090616300283,la,o
186,S0375-090616300283,generacion,o
186,S0375-090616300283,de,o
186,S0375-090616300283,respuesta,i
186,S0375-090616300283,inflamatoria,i
186,S0375-090616300283,aguda,i
186,S0375-090616300283,la,o
186,S0375-090616300283,melatonina,i
186,S0375-090616300283,tiene,o
186,S0375-090616300283,una,o
186,S0375-090616300283,variedad,o
186,S0375-090616300283,de,o
186,S0375-090616300283,efectos,o
186,S0375-090616300283,inmunomoduladores,o
186,S0375-090616300283,y,o
186,S0375-090616300283,antioxidantes,o
186,S0375-090616300283,probados,o
186,S0375-090616300283,de,o
186,S0375-090616300283,manera,o
186,S0375-090616300283,experimental,o
186,S0375-090616300283,en,o
186,S0375-090616300283,patologia,i
186,S0375-090616300283,pancreatobiliar,i
186,S0375-090616300283,Objetivo,o
186,S0375-090616300283,El,o
186,S0375-090616300283,objetivo,o
186,S0375-090616300283,del,o
186,S0375-090616300283,estudio,o
186,S0375-090616300283,fue,o
186,S0375-090616300283,evaluar,o
186,S0375-090616300283,los,o
186,S0375-090616300283,efectos,o
186,S0375-090616300283,de,o
186,S0375-090616300283,la,o
186,S0375-090616300283,administracion,i
186,S0375-090616300283,periprocedimiento,i
186,S0375-090616300283,de,o
186,S0375-090616300283,melatonina,i
186,S0375-090616300283,sobre,o
186,S0375-090616300283,la,o
186,S0375-090616300283,respuesta,i
186,S0375-090616300283,inflamatoria,i
186,S0375-090616300283,y,o
186,S0375-090616300283,peroxidacion,o
186,S0375-090616300283,lipidica,i
186,S0375-090616300283,asociada,o
186,S0375-090616300283,a,o
186,S0375-090616300283,la,o
186,S0375-090616300283,realizacion,o
186,S0375-090616300283,de,o
186,S0375-090616300283,CPRE,i
186,S0375-090616300283,Metodos,o
186,S0375-090616300283,En,o
186,S0375-090616300283,este,o
186,S0375-090616300283,ensayo,i
186,S0375-090616300283,clinico,i
186,S0375-090616300283,se,o
186,S0375-090616300283,incluyo,o
186,S0375-090616300283,a,o
186,S0375-090616300283,37,o
186,S0375-090616300283,pacientes,o
186,S0375-090616300283,con,o
186,S0375-090616300283,riesgo,o
186,S0375-090616300283,alto,o
186,S0375-090616300283,de,o
186,S0375-090616300283,coledocolitiasis,i
186,S0375-090616300283,se,o
186,S0375-090616300283,aleatorizaron,i
186,S0375-090616300283,para,o
186,S0375-090616300283,recibir,o
186,S0375-090616300283,melatonina,i
186,S0375-090616300283,o,o
186,S0375-090616300283,placebo,i
186,S0375-090616300283,periprocedimiento,o
186,S0375-090616300283,CPRE,i
186,S0375-090616300283,Se,o
186,S0375-090616300283,midio,i
186,S0375-090616300283,la,i
186,S0375-090616300283,concentracion,i
186,S0375-090616300283,serica,i
186,S0375-090616300283,de,i
186,S0375-090616300283,factor,i
186,S0375-090616300283,de,i
186,S0375-090616300283,necrosis,i
186,S0375-090616300283,tumoral,i
186,S0375-090616300283,alfa,i
186,S0375-090616300283,FNTalfa,o
186,S0375-090616300283,interleucina6,o
186,S0375-090616300283,IL6,o
186,S0375-090616300283,factor,i
186,S0375-090616300283,de,i
186,S0375-090616300283,crecimiento,i
186,S0375-090616300283,endotelial,i
186,S0375-090616300283,vascular,i
186,S0375-090616300283,FCEV,i
186,S0375-090616300283,peroxidacion,o
186,S0375-090616300283,lipidica,i
186,S0375-090616300283,amilasa,i
186,S0375-090616300283,y,o
186,S0375-090616300283,pruebas,i
186,S0375-090616300283,de,i
186,S0375-090616300283,funcionamiento,i
186,S0375-090616300283,hepatico,i
186,S0375-090616300283,24,o
186,S0375-090616300283,h,o
186,S0375-090616300283,antes,o
186,S0375-090616300283,y,o
186,S0375-090616300283,despues,o
186,S0375-090616300283,del,o
186,S0375-090616300283,procedimiento,i
186,S0375-090616300283,Resultados,o
186,S0375-090616300283,No,o
186,S0375-090616300283,encontramos,o
186,S0375-090616300283,diferencia,o
186,S0375-090616300283,entre,o
186,S0375-090616300283,las,o
186,S0375-090616300283,concentraciones,i
186,S0375-090616300283,sericas,i
186,S0375-090616300283,de,i
186,S0375-090616300283,FNT,i
186,S0375-090616300283,alfa,i
186,S0375-090616300283,melatonina,i
186,S0375-090616300283,1538,o
186,S0375-090616300283,vs,o
186,S0375-090616300283,1494,o
186,S0375-090616300283,ngmL,o
186,S0375-090616300283,placebo,i
186,S0375-090616300283,1035,o
186,S0375-090616300283,vs,o
186,S0375-090616300283,1073,o
186,S0375-090616300283,ngmL,o
186,S0375-090616300283,IL6,o
186,S0375-090616300283,melatonina,i
186,S0375-090616300283,1318,o
186,S0375-090616300283,vs,o
186,S0375-090616300283,1333,o
186,S0375-090616300283,ngmL,o
186,S0375-090616300283,placebo,i
186,S0375-090616300283,1778,o
186,S0375-090616300283,vs,o
186,S0375-090616300283,1978,o
186,S0375-090616300283,ngmL,o
186,S0375-090616300283,y,o
186,S0375-090616300283,FCEV,i
186,S0375-090616300283,melatonina,i
186,S0375-090616300283,1573,o
186,S0375-090616300283,vs,o
186,S0375-090616300283,1578,o
186,S0375-090616300283,pgmL,o
186,S0375-090616300283,placebo,i
186,S0375-090616300283,973,o
186,S0375-090616300283,vs,o
186,S0375-090616300283,978,o
186,S0375-090616300283,pgmL,o
186,S0375-090616300283,o,o
186,S0375-090616300283,en,o
186,S0375-090616300283,peroxidacion,o
186,S0375-090616300283,lipidica,i
186,S0375-090616300283,melatonina,i
186,S0375-090616300283,392,o
186,S0375-090616300283,vs,o
186,S0375-090616300283,723,o
186,S0375-090616300283,μgmL,o
186,S0375-090616300283,placebo,i
186,S0375-090616300283,664,o
186,S0375-090616300283,vs,o
186,S0375-090616300283,905,o
186,S0375-090616300283,μgmL,o
186,S0375-090616300283,preprocedimiento,o
186,S0375-090616300283,vs,o
186,S0375-090616300283,posprocedimiento,o
186,S0375-090616300283,en,o
186,S0375-090616300283,ninguno,o
186,S0375-090616300283,de,o
186,S0375-090616300283,los,o
186,S0375-090616300283,2,o
186,S0375-090616300283,grupos,o
186,S0375-090616300283,p,o
186,S0375-090616300283,005,o
186,S0375-090616300283,Posterior,o
186,S0375-090616300283,a,o
186,S0375-090616300283,la,o
186,S0375-090616300283,CPRE,i
186,S0375-090616300283,los,o
186,S0375-090616300283,niveles,i
186,S0375-090616300283,de,i
186,S0375-090616300283,aspartato,i
186,S0375-090616300283,aminotransferasa,i
186,S0375-090616300283,alanina,i
186,S0375-090616300283,aminotransferasa,i
186,S0375-090616300283,y,o
186,S0375-090616300283,bilirrubina,i
186,S0375-090616300283,total,i
186,S0375-090616300283,disminuyeron,o
186,S0375-090616300283,significativamente,o
186,S0375-090616300283,solo,o
186,S0375-090616300283,en,o
186,S0375-090616300283,el,o
186,S0375-090616300283,grupo,o
186,S0375-090616300283,de,o
186,S0375-090616300283,melatonina,i
186,S0375-090616300283,p,o
186,S0375-090616300283,005,o
186,S0375-090616300283,La,o
186,S0375-090616300283,administracion,i
186,S0375-090616300283,de,o
186,S0375-090616300283,melatonina,i
186,S0375-090616300283,es,o
186,S0375-090616300283,segura,o
186,S0375-090616300283,y,o
186,S0375-090616300283,tolerada,o
186,S0375-090616300283,Conclusiones,o
186,S0375-090616300283,La,o
186,S0375-090616300283,melatonina,i
186,S0375-090616300283,es,o
186,S0375-090616300283,segura,o
186,S0375-090616300283,y,o
186,S0375-090616300283,tolerada,o
186,S0375-090616300283,en,o
186,S0375-090616300283,pacientes,o
186,S0375-090616300283,que,o
186,S0375-090616300283,van,o
186,S0375-090616300283,a,o
186,S0375-090616300283,CPRE,i
186,S0375-090616300283,pero,o
186,S0375-090616300283,no,o
186,S0375-090616300283,parece,o
186,S0375-090616300283,afectar,o
186,S0375-090616300283,las,o
186,S0375-090616300283,concentraciones,i
186,S0375-090616300283,de,i
186,S0375-090616300283,citocinas,i
186,S0375-090616300283,proinflamatorias,o
186,S0375-090616300283,o,o
186,S0375-090616300283,peroxidacion,o
186,S0375-090616300283,lipidica,i
186,S0375-090616300283,en,o
186,S0375-090616300283,humanos,o
187,S0375-090617300940,Correlacion,o
187,S0375-090617300940,de,o
187,S0375-090617300940,los,o
187,S0375-090617300940,niveles,i
187,S0375-090617300940,de,i
187,S0375-090617300940,alfafetoproteina,i
187,S0375-090617300940,serica,i
187,S0375-090617300940,preoperatoria,o
187,S0375-090617300940,y,o
187,S0375-090617300940,sobrevida,o
187,S0375-090617300940,en,o
187,S0375-090617300940,el,o
187,S0375-090617300940,tratamiento,i
187,S0375-090617300940,quirurgico,i
187,S0375-090617300940,del,o
187,S0375-090617300940,hepatocarcinoma,i
187,S0375-090617300940,en,o
187,S0375-090617300940,una,o
187,S0375-090617300940,unidad,o
187,S0375-090617300940,medica,o
187,S0375-090617300940,de,o
187,S0375-090617300940,alta,o
187,S0375-090617300940,especialidad,o
187,S0375-090617300940,en,o
187,S0375-090617300940,Veracruz,o
187,S0375-090617300940,Mexico,o
187,S0375-090617300940,Introduccion,o
187,S0375-090617300940,Los,o
187,S0375-090617300940,niveles,i
187,S0375-090617300940,sericos,i
187,S0375-090617300940,de,i
187,S0375-090617300940,alfafetoproteina,i
187,S0375-090617300940,AFP,i
187,S0375-090617300940,preoperatoria,o
187,S0375-090617300940,pueden,o
187,S0375-090617300940,tener,o
187,S0375-090617300940,valor,o
187,S0375-090617300940,predictivo,o
187,S0375-090617300940,para,o
187,S0375-090617300940,la,o
187,S0375-090617300940,sobrevida,o
187,S0375-090617300940,del,o
187,S0375-090617300940,hepatocarcinoma,i
187,S0375-090617300940,HCC,i
187,S0375-090617300940,Objetivo,o
187,S0375-090617300940,Analizar,o
187,S0375-090617300940,la,o
187,S0375-090617300940,correlacion,o
187,S0375-090617300940,entre,o
187,S0375-090617300940,los,o
187,S0375-090617300940,niveles,i
187,S0375-090617300940,sericos,i
187,S0375-090617300940,de,i
187,S0375-090617300940,AFP,i
187,S0375-090617300940,preoperatoria,o
187,S0375-090617300940,y,o
187,S0375-090617300940,la,o
187,S0375-090617300940,sobrevida,o
187,S0375-090617300940,posterior,o
187,S0375-090617300940,al,o
187,S0375-090617300940,tratamiento,i
187,S0375-090617300940,quirurgico,i
187,S0375-090617300940,del,o
187,S0375-090617300940,HCC,i
187,S0375-090617300940,Metodos,o
187,S0375-090617300940,Diecinueve,o
187,S0375-090617300940,pacientes,o
187,S0375-090617300940,fueron,o
187,S0375-090617300940,seguidos,i
187,S0375-090617300940,prospectivamente,o
187,S0375-090617300940,julio,o
187,S0375-090617300940,del,o
187,S0375-090617300940,2005enero,o
187,S0375-090617300940,del,o
187,S0375-090617300940,2016,o
187,S0375-090617300940,Se,o
187,S0375-090617300940,realizo,o
187,S0375-090617300940,una,o
187,S0375-090617300940,curva,o
187,S0375-090617300940,ROC,o
187,S0375-090617300940,para,o
187,S0375-090617300940,determinar,o
187,S0375-090617300940,la,o
187,S0375-090617300940,sensibilidad,o
187,S0375-090617300940,y,o
187,S0375-090617300940,la,o
187,S0375-090617300940,especificidad,o
187,S0375-090617300940,de,o
187,S0375-090617300940,la,o
187,S0375-090617300940,AFP,i
187,S0375-090617300940,con,o
187,S0375-090617300940,relacion,o
187,S0375-090617300940,con,o
187,S0375-090617300940,la,o
187,S0375-090617300940,sobrevida,o
187,S0375-090617300940,KaplanMeier,o
187,S0375-090617300940,Resultados,o
187,S0375-090617300940,Se,o
187,S0375-090617300940,evaluo,o
187,S0375-090617300940,a,o
187,S0375-090617300940,19,o
187,S0375-090617300940,pacientes,o
187,S0375-090617300940,579,o
187,S0375-090617300940,hombres,o
187,S0375-090617300940,edad,o
187,S0375-090617300940,media,o
187,S0375-090617300940,681,o
187,S0375-090617300940,85,o
187,S0375-090617300940,años,o
187,S0375-090617300940,con,o
187,S0375-090617300940,sobrevida,o
187,S0375-090617300940,a,o
187,S0375-090617300940,1,o
187,S0375-090617300940,3,o
187,S0375-090617300940,y,o
187,S0375-090617300940,5,o
187,S0375-090617300940,años,o
187,S0375-090617300940,del,o
187,S0375-090617300940,894,o
187,S0375-090617300940,el,o
187,S0375-090617300940,559,o
187,S0375-090617300940,y,o
187,S0375-090617300940,el,o
187,S0375-090617300940,559,o
187,S0375-090617300940,El,o
187,S0375-090617300940,punto,o
187,S0375-090617300940,de,o
187,S0375-090617300940,corte,o
187,S0375-090617300940,de,o
187,S0375-090617300940,AFP,i
187,S0375-090617300940,fue,o
187,S0375-090617300940,151,o
187,S0375-090617300940,ngml,o
187,S0375-090617300940,sensibilidad,o
187,S0375-090617300940,100,o
187,S0375-090617300940,especificidad,o
187,S0375-090617300940,9923,o
187,S0375-090617300940,Los,o
187,S0375-090617300940,niveles,i
187,S0375-090617300940,preoperatorios,i
187,S0375-090617300940,de,i
187,S0375-090617300940,AFP,i
187,S0375-090617300940,menores,o
187,S0375-090617300940,de,o
187,S0375-090617300940,151,o
187,S0375-090617300940,200,o
187,S0375-090617300940,400,o
187,S0375-090617300940,y,o
187,S0375-090617300940,463,o
187,S0375-090617300940,ngml,o
187,S0375-090617300940,correlacionaron,o
187,S0375-090617300940,con,o
187,S0375-090617300940,mejor,o
187,S0375-090617300940,sobrevida,o
187,S0375-090617300940,a,o
187,S0375-090617300940,1,o
187,S0375-090617300940,y,o
187,S0375-090617300940,5,o
187,S0375-090617300940,años,o
187,S0375-090617300940,que,o
187,S0375-090617300940,niveles,o
187,S0375-090617300940,mayores,o
187,S0375-090617300940,de,o
187,S0375-090617300940,AFP,i
187,S0375-090617300940,p,o
187,S0375-090617300940,005,o
187,S0375-090617300940,Conclusiones,o
187,S0375-090617300940,Los,o
187,S0375-090617300940,niveles,o
187,S0375-090617300940,sericos,i
187,S0375-090617300940,preoperatorios,o
187,S0375-090617300940,elevados,o
187,S0375-090617300940,de,o
187,S0375-090617300940,AFP,i
187,S0375-090617300940,tienen,o
187,S0375-090617300940,valor,o
187,S0375-090617300940,predictivo,o
187,S0375-090617300940,en,o
187,S0375-090617300940,relacion,o
187,S0375-090617300940,con,o
187,S0375-090617300940,la,o
187,S0375-090617300940,sobrevida,o
187,S0375-090617300940,de,o
187,S0375-090617300940,HCC,i
188,S0716-10182013000600009,La,o
188,S0716-10182013000600009,vacuna,i
188,S0716-10182013000600009,polio,i
188,S0716-10182013000600009,oral,o
188,S0716-10182013000600009,en,o
188,S0716-10182013000600009,lactantes,o
188,S0716-10182013000600009,no,o
188,S0716-10182013000600009,interfiere,o
188,S0716-10182013000600009,con,o
188,S0716-10182013000600009,la,o
188,S0716-10182013000600009,deteccion,i
188,S0716-10182013000600009,de,i
188,S0716-10182013000600009,enterovirus,i
188,S0716-10182013000600009,en,o
188,S0716-10182013000600009,sangre,i
188,S0716-10182013000600009,Introduccion,o
188,S0716-10182013000600009,No,o
188,S0716-10182013000600009,existen,o
188,S0716-10182013000600009,estudios,o
188,S0716-10182013000600009,que,o
188,S0716-10182013000600009,indiquen,o
188,S0716-10182013000600009,si,o
188,S0716-10182013000600009,la,o
188,S0716-10182013000600009,vacuna,i
188,S0716-10182013000600009,polio,i
188,S0716-10182013000600009,oral,o
188,S0716-10182013000600009,VPO,i
188,S0716-10182013000600009,produce,o
188,S0716-10182013000600009,viremia,i
188,S0716-10182013000600009,detectable,o
188,S0716-10182013000600009,mediante,o
188,S0716-10182013000600009,metodos,i
188,S0716-10182013000600009,moleculares,i
188,S0716-10182013000600009,Una,o
188,S0716-10182013000600009,eventual,o
188,S0716-10182013000600009,viremia,i
188,S0716-10182013000600009,podria,o
188,S0716-10182013000600009,afectar,o
188,S0716-10182013000600009,el,o
188,S0716-10182013000600009,rendimiento,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,la,o
188,S0716-10182013000600009,RPC,i
188,S0716-10182013000600009,tiempo,i
188,S0716-10182013000600009,real,i
188,S0716-10182013000600009,para,o
188,S0716-10182013000600009,detectar,o
188,S0716-10182013000600009,enterovirus,o
188,S0716-10182013000600009,EV,i
188,S0716-10182013000600009,no,i
188,S0716-10182013000600009,polio,i
188,S0716-10182013000600009,examen,i
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,creciente,o
188,S0716-10182013000600009,uso,o
188,S0716-10182013000600009,clinico,o
188,S0716-10182013000600009,en,o
188,S0716-10182013000600009,lactantes,o
188,S0716-10182013000600009,pequeños,o
188,S0716-10182013000600009,con,o
188,S0716-10182013000600009,fiebre,i
188,S0716-10182013000600009,sin,o
188,S0716-10182013000600009,foco,o
188,S0716-10182013000600009,Objetivo,o
188,S0716-10182013000600009,Determinar,i
188,S0716-10182013000600009,viremia,i
188,S0716-10182013000600009,post,o
188,S0716-10182013000600009,VPO,i
188,S0716-10182013000600009,en,o
188,S0716-10182013000600009,lactantes,o
188,S0716-10182013000600009,sanos,o
188,S0716-10182013000600009,por,o
188,S0716-10182013000600009,metodos,i
188,S0716-10182013000600009,moleculares,i
188,S0716-10182013000600009,Metodos,o
188,S0716-10182013000600009,50,o
188,S0716-10182013000600009,menores,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,3,o
188,S0716-10182013000600009,meses,o
188,S0716-10182013000600009,al,o
188,S0716-10182013000600009,momento,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,recibir,o
188,S0716-10182013000600009,su,o
188,S0716-10182013000600009,primera,o
188,S0716-10182013000600009,VPO,i
188,S0716-10182013000600009,se,o
188,S0716-10182013000600009,distribuyeron,i
188,S0716-10182013000600009,en,i
188,S0716-10182013000600009,forma,i
188,S0716-10182013000600009,aleatoria,i
188,S0716-10182013000600009,en,o
188,S0716-10182013000600009,5,o
188,S0716-10182013000600009,grupos,o
188,S0716-10182013000600009,control,o
188,S0716-10182013000600009,muestra,i
188,S0716-10182013000600009,de,i
188,S0716-10182013000600009,sangre,i
188,S0716-10182013000600009,prevacunacion,o
188,S0716-10182013000600009,grupo,o
188,S0716-10182013000600009,1,o
188,S0716-10182013000600009,muestra,i
188,S0716-10182013000600009,al,o
188,S0716-10182013000600009,2,o
188,S0716-10182013000600009,dia,o
188,S0716-10182013000600009,grupo,o
188,S0716-10182013000600009,2,o
188,S0716-10182013000600009,al,o
188,S0716-10182013000600009,4,o
188,S0716-10182013000600009,dia,o
188,S0716-10182013000600009,grupo,o
188,S0716-10182013000600009,3,o
188,S0716-10182013000600009,al,o
188,S0716-10182013000600009,6,o
188,S0716-10182013000600009,dia,o
188,S0716-10182013000600009,y,o
188,S0716-10182013000600009,grupo,o
188,S0716-10182013000600009,4,o
188,S0716-10182013000600009,al,o
188,S0716-10182013000600009,8,o
188,S0716-10182013000600009,dia,o
188,S0716-10182013000600009,postvacunacion,o
188,S0716-10182013000600009,Se,o
188,S0716-10182013000600009,realizo,o
188,S0716-10182013000600009,RPC,i
188,S0716-10182013000600009,convencional,i
188,S0716-10182013000600009,especifica,i
188,S0716-10182013000600009,para,i
188,S0716-10182013000600009,virus,i
188,S0716-10182013000600009,polio,i
188,S0716-10182013000600009,y,o
188,S0716-10182013000600009,RPC,i
188,S0716-10182013000600009,tiempo,i
188,S0716-10182013000600009,real,i
188,S0716-10182013000600009,para,i
188,S0716-10182013000600009,EV,i
188,S0716-10182013000600009,no,i
188,S0716-10182013000600009,polio,i
188,S0716-10182013000600009,en,o
188,S0716-10182013000600009,las,o
188,S0716-10182013000600009,muestras,i
188,S0716-10182013000600009,de,i
188,S0716-10182013000600009,sangre,i
188,S0716-10182013000600009,y,o
188,S0716-10182013000600009,en,o
188,S0716-10182013000600009,muestras,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,VPO,i
188,S0716-10182013000600009,Resultados,o
188,S0716-10182013000600009,No,o
188,S0716-10182013000600009,se,o
188,S0716-10182013000600009,identifico,o
188,S0716-10182013000600009,presencia,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,material,o
188,S0716-10182013000600009,genetico,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,virus,o
188,S0716-10182013000600009,polio,i
188,S0716-10182013000600009,en,o
188,S0716-10182013000600009,lactante,o
188,S0716-10182013000600009,alguno,o
188,S0716-10182013000600009,mientras,o
188,S0716-10182013000600009,que,o
188,S0716-10182013000600009,en,o
188,S0716-10182013000600009,9,o
188,S0716-10182013000600009,18,o
188,S0716-10182013000600009,se,o
188,S0716-10182013000600009,identifico,o
188,S0716-10182013000600009,presencia,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,EV,i
188,S0716-10182013000600009,no,i
188,S0716-10182013000600009,polio,i
188,S0716-10182013000600009,La,o
188,S0716-10182013000600009,RPC,i
188,S0716-10182013000600009,tiempo,i
188,S0716-10182013000600009,real,i
188,S0716-10182013000600009,para,i
188,S0716-10182013000600009,EV,i
188,S0716-10182013000600009,no,i
188,S0716-10182013000600009,polio,i
188,S0716-10182013000600009,no,o
188,S0716-10182013000600009,amplifico,o
188,S0716-10182013000600009,material,o
188,S0716-10182013000600009,genetico,o
188,S0716-10182013000600009,a,o
188,S0716-10182013000600009,partir,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,las,o
188,S0716-10182013000600009,muestras,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,VPO,i
188,S0716-10182013000600009,Discusion,o
188,S0716-10182013000600009,Los,o
188,S0716-10182013000600009,resultados,o
188,S0716-10182013000600009,sugieren,o
188,S0716-10182013000600009,que,o
188,S0716-10182013000600009,no,o
188,S0716-10182013000600009,existe,o
188,S0716-10182013000600009,viremia,i
188,S0716-10182013000600009,postVPO,o
188,S0716-10182013000600009,detectable,o
188,S0716-10182013000600009,por,o
188,S0716-10182013000600009,metodos,i
188,S0716-10182013000600009,moleculares,i
188,S0716-10182013000600009,Considerando,o
188,S0716-10182013000600009,que,o
188,S0716-10182013000600009,la,o
188,S0716-10182013000600009,RPC,i
188,S0716-10182013000600009,tiempo,i
188,S0716-10182013000600009,real,i
188,S0716-10182013000600009,de,i
188,S0716-10182013000600009,EV,i
188,S0716-10182013000600009,no,i
188,S0716-10182013000600009,polio,i
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,uso,o
188,S0716-10182013000600009,clinico,o
188,S0716-10182013000600009,no,o
188,S0716-10182013000600009,permite,o
188,S0716-10182013000600009,identificar,o
188,S0716-10182013000600009,la,o
188,S0716-10182013000600009,presencia,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,virus,o
188,S0716-10182013000600009,polio,i
188,S0716-10182013000600009,estos,o
188,S0716-10182013000600009,hallazgos,o
188,S0716-10182013000600009,indican,o
188,S0716-10182013000600009,que,o
188,S0716-10182013000600009,no,o
188,S0716-10182013000600009,existiran,o
188,S0716-10182013000600009,falsos,o
188,S0716-10182013000600009,positivos,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,este,o
188,S0716-10182013000600009,examen,i
188,S0716-10182013000600009,como,o
188,S0716-10182013000600009,resultado,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,una,o
188,S0716-10182013000600009,vacunacion,i
188,S0716-10182013000600009,VPO,i
188,S0716-10182013000600009,reciente,o
188,S0716-10182013000600009,Adicionalmente,o
188,S0716-10182013000600009,se,o
188,S0716-10182013000600009,documento,o
188,S0716-10182013000600009,presencia,o
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,EV,i
188,S0716-10182013000600009,no,i
188,S0716-10182013000600009,polio,i
188,S0716-10182013000600009,en,o
188,S0716-10182013000600009,sangre,i
188,S0716-10182013000600009,de,o
188,S0716-10182013000600009,lactantes,o
188,S0716-10182013000600009,asintomaticos,i
189,S0716-10182014000500006,Evaluacion,i
189,S0716-10182014000500006,del,o
189,S0716-10182014000500006,efecto,i
189,S0716-10182014000500006,genotoxico,i
189,S0716-10182014000500006,en,o
189,S0716-10182014000500006,pacientes,o
189,S0716-10182014000500006,con,o
189,S0716-10182014000500006,malaria,i
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,una,o
189,S0716-10182014000500006,region,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,Colombia,o
189,S0716-10182014000500006,Introduccion,o
189,S0716-10182014000500006,Durante,o
189,S0716-10182014000500006,la,o
189,S0716-10182014000500006,infeccion,i
189,S0716-10182014000500006,de,i
189,S0716-10182014000500006,la,i
189,S0716-10182014000500006,malaria,i
189,S0716-10182014000500006,tanto,o
189,S0716-10182014000500006,el,o
189,S0716-10182014000500006,parasito,o
189,S0716-10182014000500006,como,o
189,S0716-10182014000500006,el,o
189,S0716-10182014000500006,hospedero,o
189,S0716-10182014000500006,estan,o
189,S0716-10182014000500006,bajo,o
189,S0716-10182014000500006,los,o
189,S0716-10182014000500006,efectos,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,estres,i
189,S0716-10182014000500006,oxidativo,i
189,S0716-10182014000500006,dado,o
189,S0716-10182014000500006,que,o
189,S0716-10182014000500006,se,o
189,S0716-10182014000500006,aumenta,o
189,S0716-10182014000500006,la,o
189,S0716-10182014000500006,produccion,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,especies,o
189,S0716-10182014000500006,reactivas,o
189,S0716-10182014000500006,del,o
189,S0716-10182014000500006,oxigeno,i
189,S0716-10182014000500006,las,o
189,S0716-10182014000500006,cuales,o
189,S0716-10182014000500006,pueden,o
189,S0716-10182014000500006,inducir,o
189,S0716-10182014000500006,daños,i
189,S0716-10182014000500006,en,i
189,S0716-10182014000500006,el,i
189,S0716-10182014000500006,ADN,i
189,S0716-10182014000500006,debido,o
189,S0716-10182014000500006,a,o
189,S0716-10182014000500006,su,o
189,S0716-10182014000500006,gran,o
189,S0716-10182014000500006,efecto,i
189,S0716-10182014000500006,genotoxico,i
189,S0716-10182014000500006,Objetivo,o
189,S0716-10182014000500006,Evaluar,o
189,S0716-10182014000500006,el,o
189,S0716-10182014000500006,efecto,i
189,S0716-10182014000500006,genotoxico,i
189,S0716-10182014000500006,en,o
189,S0716-10182014000500006,linfocitos,i
189,S0716-10182014000500006,humanos,o
189,S0716-10182014000500006,en,o
189,S0716-10182014000500006,una,o
189,S0716-10182014000500006,cohorte,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,pacientes,o
189,S0716-10182014000500006,con,o
189,S0716-10182014000500006,malaria,i
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,Medellin,o
189,S0716-10182014000500006,y,o
189,S0716-10182014000500006,Quibdo,o
189,S0716-10182014000500006,Metodos,o
189,S0716-10182014000500006,Se,o
189,S0716-10182014000500006,realizo,o
189,S0716-10182014000500006,un,o
189,S0716-10182014000500006,estudio,i
189,S0716-10182014000500006,observacional,i
189,S0716-10182014000500006,transversal,i
189,S0716-10182014000500006,en,o
189,S0716-10182014000500006,100,o
189,S0716-10182014000500006,personas,o
189,S0716-10182014000500006,con,o
189,S0716-10182014000500006,malaria,i
189,S0716-10182014000500006,y,o
189,S0716-10182014000500006,100,o
189,S0716-10182014000500006,controles,o
189,S0716-10182014000500006,sanos,o
189,S0716-10182014000500006,Se,o
189,S0716-10182014000500006,incluyeron,o
189,S0716-10182014000500006,pacientes,o
189,S0716-10182014000500006,infectados,i
189,S0716-10182014000500006,con,i
189,S0716-10182014000500006,Plasmodium,i
189,S0716-10182014000500006,que,o
189,S0716-10182014000500006,consultaron,i
189,S0716-10182014000500006,en,o
189,S0716-10182014000500006,el,o
189,S0716-10182014000500006,Instituto,o
189,S0716-10182014000500006,Colombiano,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,Medicina,o
189,S0716-10182014000500006,Tropical,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,Medellin,o
189,S0716-10182014000500006,y,o
189,S0716-10182014000500006,el,o
189,S0716-10182014000500006,Hospital,o
189,S0716-10182014000500006,Ismael,o
189,S0716-10182014000500006,Roldan,o
189,S0716-10182014000500006,Valencia,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,Quibdo,o
189,S0716-10182014000500006,Se,o
189,S0716-10182014000500006,realizo,o
189,S0716-10182014000500006,una,o
189,S0716-10182014000500006,valoracion,i
189,S0716-10182014000500006,transversal,i
189,S0716-10182014000500006,del,o
189,S0716-10182014000500006,efecto,o
189,S0716-10182014000500006,daño,i
189,S0716-10182014000500006,genetico,i
189,S0716-10182014000500006,mediante,o
189,S0716-10182014000500006,electroforesis,o
189,S0716-10182014000500006,en,o
189,S0716-10182014000500006,gel,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,celulas,i
189,S0716-10182014000500006,individuales,o
189,S0716-10182014000500006,ensayo,i
189,S0716-10182014000500006,Cometa,i
189,S0716-10182014000500006,Resultados,o
189,S0716-10182014000500006,El,o
189,S0716-10182014000500006,promedio,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,longitud,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,la,o
189,S0716-10182014000500006,cola,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,los,o
189,S0716-10182014000500006,pacientes,o
189,S0716-10182014000500006,269,o
189,S0716-10182014000500006,98,o
189,S0716-10182014000500006,fue,o
189,S0716-10182014000500006,significativamente,o
189,S0716-10182014000500006,mayor,o
189,S0716-10182014000500006,que,o
189,S0716-10182014000500006,la,o
189,S0716-10182014000500006,media,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,los,o
189,S0716-10182014000500006,controles,o
189,S0716-10182014000500006,sanos,o
189,S0716-10182014000500006,148,o
189,S0716-10182014000500006,32,o
189,S0716-10182014000500006,p,o
189,S0716-10182014000500006,001,o
189,S0716-10182014000500006,Conclusion,o
189,S0716-10182014000500006,Se,o
189,S0716-10182014000500006,evidencio,o
189,S0716-10182014000500006,en,o
189,S0716-10182014000500006,la,o
189,S0716-10182014000500006,poblacion,o
189,S0716-10182014000500006,de,o
189,S0716-10182014000500006,estudio,o
189,S0716-10182014000500006,que,o
189,S0716-10182014000500006,la,o
189,S0716-10182014000500006,infeccion,i
189,S0716-10182014000500006,por,i
189,S0716-10182014000500006,malaria,i
189,S0716-10182014000500006,genero,o
189,S0716-10182014000500006,genotoxicidad,i
189,S0716-10182014000500006,no,o
189,S0716-10182014000500006,asi,o
189,S0716-10182014000500006,variables,o
189,S0716-10182014000500006,como,o
189,S0716-10182014000500006,tabaquismo,i
189,S0716-10182014000500006,tratamiento,i
189,S0716-10182014000500006,antimalarico,i
189,S0716-10182014000500006,y,o
189,S0716-10182014000500006,ocupacion,o
190,S0716-10182015000300001,Evaluacion,o
190,S0716-10182015000300001,farmacocineticafarmacodinamica,o
190,S0716-10182015000300001,PKPD,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,un,o
190,S0716-10182015000300001,esquema,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,administracion,i
190,S0716-10182015000300001,oral,i
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,metronidazol,i
190,S0716-10182015000300001,en,o
190,S0716-10182015000300001,intervalo,o
190,S0716-10182015000300001,ampliado,o
190,S0716-10182015000300001,para,o
190,S0716-10182015000300001,el,o
190,S0716-10182015000300001,manejo,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,infecciones,i
190,S0716-10182015000300001,producidas,i
190,S0716-10182015000300001,por,i
190,S0716-10182015000300001,Bacteroides,i
190,S0716-10182015000300001,fragilis,i
190,S0716-10182015000300001,Introduccion,o
190,S0716-10182015000300001,Metronidazol,i
190,S0716-10182015000300001,es,o
190,S0716-10182015000300001,el,o
190,S0716-10182015000300001,antimicrobiano,i
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,eleccion,o
190,S0716-10182015000300001,para,o
190,S0716-10182015000300001,el,o
190,S0716-10182015000300001,manejo,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,infecciones,i
190,S0716-10182015000300001,anaerobicas,i
190,S0716-10182015000300001,Su,o
190,S0716-10182015000300001,administracion,i
190,S0716-10182015000300001,requiere,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,dosis,o
190,S0716-10182015000300001,multiples,o
190,S0716-10182015000300001,provocando,o
190,S0716-10182015000300001,aumento,o
190,S0716-10182015000300001,en,o
190,S0716-10182015000300001,errores,o
190,S0716-10182015000300001,medicamentosos,i
190,S0716-10182015000300001,Debido,o
190,S0716-10182015000300001,al,o
190,S0716-10182015000300001,efecto,o
190,S0716-10182015000300001,postantibiotico,o
190,S0716-10182015000300001,y,o
190,S0716-10182015000300001,a,o
190,S0716-10182015000300001,la,o
190,S0716-10182015000300001,actividad,o
190,S0716-10182015000300001,bactericida,o
190,S0716-10182015000300001,concentraciondependiente,o
190,S0716-10182015000300001,la,o
190,S0716-10182015000300001,administracion,i
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,metronidazol,i
190,S0716-10182015000300001,en,o
190,S0716-10182015000300001,intervalos,o
190,S0716-10182015000300001,ampliados,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,administracion,i
190,S0716-10182015000300001,permitiria,o
190,S0716-10182015000300001,alcanzar,o
190,S0716-10182015000300001,parametros,o
190,S0716-10182015000300001,PKPD,o
190,S0716-10182015000300001,efectivos,o
190,S0716-10182015000300001,Objetivo,o
190,S0716-10182015000300001,Evaluar,o
190,S0716-10182015000300001,la,o
190,S0716-10182015000300001,probabilidad,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,alcanzar,o
190,S0716-10182015000300001,una,o
190,S0716-10182015000300001,relacion,o
190,S0716-10182015000300001,PKPD,o
190,S0716-10182015000300001,efectiva,o
190,S0716-10182015000300001,con,o
190,S0716-10182015000300001,la,o
190,S0716-10182015000300001,administracion,i
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,1000,o
190,S0716-10182015000300001,mg,o
190,S0716-10182015000300001,cada,o
190,S0716-10182015000300001,24,o
190,S0716-10182015000300001,h,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,metronidazol,i
190,S0716-10182015000300001,para,o
190,S0716-10182015000300001,infecciones,i
190,S0716-10182015000300001,por,i
190,S0716-10182015000300001,Bacteroides,i
190,S0716-10182015000300001,fragilis,i
190,S0716-10182015000300001,Metodo,o
190,S0716-10182015000300001,Se,o
190,S0716-10182015000300001,realizo,o
190,S0716-10182015000300001,un,o
190,S0716-10182015000300001,ensayo,i
190,S0716-10182015000300001,clinico,i
190,S0716-10182015000300001,sobre,o
190,S0716-10182015000300001,un,o
190,S0716-10182015000300001,grupo,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,voluntarios,o
190,S0716-10182015000300001,a,o
190,S0716-10182015000300001,quienes,o
190,S0716-10182015000300001,se,o
190,S0716-10182015000300001,les,o
190,S0716-10182015000300001,administro,i
190,S0716-10182015000300001,una,i
190,S0716-10182015000300001,monodosis,i
190,S0716-10182015000300001,oral,i
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,500,o
190,S0716-10182015000300001,y,o
190,S0716-10182015000300001,1000,o
190,S0716-10182015000300001,mg,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,metronidazol,i
190,S0716-10182015000300001,respectivamente,o
190,S0716-10182015000300001,Se,o
190,S0716-10182015000300001,establecieron,o
190,S0716-10182015000300001,parametros,o
190,S0716-10182015000300001,farmacocineticos,o
190,S0716-10182015000300001,empleando,o
190,S0716-10182015000300001,el,o
190,S0716-10182015000300001,metodo,o
190,S0716-10182015000300001,trapezoidal,o
190,S0716-10182015000300001,Se,o
190,S0716-10182015000300001,realizo,o
190,S0716-10182015000300001,una,o
190,S0716-10182015000300001,simulacion,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,Markov,o
190,S0716-10182015000300001,que,o
190,S0716-10182015000300001,permitiera,o
190,S0716-10182015000300001,establecer,o
190,S0716-10182015000300001,la,o
190,S0716-10182015000300001,probabilidad,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,alcanzar,o
190,S0716-10182015000300001,una,o
190,S0716-10182015000300001,relacion,o
190,S0716-10182015000300001,AUC024,o
190,S0716-10182015000300001,hCIM,o
190,S0716-10182015000300001,70,o
190,S0716-10182015000300001,en,o
190,S0716-10182015000300001,infecciones,o
190,S0716-10182015000300001,por,o
190,S0716-10182015000300001,B,o
190,S0716-10182015000300001,fragilis,o
190,S0716-10182015000300001,Resultados,o
190,S0716-10182015000300001,Se,o
190,S0716-10182015000300001,determinaron,o
190,S0716-10182015000300001,los,o
190,S0716-10182015000300001,valores,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,Cmax,o
190,S0716-10182015000300001,2403,o
190,S0716-10182015000300001,689,o
190,S0716-10182015000300001,mgL,o
190,S0716-10182015000300001,tmax,o
190,S0716-10182015000300001,120,o
190,S0716-10182015000300001,08h,o
190,S0716-10182015000300001,y,o
190,S0716-10182015000300001,AUC024,o
190,S0716-10182015000300001,h,o
190,S0716-10182015000300001,24191,o
190,S0716-10182015000300001,4814,o
190,S0716-10182015000300001,mghL,o
190,S0716-10182015000300001,con,o
190,S0716-10182015000300001,lo,o
190,S0716-10182015000300001,cual,o
190,S0716-10182015000300001,la,o
190,S0716-10182015000300001,probabilidad,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,alcanzar,o
190,S0716-10182015000300001,una,o
190,S0716-10182015000300001,relacion,o
190,S0716-10182015000300001,AUC024,o
190,S0716-10182015000300001,hCIM,o
190,S0716-10182015000300001,70,o
190,S0716-10182015000300001,con,o
190,S0716-10182015000300001,1000,o
190,S0716-10182015000300001,mg,o
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,metronidazol,i
190,S0716-10182015000300001,fue,o
190,S0716-10182015000300001,superior,o
190,S0716-10182015000300001,a,o
190,S0716-10182015000300001,99,o
190,S0716-10182015000300001,Conclusion,o
190,S0716-10182015000300001,Con,o
190,S0716-10182015000300001,la,o
190,S0716-10182015000300001,administracion,i
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,1000,o
190,S0716-10182015000300001,mg,o
190,S0716-10182015000300001,cada,o
190,S0716-10182015000300001,24,o
190,S0716-10182015000300001,h,o
190,S0716-10182015000300001,seria,o
190,S0716-10182015000300001,posible,o
190,S0716-10182015000300001,alcanzar,o
190,S0716-10182015000300001,una,o
190,S0716-10182015000300001,relacion,o
190,S0716-10182015000300001,PKPD,o
190,S0716-10182015000300001,efectiva,o
190,S0716-10182015000300001,para,o
190,S0716-10182015000300001,el,o
190,S0716-10182015000300001,tratamiento,i
190,S0716-10182015000300001,de,o
190,S0716-10182015000300001,infecciones,i
190,S0716-10182015000300001,anaerobicas,i
191,S0716-10182019000100032,Efectividad,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,seguridad,o
191,S0716-10182019000100032,del,o
191,S0716-10182019000100032,esquema,o
191,S0716-10182019000100032,generico,o
191,S0716-10182019000100032,lamivudinatenofovir,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,efavirenz,i
191,S0716-10182019000100032,en,o
191,S0716-10182019000100032,pacientes,o
191,S0716-10182019000100032,con,o
191,S0716-10182019000100032,VIHSIDA,o
191,S0716-10182019000100032,naïve,o
191,S0716-10182019000100032,estudio,i
191,S0716-10182019000100032,fase,i
191,S0716-10182019000100032,IV,i
191,S0716-10182019000100032,no,i
191,S0716-10182019000100032,aleatorizado,i
191,S0716-10182019000100032,CaliColombia,o
191,S0716-10182019000100032,20122014,o
191,S0716-10182019000100032,Antecedentes,o
191,S0716-10182019000100032,Los,o
191,S0716-10182019000100032,estudios,i
191,S0716-10182019000100032,clinicos,i
191,S0716-10182019000100032,orientados,o
191,S0716-10182019000100032,a,o
191,S0716-10182019000100032,evaluar,o
191,S0716-10182019000100032,la,o
191,S0716-10182019000100032,calidad,o
191,S0716-10182019000100032,de,o
191,S0716-10182019000100032,medicamentos,i
191,S0716-10182019000100032,genericos,i
191,S0716-10182019000100032,pueden,o
191,S0716-10182019000100032,ser,o
191,S0716-10182019000100032,utiles,o
191,S0716-10182019000100032,para,o
191,S0716-10182019000100032,fortalecer,o
191,S0716-10182019000100032,politicas,o
191,S0716-10182019000100032,de,o
191,S0716-10182019000100032,acceso,o
191,S0716-10182019000100032,a,o
191,S0716-10182019000100032,terapia,o
191,S0716-10182019000100032,antiretroviral,o
191,S0716-10182019000100032,combinada,o
191,S0716-10182019000100032,TARc,i
191,S0716-10182019000100032,Objetivo,o
191,S0716-10182019000100032,Describir,o
191,S0716-10182019000100032,la,o
191,S0716-10182019000100032,efectividad,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,seguridad,o
191,S0716-10182019000100032,del,o
191,S0716-10182019000100032,esquema,o
191,S0716-10182019000100032,generico,o
191,S0716-10182019000100032,lamivudinatenofovirefavirenz,o
191,S0716-10182019000100032,3TCTDFEFV,o
191,S0716-10182019000100032,en,o
191,S0716-10182019000100032,pacientes,o
191,S0716-10182019000100032,con,o
191,S0716-10182019000100032,infeccion,o
191,S0716-10182019000100032,por,o
191,S0716-10182019000100032,VIHSIDA,o
191,S0716-10182019000100032,naïve,o
191,S0716-10182019000100032,pertenecientes,o
191,S0716-10182019000100032,a,o
191,S0716-10182019000100032,un,o
191,S0716-10182019000100032,programa,i
191,S0716-10182019000100032,de,i
191,S0716-10182019000100032,atencion,i
191,S0716-10182019000100032,integral,i
191,S0716-10182019000100032,MaterialesMetodos,o
191,S0716-10182019000100032,Estudio,i
191,S0716-10182019000100032,clinico,i
191,S0716-10182019000100032,prospectivo,i
191,S0716-10182019000100032,fase,i
191,S0716-10182019000100032,IV,i
191,S0716-10182019000100032,abierto,i
191,S0716-10182019000100032,y,i
191,S0716-10182019000100032,sin,i
191,S0716-10182019000100032,grupo,i
191,S0716-10182019000100032,control,i
191,S0716-10182019000100032,Entre,o
191,S0716-10182019000100032,20122014,o
191,S0716-10182019000100032,se,o
191,S0716-10182019000100032,incluyeron,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,siguieron,i
191,S0716-10182019000100032,40,o
191,S0716-10182019000100032,pacientes,o
191,S0716-10182019000100032,con,o
191,S0716-10182019000100032,infeccion,o
191,S0716-10182019000100032,por,o
191,S0716-10182019000100032,VIHSIDA,o
191,S0716-10182019000100032,naïve,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,con,o
191,S0716-10182019000100032,indicacion,o
191,S0716-10182019000100032,para,o
191,S0716-10182019000100032,iniciar,o
191,S0716-10182019000100032,tratamiento,i
191,S0716-10182019000100032,Los,o
191,S0716-10182019000100032,pacientes,o
191,S0716-10182019000100032,fueron,o
191,S0716-10182019000100032,tratados,i
191,S0716-10182019000100032,con,o
191,S0716-10182019000100032,el,o
191,S0716-10182019000100032,esquema,o
191,S0716-10182019000100032,generico,o
191,S0716-10182019000100032,3TCTDFEFV,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,fueron,o
191,S0716-10182019000100032,seguidos,i
191,S0716-10182019000100032,durante,o
191,S0716-10182019000100032,12,o
191,S0716-10182019000100032,meses,o
191,S0716-10182019000100032,El,o
191,S0716-10182019000100032,seguimiento,i
191,S0716-10182019000100032,incluyo,o
191,S0716-10182019000100032,valoracion,i
191,S0716-10182019000100032,clinica,i
191,S0716-10182019000100032,parametros,i
191,S0716-10182019000100032,inmunovirologicos,i
191,S0716-10182019000100032,y,i
191,S0716-10182019000100032,de,i
191,S0716-10182019000100032,laboratorio,i
191,S0716-10182019000100032,al,o
191,S0716-10182019000100032,inicio,o
191,S0716-10182019000100032,del,o
191,S0716-10182019000100032,tratamiento,i
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,a,o
191,S0716-10182019000100032,los,o
191,S0716-10182019000100032,3,o
191,S0716-10182019000100032,6,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,12,o
191,S0716-10182019000100032,meses,o
191,S0716-10182019000100032,Resultados,o
191,S0716-10182019000100032,De,o
191,S0716-10182019000100032,los,o
191,S0716-10182019000100032,40,o
191,S0716-10182019000100032,pacientes,o
191,S0716-10182019000100032,30,o
191,S0716-10182019000100032,75,o
191,S0716-10182019000100032,cumplieron,o
191,S0716-10182019000100032,los,o
191,S0716-10182019000100032,doce,o
191,S0716-10182019000100032,meses,o
191,S0716-10182019000100032,de,o
191,S0716-10182019000100032,tratamiento,i
191,S0716-10182019000100032,de,o
191,S0716-10182019000100032,ellos,o
191,S0716-10182019000100032,80,o
191,S0716-10182019000100032,alcanzo,o
191,S0716-10182019000100032,CV,i
191,S0716-10182019000100032,indetectable,o
191,S0716-10182019000100032,40,o
191,S0716-10182019000100032,copiasmL,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,833,o
191,S0716-10182019000100032,CV,i
191,S0716-10182019000100032,50,o
191,S0716-10182019000100032,copiasmL,o
191,S0716-10182019000100032,Adicionalmente,o
191,S0716-10182019000100032,en,o
191,S0716-10182019000100032,el,o
191,S0716-10182019000100032,grupo,o
191,S0716-10182019000100032,hubo,o
191,S0716-10182019000100032,un,o
191,S0716-10182019000100032,incremento,o
191,S0716-10182019000100032,en,o
191,S0716-10182019000100032,la,o
191,S0716-10182019000100032,mediana,o
191,S0716-10182019000100032,de,o
191,S0716-10182019000100032,173,o
191,S0716-10182019000100032,linfocitos,o
191,S0716-10182019000100032,TCD4mm3,o
191,S0716-10182019000100032,Por,o
191,S0716-10182019000100032,su,o
191,S0716-10182019000100032,parte,o
191,S0716-10182019000100032,los,o
191,S0716-10182019000100032,resultados,o
191,S0716-10182019000100032,del,o
191,S0716-10182019000100032,hemograma,i
191,S0716-10182019000100032,completo,i
191,S0716-10182019000100032,creatininemia,i
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,transaminasas,i
191,S0716-10182019000100032,hepaticas,i
191,S0716-10182019000100032,se,o
191,S0716-10182019000100032,conservaron,o
191,S0716-10182019000100032,en,o
191,S0716-10182019000100032,rangos,o
191,S0716-10182019000100032,normales,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,no,o
191,S0716-10182019000100032,generaron,o
191,S0716-10182019000100032,cambios,o
191,S0716-10182019000100032,del,o
191,S0716-10182019000100032,TARc,i
191,S0716-10182019000100032,Los,o
191,S0716-10182019000100032,efectos,i
191,S0716-10182019000100032,adversos,i
191,S0716-10182019000100032,reconocidos,o
191,S0716-10182019000100032,para,o
191,S0716-10182019000100032,estos,o
191,S0716-10182019000100032,medicamentos,i
191,S0716-10182019000100032,se,o
191,S0716-10182019000100032,presentaron,o
191,S0716-10182019000100032,en,o
191,S0716-10182019000100032,menos,o
191,S0716-10182019000100032,de,o
191,S0716-10182019000100032,10,o
191,S0716-10182019000100032,de,o
191,S0716-10182019000100032,los,o
191,S0716-10182019000100032,pacientes,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,no,o
191,S0716-10182019000100032,tuvieron,o
191,S0716-10182019000100032,implicaciones,o
191,S0716-10182019000100032,graves,o
191,S0716-10182019000100032,Conclusiones,o
191,S0716-10182019000100032,En,o
191,S0716-10182019000100032,este,o
191,S0716-10182019000100032,grupo,o
191,S0716-10182019000100032,pequeño,o
191,S0716-10182019000100032,de,o
191,S0716-10182019000100032,pacientes,o
191,S0716-10182019000100032,el,o
191,S0716-10182019000100032,esquema,o
191,S0716-10182019000100032,generico,o
191,S0716-10182019000100032,3TCTDFEFV,o
191,S0716-10182019000100032,es,o
191,S0716-10182019000100032,efectivo,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,seguro,o
191,S0716-10182019000100032,en,o
191,S0716-10182019000100032,el,o
191,S0716-10182019000100032,tratamiento,i
191,S0716-10182019000100032,de,o
191,S0716-10182019000100032,pacientes,o
191,S0716-10182019000100032,con,o
191,S0716-10182019000100032,infeccion,o
191,S0716-10182019000100032,por,o
191,S0716-10182019000100032,VIHSIDA,o
191,S0716-10182019000100032,naïve,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,su,o
191,S0716-10182019000100032,perfil,o
191,S0716-10182019000100032,de,o
191,S0716-10182019000100032,efectividad,o
191,S0716-10182019000100032,y,o
191,S0716-10182019000100032,seguridad,o
191,S0716-10182019000100032,es,o
191,S0716-10182019000100032,similar,o
191,S0716-10182019000100032,al,o
191,S0716-10182019000100032,del,o
191,S0716-10182019000100032,esquema,o
191,S0716-10182019000100032,3TCTDFEFV,o
191,S0716-10182019000100032,innovador,o
191,S0716-10182019000100032,en,o
191,S0716-10182019000100032,pacientes,o
191,S0716-10182019000100032,con,o
191,S0716-10182019000100032,condiciones,o
191,S0716-10182019000100032,clinicas,o
191,S0716-10182019000100032,similares,o
192,S0864-21761999000100001,Valor,o
192,S0864-21761999000100001,de,o
192,S0864-21761999000100001,la,o
192,S0864-21761999000100001,ecobiometria,i
192,S0864-21761999000100001,en,o
192,S0864-21761999000100001,el,o
192,S0864-21761999000100001,glaucoma,i
192,S0864-21761999000100001,primario,i
192,S0864-21761999000100001,de,i
192,S0864-21761999000100001,angulo,i
192,S0864-21761999000100001,estrecho,i
192,S0864-21761999000100001,Se,o
192,S0864-21761999000100001,evalua,o
192,S0864-21761999000100001,la,o
192,S0864-21761999000100001,importancia,o
192,S0864-21761999000100001,de,o
192,S0864-21761999000100001,la,o
192,S0864-21761999000100001,ecobiometria,i
192,S0864-21761999000100001,en,o
192,S0864-21761999000100001,el,o
192,S0864-21761999000100001,sistema,o
192,S0864-21761999000100001,diagnostico,o
192,S0864-21761999000100001,del,o
192,S0864-21761999000100001,glaucoma,i
192,S0864-21761999000100001,primario,i
192,S0864-21761999000100001,de,i
192,S0864-21761999000100001,angulo,i
192,S0864-21761999000100001,estrecho,i
192,S0864-21761999000100001,A,o
192,S0864-21761999000100001,manera,o
192,S0864-21761999000100001,de,o
192,S0864-21761999000100001,ensayo,i
192,S0864-21761999000100001,clinico,i
192,S0864-21761999000100001,se,o
192,S0864-21761999000100001,estudiaron,o
192,S0864-21761999000100001,105,o
192,S0864-21761999000100001,ojos,i
192,S0864-21761999000100001,con,o
192,S0864-21761999000100001,esta,o
192,S0864-21761999000100001,enfermedad,i
192,S0864-21761999000100001,que,o
192,S0864-21761999000100001,se,o
192,S0864-21761999000100001,agruparon,o
192,S0864-21761999000100001,gonioscopicamente,i
192,S0864-21761999000100001,Se,o
192,S0864-21761999000100001,les,o
192,S0864-21761999000100001,realizo,o
192,S0864-21761999000100001,ecobiometria,i
192,S0864-21761999000100001,como,o
192,S0864-21761999000100001,complemento,o
192,S0864-21761999000100001,diagnostico,o
192,S0864-21761999000100001,Se,o
192,S0864-21761999000100001,comprobo,o
192,S0864-21761999000100001,una,o
192,S0864-21761999000100001,relacion,o
192,S0864-21761999000100001,directa,o
192,S0864-21761999000100001,de,o
192,S0864-21761999000100001,la,o
192,S0864-21761999000100001,amplitud,o
192,S0864-21761999000100001,de,o
192,S0864-21761999000100001,angulo,o
192,S0864-21761999000100001,con,o
192,S0864-21761999000100001,la,o
192,S0864-21761999000100001,distancia,o
192,S0864-21761999000100001,axil,o
192,S0864-21761999000100001,y,o
192,S0864-21761999000100001,la,o
192,S0864-21761999000100001,profundidad,o
192,S0864-21761999000100001,de,o
192,S0864-21761999000100001,la,o
192,S0864-21761999000100001,camara,i
192,S0864-21761999000100001,anterior,i
192,S0864-21761999000100001,y,o
192,S0864-21761999000100001,una,o
192,S0864-21761999000100001,relacion,o
192,S0864-21761999000100001,inversa,o
192,S0864-21761999000100001,con,o
192,S0864-21761999000100001,el,o
192,S0864-21761999000100001,grosor,o
192,S0864-21761999000100001,del,o
192,S0864-21761999000100001,cristalino,i
192,S0864-21761999000100001,Se,o
192,S0864-21761999000100001,observo,o
192,S0864-21761999000100001,que,o
192,S0864-21761999000100001,la,o
192,S0864-21761999000100001,profundidad,o
192,S0864-21761999000100001,de,o
192,S0864-21761999000100001,la,o
192,S0864-21761999000100001,camara,i
192,S0864-21761999000100001,anterior,i
192,S0864-21761999000100001,menor,o
192,S0864-21761999000100001,de,o
192,S0864-21761999000100001,2,o
192,S0864-21761999000100001,mm,o
192,S0864-21761999000100001,constituye,o
192,S0864-21761999000100001,un,o
192,S0864-21761999000100001,alto,o
192,S0864-21761999000100001,riesgo,o
192,S0864-21761999000100001,para,o
192,S0864-21761999000100001,el,o
192,S0864-21761999000100001,desarrollo,o
192,S0864-21761999000100001,de,o
192,S0864-21761999000100001,un,o
192,S0864-21761999000100001,glaucoma,i
192,S0864-21761999000100001,agudo,i
192,S0864-21761999000100001,El,o
192,S0864-21761999000100001,analisis,i
192,S0864-21761999000100001,ecobiometrico,i
192,S0864-21761999000100001,permitio,o
192,S0864-21761999000100001,conocer,o
192,S0864-21761999000100001,mejor,o
192,S0864-21761999000100001,el,o
192,S0864-21761999000100001,estado,o
192,S0864-21761999000100001,anatomico,o
192,S0864-21761999000100001,del,o
192,S0864-21761999000100001,ojo,i
192,S0864-21761999000100001,facilitando,o
192,S0864-21761999000100001,una,o
192,S0864-21761999000100001,orientacion,i
192,S0864-21761999000100001,terapeutica,i
192,S0864-21761999000100001,oportuna,o
193,S0864-21762008000100006,Comparacion,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,la,o
193,S0864-21762008000100006,tecnica,i
193,S0864-21762008000100006,de,i
193,S0864-21762008000100006,Blumenthal,i
193,S0864-21762008000100006,con,o
193,S0864-21762008000100006,la,o
193,S0864-21762008000100006,tecnica,i
193,S0864-21762008000100006,convencional,i
193,S0864-21762008000100006,en,o
193,S0864-21762008000100006,la,o
193,S0864-21762008000100006,cirugia,i
193,S0864-21762008000100006,de,i
193,S0864-21762008000100006,catarata,i
193,S0864-21762008000100006,Se,o
193,S0864-21762008000100006,realizo,o
193,S0864-21762008000100006,un,o
193,S0864-21762008000100006,ensayo,i
193,S0864-21762008000100006,clinico,i
193,S0864-21762008000100006,con,i
193,S0864-21762008000100006,controles,i
193,S0864-21762008000100006,historicos,i
193,S0864-21762008000100006,en,o
193,S0864-21762008000100006,el,o
193,S0864-21762008000100006,Servicio,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,Oftalmologia,o
193,S0864-21762008000100006,del,o
193,S0864-21762008000100006,Hospital,o
193,S0864-21762008000100006,Dr,o
193,S0864-21762008000100006,Salvador,o
193,S0864-21762008000100006,Allende,o
193,S0864-21762008000100006,para,o
193,S0864-21762008000100006,comparar,o
193,S0864-21762008000100006,la,o
193,S0864-21762008000100006,tecnica,i
193,S0864-21762008000100006,de,i
193,S0864-21762008000100006,Blumenthal,i
193,S0864-21762008000100006,con,o
193,S0864-21762008000100006,la,o
193,S0864-21762008000100006,tecnica,i
193,S0864-21762008000100006,convencional,i
193,S0864-21762008000100006,en,o
193,S0864-21762008000100006,la,o
193,S0864-21762008000100006,cirugia,i
193,S0864-21762008000100006,de,i
193,S0864-21762008000100006,catarata,i
193,S0864-21762008000100006,durante,o
193,S0864-21762008000100006,el,o
193,S0864-21762008000100006,periodo,o
193,S0864-21762008000100006,comprendido,o
193,S0864-21762008000100006,entre,o
193,S0864-21762008000100006,diciembre,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,2004,o
193,S0864-21762008000100006,y,o
193,S0864-21762008000100006,junio,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,2005,o
193,S0864-21762008000100006,Se,o
193,S0864-21762008000100006,estudiaron,o
193,S0864-21762008000100006,dos,o
193,S0864-21762008000100006,grupos,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,pacientes,o
193,S0864-21762008000100006,el,o
193,S0864-21762008000100006,primero,o
193,S0864-21762008000100006,operado,i
193,S0864-21762008000100006,con,o
193,S0864-21762008000100006,la,o
193,S0864-21762008000100006,tecnica,i
193,S0864-21762008000100006,convencional,i
193,S0864-21762008000100006,n,o
193,S0864-21762008000100006,147,o
193,S0864-21762008000100006,en,o
193,S0864-21762008000100006,el,o
193,S0864-21762008000100006,periodo,o
193,S0864-21762008000100006,comprendido,o
193,S0864-21762008000100006,entre,o
193,S0864-21762008000100006,diciembre,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,2004,o
193,S0864-21762008000100006,y,o
193,S0864-21762008000100006,febrero,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,2005,o
193,S0864-21762008000100006,controles,o
193,S0864-21762008000100006,historicos,o
193,S0864-21762008000100006,el,o
193,S0864-21762008000100006,segundo,o
193,S0864-21762008000100006,grupo,o
193,S0864-21762008000100006,tambien,o
193,S0864-21762008000100006,n,o
193,S0864-21762008000100006,147,o
193,S0864-21762008000100006,fue,o
193,S0864-21762008000100006,operado,i
193,S0864-21762008000100006,con,o
193,S0864-21762008000100006,la,o
193,S0864-21762008000100006,tecnica,i
193,S0864-21762008000100006,de,i
193,S0864-21762008000100006,Blumenthal,i
193,S0864-21762008000100006,en,o
193,S0864-21762008000100006,el,o
193,S0864-21762008000100006,periodo,o
193,S0864-21762008000100006,mayojunio,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,2005,o
193,S0864-21762008000100006,Otras,o
193,S0864-21762008000100006,variables,o
193,S0864-21762008000100006,estudiadas,o
193,S0864-21762008000100006,fueron,o
193,S0864-21762008000100006,edad,o
193,S0864-21762008000100006,sexo,o
193,S0864-21762008000100006,tiempo,o
193,S0864-21762008000100006,quirurgico,o
193,S0864-21762008000100006,complicaciones,i
193,S0864-21762008000100006,transoperatorias,i
193,S0864-21762008000100006,y,i
193,S0864-21762008000100006,posoperatorias,i
193,S0864-21762008000100006,evolucion,o
193,S0864-21762008000100006,del,o
193,S0864-21762008000100006,astigmatismo,i
193,S0864-21762008000100006,y,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,la,o
193,S0864-21762008000100006,agudeza,i
193,S0864-21762008000100006,visual,i
193,S0864-21762008000100006,durante,o
193,S0864-21762008000100006,los,o
193,S0864-21762008000100006,tres,o
193,S0864-21762008000100006,primeros,o
193,S0864-21762008000100006,meses,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,operados,i
193,S0864-21762008000100006,los,o
193,S0864-21762008000100006,pacientes,o
193,S0864-21762008000100006,La,o
193,S0864-21762008000100006,tecnica,i
193,S0864-21762008000100006,de,i
193,S0864-21762008000100006,Blumenthal,i
193,S0864-21762008000100006,fue,o
193,S0864-21762008000100006,mas,o
193,S0864-21762008000100006,eficaz,o
193,S0864-21762008000100006,yo,o
193,S0864-21762008000100006,mas,o
193,S0864-21762008000100006,segura,o
193,S0864-21762008000100006,que,o
193,S0864-21762008000100006,la,o
193,S0864-21762008000100006,tecnica,i
193,S0864-21762008000100006,convencional,i
193,S0864-21762008000100006,para,o
193,S0864-21762008000100006,los,o
193,S0864-21762008000100006,pacientes,o
193,S0864-21762008000100006,ya,o
193,S0864-21762008000100006,que,o
193,S0864-21762008000100006,presento,o
193,S0864-21762008000100006,un,o
193,S0864-21762008000100006,tiempo,o
193,S0864-21762008000100006,quirurgico,o
193,S0864-21762008000100006,mas,o
193,S0864-21762008000100006,corto,o
193,S0864-21762008000100006,y,o
193,S0864-21762008000100006,tanto,o
193,S0864-21762008000100006,las,o
193,S0864-21762008000100006,complicaciones,i
193,S0864-21762008000100006,transoperatorias,i
193,S0864-21762008000100006,como,i
193,S0864-21762008000100006,posoperatorias,i
193,S0864-21762008000100006,fueron,o
193,S0864-21762008000100006,menos,o
193,S0864-21762008000100006,frecuentes,o
193,S0864-21762008000100006,que,o
193,S0864-21762008000100006,las,o
193,S0864-21762008000100006,presentadas,o
193,S0864-21762008000100006,por,o
193,S0864-21762008000100006,los,o
193,S0864-21762008000100006,pacientes,o
193,S0864-21762008000100006,pertenecientes,o
193,S0864-21762008000100006,al,o
193,S0864-21762008000100006,primer,o
193,S0864-21762008000100006,grupo,o
193,S0864-21762008000100006,El,o
193,S0864-21762008000100006,astigmatismo,i
193,S0864-21762008000100006,posoperatorio,o
193,S0864-21762008000100006,promedio,o
193,S0864-21762008000100006,en,o
193,S0864-21762008000100006,general,o
193,S0864-21762008000100006,disminuyo,o
193,S0864-21762008000100006,y,o
193,S0864-21762008000100006,la,o
193,S0864-21762008000100006,agudeza,i
193,S0864-21762008000100006,visual,i
193,S0864-21762008000100006,media,o
193,S0864-21762008000100006,aumento,o
193,S0864-21762008000100006,ambos,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,forma,o
193,S0864-21762008000100006,progresiva,o
193,S0864-21762008000100006,en,o
193,S0864-21762008000100006,los,o
193,S0864-21762008000100006,dos,o
193,S0864-21762008000100006,grupos,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,pacientes,o
193,S0864-21762008000100006,independientemente,o
193,S0864-21762008000100006,de,o
193,S0864-21762008000100006,la,o
193,S0864-21762008000100006,tecnica,i
193,S0864-21762008000100006,quirurgica,i
193,S0864-21762008000100006,utilizada,o
194,S0864-21762008000200004,Estudio,i
194,S0864-21762008000200004,comparativo,i
194,S0864-21762008000200004,del,o
194,S0864-21762008000200004,uso,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,mitomicina,i
194,S0864-21762008000200004,C,i
194,S0864-21762008000200004,en,o
194,S0864-21762008000200004,el,o
194,S0864-21762008000200004,pterigium,i
194,S0864-21762008000200004,recidivante,i
194,S0864-21762008000200004,INTRODUCCION,o
194,S0864-21762008000200004,El,o
194,S0864-21762008000200004,pterigium,i
194,S0864-21762008000200004,constituye,o
194,S0864-21762008000200004,un,o
194,S0864-21762008000200004,problema,o
194,S0864-21762008000200004,en,o
194,S0864-21762008000200004,la,o
194,S0864-21762008000200004,practica,o
194,S0864-21762008000200004,oftalmologica,o
194,S0864-21762008000200004,por,o
194,S0864-21762008000200004,su,o
194,S0864-21762008000200004,alta,o
194,S0864-21762008000200004,prevalencia,o
194,S0864-21762008000200004,y,o
194,S0864-21762008000200004,elevada,o
194,S0864-21762008000200004,frecuencia,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,recidiva,o
194,S0864-21762008000200004,El,o
194,S0864-21762008000200004,proposito,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,este,o
194,S0864-21762008000200004,estudio,o
194,S0864-21762008000200004,fue,o
194,S0864-21762008000200004,el,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,comparar,o
194,S0864-21762008000200004,la,o
194,S0864-21762008000200004,tecnica,i
194,S0864-21762008000200004,quirurgica,i
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,injerto,i
194,S0864-21762008000200004,autologo,i
194,S0864-21762008000200004,de,i
194,S0864-21762008000200004,conjuntiva,i
194,S0864-21762008000200004,con,i
194,S0864-21762008000200004,celulas,i
194,S0864-21762008000200004,limbicas,i
194,S0864-21762008000200004,mas,o
194,S0864-21762008000200004,mitomicina,i
194,S0864-21762008000200004,C,i
194,S0864-21762008000200004,con,o
194,S0864-21762008000200004,la,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,injerto,i
194,S0864-21762008000200004,de,i
194,S0864-21762008000200004,membrana,i
194,S0864-21762008000200004,amniotica,i
194,S0864-21762008000200004,con,o
194,S0864-21762008000200004,mitomicina,i
194,S0864-21762008000200004,C,i
194,S0864-21762008000200004,en,o
194,S0864-21762008000200004,pterigium,i
194,S0864-21762008000200004,recidivante,i
194,S0864-21762008000200004,en,o
194,S0864-21762008000200004,cuanto,o
194,S0864-21762008000200004,a,o
194,S0864-21762008000200004,la,o
194,S0864-21762008000200004,tasa,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,recidiva,o
194,S0864-21762008000200004,complicaciones,i
194,S0864-21762008000200004,posoperatorias,i
194,S0864-21762008000200004,inmediatas,o
194,S0864-21762008000200004,y,o
194,S0864-21762008000200004,tiempo,o
194,S0864-21762008000200004,libre,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,recidiva,o
194,S0864-21762008000200004,meses,o
194,S0864-21762008000200004,METODOS,o
194,S0864-21762008000200004,Se,o
194,S0864-21762008000200004,realizo,o
194,S0864-21762008000200004,un,o
194,S0864-21762008000200004,ensayo,i
194,S0864-21762008000200004,clinico,i
194,S0864-21762008000200004,controlado,i
194,S0864-21762008000200004,prospectivo,i
194,S0864-21762008000200004,con,o
194,S0864-21762008000200004,n,o
194,S0864-21762008000200004,57,o
194,S0864-21762008000200004,pacientes,o
194,S0864-21762008000200004,portadores,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,pterigium,i
194,S0864-21762008000200004,recidivante,i
194,S0864-21762008000200004,Se,o
194,S0864-21762008000200004,conformaron,o
194,S0864-21762008000200004,2,o
194,S0864-21762008000200004,grupos,o
194,S0864-21762008000200004,grupo,o
194,S0864-21762008000200004,1,o
194,S0864-21762008000200004,injerto,i
194,S0864-21762008000200004,de,i
194,S0864-21762008000200004,conjuntiva,i
194,S0864-21762008000200004,antologo,i
194,S0864-21762008000200004,con,i
194,S0864-21762008000200004,celulas,i
194,S0864-21762008000200004,limbicas,i
194,S0864-21762008000200004,mas,o
194,S0864-21762008000200004,mitomicina,i
194,S0864-21762008000200004,C,i
194,S0864-21762008000200004,y,o
194,S0864-21762008000200004,el,o
194,S0864-21762008000200004,grupo,o
194,S0864-21762008000200004,2,o
194,S0864-21762008000200004,injerto,i
194,S0864-21762008000200004,de,i
194,S0864-21762008000200004,membrana,i
194,S0864-21762008000200004,amniotica,i
194,S0864-21762008000200004,mas,o
194,S0864-21762008000200004,mitomicina,i
194,S0864-21762008000200004,C,i
194,S0864-21762008000200004,Se,o
194,S0864-21762008000200004,comparo,o
194,S0864-21762008000200004,el,o
194,S0864-21762008000200004,comportamiento,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,las,o
194,S0864-21762008000200004,tecnicas,o
194,S0864-21762008000200004,empleadas,o
194,S0864-21762008000200004,a,o
194,S0864-21762008000200004,partir,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,sus,o
194,S0864-21762008000200004,resultados,o
194,S0864-21762008000200004,El,o
194,S0864-21762008000200004,seguimiento,i
194,S0864-21762008000200004,fue,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,16,o
194,S0864-21762008000200004,meses,o
194,S0864-21762008000200004,RESULTADOS,o
194,S0864-21762008000200004,La,o
194,S0864-21762008000200004,agudeza,o
194,S0864-21762008000200004,visual,o
194,S0864-21762008000200004,mejoro,o
194,S0864-21762008000200004,en,o
194,S0864-21762008000200004,60,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,los,o
194,S0864-21762008000200004,casos,o
194,S0864-21762008000200004,La,o
194,S0864-21762008000200004,recidiva,o
194,S0864-21762008000200004,fue,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,2,o
194,S0864-21762008000200004,para,o
194,S0864-21762008000200004,el,o
194,S0864-21762008000200004,grupo,o
194,S0864-21762008000200004,1,o
194,S0864-21762008000200004,y,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,6,o
194,S0864-21762008000200004,para,o
194,S0864-21762008000200004,el,o
194,S0864-21762008000200004,grupo,o
194,S0864-21762008000200004,2,o
194,S0864-21762008000200004,CONCLUSIONES,o
194,S0864-21762008000200004,El,o
194,S0864-21762008000200004,metodo,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,injerto,i
194,S0864-21762008000200004,conjuntival,i
194,S0864-21762008000200004,con,i
194,S0864-21762008000200004,limbo,i
194,S0864-21762008000200004,resulto,o
194,S0864-21762008000200004,mas,o
194,S0864-21762008000200004,efectivo,o
194,S0864-21762008000200004,para,o
194,S0864-21762008000200004,el,o
194,S0864-21762008000200004,tratamiento,i
194,S0864-21762008000200004,del,o
194,S0864-21762008000200004,pterigium,i
194,S0864-21762008000200004,recidivante,i
194,S0864-21762008000200004,El,o
194,S0864-21762008000200004,metodo,i
194,S0864-21762008000200004,de,i
194,S0864-21762008000200004,membrana,i
194,S0864-21762008000200004,amniotica,i
194,S0864-21762008000200004,constituye,o
194,S0864-21762008000200004,una,o
194,S0864-21762008000200004,alternativa,o
194,S0864-21762008000200004,para,o
194,S0864-21762008000200004,el,o
194,S0864-21762008000200004,tratamiento,i
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,casos,o
194,S0864-21762008000200004,en,o
194,S0864-21762008000200004,los,o
194,S0864-21762008000200004,cuales,o
194,S0864-21762008000200004,no,o
194,S0864-21762008000200004,sea,o
194,S0864-21762008000200004,viable,o
194,S0864-21762008000200004,la,o
194,S0864-21762008000200004,aplicacion,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,de,o
194,S0864-21762008000200004,injerto,i
194,S0864-21762008000200004,antologo,i
195,S1020-49892016001200455,Comparacion,i
195,S1020-49892016001200455,de,i
195,S1020-49892016001200455,la,i
195,S1020-49892016001200455,eficacia,i
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,prueba,i
195,S1020-49892016001200455,rapida,i
195,S1020-49892016001200455,individual,i
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,prueba,i
195,S1020-49892016001200455,rapida,i
195,S1020-49892016001200455,dual,i
195,S1020-49892016001200455,para,o
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,diagnostico,i
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,sifilis,i
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,infeccion,i
195,S1020-49892016001200455,por,i
195,S1020-49892016001200455,el,i
195,S1020-49892016001200455,VIH,i
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,los,o
195,S1020-49892016001200455,servicios,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,atencion,i
195,S1020-49892016001200455,prenatal,i
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,Colombia,o
195,S1020-49892016001200455,Objetivo,o
195,S1020-49892016001200455,Evaluar,i
195,S1020-49892016001200455,la,i
195,S1020-49892016001200455,eficacia,i
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,prueba,i
195,S1020-49892016001200455,rapida,i
195,S1020-49892016001200455,dual,i
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,comparacion,o
195,S1020-49892016001200455,con,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,prueba,i
195,S1020-49892016001200455,rapida,i
195,S1020-49892016001200455,individual,i
195,S1020-49892016001200455,para,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,deteccion,i
195,S1020-49892016001200455,sistematica,i
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,sifilis,i
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,infeccion,i
195,S1020-49892016001200455,por,i
195,S1020-49892016001200455,el,i
195,S1020-49892016001200455,VIH,i
195,S1020-49892016001200455,Metodos,o
195,S1020-49892016001200455,Se,o
195,S1020-49892016001200455,realizo,o
195,S1020-49892016001200455,un,o
195,S1020-49892016001200455,ensayo,i
195,S1020-49892016001200455,clinico,i
195,S1020-49892016001200455,sin,i
195,S1020-49892016001200455,enmascaramiento,i
195,S1020-49892016001200455,y,i
195,S1020-49892016001200455,aleatorizado,i
195,S1020-49892016001200455,por,i
195,S1020-49892016001200455,grupos,i
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,12,o
195,S1020-49892016001200455,centros,o
195,S1020-49892016001200455,publicos,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,atencion,i
195,S1020-49892016001200455,prenatal,i
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,las,o
195,S1020-49892016001200455,ciudades,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,Bogota,o
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,Cali,o
195,S1020-49892016001200455,Colombia,o
195,S1020-49892016001200455,Se,o
195,S1020-49892016001200455,incluyo,o
195,S1020-49892016001200455,a,o
195,S1020-49892016001200455,las,o
195,S1020-49892016001200455,mujeres,o
195,S1020-49892016001200455,embarazadas,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,14,o
195,S1020-49892016001200455,o,o
195,S1020-49892016001200455,mas,o
195,S1020-49892016001200455,años,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,edad,o
195,S1020-49892016001200455,que,o
195,S1020-49892016001200455,asistian,o
195,S1020-49892016001200455,a,o
195,S1020-49892016001200455,su,o
195,S1020-49892016001200455,primera,o
195,S1020-49892016001200455,consulta,i
195,S1020-49892016001200455,prenatal,i
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,no,o
195,S1020-49892016001200455,se,o
195,S1020-49892016001200455,habian,o
195,S1020-49892016001200455,realizado,o
195,S1020-49892016001200455,pruebas,i
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,este,o
195,S1020-49892016001200455,embarazo,o
195,S1020-49892016001200455,Las,o
195,S1020-49892016001200455,embarazadas,o
195,S1020-49892016001200455,se,o
195,S1020-49892016001200455,dividieron,i
195,S1020-49892016001200455,de,i
195,S1020-49892016001200455,forma,i
195,S1020-49892016001200455,aleatoria,i
195,S1020-49892016001200455,para,o
195,S1020-49892016001200455,realizarles,o
195,S1020-49892016001200455,las,o
195,S1020-49892016001200455,pruebas,i
195,S1020-49892016001200455,rapidas,i
195,S1020-49892016001200455,individuales,i
195,S1020-49892016001200455,para,o
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,diagnostico,i
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,sifilis,i
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,infeccion,i
195,S1020-49892016001200455,por,i
195,S1020-49892016001200455,el,i
195,S1020-49892016001200455,VIH,i
195,S1020-49892016001200455,Grupo,o
195,S1020-49892016001200455,A,o
195,S1020-49892016001200455,o,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,prueba,i
195,S1020-49892016001200455,rapida,i
195,S1020-49892016001200455,dual,i
195,S1020-49892016001200455,para,o
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,diagnostico,i
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,sifilis,i
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,infeccion,i
195,S1020-49892016001200455,por,i
195,S1020-49892016001200455,el,i
195,S1020-49892016001200455,VIH,i
195,S1020-49892016001200455,Grupo,o
195,S1020-49892016001200455,B,o
195,S1020-49892016001200455,Se,o
195,S1020-49892016001200455,midieron,o
195,S1020-49892016001200455,principalmente,o
195,S1020-49892016001200455,cuatro,o
195,S1020-49892016001200455,resultados,o
195,S1020-49892016001200455,1,o
195,S1020-49892016001200455,aceptabilidad,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,prueba,i
195,S1020-49892016001200455,2,o
195,S1020-49892016001200455,uso,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,los,o
195,S1020-49892016001200455,servicios,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,prueba,i
195,S1020-49892016001200455,3,o
195,S1020-49892016001200455,tratamiento,i
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,mismo,o
195,S1020-49892016001200455,dia,o
195,S1020-49892016001200455,es,o
195,S1020-49892016001200455,decir,o
195,S1020-49892016001200455,tratamiento,i
195,S1020-49892016001200455,oportuno,i
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,4,o
195,S1020-49892016001200455,tratamiento,i
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,cualquier,o
195,S1020-49892016001200455,momento,o
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,los,o
195,S1020-49892016001200455,casos,o
195,S1020-49892016001200455,con,o
195,S1020-49892016001200455,resultados,o
195,S1020-49892016001200455,positivos,o
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,las,o
195,S1020-49892016001200455,pruebas,i
195,S1020-49892016001200455,rapidas,i
195,S1020-49892016001200455,Se,o
195,S1020-49892016001200455,realizaron,o
195,S1020-49892016001200455,analisis,o
195,S1020-49892016001200455,bifactoriales,o
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,multifactoriales,o
195,S1020-49892016001200455,para,o
195,S1020-49892016001200455,hacer,o
195,S1020-49892016001200455,los,o
195,S1020-49892016001200455,ajustes,o
195,S1020-49892016001200455,pertinentes,o
195,S1020-49892016001200455,por,o
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,efecto,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,division,o
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,grupos,o
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,periodo,o
195,S1020-49892016001200455,Resultados,o
195,S1020-49892016001200455,Se,o
195,S1020-49892016001200455,estudio,o
195,S1020-49892016001200455,a,o
195,S1020-49892016001200455,1,o
195,S1020-49892016001200455,048,o
195,S1020-49892016001200455,pacientes,o
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,Grupo,o
195,S1020-49892016001200455,A,o
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,a,o
195,S1020-49892016001200455,1,o
195,S1020-49892016001200455,166,o
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,Grupo,o
195,S1020-49892016001200455,B,o
195,S1020-49892016001200455,La,o
195,S1020-49892016001200455,aceptabilidad,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,las,o
195,S1020-49892016001200455,pruebas,i
195,S1020-49892016001200455,rapidas,i
195,S1020-49892016001200455,fue,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,998,o
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,Grupo,o
195,S1020-49892016001200455,A,o
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,996,o
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,Grupo,o
195,S1020-49892016001200455,B,o
195,S1020-49892016001200455,La,o
195,S1020-49892016001200455,prevalencia,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,resultados,o
195,S1020-49892016001200455,positivos,o
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,las,o
195,S1020-49892016001200455,pruebas,i
195,S1020-49892016001200455,rapidas,i
195,S1020-49892016001200455,fue,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,221,o
195,S1020-49892016001200455,para,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,sifilis,i
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,036,o
195,S1020-49892016001200455,para,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,infeccion,i
195,S1020-49892016001200455,por,i
195,S1020-49892016001200455,el,i
195,S1020-49892016001200455,VIH,i
195,S1020-49892016001200455,Se,o
195,S1020-49892016001200455,administro,o
195,S1020-49892016001200455,tratamiento,i
195,S1020-49892016001200455,oportuno,i
195,S1020-49892016001200455,a,o
195,S1020-49892016001200455,20,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,29,o
195,S1020-49892016001200455,pacientes,o
195,S1020-49892016001200455,69,o
195,S1020-49892016001200455,del,o
195,S1020-49892016001200455,Grupo,o
195,S1020-49892016001200455,A,o
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,a,o
195,S1020-49892016001200455,16,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,20,o
195,S1020-49892016001200455,pacientes,o
195,S1020-49892016001200455,80,o
195,S1020-49892016001200455,del,o
195,S1020-49892016001200455,Grupo,o
195,S1020-49892016001200455,B,o
195,S1020-49892016001200455,riesgo,o
195,S1020-49892016001200455,relativo,o
195,S1020-49892016001200455,110,o
195,S1020-49892016001200455,intervalo,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,confianza,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,95,o
195,S1020-49892016001200455,IC,o
195,S1020-49892016001200455,100120,o
195,S1020-49892016001200455,Se,o
195,S1020-49892016001200455,administro,o
195,S1020-49892016001200455,tratamiento,i
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,cualquier,o
195,S1020-49892016001200455,momento,o
195,S1020-49892016001200455,a,o
195,S1020-49892016001200455,24,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,29,o
195,S1020-49892016001200455,pacientes,o
195,S1020-49892016001200455,83,o
195,S1020-49892016001200455,del,o
195,S1020-49892016001200455,Grupo,o
195,S1020-49892016001200455,A,o
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,a,o
195,S1020-49892016001200455,20,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,20,o
195,S1020-49892016001200455,100,o
195,S1020-49892016001200455,del,o
195,S1020-49892016001200455,Grupo,o
195,S1020-49892016001200455,B,o
195,S1020-49892016001200455,riesgo,o
195,S1020-49892016001200455,relativo,o
195,S1020-49892016001200455,111,o
195,S1020-49892016001200455,IC,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,95,o
195,S1020-49892016001200455,101122,o
195,S1020-49892016001200455,Conclusiones,o
195,S1020-49892016001200455,No,o
195,S1020-49892016001200455,hubo,o
195,S1020-49892016001200455,diferencias,o
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,cuanto,o
195,S1020-49892016001200455,a,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,aceptabilidad,o
195,S1020-49892016001200455,por,o
195,S1020-49892016001200455,parte,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,los,o
195,S1020-49892016001200455,pacientes,o
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,uso,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,los,o
195,S1020-49892016001200455,servicios,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,cribaje,i
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,tratamiento,i
195,S1020-49892016001200455,oportuno,i
195,S1020-49892016001200455,entre,o
195,S1020-49892016001200455,las,o
195,S1020-49892016001200455,pruebas,i
195,S1020-49892016001200455,rapidas,i
195,S1020-49892016001200455,duales,i
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,las,o
195,S1020-49892016001200455,pruebas,i
195,S1020-49892016001200455,rapidas,i
195,S1020-49892016001200455,individuales,i
195,S1020-49892016001200455,para,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,deteccion,i
195,S1020-49892016001200455,sistematica,i
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,sifilis,i
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,infeccion,i
195,S1020-49892016001200455,por,i
195,S1020-49892016001200455,el,i
195,S1020-49892016001200455,VIH,i
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,los,o
195,S1020-49892016001200455,centros,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,atencion,i
195,S1020-49892016001200455,prenatal,i
195,S1020-49892016001200455,El,o
195,S1020-49892016001200455,tratamiento,i
195,S1020-49892016001200455,el,o
195,S1020-49892016001200455,mismo,o
195,S1020-49892016001200455,dia,o
195,S1020-49892016001200455,depende,o
195,S1020-49892016001200455,tambien,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,interpretacion,o
195,S1020-49892016001200455,y,o
195,S1020-49892016001200455,la,o
195,S1020-49892016001200455,confianza,o
195,S1020-49892016001200455,en,o
195,S1020-49892016001200455,los,o
195,S1020-49892016001200455,resultados,o
195,S1020-49892016001200455,del,o
195,S1020-49892016001200455,trabajador,o
195,S1020-49892016001200455,de,o
195,S1020-49892016001200455,salud,o
196,S1022-51292016000400002,Estudio,i
196,S1022-51292016000400002,comparativo,i
196,S1022-51292016000400002,entre,o
196,S1022-51292016000400002,el,o
196,S1022-51292016000400002,uso,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,manitol,i
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,el,o
196,S1022-51292016000400002,picosulfato,i
196,S1022-51292016000400002,sodico,i
196,S1022-51292016000400002,como,o
196,S1022-51292016000400002,preparacion,i
196,S1022-51292016000400002,para,i
196,S1022-51292016000400002,colonoscopia,i
196,S1022-51292016000400002,Objetivos,o
196,S1022-51292016000400002,El,o
196,S1022-51292016000400002,objetivo,o
196,S1022-51292016000400002,del,o
196,S1022-51292016000400002,presente,o
196,S1022-51292016000400002,estudio,o
196,S1022-51292016000400002,es,o
196,S1022-51292016000400002,comparar,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,preparacion,i
196,S1022-51292016000400002,adecuada,i
196,S1022-51292016000400002,del,i
196,S1022-51292016000400002,colon,i
196,S1022-51292016000400002,con,o
196,S1022-51292016000400002,manitol,i
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,picosulfato,i
196,S1022-51292016000400002,sodico,i
196,S1022-51292016000400002,Evaluar,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,aceptacion,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,los,o
196,S1022-51292016000400002,pacientes,o
196,S1022-51292016000400002,los,o
196,S1022-51292016000400002,efectos,i
196,S1022-51292016000400002,secundarios,i
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,capacidad,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,limpieza,i
196,S1022-51292016000400002,Materiales,o
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,metodos,o
196,S1022-51292016000400002,Este,o
196,S1022-51292016000400002,es,o
196,S1022-51292016000400002,un,o
196,S1022-51292016000400002,estudio,o
196,S1022-51292016000400002,no,o
196,S1022-51292016000400002,aleatorio,o
196,S1022-51292016000400002,prospectivo,o
196,S1022-51292016000400002,ciego,o
196,S1022-51292016000400002,en,o
196,S1022-51292016000400002,que,o
196,S1022-51292016000400002,el,o
196,S1022-51292016000400002,evaluador,o
196,S1022-51292016000400002,no,o
196,S1022-51292016000400002,tenia,o
196,S1022-51292016000400002,informacion,o
196,S1022-51292016000400002,sobre,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,preparacion,i
196,S1022-51292016000400002,aplicada,o
196,S1022-51292016000400002,La,o
196,S1022-51292016000400002,muestra,o
196,S1022-51292016000400002,obtenida,o
196,S1022-51292016000400002,se,o
196,S1022-51292016000400002,dividio,o
196,S1022-51292016000400002,en,o
196,S1022-51292016000400002,dos,o
196,S1022-51292016000400002,grupos,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,acuerdo,o
196,S1022-51292016000400002,con,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,preparacion,i
196,S1022-51292016000400002,adecuada,i
196,S1022-51292016000400002,del,i
196,S1022-51292016000400002,colon,i
196,S1022-51292016000400002,con,o
196,S1022-51292016000400002,153,o
196,S1022-51292016000400002,pacientes,o
196,S1022-51292016000400002,preparados,o
196,S1022-51292016000400002,con,o
196,S1022-51292016000400002,manitol,i
196,S1022-51292016000400002,al,o
196,S1022-51292016000400002,10,o
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,84,o
196,S1022-51292016000400002,pacientes,o
196,S1022-51292016000400002,con,o
196,S1022-51292016000400002,picosulfato,i
196,S1022-51292016000400002,sodico,i
196,S1022-51292016000400002,La,o
196,S1022-51292016000400002,evaluacion,i
196,S1022-51292016000400002,de,i
196,S1022-51292016000400002,la,i
196,S1022-51292016000400002,preparacion,i
196,S1022-51292016000400002,se,o
196,S1022-51292016000400002,realizo,o
196,S1022-51292016000400002,usando,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,Escala,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,Boston,o
196,S1022-51292016000400002,Boston,o
196,S1022-51292016000400002,Bowel,o
196,S1022-51292016000400002,Preparation,o
196,S1022-51292016000400002,Scale,o
196,S1022-51292016000400002,BBP,o
196,S1022-51292016000400002,a,o
196,S1022-51292016000400002,traves,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,un,o
196,S1022-51292016000400002,sistema,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,puntuacion,o
196,S1022-51292016000400002,para,o
196,S1022-51292016000400002,cada,o
196,S1022-51292016000400002,region,i
196,S1022-51292016000400002,del,i
196,S1022-51292016000400002,colon,i
196,S1022-51292016000400002,puntuada,o
196,S1022-51292016000400002,con,o
196,S1022-51292016000400002,3,o
196,S1022-51292016000400002,puntos,o
196,S1022-51292016000400002,derecha,o
196,S1022-51292016000400002,izquierda,o
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,colon,i
196,S1022-51292016000400002,transverso,i
196,S1022-51292016000400002,Resultados,o
196,S1022-51292016000400002,De,o
196,S1022-51292016000400002,los,o
196,S1022-51292016000400002,237,o
196,S1022-51292016000400002,pacientes,o
196,S1022-51292016000400002,que,o
196,S1022-51292016000400002,fueron,o
196,S1022-51292016000400002,evaluados,o
196,S1022-51292016000400002,146,o
196,S1022-51292016000400002,6160,o
196,S1022-51292016000400002,eran,o
196,S1022-51292016000400002,mujeres,o
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,91,o
196,S1022-51292016000400002,384,o
196,S1022-51292016000400002,eran,o
196,S1022-51292016000400002,hombres,o
196,S1022-51292016000400002,En,o
196,S1022-51292016000400002,el,o
196,S1022-51292016000400002,grupo,o
196,S1022-51292016000400002,que,o
196,S1022-51292016000400002,utilizo,o
196,S1022-51292016000400002,manitol,i
196,S1022-51292016000400002,98,o
196,S1022-51292016000400002,6405,o
196,S1022-51292016000400002,eran,o
196,S1022-51292016000400002,mujeres,o
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,55,o
196,S1022-51292016000400002,3595,o
196,S1022-51292016000400002,eran,o
196,S1022-51292016000400002,varones,o
196,S1022-51292016000400002,Entre,o
196,S1022-51292016000400002,los,o
196,S1022-51292016000400002,pacientes,o
196,S1022-51292016000400002,que,o
196,S1022-51292016000400002,utilizaron,o
196,S1022-51292016000400002,picosulfato,i
196,S1022-51292016000400002,sodico,i
196,S1022-51292016000400002,48,o
196,S1022-51292016000400002,5714eran,o
196,S1022-51292016000400002,mujeres,o
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,36,o
196,S1022-51292016000400002,4286,o
196,S1022-51292016000400002,eran,o
196,S1022-51292016000400002,hombres,o
196,S1022-51292016000400002,sin,o
196,S1022-51292016000400002,diferencias,o
196,S1022-51292016000400002,estadisticas,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,ambos,o
196,S1022-51292016000400002,grupos,o
196,S1022-51292016000400002,p032,o
196,S1022-51292016000400002,Teniendo,o
196,S1022-51292016000400002,en,o
196,S1022-51292016000400002,cuenta,o
196,S1022-51292016000400002,que,o
196,S1022-51292016000400002,con,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,adecuada,o
196,S1022-51292016000400002,preparacion,i
196,S1022-51292016000400002,del,i
196,S1022-51292016000400002,colon,i
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,con,o
196,S1022-51292016000400002,puntuacion,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,6,o
196,S1022-51292016000400002,puntos,o
196,S1022-51292016000400002,en,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,Escala,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,Boston,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,preparacion,i
196,S1022-51292016000400002,intestinal,i
196,S1022-51292016000400002,fue,o
196,S1022-51292016000400002,satisfactoria,o
196,S1022-51292016000400002,en,o
196,S1022-51292016000400002,ambos,o
196,S1022-51292016000400002,grupos,o
196,S1022-51292016000400002,El,o
196,S1022-51292016000400002,93,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,los,o
196,S1022-51292016000400002,pacientes,o
196,S1022-51292016000400002,que,o
196,S1022-51292016000400002,utilizaron,o
196,S1022-51292016000400002,manitol,i
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,el,o
196,S1022-51292016000400002,81,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,los,o
196,S1022-51292016000400002,pacientes,o
196,S1022-51292016000400002,que,o
196,S1022-51292016000400002,utilizaron,o
196,S1022-51292016000400002,picosulfato,i
196,S1022-51292016000400002,sodico,i
196,S1022-51292016000400002,tenian,o
196,S1022-51292016000400002,preparacion,i
196,S1022-51292016000400002,adecuada,o
196,S1022-51292016000400002,puntuacion,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,6,o
196,S1022-51292016000400002,La,o
196,S1022-51292016000400002,puntuacion,o
196,S1022-51292016000400002,media,o
196,S1022-51292016000400002,en,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,preparacion,i
196,S1022-51292016000400002,con,o
196,S1022-51292016000400002,manitol,i
196,S1022-51292016000400002,fue,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,9,o
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,en,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,preparacion,i
196,S1022-51292016000400002,con,o
196,S1022-51292016000400002,picosulfato,i
196,S1022-51292016000400002,sodico,i
196,S1022-51292016000400002,fue,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,7,o
196,S1022-51292016000400002,No,o
196,S1022-51292016000400002,hubo,o
196,S1022-51292016000400002,diferencias,o
196,S1022-51292016000400002,significativas,o
196,S1022-51292016000400002,entre,o
196,S1022-51292016000400002,ambos,o
196,S1022-51292016000400002,grupos,o
196,S1022-51292016000400002,Conclusion,o
196,S1022-51292016000400002,Ambas,o
196,S1022-51292016000400002,preparaciones,i
196,S1022-51292016000400002,demostraron,o
196,S1022-51292016000400002,ser,o
196,S1022-51292016000400002,seguras,o
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,eficaces,o
196,S1022-51292016000400002,para,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,limpieza,i
196,S1022-51292016000400002,del,i
196,S1022-51292016000400002,intestino,i
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,acuerdo,o
196,S1022-51292016000400002,con,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,Escala,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,Boston,o
196,S1022-51292016000400002,asi,o
196,S1022-51292016000400002,como,o
196,S1022-51292016000400002,la,o
196,S1022-51292016000400002,aceptabilidad,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,los,o
196,S1022-51292016000400002,pacientes,o
196,S1022-51292016000400002,y,o
196,S1022-51292016000400002,libre,o
196,S1022-51292016000400002,de,o
196,S1022-51292016000400002,complicaciones,i
197,S1022-51292019000400003,Efecto,o
197,S1022-51292019000400003,del,o
197,S1022-51292019000400003,polietilenglicol,i
197,S1022-51292019000400003,versus,o
197,S1022-51292019000400003,lactulosa,i
197,S1022-51292019000400003,sobre,o
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,abdominal,i
197,S1022-51292019000400003,en,o
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,estreñimiento,i
197,S1022-51292019000400003,oculto,o
197,S1022-51292019000400003,en,o
197,S1022-51292019000400003,niños,o
197,S1022-51292019000400003,Introduccion,o
197,S1022-51292019000400003,y,o
197,S1022-51292019000400003,objetivo,o
197,S1022-51292019000400003,El,o
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,abdominal,i
197,S1022-51292019000400003,funcional,i
197,S1022-51292019000400003,FAP,i
197,S1022-51292019000400003,es,o
197,S1022-51292019000400003,una,o
197,S1022-51292019000400003,de,o
197,S1022-51292019000400003,las,o
197,S1022-51292019000400003,principales,o
197,S1022-51292019000400003,molestias,i
197,S1022-51292019000400003,gastrointestinales,i
197,S1022-51292019000400003,en,o
197,S1022-51292019000400003,la,o
197,S1022-51292019000400003,infancia,o
197,S1022-51292019000400003,Los,o
197,S1022-51292019000400003,estudios,o
197,S1022-51292019000400003,han,o
197,S1022-51292019000400003,informado,o
197,S1022-51292019000400003,que,o
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,estreñimiento,i
197,S1022-51292019000400003,oculto,o
197,S1022-51292019000400003,OC,o
197,S1022-51292019000400003,es,o
197,S1022-51292019000400003,una,o
197,S1022-51292019000400003,de,o
197,S1022-51292019000400003,las,o
197,S1022-51292019000400003,principales,o
197,S1022-51292019000400003,causas,o
197,S1022-51292019000400003,de,o
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,abdominal,i
197,S1022-51292019000400003,Investigaciones,o
197,S1022-51292019000400003,recientes,o
197,S1022-51292019000400003,han,o
197,S1022-51292019000400003,propuesto,o
197,S1022-51292019000400003,laxantes,i
197,S1022-51292019000400003,como,o
197,S1022-51292019000400003,objetivos,o
197,S1022-51292019000400003,terapeuticos,o
197,S1022-51292019000400003,potentes,o
197,S1022-51292019000400003,para,o
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,abdominal,i
197,S1022-51292019000400003,en,o
197,S1022-51292019000400003,pacientes,o
197,S1022-51292019000400003,con,o
197,S1022-51292019000400003,OC,o
197,S1022-51292019000400003,Sin,o
197,S1022-51292019000400003,embargo,o
197,S1022-51292019000400003,ningun,o
197,S1022-51292019000400003,estudio,o
197,S1022-51292019000400003,ha,o
197,S1022-51292019000400003,comparado,o
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,efecto,o
197,S1022-51292019000400003,del,o
197,S1022-51292019000400003,polietilenglicol,i
197,S1022-51292019000400003,PEG,i
197,S1022-51292019000400003,y,o
197,S1022-51292019000400003,la,o
197,S1022-51292019000400003,lactulosa,i
197,S1022-51292019000400003,sobre,o
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,estreñimiento,i
197,S1022-51292019000400003,oculto,o
197,S1022-51292019000400003,Materiales,o
197,S1022-51292019000400003,y,o
197,S1022-51292019000400003,metodos,o
197,S1022-51292019000400003,Se,o
197,S1022-51292019000400003,estudiaron,o
197,S1022-51292019000400003,51,o
197,S1022-51292019000400003,pacientes,o
197,S1022-51292019000400003,de,o
197,S1022-51292019000400003,4,o
197,S1022-51292019000400003,a,o
197,S1022-51292019000400003,18,o
197,S1022-51292019000400003,años,o
197,S1022-51292019000400003,con,o
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,abdominal,i
197,S1022-51292019000400003,que,o
197,S1022-51292019000400003,tenian,o
197,S1022-51292019000400003,OC,o
197,S1022-51292019000400003,definida,o
197,S1022-51292019000400003,como,o
197,S1022-51292019000400003,impactacion,i
197,S1022-51292019000400003,fecal,i
197,S1022-51292019000400003,en,o
197,S1022-51292019000400003,rayos,i
197,S1022-51292019000400003,X,i
197,S1022-51292019000400003,abdominales,i
197,S1022-51292019000400003,Se,o
197,S1022-51292019000400003,registraron,o
197,S1022-51292019000400003,datos,o
197,S1022-51292019000400003,demograficos,o
197,S1022-51292019000400003,y,o
197,S1022-51292019000400003,clinicos,o
197,S1022-51292019000400003,que,o
197,S1022-51292019000400003,incluyen,o
197,S1022-51292019000400003,edad,o
197,S1022-51292019000400003,sexo,o
197,S1022-51292019000400003,peso,o
197,S1022-51292019000400003,corporal,i
197,S1022-51292019000400003,altura,o
197,S1022-51292019000400003,duracion,o
197,S1022-51292019000400003,del,o
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,abdominal,i
197,S1022-51292019000400003,tasa,o
197,S1022-51292019000400003,de,o
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,abdominal,i
197,S1022-51292019000400003,y,o
197,S1022-51292019000400003,olor,o
197,S1022-51292019000400003,fecal,i
197,S1022-51292019000400003,Fueron,o
197,S1022-51292019000400003,asignados,i
197,S1022-51292019000400003,aleatoriamente,i
197,S1022-51292019000400003,para,o
197,S1022-51292019000400003,recibir,o
197,S1022-51292019000400003,PEG,i
197,S1022-51292019000400003,1,o
197,S1022-51292019000400003,grkg,o
197,S1022-51292019000400003,o,o
197,S1022-51292019000400003,lactulosa,i
197,S1022-51292019000400003,1,o
197,S1022-51292019000400003,cckg,o
197,S1022-51292019000400003,durante,o
197,S1022-51292019000400003,al,o
197,S1022-51292019000400003,menos,o
197,S1022-51292019000400003,dos,o
197,S1022-51292019000400003,semanas,o
197,S1022-51292019000400003,Todos,o
197,S1022-51292019000400003,los,o
197,S1022-51292019000400003,pacientes,o
197,S1022-51292019000400003,fueron,o
197,S1022-51292019000400003,reevaluados,o
197,S1022-51292019000400003,por,o
197,S1022-51292019000400003,la,o
197,S1022-51292019000400003,escala,i
197,S1022-51292019000400003,de,i
197,S1022-51292019000400003,medicion,i
197,S1022-51292019000400003,del,i
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,despues,o
197,S1022-51292019000400003,de,o
197,S1022-51292019000400003,al,o
197,S1022-51292019000400003,menos,o
197,S1022-51292019000400003,dos,o
197,S1022-51292019000400003,semanas,o
197,S1022-51292019000400003,de,o
197,S1022-51292019000400003,tratamiento,i
197,S1022-51292019000400003,Resultados,o
197,S1022-51292019000400003,Se,o
197,S1022-51292019000400003,indica,o
197,S1022-51292019000400003,que,o
197,S1022-51292019000400003,la,o
197,S1022-51292019000400003,eficacia,o
197,S1022-51292019000400003,de,o
197,S1022-51292019000400003,PEG,i
197,S1022-51292019000400003,para,o
197,S1022-51292019000400003,reducir,o
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,abdominal,i
197,S1022-51292019000400003,en,o
197,S1022-51292019000400003,OC,o
197,S1022-51292019000400003,fue,o
197,S1022-51292019000400003,del,o
197,S1022-51292019000400003,48,o
197,S1022-51292019000400003,mientras,o
197,S1022-51292019000400003,que,o
197,S1022-51292019000400003,fue,o
197,S1022-51292019000400003,del,o
197,S1022-51292019000400003,37,o
197,S1022-51292019000400003,para,o
197,S1022-51292019000400003,la,o
197,S1022-51292019000400003,lactulosa,i
197,S1022-51292019000400003,Este,o
197,S1022-51292019000400003,estudio,o
197,S1022-51292019000400003,indico,o
197,S1022-51292019000400003,que,o
197,S1022-51292019000400003,esta,o
197,S1022-51292019000400003,eficacia,o
197,S1022-51292019000400003,no,o
197,S1022-51292019000400003,se,o
197,S1022-51292019000400003,ve,o
197,S1022-51292019000400003,afectada,o
197,S1022-51292019000400003,significativamente,o
197,S1022-51292019000400003,por,o
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,sexo,o
197,S1022-51292019000400003,y,o
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,olor,o
197,S1022-51292019000400003,fecal,i
197,S1022-51292019000400003,sin,o
197,S1022-51292019000400003,embargo,o
197,S1022-51292019000400003,esta,o
197,S1022-51292019000400003,eficacia,o
197,S1022-51292019000400003,esta,o
197,S1022-51292019000400003,influenciada,o
197,S1022-51292019000400003,por,o
197,S1022-51292019000400003,la,o
197,S1022-51292019000400003,edad,o
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,peso,o
197,S1022-51292019000400003,corporal,i
197,S1022-51292019000400003,la,o
197,S1022-51292019000400003,duracion,o
197,S1022-51292019000400003,del,o
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,abdominal,i
197,S1022-51292019000400003,y,o
197,S1022-51292019000400003,la,o
197,S1022-51292019000400003,tasa,o
197,S1022-51292019000400003,de,o
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,abdominal,i
197,S1022-51292019000400003,tanto,o
197,S1022-51292019000400003,para,o
197,S1022-51292019000400003,PEG,i
197,S1022-51292019000400003,como,o
197,S1022-51292019000400003,para,o
197,S1022-51292019000400003,lactulosa,i
197,S1022-51292019000400003,Conclusion,o
197,S1022-51292019000400003,Se,o
197,S1022-51292019000400003,podria,o
197,S1022-51292019000400003,concluir,o
197,S1022-51292019000400003,que,o
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,PEG,i
197,S1022-51292019000400003,es,o
197,S1022-51292019000400003,un,o
197,S1022-51292019000400003,farmaco,i
197,S1022-51292019000400003,mas,o
197,S1022-51292019000400003,eficaz,o
197,S1022-51292019000400003,para,o
197,S1022-51292019000400003,tratar,i
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,abdominal,i
197,S1022-51292019000400003,en,o
197,S1022-51292019000400003,el,o
197,S1022-51292019000400003,estreñimiento,i
197,S1022-51292019000400003,oculto,o
197,S1022-51292019000400003,que,o
197,S1022-51292019000400003,la,o
197,S1022-51292019000400003,lactulosa,i
197,S1022-51292019000400003,y,o
197,S1022-51292019000400003,que,o
197,S1022-51292019000400003,su,o
197,S1022-51292019000400003,efecto,o
197,S1022-51292019000400003,optimo,o
197,S1022-51292019000400003,se,o
197,S1022-51292019000400003,puede,o
197,S1022-51292019000400003,lograr,o
197,S1022-51292019000400003,en,o
197,S1022-51292019000400003,pacientes,o
197,S1022-51292019000400003,mayores,o
197,S1022-51292019000400003,con,o
197,S1022-51292019000400003,dolor,i
197,S1022-51292019000400003,abdominal,i
197,S1022-51292019000400003,mas,o
197,S1022-51292019000400003,severo,o
198,S1025-028X2005000100002,Seguimiento,i
198,S1025-028X2005000100002,de,i
198,S1025-028X2005000100002,la,i
198,S1025-028X2005000100002,reactogenicidad,i
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,vacuna,i
198,S1025-028X2005000100002,DTP,i
198,S1025-028X2005000100002,cubana,o
198,S1025-028X2005000100002,utilizando,o
198,S1025-028X2005000100002,dos,o
198,S1025-028X2005000100002,metodos,o
198,S1025-028X2005000100002,paralelos,o
198,S1025-028X2005000100002,Con,o
198,S1025-028X2005000100002,el,o
198,S1025-028X2005000100002,objetivo,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,caracterizar,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,reactogenicidad,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,vacuna,i
198,S1025-028X2005000100002,AntidiftericaAntitetanicaAntipertusis,o
198,S1025-028X2005000100002,DTP,i
198,S1025-028X2005000100002,cubana,o
198,S1025-028X2005000100002,desarrollada,o
198,S1025-028X2005000100002,por,o
198,S1025-028X2005000100002,el,o
198,S1025-028X2005000100002,Instituto,o
198,S1025-028X2005000100002,Finlay,o
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,realizo,o
198,S1025-028X2005000100002,un,o
198,S1025-028X2005000100002,estudio,o
198,S1025-028X2005000100002,utilizando,o
198,S1025-028X2005000100002,dos,o
198,S1025-028X2005000100002,metodos,o
198,S1025-028X2005000100002,o,o
198,S1025-028X2005000100002,fuentes,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,informacion,o
198,S1025-028X2005000100002,diferentes,o
198,S1025-028X2005000100002,y,o
198,S1025-028X2005000100002,paralelos,o
198,S1025-028X2005000100002,La,o
198,S1025-028X2005000100002,primera,o
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,obtuvo,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,un,o
198,S1025-028X2005000100002,ensayo,o
198,S1025-028X2005000100002,clinico,o
198,S1025-028X2005000100002,EC,i
198,S1025-028X2005000100002,Fase,o
198,S1025-028X2005000100002,IV,o
198,S1025-028X2005000100002,abierto,o
198,S1025-028X2005000100002,no,o
198,S1025-028X2005000100002,controlado,o
198,S1025-028X2005000100002,en,o
198,S1025-028X2005000100002,el,o
198,S1025-028X2005000100002,que,o
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,incluyeron,o
198,S1025-028X2005000100002,57,o
198,S1025-028X2005000100002,lactantes,o
198,S1025-028X2005000100002,La,o
198,S1025-028X2005000100002,segunda,o
198,S1025-028X2005000100002,fuente,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,informacion,o
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,obtuvo,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,los,o
198,S1025-028X2005000100002,reportes,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,los,o
198,S1025-028X2005000100002,eventos,i
198,S1025-028X2005000100002,temporalmente,i
198,S1025-028X2005000100002,asociados,i
198,S1025-028X2005000100002,a,i
198,S1025-028X2005000100002,la,i
198,S1025-028X2005000100002,vacunacion,i
198,S1025-028X2005000100002,ETAV,i
198,S1025-028X2005000100002,recepcionados,o
198,S1025-028X2005000100002,por,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,Unidad,o
198,S1025-028X2005000100002,Coordinadora,o
198,S1025-028X2005000100002,Nacional,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,Farmacovigilancia,o
198,S1025-028X2005000100002,UCNFv,o
198,S1025-028X2005000100002,que,o
198,S1025-028X2005000100002,incluyen,o
198,S1025-028X2005000100002,a,o
198,S1025-028X2005000100002,86,o
198,S1025-028X2005000100002,lactantes,o
198,S1025-028X2005000100002,que,o
198,S1025-028X2005000100002,fueron,o
198,S1025-028X2005000100002,atendidos,o
198,S1025-028X2005000100002,por,o
198,S1025-028X2005000100002,sospechas,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,ETAV,i
198,S1025-028X2005000100002,En,o
198,S1025-028X2005000100002,el,o
198,S1025-028X2005000100002,EC,i
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,aplicaron,o
198,S1025-028X2005000100002,167,o
198,S1025-028X2005000100002,dosis,o
198,S1025-028X2005000100002,los,o
198,S1025-028X2005000100002,eventos,i
198,S1025-028X2005000100002,adversos,i
198,S1025-028X2005000100002,esperados,o
198,S1025-028X2005000100002,e,o
198,S1025-028X2005000100002,inesperados,o
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,observaron,o
198,S1025-028X2005000100002,en,o
198,S1025-028X2005000100002,un,o
198,S1025-028X2005000100002,escaso,o
198,S1025-028X2005000100002,numero,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,lactantes,o
198,S1025-028X2005000100002,fueron,o
198,S1025-028X2005000100002,mayoritariamente,o
198,S1025-028X2005000100002,ligeros,o
198,S1025-028X2005000100002,y,o
198,S1025-028X2005000100002,autolimitados,o
198,S1025-028X2005000100002,en,o
198,S1025-028X2005000100002,el,o
198,S1025-028X2005000100002,tiempo,o
198,S1025-028X2005000100002,y,o
198,S1025-028X2005000100002,su,o
198,S1025-028X2005000100002,frecuencia,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,aparicion,o
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,redujo,o
198,S1025-028X2005000100002,en,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,2da,o
198,S1025-028X2005000100002,y,o
198,S1025-028X2005000100002,3ra,o
198,S1025-028X2005000100002,dosis,o
198,S1025-028X2005000100002,El,o
198,S1025-028X2005000100002,dolor,i
198,S1025-028X2005000100002,fue,o
198,S1025-028X2005000100002,el,o
198,S1025-028X2005000100002,evento,o
198,S1025-028X2005000100002,local,o
198,S1025-028X2005000100002,mas,o
198,S1025-028X2005000100002,frecuente,o
198,S1025-028X2005000100002,y,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,fiebre,i
198,S1025-028X2005000100002,fue,o
198,S1025-028X2005000100002,el,o
198,S1025-028X2005000100002,evento,o
198,S1025-028X2005000100002,general,o
198,S1025-028X2005000100002,que,o
198,S1025-028X2005000100002,mas,o
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,presento,o
198,S1025-028X2005000100002,No,o
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,reportaron,o
198,S1025-028X2005000100002,vomitos,i
198,S1025-028X2005000100002,y,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,anorexia,i
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,somnolencia,i
198,S1025-028X2005000100002,y,o
198,S1025-028X2005000100002,el,o
198,S1025-028X2005000100002,llanto,i
198,S1025-028X2005000100002,persistente,i
198,S1025-028X2005000100002,aparecieron,o
198,S1025-028X2005000100002,en,o
198,S1025-028X2005000100002,un,o
198,S1025-028X2005000100002,numero,o
198,S1025-028X2005000100002,limitado,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,sujetos,o
198,S1025-028X2005000100002,vacunados,i
198,S1025-028X2005000100002,Se,o
198,S1025-028X2005000100002,presentaron,o
198,S1025-028X2005000100002,12,o
198,S1025-028X2005000100002,eventos,i
198,S1025-028X2005000100002,no,i
198,S1025-028X2005000100002,esperados,i
198,S1025-028X2005000100002,solo,o
198,S1025-028X2005000100002,en,o
198,S1025-028X2005000100002,2,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,ellos,o
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,considero,o
198,S1025-028X2005000100002,que,o
198,S1025-028X2005000100002,existia,o
198,S1025-028X2005000100002,relacion,o
198,S1025-028X2005000100002,causal,o
198,S1025-028X2005000100002,con,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,vacunacion,i
198,S1025-028X2005000100002,Se,o
198,S1025-028X2005000100002,reporto,o
198,S1025-028X2005000100002,un,o
198,S1025-028X2005000100002,evento,i
198,S1025-028X2005000100002,adverso,i
198,S1025-028X2005000100002,grave,o
198,S1025-028X2005000100002,niña,o
198,S1025-028X2005000100002,hospitalizada,i
198,S1025-028X2005000100002,por,o
198,S1025-028X2005000100002,sindrome,i
198,S1025-028X2005000100002,febril,i
198,S1025-028X2005000100002,prolongado,o
198,S1025-028X2005000100002,postvacunacion,o
198,S1025-028X2005000100002,que,o
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,estudio,o
198,S1025-028X2005000100002,y,o
198,S1025-028X2005000100002,demostro,o
198,S1025-028X2005000100002,que,o
198,S1025-028X2005000100002,fue,o
198,S1025-028X2005000100002,causado,o
198,S1025-028X2005000100002,por,o
198,S1025-028X2005000100002,una,o
198,S1025-028X2005000100002,sepsis,i
198,S1025-028X2005000100002,urinaria,i
198,S1025-028X2005000100002,persistente,o
198,S1025-028X2005000100002,provocada,o
198,S1025-028X2005000100002,por,o
198,S1025-028X2005000100002,una,o
198,S1025-028X2005000100002,malformacion,o
198,S1025-028X2005000100002,vesicoureteral,o
198,S1025-028X2005000100002,Los,o
198,S1025-028X2005000100002,86,o
198,S1025-028X2005000100002,reportes,o
198,S1025-028X2005000100002,recepcionados,o
198,S1025-028X2005000100002,por,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,UCNFv,o
198,S1025-028X2005000100002,incluian,o
198,S1025-028X2005000100002,un,o
198,S1025-028X2005000100002,total,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,141,o
198,S1025-028X2005000100002,ETAV,i
198,S1025-028X2005000100002,dentro,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,los,o
198,S1025-028X2005000100002,sintomas,i
198,S1025-028X2005000100002,locales,i
198,S1025-028X2005000100002,el,o
198,S1025-028X2005000100002,eritema,i
198,S1025-028X2005000100002,alcanzo,o
198,S1025-028X2005000100002,un,o
198,S1025-028X2005000100002,930,o
198,S1025-028X2005000100002,y,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,induracion,i
198,S1025-028X2005000100002,un,o
198,S1025-028X2005000100002,581,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,fiebre,i
198,S1025-028X2005000100002,fue,o
198,S1025-028X2005000100002,un,o
198,S1025-028X2005000100002,sintoma,i
198,S1025-028X2005000100002,frecuente,o
198,S1025-028X2005000100002,aunque,o
198,S1025-028X2005000100002,no,o
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,especifica,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,temperatura,o
198,S1025-028X2005000100002,corporal,i
198,S1025-028X2005000100002,alcanzada,o
198,S1025-028X2005000100002,Aunque,o
198,S1025-028X2005000100002,existen,o
198,S1025-028X2005000100002,varias,o
198,S1025-028X2005000100002,diferencias,o
198,S1025-028X2005000100002,con,o
198,S1025-028X2005000100002,relacion,o
198,S1025-028X2005000100002,a,o
198,S1025-028X2005000100002,las,o
198,S1025-028X2005000100002,condiciones,o
198,S1025-028X2005000100002,en,o
198,S1025-028X2005000100002,que,o
198,S1025-028X2005000100002,se,o
198,S1025-028X2005000100002,realiza,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,vigilancia,i
198,S1025-028X2005000100002,de,i
198,S1025-028X2005000100002,eventos,i
198,S1025-028X2005000100002,adversos,i
198,S1025-028X2005000100002,en,o
198,S1025-028X2005000100002,un,o
198,S1025-028X2005000100002,EC,i
198,S1025-028X2005000100002,o,o
198,S1025-028X2005000100002,en,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,practica,i
198,S1025-028X2005000100002,clinica,i
198,S1025-028X2005000100002,habitual,o
198,S1025-028X2005000100002,los,o
198,S1025-028X2005000100002,resultados,o
198,S1025-028X2005000100002,aqui,o
198,S1025-028X2005000100002,analizados,o
198,S1025-028X2005000100002,nos,o
198,S1025-028X2005000100002,confirman,o
198,S1025-028X2005000100002,que,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,reactogenicidad,o
198,S1025-028X2005000100002,de,o
198,S1025-028X2005000100002,la,o
198,S1025-028X2005000100002,vacuna,i
198,S1025-028X2005000100002,es,o
198,S1025-028X2005000100002,escasa,o
198,S1025-028X2005000100002,comparada,o
198,S1025-028X2005000100002,con,o
198,S1025-028X2005000100002,los,o
198,S1025-028X2005000100002,beneficios,o
198,S1025-028X2005000100002,que,o
198,S1025-028X2005000100002,reporta,o
198,S1025-028X2005000100002,su,o
198,S1025-028X2005000100002,aplicacion,o
198,S1025-028X2005000100002,en,o
198,S1025-028X2005000100002,lactantes,o
199,S1025-028X2011000300001,Dosis,o
199,S1025-028X2011000300001,unica,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,vacuna,i
199,S1025-028X2011000300001,oral,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,cepa,o
199,S1025-028X2011000300001,viva,o
199,S1025-028X2011000300001,atenuada,o
199,S1025-028X2011000300001,638,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,Vibrio,o
199,S1025-028X2011000300001,cholerae,o
199,S1025-028X2011000300001,es,o
199,S1025-028X2011000300001,segura,o
199,S1025-028X2011000300001,e,o
199,S1025-028X2011000300001,inmunogenica,o
199,S1025-028X2011000300001,en,o
199,S1025-028X2011000300001,voluntarios,o
199,S1025-028X2011000300001,adultos,o
199,S1025-028X2011000300001,en,o
199,S1025-028X2011000300001,Mozambique,o
199,S1025-028X2011000300001,Se,o
199,S1025-028X2011000300001,realizo,o
199,S1025-028X2011000300001,un,o
199,S1025-028X2011000300001,ensayo,o
199,S1025-028X2011000300001,clinico,o
199,S1025-028X2011000300001,controlado,o
199,S1025-028X2011000300001,con,o
199,S1025-028X2011000300001,placebo,i
199,S1025-028X2011000300001,aleatorizado,o
199,S1025-028X2011000300001,y,o
199,S1025-028X2011000300001,a,o
199,S1025-028X2011000300001,doble,o
199,S1025-028X2011000300001,ciego,o
199,S1025-028X2011000300001,para,o
199,S1025-028X2011000300001,evaluar,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,seguridad,o
199,S1025-028X2011000300001,reactogenicidad,o
199,S1025-028X2011000300001,e,o
199,S1025-028X2011000300001,inmunogenicidad,o
199,S1025-028X2011000300001,del,o
199,S1025-028X2011000300001,candidato,i
199,S1025-028X2011000300001,vacunal,i
199,S1025-028X2011000300001,liofilizado,i
199,S1025-028X2011000300001,contra,o
199,S1025-028X2011000300001,el,o
199,S1025-028X2011000300001,colera,i
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,cepa,o
199,S1025-028X2011000300001,viva,o
199,S1025-028X2011000300001,atenuada,o
199,S1025-028X2011000300001,638,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,V,o
199,S1025-028X2011000300001,cholerae,o
199,S1025-028X2011000300001,O1,o
199,S1025-028X2011000300001,El,o
199,S1025-028X2011000300001,Tor,o
199,S1025-028X2011000300001,Ogawa,o
199,S1025-028X2011000300001,Se,o
199,S1025-028X2011000300001,incluyeron,o
199,S1025-028X2011000300001,120,o
199,S1025-028X2011000300001,voluntarios,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,ambos,o
199,S1025-028X2011000300001,sexos,o
199,S1025-028X2011000300001,aparentemente,o
199,S1025-028X2011000300001,sanos,o
199,S1025-028X2011000300001,entre,o
199,S1025-028X2011000300001,18,o
199,S1025-028X2011000300001,y,o
199,S1025-028X2011000300001,50,o
199,S1025-028X2011000300001,años,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,edad,o
199,S1025-028X2011000300001,en,o
199,S1025-028X2011000300001,Maputo,o
199,S1025-028X2011000300001,Mozambique,o
199,S1025-028X2011000300001,un,o
199,S1025-028X2011000300001,area,o
199,S1025-028X2011000300001,endemica,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,colera,i
199,S1025-028X2011000300001,donde,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,seroprevalencia,o
199,S1025-028X2011000300001,del,o
199,S1025-028X2011000300001,virus,i
199,S1025-028X2011000300001,de,i
199,S1025-028X2011000300001,inmunodeficiencia,i
199,S1025-028X2011000300001,humana,i
199,S1025-028X2011000300001,VIH,i
199,S1025-028X2011000300001,es,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,20,o
199,S1025-028X2011000300001,a,o
199,S1025-028X2011000300001,30,o
199,S1025-028X2011000300001,Ochenta,o
199,S1025-028X2011000300001,sujetos,o
199,S1025-028X2011000300001,recibieron,o
199,S1025-028X2011000300001,como,o
199,S1025-028X2011000300001,tratamiento,i
199,S1025-028X2011000300001,una,o
199,S1025-028X2011000300001,dosis,o
199,S1025-028X2011000300001,oral,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,2,o
199,S1025-028X2011000300001,x,o
199,S1025-028X2011000300001,10,o
199,S1025-028X2011000300001,9,o
199,S1025-028X2011000300001,UFC,o
199,S1025-028X2011000300001,del,o
199,S1025-028X2011000300001,candidato,i
199,S1025-028X2011000300001,vacunal,i
199,S1025-028X2011000300001,638,o
199,S1025-028X2011000300001,y,o
199,S1025-028X2011000300001,otros,o
199,S1025-028X2011000300001,40,o
199,S1025-028X2011000300001,una,o
199,S1025-028X2011000300001,dosis,o
199,S1025-028X2011000300001,del,o
199,S1025-028X2011000300001,placebo,i
199,S1025-028X2011000300001,que,o
199,S1025-028X2011000300001,contenia,o
199,S1025-028X2011000300001,solo,o
199,S1025-028X2011000300001,los,o
199,S1025-028X2011000300001,lioprotectores,i
199,S1025-028X2011000300001,Se,o
199,S1025-028X2011000300001,realizo,o
199,S1025-028X2011000300001,seguimiento,i
199,S1025-028X2011000300001,ambulatorio,i
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,los,o
199,S1025-028X2011000300001,eventos,i
199,S1025-028X2011000300001,adversos,i
199,S1025-028X2011000300001,durante,o
199,S1025-028X2011000300001,30,o
199,S1025-028X2011000300001,dias,o
199,S1025-028X2011000300001,La,o
199,S1025-028X2011000300001,respuesta,o
199,S1025-028X2011000300001,inmune,o
199,S1025-028X2011000300001,se,o
199,S1025-028X2011000300001,evaluo,o
199,S1025-028X2011000300001,por,o
199,S1025-028X2011000300001,medio,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,estimacion,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,tasa,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,seroconversion,o
199,S1025-028X2011000300001,y,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,media,o
199,S1025-028X2011000300001,geometrica,o
199,S1025-028X2011000300001,del,o
199,S1025-028X2011000300001,titulo,o
199,S1025-028X2011000300001,MGT,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,anticuerpos,i
199,S1025-028X2011000300001,vibriocidas,i
199,S1025-028X2011000300001,en,o
199,S1025-028X2011000300001,los,o
199,S1025-028X2011000300001,sueros,i
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,los,o
199,S1025-028X2011000300001,voluntaries,o
199,S1025-028X2011000300001,antes,o
199,S1025-028X2011000300001,y,o
199,S1025-028X2011000300001,a,o
199,S1025-028X2011000300001,los,o
199,S1025-028X2011000300001,14,o
199,S1025-028X2011000300001,y,o
199,S1025-028X2011000300001,21,o
199,S1025-028X2011000300001,dias,o
199,S1025-028X2011000300001,posteriores,o
199,S1025-028X2011000300001,a,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,inmunizacion,i
199,S1025-028X2011000300001,No,o
199,S1025-028X2011000300001,se,o
199,S1025-028X2011000300001,reportaron,o
199,S1025-028X2011000300001,eventos,i
199,S1025-028X2011000300001,adversos,i
199,S1025-028X2011000300001,graves,o
199,S1025-028X2011000300001,La,o
199,S1025-028X2011000300001,incidencia,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,eventos,i
199,S1025-028X2011000300001,adversos,i
199,S1025-028X2011000300001,reportados,o
199,S1025-028X2011000300001,en,o
199,S1025-028X2011000300001,el,o
199,S1025-028X2011000300001,grupo,o
199,S1025-028X2011000300001,que,o
199,S1025-028X2011000300001,recibio,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,vacuna,i
199,S1025-028X2011000300001,fue,o
199,S1025-028X2011000300001,similar,o
199,S1025-028X2011000300001,al,o
199,S1025-028X2011000300001,del,o
199,S1025-028X2011000300001,grupo,o
199,S1025-028X2011000300001,placebo,i
199,S1025-028X2011000300001,Los,o
199,S1025-028X2011000300001,eventos,i
199,S1025-028X2011000300001,adversos,i
199,S1025-028X2011000300001,encontrados,o
199,S1025-028X2011000300001,fueron,o
199,S1025-028X2011000300001,independientes,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,deteccion,i
199,S1025-028X2011000300001,de,i
199,S1025-028X2011000300001,anticuerpos,i
199,S1025-028X2011000300001,contra,o
199,S1025-028X2011000300001,el,o
199,S1025-028X2011000300001,VIH1,o
199,S1025-028X2011000300001,VIH2,o
199,S1025-028X2011000300001,hepatitis,o
199,S1025-028X2011000300001,H,o
199,S1025-028X2011000300001,A,o
199,S1025-028X2011000300001,HC,i
199,S1025-028X2011000300001,y,o
199,S1025-028X2011000300001,el,o
199,S1025-028X2011000300001,antigeno,i
199,S1025-028X2011000300001,de,i
199,S1025-028X2011000300001,superficie,i
199,S1025-028X2011000300001,del,i
199,S1025-028X2011000300001,virus,i
199,S1025-028X2011000300001,de,i
199,S1025-028X2011000300001,la,i
199,S1025-028X2011000300001,hepatitis,i
199,S1025-028X2011000300001,B,i
199,S1025-028X2011000300001,La,o
199,S1025-028X2011000300001,presencia,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,helmintos,o
199,S1025-028X2011000300001,no,o
199,S1025-028X2011000300001,modifico,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,incidencia,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,eventos,i
199,S1025-028X2011000300001,adversos,i
199,S1025-028X2011000300001,La,o
199,S1025-028X2011000300001,cepa,i
199,S1025-028X2011000300001,vacunal,i
199,S1025-028X2011000300001,fue,o
199,S1025-028X2011000300001,aislada,o
199,S1025-028X2011000300001,en,o
199,S1025-028X2011000300001,37,o
199,S1025-028X2011000300001,4625,o
199,S1025-028X2011000300001,voluntarios,o
199,S1025-028X2011000300001,que,o
199,S1025-028X2011000300001,recibieron,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,vacuna,i
199,S1025-028X2011000300001,A,o
199,S1025-028X2011000300001,los,o
199,S1025-028X2011000300001,14,o
199,S1025-028X2011000300001,dias,o
199,S1025-028X2011000300001,el,o
199,S1025-028X2011000300001,pico,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,MGT,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,anticuerpos,i
199,S1025-028X2011000300001,vibriocidas,i
199,S1025-028X2011000300001,en,o
199,S1025-028X2011000300001,el,o
199,S1025-028X2011000300001,grupo,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,la,o
199,S1025-028X2011000300001,vacuna,i
199,S1025-028X2011000300001,fue,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,9056,o
199,S1025-028X2011000300001,frente,o
199,S1025-028X2011000300001,a,o
199,S1025-028X2011000300001,39,o
199,S1025-028X2011000300001,en,o
199,S1025-028X2011000300001,el,o
199,S1025-028X2011000300001,grupo,o
199,S1025-028X2011000300001,placebo,i
199,S1025-028X2011000300001,con,o
199,S1025-028X2011000300001,una,o
199,S1025-028X2011000300001,seroconversion,o
199,S1025-028X2011000300001,total,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,974,o
199,S1025-028X2011000300001,a,o
199,S1025-028X2011000300001,los,o
199,S1025-028X2011000300001,21,o
199,S1025-028X2011000300001,dias,o
199,S1025-028X2011000300001,Se,o
199,S1025-028X2011000300001,concluye,o
199,S1025-028X2011000300001,que,o
199,S1025-028X2011000300001,el,o
199,S1025-028X2011000300001,candidato,i
199,S1025-028X2011000300001,vacunal,i
199,S1025-028X2011000300001,638,o
199,S1025-028X2011000300001,es,o
199,S1025-028X2011000300001,seguro,o
199,S1025-028X2011000300001,e,o
199,S1025-028X2011000300001,inmunogenico,o
199,S1025-028X2011000300001,en,o
199,S1025-028X2011000300001,una,o
199,S1025-028X2011000300001,region,o
199,S1025-028X2011000300001,endemica,o
199,S1025-028X2011000300001,de,o
199,S1025-028X2011000300001,colera,i
200,S1025-55832009000200004,Efecto,o
200,S1025-55832009000200004,coadyuvante,i
200,S1025-55832009000200004,del,o
200,S1025-55832009000200004,extracto,i
200,S1025-55832009000200004,liofilizado,i
200,S1025-55832009000200004,de,i
200,S1025-55832009000200004,Passiflora,i
200,S1025-55832009000200004,edulis,i
200,S1025-55832009000200004,maracuya,o
200,S1025-55832009000200004,en,o
200,S1025-55832009000200004,la,o
200,S1025-55832009000200004,reduccion,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,la,o
200,S1025-55832009000200004,presion,i
200,S1025-55832009000200004,arterial,i
200,S1025-55832009000200004,en,o
200,S1025-55832009000200004,pacientes,o
200,S1025-55832009000200004,tratados,i
200,S1025-55832009000200004,con,o
200,S1025-55832009000200004,enalapril,i
200,S1025-55832009000200004,Objetivos,o
200,S1025-55832009000200004,Determinar,o
200,S1025-55832009000200004,el,o
200,S1025-55832009000200004,efecto,o
200,S1025-55832009000200004,coadyuvante,i
200,S1025-55832009000200004,antihipertensivo,o
200,S1025-55832009000200004,y,o
200,S1025-55832009000200004,la,o
200,S1025-55832009000200004,seguridad,o
200,S1025-55832009000200004,del,o
200,S1025-55832009000200004,jugo,o
200,S1025-55832009000200004,del,o
200,S1025-55832009000200004,fruto,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,maracuya,o
200,S1025-55832009000200004,en,o
200,S1025-55832009000200004,pacientes,o
200,S1025-55832009000200004,hipertensos,i
200,S1025-55832009000200004,en,o
200,S1025-55832009000200004,tratamiento,i
200,S1025-55832009000200004,con,o
200,S1025-55832009000200004,enalapril,i
200,S1025-55832009000200004,Diseño,o
200,S1025-55832009000200004,Ensayo,o
200,S1025-55832009000200004,clinico,o
200,S1025-55832009000200004,prospectivo,o
200,S1025-55832009000200004,piloto,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,fase,o
200,S1025-55832009000200004,II,o
200,S1025-55832009000200004,aleatorizado,o
200,S1025-55832009000200004,a,o
200,S1025-55832009000200004,doble,o
200,S1025-55832009000200004,ciego,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,grupos,o
200,S1025-55832009000200004,paralelos,o
200,S1025-55832009000200004,controlado,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,busqueda,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,dosis,o
200,S1025-55832009000200004,y,o
200,S1025-55832009000200004,evaluacion,o
200,S1025-55832009000200004,del,o
200,S1025-55832009000200004,producto,o
200,S1025-55832009000200004,Institucion,o
200,S1025-55832009000200004,Instituto,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,Investigaciones,o
200,S1025-55832009000200004,Clinicas,o
200,S1025-55832009000200004,Facultad,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,Medicina,o
200,S1025-55832009000200004,UNMSM,o
200,S1025-55832009000200004,Hospital,o
200,S1025-55832009000200004,Nacional,o
200,S1025-55832009000200004,Dos,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,Mayo,o
200,S1025-55832009000200004,en,o
200,S1025-55832009000200004,Lima,o
200,S1025-55832009000200004,Hospital,o
200,S1025-55832009000200004,Belen,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,Trujillo,o
200,S1025-55832009000200004,y,o
200,S1025-55832009000200004,Centros,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,Salud,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,Moche,o
200,S1025-55832009000200004,y,o
200,S1025-55832009000200004,Laredo,o
200,S1025-55832009000200004,en,o
200,S1025-55832009000200004,la,o
200,S1025-55832009000200004,ciudad,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,Trujillo,o
200,S1025-55832009000200004,Participantes,o
200,S1025-55832009000200004,Pacientes,o
200,S1025-55832009000200004,hipertensos,i
200,S1025-55832009000200004,Intervenciones,i
200,S1025-55832009000200004,Los,o
200,S1025-55832009000200004,pacientes,o
200,S1025-55832009000200004,fueron,o
200,S1025-55832009000200004,asignados,i
200,S1025-55832009000200004,aleatoriamente,i
200,S1025-55832009000200004,a,o
200,S1025-55832009000200004,4,o
200,S1025-55832009000200004,grupos,o
200,S1025-55832009000200004,Todos,o
200,S1025-55832009000200004,recibieron,o
200,S1025-55832009000200004,enalapril,i
200,S1025-55832009000200004,10,o
200,S1025-55832009000200004,mgdia,o
200,S1025-55832009000200004,y,o
200,S1025-55832009000200004,ademas,o
200,S1025-55832009000200004,el,o
200,S1025-55832009000200004,primer,o
200,S1025-55832009000200004,grupo,o
200,S1025-55832009000200004,recibio,o
200,S1025-55832009000200004,placebo,i
200,S1025-55832009000200004,y,o
200,S1025-55832009000200004,los,o
200,S1025-55832009000200004,demas,o
200,S1025-55832009000200004,2,o
200,S1025-55832009000200004,3,o
200,S1025-55832009000200004,y,o
200,S1025-55832009000200004,4,o
200,S1025-55832009000200004,capsulas,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,500,o
200,S1025-55832009000200004,mg,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,liofilizado,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,jugo,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,maracuyadia,o
200,S1025-55832009000200004,respectivamente,o
200,S1025-55832009000200004,Principales,o
200,S1025-55832009000200004,medidas,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,resultados,o
200,S1025-55832009000200004,Disminucion,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,la,o
200,S1025-55832009000200004,presion,i
200,S1025-55832009000200004,arterial,i
200,S1025-55832009000200004,Resultados,o
200,S1025-55832009000200004,Los,o
200,S1025-55832009000200004,grupos,o
200,S1025-55832009000200004,que,o
200,S1025-55832009000200004,recibieron,o
200,S1025-55832009000200004,enalapril,i
200,S1025-55832009000200004,mas,o
200,S1025-55832009000200004,maracuya,o
200,S1025-55832009000200004,tuvieron,o
200,S1025-55832009000200004,una,o
200,S1025-55832009000200004,mejor,o
200,S1025-55832009000200004,reduccion,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,la,o
200,S1025-55832009000200004,presion,i
200,S1025-55832009000200004,sanguinea,i
200,S1025-55832009000200004,en,o
200,S1025-55832009000200004,comparacion,o
200,S1025-55832009000200004,con,o
200,S1025-55832009000200004,el,o
200,S1025-55832009000200004,grupo,o
200,S1025-55832009000200004,que,o
200,S1025-55832009000200004,recibio,o
200,S1025-55832009000200004,enalapril,i
200,S1025-55832009000200004,mas,o
200,S1025-55832009000200004,placebo,i
200,S1025-55832009000200004,El,o
200,S1025-55832009000200004,grupo,o
200,S1025-55832009000200004,tratado,i
200,S1025-55832009000200004,con,o
200,S1025-55832009000200004,enalapril,i
200,S1025-55832009000200004,mas,o
200,S1025-55832009000200004,4,o
200,S1025-55832009000200004,capsulas,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,jugo,o
200,S1025-55832009000200004,liofilizado,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,maracuyadia,o
200,S1025-55832009000200004,produjo,o
200,S1025-55832009000200004,al,o
200,S1025-55832009000200004,final,o
200,S1025-55832009000200004,del,o
200,S1025-55832009000200004,experimento,i
200,S1025-55832009000200004,una,o
200,S1025-55832009000200004,reduccion,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,la,o
200,S1025-55832009000200004,presion,i
200,S1025-55832009000200004,sistolica,i
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,673,o
200,S1025-55832009000200004,mmHg,o
200,S1025-55832009000200004,y,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,la,o
200,S1025-55832009000200004,presion,i
200,S1025-55832009000200004,diastolica,i
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,533,o
200,S1025-55832009000200004,mmHg,o
200,S1025-55832009000200004,p005,o
200,S1025-55832009000200004,en,o
200,S1025-55832009000200004,comparacion,o
200,S1025-55832009000200004,con,o
200,S1025-55832009000200004,el,o
200,S1025-55832009000200004,grupo,o
200,S1025-55832009000200004,enalapril,i
200,S1025-55832009000200004,mas,o
200,S1025-55832009000200004,placebo,i
200,S1025-55832009000200004,No,o
200,S1025-55832009000200004,se,o
200,S1025-55832009000200004,observo,o
200,S1025-55832009000200004,efectos,i
200,S1025-55832009000200004,adversos,i
200,S1025-55832009000200004,por,o
200,S1025-55832009000200004,el,o
200,S1025-55832009000200004,tratamiento,i
200,S1025-55832009000200004,Conclusiones,o
200,S1025-55832009000200004,El,o
200,S1025-55832009000200004,jugo,o
200,S1025-55832009000200004,del,o
200,S1025-55832009000200004,fruto,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,P,o
200,S1025-55832009000200004,edulis,o
200,S1025-55832009000200004,fue,o
200,S1025-55832009000200004,coadyuvante,i
200,S1025-55832009000200004,efectivo,o
200,S1025-55832009000200004,del,o
200,S1025-55832009000200004,enalapril,i
200,S1025-55832009000200004,en,o
200,S1025-55832009000200004,la,o
200,S1025-55832009000200004,disminucion,o
200,S1025-55832009000200004,de,o
200,S1025-55832009000200004,la,o
200,S1025-55832009000200004,presion,i
200,S1025-55832009000200004,arterial,i
200,S1025-55832009000200004,en,o
200,S1025-55832009000200004,pacientes,o
200,S1025-55832009000200004,con,o
200,S1025-55832009000200004,hipertension,i
200,S1025-55832009000200004,estadio,o
200,S1025-55832009000200004,1,o
200,S1025-55832009000200004,y,o
200,S1025-55832009000200004,demostro,o
200,S1025-55832009000200004,ser,o
200,S1025-55832009000200004,seguro,o
201,S1025-55832011000200004,Efecto,o
201,S1025-55832011000200004,cicatrizante,o
201,S1025-55832011000200004,del,o
201,S1025-55832011000200004,aceite,i
201,S1025-55832011000200004,de,i
201,S1025-55832011000200004,Copaifera,i
201,S1025-55832011000200004,officinalis,i
201,S1025-55832011000200004,copaiba,o
201,S1025-55832011000200004,en,o
201,S1025-55832011000200004,pacientes,o
201,S1025-55832011000200004,con,o
201,S1025-55832011000200004,ulcera,i
201,S1025-55832011000200004,peptica,i
201,S1025-55832011000200004,Objetivos,o
201,S1025-55832011000200004,Determinar,i
201,S1025-55832011000200004,la,i
201,S1025-55832011000200004,eficacia,i
201,S1025-55832011000200004,cicatrizante,o
201,S1025-55832011000200004,del,o
201,S1025-55832011000200004,aceite,i
201,S1025-55832011000200004,de,i
201,S1025-55832011000200004,copaiba,i
201,S1025-55832011000200004,obtenido,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,la,o
201,S1025-55832011000200004,corteza,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,Copaifera,o
201,S1025-55832011000200004,officinalis,o
201,S1025-55832011000200004,comparado,o
201,S1025-55832011000200004,con,o
201,S1025-55832011000200004,omeprazol,i
201,S1025-55832011000200004,20,o
201,S1025-55832011000200004,mg,o
201,S1025-55832011000200004,en,o
201,S1025-55832011000200004,pacientes,o
201,S1025-55832011000200004,con,o
201,S1025-55832011000200004,diagnostico,i
201,S1025-55832011000200004,definitivo,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,ulcera,i
201,S1025-55832011000200004,peptica,i
201,S1025-55832011000200004,Diseño,o
201,S1025-55832011000200004,Estudio,o
201,S1025-55832011000200004,experimental,o
201,S1025-55832011000200004,clinico,o
201,S1025-55832011000200004,comparativo,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,fase,o
201,S1025-55832011000200004,II,o
201,S1025-55832011000200004,aleatorio,o
201,S1025-55832011000200004,doble,o
201,S1025-55832011000200004,ciego,o
201,S1025-55832011000200004,grupo,o
201,S1025-55832011000200004,paralelo,o
201,S1025-55832011000200004,Institucion,o
201,S1025-55832011000200004,Instituto,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,Investigaciones,o
201,S1025-55832011000200004,Clinicas,o
201,S1025-55832011000200004,Facultad,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,Medicina,o
201,S1025-55832011000200004,Universidad,o
201,S1025-55832011000200004,Nacional,o
201,S1025-55832011000200004,Mayor,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,San,o
201,S1025-55832011000200004,Marcos,o
201,S1025-55832011000200004,Lima,o
201,S1025-55832011000200004,Peru,o
201,S1025-55832011000200004,Participantes,o
201,S1025-55832011000200004,Pacientes,o
201,S1025-55832011000200004,con,o
201,S1025-55832011000200004,diagnostico,i
201,S1025-55832011000200004,definitivo,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,ulcera,i
201,S1025-55832011000200004,peptica,i
201,S1025-55832011000200004,Intervenciones,i
201,S1025-55832011000200004,El,o
201,S1025-55832011000200004,diagnostico,i
201,S1025-55832011000200004,fue,o
201,S1025-55832011000200004,tanto,o
201,S1025-55832011000200004,por,o
201,S1025-55832011000200004,exploracion,i
201,S1025-55832011000200004,fisica,i
201,S1025-55832011000200004,como,o
201,S1025-55832011000200004,complementaria,o
201,S1025-55832011000200004,siendo,o
201,S1025-55832011000200004,la,o
201,S1025-55832011000200004,endoscopia,i
201,S1025-55832011000200004,la,o
201,S1025-55832011000200004,tecnica,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,eleccion,o
201,S1025-55832011000200004,con,o
201,S1025-55832011000200004,evaluacion,i
201,S1025-55832011000200004,pre,o
201,S1025-55832011000200004,y,o
201,S1025-55832011000200004,postratamiento,o
201,S1025-55832011000200004,con,o
201,S1025-55832011000200004,aceite,i
201,S1025-55832011000200004,de,i
201,S1025-55832011000200004,copaiba,i
201,S1025-55832011000200004,formulada,o
201,S1025-55832011000200004,en,o
201,S1025-55832011000200004,capsulas,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,80,o
201,S1025-55832011000200004,mg,o
201,S1025-55832011000200004,y,o
201,S1025-55832011000200004,120,o
201,S1025-55832011000200004,mg,o
201,S1025-55832011000200004,El,o
201,S1025-55832011000200004,ensayo,i
201,S1025-55832011000200004,clinico,i
201,S1025-55832011000200004,incluyo,o
201,S1025-55832011000200004,60,o
201,S1025-55832011000200004,pacientes,o
201,S1025-55832011000200004,que,o
201,S1025-55832011000200004,voluntariamente,o
201,S1025-55832011000200004,ingresaron,i
201,S1025-55832011000200004,al,o
201,S1025-55832011000200004,programa,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,estudio,o
201,S1025-55832011000200004,previa,o
201,S1025-55832011000200004,firma,o
201,S1025-55832011000200004,del,o
201,S1025-55832011000200004,consentimiento,i
201,S1025-55832011000200004,informado,i
201,S1025-55832011000200004,aprobado,o
201,S1025-55832011000200004,por,o
201,S1025-55832011000200004,el,o
201,S1025-55832011000200004,Comite,o
201,S1025-55832011000200004,institucional,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,Etica,o
201,S1025-55832011000200004,en,o
201,S1025-55832011000200004,Investigacion,o
201,S1025-55832011000200004,Los,o
201,S1025-55832011000200004,pacientes,o
201,S1025-55832011000200004,fueron,o
201,S1025-55832011000200004,distribuidos,i
201,S1025-55832011000200004,aleatoriamente,i
201,S1025-55832011000200004,en,o
201,S1025-55832011000200004,tres,o
201,S1025-55832011000200004,grupos,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,20,o
201,S1025-55832011000200004,casos,o
201,S1025-55832011000200004,cada,o
201,S1025-55832011000200004,uno,o
201,S1025-55832011000200004,segun,o
201,S1025-55832011000200004,orden,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,llegada,o
201,S1025-55832011000200004,los,o
201,S1025-55832011000200004,dos,o
201,S1025-55832011000200004,primeros,o
201,S1025-55832011000200004,grupos,o
201,S1025-55832011000200004,recibieron,o
201,S1025-55832011000200004,capsulas,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,aceite,i
201,S1025-55832011000200004,de,i
201,S1025-55832011000200004,copaiba,i
201,S1025-55832011000200004,en,o
201,S1025-55832011000200004,dosis,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,80,o
201,S1025-55832011000200004,y,o
201,S1025-55832011000200004,120,o
201,S1025-55832011000200004,mg,o
201,S1025-55832011000200004,respectivamente,o
201,S1025-55832011000200004,y,o
201,S1025-55832011000200004,un,o
201,S1025-55832011000200004,tercer,o
201,S1025-55832011000200004,grupo,o
201,S1025-55832011000200004,recibio,o
201,S1025-55832011000200004,omeprazol,i
201,S1025-55832011000200004,20,o
201,S1025-55832011000200004,mg,o
201,S1025-55832011000200004,Los,o
201,S1025-55832011000200004,tratamientos,i
201,S1025-55832011000200004,fueron,o
201,S1025-55832011000200004,administrados,i
201,S1025-55832011000200004,en,i
201,S1025-55832011000200004,ayunas,i
201,S1025-55832011000200004,una,o
201,S1025-55832011000200004,vez,o
201,S1025-55832011000200004,por,o
201,S1025-55832011000200004,la,o
201,S1025-55832011000200004,mañana,o
201,S1025-55832011000200004,30,o
201,S1025-55832011000200004,minutos,o
201,S1025-55832011000200004,antes,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,la,o
201,S1025-55832011000200004,ingesta,o
201,S1025-55832011000200004,del,o
201,S1025-55832011000200004,primer,o
201,S1025-55832011000200004,alimento,o
201,S1025-55832011000200004,Los,o
201,S1025-55832011000200004,datos,o
201,S1025-55832011000200004,fueron,o
201,S1025-55832011000200004,evaluados,o
201,S1025-55832011000200004,mediante,o
201,S1025-55832011000200004,tecnicas,o
201,S1025-55832011000200004,multivariadas,o
201,S1025-55832011000200004,considerando,o
201,S1025-55832011000200004,estadisticamente,o
201,S1025-55832011000200004,significativo,o
201,S1025-55832011000200004,p005,o
201,S1025-55832011000200004,Se,o
201,S1025-55832011000200004,tuvo,o
201,S1025-55832011000200004,en,o
201,S1025-55832011000200004,cuenta,o
201,S1025-55832011000200004,el,o
201,S1025-55832011000200004,consentimiento,i
201,S1025-55832011000200004,informado,i
201,S1025-55832011000200004,aprobado,o
201,S1025-55832011000200004,por,o
201,S1025-55832011000200004,el,o
201,S1025-55832011000200004,Comite,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,Bioetica,o
201,S1025-55832011000200004,en,o
201,S1025-55832011000200004,Investigacion,o
201,S1025-55832011000200004,del,o
201,S1025-55832011000200004,Centro,o
201,S1025-55832011000200004,Asistencial,o
201,S1025-55832011000200004,Principales,o
201,S1025-55832011000200004,medidas,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,resultados,o
201,S1025-55832011000200004,Porcentaje,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,cicatrizacion,o
201,S1025-55832011000200004,Resultados,o
201,S1025-55832011000200004,Se,o
201,S1025-55832011000200004,logro,o
201,S1025-55832011000200004,65,o
201,S1025-55832011000200004,y,o
201,S1025-55832011000200004,75,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,cicatrizacion,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,la,o
201,S1025-55832011000200004,ulcera,i
201,S1025-55832011000200004,peptica,i
201,S1025-55832011000200004,con,o
201,S1025-55832011000200004,aceite,i
201,S1025-55832011000200004,de,i
201,S1025-55832011000200004,copaiba,i
201,S1025-55832011000200004,respectivamente,o
201,S1025-55832011000200004,contra,o
201,S1025-55832011000200004,100,o
201,S1025-55832011000200004,en,o
201,S1025-55832011000200004,el,o
201,S1025-55832011000200004,grupo,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,omeprazol,i
201,S1025-55832011000200004,sin,o
201,S1025-55832011000200004,efectos,i
201,S1025-55832011000200004,adversos,i
201,S1025-55832011000200004,significativos,o
201,S1025-55832011000200004,dos,o
201,S1025-55832011000200004,presentaron,o
201,S1025-55832011000200004,nauseas,i
201,S1025-55832011000200004,y,o
201,S1025-55832011000200004,tres,o
201,S1025-55832011000200004,epigastralgia,i
201,S1025-55832011000200004,Conclusiones,o
201,S1025-55832011000200004,Los,o
201,S1025-55832011000200004,pacientes,o
201,S1025-55832011000200004,con,o
201,S1025-55832011000200004,ulcera,i
201,S1025-55832011000200004,peptica,i
201,S1025-55832011000200004,y,o
201,S1025-55832011000200004,con,o
201,S1025-55832011000200004,tratamiento,i
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,las,o
201,S1025-55832011000200004,capsulas,o
201,S1025-55832011000200004,conteniendo,o
201,S1025-55832011000200004,aceite,i
201,S1025-55832011000200004,de,i
201,S1025-55832011000200004,copaiba,i
201,S1025-55832011000200004,mostraron,o
201,S1025-55832011000200004,cicatrizacion,o
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,la,o
201,S1025-55832011000200004,ulcera,i
201,S1025-55832011000200004,de,o
201,S1025-55832011000200004,65,o
201,S1025-55832011000200004,a,o
201,S1025-55832011000200004,75,o
201,S1025-55832011000200004,y,o
201,S1025-55832011000200004,sin,o
201,S1025-55832011000200004,efectos,i
201,S1025-55832011000200004,adversos,i
201,S1025-55832011000200004,significativos,o
202,S1130-01082004000800004,Retratamiento,i
202,S1130-01082004000800004,y,o
202,S1130-01082004000800004,tratamiento,i
202,S1130-01082004000800004,de,i
202,S1130-01082004000800004,mantenimiento,i
202,S1130-01082004000800004,con,o
202,S1130-01082004000800004,infliximab,i
202,S1130-01082004000800004,en,o
202,S1130-01082004000800004,la,o
202,S1130-01082004000800004,enfermedad,i
202,S1130-01082004000800004,de,i
202,S1130-01082004000800004,Crohn,i
202,S1130-01082004000800004,fistulizante,i
202,S1130-01082004000800004,Objetivos,o
202,S1130-01082004000800004,el,o
202,S1130-01082004000800004,infliximab,i
202,S1130-01082004000800004,ha,o
202,S1130-01082004000800004,demostrado,o
202,S1130-01082004000800004,su,o
202,S1130-01082004000800004,eficacia,o
202,S1130-01082004000800004,en,o
202,S1130-01082004000800004,el,o
202,S1130-01082004000800004,tratamiento,i
202,S1130-01082004000800004,a,o
202,S1130-01082004000800004,corto,o
202,S1130-01082004000800004,plazo,o
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,la,o
202,S1130-01082004000800004,enfermedad,o
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,Crohn,o
202,S1130-01082004000800004,EC,i
202,S1130-01082004000800004,fistulosa,i
202,S1130-01082004000800004,En,o
202,S1130-01082004000800004,este,o
202,S1130-01082004000800004,trabajo,o
202,S1130-01082004000800004,presentamos,o
202,S1130-01082004000800004,los,o
202,S1130-01082004000800004,resultados,o
202,S1130-01082004000800004,del,o
202,S1130-01082004000800004,retratamiento,i
202,S1130-01082004000800004,y,o
202,S1130-01082004000800004,del,o
202,S1130-01082004000800004,tratamiento,i
202,S1130-01082004000800004,de,i
202,S1130-01082004000800004,mantenimiento,i
202,S1130-01082004000800004,a,o
202,S1130-01082004000800004,largo,o
202,S1130-01082004000800004,plazo,o
202,S1130-01082004000800004,Pacientes,o
202,S1130-01082004000800004,y,o
202,S1130-01082004000800004,metodos,o
202,S1130-01082004000800004,se,o
202,S1130-01082004000800004,trataron,i
202,S1130-01082004000800004,con,o
202,S1130-01082004000800004,infliximab,i
202,S1130-01082004000800004,un,o
202,S1130-01082004000800004,total,o
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,81,o
202,S1130-01082004000800004,pacientes,o
202,S1130-01082004000800004,consecutivos,o
202,S1130-01082004000800004,con,o
202,S1130-01082004000800004,EC,i
202,S1130-01082004000800004,fistulosa,i
202,S1130-01082004000800004,activa,o
202,S1130-01082004000800004,en,o
202,S1130-01082004000800004,los,o
202,S1130-01082004000800004,cuales,o
202,S1130-01082004000800004,habian,o
202,S1130-01082004000800004,fallado,o
202,S1130-01082004000800004,tratamientos,i
202,S1130-01082004000800004,previos,o
202,S1130-01082004000800004,Todos,o
202,S1130-01082004000800004,los,o
202,S1130-01082004000800004,pacientes,o
202,S1130-01082004000800004,recibieron,o
202,S1130-01082004000800004,como,o
202,S1130-01082004000800004,tratamiento,i
202,S1130-01082004000800004,inicial,o
202,S1130-01082004000800004,infusiones,i
202,S1130-01082004000800004,a,o
202,S1130-01082004000800004,dosis,o
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,5,o
202,S1130-01082004000800004,mgkg,o
202,S1130-01082004000800004,iv,o
202,S1130-01082004000800004,en,o
202,S1130-01082004000800004,las,o
202,S1130-01082004000800004,semanas,o
202,S1130-01082004000800004,0,o
202,S1130-01082004000800004,2,o
202,S1130-01082004000800004,y,o
202,S1130-01082004000800004,6,o
202,S1130-01082004000800004,Aquellos,o
202,S1130-01082004000800004,pacientes,o
202,S1130-01082004000800004,que,o
202,S1130-01082004000800004,no,o
202,S1130-01082004000800004,respondieron,o
202,S1130-01082004000800004,despues,o
202,S1130-01082004000800004,del,o
202,S1130-01082004000800004,ciclo,o
202,S1130-01082004000800004,inicial,o
202,S1130-01082004000800004,grupo,o
202,S1130-01082004000800004,1,o
202,S1130-01082004000800004,n25,o
202,S1130-01082004000800004,o,o
202,S1130-01082004000800004,los,o
202,S1130-01082004000800004,que,o
202,S1130-01082004000800004,recayeron,o
202,S1130-01082004000800004,despues,o
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,haber,o
202,S1130-01082004000800004,respondido,o
202,S1130-01082004000800004,grupo,o
202,S1130-01082004000800004,2,o
202,S1130-01082004000800004,n13,o
202,S1130-01082004000800004,recibieron,o
202,S1130-01082004000800004,retratamiento,i
202,S1130-01082004000800004,con,o
202,S1130-01082004000800004,3,o
202,S1130-01082004000800004,dosis,o
202,S1130-01082004000800004,similares,o
202,S1130-01082004000800004,semanas,o
202,S1130-01082004000800004,0,o
202,S1130-01082004000800004,2,o
202,S1130-01082004000800004,y,o
202,S1130-01082004000800004,6,o
202,S1130-01082004000800004,Aquellos,o
202,S1130-01082004000800004,que,o
202,S1130-01082004000800004,respondieron,o
202,S1130-01082004000800004,a,o
202,S1130-01082004000800004,la,o
202,S1130-01082004000800004,terapia,i
202,S1130-01082004000800004,de,i
202,S1130-01082004000800004,retratamiento,i
202,S1130-01082004000800004,fueron,o
202,S1130-01082004000800004,incluidos,o
202,S1130-01082004000800004,en,o
202,S1130-01082004000800004,un,o
202,S1130-01082004000800004,programa,i
202,S1130-01082004000800004,de,i
202,S1130-01082004000800004,mantenimiento,i
202,S1130-01082004000800004,a,o
202,S1130-01082004000800004,largo,o
202,S1130-01082004000800004,plazo,o
202,S1130-01082004000800004,n44,o
202,S1130-01082004000800004,con,o
202,S1130-01082004000800004,dosis,o
202,S1130-01082004000800004,repetidas,o
202,S1130-01082004000800004,infusiones,i
202,S1130-01082004000800004,con,o
202,S1130-01082004000800004,5,o
202,S1130-01082004000800004,mgkg,o
202,S1130-01082004000800004,iv,o
202,S1130-01082004000800004,cada,o
202,S1130-01082004000800004,8,o
202,S1130-01082004000800004,semanas,o
202,S1130-01082004000800004,durante,o
202,S1130-01082004000800004,12,o
202,S1130-01082004000800004,años,o
202,S1130-01082004000800004,Resultados,o
202,S1130-01082004000800004,en,o
202,S1130-01082004000800004,el,o
202,S1130-01082004000800004,tratamiento,i
202,S1130-01082004000800004,inicial,o
202,S1130-01082004000800004,el,o
202,S1130-01082004000800004,56,o
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,los,o
202,S1130-01082004000800004,pacientes,o
202,S1130-01082004000800004,respondieron,o
202,S1130-01082004000800004,parcialmente,o
202,S1130-01082004000800004,siendo,o
202,S1130-01082004000800004,la,o
202,S1130-01082004000800004,respuesta,o
202,S1130-01082004000800004,completa,o
202,S1130-01082004000800004,del,o
202,S1130-01082004000800004,44,o
202,S1130-01082004000800004,En,o
202,S1130-01082004000800004,la,o
202,S1130-01082004000800004,modalidad,o
202,S1130-01082004000800004,del,o
202,S1130-01082004000800004,retratamiento,i
202,S1130-01082004000800004,el,o
202,S1130-01082004000800004,28,o
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,los,o
202,S1130-01082004000800004,pacientes,o
202,S1130-01082004000800004,del,o
202,S1130-01082004000800004,grupo,o
202,S1130-01082004000800004,1,o
202,S1130-01082004000800004,no,o
202,S1130-01082004000800004,respondedores,o
202,S1130-01082004000800004,presentaron,o
202,S1130-01082004000800004,respuesta,o
202,S1130-01082004000800004,completa,o
202,S1130-01082004000800004,frente,o
202,S1130-01082004000800004,al,o
202,S1130-01082004000800004,77,o
202,S1130-01082004000800004,del,o
202,S1130-01082004000800004,grupo,o
202,S1130-01082004000800004,2,o
202,S1130-01082004000800004,recidivantes,o
202,S1130-01082004000800004,p,o
202,S1130-01082004000800004,00001,o
202,S1130-01082004000800004,En,o
202,S1130-01082004000800004,el,o
202,S1130-01082004000800004,grupo,o
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,tratamiento,i
202,S1130-01082004000800004,de,i
202,S1130-01082004000800004,mantenimiento,i
202,S1130-01082004000800004,la,o
202,S1130-01082004000800004,respuesta,o
202,S1130-01082004000800004,global,o
202,S1130-01082004000800004,fue,o
202,S1130-01082004000800004,del,o
202,S1130-01082004000800004,88,o
202,S1130-01082004000800004,La,o
202,S1130-01082004000800004,media,o
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,dosis,o
202,S1130-01082004000800004,por,o
202,S1130-01082004000800004,paciente,o
202,S1130-01082004000800004,fue,o
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,44,o
202,S1130-01082004000800004,2,o
202,S1130-01082004000800004,rango,o
202,S1130-01082004000800004,19,o
202,S1130-01082004000800004,con,o
202,S1130-01082004000800004,una,o
202,S1130-01082004000800004,duracion,o
202,S1130-01082004000800004,media,o
202,S1130-01082004000800004,del,o
202,S1130-01082004000800004,tratamiento,i
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,36,o
202,S1130-01082004000800004,12,o
202,S1130-01082004000800004,semanas,o
202,S1130-01082004000800004,rango,o
202,S1130-01082004000800004,872,o
202,S1130-01082004000800004,Los,o
202,S1130-01082004000800004,efectos,i
202,S1130-01082004000800004,adversos,i
202,S1130-01082004000800004,no,o
202,S1130-01082004000800004,aumentaron,o
202,S1130-01082004000800004,significativamente,o
202,S1130-01082004000800004,en,o
202,S1130-01082004000800004,los,o
202,S1130-01082004000800004,grupos,o
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,retratamiento,i
202,S1130-01082004000800004,y,o
202,S1130-01082004000800004,mantenimiento,o
202,S1130-01082004000800004,comparados,o
202,S1130-01082004000800004,con,o
202,S1130-01082004000800004,el,o
202,S1130-01082004000800004,tratamiento,i
202,S1130-01082004000800004,inicial,o
202,S1130-01082004000800004,Conclusiones,o
202,S1130-01082004000800004,ambas,o
202,S1130-01082004000800004,modalidades,o
202,S1130-01082004000800004,de,o
202,S1130-01082004000800004,administracion,i
202,S1130-01082004000800004,del,o
202,S1130-01082004000800004,infliximab,i
202,S1130-01082004000800004,a,o
202,S1130-01082004000800004,saber,o
202,S1130-01082004000800004,el,o
202,S1130-01082004000800004,retratamiento,i
202,S1130-01082004000800004,y,o
202,S1130-01082004000800004,el,o
202,S1130-01082004000800004,tratamiento,i
202,S1130-01082004000800004,de,i
202,S1130-01082004000800004,mantenimiento,i
202,S1130-01082004000800004,a,o
202,S1130-01082004000800004,largo,o
202,S1130-01082004000800004,plazo,o
202,S1130-01082004000800004,son,o
202,S1130-01082004000800004,muy,o
202,S1130-01082004000800004,efectivas,o
202,S1130-01082004000800004,y,o
202,S1130-01082004000800004,bien,o
202,S1130-01082004000800004,toleradas,o
202,S1130-01082004000800004,en,o
202,S1130-01082004000800004,pacientes,o
202,S1130-01082004000800004,con,o
202,S1130-01082004000800004,enfermedad,i
202,S1130-01082004000800004,de,i
202,S1130-01082004000800004,Crohn,i
202,S1130-01082004000800004,fistulosa,i
203,S1130-01082004001200006,Esfinterotomia,i
203,S1130-01082004001200006,lateral,i
203,S1130-01082004001200006,interna,i
203,S1130-01082004001200006,abierta,o
203,S1130-01082004001200006,con,o
203,S1130-01082004001200006,anestesia,i
203,S1130-01082004001200006,local,i
203,S1130-01082004001200006,como,o
203,S1130-01082004001200006,gold,o
203,S1130-01082004001200006,standard,o
203,S1130-01082004001200006,en,o
203,S1130-01082004001200006,el,o
203,S1130-01082004001200006,tratamiento,i
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,fisura,i
203,S1130-01082004001200006,anal,i
203,S1130-01082004001200006,cronica,i
203,S1130-01082004001200006,Estudio,i
203,S1130-01082004001200006,prospectivo,i
203,S1130-01082004001200006,clinico,i
203,S1130-01082004001200006,y,i
203,S1130-01082004001200006,manometrico,i
203,S1130-01082004001200006,a,o
203,S1130-01082004001200006,largo,o
203,S1130-01082004001200006,plazo,o
203,S1130-01082004001200006,Introduccion,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,fisura,i
203,S1130-01082004001200006,anal,i
203,S1130-01082004001200006,cronica,i
203,S1130-01082004001200006,sigue,o
203,S1130-01082004001200006,siendo,o
203,S1130-01082004001200006,uno,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,los,o
203,S1130-01082004001200006,problemas,i
203,S1130-01082004001200006,proctologicos,i
203,S1130-01082004001200006,mas,o
203,S1130-01082004001200006,frecuentes,o
203,S1130-01082004001200006,e,o
203,S1130-01082004001200006,incapacitantes,o
203,S1130-01082004001200006,en,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,poblacion,o
203,S1130-01082004001200006,occidental,o
203,S1130-01082004001200006,actual,o
203,S1130-01082004001200006,La,o
203,S1130-01082004001200006,esfinterotomia,i
203,S1130-01082004001200006,lateral,i
203,S1130-01082004001200006,interna,i
203,S1130-01082004001200006,abierta,i
203,S1130-01082004001200006,es,o
203,S1130-01082004001200006,una,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,las,o
203,S1130-01082004001200006,opciones,o
203,S1130-01082004001200006,terapeuticas,o
203,S1130-01082004001200006,descritas,o
203,S1130-01082004001200006,y,o
203,S1130-01082004001200006,aceptadas,o
203,S1130-01082004001200006,como,o
203,S1130-01082004001200006,tratamiento,i
203,S1130-01082004001200006,de,i
203,S1130-01082004001200006,eleccion,i
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,fisura,i
203,S1130-01082004001200006,anal,i
203,S1130-01082004001200006,cronica,i
203,S1130-01082004001200006,ya,o
203,S1130-01082004001200006,que,o
203,S1130-01082004001200006,reduce,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,hipertonia,i
203,S1130-01082004001200006,esfinteriana,i
203,S1130-01082004001200006,mecanismo,o
203,S1130-01082004001200006,etiopatogenico,o
203,S1130-01082004001200006,fundamental,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,fisura,i
203,S1130-01082004001200006,permitiendo,o
203,S1130-01082004001200006,por,o
203,S1130-01082004001200006,tanto,o
203,S1130-01082004001200006,disminuir,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,proctalgia,i
203,S1130-01082004001200006,y,o
203,S1130-01082004001200006,asi,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,curacion,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,fisura,i
203,S1130-01082004001200006,Material,o
203,S1130-01082004001200006,y,o
203,S1130-01082004001200006,metodos,o
203,S1130-01082004001200006,realizamos,o
203,S1130-01082004001200006,un,o
203,S1130-01082004001200006,estudio,i
203,S1130-01082004001200006,prospectivo,i
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,120,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,intervenidos,i
203,S1130-01082004001200006,por,o
203,S1130-01082004001200006,fisura,i
203,S1130-01082004001200006,anal,i
203,S1130-01082004001200006,cronica,i
203,S1130-01082004001200006,con,o
203,S1130-01082004001200006,esfinterotomia,i
203,S1130-01082004001200006,lateral,i
203,S1130-01082004001200006,interna,i
203,S1130-01082004001200006,abierta,i
203,S1130-01082004001200006,con,o
203,S1130-01082004001200006,anestesia,i
203,S1130-01082004001200006,local,i
203,S1130-01082004001200006,20,o
203,S1130-01082004001200006,cc,o
203,S1130-01082004001200006,mepivacaina,i
203,S1130-01082004001200006,al,o
203,S1130-01082004001200006,2,o
203,S1130-01082004001200006,tratados,i
203,S1130-01082004001200006,ambulatoriamente,i
203,S1130-01082004001200006,en,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,consulta,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,Unidad,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,Proctologia,o
203,S1130-01082004001200006,entre,o
203,S1130-01082004001200006,los,o
203,S1130-01082004001200006,años,o
203,S1130-01082004001200006,19982001,o
203,S1130-01082004001200006,No,o
203,S1130-01082004001200006,se,o
203,S1130-01082004001200006,requirio,o
203,S1130-01082004001200006,estudios,i
203,S1130-01082004001200006,preoperatorios,i
203,S1130-01082004001200006,preparacion,i
203,S1130-01082004001200006,con,i
203,S1130-01082004001200006,enemas,i
203,S1130-01082004001200006,profilaxis,i
203,S1130-01082004001200006,antibiotica,i
203,S1130-01082004001200006,accesos,o
203,S1130-01082004001200006,venosos,i
203,S1130-01082004001200006,ingreso,i
203,S1130-01082004001200006,ni,o
203,S1130-01082004001200006,observacion,i
203,S1130-01082004001200006,hospitalaria,i
203,S1130-01082004001200006,Los,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,fueron,o
203,S1130-01082004001200006,revisados,i
203,S1130-01082004001200006,a,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,1ª,o
203,S1130-01082004001200006,semana,o
203,S1130-01082004001200006,2º,o
203,S1130-01082004001200006,mes,o
203,S1130-01082004001200006,6º,o
203,S1130-01082004001200006,mes,o
203,S1130-01082004001200006,y,o
203,S1130-01082004001200006,al,o
203,S1130-01082004001200006,año,o
203,S1130-01082004001200006,Resultados,o
203,S1130-01082004001200006,complicaciones,i
203,S1130-01082004001200006,precoces,i
203,S1130-01082004001200006,1ª,o
203,S1130-01082004001200006,semana,o
203,S1130-01082004001200006,3,o
203,S1130-01082004001200006,hematomaequimosis,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,herida,o
203,S1130-01082004001200006,25,o
203,S1130-01082004001200006,3,o
203,S1130-01082004001200006,hemorragias,i
203,S1130-01082004001200006,autolimitadas,o
203,S1130-01082004001200006,25,o
203,S1130-01082004001200006,No,o
203,S1130-01082004001200006,encontramos,o
203,S1130-01082004001200006,trombosis,i
203,S1130-01082004001200006,hemorroidales,i
203,S1130-01082004001200006,fistulas,i
203,S1130-01082004001200006,abscesos,i
203,S1130-01082004001200006,perianales,i
203,S1130-01082004001200006,ni,o
203,S1130-01082004001200006,mortalidad,o
203,S1130-01082004001200006,Complicaciones,i
203,S1130-01082004001200006,tardias,i
203,S1130-01082004001200006,2º,o
203,S1130-01082004001200006,mes,o
203,S1130-01082004001200006,9,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,con,o
203,S1130-01082004001200006,incontinencia,i
203,S1130-01082004001200006,75,o
203,S1130-01082004001200006,y,o
203,S1130-01082004001200006,3,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,25,o
203,S1130-01082004001200006,con,o
203,S1130-01082004001200006,recurrencia,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,fisura,i
203,S1130-01082004001200006,Al,o
203,S1130-01082004001200006,6º,o
203,S1130-01082004001200006,mes,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,incontinencia,i
203,S1130-01082004001200006,disminuyo,o
203,S1130-01082004001200006,al,o
203,S1130-01082004001200006,5,o
203,S1130-01082004001200006,6,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,y,o
203,S1130-01082004001200006,aparecieron,o
203,S1130-01082004001200006,3,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,mas,o
203,S1130-01082004001200006,con,o
203,S1130-01082004001200006,recurrencia,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,fisura,i
203,S1130-01082004001200006,25,o
203,S1130-01082004001200006,Al,o
203,S1130-01082004001200006,año,o
203,S1130-01082004001200006,se,o
203,S1130-01082004001200006,mantuvo,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,tasa,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,incontinencia,i
203,S1130-01082004001200006,del,o
203,S1130-01082004001200006,5,o
203,S1130-01082004001200006,a,o
203,S1130-01082004001200006,gases,o
203,S1130-01082004001200006,y,o
203,S1130-01082004001200006,liquidos,o
203,S1130-01082004001200006,y,o
203,S1130-01082004001200006,aparecieron,o
203,S1130-01082004001200006,otros,o
203,S1130-01082004001200006,3,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,con,o
203,S1130-01082004001200006,recurrencia,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,fisura,i
203,S1130-01082004001200006,25,o
203,S1130-01082004001200006,Recurrencia,o
203,S1130-01082004001200006,global,o
203,S1130-01082004001200006,del,o
203,S1130-01082004001200006,75,o
203,S1130-01082004001200006,Los,o
203,S1130-01082004001200006,hallazgos,o
203,S1130-01082004001200006,en,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,manometria,i
203,S1130-01082004001200006,fueron,o
203,S1130-01082004001200006,PMB,i
203,S1130-01082004001200006,presion,i
203,S1130-01082004001200006,maxima,i
203,S1130-01082004001200006,basal,i
203,S1130-01082004001200006,pretratamiento,o
203,S1130-01082004001200006,similar,o
203,S1130-01082004001200006,a,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,PMB,i
203,S1130-01082004001200006,en,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,con,o
203,S1130-01082004001200006,recurrencia,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,fisura,i
203,S1130-01082004001200006,asi,o
203,S1130-01082004001200006,como,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,PMB,i
203,S1130-01082004001200006,del,o
203,S1130-01082004001200006,grupo,o
203,S1130-01082004001200006,control,o
203,S1130-01082004001200006,similar,o
203,S1130-01082004001200006,a,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,PMB,i
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,con,o
203,S1130-01082004001200006,curacion,o
203,S1130-01082004001200006,La,o
203,S1130-01082004001200006,PMB,i
203,S1130-01082004001200006,en,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,incontinentes,i
203,S1130-01082004001200006,fue,o
203,S1130-01082004001200006,mas,o
203,S1130-01082004001200006,baja,o
203,S1130-01082004001200006,que,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,PMB,i
203,S1130-01082004001200006,en,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,continentes,o
203,S1130-01082004001200006,55,o
203,S1130-01082004001200006,7,o
203,S1130-01082004001200006,frente,o
203,S1130-01082004001200006,a,o
203,S1130-01082004001200006,807,o
203,S1130-01082004001200006,21,o
203,S1130-01082004001200006,La,o
203,S1130-01082004001200006,diferencia,o
203,S1130-01082004001200006,entre,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,PMCV,i
203,S1130-01082004001200006,presion,i
203,S1130-01082004001200006,maxima,i
203,S1130-01082004001200006,de,i
203,S1130-01082004001200006,contraccion,i
203,S1130-01082004001200006,voluntaria,i
203,S1130-01082004001200006,en,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,incontinentes,i
203,S1130-01082004001200006,y,o
203,S1130-01082004001200006,pacientes,o
203,S1130-01082004001200006,continentes,o
203,S1130-01082004001200006,no,o
203,S1130-01082004001200006,fue,o
203,S1130-01082004001200006,estadisticamente,o
203,S1130-01082004001200006,significativa,o
203,S1130-01082004001200006,Conclusiones,o
203,S1130-01082004001200006,la,o
203,S1130-01082004001200006,esfinterotomia,i
203,S1130-01082004001200006,lateral,i
203,S1130-01082004001200006,interna,i
203,S1130-01082004001200006,abierta,i
203,S1130-01082004001200006,con,o
203,S1130-01082004001200006,anestesia,i
203,S1130-01082004001200006,local,i
203,S1130-01082004001200006,tiene,o
203,S1130-01082004001200006,una,o
203,S1130-01082004001200006,tasa,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,curacion,o
203,S1130-01082004001200006,a,o
203,S1130-01082004001200006,largo,o
203,S1130-01082004001200006,plazo,o
203,S1130-01082004001200006,y,o
203,S1130-01082004001200006,unos,o
203,S1130-01082004001200006,indices,o
203,S1130-01082004001200006,de,o
203,S1130-01082004001200006,morbilidad,o
203,S1130-01082004001200006,equiparables,o
203,S1130-01082004001200006,a,o
203,S1130-01082004001200006,otras,o
203,S1130-01082004001200006,tecnicas,o
203,S1130-01082004001200006,por,o
203,S1130-01082004001200006,lo,o
203,S1130-01082004001200006,que,o
203,S1130-01082004001200006,puede,o
203,S1130-01082004001200006,ser,o
203,S1130-01082004001200006,considerada,o
203,S1130-01082004001200006,como,o
203,S1130-01082004001200006,un,o
203,S1130-01082004001200006,tratamiento,i
203,S1130-01082004001200006,adecuado,o
203,S1130-01082004001200006,y,o
203,S1130-01082004001200006,eficaz,o
203,S1130-01082004001200006,para,o
203,S1130-01082004001200006,esta,o
203,S1130-01082004001200006,patologia,i
204,S1130-01082005000500005,Cirugia,i
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,enfermedad,i
204,S1130-01082005000500005,por,i
204,S1130-01082005000500005,reflujo,i
204,S1130-01082005000500005,gastroesofagico,i
204,S1130-01082005000500005,estudio,i
204,S1130-01082005000500005,comparativo,i
204,S1130-01082005000500005,entre,o
204,S1130-01082005000500005,los,o
204,S1130-01082005000500005,abordajes,o
204,S1130-01082005000500005,abierto,o
204,S1130-01082005000500005,y,o
204,S1130-01082005000500005,laparoscopico,i
204,S1130-01082005000500005,Objetivo,o
204,S1130-01082005000500005,en,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,actualidad,o
204,S1130-01082005000500005,dada,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,efectividad,o
204,S1130-01082005000500005,demostrada,o
204,S1130-01082005000500005,del,o
204,S1130-01082005000500005,tratamiento,i
204,S1130-01082005000500005,medico,i
204,S1130-01082005000500005,junto,o
204,S1130-01082005000500005,con,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,eminente,o
204,S1130-01082005000500005,aceptacion,o
204,S1130-01082005000500005,del,o
204,S1130-01082005000500005,abordaje,o
204,S1130-01082005000500005,laparoscopico,i
204,S1130-01082005000500005,las,o
204,S1130-01082005000500005,indicaciones,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,cirugia,i
204,S1130-01082005000500005,en,o
204,S1130-01082005000500005,el,o
204,S1130-01082005000500005,tratamiento,i
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,enfermedad,i
204,S1130-01082005000500005,por,i
204,S1130-01082005000500005,reflujo,i
204,S1130-01082005000500005,gastroesofagico,i
204,S1130-01082005000500005,son,o
204,S1130-01082005000500005,causa,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,continua,o
204,S1130-01082005000500005,controversia,o
204,S1130-01082005000500005,Para,o
204,S1130-01082005000500005,participar,o
204,S1130-01082005000500005,en,o
204,S1130-01082005000500005,este,o
204,S1130-01082005000500005,debate,o
204,S1130-01082005000500005,nos,o
204,S1130-01082005000500005,planteamos,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,siguiente,o
204,S1130-01082005000500005,hipotesis,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,trabajo,o
204,S1130-01082005000500005,Los,o
204,S1130-01082005000500005,resultados,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,funduplicatura,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,360,o
204,S1130-01082005000500005,corta,o
204,S1130-01082005000500005,y,o
204,S1130-01082005000500005,holgada,o
204,S1130-01082005000500005,por,o
204,S1130-01082005000500005,via,o
204,S1130-01082005000500005,laparoscopica,o
204,S1130-01082005000500005,son,o
204,S1130-01082005000500005,superiores,o
204,S1130-01082005000500005,a,o
204,S1130-01082005000500005,los,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,via,o
204,S1130-01082005000500005,abierta,o
204,S1130-01082005000500005,Diseño,o
204,S1130-01082005000500005,clinico,o
204,S1130-01082005000500005,estudio,i
204,S1130-01082005000500005,clinico,i
204,S1130-01082005000500005,prospectivo,i
204,S1130-01082005000500005,no,i
204,S1130-01082005000500005,aleatorizado,i
204,S1130-01082005000500005,Pacientes,o
204,S1130-01082005000500005,el,o
204,S1130-01082005000500005,trabajo,o
204,S1130-01082005000500005,se,o
204,S1130-01082005000500005,desarrollo,o
204,S1130-01082005000500005,entre,o
204,S1130-01082005000500005,noviembre,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,1991,o
204,S1130-01082005000500005,y,o
204,S1130-01082005000500005,diciembre,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,1998,o
204,S1130-01082005000500005,mediante,o
204,S1130-01082005000500005,un,o
204,S1130-01082005000500005,ensayo,i
204,S1130-01082005000500005,clinico,i
204,S1130-01082005000500005,prospectivo,i
204,S1130-01082005000500005,no,i
204,S1130-01082005000500005,aleatorio,i
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,dos,o
204,S1130-01082005000500005,grupos,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,pacientes,o
204,S1130-01082005000500005,Grupo,o
204,S1130-01082005000500005,I,o
204,S1130-01082005000500005,n,o
204,S1130-01082005000500005,75,o
204,S1130-01082005000500005,funduplicatura,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,360,o
204,S1130-01082005000500005,corta,o
204,S1130-01082005000500005,y,o
204,S1130-01082005000500005,holgada,o
204,S1130-01082005000500005,por,o
204,S1130-01082005000500005,laparoscopia,o
204,S1130-01082005000500005,en,o
204,S1130-01082005000500005,el,o
204,S1130-01082005000500005,Hospital,o
204,S1130-01082005000500005,Universitario,o
204,S1130-01082005000500005,Dr,o
204,S1130-01082005000500005,Peset,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,Valencia,o
204,S1130-01082005000500005,Grupo,o
204,S1130-01082005000500005,II,o
204,S1130-01082005000500005,n,o
204,S1130-01082005000500005,28,o
204,S1130-01082005000500005,funduplicatura,o
204,S1130-01082005000500005,360,o
204,S1130-01082005000500005,corta,o
204,S1130-01082005000500005,y,o
204,S1130-01082005000500005,holgada,o
204,S1130-01082005000500005,por,o
204,S1130-01082005000500005,via,o
204,S1130-01082005000500005,abierta,o
204,S1130-01082005000500005,en,o
204,S1130-01082005000500005,el,o
204,S1130-01082005000500005,Hospital,o
204,S1130-01082005000500005,General,o
204,S1130-01082005000500005,Universitario,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,Valencia,o
204,S1130-01082005000500005,Comparamos,o
204,S1130-01082005000500005,sin,o
204,S1130-01082005000500005,hallar,o
204,S1130-01082005000500005,diferencias,o
204,S1130-01082005000500005,los,o
204,S1130-01082005000500005,parametros,o
204,S1130-01082005000500005,preoperatorios,o
204,S1130-01082005000500005,lo,o
204,S1130-01082005000500005,que,o
204,S1130-01082005000500005,nos,o
204,S1130-01082005000500005,permite,o
204,S1130-01082005000500005,conocer,o
204,S1130-01082005000500005,que,o
204,S1130-01082005000500005,los,o
204,S1130-01082005000500005,dos,o
204,S1130-01082005000500005,grupos,o
204,S1130-01082005000500005,son,o
204,S1130-01082005000500005,homologables,o
204,S1130-01082005000500005,Resultados,o
204,S1130-01082005000500005,el,o
204,S1130-01082005000500005,analisis,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,los,o
204,S1130-01082005000500005,resultados,o
204,S1130-01082005000500005,peroperatorios,o
204,S1130-01082005000500005,morbilidad,o
204,S1130-01082005000500005,y,o
204,S1130-01082005000500005,tiempo,o
204,S1130-01082005000500005,quirurgico,o
204,S1130-01082005000500005,y,o
204,S1130-01082005000500005,del,o
204,S1130-01082005000500005,seguimiento,i
204,S1130-01082005000500005,clinico,i
204,S1130-01082005000500005,a,o
204,S1130-01082005000500005,los,o
204,S1130-01082005000500005,tres,o
204,S1130-01082005000500005,meses,o
204,S1130-01082005000500005,y,o
204,S1130-01082005000500005,posteriormente,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,forma,o
204,S1130-01082005000500005,anual,o
204,S1130-01082005000500005,e,o
204,S1130-01082005000500005,instrumental,o
204,S1130-01082005000500005,TEGD,i
204,S1130-01082005000500005,endoscopia,i
204,S1130-01082005000500005,digestiva,i
204,S1130-01082005000500005,alta,o
204,S1130-01082005000500005,pHmetria,i
204,S1130-01082005000500005,y,o
204,S1130-01082005000500005,manometria,i
204,S1130-01082005000500005,no,o
204,S1130-01082005000500005,demuestran,o
204,S1130-01082005000500005,diferencias,o
204,S1130-01082005000500005,mientras,o
204,S1130-01082005000500005,que,o
204,S1130-01082005000500005,en,o
204,S1130-01082005000500005,el,o
204,S1130-01082005000500005,postoperatorio,o
204,S1130-01082005000500005,inmediato,o
204,S1130-01082005000500005,existen,o
204,S1130-01082005000500005,diferencias,o
204,S1130-01082005000500005,estadisticamente,o
204,S1130-01082005000500005,significativas,o
204,S1130-01082005000500005,es,o
204,S1130-01082005000500005,en,o
204,S1130-01082005000500005,lo,o
204,S1130-01082005000500005,referente,o
204,S1130-01082005000500005,a,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,recuperacion,o
204,S1130-01082005000500005,dolor,i
204,S1130-01082005000500005,tolerancia,o
204,S1130-01082005000500005,estancia,o
204,S1130-01082005000500005,y,o
204,S1130-01082005000500005,reincorporacion,o
204,S1130-01082005000500005,a,o
204,S1130-01082005000500005,las,o
204,S1130-01082005000500005,actividades,o
204,S1130-01082005000500005,previas,o
204,S1130-01082005000500005,Conclusiones,o
204,S1130-01082005000500005,los,o
204,S1130-01082005000500005,resultados,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,funduplicatura,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,360,o
204,S1130-01082005000500005,corta,o
204,S1130-01082005000500005,y,o
204,S1130-01082005000500005,holgada,o
204,S1130-01082005000500005,por,o
204,S1130-01082005000500005,via,o
204,S1130-01082005000500005,laparoscopica,o
204,S1130-01082005000500005,son,o
204,S1130-01082005000500005,similares,o
204,S1130-01082005000500005,a,o
204,S1130-01082005000500005,los,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,via,o
204,S1130-01082005000500005,abierta,o
204,S1130-01082005000500005,beneficiandose,o
204,S1130-01082005000500005,la,o
204,S1130-01082005000500005,primera,o
204,S1130-01082005000500005,de,o
204,S1130-01082005000500005,una,o
204,S1130-01082005000500005,mejor,o
204,S1130-01082005000500005,tolerancia,o
204,S1130-01082005000500005,postoperatoria,o
205,S1130-01082006000300003,Eficacia,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,lansoprazol,i
205,S1130-01082006000300003,a,o
205,S1130-01082006000300003,dosis,o
205,S1130-01082006000300003,bajas,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,el,o
205,S1130-01082006000300003,tratamiento,i
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,enfermedad,i
205,S1130-01082006000300003,por,i
205,S1130-01082006000300003,reflujo,i
205,S1130-01082006000300003,gastroesofagico,i
205,S1130-01082006000300003,no,o
205,S1130-01082006000300003,erosiva,o
205,S1130-01082006000300003,Influencia,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,infeccion,i
205,S1130-01082006000300003,por,i
205,S1130-01082006000300003,Helicobacter,i
205,S1130-01082006000300003,pylori,i
205,S1130-01082006000300003,Introduccion,o
205,S1130-01082006000300003,los,o
205,S1130-01082006000300003,inhibidores,i
205,S1130-01082006000300003,de,i
205,S1130-01082006000300003,la,i
205,S1130-01082006000300003,bomba,i
205,S1130-01082006000300003,de,i
205,S1130-01082006000300003,protones,i
205,S1130-01082006000300003,IBP,i
205,S1130-01082006000300003,son,o
205,S1130-01082006000300003,los,o
205,S1130-01082006000300003,farmacos,i
205,S1130-01082006000300003,mas,o
205,S1130-01082006000300003,eficaces,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,curacion,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,esofagitis,i
205,S1130-01082006000300003,peptica,i
205,S1130-01082006000300003,y,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,el,o
205,S1130-01082006000300003,control,i
205,S1130-01082006000300003,de,i
205,S1130-01082006000300003,los,i
205,S1130-01082006000300003,sintomas,i
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,enfermedad,i
205,S1130-01082006000300003,por,i
205,S1130-01082006000300003,reflujo,i
205,S1130-01082006000300003,gastroesofagico,i
205,S1130-01082006000300003,ERGE,i
205,S1130-01082006000300003,En,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,mayoria,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,los,o
205,S1130-01082006000300003,pacientes,o
205,S1130-01082006000300003,con,o
205,S1130-01082006000300003,ERGE,i
205,S1130-01082006000300003,no,o
205,S1130-01082006000300003,se,o
205,S1130-01082006000300003,detecta,o
205,S1130-01082006000300003,esofagitis,i
205,S1130-01082006000300003,al,o
205,S1130-01082006000300003,practicarse,o
205,S1130-01082006000300003,endoscopia,i
205,S1130-01082006000300003,presentando,o
205,S1130-01082006000300003,una,o
205,S1130-01082006000300003,ERGE,i
205,S1130-01082006000300003,con,o
205,S1130-01082006000300003,endoscopia,i
205,S1130-01082006000300003,negativa,o
205,S1130-01082006000300003,o,o
205,S1130-01082006000300003,no,o
205,S1130-01082006000300003,erosiva,o
205,S1130-01082006000300003,ERNE,i
205,S1130-01082006000300003,La,o
205,S1130-01082006000300003,influencia,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,infeccion,o
205,S1130-01082006000300003,H,o
205,S1130-01082006000300003,pylori,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,evolucion,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,ERGE,i
205,S1130-01082006000300003,es,o
205,S1130-01082006000300003,controvertida,o
205,S1130-01082006000300003,ya,o
205,S1130-01082006000300003,que,o
205,S1130-01082006000300003,mientras,o
205,S1130-01082006000300003,que,o
205,S1130-01082006000300003,unos,o
205,S1130-01082006000300003,estudios,o
205,S1130-01082006000300003,le,o
205,S1130-01082006000300003,asignan,o
205,S1130-01082006000300003,una,o
205,S1130-01082006000300003,accion,o
205,S1130-01082006000300003,protectora,o
205,S1130-01082006000300003,otros,o
205,S1130-01082006000300003,se,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,niegan,o
205,S1130-01082006000300003,Hemos,o
205,S1130-01082006000300003,realizado,o
205,S1130-01082006000300003,un,o
205,S1130-01082006000300003,ensayo,i
205,S1130-01082006000300003,clinico,i
205,S1130-01082006000300003,para,o
205,S1130-01082006000300003,valorar,i
205,S1130-01082006000300003,la,i
205,S1130-01082006000300003,eficacia,i
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,lansoprazol,i
205,S1130-01082006000300003,15,o
205,S1130-01082006000300003,mgdia,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,el,o
205,S1130-01082006000300003,control,i
205,S1130-01082006000300003,inicial,i
205,S1130-01082006000300003,de,i
205,S1130-01082006000300003,los,i
205,S1130-01082006000300003,sintomas,i
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,ERNE,i
205,S1130-01082006000300003,y,o
205,S1130-01082006000300003,como,o
205,S1130-01082006000300003,objetivo,o
205,S1130-01082006000300003,secundario,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,influencia,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,infeccion,o
205,S1130-01082006000300003,H,o
205,S1130-01082006000300003,pylori,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,respuesta,o
205,S1130-01082006000300003,al,o
205,S1130-01082006000300003,tratamiento,i
205,S1130-01082006000300003,Pacientes,o
205,S1130-01082006000300003,y,o
205,S1130-01082006000300003,metodos,o
205,S1130-01082006000300003,se,o
205,S1130-01082006000300003,realiza,o
205,S1130-01082006000300003,un,o
205,S1130-01082006000300003,ensayo,i
205,S1130-01082006000300003,clinico,i
205,S1130-01082006000300003,piloto,o
205,S1130-01082006000300003,unicentrico,o
205,S1130-01082006000300003,simple,o
205,S1130-01082006000300003,ciego,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,cuanto,o
205,S1130-01082006000300003,a,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,medicacion,i
205,S1130-01082006000300003,experimental,i
205,S1130-01082006000300003,no,o
205,S1130-01082006000300003,conocida,o
205,S1130-01082006000300003,por,o
205,S1130-01082006000300003,los,o
205,S1130-01082006000300003,pacientes,o
205,S1130-01082006000300003,y,o
205,S1130-01082006000300003,doble,o
205,S1130-01082006000300003,ciego,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,cuanto,o
205,S1130-01082006000300003,a,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,informacion,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,infeccion,o
205,S1130-01082006000300003,por,o
205,S1130-01082006000300003,H,o
205,S1130-01082006000300003,pylori,o
205,S1130-01082006000300003,Se,o
205,S1130-01082006000300003,incluyeron,o
205,S1130-01082006000300003,inicialmente,o
205,S1130-01082006000300003,60,o
205,S1130-01082006000300003,pacientes,o
205,S1130-01082006000300003,con,o
205,S1130-01082006000300003,ERNE,i
205,S1130-01082006000300003,que,o
205,S1130-01082006000300003,presentaban,o
205,S1130-01082006000300003,al,o
205,S1130-01082006000300003,menos,o
205,S1130-01082006000300003,dos,o
205,S1130-01082006000300003,dias,o
205,S1130-01082006000300003,con,o
205,S1130-01082006000300003,pirosis,i
205,S1130-01082006000300003,diurna,o
205,S1130-01082006000300003,o,o
205,S1130-01082006000300003,nocturna,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,cada,o
205,S1130-01082006000300003,una,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,las,o
205,S1130-01082006000300003,dos,o
205,S1130-01082006000300003,ultimas,o
205,S1130-01082006000300003,semanas,o
205,S1130-01082006000300003,Se,o
205,S1130-01082006000300003,excluyeron,o
205,S1130-01082006000300003,9,o
205,S1130-01082006000300003,pacientes,o
205,S1130-01082006000300003,por,o
205,S1130-01082006000300003,incumplimiento,o
205,S1130-01082006000300003,del,o
205,S1130-01082006000300003,protocolo,i
205,S1130-01082006000300003,del,o
205,S1130-01082006000300003,estudio,o
205,S1130-01082006000300003,Los,o
205,S1130-01082006000300003,51,o
205,S1130-01082006000300003,pacientes,o
205,S1130-01082006000300003,restantes,o
205,S1130-01082006000300003,35,o
205,S1130-01082006000300003,mujeres,o
205,S1130-01082006000300003,y,o
205,S1130-01082006000300003,16,o
205,S1130-01082006000300003,hombres,o
205,S1130-01082006000300003,con,o
205,S1130-01082006000300003,edad,o
205,S1130-01082006000300003,media,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,49,o
205,S1130-01082006000300003,años,o
205,S1130-01082006000300003,constituyeron,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,poblacion,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,analisis,o
205,S1130-01082006000300003,por,o
205,S1130-01082006000300003,protocolo,i
205,S1130-01082006000300003,Los,o
205,S1130-01082006000300003,pacientes,o
205,S1130-01082006000300003,recibieron,o
205,S1130-01082006000300003,tratamiento,i
205,S1130-01082006000300003,durante,o
205,S1130-01082006000300003,dos,o
205,S1130-01082006000300003,semanas,o
205,S1130-01082006000300003,con,o
205,S1130-01082006000300003,una,o
205,S1130-01082006000300003,capsula,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,medicacion,i
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,estudio,o
205,S1130-01082006000300003,15,o
205,S1130-01082006000300003,mgdia,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,lansoprazol,i
205,S1130-01082006000300003,realizandose,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,este,o
205,S1130-01082006000300003,tiempo,o
205,S1130-01082006000300003,un,o
205,S1130-01082006000300003,seguimiento,i
205,S1130-01082006000300003,diario,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,presencia,o
205,S1130-01082006000300003,e,o
205,S1130-01082006000300003,intensidad,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,pirosis,i
205,S1130-01082006000300003,diurna,o
205,S1130-01082006000300003,y,o
205,S1130-01082006000300003,nocturna,o
205,S1130-01082006000300003,Se,o
205,S1130-01082006000300003,considero,o
205,S1130-01082006000300003,que,o
205,S1130-01082006000300003,el,o
205,S1130-01082006000300003,tratamiento,i
205,S1130-01082006000300003,era,o
205,S1130-01082006000300003,eficaz,o
205,S1130-01082006000300003,cuando,o
205,S1130-01082006000300003,a,o
205,S1130-01082006000300003,su,o
205,S1130-01082006000300003,finalizacion,o
205,S1130-01082006000300003,los,o
205,S1130-01082006000300003,pacientes,o
205,S1130-01082006000300003,referian,o
205,S1130-01082006000300003,haber,o
205,S1130-01082006000300003,presentado,o
205,S1130-01082006000300003,como,o
205,S1130-01082006000300003,maximo,o
205,S1130-01082006000300003,un,o
205,S1130-01082006000300003,episodio,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,pirosis,i
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,intensidad,o
205,S1130-01082006000300003,leve,o
205,S1130-01082006000300003,segun,o
205,S1130-01082006000300003,definicion,o
205,S1130-01082006000300003,del,o
205,S1130-01082006000300003,protocolo,i
205,S1130-01082006000300003,o,o
205,S1130-01082006000300003,bien,o
205,S1130-01082006000300003,respondian,o
205,S1130-01082006000300003,afirmativamente,o
205,S1130-01082006000300003,a,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,siguiente,o
205,S1130-01082006000300003,pregunta,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,medicacion,i
205,S1130-01082006000300003,que,o
205,S1130-01082006000300003,recibe,o
205,S1130-01082006000300003,le,o
205,S1130-01082006000300003,controla,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,forma,o
205,S1130-01082006000300003,satisfactoria,o
205,S1130-01082006000300003,los,o
205,S1130-01082006000300003,sintomas,i
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,su,o
205,S1130-01082006000300003,enfermedad,i
205,S1130-01082006000300003,Durante,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,endoscopia,i
205,S1130-01082006000300003,diagnostica,i
205,S1130-01082006000300003,se,o
205,S1130-01082006000300003,obtuvieron,o
205,S1130-01082006000300003,biopsias,i
205,S1130-01082006000300003,de,i
205,S1130-01082006000300003,cuerpo,i
205,S1130-01082006000300003,y,i
205,S1130-01082006000300003,antro,i
205,S1130-01082006000300003,gastrico,i
205,S1130-01082006000300003,para,o
205,S1130-01082006000300003,investigar,o
205,S1130-01082006000300003,mediante,o
205,S1130-01082006000300003,test,i
205,S1130-01082006000300003,de,i
205,S1130-01082006000300003,la,i
205,S1130-01082006000300003,ureasa,i
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,infeccion,o
205,S1130-01082006000300003,por,o
205,S1130-01082006000300003,H,o
205,S1130-01082006000300003,pylori,o
205,S1130-01082006000300003,Se,o
205,S1130-01082006000300003,valoro,i
205,S1130-01082006000300003,la,i
205,S1130-01082006000300003,eficacia,i
205,S1130-01082006000300003,del,i
205,S1130-01082006000300003,tratamiento,i
205,S1130-01082006000300003,sin,o
205,S1130-01082006000300003,conocerse,o
205,S1130-01082006000300003,por,o
205,S1130-01082006000300003,los,o
205,S1130-01082006000300003,pacientes,o
205,S1130-01082006000300003,y,o
205,S1130-01082006000300003,medicos,o
205,S1130-01082006000300003,responsables,o
205,S1130-01082006000300003,del,o
205,S1130-01082006000300003,estudio,o
205,S1130-01082006000300003,los,o
205,S1130-01082006000300003,resultados,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,los,o
205,S1130-01082006000300003,test,i
205,S1130-01082006000300003,de,i
205,S1130-01082006000300003,ureasa,i
205,S1130-01082006000300003,Resultados,o
205,S1130-01082006000300003,cuarenta,o
205,S1130-01082006000300003,y,o
205,S1130-01082006000300003,un,o
205,S1130-01082006000300003,pacientes,o
205,S1130-01082006000300003,803,o
205,S1130-01082006000300003,referian,o
205,S1130-01082006000300003,que,o
205,S1130-01082006000300003,el,o
205,S1130-01082006000300003,tratamiento,i
205,S1130-01082006000300003,les,o
205,S1130-01082006000300003,controlaba,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,forma,o
205,S1130-01082006000300003,satisfactoria,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,sintomatologia,i
205,S1130-01082006000300003,y,o
205,S1130-01082006000300003,34,o
205,S1130-01082006000300003,pacientes,o
205,S1130-01082006000300003,666,o
205,S1130-01082006000300003,habian,o
205,S1130-01082006000300003,presentado,o
205,S1130-01082006000300003,como,o
205,S1130-01082006000300003,maximo,o
205,S1130-01082006000300003,un,o
205,S1130-01082006000300003,episodio,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,pirosis,i
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,intensidad,o
205,S1130-01082006000300003,leve,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,ultima,o
205,S1130-01082006000300003,semana,o
205,S1130-01082006000300003,Cuarenta,o
205,S1130-01082006000300003,y,o
205,S1130-01082006000300003,dos,o
205,S1130-01082006000300003,pacientes,o
205,S1130-01082006000300003,823,o
205,S1130-01082006000300003,presentaban,o
205,S1130-01082006000300003,infeccion,o
205,S1130-01082006000300003,por,o
205,S1130-01082006000300003,H,o
205,S1130-01082006000300003,pylori,o
205,S1130-01082006000300003,No,o
205,S1130-01082006000300003,se,o
205,S1130-01082006000300003,observaron,o
205,S1130-01082006000300003,diferencias,o
205,S1130-01082006000300003,significativas,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,respuesta,o
205,S1130-01082006000300003,al,o
205,S1130-01082006000300003,tratamiento,i
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,los,o
205,S1130-01082006000300003,pacientes,o
205,S1130-01082006000300003,con,o
205,S1130-01082006000300003,o,o
205,S1130-01082006000300003,sin,o
205,S1130-01082006000300003,infeccion,o
205,S1130-01082006000300003,por,o
205,S1130-01082006000300003,H,o
205,S1130-01082006000300003,pylori,o
205,S1130-01082006000300003,Conclusiones,o
205,S1130-01082006000300003,con,o
205,S1130-01082006000300003,las,o
205,S1130-01082006000300003,limitaciones,o
205,S1130-01082006000300003,propias,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,un,o
205,S1130-01082006000300003,estudio,i
205,S1130-01082006000300003,piloto,i
205,S1130-01082006000300003,estos,o
205,S1130-01082006000300003,resultados,o
205,S1130-01082006000300003,orientan,o
205,S1130-01082006000300003,a,o
205,S1130-01082006000300003,que,o
205,S1130-01082006000300003,lansoprazol,i
205,S1130-01082006000300003,15,o
205,S1130-01082006000300003,mgdia,o
205,S1130-01082006000300003,es,o
205,S1130-01082006000300003,un,o
205,S1130-01082006000300003,tratamiento,i
205,S1130-01082006000300003,eficaz,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,el,o
205,S1130-01082006000300003,control,i
205,S1130-01082006000300003,de,i
205,S1130-01082006000300003,la,i
205,S1130-01082006000300003,sintomatologia,i
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,ERNE,i
205,S1130-01082006000300003,pudiendo,o
205,S1130-01082006000300003,ser,o
205,S1130-01082006000300003,una,o
205,S1130-01082006000300003,buena,o
205,S1130-01082006000300003,estrategia,i
205,S1130-01082006000300003,terapeutica,i
205,S1130-01082006000300003,inicial,o
205,S1130-01082006000300003,y,o
205,S1130-01082006000300003,que,o
205,S1130-01082006000300003,con,o
205,S1130-01082006000300003,los,o
205,S1130-01082006000300003,datos,o
205,S1130-01082006000300003,disponibles,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,infeccion,o
205,S1130-01082006000300003,por,o
205,S1130-01082006000300003,H,o
205,S1130-01082006000300003,pylori,o
205,S1130-01082006000300003,no,o
205,S1130-01082006000300003,influye,o
205,S1130-01082006000300003,de,o
205,S1130-01082006000300003,forma,o
205,S1130-01082006000300003,significativa,o
205,S1130-01082006000300003,en,o
205,S1130-01082006000300003,la,o
205,S1130-01082006000300003,respuesta,o
205,S1130-01082006000300003,al,o
205,S1130-01082006000300003,tratamiento,i
206,S1130-01082006000600002,Epidemiologia,o
206,S1130-01082006000600002,actual,o
206,S1130-01082006000600002,y,o
206,S1130-01082006000600002,accesibilidad,o
206,S1130-01082006000600002,al,o
206,S1130-01082006000600002,seguimiento,i
206,S1130-01082006000600002,de,i
206,S1130-01082006000600002,la,i
206,S1130-01082006000600002,dieta,i
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,la,o
206,S1130-01082006000600002,enfermedad,i
206,S1130-01082006000600002,celiaca,i
206,S1130-01082006000600002,del,o
206,S1130-01082006000600002,adulto,o
206,S1130-01082006000600002,Introduccion,o
206,S1130-01082006000600002,la,o
206,S1130-01082006000600002,generalizacion,o
206,S1130-01082006000600002,del,o
206,S1130-01082006000600002,diagnostico,i
206,S1130-01082006000600002,serologico,i
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,la,o
206,S1130-01082006000600002,enfermedad,i
206,S1130-01082006000600002,celiaca,i
206,S1130-01082006000600002,ha,o
206,S1130-01082006000600002,producido,o
206,S1130-01082006000600002,un,o
206,S1130-01082006000600002,cambio,o
206,S1130-01082006000600002,epidemiologico,o
206,S1130-01082006000600002,Se,o
206,S1130-01082006000600002,dispone,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,poca,o
206,S1130-01082006000600002,informacion,o
206,S1130-01082006000600002,actualizada,o
206,S1130-01082006000600002,sobre,o
206,S1130-01082006000600002,aspectos,o
206,S1130-01082006000600002,epidemiologicos,o
206,S1130-01082006000600002,importantes,o
206,S1130-01082006000600002,relativos,o
206,S1130-01082006000600002,al,o
206,S1130-01082006000600002,diagnostico,i
206,S1130-01082006000600002,informacion,o
206,S1130-01082006000600002,y,o
206,S1130-01082006000600002,tratamiento,i
206,S1130-01082006000600002,Objetivo,o
206,S1130-01082006000600002,analizar,o
206,S1130-01082006000600002,las,o
206,S1130-01082006000600002,formas,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,presentacion,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,la,o
206,S1130-01082006000600002,celiaquia,i
206,S1130-01082006000600002,dificultades,o
206,S1130-01082006000600002,en,o
206,S1130-01082006000600002,el,o
206,S1130-01082006000600002,diagnostico,i
206,S1130-01082006000600002,seguimiento,i
206,S1130-01082006000600002,fuentes,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,informacion,o
206,S1130-01082006000600002,y,o
206,S1130-01082006000600002,aspectos,o
206,S1130-01082006000600002,relativos,o
206,S1130-01082006000600002,al,o
206,S1130-01082006000600002,tratamiento,i
206,S1130-01082006000600002,Metodo,o
206,S1130-01082006000600002,estudio,i
206,S1130-01082006000600002,observacional,i
206,S1130-01082006000600002,transversal,i
206,S1130-01082006000600002,mediante,o
206,S1130-01082006000600002,un,o
206,S1130-01082006000600002,cuestionario,i
206,S1130-01082006000600002,autorrellenable,o
206,S1130-01082006000600002,Resultados,o
206,S1130-01082006000600002,se,o
206,S1130-01082006000600002,han,o
206,S1130-01082006000600002,incluido,o
206,S1130-01082006000600002,73,o
206,S1130-01082006000600002,pacientes,o
206,S1130-01082006000600002,adultos,o
206,S1130-01082006000600002,El,o
206,S1130-01082006000600002,150,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,casos,o
206,S1130-01082006000600002,se,o
206,S1130-01082006000600002,diagnosticaron,i
206,S1130-01082006000600002,a,o
206,S1130-01082006000600002,partir,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,los,o
206,S1130-01082006000600002,60,o
206,S1130-01082006000600002,años,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,edad,o
206,S1130-01082006000600002,La,o
206,S1130-01082006000600002,mayoria,o
206,S1130-01082006000600002,son,o
206,S1130-01082006000600002,no,o
206,S1130-01082006000600002,fumadores,i
206,S1130-01082006000600002,918,o
206,S1130-01082006000600002,La,o
206,S1130-01082006000600002,tasa,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,familiares,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,primer,o
206,S1130-01082006000600002,grado,o
206,S1130-01082006000600002,con,o
206,S1130-01082006000600002,celiaquia,i
206,S1130-01082006000600002,es,o
206,S1130-01082006000600002,del,o
206,S1130-01082006000600002,109,o
206,S1130-01082006000600002,La,o
206,S1130-01082006000600002,enfermedad,i
206,S1130-01082006000600002,se,o
206,S1130-01082006000600002,presento,o
206,S1130-01082006000600002,en,o
206,S1130-01082006000600002,su,o
206,S1130-01082006000600002,forma,o
206,S1130-01082006000600002,clasica,o
206,S1130-01082006000600002,en,o
206,S1130-01082006000600002,solo,o
206,S1130-01082006000600002,el,o
206,S1130-01082006000600002,547,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,casos,o
206,S1130-01082006000600002,En,o
206,S1130-01082006000600002,el,o
206,S1130-01082006000600002,424,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,pacientes,o
206,S1130-01082006000600002,la,o
206,S1130-01082006000600002,sospecha,o
206,S1130-01082006000600002,diagnostica,o
206,S1130-01082006000600002,inicial,o
206,S1130-01082006000600002,fue,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,trastorno,i
206,S1130-01082006000600002,funcional,i
206,S1130-01082006000600002,digestivo,i
206,S1130-01082006000600002,El,o
206,S1130-01082006000600002,seguimiento,i
206,S1130-01082006000600002,de,i
206,S1130-01082006000600002,la,i
206,S1130-01082006000600002,dieta,i
206,S1130-01082006000600002,es,o
206,S1130-01082006000600002,correcto,o
206,S1130-01082006000600002,con,o
206,S1130-01082006000600002,un,o
206,S1130-01082006000600002,incumplimiento,o
206,S1130-01082006000600002,no,o
206,S1130-01082006000600002,intencionado,o
206,S1130-01082006000600002,en,o
206,S1130-01082006000600002,el,o
206,S1130-01082006000600002,155,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,pacientes,o
206,S1130-01082006000600002,La,o
206,S1130-01082006000600002,dieta,i
206,S1130-01082006000600002,consigue,o
206,S1130-01082006000600002,la,o
206,S1130-01082006000600002,desaparicion,o
206,S1130-01082006000600002,o,o
206,S1130-01082006000600002,mejora,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,los,o
206,S1130-01082006000600002,sintomas,i
206,S1130-01082006000600002,en,o
206,S1130-01082006000600002,practicamente,o
206,S1130-01082006000600002,todos,o
206,S1130-01082006000600002,los,o
206,S1130-01082006000600002,pacientes,o
206,S1130-01082006000600002,pero,o
206,S1130-01082006000600002,la,o
206,S1130-01082006000600002,mayoria,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,ellos,o
206,S1130-01082006000600002,consideran,o
206,S1130-01082006000600002,que,o
206,S1130-01082006000600002,es,o
206,S1130-01082006000600002,dificil,o
206,S1130-01082006000600002,seguirla,o
206,S1130-01082006000600002,El,o
206,S1130-01082006000600002,40,o
206,S1130-01082006000600002,tiene,o
206,S1130-01082006000600002,dificultades,o
206,S1130-01082006000600002,para,o
206,S1130-01082006000600002,encontrar,o
206,S1130-01082006000600002,alimentos,o
206,S1130-01082006000600002,sin,o
206,S1130-01082006000600002,gluten,i
206,S1130-01082006000600002,y,o
206,S1130-01082006000600002,el,o
206,S1130-01082006000600002,508,o
206,S1130-01082006000600002,tiene,o
206,S1130-01082006000600002,problemas,o
206,S1130-01082006000600002,para,o
206,S1130-01082006000600002,reconocer,o
206,S1130-01082006000600002,el,o
206,S1130-01082006000600002,etiquetado,o
206,S1130-01082006000600002,Conclusiones,o
206,S1130-01082006000600002,La,o
206,S1130-01082006000600002,celiaquia,i
206,S1130-01082006000600002,se,o
206,S1130-01082006000600002,presenta,o
206,S1130-01082006000600002,a,o
206,S1130-01082006000600002,cualquier,o
206,S1130-01082006000600002,edad,o
206,S1130-01082006000600002,se,o
206,S1130-01082006000600002,manifiesta,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,forma,o
206,S1130-01082006000600002,muy,o
206,S1130-01082006000600002,variada,o
206,S1130-01082006000600002,y,o
206,S1130-01082006000600002,responde,o
206,S1130-01082006000600002,muy,o
206,S1130-01082006000600002,bien,o
206,S1130-01082006000600002,a,o
206,S1130-01082006000600002,la,o
206,S1130-01082006000600002,dieta,i
206,S1130-01082006000600002,sin,i
206,S1130-01082006000600002,gluten,i
206,S1130-01082006000600002,Es,o
206,S1130-01082006000600002,esencial,o
206,S1130-01082006000600002,que,o
206,S1130-01082006000600002,los,o
206,S1130-01082006000600002,pacientes,o
206,S1130-01082006000600002,esten,o
206,S1130-01082006000600002,bien,o
206,S1130-01082006000600002,motivados,o
206,S1130-01082006000600002,e,o
206,S1130-01082006000600002,informados,o
206,S1130-01082006000600002,y,o
206,S1130-01082006000600002,sepan,o
206,S1130-01082006000600002,con,o
206,S1130-01082006000600002,seguridad,o
206,S1130-01082006000600002,que,o
206,S1130-01082006000600002,alimentos,o
206,S1130-01082006000600002,y,o
206,S1130-01082006000600002,productos,o
206,S1130-01082006000600002,manufacturados,o
206,S1130-01082006000600002,pueden,o
206,S1130-01082006000600002,consumir,o
206,S1130-01082006000600002,El,o
206,S1130-01082006000600002,control,o
206,S1130-01082006000600002,idoneo,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,la,o
206,S1130-01082006000600002,enfermedad,i
206,S1130-01082006000600002,se,o
206,S1130-01082006000600002,alcanzara,o
206,S1130-01082006000600002,por,o
206,S1130-01082006000600002,tanto,o
206,S1130-01082006000600002,al,o
206,S1130-01082006000600002,conseguir,o
206,S1130-01082006000600002,la,o
206,S1130-01082006000600002,coordinacion,o
206,S1130-01082006000600002,y,o
206,S1130-01082006000600002,colaboracion,o
206,S1130-01082006000600002,de,o
206,S1130-01082006000600002,todos,o
206,S1130-01082006000600002,los,o
206,S1130-01082006000600002,recursos,o
206,S1130-01082006000600002,implicados,o
206,S1130-01082006000600002,incluyendo,o
206,S1130-01082006000600002,la,o
206,S1130-01082006000600002,atencion,i
206,S1130-01082006000600002,medica,i
206,S1130-01082006000600002,la,o
206,S1130-01082006000600002,informacion,o
206,S1130-01082006000600002,mediante,o
206,S1130-01082006000600002,las,o
206,S1130-01082006000600002,asociaciones,o
206,S1130-01082006000600002,y,o
206,S1130-01082006000600002,otras,o
206,S1130-01082006000600002,fuentes,o
206,S1130-01082006000600002,como,o
206,S1130-01082006000600002,internet,o
207,S1130-01082007000200002,Erradicacion,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,H,o
207,S1130-01082007000200002,pylori,o
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,su,o
207,S1130-01082007000200002,relacion,o
207,S1130-01082007000200002,con,o
207,S1130-01082007000200002,la,o
207,S1130-01082007000200002,resistencia,i
207,S1130-01082007000200002,a,i
207,S1130-01082007000200002,los,i
207,S1130-01082007000200002,antibioticos,i
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,el,o
207,S1130-01082007000200002,estatus,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,CYP2C19,o
207,S1130-01082007000200002,Objetivo,o
207,S1130-01082007000200002,determinar,i
207,S1130-01082007000200002,la,i
207,S1130-01082007000200002,eficacia,i
207,S1130-01082007000200002,del,o
207,S1130-01082007000200002,rabeprazol,i
207,S1130-01082007000200002,RPZ,i
207,S1130-01082007000200002,amoxicilina,i
207,S1130-01082007000200002,Am,i
207,S1130-01082007000200002,y,i
207,S1130-01082007000200002,claritromicina,i
207,S1130-01082007000200002,Cla,i
207,S1130-01082007000200002,7,o
207,S1130-01082007000200002,vs,o
207,S1130-01082007000200002,14,o
207,S1130-01082007000200002,dias,o
207,S1130-01082007000200002,en,o
207,S1130-01082007000200002,la,o
207,S1130-01082007000200002,erradicacion,i
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,H,o
207,S1130-01082007000200002,pylori,o
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,determinar,o
207,S1130-01082007000200002,el,o
207,S1130-01082007000200002,efecto,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,la,o
207,S1130-01082007000200002,resistencia,i
207,S1130-01082007000200002,a,i
207,S1130-01082007000200002,los,i
207,S1130-01082007000200002,antibioticos,i
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,el,o
207,S1130-01082007000200002,genotipo,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,CYP2C19,o
207,S1130-01082007000200002,Material,o
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,metodos,o
207,S1130-01082007000200002,inicialmente,o
207,S1130-01082007000200002,se,o
207,S1130-01082007000200002,determino,i
207,S1130-01082007000200002,el,i
207,S1130-01082007000200002,genotipo,i
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,CYP2C19,o
207,S1130-01082007000200002,a,o
207,S1130-01082007000200002,100,o
207,S1130-01082007000200002,sujetos,o
207,S1130-01082007000200002,sanos,o
207,S1130-01082007000200002,para,o
207,S1130-01082007000200002,determinar,o
207,S1130-01082007000200002,el,o
207,S1130-01082007000200002,tamaño,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,muestra,o
207,S1130-01082007000200002,del,o
207,S1130-01082007000200002,ensayo,i
207,S1130-01082007000200002,clinico,i
207,S1130-01082007000200002,Posteriormente,o
207,S1130-01082007000200002,59,o
207,S1130-01082007000200002,pacientes,o
207,S1130-01082007000200002,H,o
207,S1130-01082007000200002,pylori,o
207,S1130-01082007000200002,recibieron,o
207,S1130-01082007000200002,al,i
207,S1130-01082007000200002,azar,i
207,S1130-01082007000200002,RPZ,i
207,S1130-01082007000200002,20,o
207,S1130-01082007000200002,mg,o
207,S1130-01082007000200002,diarios,o
207,S1130-01082007000200002,Cla,i
207,S1130-01082007000200002,500,o
207,S1130-01082007000200002,mg,o
207,S1130-01082007000200002,cada,o
207,S1130-01082007000200002,12,o
207,S1130-01082007000200002,horas,o
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,Am,i
207,S1130-01082007000200002,1000,o
207,S1130-01082007000200002,mg,o
207,S1130-01082007000200002,cada,o
207,S1130-01082007000200002,12,o
207,S1130-01082007000200002,horas,o
207,S1130-01082007000200002,7,o
207,S1130-01082007000200002,vs,o
207,S1130-01082007000200002,14,o
207,S1130-01082007000200002,dias,o
207,S1130-01082007000200002,Se,o
207,S1130-01082007000200002,determino,o
207,S1130-01082007000200002,la,o
207,S1130-01082007000200002,CMI,i
207,S1130-01082007000200002,para,o
207,S1130-01082007000200002,Am,i
207,S1130-01082007000200002,y,i
207,S1130-01082007000200002,Cla,i
207,S1130-01082007000200002,por,o
207,S1130-01082007000200002,el,o
207,S1130-01082007000200002,metodo,i
207,S1130-01082007000200002,de,i
207,S1130-01082007000200002,dilucion,i
207,S1130-01082007000200002,en,i
207,S1130-01082007000200002,agar,i
207,S1130-01082007000200002,El,o
207,S1130-01082007000200002,genotipo,o
207,S1130-01082007000200002,CYP2C19,o
207,S1130-01082007000200002,fue,o
207,S1130-01082007000200002,determinado,o
207,S1130-01082007000200002,por,o
207,S1130-01082007000200002,PCRRFLP,o
207,S1130-01082007000200002,Resultados,o
207,S1130-01082007000200002,en,o
207,S1130-01082007000200002,el,o
207,S1130-01082007000200002,analisis,o
207,S1130-01082007000200002,por,o
207,S1130-01082007000200002,protocolo,i
207,S1130-01082007000200002,PP,o
207,S1130-01082007000200002,las,o
207,S1130-01082007000200002,tasas,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,erradicacion,i
207,S1130-01082007000200002,fueron,o
207,S1130-01082007000200002,del,o
207,S1130-01082007000200002,897,o
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,72,o
207,S1130-01082007000200002,para,o
207,S1130-01082007000200002,los,o
207,S1130-01082007000200002,grupos,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,7,o
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,14,o
207,S1130-01082007000200002,dias,o
207,S1130-01082007000200002,respectivamente,o
207,S1130-01082007000200002,p,o
207,S1130-01082007000200002,0159,o
207,S1130-01082007000200002,En,o
207,S1130-01082007000200002,el,o
207,S1130-01082007000200002,analisis,i
207,S1130-01082007000200002,de,i
207,S1130-01082007000200002,intencion,i
207,S1130-01082007000200002,de,i
207,S1130-01082007000200002,tratamiento,i
207,S1130-01082007000200002,IT,o
207,S1130-01082007000200002,las,o
207,S1130-01082007000200002,tasas,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,erradicacion,i
207,S1130-01082007000200002,fueron,o
207,S1130-01082007000200002,del,o
207,S1130-01082007000200002,867,o
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,621,o
207,S1130-01082007000200002,en,o
207,S1130-01082007000200002,los,o
207,S1130-01082007000200002,grupos,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,7,o
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,14,o
207,S1130-01082007000200002,dias,o
207,S1130-01082007000200002,respectivamente,o
207,S1130-01082007000200002,p,o
207,S1130-01082007000200002,006,o
207,S1130-01082007000200002,Ninguna,o
207,S1130-01082007000200002,cepa,o
207,S1130-01082007000200002,presento,o
207,S1130-01082007000200002,resistencia,i
207,S1130-01082007000200002,a,o
207,S1130-01082007000200002,Am,i
207,S1130-01082007000200002,y,i
207,S1130-01082007000200002,4,o
207,S1130-01082007000200002,cepas,o
207,S1130-01082007000200002,fueron,o
207,S1130-01082007000200002,resistentes,i
207,S1130-01082007000200002,a,o
207,S1130-01082007000200002,Cla,i
207,S1130-01082007000200002,3,o
207,S1130-01082007000200002,111,o
207,S1130-01082007000200002,en,o
207,S1130-01082007000200002,el,o
207,S1130-01082007000200002,grupo,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,14,o
207,S1130-01082007000200002,dias,o
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,1,o
207,S1130-01082007000200002,4,o
207,S1130-01082007000200002,en,o
207,S1130-01082007000200002,el,o
207,S1130-01082007000200002,grupo,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,7,o
207,S1130-01082007000200002,dias,o
207,S1130-01082007000200002,Las,o
207,S1130-01082007000200002,tasas,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,erradicacion,i
207,S1130-01082007000200002,no,o
207,S1130-01082007000200002,fueron,o
207,S1130-01082007000200002,afectadas,o
207,S1130-01082007000200002,por,o
207,S1130-01082007000200002,la,o
207,S1130-01082007000200002,resistencia,i
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,la,o
207,S1130-01082007000200002,cepa,o
207,S1130-01082007000200002,o,o
207,S1130-01082007000200002,el,o
207,S1130-01082007000200002,genotipo,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,CYP2C19,o
207,S1130-01082007000200002,Conclusiones,o
207,S1130-01082007000200002,las,o
207,S1130-01082007000200002,terapias,i
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,7,o
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,14,o
207,S1130-01082007000200002,dias,o
207,S1130-01082007000200002,fueron,o
207,S1130-01082007000200002,eficaces,o
207,S1130-01082007000200002,para,o
207,S1130-01082007000200002,la,o
207,S1130-01082007000200002,erradicacion,i
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,H,o
207,S1130-01082007000200002,pylori,o
207,S1130-01082007000200002,Al,o
207,S1130-01082007000200002,parecer,o
207,S1130-01082007000200002,la,o
207,S1130-01082007000200002,resistencia,i
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,la,o
207,S1130-01082007000200002,cepa,o
207,S1130-01082007000200002,y,o
207,S1130-01082007000200002,el,o
207,S1130-01082007000200002,genotipo,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,CYP2C19,o
207,S1130-01082007000200002,no,o
207,S1130-01082007000200002,influenciaron,o
207,S1130-01082007000200002,las,o
207,S1130-01082007000200002,tasas,o
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,erradicacion,i
207,S1130-01082007000200002,de,o
207,S1130-01082007000200002,H,o
207,S1130-01082007000200002,pylori,o
207,S1130-01082007000200002,en,o
207,S1130-01082007000200002,la,o
207,S1130-01082007000200002,poblacion,o
207,S1130-01082007000200002,estudiada,o
208,S1130-01082007000600005,Efecto,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,la,o
208,S1130-01082007000600005,administracion,i
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,indometacina,i
208,S1130-01082007000600005,rectal,o
208,S1130-01082007000600005,sobre,o
208,S1130-01082007000600005,los,o
208,S1130-01082007000600005,niveles,i
208,S1130-01082007000600005,sericos,i
208,S1130-01082007000600005,de,i
208,S1130-01082007000600005,amilasa,i
208,S1130-01082007000600005,posteriores,o
208,S1130-01082007000600005,a,o
208,S1130-01082007000600005,colangiopancreatografia,i
208,S1130-01082007000600005,retrograda,i
208,S1130-01082007000600005,endoscopica,i
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,su,o
208,S1130-01082007000600005,impacto,o
208,S1130-01082007000600005,en,o
208,S1130-01082007000600005,la,o
208,S1130-01082007000600005,aparicion,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,episodios,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,pancreatitis,i
208,S1130-01082007000600005,secundaria,o
208,S1130-01082007000600005,Introduccion,o
208,S1130-01082007000600005,hiperamilasemia,i
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,pancreatitis,i
208,S1130-01082007000600005,aguda,i
208,S1130-01082007000600005,representan,o
208,S1130-01082007000600005,las,o
208,S1130-01082007000600005,complicaciones,i
208,S1130-01082007000600005,mayores,o
208,S1130-01082007000600005,mas,o
208,S1130-01082007000600005,frecuentes,o
208,S1130-01082007000600005,posteriores,o
208,S1130-01082007000600005,a,o
208,S1130-01082007000600005,colangiopancreatografia,i
208,S1130-01082007000600005,retrograda,i
208,S1130-01082007000600005,endoscopica,i
208,S1130-01082007000600005,CPRE,i
208,S1130-01082007000600005,apareciendo,o
208,S1130-01082007000600005,en,o
208,S1130-01082007000600005,130,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,los,o
208,S1130-01082007000600005,casos,o
208,S1130-01082007000600005,Objetivo,o
208,S1130-01082007000600005,determinar,o
208,S1130-01082007000600005,la,o
208,S1130-01082007000600005,incidencia,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,hiperamilasemia,i
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,pancreatitis,i
208,S1130-01082007000600005,posterior,o
208,S1130-01082007000600005,a,o
208,S1130-01082007000600005,CPRE,i
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,evaluar,i
208,S1130-01082007000600005,la,i
208,S1130-01082007000600005,utilidad,i
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,indometacina,i
208,S1130-01082007000600005,rectal,o
208,S1130-01082007000600005,para,o
208,S1130-01082007000600005,la,o
208,S1130-01082007000600005,prevencion,i
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,estos,o
208,S1130-01082007000600005,Material,o
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,metodos,o
208,S1130-01082007000600005,ensayo,i
208,S1130-01082007000600005,clinico,i
208,S1130-01082007000600005,controlado,i
208,S1130-01082007000600005,Durante,o
208,S1130-01082007000600005,un,o
208,S1130-01082007000600005,periodo,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,12,o
208,S1130-01082007000600005,meses,o
208,S1130-01082007000600005,se,o
208,S1130-01082007000600005,incluyeron,o
208,S1130-01082007000600005,150,o
208,S1130-01082007000600005,pacientes,o
208,S1130-01082007000600005,Estos,o
208,S1130-01082007000600005,fueron,o
208,S1130-01082007000600005,divididos,o
208,S1130-01082007000600005,en,o
208,S1130-01082007000600005,grupo,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,estudio,o
208,S1130-01082007000600005,n,o
208,S1130-01082007000600005,75,o
208,S1130-01082007000600005,a,o
208,S1130-01082007000600005,quienes,o
208,S1130-01082007000600005,se,o
208,S1130-01082007000600005,administro,o
208,S1130-01082007000600005,indometacina,i
208,S1130-01082007000600005,rectal,o
208,S1130-01082007000600005,100,o
208,S1130-01082007000600005,mg,o
208,S1130-01082007000600005,2,o
208,S1130-01082007000600005,horas,o
208,S1130-01082007000600005,previas,o
208,S1130-01082007000600005,al,o
208,S1130-01082007000600005,procedimiento,i
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,control,o
208,S1130-01082007000600005,n,o
208,S1130-01082007000600005,75,o
208,S1130-01082007000600005,que,o
208,S1130-01082007000600005,recibio,o
208,S1130-01082007000600005,glicerina,i
208,S1130-01082007000600005,Dos,o
208,S1130-01082007000600005,horas,o
208,S1130-01082007000600005,posteriores,o
208,S1130-01082007000600005,a,o
208,S1130-01082007000600005,la,o
208,S1130-01082007000600005,CPRE,i
208,S1130-01082007000600005,se,o
208,S1130-01082007000600005,determino,o
208,S1130-01082007000600005,el,o
208,S1130-01082007000600005,nivel,i
208,S1130-01082007000600005,de,i
208,S1130-01082007000600005,amilasa,i
208,S1130-01082007000600005,serica,i
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,se,o
208,S1130-01082007000600005,clasificaron,o
208,S1130-01082007000600005,en,o
208,S1130-01082007000600005,0,o
208,S1130-01082007000600005,150,o
208,S1130-01082007000600005,UIl,o
208,S1130-01082007000600005,1,o
208,S1130-01082007000600005,151599,o
208,S1130-01082007000600005,UIl,o
208,S1130-01082007000600005,2,o
208,S1130-01082007000600005,600,o
208,S1130-01082007000600005,UIl,o
208,S1130-01082007000600005,Los,o
208,S1130-01082007000600005,episodios,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,pancreatitis,i
208,S1130-01082007000600005,clinica,o
208,S1130-01082007000600005,se,o
208,S1130-01082007000600005,cuantificaron,o
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,clasificaron,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,acuerdo,o
208,S1130-01082007000600005,a,o
208,S1130-01082007000600005,los,o
208,S1130-01082007000600005,criterios,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,Ranson,o
208,S1130-01082007000600005,Resultados,o
208,S1130-01082007000600005,distribucion,o
208,S1130-01082007000600005,por,o
208,S1130-01082007000600005,genero,o
208,S1130-01082007000600005,100,o
208,S1130-01082007000600005,mujeres,o
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,50,o
208,S1130-01082007000600005,hombres,o
208,S1130-01082007000600005,Edad,o
208,S1130-01082007000600005,media,o
208,S1130-01082007000600005,5537,o
208,S1130-01082007000600005,180,o
208,S1130-01082007000600005,para,o
208,S1130-01082007000600005,el,o
208,S1130-01082007000600005,grupo,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,estudio,o
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,511,o
208,S1130-01082007000600005,170,o
208,S1130-01082007000600005,para,o
208,S1130-01082007000600005,el,o
208,S1130-01082007000600005,control,o
208,S1130-01082007000600005,El,o
208,S1130-01082007000600005,diagnostico,i
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,patologia,i
208,S1130-01082007000600005,benigna,i
208,S1130-01082007000600005,se,o
208,S1130-01082007000600005,presento,o
208,S1130-01082007000600005,en,o
208,S1130-01082007000600005,56,o
208,S1130-01082007000600005,747,o
208,S1130-01082007000600005,casos,o
208,S1130-01082007000600005,del,o
208,S1130-01082007000600005,grupo,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,estudio,o
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,59,o
208,S1130-01082007000600005,787,o
208,S1130-01082007000600005,del,o
208,S1130-01082007000600005,control,o
208,S1130-01082007000600005,Posterior,o
208,S1130-01082007000600005,al,o
208,S1130-01082007000600005,procedimiento,i
208,S1130-01082007000600005,13,o
208,S1130-01082007000600005,173,o
208,S1130-01082007000600005,pacientes,o
208,S1130-01082007000600005,del,o
208,S1130-01082007000600005,grupo,o
208,S1130-01082007000600005,experimental,o
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,28,o
208,S1130-01082007000600005,373,o
208,S1130-01082007000600005,del,o
208,S1130-01082007000600005,control,o
208,S1130-01082007000600005,desarrollaron,o
208,S1130-01082007000600005,hiperamilasemia,i
208,S1130-01082007000600005,p,o
208,S1130-01082007000600005,005,o
208,S1130-01082007000600005,Se,o
208,S1130-01082007000600005,encontro,o
208,S1130-01082007000600005,hiperamilasemia,i
208,S1130-01082007000600005,600,o
208,S1130-01082007000600005,UIl,o
208,S1130-01082007000600005,en,o
208,S1130-01082007000600005,3,o
208,S1130-01082007000600005,pacientes,o
208,S1130-01082007000600005,del,o
208,S1130-01082007000600005,grupo,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,estudio,o
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,10,o
208,S1130-01082007000600005,del,o
208,S1130-01082007000600005,control,o
208,S1130-01082007000600005,p,o
208,S1130-01082007000600005,0001,o
208,S1130-01082007000600005,Se,o
208,S1130-01082007000600005,detecto,o
208,S1130-01082007000600005,pancreatitis,i
208,S1130-01082007000600005,leve,o
208,S1130-01082007000600005,en,o
208,S1130-01082007000600005,53,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,los,o
208,S1130-01082007000600005,pacientes,o
208,S1130-01082007000600005,del,o
208,S1130-01082007000600005,grupo,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,estudio,o
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,16,o
208,S1130-01082007000600005,del,o
208,S1130-01082007000600005,control,o
208,S1130-01082007000600005,p,o
208,S1130-01082007000600005,005,o
208,S1130-01082007000600005,No,o
208,S1130-01082007000600005,hubo,o
208,S1130-01082007000600005,mortalidad,o
208,S1130-01082007000600005,ni,o
208,S1130-01082007000600005,eventos,i
208,S1130-01082007000600005,adversos,i
208,S1130-01082007000600005,Conclusiones,o
208,S1130-01082007000600005,indometacina,i
208,S1130-01082007000600005,rectal,o
208,S1130-01082007000600005,previo,o
208,S1130-01082007000600005,a,o
208,S1130-01082007000600005,CPRE,i
208,S1130-01082007000600005,disminuye,o
208,S1130-01082007000600005,el,o
208,S1130-01082007000600005,riesgo,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,hiperamilasemia,i
208,S1130-01082007000600005,y,o
208,S1130-01082007000600005,pancreatitis,i
208,S1130-01082007000600005,La,o
208,S1130-01082007000600005,indometacina,i
208,S1130-01082007000600005,es,o
208,S1130-01082007000600005,accesible,o
208,S1130-01082007000600005,de,o
208,S1130-01082007000600005,bajo,o
208,S1130-01082007000600005,costo,o
208,S1130-01082007000600005,con,o
208,S1130-01082007000600005,minimos,o
208,S1130-01082007000600005,o,o
208,S1130-01082007000600005,nulos,o
208,S1130-01082007000600005,efectos,i
208,S1130-01082007000600005,secundarios,i
209,S1130-01082008000200003,Evaluacion,i
209,S1130-01082008000200003,del,i
209,S1130-01082008000200003,uso,i
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,los,o
209,S1130-01082008000200003,inhibidores,i
209,S1130-01082008000200003,de,i
209,S1130-01082008000200003,la,i
209,S1130-01082008000200003,bomba,i
209,S1130-01082008000200003,de,i
209,S1130-01082008000200003,protones,i
209,S1130-01082008000200003,en,o
209,S1130-01082008000200003,un,o
209,S1130-01082008000200003,servicio,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,medicina,o
209,S1130-01082008000200003,interna,o
209,S1130-01082008000200003,Introduccion,o
209,S1130-01082008000200003,los,o
209,S1130-01082008000200003,inhibidores,i
209,S1130-01082008000200003,de,i
209,S1130-01082008000200003,la,i
209,S1130-01082008000200003,bomba,i
209,S1130-01082008000200003,de,i
209,S1130-01082008000200003,protones,i
209,S1130-01082008000200003,IBP,i
209,S1130-01082008000200003,bloquean,o
209,S1130-01082008000200003,la,o
209,S1130-01082008000200003,enzima,o
209,S1130-01082008000200003,HK,o
209,S1130-01082008000200003,ATPasa,o
209,S1130-01082008000200003,en,o
209,S1130-01082008000200003,las,o
209,S1130-01082008000200003,celulas,i
209,S1130-01082008000200003,parietales,i
209,S1130-01082008000200003,gastricas,i
209,S1130-01082008000200003,logrando,o
209,S1130-01082008000200003,la,o
209,S1130-01082008000200003,inhibicion,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,la,o
209,S1130-01082008000200003,secrecion,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,acido,i
209,S1130-01082008000200003,clorhidrico,i
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,forma,o
209,S1130-01082008000200003,basal,o
209,S1130-01082008000200003,como,o
209,S1130-01082008000200003,tras,o
209,S1130-01082008000200003,estimulacion,o
209,S1130-01082008000200003,Las,o
209,S1130-01082008000200003,indicaciones,o
209,S1130-01082008000200003,apropiadas,o
209,S1130-01082008000200003,para,o
209,S1130-01082008000200003,su,o
209,S1130-01082008000200003,uso,o
209,S1130-01082008000200003,son,o
209,S1130-01082008000200003,enfermedad,i
209,S1130-01082008000200003,por,i
209,S1130-01082008000200003,reflujo,i
209,S1130-01082008000200003,gastroesofagico,i
209,S1130-01082008000200003,hemorragia,i
209,S1130-01082008000200003,digestiva,i
209,S1130-01082008000200003,aguda,i
209,S1130-01082008000200003,ulceras,i
209,S1130-01082008000200003,activas,o
209,S1130-01082008000200003,gastritis,i
209,S1130-01082008000200003,o,o
209,S1130-01082008000200003,esofagitis,i
209,S1130-01082008000200003,erosiva,i
209,S1130-01082008000200003,dispepsia,i
209,S1130-01082008000200003,gastropatia,i
209,S1130-01082008000200003,por,o
209,S1130-01082008000200003,AINE,i
209,S1130-01082008000200003,profilaxis,i
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,ulcera,i
209,S1130-01082008000200003,de,i
209,S1130-01082008000200003,estres,i
209,S1130-01082008000200003,en,o
209,S1130-01082008000200003,pacientes,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,riesgo,o
209,S1130-01082008000200003,El,o
209,S1130-01082008000200003,objetivo,o
209,S1130-01082008000200003,del,o
209,S1130-01082008000200003,estudio,o
209,S1130-01082008000200003,fue,o
209,S1130-01082008000200003,la,o
209,S1130-01082008000200003,revision,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,las,o
209,S1130-01082008000200003,indicaciones,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,los,o
209,S1130-01082008000200003,IBP,i
209,S1130-01082008000200003,en,o
209,S1130-01082008000200003,nuestro,o
209,S1130-01082008000200003,medio,o
209,S1130-01082008000200003,y,o
209,S1130-01082008000200003,la,o
209,S1130-01082008000200003,evaluacion,i
209,S1130-01082008000200003,de,i
209,S1130-01082008000200003,su,i
209,S1130-01082008000200003,utilizacion,i
209,S1130-01082008000200003,en,o
209,S1130-01082008000200003,el,o
209,S1130-01082008000200003,Hospital,o
209,S1130-01082008000200003,Universitario,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,Guadalajara,o
209,S1130-01082008000200003,Material,o
209,S1130-01082008000200003,y,o
209,S1130-01082008000200003,metodos,o
209,S1130-01082008000200003,se,o
209,S1130-01082008000200003,realizo,o
209,S1130-01082008000200003,un,o
209,S1130-01082008000200003,estudio,i
209,S1130-01082008000200003,de,i
209,S1130-01082008000200003,corte,i
209,S1130-01082008000200003,transversal,i
209,S1130-01082008000200003,analitico,i
209,S1130-01082008000200003,con,i
209,S1130-01082008000200003,seleccion,i
209,S1130-01082008000200003,aleatoria,i
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,los,o
209,S1130-01082008000200003,pacientes,o
209,S1130-01082008000200003,atendidos,o
209,S1130-01082008000200003,en,o
209,S1130-01082008000200003,el,o
209,S1130-01082008000200003,Servicio,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,Medicina,o
209,S1130-01082008000200003,Interna,o
209,S1130-01082008000200003,durante,o
209,S1130-01082008000200003,todo,o
209,S1130-01082008000200003,el,o
209,S1130-01082008000200003,año,o
209,S1130-01082008000200003,2003,o
209,S1130-01082008000200003,Se,o
209,S1130-01082008000200003,revisaron,o
209,S1130-01082008000200003,un,o
209,S1130-01082008000200003,total,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,208,o
209,S1130-01082008000200003,historias,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,832,o
209,S1130-01082008000200003,pacientes,o
209,S1130-01082008000200003,un,o
209,S1130-01082008000200003,25,o
209,S1130-01082008000200003,a,o
209,S1130-01082008000200003,los,o
209,S1130-01082008000200003,que,o
209,S1130-01082008000200003,se,o
209,S1130-01082008000200003,administraron,o
209,S1130-01082008000200003,IBP,i
209,S1130-01082008000200003,La,o
209,S1130-01082008000200003,edad,o
209,S1130-01082008000200003,media,o
209,S1130-01082008000200003,fue,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,67,o
209,S1130-01082008000200003,años,o
209,S1130-01082008000200003,rango,o
209,S1130-01082008000200003,1692,o
209,S1130-01082008000200003,el,o
209,S1130-01082008000200003,462,o
209,S1130-01082008000200003,fueron,o
209,S1130-01082008000200003,mujeres,o
209,S1130-01082008000200003,y,o
209,S1130-01082008000200003,las,o
209,S1130-01082008000200003,enfermedades,i
209,S1130-01082008000200003,subyacentes,o
209,S1130-01082008000200003,mas,o
209,S1130-01082008000200003,frecuentes,o
209,S1130-01082008000200003,fueron,o
209,S1130-01082008000200003,HTA,i
209,S1130-01082008000200003,EPOC,i
209,S1130-01082008000200003,y,o
209,S1130-01082008000200003,DM,i
209,S1130-01082008000200003,Resultados,o
209,S1130-01082008000200003,un,o
209,S1130-01082008000200003,346,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,los,o
209,S1130-01082008000200003,pacientes,o
209,S1130-01082008000200003,tomaban,o
209,S1130-01082008000200003,IBP,i
209,S1130-01082008000200003,antes,o
209,S1130-01082008000200003,del,o
209,S1130-01082008000200003,ingreso,i
209,S1130-01082008000200003,De,o
209,S1130-01082008000200003,estos,o
209,S1130-01082008000200003,el,o
209,S1130-01082008000200003,681,o
209,S1130-01082008000200003,no,o
209,S1130-01082008000200003,tenia,o
209,S1130-01082008000200003,indicacion,o
209,S1130-01082008000200003,Durante,o
209,S1130-01082008000200003,el,o
209,S1130-01082008000200003,ingreso,i
209,S1130-01082008000200003,se,o
209,S1130-01082008000200003,prescribio,i
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,forma,o
209,S1130-01082008000200003,inadecuada,o
209,S1130-01082008000200003,el,o
209,S1130-01082008000200003,IBP,i
209,S1130-01082008000200003,al,o
209,S1130-01082008000200003,7307,o
209,S1130-01082008000200003,y,o
209,S1130-01082008000200003,al,o
209,S1130-01082008000200003,alta,o
209,S1130-01082008000200003,se,o
209,S1130-01082008000200003,mantenia,o
209,S1130-01082008000200003,el,o
209,S1130-01082008000200003,IBP,i
209,S1130-01082008000200003,sin,o
209,S1130-01082008000200003,indicacion,o
209,S1130-01082008000200003,correcta,o
209,S1130-01082008000200003,Conclusiones,o
209,S1130-01082008000200003,los,o
209,S1130-01082008000200003,resultados,o
209,S1130-01082008000200003,estan,o
209,S1130-01082008000200003,en,o
209,S1130-01082008000200003,concordancia,o
209,S1130-01082008000200003,con,o
209,S1130-01082008000200003,los,o
209,S1130-01082008000200003,anteriormente,o
209,S1130-01082008000200003,publicados,o
209,S1130-01082008000200003,manteniendose,o
209,S1130-01082008000200003,una,o
209,S1130-01082008000200003,alta,o
209,S1130-01082008000200003,frecuencia,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,uso,o
209,S1130-01082008000200003,incorrecto,o
209,S1130-01082008000200003,de,o
209,S1130-01082008000200003,los,o
209,S1130-01082008000200003,IBP,i
209,S1130-01082008000200003,y,o
209,S1130-01082008000200003,siendo,o
209,S1130-01082008000200003,recomendable,o
209,S1130-01082008000200003,una,o
209,S1130-01082008000200003,utilizacion,o
209,S1130-01082008000200003,mas,o
209,S1130-01082008000200003,racional,o
209,S1130-01082008000200003,para,o
209,S1130-01082008000200003,evitar,o
209,S1130-01082008000200003,los,o
209,S1130-01082008000200003,efectos,i
209,S1130-01082008000200003,secundarios,i
209,S1130-01082008000200003,las,o
209,S1130-01082008000200003,interacciones,i
209,S1130-01082008000200003,con,i
209,S1130-01082008000200003,otros,i
209,S1130-01082008000200003,farmacos,i
209,S1130-01082008000200003,y,o
209,S1130-01082008000200003,aportar,o
209,S1130-01082008000200003,una,o
209,S1130-01082008000200003,atencion,i
209,S1130-01082008000200003,medica,i
209,S1130-01082008000200003,mas,o
209,S1130-01082008000200003,eficiente,o
210,S1130-01082008000600007,Efectividad,o
210,S1130-01082008000600007,seguridad,o
210,S1130-01082008000600007,y,o
210,S1130-01082008000600007,tolerancia,o
210,S1130-01082008000600007,del,o
210,S1130-01082008000600007,balon,o
210,S1130-01082008000600007,intragastrico,o
210,S1130-01082008000600007,asociado,o
210,S1130-01082008000600007,a,o
210,S1130-01082008000600007,una,o
210,S1130-01082008000600007,dieta,i
210,S1130-01082008000600007,hipocalorica,i
210,S1130-01082008000600007,para,o
210,S1130-01082008000600007,la,o
210,S1130-01082008000600007,reduccion,i
210,S1130-01082008000600007,de,i
210,S1130-01082008000600007,peso,i
210,S1130-01082008000600007,en,o
210,S1130-01082008000600007,pacientes,o
210,S1130-01082008000600007,obesos,i
210,S1130-01082008000600007,Introduccion,o
210,S1130-01082008000600007,la,o
210,S1130-01082008000600007,implantacion,i
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,un,o
210,S1130-01082008000600007,balon,o
210,S1130-01082008000600007,intragastrico,o
210,S1130-01082008000600007,BI,o
210,S1130-01082008000600007,por,o
210,S1130-01082008000600007,via,o
210,S1130-01082008000600007,endoscopica,o
210,S1130-01082008000600007,asociado,o
210,S1130-01082008000600007,a,o
210,S1130-01082008000600007,una,o
210,S1130-01082008000600007,dieta,i
210,S1130-01082008000600007,hipocalorica,i
210,S1130-01082008000600007,es,o
210,S1130-01082008000600007,una,o
210,S1130-01082008000600007,alternativa,o
210,S1130-01082008000600007,en,o
210,S1130-01082008000600007,el,o
210,S1130-01082008000600007,tratamiento,i
210,S1130-01082008000600007,de,i
210,S1130-01082008000600007,la,i
210,S1130-01082008000600007,obesidad,i
210,S1130-01082008000600007,El,o
210,S1130-01082008000600007,objetivo,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,nuestro,o
210,S1130-01082008000600007,estudio,o
210,S1130-01082008000600007,es,o
210,S1130-01082008000600007,evaluar,o
210,S1130-01082008000600007,su,o
210,S1130-01082008000600007,efectividad,o
210,S1130-01082008000600007,seguridad,o
210,S1130-01082008000600007,y,o
210,S1130-01082008000600007,tolerancia,o
210,S1130-01082008000600007,Material,o
210,S1130-01082008000600007,y,o
210,S1130-01082008000600007,metodos,o
210,S1130-01082008000600007,se,o
210,S1130-01082008000600007,incluyen,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,manera,o
210,S1130-01082008000600007,prospectiva,o
210,S1130-01082008000600007,38,o
210,S1130-01082008000600007,pacientes,o
210,S1130-01082008000600007,sin,o
210,S1130-01082008000600007,contraindicaciones,o
210,S1130-01082008000600007,para,o
210,S1130-01082008000600007,la,o
210,S1130-01082008000600007,implantacion,i
210,S1130-01082008000600007,del,i
210,S1130-01082008000600007,BI,i
210,S1130-01082008000600007,desde,o
210,S1130-01082008000600007,marzo,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,2004,o
210,S1130-01082008000600007,hasta,o
210,S1130-01082008000600007,enero,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,2007,o
210,S1130-01082008000600007,La,o
210,S1130-01082008000600007,retirada,o
210,S1130-01082008000600007,del,o
210,S1130-01082008000600007,balon,o
210,S1130-01082008000600007,se,o
210,S1130-01082008000600007,realizo,o
210,S1130-01082008000600007,6,o
210,S1130-01082008000600007,meses,o
210,S1130-01082008000600007,despues,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,la,o
210,S1130-01082008000600007,implantacion,i
210,S1130-01082008000600007,Evaluamos,i
210,S1130-01082008000600007,el,i
210,S1130-01082008000600007,peso,i
210,S1130-01082008000600007,e,o
210,S1130-01082008000600007,indice,i
210,S1130-01082008000600007,de,i
210,S1130-01082008000600007,masa,i
210,S1130-01082008000600007,corporal,i
210,S1130-01082008000600007,IMC,i
210,S1130-01082008000600007,tras,o
210,S1130-01082008000600007,la,o
210,S1130-01082008000600007,retirada,o
210,S1130-01082008000600007,del,o
210,S1130-01082008000600007,balon,o
210,S1130-01082008000600007,a,o
210,S1130-01082008000600007,los,o
210,S1130-01082008000600007,6,o
210,S1130-01082008000600007,y,o
210,S1130-01082008000600007,12,o
210,S1130-01082008000600007,meses,o
210,S1130-01082008000600007,postretirada,o
210,S1130-01082008000600007,asi,o
210,S1130-01082008000600007,como,o
210,S1130-01082008000600007,la,o
210,S1130-01082008000600007,tolerancia,o
210,S1130-01082008000600007,y,o
210,S1130-01082008000600007,aparicion,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,complicaciones,i
210,S1130-01082008000600007,durante,o
210,S1130-01082008000600007,el,o
210,S1130-01082008000600007,tratamiento,i
210,S1130-01082008000600007,Tras,o
210,S1130-01082008000600007,la,o
210,S1130-01082008000600007,retirada,o
210,S1130-01082008000600007,del,o
210,S1130-01082008000600007,balon,o
210,S1130-01082008000600007,se,o
210,S1130-01082008000600007,realizo,i
210,S1130-01082008000600007,un,i
210,S1130-01082008000600007,cuestionario,i
210,S1130-01082008000600007,a,o
210,S1130-01082008000600007,cada,o
210,S1130-01082008000600007,paciente,o
210,S1130-01082008000600007,evaluando,o
210,S1130-01082008000600007,la,o
210,S1130-01082008000600007,percepcion,o
210,S1130-01082008000600007,subjetiva,o
210,S1130-01082008000600007,al,o
210,S1130-01082008000600007,tratamiento,i
210,S1130-01082008000600007,Resultados,o
210,S1130-01082008000600007,despues,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,6,o
210,S1130-01082008000600007,meses,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,tratamiento,i
210,S1130-01082008000600007,la,o
210,S1130-01082008000600007,perdida,i
210,S1130-01082008000600007,de,i
210,S1130-01082008000600007,peso,i
210,S1130-01082008000600007,media,o
210,S1130-01082008000600007,fue,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,1410,o
210,S1130-01082008000600007,kg,o
210,S1130-01082008000600007,046,o
210,S1130-01082008000600007,y,o
210,S1130-01082008000600007,la,o
210,S1130-01082008000600007,reduccion,o
210,S1130-01082008000600007,media,o
210,S1130-01082008000600007,del,o
210,S1130-01082008000600007,IMC,i
210,S1130-01082008000600007,fue,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,523,o
210,S1130-01082008000600007,kgm2,o
210,S1130-01082008000600007,018,o
210,S1130-01082008000600007,A,o
210,S1130-01082008000600007,los,o
210,S1130-01082008000600007,12,o
210,S1130-01082008000600007,meses,o
210,S1130-01082008000600007,postretirada,o
210,S1130-01082008000600007,del,o
210,S1130-01082008000600007,balon,o
210,S1130-01082008000600007,el,o
210,S1130-01082008000600007,484,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,pacientes,o
210,S1130-01082008000600007,mantiene,o
210,S1130-01082008000600007,o,o
210,S1130-01082008000600007,sigue,o
210,S1130-01082008000600007,perdiendo,i
210,S1130-01082008000600007,peso,i
210,S1130-01082008000600007,Los,o
210,S1130-01082008000600007,sintomas,i
210,S1130-01082008000600007,precoces,o
210,S1130-01082008000600007,mas,o
210,S1130-01082008000600007,frecuentes,o
210,S1130-01082008000600007,fueron,o
210,S1130-01082008000600007,nauseas,i
210,S1130-01082008000600007,711,o
210,S1130-01082008000600007,y,o
210,S1130-01082008000600007,vomitos,i
210,S1130-01082008000600007,579,o
210,S1130-01082008000600007,con,o
210,S1130-01082008000600007,buena,o
210,S1130-01082008000600007,respuesta,o
210,S1130-01082008000600007,a,o
210,S1130-01082008000600007,tratamiento,i
210,S1130-01082008000600007,sintomatico,i
210,S1130-01082008000600007,Presentaron,o
210,S1130-01082008000600007,complicaciones,i
210,S1130-01082008000600007,7,o
210,S1130-01082008000600007,pacientes,o
210,S1130-01082008000600007,184,o
210,S1130-01082008000600007,intolerancia,i
210,S1130-01082008000600007,digestiva,i
210,S1130-01082008000600007,en,o
210,S1130-01082008000600007,4,o
210,S1130-01082008000600007,pacientes,o
210,S1130-01082008000600007,requiriendo,o
210,S1130-01082008000600007,retirada,o
210,S1130-01082008000600007,precoz,o
210,S1130-01082008000600007,del,o
210,S1130-01082008000600007,balon,o
210,S1130-01082008000600007,en,o
210,S1130-01082008000600007,3,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,ellos,o
210,S1130-01082008000600007,esofagitis,i
210,S1130-01082008000600007,moderada,o
210,S1130-01082008000600007,en,o
210,S1130-01082008000600007,2,o
210,S1130-01082008000600007,pacientes,o
210,S1130-01082008000600007,y,o
210,S1130-01082008000600007,perforacion,i
210,S1130-01082008000600007,gastrica,i
210,S1130-01082008000600007,complicada,o
210,S1130-01082008000600007,con,o
210,S1130-01082008000600007,shock,i
210,S1130-01082008000600007,septico,i
210,S1130-01082008000600007,y,o
210,S1130-01082008000600007,exitus,i
210,S1130-01082008000600007,en,o
210,S1130-01082008000600007,1,o
210,S1130-01082008000600007,paciente,o
210,S1130-01082008000600007,Conclusiones,o
210,S1130-01082008000600007,1,o
210,S1130-01082008000600007,El,o
210,S1130-01082008000600007,balon,o
210,S1130-01082008000600007,intragastrico,o
210,S1130-01082008000600007,asociado,o
210,S1130-01082008000600007,a,o
210,S1130-01082008000600007,una,o
210,S1130-01082008000600007,dieta,i
210,S1130-01082008000600007,hipocalorica,i
210,S1130-01082008000600007,puede,o
210,S1130-01082008000600007,considerarse,o
210,S1130-01082008000600007,un,o
210,S1130-01082008000600007,tratamiento,i
210,S1130-01082008000600007,efectivo,o
210,S1130-01082008000600007,seguro,o
210,S1130-01082008000600007,y,o
210,S1130-01082008000600007,bien,o
210,S1130-01082008000600007,tolerado,o
210,S1130-01082008000600007,para,o
210,S1130-01082008000600007,el,o
210,S1130-01082008000600007,tratamiento,i
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,pacientes,o
210,S1130-01082008000600007,con,o
210,S1130-01082008000600007,obesidad,i
210,S1130-01082008000600007,morbida,i
210,S1130-01082008000600007,2,o
210,S1130-01082008000600007,La,o
210,S1130-01082008000600007,perdida,i
210,S1130-01082008000600007,de,i
210,S1130-01082008000600007,peso,i
210,S1130-01082008000600007,se,o
210,S1130-01082008000600007,mantiene,o
210,S1130-01082008000600007,en,o
210,S1130-01082008000600007,casi,o
210,S1130-01082008000600007,la,o
210,S1130-01082008000600007,mitad,o
210,S1130-01082008000600007,de,o
210,S1130-01082008000600007,los,o
210,S1130-01082008000600007,pacientes,o
210,S1130-01082008000600007,al,o
210,S1130-01082008000600007,año,o
210,S1130-01082008000600007,tras,o
210,S1130-01082008000600007,la,o
210,S1130-01082008000600007,retirada,o
210,S1130-01082008000600007,del,o
210,S1130-01082008000600007,balon,o
211,S1130-01082008000800004,Inhibidores,i
211,S1130-01082008000800004,de,i
211,S1130-01082008000800004,la,i
211,S1130-01082008000800004,bomba,i
211,S1130-01082008000800004,de,i
211,S1130-01082008000800004,protones,i
211,S1130-01082008000800004,por,o
211,S1130-01082008000800004,via,o
211,S1130-01082008000800004,intravenosa,o
211,S1130-01082008000800004,en,o
211,S1130-01082008000800004,la,o
211,S1130-01082008000800004,hemorragia,i
211,S1130-01082008000800004,por,o
211,S1130-01082008000800004,ulcera,i
211,S1130-01082008000800004,peptica,i
211,S1130-01082008000800004,es,o
211,S1130-01082008000800004,necesaria,o
211,S1130-01082008000800004,la,o
211,S1130-01082008000800004,supresion,o
211,S1130-01082008000800004,acida,i
211,S1130-01082008000800004,maxima,o
211,S1130-01082008000800004,para,o
211,S1130-01082008000800004,disminuir,o
211,S1130-01082008000800004,el,o
211,S1130-01082008000800004,resangrado,i
211,S1130-01082008000800004,Objetivo,o
211,S1130-01082008000800004,comparar,o
211,S1130-01082008000800004,dos,o
211,S1130-01082008000800004,pautas,i
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,pantoprazol,i
211,S1130-01082008000800004,por,o
211,S1130-01082008000800004,via,o
211,S1130-01082008000800004,intravenosa,o
211,S1130-01082008000800004,en,o
211,S1130-01082008000800004,pacientes,o
211,S1130-01082008000800004,con,o
211,S1130-01082008000800004,hemorragia,i
211,S1130-01082008000800004,digestiva,o
211,S1130-01082008000800004,alta,o
211,S1130-01082008000800004,HDA,o
211,S1130-01082008000800004,ulcerosa,o
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,alto,o
211,S1130-01082008000800004,riesgo,o
211,S1130-01082008000800004,para,o
211,S1130-01082008000800004,presentar,o
211,S1130-01082008000800004,persistencia,i
211,S1130-01082008000800004,o,i
211,S1130-01082008000800004,recidiva,i
211,S1130-01082008000800004,hemorragica,i
211,S1130-01082008000800004,Material,o
211,S1130-01082008000800004,y,o
211,S1130-01082008000800004,metodo,o
211,S1130-01082008000800004,se,o
211,S1130-01082008000800004,randomizaron,i
211,S1130-01082008000800004,los,o
211,S1130-01082008000800004,pacientes,o
211,S1130-01082008000800004,en,o
211,S1130-01082008000800004,dos,o
211,S1130-01082008000800004,grupos,o
211,S1130-01082008000800004,grupo,o
211,S1130-01082008000800004,0,o
211,S1130-01082008000800004,tratamiento,i
211,S1130-01082008000800004,con,i
211,S1130-01082008000800004,bolo,i
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,80,o
211,S1130-01082008000800004,mg,o
211,S1130-01082008000800004,iv,o
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,pantoprazol,i
211,S1130-01082008000800004,y,o
211,S1130-01082008000800004,perfusion,i
211,S1130-01082008000800004,continua,i
211,S1130-01082008000800004,a,o
211,S1130-01082008000800004,8,o
211,S1130-01082008000800004,mgh,o
211,S1130-01082008000800004,durante,o
211,S1130-01082008000800004,72,o
211,S1130-01082008000800004,horas,o
211,S1130-01082008000800004,grupo,o
211,S1130-01082008000800004,1,o
211,S1130-01082008000800004,tratamiento,i
211,S1130-01082008000800004,con,o
211,S1130-01082008000800004,40,o
211,S1130-01082008000800004,mg,o
211,S1130-01082008000800004,iv,o
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,pantoprazol,i
211,S1130-01082008000800004,diarios,o
211,S1130-01082008000800004,Se,o
211,S1130-01082008000800004,analizo,o
211,S1130-01082008000800004,el,o
211,S1130-01082008000800004,porcentaje,o
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,persistenciarecidiva,o
211,S1130-01082008000800004,hemorragica,o
211,S1130-01082008000800004,entre,o
211,S1130-01082008000800004,ambos,o
211,S1130-01082008000800004,grupos,o
211,S1130-01082008000800004,requerimientos,i
211,S1130-01082008000800004,transfusionales,i
211,S1130-01082008000800004,necesidad,o
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,cirugia,i
211,S1130-01082008000800004,y,o
211,S1130-01082008000800004,mortalidad,o
211,S1130-01082008000800004,del,o
211,S1130-01082008000800004,episodio,i
211,S1130-01082008000800004,hemorragico,i
211,S1130-01082008000800004,Resultados,o
211,S1130-01082008000800004,se,o
211,S1130-01082008000800004,incluyeron,o
211,S1130-01082008000800004,20,o
211,S1130-01082008000800004,pacientes,o
211,S1130-01082008000800004,en,o
211,S1130-01082008000800004,el,o
211,S1130-01082008000800004,grupo,o
211,S1130-01082008000800004,0,o
211,S1130-01082008000800004,y,o
211,S1130-01082008000800004,21,o
211,S1130-01082008000800004,en,o
211,S1130-01082008000800004,el,o
211,S1130-01082008000800004,grupo,o
211,S1130-01082008000800004,1,o
211,S1130-01082008000800004,No,o
211,S1130-01082008000800004,se,o
211,S1130-01082008000800004,encontraron,o
211,S1130-01082008000800004,diferencias,o
211,S1130-01082008000800004,entre,o
211,S1130-01082008000800004,ambos,o
211,S1130-01082008000800004,grupos,o
211,S1130-01082008000800004,en,o
211,S1130-01082008000800004,cuanto,o
211,S1130-01082008000800004,al,o
211,S1130-01082008000800004,sexo,o
211,S1130-01082008000800004,edad,o
211,S1130-01082008000800004,habito,i
211,S1130-01082008000800004,tabaquico,i
211,S1130-01082008000800004,consumo,o
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,AINE,i
211,S1130-01082008000800004,presencia,o
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,inestabilidad,i
211,S1130-01082008000800004,hemodinamica,i
211,S1130-01082008000800004,estigma,i
211,S1130-01082008000800004,sobre,i
211,S1130-01082008000800004,el,i
211,S1130-01082008000800004,nicho,i
211,S1130-01082008000800004,ulceroso,i
211,S1130-01082008000800004,Forrest,o
211,S1130-01082008000800004,Ia,o
211,S1130-01082008000800004,5,o
211,S1130-01082008000800004,vs,o
211,S1130-01082008000800004,143,o
211,S1130-01082008000800004,p,o
211,S1130-01082008000800004,0322,o
211,S1130-01082008000800004,Forrest,o
211,S1130-01082008000800004,Ib,o
211,S1130-01082008000800004,30,o
211,S1130-01082008000800004,vs,o
211,S1130-01082008000800004,333,o
211,S1130-01082008000800004,p,o
211,S1130-01082008000800004,0819,o
211,S1130-01082008000800004,Forrest,o
211,S1130-01082008000800004,IIa,o
211,S1130-01082008000800004,60,o
211,S1130-01082008000800004,vs,o
211,S1130-01082008000800004,501,o
211,S1130-01082008000800004,p,o
211,S1130-01082008000800004,0753,o
211,S1130-01082008000800004,El,o
211,S1130-01082008000800004,90,o
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,los,o
211,S1130-01082008000800004,pacientes,o
211,S1130-01082008000800004,del,o
211,S1130-01082008000800004,grupo,o
211,S1130-01082008000800004,0,o
211,S1130-01082008000800004,recibio,o
211,S1130-01082008000800004,tratamiento,i
211,S1130-01082008000800004,endoscopico,i
211,S1130-01082008000800004,vs,o
211,S1130-01082008000800004,el,o
211,S1130-01082008000800004,100,o
211,S1130-01082008000800004,del,o
211,S1130-01082008000800004,grupo,o
211,S1130-01082008000800004,1,o
211,S1130-01082008000800004,p,o
211,S1130-01082008000800004,0232,o
211,S1130-01082008000800004,El,o
211,S1130-01082008000800004,50,o
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,los,o
211,S1130-01082008000800004,pacientes,o
211,S1130-01082008000800004,del,o
211,S1130-01082008000800004,grupo,o
211,S1130-01082008000800004,0,o
211,S1130-01082008000800004,recibio,o
211,S1130-01082008000800004,transfusion,i
211,S1130-01082008000800004,vs,o
211,S1130-01082008000800004,el,o
211,S1130-01082008000800004,524,o
211,S1130-01082008000800004,del,o
211,S1130-01082008000800004,grupo,o
211,S1130-01082008000800004,1,o
211,S1130-01082008000800004,p,o
211,S1130-01082008000800004,0879,o
211,S1130-01082008000800004,Dos,o
211,S1130-01082008000800004,pacientes,o
211,S1130-01082008000800004,105,o
211,S1130-01082008000800004,del,o
211,S1130-01082008000800004,grupo,o
211,S1130-01082008000800004,0,o
211,S1130-01082008000800004,presentaron,o
211,S1130-01082008000800004,recidiva,i
211,S1130-01082008000800004,hemorragica,i
211,S1130-01082008000800004,vs,o
211,S1130-01082008000800004,3,o
211,S1130-01082008000800004,pacientes,o
211,S1130-01082008000800004,143,o
211,S1130-01082008000800004,del,o
211,S1130-01082008000800004,grupo,o
211,S1130-01082008000800004,1,o
211,S1130-01082008000800004,precisando,o
211,S1130-01082008000800004,cirugia,i
211,S1130-01082008000800004,1,o
211,S1130-01082008000800004,paciente,o
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,cada,o
211,S1130-01082008000800004,grupo,o
211,S1130-01082008000800004,y,o
211,S1130-01082008000800004,falleciendo,i
211,S1130-01082008000800004,1,o
211,S1130-01082008000800004,paciente,o
211,S1130-01082008000800004,del,o
211,S1130-01082008000800004,grupo,o
211,S1130-01082008000800004,0,o
211,S1130-01082008000800004,Conclusiones,o
211,S1130-01082008000800004,la,o
211,S1130-01082008000800004,inhibicion,o
211,S1130-01082008000800004,acida,i
211,S1130-01082008000800004,maxima,o
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,la,o
211,S1130-01082008000800004,secrecion,o
211,S1130-01082008000800004,acida,i
211,S1130-01082008000800004,gastrica,i
211,S1130-01082008000800004,mediante,o
211,S1130-01082008000800004,bolo,o
211,S1130-01082008000800004,e,o
211,S1130-01082008000800004,infusion,i
211,S1130-01082008000800004,continua,i
211,S1130-01082008000800004,de,o
211,S1130-01082008000800004,pantoprazol,i
211,S1130-01082008000800004,no,o
211,S1130-01082008000800004,ofrece,o
211,S1130-01082008000800004,resultados,o
211,S1130-01082008000800004,superiores,o
211,S1130-01082008000800004,al,o
211,S1130-01082008000800004,tratamiento,i
211,S1130-01082008000800004,con,o
211,S1130-01082008000800004,dosis,o
211,S1130-01082008000800004,convencionales,o
211,S1130-01082008000800004,en,o
211,S1130-01082008000800004,el,o
211,S1130-01082008000800004,episodio,i
211,S1130-01082008000800004,hemorragico,i
211,S1130-01082008000800004,agudo,i
212,S1130-01082008000800007,Efecto,o
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,pentoxifilina,i
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,supervivencia,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,funcion,o
212,S1130-01082008000800007,cardiaca,i
212,S1130-01082008000800007,y,o
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,hemodinamica,o
212,S1130-01082008000800007,portal,i
212,S1130-01082008000800007,y,o
212,S1130-01082008000800007,sistemica,o
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,cirrosis,i
212,S1130-01082008000800007,alcoholica,i
212,S1130-01082008000800007,avanzada,o
212,S1130-01082008000800007,a,o
212,S1130-01082008000800007,randomized,o
212,S1130-01082008000800007,doubleblind,o
212,S1130-01082008000800007,placebocontrolled,o
212,S1130-01082008000800007,trial,o
212,S1130-01082008000800007,Objetivo,o
212,S1130-01082008000800007,valorar,o
212,S1130-01082008000800007,el,o
212,S1130-01082008000800007,efecto,o
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,pentoxifilina,i
212,S1130-01082008000800007,un,o
212,S1130-01082008000800007,potente,o
212,S1130-01082008000800007,inhibidor,i
212,S1130-01082008000800007,del,i
212,S1130-01082008000800007,factor,i
212,S1130-01082008000800007,de,i
212,S1130-01082008000800007,necrosis,i
212,S1130-01082008000800007,tumoral,i
212,S1130-01082008000800007,alfa,i
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,supervivencia,o
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,hemodinamica,o
212,S1130-01082008000800007,sistemica,o
212,S1130-01082008000800007,y,o
212,S1130-01082008000800007,portal,i
212,S1130-01082008000800007,y,o
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,funcion,o
212,S1130-01082008000800007,cardiaca,i
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,cirrosis,i
212,S1130-01082008000800007,alcoholica,i
212,S1130-01082008000800007,avanzada,o
212,S1130-01082008000800007,Diseño,o
212,S1130-01082008000800007,estudio,o
212,S1130-01082008000800007,aleatorizado,o
212,S1130-01082008000800007,dobleciego,o
212,S1130-01082008000800007,controlado,o
212,S1130-01082008000800007,con,o
212,S1130-01082008000800007,placebo,i
212,S1130-01082008000800007,Contexto,o
212,S1130-01082008000800007,estudio,i
212,S1130-01082008000800007,unicentrico,i
212,S1130-01082008000800007,utilizando,o
212,S1130-01082008000800007,grupos,o
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,pacientes,o
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,paralelo,o
212,S1130-01082008000800007,para,o
212,S1130-01082008000800007,comparar,o
212,S1130-01082008000800007,pentoxifilina,i
212,S1130-01082008000800007,y,o
212,S1130-01082008000800007,placebo,i
212,S1130-01082008000800007,Pacientes,o
212,S1130-01082008000800007,se,o
212,S1130-01082008000800007,incluyeron,o
212,S1130-01082008000800007,24,o
212,S1130-01082008000800007,pacientes,o
212,S1130-01082008000800007,con,o
212,S1130-01082008000800007,cirrosis,i
212,S1130-01082008000800007,alcoholica,i
212,S1130-01082008000800007,8,o
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,estadio,o
212,S1130-01082008000800007,B,o
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,ChildPugh,o
212,S1130-01082008000800007,y,o
212,S1130-01082008000800007,16,o
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,estadio,o
212,S1130-01082008000800007,C,o
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,ChildPugh,o
212,S1130-01082008000800007,Intervencion,i
212,S1130-01082008000800007,los,o
212,S1130-01082008000800007,pacientes,o
212,S1130-01082008000800007,fueron,o
212,S1130-01082008000800007,aleatorizados,i
212,S1130-01082008000800007,a,o
212,S1130-01082008000800007,recibir,o
212,S1130-01082008000800007,pentoxifilina,i
212,S1130-01082008000800007,400,o
212,S1130-01082008000800007,mg,o
212,S1130-01082008000800007,3,o
212,S1130-01082008000800007,veces,o
212,S1130-01082008000800007,al,o
212,S1130-01082008000800007,dia,o
212,S1130-01082008000800007,n,o
212,S1130-01082008000800007,12,o
212,S1130-01082008000800007,o,o
212,S1130-01082008000800007,placebo,i
212,S1130-01082008000800007,n,o
212,S1130-01082008000800007,12,o
212,S1130-01082008000800007,durante,o
212,S1130-01082008000800007,4,o
212,S1130-01082008000800007,semanas,o
212,S1130-01082008000800007,Determinaciones,o
212,S1130-01082008000800007,el,o
212,S1130-01082008000800007,objetivo,o
212,S1130-01082008000800007,principal,o
212,S1130-01082008000800007,fue,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,supervivencia,o
212,S1130-01082008000800007,a,o
212,S1130-01082008000800007,cortolargo,o
212,S1130-01082008000800007,plazo,o
212,S1130-01082008000800007,Los,o
212,S1130-01082008000800007,objetivos,o
212,S1130-01082008000800007,secundarios,o
212,S1130-01082008000800007,fueron,o
212,S1130-01082008000800007,observar,o
212,S1130-01082008000800007,beneficios,o
212,S1130-01082008000800007,hemodinamicos,o
212,S1130-01082008000800007,mejoria,o
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,funcion,o
212,S1130-01082008000800007,cardiaca,i
212,S1130-01082008000800007,yo,o
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,el,o
212,S1130-01082008000800007,indice,o
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,resistencias,o
212,S1130-01082008000800007,vasculares,i
212,S1130-01082008000800007,sistemicas,o
212,S1130-01082008000800007,o,o
212,S1130-01082008000800007,disminucion,o
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,presion,o
212,S1130-01082008000800007,portal,i
212,S1130-01082008000800007,Resultados,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,presion,o
212,S1130-01082008000800007,portal,i
212,S1130-01082008000800007,y,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,funcion,o
212,S1130-01082008000800007,cardiaca,i
212,S1130-01082008000800007,no,o
212,S1130-01082008000800007,se,o
212,S1130-01082008000800007,modificaron,o
212,S1130-01082008000800007,y,o
212,S1130-01082008000800007,no,o
212,S1130-01082008000800007,hubo,o
212,S1130-01082008000800007,diferencias,o
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,supervivencia,o
212,S1130-01082008000800007,a,o
212,S1130-01082008000800007,corto,o
212,S1130-01082008000800007,y,o
212,S1130-01082008000800007,largo,o
212,S1130-01082008000800007,plazo,o
212,S1130-01082008000800007,entre,o
212,S1130-01082008000800007,los,o
212,S1130-01082008000800007,grupos,o
212,S1130-01082008000800007,tratados,i
212,S1130-01082008000800007,y,o
212,S1130-01082008000800007,placebo,i
212,S1130-01082008000800007,Los,o
212,S1130-01082008000800007,indices,o
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,resistencia,o
212,S1130-01082008000800007,vascular,i
212,S1130-01082008000800007,sistemica,o
212,S1130-01082008000800007,y,o
212,S1130-01082008000800007,cardiaco,i
212,S1130-01082008000800007,cambiaron,o
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,el,o
212,S1130-01082008000800007,grupo,o
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,pentoxifilina,i
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,1721,o
212,S1130-01082008000800007,567,o
212,S1130-01082008000800007,a,o
212,S1130-01082008000800007,2082,o
212,S1130-01082008000800007,622,o
212,S1130-01082008000800007,Dinseg,o
212,S1130-01082008000800007,1,o
212,S1130-01082008000800007,cm5,o
212,S1130-01082008000800007,m2,o
212,S1130-01082008000800007,y,o
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,417,o
212,S1130-01082008000800007,14,o
212,S1130-01082008000800007,a,o
212,S1130-01082008000800007,34,o
212,S1130-01082008000800007,09,o
212,S1130-01082008000800007,lm2,o
212,S1130-01082008000800007,p,o
212,S1130-01082008000800007,005,o
212,S1130-01082008000800007,Conclusiones,o
212,S1130-01082008000800007,aunque,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,pentoxifilina,i
212,S1130-01082008000800007,parece,o
212,S1130-01082008000800007,producir,o
212,S1130-01082008000800007,algun,o
212,S1130-01082008000800007,beneficio,o
212,S1130-01082008000800007,hemodinamico,o
212,S1130-01082008000800007,a,o
212,S1130-01082008000800007,corto,o
212,S1130-01082008000800007,plazo,o
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,pacientes,o
212,S1130-01082008000800007,con,o
212,S1130-01082008000800007,cirrosis,i
212,S1130-01082008000800007,alcoholica,i
212,S1130-01082008000800007,avanzada,o
212,S1130-01082008000800007,no,o
212,S1130-01082008000800007,tiene,o
212,S1130-01082008000800007,efecto,o
212,S1130-01082008000800007,sobre,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,tasa,o
212,S1130-01082008000800007,de,o
212,S1130-01082008000800007,supervivencia,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,funcion,o
212,S1130-01082008000800007,cardiaca,i
212,S1130-01082008000800007,ni,o
212,S1130-01082008000800007,sobre,o
212,S1130-01082008000800007,la,o
212,S1130-01082008000800007,presion,o
212,S1130-01082008000800007,portal,i
212,S1130-01082008000800007,en,o
212,S1130-01082008000800007,estos,o
212,S1130-01082008000800007,pacientes,o
213,S1130-01082008000900002,Efecto,o
213,S1130-01082008000900002,del,o
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,erradicador,i
213,S1130-01082008000900002,para,i
213,S1130-01082008000900002,Helicobacter,i
213,S1130-01082008000900002,pylori,i
213,S1130-01082008000900002,en,o
213,S1130-01082008000900002,pacientes,o
213,S1130-01082008000900002,con,o
213,S1130-01082008000900002,dispepsia,i
213,S1130-01082008000900002,funcional,i
213,S1130-01082008000900002,Objetivo,o
213,S1130-01082008000900002,este,o
213,S1130-01082008000900002,estudio,o
213,S1130-01082008000900002,ha,o
213,S1130-01082008000900002,tenido,o
213,S1130-01082008000900002,un,o
213,S1130-01082008000900002,doble,o
213,S1130-01082008000900002,objetivo,o
213,S1130-01082008000900002,por,o
213,S1130-01082008000900002,un,o
213,S1130-01082008000900002,lado,o
213,S1130-01082008000900002,evaluar,o
213,S1130-01082008000900002,el,o
213,S1130-01082008000900002,efecto,o
213,S1130-01082008000900002,del,o
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,erradicador,i
213,S1130-01082008000900002,para,i
213,S1130-01082008000900002,Helicobacter,i
213,S1130-01082008000900002,pylori,i
213,S1130-01082008000900002,en,o
213,S1130-01082008000900002,la,o
213,S1130-01082008000900002,respuesta,o
213,S1130-01082008000900002,sintomatica,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,pacientes,o
213,S1130-01082008000900002,diagnosticados,i
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,dispepsia,i
213,S1130-01082008000900002,funcional,i
213,S1130-01082008000900002,y,o
213,S1130-01082008000900002,por,o
213,S1130-01082008000900002,otro,o
213,S1130-01082008000900002,determinar,o
213,S1130-01082008000900002,si,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,hallazgos,o
213,S1130-01082008000900002,histologicos,o
213,S1130-01082008000900002,podian,o
213,S1130-01082008000900002,servir,o
213,S1130-01082008000900002,como,o
213,S1130-01082008000900002,predictor,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,la,o
213,S1130-01082008000900002,efectividad,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,la,o
213,S1130-01082008000900002,terapia,i
213,S1130-01082008000900002,En,o
213,S1130-01082008000900002,particular,o
213,S1130-01082008000900002,se,o
213,S1130-01082008000900002,trato,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,averiguar,o
213,S1130-01082008000900002,si,o
213,S1130-01082008000900002,la,o
213,S1130-01082008000900002,presencia,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,gastritis,i
213,S1130-01082008000900002,antral,i
213,S1130-01082008000900002,la,o
213,S1130-01082008000900002,que,o
213,S1130-01082008000900002,se,o
213,S1130-01082008000900002,asocia,o
213,S1130-01082008000900002,a,o
213,S1130-01082008000900002,la,o
213,S1130-01082008000900002,enfermedad,i
213,S1130-01082008000900002,ulcerosa,i
213,S1130-01082008000900002,peptica,i
213,S1130-01082008000900002,podria,o
213,S1130-01082008000900002,predecir,o
213,S1130-01082008000900002,una,o
213,S1130-01082008000900002,mayor,o
213,S1130-01082008000900002,respuesta,o
213,S1130-01082008000900002,sintomatica,o
213,S1130-01082008000900002,al,o
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,erradicador,i
213,S1130-01082008000900002,en,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,pacientes,o
213,S1130-01082008000900002,con,o
213,S1130-01082008000900002,dispepsia,i
213,S1130-01082008000900002,funcional,i
213,S1130-01082008000900002,e,o
213,S1130-01082008000900002,infeccion,i
213,S1130-01082008000900002,por,i
213,S1130-01082008000900002,Helicobacter,i
213,S1130-01082008000900002,pylori,i
213,S1130-01082008000900002,Pacientes,o
213,S1130-01082008000900002,y,o
213,S1130-01082008000900002,metodos,o
213,S1130-01082008000900002,estudio,o
213,S1130-01082008000900002,prospectivo,o
213,S1130-01082008000900002,monocentrico,o
213,S1130-01082008000900002,y,o
213,S1130-01082008000900002,aleatorizado,o
213,S1130-01082008000900002,que,o
213,S1130-01082008000900002,incluyo,o
213,S1130-01082008000900002,a,o
213,S1130-01082008000900002,48,o
213,S1130-01082008000900002,pacientes,o
213,S1130-01082008000900002,con,o
213,S1130-01082008000900002,dispepsia,i
213,S1130-01082008000900002,funcional,i
213,S1130-01082008000900002,e,o
213,S1130-01082008000900002,infeccion,i
213,S1130-01082008000900002,por,i
213,S1130-01082008000900002,Helicobacter,i
213,S1130-01082008000900002,pylori,i
213,S1130-01082008000900002,27,o
213,S1130-01082008000900002,mujeres,o
213,S1130-01082008000900002,y,o
213,S1130-01082008000900002,21,o
213,S1130-01082008000900002,hombres,o
213,S1130-01082008000900002,con,o
213,S1130-01082008000900002,edad,o
213,S1130-01082008000900002,media,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,37,o
213,S1130-01082008000900002,135,o
213,S1130-01082008000900002,años,o
213,S1130-01082008000900002,Veintisiete,o
213,S1130-01082008000900002,pacientes,o
213,S1130-01082008000900002,recibieron,o
213,S1130-01082008000900002,el,o
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,erradicador,i
213,S1130-01082008000900002,rabeprazol,i
213,S1130-01082008000900002,claritromicina,i
213,S1130-01082008000900002,y,o
213,S1130-01082008000900002,amoxicilina,i
213,S1130-01082008000900002,durante,o
213,S1130-01082008000900002,10,o
213,S1130-01082008000900002,dias,o
213,S1130-01082008000900002,seguido,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,20,o
213,S1130-01082008000900002,mgdia,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,rabeprazol,i
213,S1130-01082008000900002,3,o
213,S1130-01082008000900002,meses,o
213,S1130-01082008000900002,y,o
213,S1130-01082008000900002,21,o
213,S1130-01082008000900002,el,o
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,control,o
213,S1130-01082008000900002,20,o
213,S1130-01082008000900002,mgdia,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,rabeprazol,i
213,S1130-01082008000900002,3,o
213,S1130-01082008000900002,meses,o
213,S1130-01082008000900002,Los,o
213,S1130-01082008000900002,pacientes,o
213,S1130-01082008000900002,fueron,o
213,S1130-01082008000900002,seguidos,i
213,S1130-01082008000900002,durante,o
213,S1130-01082008000900002,un,o
213,S1130-01082008000900002,año,o
213,S1130-01082008000900002,Todos,o
213,S1130-01082008000900002,rellenaron,i
213,S1130-01082008000900002,el,i
213,S1130-01082008000900002,Cuestionario,i
213,S1130-01082008000900002,de,i
213,S1130-01082008000900002,calidad,i
213,S1130-01082008000900002,de,i
213,S1130-01082008000900002,vida,i
213,S1130-01082008000900002,asociada,o
213,S1130-01082008000900002,a,o
213,S1130-01082008000900002,dispepsia,i
213,S1130-01082008000900002,que,o
213,S1130-01082008000900002,evalua,o
213,S1130-01082008000900002,cuatro,o
213,S1130-01082008000900002,apartados,o
213,S1130-01082008000900002,intensidad,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,sintomas,i
213,S1130-01082008000900002,habituales,o
213,S1130-01082008000900002,intensidad,o
213,S1130-01082008000900002,del,o
213,S1130-01082008000900002,dolor,i
213,S1130-01082008000900002,de,i
213,S1130-01082008000900002,estomago,i
213,S1130-01082008000900002,incapacidad,i
213,S1130-01082008000900002,debida,o
213,S1130-01082008000900002,al,o
213,S1130-01082008000900002,dolor,i
213,S1130-01082008000900002,y,o
213,S1130-01082008000900002,satisfaccion,o
213,S1130-01082008000900002,con,o
213,S1130-01082008000900002,la,o
213,S1130-01082008000900002,salud,o
213,S1130-01082008000900002,Resultados,o
213,S1130-01082008000900002,existio,o
213,S1130-01082008000900002,una,o
213,S1130-01082008000900002,mejoria,o
213,S1130-01082008000900002,significativa,o
213,S1130-01082008000900002,p,o
213,S1130-01082008000900002,0002,o
213,S1130-01082008000900002,en,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,sintomas,i
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,pacientes,o
213,S1130-01082008000900002,tanto,o
213,S1130-01082008000900002,a,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,6,o
213,S1130-01082008000900002,como,o
213,S1130-01082008000900002,a,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,12,o
213,S1130-01082008000900002,meses,o
213,S1130-01082008000900002,tras,o
213,S1130-01082008000900002,el,o
213,S1130-01082008000900002,inicio,o
213,S1130-01082008000900002,del,o
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,que,o
213,S1130-01082008000900002,ademas,o
213,S1130-01082008000900002,fue,o
213,S1130-01082008000900002,comun,o
213,S1130-01082008000900002,a,o
213,S1130-01082008000900002,las,o
213,S1130-01082008000900002,dos,o
213,S1130-01082008000900002,pautas,i
213,S1130-01082008000900002,de,i
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,En,o
213,S1130-01082008000900002,el,o
213,S1130-01082008000900002,analisis,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,regresion,o
213,S1130-01082008000900002,lineal,o
213,S1130-01082008000900002,multiple,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,efectos,o
213,S1130-01082008000900002,del,o
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,erradicador,i
213,S1130-01082008000900002,y,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,tener,o
213,S1130-01082008000900002,una,o
213,S1130-01082008000900002,sintomatologia,i
213,S1130-01082008000900002,menos,o
213,S1130-01082008000900002,intensa,o
213,S1130-01082008000900002,antes,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,recibir,o
213,S1130-01082008000900002,el,o
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,fueron,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,dos,o
213,S1130-01082008000900002,unicos,o
213,S1130-01082008000900002,factores,o
213,S1130-01082008000900002,independientes,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,forma,o
213,S1130-01082008000900002,significativa,o
213,S1130-01082008000900002,La,o
213,S1130-01082008000900002,respuesta,o
213,S1130-01082008000900002,al,o
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,erradicador,i
213,S1130-01082008000900002,a,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,6,o
213,S1130-01082008000900002,meses,o
213,S1130-01082008000900002,fue,o
213,S1130-01082008000900002,significativamente,o
213,S1130-01082008000900002,mayor,o
213,S1130-01082008000900002,que,o
213,S1130-01082008000900002,con,o
213,S1130-01082008000900002,el,o
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,control,o
213,S1130-01082008000900002,p,o
213,S1130-01082008000900002,001,o
213,S1130-01082008000900002,en,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,pacientes,o
213,S1130-01082008000900002,con,o
213,S1130-01082008000900002,gastritis,i
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,predominio,o
213,S1130-01082008000900002,antral,i
213,S1130-01082008000900002,y,o
213,S1130-01082008000900002,en,o
213,S1130-01082008000900002,el,o
213,S1130-01082008000900002,apartado,o
213,S1130-01082008000900002,concreto,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,sintomas,i
213,S1130-01082008000900002,habituales,o
213,S1130-01082008000900002,Conclusiones,o
213,S1130-01082008000900002,ambos,o
213,S1130-01082008000900002,tratamientos,i
213,S1130-01082008000900002,producen,o
213,S1130-01082008000900002,una,o
213,S1130-01082008000900002,mejoria,o
213,S1130-01082008000900002,sintomatica,o
213,S1130-01082008000900002,significativa,o
213,S1130-01082008000900002,en,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,pacientes,o
213,S1130-01082008000900002,con,o
213,S1130-01082008000900002,dispepsia,i
213,S1130-01082008000900002,funcional,i
213,S1130-01082008000900002,Se,o
213,S1130-01082008000900002,observa,o
213,S1130-01082008000900002,una,o
213,S1130-01082008000900002,tendencia,o
213,S1130-01082008000900002,hacia,o
213,S1130-01082008000900002,un,o
213,S1130-01082008000900002,beneficio,o
213,S1130-01082008000900002,sintomatico,o
213,S1130-01082008000900002,mayor,o
213,S1130-01082008000900002,con,o
213,S1130-01082008000900002,el,o
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,erradicador,i
213,S1130-01082008000900002,respecto,o
213,S1130-01082008000900002,al,o
213,S1130-01082008000900002,control,o
213,S1130-01082008000900002,en,o
213,S1130-01082008000900002,pacientes,o
213,S1130-01082008000900002,con,o
213,S1130-01082008000900002,dispepsia,i
213,S1130-01082008000900002,funcional,i
213,S1130-01082008000900002,y,o
213,S1130-01082008000900002,en,o
213,S1130-01082008000900002,un,o
213,S1130-01082008000900002,medio,o
213,S1130-01082008000900002,con,o
213,S1130-01082008000900002,elevada,o
213,S1130-01082008000900002,prevalencia,o
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,infeccion,i
213,S1130-01082008000900002,por,i
213,S1130-01082008000900002,Helicobacter,i
213,S1130-01082008000900002,pylori,i
213,S1130-01082008000900002,Existe,o
213,S1130-01082008000900002,una,o
213,S1130-01082008000900002,tendencia,o
213,S1130-01082008000900002,hacia,o
213,S1130-01082008000900002,la,o
213,S1130-01082008000900002,mejoria,o
213,S1130-01082008000900002,sintomatica,o
213,S1130-01082008000900002,con,o
213,S1130-01082008000900002,el,o
213,S1130-01082008000900002,tratamiento,i
213,S1130-01082008000900002,erradicador,i
213,S1130-01082008000900002,en,o
213,S1130-01082008000900002,los,o
213,S1130-01082008000900002,pacientes,o
213,S1130-01082008000900002,que,o
213,S1130-01082008000900002,tienen,o
213,S1130-01082008000900002,una,o
213,S1130-01082008000900002,gastritis,i
213,S1130-01082008000900002,de,o
213,S1130-01082008000900002,predominio,o
213,S1130-01082008000900002,antral,i
214,S1130-01082008001100002,Tratamiento,i
214,S1130-01082008001100002,de,i
214,S1130-01082008001100002,induccion,i
214,S1130-01082008001100002,y,i
214,S1130-01082008001100002,mantenimiento,i
214,S1130-01082008001100002,con,o
214,S1130-01082008001100002,adalimumab,i
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,enfermedad,i
214,S1130-01082008001100002,de,i
214,S1130-01082008001100002,Crohn,i
214,S1130-01082008001100002,un,o
214,S1130-01082008001100002,estudio,i
214,S1130-01082008001100002,abierto,i
214,S1130-01082008001100002,Introduccion,o
214,S1130-01082008001100002,el,o
214,S1130-01082008001100002,adalimumab,i
214,S1130-01082008001100002,ha,o
214,S1130-01082008001100002,demostrado,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,ensayos,i
214,S1130-01082008001100002,clinicos,i
214,S1130-01082008001100002,controlados,i
214,S1130-01082008001100002,con,i
214,S1130-01082008001100002,placebo,i
214,S1130-01082008001100002,y,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,estudios,i
214,S1130-01082008001100002,no,i
214,S1130-01082008001100002,controlados,i
214,S1130-01082008001100002,ser,o
214,S1130-01082008001100002,efectivo,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,EC,i
214,S1130-01082008001100002,luminal,i
214,S1130-01082008001100002,y,i
214,S1130-01082008001100002,fistulosa,i
214,S1130-01082008001100002,perianal,i
214,S1130-01082008001100002,Objetivo,o
214,S1130-01082008001100002,evaluar,i
214,S1130-01082008001100002,la,i
214,S1130-01082008001100002,eficacia,i
214,S1130-01082008001100002,y,i
214,S1130-01082008001100002,seguridad,i
214,S1130-01082008001100002,del,o
214,S1130-01082008001100002,adalimumab,i
214,S1130-01082008001100002,como,o
214,S1130-01082008001100002,tratamiento,i
214,S1130-01082008001100002,de,i
214,S1130-01082008001100002,induccion,i
214,S1130-01082008001100002,y,i
214,S1130-01082008001100002,mantenimiento,i
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,EC,i
214,S1130-01082008001100002,Metodologia,o
214,S1130-01082008001100002,se,o
214,S1130-01082008001100002,incluyeron,o
214,S1130-01082008001100002,22,o
214,S1130-01082008001100002,pacientes,o
214,S1130-01082008001100002,con,o
214,S1130-01082008001100002,EC,i
214,S1130-01082008001100002,tratados,i
214,S1130-01082008001100002,con,o
214,S1130-01082008001100002,adalimumab,i
214,S1130-01082008001100002,16,o
214,S1130-01082008001100002,por,o
214,S1130-01082008001100002,enfermedad,i
214,S1130-01082008001100002,luminal,i
214,S1130-01082008001100002,y,o
214,S1130-01082008001100002,6,o
214,S1130-01082008001100002,por,o
214,S1130-01082008001100002,enfermedad,i
214,S1130-01082008001100002,fistulosa,i
214,S1130-01082008001100002,perianal,i
214,S1130-01082008001100002,activa,o
214,S1130-01082008001100002,Veintiun,o
214,S1130-01082008001100002,pacientes,o
214,S1130-01082008001100002,habian,o
214,S1130-01082008001100002,recibido,o
214,S1130-01082008001100002,previamente,o
214,S1130-01082008001100002,IFX,i
214,S1130-01082008001100002,Se,o
214,S1130-01082008001100002,realizo,o
214,S1130-01082008001100002,tratamiento,i
214,S1130-01082008001100002,de,i
214,S1130-01082008001100002,induccion,i
214,S1130-01082008001100002,con,o
214,S1130-01082008001100002,160,o
214,S1130-01082008001100002,mg,o
214,S1130-01082008001100002,sc,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,semana,o
214,S1130-01082008001100002,0,o
214,S1130-01082008001100002,y,o
214,S1130-01082008001100002,80,o
214,S1130-01082008001100002,mg,o
214,S1130-01082008001100002,sc,o
214,S1130-01082008001100002,a,o
214,S1130-01082008001100002,las,o
214,S1130-01082008001100002,2,o
214,S1130-01082008001100002,semanas,o
214,S1130-01082008001100002,Los,o
214,S1130-01082008001100002,respondedores,o
214,S1130-01082008001100002,recibieron,o
214,S1130-01082008001100002,40,o
214,S1130-01082008001100002,mg,o
214,S1130-01082008001100002,sc,o
214,S1130-01082008001100002,cada,o
214,S1130-01082008001100002,14,o
214,S1130-01082008001100002,dias,o
214,S1130-01082008001100002,como,o
214,S1130-01082008001100002,tratamiento,i
214,S1130-01082008001100002,de,i
214,S1130-01082008001100002,mantenimiento,i
214,S1130-01082008001100002,Se,o
214,S1130-01082008001100002,valoro,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,respuesta,o
214,S1130-01082008001100002,a,o
214,S1130-01082008001100002,las,o
214,S1130-01082008001100002,4,o
214,S1130-01082008001100002,semanas,o
214,S1130-01082008001100002,de,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,dosis,o
214,S1130-01082008001100002,inicial,o
214,S1130-01082008001100002,y,o
214,S1130-01082008001100002,se,o
214,S1130-01082008001100002,clasifico,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,respuesta,o
214,S1130-01082008001100002,como,o
214,S1130-01082008001100002,remision,o
214,S1130-01082008001100002,respuesta,o
214,S1130-01082008001100002,parcial,o
214,S1130-01082008001100002,o,o
214,S1130-01082008001100002,ausencia,o
214,S1130-01082008001100002,de,o
214,S1130-01082008001100002,respuesta,o
214,S1130-01082008001100002,Resultados,o
214,S1130-01082008001100002,tras,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,induccion,i
214,S1130-01082008001100002,el,o
214,S1130-01082008001100002,25,o
214,S1130-01082008001100002,de,o
214,S1130-01082008001100002,los,o
214,S1130-01082008001100002,pacientes,o
214,S1130-01082008001100002,con,o
214,S1130-01082008001100002,enfermedad,i
214,S1130-01082008001100002,luminal,i
214,S1130-01082008001100002,tuvieron,o
214,S1130-01082008001100002,remision,o
214,S1130-01082008001100002,completa,o
214,S1130-01082008001100002,y,o
214,S1130-01082008001100002,el,o
214,S1130-01082008001100002,563,o
214,S1130-01082008001100002,respuesta,o
214,S1130-01082008001100002,parcial,o
214,S1130-01082008001100002,La,o
214,S1130-01082008001100002,respuesta,o
214,S1130-01082008001100002,clinica,o
214,S1130-01082008001100002,se,o
214,S1130-01082008001100002,mantuvo,o
214,S1130-01082008001100002,al,o
214,S1130-01082008001100002,año,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,el,o
214,S1130-01082008001100002,716,o
214,S1130-01082008001100002,de,o
214,S1130-01082008001100002,los,o
214,S1130-01082008001100002,pacientes,o
214,S1130-01082008001100002,a,o
214,S1130-01082008001100002,los,o
214,S1130-01082008001100002,18,o
214,S1130-01082008001100002,meses,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,el,o
214,S1130-01082008001100002,537,o
214,S1130-01082008001100002,y,o
214,S1130-01082008001100002,a,o
214,S1130-01082008001100002,los,o
214,S1130-01082008001100002,48,o
214,S1130-01082008001100002,meses,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,el,o
214,S1130-01082008001100002,358,o
214,S1130-01082008001100002,No,o
214,S1130-01082008001100002,se,o
214,S1130-01082008001100002,objetivaron,o
214,S1130-01082008001100002,diferencias,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,respuesta,o
214,S1130-01082008001100002,entre,o
214,S1130-01082008001100002,pacientes,o
214,S1130-01082008001100002,que,o
214,S1130-01082008001100002,presentaron,o
214,S1130-01082008001100002,reacciones,i
214,S1130-01082008001100002,de,i
214,S1130-01082008001100002,hipersensibilidad,i
214,S1130-01082008001100002,o,o
214,S1130-01082008001100002,perdida,o
214,S1130-01082008001100002,de,o
214,S1130-01082008001100002,respuesta,o
214,S1130-01082008001100002,a,o
214,S1130-01082008001100002,IFX,i
214,S1130-01082008001100002,Todos,o
214,S1130-01082008001100002,los,o
214,S1130-01082008001100002,pacientes,o
214,S1130-01082008001100002,con,o
214,S1130-01082008001100002,enfermedad,i
214,S1130-01082008001100002,fistulosa,i
214,S1130-01082008001100002,perianal,i
214,S1130-01082008001100002,n,o
214,S1130-01082008001100002,6,o
214,S1130-01082008001100002,habian,o
214,S1130-01082008001100002,recibido,o
214,S1130-01082008001100002,previamente,o
214,S1130-01082008001100002,tratamiento,i
214,S1130-01082008001100002,con,o
214,S1130-01082008001100002,IFX,i
214,S1130-01082008001100002,Tras,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,induccion,i
214,S1130-01082008001100002,un,o
214,S1130-01082008001100002,167,o
214,S1130-01082008001100002,entran,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,remision,o
214,S1130-01082008001100002,y,o
214,S1130-01082008001100002,un,o
214,S1130-01082008001100002,667,o
214,S1130-01082008001100002,presentan,o
214,S1130-01082008001100002,respuesta,o
214,S1130-01082008001100002,parcial,o
214,S1130-01082008001100002,Todos,o
214,S1130-01082008001100002,los,o
214,S1130-01082008001100002,pacientes,o
214,S1130-01082008001100002,mantienen,o
214,S1130-01082008001100002,remision,o
214,S1130-01082008001100002,o,o
214,S1130-01082008001100002,respuesta,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,el,o
214,S1130-01082008001100002,tiempo,o
214,S1130-01082008001100002,con,o
214,S1130-01082008001100002,una,o
214,S1130-01082008001100002,mediana,o
214,S1130-01082008001100002,de,o
214,S1130-01082008001100002,seguimiento,i
214,S1130-01082008001100002,de,o
214,S1130-01082008001100002,15,o
214,S1130-01082008001100002,meses,o
214,S1130-01082008001100002,Conclusiones,o
214,S1130-01082008001100002,el,o
214,S1130-01082008001100002,adalimumab,i
214,S1130-01082008001100002,es,o
214,S1130-01082008001100002,un,o
214,S1130-01082008001100002,tratamiento,i
214,S1130-01082008001100002,eficaz,o
214,S1130-01082008001100002,y,o
214,S1130-01082008001100002,seguro,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,induccion,i
214,S1130-01082008001100002,y,o
214,S1130-01082008001100002,mantenimiento,i
214,S1130-01082008001100002,de,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,respuesta,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,EC,i
214,S1130-01082008001100002,luminal,i
214,S1130-01082008001100002,y,i
214,S1130-01082008001100002,fistulosa,i
214,S1130-01082008001100002,perianal,i
214,S1130-01082008001100002,Estos,o
214,S1130-01082008001100002,resultados,o
214,S1130-01082008001100002,confirman,o
214,S1130-01082008001100002,que,o
214,S1130-01082008001100002,los,o
214,S1130-01082008001100002,hallazgos,o
214,S1130-01082008001100002,obtenidos,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,los,o
214,S1130-01082008001100002,ensayos,i
214,S1130-01082008001100002,clinicos,i
214,S1130-01082008001100002,controlados,i
214,S1130-01082008001100002,son,o
214,S1130-01082008001100002,reproducibles,o
214,S1130-01082008001100002,en,o
214,S1130-01082008001100002,la,o
214,S1130-01082008001100002,practica,i
214,S1130-01082008001100002,clinica,i
214,S1130-01082008001100002,diaria,o
215,S1130-01082009000600004,Eficacia,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,una,o
215,S1130-01082009000600004,triple,o
215,S1130-01082009000600004,terapia,i
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,un,o
215,S1130-01082009000600004,inhibidor,i
215,S1130-01082009000600004,de,i
215,S1130-01082009000600004,la,i
215,S1130-01082009000600004,bomba,i
215,S1130-01082009000600004,de,i
215,S1130-01082009000600004,protones,i
215,S1130-01082009000600004,levofloxacino,i
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,amoxicilina,i
215,S1130-01082009000600004,como,o
215,S1130-01082009000600004,primer,o
215,S1130-01082009000600004,tratamiento,i
215,S1130-01082009000600004,en,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,erradicacion,i
215,S1130-01082009000600004,de,i
215,S1130-01082009000600004,Helicobacter,i
215,S1130-01082009000600004,pylori,i
215,S1130-01082009000600004,Introduccion,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,triple,o
215,S1130-01082009000600004,terapia,i
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,un,o
215,S1130-01082009000600004,inhibidor,i
215,S1130-01082009000600004,de,i
215,S1130-01082009000600004,la,i
215,S1130-01082009000600004,bomba,i
215,S1130-01082009000600004,de,i
215,S1130-01082009000600004,protones,i
215,S1130-01082009000600004,claritromicina,i
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,amoxicilina,i
215,S1130-01082009000600004,IBPCA,o
215,S1130-01082009000600004,es,o
215,S1130-01082009000600004,el,o
215,S1130-01082009000600004,tratamiento,i
215,S1130-01082009000600004,de,i
215,S1130-01082009000600004,primera,i
215,S1130-01082009000600004,eleccion,i
215,S1130-01082009000600004,mas,o
215,S1130-01082009000600004,utilizado,o
215,S1130-01082009000600004,en,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,erradicacion,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,H,o
215,S1130-01082009000600004,pylori,o
215,S1130-01082009000600004,La,o
215,S1130-01082009000600004,eficacia,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,este,o
215,S1130-01082009000600004,tratamiento,i
215,S1130-01082009000600004,esta,o
215,S1130-01082009000600004,disminuyendo,o
215,S1130-01082009000600004,en,o
215,S1130-01082009000600004,los,o
215,S1130-01082009000600004,ultimos,o
215,S1130-01082009000600004,años,o
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,se,o
215,S1130-01082009000600004,estan,o
215,S1130-01082009000600004,valorando,o
215,S1130-01082009000600004,otras,o
215,S1130-01082009000600004,alternativas,o
215,S1130-01082009000600004,terapeuticas,o
215,S1130-01082009000600004,Objetivos,o
215,S1130-01082009000600004,valorar,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,eficacia,o
215,S1130-01082009000600004,cumplimiento,o
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,seguridad,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,una,o
215,S1130-01082009000600004,triple,o
215,S1130-01082009000600004,terapia,i
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,un,o
215,S1130-01082009000600004,IBP,i
215,S1130-01082009000600004,amoxicilina,i
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,levofloxacino,i
215,S1130-01082009000600004,sustituyendo,o
215,S1130-01082009000600004,a,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,claritromicina,i
215,S1130-01082009000600004,en,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,erradicacion,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,H,o
215,S1130-01082009000600004,pylori,o
215,S1130-01082009000600004,Metodos,o
215,S1130-01082009000600004,periodo,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,estudio,o
215,S1130-01082009000600004,20072008,o
215,S1130-01082009000600004,Se,o
215,S1130-01082009000600004,incluyen,o
215,S1130-01082009000600004,135,o
215,S1130-01082009000600004,pacientes,o
215,S1130-01082009000600004,65,o
215,S1130-01082009000600004,mujeres,o
215,S1130-01082009000600004,edad,o
215,S1130-01082009000600004,media,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,53,o
215,S1130-01082009000600004,años,o
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,sintomas,i
215,S1130-01082009000600004,dispepticos,i
215,S1130-01082009000600004,e,o
215,S1130-01082009000600004,infeccion,o
215,S1130-01082009000600004,por,o
215,S1130-01082009000600004,H,o
215,S1130-01082009000600004,pylori,o
215,S1130-01082009000600004,constatada,o
215,S1130-01082009000600004,por,o
215,S1130-01082009000600004,positividad,o
215,S1130-01082009000600004,del,o
215,S1130-01082009000600004,test,i
215,S1130-01082009000600004,rapido,i
215,S1130-01082009000600004,de,i
215,S1130-01082009000600004,la,i
215,S1130-01082009000600004,ureasa,i
215,S1130-01082009000600004,histologia,i
215,S1130-01082009000600004,o,o
215,S1130-01082009000600004,prueba,o
215,S1130-01082009000600004,del,o
215,S1130-01082009000600004,aliento,o
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,ureaC13,o
215,S1130-01082009000600004,Diagnosticos,i
215,S1130-01082009000600004,dispepsia,i
215,S1130-01082009000600004,no,o
215,S1130-01082009000600004,investigada,o
215,S1130-01082009000600004,489,o
215,S1130-01082009000600004,dispepsia,i
215,S1130-01082009000600004,funcional,i
215,S1130-01082009000600004,363,o
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,dispepsia,i
215,S1130-01082009000600004,ulcerosa,i
215,S1130-01082009000600004,148,o
215,S1130-01082009000600004,Se,o
215,S1130-01082009000600004,indica,o
215,S1130-01082009000600004,tratamiento,i
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,un,o
215,S1130-01082009000600004,inhibidor,i
215,S1130-01082009000600004,de,i
215,S1130-01082009000600004,la,i
215,S1130-01082009000600004,bomba,i
215,S1130-01082009000600004,de,i
215,S1130-01082009000600004,protones,i
215,S1130-01082009000600004,a,o
215,S1130-01082009000600004,dosis,o
215,S1130-01082009000600004,habitual,o
215,S1130-01082009000600004,amoxicilina,i
215,S1130-01082009000600004,1,o
215,S1130-01082009000600004,g,o
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,levofloxacino,i
215,S1130-01082009000600004,500,o
215,S1130-01082009000600004,mg,o
215,S1130-01082009000600004,IBPLA,o
215,S1130-01082009000600004,administrados,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,forma,o
215,S1130-01082009000600004,conjunta,o
215,S1130-01082009000600004,en,o
215,S1130-01082009000600004,desayuno,o
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,cena,o
215,S1130-01082009000600004,durante,o
215,S1130-01082009000600004,10,o
215,S1130-01082009000600004,dias,o
215,S1130-01082009000600004,Se,o
215,S1130-01082009000600004,valora,i
215,S1130-01082009000600004,el,i
215,S1130-01082009000600004,cumplimiento,i
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,triple,o
215,S1130-01082009000600004,terapia,i
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,sus,o
215,S1130-01082009000600004,efectos,i
215,S1130-01082009000600004,adversos,i
215,S1130-01082009000600004,mediante,o
215,S1130-01082009000600004,interrogatorio,i
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,su,o
215,S1130-01082009000600004,eficacia,o
215,S1130-01082009000600004,mediante,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,negatividad,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,prueba,o
215,S1130-01082009000600004,del,o
215,S1130-01082009000600004,aliento,o
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,ureaC13,o
215,S1130-01082009000600004,practicada,o
215,S1130-01082009000600004,a,o
215,S1130-01082009000600004,las,o
215,S1130-01082009000600004,68,o
215,S1130-01082009000600004,semanas,o
215,S1130-01082009000600004,del,o
215,S1130-01082009000600004,termino,o
215,S1130-01082009000600004,del,o
215,S1130-01082009000600004,tratamiento,i
215,S1130-01082009000600004,Se,o
215,S1130-01082009000600004,compara,i
215,S1130-01082009000600004,la,i
215,S1130-01082009000600004,eficacia,i
215,S1130-01082009000600004,por,o
215,S1130-01082009000600004,protocolo,i
215,S1130-01082009000600004,del,o
215,S1130-01082009000600004,tratamiento,i
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,IBPLA,o
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,observada,o
215,S1130-01082009000600004,en,o
215,S1130-01082009000600004,un,o
215,S1130-01082009000600004,grupo,o
215,S1130-01082009000600004,control,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,270,o
215,S1130-01082009000600004,pacientes,o
215,S1130-01082009000600004,tratados,i
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,IBPCA,o
215,S1130-01082009000600004,durante,o
215,S1130-01082009000600004,10,o
215,S1130-01082009000600004,dias,o
215,S1130-01082009000600004,en,o
215,S1130-01082009000600004,los,o
215,S1130-01082009000600004,años,o
215,S1130-01082009000600004,20062007,o
215,S1130-01082009000600004,Resultados,o
215,S1130-01082009000600004,130135,o
215,S1130-01082009000600004,pacientes,o
215,S1130-01082009000600004,962,o
215,S1130-01082009000600004,del,o
215,S1130-01082009000600004,grupo,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,estudio,o
215,S1130-01082009000600004,completaron,o
215,S1130-01082009000600004,el,o
215,S1130-01082009000600004,tratamiento,i
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,el,o
215,S1130-01082009000600004,protocolo,i
215,S1130-01082009000600004,del,o
215,S1130-01082009000600004,seguimiento,i
215,S1130-01082009000600004,La,o
215,S1130-01082009000600004,eficacia,o
215,S1130-01082009000600004,por,o
215,S1130-01082009000600004,intencion,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,tratar,i
215,S1130-01082009000600004,fue,o
215,S1130-01082009000600004,del,o
215,S1130-01082009000600004,718,o
215,S1130-01082009000600004,97135,o
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,por,o
215,S1130-01082009000600004,protocolo,i
215,S1130-01082009000600004,del,o
215,S1130-01082009000600004,746,o
215,S1130-01082009000600004,97130,o
215,S1130-01082009000600004,Dieciseis,o
215,S1130-01082009000600004,pacientes,o
215,S1130-01082009000600004,118,o
215,S1130-01082009000600004,presentaron,o
215,S1130-01082009000600004,efectos,i
215,S1130-01082009000600004,adversos,i
215,S1130-01082009000600004,bien,o
215,S1130-01082009000600004,tolerados,o
215,S1130-01082009000600004,excepto,o
215,S1130-01082009000600004,en,o
215,S1130-01082009000600004,5,o
215,S1130-01082009000600004,pacientes,o
215,S1130-01082009000600004,37,o
215,S1130-01082009000600004,que,o
215,S1130-01082009000600004,motivan,o
215,S1130-01082009000600004,el,o
215,S1130-01082009000600004,abandono,o
215,S1130-01082009000600004,del,o
215,S1130-01082009000600004,tratamiento,i
215,S1130-01082009000600004,El,o
215,S1130-01082009000600004,tratamiento,i
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,IBPCA,o
215,S1130-01082009000600004,resulto,o
215,S1130-01082009000600004,eficaz,o
215,S1130-01082009000600004,por,o
215,S1130-01082009000600004,protocolo,i
215,S1130-01082009000600004,en,o
215,S1130-01082009000600004,204270,o
215,S1130-01082009000600004,755,o
215,S1130-01082009000600004,pacientes,o
215,S1130-01082009000600004,del,o
215,S1130-01082009000600004,grupo,o
215,S1130-01082009000600004,control,o
215,S1130-01082009000600004,Conclusiones,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,triple,o
215,S1130-01082009000600004,terapia,i
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,un,o
215,S1130-01082009000600004,IBP,i
215,S1130-01082009000600004,amoxicilina,i
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,levofloxacino,i
215,S1130-01082009000600004,durante,o
215,S1130-01082009000600004,10,o
215,S1130-01082009000600004,dias,o
215,S1130-01082009000600004,es,o
215,S1130-01082009000600004,un,o
215,S1130-01082009000600004,tratamiento,i
215,S1130-01082009000600004,bien,o
215,S1130-01082009000600004,tolerado,o
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,facil,o
215,S1130-01082009000600004,cumplimiento,o
215,S1130-01082009000600004,pero,o
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,una,o
215,S1130-01082009000600004,baja,o
215,S1130-01082009000600004,eficacia,o
215,S1130-01082009000600004,inferior,o
215,S1130-01082009000600004,al,o
215,S1130-01082009000600004,80,o
215,S1130-01082009000600004,similar,o
215,S1130-01082009000600004,a,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,obtenida,o
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,triple,o
215,S1130-01082009000600004,terapia,i
215,S1130-01082009000600004,clasica,o
215,S1130-01082009000600004,con,o
215,S1130-01082009000600004,un,o
215,S1130-01082009000600004,IBP,i
215,S1130-01082009000600004,claritromicina,i
215,S1130-01082009000600004,y,o
215,S1130-01082009000600004,amoxicilina,i
215,S1130-01082009000600004,no,o
215,S1130-01082009000600004,siendo,o
215,S1130-01082009000600004,un,o
215,S1130-01082009000600004,tratamiento,i
215,S1130-01082009000600004,de,i
215,S1130-01082009000600004,primera,i
215,S1130-01082009000600004,eleccion,i
215,S1130-01082009000600004,recomendable,o
215,S1130-01082009000600004,en,o
215,S1130-01082009000600004,nuestra,o
215,S1130-01082009000600004,area,o
215,S1130-01082009000600004,sanitaria,o
215,S1130-01082009000600004,en,o
215,S1130-01082009000600004,la,o
215,S1130-01082009000600004,erradicacion,o
215,S1130-01082009000600004,de,o
215,S1130-01082009000600004,H,o
215,S1130-01082009000600004,pylori,o
216,S1130-01082011001100004,Argon,i
216,S1130-01082011001100004,plasma,i
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,oxigeno,i
216,S1130-01082011001100004,hiperbarico,i
216,S1130-01082011001100004,para,o
216,S1130-01082011001100004,el,o
216,S1130-01082011001100004,control,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,rectorragia,i
216,S1130-01082011001100004,cronica,o
216,S1130-01082011001100004,secundaria,o
216,S1130-01082011001100004,a,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,proctopatia,i
216,S1130-01082011001100004,por,i
216,S1130-01082011001100004,radiacion,i
216,S1130-01082011001100004,Introduccion,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,proctopatia,i
216,S1130-01082011001100004,por,i
216,S1130-01082011001100004,radiacion,i
216,S1130-01082011001100004,PPR,o
216,S1130-01082011001100004,se,o
216,S1130-01082011001100004,asocia,o
216,S1130-01082011001100004,con,o
216,S1130-01082011001100004,rectorragia,i
216,S1130-01082011001100004,recurrente,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,requerimientos,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,trasfusiones,i
216,S1130-01082011001100004,La,o
216,S1130-01082011001100004,coagulacion,i
216,S1130-01082011001100004,con,i
216,S1130-01082011001100004,argon,i
216,S1130-01082011001100004,plasma,i
216,S1130-01082011001100004,APC,i
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,terapia,i
216,S1130-01082011001100004,con,i
216,S1130-01082011001100004,oxigeno,i
216,S1130-01082011001100004,hiperbarico,i
216,S1130-01082011001100004,HOT,i
216,S1130-01082011001100004,han,o
216,S1130-01082011001100004,sido,o
216,S1130-01082011001100004,efectivas,o
216,S1130-01082011001100004,en,o
216,S1130-01082011001100004,el,o
216,S1130-01082011001100004,control,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,PPR,o
216,S1130-01082011001100004,No,o
216,S1130-01082011001100004,hay,o
216,S1130-01082011001100004,estudios,i
216,S1130-01082011001100004,prospectivos,i
216,S1130-01082011001100004,comparativos,i
216,S1130-01082011001100004,entre,o
216,S1130-01082011001100004,ambas,o
216,S1130-01082011001100004,tecnicas,o
216,S1130-01082011001100004,Objetivo,o
216,S1130-01082011001100004,el,o
216,S1130-01082011001100004,objetivo,o
216,S1130-01082011001100004,del,o
216,S1130-01082011001100004,estudio,o
216,S1130-01082011001100004,es,o
216,S1130-01082011001100004,evaluar,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,efectividad,o
216,S1130-01082011001100004,seguridad,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,el,o
216,S1130-01082011001100004,impacto,o
216,S1130-01082011001100004,en,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,toxicidad,i
216,S1130-01082011001100004,tisular,i
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,APC,i
216,S1130-01082011001100004,comparado,o
216,S1130-01082011001100004,con,o
216,S1130-01082011001100004,el,o
216,S1130-01082011001100004,HOT,i
216,S1130-01082011001100004,en,o
216,S1130-01082011001100004,los,o
216,S1130-01082011001100004,pacientes,o
216,S1130-01082011001100004,con,o
216,S1130-01082011001100004,PR,o
216,S1130-01082011001100004,Material,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,metodos,o
216,S1130-01082011001100004,se,o
216,S1130-01082011001100004,realizo,o
216,S1130-01082011001100004,un,o
216,S1130-01082011001100004,estudio,i
216,S1130-01082011001100004,prospectivo,i
216,S1130-01082011001100004,para,o
216,S1130-01082011001100004,evaluar,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,respuesta,o
216,S1130-01082011001100004,al,o
216,S1130-01082011001100004,tratamiento,i
216,S1130-01082011001100004,Se,o
216,S1130-01082011001100004,incluyeron,o
216,S1130-01082011001100004,a,o
216,S1130-01082011001100004,pacientes,o
216,S1130-01082011001100004,con,o
216,S1130-01082011001100004,cancer,i
216,S1130-01082011001100004,cervicouterino,i
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,PPR,o
216,S1130-01082011001100004,con,o
216,S1130-01082011001100004,rectorragia,i
216,S1130-01082011001100004,recurrente,o
216,S1130-01082011001100004,sin,o
216,S1130-01082011001100004,haber,o
216,S1130-01082011001100004,recibido,o
216,S1130-01082011001100004,tratamientos,i
216,S1130-01082011001100004,previos,o
216,S1130-01082011001100004,Se,o
216,S1130-01082011001100004,tomaron,o
216,S1130-01082011001100004,datos,o
216,S1130-01082011001100004,demograficos,o
216,S1130-01082011001100004,dosis,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,radiacion,o
216,S1130-01082011001100004,duracion,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,severidad,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,rectorragia,i
216,S1130-01082011001100004,niveles,i
216,S1130-01082011001100004,de,i
216,S1130-01082011001100004,hemoglobina,i
216,S1130-01082011001100004,requerimientos,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,trasfusiones,i
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,toxicidad,i
216,S1130-01082011001100004,tisular,i
216,S1130-01082011001100004,Cuestionario,i
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,SOMALENT,o
216,S1130-01082011001100004,al,o
216,S1130-01082011001100004,inicio,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,a,o
216,S1130-01082011001100004,los,o
216,S1130-01082011001100004,1,o
216,S1130-01082011001100004,2,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,3,o
216,S1130-01082011001100004,meses,o
216,S1130-01082011001100004,del,o
216,S1130-01082011001100004,tratamiento,i
216,S1130-01082011001100004,Resultados,o
216,S1130-01082011001100004,se,o
216,S1130-01082011001100004,incluyeron,o
216,S1130-01082011001100004,a,o
216,S1130-01082011001100004,31,o
216,S1130-01082011001100004,pacientes,o
216,S1130-01082011001100004,con,o
216,S1130-01082011001100004,PPR,o
216,S1130-01082011001100004,14,o
216,S1130-01082011001100004,en,o
216,S1130-01082011001100004,el,o
216,S1130-01082011001100004,grupo,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,APC,i
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,17,o
216,S1130-01082011001100004,en,o
216,S1130-01082011001100004,el,o
216,S1130-01082011001100004,grupo,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,HOT,i
216,S1130-01082011001100004,No,o
216,S1130-01082011001100004,hubo,o
216,S1130-01082011001100004,respuesta,o
216,S1130-01082011001100004,en,o
216,S1130-01082011001100004,el,o
216,S1130-01082011001100004,13,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,18,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,los,o
216,S1130-01082011001100004,pacientes,o
216,S1130-01082011001100004,en,o
216,S1130-01082011001100004,el,o
216,S1130-01082011001100004,grupo,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,APC,i
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,OHT,o
216,S1130-01082011001100004,respectivamente,o
216,S1130-01082011001100004,p,o
216,S1130-01082011001100004,NS,o
216,S1130-01082011001100004,Al,o
216,S1130-01082011001100004,primer,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,segundo,o
216,S1130-01082011001100004,mes,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,seguimiento,i
216,S1130-01082011001100004,el,o
216,S1130-01082011001100004,grupo,o
216,S1130-01082011001100004,APC,i
216,S1130-01082011001100004,mostro,o
216,S1130-01082011001100004,una,o
216,S1130-01082011001100004,mejoria,o
216,S1130-01082011001100004,significativa,o
216,S1130-01082011001100004,en,o
216,S1130-01082011001100004,los,o
216,S1130-01082011001100004,parametros,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,requerimientos,i
216,S1130-01082011001100004,trasfusionales,i
216,S1130-01082011001100004,06,o
216,S1130-01082011001100004,vs,o
216,S1130-01082011001100004,34,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,07,o
216,S1130-01082011001100004,vs,o
216,S1130-01082011001100004,25,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,en,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,toxicidad,i
216,S1130-01082011001100004,tisular,i
216,S1130-01082011001100004,53,o
216,S1130-01082011001100004,vs,o
216,S1130-01082011001100004,86,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,38,o
216,S1130-01082011001100004,vs,o
216,S1130-01082011001100004,72,o
216,S1130-01082011001100004,Despues,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,3,o
216,S1130-01082011001100004,meses,o
216,S1130-01082011001100004,de,o
216,S1130-01082011001100004,seguimiento,i
216,S1130-01082011001100004,ambos,o
216,S1130-01082011001100004,grupos,o
216,S1130-01082011001100004,mostraron,o
216,S1130-01082011001100004,mejoria,o
216,S1130-01082011001100004,en,o
216,S1130-01082011001100004,todos,o
216,S1130-01082011001100004,los,o
216,S1130-01082011001100004,parametros,o
216,S1130-01082011001100004,sin,o
216,S1130-01082011001100004,haber,o
216,S1130-01082011001100004,diferencias,o
216,S1130-01082011001100004,estadisticamente,o
216,S1130-01082011001100004,significativas,o
216,S1130-01082011001100004,Conclusiones,o
216,S1130-01082011001100004,APC,i
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,HOT,i
216,S1130-01082011001100004,fueron,o
216,S1130-01082011001100004,efectivos,o
216,S1130-01082011001100004,seguros,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,disminuyeron,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,toxicidad,i
216,S1130-01082011001100004,tisular,i
216,S1130-01082011001100004,en,o
216,S1130-01082011001100004,los,o
216,S1130-01082011001100004,pacientes,o
216,S1130-01082011001100004,con,o
216,S1130-01082011001100004,PPR,o
216,S1130-01082011001100004,Sin,o
216,S1130-01082011001100004,embargo,o
216,S1130-01082011001100004,la,o
216,S1130-01082011001100004,respuesta,o
216,S1130-01082011001100004,fue,o
216,S1130-01082011001100004,mas,o
216,S1130-01082011001100004,efectiva,o
216,S1130-01082011001100004,y,o
216,S1130-01082011001100004,rapida,o
216,S1130-01082011001100004,en,o
216,S1130-01082011001100004,el,o
216,S1130-01082011001100004,grupo,o
216,S1130-01082011001100004,del,o
216,S1130-01082011001100004,APC,i
217,S1130-01082012000500003,Insuflacion,i
217,S1130-01082012000500003,de,i
217,S1130-01082012000500003,CO2,i
217,S1130-01082012000500003,vs,o
217,S1130-01082012000500003,aire,o
217,S1130-01082012000500003,en,o
217,S1130-01082012000500003,ileocolonoscopia,o
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,en,o
217,S1130-01082012000500003,gastroscopia,i
217,S1130-01082012000500003,mas,o
217,S1130-01082012000500003,ileocolonoscopia,o
217,S1130-01082012000500003,estudio,i
217,S1130-01082012000500003,comparativo,i
217,S1130-01082012000500003,Introduccion,o
217,S1130-01082012000500003,la,o
217,S1130-01082012000500003,insuflacion,i
217,S1130-01082012000500003,con,i
217,S1130-01082012000500003,dioxido,i
217,S1130-01082012000500003,de,i
217,S1130-01082012000500003,carbono,i
217,S1130-01082012000500003,CO2,i
217,S1130-01082012000500003,durante,o
217,S1130-01082012000500003,las,o
217,S1130-01082012000500003,endoscopias,i
217,S1130-01082012000500003,digestivas,i
217,S1130-01082012000500003,comparado,o
217,S1130-01082012000500003,con,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,aire,o
217,S1130-01082012000500003,se,o
217,S1130-01082012000500003,asocia,o
217,S1130-01082012000500003,a,o
217,S1130-01082012000500003,una,o
217,S1130-01082012000500003,disminucion,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,las,o
217,S1130-01082012000500003,molestias,i
217,S1130-01082012000500003,abdominales,i
217,S1130-01082012000500003,despues,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,la,o
217,S1130-01082012000500003,exploracion,i
217,S1130-01082012000500003,ya,o
217,S1130-01082012000500003,que,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,CO2,i
217,S1130-01082012000500003,es,o
217,S1130-01082012000500003,facilmente,o
217,S1130-01082012000500003,absorbido,o
217,S1130-01082012000500003,por,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,intestino,i
217,S1130-01082012000500003,delgado,i
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,eliminado,o
217,S1130-01082012000500003,por,o
217,S1130-01082012000500003,los,o
217,S1130-01082012000500003,pulmones,i
217,S1130-01082012000500003,Objetivo,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,objetivo,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,este,o
217,S1130-01082012000500003,ensayo,i
217,S1130-01082012000500003,clinico,i
217,S1130-01082012000500003,aleatorizado,i
217,S1130-01082012000500003,fue,o
217,S1130-01082012000500003,valorar,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,efecto,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,la,o
217,S1130-01082012000500003,insuflacion,i
217,S1130-01082012000500003,de,i
217,S1130-01082012000500003,CO2,i
217,S1130-01082012000500003,sobre,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,dolor,i
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,la,o
217,S1130-01082012000500003,distension,i
217,S1130-01082012000500003,abdominal,i
217,S1130-01082012000500003,despues,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,una,o
217,S1130-01082012000500003,ileocolonoscopia,o
217,S1130-01082012000500003,I,o
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,despues,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,una,o
217,S1130-01082012000500003,ileocolonoscopia,o
217,S1130-01082012000500003,gastroscopia,i
217,S1130-01082012000500003,IG,o
217,S1130-01082012000500003,Material,o
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,metodos,o
217,S1130-01082012000500003,se,o
217,S1130-01082012000500003,incluyeron,o
217,S1130-01082012000500003,un,o
217,S1130-01082012000500003,total,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,309,o
217,S1130-01082012000500003,pacientes,o
217,S1130-01082012000500003,en,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,estudio,o
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,todas,o
217,S1130-01082012000500003,las,o
217,S1130-01082012000500003,endoscopias,i
217,S1130-01082012000500003,fueron,o
217,S1130-01082012000500003,realizadas,o
217,S1130-01082012000500003,bajo,o
217,S1130-01082012000500003,sedacion,i
217,S1130-01082012000500003,con,o
217,S1130-01082012000500003,propofol,i
217,S1130-01082012000500003,A,o
217,S1130-01082012000500003,214,o
217,S1130-01082012000500003,pacientes,o
217,S1130-01082012000500003,se,o
217,S1130-01082012000500003,les,o
217,S1130-01082012000500003,realizo,o
217,S1130-01082012000500003,una,o
217,S1130-01082012000500003,I,o
217,S1130-01082012000500003,132,o
217,S1130-01082012000500003,con,o
217,S1130-01082012000500003,CO2,i
217,S1130-01082012000500003,82,o
217,S1130-01082012000500003,con,o
217,S1130-01082012000500003,aire,o
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,a,o
217,S1130-01082012000500003,95,o
217,S1130-01082012000500003,se,o
217,S1130-01082012000500003,les,o
217,S1130-01082012000500003,realizo,o
217,S1130-01082012000500003,una,o
217,S1130-01082012000500003,IG,o
217,S1130-01082012000500003,53,o
217,S1130-01082012000500003,con,o
217,S1130-01082012000500003,CO2,i
217,S1130-01082012000500003,42,o
217,S1130-01082012000500003,con,o
217,S1130-01082012000500003,aire,o
217,S1130-01082012000500003,Se,o
217,S1130-01082012000500003,estudio,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,dolor,i
217,S1130-01082012000500003,abdominal,i
217,S1130-01082012000500003,a,o
217,S1130-01082012000500003,los,o
217,S1130-01082012000500003,10,o
217,S1130-01082012000500003,30,o
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,120,o
217,S1130-01082012000500003,min,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,la,o
217,S1130-01082012000500003,exploracion,i
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,la,o
217,S1130-01082012000500003,diferencia,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,perimetro,i
217,S1130-01082012000500003,abdominal,i
217,S1130-01082012000500003,antes,o
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,despues,o
217,S1130-01082012000500003,del,o
217,S1130-01082012000500003,procedimiento,i
217,S1130-01082012000500003,Resultados,o
217,S1130-01082012000500003,tanto,o
217,S1130-01082012000500003,en,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,grupo,o
217,S1130-01082012000500003,I,o
217,S1130-01082012000500003,como,o
217,S1130-01082012000500003,en,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,grupo,o
217,S1130-01082012000500003,IG,o
217,S1130-01082012000500003,se,o
217,S1130-01082012000500003,objetivo,o
217,S1130-01082012000500003,una,o
217,S1130-01082012000500003,media,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,dolor,i
217,S1130-01082012000500003,abdominal,i
217,S1130-01082012000500003,en,o
217,S1130-01082012000500003,los,o
217,S1130-01082012000500003,pacientes,o
217,S1130-01082012000500003,en,o
217,S1130-01082012000500003,los,o
217,S1130-01082012000500003,que,o
217,S1130-01082012000500003,se,o
217,S1130-01082012000500003,utilizo,o
217,S1130-01082012000500003,CO2,i
217,S1130-01082012000500003,significativamente,o
217,S1130-01082012000500003,menor,o
217,S1130-01082012000500003,que,o
217,S1130-01082012000500003,en,o
217,S1130-01082012000500003,los,o
217,S1130-01082012000500003,que,o
217,S1130-01082012000500003,se,o
217,S1130-01082012000500003,utilizo,o
217,S1130-01082012000500003,aire,o
217,S1130-01082012000500003,p,o
217,S1130-01082012000500003,005,o
217,S1130-01082012000500003,Y,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,igual,o
217,S1130-01082012000500003,modo,o
217,S1130-01082012000500003,se,o
217,S1130-01082012000500003,objetivo,o
217,S1130-01082012000500003,un,o
217,S1130-01082012000500003,menor,o
217,S1130-01082012000500003,incremento,o
217,S1130-01082012000500003,en,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,perimetro,i
217,S1130-01082012000500003,abdominal,i
217,S1130-01082012000500003,para,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,grupo,o
217,S1130-01082012000500003,I,o
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,para,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,IG,o
217,S1130-01082012000500003,en,o
217,S1130-01082012000500003,los,o
217,S1130-01082012000500003,pacientes,o
217,S1130-01082012000500003,en,o
217,S1130-01082012000500003,que,o
217,S1130-01082012000500003,se,o
217,S1130-01082012000500003,utilizo,o
217,S1130-01082012000500003,CO2,i
217,S1130-01082012000500003,frente,o
217,S1130-01082012000500003,a,o
217,S1130-01082012000500003,los,o
217,S1130-01082012000500003,que,o
217,S1130-01082012000500003,se,o
217,S1130-01082012000500003,utilizo,o
217,S1130-01082012000500003,aire,o
217,S1130-01082012000500003,p,o
217,S1130-01082012000500003,005,o
217,S1130-01082012000500003,Conclusion,o
217,S1130-01082012000500003,la,o
217,S1130-01082012000500003,insuflacion,i
217,S1130-01082012000500003,de,i
217,S1130-01082012000500003,CO2,i
217,S1130-01082012000500003,en,o
217,S1130-01082012000500003,vez,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,aire,o
217,S1130-01082012000500003,durante,o
217,S1130-01082012000500003,la,o
217,S1130-01082012000500003,realizacion,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,la,o
217,S1130-01082012000500003,exploracion,i
217,S1130-01082012000500003,endoscopica,i
217,S1130-01082012000500003,reduce,o
217,S1130-01082012000500003,significativamente,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,disconfort,i
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,el,o
217,S1130-01082012000500003,dolor,i
217,S1130-01082012000500003,abdominal,i
217,S1130-01082012000500003,despues,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,una,o
217,S1130-01082012000500003,ileocolonoscopia,o
217,S1130-01082012000500003,y,o
217,S1130-01082012000500003,despues,o
217,S1130-01082012000500003,de,o
217,S1130-01082012000500003,una,o
217,S1130-01082012000500003,ileocolonoscopia,o
217,S1130-01082012000500003,gastroscopia,i
218,S1130-01082012000800004,Comparacion,o
218,S1130-01082012000800004,entre,o
218,S1130-01082012000800004,la,o
218,S1130-01082012000800004,insuflacion,i
218,S1130-01082012000800004,con,i
218,S1130-01082012000800004,aire,i
218,S1130-01082012000800004,ambiente,o
218,S1130-01082012000800004,o,o
218,S1130-01082012000800004,con,o
218,S1130-01082012000800004,dioxido,i
218,S1130-01082012000800004,de,i
218,S1130-01082012000800004,carbono,i
218,S1130-01082012000800004,durante,o
218,S1130-01082012000800004,la,o
218,S1130-01082012000800004,colonoscopia,i
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,pacientes,o
218,S1130-01082012000800004,sedados,i
218,S1130-01082012000800004,con,o
218,S1130-01082012000800004,propofol,i
218,S1130-01082012000800004,Objetivos,o
218,S1130-01082012000800004,comparar,o
218,S1130-01082012000800004,la,o
218,S1130-01082012000800004,intensidad,o
218,S1130-01082012000800004,del,o
218,S1130-01082012000800004,dolor,i
218,S1130-01082012000800004,experimentado,o
218,S1130-01082012000800004,tras,o
218,S1130-01082012000800004,una,o
218,S1130-01082012000800004,colonoscopia,i
218,S1130-01082012000800004,con,o
218,S1130-01082012000800004,aire,o
218,S1130-01082012000800004,ambiente,o
218,S1130-01082012000800004,o,o
218,S1130-01082012000800004,con,o
218,S1130-01082012000800004,dioxido,i
218,S1130-01082012000800004,de,i
218,S1130-01082012000800004,carbono,i
218,S1130-01082012000800004,CO2,i
218,S1130-01082012000800004,y,o
218,S1130-01082012000800004,evaluar,i
218,S1130-01082012000800004,la,i
218,S1130-01082012000800004,seguridad,i
218,S1130-01082012000800004,del,o
218,S1130-01082012000800004,CO2,i
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,pacientes,o
218,S1130-01082012000800004,con,o
218,S1130-01082012000800004,sedacion,i
218,S1130-01082012000800004,moderada,i
218,S1130-01082012000800004,o,i
218,S1130-01082012000800004,profunda,i
218,S1130-01082012000800004,Materiales,o
218,S1130-01082012000800004,y,o
218,S1130-01082012000800004,metodos,o
218,S1130-01082012000800004,individuos,o
218,S1130-01082012000800004,sometidos,o
218,S1130-01082012000800004,a,o
218,S1130-01082012000800004,una,o
218,S1130-01082012000800004,colonoscopia,i
218,S1130-01082012000800004,ambulatoria,o
218,S1130-01082012000800004,sin,o
218,S1130-01082012000800004,enfermedad,i
218,S1130-01082012000800004,respiratoria,i
218,S1130-01082012000800004,severa,o
218,S1130-01082012000800004,ni,o
218,S1130-01082012000800004,obesidad,i
218,S1130-01082012000800004,morbida,i
218,S1130-01082012000800004,randomizados,i
218,S1130-01082012000800004,a,o
218,S1130-01082012000800004,grupo,o
218,S1130-01082012000800004,aire,o
218,S1130-01082012000800004,o,o
218,S1130-01082012000800004,CO2,i
218,S1130-01082012000800004,Se,o
218,S1130-01082012000800004,recogieron,o
218,S1130-01082012000800004,diferentes,o
218,S1130-01082012000800004,variables,o
218,S1130-01082012000800004,antes,o
218,S1130-01082012000800004,durante,o
218,S1130-01082012000800004,y,o
218,S1130-01082012000800004,tras,o
218,S1130-01082012000800004,la,o
218,S1130-01082012000800004,colonoscopia,i
218,S1130-01082012000800004,Todos,o
218,S1130-01082012000800004,los,o
218,S1130-01082012000800004,pacientes,o
218,S1130-01082012000800004,fueron,o
218,S1130-01082012000800004,monitorizados,i
218,S1130-01082012000800004,mediante,o
218,S1130-01082012000800004,capnografia,i
218,S1130-01082012000800004,y,o
218,S1130-01082012000800004,pulsioximetria,i
218,S1130-01082012000800004,Posteriormente,o
218,S1130-01082012000800004,cada,o
218,S1130-01082012000800004,paciente,o
218,S1130-01082012000800004,puntuo,i
218,S1130-01082012000800004,mediante,i
218,S1130-01082012000800004,una,i
218,S1130-01082012000800004,escala,i
218,S1130-01082012000800004,visual,i
218,S1130-01082012000800004,numerica,i
218,S1130-01082012000800004,la,o
218,S1130-01082012000800004,intensidad,o
218,S1130-01082012000800004,del,o
218,S1130-01082012000800004,dolor,i
218,S1130-01082012000800004,experimentado,o
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,diferentes,o
218,S1130-01082012000800004,momentos,o
218,S1130-01082012000800004,tras,o
218,S1130-01082012000800004,la,o
218,S1130-01082012000800004,colonoscopia,i
218,S1130-01082012000800004,Resultados,o
218,S1130-01082012000800004,141,o
218,S1130-01082012000800004,pacientes,o
218,S1130-01082012000800004,incluidos,o
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,grupo,o
218,S1130-01082012000800004,aire,o
218,S1130-01082012000800004,hombres,o
218,S1130-01082012000800004,mujeres,o
218,S1130-01082012000800004,6378,o
218,S1130-01082012000800004,rango,o
218,S1130-01082012000800004,edad,o
218,S1130-01082012000800004,2483,o
218,S1130-01082012000800004,y,o
218,S1130-01082012000800004,129,o
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,CO2,i
218,S1130-01082012000800004,hombresmujeres,o
218,S1130-01082012000800004,5970,o
218,S1130-01082012000800004,rango,o
218,S1130-01082012000800004,edad,o
218,S1130-01082012000800004,2482,o
218,S1130-01082012000800004,No,o
218,S1130-01082012000800004,existieron,o
218,S1130-01082012000800004,diferencias,o
218,S1130-01082012000800004,significativas,o
218,S1130-01082012000800004,entre,o
218,S1130-01082012000800004,ambos,o
218,S1130-01082012000800004,grupos,o
218,S1130-01082012000800004,a,o
218,S1130-01082012000800004,excepcion,o
218,S1130-01082012000800004,del,o
218,S1130-01082012000800004,mayor,o
218,S1130-01082012000800004,numero,o
218,S1130-01082012000800004,de,o
218,S1130-01082012000800004,exploraciones,i
218,S1130-01082012000800004,realizadas,o
218,S1130-01082012000800004,por,o
218,S1130-01082012000800004,un,o
218,S1130-01082012000800004,endoscopista,o
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,formacion,o
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,el,o
218,S1130-01082012000800004,grupo,o
218,S1130-01082012000800004,aire,o
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,comparacion,o
218,S1130-01082012000800004,con,o
218,S1130-01082012000800004,las,o
218,S1130-01082012000800004,realizadas,o
218,S1130-01082012000800004,por,o
218,S1130-01082012000800004,endoscopistas,o
218,S1130-01082012000800004,experimentados,o
218,S1130-01082012000800004,El,o
218,S1130-01082012000800004,CO2,i
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,aire,o
218,S1130-01082012000800004,espirado,o
218,S1130-01082012000800004,los,o
218,S1130-01082012000800004,episodios,o
218,S1130-01082012000800004,de,o
218,S1130-01082012000800004,desaturacion,o
218,S1130-01082012000800004,de,o
218,S1130-01082012000800004,oxigeno,i
218,S1130-01082012000800004,y,o
218,S1130-01082012000800004,las,o
218,S1130-01082012000800004,dosis,o
218,S1130-01082012000800004,de,o
218,S1130-01082012000800004,propofol,i
218,S1130-01082012000800004,o,o
218,S1130-01082012000800004,midazolam,i
218,S1130-01082012000800004,empleadas,o
218,S1130-01082012000800004,fueron,o
218,S1130-01082012000800004,similares,o
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,ambos,o
218,S1130-01082012000800004,grupos,o
218,S1130-01082012000800004,No,o
218,S1130-01082012000800004,existieron,o
218,S1130-01082012000800004,episodios,o
218,S1130-01082012000800004,de,o
218,S1130-01082012000800004,hipercapnia,i
218,S1130-01082012000800004,severos,o
218,S1130-01082012000800004,ni,o
218,S1130-01082012000800004,complicaciones,i
218,S1130-01082012000800004,clinicamente,o
218,S1130-01082012000800004,relevantes,o
218,S1130-01082012000800004,El,o
218,S1130-01082012000800004,dolor,i
218,S1130-01082012000800004,experimentado,o
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,el,o
218,S1130-01082012000800004,grupo,o
218,S1130-01082012000800004,aire,o
218,S1130-01082012000800004,fue,o
218,S1130-01082012000800004,significativamente,o
218,S1130-01082012000800004,mayor,o
218,S1130-01082012000800004,a,o
218,S1130-01082012000800004,los,o
218,S1130-01082012000800004,15,o
218,S1130-01082012000800004,minutos,o
218,S1130-01082012000800004,1,o
218,S1130-01082012000800004,3,o
218,S1130-01082012000800004,y,o
218,S1130-01082012000800004,6,o
218,S1130-01082012000800004,horas,o
218,S1130-01082012000800004,tras,o
218,S1130-01082012000800004,la,o
218,S1130-01082012000800004,colonoscopia,i
218,S1130-01082012000800004,igualandose,o
218,S1130-01082012000800004,a,o
218,S1130-01082012000800004,las,o
218,S1130-01082012000800004,24,o
218,S1130-01082012000800004,horas,o
218,S1130-01082012000800004,Tras,o
218,S1130-01082012000800004,la,o
218,S1130-01082012000800004,realizacion,o
218,S1130-01082012000800004,de,o
218,S1130-01082012000800004,un,o
218,S1130-01082012000800004,analisis,o
218,S1130-01082012000800004,multivariante,o
218,S1130-01082012000800004,segun,o
218,S1130-01082012000800004,el,o
218,S1130-01082012000800004,tipo,o
218,S1130-01082012000800004,de,o
218,S1130-01082012000800004,endoscopista,o
218,S1130-01082012000800004,experimentado,o
218,S1130-01082012000800004,o,o
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,formacion,o
218,S1130-01082012000800004,las,o
218,S1130-01082012000800004,diferencias,o
218,S1130-01082012000800004,observadas,o
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,la,o
218,S1130-01082012000800004,intensidad,o
218,S1130-01082012000800004,del,o
218,S1130-01082012000800004,dolor,i
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,cada,o
218,S1130-01082012000800004,grupo,o
218,S1130-01082012000800004,se,o
218,S1130-01082012000800004,mantuvieron,o
218,S1130-01082012000800004,Conclusiones,o
218,S1130-01082012000800004,a,o
218,S1130-01082012000800004,el,o
218,S1130-01082012000800004,uso,i
218,S1130-01082012000800004,de,i
218,S1130-01082012000800004,CO2,i
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,la,o
218,S1130-01082012000800004,colonoscopia,i
218,S1130-01082012000800004,causa,o
218,S1130-01082012000800004,significativamente,o
218,S1130-01082012000800004,menos,o
218,S1130-01082012000800004,dolor,i
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,las,o
218,S1130-01082012000800004,siguientes,o
218,S1130-01082012000800004,6,o
218,S1130-01082012000800004,horas,o
218,S1130-01082012000800004,b,o
218,S1130-01082012000800004,su,o
218,S1130-01082012000800004,uso,o
218,S1130-01082012000800004,en,o
218,S1130-01082012000800004,pacientes,o
218,S1130-01082012000800004,con,o
218,S1130-01082012000800004,sedacion,i
218,S1130-01082012000800004,moderada,i
218,S1130-01082012000800004,o,i
218,S1130-01082012000800004,profunda,i
218,S1130-01082012000800004,es,o
218,S1130-01082012000800004,seguro,o
218,S1130-01082012000800004,y,o
218,S1130-01082012000800004,c,o
218,S1130-01082012000800004,la,o
218,S1130-01082012000800004,realizacion,o
218,S1130-01082012000800004,de,o
218,S1130-01082012000800004,la,o
218,S1130-01082012000800004,tecnica,o
218,S1130-01082012000800004,no,o
218,S1130-01082012000800004,se,o
218,S1130-01082012000800004,ve,o
218,S1130-01082012000800004,modificada,o
218,S1130-01082012000800004,ni,o
218,S1130-01082012000800004,sus,o
218,S1130-01082012000800004,tiempos,o
218,S1130-01082012000800004,reducidos,o
219,S1130-01082017001100005,Ultrasonografia,i
219,S1130-01082017001100005,endoscopica,i
219,S1130-01082017001100005,versus,o
219,S1130-01082017001100005,tomografia,i
219,S1130-01082017001100005,computarizada,i
219,S1130-01082017001100005,en,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,estadificacion,i
219,S1130-01082017001100005,preoperatoria,o
219,S1130-01082017001100005,del,o
219,S1130-01082017001100005,cancer,i
219,S1130-01082017001100005,gastrico,i
219,S1130-01082017001100005,Introduccion,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,ultrasonografia,i
219,S1130-01082017001100005,endoscopica,i
219,S1130-01082017001100005,USE,i
219,S1130-01082017001100005,es,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,tecnica,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,eleccion,o
219,S1130-01082017001100005,para,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,estadificacion,i
219,S1130-01082017001100005,locoregional,o
219,S1130-01082017001100005,del,o
219,S1130-01082017001100005,adenocarcinoma,i
219,S1130-01082017001100005,gastrico,i
219,S1130-01082017001100005,ACG,i
219,S1130-01082017001100005,Sin,o
219,S1130-01082017001100005,embargo,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,introduccion,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,tomografia,i
219,S1130-01082017001100005,computarizada,i
219,S1130-01082017001100005,multidetector,i
219,S1130-01082017001100005,TCMD,i
219,S1130-01082017001100005,permite,o
219,S1130-01082017001100005,obtener,o
219,S1130-01082017001100005,estudios,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,muy,o
219,S1130-01082017001100005,alta,o
219,S1130-01082017001100005,calidad,o
219,S1130-01082017001100005,diagnostica,o
219,S1130-01082017001100005,Objetivo,o
219,S1130-01082017001100005,nuestro,o
219,S1130-01082017001100005,objetivo,o
219,S1130-01082017001100005,fue,o
219,S1130-01082017001100005,comparar,i
219,S1130-01082017001100005,la,i
219,S1130-01082017001100005,rentabilidad,i
219,S1130-01082017001100005,diagnostica,i
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,USE,i
219,S1130-01082017001100005,frente,o
219,S1130-01082017001100005,a,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,TCMD,i
219,S1130-01082017001100005,en,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,estadificacion,i
219,S1130-01082017001100005,locoregional,o
219,S1130-01082017001100005,preoperatoria,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,los,o
219,S1130-01082017001100005,pacientes,o
219,S1130-01082017001100005,con,o
219,S1130-01082017001100005,ACG,i
219,S1130-01082017001100005,Material,o
219,S1130-01082017001100005,y,o
219,S1130-01082017001100005,metodos,o
219,S1130-01082017001100005,se,o
219,S1130-01082017001100005,realizo,o
219,S1130-01082017001100005,un,o
219,S1130-01082017001100005,estudio,i
219,S1130-01082017001100005,retrospectivo,i
219,S1130-01082017001100005,y,i
219,S1130-01082017001100005,comparativo,i
219,S1130-01082017001100005,entre,o
219,S1130-01082017001100005,pacientes,o
219,S1130-01082017001100005,intervenidos,i
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,ACG,i
219,S1130-01082017001100005,con,o
219,S1130-01082017001100005,estadificacion,i
219,S1130-01082017001100005,preoperatoria,o
219,S1130-01082017001100005,mediante,o
219,S1130-01082017001100005,USE,i
219,S1130-01082017001100005,y,o
219,S1130-01082017001100005,TCMD,i
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,64,o
219,S1130-01082017001100005,filas,o
219,S1130-01082017001100005,comparando,o
219,S1130-01082017001100005,en,o
219,S1130-01082017001100005,cada,o
219,S1130-01082017001100005,caso,o
219,S1130-01082017001100005,los,o
219,S1130-01082017001100005,resultados,o
219,S1130-01082017001100005,con,o
219,S1130-01082017001100005,el,o
219,S1130-01082017001100005,informe,o
219,S1130-01082017001100005,anatomopatologico,o
219,S1130-01082017001100005,final,o
219,S1130-01082017001100005,Resultados,o
219,S1130-01082017001100005,se,o
219,S1130-01082017001100005,analizaron,o
219,S1130-01082017001100005,77,o
219,S1130-01082017001100005,pacientes,o
219,S1130-01082017001100005,intervenidos,i
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,ACG,i
219,S1130-01082017001100005,incluyendose,o
219,S1130-01082017001100005,finalmente,o
219,S1130-01082017001100005,42,o
219,S1130-01082017001100005,que,o
219,S1130-01082017001100005,disponian,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,estadificacion,i
219,S1130-01082017001100005,completa,o
219,S1130-01082017001100005,Para,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,estadificacion,i
219,S1130-01082017001100005,T,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,precision,o
219,S1130-01082017001100005,diagnostica,o
219,S1130-01082017001100005,PD,o
219,S1130-01082017001100005,global,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,USE,i
219,S1130-01082017001100005,fue,o
219,S1130-01082017001100005,superior,o
219,S1130-01082017001100005,a,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,TCMD,i
219,S1130-01082017001100005,62,o
219,S1130-01082017001100005,vs,o
219,S1130-01082017001100005,50,o
219,S1130-01082017001100005,En,o
219,S1130-01082017001100005,un,o
219,S1130-01082017001100005,subanalisis,o
219,S1130-01082017001100005,entre,o
219,S1130-01082017001100005,estadios,o
219,S1130-01082017001100005,precoces,o
219,S1130-01082017001100005,T12,o
219,S1130-01082017001100005,y,o
219,S1130-01082017001100005,avanzados,o
219,S1130-01082017001100005,T3T4,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,PD,o
219,S1130-01082017001100005,y,o
219,S1130-01082017001100005,sensibilidad,o
219,S1130-01082017001100005,S,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,USE,i
219,S1130-01082017001100005,resultaron,o
219,S1130-01082017001100005,ser,o
219,S1130-01082017001100005,superiores,o
219,S1130-01082017001100005,a,o
219,S1130-01082017001100005,las,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,TCMD,i
219,S1130-01082017001100005,833,o
219,S1130-01082017001100005,vs,o
219,S1130-01082017001100005,6429,o
219,S1130-01082017001100005,y,o
219,S1130-01082017001100005,844,o
219,S1130-01082017001100005,vs,o
219,S1130-01082017001100005,595,o
219,S1130-01082017001100005,respectivamente,o
219,S1130-01082017001100005,aunque,o
219,S1130-01082017001100005,sin,o
219,S1130-01082017001100005,alcanzarse,o
219,S1130-01082017001100005,niveles,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,significacion,o
219,S1130-01082017001100005,estadistica,o
219,S1130-01082017001100005,Respecto,o
219,S1130-01082017001100005,al,o
219,S1130-01082017001100005,estadio,o
219,S1130-01082017001100005,N,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,PD,o
219,S1130-01082017001100005,y,o
219,S1130-01082017001100005,S,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,USE,i
219,S1130-01082017001100005,resultaron,o
219,S1130-01082017001100005,inferiores,o
219,S1130-01082017001100005,a,o
219,S1130-01082017001100005,las,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,TCMD,i
219,S1130-01082017001100005,aunque,o
219,S1130-01082017001100005,tampoco,o
219,S1130-01082017001100005,se,o
219,S1130-01082017001100005,alcanzaron,o
219,S1130-01082017001100005,diferencias,o
219,S1130-01082017001100005,estadisticamente,o
219,S1130-01082017001100005,significativas,o
219,S1130-01082017001100005,57,o
219,S1130-01082017001100005,vs,o
219,S1130-01082017001100005,64,o
219,S1130-01082017001100005,y,o
219,S1130-01082017001100005,29,o
219,S1130-01082017001100005,vs,o
219,S1130-01082017001100005,55,o
219,S1130-01082017001100005,Conclusiones,o
219,S1130-01082017001100005,en,o
219,S1130-01082017001100005,nuestra,o
219,S1130-01082017001100005,experiencia,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,rentabilidad,o
219,S1130-01082017001100005,diagnostica,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,ecoendoscopia,i
219,S1130-01082017001100005,es,o
219,S1130-01082017001100005,similar,o
219,S1130-01082017001100005,a,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,de,o
219,S1130-01082017001100005,los,o
219,S1130-01082017001100005,nuevos,o
219,S1130-01082017001100005,TCMD,i
219,S1130-01082017001100005,en,o
219,S1130-01082017001100005,la,o
219,S1130-01082017001100005,estadificacion,i
219,S1130-01082017001100005,preoperatoria,o
219,S1130-01082017001100005,T,o
219,S1130-01082017001100005,y,o
219,S1130-01082017001100005,N,o
219,S1130-01082017001100005,en,o
219,S1130-01082017001100005,pacientes,o
219,S1130-01082017001100005,con,o
219,S1130-01082017001100005,ACG,i
219,S1130-01082017001100005,Sin,o
219,S1130-01082017001100005,embargo,o
219,S1130-01082017001100005,ambas,o
219,S1130-01082017001100005,tecnicas,o
219,S1130-01082017001100005,deberian,o
219,S1130-01082017001100005,considerarse,o
219,S1130-01082017001100005,complementarias,o
219,S1130-01082017001100005,hasta,o
219,S1130-01082017001100005,que,o
219,S1130-01082017001100005,estudios,o
219,S1130-01082017001100005,mas,o
219,S1130-01082017001100005,extensos,o
219,S1130-01082017001100005,y,o
219,S1130-01082017001100005,aleatorizados,i
219,S1130-01082017001100005,puedan,o
219,S1130-01082017001100005,confirmar,o
219,S1130-01082017001100005,estos,o
219,S1130-01082017001100005,resultados,o
220,S1130-01082018001100003,Ensayo,i
220,S1130-01082018001100003,clinico,i
220,S1130-01082018001100003,comparando,o
220,S1130-01082018001100003,propofol,i
220,S1130-01082018001100003,versus,o
220,S1130-01082018001100003,propofol,i
220,S1130-01082018001100003,mas,o
220,S1130-01082018001100003,midazolam,i
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,endoscopia,i
220,S1130-01082018001100003,diagnostica,i
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,pacientes,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,bajo,o
220,S1130-01082018001100003,riesgo,o
220,S1130-01082018001100003,anestesico,o
220,S1130-01082018001100003,Antecedentes,o
220,S1130-01082018001100003,y,o
220,S1130-01082018001100003,objetivos,o
220,S1130-01082018001100003,propofol,i
220,S1130-01082018001100003,y,o
220,S1130-01082018001100003,midazolam,i
220,S1130-01082018001100003,son,o
220,S1130-01082018001100003,dos,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,los,o
220,S1130-01082018001100003,farmacos,i
220,S1130-01082018001100003,mas,o
220,S1130-01082018001100003,utilizados,o
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,la,o
220,S1130-01082018001100003,endoscopia,i
220,S1130-01082018001100003,digestiva,i
220,S1130-01082018001100003,alta,i
220,S1130-01082018001100003,EDA,i
220,S1130-01082018001100003,El,o
220,S1130-01082018001100003,objetivo,o
220,S1130-01082018001100003,del,o
220,S1130-01082018001100003,estudio,o
220,S1130-01082018001100003,fue,o
220,S1130-01082018001100003,evaluar,o
220,S1130-01082018001100003,dos,o
220,S1130-01082018001100003,protocolos,i
220,S1130-01082018001100003,de,i
220,S1130-01082018001100003,sedacion,i
220,S1130-01082018001100003,utilizando,o
220,S1130-01082018001100003,estos,o
220,S1130-01082018001100003,farmacos,i
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,pacientes,o
220,S1130-01082018001100003,sometidos,o
220,S1130-01082018001100003,a,o
220,S1130-01082018001100003,una,o
220,S1130-01082018001100003,EDA,i
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,terminos,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,seguridad,o
220,S1130-01082018001100003,eficiencia,o
220,S1130-01082018001100003,calidad,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,la,o
220,S1130-01082018001100003,exploracion,i
220,S1130-01082018001100003,y,o
220,S1130-01082018001100003,aceptacion,o
220,S1130-01082018001100003,del,o
220,S1130-01082018001100003,paciente,o
220,S1130-01082018001100003,Pacientes,o
220,S1130-01082018001100003,y,o
220,S1130-01082018001100003,metodos,o
220,S1130-01082018001100003,estudio,o
220,S1130-01082018001100003,prospectivo,o
220,S1130-01082018001100003,randomizado,o
220,S1130-01082018001100003,y,o
220,S1130-01082018001100003,a,o
220,S1130-01082018001100003,doble,o
220,S1130-01082018001100003,ciego,o
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,el,o
220,S1130-01082018001100003,que,o
220,S1130-01082018001100003,se,o
220,S1130-01082018001100003,incluyo,o
220,S1130-01082018001100003,a,o
220,S1130-01082018001100003,83,o
220,S1130-01082018001100003,pacientes,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,1880,o
220,S1130-01082018001100003,años,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,bajo,o
220,S1130-01082018001100003,riesgo,o
220,S1130-01082018001100003,anestesico,o
220,S1130-01082018001100003,ASA,o
220,S1130-01082018001100003,III,o
220,S1130-01082018001100003,sometidos,o
220,S1130-01082018001100003,a,o
220,S1130-01082018001100003,EDA,i
220,S1130-01082018001100003,diagnostica,i
220,S1130-01082018001100003,aleatorizados,i
220,S1130-01082018001100003,a,o
220,S1130-01082018001100003,recibir,o
220,S1130-01082018001100003,propofol,i
220,S1130-01082018001100003,mas,o
220,S1130-01082018001100003,placebo,i
220,S1130-01082018001100003,grupo,o
220,S1130-01082018001100003,A,o
220,S1130-01082018001100003,o,o
220,S1130-01082018001100003,midazolam,i
220,S1130-01082018001100003,mas,o
220,S1130-01082018001100003,propofol,i
220,S1130-01082018001100003,grupo,o
220,S1130-01082018001100003,B,o
220,S1130-01082018001100003,Resultados,o
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,el,o
220,S1130-01082018001100003,grupo,o
220,S1130-01082018001100003,A,o
220,S1130-01082018001100003,42,o
220,S1130-01082018001100003,pacientes,o
220,S1130-01082018001100003,recibieron,o
220,S1130-01082018001100003,un,o
220,S1130-01082018001100003,bolo,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,placebo,i
220,S1130-01082018001100003,suero,i
220,S1130-01082018001100003,salino,i
220,S1130-01082018001100003,y,o
220,S1130-01082018001100003,propofol,i
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,bolos,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,20,o
220,S1130-01082018001100003,mg,o
220,S1130-01082018001100003,hasta,o
220,S1130-01082018001100003,una,o
220,S1130-01082018001100003,media,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,115,o
220,S1130-01082018001100003,mg,o
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,el,o
220,S1130-01082018001100003,grupo,o
220,S1130-01082018001100003,B,o
220,S1130-01082018001100003,41,o
220,S1130-01082018001100003,pacientes,o
220,S1130-01082018001100003,recibieron,o
220,S1130-01082018001100003,3,o
220,S1130-01082018001100003,mg,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,midazolam,i
220,S1130-01082018001100003,y,o
220,S1130-01082018001100003,bolos,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,20,o
220,S1130-01082018001100003,mg,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,propofol,i
220,S1130-01082018001100003,hasta,o
220,S1130-01082018001100003,una,o
220,S1130-01082018001100003,media,o
220,S1130-01082018001100003,83,o
220,S1130-01082018001100003,mg,o
220,S1130-01082018001100003,No,o
220,S1130-01082018001100003,hubo,o
220,S1130-01082018001100003,diferencias,o
220,S1130-01082018001100003,significativas,o
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,los,o
220,S1130-01082018001100003,efectos,i
220,S1130-01082018001100003,adversos,i
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,ambos,o
220,S1130-01082018001100003,grupos,o
220,S1130-01082018001100003,y,o
220,S1130-01082018001100003,los,o
220,S1130-01082018001100003,que,o
220,S1130-01082018001100003,se,o
220,S1130-01082018001100003,presentaron,o
220,S1130-01082018001100003,se,o
220,S1130-01082018001100003,trataron,i
220,S1130-01082018001100003,de,i
220,S1130-01082018001100003,forma,i
220,S1130-01082018001100003,conservadora,i
220,S1130-01082018001100003,Los,o
220,S1130-01082018001100003,pacientes,o
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,el,o
220,S1130-01082018001100003,grupo,o
220,S1130-01082018001100003,B,o
220,S1130-01082018001100003,midazolam,i
220,S1130-01082018001100003,mas,o
220,S1130-01082018001100003,propofol,i
220,S1130-01082018001100003,alcanzaron,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,forma,o
220,S1130-01082018001100003,mas,o
220,S1130-01082018001100003,rapida,o
220,S1130-01082018001100003,la,o
220,S1130-01082018001100003,sedacion,i
220,S1130-01082018001100003,deseada,o
220,S1130-01082018001100003,sin,o
220,S1130-01082018001100003,variar,o
220,S1130-01082018001100003,el,o
220,S1130-01082018001100003,tiempo,o
220,S1130-01082018001100003,global,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,la,o
220,S1130-01082018001100003,exploracion,i
220,S1130-01082018001100003,La,o
220,S1130-01082018001100003,calidad,o
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,la,o
220,S1130-01082018001100003,evaluacion,i
220,S1130-01082018001100003,endoscopica,i
220,S1130-01082018001100003,fue,o
220,S1130-01082018001100003,similar,o
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,ambos,o
220,S1130-01082018001100003,grupos,o
220,S1130-01082018001100003,y,o
220,S1130-01082018001100003,los,o
220,S1130-01082018001100003,pacientes,o
220,S1130-01082018001100003,se,o
220,S1130-01082018001100003,sintieron,o
220,S1130-01082018001100003,igualmente,o
220,S1130-01082018001100003,satisfechos,o
220,S1130-01082018001100003,con,o
220,S1130-01082018001100003,ambos,o
220,S1130-01082018001100003,regimenes,i
220,S1130-01082018001100003,de,i
220,S1130-01082018001100003,sedacion,i
220,S1130-01082018001100003,Conclusiones,o
220,S1130-01082018001100003,la,o
220,S1130-01082018001100003,sedacion,i
220,S1130-01082018001100003,con,o
220,S1130-01082018001100003,midazolam,i
220,S1130-01082018001100003,mas,o
220,S1130-01082018001100003,propofol,i
220,S1130-01082018001100003,no,o
220,S1130-01082018001100003,afecta,o
220,S1130-01082018001100003,al,o
220,S1130-01082018001100003,tiempo,o
220,S1130-01082018001100003,global,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,la,o
220,S1130-01082018001100003,exploracion,i
220,S1130-01082018001100003,utiliza,o
220,S1130-01082018001100003,menos,o
220,S1130-01082018001100003,dosis,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,propofol,i
220,S1130-01082018001100003,es,o
220,S1130-01082018001100003,tan,o
220,S1130-01082018001100003,segura,o
220,S1130-01082018001100003,como,o
220,S1130-01082018001100003,la,o
220,S1130-01082018001100003,administracion,i
220,S1130-01082018001100003,del,o
220,S1130-01082018001100003,propofol,i
220,S1130-01082018001100003,en,o
220,S1130-01082018001100003,monoterapia,i
220,S1130-01082018001100003,proporciona,o
220,S1130-01082018001100003,igual,o
220,S1130-01082018001100003,calidad,o
220,S1130-01082018001100003,de,o
220,S1130-01082018001100003,exploracion,i
220,S1130-01082018001100003,y,o
220,S1130-01082018001100003,similar,o
220,S1130-01082018001100003,aceptacion,o
220,S1130-01082018001100003,por,o
220,S1130-01082018001100003,los,o
220,S1130-01082018001100003,pacientes,o
221,S1130-05582016000200002,Estudio,i
221,S1130-05582016000200002,comparativo,i
221,S1130-05582016000200002,en,o
221,S1130-05582016000200002,la,o
221,S1130-05582016000200002,utilizacion,o
221,S1130-05582016000200002,de,o
221,S1130-05582016000200002,drenaje,i
221,S1130-05582016000200002,postextraccion,o
221,S1130-05582016000200002,de,o
221,S1130-05582016000200002,terceros,i
221,S1130-05582016000200002,molares,i
221,S1130-05582016000200002,impactados,i
221,S1130-05582016000200002,Objetivos,o
221,S1130-05582016000200002,Determinar,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,efecto,o
221,S1130-05582016000200002,de,o
221,S1130-05582016000200002,la,o
221,S1130-05582016000200002,utilizacion,i
221,S1130-05582016000200002,de,i
221,S1130-05582016000200002,tubos,i
221,S1130-05582016000200002,de,i
221,S1130-05582016000200002,drenaje,i
221,S1130-05582016000200002,con,o
221,S1130-05582016000200002,relacion,o
221,S1130-05582016000200002,a,o
221,S1130-05582016000200002,la,o
221,S1130-05582016000200002,respuesta,i
221,S1130-05582016000200002,inflamatoria,i
221,S1130-05582016000200002,y,i
221,S1130-05582016000200002,dolorosa,i
221,S1130-05582016000200002,postoperatoria,o
221,S1130-05582016000200002,en,o
221,S1130-05582016000200002,las,o
221,S1130-05582016000200002,exodoncias,i
221,S1130-05582016000200002,de,i
221,S1130-05582016000200002,terceros,i
221,S1130-05582016000200002,molares,i
221,S1130-05582016000200002,inferiores,i
221,S1130-05582016000200002,impactados,i
221,S1130-05582016000200002,Material,o
221,S1130-05582016000200002,y,o
221,S1130-05582016000200002,metodo,o
221,S1130-05582016000200002,Mediante,o
221,S1130-05582016000200002,un,o
221,S1130-05582016000200002,estudio,o
221,S1130-05582016000200002,experimental,o
221,S1130-05582016000200002,aleatorizado,o
221,S1130-05582016000200002,se,o
221,S1130-05582016000200002,analizo,o
221,S1130-05582016000200002,la,o
221,S1130-05582016000200002,respuesta,o
221,S1130-05582016000200002,de,o
221,S1130-05582016000200002,edema,i
221,S1130-05582016000200002,y,o
221,S1130-05582016000200002,dolor,i
221,S1130-05582016000200002,en,o
221,S1130-05582016000200002,20,o
221,S1130-05582016000200002,pacientes,o
221,S1130-05582016000200002,con,o
221,S1130-05582016000200002,relacion,o
221,S1130-05582016000200002,al,o
221,S1130-05582016000200002,uso,o
221,S1130-05582016000200002,de,o
221,S1130-05582016000200002,drenajes,i
221,S1130-05582016000200002,tras,o
221,S1130-05582016000200002,la,o
221,S1130-05582016000200002,extraccion,i
221,S1130-05582016000200002,de,o
221,S1130-05582016000200002,sus,o
221,S1130-05582016000200002,2,o
221,S1130-05582016000200002,terceros,i
221,S1130-05582016000200002,molares,i
221,S1130-05582016000200002,inferiores,i
221,S1130-05582016000200002,impactados,i
221,S1130-05582016000200002,los,o
221,S1130-05582016000200002,cuales,o
221,S1130-05582016000200002,debian,o
221,S1130-05582016000200002,estar,o
221,S1130-05582016000200002,en,o
221,S1130-05582016000200002,posicion,o
221,S1130-05582016000200002,similar,o
221,S1130-05582016000200002,Para,o
221,S1130-05582016000200002,ello,o
221,S1130-05582016000200002,en,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,mismo,o
221,S1130-05582016000200002,acto,i
221,S1130-05582016000200002,quirurgico,i
221,S1130-05582016000200002,una,o
221,S1130-05582016000200002,herida,i
221,S1130-05582016000200002,operatoria,i
221,S1130-05582016000200002,se,o
221,S1130-05582016000200002,suturo,i
221,S1130-05582016000200002,con,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,objetivo,o
221,S1130-05582016000200002,de,o
221,S1130-05582016000200002,lograr,o
221,S1130-05582016000200002,una,o
221,S1130-05582016000200002,cicatrizacion,o
221,S1130-05582016000200002,por,o
221,S1130-05582016000200002,primera,o
221,S1130-05582016000200002,intencion,o
221,S1130-05582016000200002,constituyendo,o
221,S1130-05582016000200002,este,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,lado,o
221,S1130-05582016000200002,control,o
221,S1130-05582016000200002,En,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,lado,o
221,S1130-05582016000200002,contralateral,o
221,S1130-05582016000200002,se,o
221,S1130-05582016000200002,instalo,i
221,S1130-05582016000200002,un,i
221,S1130-05582016000200002,tubo,i
221,S1130-05582016000200002,de,i
221,S1130-05582016000200002,drenaje,i
221,S1130-05582016000200002,por,o
221,S1130-05582016000200002,48,o
221,S1130-05582016000200002,h,o
221,S1130-05582016000200002,en,o
221,S1130-05582016000200002,la,o
221,S1130-05582016000200002,herida,i
221,S1130-05582016000200002,operatoria,i
221,S1130-05582016000200002,siendo,o
221,S1130-05582016000200002,este,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,lado,o
221,S1130-05582016000200002,experimental,o
221,S1130-05582016000200002,Para,o
221,S1130-05582016000200002,comparar,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,edema,i
221,S1130-05582016000200002,de,o
221,S1130-05582016000200002,ambos,o
221,S1130-05582016000200002,lados,o
221,S1130-05582016000200002,en,o
221,S1130-05582016000200002,cada,o
221,S1130-05582016000200002,paciente,o
221,S1130-05582016000200002,se,o
221,S1130-05582016000200002,realizo,o
221,S1130-05582016000200002,una,o
221,S1130-05582016000200002,fotografia,i
221,S1130-05582016000200002,estandarizada,o
221,S1130-05582016000200002,y,o
221,S1130-05582016000200002,una,o
221,S1130-05582016000200002,medicion,i
221,S1130-05582016000200002,clinica,i
221,S1130-05582016000200002,numerica,i
221,S1130-05582016000200002,preoperatoria,o
221,S1130-05582016000200002,y,o
221,S1130-05582016000200002,a,o
221,S1130-05582016000200002,las,o
221,S1130-05582016000200002,48,o
221,S1130-05582016000200002,h,o
221,S1130-05582016000200002,postoperatorias,o
221,S1130-05582016000200002,A,o
221,S1130-05582016000200002,su,o
221,S1130-05582016000200002,vez,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,dolor,i
221,S1130-05582016000200002,se,i
221,S1130-05582016000200002,evaluo,i
221,S1130-05582016000200002,con,o
221,S1130-05582016000200002,la,o
221,S1130-05582016000200002,escala,i
221,S1130-05582016000200002,visual,i
221,S1130-05582016000200002,analoga,i
221,S1130-05582016000200002,a,o
221,S1130-05582016000200002,las,o
221,S1130-05582016000200002,48,o
221,S1130-05582016000200002,h,o
221,S1130-05582016000200002,y,o
221,S1130-05582016000200002,a,o
221,S1130-05582016000200002,la,o
221,S1130-05582016000200002,semana,o
221,S1130-05582016000200002,postoperatoria,o
221,S1130-05582016000200002,Resultados,o
221,S1130-05582016000200002,Segun,o
221,S1130-05582016000200002,este,o
221,S1130-05582016000200002,estudio,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,uso,i
221,S1130-05582016000200002,de,i
221,S1130-05582016000200002,un,i
221,S1130-05582016000200002,tubo,i
221,S1130-05582016000200002,de,i
221,S1130-05582016000200002,drenaje,i
221,S1130-05582016000200002,reduce,o
221,S1130-05582016000200002,con,o
221,S1130-05582016000200002,diferencia,o
221,S1130-05582016000200002,estadisticamente,o
221,S1130-05582016000200002,significativa,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,edema,i
221,S1130-05582016000200002,postoperatorio,o
221,S1130-05582016000200002,en,o
221,S1130-05582016000200002,comparacion,o
221,S1130-05582016000200002,con,o
221,S1130-05582016000200002,las,o
221,S1130-05582016000200002,heridas,i
221,S1130-05582016000200002,suturadas,i
221,S1130-05582016000200002,sin,o
221,S1130-05582016000200002,drenaje,i
221,S1130-05582016000200002,en,o
221,S1130-05582016000200002,la,o
221,S1130-05582016000200002,exodoncia,i
221,S1130-05582016000200002,de,i
221,S1130-05582016000200002,terceros,i
221,S1130-05582016000200002,molares,i
221,S1130-05582016000200002,inferiores,i
221,S1130-05582016000200002,impactados,i
221,S1130-05582016000200002,Por,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,contrario,o
221,S1130-05582016000200002,no,o
221,S1130-05582016000200002,existieron,o
221,S1130-05582016000200002,diferencias,o
221,S1130-05582016000200002,significativas,o
221,S1130-05582016000200002,con,o
221,S1130-05582016000200002,relacion,o
221,S1130-05582016000200002,a,o
221,S1130-05582016000200002,la,o
221,S1130-05582016000200002,respuesta,i
221,S1130-05582016000200002,dolorosa,i
221,S1130-05582016000200002,al,o
221,S1130-05582016000200002,comparar,o
221,S1130-05582016000200002,ambos,o
221,S1130-05582016000200002,lados,o
221,S1130-05582016000200002,Conclusiones,o
221,S1130-05582016000200002,El,o
221,S1130-05582016000200002,uso,o
221,S1130-05582016000200002,de,o
221,S1130-05582016000200002,drenaje,i
221,S1130-05582016000200002,posterior,o
221,S1130-05582016000200002,a,o
221,S1130-05582016000200002,la,o
221,S1130-05582016000200002,extraccion,i
221,S1130-05582016000200002,de,i
221,S1130-05582016000200002,terceros,i
221,S1130-05582016000200002,molares,i
221,S1130-05582016000200002,inferiores,i
221,S1130-05582016000200002,impactados,i
221,S1130-05582016000200002,reduce,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,edema,i
221,S1130-05582016000200002,mejorando,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,bienestar,o
221,S1130-05582016000200002,del,o
221,S1130-05582016000200002,paciente,o
221,S1130-05582016000200002,en,o
221,S1130-05582016000200002,el,o
221,S1130-05582016000200002,postoperatorio,o
222,S1130-05582017000300164,Eficacia,o
222,S1130-05582017000300164,del,o
222,S1130-05582017000300164,uso,o
222,S1130-05582017000300164,del,o
222,S1130-05582017000300164,plasma,i
222,S1130-05582017000300164,rico,i
222,S1130-05582017000300164,en,i
222,S1130-05582017000300164,factores,i
222,S1130-05582017000300164,de,i
222,S1130-05582017000300164,crecimiento,i
222,S1130-05582017000300164,en,o
222,S1130-05582017000300164,defectos,i
222,S1130-05582017000300164,periodontales,i
222,S1130-05582017000300164,distales,i
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,segundos,i
222,S1130-05582017000300164,molares,i
222,S1130-05582017000300164,inferiores,i
222,S1130-05582017000300164,posterior,o
222,S1130-05582017000300164,a,o
222,S1130-05582017000300164,la,o
222,S1130-05582017000300164,extraccion,i
222,S1130-05582017000300164,de,i
222,S1130-05582017000300164,un,i
222,S1130-05582017000300164,tercer,i
222,S1130-05582017000300164,molar,i
222,S1130-05582017000300164,mandibular,i
222,S1130-05582017000300164,Objetivo,o
222,S1130-05582017000300164,El,o
222,S1130-05582017000300164,proposito,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,este,o
222,S1130-05582017000300164,estudio,o
222,S1130-05582017000300164,fue,o
222,S1130-05582017000300164,evaluar,i
222,S1130-05582017000300164,la,i
222,S1130-05582017000300164,eficacia,i
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,la,o
222,S1130-05582017000300164,aplicacion,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,plasma,i
222,S1130-05582017000300164,rico,i
222,S1130-05582017000300164,en,i
222,S1130-05582017000300164,factores,i
222,S1130-05582017000300164,de,i
222,S1130-05582017000300164,crecimiento,i
222,S1130-05582017000300164,PRFC,i
222,S1130-05582017000300164,dentro,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,un,o
222,S1130-05582017000300164,defecto,i
222,S1130-05582017000300164,periodontal,i
222,S1130-05582017000300164,distal,i
222,S1130-05582017000300164,a,o
222,S1130-05582017000300164,los,o
222,S1130-05582017000300164,segundos,i
222,S1130-05582017000300164,molares,i
222,S1130-05582017000300164,inferiores,i
222,S1130-05582017000300164,despues,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,la,o
222,S1130-05582017000300164,extraccion,i
222,S1130-05582017000300164,de,i
222,S1130-05582017000300164,un,i
222,S1130-05582017000300164,tercer,i
222,S1130-05582017000300164,molar,i
222,S1130-05582017000300164,mandibular,i
222,S1130-05582017000300164,Material,o
222,S1130-05582017000300164,y,o
222,S1130-05582017000300164,metodos,o
222,S1130-05582017000300164,Se,o
222,S1130-05582017000300164,realizo,o
222,S1130-05582017000300164,un,o
222,S1130-05582017000300164,ensayo,o
222,S1130-05582017000300164,clinico,o
222,S1130-05582017000300164,controlado,o
222,S1130-05582017000300164,doble,o
222,S1130-05582017000300164,ciego,o
222,S1130-05582017000300164,aleatorizado,o
222,S1130-05582017000300164,en,o
222,S1130-05582017000300164,20,o
222,S1130-05582017000300164,pacientes,o
222,S1130-05582017000300164,sanos,o
222,S1130-05582017000300164,con,o
222,S1130-05582017000300164,defectos,i
222,S1130-05582017000300164,oseos,i
222,S1130-05582017000300164,bilaterales,i
222,S1130-05582017000300164,posterior,o
222,S1130-05582017000300164,a,o
222,S1130-05582017000300164,la,o
222,S1130-05582017000300164,extraccion,i
222,S1130-05582017000300164,de,i
222,S1130-05582017000300164,un,i
222,S1130-05582017000300164,tercer,i
222,S1130-05582017000300164,molar,i
222,S1130-05582017000300164,retenido,i
222,S1130-05582017000300164,Los,o
222,S1130-05582017000300164,pacientes,o
222,S1130-05582017000300164,fueron,o
222,S1130-05582017000300164,divididos,o
222,S1130-05582017000300164,en,o
222,S1130-05582017000300164,grupo,o
222,S1130-05582017000300164,experimental,o
222,S1130-05582017000300164,y,o
222,S1130-05582017000300164,control,o
222,S1130-05582017000300164,Se,o
222,S1130-05582017000300164,realizaron,o
222,S1130-05582017000300164,mediciones,i
222,S1130-05582017000300164,de,i
222,S1130-05582017000300164,nivel,i
222,S1130-05582017000300164,clinico,i
222,S1130-05582017000300164,de,i
222,S1130-05582017000300164,insercion,i
222,S1130-05582017000300164,en,o
222,S1130-05582017000300164,el,o
222,S1130-05582017000300164,area,o
222,S1130-05582017000300164,distal,o
222,S1130-05582017000300164,del,o
222,S1130-05582017000300164,segundo,i
222,S1130-05582017000300164,molar,i
222,S1130-05582017000300164,previamente,o
222,S1130-05582017000300164,a,o
222,S1130-05582017000300164,la,o
222,S1130-05582017000300164,cirugia,i
222,S1130-05582017000300164,usando,o
222,S1130-05582017000300164,una,o
222,S1130-05582017000300164,ferula,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,acetato,i
222,S1130-05582017000300164,con,o
222,S1130-05582017000300164,el,o
222,S1130-05582017000300164,fin,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,tener,o
222,S1130-05582017000300164,la,o
222,S1130-05582017000300164,misma,o
222,S1130-05582017000300164,referencia,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,medicion,o
222,S1130-05582017000300164,posterior,o
222,S1130-05582017000300164,al,o
222,S1130-05582017000300164,procedimiento,i
222,S1130-05582017000300164,Las,o
222,S1130-05582017000300164,mediciones,o
222,S1130-05582017000300164,posquirurgicas,o
222,S1130-05582017000300164,fueron,o
222,S1130-05582017000300164,realizadas,o
222,S1130-05582017000300164,a,o
222,S1130-05582017000300164,las,o
222,S1130-05582017000300164,semanas,o
222,S1130-05582017000300164,1,o
222,S1130-05582017000300164,4,o
222,S1130-05582017000300164,y,o
222,S1130-05582017000300164,12,o
222,S1130-05582017000300164,Estas,o
222,S1130-05582017000300164,mediciones,o
222,S1130-05582017000300164,asi,o
222,S1130-05582017000300164,como,o
222,S1130-05582017000300164,los,o
222,S1130-05582017000300164,tiempos,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,evaluacion,i
222,S1130-05582017000300164,fueron,o
222,S1130-05582017000300164,analizados,o
222,S1130-05582017000300164,por,o
222,S1130-05582017000300164,medio,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,las,o
222,S1130-05582017000300164,pruebas,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,t,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,Student,o
222,S1130-05582017000300164,Chi2,o
222,S1130-05582017000300164,y,o
222,S1130-05582017000300164,KruskalWallis,o
222,S1130-05582017000300164,Resultados,o
222,S1130-05582017000300164,Las,o
222,S1130-05582017000300164,variables,o
222,S1130-05582017000300164,demostraron,o
222,S1130-05582017000300164,similitud,o
222,S1130-05582017000300164,en,o
222,S1130-05582017000300164,cuanto,o
222,S1130-05582017000300164,a,o
222,S1130-05582017000300164,edad,o
222,S1130-05582017000300164,sexo,o
222,S1130-05582017000300164,dificultad,o
222,S1130-05582017000300164,y,o
222,S1130-05582017000300164,duracion,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,los,o
222,S1130-05582017000300164,tiempos,o
222,S1130-05582017000300164,quirurgicos,o
222,S1130-05582017000300164,La,o
222,S1130-05582017000300164,medicion,i
222,S1130-05582017000300164,del,i
222,S1130-05582017000300164,nivel,i
222,S1130-05582017000300164,clinico,i
222,S1130-05582017000300164,de,i
222,S1130-05582017000300164,insercion,i
222,S1130-05582017000300164,preoperatoria,o
222,S1130-05582017000300164,en,o
222,S1130-05582017000300164,milimetros,o
222,S1130-05582017000300164,fue,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,268,o
222,S1130-05582017000300164,056,o
222,S1130-05582017000300164,vs,o
222,S1130-05582017000300164,263,o
222,S1130-05582017000300164,050,o
222,S1130-05582017000300164,experimental,o
222,S1130-05582017000300164,vs,o
222,S1130-05582017000300164,control,o
222,S1130-05582017000300164,Durante,o
222,S1130-05582017000300164,la,o
222,S1130-05582017000300164,primera,o
222,S1130-05582017000300164,semana,o
222,S1130-05582017000300164,posterior,o
222,S1130-05582017000300164,al,o
222,S1130-05582017000300164,procedimiento,i
222,S1130-05582017000300164,los,o
222,S1130-05582017000300164,resultados,o
222,S1130-05582017000300164,fueron,o
222,S1130-05582017000300164,537,o
222,S1130-05582017000300164,181,o
222,S1130-05582017000300164,vs,o
222,S1130-05582017000300164,535,o
222,S1130-05582017000300164,172,o
222,S1130-05582017000300164,y,o
222,S1130-05582017000300164,a,o
222,S1130-05582017000300164,los,o
222,S1130-05582017000300164,3,o
222,S1130-05582017000300164,meses,o
222,S1130-05582017000300164,la,o
222,S1130-05582017000300164,recuperacion,o
222,S1130-05582017000300164,fue,o
222,S1130-05582017000300164,similar,o
222,S1130-05582017000300164,en,o
222,S1130-05582017000300164,ambos,o
222,S1130-05582017000300164,grupos,o
222,S1130-05582017000300164,casi,o
222,S1130-05582017000300164,a,o
222,S1130-05582017000300164,sus,o
222,S1130-05582017000300164,niveles,o
222,S1130-05582017000300164,basales,o
222,S1130-05582017000300164,243,o
222,S1130-05582017000300164,089,o
222,S1130-05582017000300164,vs,o
222,S1130-05582017000300164,255,o
222,S1130-05582017000300164,092,o
222,S1130-05582017000300164,Conclusiones,o
222,S1130-05582017000300164,No,o
222,S1130-05582017000300164,se,o
222,S1130-05582017000300164,encontro,o
222,S1130-05582017000300164,diferencia,o
222,S1130-05582017000300164,significativa,o
222,S1130-05582017000300164,con,o
222,S1130-05582017000300164,el,o
222,S1130-05582017000300164,uso,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,PRFC,i
222,S1130-05582017000300164,en,o
222,S1130-05582017000300164,cuanto,o
222,S1130-05582017000300164,a,o
222,S1130-05582017000300164,ganancia,o
222,S1130-05582017000300164,en,o
222,S1130-05582017000300164,el,o
222,S1130-05582017000300164,nivel,o
222,S1130-05582017000300164,clinico,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,insercion,o
222,S1130-05582017000300164,periodontal,i
222,S1130-05582017000300164,en,o
222,S1130-05582017000300164,el,o
222,S1130-05582017000300164,area,o
222,S1130-05582017000300164,distal,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,segundos,i
222,S1130-05582017000300164,molares,i
222,S1130-05582017000300164,despues,o
222,S1130-05582017000300164,de,o
222,S1130-05582017000300164,la,o
222,S1130-05582017000300164,extraccion,i
222,S1130-05582017000300164,de,i
222,S1130-05582017000300164,terceros,i
222,S1130-05582017000300164,molares,i
222,S1130-05582017000300164,inferiores,i
222,S1130-05582017000300164,retenidos,i
223,S1130-05582018000300129,Eficacia,o
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,la,o
223,S1130-05582018000300129,azitromicina,i
223,S1130-05582018000300129,asociada,o
223,S1130-05582018000300129,al,o
223,S1130-05582018000300129,RAR,i
223,S1130-05582018000300129,en,o
223,S1130-05582018000300129,periodontitis,i
223,S1130-05582018000300129,cronica,i
223,S1130-05582018000300129,ensayo,o
223,S1130-05582018000300129,clinico,o
223,S1130-05582018000300129,aleatorizado,o
223,S1130-05582018000300129,controlado,o
223,S1130-05582018000300129,y,o
223,S1130-05582018000300129,triple,o
223,S1130-05582018000300129,ciego,o
223,S1130-05582018000300129,en,o
223,S1130-05582018000300129,grupos,o
223,S1130-05582018000300129,en,o
223,S1130-05582018000300129,paralelo,o
223,S1130-05582018000300129,Objetivo,o
223,S1130-05582018000300129,Evaluar,i
223,S1130-05582018000300129,la,i
223,S1130-05582018000300129,eficacia,i
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,la,o
223,S1130-05582018000300129,azitromicina,i
223,S1130-05582018000300129,asociada,o
223,S1130-05582018000300129,al,o
223,S1130-05582018000300129,RAR,i
223,S1130-05582018000300129,en,o
223,S1130-05582018000300129,pacientes,o
223,S1130-05582018000300129,con,o
223,S1130-05582018000300129,periodontitis,i
223,S1130-05582018000300129,cronica,i
223,S1130-05582018000300129,Material,o
223,S1130-05582018000300129,y,o
223,S1130-05582018000300129,metodo,o
223,S1130-05582018000300129,El,o
223,S1130-05582018000300129,presente,o
223,S1130-05582018000300129,ensayo,o
223,S1130-05582018000300129,clinico,o
223,S1130-05582018000300129,paralelo,o
223,S1130-05582018000300129,aleatorizado,o
223,S1130-05582018000300129,controlado,o
223,S1130-05582018000300129,y,o
223,S1130-05582018000300129,triple,o
223,S1130-05582018000300129,ciego,o
223,S1130-05582018000300129,se,o
223,S1130-05582018000300129,desarrollo,o
223,S1130-05582018000300129,en,o
223,S1130-05582018000300129,la,o
223,S1130-05582018000300129,Clinica,o
223,S1130-05582018000300129,Estomatologica,o
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,la,o
223,S1130-05582018000300129,Universidad,o
223,S1130-05582018000300129,Catolica,o
223,S1130-05582018000300129,los,o
223,S1130-05582018000300129,Angeles,o
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,Chimbote,o
223,S1130-05582018000300129,Trujillo,o
223,S1130-05582018000300129,Peru,o
223,S1130-05582018000300129,entre,o
223,S1130-05582018000300129,marzo,o
223,S1130-05582018000300129,del,o
223,S1130-05582018000300129,2015,o
223,S1130-05582018000300129,y,o
223,S1130-05582018000300129,febrero,o
223,S1130-05582018000300129,del,o
223,S1130-05582018000300129,2017,o
223,S1130-05582018000300129,Participaron,o
223,S1130-05582018000300129,70,o
223,S1130-05582018000300129,pacientes,o
223,S1130-05582018000300129,adultos,o
223,S1130-05582018000300129,distribuidos,i
223,S1130-05582018000300129,aleatoriamente,i
223,S1130-05582018000300129,en,o
223,S1130-05582018000300129,2,o
223,S1130-05582018000300129,grupos,o
223,S1130-05582018000300129,designados,o
223,S1130-05582018000300129,con,o
223,S1130-05582018000300129,las,o
223,S1130-05582018000300129,letras,o
223,S1130-05582018000300129,A,o
223,S1130-05582018000300129,y,o
223,S1130-05582018000300129,B,o
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,35,o
223,S1130-05582018000300129,integrantes,o
223,S1130-05582018000300129,cada,o
223,S1130-05582018000300129,uno,o
223,S1130-05582018000300129,Cada,o
223,S1130-05582018000300129,paciente,o
223,S1130-05582018000300129,fue,o
223,S1130-05582018000300129,evaluado,i
223,S1130-05582018000300129,periodontalmente,i
223,S1130-05582018000300129,antes,o
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,realizarle,o
223,S1130-05582018000300129,el,o
223,S1130-05582018000300129,raspado,i
223,S1130-05582018000300129,y,i
223,S1130-05582018000300129,alisado,i
223,S1130-05582018000300129,radicular,i
223,S1130-05582018000300129,y,o
223,S1130-05582018000300129,optimizacion,o
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,las,o
223,S1130-05582018000300129,tecnicas,i
223,S1130-05582018000300129,de,i
223,S1130-05582018000300129,higiene,i
223,S1130-05582018000300129,A,o
223,S1130-05582018000300129,los,o
223,S1130-05582018000300129,pacientes,o
223,S1130-05582018000300129,del,o
223,S1130-05582018000300129,grupo,o
223,S1130-05582018000300129,A,o
223,S1130-05582018000300129,se,o
223,S1130-05582018000300129,les,o
223,S1130-05582018000300129,indico,o
223,S1130-05582018000300129,tratamiento,i
223,S1130-05582018000300129,antibiotico,i
223,S1130-05582018000300129,con,o
223,S1130-05582018000300129,azitromicina,i
223,S1130-05582018000300129,500,o
223,S1130-05582018000300129,mg,o
223,S1130-05582018000300129,por,o
223,S1130-05582018000300129,via,o
223,S1130-05582018000300129,oral,o
223,S1130-05582018000300129,cada,o
223,S1130-05582018000300129,24,o
223,S1130-05582018000300129,h,o
223,S1130-05582018000300129,durante,o
223,S1130-05582018000300129,3,o
223,S1130-05582018000300129,dias,o
223,S1130-05582018000300129,y,o
223,S1130-05582018000300129,al,o
223,S1130-05582018000300129,grupo,o
223,S1130-05582018000300129,B,o
223,S1130-05582018000300129,se,o
223,S1130-05582018000300129,le,o
223,S1130-05582018000300129,indico,o
223,S1130-05582018000300129,un,o
223,S1130-05582018000300129,placebo,i
223,S1130-05582018000300129,con,o
223,S1130-05582018000300129,las,o
223,S1130-05582018000300129,mismas,o
223,S1130-05582018000300129,caracteristicas,o
223,S1130-05582018000300129,fisicas,o
223,S1130-05582018000300129,del,o
223,S1130-05582018000300129,antibiotico,i
223,S1130-05582018000300129,escogido,o
223,S1130-05582018000300129,Los,o
223,S1130-05582018000300129,pacientes,o
223,S1130-05582018000300129,fueron,o
223,S1130-05582018000300129,evaluados,o
223,S1130-05582018000300129,a,o
223,S1130-05582018000300129,los,o
223,S1130-05582018000300129,3,o
223,S1130-05582018000300129,4,o
223,S1130-05582018000300129,y,o
223,S1130-05582018000300129,5,o
223,S1130-05582018000300129,meses,o
223,S1130-05582018000300129,La,o
223,S1130-05582018000300129,eficacia,i
223,S1130-05582018000300129,fue,i
223,S1130-05582018000300129,evaluada,i
223,S1130-05582018000300129,mediante,o
223,S1130-05582018000300129,el,o
223,S1130-05582018000300129,test,o
223,S1130-05582018000300129,T,o
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,Student,o
223,S1130-05582018000300129,para,o
223,S1130-05582018000300129,comparacion,o
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,medias,o
223,S1130-05582018000300129,considerando,o
223,S1130-05582018000300129,un,o
223,S1130-05582018000300129,nivel,o
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,significacion,o
223,S1130-05582018000300129,para,o
223,S1130-05582018000300129,los,o
223,S1130-05582018000300129,valores,o
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,p,o
223,S1130-05582018000300129,005,o
223,S1130-05582018000300129,Resultados,o
223,S1130-05582018000300129,Se,o
223,S1130-05582018000300129,encontro,o
223,S1130-05582018000300129,que,o
223,S1130-05582018000300129,ambos,o
223,S1130-05582018000300129,grupos,o
223,S1130-05582018000300129,lograron,o
223,S1130-05582018000300129,mejorar,o
223,S1130-05582018000300129,la,o
223,S1130-05582018000300129,profundidad,o
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,sondaje,i
223,S1130-05582018000300129,y,o
223,S1130-05582018000300129,el,o
223,S1130-05582018000300129,nivel,o
223,S1130-05582018000300129,de,o
223,S1130-05582018000300129,adherencia,o
223,S1130-05582018000300129,clinica,o
223,S1130-05582018000300129,sin,o
223,S1130-05582018000300129,embargo,o
223,S1130-05582018000300129,no,o
223,S1130-05582018000300129,presentaron,o
223,S1130-05582018000300129,diferencias,o
223,S1130-05582018000300129,estadisticamente,o
223,S1130-05582018000300129,significativas,o
223,S1130-05582018000300129,entre,o
223,S1130-05582018000300129,ellos,o
223,S1130-05582018000300129,Conclusion,o
223,S1130-05582018000300129,La,o
223,S1130-05582018000300129,azitromicina,i
223,S1130-05582018000300129,asociada,o
223,S1130-05582018000300129,al,o
223,S1130-05582018000300129,RAR,i
223,S1130-05582018000300129,no,o
223,S1130-05582018000300129,es,o
223,S1130-05582018000300129,eficaz,o
223,S1130-05582018000300129,como,o
223,S1130-05582018000300129,terapia,i
223,S1130-05582018000300129,coadyuvante,i
223,S1130-05582018000300129,en,o
223,S1130-05582018000300129,pacientes,o
223,S1130-05582018000300129,con,o
223,S1130-05582018000300129,periodontitis,i
223,S1130-05582018000300129,cronica,i
224,S1130-14732005000500002,Efectos,o
224,S1130-14732005000500002,de,o
224,S1130-14732005000500002,la,o
224,S1130-14732005000500002,dexmedetomidina,i
224,S1130-14732005000500002,sobre,o
224,S1130-14732005000500002,la,o
224,S1130-14732005000500002,hemodinamica,o
224,S1130-14732005000500002,intracraneal,i
224,S1130-14732005000500002,en,o
224,S1130-14732005000500002,pacientes,o
224,S1130-14732005000500002,con,o
224,S1130-14732005000500002,lesion,i
224,S1130-14732005000500002,encefalica,i
224,S1130-14732005000500002,traumatica,i
224,S1130-14732005000500002,grave,o
224,S1130-14732005000500002,La,o
224,S1130-14732005000500002,dexmedetomidina,i
224,S1130-14732005000500002,un,o
224,S1130-14732005000500002,agonista,i
224,S1130-14732005000500002,adrenergico,i
224,S1130-14732005000500002,selectivo,i
224,S1130-14732005000500002,α2,i
224,S1130-14732005000500002,constituye,o
224,S1130-14732005000500002,un,o
224,S1130-14732005000500002,intento,o
224,S1130-14732005000500002,de,o
224,S1130-14732005000500002,mejorar,o
224,S1130-14732005000500002,la,o
224,S1130-14732005000500002,sedoanalgesia,i
224,S1130-14732005000500002,de,o
224,S1130-14732005000500002,los,o
224,S1130-14732005000500002,pacientes,o
224,S1130-14732005000500002,criticos,o
224,S1130-14732005000500002,por,o
224,S1130-14732005000500002,sus,o
224,S1130-14732005000500002,efectos,o
224,S1130-14732005000500002,distintivos,o
224,S1130-14732005000500002,en,o
224,S1130-14732005000500002,comparacion,o
224,S1130-14732005000500002,a,o
224,S1130-14732005000500002,los,o
224,S1130-14732005000500002,planes,o
224,S1130-14732005000500002,tradicionales,o
224,S1130-14732005000500002,como,o
224,S1130-14732005000500002,son,o
224,S1130-14732005000500002,sedacion,i
224,S1130-14732005000500002,consciente,i
224,S1130-14732005000500002,simpaticolisis,i
224,S1130-14732005000500002,y,o
224,S1130-14732005000500002,ausencia,o
224,S1130-14732005000500002,de,o
224,S1130-14732005000500002,depresion,i
224,S1130-14732005000500002,respiratoria,i
224,S1130-14732005000500002,Objetivo,o
224,S1130-14732005000500002,Estudiar,o
224,S1130-14732005000500002,el,o
224,S1130-14732005000500002,efecto,o
224,S1130-14732005000500002,de,o
224,S1130-14732005000500002,la,o
224,S1130-14732005000500002,dexmedetomidina,i
224,S1130-14732005000500002,un,o
224,S1130-14732005000500002,nuevo,o
224,S1130-14732005000500002,agonista,i
224,S1130-14732005000500002,α28,i
224,S1130-14732005000500002,sobre,o
224,S1130-14732005000500002,la,o
224,S1130-14732005000500002,hemodinamica,o
224,S1130-14732005000500002,intracraneal,i
224,S1130-14732005000500002,y,o
224,S1130-14732005000500002,sobre,o
224,S1130-14732005000500002,los,o
224,S1130-14732005000500002,parametros,o
224,S1130-14732005000500002,hemometabolicos,o
224,S1130-14732005000500002,cerebrales,i
224,S1130-14732005000500002,en,o
224,S1130-14732005000500002,un,o
224,S1130-14732005000500002,grupo,o
224,S1130-14732005000500002,de,o
224,S1130-14732005000500002,pacientes,o
224,S1130-14732005000500002,con,o
224,S1130-14732005000500002,trauma,i
224,S1130-14732005000500002,craneoencefalico,i
224,S1130-14732005000500002,grave,o
224,S1130-14732005000500002,Material,o
224,S1130-14732005000500002,y,o
224,S1130-14732005000500002,metodos,o
224,S1130-14732005000500002,Estudio,i
224,S1130-14732005000500002,prospectivo,i
224,S1130-14732005000500002,de,o
224,S1130-14732005000500002,los,o
224,S1130-14732005000500002,pacientes,o
224,S1130-14732005000500002,con,o
224,S1130-14732005000500002,lesion,i
224,S1130-14732005000500002,encefalica,i
224,S1130-14732005000500002,traumatica,i
224,S1130-14732005000500002,grave,o
224,S1130-14732005000500002,Glasgow,i
224,S1130-14732005000500002,Coma,i
224,S1130-14732005000500002,Scale,i
224,S1130-14732005000500002,8,o
224,S1130-14732005000500002,ingresados,i
224,S1130-14732005000500002,en,o
224,S1130-14732005000500002,un,o
224,S1130-14732005000500002,Centro,o
224,S1130-14732005000500002,de,o
224,S1130-14732005000500002,Tratamiento,o
224,S1130-14732005000500002,Intensivo,o
224,S1130-14732005000500002,CTI,o
224,S1130-14732005000500002,que,o
224,S1130-14732005000500002,recibieron,o
224,S1130-14732005000500002,monitorizacion,i
224,S1130-14732005000500002,de,i
224,S1130-14732005000500002,la,i
224,S1130-14732005000500002,presion,i
224,S1130-14732005000500002,intracraneal,i
224,S1130-14732005000500002,PIC,i
224,S1130-14732005000500002,y,o
224,S1130-14732005000500002,monitorizacion,i
224,S1130-14732005000500002,de,i
224,S1130-14732005000500002,saturacion,i
224,S1130-14732005000500002,de,i
224,S1130-14732005000500002,O2,i
224,S1130-14732005000500002,del,o
224,S1130-14732005000500002,bulbo,i
224,S1130-14732005000500002,yugular,i
224,S1130-14732005000500002,SjO2,i
224,S1130-14732005000500002,Se,o
224,S1130-14732005000500002,realizo,o
224,S1130-14732005000500002,una,o
224,S1130-14732005000500002,perfusion,i
224,S1130-14732005000500002,intravenosa,i
224,S1130-14732005000500002,de,i
224,S1130-14732005000500002,la,i
224,S1130-14732005000500002,droga,i
224,S1130-14732005000500002,durante,o
224,S1130-14732005000500002,3,o
224,S1130-14732005000500002,horas,o
224,S1130-14732005000500002,en,o
224,S1130-14732005000500002,dosis,o
224,S1130-14732005000500002,progresivas,o
224,S1130-14732005000500002,02,o
224,S1130-14732005000500002,04,o
224,S1130-14732005000500002,y,o
224,S1130-14732005000500002,07,o
224,S1130-14732005000500002,ugkgh,o
224,S1130-14732005000500002,previa,o
224,S1130-14732005000500002,suspension,o
224,S1130-14732005000500002,de,o
224,S1130-14732005000500002,otros,o
224,S1130-14732005000500002,sedantes,i
224,S1130-14732005000500002,y,o
224,S1130-14732005000500002,analgesicos,i
224,S1130-14732005000500002,Resultados,o
224,S1130-14732005000500002,Se,o
224,S1130-14732005000500002,estudiaron,o
224,S1130-14732005000500002,12,o
224,S1130-14732005000500002,pacientes,o
224,S1130-14732005000500002,sin,o
224,S1130-14732005000500002,hipertension,i
224,S1130-14732005000500002,intracraneal,i
224,S1130-14732005000500002,No,o
224,S1130-14732005000500002,se,o
224,S1130-14732005000500002,encontraron,o
224,S1130-14732005000500002,diferencias,o
224,S1130-14732005000500002,significativas,o
224,S1130-14732005000500002,entre,o
224,S1130-14732005000500002,los,o
224,S1130-14732005000500002,valores,i
224,S1130-14732005000500002,de,i
224,S1130-14732005000500002,PIC,i
224,S1130-14732005000500002,y,o
224,S1130-14732005000500002,presion,i
224,S1130-14732005000500002,arterial,i
224,S1130-14732005000500002,media,i
224,S1130-14732005000500002,PAM,i
224,S1130-14732005000500002,tras,o
224,S1130-14732005000500002,la,o
224,S1130-14732005000500002,infusion,i
224,S1130-14732005000500002,de,i
224,S1130-14732005000500002,la,i
224,S1130-14732005000500002,droga,i
224,S1130-14732005000500002,en,o
224,S1130-14732005000500002,relacion,o
224,S1130-14732005000500002,con,o
224,S1130-14732005000500002,los,o
224,S1130-14732005000500002,valores,o
224,S1130-14732005000500002,basales,o
224,S1130-14732005000500002,La,o
224,S1130-14732005000500002,presion,i
224,S1130-14732005000500002,de,i
224,S1130-14732005000500002,perfusion,i
224,S1130-14732005000500002,cerebral,i
224,S1130-14732005000500002,PPC,i
224,S1130-14732005000500002,mostro,o
224,S1130-14732005000500002,una,o
224,S1130-14732005000500002,tendencia,o
224,S1130-14732005000500002,a,o
224,S1130-14732005000500002,disminuir,o
224,S1130-14732005000500002,durante,o
224,S1130-14732005000500002,el,o
224,S1130-14732005000500002,estudio,o
224,S1130-14732005000500002,efecto,o
224,S1130-14732005000500002,marginal,o
224,S1130-14732005000500002,p0058,o
224,S1130-14732005000500002,Se,o
224,S1130-14732005000500002,encontro,o
224,S1130-14732005000500002,un,o
224,S1130-14732005000500002,descenso,o
224,S1130-14732005000500002,significativo,o
224,S1130-14732005000500002,de,o
224,S1130-14732005000500002,la,o
224,S1130-14732005000500002,frecuencia,i
224,S1130-14732005000500002,cardiaca,i
224,S1130-14732005000500002,FC,i
224,S1130-14732005000500002,p00001,o
224,S1130-14732005000500002,en,o
224,S1130-14732005000500002,relacion,o
224,S1130-14732005000500002,a,o
224,S1130-14732005000500002,los,o
224,S1130-14732005000500002,valores,o
224,S1130-14732005000500002,basales,o
224,S1130-14732005000500002,No,o
224,S1130-14732005000500002,se,o
224,S1130-14732005000500002,hallaron,o
224,S1130-14732005000500002,diferencias,o
224,S1130-14732005000500002,significativas,o
224,S1130-14732005000500002,en,o
224,S1130-14732005000500002,los,o
224,S1130-14732005000500002,parametros,o
224,S1130-14732005000500002,hemometabolicos,o
224,S1130-14732005000500002,cerebrales,i
224,S1130-14732005000500002,SjO2,i
224,S1130-14732005000500002,y,o
224,S1130-14732005000500002,CEO2,o
224,S1130-14732005000500002,Conclusion,o
224,S1130-14732005000500002,A,o
224,S1130-14732005000500002,las,o
224,S1130-14732005000500002,dosis,o
224,S1130-14732005000500002,utilizadas,o
224,S1130-14732005000500002,la,o
224,S1130-14732005000500002,dexmedetomidina,i
224,S1130-14732005000500002,fue,o
224,S1130-14732005000500002,segura,o
224,S1130-14732005000500002,no,o
224,S1130-14732005000500002,asociandose,o
224,S1130-14732005000500002,a,o
224,S1130-14732005000500002,alteraciones,o
224,S1130-14732005000500002,significativas,o
224,S1130-14732005000500002,de,o
224,S1130-14732005000500002,la,o
224,S1130-14732005000500002,hemodinamica,o
224,S1130-14732005000500002,intracraneal,i
224,S1130-14732005000500002,ni,o
224,S1130-14732005000500002,del,o
224,S1130-14732005000500002,metabolismo,o
224,S1130-14732005000500002,sanguineo,i
224,S1130-14732005000500002,cerebral,i
224,S1130-14732005000500002,en,o
224,S1130-14732005000500002,pacientes,o
224,S1130-14732005000500002,en,o
224,S1130-14732005000500002,la,o
224,S1130-14732005000500002,etapa,o
224,S1130-14732005000500002,aguda,o
224,S1130-14732005000500002,del,o
224,S1130-14732005000500002,trauma,i
224,S1130-14732005000500002,craneoencefalico,i
224,S1130-14732005000500002,grave,o
224,S1130-14732005000500002,TECG,i
225,S1130-14732006000200008,Artrodesis,i
225,S1130-14732006000200008,cervical,i
225,S1130-14732006000200008,anterior,i
225,S1130-14732006000200008,mediante,o
225,S1130-14732006000200008,implante,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,tantalio,i
225,S1130-14732006000200008,Resultados,o
225,S1130-14732006000200008,clinicos,o
225,S1130-14732006000200008,y,o
225,S1130-14732006000200008,radiologicos,o
225,S1130-14732006000200008,La,o
225,S1130-14732006000200008,discectomia,i
225,S1130-14732006000200008,cervical,i
225,S1130-14732006000200008,anterior,i
225,S1130-14732006000200008,con,i
225,S1130-14732006000200008,artrodesis,i
225,S1130-14732006000200008,intersomatica,i
225,S1130-14732006000200008,DCAA,o
225,S1130-14732006000200008,es,o
225,S1130-14732006000200008,una,o
225,S1130-14732006000200008,tecnica,i
225,S1130-14732006000200008,quirurgica,i
225,S1130-14732006000200008,ampliamente,o
225,S1130-14732006000200008,aceptada,o
225,S1130-14732006000200008,en,o
225,S1130-14732006000200008,el,o
225,S1130-14732006000200008,tratamiento,i
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,la,o
225,S1130-14732006000200008,enfermedad,i
225,S1130-14732006000200008,discal,i
225,S1130-14732006000200008,cervical,i
225,S1130-14732006000200008,Recientemente,o
225,S1130-14732006000200008,se,o
225,S1130-14732006000200008,han,o
225,S1130-14732006000200008,introducido,o
225,S1130-14732006000200008,con,o
225,S1130-14732006000200008,esta,o
225,S1130-14732006000200008,indicacion,o
225,S1130-14732006000200008,las,o
225,S1130-14732006000200008,cajas,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,tantalio,i
225,S1130-14732006000200008,debido,o
225,S1130-14732006000200008,a,o
225,S1130-14732006000200008,sus,o
225,S1130-14732006000200008,excelentes,o
225,S1130-14732006000200008,propiedades,o
225,S1130-14732006000200008,mecanicas,o
225,S1130-14732006000200008,y,o
225,S1130-14732006000200008,biologicas,o
225,S1130-14732006000200008,Presentamos,o
225,S1130-14732006000200008,los,o
225,S1130-14732006000200008,resultados,o
225,S1130-14732006000200008,iniciales,o
225,S1130-14732006000200008,clinicos,o
225,S1130-14732006000200008,y,o
225,S1130-14732006000200008,radiologicos,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,un,o
225,S1130-14732006000200008,estudio,i
225,S1130-14732006000200008,prospectivo,i
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,24,o
225,S1130-14732006000200008,pacientes,o
225,S1130-14732006000200008,intervenidos,i
225,S1130-14732006000200008,en,o
225,S1130-14732006000200008,nuestro,o
225,S1130-14732006000200008,servicio,o
225,S1130-14732006000200008,tras,o
225,S1130-14732006000200008,el,o
225,S1130-14732006000200008,empleo,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,cajas,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,tantalio,i
225,S1130-14732006000200008,en,o
225,S1130-14732006000200008,la,o
225,S1130-14732006000200008,DCAA,o
225,S1130-14732006000200008,La,o
225,S1130-14732006000200008,evaluacion,i
225,S1130-14732006000200008,clinica,i
225,S1130-14732006000200008,pre,o
225,S1130-14732006000200008,y,o
225,S1130-14732006000200008,postoperatoria,o
225,S1130-14732006000200008,se,o
225,S1130-14732006000200008,realizo,o
225,S1130-14732006000200008,mediante,o
225,S1130-14732006000200008,cuestionario,i
225,S1130-14732006000200008,que,o
225,S1130-14732006000200008,incluia,o
225,S1130-14732006000200008,una,o
225,S1130-14732006000200008,Escala,i
225,S1130-14732006000200008,Visual,i
225,S1130-14732006000200008,Analogica,i
225,S1130-14732006000200008,de,i
225,S1130-14732006000200008,dolor,i
225,S1130-14732006000200008,el,o
225,S1130-14732006000200008,Indice,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,Oswestry,o
225,S1130-14732006000200008,y,o
225,S1130-14732006000200008,la,o
225,S1130-14732006000200008,Escala,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,Zung,o
225,S1130-14732006000200008,Los,o
225,S1130-14732006000200008,resultados,o
225,S1130-14732006000200008,fueron,o
225,S1130-14732006000200008,clasificados,o
225,S1130-14732006000200008,mediante,o
225,S1130-14732006000200008,los,o
225,S1130-14732006000200008,criterios,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,Odom,o
225,S1130-14732006000200008,La,o
225,S1130-14732006000200008,evaluacion,i
225,S1130-14732006000200008,radiologica,i
225,S1130-14732006000200008,incluyo,o
225,S1130-14732006000200008,radiografias,i
225,S1130-14732006000200008,dinamicas,i
225,S1130-14732006000200008,en,o
225,S1130-14732006000200008,las,o
225,S1130-14732006000200008,que,o
225,S1130-14732006000200008,se,o
225,S1130-14732006000200008,midieron,o
225,S1130-14732006000200008,las,o
225,S1130-14732006000200008,variaciones,o
225,S1130-14732006000200008,del,o
225,S1130-14732006000200008,angulo,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,Cobb,o
225,S1130-14732006000200008,y,o
225,S1130-14732006000200008,la,o
225,S1130-14732006000200008,distancia,i
225,S1130-14732006000200008,interespinosa,i
225,S1130-14732006000200008,Postoperatoriamente,o
225,S1130-14732006000200008,los,o
225,S1130-14732006000200008,pacientes,o
225,S1130-14732006000200008,fueron,o
225,S1130-14732006000200008,revisados,i
225,S1130-14732006000200008,en,o
225,S1130-14732006000200008,el,o
225,S1130-14732006000200008,tercer,o
225,S1130-14732006000200008,mes,o
225,S1130-14732006000200008,y,o
225,S1130-14732006000200008,al,o
225,S1130-14732006000200008,año,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,la,o
225,S1130-14732006000200008,intervencion,i
225,S1130-14732006000200008,Todos,o
225,S1130-14732006000200008,los,o
225,S1130-14732006000200008,parametros,o
225,S1130-14732006000200008,clinicos,o
225,S1130-14732006000200008,mejoraron,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,forma,o
225,S1130-14732006000200008,estadisticamente,o
225,S1130-14732006000200008,significativa,o
225,S1130-14732006000200008,Segun,o
225,S1130-14732006000200008,con,o
225,S1130-14732006000200008,los,o
225,S1130-14732006000200008,criterios,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,Odom,o
225,S1130-14732006000200008,el,o
225,S1130-14732006000200008,75,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,los,o
225,S1130-14732006000200008,casos,o
225,S1130-14732006000200008,fueron,o
225,S1130-14732006000200008,considerados,o
225,S1130-14732006000200008,como,o
225,S1130-14732006000200008,excelentes,o
225,S1130-14732006000200008,o,o
225,S1130-14732006000200008,buenos,o
225,S1130-14732006000200008,Solo,o
225,S1130-14732006000200008,se,o
225,S1130-14732006000200008,confirmo,o
225,S1130-14732006000200008,clinica,o
225,S1130-14732006000200008,y,o
225,S1130-14732006000200008,radiologicamente,o
225,S1130-14732006000200008,un,o
225,S1130-14732006000200008,caso,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,pseudoartrosis,i
225,S1130-14732006000200008,No,o
225,S1130-14732006000200008,se,o
225,S1130-14732006000200008,observaron,o
225,S1130-14732006000200008,diferencias,o
225,S1130-14732006000200008,significativas,o
225,S1130-14732006000200008,en,o
225,S1130-14732006000200008,las,o
225,S1130-14732006000200008,revisiones,i
225,S1130-14732006000200008,al,o
225,S1130-14732006000200008,año,o
225,S1130-14732006000200008,y,o
225,S1130-14732006000200008,a,o
225,S1130-14732006000200008,los,o
225,S1130-14732006000200008,3,o
225,S1130-14732006000200008,meses,o
225,S1130-14732006000200008,Conclusion,o
225,S1130-14732006000200008,Las,o
225,S1130-14732006000200008,cajas,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,tantalio,i
225,S1130-14732006000200008,constituyen,o
225,S1130-14732006000200008,un,o
225,S1130-14732006000200008,implante,o
225,S1130-14732006000200008,prometedor,o
225,S1130-14732006000200008,y,o
225,S1130-14732006000200008,pensamos,o
225,S1130-14732006000200008,que,o
225,S1130-14732006000200008,util,o
225,S1130-14732006000200008,entre,o
225,S1130-14732006000200008,las,o
225,S1130-14732006000200008,diversas,o
225,S1130-14732006000200008,opciones,o
225,S1130-14732006000200008,quirurgicas,o
225,S1130-14732006000200008,para,o
225,S1130-14732006000200008,la,o
225,S1130-14732006000200008,DCAA,o
225,S1130-14732006000200008,por,o
225,S1130-14732006000200008,sus,o
225,S1130-14732006000200008,buenos,o
225,S1130-14732006000200008,resultados,o
225,S1130-14732006000200008,clinicos,o
225,S1130-14732006000200008,por,o
225,S1130-14732006000200008,la,o
225,S1130-14732006000200008,no,o
225,S1130-14732006000200008,necesidad,o
225,S1130-14732006000200008,de,o
225,S1130-14732006000200008,autoinjerto,i
225,S1130-14732006000200008,y,o
225,S1130-14732006000200008,por,o
225,S1130-14732006000200008,su,o
225,S1130-14732006000200008,excelente,o
225,S1130-14732006000200008,compatibilidad,o
225,S1130-14732006000200008,con,o
225,S1130-14732006000200008,la,o
225,S1130-14732006000200008,resonancia,i
225,S1130-14732006000200008,nuclear,i
225,S1130-14732006000200008,magnetica,i
226,S1130-14732009000400002,Comparacion,o
226,S1130-14732009000400002,del,o
226,S1130-14732009000400002,abordaje,o
226,S1130-14732009000400002,sublabial,o
226,S1130-14732009000400002,transesfenoidal,o
226,S1130-14732009000400002,microquirurgico,i
226,S1130-14732009000400002,frente,o
226,S1130-14732009000400002,al,o
226,S1130-14732009000400002,abordaje,o
226,S1130-14732009000400002,endonasal,o
226,S1130-14732009000400002,transesfenoidal,o
226,S1130-14732009000400002,endoscopico,i
226,S1130-14732009000400002,Estudio,i
226,S1130-14732009000400002,prospectivo,i
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,50,o
226,S1130-14732009000400002,pacientes,o
226,S1130-14732009000400002,Objetivos,o
226,S1130-14732009000400002,Comparar,o
226,S1130-14732009000400002,el,o
226,S1130-14732009000400002,abordaje,o
226,S1130-14732009000400002,transesfenoidal,o
226,S1130-14732009000400002,endonasal,o
226,S1130-14732009000400002,endoscopico,i
226,S1130-14732009000400002,con,o
226,S1130-14732009000400002,el,o
226,S1130-14732009000400002,abordaje,o
226,S1130-14732009000400002,transesfenoidal,o
226,S1130-14732009000400002,sublabial,o
226,S1130-14732009000400002,microquirurgico,i
226,S1130-14732009000400002,Valoracion,o
226,S1130-14732009000400002,del,o
226,S1130-14732009000400002,grado,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,reseccion,i
226,S1130-14732009000400002,tumoral,i
226,S1130-14732009000400002,grado,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,invasividad,o
226,S1130-14732009000400002,tumoral,i
226,S1130-14732009000400002,complicaciones,i
226,S1130-14732009000400002,y,o
226,S1130-14732009000400002,estancia,o
226,S1130-14732009000400002,postoperatoria,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,ambos,o
226,S1130-14732009000400002,grupos,o
226,S1130-14732009000400002,Material,o
226,S1130-14732009000400002,y,o
226,S1130-14732009000400002,metodos,o
226,S1130-14732009000400002,Estudio,i
226,S1130-14732009000400002,prospectivo,i
226,S1130-14732009000400002,no,i
226,S1130-14732009000400002,randomizado,i
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,50,o
226,S1130-14732009000400002,pacientes,o
226,S1130-14732009000400002,intervenidos,i
226,S1130-14732009000400002,en,o
226,S1130-14732009000400002,nuestro,o
226,S1130-14732009000400002,centro,o
226,S1130-14732009000400002,entre,o
226,S1130-14732009000400002,2002,o
226,S1130-14732009000400002,y,o
226,S1130-14732009000400002,2006,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,lesiones,i
226,S1130-14732009000400002,en,i
226,S1130-14732009000400002,la,i
226,S1130-14732009000400002,region,i
226,S1130-14732009000400002,selar,i
226,S1130-14732009000400002,con,o
226,S1130-14732009000400002,diferentes,o
226,S1130-14732009000400002,grados,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,invasion,i
226,S1130-14732009000400002,del,i
226,S1130-14732009000400002,seno,i
226,S1130-14732009000400002,cavernoso,i
226,S1130-14732009000400002,segun,o
226,S1130-14732009000400002,la,o
226,S1130-14732009000400002,clasificacion,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,Knosp,o
226,S1130-14732009000400002,Entre,o
226,S1130-14732009000400002,las,o
226,S1130-14732009000400002,variables,o
226,S1130-14732009000400002,a,o
226,S1130-14732009000400002,estudio,o
226,S1130-14732009000400002,se,o
226,S1130-14732009000400002,incluyeron,o
226,S1130-14732009000400002,los,o
226,S1130-14732009000400002,grados,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,invasion,i
226,S1130-14732009000400002,los,o
226,S1130-14732009000400002,grados,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,reseccion,i
226,S1130-14732009000400002,postoperatoria,o
226,S1130-14732009000400002,total,o
226,S1130-14732009000400002,subtotal,o
226,S1130-14732009000400002,y,o
226,S1130-14732009000400002,parcial,o
226,S1130-14732009000400002,lesion,i
226,S1130-14732009000400002,del,i
226,S1130-14732009000400002,nervio,i
226,S1130-14732009000400002,optico,i
226,S1130-14732009000400002,panhipopituitarismo,i
226,S1130-14732009000400002,postoperatorio,o
226,S1130-14732009000400002,fistula,i
226,S1130-14732009000400002,de,i
226,S1130-14732009000400002,LCR,i
226,S1130-14732009000400002,deficit,i
226,S1130-14732009000400002,de,i
226,S1130-14732009000400002,pares,i
226,S1130-14732009000400002,craneales,i
226,S1130-14732009000400002,epistaxis,i
226,S1130-14732009000400002,meningitis,i
226,S1130-14732009000400002,diabetes,i
226,S1130-14732009000400002,insipida,i
226,S1130-14732009000400002,y,o
226,S1130-14732009000400002,lesion,i
226,S1130-14732009000400002,de,i
226,S1130-14732009000400002,arteria,i
226,S1130-14732009000400002,carotida,i
226,S1130-14732009000400002,Nuestra,o
226,S1130-14732009000400002,serie,o
226,S1130-14732009000400002,consta,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,27,o
226,S1130-14732009000400002,hombres,o
226,S1130-14732009000400002,y,o
226,S1130-14732009000400002,23,o
226,S1130-14732009000400002,mujeres,o
226,S1130-14732009000400002,con,o
226,S1130-14732009000400002,una,o
226,S1130-14732009000400002,edad,o
226,S1130-14732009000400002,media,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,48,o
226,S1130-14732009000400002,años,o
226,S1130-14732009000400002,1980,o
226,S1130-14732009000400002,años,o
226,S1130-14732009000400002,En,o
226,S1130-14732009000400002,23,o
226,S1130-14732009000400002,casos,o
226,S1130-14732009000400002,se,o
226,S1130-14732009000400002,utilizo,o
226,S1130-14732009000400002,una,o
226,S1130-14732009000400002,via,o
226,S1130-14732009000400002,transesfenoidal,o
226,S1130-14732009000400002,sublabial,o
226,S1130-14732009000400002,microquirurgica,i
226,S1130-14732009000400002,2,o
226,S1130-14732009000400002,pacientes,o
226,S1130-14732009000400002,fueron,o
226,S1130-14732009000400002,excluidos,o
226,S1130-14732009000400002,y,o
226,S1130-14732009000400002,en,o
226,S1130-14732009000400002,25,o
226,S1130-14732009000400002,casos,o
226,S1130-14732009000400002,se,o
226,S1130-14732009000400002,realizo,o
226,S1130-14732009000400002,un,o
226,S1130-14732009000400002,abordaje,o
226,S1130-14732009000400002,transesfenoidal,o
226,S1130-14732009000400002,endoscopico,i
226,S1130-14732009000400002,El,o
226,S1130-14732009000400002,seguimiento,i
226,S1130-14732009000400002,medio,o
226,S1130-14732009000400002,fue,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,12,o
226,S1130-14732009000400002,meses,o
226,S1130-14732009000400002,Resultados,o
226,S1130-14732009000400002,En,o
226,S1130-14732009000400002,nuestra,o
226,S1130-14732009000400002,experiencia,o
226,S1130-14732009000400002,la,o
226,S1130-14732009000400002,tecnica,i
226,S1130-14732009000400002,endoscopica,i
226,S1130-14732009000400002,presenta,o
226,S1130-14732009000400002,un,o
226,S1130-14732009000400002,porcentaje,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,exeresis,i
226,S1130-14732009000400002,completa,i
226,S1130-14732009000400002,superior,o
226,S1130-14732009000400002,al,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,la,o
226,S1130-14732009000400002,tecnica,i
226,S1130-14732009000400002,clasica,i
226,S1130-14732009000400002,60,o
226,S1130-14732009000400002,frente,o
226,S1130-14732009000400002,a,o
226,S1130-14732009000400002,348,o
226,S1130-14732009000400002,que,o
226,S1130-14732009000400002,tambien,o
226,S1130-14732009000400002,se,o
226,S1130-14732009000400002,hace,o
226,S1130-14732009000400002,evidente,o
226,S1130-14732009000400002,en,o
226,S1130-14732009000400002,el,o
226,S1130-14732009000400002,caso,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,la,o
226,S1130-14732009000400002,reseccion,i
226,S1130-14732009000400002,subtotal,i
226,S1130-14732009000400002,32,o
226,S1130-14732009000400002,frente,o
226,S1130-14732009000400002,26,o
226,S1130-14732009000400002,existiendo,o
226,S1130-14732009000400002,una,o
226,S1130-14732009000400002,diferencia,o
226,S1130-14732009000400002,estadisticamente,o
226,S1130-14732009000400002,significativa,o
226,S1130-14732009000400002,p0033,o
226,S1130-14732009000400002,En,o
226,S1130-14732009000400002,contraposicion,o
226,S1130-14732009000400002,no,o
226,S1130-14732009000400002,encontramos,o
226,S1130-14732009000400002,diferencias,o
226,S1130-14732009000400002,en,o
226,S1130-14732009000400002,cuanto,o
226,S1130-14732009000400002,a,o
226,S1130-14732009000400002,complicaciones,i
226,S1130-14732009000400002,Tambien,o
226,S1130-14732009000400002,hemos,o
226,S1130-14732009000400002,evidenciado,o
226,S1130-14732009000400002,que,o
226,S1130-14732009000400002,existe,o
226,S1130-14732009000400002,una,o
226,S1130-14732009000400002,diferencia,o
226,S1130-14732009000400002,estadisticamente,o
226,S1130-14732009000400002,significativa,o
226,S1130-14732009000400002,en,o
226,S1130-14732009000400002,cuanto,o
226,S1130-14732009000400002,a,o
226,S1130-14732009000400002,la,o
226,S1130-14732009000400002,estancia,o
226,S1130-14732009000400002,postoperatoria,o
226,S1130-14732009000400002,p0001,o
226,S1130-14732009000400002,reduciendose,o
226,S1130-14732009000400002,esta,o
226,S1130-14732009000400002,a,o
226,S1130-14732009000400002,la,o
226,S1130-14732009000400002,mitad,o
226,S1130-14732009000400002,3,o
226,S1130-14732009000400002,dias,o
226,S1130-14732009000400002,con,o
226,S1130-14732009000400002,la,o
226,S1130-14732009000400002,tecnica,i
226,S1130-14732009000400002,endoscopica,i
226,S1130-14732009000400002,Si,o
226,S1130-14732009000400002,bien,o
226,S1130-14732009000400002,no,o
226,S1130-14732009000400002,hemos,o
226,S1130-14732009000400002,encontrado,o
226,S1130-14732009000400002,diferencias,o
226,S1130-14732009000400002,significativas,o
226,S1130-14732009000400002,en,o
226,S1130-14732009000400002,cuanto,o
226,S1130-14732009000400002,al,o
226,S1130-14732009000400002,grado,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,invasividad,o
226,S1130-14732009000400002,tumoral,i
226,S1130-14732009000400002,y,o
226,S1130-14732009000400002,al,o
226,S1130-14732009000400002,grado,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,reseccion,i
226,S1130-14732009000400002,un,o
226,S1130-14732009000400002,mayor,o
226,S1130-14732009000400002,grado,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,invasividad,o
226,S1130-14732009000400002,aumenta,o
226,S1130-14732009000400002,en,o
226,S1130-14732009000400002,359,o
226,S1130-14732009000400002,veces,o
226,S1130-14732009000400002,el,o
226,S1130-14732009000400002,riesgo,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,poco,o
226,S1130-14732009000400002,exito,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,la,o
226,S1130-14732009000400002,cirugia,i
226,S1130-14732009000400002,Discusion,o
226,S1130-14732009000400002,y,o
226,S1130-14732009000400002,conclusiones,o
226,S1130-14732009000400002,En,o
226,S1130-14732009000400002,nuestra,o
226,S1130-14732009000400002,experiencia,o
226,S1130-14732009000400002,con,o
226,S1130-14732009000400002,la,o
226,S1130-14732009000400002,tecnica,i
226,S1130-14732009000400002,endoscopica,i
226,S1130-14732009000400002,obtenemos,o
226,S1130-14732009000400002,un,o
226,S1130-14732009000400002,mayor,o
226,S1130-14732009000400002,grado,o
226,S1130-14732009000400002,de,o
226,S1130-14732009000400002,reseccion,i
226,S1130-14732009000400002,quirurgica,i
226,S1130-14732009000400002,y,o
226,S1130-14732009000400002,una,o
226,S1130-14732009000400002,estancia,o
226,S1130-14732009000400002,postoperatoria,o
226,S1130-14732009000400002,menor,o
226,S1130-14732009000400002,No,o
226,S1130-14732009000400002,hemos,o
226,S1130-14732009000400002,observado,o
226,S1130-14732009000400002,diferencias,o
226,S1130-14732009000400002,en,o
226,S1130-14732009000400002,cuanto,o
226,S1130-14732009000400002,a,o
226,S1130-14732009000400002,complicaciones,i
227,S1130-14732009000400003,Tratamiento,i
227,S1130-14732009000400003,con,o
227,S1130-14732009000400003,dexametasona,i
227,S1130-14732009000400003,del,o
227,S1130-14732009000400003,hematoma,i
227,S1130-14732009000400003,subdural,i
227,S1130-14732009000400003,cronico,i
227,S1130-14732009000400003,Introduccion,o
227,S1130-14732009000400003,El,o
227,S1130-14732009000400003,hematoma,i
227,S1130-14732009000400003,subdural,i
227,S1130-14732009000400003,cronico,i
227,S1130-14732009000400003,HSC,i
227,S1130-14732009000400003,es,o
227,S1130-14732009000400003,una,o
227,S1130-14732009000400003,entidad,o
227,S1130-14732009000400003,clinica,o
227,S1130-14732009000400003,bien,o
227,S1130-14732009000400003,conocida,o
227,S1130-14732009000400003,por,o
227,S1130-14732009000400003,los,o
227,S1130-14732009000400003,neurocirujanos,o
227,S1130-14732009000400003,cuyo,o
227,S1130-14732009000400003,tratamiento,i
227,S1130-14732009000400003,habitual,o
227,S1130-14732009000400003,es,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,evacuacion,i
227,S1130-14732009000400003,del,o
227,S1130-14732009000400003,mismo,o
227,S1130-14732009000400003,a,o
227,S1130-14732009000400003,traves,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,alguna,o
227,S1130-14732009000400003,modalidad,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,trepanacion,i
227,S1130-14732009000400003,A,o
227,S1130-14732009000400003,pesar,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,los,o
227,S1130-14732009000400003,excelentes,o
227,S1130-14732009000400003,resultados,o
227,S1130-14732009000400003,asi,o
227,S1130-14732009000400003,obtenidos,o
227,S1130-14732009000400003,pueden,o
227,S1130-14732009000400003,ocurrir,o
227,S1130-14732009000400003,diversas,o
227,S1130-14732009000400003,complicaciones,i
227,S1130-14732009000400003,algunas,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,las,o
227,S1130-14732009000400003,cuales,o
227,S1130-14732009000400003,son,o
227,S1130-14732009000400003,potencialmente,o
227,S1130-14732009000400003,graves,o
227,S1130-14732009000400003,o,o
227,S1130-14732009000400003,mortales,o
227,S1130-14732009000400003,Ademas,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,tasa,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,recidivas,o
227,S1130-14732009000400003,puede,o
227,S1130-14732009000400003,alcanzar,o
227,S1130-14732009000400003,el,o
227,S1130-14732009000400003,25,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,los,o
227,S1130-14732009000400003,casos,o
227,S1130-14732009000400003,Presentamos,o
227,S1130-14732009000400003,una,o
227,S1130-14732009000400003,aproximacion,o
227,S1130-14732009000400003,novedosa,o
227,S1130-14732009000400003,al,o
227,S1130-14732009000400003,manejo,o
227,S1130-14732009000400003,del,o
227,S1130-14732009000400003,HSC,i
227,S1130-14732009000400003,basada,o
227,S1130-14732009000400003,en,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,utilizacion,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,dexametasona,i
227,S1130-14732009000400003,como,o
227,S1130-14732009000400003,tratamiento,i
227,S1130-14732009000400003,de,i
227,S1130-14732009000400003,eleccion,i
227,S1130-14732009000400003,en,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,gran,o
227,S1130-14732009000400003,mayoria,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,los,o
227,S1130-14732009000400003,pacientes,o
227,S1130-14732009000400003,Pacientes,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,metodos,o
227,S1130-14732009000400003,Se,o
227,S1130-14732009000400003,analizaron,o
227,S1130-14732009000400003,los,o
227,S1130-14732009000400003,historiales,o
227,S1130-14732009000400003,medicos,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,122,o
227,S1130-14732009000400003,pacientes,o
227,S1130-14732009000400003,consecutivos,o
227,S1130-14732009000400003,diagnosticados,i
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,HSC,i
227,S1130-14732009000400003,Al,o
227,S1130-14732009000400003,ingreso,i
227,S1130-14732009000400003,todos,o
227,S1130-14732009000400003,los,o
227,S1130-14732009000400003,pacientes,o
227,S1130-14732009000400003,sintomaticos,i
227,S1130-14732009000400003,fueron,o
227,S1130-14732009000400003,clasificados,o
227,S1130-14732009000400003,mediante,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,Escala,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,Puntuacion,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,Markwalder,o
227,S1130-14732009000400003,EPM,o
227,S1130-14732009000400003,Aquellos,o
227,S1130-14732009000400003,con,o
227,S1130-14732009000400003,EPM,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,12,o
227,S1130-14732009000400003,fueron,o
227,S1130-14732009000400003,asignados,o
227,S1130-14732009000400003,al,o
227,S1130-14732009000400003,Protocolo,i
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,Dexametasona,i
227,S1130-14732009000400003,4mg,o
227,S1130-14732009000400003,cada,o
227,S1130-14732009000400003,8h,o
227,S1130-14732009000400003,reevaluacion,o
227,S1130-14732009000400003,a,o
227,S1130-14732009000400003,las,o
227,S1130-14732009000400003,72h,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,disminucion,o
227,S1130-14732009000400003,progresiva,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,dosis,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,aquellos,o
227,S1130-14732009000400003,con,o
227,S1130-14732009000400003,EPM,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,34,o
227,S1130-14732009000400003,se,o
227,S1130-14732009000400003,asignaron,o
227,S1130-14732009000400003,en,o
227,S1130-14732009000400003,general,o
227,S1130-14732009000400003,al,o
227,S1130-14732009000400003,Protocolo,i
227,S1130-14732009000400003,Quirurgico,i
227,S1130-14732009000400003,unico,o
227,S1130-14732009000400003,minitrepano,o
227,S1130-14732009000400003,tipo,o
227,S1130-14732009000400003,twistdrill,o
227,S1130-14732009000400003,frontal,o
227,S1130-14732009000400003,sin,o
227,S1130-14732009000400003,irrigacion,i
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,drenaje,i
227,S1130-14732009000400003,a,i
227,S1130-14732009000400003,sistema,i
227,S1130-14732009000400003,cerrado,i
227,S1130-14732009000400003,El,o
227,S1130-14732009000400003,seguimiento,i
227,S1130-14732009000400003,clinico,i
227,S1130-14732009000400003,se,o
227,S1130-14732009000400003,realizo,o
227,S1130-14732009000400003,mediante,o
227,S1130-14732009000400003,TAC,i
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,valoracion,i
227,S1130-14732009000400003,neurologica,i
227,S1130-14732009000400003,en,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,consulta,i
227,S1130-14732009000400003,externa,i
227,S1130-14732009000400003,Resultados,o
227,S1130-14732009000400003,En,o
227,S1130-14732009000400003,el,o
227,S1130-14732009000400003,periodo,o
227,S1130-14732009000400003,entre,o
227,S1130-14732009000400003,Marzo,o
227,S1130-14732009000400003,2001,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,Mayo,o
227,S1130-14732009000400003,2006,o
227,S1130-14732009000400003,se,o
227,S1130-14732009000400003,trataron,i
227,S1130-14732009000400003,122,o
227,S1130-14732009000400003,pacientes,o
227,S1130-14732009000400003,con,o
227,S1130-14732009000400003,HSC,i
227,S1130-14732009000400003,69,o
227,S1130-14732009000400003,varones,o
227,S1130-14732009000400003,con,o
227,S1130-14732009000400003,una,o
227,S1130-14732009000400003,mediana,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,edad,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,78,o
227,S1130-14732009000400003,años,o
227,S1130-14732009000400003,rango,o
227,S1130-14732009000400003,2597,o
227,S1130-14732009000400003,El,o
227,S1130-14732009000400003,73,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,los,o
227,S1130-14732009000400003,pacientes,o
227,S1130-14732009000400003,presentaban,o
227,S1130-14732009000400003,algun,o
227,S1130-14732009000400003,deficit,i
227,S1130-14732009000400003,neurologico,i
227,S1130-14732009000400003,EPM,o
227,S1130-14732009000400003,234,o
227,S1130-14732009000400003,No,o
227,S1130-14732009000400003,se,o
227,S1130-14732009000400003,trataron,i
227,S1130-14732009000400003,pacientes,o
227,S1130-14732009000400003,asintomaticos,i
227,S1130-14732009000400003,EPM,o
227,S1130-14732009000400003,0,o
227,S1130-14732009000400003,La,o
227,S1130-14732009000400003,asignacion,o
227,S1130-14732009000400003,inicial,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,tratamientos,i
227,S1130-14732009000400003,fue,o
227,S1130-14732009000400003,101,o
227,S1130-14732009000400003,dexametasona,i
227,S1130-14732009000400003,15,o
227,S1130-14732009000400003,drenaje,i
227,S1130-14732009000400003,subdural,i
227,S1130-14732009000400003,4,o
227,S1130-14732009000400003,craneotomia,i
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,2,o
227,S1130-14732009000400003,no,o
227,S1130-14732009000400003,recibieron,o
227,S1130-14732009000400003,tratamiento,i
227,S1130-14732009000400003,Precisaron,o
227,S1130-14732009000400003,drenaje,i
227,S1130-14732009000400003,22,o
227,S1130-14732009000400003,pacientes,o
227,S1130-14732009000400003,inicialmente,o
227,S1130-14732009000400003,asignados,o
227,S1130-14732009000400003,a,o
227,S1130-14732009000400003,dexametasona,i
227,S1130-14732009000400003,218,o
227,S1130-14732009000400003,Se,o
227,S1130-14732009000400003,obtuvo,o
227,S1130-14732009000400003,resultado,o
227,S1130-14732009000400003,favorable,o
227,S1130-14732009000400003,EPM,o
227,S1130-14732009000400003,012,o
227,S1130-14732009000400003,en,o
227,S1130-14732009000400003,el,o
227,S1130-14732009000400003,96,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,939,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,los,o
227,S1130-14732009000400003,tratados,i
227,S1130-14732009000400003,con,o
227,S1130-14732009000400003,dexametasona,i
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,drenaje,i
227,S1130-14732009000400003,respectivamente,o
227,S1130-14732009000400003,La,o
227,S1130-14732009000400003,mediana,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,estancia,o
227,S1130-14732009000400003,fue,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,6,o
227,S1130-14732009000400003,dias,o
227,S1130-14732009000400003,para,o
227,S1130-14732009000400003,el,o
227,S1130-14732009000400003,grupo,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,dexametasona,i
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,para,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,serie,o
227,S1130-14732009000400003,al,o
227,S1130-14732009000400003,completo,o
227,S1130-14732009000400003,rango,o
227,S1130-14732009000400003,141,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,8,o
227,S1130-14732009000400003,dias,o
227,S1130-14732009000400003,para,o
227,S1130-14732009000400003,el,o
227,S1130-14732009000400003,grupo,o
227,S1130-14732009000400003,intervenido,i
227,S1130-14732009000400003,rango,o
227,S1130-14732009000400003,548,o
227,S1130-14732009000400003,La,o
227,S1130-14732009000400003,mortalidad,o
227,S1130-14732009000400003,global,o
227,S1130-14732009000400003,fue,o
227,S1130-14732009000400003,del,o
227,S1130-14732009000400003,08,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,proporcion,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,reingresos,i
227,S1130-14732009000400003,debido,o
227,S1130-14732009000400003,al,o
227,S1130-14732009000400003,HSD,i
227,S1130-14732009000400003,del,o
227,S1130-14732009000400003,147,o
227,S1130-14732009000400003,todos,o
227,S1130-14732009000400003,mejoraron,o
227,S1130-14732009000400003,o,o
227,S1130-14732009000400003,estabilizaron,o
227,S1130-14732009000400003,su,o
227,S1130-14732009000400003,EPM,o
227,S1130-14732009000400003,Ocurrieron,o
227,S1130-14732009000400003,complicaciones,i
227,S1130-14732009000400003,medicas,i
227,S1130-14732009000400003,en,o
227,S1130-14732009000400003,34,o
227,S1130-14732009000400003,pacientes,o
227,S1130-14732009000400003,278,o
227,S1130-14732009000400003,fundamentalmente,o
227,S1130-14732009000400003,descompensaciones,i
227,S1130-14732009000400003,hiperglucemicas,i
227,S1130-14732009000400003,leves,o
227,S1130-14732009000400003,El,o
227,S1130-14732009000400003,seguimiento,i
227,S1130-14732009000400003,mediano,i
227,S1130-14732009000400003,extrahospitalario,i
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,serie,o
227,S1130-14732009000400003,fue,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,25,o
227,S1130-14732009000400003,semanas,o
227,S1130-14732009000400003,rango,o
227,S1130-14732009000400003,890,o
227,S1130-14732009000400003,con,o
227,S1130-14732009000400003,dos,o
227,S1130-14732009000400003,unicas,o
227,S1130-14732009000400003,perdidas,o
227,S1130-14732009000400003,Discusion,o
227,S1130-14732009000400003,La,o
227,S1130-14732009000400003,utilizacion,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,dexametasona,i
227,S1130-14732009000400003,en,o
227,S1130-14732009000400003,el,o
227,S1130-14732009000400003,HSC,i
227,S1130-14732009000400003,se,o
227,S1130-14732009000400003,basa,o
227,S1130-14732009000400003,en,o
227,S1130-14732009000400003,sus,o
227,S1130-14732009000400003,propiedades,o
227,S1130-14732009000400003,antiangiogenicas,o
227,S1130-14732009000400003,sobre,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,membrana,i
227,S1130-14732009000400003,del,o
227,S1130-14732009000400003,coagulo,i
227,S1130-14732009000400003,subdural,i
227,S1130-14732009000400003,segun,o
227,S1130-14732009000400003,se,o
227,S1130-14732009000400003,desprende,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,estudios,i
227,S1130-14732009000400003,experimentales,i
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,las,o
227,S1130-14732009000400003,muy,o
227,S1130-14732009000400003,escasas,o
227,S1130-14732009000400003,observaciones,i
227,S1130-14732009000400003,clinicas,i
227,S1130-14732009000400003,publicadas,o
227,S1130-14732009000400003,El,o
227,S1130-14732009000400003,tratamiento,i
227,S1130-14732009000400003,quirurgico,i
227,S1130-14732009000400003,del,o
227,S1130-14732009000400003,HSC,i
227,S1130-14732009000400003,es,o
227,S1130-14732009000400003,conocido,o
227,S1130-14732009000400003,que,o
227,S1130-14732009000400003,obtiene,o
227,S1130-14732009000400003,excelentes,o
227,S1130-14732009000400003,resultados,o
227,S1130-14732009000400003,aunque,o
227,S1130-14732009000400003,no,o
227,S1130-14732009000400003,existen,o
227,S1130-14732009000400003,ensayos,o
227,S1130-14732009000400003,bien,o
227,S1130-14732009000400003,diseñados,o
227,S1130-14732009000400003,que,o
227,S1130-14732009000400003,comparen,o
227,S1130-14732009000400003,ambas,o
227,S1130-14732009000400003,modalidades,o
227,S1130-14732009000400003,terapeuticas,o
227,S1130-14732009000400003,La,o
227,S1130-14732009000400003,experiencia,o
227,S1130-14732009000400003,que,o
227,S1130-14732009000400003,aporta,o
227,S1130-14732009000400003,esta,o
227,S1130-14732009000400003,serie,o
227,S1130-14732009000400003,nos,o
227,S1130-14732009000400003,permite,o
227,S1130-14732009000400003,realizar,o
227,S1130-14732009000400003,una,o
227,S1130-14732009000400003,serie,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,consideraciones,o
227,S1130-14732009000400003,clinicas,o
227,S1130-14732009000400003,el,o
227,S1130-14732009000400003,tratamiento,i
227,S1130-14732009000400003,del,o
227,S1130-14732009000400003,HSC,i
227,S1130-14732009000400003,con,o
227,S1130-14732009000400003,dexametasona,i
227,S1130-14732009000400003,es,o
227,S1130-14732009000400003,factible,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,se,o
227,S1130-14732009000400003,compara,o
227,S1130-14732009000400003,positivamente,o
227,S1130-14732009000400003,con,o
227,S1130-14732009000400003,el,o
227,S1130-14732009000400003,tratamiento,i
227,S1130-14732009000400003,quirurgico,i
227,S1130-14732009000400003,evito,o
227,S1130-14732009000400003,dos,o
227,S1130-14732009000400003,tercios,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,las,o
227,S1130-14732009000400003,intervenciones,i
227,S1130-14732009000400003,en,o
227,S1130-14732009000400003,nuestra,o
227,S1130-14732009000400003,serie,o
227,S1130-14732009000400003,creemos,o
227,S1130-14732009000400003,que,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,historia,o
227,S1130-14732009000400003,natural,o
227,S1130-14732009000400003,del,o
227,S1130-14732009000400003,HSC,i
227,S1130-14732009000400003,permite,o
227,S1130-14732009000400003,un,o
227,S1130-14732009000400003,periodo,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,prueba,o
227,S1130-14732009000400003,con,o
227,S1130-14732009000400003,dexametasona,i
227,S1130-14732009000400003,4872h,o
227,S1130-14732009000400003,sin,o
227,S1130-14732009000400003,someter,o
227,S1130-14732009000400003,a,o
227,S1130-14732009000400003,riesgo,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,deterioro,i
227,S1130-14732009000400003,irreversible,i
227,S1130-14732009000400003,al,o
227,S1130-14732009000400003,paciente,o
227,S1130-14732009000400003,se,o
227,S1130-14732009000400003,elimina,o
227,S1130-14732009000400003,toda,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,morbilidad,o
227,S1130-14732009000400003,asociada,o
227,S1130-14732009000400003,a,o
227,S1130-14732009000400003,las,o
227,S1130-14732009000400003,intervenciones,i
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,las,o
227,S1130-14732009000400003,recidivas,o
227,S1130-14732009000400003,no,o
227,S1130-14732009000400003,provoca,o
227,S1130-14732009000400003,complicaciones,i
227,S1130-14732009000400003,significativas,o
227,S1130-14732009000400003,reduce,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,estancia,o
227,S1130-14732009000400003,media,o
227,S1130-14732009000400003,no,o
227,S1130-14732009000400003,impide,o
227,S1130-14732009000400003,ni,o
227,S1130-14732009000400003,perjudica,o
227,S1130-14732009000400003,un,o
227,S1130-14732009000400003,ulterior,o
227,S1130-14732009000400003,tratamiento,i
227,S1130-14732009000400003,quirurgico,i
227,S1130-14732009000400003,es,o
227,S1130-14732009000400003,una,o
227,S1130-14732009000400003,terapia,i
227,S1130-14732009000400003,bien,o
227,S1130-14732009000400003,tolerada,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,entendida,o
227,S1130-14732009000400003,por,o
227,S1130-14732009000400003,el,o
227,S1130-14732009000400003,paciente,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,sus,o
227,S1130-14732009000400003,acompañantes,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,posiblemente,o
227,S1130-14732009000400003,abarata,o
227,S1130-14732009000400003,costes,o
227,S1130-14732009000400003,Los,o
227,S1130-14732009000400003,autores,o
227,S1130-14732009000400003,proponen,o
227,S1130-14732009000400003,un,o
227,S1130-14732009000400003,protocolo,i
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,manejo,o
227,S1130-14732009000400003,que,o
227,S1130-14732009000400003,no,o
227,S1130-14732009000400003,pretende,o
227,S1130-14732009000400003,sustituir,o
227,S1130-14732009000400003,al,o
227,S1130-14732009000400003,tratamiento,i
227,S1130-14732009000400003,quirurgico,i
227,S1130-14732009000400003,sino,o
227,S1130-14732009000400003,ofrecer,o
227,S1130-14732009000400003,una,o
227,S1130-14732009000400003,alternativa,o
227,S1130-14732009000400003,efectiva,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,segura,o
227,S1130-14732009000400003,Conclusion,o
227,S1130-14732009000400003,Los,o
227,S1130-14732009000400003,datos,o
227,S1130-14732009000400003,obtenidos,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,esta,o
227,S1130-14732009000400003,larga,o
227,S1130-14732009000400003,serie,o
227,S1130-14732009000400003,retrospectiva,o
227,S1130-14732009000400003,sugieren,o
227,S1130-14732009000400003,que,o
227,S1130-14732009000400003,la,o
227,S1130-14732009000400003,utilizacion,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,dexametasona,i
227,S1130-14732009000400003,en,o
227,S1130-14732009000400003,el,o
227,S1130-14732009000400003,HSC,i
227,S1130-14732009000400003,es,o
227,S1130-14732009000400003,una,o
227,S1130-14732009000400003,opcion,o
227,S1130-14732009000400003,factible,o
227,S1130-14732009000400003,y,o
227,S1130-14732009000400003,segura,o
227,S1130-14732009000400003,En,o
227,S1130-14732009000400003,nuestra,o
227,S1130-14732009000400003,experiencia,o
227,S1130-14732009000400003,curo,o
227,S1130-14732009000400003,o,o
227,S1130-14732009000400003,mejoro,o
227,S1130-14732009000400003,a,o
227,S1130-14732009000400003,dos,o
227,S1130-14732009000400003,tercios,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,todos,o
227,S1130-14732009000400003,los,o
227,S1130-14732009000400003,pacientes,o
227,S1130-14732009000400003,hecho,o
227,S1130-14732009000400003,que,o
227,S1130-14732009000400003,debe,o
227,S1130-14732009000400003,ser,o
227,S1130-14732009000400003,corroborado,o
227,S1130-14732009000400003,por,o
227,S1130-14732009000400003,otros,o
227,S1130-14732009000400003,autores,o
227,S1130-14732009000400003,La,o
227,S1130-14732009000400003,verdadera,o
227,S1130-14732009000400003,efectividad,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,esta,o
227,S1130-14732009000400003,terapia,i
227,S1130-14732009000400003,podria,o
227,S1130-14732009000400003,ser,o
227,S1130-14732009000400003,objeto,o
227,S1130-14732009000400003,idealmente,o
227,S1130-14732009000400003,de,o
227,S1130-14732009000400003,un,o
227,S1130-14732009000400003,ensayo,i
227,S1130-14732009000400003,aleatorizado,i
227,S1130-14732009000400003,y,i
227,S1130-14732009000400003,prospectivo,i
227,S1130-14732009000400003,que,o
227,S1130-14732009000400003,compare,o
227,S1130-14732009000400003,el,o
227,S1130-14732009000400003,tratamiento,i
227,S1130-14732009000400003,quirurgico,i
227,S1130-14732009000400003,con,o
227,S1130-14732009000400003,el,o
227,S1130-14732009000400003,corticoideo,i
228,S1130-63432013000200002,Estudio,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,las,o
228,S1130-63432013000200002,reacciones,i
228,S1130-63432013000200002,adversas,i
228,S1130-63432013000200002,relacionadas,o
228,S1130-63432013000200002,con,o
228,S1130-63432013000200002,la,o
228,S1130-63432013000200002,infusion,i
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,paclitaxel,i
228,S1130-63432013000200002,y,o
228,S1130-63432013000200002,docetaxel,i
228,S1130-63432013000200002,Objetivo,o
228,S1130-63432013000200002,Determinar,o
228,S1130-63432013000200002,la,o
228,S1130-63432013000200002,incidencia,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,reacciones,i
228,S1130-63432013000200002,a,o
228,S1130-63432013000200002,la,o
228,S1130-63432013000200002,infusion,i
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,paclitaxel,i
228,S1130-63432013000200002,y,o
228,S1130-63432013000200002,docetaxel,i
228,S1130-63432013000200002,y,o
228,S1130-63432013000200002,las,o
228,S1130-63432013000200002,posibles,o
228,S1130-63432013000200002,causas,o
228,S1130-63432013000200002,que,o
228,S1130-63432013000200002,pueden,o
228,S1130-63432013000200002,desencadenarlas,o
228,S1130-63432013000200002,Metodo,o
228,S1130-63432013000200002,Estudio,i
228,S1130-63432013000200002,de,i
228,S1130-63432013000200002,cohortes,i
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,las,o
228,S1130-63432013000200002,infusiones,i
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,paclitaxel,i
228,S1130-63432013000200002,y,o
228,S1130-63432013000200002,docetaxel,i
228,S1130-63432013000200002,realizadas,o
228,S1130-63432013000200002,en,o
228,S1130-63432013000200002,un,o
228,S1130-63432013000200002,hospital,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,tercer,o
228,S1130-63432013000200002,nivel,o
228,S1130-63432013000200002,desde,o
228,S1130-63432013000200002,julio,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,2010,o
228,S1130-63432013000200002,hasta,o
228,S1130-63432013000200002,diciembre,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,2011,o
228,S1130-63432013000200002,18,o
228,S1130-63432013000200002,meses,o
228,S1130-63432013000200002,Para,o
228,S1130-63432013000200002,cada,o
228,S1130-63432013000200002,infusion,i
228,S1130-63432013000200002,se,o
228,S1130-63432013000200002,registraron,o
228,S1130-63432013000200002,los,o
228,S1130-63432013000200002,datos,o
228,S1130-63432013000200002,clinicos,o
228,S1130-63432013000200002,del,o
228,S1130-63432013000200002,paciente,o
228,S1130-63432013000200002,y,o
228,S1130-63432013000200002,los,o
228,S1130-63432013000200002,referentes,o
228,S1130-63432013000200002,al,o
228,S1130-63432013000200002,taxano,i
228,S1130-63432013000200002,administrado,o
228,S1130-63432013000200002,Ante,o
228,S1130-63432013000200002,la,o
228,S1130-63432013000200002,aparicion,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,una,o
228,S1130-63432013000200002,reaccion,i
228,S1130-63432013000200002,durante,o
228,S1130-63432013000200002,la,o
228,S1130-63432013000200002,infusion,i
228,S1130-63432013000200002,se,o
228,S1130-63432013000200002,especifico,o
228,S1130-63432013000200002,tipo,o
228,S1130-63432013000200002,gravedad,o
228,S1130-63432013000200002,y,o
228,S1130-63432013000200002,si,o
228,S1130-63432013000200002,esta,o
228,S1130-63432013000200002,obligo,o
228,S1130-63432013000200002,a,o
228,S1130-63432013000200002,la,o
228,S1130-63432013000200002,suspension,i
228,S1130-63432013000200002,del,i
228,S1130-63432013000200002,tratamiento,i
228,S1130-63432013000200002,Se,o
228,S1130-63432013000200002,consultaron,i
228,S1130-63432013000200002,las,i
228,S1130-63432013000200002,historias,i
228,S1130-63432013000200002,clinicas,i
228,S1130-63432013000200002,y,i
228,S1130-63432013000200002,las,i
228,S1130-63432013000200002,ordenes,i
228,S1130-63432013000200002,medicas,i
228,S1130-63432013000200002,El,o
228,S1130-63432013000200002,seguimiento,i
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,las,o
228,S1130-63432013000200002,infusiones,i
228,S1130-63432013000200002,se,o
228,S1130-63432013000200002,realizo,o
228,S1130-63432013000200002,contactando,o
228,S1130-63432013000200002,con,o
228,S1130-63432013000200002,las,o
228,S1130-63432013000200002,enfermeras,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,hospital,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,dia,o
228,S1130-63432013000200002,Se,o
228,S1130-63432013000200002,efectuo,o
228,S1130-63432013000200002,un,o
228,S1130-63432013000200002,estudio,i
228,S1130-63432013000200002,descriptivo,i
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,las,o
228,S1130-63432013000200002,variables,o
228,S1130-63432013000200002,mas,o
228,S1130-63432013000200002,relevantes,o
228,S1130-63432013000200002,incluidas,o
228,S1130-63432013000200002,en,o
228,S1130-63432013000200002,el,o
228,S1130-63432013000200002,seguimiento,i
228,S1130-63432013000200002,y,o
228,S1130-63432013000200002,se,o
228,S1130-63432013000200002,analizo,o
228,S1130-63432013000200002,si,o
228,S1130-63432013000200002,alguna,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,ellas,o
228,S1130-63432013000200002,podia,o
228,S1130-63432013000200002,influir,o
228,S1130-63432013000200002,en,o
228,S1130-63432013000200002,la,o
228,S1130-63432013000200002,aparicion,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,reacciones,i
228,S1130-63432013000200002,Resultados,o
228,S1130-63432013000200002,Durante,o
228,S1130-63432013000200002,el,o
228,S1130-63432013000200002,periodo,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,estudio,o
228,S1130-63432013000200002,se,o
228,S1130-63432013000200002,administraron,o
228,S1130-63432013000200002,357,o
228,S1130-63432013000200002,infusiones,i
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,paclitaxel,i
228,S1130-63432013000200002,y,o
228,S1130-63432013000200002,docetaxel,i
228,S1130-63432013000200002,a,o
228,S1130-63432013000200002,92,o
228,S1130-63432013000200002,pacientes,o
228,S1130-63432013000200002,media,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,edad,o
228,S1130-63432013000200002,614,o
228,S1130-63432013000200002,años,o
228,S1130-63432013000200002,DE,o
228,S1130-63432013000200002,111,o
228,S1130-63432013000200002,500,o
228,S1130-63432013000200002,mujeres,o
228,S1130-63432013000200002,Se,o
228,S1130-63432013000200002,detectaron,o
228,S1130-63432013000200002,9,o
228,S1130-63432013000200002,reacciones,i
228,S1130-63432013000200002,infusionales,i
228,S1130-63432013000200002,que,o
228,S1130-63432013000200002,afectaron,o
228,S1130-63432013000200002,a,o
228,S1130-63432013000200002,8,o
228,S1130-63432013000200002,pacientes,o
228,S1130-63432013000200002,todas,o
228,S1130-63432013000200002,ellas,o
228,S1130-63432013000200002,causadas,o
228,S1130-63432013000200002,por,o
228,S1130-63432013000200002,docetaxel,i
228,S1130-63432013000200002,χ2,o
228,S1130-63432013000200002,83,o
228,S1130-63432013000200002,p,o
228,S1130-63432013000200002,0004,o
228,S1130-63432013000200002,el,o
228,S1130-63432013000200002,145,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,los,o
228,S1130-63432013000200002,pacientes,o
228,S1130-63432013000200002,que,o
228,S1130-63432013000200002,lo,o
228,S1130-63432013000200002,llevaron,o
228,S1130-63432013000200002,y,o
228,S1130-63432013000200002,siempre,o
228,S1130-63432013000200002,durante,o
228,S1130-63432013000200002,el,o
228,S1130-63432013000200002,primer,o
228,S1130-63432013000200002,o,o
228,S1130-63432013000200002,segundo,o
228,S1130-63432013000200002,ciclo,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,tratamiento,i
228,S1130-63432013000200002,Las,o
228,S1130-63432013000200002,variables,o
228,S1130-63432013000200002,asociadas,o
228,S1130-63432013000200002,significativamente,o
228,S1130-63432013000200002,a,o
228,S1130-63432013000200002,la,o
228,S1130-63432013000200002,aparicion,o
228,S1130-63432013000200002,de,o
228,S1130-63432013000200002,reacciones,i
228,S1130-63432013000200002,fueron,o
228,S1130-63432013000200002,neoplasia,i
228,S1130-63432013000200002,de,i
228,S1130-63432013000200002,pulmon,i
228,S1130-63432013000200002,p0005,o
228,S1130-63432013000200002,esquema,o
228,S1130-63432013000200002,docetaxelcisplatino,o
228,S1130-63432013000200002,p,o
228,S1130-63432013000200002,0005,o
228,S1130-63432013000200002,recibir,o
228,S1130-63432013000200002,el,o
228,S1130-63432013000200002,farmaco,i
228,S1130-63432013000200002,en,o
228,S1130-63432013000200002,primera,o
228,S1130-63432013000200002,linea,o
228,S1130-63432013000200002,p,o
228,S1130-63432013000200002,0021,o
228,S1130-63432013000200002,y,o
228,S1130-63432013000200002,enfermedad,i
228,S1130-63432013000200002,no,o
228,S1130-63432013000200002,avanzada,o
228,S1130-63432013000200002,p,o
228,S1130-63432013000200002,0014,o
228,S1130-63432013000200002,Conclusiones,o
228,S1130-63432013000200002,En,o
228,S1130-63432013000200002,nuestro,o
228,S1130-63432013000200002,centro,o
228,S1130-63432013000200002,hospitalario,o
228,S1130-63432013000200002,docetaxel,i
228,S1130-63432013000200002,es,o
228,S1130-63432013000200002,el,o
228,S1130-63432013000200002,taxano,i
228,S1130-63432013000200002,que,o
228,S1130-63432013000200002,ha,o
228,S1130-63432013000200002,provocado,o
228,S1130-63432013000200002,mas,o
228,S1130-63432013000200002,problemas,i
228,S1130-63432013000200002,de,i
228,S1130-63432013000200002,seguridad,i
228,S1130-63432013000200002,durante,o
228,S1130-63432013000200002,su,o
228,S1130-63432013000200002,infusion,i
229,S1130-63432014000400005,Adherencia,o
229,S1130-63432014000400005,satisfaccion,o
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,calidad,i
229,S1130-63432014000400005,de,i
229,S1130-63432014000400005,vida,i
229,S1130-63432014000400005,relacionada,i
229,S1130-63432014000400005,con,i
229,S1130-63432014000400005,la,i
229,S1130-63432014000400005,salud,i
229,S1130-63432014000400005,en,o
229,S1130-63432014000400005,pacientes,o
229,S1130-63432014000400005,infectados,i
229,S1130-63432014000400005,por,i
229,S1130-63432014000400005,el,i
229,S1130-63432014000400005,VIH,i
229,S1130-63432014000400005,con,o
229,S1130-63432014000400005,tratamiento,i
229,S1130-63432014000400005,antirretroviral,i
229,S1130-63432014000400005,en,o
229,S1130-63432014000400005,España,o
229,S1130-63432014000400005,Estudio,o
229,S1130-63432014000400005,ARPAS,o
229,S1130-63432014000400005,Objetivo,o
229,S1130-63432014000400005,Determinar,o
229,S1130-63432014000400005,la,o
229,S1130-63432014000400005,relacion,o
229,S1130-63432014000400005,entre,o
229,S1130-63432014000400005,satisfaccion,o
229,S1130-63432014000400005,con,o
229,S1130-63432014000400005,el,o
229,S1130-63432014000400005,tratamiento,i
229,S1130-63432014000400005,antirretroviral,i
229,S1130-63432014000400005,TAR,i
229,S1130-63432014000400005,adherencia,o
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,calidad,i
229,S1130-63432014000400005,de,i
229,S1130-63432014000400005,vida,i
229,S1130-63432014000400005,CV,i
229,S1130-63432014000400005,en,o
229,S1130-63432014000400005,pacientes,o
229,S1130-63432014000400005,adultos,o
229,S1130-63432014000400005,diagnosticados,i
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,infeccion,i
229,S1130-63432014000400005,por,i
229,S1130-63432014000400005,VIH,i
229,S1130-63432014000400005,con,o
229,S1130-63432014000400005,TAR,i
229,S1130-63432014000400005,segun,o
229,S1130-63432014000400005,la,o
229,S1130-63432014000400005,carga,o
229,S1130-63432014000400005,posologica,o
229,S1130-63432014000400005,Metodo,o
229,S1130-63432014000400005,Estudio,o
229,S1130-63432014000400005,observacional,o
229,S1130-63432014000400005,transversal,o
229,S1130-63432014000400005,multicentrico,o
229,S1130-63432014000400005,Se,o
229,S1130-63432014000400005,recogieron,o
229,S1130-63432014000400005,variables,o
229,S1130-63432014000400005,sociodemograficas,o
229,S1130-63432014000400005,clinicas,o
229,S1130-63432014000400005,carga,o
229,S1130-63432014000400005,posologica,o
229,S1130-63432014000400005,1,o
229,S1130-63432014000400005,24,o
229,S1130-63432014000400005,o,o
229,S1130-63432014000400005,mas,o
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,4,o
229,S1130-63432014000400005,comprimidos,o
229,S1130-63432014000400005,al,o
229,S1130-63432014000400005,dia,o
229,S1130-63432014000400005,adherencia,o
229,S1130-63432014000400005,SMAQ,o
229,S1130-63432014000400005,registros,o
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,dispensacion,o
229,S1130-63432014000400005,RD,o
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,escala,i
229,S1130-63432014000400005,visual,i
229,S1130-63432014000400005,analogica,i
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,satisfaccion,o
229,S1130-63432014000400005,cuestionario,i
229,S1130-63432014000400005,ESTAR,o
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,CV,i
229,S1130-63432014000400005,MOSHIV,o
229,S1130-63432014000400005,Se,o
229,S1130-63432014000400005,definio,o
229,S1130-63432014000400005,paciente,o
229,S1130-63432014000400005,adherente,o
229,S1130-63432014000400005,cuando,o
229,S1130-63432014000400005,simultaneamente,o
229,S1130-63432014000400005,presentaba,o
229,S1130-63432014000400005,adherencia,o
229,S1130-63432014000400005,segun,o
229,S1130-63432014000400005,SMAQ,o
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,un,o
229,S1130-63432014000400005,RD,o
229,S1130-63432014000400005,95,o
229,S1130-63432014000400005,Resultados,o
229,S1130-63432014000400005,Se,o
229,S1130-63432014000400005,evaluaron,o
229,S1130-63432014000400005,328,o
229,S1130-63432014000400005,pacientes,o
229,S1130-63432014000400005,76,o
229,S1130-63432014000400005,varones,o
229,S1130-63432014000400005,460,o
229,S1130-63432014000400005,92,o
229,S1130-63432014000400005,años,o
229,S1130-63432014000400005,El,o
229,S1130-63432014000400005,esquema,o
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,Icdia,o
229,S1130-63432014000400005,24,o
229,S1130-63432014000400005,cdia,o
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,4,o
229,S1130-63432014000400005,cdia,o
229,S1130-63432014000400005,se,o
229,S1130-63432014000400005,dio,o
229,S1130-63432014000400005,en,o
229,S1130-63432014000400005,el,o
229,S1130-63432014000400005,29,o
229,S1130-63432014000400005,37,o
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,34,o
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,los,o
229,S1130-63432014000400005,pacientes,o
229,S1130-63432014000400005,respectivamente,o
229,S1130-63432014000400005,Pese,o
229,S1130-63432014000400005,que,o
229,S1130-63432014000400005,la,o
229,S1130-63432014000400005,evaluacion,i
229,S1130-63432014000400005,realizada,i
229,S1130-63432014000400005,por,i
229,S1130-63432014000400005,el,i
229,S1130-63432014000400005,cuestionario,i
229,S1130-63432014000400005,SMAQ,o
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,la,o
229,S1130-63432014000400005,escala,o
229,S1130-63432014000400005,EVA,i
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,forma,o
229,S1130-63432014000400005,independiente,o
229,S1130-63432014000400005,muestra,o
229,S1130-63432014000400005,diferencias,o
229,S1130-63432014000400005,estadisticamente,o
229,S1130-63432014000400005,significativas,o
229,S1130-63432014000400005,a,o
229,S1130-63432014000400005,favor,o
229,S1130-63432014000400005,del,o
229,S1130-63432014000400005,esquema,o
229,S1130-63432014000400005,Icdia,o
229,S1130-63432014000400005,el,o
229,S1130-63432014000400005,porcentaje,o
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,pacientes,o
229,S1130-63432014000400005,adherentes,o
229,S1130-63432014000400005,segun,o
229,S1130-63432014000400005,la,o
229,S1130-63432014000400005,variable,o
229,S1130-63432014000400005,combinada,o
229,S1130-63432014000400005,49,o
229,S1130-63432014000400005,no,o
229,S1130-63432014000400005,difiere,o
229,S1130-63432014000400005,entre,o
229,S1130-63432014000400005,los,o
229,S1130-63432014000400005,grupos,o
229,S1130-63432014000400005,en,o
229,S1130-63432014000400005,funcion,o
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,la,o
229,S1130-63432014000400005,carga,o
229,S1130-63432014000400005,posologica,o
229,S1130-63432014000400005,La,o
229,S1130-63432014000400005,satisfaccion,o
229,S1130-63432014000400005,al,o
229,S1130-63432014000400005,TAR,i
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,fueron,o
229,S1130-63432014000400005,elevadas,o
229,S1130-63432014000400005,en,o
229,S1130-63432014000400005,los,o
229,S1130-63432014000400005,tres,o
229,S1130-63432014000400005,grupos,o
229,S1130-63432014000400005,siendo,o
229,S1130-63432014000400005,los,o
229,S1130-63432014000400005,esquemas,o
229,S1130-63432014000400005,1,o
229,S1130-63432014000400005,cdia,o
229,S1130-63432014000400005,los,o
229,S1130-63432014000400005,relacionados,o
229,S1130-63432014000400005,con,o
229,S1130-63432014000400005,mayor,o
229,S1130-63432014000400005,satisfaccion,o
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,menores,o
229,S1130-63432014000400005,efectos,i
229,S1130-63432014000400005,adversos,i
229,S1130-63432014000400005,del,o
229,S1130-63432014000400005,metabolismo,o
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,las,o
229,S1130-63432014000400005,grasas,i
229,S1130-63432014000400005,No,o
229,S1130-63432014000400005,se,o
229,S1130-63432014000400005,observaron,o
229,S1130-63432014000400005,diferencias,o
229,S1130-63432014000400005,en,o
229,S1130-63432014000400005,la,o
229,S1130-63432014000400005,satisfaccion,o
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,los,o
229,S1130-63432014000400005,pacientes,o
229,S1130-63432014000400005,segun,o
229,S1130-63432014000400005,la,o
229,S1130-63432014000400005,adherencia,o
229,S1130-63432014000400005,Conclusiones,o
229,S1130-63432014000400005,La,o
229,S1130-63432014000400005,adherencia,o
229,S1130-63432014000400005,la,o
229,S1130-63432014000400005,satisfaccion,o
229,S1130-63432014000400005,al,o
229,S1130-63432014000400005,TAR,i
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,los,o
229,S1130-63432014000400005,pacientes,o
229,S1130-63432014000400005,con,o
229,S1130-63432014000400005,TAR,i
229,S1130-63432014000400005,es,o
229,S1130-63432014000400005,alta,o
229,S1130-63432014000400005,La,o
229,S1130-63432014000400005,satisfaccion,o
229,S1130-63432014000400005,mayor,o
229,S1130-63432014000400005,en,o
229,S1130-63432014000400005,pacientes,o
229,S1130-63432014000400005,que,o
229,S1130-63432014000400005,toman,o
229,S1130-63432014000400005,1,o
229,S1130-63432014000400005,cdia,o
229,S1130-63432014000400005,no,o
229,S1130-63432014000400005,difiere,o
229,S1130-63432014000400005,en,o
229,S1130-63432014000400005,funcion,o
229,S1130-63432014000400005,de,o
229,S1130-63432014000400005,la,o
229,S1130-63432014000400005,adherencia,o
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,no,o
229,S1130-63432014000400005,se,o
229,S1130-63432014000400005,observo,o
229,S1130-63432014000400005,correlacion,o
229,S1130-63432014000400005,entre,o
229,S1130-63432014000400005,satisfaccion,o
229,S1130-63432014000400005,con,o
229,S1130-63432014000400005,el,o
229,S1130-63432014000400005,TAR,i
229,S1130-63432014000400005,y,o
229,S1130-63432014000400005,calidad,i
229,S1130-63432014000400005,de,i
229,S1130-63432014000400005,vida,i
230,S1130-63432016000400006,Comparacion,i
230,S1130-63432016000400006,entre,i
230,S1130-63432016000400006,la,i
230,S1130-63432016000400006,efectividad,i
230,S1130-63432016000400006,y,i
230,S1130-63432016000400006,la,i
230,S1130-63432016000400006,seguridad,i
230,S1130-63432016000400006,renal,i
230,S1130-63432016000400006,del,o
230,S1130-63432016000400006,tenofovir,i
230,S1130-63432016000400006,y,o
230,S1130-63432016000400006,el,o
230,S1130-63432016000400006,entecavir,i
230,S1130-63432016000400006,en,o
230,S1130-63432016000400006,pacientes,o
230,S1130-63432016000400006,con,o
230,S1130-63432016000400006,hepatitis,i
230,S1130-63432016000400006,B,i
230,S1130-63432016000400006,cronica,i
230,S1130-63432016000400006,Objetivo,o
230,S1130-63432016000400006,Comparar,i
230,S1130-63432016000400006,la,i
230,S1130-63432016000400006,efectividad,i
230,S1130-63432016000400006,y,i
230,S1130-63432016000400006,seguridad,i
230,S1130-63432016000400006,renal,i
230,S1130-63432016000400006,del,o
230,S1130-63432016000400006,tratamiento,i
230,S1130-63432016000400006,con,o
230,S1130-63432016000400006,tenofovir,i
230,S1130-63432016000400006,frente,o
230,S1130-63432016000400006,al,o
230,S1130-63432016000400006,entecavir,i
230,S1130-63432016000400006,en,o
230,S1130-63432016000400006,pacientes,o
230,S1130-63432016000400006,con,o
230,S1130-63432016000400006,hepatitis,i
230,S1130-63432016000400006,B,i
230,S1130-63432016000400006,cronica,i
230,S1130-63432016000400006,Metodos,o
230,S1130-63432016000400006,Estudio,i
230,S1130-63432016000400006,retrospectivo,i
230,S1130-63432016000400006,en,o
230,S1130-63432016000400006,pacientes,o
230,S1130-63432016000400006,con,o
230,S1130-63432016000400006,hepatitis,i
230,S1130-63432016000400006,B,i
230,S1130-63432016000400006,que,o
230,S1130-63432016000400006,iniciaron,o
230,S1130-63432016000400006,tratamiento,i
230,S1130-63432016000400006,con,o
230,S1130-63432016000400006,tenofovir,i
230,S1130-63432016000400006,o,o
230,S1130-63432016000400006,entecavir,i
230,S1130-63432016000400006,entre,o
230,S1130-63432016000400006,enero,o
230,S1130-63432016000400006,19982013,o
230,S1130-63432016000400006,La,o
230,S1130-63432016000400006,variable,o
230,S1130-63432016000400006,principal,o
230,S1130-63432016000400006,de,o
230,S1130-63432016000400006,la,o
230,S1130-63432016000400006,efectividad,o
230,S1130-63432016000400006,fue,o
230,S1130-63432016000400006,definida,o
230,S1130-63432016000400006,como,o
230,S1130-63432016000400006,DNA,i
230,S1130-63432016000400006,viral,i
230,S1130-63432016000400006,20,o
230,S1130-63432016000400006,Ulml,o
230,S1130-63432016000400006,HBVDNA,o
230,S1130-63432016000400006,y,o
230,S1130-63432016000400006,la,o
230,S1130-63432016000400006,de,o
230,S1130-63432016000400006,la,o
230,S1130-63432016000400006,seguridad,o
230,S1130-63432016000400006,renal,i
230,S1130-63432016000400006,como,o
230,S1130-63432016000400006,variaciones,o
230,S1130-63432016000400006,en,o
230,S1130-63432016000400006,el,o
230,S1130-63432016000400006,filtrado,i
230,S1130-63432016000400006,glomerular,i
230,S1130-63432016000400006,eGFR,i
230,S1130-63432016000400006,tras,o
230,S1130-63432016000400006,48,o
230,S1130-63432016000400006,semanas,o
230,S1130-63432016000400006,de,o
230,S1130-63432016000400006,tratamiento,i
230,S1130-63432016000400006,Resultados,o
230,S1130-63432016000400006,Se,o
230,S1130-63432016000400006,analizaron,o
230,S1130-63432016000400006,un,o
230,S1130-63432016000400006,total,o
230,S1130-63432016000400006,de,o
230,S1130-63432016000400006,64,o
230,S1130-63432016000400006,pacientes,o
230,S1130-63432016000400006,11,o
230,S1130-63432016000400006,con,o
230,S1130-63432016000400006,caracteristicas,o
230,S1130-63432016000400006,semejantes,o
230,S1130-63432016000400006,excepto,o
230,S1130-63432016000400006,por,o
230,S1130-63432016000400006,el,o
230,S1130-63432016000400006,predominio,o
230,S1130-63432016000400006,de,o
230,S1130-63432016000400006,pacientes,o
230,S1130-63432016000400006,sin,o
230,S1130-63432016000400006,tratamiento,i
230,S1130-63432016000400006,previo,o
230,S1130-63432016000400006,p0036,o
230,S1130-63432016000400006,comorbilidades,i
230,S1130-63432016000400006,p0077,o
230,S1130-63432016000400006,y,o
230,S1130-63432016000400006,farmacos,i
230,S1130-63432016000400006,nefrotoxicos,o
230,S1130-63432016000400006,p0088,o
230,S1130-63432016000400006,en,o
230,S1130-63432016000400006,el,o
230,S1130-63432016000400006,grupoentecavir,o
230,S1130-63432016000400006,y,o
230,S1130-63432016000400006,de,o
230,S1130-63432016000400006,pacientes,o
230,S1130-63432016000400006,con,o
230,S1130-63432016000400006,HBVDNA,o
230,S1130-63432016000400006,20,o
230,S1130-63432016000400006,Ulml,o
230,S1130-63432016000400006,p0032,o
230,S1130-63432016000400006,y,o
230,S1130-63432016000400006,HBeAgpositivo,o
230,S1130-63432016000400006,p0050,o
230,S1130-63432016000400006,en,o
230,S1130-63432016000400006,el,o
230,S1130-63432016000400006,grupotenofovir,o
230,S1130-63432016000400006,Se,o
230,S1130-63432016000400006,realizaron,o
230,S1130-63432016000400006,analisis,o
230,S1130-63432016000400006,estadisticos,o
230,S1130-63432016000400006,univariantes,o
230,S1130-63432016000400006,y,o
230,S1130-63432016000400006,se,o
230,S1130-63432016000400006,ajustaron,o
230,S1130-63432016000400006,las,o
230,S1130-63432016000400006,variables,o
230,S1130-63432016000400006,confusoras,o
230,S1130-63432016000400006,mediante,o
230,S1130-63432016000400006,Propensity,o
230,S1130-63432016000400006,score,o
230,S1130-63432016000400006,PS,o
230,S1130-63432016000400006,Los,o
230,S1130-63432016000400006,resultados,o
230,S1130-63432016000400006,para,o
230,S1130-63432016000400006,la,o
230,S1130-63432016000400006,variable,o
230,S1130-63432016000400006,principal,o
230,S1130-63432016000400006,de,o
230,S1130-63432016000400006,efectividad,o
230,S1130-63432016000400006,HBVDNA,o
230,S1130-63432016000400006,20,o
230,S1130-63432016000400006,Ulml,o
230,S1130-63432016000400006,denotan,o
230,S1130-63432016000400006,una,o
230,S1130-63432016000400006,superioridad,o
230,S1130-63432016000400006,del,o
230,S1130-63432016000400006,tenofovir,i
230,S1130-63432016000400006,tras,o
230,S1130-63432016000400006,el,o
230,S1130-63432016000400006,ajuste,o
230,S1130-63432016000400006,por,o
230,S1130-63432016000400006,PS,o
230,S1130-63432016000400006,con,o
230,S1130-63432016000400006,una,o
230,S1130-63432016000400006,ORadj,o
230,S1130-63432016000400006,67,o
230,S1130-63432016000400006,IC95,o
230,S1130-63432016000400006,12353,o
230,S1130-63432016000400006,p0028,o
230,S1130-63432016000400006,Tres,o
230,S1130-63432016000400006,pacientes,o
230,S1130-63432016000400006,con,o
230,S1130-63432016000400006,tenofovir,i
230,S1130-63432016000400006,sufrieron,o
230,S1130-63432016000400006,seroconversion,o
230,S1130-63432016000400006,p0148,o
230,S1130-63432016000400006,Los,o
230,S1130-63432016000400006,resultados,o
230,S1130-63432016000400006,para,o
230,S1130-63432016000400006,la,o
230,S1130-63432016000400006,variable,o
230,S1130-63432016000400006,principal,o
230,S1130-63432016000400006,de,o
230,S1130-63432016000400006,seguridad,o
230,S1130-63432016000400006,eGFR,i
230,S1130-63432016000400006,60mlmin173m2,o
230,S1130-63432016000400006,no,o
230,S1130-63432016000400006,mostraron,o
230,S1130-63432016000400006,diferencias,o
230,S1130-63432016000400006,entre,o
230,S1130-63432016000400006,ambas,o
230,S1130-63432016000400006,ramas,o
230,S1130-63432016000400006,tras,o
230,S1130-63432016000400006,el,o
230,S1130-63432016000400006,ajuste,o
230,S1130-63432016000400006,obteniendo,o
230,S1130-63432016000400006,una,o
230,S1130-63432016000400006,ORad,o
230,S1130-63432016000400006,06,o
230,S1130-63432016000400006,IC95,o
230,S1130-63432016000400006,0128,o
230,S1130-63432016000400006,p0521,o
230,S1130-63432016000400006,El,o
230,S1130-63432016000400006,grupotenofovir,o
230,S1130-63432016000400006,registro,o
230,S1130-63432016000400006,dos,o
230,S1130-63432016000400006,casos,o
230,S1130-63432016000400006,de,o
230,S1130-63432016000400006,suspension,i
230,S1130-63432016000400006,por,o
230,S1130-63432016000400006,toxicidad,i
230,S1130-63432016000400006,renal,i
230,S1130-63432016000400006,con,o
230,S1130-63432016000400006,posterior,o
230,S1130-63432016000400006,recuperacion,o
230,S1130-63432016000400006,entre,o
230,S1130-63432016000400006,ellos,o
230,S1130-63432016000400006,un,o
230,S1130-63432016000400006,sindrome,i
230,S1130-63432016000400006,de,i
230,S1130-63432016000400006,Fanconi,i
230,S1130-63432016000400006,Conclusiones,o
230,S1130-63432016000400006,En,o
230,S1130-63432016000400006,nuestro,o
230,S1130-63432016000400006,estudio,o
230,S1130-63432016000400006,existen,o
230,S1130-63432016000400006,diferencias,o
230,S1130-63432016000400006,significativas,o
230,S1130-63432016000400006,entre,o
230,S1130-63432016000400006,ambos,o
230,S1130-63432016000400006,tratamientos,i
230,S1130-63432016000400006,respecto,o
230,S1130-63432016000400006,a,o
230,S1130-63432016000400006,su,o
230,S1130-63432016000400006,efectividad,o
230,S1130-63432016000400006,mostrandose,o
230,S1130-63432016000400006,el,o
230,S1130-63432016000400006,tenofovir,i
230,S1130-63432016000400006,superior,o
230,S1130-63432016000400006,En,o
230,S1130-63432016000400006,cuanto,o
230,S1130-63432016000400006,a,o
230,S1130-63432016000400006,la,o
230,S1130-63432016000400006,seguridad,o
230,S1130-63432016000400006,renal,i
230,S1130-63432016000400006,no,o
230,S1130-63432016000400006,hemos,o
230,S1130-63432016000400006,encontrado,o
230,S1130-63432016000400006,diferencias,o
230,S1130-63432016000400006,significativas,o
230,S1130-63432016000400006,pero,o
230,S1130-63432016000400006,dos,o
230,S1130-63432016000400006,casos,o
230,S1130-63432016000400006,de,o
230,S1130-63432016000400006,suspension,i
230,S1130-63432016000400006,de,i
230,S1130-63432016000400006,tratamiento,i
230,S1130-63432016000400006,por,o
230,S1130-63432016000400006,toxicidad,i
230,S1130-63432016000400006,renal,i
230,S1130-63432016000400006,con,o
230,S1130-63432016000400006,tenofovir,i
230,S1130-63432016000400006,nos,o
230,S1130-63432016000400006,llevan,o
230,S1130-63432016000400006,a,o
230,S1130-63432016000400006,concluir,o
230,S1130-63432016000400006,que,o
230,S1130-63432016000400006,la,o
230,S1130-63432016000400006,decision,o
230,S1130-63432016000400006,de,o
230,S1130-63432016000400006,tratamiento,i
230,S1130-63432016000400006,en,o
230,S1130-63432016000400006,los,o
230,S1130-63432016000400006,pacientes,o
230,S1130-63432016000400006,con,o
230,S1130-63432016000400006,alteraciones,i
230,S1130-63432016000400006,en,i
230,S1130-63432016000400006,la,i
230,S1130-63432016000400006,funcion,i
230,S1130-63432016000400006,renal,i
230,S1130-63432016000400006,deberia,o
230,S1130-63432016000400006,incluir,o
230,S1130-63432016000400006,un,o
230,S1130-63432016000400006,analisis,o
230,S1130-63432016000400006,individualizado,o
230,S1130-63432016000400006,de,o
230,S1130-63432016000400006,cada,o
230,S1130-63432016000400006,caso,o
231,S1130-63432019000200056,Calidad,o
231,S1130-63432019000200056,de,o
231,S1130-63432019000200056,vida,o
231,S1130-63432019000200056,en,o
231,S1130-63432019000200056,pacientes,o
231,S1130-63432019000200056,con,o
231,S1130-63432019000200056,carcinoma,i
231,S1130-63432019000200056,colorrectal,i
231,S1130-63432019000200056,no,i
231,S1130-63432019000200056,metastasico,i
231,S1130-63432019000200056,tratados,i
231,S1130-63432019000200056,con,o
231,S1130-63432019000200056,esquema,o
231,S1130-63432019000200056,FOLFOX,i
231,S1130-63432019000200056,o,o
231,S1130-63432019000200056,XELOX,i
231,S1130-63432019000200056,Objetivo,o
231,S1130-63432019000200056,Evaluar,o
231,S1130-63432019000200056,y,o
231,S1130-63432019000200056,comparar,o
231,S1130-63432019000200056,la,o
231,S1130-63432019000200056,calidad,o
231,S1130-63432019000200056,de,o
231,S1130-63432019000200056,vida,o
231,S1130-63432019000200056,de,o
231,S1130-63432019000200056,pacientes,o
231,S1130-63432019000200056,con,o
231,S1130-63432019000200056,cancer,i
231,S1130-63432019000200056,colorrectal,i
231,S1130-63432019000200056,no,i
231,S1130-63432019000200056,metastasico,i
231,S1130-63432019000200056,tratados,i
231,S1130-63432019000200056,con,o
231,S1130-63432019000200056,el,o
231,S1130-63432019000200056,esquema,o
231,S1130-63432019000200056,FOLFOX,i
231,S1130-63432019000200056,o,o
231,S1130-63432019000200056,XELOX,i
231,S1130-63432019000200056,Metodo,o
231,S1130-63432019000200056,Estudio,i
231,S1130-63432019000200056,descriptivo,i
231,S1130-63432019000200056,prospectivo,i
231,S1130-63432019000200056,de,o
231,S1130-63432019000200056,24,o
231,S1130-63432019000200056,meses,o
231,S1130-63432019000200056,de,o
231,S1130-63432019000200056,duracion,o
231,S1130-63432019000200056,octubre,o
231,S1130-63432019000200056,2015octubre,o
231,S1130-63432019000200056,2017,o
231,S1130-63432019000200056,en,o
231,S1130-63432019000200056,pacientes,o
231,S1130-63432019000200056,con,o
231,S1130-63432019000200056,cancer,i
231,S1130-63432019000200056,colorrectal,i
231,S1130-63432019000200056,no,i
231,S1130-63432019000200056,metastasico,i
231,S1130-63432019000200056,en,o
231,S1130-63432019000200056,tratamiento,i
231,S1130-63432019000200056,quimioterapico,i
231,S1130-63432019000200056,adyuvante,i
231,S1130-63432019000200056,Se,o
231,S1130-63432019000200056,paso,o
231,S1130-63432019000200056,a,o
231,S1130-63432019000200056,los,o
231,S1130-63432019000200056,pacientes,o
231,S1130-63432019000200056,el,o
231,S1130-63432019000200056,cuestionario,i
231,S1130-63432019000200056,de,i
231,S1130-63432019000200056,calidad,i
231,S1130-63432019000200056,de,i
231,S1130-63432019000200056,vida,i
231,S1130-63432019000200056,EORTC,o
231,S1130-63432019000200056,QLQC30,o
231,S1130-63432019000200056,al,o
231,S1130-63432019000200056,inicio,o
231,S1130-63432019000200056,del,o
231,S1130-63432019000200056,tratamiento,i
231,S1130-63432019000200056,y,o
231,S1130-63432019000200056,a,o
231,S1130-63432019000200056,las,o
231,S1130-63432019000200056,12,o
231,S1130-63432019000200056,semanas,o
231,S1130-63432019000200056,Variables,o
231,S1130-63432019000200056,recogidas,o
231,S1130-63432019000200056,exposicion,o
231,S1130-63432019000200056,esquema,i
231,S1130-63432019000200056,quimioterapico,i
231,S1130-63432019000200056,control,o
231,S1130-63432019000200056,datos,o
231,S1130-63432019000200056,demograficos,o
231,S1130-63432019000200056,de,o
231,S1130-63432019000200056,la,o
231,S1130-63432019000200056,enfermedad,i
231,S1130-63432019000200056,y,o
231,S1130-63432019000200056,del,o
231,S1130-63432019000200056,tratamiento,i
231,S1130-63432019000200056,y,o
231,S1130-63432019000200056,respuesta,o
231,S1130-63432019000200056,puntuaciones,o
231,S1130-63432019000200056,del,o
231,S1130-63432019000200056,cuestionario,o
231,S1130-63432019000200056,El,o
231,S1130-63432019000200056,analisis,o
231,S1130-63432019000200056,estadistico,o
231,S1130-63432019000200056,se,o
231,S1130-63432019000200056,efectuo,o
231,S1130-63432019000200056,con,o
231,S1130-63432019000200056,el,o
231,S1130-63432019000200056,programa,o
231,S1130-63432019000200056,SPSS,o
231,S1130-63432019000200056,150,o
231,S1130-63432019000200056,Resultados,o
231,S1130-63432019000200056,Se,o
231,S1130-63432019000200056,incluyeron,o
231,S1130-63432019000200056,30,o
231,S1130-63432019000200056,pacientes,o
231,S1130-63432019000200056,encontrandose,o
231,S1130-63432019000200056,diferencias,o
231,S1130-63432019000200056,estadisticamente,o
231,S1130-63432019000200056,significativas,o
231,S1130-63432019000200056,en,o
231,S1130-63432019000200056,el,o
231,S1130-63432019000200056,item,o
231,S1130-63432019000200056,rol,o
231,S1130-63432019000200056,emocional,o
231,S1130-63432019000200056,a,o
231,S1130-63432019000200056,las,o
231,S1130-63432019000200056,12,o
231,S1130-63432019000200056,semanas,o
231,S1130-63432019000200056,de,o
231,S1130-63432019000200056,tratamiento,i
231,S1130-63432019000200056,FOLFOX,i
231,S1130-63432019000200056,92,o
231,S1130-63432019000200056,puntos,o
231,S1130-63432019000200056,versus,o
231,S1130-63432019000200056,XELOX,i
231,S1130-63432019000200056,82,o
231,S1130-63432019000200056,puntos,o
231,S1130-63432019000200056,p,o
231,S1130-63432019000200056,0036,o
231,S1130-63432019000200056,Ademas,o
231,S1130-63432019000200056,los,o
231,S1130-63432019000200056,pacientes,o
231,S1130-63432019000200056,tratados,i
231,S1130-63432019000200056,con,i
231,S1130-63432019000200056,FOLFOX,i
231,S1130-63432019000200056,presentaron,o
231,S1130-63432019000200056,un,o
231,S1130-63432019000200056,empeoramiento,o
231,S1130-63432019000200056,clinicamente,o
231,S1130-63432019000200056,relevante,o
231,S1130-63432019000200056,en,o
231,S1130-63432019000200056,actividades,o
231,S1130-63432019000200056,cotidianas,o
231,S1130-63432019000200056,estreñimiento,i
231,S1130-63432019000200056,e,o
231,S1130-63432019000200056,insomnio,i
231,S1130-63432019000200056,mientras,o
231,S1130-63432019000200056,que,o
231,S1130-63432019000200056,los,o
231,S1130-63432019000200056,tratados,i
231,S1130-63432019000200056,con,i
231,S1130-63432019000200056,XELOX,i
231,S1130-63432019000200056,mostraron,o
231,S1130-63432019000200056,un,o
231,S1130-63432019000200056,empeoramiento,o
231,S1130-63432019000200056,clinicamente,o
231,S1130-63432019000200056,relevante,o
231,S1130-63432019000200056,en,o
231,S1130-63432019000200056,actividades,o
231,S1130-63432019000200056,cotidianas,o
231,S1130-63432019000200056,estreñimiento,i
231,S1130-63432019000200056,fatiga,i
231,S1130-63432019000200056,nauseas,i
231,S1130-63432019000200056,vomitos,i
231,S1130-63432019000200056,anorexia,i
231,S1130-63432019000200056,y,o
231,S1130-63432019000200056,diarrea,i
231,S1130-63432019000200056,Conclusiones,o
231,S1130-63432019000200056,Los,o
231,S1130-63432019000200056,pacientes,o
231,S1130-63432019000200056,tratados,i
231,S1130-63432019000200056,con,o
231,S1130-63432019000200056,el,o
231,S1130-63432019000200056,esquema,o
231,S1130-63432019000200056,XELOX,i
231,S1130-63432019000200056,se,o
231,S1130-63432019000200056,encontraron,o
231,S1130-63432019000200056,peor,o
231,S1130-63432019000200056,emocionalmente,o
231,S1130-63432019000200056,a,o
231,S1130-63432019000200056,las,o
231,S1130-63432019000200056,12,o
231,S1130-63432019000200056,semanas,o
231,S1130-63432019000200056,del,o
231,S1130-63432019000200056,tratamiento,i
231,S1130-63432019000200056,adyuvante,i
231,S1130-63432019000200056,que,o
231,S1130-63432019000200056,los,o
231,S1130-63432019000200056,tratados,i
231,S1130-63432019000200056,con,i
231,S1130-63432019000200056,FOLFOX,i
231,S1130-63432019000200056,y,o
231,S1130-63432019000200056,presentaron,o
231,S1130-63432019000200056,empeoramiento,o
231,S1130-63432019000200056,en,o
231,S1130-63432019000200056,fatiga,i
231,S1130-63432019000200056,nauseas,i
231,S1130-63432019000200056,vomitos,i
231,S1130-63432019000200056,anorexia,i
231,S1130-63432019000200056,y,o
231,S1130-63432019000200056,diarrea,i
232,S1130-6343201900050015,OTAC,o
232,S1130-6343201900050015,Optimizacion,i
232,S1130-6343201900050015,de,i
232,S1130-6343201900050015,la,i
232,S1130-6343201900050015,Terapia,i
232,S1130-6343201900050015,Antibiotica,i
232,S1130-6343201900050015,en,o
232,S1130-6343201900050015,el,o
232,S1130-6343201900050015,paciente,o
232,S1130-6343201900050015,Critico,o
232,S1130-6343201900050015,Antibioticos,i
232,S1130-6343201900050015,betalactamicos,i
232,S1130-6343201900050015,en,o
232,S1130-6343201900050015,perfusion,i
232,S1130-6343201900050015,continua,i
232,S1130-6343201900050015,Objetivo,o
232,S1130-6343201900050015,Determinar,o
232,S1130-6343201900050015,el,o
232,S1130-6343201900050015,porcentaje,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,pacientes,o
232,S1130-6343201900050015,a,o
232,S1130-6343201900050015,los,o
232,S1130-6343201900050015,que,o
232,S1130-6343201900050015,se,o
232,S1130-6343201900050015,les,o
232,S1130-6343201900050015,administro,o
232,S1130-6343201900050015,dosis,o
232,S1130-6343201900050015,estandar,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,piperacilinatazobactam,o
232,S1130-6343201900050015,o,o
232,S1130-6343201900050015,meropenem,i
232,S1130-6343201900050015,en,o
232,S1130-6343201900050015,perfusion,i
232,S1130-6343201900050015,continua,i
232,S1130-6343201900050015,que,o
232,S1130-6343201900050015,alcanzaban,o
232,S1130-6343201900050015,el,o
232,S1130-6343201900050015,indice,o
232,S1130-6343201900050015,farmacocineticofarmacodinamico,o
232,S1130-6343201900050015,diana,o
232,S1130-6343201900050015,definido,o
232,S1130-6343201900050015,como,o
232,S1130-6343201900050015,el,o
232,S1130-6343201900050015,100,o
232,S1130-6343201900050015,del,o
232,S1130-6343201900050015,intervalo,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,administracion,i
232,S1130-6343201900050015,en,o
232,S1130-6343201900050015,que,o
232,S1130-6343201900050015,las,o
232,S1130-6343201900050015,concentraciones,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,antibiotico,i
232,S1130-6343201900050015,libre,o
232,S1130-6343201900050015,fueron,o
232,S1130-6343201900050015,cuatro,o
232,S1130-6343201900050015,veces,o
232,S1130-6343201900050015,iguales,o
232,S1130-6343201900050015,o,o
232,S1130-6343201900050015,superiores,o
232,S1130-6343201900050015,a,o
232,S1130-6343201900050015,la,o
232,S1130-6343201900050015,concentracion,i
232,S1130-6343201900050015,minima,i
232,S1130-6343201900050015,inhibitoria,i
232,S1130-6343201900050015,100,o
232,S1130-6343201900050015,fT,o
232,S1130-6343201900050015,4,o
232,S1130-6343201900050015,x,o
232,S1130-6343201900050015,CMI,i
232,S1130-6343201900050015,Metodo,o
232,S1130-6343201900050015,Datos,o
232,S1130-6343201900050015,preliminares,o
232,S1130-6343201900050015,obtenidos,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,un,o
232,S1130-6343201900050015,estudio,i
232,S1130-6343201900050015,clinico,i
232,S1130-6343201900050015,prospectivo,i
232,S1130-6343201900050015,que,o
232,S1130-6343201900050015,analiza,o
232,S1130-6343201900050015,el,o
232,S1130-6343201900050015,comportamiento,o
232,S1130-6343201900050015,farmacocineticofarmacodinamico,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,los,o
232,S1130-6343201900050015,antibioticos,i
232,S1130-6343201900050015,betalactamicos,i
232,S1130-6343201900050015,administrados,o
232,S1130-6343201900050015,en,o
232,S1130-6343201900050015,perfusion,i
232,S1130-6343201900050015,continua,i
232,S1130-6343201900050015,en,o
232,S1130-6343201900050015,pacientes,o
232,S1130-6343201900050015,criticos,o
232,S1130-6343201900050015,Se,o
232,S1130-6343201900050015,realizo,o
232,S1130-6343201900050015,en,o
232,S1130-6343201900050015,unidades,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,cuidados,o
232,S1130-6343201900050015,intensivos,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,un,o
232,S1130-6343201900050015,hospital,o
232,S1130-6343201900050015,universitario,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,tercer,o
232,S1130-6343201900050015,nivel,o
232,S1130-6343201900050015,desde,o
232,S1130-6343201900050015,junio,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,2015,o
232,S1130-6343201900050015,a,o
232,S1130-6343201900050015,mayo,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,2017,o
232,S1130-6343201900050015,Criterios,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,inclusion,o
232,S1130-6343201900050015,adultos,o
232,S1130-6343201900050015,con,o
232,S1130-6343201900050015,funcion,o
232,S1130-6343201900050015,renal,i
232,S1130-6343201900050015,correcta,o
232,S1130-6343201900050015,filtrado,i
232,S1130-6343201900050015,glomerular,i
232,S1130-6343201900050015,segun,o
232,S1130-6343201900050015,la,o
232,S1130-6343201900050015,formula,o
232,S1130-6343201900050015,CKDEPI,o
232,S1130-6343201900050015,60,o
232,S1130-6343201900050015,mlmin173,o
232,S1130-6343201900050015,m,o
232,S1130-6343201900050015,2,o
232,S1130-6343201900050015,y,o
232,S1130-6343201900050015,tratados,i
232,S1130-6343201900050015,con,o
232,S1130-6343201900050015,dosis,o
232,S1130-6343201900050015,estandar,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,antibioticos,i
232,S1130-6343201900050015,betalactamicos,i
232,S1130-6343201900050015,en,o
232,S1130-6343201900050015,perfusion,i
232,S1130-6343201900050015,continua,i
232,S1130-6343201900050015,Las,o
232,S1130-6343201900050015,concentraciones,o
232,S1130-6343201900050015,en,o
232,S1130-6343201900050015,estado,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,equilibrio,o
232,S1130-6343201900050015,estacionario,o
232,S1130-6343201900050015,fueron,o
232,S1130-6343201900050015,determinadas,o
232,S1130-6343201900050015,mediante,o
232,S1130-6343201900050015,cromatografia,i
232,S1130-6343201900050015,liquida,i
232,S1130-6343201900050015,acoplada,o
232,S1130-6343201900050015,a,o
232,S1130-6343201900050015,espectrometria,i
232,S1130-6343201900050015,de,i
232,S1130-6343201900050015,masas,i
232,S1130-6343201900050015,UHPLCMSMS,o
232,S1130-6343201900050015,Se,o
232,S1130-6343201900050015,utilizaron,o
232,S1130-6343201900050015,valores,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,concentracion,i
232,S1130-6343201900050015,minima,i
232,S1130-6343201900050015,inhibitoria,i
232,S1130-6343201900050015,teoricos,o
232,S1130-6343201900050015,para,o
232,S1130-6343201900050015,microorganismos,o
232,S1130-6343201900050015,mas,o
232,S1130-6343201900050015,resistentes,o
232,S1130-6343201900050015,piperacilina,i
232,S1130-6343201900050015,tazobactam,o
232,S1130-6343201900050015,16,o
232,S1130-6343201900050015,mgl,o
232,S1130-6343201900050015,para,o
232,S1130-6343201900050015,Pseudomonas,o
232,S1130-6343201900050015,aeruginosa,o
232,S1130-6343201900050015,y,o
232,S1130-6343201900050015,8,o
232,S1130-6343201900050015,mgl,o
232,S1130-6343201900050015,para,o
232,S1130-6343201900050015,Enterobacteriaceae,o
232,S1130-6343201900050015,meropenem,i
232,S1130-6343201900050015,2,o
232,S1130-6343201900050015,mgl,o
232,S1130-6343201900050015,independientemente,o
232,S1130-6343201900050015,del,o
232,S1130-6343201900050015,microorganismo,o
232,S1130-6343201900050015,Ademas,o
232,S1130-6343201900050015,se,o
232,S1130-6343201900050015,realizo,o
232,S1130-6343201900050015,un,o
232,S1130-6343201900050015,subanalisis,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,los,o
232,S1130-6343201900050015,pacientes,o
232,S1130-6343201900050015,con,o
232,S1130-6343201900050015,aislamiento,o
232,S1130-6343201900050015,microbiologico,o
232,S1130-6343201900050015,concentraciones,i
232,S1130-6343201900050015,minimas,i
232,S1130-6343201900050015,inhibitorias,i
232,S1130-6343201900050015,reales,o
232,S1130-6343201900050015,Resultados,o
232,S1130-6343201900050015,Se,o
232,S1130-6343201900050015,incluyeron,o
232,S1130-6343201900050015,61,o
232,S1130-6343201900050015,pacientes,o
232,S1130-6343201900050015,25,o
232,S1130-6343201900050015,meropenem,i
232,S1130-6343201900050015,y,o
232,S1130-6343201900050015,36,o
232,S1130-6343201900050015,piperacilinatazobactam,o
232,S1130-6343201900050015,Edad,o
232,S1130-6343201900050015,media,o
232,S1130-6343201900050015,59,o
232,S1130-6343201900050015,años,o
232,S1130-6343201900050015,15,o
232,S1130-6343201900050015,mediana,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,filtrado,i
232,S1130-6343201900050015,glomerular,i
232,S1130-6343201900050015,95,o
232,S1130-6343201900050015,mlmin173,o
232,S1130-6343201900050015,m2,o
232,S1130-6343201900050015,83115,o
232,S1130-6343201900050015,Mediana,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,concentraciones,o
232,S1130-6343201900050015,en,o
232,S1130-6343201900050015,estado,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,equilibrio,o
232,S1130-6343201900050015,estacionario,o
232,S1130-6343201900050015,libre,o
232,S1130-6343201900050015,16,o
232,S1130-6343201900050015,mgl,o
232,S1130-6343201900050015,1129,o
232,S1130-6343201900050015,meropenem,i
232,S1130-6343201900050015,y,o
232,S1130-6343201900050015,40,o
232,S1130-6343201900050015,mgl,o
232,S1130-6343201900050015,2151,o
232,S1130-6343201900050015,piperacilina,i
232,S1130-6343201900050015,El,o
232,S1130-6343201900050015,88,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,los,o
232,S1130-6343201900050015,pacientes,o
232,S1130-6343201900050015,tratados,i
232,S1130-6343201900050015,con,o
232,S1130-6343201900050015,meropenem,i
232,S1130-6343201900050015,alcanzaron,o
232,S1130-6343201900050015,el,o
232,S1130-6343201900050015,objetivo,o
232,S1130-6343201900050015,farmacocineticofarmacodinamico,o
232,S1130-6343201900050015,sin,o
232,S1130-6343201900050015,diferencias,o
232,S1130-6343201900050015,entre,o
232,S1130-6343201900050015,Enterobacteriaceae,o
232,S1130-6343201900050015,y,o
232,S1130-6343201900050015,Pseudomonas,o
232,S1130-6343201900050015,En,o
232,S1130-6343201900050015,el,o
232,S1130-6343201900050015,caso,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,piperacilinatazobactam,o
232,S1130-6343201900050015,el,o
232,S1130-6343201900050015,61,o
232,S1130-6343201900050015,y,o
232,S1130-6343201900050015,el,o
232,S1130-6343201900050015,11,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,los,o
232,S1130-6343201900050015,pacientes,o
232,S1130-6343201900050015,alcanzaron,o
232,S1130-6343201900050015,la,o
232,S1130-6343201900050015,diana,o
232,S1130-6343201900050015,considerando,o
232,S1130-6343201900050015,Enterobacteriaceae,o
232,S1130-6343201900050015,y,o
232,S1130-6343201900050015,Pseudomonas,o
232,S1130-6343201900050015,como,o
232,S1130-6343201900050015,microorganismo,o
232,S1130-6343201900050015,sospechoso,o
232,S1130-6343201900050015,Un,o
232,S1130-6343201900050015,total,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,35,o
232,S1130-6343201900050015,57,o
232,S1130-6343201900050015,pacientes,o
232,S1130-6343201900050015,presentaron,o
232,S1130-6343201900050015,aislamiento,o
232,S1130-6343201900050015,microbiologico,o
232,S1130-6343201900050015,El,o
232,S1130-6343201900050015,94,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,ellos,o
232,S1130-6343201900050015,alcanzaron,o
232,S1130-6343201900050015,la,o
232,S1130-6343201900050015,diana,o
232,S1130-6343201900050015,sin,o
232,S1130-6343201900050015,diferencias,o
232,S1130-6343201900050015,entre,o
232,S1130-6343201900050015,los,o
232,S1130-6343201900050015,dos,o
232,S1130-6343201900050015,antibioticos,i
232,S1130-6343201900050015,Conclusiones,o
232,S1130-6343201900050015,Ante,o
232,S1130-6343201900050015,la,o
232,S1130-6343201900050015,sospecha,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,infecciones,i
232,S1130-6343201900050015,por,i
232,S1130-6343201900050015,microorganismos,i
232,S1130-6343201900050015,con,o
232,S1130-6343201900050015,concentraciones,i
232,S1130-6343201900050015,minimas,i
232,S1130-6343201900050015,inhibitorias,i
232,S1130-6343201900050015,elevadas,o
232,S1130-6343201900050015,Pseudomonas,o
232,S1130-6343201900050015,aeruginosa,o
232,S1130-6343201900050015,o,o
232,S1130-6343201900050015,enterobacterias,o
232,S1130-6343201900050015,se,o
232,S1130-6343201900050015,observa,o
232,S1130-6343201900050015,que,o
232,S1130-6343201900050015,dosis,o
232,S1130-6343201900050015,convencionales,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,meropenem,i
232,S1130-6343201900050015,en,o
232,S1130-6343201900050015,perfusion,i
232,S1130-6343201900050015,continua,i
232,S1130-6343201900050015,son,o
232,S1130-6343201900050015,suficientes,o
232,S1130-6343201900050015,para,o
232,S1130-6343201900050015,lograr,o
232,S1130-6343201900050015,la,o
232,S1130-6343201900050015,diana,o
232,S1130-6343201900050015,100,o
232,S1130-6343201900050015,fT,o
232,S1130-6343201900050015,4,o
232,S1130-6343201900050015,x,o
232,S1130-6343201900050015,MIC,i
232,S1130-6343201900050015,Sin,o
232,S1130-6343201900050015,embargo,o
232,S1130-6343201900050015,se,o
232,S1130-6343201900050015,requeririan,o
232,S1130-6343201900050015,dosis,o
232,S1130-6343201900050015,superiores,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,piperacilinatazobactam,o
232,S1130-6343201900050015,En,o
232,S1130-6343201900050015,casos,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,aislamiento,o
232,S1130-6343201900050015,microbiologico,o
232,S1130-6343201900050015,dosis,o
232,S1130-6343201900050015,estandar,o
232,S1130-6343201900050015,de,o
232,S1130-6343201900050015,ambos,o
232,S1130-6343201900050015,antibioticos,i
232,S1130-6343201900050015,fueron,o
232,S1130-6343201900050015,suficientes,o
232,S1130-6343201900050015,para,o
232,S1130-6343201900050015,lograr,o
232,S1130-6343201900050015,la,o
232,S1130-6343201900050015,diana,o
232,S1130-6343201900050015,La,o
232,S1130-6343201900050015,monitorizacion,i
232,S1130-6343201900050015,farmacocinetica,i
232,S1130-6343201900050015,es,o
232,S1130-6343201900050015,altamente,o
232,S1130-6343201900050015,recomendable,o
232,S1130-6343201900050015,para,o
232,S1130-6343201900050015,la,o
232,S1130-6343201900050015,optimizacion,i
232,S1130-6343201900050015,terapeutica,i
233,S1131-57682003000400010,Efectividad,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,vacuna,i
233,S1131-57682003000400010,antineumococica,i
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,pacientes,o
233,S1131-57682003000400010,mayores,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,65,o
233,S1131-57682003000400010,años,o
233,S1131-57682003000400010,Fundamentos,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,efectividad,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,vacuna,i
233,S1131-57682003000400010,antineumococica,i
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,23,o
233,S1131-57682003000400010,serotipos,o
233,S1131-57682003000400010,VAN,o
233,S1131-57682003000400010,23S,o
233,S1131-57682003000400010,respecto,o
233,S1131-57682003000400010,a,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,prevencion,i
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,adquisicion,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,infeccion,i
233,S1131-57682003000400010,esta,o
233,S1131-57682003000400010,actualmente,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,discusion,o
233,S1131-57682003000400010,y,o
233,S1131-57682003000400010,esta,o
233,S1131-57682003000400010,ademas,o
233,S1131-57682003000400010,parece,o
233,S1131-57682003000400010,disminuir,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,poblacion,o
233,S1131-57682003000400010,anciana,o
233,S1131-57682003000400010,Sin,o
233,S1131-57682003000400010,embargo,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,indicacion,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,vacuna,i
233,S1131-57682003000400010,sigue,o
233,S1131-57682003000400010,manteniendose,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,este,o
233,S1131-57682003000400010,grupo,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,edad,o
233,S1131-57682003000400010,El,o
233,S1131-57682003000400010,objetivo,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,nuestro,o
233,S1131-57682003000400010,estudio,o
233,S1131-57682003000400010,fue,o
233,S1131-57682003000400010,evaluar,i
233,S1131-57682003000400010,la,i
233,S1131-57682003000400010,efectividad,i
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,vacuna,i
233,S1131-57682003000400010,antineumococica,i
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,dos,o
233,S1131-57682003000400010,cohortes,o
233,S1131-57682003000400010,vacunados,i
233,S1131-57682003000400010,y,o
233,S1131-57682003000400010,no,o
233,S1131-57682003000400010,vacunados,i
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,personas,o
233,S1131-57682003000400010,mayores,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,65,o
233,S1131-57682003000400010,años,o
233,S1131-57682003000400010,mediante,o
233,S1131-57682003000400010,comparacion,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,tasas,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,incidencia,o
233,S1131-57682003000400010,y,o
233,S1131-57682003000400010,nivel,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,severidad,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,las,o
233,S1131-57682003000400010,neumonias,i
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,ambas,o
233,S1131-57682003000400010,cohortes,o
233,S1131-57682003000400010,Metodos,o
233,S1131-57682003000400010,estudio,i
233,S1131-57682003000400010,de,i
233,S1131-57682003000400010,cohortes,i
233,S1131-57682003000400010,retrospectivo,i
233,S1131-57682003000400010,realizado,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,una,o
233,S1131-57682003000400010,Area,o
233,S1131-57682003000400010,Basica,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,Salud,o
233,S1131-57682003000400010,urbana,o
233,S1131-57682003000400010,ABS,o
233,S1131-57682003000400010,sobre,o
233,S1131-57682003000400010,dos,o
233,S1131-57682003000400010,cohortes,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,personas,o
233,S1131-57682003000400010,mayores,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,65,o
233,S1131-57682003000400010,años,o
233,S1131-57682003000400010,301,o
233,S1131-57682003000400010,vacunados,i
233,S1131-57682003000400010,CV,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,1993,o
233,S1131-57682003000400010,y,o
233,S1131-57682003000400010,301,o
233,S1131-57682003000400010,no,o
233,S1131-57682003000400010,vacunados,i
233,S1131-57682003000400010,CNV,o
233,S1131-57682003000400010,hasta,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,actualidad,o
233,S1131-57682003000400010,Se,o
233,S1131-57682003000400010,identificaron,o
233,S1131-57682003000400010,todas,o
233,S1131-57682003000400010,las,o
233,S1131-57682003000400010,neumonias,i
233,S1131-57682003000400010,acaecidas,o
233,S1131-57682003000400010,durante,o
233,S1131-57682003000400010,el,o
233,S1131-57682003000400010,periodo,o
233,S1131-57682003000400010,19941999,o
233,S1131-57682003000400010,calculando,o
233,S1131-57682003000400010,tasas,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,incidencia,o
233,S1131-57682003000400010,grado,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,severidad,o
233,S1131-57682003000400010,e,o
233,S1131-57682003000400010,indice,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,letalidad,o
233,S1131-57682003000400010,Resultados,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,tasa,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,incidencia,o
233,S1131-57682003000400010,media,o
233,S1131-57682003000400010,anual,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,neumonia,i
233,S1131-57682003000400010,fue,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,1329,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,personas,o
233,S1131-57682003000400010,mayores,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,65,o
233,S1131-57682003000400010,años,o
233,S1131-57682003000400010,166,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,CV,o
233,S1131-57682003000400010,y,o
233,S1131-57682003000400010,996,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,CNV,o
233,S1131-57682003000400010,siendo,o
233,S1131-57682003000400010,el,o
233,S1131-57682003000400010,riesgo,o
233,S1131-57682003000400010,relativo,o
233,S1131-57682003000400010,para,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,cohorte,o
233,S1131-57682003000400010,vacunada,i
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,167IC,o
233,S1131-57682003000400010,95,o
233,S1131-57682003000400010,095292,o
233,S1131-57682003000400010,No,o
233,S1131-57682003000400010,observamos,o
233,S1131-57682003000400010,diferencias,o
233,S1131-57682003000400010,significativas,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,cuanto,o
233,S1131-57682003000400010,al,o
233,S1131-57682003000400010,indice,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,letalidad,o
233,S1131-57682003000400010,CV,o
233,S1131-57682003000400010,137,o
233,S1131-57682003000400010,frente,o
233,S1131-57682003000400010,a,o
233,S1131-57682003000400010,157,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,CNV,o
233,S1131-57682003000400010,y,o
233,S1131-57682003000400010,el,o
233,S1131-57682003000400010,grado,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,severidad,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,las,o
233,S1131-57682003000400010,neumonias,i
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,ambas,o
233,S1131-57682003000400010,cohortes,o
233,S1131-57682003000400010,Conclusiones,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,nuestro,o
233,S1131-57682003000400010,ambito,o
233,S1131-57682003000400010,no,o
233,S1131-57682003000400010,se,o
233,S1131-57682003000400010,ha,o
233,S1131-57682003000400010,podido,o
233,S1131-57682003000400010,demostrar,o
233,S1131-57682003000400010,un,o
233,S1131-57682003000400010,efecto,o
233,S1131-57682003000400010,protector,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,VAN,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,CV,o
233,S1131-57682003000400010,respecto,o
233,S1131-57682003000400010,a,o
233,S1131-57682003000400010,CNV,o
233,S1131-57682003000400010,ante,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,infeccion,i
233,S1131-57682003000400010,y,o
233,S1131-57682003000400010,tampoco,o
233,S1131-57682003000400010,se,o
233,S1131-57682003000400010,ha,o
233,S1131-57682003000400010,evidenciado,o
233,S1131-57682003000400010,efecto,o
233,S1131-57682003000400010,sobre,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,disminucion,o
233,S1131-57682003000400010,de,o
233,S1131-57682003000400010,la,o
233,S1131-57682003000400010,severidad,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,las,o
233,S1131-57682003000400010,neumonias,i
233,S1131-57682003000400010,acaecidas,o
233,S1131-57682003000400010,en,o
233,S1131-57682003000400010,CV,o
234,S1134-009605703727,Efecto,o
234,S1134-009605703727,del,o
234,S1134-009605703727,tratamiento,i
234,S1134-009605703727,preoperatorio,o
234,S1134-009605703727,con,o
234,S1134-009605703727,estatinas,i
234,S1134-009605703727,sobre,o
234,S1134-009605703727,los,o
234,S1134-009605703727,resultados,o
234,S1134-009605703727,de,o
234,S1134-009605703727,la,o
234,S1134-009605703727,cirugia,i
234,S1134-009605703727,coronaria,i
234,S1134-009605703727,Introduccion,o
234,S1134-009605703727,El,o
234,S1134-009605703727,uso,o
234,S1134-009605703727,de,o
234,S1134-009605703727,estatinas,i
234,S1134-009605703727,se,o
234,S1134-009605703727,asocia,o
234,S1134-009605703727,a,o
234,S1134-009605703727,una,o
234,S1134-009605703727,reduccion,o
234,S1134-009605703727,de,o
234,S1134-009605703727,accidentes,i
234,S1134-009605703727,coronarios,i
234,S1134-009605703727,en,o
234,S1134-009605703727,prevencion,i
234,S1134-009605703727,primaria,i
234,S1134-009605703727,y,i
234,S1134-009605703727,secundaria,i
234,S1134-009605703727,y,o
234,S1134-009605703727,despues,o
234,S1134-009605703727,de,o
234,S1134-009605703727,angioplastia,i
234,S1134-009605703727,primaria,o
234,S1134-009605703727,Objetivo,o
234,S1134-009605703727,Investigar,o
234,S1134-009605703727,si,o
234,S1134-009605703727,el,o
234,S1134-009605703727,empleo,o
234,S1134-009605703727,de,o
234,S1134-009605703727,estatinas,i
234,S1134-009605703727,en,o
234,S1134-009605703727,pacientes,o
234,S1134-009605703727,sometidos,o
234,S1134-009605703727,a,o
234,S1134-009605703727,cirugia,i
234,S1134-009605703727,de,i
234,S1134-009605703727,revascularizacion,i
234,S1134-009605703727,coronaria,i
234,S1134-009605703727,CRC,i
234,S1134-009605703727,se,o
234,S1134-009605703727,asocia,o
234,S1134-009605703727,a,o
234,S1134-009605703727,beneficio,o
234,S1134-009605703727,clinico,o
234,S1134-009605703727,Metodos,o
234,S1134-009605703727,Se,o
234,S1134-009605703727,incluyeron,o
234,S1134-009605703727,102,o
234,S1134-009605703727,pacientes,o
234,S1134-009605703727,consecutivos,o
234,S1134-009605703727,con,o
234,S1134-009605703727,enfermedad,i
234,S1134-009605703727,coronaria,i
234,S1134-009605703727,para,o
234,S1134-009605703727,CRC,i
234,S1134-009605703727,electiva,o
234,S1134-009605703727,y,o
234,S1134-009605703727,aislada,o
234,S1134-009605703727,En,o
234,S1134-009605703727,el,o
234,S1134-009605703727,momento,o
234,S1134-009605703727,de,o
234,S1134-009605703727,la,o
234,S1134-009605703727,inclusion,o
234,S1134-009605703727,se,o
234,S1134-009605703727,registro,o
234,S1134-009605703727,el,o
234,S1134-009605703727,tratamiento,i
234,S1134-009605703727,preoperatorio,o
234,S1134-009605703727,y,o
234,S1134-009605703727,las,o
234,S1134-009605703727,variables,o
234,S1134-009605703727,clinicas,o
234,S1134-009605703727,basales,o
234,S1134-009605703727,En,o
234,S1134-009605703727,el,o
234,S1134-009605703727,seguimiento,i
234,S1134-009605703727,se,o
234,S1134-009605703727,registro,o
234,S1134-009605703727,la,o
234,S1134-009605703727,aparicion,o
234,S1134-009605703727,de,o
234,S1134-009605703727,muerte,i
234,S1134-009605703727,de,i
234,S1134-009605703727,origen,i
234,S1134-009605703727,cardiaco,i
234,S1134-009605703727,e,o
234,S1134-009605703727,infarto,i
234,S1134-009605703727,agudo,i
234,S1134-009605703727,de,i
234,S1134-009605703727,miocardio,i
234,S1134-009605703727,IAM,i
234,S1134-009605703727,en,o
234,S1134-009605703727,los,o
234,S1134-009605703727,primeros,o
234,S1134-009605703727,30,o
234,S1134-009605703727,dias,o
234,S1134-009605703727,Resultados,o
234,S1134-009605703727,Recibian,o
234,S1134-009605703727,estatinas,i
234,S1134-009605703727,61,o
234,S1134-009605703727,pacientes,o
234,S1134-009605703727,60,o
234,S1134-009605703727,frente,o
234,S1134-009605703727,a,o
234,S1134-009605703727,41,o
234,S1134-009605703727,40,o
234,S1134-009605703727,que,o
234,S1134-009605703727,no,o
234,S1134-009605703727,las,o
234,S1134-009605703727,recibian,o
234,S1134-009605703727,No,o
234,S1134-009605703727,se,o
234,S1134-009605703727,encontraron,o
234,S1134-009605703727,diferencias,o
234,S1134-009605703727,significativas,o
234,S1134-009605703727,entre,o
234,S1134-009605703727,ambas,o
234,S1134-009605703727,poblaciones,o
234,S1134-009605703727,respecto,o
234,S1134-009605703727,a,o
234,S1134-009605703727,las,o
234,S1134-009605703727,caracteristicas,o
234,S1134-009605703727,basales,o
234,S1134-009605703727,A,o
234,S1134-009605703727,los,o
234,S1134-009605703727,30,o
234,S1134-009605703727,dias,o
234,S1134-009605703727,se,o
234,S1134-009605703727,produjo,o
234,S1134-009605703727,una,o
234,S1134-009605703727,muerte,i
234,S1134-009605703727,cardiaca,i
234,S1134-009605703727,16,o
234,S1134-009605703727,en,o
234,S1134-009605703727,el,o
234,S1134-009605703727,grupo,o
234,S1134-009605703727,que,o
234,S1134-009605703727,recibio,o
234,S1134-009605703727,estatinas,i
234,S1134-009605703727,frente,o
234,S1134-009605703727,a,o
234,S1134-009605703727,cinco,o
234,S1134-009605703727,122,o
234,S1134-009605703727,en,o
234,S1134-009605703727,el,o
234,S1134-009605703727,grupo,o
234,S1134-009605703727,que,o
234,S1134-009605703727,no,o
234,S1134-009605703727,las,o
234,S1134-009605703727,recibian,o
234,S1134-009605703727,p,o
234,S1134-009605703727,002,o
234,S1134-009605703727,el,o
234,S1134-009605703727,IAM,i
234,S1134-009605703727,ocurrio,o
234,S1134-009605703727,en,o
234,S1134-009605703727,cuatro,o
234,S1134-009605703727,66,o
234,S1134-009605703727,frente,o
234,S1134-009605703727,a,o
234,S1134-009605703727,8,o
234,S1134-009605703727,195,o
234,S1134-009605703727,p,o
234,S1134-009605703727,004,o
234,S1134-009605703727,y,o
234,S1134-009605703727,el,o
234,S1134-009605703727,resultado,o
234,S1134-009605703727,compuesto,o
234,S1134-009605703727,de,o
234,S1134-009605703727,muerte,i
234,S1134-009605703727,cardiaca,i
234,S1134-009605703727,o,o
234,S1134-009605703727,IAM,i
234,S1134-009605703727,ocurrio,o
234,S1134-009605703727,en,o
234,S1134-009605703727,cinco,o
234,S1134-009605703727,82,o
234,S1134-009605703727,frente,o
234,S1134-009605703727,a,o
234,S1134-009605703727,10,o
234,S1134-009605703727,244,o
234,S1134-009605703727,p,o
234,S1134-009605703727,002,o
234,S1134-009605703727,En,o
234,S1134-009605703727,un,o
234,S1134-009605703727,modelo,o
234,S1134-009605703727,multivariado,o
234,S1134-009605703727,el,o
234,S1134-009605703727,tratamiento,i
234,S1134-009605703727,preoperatorio,o
234,S1134-009605703727,con,o
234,S1134-009605703727,estatinas,i
234,S1134-009605703727,se,o
234,S1134-009605703727,mantuvo,o
234,S1134-009605703727,como,o
234,S1134-009605703727,un,o
234,S1134-009605703727,factor,o
234,S1134-009605703727,independiente,o
234,S1134-009605703727,de,o
234,S1134-009605703727,prediccion,o
234,S1134-009605703727,p,o
234,S1134-009605703727,001,o
234,S1134-009605703727,odds,o
234,S1134-009605703727,ratio,o
234,S1134-009605703727,OR,o
234,S1134-009605703727,36,o
234,S1134-009605703727,de,o
234,S1134-009605703727,la,o
234,S1134-009605703727,aparicion,o
234,S1134-009605703727,de,o
234,S1134-009605703727,muerte,i
234,S1134-009605703727,de,i
234,S1134-009605703727,causa,i
234,S1134-009605703727,cardiaca,i
234,S1134-009605703727,o,o
234,S1134-009605703727,IAM,i
234,S1134-009605703727,durante,o
234,S1134-009605703727,los,o
234,S1134-009605703727,primeros,o
234,S1134-009605703727,30,o
234,S1134-009605703727,dias,o
234,S1134-009605703727,despues,o
234,S1134-009605703727,de,o
234,S1134-009605703727,la,o
234,S1134-009605703727,intervencion,i
234,S1134-009605703727,Conclusion,o
234,S1134-009605703727,El,o
234,S1134-009605703727,tratamiento,i
234,S1134-009605703727,previo,o
234,S1134-009605703727,con,o
234,S1134-009605703727,estatinas,i
234,S1134-009605703727,se,o
234,S1134-009605703727,asocia,o
234,S1134-009605703727,de,o
234,S1134-009605703727,forma,o
234,S1134-009605703727,significativa,o
234,S1134-009605703727,e,o
234,S1134-009605703727,independiente,o
234,S1134-009605703727,a,o
234,S1134-009605703727,un,o
234,S1134-009605703727,menor,o
234,S1134-009605703727,riesgo,o
234,S1134-009605703727,de,o
234,S1134-009605703727,IAM,i
234,S1134-009605703727,o,o
234,S1134-009605703727,muerte,i
234,S1134-009605703727,de,i
234,S1134-009605703727,origen,i
234,S1134-009605703727,cardiaco,i
234,S1134-009605703727,en,o
234,S1134-009605703727,pacientes,o
234,S1134-009605703727,sometidos,o
234,S1134-009605703727,a,o
234,S1134-009605703727,CRC,i
235,S1134-009612700384,Reduce,o
235,S1134-009612700384,la,o
235,S1134-009612700384,cirugia,i
235,S1134-009612700384,sin,o
235,S1134-009612700384,circulacion,i
235,S1134-009612700384,extracorporea,i
235,S1134-009612700384,el,o
235,S1134-009612700384,sangrado,i
235,S1134-009612700384,postoperatorio,o
235,S1134-009612700384,y,o
235,S1134-009612700384,los,o
235,S1134-009612700384,concentrados,i
235,S1134-009612700384,de,i
235,S1134-009612700384,hematies,i
235,S1134-009612700384,transfundidos,i
235,S1134-009612700384,en,o
235,S1134-009612700384,grupos,o
235,S1134-009612700384,de,o
235,S1134-009612700384,alto,o
235,S1134-009612700384,riesgo,o
235,S1134-009612700384,Introduccion,o
235,S1134-009612700384,y,o
235,S1134-009612700384,objetivos,o
235,S1134-009612700384,La,o
235,S1134-009612700384,influencia,o
235,S1134-009612700384,de,o
235,S1134-009612700384,la,o
235,S1134-009612700384,cirugia,i
235,S1134-009612700384,de,i
235,S1134-009612700384,revascularizacion,i
235,S1134-009612700384,miocardica,i
235,S1134-009612700384,CRM,i
235,S1134-009612700384,sin,o
235,S1134-009612700384,circulacion,i
235,S1134-009612700384,extracorporea,i
235,S1134-009612700384,CEC,i
235,S1134-009612700384,en,o
235,S1134-009612700384,el,o
235,S1134-009612700384,sangrado,i
235,S1134-009612700384,postoperatorio,o
235,S1134-009612700384,es,o
235,S1134-009612700384,desconocida,o
235,S1134-009612700384,Nuestro,o
235,S1134-009612700384,objetivo,o
235,S1134-009612700384,fue,o
235,S1134-009612700384,conocer,o
235,S1134-009612700384,el,o
235,S1134-009612700384,impacto,o
235,S1134-009612700384,de,o
235,S1134-009612700384,esta,o
235,S1134-009612700384,tecnica,o
235,S1134-009612700384,sobre,o
235,S1134-009612700384,el,o
235,S1134-009612700384,sangrado,i
235,S1134-009612700384,postoperatorio,o
235,S1134-009612700384,y,o
235,S1134-009612700384,los,o
235,S1134-009612700384,concentrados,i
235,S1134-009612700384,de,i
235,S1134-009612700384,hematies,i
235,S1134-009612700384,transfundidos,i
235,S1134-009612700384,en,o
235,S1134-009612700384,grupos,o
235,S1134-009612700384,de,o
235,S1134-009612700384,alto,o
235,S1134-009612700384,riesgo,o
235,S1134-009612700384,de,o
235,S1134-009612700384,sangrado,i
235,S1134-009612700384,Metodos,o
235,S1134-009612700384,Se,o
235,S1134-009612700384,estudiaron,o
235,S1134-009612700384,todos,o
235,S1134-009612700384,los,o
235,S1134-009612700384,pacientes,o
235,S1134-009612700384,intervenidos,i
235,S1134-009612700384,de,o
235,S1134-009612700384,CRM,i
235,S1134-009612700384,aislada,o
235,S1134-009612700384,con,o
235,S1134-009612700384,caracter,o
235,S1134-009612700384,electivo,o
235,S1134-009612700384,en,o
235,S1134-009612700384,nuestro,o
235,S1134-009612700384,centro,o
235,S1134-009612700384,desde,o
235,S1134-009612700384,enero,o
235,S1134-009612700384,de,o
235,S1134-009612700384,2007,o
235,S1134-009612700384,hasta,o
235,S1134-009612700384,septiembre,o
235,S1134-009612700384,de,o
235,S1134-009612700384,2010,o
235,S1134-009612700384,Se,o
235,S1134-009612700384,crearon,o
235,S1134-009612700384,cuatro,o
235,S1134-009612700384,grupos,o
235,S1134-009612700384,de,o
235,S1134-009612700384,pacientes,o
235,S1134-009612700384,documentados,o
235,S1134-009612700384,bibliograficamente,o
235,S1134-009612700384,como,o
235,S1134-009612700384,de,o
235,S1134-009612700384,elevado,o
235,S1134-009612700384,riesgo,o
235,S1134-009612700384,de,o
235,S1134-009612700384,sangrado,i
235,S1134-009612700384,pacientes,o
235,S1134-009612700384,con,o
235,S1134-009612700384,insuficiencia,i
235,S1134-009612700384,renal,i
235,S1134-009612700384,IR,i
235,S1134-009612700384,edad,o
235,S1134-009612700384,superior,o
235,S1134-009612700384,a,o
235,S1134-009612700384,75,o
235,S1134-009612700384,años,o
235,S1134-009612700384,menor,o
235,S1134-009612700384,superficie,i
235,S1134-009612700384,corporal,i
235,S1134-009612700384,SC,i
235,S1134-009612700384,y,o
235,S1134-009612700384,menor,o
235,S1134-009612700384,indice,i
235,S1134-009612700384,de,i
235,S1134-009612700384,masa,i
235,S1134-009612700384,corporal,i
235,S1134-009612700384,IMC,i
235,S1134-009612700384,Se,o
235,S1134-009612700384,estudio,o
235,S1134-009612700384,la,o
235,S1134-009612700384,influencia,o
235,S1134-009612700384,de,o
235,S1134-009612700384,la,o
235,S1134-009612700384,cirugia,i
235,S1134-009612700384,sin,o
235,S1134-009612700384,CEC,i
235,S1134-009612700384,en,o
235,S1134-009612700384,el,o
235,S1134-009612700384,sangrado,i
235,S1134-009612700384,postoperatorio,o
235,S1134-009612700384,y,o
235,S1134-009612700384,los,o
235,S1134-009612700384,concentrados,i
235,S1134-009612700384,de,i
235,S1134-009612700384,hematies,i
235,S1134-009612700384,transfundidos,i
235,S1134-009612700384,en,o
235,S1134-009612700384,cada,o
235,S1134-009612700384,uno,o
235,S1134-009612700384,mediante,o
235,S1134-009612700384,un,o
235,S1134-009612700384,analisis,o
235,S1134-009612700384,ajustado,o
235,S1134-009612700384,por,o
235,S1134-009612700384,indice,o
235,S1134-009612700384,de,o
235,S1134-009612700384,propension,o
235,S1134-009612700384,propensity,o
235,S1134-009612700384,score,o
235,S1134-009612700384,PS,o
235,S1134-009612700384,Resultados,o
235,S1134-009612700384,La,o
235,S1134-009612700384,cirugia,i
235,S1134-009612700384,sin,o
235,S1134-009612700384,CEC,i
235,S1134-009612700384,redujo,o
235,S1134-009612700384,el,o
235,S1134-009612700384,sangrado,i
235,S1134-009612700384,postoperatorio,o
235,S1134-009612700384,Cr,o
235,S1134-009612700384,25641,o
235,S1134-009612700384,p,o
235,S1134-009612700384,0039,o
235,S1134-009612700384,y,o
235,S1134-009612700384,los,o
235,S1134-009612700384,concentrados,i
235,S1134-009612700384,de,i
235,S1134-009612700384,hematies,i
235,S1134-009612700384,transfundidos,i
235,S1134-009612700384,CR,o
235,S1134-009612700384,066,o
235,S1134-009612700384,p,o
235,S1134-009612700384,0027,o
235,S1134-009612700384,en,o
235,S1134-009612700384,los,o
235,S1134-009612700384,138,o
235,S1134-009612700384,pacientes,o
235,S1134-009612700384,con,o
235,S1134-009612700384,unos,o
235,S1134-009612700384,niveles,i
235,S1134-009612700384,preoperatorios,i
235,S1134-009612700384,de,i
235,S1134-009612700384,creatinina,i
235,S1134-009612700384,superior,o
235,S1134-009612700384,a,o
235,S1134-009612700384,12,o
235,S1134-009612700384,mgdl,o
235,S1134-009612700384,Mientras,o
235,S1134-009612700384,que,o
235,S1134-009612700384,en,o
235,S1134-009612700384,los,o
235,S1134-009612700384,120,o
235,S1134-009612700384,pacientes,o
235,S1134-009612700384,mayores,o
235,S1134-009612700384,de,o
235,S1134-009612700384,75,o
235,S1134-009612700384,años,o
235,S1134-009612700384,no,o
235,S1134-009612700384,influyo,o
235,S1134-009612700384,en,o
235,S1134-009612700384,ninguna,o
235,S1134-009612700384,de,o
235,S1134-009612700384,las,o
235,S1134-009612700384,dos,o
235,S1134-009612700384,variables,o
235,S1134-009612700384,en,o
235,S1134-009612700384,los,o
235,S1134-009612700384,grupos,o
235,S1134-009612700384,tercero,o
235,S1134-009612700384,y,o
235,S1134-009612700384,cuarto,o
235,S1134-009612700384,si,o
235,S1134-009612700384,redujo,o
235,S1134-009612700384,los,o
235,S1134-009612700384,concentrados,i
235,S1134-009612700384,de,i
235,S1134-009612700384,hematies,i
235,S1134-009612700384,transfundidos,i
235,S1134-009612700384,CR,o
235,S1134-009612700384,111,o
235,S1134-009612700384,p,o
235,S1134-009612700384,0001,o
235,S1134-009612700384,y,o
235,S1134-009612700384,CR,o
235,S1134-009612700384,079,o
235,S1134-009612700384,p,o
235,S1134-009612700384,0017,o
235,S1134-009612700384,respectivamente,o
235,S1134-009612700384,sin,o
235,S1134-009612700384,disminuir,o
235,S1134-009612700384,el,o
235,S1134-009612700384,sangrado,i
235,S1134-009612700384,Conclusiones,o
235,S1134-009612700384,Mientras,o
235,S1134-009612700384,los,o
235,S1134-009612700384,pacientes,o
235,S1134-009612700384,con,o
235,S1134-009612700384,ir,o
235,S1134-009612700384,redujeron,o
235,S1134-009612700384,el,o
235,S1134-009612700384,sangrado,i
235,S1134-009612700384,postoperatorio,o
235,S1134-009612700384,y,o
235,S1134-009612700384,los,o
235,S1134-009612700384,concentrados,i
235,S1134-009612700384,de,i
235,S1134-009612700384,hematies,i
235,S1134-009612700384,transfundidos,i
235,S1134-009612700384,Los,o
235,S1134-009612700384,pacientes,o
235,S1134-009612700384,mayores,o
235,S1134-009612700384,de,o
235,S1134-009612700384,75,o
235,S1134-009612700384,años,o
235,S1134-009612700384,no,o
235,S1134-009612700384,se,o
235,S1134-009612700384,beneficiaron,o
235,S1134-009612700384,Los,o
235,S1134-009612700384,pacientes,o
235,S1134-009612700384,con,o
235,S1134-009612700384,menor,o
235,S1134-009612700384,SC,i
235,S1134-009612700384,y,o
235,S1134-009612700384,menor,o
235,S1134-009612700384,IMC,i
235,S1134-009612700384,redujeron,o
235,S1134-009612700384,los,o
235,S1134-009612700384,concentrados,i
235,S1134-009612700384,de,i
235,S1134-009612700384,hematies,i
235,S1134-009612700384,transfundidos,i
235,S1134-009612700384,sin,o
235,S1134-009612700384,disminuir,o
235,S1134-009612700384,el,o
235,S1134-009612700384,sangrado,i
235,S1134-009612700384,postoperatorio,o
235,S1134-009612700384,lo,o
235,S1134-009612700384,que,o
235,S1134-009612700384,posiblemente,o
235,S1134-009612700384,se,o
235,S1134-009612700384,deba,o
235,S1134-009612700384,a,o
235,S1134-009612700384,una,o
235,S1134-009612700384,menor,o
235,S1134-009612700384,hemodilucion,i
236,S1134-009612705120,Terapia,i
236,S1134-009612705120,Celular,i
236,S1134-009612705120,Durante,o
236,S1134-009612705120,la,o
236,S1134-009612705120,Revascularizacion,i
236,S1134-009612705120,Quirurgica,i
236,S1134-009612705120,en,o
236,S1134-009612705120,el,o
236,S1134-009612705120,Infarto,i
236,S1134-009612705120,Agudo,i
236,S1134-009612705120,de,i
236,S1134-009612705120,Miocardio,i
236,S1134-009612705120,Objetivos,o
236,S1134-009612705120,valorar,i
236,S1134-009612705120,la,i
236,S1134-009612705120,seguridad,i
236,S1134-009612705120,y,i
236,S1134-009612705120,la,i
236,S1134-009612705120,eficacia,i
236,S1134-009612705120,del,o
236,S1134-009612705120,implante,i
236,S1134-009612705120,de,i
236,S1134-009612705120,celulas,i
236,S1134-009612705120,madre,i
236,S1134-009612705120,mononucleadas,i
236,S1134-009612705120,autologas,o
236,S1134-009612705120,CMMA,o
236,S1134-009612705120,combinado,o
236,S1134-009612705120,con,o
236,S1134-009612705120,cirugia,i
236,S1134-009612705120,de,i
236,S1134-009612705120,revascularizacion,i
236,S1134-009612705120,coronaria,i
236,S1134-009612705120,en,o
236,S1134-009612705120,pacientes,o
236,S1134-009612705120,que,o
236,S1134-009612705120,han,o
236,S1134-009612705120,tenido,o
236,S1134-009612705120,un,o
236,S1134-009612705120,infarto,i
236,S1134-009612705120,agudo,i
236,S1134-009612705120,de,i
236,S1134-009612705120,miocardio,i
236,S1134-009612705120,Material,o
236,S1134-009612705120,y,o
236,S1134-009612705120,metodos,o
236,S1134-009612705120,ensayo,o
236,S1134-009612705120,clinico,o
236,S1134-009612705120,prospectivo,o
236,S1134-009612705120,aleatorizado,i
236,S1134-009612705120,controlado,o
236,S1134-009612705120,en,o
236,S1134-009612705120,el,o
236,S1134-009612705120,que,o
236,S1134-009612705120,se,o
236,S1134-009612705120,incluiran,o
236,S1134-009612705120,20,o
236,S1134-009612705120,pacientes,o
236,S1134-009612705120,Se,o
236,S1134-009612705120,han,o
236,S1134-009612705120,aleatorizado,i
236,S1134-009612705120,14,o
236,S1134-009612705120,pacientes,o
236,S1134-009612705120,con,o
236,S1134-009612705120,infarto,i
236,S1134-009612705120,agudo,i
236,S1134-009612705120,de,i
236,S1134-009612705120,miocardio,i
236,S1134-009612705120,e,o
236,S1134-009612705120,indicacion,o
236,S1134-009612705120,de,o
236,S1134-009612705120,cirugia,i
236,S1134-009612705120,a,o
236,S1134-009612705120,tratamiento,i
236,S1134-009612705120,de,i
236,S1134-009612705120,revascularizacion,i
236,S1134-009612705120,quirurgica,i
236,S1134-009612705120,e,o
236,S1134-009612705120,implante,i
236,S1134-009612705120,de,o
236,S1134-009612705120,CMMA,o
236,S1134-009612705120,en,o
236,S1134-009612705120,la,o
236,S1134-009612705120,zona,o
236,S1134-009612705120,periinfarto,o
236,S1134-009612705120,frente,o
236,S1134-009612705120,a,o
236,S1134-009612705120,cirugia,i
236,S1134-009612705120,aislada,i
236,S1134-009612705120,Las,o
236,S1134-009612705120,CMMA,o
236,S1134-009612705120,se,o
236,S1134-009612705120,obtuvieron,o
236,S1134-009612705120,con,o
236,S1134-009612705120,puncion,i
236,S1134-009612705120,de,i
236,S1134-009612705120,la,i
236,S1134-009612705120,medula,i
236,S1134-009612705120,osea,i
236,S1134-009612705120,y,o
236,S1134-009612705120,centrifugacion,i
236,S1134-009612705120,de,i
236,S1134-009612705120,Ficoll,i
236,S1134-009612705120,Se,o
236,S1134-009612705120,realizo,o
236,S1134-009612705120,una,o
236,S1134-009612705120,resonancia,i
236,S1134-009612705120,magnetica,i
236,S1134-009612705120,antes,o
236,S1134-009612705120,y,o
236,S1134-009612705120,9,o
236,S1134-009612705120,meses,o
236,S1134-009612705120,despues,o
236,S1134-009612705120,de,o
236,S1134-009612705120,la,o
236,S1134-009612705120,cirugia,i
236,S1134-009612705120,Se,o
236,S1134-009612705120,recogieron,o
236,S1134-009612705120,80,o
236,S1134-009612705120,variables,o
236,S1134-009612705120,en,o
236,S1134-009612705120,ambos,o
236,S1134-009612705120,grupos,o
236,S1134-009612705120,Resultados,o
236,S1134-009612705120,doce,o
236,S1134-009612705120,pacientes,o
236,S1134-009612705120,han,o
236,S1134-009612705120,finalizado,o
236,S1134-009612705120,el,o
236,S1134-009612705120,estudio,o
236,S1134-009612705120,Ambos,o
236,S1134-009612705120,grupos,o
236,S1134-009612705120,fueron,o
236,S1134-009612705120,homogeneos,o
236,S1134-009612705120,en,o
236,S1134-009612705120,las,o
236,S1134-009612705120,caracteristicas,o
236,S1134-009612705120,basales,o
236,S1134-009612705120,No,o
236,S1134-009612705120,hubo,o
236,S1134-009612705120,complicaciones,i
236,S1134-009612705120,relacionadas,o
236,S1134-009612705120,con,o
236,S1134-009612705120,el,o
236,S1134-009612705120,implante,i
236,S1134-009612705120,celular,i
236,S1134-009612705120,Los,o
236,S1134-009612705120,resultados,o
236,S1134-009612705120,se,o
236,S1134-009612705120,muestran,o
236,S1134-009612705120,en,o
236,S1134-009612705120,la,o
236,S1134-009612705120,tabla,o
236,S1134-009612705120,1,o
236,S1134-009612705120,Se,o
236,S1134-009612705120,han,o
236,S1134-009612705120,analizado,o
236,S1134-009612705120,los,o
236,S1134-009612705120,39,o
236,S1134-009612705120,segmentos,o
236,S1134-009612705120,infartados,i
236,S1134-009612705120,No,o
236,S1134-009612705120,se,o
236,S1134-009612705120,observaron,o
236,S1134-009612705120,diferencias,o
236,S1134-009612705120,estadisticamente,o
236,S1134-009612705120,significativas,o
236,S1134-009612705120,en,o
236,S1134-009612705120,la,o
236,S1134-009612705120,mejoria,o
236,S1134-009612705120,del,o
236,S1134-009612705120,indice,o
236,S1134-009612705120,de,o
236,S1134-009612705120,motilidad,o
236,S1134-009612705120,global,o
236,S1134-009612705120,ni,o
236,S1134-009612705120,de,o
236,S1134-009612705120,la,o
236,S1134-009612705120,fraccion,i
236,S1134-009612705120,de,i
236,S1134-009612705120,eyeccion,i
236,S1134-009612705120,pero,o
236,S1134-009612705120,si,o
236,S1134-009612705120,en,o
236,S1134-009612705120,la,o
236,S1134-009612705120,contractilidad,o
236,S1134-009612705120,regional,o
236,S1134-009612705120,grupo,o
236,S1134-009612705120,Ce,o
236,S1134-009612705120,065,o
236,S1134-009612705120,026,o
236,S1134-009612705120,vs,o
236,S1134-009612705120,grupo,o
236,S1134-009612705120,Co,o
236,S1134-009612705120,025,o
236,S1134-009612705120,029,o
236,S1134-009612705120,p,o
236,S1134-009612705120,0001,o
236,S1134-009612705120,Conclusiones,o
236,S1134-009612705120,el,o
236,S1134-009612705120,trasplante,i
236,S1134-009612705120,de,o
236,S1134-009612705120,CMMA,o
236,S1134-009612705120,puede,o
236,S1134-009612705120,llevarse,o
236,S1134-009612705120,a,o
236,S1134-009612705120,cabo,o
236,S1134-009612705120,de,o
236,S1134-009612705120,forma,o
236,S1134-009612705120,segura,o
236,S1134-009612705120,La,o
236,S1134-009612705120,mejoria,o
236,S1134-009612705120,en,o
236,S1134-009612705120,la,o
236,S1134-009612705120,contractilidad,o
236,S1134-009612705120,de,o
236,S1134-009612705120,los,o
236,S1134-009612705120,segmentos,o
236,S1134-009612705120,infartados,i
236,S1134-009612705120,es,o
236,S1134-009612705120,significativamente,o
236,S1134-009612705120,mayor,o
236,S1134-009612705120,con,o
236,S1134-009612705120,el,o
236,S1134-009612705120,implante,i
236,S1134-009612705120,de,i
236,S1134-009612705120,celulas,i
236,S1134-009612705120,madre,i
237,S1134-009615001680,Efecto,o
237,S1134-009615001680,del,o
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,en,o
237,S1134-009615001680,el,o
237,S1134-009615001680,fracaso,i
237,S1134-009615001680,renal,i
237,S1134-009615001680,agudo,i
237,S1134-009615001680,en,o
237,S1134-009615001680,pacientes,o
237,S1134-009615001680,de,o
237,S1134-009615001680,alto,o
237,S1134-009615001680,riesgo,o
237,S1134-009615001680,sometidos,o
237,S1134-009615001680,a,o
237,S1134-009615001680,cirugia,i
237,S1134-009615001680,cardiaca,i
237,S1134-009615001680,un,o
237,S1134-009615001680,ensayo,i
237,S1134-009615001680,clinico,i
237,S1134-009615001680,aleatorizado,i
237,S1134-009615001680,Importancia,o
237,S1134-009615001680,Actualmente,o
237,S1134-009615001680,no,o
237,S1134-009615001680,se,o
237,S1134-009615001680,han,o
237,S1134-009615001680,identificado,o
237,S1134-009615001680,intervenciones,i
237,S1134-009615001680,que,o
237,S1134-009615001680,logren,o
237,S1134-009615001680,reducir,o
237,S1134-009615001680,el,o
237,S1134-009615001680,riesgo,o
237,S1134-009615001680,de,o
237,S1134-009615001680,la,o
237,S1134-009615001680,insuficiencia,i
237,S1134-009615001680,renal,i
237,S1134-009615001680,aguda,i
237,S1134-009615001680,en,o
237,S1134-009615001680,el,o
237,S1134-009615001680,marco,o
237,S1134-009615001680,de,o
237,S1134-009615001680,la,o
237,S1134-009615001680,cirugia,i
237,S1134-009615001680,cardiaca,i
237,S1134-009615001680,Objetivo,o
237,S1134-009615001680,Determinar,o
237,S1134-009615001680,si,o
237,S1134-009615001680,el,o
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,reduce,o
237,S1134-009615001680,la,o
237,S1134-009615001680,incidencia,o
237,S1134-009615001680,y,o
237,S1134-009615001680,la,o
237,S1134-009615001680,gravedad,o
237,S1134-009615001680,de,o
237,S1134-009615001680,la,o
237,S1134-009615001680,insuficiencia,i
237,S1134-009615001680,renal,i
237,S1134-009615001680,aguda,i
237,S1134-009615001680,en,o
237,S1134-009615001680,pacientes,o
237,S1134-009615001680,sometidos,o
237,S1134-009615001680,a,o
237,S1134-009615001680,cirugia,i
237,S1134-009615001680,cardiaca,i
237,S1134-009615001680,Diseño,o
237,S1134-009615001680,Estudio,i
237,S1134-009615001680,multicentrico,i
237,S1134-009615001680,aleatorizado,i
237,S1134-009615001680,de,o
237,S1134-009615001680,240,o
237,S1134-009615001680,pacientes,o
237,S1134-009615001680,seleccionados,o
237,S1134-009615001680,entre,o
237,S1134-009615001680,agosto,o
237,S1134-009615001680,de,o
237,S1134-009615001680,2013,o
237,S1134-009615001680,y,o
237,S1134-009615001680,junio,o
237,S1134-009615001680,de,o
237,S1134-009615001680,2014,o
237,S1134-009615001680,en,o
237,S1134-009615001680,4,o
237,S1134-009615001680,hospitales,o
237,S1134-009615001680,en,o
237,S1134-009615001680,Alemania,o
237,S1134-009615001680,con,o
237,S1134-009615001680,alto,o
237,S1134-009615001680,riesgo,o
237,S1134-009615001680,de,o
237,S1134-009615001680,desarrollar,o
237,S1134-009615001680,insuficiencia,i
237,S1134-009615001680,renal,i
237,S1134-009615001680,aguda,i
237,S1134-009615001680,segun,o
237,S1134-009615001680,el,o
237,S1134-009615001680,score,o
237,S1134-009615001680,de,o
237,S1134-009615001680,la,o
237,S1134-009615001680,Cleveland,o
237,S1134-009615001680,Clinic,o
237,S1134-009615001680,Foundation,o
237,S1134-009615001680,con,o
237,S1134-009615001680,una,o
237,S1134-009615001680,puntuacion,o
237,S1134-009615001680,6,o
237,S1134-009615001680,o,o
237,S1134-009615001680,superior,o
237,S1134-009615001680,Los,o
237,S1134-009615001680,pacientes,o
237,S1134-009615001680,fueron,o
237,S1134-009615001680,asignados,i
237,S1134-009615001680,de,i
237,S1134-009615001680,forma,i
237,S1134-009615001680,aleatorizada,i
237,S1134-009615001680,a,o
237,S1134-009615001680,recibir,o
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,o,o
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,simulado,i
237,S1134-009615001680,sham,o
237,S1134-009615001680,Todos,o
237,S1134-009615001680,los,o
237,S1134-009615001680,pacientes,o
237,S1134-009615001680,completaron,o
237,S1134-009615001680,el,o
237,S1134-009615001680,seguimiento,i
237,S1134-009615001680,a,o
237,S1134-009615001680,30,o
237,S1134-009615001680,dias,o
237,S1134-009615001680,despues,o
237,S1134-009615001680,de,o
237,S1134-009615001680,la,o
237,S1134-009615001680,cirugia,i
237,S1134-009615001680,y,o
237,S1134-009615001680,se,o
237,S1134-009615001680,analizaron,i
237,S1134-009615001680,de,i
237,S1134-009615001680,acuerdo,i
237,S1134-009615001680,con,i
237,S1134-009615001680,el,i
237,S1134-009615001680,principio,i
237,S1134-009615001680,de,i
237,S1134-009615001680,intencion,i
237,S1134-009615001680,de,i
237,S1134-009615001680,tratar,i
237,S1134-009615001680,Intervenciones,i
237,S1134-009615001680,Los,o
237,S1134-009615001680,pacientes,o
237,S1134-009615001680,recibieron,o
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,3,o
237,S1134-009615001680,ciclos,o
237,S1134-009615001680,de,o
237,S1134-009615001680,5,o
237,S1134-009615001680,min,o
237,S1134-009615001680,de,o
237,S1134-009615001680,isquemia,i
237,S1134-009615001680,y,o
237,S1134-009615001680,5,o
237,S1134-009615001680,min,o
237,S1134-009615001680,de,o
237,S1134-009615001680,reperfusion,i
237,S1134-009615001680,en,i
237,S1134-009615001680,un,i
237,S1134-009615001680,brazo,i
237,S1134-009615001680,despues,o
237,S1134-009615001680,de,o
237,S1134-009615001680,la,o
237,S1134-009615001680,induccion,i
237,S1134-009615001680,anestesica,i
237,S1134-009615001680,o,o
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,simulado,i
237,S1134-009615001680,sham,o
237,S1134-009615001680,ambos,o
237,S1134-009615001680,a,o
237,S1134-009615001680,traves,o
237,S1134-009615001680,de,o
237,S1134-009615001680,un,o
237,S1134-009615001680,manguito,o
237,S1134-009615001680,de,o
237,S1134-009615001680,presion,o
237,S1134-009615001680,Principales,o
237,S1134-009615001680,resultados,o
237,S1134-009615001680,y,o
237,S1134-009615001680,medidas,o
237,S1134-009615001680,El,o
237,S1134-009615001680,objetivo,o
237,S1134-009615001680,principal,o
237,S1134-009615001680,fue,o
237,S1134-009615001680,determinar,o
237,S1134-009615001680,la,o
237,S1134-009615001680,incidencia,o
237,S1134-009615001680,de,o
237,S1134-009615001680,insuficiencia,i
237,S1134-009615001680,renal,i
237,S1134-009615001680,aguda,i
237,S1134-009615001680,definida,o
237,S1134-009615001680,por,o
237,S1134-009615001680,los,o
237,S1134-009615001680,criterios,o
237,S1134-009615001680,Kidney,o
237,S1134-009615001680,Disease,o
237,S1134-009615001680,Improving,o
237,S1134-009615001680,Global,o
237,S1134-009615001680,Outcomes,o
237,S1134-009615001680,en,o
237,S1134-009615001680,las,o
237,S1134-009615001680,primeras,o
237,S1134-009615001680,72,o
237,S1134-009615001680,h,o
237,S1134-009615001680,tras,o
237,S1134-009615001680,cirugia,i
237,S1134-009615001680,cardiaca,i
237,S1134-009615001680,Los,o
237,S1134-009615001680,objetivos,o
237,S1134-009615001680,secundarios,o
237,S1134-009615001680,incluyeron,o
237,S1134-009615001680,el,o
237,S1134-009615001680,uso,o
237,S1134-009615001680,de,o
237,S1134-009615001680,terapia,i
237,S1134-009615001680,de,i
237,S1134-009615001680,reemplazo,i
237,S1134-009615001680,renal,i
237,S1134-009615001680,la,o
237,S1134-009615001680,duracion,o
237,S1134-009615001680,de,o
237,S1134-009615001680,la,o
237,S1134-009615001680,estancia,o
237,S1134-009615001680,en,o
237,S1134-009615001680,la,o
237,S1134-009615001680,unidad,o
237,S1134-009615001680,de,o
237,S1134-009615001680,cuidados,o
237,S1134-009615001680,intensivos,o
237,S1134-009615001680,la,o
237,S1134-009615001680,aparicion,o
237,S1134-009615001680,de,o
237,S1134-009615001680,infarto,i
237,S1134-009615001680,de,i
237,S1134-009615001680,miocardio,i
237,S1134-009615001680,y,o
237,S1134-009615001680,accidente,i
237,S1134-009615001680,cerebrovascular,i
237,S1134-009615001680,la,o
237,S1134-009615001680,mortalidad,o
237,S1134-009615001680,hospitalaria,o
237,S1134-009615001680,y,o
237,S1134-009615001680,a,o
237,S1134-009615001680,los,o
237,S1134-009615001680,30,o
237,S1134-009615001680,dias,o
237,S1134-009615001680,y,o
237,S1134-009615001680,los,o
237,S1134-009615001680,cambios,o
237,S1134-009615001680,evolutivos,o
237,S1134-009615001680,en,o
237,S1134-009615001680,los,o
237,S1134-009615001680,biomarcadores,o
237,S1134-009615001680,de,o
237,S1134-009615001680,lesion,i
237,S1134-009615001680,renal,i
237,S1134-009615001680,aguda,i
237,S1134-009615001680,Resultados,o
237,S1134-009615001680,La,o
237,S1134-009615001680,insuficiencia,i
237,S1134-009615001680,renal,i
237,S1134-009615001680,aguda,i
237,S1134-009615001680,se,o
237,S1134-009615001680,redujo,o
237,S1134-009615001680,significativamente,o
237,S1134-009615001680,con,o
237,S1134-009615001680,el,o
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,45,o
237,S1134-009615001680,de,o
237,S1134-009615001680,120,o
237,S1134-009615001680,pacientes,o
237,S1134-009615001680,375,o
237,S1134-009615001680,en,o
237,S1134-009615001680,comparacion,o
237,S1134-009615001680,con,o
237,S1134-009615001680,el,o
237,S1134-009615001680,control,o
237,S1134-009615001680,63,o
237,S1134-009615001680,de,o
237,S1134-009615001680,120,o
237,S1134-009615001680,pacientes,o
237,S1134-009615001680,525,o
237,S1134-009615001680,reduccion,o
237,S1134-009615001680,absoluta,o
237,S1134-009615001680,de,o
237,S1134-009615001680,riesgo,o
237,S1134-009615001680,15,o
237,S1134-009615001680,IC,o
237,S1134-009615001680,95,o
237,S1134-009615001680,2562744,o
237,S1134-009615001680,p,o
237,S1134-009615001680,002,o
237,S1134-009615001680,Los,o
237,S1134-009615001680,pacientes,o
237,S1134-009615001680,que,o
237,S1134-009615001680,recibieron,o
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,presentaron,o
237,S1134-009615001680,menor,o
237,S1134-009615001680,necesidad,o
237,S1134-009615001680,de,o
237,S1134-009615001680,terapia,i
237,S1134-009615001680,de,i
237,S1134-009615001680,reemplazo,i
237,S1134-009615001680,renal,i
237,S1134-009615001680,7,o
237,S1134-009615001680,58,o
237,S1134-009615001680,frente,o
237,S1134-009615001680,a,o
237,S1134-009615001680,19,o
237,S1134-009615001680,158,o
237,S1134-009615001680,reduccion,o
237,S1134-009615001680,absoluta,o
237,S1134-009615001680,de,o
237,S1134-009615001680,riesgo,o
237,S1134-009615001680,10,o
237,S1134-009615001680,IC,o
237,S1134-009615001680,95,o
237,S1134-009615001680,2251775,o
237,S1134-009615001680,p,o
237,S1134-009615001680,001,o
237,S1134-009615001680,y,o
237,S1134-009615001680,redujo,o
237,S1134-009615001680,la,o
237,S1134-009615001680,estancia,o
237,S1134-009615001680,en,o
237,S1134-009615001680,la,o
237,S1134-009615001680,unidad,o
237,S1134-009615001680,de,o
237,S1134-009615001680,cuidados,o
237,S1134-009615001680,intensivos,o
237,S1134-009615001680,3,o
237,S1134-009615001680,dias,o
237,S1134-009615001680,rango,o
237,S1134-009615001680,intercuartilico,o
237,S1134-009615001680,25,o
237,S1134-009615001680,vs,o
237,S1134-009615001680,4,o
237,S1134-009615001680,dias,o
237,S1134-009615001680,rango,o
237,S1134-009615001680,intercuartilico,o
237,S1134-009615001680,27,o
237,S1134-009615001680,p,o
237,S1134-009615001680,004,o
237,S1134-009615001680,No,o
237,S1134-009615001680,se,o
237,S1134-009615001680,observo,o
237,S1134-009615001680,un,o
237,S1134-009615001680,efecto,o
237,S1134-009615001680,significativo,o
237,S1134-009615001680,del,o
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,sobre,o
237,S1134-009615001680,la,o
237,S1134-009615001680,incidencia,o
237,S1134-009615001680,de,o
237,S1134-009615001680,infarto,i
237,S1134-009615001680,de,i
237,S1134-009615001680,miocardio,i
237,S1134-009615001680,accidente,i
237,S1134-009615001680,cerebrovascular,i
237,S1134-009615001680,o,o
237,S1134-009615001680,mortalidad,o
237,S1134-009615001680,El,o
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,redujo,o
237,S1134-009615001680,significativamente,o
237,S1134-009615001680,la,o
237,S1134-009615001680,liberacion,o
237,S1134-009615001680,de,o
237,S1134-009615001680,IGFBP7,i
237,S1134-009615001680,y,o
237,S1134-009615001680,TIMP2,o
237,S1134-009615001680,despues,o
237,S1134-009615001680,de,o
237,S1134-009615001680,la,o
237,S1134-009615001680,cirugia,i
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,036,o
237,S1134-009615001680,vs,o
237,S1134-009615001680,control,o
237,S1134-009615001680,097,o
237,S1134-009615001680,ngml,o
237,S1134-009615001680,21000,o
237,S1134-009615001680,diferencia,o
237,S1134-009615001680,061,o
237,S1134-009615001680,IC,o
237,S1134-009615001680,95,o
237,S1134-009615001680,027086,o
237,S1134-009615001680,p,o
237,S1134-009615001680,0001,o
237,S1134-009615001680,No,o
237,S1134-009615001680,se,o
237,S1134-009615001680,informaron,o
237,S1134-009615001680,efectos,i
237,S1134-009615001680,adversos,i
237,S1134-009615001680,con,o
237,S1134-009615001680,el,o
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,Conclusiones,o
237,S1134-009615001680,Entre,o
237,S1134-009615001680,los,o
237,S1134-009615001680,pacientes,o
237,S1134-009615001680,de,o
237,S1134-009615001680,alto,o
237,S1134-009615001680,riesgo,o
237,S1134-009615001680,sometidos,o
237,S1134-009615001680,a,o
237,S1134-009615001680,cirugia,i
237,S1134-009615001680,cardiaca,i
237,S1134-009615001680,el,o
237,S1134-009615001680,precondicionamiento,i
237,S1134-009615001680,isquemico,i
237,S1134-009615001680,remoto,i
237,S1134-009615001680,redujo,o
237,S1134-009615001680,significativamente,o
237,S1134-009615001680,la,o
237,S1134-009615001680,incidencia,o
237,S1134-009615001680,de,o
237,S1134-009615001680,insuficiencia,i
237,S1134-009615001680,renal,i
237,S1134-009615001680,aguda,i
237,S1134-009615001680,y,o
237,S1134-009615001680,la,o
237,S1134-009615001680,necesidad,o
237,S1134-009615001680,de,o
237,S1134-009615001680,terapia,i
237,S1134-009615001680,de,i
237,S1134-009615001680,reemplazo,i
237,S1134-009615001680,renal,i
238,S1134-009615002090,Estudio,o
238,S1134-009615002090,EPRICS,o
238,S1134-009615002090,con,o
238,S1134-009615002090,eritropoyetina,i
238,S1134-009615002090,otro,o
238,S1134-009615002090,intento,o
238,S1134-009615002090,fallido,o
238,S1134-009615002090,para,o
238,S1134-009615002090,evitar,o
238,S1134-009615002090,el,o
238,S1134-009615002090,daño,i
238,S1134-009615002090,renal,i
238,S1134-009615002090,poscirugia,o
238,S1134-009615002090,cardiaca,i
238,S1134-009615002090,Antecedentes,o
238,S1134-009615002090,No,o
238,S1134-009615002090,existen,o
238,S1134-009615002090,metodos,o
238,S1134-009615002090,adecuados,o
238,S1134-009615002090,para,o
238,S1134-009615002090,evitar,o
238,S1134-009615002090,el,o
238,S1134-009615002090,fracaso,i
238,S1134-009615002090,renal,i
238,S1134-009615002090,agudo,i
238,S1134-009615002090,FRA,i
238,S1134-009615002090,tras,o
238,S1134-009615002090,cirugia,i
238,S1134-009615002090,cardiaca,i
238,S1134-009615002090,La,o
238,S1134-009615002090,eritropoyetina,i
238,S1134-009615002090,recombinante,i
238,S1134-009615002090,rHuEPO,i
238,S1134-009615002090,a,o
238,S1134-009615002090,dosis,o
238,S1134-009615002090,altas,o
238,S1134-009615002090,ha,o
238,S1134-009615002090,demostrado,o
238,S1134-009615002090,efectos,o
238,S1134-009615002090,pleiotropicos,o
238,S1134-009615002090,que,o
238,S1134-009615002090,ofrecen,o
238,S1134-009615002090,proteccion,o
238,S1134-009615002090,tisular,i
238,S1134-009615002090,Se,o
238,S1134-009615002090,pretende,o
238,S1134-009615002090,confirmar,o
238,S1134-009615002090,estos,o
238,S1134-009615002090,efectos,o
238,S1134-009615002090,en,o
238,S1134-009615002090,un,o
238,S1134-009615002090,entorno,o
238,S1134-009615002090,clinico,o
238,S1134-009615002090,en,o
238,S1134-009615002090,pacientes,o
238,S1134-009615002090,de,o
238,S1134-009615002090,alto,o
238,S1134-009615002090,riesgo,o
238,S1134-009615002090,sometidos,o
238,S1134-009615002090,a,o
238,S1134-009615002090,cirugia,i
238,S1134-009615002090,de,i
238,S1134-009615002090,bypass,i
238,S1134-009615002090,coronario,i
238,S1134-009615002090,CABG,i
238,S1134-009615002090,Diseño,o
238,S1134-009615002090,Se,o
238,S1134-009615002090,trata,o
238,S1134-009615002090,de,o
238,S1134-009615002090,un,o
238,S1134-009615002090,ensayo,o
238,S1134-009615002090,clinico,o
238,S1134-009615002090,controlado,o
238,S1134-009615002090,aleatorizado,o
238,S1134-009615002090,doble,o
238,S1134-009615002090,ciego,o
238,S1134-009615002090,y,o
238,S1134-009615002090,unicentrico,o
238,S1134-009615002090,Intervencion,i
238,S1134-009615002090,Los,o
238,S1134-009615002090,pacientes,o
238,S1134-009615002090,se,o
238,S1134-009615002090,asignaron,i
238,S1134-009615002090,aleatoriamente,i
238,S1134-009615002090,a,o
238,S1134-009615002090,recibir,o
238,S1134-009615002090,una,o
238,S1134-009615002090,dosis,o
238,S1134-009615002090,unica,o
238,S1134-009615002090,y,o
238,S1134-009615002090,alta,o
238,S1134-009615002090,de,o
238,S1134-009615002090,rHuEPO,i
238,S1134-009615002090,Retacrit,i
238,S1134-009615002090,HospiraNordic,o
238,S1134-009615002090,AB,o
238,S1134-009615002090,Suecia,o
238,S1134-009615002090,400,o
238,S1134-009615002090,UIkg,o
238,S1134-009615002090,por,o
238,S1134-009615002090,via,o
238,S1134-009615002090,IV,o
238,S1134-009615002090,o,o
238,S1134-009615002090,un,o
238,S1134-009615002090,placebo,i
238,S1134-009615002090,La,o
238,S1134-009615002090,tecnica,i
238,S1134-009615002090,quirurgica,i
238,S1134-009615002090,y,o
238,S1134-009615002090,resto,o
238,S1134-009615002090,de,o
238,S1134-009615002090,cuidados,i
238,S1134-009615002090,fueron,o
238,S1134-009615002090,similares,o
238,S1134-009615002090,en,o
238,S1134-009615002090,ambos,o
238,S1134-009615002090,grupos,o
238,S1134-009615002090,Se,o
238,S1134-009615002090,incluyen,o
238,S1134-009615002090,75,o
238,S1134-009615002090,pacientes,o
238,S1134-009615002090,con,o
238,S1134-009615002090,enfermedad,i
238,S1134-009615002090,renal,i
238,S1134-009615002090,cronica,i
238,S1134-009615002090,previa,o
238,S1134-009615002090,FGe,i
238,S1134-009615002090,entre,o
238,S1134-009615002090,15,o
238,S1134-009615002090,y,o
238,S1134-009615002090,60,o
238,S1134-009615002090,mlmin173,o
238,S1134-009615002090,m2,o
238,S1134-009615002090,ERC,i
238,S1134-009615002090,estadio,o
238,S1134-009615002090,3A4,o
238,S1134-009615002090,programados,o
238,S1134-009615002090,para,o
238,S1134-009615002090,CABG,i
238,S1134-009615002090,Resultados,o
238,S1134-009615002090,Como,o
238,S1134-009615002090,evento,o
238,S1134-009615002090,primario,o
238,S1134-009615002090,se,o
238,S1134-009615002090,evaluo,o
238,S1134-009615002090,el,o
238,S1134-009615002090,cambio,o
238,S1134-009615002090,de,o
238,S1134-009615002090,los,o
238,S1134-009615002090,niveles,i
238,S1134-009615002090,de,i
238,S1134-009615002090,cistatina,i
238,S1134-009615002090,C,i
238,S1134-009615002090,plasmatica,i
238,S1134-009615002090,al,o
238,S1134-009615002090,tercer,o
238,S1134-009615002090,dia,o
238,S1134-009615002090,poscirugia,o
238,S1134-009615002090,No,o
238,S1134-009615002090,se,o
238,S1134-009615002090,encontraron,o
238,S1134-009615002090,diferencias,o
238,S1134-009615002090,entre,o
238,S1134-009615002090,el,o
238,S1134-009615002090,grupo,o
238,S1134-009615002090,de,o
238,S1134-009615002090,intervencion,i
238,S1134-009615002090,y,o
238,S1134-009615002090,control,o
238,S1134-009615002090,131,o
238,S1134-009615002090,31,o
238,S1134-009615002090,vs,o
238,S1134-009615002090,125,o
238,S1134-009615002090,24,o
238,S1134-009615002090,p,o
238,S1134-009615002090,031,o
238,S1134-009615002090,IC,o
238,S1134-009615002090,95,o
238,S1134-009615002090,para,o
238,S1134-009615002090,la,o
238,S1134-009615002090,diferencia,o
238,S1134-009615002090,06,o
238,S1134-009615002090,a,o
238,S1134-009615002090,20,o
238,S1134-009615002090,Tampoco,o
238,S1134-009615002090,se,o
238,S1134-009615002090,hallaron,o
238,S1134-009615002090,diferencias,o
238,S1134-009615002090,en,o
238,S1134-009615002090,otros,o
238,S1134-009615002090,marcadores,o
238,S1134-009615002090,de,o
238,S1134-009615002090,daño,i
238,S1134-009615002090,renal,i
238,S1134-009615002090,como,o
238,S1134-009615002090,NGAL,i
238,S1134-009615002090,creatinina,i
238,S1134-009615002090,o,o
238,S1134-009615002090,urea,i
238,S1134-009615002090,plasmaticas,i
238,S1134-009615002090,o,o
238,S1134-009615002090,filtrado,i
238,S1134-009615002090,glomerular,i
238,S1134-009615002090,estimado,i
238,S1134-009615002090,asi,o
238,S1134-009615002090,como,o
238,S1134-009615002090,tampoco,o
238,S1134-009615002090,en,o
238,S1134-009615002090,mortalidad,o
238,S1134-009615002090,necesidad,o
238,S1134-009615002090,de,o
238,S1134-009615002090,dialisis,i
238,S1134-009615002090,o,o
238,S1134-009615002090,incidencia,o
238,S1134-009615002090,de,o
238,S1134-009615002090,FRA,i
238,S1134-009615002090,estratificado,o
238,S1134-009615002090,segun,o
238,S1134-009615002090,la,o
238,S1134-009615002090,escala,o
238,S1134-009615002090,RIFLE,o
238,S1134-009615002090,La,o
238,S1134-009615002090,intervencion,i
238,S1134-009615002090,no,o
238,S1134-009615002090,se,o
238,S1134-009615002090,asocio,o
238,S1134-009615002090,con,o
238,S1134-009615002090,eventos,i
238,S1134-009615002090,adversos,i
238,S1134-009615002090,atribuibles,i
238,S1134-009615002090,al,i
238,S1134-009615002090,farmaco,i
238,S1134-009615002090,Conclusion,o
238,S1134-009615002090,La,o
238,S1134-009615002090,intervencion,i
238,S1134-009615002090,con,o
238,S1134-009615002090,una,o
238,S1134-009615002090,dosis,o
238,S1134-009615002090,unica,o
238,S1134-009615002090,de,o
238,S1134-009615002090,eritropoyetina,i
238,S1134-009615002090,recombinante,i
238,S1134-009615002090,humana,i
238,S1134-009615002090,rHuEPO,i
238,S1134-009615002090,400,o
238,S1134-009615002090,UIkg,o
238,S1134-009615002090,por,o
238,S1134-009615002090,via,o
238,S1134-009615002090,IV,o
238,S1134-009615002090,no,o
238,S1134-009615002090,es,o
238,S1134-009615002090,eficaz,o
238,S1134-009615002090,para,o
238,S1134-009615002090,prevenir,i
238,S1134-009615002090,el,o
238,S1134-009615002090,daño,i
238,S1134-009615002090,renal,i
238,S1134-009615002090,tras,o
238,S1134-009615002090,cirugia,i
238,S1134-009615002090,de,i
238,S1134-009615002090,CABG,i
238,S1134-009615002090,en,o
238,S1134-009615002090,pacientes,o
238,S1134-009615002090,con,o
238,S1134-009615002090,daño,i
238,S1134-009615002090,renal,i
238,S1134-009615002090,prequirurgico,o
239,S1134-00961630047X,Metilprednisolona,i
239,S1134-00961630047X,en,o
239,S1134-00961630047X,pacientes,o
239,S1134-00961630047X,sometidos,o
239,S1134-00961630047X,a,o
239,S1134-00961630047X,bypass,i
239,S1134-00961630047X,cardiopulmonar,i
239,S1134-00961630047X,Estudio,o
239,S1134-00961630047X,SIRS,o
239,S1134-00961630047X,estudio,i
239,S1134-00961630047X,doble,i
239,S1134-00961630047X,ciego,i
239,S1134-00961630047X,randomizado,i
239,S1134-00961630047X,Introduccion,o
239,S1134-00961630047X,El,o
239,S1134-00961630047X,bypass,i
239,S1134-00961630047X,cardiopulmonar,i
239,S1134-00961630047X,con,o
239,S1134-00961630047X,circulacion,i
239,S1134-00961630047X,extracorporea,i
239,S1134-00961630047X,desencadena,o
239,S1134-00961630047X,el,o
239,S1134-00961630047X,sindrome,i
239,S1134-00961630047X,de,i
239,S1134-00961630047X,respuesta,i
239,S1134-00961630047X,inflamatoria,i
239,S1134-00961630047X,sistemica,i
239,S1134-00961630047X,que,o
239,S1134-00961630047X,esta,o
239,S1134-00961630047X,asociado,o
239,S1134-00961630047X,a,o
239,S1134-00961630047X,un,o
239,S1134-00961630047X,aumento,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,morbimortalidad,o
239,S1134-00961630047X,postoperatoria,o
239,S1134-00961630047X,Los,o
239,S1134-00961630047X,corticoides,i
239,S1134-00961630047X,suprimen,o
239,S1134-00961630047X,esta,o
239,S1134-00961630047X,respuesta,o
239,S1134-00961630047X,inflamatoria,i
239,S1134-00961630047X,y,o
239,S1134-00961630047X,podrian,o
239,S1134-00961630047X,mejorar,o
239,S1134-00961630047X,los,o
239,S1134-00961630047X,resultados,o
239,S1134-00961630047X,en,o
239,S1134-00961630047X,pacientes,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,alto,o
239,S1134-00961630047X,riesgo,o
239,S1134-00961630047X,sometidos,o
239,S1134-00961630047X,a,o
239,S1134-00961630047X,cirugia,i
239,S1134-00961630047X,cardiaca,i
239,S1134-00961630047X,El,o
239,S1134-00961630047X,estudio,o
239,S1134-00961630047X,tiene,o
239,S1134-00961630047X,como,o
239,S1134-00961630047X,objetivo,o
239,S1134-00961630047X,evaluar,o
239,S1134-00961630047X,los,o
239,S1134-00961630047X,efectos,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,los,o
239,S1134-00961630047X,esteroides,i
239,S1134-00961630047X,en,o
239,S1134-00961630047X,los,o
239,S1134-00961630047X,pacientes,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,alto,o
239,S1134-00961630047X,riesgo,o
239,S1134-00961630047X,sometidos,o
239,S1134-00961630047X,a,o
239,S1134-00961630047X,cirugia,i
239,S1134-00961630047X,de,i
239,S1134-00961630047X,bypass,i
239,S1134-00961630047X,cardiopulmonar,i
239,S1134-00961630047X,Metodos,o
239,S1134-00961630047X,El,o
239,S1134-00961630047X,estudio,o
239,S1134-00961630047X,Steroids,o
239,S1134-00961630047X,In,o
239,S1134-00961630047X,Cardiac,o
239,S1134-00961630047X,Surgery,o
239,S1134-00961630047X,SIRS,o
239,S1134-00961630047X,es,o
239,S1134-00961630047X,un,o
239,S1134-00961630047X,ensayo,o
239,S1134-00961630047X,randomizado,o
239,S1134-00961630047X,controlado,o
239,S1134-00961630047X,y,o
239,S1134-00961630047X,doble,o
239,S1134-00961630047X,ciego,o
239,S1134-00961630047X,en,o
239,S1134-00961630047X,el,o
239,S1134-00961630047X,que,o
239,S1134-00961630047X,se,o
239,S1134-00961630047X,incluyen,o
239,S1134-00961630047X,a,o
239,S1134-00961630047X,pacientes,o
239,S1134-00961630047X,con,o
239,S1134-00961630047X,alto,o
239,S1134-00961630047X,riesgo,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,morbimortalidad,o
239,S1134-00961630047X,procedentes,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,80,o
239,S1134-00961630047X,hospitales,o
239,S1134-00961630047X,o,o
239,S1134-00961630047X,centros,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,cirugia,i
239,S1134-00961630047X,cardiaca,i
239,S1134-00961630047X,de,o
239,S1134-00961630047X,18,o
239,S1134-00961630047X,paises,o
239,S1134-00961630047X,sometidos,o
239,S1134-00961630047X,a,o
239,S1134-00961630047X,cirugia,i
239,S1134-00961630047X,con,i
239,S1134-00961630047X,bypass,i
239,S1134-00961630047X,cardiopulmonar,i
239,S1134-00961630047X,y,o
239,S1134-00961630047X,que,o
239,S1134-00961630047X,reciben,o
239,S1134-00961630047X,metilprednisolona,i
239,S1134-00961630047X,250,o
239,S1134-00961630047X,mg,o
239,S1134-00961630047X,en,o
239,S1134-00961630047X,induccion,i
239,S1134-00961630047X,anestesica,i
239,S1134-00961630047X,y,o
239,S1134-00961630047X,250,o
239,S1134-00961630047X,mg,o
239,S1134-00961630047X,al,o
239,S1134-00961630047X,comienzo,o
239,S1134-00961630047X,del,o
239,S1134-00961630047X,bypass,i
239,S1134-00961630047X,o,o
239,S1134-00961630047X,placebo,i
239,S1134-00961630047X,Se,o
239,S1134-00961630047X,excluyen,o
239,S1134-00961630047X,a,o
239,S1134-00961630047X,los,o
239,S1134-00961630047X,pacientes,o
239,S1134-00961630047X,consumidores,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,corticoides,i
239,S1134-00961630047X,de,o
239,S1134-00961630047X,forma,o
239,S1134-00961630047X,cronica,o
239,S1134-00961630047X,o,o
239,S1134-00961630047X,los,o
239,S1134-00961630047X,que,o
239,S1134-00961630047X,se,o
239,S1134-00961630047X,prevea,o
239,S1134-00961630047X,que,o
239,S1134-00961630047X,recibiran,o
239,S1134-00961630047X,tratamiento,i
239,S1134-00961630047X,con,i
239,S1134-00961630047X,corticoides,i
239,S1134-00961630047X,sistemicos,i
239,S1134-00961630047X,en,o
239,S1134-00961630047X,el,o
239,S1134-00961630047X,postoperatorio,o
239,S1134-00961630047X,inmediato,o
239,S1134-00961630047X,Se,o
239,S1134-00961630047X,excluyen,o
239,S1134-00961630047X,a,o
239,S1134-00961630047X,su,o
239,S1134-00961630047X,vez,o
239,S1134-00961630047X,los,o
239,S1134-00961630047X,pacientes,o
239,S1134-00961630047X,con,o
239,S1134-00961630047X,antecedentes,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,infeccion,i
239,S1134-00961630047X,bacteriana,i
239,S1134-00961630047X,o,i
239,S1134-00961630047X,fungica,i
239,S1134-00961630047X,los,o
239,S1134-00961630047X,30,o
239,S1134-00961630047X,dias,o
239,S1134-00961630047X,previos,o
239,S1134-00961630047X,a,o
239,S1134-00961630047X,la,o
239,S1134-00961630047X,cirugia,i
239,S1134-00961630047X,Se,o
239,S1134-00961630047X,analiza,o
239,S1134-00961630047X,como,o
239,S1134-00961630047X,variable,o
239,S1134-00961630047X,principal,o
239,S1134-00961630047X,la,o
239,S1134-00961630047X,mortalidad,o
239,S1134-00961630047X,a,o
239,S1134-00961630047X,los,o
239,S1134-00961630047X,30,o
239,S1134-00961630047X,dias,o
239,S1134-00961630047X,y,o
239,S1134-00961630047X,la,o
239,S1134-00961630047X,combinacion,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,mortalidad,o
239,S1134-00961630047X,yo,o
239,S1134-00961630047X,enfermedad,i
239,S1134-00961630047X,grave,o
239,S1134-00961630047X,ambas,o
239,S1134-00961630047X,analizadas,i
239,S1134-00961630047X,por,i
239,S1134-00961630047X,intencion,i
239,S1134-00961630047X,de,i
239,S1134-00961630047X,tratar,i
239,S1134-00961630047X,Hallazgos,o
239,S1134-00961630047X,Siete,o
239,S1134-00961630047X,mil,o
239,S1134-00961630047X,quinientos,o
239,S1134-00961630047X,siete,o
239,S1134-00961630047X,pacientes,o
239,S1134-00961630047X,n,o
239,S1134-00961630047X,3755,o
239,S1134-00961630047X,metilprednisolona,i
239,S1134-00961630047X,y,o
239,S1134-00961630047X,n,o
239,S1134-00961630047X,3752,o
239,S1134-00961630047X,placebo,i
239,S1134-00961630047X,reclutados,o
239,S1134-00961630047X,entre,o
239,S1134-00961630047X,el,o
239,S1134-00961630047X,21,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,junio,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,2007,o
239,S1134-00961630047X,hasta,o
239,S1134-00961630047X,el,o
239,S1134-00961630047X,19,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,diciembre,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,2013,o
239,S1134-00961630047X,La,o
239,S1134-00961630047X,metilprednisolona,i
239,S1134-00961630047X,comparada,o
239,S1134-00961630047X,con,o
239,S1134-00961630047X,placebo,i
239,S1134-00961630047X,no,o
239,S1134-00961630047X,reduce,o
239,S1134-00961630047X,el,o
239,S1134-00961630047X,riesgo,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,muerte,i
239,S1134-00961630047X,a,o
239,S1134-00961630047X,los,o
239,S1134-00961630047X,30,o
239,S1134-00961630047X,dias,o
239,S1134-00961630047X,ni,o
239,S1134-00961630047X,la,o
239,S1134-00961630047X,mortalidad,o
239,S1134-00961630047X,o,o
239,S1134-00961630047X,patologia,i
239,S1134-00961630047X,grave,o
239,S1134-00961630047X,Interpretacion,o
239,S1134-00961630047X,El,o
239,S1134-00961630047X,estudio,o
239,S1134-00961630047X,SIRS,o
239,S1134-00961630047X,no,o
239,S1134-00961630047X,recomienda,o
239,S1134-00961630047X,el,o
239,S1134-00961630047X,uso,o
239,S1134-00961630047X,rutinario,o
239,S1134-00961630047X,de,o
239,S1134-00961630047X,metilprednisolona,i
239,S1134-00961630047X,en,o
239,S1134-00961630047X,pacientes,o
239,S1134-00961630047X,sometidos,o
239,S1134-00961630047X,a,o
239,S1134-00961630047X,bypass,i
239,S1134-00961630047X,cardiopulmonar,i
240,S1134-009616300663,Mejora,o
240,S1134-009616300663,de,o
240,S1134-009616300663,la,o
240,S1134-009616300663,morbilidad,o
240,S1134-009616300663,postoperatoria,o
240,S1134-009616300663,en,o
240,S1134-009616300663,recambio,i
240,S1134-009616300663,valvular,i
240,S1134-009616300663,aortico,i
240,S1134-009616300663,aislado,i
240,S1134-009616300663,con,i
240,S1134-009616300663,miniesternotomia,i
240,S1134-009616300663,estudio,i
240,S1134-009616300663,pareado,i
240,S1134-009616300663,por,o
240,S1134-009616300663,puntuacion,o
240,S1134-009616300663,de,o
240,S1134-009616300663,propension,o
240,S1134-009616300663,Fundamento,o
240,S1134-009616300663,La,o
240,S1134-009616300663,cirugia,i
240,S1134-009616300663,valvular,i
240,S1134-009616300663,aortica,i
240,S1134-009616300663,aislada,i
240,S1134-009616300663,minimamente,i
240,S1134-009616300663,invasiva,i
240,S1134-009616300663,mediante,i
240,S1134-009616300663,miniesternotomia,i
240,S1134-009616300663,superior,i
240,S1134-009616300663,se,o
240,S1134-009616300663,esta,o
240,S1134-009616300663,generalizando,o
240,S1134-009616300663,debido,o
240,S1134-009616300663,a,o
240,S1134-009616300663,ventajas,o
240,S1134-009616300663,respecto,o
240,S1134-009616300663,a,o
240,S1134-009616300663,la,o
240,S1134-009616300663,cirugia,i
240,S1134-009616300663,convencional,i
240,S1134-009616300663,Analizamos,o
240,S1134-009616300663,los,o
240,S1134-009616300663,resultados,o
240,S1134-009616300663,a,o
240,S1134-009616300663,2,o
240,S1134-009616300663,años,o
240,S1134-009616300663,en,o
240,S1134-009616300663,nuestro,o
240,S1134-009616300663,centro,o
240,S1134-009616300663,tras,o
240,S1134-009616300663,la,o
240,S1134-009616300663,implementacion,o
240,S1134-009616300663,de,o
240,S1134-009616300663,la,o
240,S1134-009616300663,tecnica,o
240,S1134-009616300663,en,o
240,S1134-009616300663,noviembre,o
240,S1134-009616300663,del,o
240,S1134-009616300663,2013,o
240,S1134-009616300663,Metodos,o
240,S1134-009616300663,Estudio,i
240,S1134-009616300663,observacional,i
240,S1134-009616300663,analitico,i
240,S1134-009616300663,retrospectivo,i
240,S1134-009616300663,de,o
240,S1134-009616300663,92,o
240,S1134-009616300663,pacientes,o
240,S1134-009616300663,consecutivos,o
240,S1134-009616300663,intervenidos,i
240,S1134-009616300663,de,o
240,S1134-009616300663,sustitucion,i
240,S1134-009616300663,valvular,i
240,S1134-009616300663,aortica,i
240,S1134-009616300663,aislada,o
240,S1134-009616300663,por,o
240,S1134-009616300663,estenosis,i
240,S1134-009616300663,aortica,i
240,S1134-009616300663,severa,o
240,S1134-009616300663,desde,o
240,S1134-009616300663,noviembre,o
240,S1134-009616300663,del,o
240,S1134-009616300663,2013,o
240,S1134-009616300663,Se,o
240,S1134-009616300663,obtuvieron,o
240,S1134-009616300663,2,o
240,S1134-009616300663,grupos,o
240,S1134-009616300663,grupo,o
240,S1134-009616300663,miniesternotomia,i
240,S1134-009616300663,y,o
240,S1134-009616300663,grupo,o
240,S1134-009616300663,convencional,o
240,S1134-009616300663,de,o
240,S1134-009616300663,40,o
240,S1134-009616300663,pacientes,o
240,S1134-009616300663,mediante,o
240,S1134-009616300663,puntuacion,o
240,S1134-009616300663,de,o
240,S1134-009616300663,propension,o
240,S1134-009616300663,para,o
240,S1134-009616300663,su,o
240,S1134-009616300663,comparacion,o
240,S1134-009616300663,objetivo,o
240,S1134-009616300663,primario,o
240,S1134-009616300663,compuesto,o
240,S1134-009616300663,de,o
240,S1134-009616300663,6,o
240,S1134-009616300663,complicaciones,i
240,S1134-009616300663,cardiacas,i
240,S1134-009616300663,y,i
240,S1134-009616300663,cerebrovasculares,i
240,S1134-009616300663,mayores,o
240,S1134-009616300663,y,o
240,S1134-009616300663,secundarios,o
240,S1134-009616300663,como,o
240,S1134-009616300663,tiempos,o
240,S1134-009616300663,de,o
240,S1134-009616300663,circulacion,i
240,S1134-009616300663,extracorporea,i
240,S1134-009616300663,e,o
240,S1134-009616300663,isquemia,i
240,S1134-009616300663,tiempo,o
240,S1134-009616300663,intubacion,i
240,S1134-009616300663,sangrado,i
240,S1134-009616300663,en,o
240,S1134-009616300663,24,o
240,S1134-009616300663,h,o
240,S1134-009616300663,transfusiones,i
240,S1134-009616300663,y,o
240,S1134-009616300663,supervivencia,o
240,S1134-009616300663,Resultados,o
240,S1134-009616300663,La,o
240,S1134-009616300663,mediana,o
240,S1134-009616300663,de,o
240,S1134-009616300663,los,o
240,S1134-009616300663,tiempos,o
240,S1134-009616300663,de,o
240,S1134-009616300663,circulacion,i
240,S1134-009616300663,extracorporea,i
240,S1134-009616300663,e,o
240,S1134-009616300663,isquemia,i
240,S1134-009616300663,fueron,o
240,S1134-009616300663,15,o
240,S1134-009616300663,y,o
240,S1134-009616300663,10,o
240,S1134-009616300663,min,o
240,S1134-009616300663,mas,o
240,S1134-009616300663,largos,o
240,S1134-009616300663,en,o
240,S1134-009616300663,el,o
240,S1134-009616300663,grupo,o
240,S1134-009616300663,miniesternotomia,i
240,S1134-009616300663,89,o
240,S1134-009616300663,75110,o
240,S1134-009616300663,y,o
240,S1134-009616300663,74,o
240,S1134-009616300663,6490,o
240,S1134-009616300663,vs,o
240,S1134-009616300663,convencional,o
240,S1134-009616300663,65,o
240,S1134-009616300663,5573,o
240,S1134-009616300663,y,o
240,S1134-009616300663,55,o
240,S1134-009616300663,4763,o
240,S1134-009616300663,min,o
240,S1134-009616300663,respectivamente,o
240,S1134-009616300663,p,o
240,S1134-009616300663,0001,o
240,S1134-009616300663,El,o
240,S1134-009616300663,grupo,o
240,S1134-009616300663,miniesternotomia,i
240,S1134-009616300663,presento,o
240,S1134-009616300663,menores,o
240,S1134-009616300663,complicaciones,i
240,S1134-009616300663,mayores,o
240,S1134-009616300663,125,o
240,S1134-009616300663,vs,o
240,S1134-009616300663,30,o
240,S1134-009616300663,convencional,o
240,S1134-009616300663,p,o
240,S1134-009616300663,005,o
240,S1134-009616300663,odds,o
240,S1134-009616300663,ratio,o
240,S1134-009616300663,032,o
240,S1134-009616300663,intervalo,o
240,S1134-009616300663,de,o
240,S1134-009616300663,confianza,o
240,S1134-009616300663,del,o
240,S1134-009616300663,95,o
240,S1134-009616300663,009093,o
240,S1134-009616300663,menor,o
240,S1134-009616300663,sangrado,i
240,S1134-009616300663,en,o
240,S1134-009616300663,las,o
240,S1134-009616300663,primeras,o
240,S1134-009616300663,24,o
240,S1134-009616300663,h,o
240,S1134-009616300663,304,o
240,S1134-009616300663,150,o
240,S1134-009616300663,vs,o
240,S1134-009616300663,506,o
240,S1134-009616300663,300,o
240,S1134-009616300663,ml,o
240,S1134-009616300663,p,o
240,S1134-009616300663,0001,o
240,S1134-009616300663,y,o
240,S1134-009616300663,menores,o
240,S1134-009616300663,necesidades,i
240,S1134-009616300663,transfusionales,i
240,S1134-009616300663,08,o
240,S1134-009616300663,02,o
240,S1134-009616300663,vs,o
240,S1134-009616300663,16,o
240,S1134-009616300663,03,o
240,S1134-009616300663,concentrados,o
240,S1134-009616300663,de,o
240,S1134-009616300663,hematiespaciente,o
240,S1134-009616300663,p,o
240,S1134-009616300663,004,o
240,S1134-009616300663,No,o
240,S1134-009616300663,existieron,o
240,S1134-009616300663,diferencias,o
240,S1134-009616300663,en,o
240,S1134-009616300663,tiempo,o
240,S1134-009616300663,de,o
240,S1134-009616300663,intubacion,i
240,S1134-009616300663,estancia,o
240,S1134-009616300663,hospitalaria,o
240,S1134-009616300663,mortalidad,o
240,S1134-009616300663,ni,o
240,S1134-009616300663,supervivencia,o
240,S1134-009616300663,Conclusiones,o
240,S1134-009616300663,La,o
240,S1134-009616300663,sustitucion,i
240,S1134-009616300663,valvular,i
240,S1134-009616300663,aortica,i
240,S1134-009616300663,aislada,i
240,S1134-009616300663,por,i
240,S1134-009616300663,miniesternotomia,i
240,S1134-009616300663,presenta,o
240,S1134-009616300663,una,o
240,S1134-009616300663,reduccion,o
240,S1134-009616300663,de,o
240,S1134-009616300663,la,o
240,S1134-009616300663,morbimortalidad,o
240,S1134-009616300663,lo,o
240,S1134-009616300663,que,o
240,S1134-009616300663,recomendaria,o
240,S1134-009616300663,su,o
240,S1134-009616300663,utilizacion,o
240,S1134-009616300663,frente,o
240,S1134-009616300663,a,o
240,S1134-009616300663,la,o
240,S1134-009616300663,cirugia,i
240,S1134-009616300663,convencional,i
240,S1134-009616300663,siempre,o
240,S1134-009616300663,que,o
240,S1134-009616300663,sea,o
240,S1134-009616300663,factible,o
240,S1134-009616300663,Son,o
240,S1134-009616300663,precisos,o
240,S1134-009616300663,nuevos,o
240,S1134-009616300663,ensayos,i
240,S1134-009616300663,clinicos,i
240,S1134-009616300663,para,o
240,S1134-009616300663,confirmar,o
240,S1134-009616300663,estos,o
240,S1134-009616300663,datos,o
241,S1134-009617301249,Reparacion,i
241,S1134-009617301249,de,o
241,S1134-009617301249,la,o
241,S1134-009617301249,insuficiencia,i
241,S1134-009617301249,mitral,i
241,S1134-009617301249,funcional,i
241,S1134-009617301249,mediante,o
241,S1134-009617301249,abordaje,o
241,S1134-009617301249,del,o
241,S1134-009617301249,aparato,i
241,S1134-009617301249,subvalvular,i
241,S1134-009617301249,Resultados,o
241,S1134-009617301249,a,o
241,S1134-009617301249,medio,o
241,S1134-009617301249,plazo,o
241,S1134-009617301249,Introduccion,o
241,S1134-009617301249,y,o
241,S1134-009617301249,objetivos,o
241,S1134-009617301249,El,o
241,S1134-009617301249,tratamiento,i
241,S1134-009617301249,quirurgico,i
241,S1134-009617301249,de,o
241,S1134-009617301249,la,o
241,S1134-009617301249,insuficiencia,i
241,S1134-009617301249,mitral,i
241,S1134-009617301249,funcional,i
241,S1134-009617301249,continua,o
241,S1134-009617301249,siendo,o
241,S1134-009617301249,objeto,o
241,S1134-009617301249,de,o
241,S1134-009617301249,amplio,o
241,S1134-009617301249,debate,o
241,S1134-009617301249,dada,o
241,S1134-009617301249,su,o
241,S1134-009617301249,elevada,o
241,S1134-009617301249,morbimortalidad,o
241,S1134-009617301249,y,o
241,S1134-009617301249,la,o
241,S1134-009617301249,ausencia,o
241,S1134-009617301249,de,o
241,S1134-009617301249,consenso,o
241,S1134-009617301249,acerca,o
241,S1134-009617301249,de,o
241,S1134-009617301249,la,o
241,S1134-009617301249,mejor,o
241,S1134-009617301249,opcion,o
241,S1134-009617301249,terapeutica,o
241,S1134-009617301249,reparacion,i
241,S1134-009617301249,vs,o
241,S1134-009617301249,sustitucion,i
241,S1134-009617301249,Presentamos,o
241,S1134-009617301249,nuestra,o
241,S1134-009617301249,experiencia,o
241,S1134-009617301249,a,o
241,S1134-009617301249,medio,o
241,S1134-009617301249,plazo,o
241,S1134-009617301249,en,o
241,S1134-009617301249,su,o
241,S1134-009617301249,tratamiento,i
241,S1134-009617301249,mediante,o
241,S1134-009617301249,reparacion,i
241,S1134-009617301249,valvular,i
241,S1134-009617301249,con,o
241,S1134-009617301249,abordaje,o
241,S1134-009617301249,del,o
241,S1134-009617301249,aparato,i
241,S1134-009617301249,subvalvular,i
241,S1134-009617301249,Metodos,o
241,S1134-009617301249,Entre,o
241,S1134-009617301249,los,o
241,S1134-009617301249,años,o
241,S1134-009617301249,2012,o
241,S1134-009617301249,y,o
241,S1134-009617301249,2016,o
241,S1134-009617301249,se,o
241,S1134-009617301249,intervino,i
241,S1134-009617301249,en,o
241,S1134-009617301249,nuestro,o
241,S1134-009617301249,centro,o
241,S1134-009617301249,a,o
241,S1134-009617301249,un,o
241,S1134-009617301249,total,o
241,S1134-009617301249,de,o
241,S1134-009617301249,16,o
241,S1134-009617301249,pacientes,o
241,S1134-009617301249,con,o
241,S1134-009617301249,insuficiencia,i
241,S1134-009617301249,mitral,i
241,S1134-009617301249,de,o
241,S1134-009617301249,mecanismo,o
241,S1134-009617301249,iiib,o
241,S1134-009617301249,de,o
241,S1134-009617301249,Carpentier,o
241,S1134-009617301249,con,o
241,S1134-009617301249,un,o
241,S1134-009617301249,EuroSCORE,i
241,S1134-009617301249,logistico,o
241,S1134-009617301249,medio,o
241,S1134-009617301249,del,o
241,S1134-009617301249,1081,o
241,S1134-009617301249,En,o
241,S1134-009617301249,todos,o
241,S1134-009617301249,ellos,o
241,S1134-009617301249,se,o
241,S1134-009617301249,llevo,o
241,S1134-009617301249,a,o
241,S1134-009617301249,cabo,o
241,S1134-009617301249,una,o
241,S1134-009617301249,anuloplastia,i
241,S1134-009617301249,mitral,i
241,S1134-009617301249,restrictiva,o
241,S1134-009617301249,junto,o
241,S1134-009617301249,con,o
241,S1134-009617301249,reposicionamiento,i
241,S1134-009617301249,del,i
241,S1134-009617301249,musculo,i
241,S1134-009617301249,papilar,i
241,S1134-009617301249,posteromedial,i
241,S1134-009617301249,en,o
241,S1134-009617301249,14,o
241,S1134-009617301249,casos,o
241,S1134-009617301249,y,o
241,S1134-009617301249,reaproximacion,i
241,S1134-009617301249,de,i
241,S1134-009617301249,los,i
241,S1134-009617301249,musculos,i
241,S1134-009617301249,papilares,i
241,S1134-009617301249,en,o
241,S1134-009617301249,2,o
241,S1134-009617301249,casos,o
241,S1134-009617301249,En,o
241,S1134-009617301249,12,o
241,S1134-009617301249,pacientes,o
241,S1134-009617301249,se,o
241,S1134-009617301249,llevo,o
241,S1134-009617301249,a,o
241,S1134-009617301249,cabo,o
241,S1134-009617301249,otro,o
241,S1134-009617301249,procedimiento,i
241,S1134-009617301249,asociado,o
241,S1134-009617301249,Resultados,o
241,S1134-009617301249,El,o
241,S1134-009617301249,tiempo,o
241,S1134-009617301249,de,o
241,S1134-009617301249,seguimiento,i
241,S1134-009617301249,medio,o
241,S1134-009617301249,fue,o
241,S1134-009617301249,de,o
241,S1134-009617301249,295,o
241,S1134-009617301249,meses,o
241,S1134-009617301249,Hubo,o
241,S1134-009617301249,2,o
241,S1134-009617301249,muertes,i
241,S1134-009617301249,perioperatorias,i
241,S1134-009617301249,No,o
241,S1134-009617301249,hubo,o
241,S1134-009617301249,mas,o
241,S1134-009617301249,fallecimientos,i
241,S1134-009617301249,durante,o
241,S1134-009617301249,el,o
241,S1134-009617301249,seguimiento,i
241,S1134-009617301249,La,o
241,S1134-009617301249,recurrencia,o
241,S1134-009617301249,de,o
241,S1134-009617301249,insuficiencia,i
241,S1134-009617301249,mitral,i
241,S1134-009617301249,2,o
241,S1134-009617301249,fue,o
241,S1134-009617301249,del,o
241,S1134-009617301249,125,o
241,S1134-009617301249,2,o
241,S1134-009617301249,pacientes,o
241,S1134-009617301249,Unicamente,o
241,S1134-009617301249,los,o
241,S1134-009617301249,2,o
241,S1134-009617301249,pacientes,o
241,S1134-009617301249,con,o
241,S1134-009617301249,insuficiencia,i
241,S1134-009617301249,mitral,i
241,S1134-009617301249,2,o
241,S1134-009617301249,reingresaron,i
241,S1134-009617301249,en,o
241,S1134-009617301249,algun,o
241,S1134-009617301249,momento,o
241,S1134-009617301249,del,o
241,S1134-009617301249,seguimiento,i
241,S1134-009617301249,por,o
241,S1134-009617301249,insuficiencia,i
241,S1134-009617301249,cardiaca,i
241,S1134-009617301249,permaneciendo,o
241,S1134-009617301249,el,o
241,S1134-009617301249,resto,o
241,S1134-009617301249,en,o
241,S1134-009617301249,clase,o
241,S1134-009617301249,funcional,o
241,S1134-009617301249,iiiiv,o
241,S1134-009617301249,Conclusiones,o
241,S1134-009617301249,El,o
241,S1134-009617301249,abordaje,o
241,S1134-009617301249,del,o
241,S1134-009617301249,aparato,i
241,S1134-009617301249,subvalvular,i
241,S1134-009617301249,en,o
241,S1134-009617301249,la,o
241,S1134-009617301249,reparacion,i
241,S1134-009617301249,de,o
241,S1134-009617301249,la,o
241,S1134-009617301249,insuficiencia,i
241,S1134-009617301249,mitral,i
241,S1134-009617301249,funcional,i
241,S1134-009617301249,se,o
241,S1134-009617301249,presenta,o
241,S1134-009617301249,como,o
241,S1134-009617301249,una,o
241,S1134-009617301249,alternativa,o
241,S1134-009617301249,valida,o
241,S1134-009617301249,en,o
241,S1134-009617301249,el,o
241,S1134-009617301249,tratamiento,i
241,S1134-009617301249,de,o
241,S1134-009617301249,este,o
241,S1134-009617301249,tipo,o
241,S1134-009617301249,de,o
241,S1134-009617301249,insuficiencia,i
241,S1134-009617301249,ofreciendo,o
241,S1134-009617301249,buenos,o
241,S1134-009617301249,resultados,o
241,S1134-009617301249,en,o
241,S1134-009617301249,lo,o
241,S1134-009617301249,que,o
241,S1134-009617301249,a,o
241,S1134-009617301249,evolucion,o
241,S1134-009617301249,postoperatoria,o
241,S1134-009617301249,y,o
241,S1134-009617301249,tasa,o
241,S1134-009617301249,de,o
241,S1134-009617301249,recidiva,o
241,S1134-009617301249,a,o
241,S1134-009617301249,medio,o
241,S1134-009617301249,plazo,o
241,S1134-009617301249,se,o
241,S1134-009617301249,refiere,o
242,S1134-009617302140,Manejo,o
242,S1134-009617302140,de,o
242,S1134-009617302140,la,o
242,S1134-009617302140,hipertension,i
242,S1134-009617302140,pulmonar,i
242,S1134-009617302140,tromboembolica,i
242,S1134-009617302140,cronica,i
242,S1134-009617302140,Experiencia,o
242,S1134-009617302140,de,o
242,S1134-009617302140,un,o
242,S1134-009617302140,centro,o
242,S1134-009617302140,de,o
242,S1134-009617302140,referencia,o
242,S1134-009617302140,nacional,o
242,S1134-009617302140,Introduccion,o
242,S1134-009617302140,La,o
242,S1134-009617302140,tromboendarterectomia,i
242,S1134-009617302140,pulmonar,i
242,S1134-009617302140,es,o
242,S1134-009617302140,el,o
242,S1134-009617302140,tratamiento,i
242,S1134-009617302140,de,i
242,S1134-009617302140,eleccion,i
242,S1134-009617302140,y,o
242,S1134-009617302140,potencialmente,o
242,S1134-009617302140,curativo,o
242,S1134-009617302140,de,o
242,S1134-009617302140,la,o
242,S1134-009617302140,hipertension,i
242,S1134-009617302140,pulmonar,i
242,S1134-009617302140,tromboembolica,i
242,S1134-009617302140,cronica,i
242,S1134-009617302140,el,o
242,S1134-009617302140,tratamiento,i
242,S1134-009617302140,medico,i
242,S1134-009617302140,quedaria,o
242,S1134-009617302140,limitado,o
242,S1134-009617302140,a,o
242,S1134-009617302140,los,o
242,S1134-009617302140,pacientes,o
242,S1134-009617302140,considerados,o
242,S1134-009617302140,inoperables,o
242,S1134-009617302140,Este,o
242,S1134-009617302140,estudio,o
242,S1134-009617302140,evalua,o
242,S1134-009617302140,los,o
242,S1134-009617302140,resultados,o
242,S1134-009617302140,a,o
242,S1134-009617302140,largo,o
242,S1134-009617302140,plazo,o
242,S1134-009617302140,con,o
242,S1134-009617302140,ambos,o
242,S1134-009617302140,tratamientos,i
242,S1134-009617302140,en,o
242,S1134-009617302140,una,o
242,S1134-009617302140,Unidad,o
242,S1134-009617302140,de,o
242,S1134-009617302140,Referencia,o
242,S1134-009617302140,Nacional,o
242,S1134-009617302140,Metodos,o
242,S1134-009617302140,Desde,o
242,S1134-009617302140,febrero,o
242,S1134-009617302140,de,o
242,S1134-009617302140,1996,o
242,S1134-009617302140,hasta,o
242,S1134-009617302140,diciembre,o
242,S1134-009617302140,del,o
242,S1134-009617302140,2015,o
242,S1134-009617302140,se,o
242,S1134-009617302140,ha,o
242,S1134-009617302140,valorado,o
242,S1134-009617302140,a,o
242,S1134-009617302140,292,o
242,S1134-009617302140,pacientes,o
242,S1134-009617302140,intervenido,i
242,S1134-009617302140,142,o
242,S1134-009617302140,grupo,o
242,S1134-009617302140,1,o
242,S1134-009617302140,y,o
242,S1134-009617302140,considerado,o
242,S1134-009617302140,inoperables,o
242,S1134-009617302140,116,o
242,S1134-009617302140,grupo,o
242,S1134-009617302140,2,o
242,S1134-009617302140,El,o
242,S1134-009617302140,seguimiento,i
242,S1134-009617302140,finalizo,o
242,S1134-009617302140,en,o
242,S1134-009617302140,diciembre,o
242,S1134-009617302140,del,o
242,S1134-009617302140,2016,o
242,S1134-009617302140,Resultados,o
242,S1134-009617302140,La,o
242,S1134-009617302140,supervivencia,o
242,S1134-009617302140,a,o
242,S1134-009617302140,los,o
242,S1134-009617302140,3,o
242,S1134-009617302140,años,o
242,S1134-009617302140,fue,o
242,S1134-009617302140,del,o
242,S1134-009617302140,92,o
242,S1134-009617302140,en,o
242,S1134-009617302140,el,o
242,S1134-009617302140,grupo,o
242,S1134-009617302140,1,o
242,S1134-009617302140,y,o
242,S1134-009617302140,del,o
242,S1134-009617302140,86,o
242,S1134-009617302140,en,o
242,S1134-009617302140,el,o
242,S1134-009617302140,grupo,o
242,S1134-009617302140,2,o
242,S1134-009617302140,a,o
242,S1134-009617302140,los,o
242,S1134-009617302140,5,o
242,S1134-009617302140,años,o
242,S1134-009617302140,el,o
242,S1134-009617302140,91,o
242,S1134-009617302140,y,o
242,S1134-009617302140,el,o
242,S1134-009617302140,78,o
242,S1134-009617302140,respectivamente,o
242,S1134-009617302140,p,o
242,S1134-009617302140,0001,o
242,S1134-009617302140,En,o
242,S1134-009617302140,el,o
242,S1134-009617302140,analisis,o
242,S1134-009617302140,multivariante,o
242,S1134-009617302140,la,o
242,S1134-009617302140,supervivencia,o
242,S1134-009617302140,en,o
242,S1134-009617302140,ambos,o
242,S1134-009617302140,grupos,o
242,S1134-009617302140,estuvo,o
242,S1134-009617302140,relacionada,o
242,S1134-009617302140,con,o
242,S1134-009617302140,la,o
242,S1134-009617302140,tromboendarterectomia,i
242,S1134-009617302140,HR,o
242,S1134-009617302140,037,o
242,S1134-009617302140,IC,o
242,S1134-009617302140,del,o
242,S1134-009617302140,95,o
242,S1134-009617302140,019072,o
242,S1134-009617302140,p,o
242,S1134-009617302140,0003,o
242,S1134-009617302140,el,o
242,S1134-009617302140,antecedente,o
242,S1134-009617302140,de,o
242,S1134-009617302140,embolia,i
242,S1134-009617302140,aguda,i
242,S1134-009617302140,de,i
242,S1134-009617302140,pulmon,i
242,S1134-009617302140,HR,o
242,S1134-009617302140,050,o
242,S1134-009617302140,IC,o
242,S1134-009617302140,del,o
242,S1134-009617302140,95,o
242,S1134-009617302140,027092,o
242,S1134-009617302140,p,o
242,S1134-009617302140,0026,o
242,S1134-009617302140,el,o
242,S1134-009617302140,test,i
242,S1134-009617302140,de,i
242,S1134-009617302140,la,i
242,S1134-009617302140,marcha,i
242,S1134-009617302140,de,i
242,S1134-009617302140,6,i
242,S1134-009617302140,min,i
242,S1134-009617302140,HR,o
242,S1134-009617302140,079,o
242,S1134-009617302140,IC,o
242,S1134-009617302140,del,o
242,S1134-009617302140,95,o
242,S1134-009617302140,073085,o
242,S1134-009617302140,p,o
242,S1134-009617302140,0001,o
242,S1134-009617302140,la,o
242,S1134-009617302140,historia,o
242,S1134-009617302140,de,o
242,S1134-009617302140,cancer,i
242,S1134-009617302140,HR,o
242,S1134-009617302140,257,o
242,S1134-009617302140,IC,o
242,S1134-009617302140,del,o
242,S1134-009617302140,95,o
242,S1134-009617302140,122543,o
242,S1134-009617302140,p,o
242,S1134-009617302140,0013,o
242,S1134-009617302140,y,o
242,S1134-009617302140,las,o
242,S1134-009617302140,resistencias,i
242,S1134-009617302140,vasculares,i
242,S1134-009617302140,pulmonares,i
242,S1134-009617302140,HR,o
242,S1134-009617302140,119,o
242,S1134-009617302140,IC,o
242,S1134-009617302140,del,o
242,S1134-009617302140,95,o
242,S1134-009617302140,102139,o
242,S1134-009617302140,p,o
242,S1134-009617302140,0024,o
242,S1134-009617302140,En,o
242,S1134-009617302140,el,o
242,S1134-009617302140,grupo,o
242,S1134-009617302140,1,o
242,S1134-009617302140,la,o
242,S1134-009617302140,supervivencia,o
242,S1134-009617302140,se,o
242,S1134-009617302140,relaciono,o
242,S1134-009617302140,con,o
242,S1134-009617302140,el,o
242,S1134-009617302140,test,i
242,S1134-009617302140,de,i
242,S1134-009617302140,6,i
242,S1134-009617302140,min,i
242,S1134-009617302140,HR,o
242,S1134-009617302140,084,o
242,S1134-009617302140,IC,o
242,S1134-009617302140,del,o
242,S1134-009617302140,95,o
242,S1134-009617302140,079096,o
242,S1134-009617302140,p,o
242,S1134-009617302140,0009,o
242,S1134-009617302140,y,o
242,S1134-009617302140,el,o
242,S1134-009617302140,gasto,i
242,S1134-009617302140,cardiaco,i
242,S1134-009617302140,HR,o
242,S1134-009617302140,061,o
242,S1134-009617302140,IC,o
242,S1134-009617302140,del,o
242,S1134-009617302140,95,o
242,S1134-009617302140,039096,o
242,S1134-009617302140,p,o
242,S1134-009617302140,0033,o
242,S1134-009617302140,en,o
242,S1134-009617302140,el,o
242,S1134-009617302140,grupo,o
242,S1134-009617302140,2,o
242,S1134-009617302140,unicamente,o
242,S1134-009617302140,con,o
242,S1134-009617302140,el,o
242,S1134-009617302140,test,i
242,S1134-009617302140,de,i
242,S1134-009617302140,6,i
242,S1134-009617302140,min,i
242,S1134-009617302140,HR,o
242,S1134-009617302140,081,o
242,S1134-009617302140,IC,o
242,S1134-009617302140,del,o
242,S1134-009617302140,95,o
242,S1134-009617302140,071092,o
242,S1134-009617302140,p,o
242,S1134-009617302140,0001,o
242,S1134-009617302140,Conclusiones,o
242,S1134-009617302140,Los,o
242,S1134-009617302140,pacientes,o
242,S1134-009617302140,con,o
242,S1134-009617302140,hipertension,i
242,S1134-009617302140,pulmonar,i
242,S1134-009617302140,tromboembolica,i
242,S1134-009617302140,cronica,i
242,S1134-009617302140,intervenidos,i
242,S1134-009617302140,con,o
242,S1134-009617302140,tromboendarterectomia,i
242,S1134-009617302140,tienen,o
242,S1134-009617302140,una,o
242,S1134-009617302140,supervivencia,o
242,S1134-009617302140,excelente,o
242,S1134-009617302140,y,o
242,S1134-009617302140,significativamente,o
242,S1134-009617302140,superior,o
242,S1134-009617302140,a,o
242,S1134-009617302140,la,o
242,S1134-009617302140,de,o
242,S1134-009617302140,los,o
242,S1134-009617302140,pacientes,o
242,S1134-009617302140,tratados,i
242,S1134-009617302140,medicamente,i
242,S1134-009617302140,En,o
242,S1134-009617302140,la,o
242,S1134-009617302140,presente,o
242,S1134-009617302140,serie,o
242,S1134-009617302140,la,o
242,S1134-009617302140,tromboendarterectomia,i
242,S1134-009617302140,es,o
242,S1134-009617302140,el,o
242,S1134-009617302140,factor,o
242,S1134-009617302140,predictor,o
242,S1134-009617302140,de,o
242,S1134-009617302140,supervivencia,o
242,S1134-009617302140,mas,o
242,S1134-009617302140,importante,o
243,S1134-80462006000300002,Ketamina,i
243,S1134-80462006000300002,epidural,o
243,S1134-80462006000300002,en,o
243,S1134-80462006000300002,cirugia,i
243,S1134-80462006000300002,de,i
243,S1134-80462006000300002,hemiabdomen,i
243,S1134-80462006000300002,inferior,i
243,S1134-80462006000300002,Introduccion,o
243,S1134-80462006000300002,La,o
243,S1134-80462006000300002,ketamina,i
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,uso,o
243,S1134-80462006000300002,corriente,o
243,S1134-80462006000300002,es,o
243,S1134-80462006000300002,una,o
243,S1134-80462006000300002,droga,i
243,S1134-80462006000300002,utilizada,o
243,S1134-80462006000300002,principalmente,o
243,S1134-80462006000300002,para,o
243,S1134-80462006000300002,la,o
243,S1134-80462006000300002,induccion,i
243,S1134-80462006000300002,y,i
243,S1134-80462006000300002,el,i
243,S1134-80462006000300002,mantenimiento,i
243,S1134-80462006000300002,de,i
243,S1134-80462006000300002,la,i
243,S1134-80462006000300002,anestesia,i
243,S1134-80462006000300002,compuesta,o
243,S1134-80462006000300002,por,o
243,S1134-80462006000300002,una,o
243,S1134-80462006000300002,mezcla,o
243,S1134-80462006000300002,racemica,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,enantiomeros,i
243,S1134-80462006000300002,R,o
243,S1134-80462006000300002,y,o
243,S1134-80462006000300002,S,o
243,S1134-80462006000300002,En,o
243,S1134-80462006000300002,la,o
243,S1134-80462006000300002,decada,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,los,o
243,S1134-80462006000300002,años,o
243,S1134-80462006000300002,80,o
243,S1134-80462006000300002,comienza,o
243,S1134-80462006000300002,la,o
243,S1134-80462006000300002,administracion,i
243,S1134-80462006000300002,humana,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,la,o
243,S1134-80462006000300002,ketamina,i
243,S1134-80462006000300002,por,o
243,S1134-80462006000300002,via,o
243,S1134-80462006000300002,epidural,o
243,S1134-80462006000300002,A,o
243,S1134-80462006000300002,partir,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,entonces,o
243,S1134-80462006000300002,se,o
243,S1134-80462006000300002,han,o
243,S1134-80462006000300002,presentado,o
243,S1134-80462006000300002,disimiles,o
243,S1134-80462006000300002,investigaciones,o
243,S1134-80462006000300002,para,o
243,S1134-80462006000300002,justificar,o
243,S1134-80462006000300002,su,o
243,S1134-80462006000300002,accion,o
243,S1134-80462006000300002,analgesica,o
243,S1134-80462006000300002,en,o
243,S1134-80462006000300002,este,o
243,S1134-80462006000300002,espacio,o
243,S1134-80462006000300002,con,o
243,S1134-80462006000300002,varias,o
243,S1134-80462006000300002,hipotesis,o
243,S1134-80462006000300002,1,o
243,S1134-80462006000300002,supresion,o
243,S1134-80462006000300002,especifica,o
243,S1134-80462006000300002,laminar,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,las,o
243,S1134-80462006000300002,astas,i
243,S1134-80462006000300002,dorsales,i
243,S1134-80462006000300002,2,o
243,S1134-80462006000300002,mediacion,o
243,S1134-80462006000300002,por,o
243,S1134-80462006000300002,el,o
243,S1134-80462006000300002,sistema,o
243,S1134-80462006000300002,opioide,i
243,S1134-80462006000300002,endogeno,o
243,S1134-80462006000300002,y,o
243,S1134-80462006000300002,sustancia,i
243,S1134-80462006000300002,gris,i
243,S1134-80462006000300002,periacueductal,i
243,S1134-80462006000300002,y,o
243,S1134-80462006000300002,3,o
243,S1134-80462006000300002,bloqueo,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,los,o
243,S1134-80462006000300002,canales,i
243,S1134-80462006000300002,del,i
243,S1134-80462006000300002,calcio,i
243,S1134-80462006000300002,por,o
243,S1134-80462006000300002,antagonismo,o
243,S1134-80462006000300002,no,o
243,S1134-80462006000300002,competitivo,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,los,o
243,S1134-80462006000300002,receptores,o
243,S1134-80462006000300002,Nmetildaspartato,o
243,S1134-80462006000300002,Objetivo,o
243,S1134-80462006000300002,Demostrar,i
243,S1134-80462006000300002,la,i
243,S1134-80462006000300002,eficacia,i
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,la,o
243,S1134-80462006000300002,ketamina,i
243,S1134-80462006000300002,por,o
243,S1134-80462006000300002,via,o
243,S1134-80462006000300002,epidural,o
243,S1134-80462006000300002,como,o
243,S1134-80462006000300002,analgesico,i
243,S1134-80462006000300002,postoperatorio,o
243,S1134-80462006000300002,en,o
243,S1134-80462006000300002,la,o
243,S1134-80462006000300002,cirugia,i
243,S1134-80462006000300002,de,i
243,S1134-80462006000300002,hemiabdomen,i
243,S1134-80462006000300002,inferior,i
243,S1134-80462006000300002,Material,o
243,S1134-80462006000300002,y,o
243,S1134-80462006000300002,Metodo,o
243,S1134-80462006000300002,Se,o
243,S1134-80462006000300002,realizo,o
243,S1134-80462006000300002,un,o
243,S1134-80462006000300002,ensayo,i
243,S1134-80462006000300002,clinico,i
243,S1134-80462006000300002,aleatorizado,i
243,S1134-80462006000300002,y,i
243,S1134-80462006000300002,prospectivo,i
243,S1134-80462006000300002,en,o
243,S1134-80462006000300002,una,o
243,S1134-80462006000300002,muestra,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,50,o
243,S1134-80462006000300002,pacientes,o
243,S1134-80462006000300002,operados,i
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,hernia,i
243,S1134-80462006000300002,inguinal,i
243,S1134-80462006000300002,electiva,o
243,S1134-80462006000300002,Los,o
243,S1134-80462006000300002,pacientes,o
243,S1134-80462006000300002,fueron,o
243,S1134-80462006000300002,divididos,o
243,S1134-80462006000300002,en,o
243,S1134-80462006000300002,dos,o
243,S1134-80462006000300002,grupos,o
243,S1134-80462006000300002,un,o
243,S1134-80462006000300002,grupo,o
243,S1134-80462006000300002,tratado,i
243,S1134-80462006000300002,con,o
243,S1134-80462006000300002,50,o
243,S1134-80462006000300002,mg,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,ketamina,i
243,S1134-80462006000300002,y,o
243,S1134-80462006000300002,otro,o
243,S1134-80462006000300002,grupo,o
243,S1134-80462006000300002,al,o
243,S1134-80462006000300002,que,o
243,S1134-80462006000300002,se,o
243,S1134-80462006000300002,le,o
243,S1134-80462006000300002,administro,o
243,S1134-80462006000300002,una,o
243,S1134-80462006000300002,dosis,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,2,o
243,S1134-80462006000300002,mg,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,morfina,i
243,S1134-80462006000300002,liofilizada,i
243,S1134-80462006000300002,Resultados,o
243,S1134-80462006000300002,la,o
243,S1134-80462006000300002,ketamina,i
243,S1134-80462006000300002,por,o
243,S1134-80462006000300002,via,o
243,S1134-80462006000300002,epidural,o
243,S1134-80462006000300002,en,o
243,S1134-80462006000300002,una,o
243,S1134-80462006000300002,dosis,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,50,o
243,S1134-80462006000300002,mg,o
243,S1134-80462006000300002,proporciona,o
243,S1134-80462006000300002,una,o
243,S1134-80462006000300002,analgesia,i
243,S1134-80462006000300002,adecuada,o
243,S1134-80462006000300002,por,o
243,S1134-80462006000300002,un,o
243,S1134-80462006000300002,periodo,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,al,o
243,S1134-80462006000300002,menos,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,6,o
243,S1134-80462006000300002,horas,o
243,S1134-80462006000300002,La,o
243,S1134-80462006000300002,morfina,i
243,S1134-80462006000300002,brinda,o
243,S1134-80462006000300002,una,o
243,S1134-80462006000300002,analgesia,i
243,S1134-80462006000300002,por,o
243,S1134-80462006000300002,encima,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,las,o
243,S1134-80462006000300002,18,o
243,S1134-80462006000300002,horas,o
243,S1134-80462006000300002,Conclusion,o
243,S1134-80462006000300002,La,o
243,S1134-80462006000300002,ketamina,i
243,S1134-80462006000300002,por,o
243,S1134-80462006000300002,via,o
243,S1134-80462006000300002,epidural,o
243,S1134-80462006000300002,es,o
243,S1134-80462006000300002,menos,o
243,S1134-80462006000300002,efectiva,o
243,S1134-80462006000300002,que,o
243,S1134-80462006000300002,la,o
243,S1134-80462006000300002,morfina,i
243,S1134-80462006000300002,desde,o
243,S1134-80462006000300002,el,o
243,S1134-80462006000300002,punto,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,vista,o
243,S1134-80462006000300002,analgesico,i
243,S1134-80462006000300002,pero,o
243,S1134-80462006000300002,es,o
243,S1134-80462006000300002,una,o
243,S1134-80462006000300002,alternativa,o
243,S1134-80462006000300002,importante,o
243,S1134-80462006000300002,pues,o
243,S1134-80462006000300002,permite,o
243,S1134-80462006000300002,disminuir,o
243,S1134-80462006000300002,la,o
243,S1134-80462006000300002,dosis,o
243,S1134-80462006000300002,de,o
243,S1134-80462006000300002,morfina,i
243,S1134-80462006000300002,si,o
243,S1134-80462006000300002,se,o
243,S1134-80462006000300002,combinan,o
243,S1134-80462006000300002,ambos,o
243,S1134-80462006000300002,farmacos,i
243,S1134-80462006000300002,o,o
243,S1134-80462006000300002,se,o
243,S1134-80462006000300002,asocia,o
243,S1134-80462006000300002,a,o
243,S1134-80462006000300002,anestesicos,i
243,S1134-80462006000300002,locales,i
244,S1134-80462008000200002,Utilidad,o
244,S1134-80462008000200002,del,o
244,S1134-80462008000200002,citrato,i
244,S1134-80462008000200002,fentanilo,i
244,S1134-80462008000200002,oral,i
244,S1134-80462008000200002,transmucosa,i
244,S1134-80462008000200002,CFOT,i
244,S1134-80462008000200002,para,o
244,S1134-80462008000200002,procurar,o
244,S1134-80462008000200002,ansiolisis,i
244,S1134-80462008000200002,preoperatoria,o
244,S1134-80462008000200002,y,o
244,S1134-80462008000200002,analgesia,i
244,S1134-80462008000200002,postoperatoria,i
244,S1134-80462008000200002,en,o
244,S1134-80462008000200002,cirugia,i
244,S1134-80462008000200002,pediatrica,i
244,S1134-80462008000200002,La,o
244,S1134-80462008000200002,cirugia,i
244,S1134-80462008000200002,en,o
244,S1134-80462008000200002,la,o
244,S1134-80462008000200002,poblacion,o
244,S1134-80462008000200002,infantil,o
244,S1134-80462008000200002,representa,o
244,S1134-80462008000200002,una,o
244,S1134-80462008000200002,fuente,o
244,S1134-80462008000200002,de,o
244,S1134-80462008000200002,disconfort,i
244,S1134-80462008000200002,para,o
244,S1134-80462008000200002,el,o
244,S1134-80462008000200002,paciente,o
244,S1134-80462008000200002,y,o
244,S1134-80462008000200002,su,o
244,S1134-80462008000200002,entorno,o
244,S1134-80462008000200002,familiar,o
244,S1134-80462008000200002,que,o
244,S1134-80462008000200002,a,o
244,S1134-80462008000200002,menudo,o
244,S1134-80462008000200002,es,o
244,S1134-80462008000200002,infravalorado,o
244,S1134-80462008000200002,tanto,o
244,S1134-80462008000200002,por,o
244,S1134-80462008000200002,estos,o
244,S1134-80462008000200002,como,o
244,S1134-80462008000200002,por,o
244,S1134-80462008000200002,los,o
244,S1134-80462008000200002,profesionales,o
244,S1134-80462008000200002,Aun,o
244,S1134-80462008000200002,hay,o
244,S1134-80462008000200002,mucho,o
244,S1134-80462008000200002,por,o
244,S1134-80462008000200002,hacer,o
244,S1134-80462008000200002,para,o
244,S1134-80462008000200002,disminuir,o
244,S1134-80462008000200002,este,o
244,S1134-80462008000200002,impacto,o
244,S1134-80462008000200002,y,o
244,S1134-80462008000200002,proporcionar,o
244,S1134-80462008000200002,a,o
244,S1134-80462008000200002,los,o
244,S1134-80462008000200002,niños,o
244,S1134-80462008000200002,unas,o
244,S1134-80462008000200002,condiciones,o
244,S1134-80462008000200002,emocionales,o
244,S1134-80462008000200002,adecuadas,o
244,S1134-80462008000200002,para,o
244,S1134-80462008000200002,enfrentarse,o
244,S1134-80462008000200002,a,o
244,S1134-80462008000200002,la,o
244,S1134-80462008000200002,cirugia,i
244,S1134-80462008000200002,y,o
244,S1134-80462008000200002,al,o
244,S1134-80462008000200002,postoperatorio,o
244,S1134-80462008000200002,El,o
244,S1134-80462008000200002,objetivo,o
244,S1134-80462008000200002,de,o
244,S1134-80462008000200002,este,o
244,S1134-80462008000200002,trabajo,o
244,S1134-80462008000200002,era,o
244,S1134-80462008000200002,demostrar,o
244,S1134-80462008000200002,la,o
244,S1134-80462008000200002,utilidad,o
244,S1134-80462008000200002,del,o
244,S1134-80462008000200002,citrato,i
244,S1134-80462008000200002,de,i
244,S1134-80462008000200002,fentanilo,i
244,S1134-80462008000200002,oral,i
244,S1134-80462008000200002,transmucosa,i
244,S1134-80462008000200002,CFOT,i
244,S1134-80462008000200002,como,o
244,S1134-80462008000200002,medio,o
244,S1134-80462008000200002,de,o
244,S1134-80462008000200002,ansiolisis,i
244,S1134-80462008000200002,preoperatorio,o
244,S1134-80462008000200002,y,o
244,S1134-80462008000200002,analgesia,i
244,S1134-80462008000200002,postoperatoria,i
244,S1134-80462008000200002,Para,o
244,S1134-80462008000200002,ello,o
244,S1134-80462008000200002,se,o
244,S1134-80462008000200002,administro,o
244,S1134-80462008000200002,previo,o
244,S1134-80462008000200002,a,o
244,S1134-80462008000200002,la,o
244,S1134-80462008000200002,intervencion,i
244,S1134-80462008000200002,10,o
244,S1134-80462008000200002,ugKg,o
244,S1134-80462008000200002,de,o
244,S1134-80462008000200002,CFOT,i
244,S1134-80462008000200002,a,o
244,S1134-80462008000200002,un,o
244,S1134-80462008000200002,grupo,o
244,S1134-80462008000200002,de,o
244,S1134-80462008000200002,45,o
244,S1134-80462008000200002,niños,o
244,S1134-80462008000200002,sometidos,o
244,S1134-80462008000200002,a,o
244,S1134-80462008000200002,adenoamigdalectomia,i
244,S1134-80462008000200002,y,o
244,S1134-80462008000200002,se,o
244,S1134-80462008000200002,valoro,o
244,S1134-80462008000200002,el,o
244,S1134-80462008000200002,comportamiento,o
244,S1134-80462008000200002,la,o
244,S1134-80462008000200002,colaboracion,o
244,S1134-80462008000200002,y,o
244,S1134-80462008000200002,la,o
244,S1134-80462008000200002,analgesia,i
244,S1134-80462008000200002,obtenida,o
244,S1134-80462008000200002,en,o
244,S1134-80462008000200002,el,o
244,S1134-80462008000200002,antequirofano,o
244,S1134-80462008000200002,y,o
244,S1134-80462008000200002,postoperatorio,o
244,S1134-80462008000200002,inmediato,o
244,S1134-80462008000200002,Los,o
244,S1134-80462008000200002,resultados,o
244,S1134-80462008000200002,obtenidos,o
244,S1134-80462008000200002,se,o
244,S1134-80462008000200002,compararon,o
244,S1134-80462008000200002,con,o
244,S1134-80462008000200002,los,o
244,S1134-80462008000200002,de,o
244,S1134-80462008000200002,un,o
244,S1134-80462008000200002,grupo,o
244,S1134-80462008000200002,control,o
244,S1134-80462008000200002,similar,o
244,S1134-80462008000200002,utilizando,o
244,S1134-80462008000200002,para,o
244,S1134-80462008000200002,ello,o
244,S1134-80462008000200002,la,o
244,S1134-80462008000200002,T,o
244,S1134-80462008000200002,de,o
244,S1134-80462008000200002,student,o
244,S1134-80462008000200002,y,o
244,S1134-80462008000200002,ANOVA,o
244,S1134-80462008000200002,obteniendose,o
244,S1134-80462008000200002,diferencias,o
244,S1134-80462008000200002,significativas,o
244,S1134-80462008000200002,en,o
244,S1134-80462008000200002,cuanto,o
244,S1134-80462008000200002,al,o
244,S1134-80462008000200002,grado,o
244,S1134-80462008000200002,de,o
244,S1134-80462008000200002,colaboracion,o
244,S1134-80462008000200002,ansiolisis,i
244,S1134-80462008000200002,y,o
244,S1134-80462008000200002,analgesia,i
244,S1134-80462008000200002,a,o
244,S1134-80462008000200002,favor,o
244,S1134-80462008000200002,del,o
244,S1134-80462008000200002,grupo,o
244,S1134-80462008000200002,CFOT,i
244,S1134-80462008000200002,Nosotros,o
244,S1134-80462008000200002,sostenemos,o
244,S1134-80462008000200002,que,o
244,S1134-80462008000200002,este,o
244,S1134-80462008000200002,metodo,o
244,S1134-80462008000200002,es,o
244,S1134-80462008000200002,ademas,o
244,S1134-80462008000200002,seguro,o
244,S1134-80462008000200002,sencillo,o
244,S1134-80462008000200002,y,o
244,S1134-80462008000200002,goza,o
244,S1134-80462008000200002,de,o
244,S1134-80462008000200002,una,o
244,S1134-80462008000200002,gran,o
244,S1134-80462008000200002,aceptacion,o
244,S1134-80462008000200002,por,o
244,S1134-80462008000200002,parte,o
244,S1134-80462008000200002,de,o
244,S1134-80462008000200002,los,o
244,S1134-80462008000200002,padres,o
244,S1134-80462008000200002,y,o
244,S1134-80462008000200002,profesionales,o
244,S1134-80462008000200002,implicados,o
244,S1134-80462008000200002,en,o
244,S1134-80462008000200002,el,o
244,S1134-80462008000200002,proceso,i
244,S1134-80462008000200002,asistencial,i
245,S1134-80462008000700003,Analgesia,i
245,S1134-80462008000700003,PCA,i
245,S1134-80462008000700003,por,i
245,S1134-80462008000700003,cateter,i
245,S1134-80462008000700003,interesternocleidomastoideo,i
245,S1134-80462008000700003,frente,o
245,S1134-80462008000700003,analgesia,i
245,S1134-80462008000700003,PCA,i
245,S1134-80462008000700003,intravenosa,i
245,S1134-80462008000700003,tras,o
245,S1134-80462008000700003,cirugia,i
245,S1134-80462008000700003,proximal,i
245,S1134-80462008000700003,de,i
245,S1134-80462008000700003,humero,i
245,S1134-80462008000700003,Introduccion,o
245,S1134-80462008000700003,Comparar,i
245,S1134-80462008000700003,la,i
245,S1134-80462008000700003,eficacia,i
245,S1134-80462008000700003,analgesica,o
245,S1134-80462008000700003,e,o
245,S1134-80462008000700003,incidencia,o
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,efectos,i
245,S1134-80462008000700003,adversos,i
245,S1134-80462008000700003,entre,o
245,S1134-80462008000700003,el,o
245,S1134-80462008000700003,bloqueo,i
245,S1134-80462008000700003,interesternocleidomastoideo,i
245,S1134-80462008000700003,continuo,i
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,una,o
245,S1134-80462008000700003,pauta,i
245,S1134-80462008000700003,analgesica,i
245,S1134-80462008000700003,intravenosa,i
245,S1134-80462008000700003,tras,o
245,S1134-80462008000700003,cirugia,i
245,S1134-80462008000700003,proximal,i
245,S1134-80462008000700003,de,i
245,S1134-80462008000700003,humero,i
245,S1134-80462008000700003,Material,o
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,Metodos,o
245,S1134-80462008000700003,Estudio,i
245,S1134-80462008000700003,prospectivo,i
245,S1134-80462008000700003,descriptivo,i
245,S1134-80462008000700003,no,i
245,S1134-80462008000700003,aleatorizado,i
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,pacientes,o
245,S1134-80462008000700003,intervenidos,i
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,cirugia,i
245,S1134-80462008000700003,de,i
245,S1134-80462008000700003,hombro,i
245,S1134-80462008000700003,bajo,o
245,S1134-80462008000700003,anestesia,i
245,S1134-80462008000700003,general,i
245,S1134-80462008000700003,con,o
245,S1134-80462008000700003,fentanilo,i
245,S1134-80462008000700003,intravenoso,o
245,S1134-80462008000700003,como,o
245,S1134-80462008000700003,analgesia,i
245,S1134-80462008000700003,intraoperatoria,o
245,S1134-80462008000700003,Al,o
245,S1134-80462008000700003,grupo,o
245,S1134-80462008000700003,1,o
245,S1134-80462008000700003,se,o
245,S1134-80462008000700003,realizo,o
245,S1134-80462008000700003,bloqueo,i
245,S1134-80462008000700003,interesternocleidomastoideo,i
245,S1134-80462008000700003,con,o
245,S1134-80462008000700003,ropivacaina,i
245,S1134-80462008000700003,05,o
245,S1134-80462008000700003,04,o
245,S1134-80462008000700003,mL,o
245,S1134-80462008000700003,Kg1,o
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,en,o
245,S1134-80462008000700003,URPA,o
245,S1134-80462008000700003,se,o
245,S1134-80462008000700003,comenzo,o
245,S1134-80462008000700003,una,o
245,S1134-80462008000700003,perfusion,i
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,ropivacaina,i
245,S1134-80462008000700003,02,o
245,S1134-80462008000700003,5mL,o
245,S1134-80462008000700003,h1,o
245,S1134-80462008000700003,con,o
245,S1134-80462008000700003,bolos,i
245,S1134-80462008000700003,PCA,i
245,S1134-80462008000700003,5,o
245,S1134-80462008000700003,mL,o
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,tiempo,o
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,cierre,o
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,30,o
245,S1134-80462008000700003,minutos,o
245,S1134-80462008000700003,Al,o
245,S1134-80462008000700003,grupo,o
245,S1134-80462008000700003,2,o
245,S1134-80462008000700003,a,o
245,S1134-80462008000700003,su,o
245,S1134-80462008000700003,llegada,o
245,S1134-80462008000700003,a,o
245,S1134-80462008000700003,la,o
245,S1134-80462008000700003,URPA,o
245,S1134-80462008000700003,se,o
245,S1134-80462008000700003,administro,o
245,S1134-80462008000700003,una,o
245,S1134-80462008000700003,dosis,o
245,S1134-80462008000700003,carga,o
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,metamizol,i
245,S1134-80462008000700003,2,o
245,S1134-80462008000700003,gr,o
245,S1134-80462008000700003,tramadol,i
245,S1134-80462008000700003,100,o
245,S1134-80462008000700003,mgr,o
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,ondansetron,i
245,S1134-80462008000700003,4,o
245,S1134-80462008000700003,mgr,o
245,S1134-80462008000700003,seguido,o
245,S1134-80462008000700003,por,o
245,S1134-80462008000700003,una,o
245,S1134-80462008000700003,perfusion,i
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,metamizol,i
245,S1134-80462008000700003,016,o
245,S1134-80462008000700003,tramadol,i
245,S1134-80462008000700003,004,o
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,ondansetron,i
245,S1134-80462008000700003,00016,o
245,S1134-80462008000700003,a,o
245,S1134-80462008000700003,15,o
245,S1134-80462008000700003,mL,o
245,S1134-80462008000700003,h1,o
245,S1134-80462008000700003,bolos,i
245,S1134-80462008000700003,PCA,i
245,S1134-80462008000700003,1,o
245,S1134-80462008000700003,mL,o
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,tiempo,o
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,cierre,o
245,S1134-80462008000700003,20,o
245,S1134-80462008000700003,minutos,o
245,S1134-80462008000700003,La,o
245,S1134-80462008000700003,variable,o
245,S1134-80462008000700003,principal,o
245,S1134-80462008000700003,fue,o
245,S1134-80462008000700003,la,o
245,S1134-80462008000700003,valoracion,i
245,S1134-80462008000700003,del,i
245,S1134-80462008000700003,dolor,i
245,S1134-80462008000700003,postoperatorio,i
245,S1134-80462008000700003,en,o
245,S1134-80462008000700003,reposo,o
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,movimiento,o
245,S1134-80462008000700003,mediante,o
245,S1134-80462008000700003,escala,o
245,S1134-80462008000700003,verbal,o
245,S1134-80462008000700003,numerica,o
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,0,o
245,S1134-80462008000700003,no,o
245,S1134-80462008000700003,dolor,i
245,S1134-80462008000700003,a,o
245,S1134-80462008000700003,10,o
245,S1134-80462008000700003,maximo,o
245,S1134-80462008000700003,dolor,i
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,la,o
245,S1134-80462008000700003,aparicion,o
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,efectos,i
245,S1134-80462008000700003,indeseables,i
245,S1134-80462008000700003,Resultados,o
245,S1134-80462008000700003,Se,o
245,S1134-80462008000700003,incluyeron,o
245,S1134-80462008000700003,38,o
245,S1134-80462008000700003,pacientes,o
245,S1134-80462008000700003,en,o
245,S1134-80462008000700003,el,o
245,S1134-80462008000700003,grupo,o
245,S1134-80462008000700003,1,o
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,39,o
245,S1134-80462008000700003,en,o
245,S1134-80462008000700003,el,o
245,S1134-80462008000700003,2,o
245,S1134-80462008000700003,La,o
245,S1134-80462008000700003,valoracion,i
245,S1134-80462008000700003,del,i
245,S1134-80462008000700003,dolor,i
245,S1134-80462008000700003,postoperatorio,i
245,S1134-80462008000700003,puso,o
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,manifiesto,o
245,S1134-80462008000700003,valores,o
245,S1134-80462008000700003,mas,o
245,S1134-80462008000700003,elevados,o
245,S1134-80462008000700003,en,o
245,S1134-80462008000700003,las,o
245,S1134-80462008000700003,primeras,o
245,S1134-80462008000700003,24,o
245,S1134-80462008000700003,horas,o
245,S1134-80462008000700003,al,o
245,S1134-80462008000700003,movimiento,o
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,a,o
245,S1134-80462008000700003,las,o
245,S1134-80462008000700003,48,o
245,S1134-80462008000700003,horas,o
245,S1134-80462008000700003,tanto,o
245,S1134-80462008000700003,en,o
245,S1134-80462008000700003,reposo,o
245,S1134-80462008000700003,como,o
245,S1134-80462008000700003,al,o
245,S1134-80462008000700003,movimiento,o
245,S1134-80462008000700003,en,o
245,S1134-80462008000700003,el,o
245,S1134-80462008000700003,grupo,o
245,S1134-80462008000700003,2,o
245,S1134-80462008000700003,p005,o
245,S1134-80462008000700003,No,o
245,S1134-80462008000700003,hubo,o
245,S1134-80462008000700003,diferencias,o
245,S1134-80462008000700003,en,o
245,S1134-80462008000700003,analgesia,i
245,S1134-80462008000700003,de,i
245,S1134-80462008000700003,rescate,i
245,S1134-80462008000700003,demandada,o
245,S1134-80462008000700003,Se,o
245,S1134-80462008000700003,registraron,o
245,S1134-80462008000700003,2,o
245,S1134-80462008000700003,episodios,o
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,disfonia,i
245,S1134-80462008000700003,2,o
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,ptosis,i
245,S1134-80462008000700003,palpebral,i
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,3,o
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,nauseas,i
245,S1134-80462008000700003,y,i
245,S1134-80462008000700003,vomitos,i
245,S1134-80462008000700003,en,o
245,S1134-80462008000700003,el,o
245,S1134-80462008000700003,grupo,o
245,S1134-80462008000700003,1,o
245,S1134-80462008000700003,mientras,o
245,S1134-80462008000700003,que,o
245,S1134-80462008000700003,en,o
245,S1134-80462008000700003,el,o
245,S1134-80462008000700003,grupo,o
245,S1134-80462008000700003,2,o
245,S1134-80462008000700003,12,o
245,S1134-80462008000700003,pacientes,o
245,S1134-80462008000700003,presentaron,o
245,S1134-80462008000700003,nauseas,i
245,S1134-80462008000700003,y,i
245,S1134-80462008000700003,vomitos,i
245,S1134-80462008000700003,p005,o
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,otros,o
245,S1134-80462008000700003,3,o
245,S1134-80462008000700003,sedacion,i
245,S1134-80462008000700003,Conclusiones,o
245,S1134-80462008000700003,El,o
245,S1134-80462008000700003,uso,o
245,S1134-80462008000700003,de,o
245,S1134-80462008000700003,PCA,i
245,S1134-80462008000700003,por,i
245,S1134-80462008000700003,cateter,i
245,S1134-80462008000700003,interesternocleidomastoideo,i
245,S1134-80462008000700003,en,o
245,S1134-80462008000700003,nuestro,o
245,S1134-80462008000700003,estudio,o
245,S1134-80462008000700003,ha,o
245,S1134-80462008000700003,constituido,o
245,S1134-80462008000700003,una,o
245,S1134-80462008000700003,tecnica,o
245,S1134-80462008000700003,segura,o
245,S1134-80462008000700003,y,o
245,S1134-80462008000700003,ha,o
245,S1134-80462008000700003,proporcionado,o
245,S1134-80462008000700003,mejor,o
245,S1134-80462008000700003,analgesia,i
245,S1134-80462008000700003,que,o
245,S1134-80462008000700003,una,o
245,S1134-80462008000700003,PCA,i
245,S1134-80462008000700003,intravenosa,i
245,S1134-80462008000700003,con,o
245,S1134-80462008000700003,menos,o
245,S1134-80462008000700003,efectos,i
245,S1134-80462008000700003,indeseables,i
245,S1134-80462008000700003,en,o
245,S1134-80462008000700003,las,o
245,S1134-80462008000700003,primeras,o
245,S1134-80462008000700003,48,o
245,S1134-80462008000700003,horas,o
245,S1134-80462008000700003,del,o
245,S1134-80462008000700003,postoperatorio,o
246,S1134-80462010000700004,Modificaciones,o
246,S1134-80462010000700004,del,o
246,S1134-80462010000700004,umbral,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,dolor,i
246,S1134-80462010000700004,en,o
246,S1134-80462010000700004,un,o
246,S1134-80462010000700004,punto,i
246,S1134-80462010000700004,gatillo,i
246,S1134-80462010000700004,miofascial,i
246,S1134-80462010000700004,tras,o
246,S1134-80462010000700004,tecnica,i
246,S1134-80462010000700004,de,i
246,S1134-80462010000700004,energia,i
246,S1134-80462010000700004,muscular,i
246,S1134-80462010000700004,Objetivos,o
246,S1134-80462010000700004,Valorar,o
246,S1134-80462010000700004,los,o
246,S1134-80462010000700004,cambios,o
246,S1134-80462010000700004,en,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,umbral,i
246,S1134-80462010000700004,del,i
246,S1134-80462010000700004,dolor,i
246,S1134-80462010000700004,a,i
246,S1134-80462010000700004,la,i
246,S1134-80462010000700004,presion,i
246,S1134-80462010000700004,del,o
246,S1134-80462010000700004,punto,i
246,S1134-80462010000700004,gatillo,i
246,S1134-80462010000700004,1,i
246,S1134-80462010000700004,latente,i
246,S1134-80462010000700004,del,o
246,S1134-80462010000700004,trapecio,i
246,S1134-80462010000700004,superior,i
246,S1134-80462010000700004,tras,o
246,S1134-80462010000700004,la,o
246,S1134-80462010000700004,aplicacion,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,una,o
246,S1134-80462010000700004,tecnica,i
246,S1134-80462010000700004,de,i
246,S1134-80462010000700004,energia,i
246,S1134-80462010000700004,muscular,i
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,valorar,o
246,S1134-80462010000700004,la,o
246,S1134-80462010000700004,fiabilidad,o
246,S1134-80462010000700004,intraobservador,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,la,o
246,S1134-80462010000700004,algometria,i
246,S1134-80462010000700004,analogica,i
246,S1134-80462010000700004,sobre,o
246,S1134-80462010000700004,dicho,o
246,S1134-80462010000700004,punto,o
246,S1134-80462010000700004,Material,o
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,metodos,o
246,S1134-80462010000700004,Treinta,o
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,cinco,o
246,S1134-80462010000700004,sujetos,o
246,S1134-80462010000700004,asintomaticos,i
246,S1134-80462010000700004,con,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,punto,i
246,S1134-80462010000700004,gatillo,i
246,S1134-80462010000700004,miofascial,i
246,S1134-80462010000700004,1,i
246,S1134-80462010000700004,PGM1,i
246,S1134-80462010000700004,del,o
246,S1134-80462010000700004,trapecio,i
246,S1134-80462010000700004,superior,i
246,S1134-80462010000700004,latente,o
246,S1134-80462010000700004,fueron,o
246,S1134-80462010000700004,aleatorizados,i
246,S1134-80462010000700004,en,o
246,S1134-80462010000700004,dos,o
246,S1134-80462010000700004,grupos,o
246,S1134-80462010000700004,un,o
246,S1134-80462010000700004,grupo,o
246,S1134-80462010000700004,recibio,o
246,S1134-80462010000700004,como,o
246,S1134-80462010000700004,tratamiento,i
246,S1134-80462010000700004,la,o
246,S1134-80462010000700004,aplicacion,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,una,o
246,S1134-80462010000700004,tecnica,i
246,S1134-80462010000700004,de,i
246,S1134-80462010000700004,energia,i
246,S1134-80462010000700004,muscular,i
246,S1134-80462010000700004,sobre,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,trapecio,i
246,S1134-80462010000700004,superior,i
246,S1134-80462010000700004,grupo,o
246,S1134-80462010000700004,1,o
246,S1134-80462010000700004,mientras,o
246,S1134-80462010000700004,que,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,otro,o
246,S1134-80462010000700004,grupo,o
246,S1134-80462010000700004,no,o
246,S1134-80462010000700004,recibio,o
246,S1134-80462010000700004,ninguna,o
246,S1134-80462010000700004,aplicacion,o
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,fue,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,grupo,o
246,S1134-80462010000700004,control,o
246,S1134-80462010000700004,grupo,o
246,S1134-80462010000700004,2,o
246,S1134-80462010000700004,Se,o
246,S1134-80462010000700004,evaluaron,o
246,S1134-80462010000700004,variables,o
246,S1134-80462010000700004,demograficas,o
246,S1134-80462010000700004,como,o
246,S1134-80462010000700004,sexo,o
246,S1134-80462010000700004,edad,o
246,S1134-80462010000700004,altura,o
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,peso,o
246,S1134-80462010000700004,asi,o
246,S1134-80462010000700004,como,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,umbral,i
246,S1134-80462010000700004,de,i
246,S1134-80462010000700004,dolor,i
246,S1134-80462010000700004,a,i
246,S1134-80462010000700004,la,i
246,S1134-80462010000700004,presion,i
246,S1134-80462010000700004,UDP,i
246,S1134-80462010000700004,El,o
246,S1134-80462010000700004,UDP,i
246,S1134-80462010000700004,se,o
246,S1134-80462010000700004,midio,o
246,S1134-80462010000700004,por,o
246,S1134-80462010000700004,medio,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,un,o
246,S1134-80462010000700004,algometro,o
246,S1134-80462010000700004,analogico,o
246,S1134-80462010000700004,en,o
246,S1134-80462010000700004,3,o
246,S1134-80462010000700004,momentos,o
246,S1134-80462010000700004,antes,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,la,o
246,S1134-80462010000700004,intervencion,i
246,S1134-80462010000700004,5min,o
246,S1134-80462010000700004,despues,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,la,o
246,S1134-80462010000700004,intervencion,i
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,24horas,o
246,S1134-80462010000700004,despues,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,la,o
246,S1134-80462010000700004,intervencion,i
246,S1134-80462010000700004,En,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,analisis,o
246,S1134-80462010000700004,estadistico,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,las,o
246,S1134-80462010000700004,variables,o
246,S1134-80462010000700004,cuantitativas,o
246,S1134-80462010000700004,se,o
246,S1134-80462010000700004,utilizaron,o
246,S1134-80462010000700004,medias,o
246,S1134-80462010000700004,rangos,o
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,desviaciones,o
246,S1134-80462010000700004,tipicas,o
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,porcentajes,o
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,frecuencias,o
246,S1134-80462010000700004,para,o
246,S1134-80462010000700004,las,o
246,S1134-80462010000700004,variables,o
246,S1134-80462010000700004,cualitativas,o
246,S1134-80462010000700004,En,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,analisis,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,la,o
246,S1134-80462010000700004,fiabilidad,o
246,S1134-80462010000700004,intraobservador,o
246,S1134-80462010000700004,se,o
246,S1134-80462010000700004,empleo,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,coeficiente,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,correlacion,o
246,S1134-80462010000700004,intraclase,o
246,S1134-80462010000700004,Para,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,analisis,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,los,o
246,S1134-80462010000700004,cambios,o
246,S1134-80462010000700004,en,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,UDP,i
246,S1134-80462010000700004,se,o
246,S1134-80462010000700004,utilizo,o
246,S1134-80462010000700004,la,o
246,S1134-80462010000700004,prueba,o
246,S1134-80462010000700004,ANOVA,o
246,S1134-80462010000700004,para,o
246,S1134-80462010000700004,medidas,o
246,S1134-80462010000700004,repetidas,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,dos,o
246,S1134-80462010000700004,factores,o
246,S1134-80462010000700004,En,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,analisis,o
246,S1134-80462010000700004,estadistico,o
246,S1134-80462010000700004,se,o
246,S1134-80462010000700004,empleo,o
246,S1134-80462010000700004,un,o
246,S1134-80462010000700004,nivel,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,confianza,o
246,S1134-80462010000700004,al,o
246,S1134-80462010000700004,95,o
246,S1134-80462010000700004,Resultados,o
246,S1134-80462010000700004,El,o
246,S1134-80462010000700004,coeficiente,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,correlacion,o
246,S1134-80462010000700004,intraclase,o
246,S1134-80462010000700004,mostro,o
246,S1134-80462010000700004,valores,o
246,S1134-80462010000700004,entre,o
246,S1134-80462010000700004,084,o
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,092,o
246,S1134-80462010000700004,No,o
246,S1134-80462010000700004,se,o
246,S1134-80462010000700004,observaron,o
246,S1134-80462010000700004,diferencias,o
246,S1134-80462010000700004,significativas,o
246,S1134-80462010000700004,en,o
246,S1134-80462010000700004,los,o
246,S1134-80462010000700004,valores,o
246,S1134-80462010000700004,basales,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,los,o
246,S1134-80462010000700004,grupos,o
246,S1134-80462010000700004,La,o
246,S1134-80462010000700004,prueba,o
246,S1134-80462010000700004,ANOVA,o
246,S1134-80462010000700004,mostro,o
246,S1134-80462010000700004,efectos,o
246,S1134-80462010000700004,significativos,o
246,S1134-80462010000700004,para,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,tiempo,o
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,la,o
246,S1134-80462010000700004,interaccion,o
246,S1134-80462010000700004,entre,o
246,S1134-80462010000700004,tiempo,o
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,grupo,o
246,S1134-80462010000700004,En,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,grupo,o
246,S1134-80462010000700004,1,o
246,S1134-80462010000700004,se,o
246,S1134-80462010000700004,observo,o
246,S1134-80462010000700004,un,o
246,S1134-80462010000700004,incremento,o
246,S1134-80462010000700004,significativo,o
246,S1134-80462010000700004,del,o
246,S1134-80462010000700004,UDP,i
246,S1134-80462010000700004,despues,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,5min,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,tratamiento,i
246,S1134-80462010000700004,que,o
246,S1134-80462010000700004,desaparecio,o
246,S1134-80462010000700004,a,o
246,S1134-80462010000700004,las,o
246,S1134-80462010000700004,24horas,o
246,S1134-80462010000700004,En,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,grupo,o
246,S1134-80462010000700004,2,o
246,S1134-80462010000700004,no,o
246,S1134-80462010000700004,se,o
246,S1134-80462010000700004,encontraron,o
246,S1134-80462010000700004,diferencias,o
246,S1134-80462010000700004,significativas,o
246,S1134-80462010000700004,en,o
246,S1134-80462010000700004,ningun,o
246,S1134-80462010000700004,tiempo,o
246,S1134-80462010000700004,Conclusiones,o
246,S1134-80462010000700004,La,o
246,S1134-80462010000700004,fiabilidad,o
246,S1134-80462010000700004,intraobservador,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,la,o
246,S1134-80462010000700004,medicion,i
246,S1134-80462010000700004,del,i
246,S1134-80462010000700004,UDP,i
246,S1134-80462010000700004,ha,o
246,S1134-80462010000700004,demostrado,o
246,S1134-80462010000700004,ser,o
246,S1134-80462010000700004,buena,o
246,S1134-80462010000700004,La,o
246,S1134-80462010000700004,tecnica,i
246,S1134-80462010000700004,de,i
246,S1134-80462010000700004,energia,i
246,S1134-80462010000700004,muscular,i
246,S1134-80462010000700004,en,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,punto,i
246,S1134-80462010000700004,gatillo,i
246,S1134-80462010000700004,miofascial,i
246,S1134-80462010000700004,latente,i
246,S1134-80462010000700004,1,i
246,S1134-80462010000700004,del,o
246,S1134-80462010000700004,trapecio,i
246,S1134-80462010000700004,superior,i
246,S1134-80462010000700004,ha,o
246,S1134-80462010000700004,mostrado,o
246,S1134-80462010000700004,un,o
246,S1134-80462010000700004,aumento,o
246,S1134-80462010000700004,inmediato,o
246,S1134-80462010000700004,en,o
246,S1134-80462010000700004,el,o
246,S1134-80462010000700004,umbral,o
246,S1134-80462010000700004,de,o
246,S1134-80462010000700004,dolor,i
246,S1134-80462010000700004,quien,o
246,S1134-80462010000700004,no,o
246,S1134-80462010000700004,se,o
246,S1134-80462010000700004,mantuvo,o
246,S1134-80462010000700004,a,o
246,S1134-80462010000700004,las,o
246,S1134-80462010000700004,24horas,o
246,S1134-80462010000700004,Son,o
246,S1134-80462010000700004,necesarias,o
246,S1134-80462010000700004,investigaciones,o
246,S1134-80462010000700004,con,o
246,S1134-80462010000700004,una,o
246,S1134-80462010000700004,muestra,o
246,S1134-80462010000700004,mayor,o
246,S1134-80462010000700004,y,o
246,S1134-80462010000700004,con,o
246,S1134-80462010000700004,sujetos,o
246,S1134-80462010000700004,sintomaticos,i
247,S1134-80462013000600002,Validacion,o
247,S1134-80462013000600002,del,o
247,S1134-80462013000600002,segundo,o
247,S1134-80462013000600002,paso,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,la,o
247,S1134-80462013000600002,escalera,i
247,S1134-80462013000600002,analgesica,i
247,S1134-80462013000600002,de,i
247,S1134-80462013000600002,la,i
247,S1134-80462013000600002,OMS,i
247,S1134-80462013000600002,es,o
247,S1134-80462013000600002,necesario,o
247,S1134-80462013000600002,el,o
247,S1134-80462013000600002,uso,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,opioides,i
247,S1134-80462013000600002,debiles,o
247,S1134-80462013000600002,Objetivo,o
247,S1134-80462013000600002,Comparar,o
247,S1134-80462013000600002,la,o
247,S1134-80462013000600002,eficacia,o
247,S1134-80462013000600002,seguridad,o
247,S1134-80462013000600002,y,o
247,S1134-80462013000600002,tiempo,o
247,S1134-80462013000600002,hasta,o
247,S1134-80462013000600002,el,o
247,S1134-80462013000600002,alivio,o
247,S1134-80462013000600002,del,o
247,S1134-80462013000600002,dolor,i
247,S1134-80462013000600002,por,i
247,S1134-80462013000600002,cancer,i
247,S1134-80462013000600002,con,o
247,S1134-80462013000600002,acetaminofen,i
247,S1134-80462013000600002,solo,o
247,S1134-80462013000600002,versus,o
247,S1134-80462013000600002,acetaminofen,i
247,S1134-80462013000600002,mas,i
247,S1134-80462013000600002,codeina,i
247,S1134-80462013000600002,con,o
247,S1134-80462013000600002,el,o
247,S1134-80462013000600002,fin,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,analizar,o
247,S1134-80462013000600002,si,o
247,S1134-80462013000600002,es,o
247,S1134-80462013000600002,necesario,o
247,S1134-80462013000600002,el,o
247,S1134-80462013000600002,segundo,o
247,S1134-80462013000600002,paso,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,la,o
247,S1134-80462013000600002,escalera,i
247,S1134-80462013000600002,analgesica,i
247,S1134-80462013000600002,de,i
247,S1134-80462013000600002,la,i
247,S1134-80462013000600002,OMS,i
247,S1134-80462013000600002,Metodos,o
247,S1134-80462013000600002,Se,o
247,S1134-80462013000600002,realizo,o
247,S1134-80462013000600002,un,o
247,S1134-80462013000600002,ensayo,o
247,S1134-80462013000600002,clinico,o
247,S1134-80462013000600002,controlado,o
247,S1134-80462013000600002,aleatorizado,o
247,S1134-80462013000600002,doble,o
247,S1134-80462013000600002,ciego,o
247,S1134-80462013000600002,en,o
247,S1134-80462013000600002,mayores,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,18,o
247,S1134-80462013000600002,años,o
247,S1134-80462013000600002,con,o
247,S1134-80462013000600002,dolor,i
247,S1134-80462013000600002,por,i
247,S1134-80462013000600002,cancer,i
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,intensidad,o
247,S1134-80462013000600002,moderada,o
247,S1134-80462013000600002,o,o
247,S1134-80462013000600002,severa,o
247,S1134-80462013000600002,y,o
247,S1134-80462013000600002,Karnofsky,i
247,S1134-80462013000600002,50100,o
247,S1134-80462013000600002,Se,o
247,S1134-80462013000600002,excluyeron,o
247,S1134-80462013000600002,pacientes,o
247,S1134-80462013000600002,con,o
247,S1134-80462013000600002,antecedentes,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,drogadiccion,i
247,S1134-80462013000600002,insuficiencia,i
247,S1134-80462013000600002,renal,i
247,S1134-80462013000600002,o,i
247,S1134-80462013000600002,hepatica,i
247,S1134-80462013000600002,y,o
247,S1134-80462013000600002,embarazo,o
247,S1134-80462013000600002,Se,o
247,S1134-80462013000600002,dividieron,o
247,S1134-80462013000600002,en,o
247,S1134-80462013000600002,dos,o
247,S1134-80462013000600002,grupos,o
247,S1134-80462013000600002,uno,o
247,S1134-80462013000600002,tratado,i
247,S1134-80462013000600002,con,o
247,S1134-80462013000600002,acetaminofen,i
247,S1134-80462013000600002,y,o
247,S1134-80462013000600002,otro,o
247,S1134-80462013000600002,con,o
247,S1134-80462013000600002,acetaminofen,i
247,S1134-80462013000600002,mas,i
247,S1134-80462013000600002,codeina,i
247,S1134-80462013000600002,Se,o
247,S1134-80462013000600002,realizo,o
247,S1134-80462013000600002,una,o
247,S1134-80462013000600002,evaluacion,i
247,S1134-80462013000600002,inicial,o
247,S1134-80462013000600002,y,o
247,S1134-80462013000600002,controles,i
247,S1134-80462013000600002,diarios,o
247,S1134-80462013000600002,durante,o
247,S1134-80462013000600002,7,o
247,S1134-80462013000600002,dias,o
247,S1134-80462013000600002,evaluando,o
247,S1134-80462013000600002,analgesia,i
247,S1134-80462013000600002,tiempo,o
247,S1134-80462013000600002,hasta,o
247,S1134-80462013000600002,el,o
247,S1134-80462013000600002,alivio,o
247,S1134-80462013000600002,del,o
247,S1134-80462013000600002,dolor,i
247,S1134-80462013000600002,y,o
247,S1134-80462013000600002,efectos,i
247,S1134-80462013000600002,colaterales,i
247,S1134-80462013000600002,Se,o
247,S1134-80462013000600002,utilizaron,o
247,S1134-80462013000600002,las,o
247,S1134-80462013000600002,pruebas,o
247,S1134-80462013000600002,Chi,o
247,S1134-80462013000600002,cuadrado,o
247,S1134-80462013000600002,y,o
247,S1134-80462013000600002,Fisher,o
247,S1134-80462013000600002,para,o
247,S1134-80462013000600002,comparar,o
247,S1134-80462013000600002,proporciones,o
247,S1134-80462013000600002,T,o
247,S1134-80462013000600002,y,o
247,S1134-80462013000600002,ANOVA,o
247,S1134-80462013000600002,para,o
247,S1134-80462013000600002,promedios,o
247,S1134-80462013000600002,La,o
247,S1134-80462013000600002,comparacion,o
247,S1134-80462013000600002,del,o
247,S1134-80462013000600002,tiempo,o
247,S1134-80462013000600002,en,o
247,S1134-80462013000600002,lograr,o
247,S1134-80462013000600002,alivio,o
247,S1134-80462013000600002,se,o
247,S1134-80462013000600002,realizo,o
247,S1134-80462013000600002,mediante,o
247,S1134-80462013000600002,una,o
247,S1134-80462013000600002,curva,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,KaplanMeier,o
247,S1134-80462013000600002,Resultados,o
247,S1134-80462013000600002,Se,o
247,S1134-80462013000600002,asignaron,o
247,S1134-80462013000600002,veinte,o
247,S1134-80462013000600002,pacientes,o
247,S1134-80462013000600002,al,o
247,S1134-80462013000600002,grupo,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,acetaminofen,i
247,S1134-80462013000600002,y,o
247,S1134-80462013000600002,16,o
247,S1134-80462013000600002,al,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,acetaminofen,i
247,S1134-80462013000600002,mas,i
247,S1134-80462013000600002,codeina,i
247,S1134-80462013000600002,No,o
247,S1134-80462013000600002,se,o
247,S1134-80462013000600002,presentaron,o
247,S1134-80462013000600002,diferencias,o
247,S1134-80462013000600002,estadisticamente,o
247,S1134-80462013000600002,significativas,o
247,S1134-80462013000600002,en,o
247,S1134-80462013000600002,la,o
247,S1134-80462013000600002,eficacia,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,los,o
247,S1134-80462013000600002,dos,o
247,S1134-80462013000600002,tratamientos,i
247,S1134-80462013000600002,El,o
247,S1134-80462013000600002,tiempo,o
247,S1134-80462013000600002,transcurrido,o
247,S1134-80462013000600002,entre,o
247,S1134-80462013000600002,la,o
247,S1134-80462013000600002,primera,o
247,S1134-80462013000600002,dosis,o
247,S1134-80462013000600002,y,o
247,S1134-80462013000600002,el,o
247,S1134-80462013000600002,alivio,o
247,S1134-80462013000600002,fue,o
247,S1134-80462013000600002,41,o
247,S1134-80462013000600002,minutos,o
247,S1134-80462013000600002,para,o
247,S1134-80462013000600002,acetaminofen,i
247,S1134-80462013000600002,y,o
247,S1134-80462013000600002,34,o
247,S1134-80462013000600002,minutos,o
247,S1134-80462013000600002,para,o
247,S1134-80462013000600002,codeina,i
247,S1134-80462013000600002,mas,i
247,S1134-80462013000600002,acetaminofen,i
247,S1134-80462013000600002,p,o
247,S1134-80462013000600002,005,o
247,S1134-80462013000600002,El,o
247,S1134-80462013000600002,grupo,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,codeina,i
247,S1134-80462013000600002,presento,o
247,S1134-80462013000600002,mas,o
247,S1134-80462013000600002,estreñimiento,i
247,S1134-80462013000600002,p,o
247,S1134-80462013000600002,0001,o
247,S1134-80462013000600002,Conclusion,o
247,S1134-80462013000600002,No,o
247,S1134-80462013000600002,se,o
247,S1134-80462013000600002,presentaron,o
247,S1134-80462013000600002,diferencias,o
247,S1134-80462013000600002,significativas,o
247,S1134-80462013000600002,en,o
247,S1134-80462013000600002,eficacia,o
247,S1134-80462013000600002,y,o
247,S1134-80462013000600002,tiempo,o
247,S1134-80462013000600002,hasta,o
247,S1134-80462013000600002,el,o
247,S1134-80462013000600002,alivio,o
247,S1134-80462013000600002,del,o
247,S1134-80462013000600002,dolor,i
247,S1134-80462013000600002,El,o
247,S1134-80462013000600002,grupo,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,codeina,i
247,S1134-80462013000600002,presento,o
247,S1134-80462013000600002,mas,o
247,S1134-80462013000600002,estreñimiento,i
247,S1134-80462013000600002,que,o
247,S1134-80462013000600002,el,o
247,S1134-80462013000600002,de,o
247,S1134-80462013000600002,acetaminofen,i
248,S1134-80462015000300002,Efectos,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,la,o
248,S1134-80462015000300002,intervencion,i
248,S1134-80462015000300002,desde,o
248,S1134-80462015000300002,terapia,i
248,S1134-80462015000300002,ocupacional,i
248,S1134-80462015000300002,sobre,o
248,S1134-80462015000300002,la,o
248,S1134-80462015000300002,percepcion,o
248,S1134-80462015000300002,del,o
248,S1134-80462015000300002,dolor,i
248,S1134-80462015000300002,cronico,i
248,S1134-80462015000300002,y,o
248,S1134-80462015000300002,la,o
248,S1134-80462015000300002,calidad,i
248,S1134-80462015000300002,de,i
248,S1134-80462015000300002,vida,i
248,S1134-80462015000300002,en,o
248,S1134-80462015000300002,pacientes,o
248,S1134-80462015000300002,con,o
248,S1134-80462015000300002,artritis,i
248,S1134-80462015000300002,reumatoide,i
248,S1134-80462015000300002,Objetivos,o
248,S1134-80462015000300002,determinar,o
248,S1134-80462015000300002,si,o
248,S1134-80462015000300002,una,o
248,S1134-80462015000300002,propuesta,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,intervencion,i
248,S1134-80462015000300002,experimental,i
248,S1134-80462015000300002,desarrollada,o
248,S1134-80462015000300002,desde,o
248,S1134-80462015000300002,el,o
248,S1134-80462015000300002,campo,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,trabajo,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,la,o
248,S1134-80462015000300002,terapia,i
248,S1134-80462015000300002,ocupacional,i
248,S1134-80462015000300002,dirigida,o
248,S1134-80462015000300002,a,o
248,S1134-80462015000300002,la,o
248,S1134-80462015000300002,reestructuracion,o
248,S1134-80462015000300002,del,o
248,S1134-80462015000300002,desempeño,o
248,S1134-80462015000300002,ocupacional,o
248,S1134-80462015000300002,en,o
248,S1134-80462015000300002,pacientes,o
248,S1134-80462015000300002,con,o
248,S1134-80462015000300002,artritis,i
248,S1134-80462015000300002,reumatoide,i
248,S1134-80462015000300002,reduce,o
248,S1134-80462015000300002,los,o
248,S1134-80462015000300002,niveles,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,dolor,i
248,S1134-80462015000300002,percibidos,o
248,S1134-80462015000300002,y,o
248,S1134-80462015000300002,mejora,o
248,S1134-80462015000300002,la,o
248,S1134-80462015000300002,autoeficacia,i
248,S1134-80462015000300002,y,o
248,S1134-80462015000300002,la,o
248,S1134-80462015000300002,calidad,i
248,S1134-80462015000300002,de,i
248,S1134-80462015000300002,vida,i
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,los,o
248,S1134-80462015000300002,mismos,o
248,S1134-80462015000300002,Esta,o
248,S1134-80462015000300002,intervencion,i
248,S1134-80462015000300002,se,o
248,S1134-80462015000300002,llevo,o
248,S1134-80462015000300002,a,o
248,S1134-80462015000300002,cabo,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,forma,o
248,S1134-80462015000300002,grupal,o
248,S1134-80462015000300002,utilizando,o
248,S1134-80462015000300002,modelos,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,formacion,o
248,S1134-80462015000300002,y,o
248,S1134-80462015000300002,enseñanza,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,estrategias,o
248,S1134-80462015000300002,a,o
248,S1134-80462015000300002,los,o
248,S1134-80462015000300002,pacientes,o
248,S1134-80462015000300002,Material,o
248,S1134-80462015000300002,y,o
248,S1134-80462015000300002,metodo,o
248,S1134-80462015000300002,estudio,i
248,S1134-80462015000300002,de,i
248,S1134-80462015000300002,intervencion,i
248,S1134-80462015000300002,controlado,i
248,S1134-80462015000300002,aleatorizado,i
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,un,o
248,S1134-80462015000300002,programa,o
248,S1134-80462015000300002,grupal,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,terapia,i
248,S1134-80462015000300002,ocupacional,i
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,siete,o
248,S1134-80462015000300002,sesiones,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,dos,o
248,S1134-80462015000300002,horas,o
248,S1134-80462015000300002,cada,o
248,S1134-80462015000300002,una,o
248,S1134-80462015000300002,realizadas,o
248,S1134-80462015000300002,en,o
248,S1134-80462015000300002,cinco,o
248,S1134-80462015000300002,semanas,o
248,S1134-80462015000300002,Resultados,o
248,S1134-80462015000300002,se,o
248,S1134-80462015000300002,detecto,o
248,S1134-80462015000300002,una,o
248,S1134-80462015000300002,mejora,o
248,S1134-80462015000300002,en,o
248,S1134-80462015000300002,las,o
248,S1134-80462015000300002,puntuaciones,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,autoeficacia,i
248,S1134-80462015000300002,p,o
248,S1134-80462015000300002,0001,o
248,S1134-80462015000300002,y,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,calidad,i
248,S1134-80462015000300002,de,i
248,S1134-80462015000300002,vida,i
248,S1134-80462015000300002,p,o
248,S1134-80462015000300002,0001,o
248,S1134-80462015000300002,p,o
248,S1134-80462015000300002,008,o
248,S1134-80462015000300002,asi,o
248,S1134-80462015000300002,como,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,las,o
248,S1134-80462015000300002,puntuaciones,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,intensidad,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,dolor,i
248,S1134-80462015000300002,medidas,o
248,S1134-80462015000300002,con,o
248,S1134-80462015000300002,MPQ,o
248,S1134-80462015000300002,McGill,o
248,S1134-80462015000300002,Pain,o
248,S1134-80462015000300002,Questionnaire,o
248,S1134-80462015000300002,aunque,o
248,S1134-80462015000300002,los,o
248,S1134-80462015000300002,valores,o
248,S1134-80462015000300002,recogidos,o
248,S1134-80462015000300002,con,o
248,S1134-80462015000300002,EVA,i
248,S1134-80462015000300002,escala,i
248,S1134-80462015000300002,visual,i
248,S1134-80462015000300002,analogica,i
248,S1134-80462015000300002,se,o
248,S1134-80462015000300002,mantienen,o
248,S1134-80462015000300002,en,o
248,S1134-80462015000300002,el,o
248,S1134-80462015000300002,tiempo,o
248,S1134-80462015000300002,Conclusiones,o
248,S1134-80462015000300002,el,o
248,S1134-80462015000300002,programa,o
248,S1134-80462015000300002,resulto,o
248,S1134-80462015000300002,eficaz,o
248,S1134-80462015000300002,en,o
248,S1134-80462015000300002,la,o
248,S1134-80462015000300002,modificacion,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,las,o
248,S1134-80462015000300002,variables,o
248,S1134-80462015000300002,estudiadas,o
248,S1134-80462015000300002,apreciandose,o
248,S1134-80462015000300002,cambios,o
248,S1134-80462015000300002,significativos,o
248,S1134-80462015000300002,tanto,o
248,S1134-80462015000300002,en,o
248,S1134-80462015000300002,intensidad,o
248,S1134-80462015000300002,de,o
248,S1134-80462015000300002,dolor,i
248,S1134-80462015000300002,como,o
248,S1134-80462015000300002,en,o
248,S1134-80462015000300002,los,o
248,S1134-80462015000300002,valores,o
248,S1134-80462015000300002,referidos,o
248,S1134-80462015000300002,a,o
248,S1134-80462015000300002,autoeficacia,i
248,S1134-80462015000300002,y,o
248,S1134-80462015000300002,calidad,i
248,S1134-80462015000300002,de,i
248,S1134-80462015000300002,vida,i
248,S1134-80462015000300002,Es,o
248,S1134-80462015000300002,recomendable,o
248,S1134-80462015000300002,repetir,o
248,S1134-80462015000300002,el,o
248,S1134-80462015000300002,trabajo,o
248,S1134-80462015000300002,con,o
248,S1134-80462015000300002,una,o
248,S1134-80462015000300002,muestra,o
248,S1134-80462015000300002,mayor,o
248,S1134-80462015000300002,que,o
248,S1134-80462015000300002,permita,o
248,S1134-80462015000300002,obtener,o
248,S1134-80462015000300002,datos,o
248,S1134-80462015000300002,mas,o
248,S1134-80462015000300002,consistentes,o
249,S1134-80462015000500003,Gabapentina,i
249,S1134-80462015000500003,preoperatoria,o
249,S1134-80462015000500003,como,o
249,S1134-80462015000500003,adyuvante,i
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,manejo,o
249,S1134-80462015000500003,del,o
249,S1134-80462015000500003,dolor,i
249,S1134-80462015000500003,agudo,i
249,S1134-80462015000500003,postoperatorio,i
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,histerectomia,i
249,S1134-80462015000500003,abdominal,i
249,S1134-80462015000500003,Introduccion,o
249,S1134-80462015000500003,es,o
249,S1134-80462015000500003,bien,o
249,S1134-80462015000500003,conocido,o
249,S1134-80462015000500003,que,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,dolor,i
249,S1134-80462015000500003,es,o
249,S1134-80462015000500003,sintoma,i
249,S1134-80462015000500003,subjetivo,i
249,S1134-80462015000500003,y,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,dolor,i
249,S1134-80462015000500003,postoperatorio,i
249,S1134-80462015000500003,sigue,o
249,S1134-80462015000500003,teniendo,o
249,S1134-80462015000500003,preponderancia,o
249,S1134-80462015000500003,mundial,o
249,S1134-80462015000500003,ya,o
249,S1134-80462015000500003,que,o
249,S1134-80462015000500003,a,o
249,S1134-80462015000500003,pesar,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,todos,o
249,S1134-80462015000500003,los,o
249,S1134-80462015000500003,avances,o
249,S1134-80462015000500003,aun,o
249,S1134-80462015000500003,no,o
249,S1134-80462015000500003,se,o
249,S1134-80462015000500003,ha,o
249,S1134-80462015000500003,podido,o
249,S1134-80462015000500003,erradicar,i
249,S1134-80462015000500003,por,o
249,S1134-80462015000500003,completo,o
249,S1134-80462015000500003,Objetivo,o
249,S1134-80462015000500003,evaluar,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,efecto,o
249,S1134-80462015000500003,adyuvante,i
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,la,o
249,S1134-80462015000500003,intensidad,o
249,S1134-80462015000500003,del,o
249,S1134-80462015000500003,dolor,i
249,S1134-80462015000500003,agudo,i
249,S1134-80462015000500003,postoperatorio,i
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,600,o
249,S1134-80462015000500003,mg,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,gabapentina,i
249,S1134-80462015000500003,administrada,o
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,preoperatorio,o
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,pacientes,o
249,S1134-80462015000500003,sometidas,o
249,S1134-80462015000500003,a,o
249,S1134-80462015000500003,histerectomia,i
249,S1134-80462015000500003,abdominal,i
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,Hospital,o
249,S1134-80462015000500003,Santo,o
249,S1134-80462015000500003,Tomas,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,abril,o
249,S1134-80462015000500003,a,o
249,S1134-80462015000500003,agosto,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,2014,o
249,S1134-80462015000500003,Metodos,o
249,S1134-80462015000500003,se,o
249,S1134-80462015000500003,realizo,o
249,S1134-80462015000500003,un,o
249,S1134-80462015000500003,estudio,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,cohorte,o
249,S1134-80462015000500003,experimental,o
249,S1134-80462015000500003,prospectivo,o
249,S1134-80462015000500003,aleatorizado,o
249,S1134-80462015000500003,controlado,o
249,S1134-80462015000500003,doble,o
249,S1134-80462015000500003,ciego,o
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,pacientes,o
249,S1134-80462015000500003,sometidas,o
249,S1134-80462015000500003,a,o
249,S1134-80462015000500003,histerectomia,i
249,S1134-80462015000500003,abdominal,i
249,S1134-80462015000500003,con,o
249,S1134-80462015000500003,anestesia,i
249,S1134-80462015000500003,general,i
249,S1134-80462015000500003,Se,o
249,S1134-80462015000500003,aleatorizo,i
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,dos,o
249,S1134-80462015000500003,grupos,o
249,S1134-80462015000500003,grupo,o
249,S1134-80462015000500003,gabapentina,i
249,S1134-80462015000500003,gabapentina,i
249,S1134-80462015000500003,600,o
249,S1134-80462015000500003,mg,o
249,S1134-80462015000500003,2,o
249,S1134-80462015000500003,horas,o
249,S1134-80462015000500003,preoperatoria,o
249,S1134-80462015000500003,analgesia,i
249,S1134-80462015000500003,con,o
249,S1134-80462015000500003,morfina,i
249,S1134-80462015000500003,a,o
249,S1134-80462015000500003,traves,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,bomba,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,analgesia,i
249,S1134-80462015000500003,controlada,i
249,S1134-80462015000500003,por,i
249,S1134-80462015000500003,el,i
249,S1134-80462015000500003,paciente,i
249,S1134-80462015000500003,PCA,i
249,S1134-80462015000500003,y,o
249,S1134-80462015000500003,grupo,o
249,S1134-80462015000500003,control,o
249,S1134-80462015000500003,analgesia,i
249,S1134-80462015000500003,con,o
249,S1134-80462015000500003,morfina,i
249,S1134-80462015000500003,a,o
249,S1134-80462015000500003,traves,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,bomba,o
249,S1134-80462015000500003,PCA,i
249,S1134-80462015000500003,la,o
249,S1134-80462015000500003,dosis,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,morfina,i
249,S1134-80462015000500003,se,o
249,S1134-80462015000500003,calculo,o
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,funcion,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,rangos,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,peso,o
249,S1134-80462015000500003,a,o
249,S1134-80462015000500003,0016,o
249,S1134-80462015000500003,mgkgh,o
249,S1134-80462015000500003,Se,o
249,S1134-80462015000500003,evaluo,o
249,S1134-80462015000500003,la,o
249,S1134-80462015000500003,intensidad,o
249,S1134-80462015000500003,del,o
249,S1134-80462015000500003,dolor,i
249,S1134-80462015000500003,con,o
249,S1134-80462015000500003,la,o
249,S1134-80462015000500003,escala,i
249,S1134-80462015000500003,verbal,i
249,S1134-80462015000500003,numerica,i
249,S1134-80462015000500003,EVN,i
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,11,o
249,S1134-80462015000500003,puntos,o
249,S1134-80462015000500003,a,o
249,S1134-80462015000500003,las,o
249,S1134-80462015000500003,2,o
249,S1134-80462015000500003,6,o
249,S1134-80462015000500003,y,o
249,S1134-80462015000500003,24,o
249,S1134-80462015000500003,horas,o
249,S1134-80462015000500003,se,o
249,S1134-80462015000500003,cuantifico,o
249,S1134-80462015000500003,la,o
249,S1134-80462015000500003,cantidad,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,rescates,i
249,S1134-80462015000500003,administrados,o
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,postoperatorio,o
249,S1134-80462015000500003,y,o
249,S1134-80462015000500003,se,o
249,S1134-80462015000500003,midio,o
249,S1134-80462015000500003,la,o
249,S1134-80462015000500003,prevalencia,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,efectos,i
249,S1134-80462015000500003,adversos,i
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,ambos,o
249,S1134-80462015000500003,grupos,o
249,S1134-80462015000500003,Resultados,o
249,S1134-80462015000500003,se,o
249,S1134-80462015000500003,reclutaron,o
249,S1134-80462015000500003,72,o
249,S1134-80462015000500003,pacientes,o
249,S1134-80462015000500003,divididos,o
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,dos,o
249,S1134-80462015000500003,grupos,o
249,S1134-80462015000500003,homogeneos,o
249,S1134-80462015000500003,la,o
249,S1134-80462015000500003,edad,o
249,S1134-80462015000500003,media,o
249,S1134-80462015000500003,fue,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,4472,o
249,S1134-80462015000500003,617,o
249,S1134-80462015000500003,años,o
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,grupo,o
249,S1134-80462015000500003,gabapentina,i
249,S1134-80462015000500003,y,o
249,S1134-80462015000500003,4936,o
249,S1134-80462015000500003,931,o
249,S1134-80462015000500003,años,o
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,grupo,o
249,S1134-80462015000500003,control,o
249,S1134-80462015000500003,En,o
249,S1134-80462015000500003,cuanto,o
249,S1134-80462015000500003,al,o
249,S1134-80462015000500003,dolor,i
249,S1134-80462015000500003,postoperatorio,i
249,S1134-80462015000500003,hubo,o
249,S1134-80462015000500003,diferencia,o
249,S1134-80462015000500003,estadisticamente,o
249,S1134-80462015000500003,significativa,o
249,S1134-80462015000500003,entre,o
249,S1134-80462015000500003,los,o
249,S1134-80462015000500003,dos,o
249,S1134-80462015000500003,grupos,o
249,S1134-80462015000500003,p,o
249,S1134-80462015000500003,005,o
249,S1134-80462015000500003,se,o
249,S1134-80462015000500003,encontro,o
249,S1134-80462015000500003,una,o
249,S1134-80462015000500003,diferencia,o
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,la,o
249,S1134-80462015000500003,EVN,i
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,11,o
249,S1134-80462015000500003,puntos,o
249,S1134-80462015000500003,427,o
249,S1134-80462015000500003,232,o
249,S1134-80462015000500003,194,o
249,S1134-80462015000500003,195,o
249,S1134-80462015000500003,y,o
249,S1134-80462015000500003,077,o
249,S1134-80462015000500003,128,o
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,grupo,o
249,S1134-80462015000500003,gabapentina,i
249,S1134-80462015000500003,y,o
249,S1134-80462015000500003,713,o
249,S1134-80462015000500003,241,o
249,S1134-80462015000500003,45,o
249,S1134-80462015000500003,237,o
249,S1134-80462015000500003,y,o
249,S1134-80462015000500003,325,o
249,S1134-80462015000500003,218,o
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,grupo,o
249,S1134-80462015000500003,control,o
249,S1134-80462015000500003,a,o
249,S1134-80462015000500003,las,o
249,S1134-80462015000500003,2,o
249,S1134-80462015000500003,6,o
249,S1134-80462015000500003,y,o
249,S1134-80462015000500003,24,o
249,S1134-80462015000500003,horas,o
249,S1134-80462015000500003,respectivamente,o
249,S1134-80462015000500003,se,o
249,S1134-80462015000500003,cuantifico,o
249,S1134-80462015000500003,la,o
249,S1134-80462015000500003,cantidad,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,rescates,i
249,S1134-80462015000500003,administrados,o
249,S1134-80462015000500003,por,o
249,S1134-80462015000500003,bomba,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,PCA,i
249,S1134-80462015000500003,durante,o
249,S1134-80462015000500003,las,o
249,S1134-80462015000500003,primeras,o
249,S1134-80462015000500003,24,o
249,S1134-80462015000500003,horas,o
249,S1134-80462015000500003,postoperatorias,o
249,S1134-80462015000500003,fue,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,672,o
249,S1134-80462015000500003,57,o
249,S1134-80462015000500003,para,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,grupo,o
249,S1134-80462015000500003,gabapentina,i
249,S1134-80462015000500003,y,o
249,S1134-80462015000500003,2413,o
249,S1134-80462015000500003,4701,o
249,S1134-80462015000500003,para,o
249,S1134-80462015000500003,el,o
249,S1134-80462015000500003,grupo,o
249,S1134-80462015000500003,control,o
249,S1134-80462015000500003,una,o
249,S1134-80462015000500003,diferencia,o
249,S1134-80462015000500003,estadisticamente,o
249,S1134-80462015000500003,significativa,o
249,S1134-80462015000500003,p,o
249,S1134-80462015000500003,005,o
249,S1134-80462015000500003,la,o
249,S1134-80462015000500003,prevalencia,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,efectos,i
249,S1134-80462015000500003,adversos,i
249,S1134-80462015000500003,no,o
249,S1134-80462015000500003,fue,o
249,S1134-80462015000500003,estadisticamente,o
249,S1134-80462015000500003,significativa,o
249,S1134-80462015000500003,entre,o
249,S1134-80462015000500003,ambos,o
249,S1134-80462015000500003,grupos,o
249,S1134-80462015000500003,Conclusion,o
249,S1134-80462015000500003,estos,o
249,S1134-80462015000500003,resultados,o
249,S1134-80462015000500003,indican,o
249,S1134-80462015000500003,que,o
249,S1134-80462015000500003,la,o
249,S1134-80462015000500003,gabapentina,i
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,dosis,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,600,o
249,S1134-80462015000500003,mg,o
249,S1134-80462015000500003,preoperatoria,o
249,S1134-80462015000500003,es,o
249,S1134-80462015000500003,una,o
249,S1134-80462015000500003,opcion,o
249,S1134-80462015000500003,terapeutica,o
249,S1134-80462015000500003,valida,o
249,S1134-80462015000500003,en,o
249,S1134-80462015000500003,analgesia,i
249,S1134-80462015000500003,preoperatoria,o
249,S1134-80462015000500003,para,o
249,S1134-80462015000500003,histerectomia,i
249,S1134-80462015000500003,abdominal,i
249,S1134-80462015000500003,Cabe,o
249,S1134-80462015000500003,destacar,o
249,S1134-80462015000500003,que,o
249,S1134-80462015000500003,aun,o
249,S1134-80462015000500003,nos,o
249,S1134-80462015000500003,queda,o
249,S1134-80462015000500003,por,o
249,S1134-80462015000500003,dilucidar,o
249,S1134-80462015000500003,la,o
249,S1134-80462015000500003,dosis,o
249,S1134-80462015000500003,optima,o
249,S1134-80462015000500003,efectiva,o
249,S1134-80462015000500003,y,o
249,S1134-80462015000500003,que,o
249,S1134-80462015000500003,presente,o
249,S1134-80462015000500003,menor,o
249,S1134-80462015000500003,incidencia,o
249,S1134-80462015000500003,de,o
249,S1134-80462015000500003,efectos,i
249,S1134-80462015000500003,adversos,i
250,S1134-80462017000200068,Comparacion,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,dos,o
250,S1134-80462017000200068,concentraciones,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,bupivacaina,i
250,S1134-80462017000200068,en,o
250,S1134-80462017000200068,infusion,i
250,S1134-80462017000200068,continua,i
250,S1134-80462017000200068,para,i
250,S1134-80462017000200068,vertebral,i
250,S1134-80462017000200068,para,o
250,S1134-80462017000200068,tratamiento,i
250,S1134-80462017000200068,del,i
250,S1134-80462017000200068,dolor,i
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,toracotomia,i
250,S1134-80462017000200068,con,o
250,S1134-80462017000200068,reseccion,i
250,S1134-80462017000200068,pulmonar,i
250,S1134-80462017000200068,ensayo,i
250,S1134-80462017000200068,clinico,i
250,S1134-80462017000200068,aleatorizado,i
250,S1134-80462017000200068,doble,i
250,S1134-80462017000200068,ciego,i
250,S1134-80462017000200068,Antecedentes,o
250,S1134-80462017000200068,y,o
250,S1134-80462017000200068,objetivos,o
250,S1134-80462017000200068,El,o
250,S1134-80462017000200068,manejo,o
250,S1134-80462017000200068,del,o
250,S1134-80462017000200068,dolor,i
250,S1134-80462017000200068,posttoracotomia,o
250,S1134-80462017000200068,debe,o
250,S1134-80462017000200068,basarse,o
250,S1134-80462017000200068,en,o
250,S1134-80462017000200068,un,o
250,S1134-80462017000200068,enfoque,o
250,S1134-80462017000200068,multimodal,o
250,S1134-80462017000200068,que,o
250,S1134-80462017000200068,incluye,o
250,S1134-80462017000200068,la,o
250,S1134-80462017000200068,analgesia,i
250,S1134-80462017000200068,regional,i
250,S1134-80462017000200068,continua,i
250,S1134-80462017000200068,El,o
250,S1134-80462017000200068,objetivo,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,este,o
250,S1134-80462017000200068,estudio,o
250,S1134-80462017000200068,fue,o
250,S1134-80462017000200068,comparar,i
250,S1134-80462017000200068,la,i
250,S1134-80462017000200068,eficacia,i
250,S1134-80462017000200068,analgesica,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,dos,o
250,S1134-80462017000200068,concentraciones,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,bupivacaina,i
250,S1134-80462017000200068,02,o
250,S1134-80462017000200068,y,o
250,S1134-80462017000200068,03,o
250,S1134-80462017000200068,a,o
250,S1134-80462017000200068,traves,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,un,o
250,S1134-80462017000200068,cateter,o
250,S1134-80462017000200068,paravertebral,o
250,S1134-80462017000200068,ambos,o
250,S1134-80462017000200068,grupos,o
250,S1134-80462017000200068,mas,o
250,S1134-80462017000200068,fentanilo,i
250,S1134-80462017000200068,2,o
250,S1134-80462017000200068,mcgml,o
250,S1134-80462017000200068,Material,o
250,S1134-80462017000200068,y,o
250,S1134-80462017000200068,metodos,o
250,S1134-80462017000200068,Se,o
250,S1134-80462017000200068,realizo,o
250,S1134-80462017000200068,un,o
250,S1134-80462017000200068,ensayo,i
250,S1134-80462017000200068,clinico,i
250,S1134-80462017000200068,aleatorizado,i
250,S1134-80462017000200068,doble,i
250,S1134-80462017000200068,ciego,i
250,S1134-80462017000200068,para,o
250,S1134-80462017000200068,comparar,o
250,S1134-80462017000200068,estas,o
250,S1134-80462017000200068,dos,o
250,S1134-80462017000200068,concentraciones,o
250,S1134-80462017000200068,en,o
250,S1134-80462017000200068,pacientes,o
250,S1134-80462017000200068,sometidos,o
250,S1134-80462017000200068,a,o
250,S1134-80462017000200068,reseccion,i
250,S1134-80462017000200068,pulmonar,i
250,S1134-80462017000200068,por,o
250,S1134-80462017000200068,toracotomia,i
250,S1134-80462017000200068,en,o
250,S1134-80462017000200068,el,o
250,S1134-80462017000200068,Hospital,o
250,S1134-80462017000200068,Universitario,o
250,S1134-80462017000200068,Donostia,o
250,S1134-80462017000200068,entre,o
250,S1134-80462017000200068,noviembre,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,2010,o
250,S1134-80462017000200068,y,o
250,S1134-80462017000200068,mayo,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,2011,o
250,S1134-80462017000200068,n,o
250,S1134-80462017000200068,59,o
250,S1134-80462017000200068,El,o
250,S1134-80462017000200068,cateter,o
250,S1134-80462017000200068,paravertebral,o
250,S1134-80462017000200068,se,o
250,S1134-80462017000200068,coloco,o
250,S1134-80462017000200068,antes,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,la,o
250,S1134-80462017000200068,intervencion,i
250,S1134-80462017000200068,quirurgica,i
250,S1134-80462017000200068,con,o
250,S1134-80462017000200068,el,o
250,S1134-80462017000200068,paciente,o
250,S1134-80462017000200068,despierto,o
250,S1134-80462017000200068,en,o
250,S1134-80462017000200068,posicion,o
250,S1134-80462017000200068,sentada,o
250,S1134-80462017000200068,Los,o
250,S1134-80462017000200068,datos,o
250,S1134-80462017000200068,se,o
250,S1134-80462017000200068,analizaron,i
250,S1134-80462017000200068,sobre,i
250,S1134-80462017000200068,la,i
250,S1134-80462017000200068,base,i
250,S1134-80462017000200068,de,i
250,S1134-80462017000200068,intencion,i
250,S1134-80462017000200068,de,i
250,S1134-80462017000200068,tratar,i
250,S1134-80462017000200068,Se,o
250,S1134-80462017000200068,utilizo,o
250,S1134-80462017000200068,la,o
250,S1134-80462017000200068,prueba,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,Chi,o
250,S1134-80462017000200068,cuadrado,o
250,S1134-80462017000200068,para,o
250,S1134-80462017000200068,variables,o
250,S1134-80462017000200068,cualitativas,o
250,S1134-80462017000200068,y,o
250,S1134-80462017000200068,la,o
250,S1134-80462017000200068,t,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,Student,o
250,S1134-80462017000200068,o,o
250,S1134-80462017000200068,pruebas,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,MannWhitneyWilcoxon,o
250,S1134-80462017000200068,para,o
250,S1134-80462017000200068,las,o
250,S1134-80462017000200068,variables,o
250,S1134-80462017000200068,cuantitativas,o
250,S1134-80462017000200068,en,o
250,S1134-80462017000200068,funcion,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,la,o
250,S1134-80462017000200068,distribucion,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,las,o
250,S1134-80462017000200068,variables,o
250,S1134-80462017000200068,El,o
250,S1134-80462017000200068,analisis,o
250,S1134-80462017000200068,estadistico,o
250,S1134-80462017000200068,se,o
250,S1134-80462017000200068,realizo,o
250,S1134-80462017000200068,utilizando,o
250,S1134-80462017000200068,el,o
250,S1134-80462017000200068,software,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,IBM,o
250,S1134-80462017000200068,SPSS,o
250,S1134-80462017000200068,version,o
250,S1134-80462017000200068,17,o
250,S1134-80462017000200068,Resultados,o
250,S1134-80462017000200068,No,o
250,S1134-80462017000200068,se,o
250,S1134-80462017000200068,encontraron,o
250,S1134-80462017000200068,diferencias,o
250,S1134-80462017000200068,estadisticamente,o
250,S1134-80462017000200068,significativas,o
250,S1134-80462017000200068,en,o
250,S1134-80462017000200068,la,o
250,S1134-80462017000200068,funcion,i
250,S1134-80462017000200068,pulmonar,i
250,S1134-80462017000200068,postoperatoria,o
250,S1134-80462017000200068,p,o
250,S1134-80462017000200068,049,o
250,S1134-80462017000200068,la,o
250,S1134-80462017000200068,percepcion,i
250,S1134-80462017000200068,subjetiva,i
250,S1134-80462017000200068,de,i
250,S1134-80462017000200068,dolor,i
250,S1134-80462017000200068,VAS,i
250,S1134-80462017000200068,p,o
250,S1134-80462017000200068,028,o
250,S1134-80462017000200068,o,o
250,S1134-80462017000200068,el,o
250,S1134-80462017000200068,consumo,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,morfina,i
250,S1134-80462017000200068,acumulada,o
250,S1134-80462017000200068,p,o
250,S1134-80462017000200068,0101,o
250,S1134-80462017000200068,en,o
250,S1134-80462017000200068,los,o
250,S1134-80462017000200068,dos,o
250,S1134-80462017000200068,grupos,o
250,S1134-80462017000200068,Hemos,o
250,S1134-80462017000200068,observado,o
250,S1134-80462017000200068,efectos,i
250,S1134-80462017000200068,adversos,i
250,S1134-80462017000200068,en,o
250,S1134-80462017000200068,8,o
250,S1134-80462017000200068,pacientes,o
250,S1134-80462017000200068,del,o
250,S1134-80462017000200068,grupo,o
250,S1134-80462017000200068,1,o
250,S1134-80462017000200068,296,o
250,S1134-80462017000200068,y,o
250,S1134-80462017000200068,en,o
250,S1134-80462017000200068,12,o
250,S1134-80462017000200068,pacientes,o
250,S1134-80462017000200068,375,o
250,S1134-80462017000200068,del,o
250,S1134-80462017000200068,grupo,o
250,S1134-80462017000200068,2,o
250,S1134-80462017000200068,la,o
250,S1134-80462017000200068,diferencia,o
250,S1134-80462017000200068,no,o
250,S1134-80462017000200068,fue,o
250,S1134-80462017000200068,estadisticamente,o
250,S1134-80462017000200068,significativa,o
250,S1134-80462017000200068,p,o
250,S1134-80462017000200068,052,o
250,S1134-80462017000200068,Conclusiones,o
250,S1134-80462017000200068,El,o
250,S1134-80462017000200068,bloqueo,i
250,S1134-80462017000200068,paravertebral,i
250,S1134-80462017000200068,toracico,i
250,S1134-80462017000200068,continuo,i
250,S1134-80462017000200068,durante,o
250,S1134-80462017000200068,48,o
250,S1134-80462017000200068,horas,o
250,S1134-80462017000200068,es,o
250,S1134-80462017000200068,una,o
250,S1134-80462017000200068,buena,o
250,S1134-80462017000200068,tecnica,o
250,S1134-80462017000200068,para,o
250,S1134-80462017000200068,el,o
250,S1134-80462017000200068,manejo,o
250,S1134-80462017000200068,del,o
250,S1134-80462017000200068,dolor,i
250,S1134-80462017000200068,postoperatorio,i
250,S1134-80462017000200068,despues,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,la,o
250,S1134-80462017000200068,reseccion,i
250,S1134-80462017000200068,pulmonar,i
250,S1134-80462017000200068,por,o
250,S1134-80462017000200068,toracotomia,i
250,S1134-80462017000200068,Con,o
250,S1134-80462017000200068,dosis,o
250,S1134-80462017000200068,moderadas,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,anestesicos,i
250,S1134-80462017000200068,locales,i
250,S1134-80462017000200068,bupivacaina,i
250,S1134-80462017000200068,020,o
250,S1134-80462017000200068,se,o
250,S1134-80462017000200068,logro,o
250,S1134-80462017000200068,un,o
250,S1134-80462017000200068,buen,o
250,S1134-80462017000200068,control,i
250,S1134-80462017000200068,del,i
250,S1134-80462017000200068,dolor,i
250,S1134-80462017000200068,y,o
250,S1134-80462017000200068,observamos,o
250,S1134-80462017000200068,un,o
250,S1134-80462017000200068,numero,o
250,S1134-80462017000200068,menor,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,complicaciones,i
250,S1134-80462017000200068,sistemicas,o
250,S1134-80462017000200068,que,o
250,S1134-80462017000200068,el,o
250,S1134-80462017000200068,grupo,o
250,S1134-80462017000200068,de,o
250,S1134-80462017000200068,dosis,o
250,S1134-80462017000200068,mayores,o
250,S1134-80462017000200068,bupivacaina,i
250,S1134-80462017000200068,030,o
251,S1134-80462019000100014,Dexmedetomidina,i
251,S1134-80462019000100014,versus,o
251,S1134-80462019000100014,lidocaina,i
251,S1134-80462019000100014,endovenosa,o
251,S1134-80462019000100014,en,o
251,S1134-80462019000100014,el,o
251,S1134-80462019000100014,control,i
251,S1134-80462019000100014,de,i
251,S1134-80462019000100014,dolor,i
251,S1134-80462019000100014,irruptivo,i
251,S1134-80462019000100014,y,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,funcionalidad,o
251,S1134-80462019000100014,en,o
251,S1134-80462019000100014,pacientes,o
251,S1134-80462019000100014,con,o
251,S1134-80462019000100014,canal,i
251,S1134-80462019000100014,lumbar,i
251,S1134-80462019000100014,estrecho,i
251,S1134-80462019000100014,Introduccion,o
251,S1134-80462019000100014,El,o
251,S1134-80462019000100014,dolor,i
251,S1134-80462019000100014,es,o
251,S1134-80462019000100014,un,o
251,S1134-80462019000100014,motivo,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,ausentismo,o
251,S1134-80462019000100014,laboral,o
251,S1134-80462019000100014,en,o
251,S1134-80462019000100014,especial,o
251,S1134-80462019000100014,el,o
251,S1134-80462019000100014,dolor,i
251,S1134-80462019000100014,irruptivo,i
251,S1134-80462019000100014,secundario,o
251,S1134-80462019000100014,a,o
251,S1134-80462019000100014,canal,i
251,S1134-80462019000100014,lumbar,i
251,S1134-80462019000100014,estrecho,i
251,S1134-80462019000100014,La,o
251,S1134-80462019000100014,dexmedetomidina,i
251,S1134-80462019000100014,como,o
251,S1134-80462019000100014,analgesico,i
251,S1134-80462019000100014,actua,o
251,S1134-80462019000100014,inhibiendo,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,liberacion,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,sustancia,i
251,S1134-80462019000100014,P,i
251,S1134-80462019000100014,en,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,via,o
251,S1134-80462019000100014,nociceptiva,o
251,S1134-80462019000100014,y,o
251,S1134-80462019000100014,bloquea,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,receptores,i
251,S1134-80462019000100014,de,i
251,S1134-80462019000100014,aspartato,i
251,S1134-80462019000100014,y,i
251,S1134-80462019000100014,glutamato,i
251,S1134-80462019000100014,Por,o
251,S1134-80462019000100014,otro,o
251,S1134-80462019000100014,lado,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,lidocaina,i
251,S1134-80462019000100014,tambien,o
251,S1134-80462019000100014,previene,i
251,S1134-80462019000100014,y,o
251,S1134-80462019000100014,alivia,o
251,S1134-80462019000100014,el,o
251,S1134-80462019000100014,dolor,i
251,S1134-80462019000100014,mediante,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,interrupcion,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,neuroconduccion,o
251,S1134-80462019000100014,uniendose,o
251,S1134-80462019000100014,a,o
251,S1134-80462019000100014,su,o
251,S1134-80462019000100014,receptor,i
251,S1134-80462019000100014,especifico,o
251,S1134-80462019000100014,dentro,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,canales,i
251,S1134-80462019000100014,de,i
251,S1134-80462019000100014,sodio,i
251,S1134-80462019000100014,Objetivo,o
251,S1134-80462019000100014,Evaluar,i
251,S1134-80462019000100014,la,i
251,S1134-80462019000100014,eficacia,i
251,S1134-80462019000100014,analgesica,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,dexmedetomidina,i
251,S1134-80462019000100014,versus,o
251,S1134-80462019000100014,lidocaina,i
251,S1134-80462019000100014,en,o
251,S1134-80462019000100014,perfusion,i
251,S1134-80462019000100014,endovenosa,i
251,S1134-80462019000100014,como,o
251,S1134-80462019000100014,tratamiento,i
251,S1134-80462019000100014,del,i
251,S1134-80462019000100014,dolor,i
251,S1134-80462019000100014,irruptivo,i
251,S1134-80462019000100014,secundario,o
251,S1134-80462019000100014,a,o
251,S1134-80462019000100014,canal,i
251,S1134-80462019000100014,lumbar,i
251,S1134-80462019000100014,estrecho,i
251,S1134-80462019000100014,Material,o
251,S1134-80462019000100014,y,o
251,S1134-80462019000100014,metodos,o
251,S1134-80462019000100014,Ensayo,o
251,S1134-80462019000100014,clinico,o
251,S1134-80462019000100014,controlado,o
251,S1134-80462019000100014,aleatorizado,o
251,S1134-80462019000100014,triple,o
251,S1134-80462019000100014,ciego,o
251,S1134-80462019000100014,realizado,o
251,S1134-80462019000100014,en,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,clinica,o
251,S1134-80462019000100014,del,o
251,S1134-80462019000100014,dolor,i
251,S1134-80462019000100014,del,o
251,S1134-80462019000100014,HGM,o
251,S1134-80462019000100014,se,o
251,S1134-80462019000100014,evaluaron,o
251,S1134-80462019000100014,dos,o
251,S1134-80462019000100014,grupos,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,pacientes,o
251,S1134-80462019000100014,con,o
251,S1134-80462019000100014,diagnostico,i
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,dolor,i
251,S1134-80462019000100014,irruptivo,i
251,S1134-80462019000100014,secundario,o
251,S1134-80462019000100014,a,o
251,S1134-80462019000100014,canal,i
251,S1134-80462019000100014,lumbar,i
251,S1134-80462019000100014,estrecho,i
251,S1134-80462019000100014,un,o
251,S1134-80462019000100014,grupo,o
251,S1134-80462019000100014,tratado,i
251,S1134-80462019000100014,con,o
251,S1134-80462019000100014,dexmedetomidina,i
251,S1134-80462019000100014,03,o
251,S1134-80462019000100014,mcgkg,o
251,S1134-80462019000100014,y,o
251,S1134-80462019000100014,otro,o
251,S1134-80462019000100014,grupo,o
251,S1134-80462019000100014,tratado,i
251,S1134-80462019000100014,con,o
251,S1134-80462019000100014,lidocaina,i
251,S1134-80462019000100014,2,o
251,S1134-80462019000100014,mgkg,o
251,S1134-80462019000100014,en,o
251,S1134-80462019000100014,perfusion,i
251,S1134-80462019000100014,endovenosa,i
251,S1134-80462019000100014,Se,o
251,S1134-80462019000100014,realizo,o
251,S1134-80462019000100014,medicion,i
251,S1134-80462019000100014,de,i
251,S1134-80462019000100014,la,i
251,S1134-80462019000100014,intensidad,i
251,S1134-80462019000100014,del,i
251,S1134-80462019000100014,dolor,i
251,S1134-80462019000100014,y,i
251,S1134-80462019000100014,el,i
251,S1134-80462019000100014,estado,i
251,S1134-80462019000100014,de,i
251,S1134-80462019000100014,sedacion,i
251,S1134-80462019000100014,antes,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,iniciar,o
251,S1134-80462019000100014,el,o
251,S1134-80462019000100014,tratamiento,i
251,S1134-80462019000100014,y,o
251,S1134-80462019000100014,posteriormente,o
251,S1134-80462019000100014,a,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,30,o
251,S1134-80462019000100014,60,o
251,S1134-80462019000100014,y,o
251,S1134-80462019000100014,120,o
251,S1134-80462019000100014,minutos,o
251,S1134-80462019000100014,Tambien,o
251,S1134-80462019000100014,se,o
251,S1134-80462019000100014,evaluo,i
251,S1134-80462019000100014,la,i
251,S1134-80462019000100014,funcionalidad,i
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,pacientes,o
251,S1134-80462019000100014,a,o
251,S1134-80462019000100014,traves,o
251,S1134-80462019000100014,del,o
251,S1134-80462019000100014,indice,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,discapacidad,i
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,Oswestry,o
251,S1134-80462019000100014,antes,o
251,S1134-80462019000100014,y,o
251,S1134-80462019000100014,a,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,siete,o
251,S1134-80462019000100014,dias,o
251,S1134-80462019000100014,del,o
251,S1134-80462019000100014,tratamiento,i
251,S1134-80462019000100014,Se,o
251,S1134-80462019000100014,evaluo,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,forma,o
251,S1134-80462019000100014,secundaria,o
251,S1134-80462019000100014,el,o
251,S1134-80462019000100014,efecto,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,tratamientos,i
251,S1134-80462019000100014,sobre,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,signos,o
251,S1134-80462019000100014,vitales,o
251,S1134-80462019000100014,Resultados,o
251,S1134-80462019000100014,No,o
251,S1134-80462019000100014,hubo,o
251,S1134-80462019000100014,diferencia,o
251,S1134-80462019000100014,estadisticamente,o
251,S1134-80462019000100014,significativa,o
251,S1134-80462019000100014,en,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,reduccion,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,intensidad,o
251,S1134-80462019000100014,del,o
251,S1134-80462019000100014,dolor,i
251,S1134-80462019000100014,a,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,120,o
251,S1134-80462019000100014,minutos,o
251,S1134-80462019000100014,entre,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,pacientes,o
251,S1134-80462019000100014,tratados,i
251,S1134-80462019000100014,con,o
251,S1134-80462019000100014,dexmedetomidina,i
251,S1134-80462019000100014,EVA,i
251,S1134-80462019000100014,129,o
251,S1134-80462019000100014,163,o
251,S1134-80462019000100014,comparados,o
251,S1134-80462019000100014,con,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,tratados,i
251,S1134-80462019000100014,con,o
251,S1134-80462019000100014,lidocaina,i
251,S1134-80462019000100014,EVA,i
251,S1134-80462019000100014,1,o
251,S1134-80462019000100014,119,o
251,S1134-80462019000100014,p,o
251,S1134-80462019000100014,0594,o
251,S1134-80462019000100014,Se,o
251,S1134-80462019000100014,observo,o
251,S1134-80462019000100014,que,o
251,S1134-80462019000100014,al,o
251,S1134-80462019000100014,final,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,perfusion,i
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,farmacos,i
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,dexmedetomidina,i
251,S1134-80462019000100014,produjo,o
251,S1134-80462019000100014,mayor,o
251,S1134-80462019000100014,sedacion,i
251,S1134-80462019000100014,a,o
251,S1134-80462019000100014,diferencia,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,lidocaina,i
251,S1134-80462019000100014,p,o
251,S1134-80462019000100014,0003,o
251,S1134-80462019000100014,Ambos,o
251,S1134-80462019000100014,tratamientos,i
251,S1134-80462019000100014,mejoran,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,funcionalidad,o
251,S1134-80462019000100014,en,o
251,S1134-80462019000100014,todos,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,pacientes,o
251,S1134-80462019000100014,sin,o
251,S1134-80462019000100014,haber,o
251,S1134-80462019000100014,diferencia,o
251,S1134-80462019000100014,estadisticamente,o
251,S1134-80462019000100014,significativa,o
251,S1134-80462019000100014,entre,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,tratamientos,i
251,S1134-80462019000100014,p,o
251,S1134-80462019000100014,0508,o
251,S1134-80462019000100014,no,o
251,S1134-80462019000100014,se,o
251,S1134-80462019000100014,observaron,o
251,S1134-80462019000100014,efectos,o
251,S1134-80462019000100014,depresores,o
251,S1134-80462019000100014,sobre,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,signos,o
251,S1134-80462019000100014,vitales,o
251,S1134-80462019000100014,Conclusiones,o
251,S1134-80462019000100014,La,o
251,S1134-80462019000100014,dexmedetomidina,i
251,S1134-80462019000100014,y,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,lidocaina,i
251,S1134-80462019000100014,son,o
251,S1134-80462019000100014,igual,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,eficaces,o
251,S1134-80462019000100014,para,o
251,S1134-80462019000100014,el,o
251,S1134-80462019000100014,tratamiento,i
251,S1134-80462019000100014,del,i
251,S1134-80462019000100014,dolor,i
251,S1134-80462019000100014,irruptivo,i
251,S1134-80462019000100014,con,o
251,S1134-80462019000100014,inicio,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,accion,o
251,S1134-80462019000100014,en,o
251,S1134-80462019000100014,los,o
251,S1134-80462019000100014,primeros,o
251,S1134-80462019000100014,30,o
251,S1134-80462019000100014,minutos,o
251,S1134-80462019000100014,de,o
251,S1134-80462019000100014,iniciada,o
251,S1134-80462019000100014,la,o
251,S1134-80462019000100014,perfusion,i
251,S1134-80462019000100014,hasta,o
251,S1134-80462019000100014,las,o
251,S1134-80462019000100014,siguientes,o
251,S1134-80462019000100014,2,o
251,S1134-80462019000100014,horas,o
251,S1134-80462019000100014,No,o
251,S1134-80462019000100014,se,o
251,S1134-80462019000100014,observaron,o
251,S1134-80462019000100014,eventos,i
251,S1134-80462019000100014,adversos,i
251,S1134-80462019000100014,medicamentosos,i
251,S1134-80462019000100014,a,o
251,S1134-80462019000100014,las,o
251,S1134-80462019000100014,dosis,o
251,S1134-80462019000100014,recomendadas,o
252,S1134-928X2014000200005,Eficacia,o
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,prevencion,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,ulceras,i
252,S1134-928X2014000200005,por,i
252,S1134-928X2014000200005,presion,i
252,S1134-928X2014000200005,del,o
252,S1134-928X2014000200005,aceite,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,oliva,i
252,S1134-928X2014000200005,virgen,o
252,S1134-928X2014000200005,extra,o
252,S1134-928X2014000200005,frente,o
252,S1134-928X2014000200005,a,o
252,S1134-928X2014000200005,los,o
252,S1134-928X2014000200005,acidos,i
252,S1134-928X2014000200005,grasos,i
252,S1134-928X2014000200005,hiperoxigenados,i
252,S1134-928X2014000200005,resultados,o
252,S1134-928X2014000200005,intermedios,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,un,o
252,S1134-928X2014000200005,estudio,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,no,i
252,S1134-928X2014000200005,inferioridad,i
252,S1134-928X2014000200005,Objetivos,o
252,S1134-928X2014000200005,a,o
252,S1134-928X2014000200005,Evaluar,i
252,S1134-928X2014000200005,la,i
252,S1134-928X2014000200005,eficacia,i
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,aplicacion,i
252,S1134-928X2014000200005,topica,i
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,aceite,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,oliva,i
252,S1134-928X2014000200005,virgen,o
252,S1134-928X2014000200005,extra,o
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,prevencion,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,ulceras,i
252,S1134-928X2014000200005,por,i
252,S1134-928X2014000200005,presion,i
252,S1134-928X2014000200005,UPP,i
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,pacientes,o
252,S1134-928X2014000200005,ancianos,o
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,comparacion,o
252,S1134-928X2014000200005,con,o
252,S1134-928X2014000200005,los,o
252,S1134-928X2014000200005,acidos,i
252,S1134-928X2014000200005,grasos,i
252,S1134-928X2014000200005,hiperoxigenados,i
252,S1134-928X2014000200005,AGHO,i
252,S1134-928X2014000200005,medida,o
252,S1134-928X2014000200005,por,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,incidencia,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,UPP,i
252,S1134-928X2014000200005,b,o
252,S1134-928X2014000200005,Determinar,i
252,S1134-928X2014000200005,la,i
252,S1134-928X2014000200005,seguridad,i
252,S1134-928X2014000200005,terapeutica,i
252,S1134-928X2014000200005,efectos,i
252,S1134-928X2014000200005,adversos,i
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,aplicacion,i
252,S1134-928X2014000200005,topica,i
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,aceite,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,oliva,i
252,S1134-928X2014000200005,virgen,o
252,S1134-928X2014000200005,extra,o
252,S1134-928X2014000200005,La,o
252,S1134-928X2014000200005,hipotesis,o
252,S1134-928X2014000200005,por,o
252,S1134-928X2014000200005,contrastar,o
252,S1134-928X2014000200005,es,o
252,S1134-928X2014000200005,que,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,incidencia,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,UPP,i
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,el,o
252,S1134-928X2014000200005,grupo,o
252,S1134-928X2014000200005,tratado,i
252,S1134-928X2014000200005,con,o
252,S1134-928X2014000200005,el,o
252,S1134-928X2014000200005,preparado,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,aceite,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,oliva,i
252,S1134-928X2014000200005,no,o
252,S1134-928X2014000200005,es,o
252,S1134-928X2014000200005,superior,o
252,S1134-928X2014000200005,a,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,incidencia,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,UPP,i
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,el,o
252,S1134-928X2014000200005,grupo,o
252,S1134-928X2014000200005,tratado,i
252,S1134-928X2014000200005,con,o
252,S1134-928X2014000200005,AGHO,i
252,S1134-928X2014000200005,estableciendo,o
252,S1134-928X2014000200005,un,o
252,S1134-928X2014000200005,margen,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,no,o
252,S1134-928X2014000200005,inferioridad,o
252,S1134-928X2014000200005,del,o
252,S1134-928X2014000200005,7,o
252,S1134-928X2014000200005,Metodos,o
252,S1134-928X2014000200005,ensayo,o
252,S1134-928X2014000200005,clinico,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,no,o
252,S1134-928X2014000200005,inferioridad,o
252,S1134-928X2014000200005,multicentrico,o
252,S1134-928X2014000200005,aleatorizado,o
252,S1134-928X2014000200005,y,o
252,S1134-928X2014000200005,controlado,o
252,S1134-928X2014000200005,con,o
252,S1134-928X2014000200005,doble,o
252,S1134-928X2014000200005,enmascaramiento,o
252,S1134-928X2014000200005,Se,o
252,S1134-928X2014000200005,ha,o
252,S1134-928X2014000200005,incluido,o
252,S1134-928X2014000200005,a,o
252,S1134-928X2014000200005,residentes,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,residencias,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,mayores,o
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,provincia,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,Cordoba,o
252,S1134-928X2014000200005,España,o
252,S1134-928X2014000200005,con,o
252,S1134-928X2014000200005,riesgo,o
252,S1134-928X2014000200005,moderado,o
252,S1134-928X2014000200005,o,o
252,S1134-928X2014000200005,alto,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,UPP,i
252,S1134-928X2014000200005,entre,o
252,S1134-928X2014000200005,enero,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,2011,o
252,S1134-928X2014000200005,y,o
252,S1134-928X2014000200005,abril,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,2013,o
252,S1134-928X2014000200005,Se,o
252,S1134-928X2014000200005,excluyeron,o
252,S1134-928X2014000200005,residentes,o
252,S1134-928X2014000200005,que,o
252,S1134-928X2014000200005,ya,o
252,S1134-928X2014000200005,tenian,o
252,S1134-928X2014000200005,alguna,o
252,S1134-928X2014000200005,UPP,i
252,S1134-928X2014000200005,al,o
252,S1134-928X2014000200005,inicio,o
252,S1134-928X2014000200005,con,o
252,S1134-928X2014000200005,enfermedad,i
252,S1134-928X2014000200005,vascular,i
252,S1134-928X2014000200005,o,o
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,situacion,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,gravedad,i
252,S1134-928X2014000200005,extrema,i
252,S1134-928X2014000200005,El,o
252,S1134-928X2014000200005,tamaño,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,muestra,o
252,S1134-928X2014000200005,estimado,o
252,S1134-928X2014000200005,es,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,560,o
252,S1134-928X2014000200005,personas,o
252,S1134-928X2014000200005,con,o
252,S1134-928X2014000200005,un,o
252,S1134-928X2014000200005,muestreo,o
252,S1134-928X2014000200005,sistematico,o
252,S1134-928X2014000200005,consecutivo,o
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,cada,o
252,S1134-928X2014000200005,una,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,las,o
252,S1134-928X2014000200005,residencias,o
252,S1134-928X2014000200005,La,o
252,S1134-928X2014000200005,intervencion,i
252,S1134-928X2014000200005,testada,o
252,S1134-928X2014000200005,fue,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,aplicacion,o
252,S1134-928X2014000200005,cada,o
252,S1134-928X2014000200005,12,o
252,S1134-928X2014000200005,horas,o
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,zonas,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,riesgo,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,un,o
252,S1134-928X2014000200005,preparado,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,aceite,i
252,S1134-928X2014000200005,oliva,i
252,S1134-928X2014000200005,virgen,o
252,S1134-928X2014000200005,extra,o
252,S1134-928X2014000200005,Oleicopiel,o
252,S1134-928X2014000200005,grupo,o
252,S1134-928X2014000200005,experimental,o
252,S1134-928X2014000200005,frente,o
252,S1134-928X2014000200005,a,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,aplicacion,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,AGHO,i
252,S1134-928X2014000200005,Mepentol,i
252,S1134-928X2014000200005,grupo,o
252,S1134-928X2014000200005,control,o
252,S1134-928X2014000200005,Variable,o
252,S1134-928X2014000200005,principal,o
252,S1134-928X2014000200005,incidencia,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,UPP,i
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,cada,o
252,S1134-928X2014000200005,grupo,o
252,S1134-928X2014000200005,Analisis,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,diferencia,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,incidencias,o
252,S1134-928X2014000200005,entre,o
252,S1134-928X2014000200005,los,o
252,S1134-928X2014000200005,dos,o
252,S1134-928X2014000200005,grupos,o
252,S1134-928X2014000200005,y,o
252,S1134-928X2014000200005,tiempo,o
252,S1134-928X2014000200005,hasta,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,aparicion,o
252,S1134-928X2014000200005,analisis,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,supervivencia,i
252,S1134-928X2014000200005,Resultados,o
252,S1134-928X2014000200005,datos,o
252,S1134-928X2014000200005,intermedios,o
252,S1134-928X2014000200005,sobre,o
252,S1134-928X2014000200005,una,o
252,S1134-928X2014000200005,muestra,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,247,o
252,S1134-928X2014000200005,residentes,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,12,o
252,S1134-928X2014000200005,residencias,o
252,S1134-928X2014000200005,Ambos,o
252,S1134-928X2014000200005,grupos,o
252,S1134-928X2014000200005,son,o
252,S1134-928X2014000200005,equivalentes,o
252,S1134-928X2014000200005,al,o
252,S1134-928X2014000200005,inicio,o
252,S1134-928X2014000200005,La,o
252,S1134-928X2014000200005,incidencia,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,UPP,i
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,el,o
252,S1134-928X2014000200005,grupo,o
252,S1134-928X2014000200005,del,o
252,S1134-928X2014000200005,aceite,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,oliva,i
252,S1134-928X2014000200005,fue,o
252,S1134-928X2014000200005,del,o
252,S1134-928X2014000200005,71,o
252,S1134-928X2014000200005,8,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,112,o
252,S1134-928X2014000200005,residentes,o
252,S1134-928X2014000200005,y,o
252,S1134-928X2014000200005,del,o
252,S1134-928X2014000200005,68,o
252,S1134-928X2014000200005,8,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,117,o
252,S1134-928X2014000200005,residentes,o
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,el,o
252,S1134-928X2014000200005,grupo,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,AGHO,i
252,S1134-928X2014000200005,con,o
252,S1134-928X2014000200005,una,o
252,S1134-928X2014000200005,diferencia,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,incidencias,o
252,S1134-928X2014000200005,del,o
252,S1134-928X2014000200005,031,o
252,S1134-928X2014000200005,intervalo,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,confianza,o
252,S1134-928X2014000200005,IC,o
252,S1134-928X2014000200005,al,o
252,S1134-928X2014000200005,90,o
252,S1134-928X2014000200005,619,o
252,S1134-928X2014000200005,a,o
252,S1134-928X2014000200005,547,o
252,S1134-928X2014000200005,que,o
252,S1134-928X2014000200005,esta,o
252,S1134-928X2014000200005,dentro,o
252,S1134-928X2014000200005,del,o
252,S1134-928X2014000200005,margen,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,no,o
252,S1134-928X2014000200005,inferioridad,o
252,S1134-928X2014000200005,establecido,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,7,o
252,S1134-928X2014000200005,y,o
252,S1134-928X2014000200005,apoya,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,hipotesis,o
252,S1134-928X2014000200005,inicial,o
252,S1134-928X2014000200005,No,o
252,S1134-928X2014000200005,se,o
252,S1134-928X2014000200005,observo,o
252,S1134-928X2014000200005,ningun,o
252,S1134-928X2014000200005,efecto,i
252,S1134-928X2014000200005,adverso,i
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,ninguno,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,los,o
252,S1134-928X2014000200005,grupos,o
252,S1134-928X2014000200005,Conclusiones,o
252,S1134-928X2014000200005,se,o
252,S1134-928X2014000200005,aportan,o
252,S1134-928X2014000200005,las,o
252,S1134-928X2014000200005,primeras,o
252,S1134-928X2014000200005,evidencias,o
252,S1134-928X2014000200005,sobre,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,eficacia,o
252,S1134-928X2014000200005,y,o
252,S1134-928X2014000200005,seguridad,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,la,o
252,S1134-928X2014000200005,aplicacion,i
252,S1134-928X2014000200005,topica,i
252,S1134-928X2014000200005,del,o
252,S1134-928X2014000200005,aceite,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,oliva,i
252,S1134-928X2014000200005,virgen,o
252,S1134-928X2014000200005,extra,o
252,S1134-928X2014000200005,para,o
252,S1134-928X2014000200005,prevenir,i
252,S1134-928X2014000200005,la,i
252,S1134-928X2014000200005,aparicion,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,UPP,i
252,S1134-928X2014000200005,en,o
252,S1134-928X2014000200005,pacientes,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,residencias,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,mayores,o
252,S1134-928X2014000200005,De,o
252,S1134-928X2014000200005,acuerdo,o
252,S1134-928X2014000200005,con,o
252,S1134-928X2014000200005,estas,o
252,S1134-928X2014000200005,evidencias,o
252,S1134-928X2014000200005,es,o
252,S1134-928X2014000200005,posible,o
252,S1134-928X2014000200005,afirmar,o
252,S1134-928X2014000200005,que,o
252,S1134-928X2014000200005,el,o
252,S1134-928X2014000200005,producto,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,aceite,i
252,S1134-928X2014000200005,de,i
252,S1134-928X2014000200005,oliva,i
252,S1134-928X2014000200005,virgen,o
252,S1134-928X2014000200005,extra,o
252,S1134-928X2014000200005,es,o
252,S1134-928X2014000200005,al,o
252,S1134-928X2014000200005,menos,o
252,S1134-928X2014000200005,igual,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,eficaz,o
252,S1134-928X2014000200005,que,o
252,S1134-928X2014000200005,los,o
252,S1134-928X2014000200005,AGHO,i
252,S1134-928X2014000200005,y,o
252,S1134-928X2014000200005,que,o
252,S1134-928X2014000200005,por,o
252,S1134-928X2014000200005,tanto,o
252,S1134-928X2014000200005,es,o
252,S1134-928X2014000200005,otra,o
252,S1134-928X2014000200005,opcion,o
252,S1134-928X2014000200005,terapeutica,o
252,S1134-928X2014000200005,para,o
252,S1134-928X2014000200005,prevenir,i
252,S1134-928X2014000200005,las,i
252,S1134-928X2014000200005,UPP,i
252,S1134-928X2014000200005,a,o
252,S1134-928X2014000200005,disposicion,o
252,S1134-928X2014000200005,de,o
252,S1134-928X2014000200005,los,o
252,S1134-928X2014000200005,profesionales,o
252,S1134-928X2014000200005,y,o
252,S1134-928X2014000200005,los,o
252,S1134-928X2014000200005,usuarios,o
253,S1137-66272005000600004,Cirugia,i
253,S1137-66272005000600004,laparoscopica,i
253,S1137-66272005000600004,del,o
253,S1137-66272005000600004,cancer,i
253,S1137-66272005000600004,gastrico,i
253,S1137-66272005000600004,Introduccion,o
253,S1137-66272005000600004,Se,o
253,S1137-66272005000600004,realiza,o
253,S1137-66272005000600004,una,o
253,S1137-66272005000600004,revision,i
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,la,o
253,S1137-66272005000600004,situacion,o
253,S1137-66272005000600004,actual,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,la,o
253,S1137-66272005000600004,cirugia,i
253,S1137-66272005000600004,minimamente,i
253,S1137-66272005000600004,invasiva,i
253,S1137-66272005000600004,en,o
253,S1137-66272005000600004,el,o
253,S1137-66272005000600004,cancer,i
253,S1137-66272005000600004,gastrico,i
253,S1137-66272005000600004,y,o
253,S1137-66272005000600004,se,o
253,S1137-66272005000600004,detallan,o
253,S1137-66272005000600004,aspectos,o
253,S1137-66272005000600004,tecnicos,o
253,S1137-66272005000600004,Pacientes,o
253,S1137-66272005000600004,y,o
253,S1137-66272005000600004,metodo,o
253,S1137-66272005000600004,Se,o
253,S1137-66272005000600004,aporta,o
253,S1137-66272005000600004,la,o
253,S1137-66272005000600004,experiencia,o
253,S1137-66272005000600004,personal,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,los,o
253,S1137-66272005000600004,autores,o
253,S1137-66272005000600004,en,o
253,S1137-66272005000600004,un,o
253,S1137-66272005000600004,estudio,i
253,S1137-66272005000600004,prospectivo,i
253,S1137-66272005000600004,no,i
253,S1137-66272005000600004,aleatorizado,i
253,S1137-66272005000600004,bicentrico,i
253,S1137-66272005000600004,el,o
253,S1137-66272005000600004,CHU,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,Charleroi,o
253,S1137-66272005000600004,Belgica,o
253,S1137-66272005000600004,y,o
253,S1137-66272005000600004,el,o
253,S1137-66272005000600004,Hospital,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,Zumarraga,o
253,S1137-66272005000600004,Pais,o
253,S1137-66272005000600004,Vasco,o
253,S1137-66272005000600004,España,o
253,S1137-66272005000600004,realizado,o
253,S1137-66272005000600004,entre,o
253,S1137-66272005000600004,junio,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,1993,o
253,S1137-66272005000600004,y,o
253,S1137-66272005000600004,enero,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,2004,o
253,S1137-66272005000600004,en,o
253,S1137-66272005000600004,el,o
253,S1137-66272005000600004,que,o
253,S1137-66272005000600004,en,o
253,S1137-66272005000600004,101,o
253,S1137-66272005000600004,pacientes,o
253,S1137-66272005000600004,con,o
253,S1137-66272005000600004,adenocarcinoma,i
253,S1137-66272005000600004,gastrico,i
253,S1137-66272005000600004,el,o
253,S1137-66272005000600004,abordaje,o
253,S1137-66272005000600004,laparoscopico,i
253,S1137-66272005000600004,miniinvasivo,o
253,S1137-66272005000600004,ha,o
253,S1137-66272005000600004,sido,o
253,S1137-66272005000600004,utilizado,o
253,S1137-66272005000600004,como,o
253,S1137-66272005000600004,una,o
253,S1137-66272005000600004,herramienta,o
253,S1137-66272005000600004,quirurgica,o
253,S1137-66272005000600004,con,o
253,S1137-66272005000600004,la,o
253,S1137-66272005000600004,intencion,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,tratar,o
253,S1137-66272005000600004,por,o
253,S1137-66272005000600004,laparoscopia,i
253,S1137-66272005000600004,La,o
253,S1137-66272005000600004,edad,o
253,S1137-66272005000600004,media,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,los,o
253,S1137-66272005000600004,pacientes,o
253,S1137-66272005000600004,ha,o
253,S1137-66272005000600004,sido,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,67,o
253,S1137-66272005000600004,años,o
253,S1137-66272005000600004,3783,o
253,S1137-66272005000600004,Resultados,o
253,S1137-66272005000600004,La,o
253,S1137-66272005000600004,mortalidad,o
253,S1137-66272005000600004,postoperatoria,o
253,S1137-66272005000600004,a,o
253,S1137-66272005000600004,60,o
253,S1137-66272005000600004,dias,o
253,S1137-66272005000600004,ha,o
253,S1137-66272005000600004,sido,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,5,o
253,S1137-66272005000600004,pacientes,o
253,S1137-66272005000600004,87,o
253,S1137-66272005000600004,pacientes,o
253,S1137-66272005000600004,fueron,o
253,S1137-66272005000600004,sometidos,o
253,S1137-66272005000600004,a,o
253,S1137-66272005000600004,un,o
253,S1137-66272005000600004,seguimiento,i
253,S1137-66272005000600004,oncologico,i
253,S1137-66272005000600004,medio,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,41,o
253,S1137-66272005000600004,meses,o
253,S1137-66272005000600004,7129,o
253,S1137-66272005000600004,La,o
253,S1137-66272005000600004,media,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,supervivencia,o
253,S1137-66272005000600004,observada,o
253,S1137-66272005000600004,en,o
253,S1137-66272005000600004,los,o
253,S1137-66272005000600004,10,o
253,S1137-66272005000600004,pacientes,o
253,S1137-66272005000600004,no,o
253,S1137-66272005000600004,resecados,i
253,S1137-66272005000600004,fue,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,45,o
253,S1137-66272005000600004,meses,o
253,S1137-66272005000600004,La,o
253,S1137-66272005000600004,media,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,supervivencia,o
253,S1137-66272005000600004,observada,o
253,S1137-66272005000600004,en,o
253,S1137-66272005000600004,los,o
253,S1137-66272005000600004,10,o
253,S1137-66272005000600004,pacientes,o
253,S1137-66272005000600004,resecados,i
253,S1137-66272005000600004,paliativamente,i
253,S1137-66272005000600004,fue,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,71,o
253,S1137-66272005000600004,meses,o
253,S1137-66272005000600004,La,o
253,S1137-66272005000600004,supervivencia,o
253,S1137-66272005000600004,actuarial,o
253,S1137-66272005000600004,a,o
253,S1137-66272005000600004,5,o
253,S1137-66272005000600004,años,o
253,S1137-66272005000600004,observada,o
253,S1137-66272005000600004,tras,o
253,S1137-66272005000600004,exeresis,i
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,tipo,o
253,S1137-66272005000600004,R0,o
253,S1137-66272005000600004,es,o
253,S1137-66272005000600004,del,o
253,S1137-66272005000600004,34,o
253,S1137-66272005000600004,La,o
253,S1137-66272005000600004,supervivencia,o
253,S1137-66272005000600004,actuarial,o
253,S1137-66272005000600004,global,o
253,S1137-66272005000600004,a,o
253,S1137-66272005000600004,5,o
253,S1137-66272005000600004,años,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,los,o
253,S1137-66272005000600004,pacientes,o
253,S1137-66272005000600004,resecados,i
253,S1137-66272005000600004,fue,o
253,S1137-66272005000600004,del,o
253,S1137-66272005000600004,29,o
253,S1137-66272005000600004,Conclusiones,o
253,S1137-66272005000600004,La,o
253,S1137-66272005000600004,gastrectomia,i
253,S1137-66272005000600004,laparoscopica,i
253,S1137-66272005000600004,asociada,o
253,S1137-66272005000600004,a,o
253,S1137-66272005000600004,cualquier,o
253,S1137-66272005000600004,tipo,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,linfadenectomia,i
253,S1137-66272005000600004,es,o
253,S1137-66272005000600004,una,o
253,S1137-66272005000600004,intervencion,i
253,S1137-66272005000600004,importante,o
253,S1137-66272005000600004,pero,o
253,S1137-66272005000600004,segura,o
253,S1137-66272005000600004,con,o
253,S1137-66272005000600004,tasas,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,morbimortalidad,o
253,S1137-66272005000600004,aceptables,o
253,S1137-66272005000600004,en,o
253,S1137-66272005000600004,pacientes,o
253,S1137-66272005000600004,con,o
253,S1137-66272005000600004,cancer,i
253,S1137-66272005000600004,gastrico,i
253,S1137-66272005000600004,avanzado,o
253,S1137-66272005000600004,que,o
253,S1137-66272005000600004,frecuentemente,o
253,S1137-66272005000600004,presentan,o
253,S1137-66272005000600004,un,o
253,S1137-66272005000600004,mal,i
253,S1137-66272005000600004,estado,i
253,S1137-66272005000600004,general,i
253,S1137-66272005000600004,Los,o
253,S1137-66272005000600004,resultados,o
253,S1137-66272005000600004,oncologicos,o
253,S1137-66272005000600004,a,o
253,S1137-66272005000600004,largo,o
253,S1137-66272005000600004,plazo,o
253,S1137-66272005000600004,son,o
253,S1137-66272005000600004,similares,o
253,S1137-66272005000600004,a,o
253,S1137-66272005000600004,los,o
253,S1137-66272005000600004,obtenidos,o
253,S1137-66272005000600004,por,o
253,S1137-66272005000600004,via,o
253,S1137-66272005000600004,laparotomica,i
253,S1137-66272005000600004,Son,o
253,S1137-66272005000600004,necesarios,o
253,S1137-66272005000600004,mas,o
253,S1137-66272005000600004,estudios,i
253,S1137-66272005000600004,prospectivos,i
253,S1137-66272005000600004,que,o
253,S1137-66272005000600004,evaluen,o
253,S1137-66272005000600004,los,o
253,S1137-66272005000600004,resultados,o
253,S1137-66272005000600004,de,o
253,S1137-66272005000600004,este,o
253,S1137-66272005000600004,abordaje,o
253,S1137-66272005000600004,tanto,o
253,S1137-66272005000600004,en,o
253,S1137-66272005000600004,sus,o
253,S1137-66272005000600004,beneficios,o
253,S1137-66272005000600004,a,o
253,S1137-66272005000600004,corto,o
253,S1137-66272005000600004,plazo,o
253,S1137-66272005000600004,como,o
253,S1137-66272005000600004,en,o
253,S1137-66272005000600004,el,o
253,S1137-66272005000600004,resultado,o
253,S1137-66272005000600004,oncologico,o
253,S1137-66272005000600004,a,o
253,S1137-66272005000600004,distancia,o
254,S1137-66272010000300002,Abordaje,o
254,S1137-66272010000300002,posterior,o
254,S1137-66272010000300002,minimamente,o
254,S1137-66272010000300002,invasivo,o
254,S1137-66272010000300002,en,o
254,S1137-66272010000300002,artroplastia,i
254,S1137-66272010000300002,total,i
254,S1137-66272010000300002,de,i
254,S1137-66272010000300002,cadera,i
254,S1137-66272010000300002,Estudio,i
254,S1137-66272010000300002,prospectivo,i
254,S1137-66272010000300002,y,i
254,S1137-66272010000300002,aleatorizado,i
254,S1137-66272010000300002,Un,o
254,S1137-66272010000300002,año,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,seguimiento,i
254,S1137-66272010000300002,Fundamento,o
254,S1137-66272010000300002,La,o
254,S1137-66272010000300002,hipotesis,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,trabajo,o
254,S1137-66272010000300002,fue,o
254,S1137-66272010000300002,que,o
254,S1137-66272010000300002,la,o
254,S1137-66272010000300002,cirugia,i
254,S1137-66272010000300002,minimamente,i
254,S1137-66272010000300002,invasiva,i
254,S1137-66272010000300002,era,o
254,S1137-66272010000300002,superior,o
254,S1137-66272010000300002,a,o
254,S1137-66272010000300002,la,o
254,S1137-66272010000300002,convencional,o
254,S1137-66272010000300002,para,o
254,S1137-66272010000300002,el,o
254,S1137-66272010000300002,proceso,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,artroplastia,i
254,S1137-66272010000300002,total,i
254,S1137-66272010000300002,de,i
254,S1137-66272010000300002,cadera,i
254,S1137-66272010000300002,Para,o
254,S1137-66272010000300002,ello,o
254,S1137-66272010000300002,se,o
254,S1137-66272010000300002,compararon,o
254,S1137-66272010000300002,los,o
254,S1137-66272010000300002,resultados,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,la,o
254,S1137-66272010000300002,cirugia,i
254,S1137-66272010000300002,minimamente,i
254,S1137-66272010000300002,invasiva,i
254,S1137-66272010000300002,con,o
254,S1137-66272010000300002,los,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,la,o
254,S1137-66272010000300002,cirugia,i
254,S1137-66272010000300002,convencional,i
254,S1137-66272010000300002,en,o
254,S1137-66272010000300002,artroplastia,i
254,S1137-66272010000300002,total,i
254,S1137-66272010000300002,de,i
254,S1137-66272010000300002,cadera,i
254,S1137-66272010000300002,Material,o
254,S1137-66272010000300002,y,o
254,S1137-66272010000300002,metodos,o
254,S1137-66272010000300002,Ensayo,i
254,S1137-66272010000300002,clinico,i
254,S1137-66272010000300002,prospectivo,i
254,S1137-66272010000300002,y,i
254,S1137-66272010000300002,aleatorizado,i
254,S1137-66272010000300002,Se,o
254,S1137-66272010000300002,seleccionaron,o
254,S1137-66272010000300002,50,o
254,S1137-66272010000300002,pacientes,o
254,S1137-66272010000300002,los,o
254,S1137-66272010000300002,cuales,o
254,S1137-66272010000300002,fueron,o
254,S1137-66272010000300002,divididos,o
254,S1137-66272010000300002,en,o
254,S1137-66272010000300002,dos,o
254,S1137-66272010000300002,grupos,o
254,S1137-66272010000300002,en,o
254,S1137-66272010000300002,funcion,o
254,S1137-66272010000300002,del,o
254,S1137-66272010000300002,abordaje,o
254,S1137-66272010000300002,quirurgico,o
254,S1137-66272010000300002,posterior,o
254,S1137-66272010000300002,minimamente,o
254,S1137-66272010000300002,invasivo,o
254,S1137-66272010000300002,o,o
254,S1137-66272010000300002,posterior,o
254,S1137-66272010000300002,directo,o
254,S1137-66272010000300002,convencional,o
254,S1137-66272010000300002,Se,o
254,S1137-66272010000300002,evaluaron,o
254,S1137-66272010000300002,el,o
254,S1137-66272010000300002,sangrado,i
254,S1137-66272010000300002,perioperatorio,o
254,S1137-66272010000300002,el,o
254,S1137-66272010000300002,dolor,i
254,S1137-66272010000300002,postoperatorio,i
254,S1137-66272010000300002,el,o
254,S1137-66272010000300002,tiempo,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,recuperacion,o
254,S1137-66272010000300002,la,o
254,S1137-66272010000300002,orientacion,o
254,S1137-66272010000300002,y,o
254,S1137-66272010000300002,ajuste,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,los,o
254,S1137-66272010000300002,componentes,o
254,S1137-66272010000300002,la,o
254,S1137-66272010000300002,tasa,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,complicaciones,i
254,S1137-66272010000300002,y,o
254,S1137-66272010000300002,el,o
254,S1137-66272010000300002,resultado,o
254,S1137-66272010000300002,funcional,o
254,S1137-66272010000300002,y,o
254,S1137-66272010000300002,se,o
254,S1137-66272010000300002,han,o
254,S1137-66272010000300002,seguido,i
254,S1137-66272010000300002,a,o
254,S1137-66272010000300002,los,o
254,S1137-66272010000300002,pacientes,o
254,S1137-66272010000300002,un,o
254,S1137-66272010000300002,año,o
254,S1137-66272010000300002,minimo,o
254,S1137-66272010000300002,Resultados,o
254,S1137-66272010000300002,No,o
254,S1137-66272010000300002,se,o
254,S1137-66272010000300002,han,o
254,S1137-66272010000300002,encontrado,o
254,S1137-66272010000300002,diferencias,o
254,S1137-66272010000300002,significativas,o
254,S1137-66272010000300002,entre,o
254,S1137-66272010000300002,los,o
254,S1137-66272010000300002,grupos,o
254,S1137-66272010000300002,en,o
254,S1137-66272010000300002,cuanto,o
254,S1137-66272010000300002,a,o
254,S1137-66272010000300002,sangrado,i
254,S1137-66272010000300002,perioperatorio,o
254,S1137-66272010000300002,El,o
254,S1137-66272010000300002,dolor,i
254,S1137-66272010000300002,postoperatorio,i
254,S1137-66272010000300002,fue,o
254,S1137-66272010000300002,menor,o
254,S1137-66272010000300002,con,o
254,S1137-66272010000300002,la,o
254,S1137-66272010000300002,cirugia,i
254,S1137-66272010000300002,minimamente,i
254,S1137-66272010000300002,invasiva,i
254,S1137-66272010000300002,la,o
254,S1137-66272010000300002,velocidad,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,recuperacion,o
254,S1137-66272010000300002,fue,o
254,S1137-66272010000300002,significativamente,o
254,S1137-66272010000300002,mayor,o
254,S1137-66272010000300002,con,o
254,S1137-66272010000300002,el,o
254,S1137-66272010000300002,abordaje,o
254,S1137-66272010000300002,posterior,o
254,S1137-66272010000300002,minimamente,o
254,S1137-66272010000300002,invasivo,o
254,S1137-66272010000300002,al,o
254,S1137-66272010000300002,detectarse,o
254,S1137-66272010000300002,una,o
254,S1137-66272010000300002,menor,o
254,S1137-66272010000300002,estancia,o
254,S1137-66272010000300002,hospitalaria,o
254,S1137-66272010000300002,y,o
254,S1137-66272010000300002,un,o
254,S1137-66272010000300002,inicio,o
254,S1137-66272010000300002,mas,o
254,S1137-66272010000300002,precoz,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,la,o
254,S1137-66272010000300002,deambulacion,o
254,S1137-66272010000300002,No,o
254,S1137-66272010000300002,se,o
254,S1137-66272010000300002,encontraron,o
254,S1137-66272010000300002,diferencias,o
254,S1137-66272010000300002,en,o
254,S1137-66272010000300002,cuanto,o
254,S1137-66272010000300002,a,o
254,S1137-66272010000300002,tiempo,o
254,S1137-66272010000300002,quirurgico,o
254,S1137-66272010000300002,orientacion,o
254,S1137-66272010000300002,y,o
254,S1137-66272010000300002,ajuste,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,los,o
254,S1137-66272010000300002,componentes,o
254,S1137-66272010000300002,tasa,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,complicaciones,i
254,S1137-66272010000300002,ni,o
254,S1137-66272010000300002,resultado,o
254,S1137-66272010000300002,funcional,o
254,S1137-66272010000300002,Impacto,o
254,S1137-66272010000300002,economico,o
254,S1137-66272010000300002,favorable,o
254,S1137-66272010000300002,a,o
254,S1137-66272010000300002,la,o
254,S1137-66272010000300002,cirugia,i
254,S1137-66272010000300002,minimamente,i
254,S1137-66272010000300002,invasiva,i
254,S1137-66272010000300002,con,o
254,S1137-66272010000300002,un,o
254,S1137-66272010000300002,ahorro,o
254,S1137-66272010000300002,del,o
254,S1137-66272010000300002,5,o
254,S1137-66272010000300002,del,o
254,S1137-66272010000300002,total,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,coste,o
254,S1137-66272010000300002,del,o
254,S1137-66272010000300002,proceso,o
254,S1137-66272010000300002,Conclusiones,o
254,S1137-66272010000300002,El,o
254,S1137-66272010000300002,abordaje,o
254,S1137-66272010000300002,posterior,o
254,S1137-66272010000300002,minimamente,o
254,S1137-66272010000300002,invasivo,o
254,S1137-66272010000300002,disminuye,o
254,S1137-66272010000300002,el,o
254,S1137-66272010000300002,dolor,i
254,S1137-66272010000300002,y,o
254,S1137-66272010000300002,acelera,o
254,S1137-66272010000300002,la,o
254,S1137-66272010000300002,recuperacion,o
254,S1137-66272010000300002,con,o
254,S1137-66272010000300002,un,o
254,S1137-66272010000300002,impacto,o
254,S1137-66272010000300002,economico,o
254,S1137-66272010000300002,favorable,o
254,S1137-66272010000300002,sin,o
254,S1137-66272010000300002,mostrar,o
254,S1137-66272010000300002,diferencias,o
254,S1137-66272010000300002,en,o
254,S1137-66272010000300002,ninguna,o
254,S1137-66272010000300002,de,o
254,S1137-66272010000300002,los,o
254,S1137-66272010000300002,demas,o
254,S1137-66272010000300002,aspectos,o
254,S1137-66272010000300002,estudiados,o
255,S1137-66272013000300007,Crosectomia,i
255,S1137-66272013000300007,alta,i
255,S1137-66272013000300007,sin,i
255,S1137-66272013000300007,seccion,i
255,S1137-66272013000300007,vascular,i
255,S1137-66272013000300007,frente,o
255,S1137-66272013000300007,a,o
255,S1137-66272013000300007,safenectomia,i
255,S1137-66272013000300007,clasica,o
255,S1137-66272013000300007,Ensayo,i
255,S1137-66272013000300007,clinico,i
255,S1137-66272013000300007,aleatorizado,i
255,S1137-66272013000300007,analisis,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,la,o
255,S1137-66272013000300007,recidiva,i
255,S1137-66272013000300007,varicosa,i
255,S1137-66272013000300007,Fundamento,o
255,S1137-66272013000300007,El,o
255,S1137-66272013000300007,presente,o
255,S1137-66272013000300007,estudio,o
255,S1137-66272013000300007,fue,o
255,S1137-66272013000300007,diseñado,o
255,S1137-66272013000300007,con,o
255,S1137-66272013000300007,el,o
255,S1137-66272013000300007,proposito,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,definir,o
255,S1137-66272013000300007,un,o
255,S1137-66272013000300007,nuevo,o
255,S1137-66272013000300007,procedimiento,i
255,S1137-66272013000300007,quirurgico,i
255,S1137-66272013000300007,para,o
255,S1137-66272013000300007,la,o
255,S1137-66272013000300007,cirugia,i
255,S1137-66272013000300007,de,i
255,S1137-66272013000300007,las,i
255,S1137-66272013000300007,varices,i
255,S1137-66272013000300007,y,o
255,S1137-66272013000300007,compararlo,o
255,S1137-66272013000300007,con,o
255,S1137-66272013000300007,estudios,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,crosectomia,i
255,S1137-66272013000300007,clasica,o
255,S1137-66272013000300007,en,o
255,S1137-66272013000300007,terminos,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,reducir,o
255,S1137-66272013000300007,la,o
255,S1137-66272013000300007,tasa,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,recidiva,i
255,S1137-66272013000300007,varicosa,i
255,S1137-66272013000300007,Material,o
255,S1137-66272013000300007,y,o
255,S1137-66272013000300007,metodos,o
255,S1137-66272013000300007,El,o
255,S1137-66272013000300007,estudio,o
255,S1137-66272013000300007,presentado,o
255,S1137-66272013000300007,es,o
255,S1137-66272013000300007,un,o
255,S1137-66272013000300007,ensayo,o
255,S1137-66272013000300007,clinico,o
255,S1137-66272013000300007,aleatorizado,o
255,S1137-66272013000300007,doble,o
255,S1137-66272013000300007,ciego,o
255,S1137-66272013000300007,Para,o
255,S1137-66272013000300007,facilitar,o
255,S1137-66272013000300007,el,o
255,S1137-66272013000300007,acceso,o
255,S1137-66272013000300007,se,o
255,S1137-66272013000300007,seleccionaron,o
255,S1137-66272013000300007,150,o
255,S1137-66272013000300007,pacientes,o
255,S1137-66272013000300007,que,o
255,S1137-66272013000300007,acudieron,o
255,S1137-66272013000300007,a,o
255,S1137-66272013000300007,consulta,i
255,S1137-66272013000300007,Unidad,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,Flebologia,o
255,S1137-66272013000300007,que,o
255,S1137-66272013000300007,facilitaron,o
255,S1137-66272013000300007,su,o
255,S1137-66272013000300007,consentimiento,i
255,S1137-66272013000300007,cumpliendo,o
255,S1137-66272013000300007,los,o
255,S1137-66272013000300007,criterios,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,inclusion,o
255,S1137-66272013000300007,Se,o
255,S1137-66272013000300007,hicieron,o
255,S1137-66272013000300007,dos,o
255,S1137-66272013000300007,grupos,o
255,S1137-66272013000300007,Grupo,o
255,S1137-66272013000300007,1,o
255,S1137-66272013000300007,safenectomia,i
255,S1137-66272013000300007,clasica,o
255,S1137-66272013000300007,CS,o
255,S1137-66272013000300007,75,o
255,S1137-66272013000300007,pacientes,o
255,S1137-66272013000300007,Grupo,o
255,S1137-66272013000300007,2,o
255,S1137-66272013000300007,crosectomia,i
255,S1137-66272013000300007,alta,i
255,S1137-66272013000300007,sin,i
255,S1137-66272013000300007,seccion,i
255,S1137-66272013000300007,vascular,i
255,S1137-66272013000300007,HCWVS,o
255,S1137-66272013000300007,En,o
255,S1137-66272013000300007,ambos,o
255,S1137-66272013000300007,grupos,o
255,S1137-66272013000300007,el,o
255,S1137-66272013000300007,seguimiento,i
255,S1137-66272013000300007,se,o
255,S1137-66272013000300007,realizo,o
255,S1137-66272013000300007,a,o
255,S1137-66272013000300007,los,o
255,S1137-66272013000300007,12,o
255,S1137-66272013000300007,y,o
255,S1137-66272013000300007,24,o
255,S1137-66272013000300007,meses,o
255,S1137-66272013000300007,por,o
255,S1137-66272013000300007,estudio,o
255,S1137-66272013000300007,ecoDoppler,o
255,S1137-66272013000300007,Resultados,o
255,S1137-66272013000300007,La,o
255,S1137-66272013000300007,incidencia,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,recidiva,i
255,S1137-66272013000300007,varicosa,i
255,S1137-66272013000300007,a,o
255,S1137-66272013000300007,los,o
255,S1137-66272013000300007,12,o
255,S1137-66272013000300007,meses,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,seguimiento,i
255,S1137-66272013000300007,fue,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,693,o
255,S1137-66272013000300007,en,o
255,S1137-66272013000300007,el,o
255,S1137-66272013000300007,grupo,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,pacientes,o
255,S1137-66272013000300007,sometidos,o
255,S1137-66272013000300007,a,o
255,S1137-66272013000300007,safenectomia,i
255,S1137-66272013000300007,clasica,o
255,S1137-66272013000300007,mientras,o
255,S1137-66272013000300007,que,o
255,S1137-66272013000300007,en,o
255,S1137-66272013000300007,el,o
255,S1137-66272013000300007,grupo,o
255,S1137-66272013000300007,que,o
255,S1137-66272013000300007,recibio,o
255,S1137-66272013000300007,HCWVS,o
255,S1137-66272013000300007,fue,o
255,S1137-66272013000300007,293,o
255,S1137-66272013000300007,p,o
255,S1137-66272013000300007,00001,o
255,S1137-66272013000300007,Estas,o
255,S1137-66272013000300007,diferencias,o
255,S1137-66272013000300007,aunque,o
255,S1137-66272013000300007,menores,o
255,S1137-66272013000300007,siguen,o
255,S1137-66272013000300007,siendo,o
255,S1137-66272013000300007,estadisticamente,o
255,S1137-66272013000300007,significativa,o
255,S1137-66272013000300007,a,o
255,S1137-66272013000300007,los,o
255,S1137-66272013000300007,24,o
255,S1137-66272013000300007,meses,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,evolucion,o
255,S1137-66272013000300007,76,o
255,S1137-66272013000300007,vs,o
255,S1137-66272013000300007,48,o
255,S1137-66272013000300007,p,o
255,S1137-66272013000300007,00004,o
255,S1137-66272013000300007,El,o
255,S1137-66272013000300007,tipo,o
255,S1137-66272013000300007,mas,o
255,S1137-66272013000300007,comun,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,recurrencia,o
255,S1137-66272013000300007,es,o
255,S1137-66272013000300007,del,o
255,S1137-66272013000300007,tipo,o
255,S1137-66272013000300007,I,o
255,S1137-66272013000300007,con,o
255,S1137-66272013000300007,diferencias,o
255,S1137-66272013000300007,estadisticamente,o
255,S1137-66272013000300007,significativas,o
255,S1137-66272013000300007,a,o
255,S1137-66272013000300007,los,o
255,S1137-66272013000300007,12,o
255,S1137-66272013000300007,y,o
255,S1137-66272013000300007,24,o
255,S1137-66272013000300007,meses,o
255,S1137-66272013000300007,Conclusiones,o
255,S1137-66272013000300007,La,o
255,S1137-66272013000300007,crosectomia,i
255,S1137-66272013000300007,alta,i
255,S1137-66272013000300007,sin,i
255,S1137-66272013000300007,seccion,i
255,S1137-66272013000300007,vascular,i
255,S1137-66272013000300007,tiene,o
255,S1137-66272013000300007,una,o
255,S1137-66272013000300007,probabilidad,o
255,S1137-66272013000300007,global,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,recurrencia,o
255,S1137-66272013000300007,significativamente,o
255,S1137-66272013000300007,menor,o
255,S1137-66272013000300007,que,o
255,S1137-66272013000300007,la,o
255,S1137-66272013000300007,safenectomia,i
255,S1137-66272013000300007,clasica,o
255,S1137-66272013000300007,a,o
255,S1137-66272013000300007,los,o
255,S1137-66272013000300007,12,o
255,S1137-66272013000300007,meses,o
255,S1137-66272013000300007,293,o
255,S1137-66272013000300007,frente,o
255,S1137-66272013000300007,a,o
255,S1137-66272013000300007,693,o
255,S1137-66272013000300007,que,o
255,S1137-66272013000300007,sigue,o
255,S1137-66272013000300007,siendo,o
255,S1137-66272013000300007,aunque,o
255,S1137-66272013000300007,mas,o
255,S1137-66272013000300007,pequeña,o
255,S1137-66272013000300007,estadisticamente,o
255,S1137-66272013000300007,significativa,o
255,S1137-66272013000300007,a,o
255,S1137-66272013000300007,los,o
255,S1137-66272013000300007,dos,o
255,S1137-66272013000300007,años,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,evolucion,o
255,S1137-66272013000300007,48,o
255,S1137-66272013000300007,vs,o
255,S1137-66272013000300007,76,o
255,S1137-66272013000300007,La,o
255,S1137-66272013000300007,tasa,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,recurrencia,o
255,S1137-66272013000300007,del,o
255,S1137-66272013000300007,tipo,o
255,S1137-66272013000300007,reticular,o
255,S1137-66272013000300007,es,o
255,S1137-66272013000300007,significativamente,o
255,S1137-66272013000300007,menor,o
255,S1137-66272013000300007,en,o
255,S1137-66272013000300007,el,o
255,S1137-66272013000300007,grupo,o
255,S1137-66272013000300007,de,o
255,S1137-66272013000300007,pacientes,o
255,S1137-66272013000300007,sometidos,o
255,S1137-66272013000300007,a,o
255,S1137-66272013000300007,alta,i
255,S1137-66272013000300007,crosectomia,i
255,S1137-66272013000300007,sin,i
255,S1137-66272013000300007,seccion,i
255,S1137-66272013000300007,vascular,i
255,S1137-66272013000300007,que,o
255,S1137-66272013000300007,en,o
255,S1137-66272013000300007,los,o
255,S1137-66272013000300007,sometidos,o
255,S1137-66272013000300007,a,o
255,S1137-66272013000300007,safenectomia,i
255,S1137-66272013000300007,clasica,o
256,S1139-67092004000100009,Estudio,i
256,S1139-67092004000100009,piloto,i
256,S1139-67092004000100009,de,o
256,S1139-67092004000100009,Clostridium,o
256,S1139-67092004000100009,difficile,o
256,S1139-67092004000100009,efecto,o
256,S1139-67092004000100009,del,o
256,S1139-67092004000100009,aporte,i
256,S1139-67092004000100009,suplementario,i
256,S1139-67092004000100009,de,i
256,S1139-67092004000100009,probioticos,i
256,S1139-67092004000100009,sobre,o
256,S1139-67092004000100009,la,o
256,S1139-67092004000100009,incidencia,o
256,S1139-67092004000100009,de,o
256,S1139-67092004000100009,diarrea,i
256,S1139-67092004000100009,causada,o
256,S1139-67092004000100009,por,o
256,S1139-67092004000100009,C,o
256,S1139-67092004000100009,difficile,o
256,S1139-67092004000100009,La,o
256,S1139-67092004000100009,infeccion,i
256,S1139-67092004000100009,de,i
256,S1139-67092004000100009,colon,i
256,S1139-67092004000100009,por,i
256,S1139-67092004000100009,Clostridium,i
256,S1139-67092004000100009,difficile,i
256,S1139-67092004000100009,que,o
256,S1139-67092004000100009,produce,o
256,S1139-67092004000100009,colitis,i
256,S1139-67092004000100009,pseudomembranosa,i
256,S1139-67092004000100009,es,o
256,S1139-67092004000100009,una,o
256,S1139-67092004000100009,complicacion,i
256,S1139-67092004000100009,frecuente,o
256,S1139-67092004000100009,en,o
256,S1139-67092004000100009,las,o
256,S1139-67092004000100009,terapias,i
256,S1139-67092004000100009,con,o
256,S1139-67092004000100009,antibioticos,i
256,S1139-67092004000100009,especialmente,o
256,S1139-67092004000100009,en,o
256,S1139-67092004000100009,pacientes,o
256,S1139-67092004000100009,de,o
256,S1139-67092004000100009,la,o
256,S1139-67092004000100009,tercera,o
256,S1139-67092004000100009,edad,o
256,S1139-67092004000100009,Se,o
256,S1139-67092004000100009,ha,o
256,S1139-67092004000100009,sugerido,o
256,S1139-67092004000100009,que,o
256,S1139-67092004000100009,las,o
256,S1139-67092004000100009,bacterias,o
256,S1139-67092004000100009,probioticas,o
256,S1139-67092004000100009,no,o
256,S1139-67092004000100009,patogenas,o
256,S1139-67092004000100009,podrian,o
256,S1139-67092004000100009,prevenir,i
256,S1139-67092004000100009,el,o
256,S1139-67092004000100009,desarrollo,o
256,S1139-67092004000100009,de,o
256,S1139-67092004000100009,la,o
256,S1139-67092004000100009,infeccion,o
256,S1139-67092004000100009,por,o
256,S1139-67092004000100009,C,o
256,S1139-67092004000100009,difficile,o
256,S1139-67092004000100009,Este,o
256,S1139-67092004000100009,estudio,i
256,S1139-67092004000100009,de,i
256,S1139-67092004000100009,doble,i
256,S1139-67092004000100009,ciego,i
256,S1139-67092004000100009,con,i
256,S1139-67092004000100009,control,i
256,S1139-67092004000100009,mediante,i
256,S1139-67092004000100009,placebos,i
256,S1139-67092004000100009,examina,o
256,S1139-67092004000100009,la,o
256,S1139-67092004000100009,influencia,o
256,S1139-67092004000100009,de,o
256,S1139-67092004000100009,la,o
256,S1139-67092004000100009,administracion,i
256,S1139-67092004000100009,de,i
256,S1139-67092004000100009,probioticos,i
256,S1139-67092004000100009,en,o
256,S1139-67092004000100009,la,o
256,S1139-67092004000100009,prevencion,i
256,S1139-67092004000100009,de,o
256,S1139-67092004000100009,diarrea,i
256,S1139-67092004000100009,asociada,o
256,S1139-67092004000100009,a,o
256,S1139-67092004000100009,C,o
256,S1139-67092004000100009,difficile,o
256,S1139-67092004000100009,CDAD,i
256,S1139-67092004000100009,en,o
256,S1139-67092004000100009,pacientes,o
256,S1139-67092004000100009,de,o
256,S1139-67092004000100009,la,o
256,S1139-67092004000100009,tercera,o
256,S1139-67092004000100009,edad,o
256,S1139-67092004000100009,sometidos,o
256,S1139-67092004000100009,a,o
256,S1139-67092004000100009,terapia,i
256,S1139-67092004000100009,con,o
256,S1139-67092004000100009,antibioticos,i
256,S1139-67092004000100009,Se,o
256,S1139-67092004000100009,escogieron,i
256,S1139-67092004000100009,al,i
256,S1139-67092004000100009,azar,i
256,S1139-67092004000100009,150,o
256,S1139-67092004000100009,pacientes,o
256,S1139-67092004000100009,consecutivos,o
256,S1139-67092004000100009,sometidos,o
256,S1139-67092004000100009,a,o
256,S1139-67092004000100009,terapia,i
256,S1139-67092004000100009,con,o
256,S1139-67092004000100009,antibioticos,i
256,S1139-67092004000100009,y,o
256,S1139-67092004000100009,se,o
256,S1139-67092004000100009,les,o
256,S1139-67092004000100009,administro,o
256,S1139-67092004000100009,aleatoriamente,i
256,S1139-67092004000100009,durante,o
256,S1139-67092004000100009,20,o
256,S1139-67092004000100009,dias,o
256,S1139-67092004000100009,un,o
256,S1139-67092004000100009,probiotico,o
256,S1139-67092004000100009,que,o
256,S1139-67092004000100009,contenia,o
256,S1139-67092004000100009,Lactobacillus,o
256,S1139-67092004000100009,y,o
256,S1139-67092004000100009,Bifidobacterium,o
256,S1139-67092004000100009,o,o
256,S1139-67092004000100009,un,o
256,S1139-67092004000100009,placebo,i
256,S1139-67092004000100009,Tras,o
256,S1139-67092004000100009,su,o
256,S1139-67092004000100009,ingreso,i
256,S1139-67092004000100009,hospitalario,i
256,S1139-67092004000100009,se,o
256,S1139-67092004000100009,anoto,o
256,S1139-67092004000100009,su,o
256,S1139-67092004000100009,regimen,i
256,S1139-67092004000100009,intestinal,i
256,S1139-67092004000100009,y,o
256,S1139-67092004000100009,se,o
256,S1139-67092004000100009,tomo,o
256,S1139-67092004000100009,una,o
256,S1139-67092004000100009,muestra,i
256,S1139-67092004000100009,fecal,i
256,S1139-67092004000100009,El,o
256,S1139-67092004000100009,probiotico,o
256,S1139-67092004000100009,o,o
256,S1139-67092004000100009,el,o
256,S1139-67092004000100009,placebo,i
256,S1139-67092004000100009,se,o
256,S1139-67092004000100009,administro,o
256,S1139-67092004000100009,durante,o
256,S1139-67092004000100009,las,o
256,S1139-67092004000100009,72,o
256,S1139-67092004000100009,h,o
256,S1139-67092004000100009,primeras,o
256,S1139-67092004000100009,del,o
256,S1139-67092004000100009,tratamiento,i
256,S1139-67092004000100009,con,o
256,S1139-67092004000100009,antibioticos,i
256,S1139-67092004000100009,y,o
256,S1139-67092004000100009,se,o
256,S1139-67092004000100009,tomo,o
256,S1139-67092004000100009,una,o
256,S1139-67092004000100009,segunda,o
256,S1139-67092004000100009,muestra,i
256,S1139-67092004000100009,de,i
256,S1139-67092004000100009,heces,i
256,S1139-67092004000100009,en,o
256,S1139-67092004000100009,el,o
256,S1139-67092004000100009,caso,o
256,S1139-67092004000100009,de,o
256,S1139-67092004000100009,aparecer,o
256,S1139-67092004000100009,diarrea,i
256,S1139-67092004000100009,durante,o
256,S1139-67092004000100009,la,o
256,S1139-67092004000100009,hospitalizacion,i
256,S1139-67092004000100009,o,o
256,S1139-67092004000100009,tras,o
256,S1139-67092004000100009,el,o
256,S1139-67092004000100009,alta,i
256,S1139-67092004000100009,medica,i
256,S1139-67092004000100009,De,o
256,S1139-67092004000100009,los,o
256,S1139-67092004000100009,pacientes,o
256,S1139-67092004000100009,escogidos,o
256,S1139-67092004000100009,138,o
256,S1139-67092004000100009,completaron,o
256,S1139-67092004000100009,el,o
256,S1139-67092004000100009,estudio,o
256,S1139-67092004000100009,69,o
256,S1139-67092004000100009,tratados,i
256,S1139-67092004000100009,con,o
256,S1139-67092004000100009,antibioticos,i
256,S1139-67092004000100009,y,o
256,S1139-67092004000100009,probioticos,o
256,S1139-67092004000100009,y,o
256,S1139-67092004000100009,69,o
256,S1139-67092004000100009,solamente,o
256,S1139-67092004000100009,con,o
256,S1139-67092004000100009,antibioticos,i
256,S1139-67092004000100009,Entre,o
256,S1139-67092004000100009,los,o
256,S1139-67092004000100009,pacientes,o
256,S1139-67092004000100009,que,o
256,S1139-67092004000100009,tuvieron,o
256,S1139-67092004000100009,diarrea,i
256,S1139-67092004000100009,se,o
256,S1139-67092004000100009,encontro,o
256,S1139-67092004000100009,un,o
256,S1139-67092004000100009,29,o
256,S1139-67092004000100009,de,o
256,S1139-67092004000100009,muestras,i
256,S1139-67092004000100009,positivas,o
256,S1139-67092004000100009,para,o
256,S1139-67092004000100009,la,o
256,S1139-67092004000100009,toxina,i
256,S1139-67092004000100009,asociada,o
256,S1139-67092004000100009,a,o
256,S1139-67092004000100009,C,o
256,S1139-67092004000100009,difficile,o
256,S1139-67092004000100009,en,o
256,S1139-67092004000100009,el,o
256,S1139-67092004000100009,grupo,o
256,S1139-67092004000100009,tratado,i
256,S1139-67092004000100009,con,i
256,S1139-67092004000100009,probioticos,i
256,S1139-67092004000100009,en,o
256,S1139-67092004000100009,comparacion,o
256,S1139-67092004000100009,con,o
256,S1139-67092004000100009,el,o
256,S1139-67092004000100009,725,o
256,S1139-67092004000100009,detectado,o
256,S1139-67092004000100009,en,o
256,S1139-67092004000100009,el,o
256,S1139-67092004000100009,grupo,o
256,S1139-67092004000100009,control,o
256,S1139-67092004000100009,tratado,i
256,S1139-67092004000100009,con,i
256,S1139-67092004000100009,placebo,i
256,S1139-67092004000100009,Cuando,o
256,S1139-67092004000100009,se,o
256,S1139-67092004000100009,analizaron,i
256,S1139-67092004000100009,muestras,i
256,S1139-67092004000100009,de,o
256,S1139-67092004000100009,todos,o
256,S1139-67092004000100009,los,o
256,S1139-67092004000100009,pacientes,o
256,S1139-67092004000100009,no,o
256,S1139-67092004000100009,solamente,o
256,S1139-67092004000100009,los,o
256,S1139-67092004000100009,que,o
256,S1139-67092004000100009,tuvieron,o
256,S1139-67092004000100009,diarrea,i
256,S1139-67092004000100009,un,o
256,S1139-67092004000100009,46,o
256,S1139-67092004000100009,de,o
256,S1139-67092004000100009,los,o
256,S1139-67092004000100009,pacientes,o
256,S1139-67092004000100009,tratados,i
256,S1139-67092004000100009,con,i
256,S1139-67092004000100009,probioticos,i
256,S1139-67092004000100009,dieron,o
256,S1139-67092004000100009,positivo,o
256,S1139-67092004000100009,para,o
256,S1139-67092004000100009,la,o
256,S1139-67092004000100009,toxina,i
256,S1139-67092004000100009,en,o
256,S1139-67092004000100009,comparacion,o
256,S1139-67092004000100009,con,o
256,S1139-67092004000100009,el,o
256,S1139-67092004000100009,78,o
256,S1139-67092004000100009,del,o
256,S1139-67092004000100009,grupo,o
256,S1139-67092004000100009,tratado,i
256,S1139-67092004000100009,con,i
256,S1139-67092004000100009,placebo,i
257,S1139-76322014000500005,Uso,i
257,S1139-76322014000500005,de,i
257,S1139-76322014000500005,las,i
257,S1139-76322014000500005,nuevas,i
257,S1139-76322014000500005,tecnologias,i
257,S1139-76322014000500005,y,o
257,S1139-76322014000500005,telemedicina,i
257,S1139-76322014000500005,en,o
257,S1139-76322014000500005,el,o
257,S1139-76322014000500005,seguimiento,i
257,S1139-76322014000500005,del,o
257,S1139-76322014000500005,recien,i
257,S1139-76322014000500005,nacido,i
257,S1139-76322014000500005,sano,o
257,S1139-76322014000500005,Introduccion,o
257,S1139-76322014000500005,la,o
257,S1139-76322014000500005,implementacion,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,la,o
257,S1139-76322014000500005,telemedicina,i
257,S1139-76322014000500005,es,o
257,S1139-76322014000500005,cada,o
257,S1139-76322014000500005,vez,o
257,S1139-76322014000500005,mayor,o
257,S1139-76322014000500005,sin,o
257,S1139-76322014000500005,embargo,o
257,S1139-76322014000500005,no,o
257,S1139-76322014000500005,existen,o
257,S1139-76322014000500005,estudios,i
257,S1139-76322014000500005,controlados,i
257,S1139-76322014000500005,en,o
257,S1139-76322014000500005,nuestro,o
257,S1139-76322014000500005,medio,o
257,S1139-76322014000500005,que,o
257,S1139-76322014000500005,demuestren,o
257,S1139-76322014000500005,su,o
257,S1139-76322014000500005,efecto,o
257,S1139-76322014000500005,en,o
257,S1139-76322014000500005,Atencion,i
257,S1139-76322014000500005,Primaria,i
257,S1139-76322014000500005,AP,i
257,S1139-76322014000500005,Nuestro,o
257,S1139-76322014000500005,objetivo,o
257,S1139-76322014000500005,es,o
257,S1139-76322014000500005,analizar,o
257,S1139-76322014000500005,si,o
257,S1139-76322014000500005,la,o
257,S1139-76322014000500005,implementacion,i
257,S1139-76322014000500005,de,i
257,S1139-76322014000500005,practicas,i
257,S1139-76322014000500005,tecnologicas,i
257,S1139-76322014000500005,puede,o
257,S1139-76322014000500005,ir,o
257,S1139-76322014000500005,encaminada,o
257,S1139-76322014000500005,al,o
257,S1139-76322014000500005,asesoramiento,i
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,las,o
257,S1139-76322014000500005,familias,o
257,S1139-76322014000500005,Materiales,o
257,S1139-76322014000500005,y,o
257,S1139-76322014000500005,metodos,o
257,S1139-76322014000500005,estudio,o
257,S1139-76322014000500005,piloto,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,intervencion,i
257,S1139-76322014000500005,prospectivo,o
257,S1139-76322014000500005,controlado,o
257,S1139-76322014000500005,no,o
257,S1139-76322014000500005,aleatorizado,o
257,S1139-76322014000500005,muestreo,o
257,S1139-76322014000500005,consecutivo,o
257,S1139-76322014000500005,con,o
257,S1139-76322014000500005,seguimiento,i
257,S1139-76322014000500005,longitudinal,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,seis,o
257,S1139-76322014000500005,meses,o
257,S1139-76322014000500005,realizado,o
257,S1139-76322014000500005,en,o
257,S1139-76322014000500005,un,o
257,S1139-76322014000500005,centro,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,AP,i
257,S1139-76322014000500005,pediatrica,o
257,S1139-76322014000500005,Seguimiento,i
257,S1139-76322014000500005,a,o
257,S1139-76322014000500005,traves,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,web,o
257,S1139-76322014000500005,redes,o
257,S1139-76322014000500005,sociales,o
257,S1139-76322014000500005,y,o
257,S1139-76322014000500005,telemedicina,i
257,S1139-76322014000500005,entre,o
257,S1139-76322014000500005,las,o
257,S1139-76322014000500005,revisiones,i
257,S1139-76322014000500005,del,o
257,S1139-76322014000500005,niño,o
257,S1139-76322014000500005,sano,o
257,S1139-76322014000500005,12,o
257,S1139-76322014000500005,24,o
257,S1139-76322014000500005,y,o
257,S1139-76322014000500005,46,o
257,S1139-76322014000500005,meses,o
257,S1139-76322014000500005,Charlas,o
257,S1139-76322014000500005,grupales,o
257,S1139-76322014000500005,por,o
257,S1139-76322014000500005,telemedicina,i
257,S1139-76322014000500005,vacunas,i
257,S1139-76322014000500005,lactancia,o
257,S1139-76322014000500005,materna,o
257,S1139-76322014000500005,e,o
257,S1139-76322014000500005,introduccion,o
257,S1139-76322014000500005,alimentos,o
257,S1139-76322014000500005,El,o
257,S1139-76322014000500005,grupo,o
257,S1139-76322014000500005,control,i
257,S1139-76322014000500005,recibio,o
257,S1139-76322014000500005,el,o
257,S1139-76322014000500005,seguimiento,i
257,S1139-76322014000500005,habitual,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,AP,i
257,S1139-76322014000500005,Resultados,o
257,S1139-76322014000500005,la,o
257,S1139-76322014000500005,distribucion,o
257,S1139-76322014000500005,sociodemografica,o
257,S1139-76322014000500005,revisiones,i
257,S1139-76322014000500005,presenciales,i
257,S1139-76322014000500005,del,o
257,S1139-76322014000500005,niño,o
257,S1139-76322014000500005,sano,o
257,S1139-76322014000500005,deteccion,i
257,S1139-76322014000500005,de,i
257,S1139-76322014000500005,patologias,i
257,S1139-76322014000500005,fueron,o
257,S1139-76322014000500005,homogeneas,o
257,S1139-76322014000500005,en,o
257,S1139-76322014000500005,los,o
257,S1139-76322014000500005,dos,o
257,S1139-76322014000500005,grupos,o
257,S1139-76322014000500005,En,o
257,S1139-76322014000500005,el,o
257,S1139-76322014000500005,grupo,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,intervencion,i
257,S1139-76322014000500005,se,o
257,S1139-76322014000500005,objetivo,o
257,S1139-76322014000500005,una,o
257,S1139-76322014000500005,disminucion,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,la,o
257,S1139-76322014000500005,frecuentacion,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,visita,o
257,S1139-76322014000500005,pediatricaenfermeria,o
257,S1139-76322014000500005,p005,o
257,S1139-76322014000500005,se,o
257,S1139-76322014000500005,reforzo,o
257,S1139-76322014000500005,la,o
257,S1139-76322014000500005,lactancia,o
257,S1139-76322014000500005,materna,o
257,S1139-76322014000500005,exclusiva,o
257,S1139-76322014000500005,hasta,o
257,S1139-76322014000500005,el,o
257,S1139-76322014000500005,sexto,o
257,S1139-76322014000500005,mes,o
257,S1139-76322014000500005,control,i
257,S1139-76322014000500005,186,o
257,S1139-76322014000500005,e,o
257,S1139-76322014000500005,intervencion,i
257,S1139-76322014000500005,36,o
257,S1139-76322014000500005,Seguimiento,i
257,S1139-76322014000500005,web,o
257,S1139-76322014000500005,725,o
257,S1139-76322014000500005,redes,o
257,S1139-76322014000500005,sociales,o
257,S1139-76322014000500005,588,o
257,S1139-76322014000500005,telemedicina,i
257,S1139-76322014000500005,883,o
257,S1139-76322014000500005,y,o
257,S1139-76322014000500005,charlas,o
257,S1139-76322014000500005,784,o
257,S1139-76322014000500005,Satisfaccion,o
257,S1139-76322014000500005,862,o
257,S1139-76322014000500005,Encuesta,i
257,S1139-76322014000500005,pre,o
257,S1139-76322014000500005,y,o
257,S1139-76322014000500005,posintervencion,o
257,S1139-76322014000500005,cambio,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,actitud,o
257,S1139-76322014000500005,en,o
257,S1139-76322014000500005,desplazarse,o
257,S1139-76322014000500005,a,o
257,S1139-76322014000500005,urgenciahospital,o
257,S1139-76322014000500005,por,o
257,S1139-76322014000500005,dudas,o
257,S1139-76322014000500005,del,o
257,S1139-76322014000500005,5862,o
257,S1139-76322014000500005,al,o
257,S1139-76322014000500005,0,o
257,S1139-76322014000500005,p005,o
257,S1139-76322014000500005,Posicion,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,seguridad,o
257,S1139-76322014000500005,al,o
257,S1139-76322014000500005,dormir,o
257,S1139-76322014000500005,boca,i
257,S1139-76322014000500005,arribalado,o
257,S1139-76322014000500005,del,o
257,S1139-76322014000500005,7368,o
257,S1139-76322014000500005,al,o
257,S1139-76322014000500005,100,o
257,S1139-76322014000500005,p005,o
257,S1139-76322014000500005,Conclusiones,o
257,S1139-76322014000500005,la,o
257,S1139-76322014000500005,telemedicina,i
257,S1139-76322014000500005,ha,o
257,S1139-76322014000500005,demostrado,o
257,S1139-76322014000500005,ser,o
257,S1139-76322014000500005,eficaz,o
257,S1139-76322014000500005,y,o
257,S1139-76322014000500005,eficiente,o
257,S1139-76322014000500005,en,o
257,S1139-76322014000500005,AP,i
257,S1139-76322014000500005,en,o
257,S1139-76322014000500005,el,o
257,S1139-76322014000500005,control,i
257,S1139-76322014000500005,seguimiento,i
257,S1139-76322014000500005,y,o
257,S1139-76322014000500005,prevencion,i
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,los,o
257,S1139-76322014000500005,problemas,o
257,S1139-76322014000500005,habituales,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,los,o
257,S1139-76322014000500005,lactantes,o
257,S1139-76322014000500005,sanos,o
257,S1139-76322014000500005,en,o
257,S1139-76322014000500005,los,o
257,S1139-76322014000500005,primeros,o
257,S1139-76322014000500005,seis,o
257,S1139-76322014000500005,meses,o
257,S1139-76322014000500005,de,o
257,S1139-76322014000500005,vida,o
257,S1139-76322014000500005,Una,o
257,S1139-76322014000500005,web,o
257,S1139-76322014000500005,especializada,o
257,S1139-76322014000500005,redes,o
257,S1139-76322014000500005,sociales,o
257,S1139-76322014000500005,y,o
257,S1139-76322014000500005,telemedicina,i
257,S1139-76322014000500005,resuelven,o
257,S1139-76322014000500005,dudas,o
257,S1139-76322014000500005,sobre,o
257,S1139-76322014000500005,lactancia,o
257,S1139-76322014000500005,materna,o
257,S1139-76322014000500005,alimentacion,o
257,S1139-76322014000500005,y,o
257,S1139-76322014000500005,vacunas,i
257,S1139-76322014000500005,La,o
257,S1139-76322014000500005,telemedicina,i
257,S1139-76322014000500005,fortalece,o
257,S1139-76322014000500005,la,o
257,S1139-76322014000500005,atencion,i
257,S1139-76322014000500005,medica,i
257,S1139-76322014000500005,continuada,o
257,S1139-76322014000500005,disminuyendo,o
257,S1139-76322014000500005,la,o
257,S1139-76322014000500005,frecuentacion,o
257,S1139-76322014000500005,Pediatriaenfermeria,o
258,S1139-76322015000500016,No,o
258,S1139-76322015000500016,existen,o
258,S1139-76322015000500016,pruebas,o
258,S1139-76322015000500016,suficientes,o
258,S1139-76322015000500016,que,o
258,S1139-76322015000500016,recomienden,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,azitromicina,i
258,S1139-76322015000500016,para,o
258,S1139-76322015000500016,prevenir,i
258,S1139-76322015000500016,episodios,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,sibilancias,i
258,S1139-76322015000500016,recurrentes,o
258,S1139-76322015000500016,posbronquiolitis,o
258,S1139-76322015000500016,Objetivo,o
258,S1139-76322015000500016,determinar,o
258,S1139-76322015000500016,si,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,niños,o
258,S1139-76322015000500016,ingresados,i
258,S1139-76322015000500016,por,o
258,S1139-76322015000500016,bronquiolitis,i
258,S1139-76322015000500016,aguda,i
258,S1139-76322015000500016,BA,i
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,administracion,i
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,azitromicina,i
258,S1139-76322015000500016,AZT,i
258,S1139-76322015000500016,disminuye,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,concentracion,i
258,S1139-76322015000500016,de,i
258,S1139-76322015000500016,interleucina,i
258,S1139-76322015000500016,8,i
258,S1139-76322015000500016,IL8,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,suero,i
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,fluido,i
258,S1139-76322015000500016,nasal,i
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,disminuye,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,incidencia,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,episodios,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,sibilancias,i
258,S1139-76322015000500016,recurrentes,o
258,S1139-76322015000500016,ESR,o
258,S1139-76322015000500016,posbronquiolitis,o
258,S1139-76322015000500016,Diseño,o
258,S1139-76322015000500016,ensayo,o
258,S1139-76322015000500016,clinico,o
258,S1139-76322015000500016,aleatorizado,o
258,S1139-76322015000500016,ECA,i
258,S1139-76322015000500016,piloto,o
258,S1139-76322015000500016,doble,o
258,S1139-76322015000500016,ciego,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,controlado,o
258,S1139-76322015000500016,con,o
258,S1139-76322015000500016,placebo1,o
258,S1139-76322015000500016,Emplazamiento,o
258,S1139-76322015000500016,hospitalario,o
258,S1139-76322015000500016,un,o
258,S1139-76322015000500016,hospital,o
258,S1139-76322015000500016,infantil,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,EE,o
258,S1139-76322015000500016,UU,o
258,S1139-76322015000500016,Poblacion,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,estudio,o
258,S1139-76322015000500016,niños,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,edad,o
258,S1139-76322015000500016,comprendida,o
258,S1139-76322015000500016,entre,o
258,S1139-76322015000500016,uno,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,18,o
258,S1139-76322015000500016,meses,o
258,S1139-76322015000500016,con,o
258,S1139-76322015000500016,deteccion,i
258,S1139-76322015000500016,positiva,i
258,S1139-76322015000500016,nasofaringea,i
258,S1139-76322015000500016,mediante,o
258,S1139-76322015000500016,inmunofluorescencia,i
258,S1139-76322015000500016,directa,i
258,S1139-76322015000500016,de,i
258,S1139-76322015000500016,virus,i
258,S1139-76322015000500016,respiratorio,i
258,S1139-76322015000500016,sincitial,i
258,S1139-76322015000500016,VRS,i
258,S1139-76322015000500016,realizada,o
258,S1139-76322015000500016,por,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,Servicio,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,Virologia,o
258,S1139-76322015000500016,del,o
258,S1139-76322015000500016,hospital,o
258,S1139-76322015000500016,donde,o
258,S1139-76322015000500016,se,o
258,S1139-76322015000500016,efectuo,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,estudio,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,que,o
258,S1139-76322015000500016,requirieron,o
258,S1139-76322015000500016,ingreso,i
258,S1139-76322015000500016,hospitalario,i
258,S1139-76322015000500016,IH,o
258,S1139-76322015000500016,durante,o
258,S1139-76322015000500016,dos,o
258,S1139-76322015000500016,estaciones,o
258,S1139-76322015000500016,invernales,o
258,S1139-76322015000500016,seguidas,o
258,S1139-76322015000500016,201112,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,201213,o
258,S1139-76322015000500016,Otros,o
258,S1139-76322015000500016,criterios,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,inclusion,o
258,S1139-76322015000500016,fueron,o
258,S1139-76322015000500016,ser,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,primer,o
258,S1139-76322015000500016,episodio,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,infeccion,i
258,S1139-76322015000500016,del,i
258,S1139-76322015000500016,tracto,i
258,S1139-76322015000500016,respiratorio,i
258,S1139-76322015000500016,inferior,i
258,S1139-76322015000500016,que,o
258,S1139-76322015000500016,requeria,o
258,S1139-76322015000500016,IH,o
258,S1139-76322015000500016,duracion,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,los,o
258,S1139-76322015000500016,sintomas,i
258,S1139-76322015000500016,desde,o
258,S1139-76322015000500016,su,o
258,S1139-76322015000500016,inicio,o
258,S1139-76322015000500016,hasta,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,IH,o
258,S1139-76322015000500016,igual,o
258,S1139-76322015000500016,o,o
258,S1139-76322015000500016,menor,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,cinco,o
258,S1139-76322015000500016,dias,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,aleatorizacion,i
258,S1139-76322015000500016,dentro,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,los,o
258,S1139-76322015000500016,siete,o
258,S1139-76322015000500016,dias,o
258,S1139-76322015000500016,posteriores,o
258,S1139-76322015000500016,al,o
258,S1139-76322015000500016,inicio,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,los,o
258,S1139-76322015000500016,sintomas,i
258,S1139-76322015000500016,respiratorios,i
258,S1139-76322015000500016,Criterios,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,exclusion,o
258,S1139-76322015000500016,historia,o
258,S1139-76322015000500016,previa,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,episodios,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,sibilancias,i
258,S1139-76322015000500016,tratamiento,i
258,S1139-76322015000500016,previo,o
258,S1139-76322015000500016,con,o
258,S1139-76322015000500016,corticoides,i
258,S1139-76322015000500016,tanto,o
258,S1139-76322015000500016,sistemicos,o
258,S1139-76322015000500016,como,o
258,S1139-76322015000500016,inhalados,o
258,S1139-76322015000500016,tratamiento,i
258,S1139-76322015000500016,con,o
258,S1139-76322015000500016,broncodilatadores,i
258,S1139-76322015000500016,previo,o
258,S1139-76322015000500016,al,o
258,S1139-76322015000500016,episodio,o
258,S1139-76322015000500016,objeto,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,estudio,o
258,S1139-76322015000500016,estar,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,tratamiento,i
258,S1139-76322015000500016,por,o
258,S1139-76322015000500016,padecer,o
258,S1139-76322015000500016,reflujo,i
258,S1139-76322015000500016,gastroesofagico,i
258,S1139-76322015000500016,haber,o
258,S1139-76322015000500016,recibido,o
258,S1139-76322015000500016,tratamiento,i
258,S1139-76322015000500016,antibiotico,i
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,las,o
258,S1139-76322015000500016,ultimas,o
258,S1139-76322015000500016,dos,o
258,S1139-76322015000500016,semanas,o
258,S1139-76322015000500016,cuatro,o
258,S1139-76322015000500016,semanas,o
258,S1139-76322015000500016,si,o
258,S1139-76322015000500016,recibio,o
258,S1139-76322015000500016,tratamiento,i
258,S1139-76322015000500016,con,o
258,S1139-76322015000500016,macrolidos,i
258,S1139-76322015000500016,edad,o
258,S1139-76322015000500016,gestacional,o
258,S1139-76322015000500016,36,o
258,S1139-76322015000500016,semanas,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,padecimiento,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,enfermedades,o
258,S1139-76322015000500016,cronicas,o
258,S1139-76322015000500016,pulmonares,i
258,S1139-76322015000500016,cardiacas,i
258,S1139-76322015000500016,renales,i
258,S1139-76322015000500016,o,o
258,S1139-76322015000500016,hepaticas,i
258,S1139-76322015000500016,Se,o
258,S1139-76322015000500016,evaluaron,o
258,S1139-76322015000500016,para,o
258,S1139-76322015000500016,su,o
258,S1139-76322015000500016,elegibilidad,o
258,S1139-76322015000500016,1391,o
258,S1139-76322015000500016,niños,o
258,S1139-76322015000500016,VRS,i
258,S1139-76322015000500016,positivos,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,se,o
258,S1139-76322015000500016,excluyeron,o
258,S1139-76322015000500016,1351,o
258,S1139-76322015000500016,por,o
258,S1139-76322015000500016,no,o
258,S1139-76322015000500016,cumplir,o
258,S1139-76322015000500016,los,o
258,S1139-76322015000500016,criterios,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,seleccion,o
258,S1139-76322015000500016,Participaron,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,estudio,o
258,S1139-76322015000500016,40,o
258,S1139-76322015000500016,niños,o
258,S1139-76322015000500016,El,o
258,S1139-76322015000500016,tamaño,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,muestra,o
258,S1139-76322015000500016,se,o
258,S1139-76322015000500016,calculo,o
258,S1139-76322015000500016,para,o
258,S1139-76322015000500016,detectar,o
258,S1139-76322015000500016,una,o
258,S1139-76322015000500016,reduccion,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,concentracion,o
258,S1139-76322015000500016,serica,i
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,IL8,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,un,o
258,S1139-76322015000500016,25,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,los,o
258,S1139-76322015000500016,niños,o
258,S1139-76322015000500016,que,o
258,S1139-76322015000500016,recibieron,o
258,S1139-76322015000500016,AZT,i
258,S1139-76322015000500016,Intervencion,i
258,S1139-76322015000500016,los,o
258,S1139-76322015000500016,participantes,o
258,S1139-76322015000500016,se,o
258,S1139-76322015000500016,asignaron,i
258,S1139-76322015000500016,aleatoriamente,i
258,S1139-76322015000500016,metodo,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,aleatorizacion,i
258,S1139-76322015000500016,por,i
258,S1139-76322015000500016,bloques,i
258,S1139-76322015000500016,para,o
258,S1139-76322015000500016,recibir,o
258,S1139-76322015000500016,grupo,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,intervencion,i
258,S1139-76322015000500016,GI,o
258,S1139-76322015000500016,n20,o
258,S1139-76322015000500016,AZT,i
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,suspension,o
258,S1139-76322015000500016,oral,o
258,S1139-76322015000500016,10,o
258,S1139-76322015000500016,mgkg,o
258,S1139-76322015000500016,una,o
258,S1139-76322015000500016,vez,o
258,S1139-76322015000500016,al,o
258,S1139-76322015000500016,dia,o
258,S1139-76322015000500016,durante,o
258,S1139-76322015000500016,siete,o
258,S1139-76322015000500016,dias,o
258,S1139-76322015000500016,seguido,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,AZT,i
258,S1139-76322015000500016,oral,o
258,S1139-76322015000500016,5,o
258,S1139-76322015000500016,mgkg,o
258,S1139-76322015000500016,una,o
258,S1139-76322015000500016,vez,o
258,S1139-76322015000500016,al,o
258,S1139-76322015000500016,dia,o
258,S1139-76322015000500016,durante,o
258,S1139-76322015000500016,otros,o
258,S1139-76322015000500016,siete,o
258,S1139-76322015000500016,dias,o
258,S1139-76322015000500016,grupo,o
258,S1139-76322015000500016,control,o
258,S1139-76322015000500016,GC,o
258,S1139-76322015000500016,n20,o
258,S1139-76322015000500016,placebo,i
258,S1139-76322015000500016,del,o
258,S1139-76322015000500016,mismo,o
258,S1139-76322015000500016,sabor,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,apariencia,o
258,S1139-76322015000500016,externa,o
258,S1139-76322015000500016,que,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,AZT,i
258,S1139-76322015000500016,Medicion,o
258,S1139-76322015000500016,del,o
258,S1139-76322015000500016,resultado,o
258,S1139-76322015000500016,resultado,o
258,S1139-76322015000500016,biologico,o
258,S1139-76322015000500016,principal,o
258,S1139-76322015000500016,niveles,o
258,S1139-76322015000500016,sericos,i
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,nasales,i
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,IL8,o
258,S1139-76322015000500016,Resultado,o
258,S1139-76322015000500016,clinico,o
258,S1139-76322015000500016,principal,o
258,S1139-76322015000500016,efecto,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,AZT,i
258,S1139-76322015000500016,sobre,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,incidencia,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,ESR,o
258,S1139-76322015000500016,posBA,o
258,S1139-76322015000500016,durante,o
258,S1139-76322015000500016,las,o
258,S1139-76322015000500016,50,o
258,S1139-76322015000500016,semanas,o
258,S1139-76322015000500016,posteriores,o
258,S1139-76322015000500016,al,o
258,S1139-76322015000500016,inicio,o
258,S1139-76322015000500016,del,o
258,S1139-76322015000500016,ECA,i
258,S1139-76322015000500016,variable,o
258,S1139-76322015000500016,medida,o
258,S1139-76322015000500016,mediante,o
258,S1139-76322015000500016,entrevista,i
258,S1139-76322015000500016,a,o
258,S1139-76322015000500016,los,o
258,S1139-76322015000500016,padres,o
258,S1139-76322015000500016,Se,o
258,S1139-76322015000500016,utilizaron,o
258,S1139-76322015000500016,modelos,o
258,S1139-76322015000500016,mixtos,o
258,S1139-76322015000500016,para,o
258,S1139-76322015000500016,analisis,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,medidas,o
258,S1139-76322015000500016,repetidas,o
258,S1139-76322015000500016,analisis,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,covarianza,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,curvas,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,supervivencia,o
258,S1139-76322015000500016,Resultados,o
258,S1139-76322015000500016,principales,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,AZT,i
258,S1139-76322015000500016,comparada,o
258,S1139-76322015000500016,con,o
258,S1139-76322015000500016,placebo,i
258,S1139-76322015000500016,no,o
258,S1139-76322015000500016,produjo,o
258,S1139-76322015000500016,una,o
258,S1139-76322015000500016,disminucion,o
258,S1139-76322015000500016,estadisticamente,o
258,S1139-76322015000500016,significativa,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,los,o
258,S1139-76322015000500016,niveles,o
258,S1139-76322015000500016,sericos,i
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,IL8,o
258,S1139-76322015000500016,al,o
258,S1139-76322015000500016,octavo,o
258,S1139-76322015000500016,dia,o
258,S1139-76322015000500016,del,o
258,S1139-76322015000500016,inicio,o
258,S1139-76322015000500016,del,o
258,S1139-76322015000500016,ECA,i
258,S1139-76322015000500016,niveles,o
258,S1139-76322015000500016,basales,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,IL8,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,GI,o
258,S1139-76322015000500016,14676,o
258,S1139-76322015000500016,fgml,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,12795,o
258,S1139-76322015000500016,fgml,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,GC,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,momento,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,aleatorizacion,i
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,niveles,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,IL8,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,6971,o
258,S1139-76322015000500016,fgml,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,GI,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,5050,o
258,S1139-76322015000500016,fgml,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,GC,o
258,S1139-76322015000500016,p062,o
258,S1139-76322015000500016,En,o
258,S1139-76322015000500016,comparacion,o
258,S1139-76322015000500016,con,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,placebo,i
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,AZT,i
258,S1139-76322015000500016,produjo,o
258,S1139-76322015000500016,una,o
258,S1139-76322015000500016,disminucion,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,los,o
258,S1139-76322015000500016,niveles,o
258,S1139-76322015000500016,nasofaringeos,i
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,IL8,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,dia,o
258,S1139-76322015000500016,15,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,seguimiento,i
258,S1139-76322015000500016,p0026,o
258,S1139-76322015000500016,pero,o
258,S1139-76322015000500016,no,o
258,S1139-76322015000500016,al,o
258,S1139-76322015000500016,octavo,o
258,S1139-76322015000500016,dia,o
258,S1139-76322015000500016,p011,o
258,S1139-76322015000500016,ni,o
258,S1139-76322015000500016,al,o
258,S1139-76322015000500016,valorar,o
258,S1139-76322015000500016,todo,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,periodo,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,forma,o
258,S1139-76322015000500016,global,o
258,S1139-76322015000500016,p0076,o
258,S1139-76322015000500016,La,o
258,S1139-76322015000500016,proporcion,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,niños,o
258,S1139-76322015000500016,que,o
258,S1139-76322015000500016,presentaron,o
258,S1139-76322015000500016,2,o
258,S1139-76322015000500016,ESR,o
258,S1139-76322015000500016,hasta,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,semana,o
258,S1139-76322015000500016,50,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,seguimiento,i
258,S1139-76322015000500016,fue,o
258,S1139-76322015000500016,del,o
258,S1139-76322015000500016,39,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,GI,o
258,S1139-76322015000500016,frente,o
258,S1139-76322015000500016,al,o
258,S1139-76322015000500016,50,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,GC,o
258,S1139-76322015000500016,p05,o
258,S1139-76322015000500016,La,o
258,S1139-76322015000500016,proporcion,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,niños,o
258,S1139-76322015000500016,que,o
258,S1139-76322015000500016,presentaron,o
258,S1139-76322015000500016,3,o
258,S1139-76322015000500016,ESR,o
258,S1139-76322015000500016,hasta,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,semana,o
258,S1139-76322015000500016,50,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,seguimiento,i
258,S1139-76322015000500016,fue,o
258,S1139-76322015000500016,del,o
258,S1139-76322015000500016,22,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,GI,o
258,S1139-76322015000500016,frente,o
258,S1139-76322015000500016,al,o
258,S1139-76322015000500016,50,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,GC,o
258,S1139-76322015000500016,p007,o
258,S1139-76322015000500016,El,o
258,S1139-76322015000500016,tiempo,o
258,S1139-76322015000500016,transcurrido,o
258,S1139-76322015000500016,entre,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,segundo,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,tercer,o
258,S1139-76322015000500016,episodio,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,ESR,o
258,S1139-76322015000500016,fue,o
258,S1139-76322015000500016,superior,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,GI,o
258,S1139-76322015000500016,p0048,o
258,S1139-76322015000500016,Conclusion,o
258,S1139-76322015000500016,los,o
258,S1139-76322015000500016,autores,o
258,S1139-76322015000500016,concluyen,o
258,S1139-76322015000500016,que,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,AZT,i
258,S1139-76322015000500016,disminuye,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,concentracion,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,los,o
258,S1139-76322015000500016,niveles,o
258,S1139-76322015000500016,nasofaringeos,i
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,IL8,o
258,S1139-76322015000500016,durante,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,duracion,o
258,S1139-76322015000500016,del,o
258,S1139-76322015000500016,estudio,o
258,S1139-76322015000500016,y,o
258,S1139-76322015000500016,produce,o
258,S1139-76322015000500016,un,o
258,S1139-76322015000500016,retraso,o
258,S1139-76322015000500016,en,o
258,S1139-76322015000500016,la,o
258,S1139-76322015000500016,aparicion,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,un,o
258,S1139-76322015000500016,tercer,o
258,S1139-76322015000500016,episodio,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,ESR,o
258,S1139-76322015000500016,durante,o
258,S1139-76322015000500016,el,o
258,S1139-76322015000500016,periodo,o
258,S1139-76322015000500016,de,o
258,S1139-76322015000500016,seguimiento,i
259,S1405-99402002000300004,Disminucion,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,hemorragias,i
259,S1405-99402002000300004,totales,o
259,S1405-99402002000300004,con,o
259,S1405-99402002000300004,dosis,o
259,S1405-99402002000300004,reducidas,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,enoxaparina,i
259,S1405-99402002000300004,en,o
259,S1405-99402002000300004,angina,i
259,S1405-99402002000300004,inestable,i
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,alto,o
259,S1405-99402002000300004,riesgo,o
259,S1405-99402002000300004,Estudio,o
259,S1405-99402002000300004,ENHNFAI,o
259,S1405-99402002000300004,ENoxaparina,i
259,S1405-99402002000300004,vs,o
259,S1405-99402002000300004,Heparina,i
259,S1405-99402002000300004,No,i
259,S1405-99402002000300004,Fraccionada,i
259,S1405-99402002000300004,en,o
259,S1405-99402002000300004,Angina,i
259,S1405-99402002000300004,Inestable,i
259,S1405-99402002000300004,Informe,o
259,S1405-99402002000300004,preliminar,o
259,S1405-99402002000300004,En,o
259,S1405-99402002000300004,este,o
259,S1405-99402002000300004,estudio,o
259,S1405-99402002000300004,prospectivo,o
259,S1405-99402002000300004,aleatorizado,o
259,S1405-99402002000300004,y,o
259,S1405-99402002000300004,controlado,o
259,S1405-99402002000300004,se,o
259,S1405-99402002000300004,compararon,o
259,S1405-99402002000300004,complicaciones,i
259,S1405-99402002000300004,en,o
259,S1405-99402002000300004,2,o
259,S1405-99402002000300004,grupos,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,tratamiento,i
259,S1405-99402002000300004,Grupo,o
259,S1405-99402002000300004,1,o
259,S1405-99402002000300004,recibio,o
259,S1405-99402002000300004,enoxaparina,i
259,S1405-99402002000300004,08,o
259,S1405-99402002000300004,mgkg,o
259,S1405-99402002000300004,subcutanea,o
259,S1405-99402002000300004,cada,o
259,S1405-99402002000300004,12,o
259,S1405-99402002000300004,horas,o
259,S1405-99402002000300004,durante,o
259,S1405-99402002000300004,5,o
259,S1405-99402002000300004,dias,o
259,S1405-99402002000300004,y,o
259,S1405-99402002000300004,el,o
259,S1405-99402002000300004,Grupo,o
259,S1405-99402002000300004,2,o
259,S1405-99402002000300004,HNF,i
259,S1405-99402002000300004,intravenosa,o
259,S1405-99402002000300004,continua,o
259,S1405-99402002000300004,durante,o
259,S1405-99402002000300004,5,o
259,S1405-99402002000300004,dias,o
259,S1405-99402002000300004,ajustada,o
259,S1405-99402002000300004,para,o
259,S1405-99402002000300004,alargar,o
259,S1405-99402002000300004,el,o
259,S1405-99402002000300004,TTPa,i
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,15,o
259,S1405-99402002000300004,a,o
259,S1405-99402002000300004,25,o
259,S1405-99402002000300004,veces,o
259,S1405-99402002000300004,Se,o
259,S1405-99402002000300004,midieron,o
259,S1405-99402002000300004,niveles,o
259,S1405-99402002000300004,sericos,i
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,antiXa,o
259,S1405-99402002000300004,a,o
259,S1405-99402002000300004,las,o
259,S1405-99402002000300004,4,o
259,S1405-99402002000300004,12,o
259,S1405-99402002000300004,24,o
259,S1405-99402002000300004,horas,o
259,S1405-99402002000300004,y,o
259,S1405-99402002000300004,quinto,o
259,S1405-99402002000300004,dia,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,tratamiento,i
259,S1405-99402002000300004,evaluando,o
259,S1405-99402002000300004,puntos,o
259,S1405-99402002000300004,finales,o
259,S1405-99402002000300004,entre,o
259,S1405-99402002000300004,grupos,o
259,S1405-99402002000300004,con,o
259,S1405-99402002000300004,seguimiento,i
259,S1405-99402002000300004,a,o
259,S1405-99402002000300004,30,o
259,S1405-99402002000300004,dias,o
259,S1405-99402002000300004,Se,o
259,S1405-99402002000300004,realizo,o
259,S1405-99402002000300004,analisis,o
259,S1405-99402002000300004,univariado,o
259,S1405-99402002000300004,y,o
259,S1405-99402002000300004,multivariado,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,las,o
259,S1405-99402002000300004,caracteristicas,o
259,S1405-99402002000300004,clinicas,o
259,S1405-99402002000300004,angiograficas,i
259,S1405-99402002000300004,y,o
259,S1405-99402002000300004,eventos,o
259,S1405-99402002000300004,entre,o
259,S1405-99402002000300004,grupos,o
259,S1405-99402002000300004,considerando,o
259,S1405-99402002000300004,p,o
259,S1405-99402002000300004,005,o
259,S1405-99402002000300004,Resultados,o
259,S1405-99402002000300004,De,o
259,S1405-99402002000300004,un,o
259,S1405-99402002000300004,total,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,203,o
259,S1405-99402002000300004,pacientes,o
259,S1405-99402002000300004,predomino,o
259,S1405-99402002000300004,el,o
259,S1405-99402002000300004,sexo,o
259,S1405-99402002000300004,masculino,o
259,S1405-99402002000300004,80,o
259,S1405-99402002000300004,se,o
259,S1405-99402002000300004,incluyeron,o
259,S1405-99402002000300004,107,o
259,S1405-99402002000300004,pacientes,o
259,S1405-99402002000300004,en,o
259,S1405-99402002000300004,el,o
259,S1405-99402002000300004,grupo,o
259,S1405-99402002000300004,1,o
259,S1405-99402002000300004,y,o
259,S1405-99402002000300004,96,o
259,S1405-99402002000300004,en,o
259,S1405-99402002000300004,el,o
259,S1405-99402002000300004,grupo,o
259,S1405-99402002000300004,2,o
259,S1405-99402002000300004,No,o
259,S1405-99402002000300004,existieron,o
259,S1405-99402002000300004,diferencias,o
259,S1405-99402002000300004,entre,o
259,S1405-99402002000300004,grupos,o
259,S1405-99402002000300004,al,o
259,S1405-99402002000300004,comparar,o
259,S1405-99402002000300004,caracteristicas,o
259,S1405-99402002000300004,clinicas,o
259,S1405-99402002000300004,y,o
259,S1405-99402002000300004,angiograficas,i
259,S1405-99402002000300004,Se,o
259,S1405-99402002000300004,lograron,o
259,S1405-99402002000300004,niveles,o
259,S1405-99402002000300004,utiles,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,antiXa,o
259,S1405-99402002000300004,en,o
259,S1405-99402002000300004,todos,o
259,S1405-99402002000300004,los,o
259,S1405-99402002000300004,pacientes,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,enoxaparina,i
259,S1405-99402002000300004,con,o
259,S1405-99402002000300004,rangos,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,05,o
259,S1405-99402002000300004,a,o
259,S1405-99402002000300004,067,o
259,S1405-99402002000300004,UmL,o
259,S1405-99402002000300004,Existio,o
259,S1405-99402002000300004,un,o
259,S1405-99402002000300004,mayor,o
259,S1405-99402002000300004,riesgo,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,hemorragias,i
259,S1405-99402002000300004,totales,o
259,S1405-99402002000300004,en,o
259,S1405-99402002000300004,el,o
259,S1405-99402002000300004,grupo,o
259,S1405-99402002000300004,2,o
259,S1405-99402002000300004,187,o
259,S1405-99402002000300004,comparado,o
259,S1405-99402002000300004,con,o
259,S1405-99402002000300004,el,o
259,S1405-99402002000300004,grupo,o
259,S1405-99402002000300004,1,o
259,S1405-99402002000300004,56,o
259,S1405-99402002000300004,con,o
259,S1405-99402002000300004,un,o
259,S1405-99402002000300004,RR,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,172,o
259,S1405-99402002000300004,95,o
259,S1405-99402002000300004,CI,o
259,S1405-99402002000300004,129,o
259,S1405-99402002000300004,229,o
259,S1405-99402002000300004,y,o
259,S1405-99402002000300004,p,o
259,S1405-99402002000300004,003,o
259,S1405-99402002000300004,Se,o
259,S1405-99402002000300004,corroboro,o
259,S1405-99402002000300004,un,o
259,S1405-99402002000300004,mayor,o
259,S1405-99402002000300004,numero,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,MACE,o
259,S1405-99402002000300004,eventos,i
259,S1405-99402002000300004,cardiovasculares,i
259,S1405-99402002000300004,mayores,o
259,S1405-99402002000300004,en,o
259,S1405-99402002000300004,el,o
259,S1405-99402002000300004,grupo,o
259,S1405-99402002000300004,2,o
259,S1405-99402002000300004,333,o
259,S1405-99402002000300004,comparado,o
259,S1405-99402002000300004,con,o
259,S1405-99402002000300004,el,o
259,S1405-99402002000300004,grupo,o
259,S1405-99402002000300004,1,o
259,S1405-99402002000300004,178,o
259,S1405-99402002000300004,con,o
259,S1405-99402002000300004,RR,o
259,S1405-99402002000300004,188,o
259,S1405-99402002000300004,95,o
259,S1405-99402002000300004,CI,o
259,S1405-99402002000300004,114,o
259,S1405-99402002000300004,308,o
259,S1405-99402002000300004,y,o
259,S1405-99402002000300004,p,o
259,S1405-99402002000300004,011,o
259,S1405-99402002000300004,Conclusiones,o
259,S1405-99402002000300004,1,o
259,S1405-99402002000300004,La,o
259,S1405-99402002000300004,dosis,o
259,S1405-99402002000300004,menor,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,enoxaparina,i
259,S1405-99402002000300004,logra,o
259,S1405-99402002000300004,niveles,o
259,S1405-99402002000300004,terapeuticos,o
259,S1405-99402002000300004,desde,o
259,S1405-99402002000300004,las,o
259,S1405-99402002000300004,primeras,o
259,S1405-99402002000300004,4,o
259,S1405-99402002000300004,horas,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,tratamiento,i
259,S1405-99402002000300004,2,o
259,S1405-99402002000300004,Existe,o
259,S1405-99402002000300004,una,o
259,S1405-99402002000300004,disminucion,o
259,S1405-99402002000300004,significativa,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,las,o
259,S1405-99402002000300004,hemorragias,i
259,S1405-99402002000300004,totales,o
259,S1405-99402002000300004,con,o
259,S1405-99402002000300004,la,o
259,S1405-99402002000300004,dosis,o
259,S1405-99402002000300004,reducida,o
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,enoxaparina,i
259,S1405-99402002000300004,conservando,o
259,S1405-99402002000300004,su,o
259,S1405-99402002000300004,eficacia,o
259,S1405-99402002000300004,en,o
259,S1405-99402002000300004,el,o
259,S1405-99402002000300004,seguimiento,i
259,S1405-99402002000300004,de,o
259,S1405-99402002000300004,MACE,o
260,S1561-31942005000300004,Morfina,i
260,S1561-31942005000300004,peridural,o
260,S1561-31942005000300004,en,o
260,S1561-31942005000300004,la,o
260,S1561-31942005000300004,operacion,i
260,S1561-31942005000300004,cesarea,i
260,S1561-31942005000300004,Los,o
260,S1561-31942005000300004,opioides,i
260,S1561-31942005000300004,son,o
260,S1561-31942005000300004,las,o
260,S1561-31942005000300004,drogas,i
260,S1561-31942005000300004,mas,o
260,S1561-31942005000300004,eficaces,o
260,S1561-31942005000300004,y,o
260,S1561-31942005000300004,frecuentemente,o
260,S1561-31942005000300004,utilizadas,o
260,S1561-31942005000300004,para,o
260,S1561-31942005000300004,el,o
260,S1561-31942005000300004,alivio,o
260,S1561-31942005000300004,del,o
260,S1561-31942005000300004,dolor,i
260,S1561-31942005000300004,postoperatorio,i
260,S1561-31942005000300004,Con,o
260,S1561-31942005000300004,el,o
260,S1561-31942005000300004,objetivo,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,evaluar,i
260,S1561-31942005000300004,la,i
260,S1561-31942005000300004,eficacia,i
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,la,o
260,S1561-31942005000300004,administracion,i
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,morfina,i
260,S1561-31942005000300004,peridural,o
260,S1561-31942005000300004,como,o
260,S1561-31942005000300004,metodo,i
260,S1561-31942005000300004,analgesico,i
260,S1561-31942005000300004,en,o
260,S1561-31942005000300004,las,o
260,S1561-31942005000300004,pacientes,o
260,S1561-31942005000300004,cesareadas,i
260,S1561-31942005000300004,realizamos,o
260,S1561-31942005000300004,el,o
260,S1561-31942005000300004,siguiente,o
260,S1561-31942005000300004,ensayo,i
260,S1561-31942005000300004,clinico,i
260,S1561-31942005000300004,prospectivo,i
260,S1561-31942005000300004,y,i
260,S1561-31942005000300004,aleatorio,i
260,S1561-31942005000300004,a,o
260,S1561-31942005000300004,200,o
260,S1561-31942005000300004,pacientes,o
260,S1561-31942005000300004,con,o
260,S1561-31942005000300004,condiciones,o
260,S1561-31942005000300004,fisicas,o
260,S1561-31942005000300004,ASA,o
260,S1561-31942005000300004,I,o
260,S1561-31942005000300004,y,o
260,S1561-31942005000300004,II,o
260,S1561-31942005000300004,distribuidos,o
260,S1561-31942005000300004,en,o
260,S1561-31942005000300004,cuatro,o
260,S1561-31942005000300004,grupos,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,50,o
260,S1561-31942005000300004,cada,o
260,S1561-31942005000300004,uno,o
260,S1561-31942005000300004,en,o
260,S1561-31942005000300004,el,o
260,S1561-31942005000300004,Hospital,o
260,S1561-31942005000300004,Universitario,o
260,S1561-31942005000300004,Abel,o
260,S1561-31942005000300004,Santamaria,o
260,S1561-31942005000300004,Cuadrado,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,Pinar,o
260,S1561-31942005000300004,del,o
260,S1561-31942005000300004,Rio,o
260,S1561-31942005000300004,en,o
260,S1561-31942005000300004,el,o
260,S1561-31942005000300004,periodo,o
260,S1561-31942005000300004,comprendido,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,enero,o
260,S1561-31942005000300004,del,o
260,S1561-31942005000300004,2001,o
260,S1561-31942005000300004,y,o
260,S1561-31942005000300004,enero,o
260,S1561-31942005000300004,del,o
260,S1561-31942005000300004,2004,o
260,S1561-31942005000300004,A,o
260,S1561-31942005000300004,todas,o
260,S1561-31942005000300004,se,o
260,S1561-31942005000300004,les,o
260,S1561-31942005000300004,administro,i
260,S1561-31942005000300004,por,i
260,S1561-31942005000300004,via,i
260,S1561-31942005000300004,peridural,i
260,S1561-31942005000300004,Lidocaina,i
260,S1561-31942005000300004,al,o
260,S1561-31942005000300004,2,o
260,S1561-31942005000300004,segun,o
260,S1561-31942005000300004,recomienda,o
260,S1561-31942005000300004,Morgan,o
260,S1561-31942005000300004,y,o
260,S1561-31942005000300004,Barash,o
260,S1561-31942005000300004,al,o
260,S1561-31942005000300004,grupo,o
260,S1561-31942005000300004,I,o
260,S1561-31942005000300004,solo,o
260,S1561-31942005000300004,se,o
260,S1561-31942005000300004,le,o
260,S1561-31942005000300004,administro,o
260,S1561-31942005000300004,el,o
260,S1561-31942005000300004,anestesico,i
260,S1561-31942005000300004,local,i
260,S1561-31942005000300004,antes,o
260,S1561-31942005000300004,mencionado,o
260,S1561-31942005000300004,sin,o
260,S1561-31942005000300004,opiaceos,i
260,S1561-31942005000300004,a,o
260,S1561-31942005000300004,los,o
260,S1561-31942005000300004,restantes,o
260,S1561-31942005000300004,grupos,o
260,S1561-31942005000300004,II,o
260,S1561-31942005000300004,III,o
260,S1561-31942005000300004,y,o
260,S1561-31942005000300004,IV,o
260,S1561-31942005000300004,se,o
260,S1561-31942005000300004,le,o
260,S1561-31942005000300004,añadio,o
260,S1561-31942005000300004,1,o
260,S1561-31942005000300004,mg,o
260,S1561-31942005000300004,2mg,o
260,S1561-31942005000300004,y,o
260,S1561-31942005000300004,3mg,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,morfina,i
260,S1561-31942005000300004,respectivamente,o
260,S1561-31942005000300004,Posterior,o
260,S1561-31942005000300004,al,o
260,S1561-31942005000300004,procesamiento,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,los,o
260,S1561-31942005000300004,datos,o
260,S1561-31942005000300004,resulto,o
260,S1561-31942005000300004,haberse,o
260,S1561-31942005000300004,logrado,o
260,S1561-31942005000300004,una,o
260,S1561-31942005000300004,excelente,o
260,S1561-31942005000300004,analgesia,i
260,S1561-31942005000300004,en,o
260,S1561-31942005000300004,el,o
260,S1561-31942005000300004,100,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,las,o
260,S1561-31942005000300004,pacientes,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,los,o
260,S1561-31942005000300004,grupos,o
260,S1561-31942005000300004,III,o
260,S1561-31942005000300004,y,o
260,S1561-31942005000300004,IV,o
260,S1561-31942005000300004,En,o
260,S1561-31942005000300004,el,o
260,S1561-31942005000300004,grupo,o
260,S1561-31942005000300004,IV,o
260,S1561-31942005000300004,se,o
260,S1561-31942005000300004,obtuvo,o
260,S1561-31942005000300004,la,o
260,S1561-31942005000300004,mayor,o
260,S1561-31942005000300004,incidencia,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,cambios,o
260,S1561-31942005000300004,hemodinamicos,o
260,S1561-31942005000300004,p005,o
260,S1561-31942005000300004,y,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,efectos,i
260,S1561-31942005000300004,indeseables,i
260,S1561-31942005000300004,en,o
260,S1561-31942005000300004,la,o
260,S1561-31942005000300004,madre,o
260,S1561-31942005000300004,p,o
260,S1561-31942005000300004,001,o
260,S1561-31942005000300004,sin,o
260,S1561-31942005000300004,embargo,o
260,S1561-31942005000300004,no,o
260,S1561-31942005000300004,se,o
260,S1561-31942005000300004,encontro,o
260,S1561-31942005000300004,depresion,i
260,S1561-31942005000300004,neonatal,i
260,S1561-31942005000300004,en,o
260,S1561-31942005000300004,ninguno,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,los,o
260,S1561-31942005000300004,grupos,o
260,S1561-31942005000300004,La,o
260,S1561-31942005000300004,dosis,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,analgesia,i
260,S1561-31942005000300004,sistemica,i
260,S1561-31942005000300004,o,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,rescate,i
260,S1561-31942005000300004,analgesico,i
260,S1561-31942005000300004,solo,o
260,S1561-31942005000300004,fueron,o
260,S1561-31942005000300004,necesarias,o
260,S1561-31942005000300004,en,o
260,S1561-31942005000300004,los,o
260,S1561-31942005000300004,grupos,o
260,S1561-31942005000300004,I,o
260,S1561-31942005000300004,y,o
260,S1561-31942005000300004,II,o
260,S1561-31942005000300004,556,o
260,S1561-31942005000300004,y,o
260,S1561-31942005000300004,444,o
260,S1561-31942005000300004,respectivamente,o
260,S1561-31942005000300004,El,o
260,S1561-31942005000300004,metodo,o
260,S1561-31942005000300004,utilizado,o
260,S1561-31942005000300004,en,o
260,S1561-31942005000300004,el,o
260,S1561-31942005000300004,grupo,o
260,S1561-31942005000300004,III,o
260,S1561-31942005000300004,fue,o
260,S1561-31942005000300004,el,o
260,S1561-31942005000300004,de,o
260,S1561-31942005000300004,mejores,o
260,S1561-31942005000300004,resultados,o
260,S1561-31942005000300004,al,o
260,S1561-31942005000300004,brindar,o
260,S1561-31942005000300004,una,o
260,S1561-31942005000300004,excelente,o
260,S1561-31942005000300004,analgesia,i
260,S1561-31942005000300004,con,o
260,S1561-31942005000300004,minimos,o
260,S1561-31942005000300004,cambios,o
260,S1561-31942005000300004,hemodinamicos,o
260,S1561-31942005000300004,y,o
260,S1561-31942005000300004,efectos,i
260,S1561-31942005000300004,indeseados,i
261,S1657-95342006000200005,Estudio,o
261,S1657-95342006000200005,comparativo,o
261,S1657-95342006000200005,cruzado,o
261,S1657-95342006000200005,doble,o
261,S1657-95342006000200005,ciego,o
261,S1657-95342006000200005,al,o
261,S1657-95342006000200005,azar,o
261,S1657-95342006000200005,para,o
261,S1657-95342006000200005,determinar,i
261,S1657-95342006000200005,la,i
261,S1657-95342006000200005,bioequivalencia,i
261,S1657-95342006000200005,entre,o
261,S1657-95342006000200005,dos,o
261,S1657-95342006000200005,formulaciones,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,valsartan,i
261,S1657-95342006000200005,en,o
261,S1657-95342006000200005,tabletas,o
261,S1657-95342006000200005,y,o
261,S1657-95342006000200005,capsulas,o
261,S1657-95342006000200005,Introduccion,o
261,S1657-95342006000200005,Los,o
261,S1657-95342006000200005,estudios,i
261,S1657-95342006000200005,de,i
261,S1657-95342006000200005,bioequivalencia,i
261,S1657-95342006000200005,o,i
261,S1657-95342006000200005,equivalencia,i
261,S1657-95342006000200005,comparada,i
261,S1657-95342006000200005,se,o
261,S1657-95342006000200005,realizan,o
261,S1657-95342006000200005,para,o
261,S1657-95342006000200005,demostrar,o
261,S1657-95342006000200005,que,o
261,S1657-95342006000200005,el,o
261,S1657-95342006000200005,producto,o
261,S1657-95342006000200005,en,o
261,S1657-95342006000200005,estudio,o
261,S1657-95342006000200005,conocido,o
261,S1657-95342006000200005,como,o
261,S1657-95342006000200005,producto,i
261,S1657-95342006000200005,generico,i
261,S1657-95342006000200005,tiene,o
261,S1657-95342006000200005,la,o
261,S1657-95342006000200005,misma,o
261,S1657-95342006000200005,biodisponibilidad,o
261,S1657-95342006000200005,del,o
261,S1657-95342006000200005,producto,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,referencia,o
261,S1657-95342006000200005,tambien,o
261,S1657-95342006000200005,conocido,o
261,S1657-95342006000200005,como,o
261,S1657-95342006000200005,producto,o
261,S1657-95342006000200005,innovador,o
261,S1657-95342006000200005,o,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,marca,o
261,S1657-95342006000200005,Si,o
261,S1657-95342006000200005,los,o
261,S1657-95342006000200005,dos,o
261,S1657-95342006000200005,productos,o
261,S1657-95342006000200005,son,o
261,S1657-95342006000200005,bioequivalentes,o
261,S1657-95342006000200005,se,o
261,S1657-95342006000200005,espera,o
261,S1657-95342006000200005,que,o
261,S1657-95342006000200005,tengan,o
261,S1657-95342006000200005,las,o
261,S1657-95342006000200005,mismas,o
261,S1657-95342006000200005,caracteristicas,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,seguridad,o
261,S1657-95342006000200005,y,o
261,S1657-95342006000200005,eficacia,o
261,S1657-95342006000200005,La,o
261,S1657-95342006000200005,bioequivalencia,o
261,S1657-95342006000200005,es,o
261,S1657-95342006000200005,establecida,o
261,S1657-95342006000200005,por,o
261,S1657-95342006000200005,la,o
261,S1657-95342006000200005,estimacion,o
261,S1657-95342006000200005,estadistica,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,diferencias,o
261,S1657-95342006000200005,significativas,o
261,S1657-95342006000200005,o,o
261,S1657-95342006000200005,no,o
261,S1657-95342006000200005,en,o
261,S1657-95342006000200005,los,o
261,S1657-95342006000200005,parametros,o
261,S1657-95342006000200005,farmacocineticos,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,area,o
261,S1657-95342006000200005,bajo,o
261,S1657-95342006000200005,la,o
261,S1657-95342006000200005,curva,o
261,S1657-95342006000200005,ABC,o
261,S1657-95342006000200005,y,o
261,S1657-95342006000200005,concentracion,o
261,S1657-95342006000200005,maxima,o
261,S1657-95342006000200005,Cmax,o
261,S1657-95342006000200005,En,o
261,S1657-95342006000200005,este,o
261,S1657-95342006000200005,caso,o
261,S1657-95342006000200005,se,i
261,S1657-95342006000200005,evaluara,i
261,S1657-95342006000200005,y,i
261,S1657-95342006000200005,se,i
261,S1657-95342006000200005,comparara,i
261,S1657-95342006000200005,la,i
261,S1657-95342006000200005,biodisponibilidad,i
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,valsartan,i
261,S1657-95342006000200005,un,o
261,S1657-95342006000200005,agente,i
261,S1657-95342006000200005,antihipertensivo,i
261,S1657-95342006000200005,inhibidor,i
261,S1657-95342006000200005,especifico,i
261,S1657-95342006000200005,del,i
261,S1657-95342006000200005,receptor,i
261,S1657-95342006000200005,de,i
261,S1657-95342006000200005,angiotensina,i
261,S1657-95342006000200005,II,i
261,S1657-95342006000200005,subtipo,i
261,S1657-95342006000200005,AT1,i
261,S1657-95342006000200005,en,o
261,S1657-95342006000200005,las,o
261,S1657-95342006000200005,membranas,i
261,S1657-95342006000200005,celulares,i
261,S1657-95342006000200005,del,o
261,S1657-95342006000200005,musculo,i
261,S1657-95342006000200005,liso,i
261,S1657-95342006000200005,vascular,i
261,S1657-95342006000200005,Objetivo,o
261,S1657-95342006000200005,Evaluar,i
261,S1657-95342006000200005,la,i
261,S1657-95342006000200005,bioequivalencia,i
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,dos,o
261,S1657-95342006000200005,productos,i
261,S1657-95342006000200005,farmaceuticos,i
261,S1657-95342006000200005,cuyo,o
261,S1657-95342006000200005,principio,i
261,S1657-95342006000200005,activo,i
261,S1657-95342006000200005,es,o
261,S1657-95342006000200005,valsartan,i
261,S1657-95342006000200005,con,o
261,S1657-95342006000200005,base,o
261,S1657-95342006000200005,en,o
261,S1657-95342006000200005,la,o
261,S1657-95342006000200005,comparacion,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,las,o
261,S1657-95342006000200005,medidas,i
261,S1657-95342006000200005,farmacocineticas,i
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,cantidad,o
261,S1657-95342006000200005,y,o
261,S1657-95342006000200005,velocidad,o
261,S1657-95342006000200005,en,o
261,S1657-95342006000200005,terminos,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,tiempo,o
261,S1657-95342006000200005,requerido,o
261,S1657-95342006000200005,con,o
261,S1657-95342006000200005,que,o
261,S1657-95342006000200005,el,o
261,S1657-95342006000200005,valsartan,i
261,S1657-95342006000200005,alcanza,o
261,S1657-95342006000200005,la,o
261,S1657-95342006000200005,circulacion,o
261,S1657-95342006000200005,sanguinea,i
261,S1657-95342006000200005,despues,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,ser,o
261,S1657-95342006000200005,administrado,i
261,S1657-95342006000200005,por,i
261,S1657-95342006000200005,via,i
261,S1657-95342006000200005,oral,i
261,S1657-95342006000200005,a,o
261,S1657-95342006000200005,15,o
261,S1657-95342006000200005,voluntarios,o
261,S1657-95342006000200005,Metodologia,o
261,S1657-95342006000200005,Se,o
261,S1657-95342006000200005,realizo,o
261,S1657-95342006000200005,un,o
261,S1657-95342006000200005,estudio,o
261,S1657-95342006000200005,aleatorizado,o
261,S1657-95342006000200005,cruzado,o
261,S1657-95342006000200005,a,o
261,S1657-95342006000200005,doble,o
261,S1657-95342006000200005,ciego,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,dosis,o
261,S1657-95342006000200005,unica,o
261,S1657-95342006000200005,en,o
261,S1657-95342006000200005,15,o
261,S1657-95342006000200005,voluntarios,o
261,S1657-95342006000200005,sanos,o
261,S1657-95342006000200005,con,o
261,S1657-95342006000200005,edades,o
261,S1657-95342006000200005,entre,o
261,S1657-95342006000200005,19,o
261,S1657-95342006000200005,y,o
261,S1657-95342006000200005,28,o
261,S1657-95342006000200005,años,o
261,S1657-95342006000200005,El,o
261,S1657-95342006000200005,estudio,o
261,S1657-95342006000200005,se,o
261,S1657-95342006000200005,realizo,o
261,S1657-95342006000200005,en,o
261,S1657-95342006000200005,dos,o
261,S1657-95342006000200005,periodos,o
261,S1657-95342006000200005,en,o
261,S1657-95342006000200005,cada,o
261,S1657-95342006000200005,periodo,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,tratamiento,i
261,S1657-95342006000200005,se,o
261,S1657-95342006000200005,administro,o
261,S1657-95342006000200005,una,o
261,S1657-95342006000200005,dosis,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,320,o
261,S1657-95342006000200005,mg,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,valsartan,i
261,S1657-95342006000200005,con,o
261,S1657-95342006000200005,un,o
261,S1657-95342006000200005,periodo,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,lavado,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,8,o
261,S1657-95342006000200005,dias,o
261,S1657-95342006000200005,entre,o
261,S1657-95342006000200005,el,o
261,S1657-95342006000200005,primero,o
261,S1657-95342006000200005,y,o
261,S1657-95342006000200005,segundo,o
261,S1657-95342006000200005,tratamiento,i
261,S1657-95342006000200005,Las,o
261,S1657-95342006000200005,concentraciones,o
261,S1657-95342006000200005,plasmaticas,i
261,S1657-95342006000200005,se,o
261,S1657-95342006000200005,evaluaron,o
261,S1657-95342006000200005,por,o
261,S1657-95342006000200005,HPLCUV,o
261,S1657-95342006000200005,con,o
261,S1657-95342006000200005,el,o
261,S1657-95342006000200005,metodo,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,adicion,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,estandar,o
261,S1657-95342006000200005,empleando,o
261,S1657-95342006000200005,losartan,i
261,S1657-95342006000200005,como,o
261,S1657-95342006000200005,estandar,o
261,S1657-95342006000200005,interno,o
261,S1657-95342006000200005,Resultados,o
261,S1657-95342006000200005,Para,o
261,S1657-95342006000200005,las,o
261,S1657-95342006000200005,tabletas,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,valsartan,i
261,S1657-95342006000200005,se,o
261,S1657-95342006000200005,obtuvieron,o
261,S1657-95342006000200005,los,o
261,S1657-95342006000200005,siguientes,o
261,S1657-95342006000200005,parametros,o
261,S1657-95342006000200005,farmacocineticas,o
261,S1657-95342006000200005,ABC,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,44893,o
261,S1657-95342006000200005,µgmlxh,o
261,S1657-95342006000200005,Cmax,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,64303,o
261,S1657-95342006000200005,µgml,o
261,S1657-95342006000200005,y,o
261,S1657-95342006000200005,Tmax,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,2,o
261,S1657-95342006000200005,h,o
261,S1657-95342006000200005,Para,o
261,S1657-95342006000200005,las,o
261,S1657-95342006000200005,capsulas,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,valsartan,i
261,S1657-95342006000200005,se,o
261,S1657-95342006000200005,obtuvieron,o
261,S1657-95342006000200005,los,o
261,S1657-95342006000200005,siguientes,o
261,S1657-95342006000200005,parametros,o
261,S1657-95342006000200005,farmacocineticas,o
261,S1657-95342006000200005,ABC,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,44963,o
261,S1657-95342006000200005,µgmlxh,o
261,S1657-95342006000200005,Cmax,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,58314,o
261,S1657-95342006000200005,µgml,o
261,S1657-95342006000200005,y,o
261,S1657-95342006000200005,Tmax,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,25,o
261,S1657-95342006000200005,h,o
261,S1657-95342006000200005,Conclusion,o
261,S1657-95342006000200005,Los,o
261,S1657-95342006000200005,resultados,o
261,S1657-95342006000200005,del,o
261,S1657-95342006000200005,estudio,o
261,S1657-95342006000200005,no,o
261,S1657-95342006000200005,mostraron,o
261,S1657-95342006000200005,diferencias,o
261,S1657-95342006000200005,significativas,o
261,S1657-95342006000200005,en,o
261,S1657-95342006000200005,los,o
261,S1657-95342006000200005,niveles,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,concentraciones,o
261,S1657-95342006000200005,plasmaticas,i
261,S1657-95342006000200005,despues,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,la,o
261,S1657-95342006000200005,administracion,i
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,las,o
261,S1657-95342006000200005,dos,o
261,S1657-95342006000200005,formulaciones,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,valsartan,i
261,S1657-95342006000200005,80,o
261,S1657-95342006000200005,mg,o
261,S1657-95342006000200005,tabletas,o
261,S1657-95342006000200005,y,o
261,S1657-95342006000200005,80,o
261,S1657-95342006000200005,mg,o
261,S1657-95342006000200005,capsulas,o
261,S1657-95342006000200005,Por,o
261,S1657-95342006000200005,tanto,o
261,S1657-95342006000200005,el,o
261,S1657-95342006000200005,diseño,o
261,S1657-95342006000200005,del,o
261,S1657-95342006000200005,estudio,o
261,S1657-95342006000200005,y,o
261,S1657-95342006000200005,la,o
261,S1657-95342006000200005,aplicacion,o
261,S1657-95342006000200005,de,o
261,S1657-95342006000200005,los,o
261,S1657-95342006000200005,protocolos,i
261,S1657-95342006000200005,escogidos,o
261,S1657-95342006000200005,permitieron,o
261,S1657-95342006000200005,demostrar,o
261,S1657-95342006000200005,la,o
261,S1657-95342006000200005,bioequivalencia,o
261,S1657-95342006000200005,entre,o
261,S1657-95342006000200005,los,o
261,S1657-95342006000200005,productos,o
262,S1665-11462010000500005,Efectividad,o
262,S1665-11462010000500005,del,o
262,S1665-11462010000500005,acido,i
262,S1665-11462010000500005,ursodesoxicolico,i
262,S1665-11462010000500005,versus,o
262,S1665-11462010000500005,fenobarbital,i
262,S1665-11462010000500005,para,o
262,S1665-11462010000500005,el,o
262,S1665-11462010000500005,tratamiento,i
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,la,o
262,S1665-11462010000500005,colestasis,i
262,S1665-11462010000500005,en,o
262,S1665-11462010000500005,prematuros,i
262,S1665-11462010000500005,Ensayo,i
262,S1665-11462010000500005,clinico,i
262,S1665-11462010000500005,cruzado,i
262,S1665-11462010000500005,Introduccion,o
262,S1665-11462010000500005,La,o
262,S1665-11462010000500005,prevalencia,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,colestasis,i
262,S1665-11462010000500005,neonatal,i
262,S1665-11462010000500005,varia,o
262,S1665-11462010000500005,del,o
262,S1665-11462010000500005,757,o
262,S1665-11462010000500005,Parte,o
262,S1665-11462010000500005,del,o
262,S1665-11462010000500005,manejo,o
262,S1665-11462010000500005,incluye,o
262,S1665-11462010000500005,al,o
262,S1665-11462010000500005,acido,i
262,S1665-11462010000500005,ursodesoxicolico,i
262,S1665-11462010000500005,UDCA,i
262,S1665-11462010000500005,y,o
262,S1665-11462010000500005,al,o
262,S1665-11462010000500005,fenobarbital,i
262,S1665-11462010000500005,ambos,o
262,S1665-11462010000500005,con,o
262,S1665-11462010000500005,debil,o
262,S1665-11462010000500005,sustento,o
262,S1665-11462010000500005,en,o
262,S1665-11462010000500005,la,o
262,S1665-11462010000500005,literatura,o
262,S1665-11462010000500005,El,o
262,S1665-11462010000500005,objetivo,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,este,o
262,S1665-11462010000500005,trabajo,o
262,S1665-11462010000500005,es,o
262,S1665-11462010000500005,comparar,i
262,S1665-11462010000500005,la,i
262,S1665-11462010000500005,efectividad,i
262,S1665-11462010000500005,del,o
262,S1665-11462010000500005,UDCA,i
262,S1665-11462010000500005,vs,o
262,S1665-11462010000500005,fenobarbital,i
262,S1665-11462010000500005,en,o
262,S1665-11462010000500005,la,o
262,S1665-11462010000500005,reduccion,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,las,o
262,S1665-11462010000500005,cifras,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,bilirrubina,i
262,S1665-11462010000500005,directa,i
262,S1665-11462010000500005,en,o
262,S1665-11462010000500005,recien,i
262,S1665-11462010000500005,nacidos,i
262,S1665-11462010000500005,prematuros,i
262,S1665-11462010000500005,con,o
262,S1665-11462010000500005,colestasis,i
262,S1665-11462010000500005,con,o
262,S1665-11462010000500005,peso,o
262,S1665-11462010000500005,entre,o
262,S1665-11462010000500005,1,o
262,S1665-11462010000500005,0002,o
262,S1665-11462010000500005,000,o
262,S1665-11462010000500005,g,o
262,S1665-11462010000500005,Metodos,o
262,S1665-11462010000500005,Se,o
262,S1665-11462010000500005,realizo,o
262,S1665-11462010000500005,un,o
262,S1665-11462010000500005,ensayo,i
262,S1665-11462010000500005,clinico,i
262,S1665-11462010000500005,aleatorizado,i
262,S1665-11462010000500005,cruzado,i
262,S1665-11462010000500005,en,o
262,S1665-11462010000500005,18,o
262,S1665-11462010000500005,pacientes,o
262,S1665-11462010000500005,Cada,o
262,S1665-11462010000500005,individuo,o
262,S1665-11462010000500005,recibio,o
262,S1665-11462010000500005,al,i
262,S1665-11462010000500005,azar,i
262,S1665-11462010000500005,una,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,las,o
262,S1665-11462010000500005,dos,o
262,S1665-11462010000500005,intervenciones,i
262,S1665-11462010000500005,UDCA,i
262,S1665-11462010000500005,10,o
262,S1665-11462010000500005,mgkgdia,o
262,S1665-11462010000500005,c12,o
262,S1665-11462010000500005,h,o
262,S1665-11462010000500005,o,o
262,S1665-11462010000500005,fenobarbital,i
262,S1665-11462010000500005,a,o
262,S1665-11462010000500005,3,o
262,S1665-11462010000500005,mgkgdia,o
262,S1665-11462010000500005,c24,o
262,S1665-11462010000500005,h,o
262,S1665-11462010000500005,durante,o
262,S1665-11462010000500005,un,o
262,S1665-11462010000500005,periodo,o
262,S1665-11462010000500005,inicial,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,7,o
262,S1665-11462010000500005,dias,o
262,S1665-11462010000500005,Despues,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,7,o
262,S1665-11462010000500005,dias,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,lavado,o
262,S1665-11462010000500005,se,o
262,S1665-11462010000500005,les,o
262,S1665-11462010000500005,asigno,o
262,S1665-11462010000500005,el,o
262,S1665-11462010000500005,tratamiento,i
262,S1665-11462010000500005,contrario,o
262,S1665-11462010000500005,En,o
262,S1665-11462010000500005,total,o
262,S1665-11462010000500005,se,o
262,S1665-11462010000500005,realizaron,o
262,S1665-11462010000500005,36,o
262,S1665-11462010000500005,tratamientos,i
262,S1665-11462010000500005,Se,o
262,S1665-11462010000500005,midieron,o
262,S1665-11462010000500005,bilirrubinas,i
262,S1665-11462010000500005,y,o
262,S1665-11462010000500005,pruebas,i
262,S1665-11462010000500005,de,i
262,S1665-11462010000500005,funcion,i
262,S1665-11462010000500005,hepatica,i
262,S1665-11462010000500005,al,o
262,S1665-11462010000500005,inicio,o
262,S1665-11462010000500005,y,o
262,S1665-11462010000500005,final,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,cada,o
262,S1665-11462010000500005,tratamiento,i
262,S1665-11462010000500005,El,o
262,S1665-11462010000500005,analisis,o
262,S1665-11462010000500005,se,o
262,S1665-11462010000500005,realizo,o
262,S1665-11462010000500005,por,o
262,S1665-11462010000500005,medio,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,medidas,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,tendencia,o
262,S1665-11462010000500005,central,o
262,S1665-11462010000500005,y,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,dispersion,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,acuerdo,o
262,S1665-11462010000500005,al,o
262,S1665-11462010000500005,tipo,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,variable,o
262,S1665-11462010000500005,Para,o
262,S1665-11462010000500005,la,o
262,S1665-11462010000500005,comprobacion,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,hipotesis,o
262,S1665-11462010000500005,se,o
262,S1665-11462010000500005,realizo,o
262,S1665-11462010000500005,t,o
262,S1665-11462010000500005,pareada,o
262,S1665-11462010000500005,Resultados,o
262,S1665-11462010000500005,En,o
262,S1665-11462010000500005,el,o
262,S1665-11462010000500005,grupo,o
262,S1665-11462010000500005,que,o
262,S1665-11462010000500005,recibio,o
262,S1665-11462010000500005,UDCA,i
262,S1665-11462010000500005,a,o
262,S1665-11462010000500005,10,o
262,S1665-11462010000500005,mgkgdia,o
262,S1665-11462010000500005,c12,o
262,S1665-11462010000500005,h,o
262,S1665-11462010000500005,por,o
262,S1665-11462010000500005,7,o
262,S1665-11462010000500005,dias,o
262,S1665-11462010000500005,disminuyeron,o
262,S1665-11462010000500005,las,o
262,S1665-11462010000500005,cifras,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,bilirrubina,i
262,S1665-11462010000500005,directa,i
262,S1665-11462010000500005,en,o
262,S1665-11462010000500005,27,o
262,S1665-11462010000500005,mgdL,o
262,S1665-11462010000500005,P001,o
262,S1665-11462010000500005,Conclusiones,o
262,S1665-11462010000500005,Se,o
262,S1665-11462010000500005,recomienda,o
262,S1665-11462010000500005,el,o
262,S1665-11462010000500005,uso,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,UDCA,i
262,S1665-11462010000500005,a,o
262,S1665-11462010000500005,dosis,o
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,10,o
262,S1665-11462010000500005,mgkgdia,o
262,S1665-11462010000500005,c12,o
262,S1665-11462010000500005,h,o
262,S1665-11462010000500005,por,o
262,S1665-11462010000500005,via,o
262,S1665-11462010000500005,enteral,o
262,S1665-11462010000500005,como,o
262,S1665-11462010000500005,coadyuvante,i
262,S1665-11462010000500005,para,o
262,S1665-11462010000500005,el,o
262,S1665-11462010000500005,tratamiento,i
262,S1665-11462010000500005,de,o
262,S1665-11462010000500005,colestasis,i
262,S1665-11462010000500005,neonatal,i
263,S1665-11462016000500309,Estudio,i
263,S1665-11462016000500309,comparativo,i
263,S1665-11462016000500309,entre,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,esquema,i
263,S1665-11462016000500309,convencional,i
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,tratamiento,i
263,S1665-11462016000500309,prolongado,i
263,S1665-11462016000500309,con,o
263,S1665-11462016000500309,esteroides,i
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,sindrome,o
263,S1665-11462016000500309,nefrotico,o
263,S1665-11462016000500309,corticosensible,o
263,S1665-11462016000500309,primario,o
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,Pediatria,o
263,S1665-11462016000500309,Introduccion,o
263,S1665-11462016000500309,En,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,sindrome,o
263,S1665-11462016000500309,nefrotico,o
263,S1665-11462016000500309,corticosensible,o
263,S1665-11462016000500309,SNCS,i
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,corticoterapia,i
263,S1665-11462016000500309,prolongada,i
263,S1665-11462016000500309,podria,o
263,S1665-11462016000500309,reducir,o
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,frecuencia,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,recaidas,o
263,S1665-11462016000500309,El,o
263,S1665-11462016000500309,objetivo,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,este,o
263,S1665-11462016000500309,trabajo,o
263,S1665-11462016000500309,fue,o
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,comparacion,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,un,o
263,S1665-11462016000500309,esquema,i
263,S1665-11462016000500309,corticoide,i
263,S1665-11462016000500309,prolongado,i
263,S1665-11462016000500309,frente,o
263,S1665-11462016000500309,al,o
263,S1665-11462016000500309,tratamiento,i
263,S1665-11462016000500309,habitual,o
263,S1665-11462016000500309,del,o
263,S1665-11462016000500309,SNCS,i
263,S1665-11462016000500309,primario,o
263,S1665-11462016000500309,evaluando,o
263,S1665-11462016000500309,los,o
263,S1665-11462016000500309,siguientes,o
263,S1665-11462016000500309,parametros,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,numero,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,pacientes,o
263,S1665-11462016000500309,con,o
263,S1665-11462016000500309,recaidas,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,numero,o
263,S1665-11462016000500309,total,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,recaidas,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,tiempo,o
263,S1665-11462016000500309,medio,o
263,S1665-11462016000500309,transcurrido,o
263,S1665-11462016000500309,al,o
263,S1665-11462016000500309,iniciar,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,tratamiento,i
263,S1665-11462016000500309,hasta,o
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,remision,o
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,hasta,o
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,primera,o
263,S1665-11462016000500309,recaida,o
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,dosis,o
263,S1665-11462016000500309,acumulada,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,corticosteroides,i
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,toxicidad,i
263,S1665-11462016000500309,esteroide,i
263,S1665-11462016000500309,Metodos,o
263,S1665-11462016000500309,La,o
263,S1665-11462016000500309,poblacion,o
263,S1665-11462016000500309,se,o
263,S1665-11462016000500309,dividio,o
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,dos,o
263,S1665-11462016000500309,grupos,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,A,o
263,S1665-11462016000500309,27,o
263,S1665-11462016000500309,pacientes,o
263,S1665-11462016000500309,recibio,o
263,S1665-11462016000500309,16βmetilprednisona,o
263,S1665-11462016000500309,durante,o
263,S1665-11462016000500309,12,o
263,S1665-11462016000500309,semanas,o
263,S1665-11462016000500309,reduciendo,o
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,dosis,o
263,S1665-11462016000500309,hasta,o
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,semana,o
263,S1665-11462016000500309,24,o
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,B,o
263,S1665-11462016000500309,29,o
263,S1665-11462016000500309,pacientes,o
263,S1665-11462016000500309,recibio,o
263,S1665-11462016000500309,16βmetilprednisona,o
263,S1665-11462016000500309,durante,o
263,S1665-11462016000500309,12,o
263,S1665-11462016000500309,semanas,o
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,placebo,i
263,S1665-11462016000500309,hasta,o
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,semana,o
263,S1665-11462016000500309,24,o
263,S1665-11462016000500309,Resultados,o
263,S1665-11462016000500309,La,o
263,S1665-11462016000500309,tasa,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,incidencia,o
263,S1665-11462016000500309,acumulada,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,recaidas,o
263,S1665-11462016000500309,personaaño,o
263,S1665-11462016000500309,fue,o
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,A,o
263,S1665-11462016000500309,36100,o
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,B,o
263,S1665-11462016000500309,66100,o
263,S1665-11462016000500309,p,o
263,S1665-11462016000500309,004,o
263,S1665-11462016000500309,El,o
263,S1665-11462016000500309,tiempo,o
263,S1665-11462016000500309,medio,o
263,S1665-11462016000500309,transcurrido,o
263,S1665-11462016000500309,dias,o
263,S1665-11462016000500309,hasta,o
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,primera,o
263,S1665-11462016000500309,recaida,o
263,S1665-11462016000500309,fue,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,114,o
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,A,o
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,75,o
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,B,o
263,S1665-11462016000500309,p,o
263,S1665-11462016000500309,001,o
263,S1665-11462016000500309,Las,o
263,S1665-11462016000500309,diferencias,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,tiempo,o
263,S1665-11462016000500309,transcurrido,o
263,S1665-11462016000500309,al,o
263,S1665-11462016000500309,iniciar,o
263,S1665-11462016000500309,tratamiento,i
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,hasta,o
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,remision,o
263,S1665-11462016000500309,entre,o
263,S1665-11462016000500309,ambos,o
263,S1665-11462016000500309,grupos,o
263,S1665-11462016000500309,no,o
263,S1665-11462016000500309,fueron,o
263,S1665-11462016000500309,significativas,o
263,S1665-11462016000500309,El,o
263,S1665-11462016000500309,total,o
263,S1665-11462016000500309,acumulado,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,recaidas,o
263,S1665-11462016000500309,fue,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,9,o
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,A,o
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,17,o
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,B,o
263,S1665-11462016000500309,p,o
263,S1665-11462016000500309,004,o
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,total,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,pacientes,o
263,S1665-11462016000500309,con,o
263,S1665-11462016000500309,recaidas,o
263,S1665-11462016000500309,fue,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,3,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,A,o
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,7,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,B,o
263,S1665-11462016000500309,p,o
263,S1665-11462016000500309,017,o
263,S1665-11462016000500309,La,o
263,S1665-11462016000500309,dosis,o
263,S1665-11462016000500309,media,o
263,S1665-11462016000500309,acumulada,o
263,S1665-11462016000500309,mgm2,o
263,S1665-11462016000500309,por,o
263,S1665-11462016000500309,paciente,o
263,S1665-11462016000500309,fue,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,5243,o
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,A,o
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,4306,o
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,B,o
263,S1665-11462016000500309,p,o
263,S1665-11462016000500309,03,o
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,cortisol,i
263,S1665-11462016000500309,serico,i
263,S1665-11462016000500309,μgdl,o
263,S1665-11462016000500309,final,o
263,S1665-11462016000500309,fue,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,14,o
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,A,o
263,S1665-11462016000500309,y,o
263,S1665-11462016000500309,16,o
263,S1665-11462016000500309,en,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,grupo,o
263,S1665-11462016000500309,B,o
263,S1665-11462016000500309,p,o
263,S1665-11462016000500309,04,o
263,S1665-11462016000500309,La,o
263,S1665-11462016000500309,toxicidad,i
263,S1665-11462016000500309,esteroide,i
263,S1665-11462016000500309,fue,o
263,S1665-11462016000500309,similar,o
263,S1665-11462016000500309,entre,o
263,S1665-11462016000500309,ambos,o
263,S1665-11462016000500309,grupos,o
263,S1665-11462016000500309,Conclusiones,o
263,S1665-11462016000500309,La,o
263,S1665-11462016000500309,duracion,o
263,S1665-11462016000500309,del,o
263,S1665-11462016000500309,tratamiento,i
263,S1665-11462016000500309,disminuyo,o
263,S1665-11462016000500309,el,o
263,S1665-11462016000500309,numero,o
263,S1665-11462016000500309,de,o
263,S1665-11462016000500309,recaidas,o
263,S1665-11462016000500309,sin,o
263,S1665-11462016000500309,incrementar,o
263,S1665-11462016000500309,la,o
263,S1665-11462016000500309,toxicidad,i
263,S1665-11462016000500309,esteroide,i
264,S1665-1146201700050034,Tolerancia,o
264,S1665-1146201700050034,seguridad,o
264,S1665-1146201700050034,y,o
264,S1665-1146201700050034,eficacia,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,la,o
264,S1665-1146201700050034,preparacion,i
264,S1665-1146201700050034,intestinal,i
264,S1665-1146201700050034,con,o
264,S1665-1146201700050034,un,o
264,S1665-1146201700050034,dia,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,PEG3350,i
264,S1665-1146201700050034,bisacodilo,i
264,S1665-1146201700050034,en,o
264,S1665-1146201700050034,comparacion,o
264,S1665-1146201700050034,con,o
264,S1665-1146201700050034,2,o
264,S1665-1146201700050034,dias,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,PEG3350,i
264,S1665-1146201700050034,bisacodilo,i
264,S1665-1146201700050034,en,o
264,S1665-1146201700050034,pacientes,o
264,S1665-1146201700050034,pediatricos,o
264,S1665-1146201700050034,Introduccion,o
264,S1665-1146201700050034,Multiples,o
264,S1665-1146201700050034,preparaciones,i
264,S1665-1146201700050034,intestinales,i
264,S1665-1146201700050034,se,o
264,S1665-1146201700050034,han,o
264,S1665-1146201700050034,utilizado,o
264,S1665-1146201700050034,en,o
264,S1665-1146201700050034,niños,o
264,S1665-1146201700050034,sometidos,o
264,S1665-1146201700050034,a,o
264,S1665-1146201700050034,una,o
264,S1665-1146201700050034,colonoscopia,i
264,S1665-1146201700050034,con,o
264,S1665-1146201700050034,limitacion,o
264,S1665-1146201700050034,variable,o
264,S1665-1146201700050034,debido,o
264,S1665-1146201700050034,a,o
264,S1665-1146201700050034,la,o
264,S1665-1146201700050034,aceptacion,o
264,S1665-1146201700050034,tolerancia,o
264,S1665-1146201700050034,y,o
264,S1665-1146201700050034,la,o
264,S1665-1146201700050034,limpieza,o
264,S1665-1146201700050034,adecuada,o
264,S1665-1146201700050034,El,o
264,S1665-1146201700050034,objetivo,o
264,S1665-1146201700050034,del,o
264,S1665-1146201700050034,estudio,o
264,S1665-1146201700050034,fue,o
264,S1665-1146201700050034,comparar,i
264,S1665-1146201700050034,la,i
264,S1665-1146201700050034,tolerancia,i
264,S1665-1146201700050034,seguridad,i
264,S1665-1146201700050034,y,i
264,S1665-1146201700050034,eficacia,i
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,la,o
264,S1665-1146201700050034,preparacion,i
264,S1665-1146201700050034,intestinal,i
264,S1665-1146201700050034,para,o
264,S1665-1146201700050034,colonoscopia,i
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,1,o
264,S1665-1146201700050034,dia,o
264,S1665-1146201700050034,con,o
264,S1665-1146201700050034,PEG,i
264,S1665-1146201700050034,3350,i
264,S1665-1146201700050034,polietilenglicol,i
264,S1665-1146201700050034,4,o
264,S1665-1146201700050034,gkgdia,o
264,S1665-1146201700050034,bisacodilo,i
264,S1665-1146201700050034,y,o
264,S1665-1146201700050034,el,o
264,S1665-1146201700050034,tratamiento,i
264,S1665-1146201700050034,con,o
264,S1665-1146201700050034,2,o
264,S1665-1146201700050034,dias,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,preparacion,i
264,S1665-1146201700050034,con,o
264,S1665-1146201700050034,PEG,i
264,S1665-1146201700050034,3350,i
264,S1665-1146201700050034,2,o
264,S1665-1146201700050034,gkgdia,o
264,S1665-1146201700050034,bisacodilo,i
264,S1665-1146201700050034,en,o
264,S1665-1146201700050034,pacientes,o
264,S1665-1146201700050034,pediatricos,o
264,S1665-1146201700050034,Metodos,o
264,S1665-1146201700050034,Se,o
264,S1665-1146201700050034,realizo,o
264,S1665-1146201700050034,un,o
264,S1665-1146201700050034,ensayo,o
264,S1665-1146201700050034,clinico,o
264,S1665-1146201700050034,aleatorizado,o
264,S1665-1146201700050034,y,o
264,S1665-1146201700050034,ciego,o
264,S1665-1146201700050034,Se,o
264,S1665-1146201700050034,incluyeron,o
264,S1665-1146201700050034,pacientes,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,2,o
264,S1665-1146201700050034,a,o
264,S1665-1146201700050034,18,o
264,S1665-1146201700050034,años,o
264,S1665-1146201700050034,que,o
264,S1665-1146201700050034,ameritaron,o
264,S1665-1146201700050034,colonoscopia,i
264,S1665-1146201700050034,en,o
264,S1665-1146201700050034,forma,o
264,S1665-1146201700050034,programada,o
264,S1665-1146201700050034,Los,o
264,S1665-1146201700050034,pacientes,o
264,S1665-1146201700050034,se,o
264,S1665-1146201700050034,asignaron,i
264,S1665-1146201700050034,de,i
264,S1665-1146201700050034,manera,i
264,S1665-1146201700050034,aleatoria,i
264,S1665-1146201700050034,en,o
264,S1665-1146201700050034,dos,o
264,S1665-1146201700050034,grupos,o
264,S1665-1146201700050034,1,o
264,S1665-1146201700050034,dia,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,preparacion,i
264,S1665-1146201700050034,con,o
264,S1665-1146201700050034,PEG,i
264,S1665-1146201700050034,3350,i
264,S1665-1146201700050034,4,o
264,S1665-1146201700050034,gkgdia,o
264,S1665-1146201700050034,bisacodilo,i
264,S1665-1146201700050034,y,o
264,S1665-1146201700050034,2,o
264,S1665-1146201700050034,dias,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,preparacion,i
264,S1665-1146201700050034,con,o
264,S1665-1146201700050034,PEG,i
264,S1665-1146201700050034,3350,i
264,S1665-1146201700050034,2,o
264,S1665-1146201700050034,gkgdia,o
264,S1665-1146201700050034,bisacodilo,i
264,S1665-1146201700050034,Por,o
264,S1665-1146201700050034,medio,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,un,o
264,S1665-1146201700050034,cuestionario,i
264,S1665-1146201700050034,exploracion,i
264,S1665-1146201700050034,fisica,i
264,S1665-1146201700050034,y,o
264,S1665-1146201700050034,valoracion,i
264,S1665-1146201700050034,endoscopica,i
264,S1665-1146201700050034,escala,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,Boston,o
264,S1665-1146201700050034,se,o
264,S1665-1146201700050034,determino,o
264,S1665-1146201700050034,la,o
264,S1665-1146201700050034,tolerancia,o
264,S1665-1146201700050034,seguridad,o
264,S1665-1146201700050034,y,o
264,S1665-1146201700050034,eficacia,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,las,o
264,S1665-1146201700050034,2,o
264,S1665-1146201700050034,preparaciones,i
264,S1665-1146201700050034,a,o
264,S1665-1146201700050034,evaluar,o
264,S1665-1146201700050034,Se,o
264,S1665-1146201700050034,realizo,o
264,S1665-1146201700050034,una,o
264,S1665-1146201700050034,prueba,o
264,S1665-1146201700050034,t,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,Student,o
264,S1665-1146201700050034,para,o
264,S1665-1146201700050034,variables,o
264,S1665-1146201700050034,cuantitativas,o
264,S1665-1146201700050034,y,o
264,S1665-1146201700050034,χ2,o
264,S1665-1146201700050034,para,o
264,S1665-1146201700050034,variables,o
264,S1665-1146201700050034,cualitativas,o
264,S1665-1146201700050034,Resultados,o
264,S1665-1146201700050034,No,o
264,S1665-1146201700050034,hubo,o
264,S1665-1146201700050034,diferencias,o
264,S1665-1146201700050034,significativas,o
264,S1665-1146201700050034,en,o
264,S1665-1146201700050034,las,o
264,S1665-1146201700050034,tasas,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,cumplimiento,o
264,S1665-1146201700050034,los,o
264,S1665-1146201700050034,efectos,i
264,S1665-1146201700050034,adversos,i
264,S1665-1146201700050034,y,o
264,S1665-1146201700050034,la,o
264,S1665-1146201700050034,extension,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,la,o
264,S1665-1146201700050034,evaluacion,i
264,S1665-1146201700050034,colonoscopica,i
264,S1665-1146201700050034,Conclusiones,o
264,S1665-1146201700050034,La,o
264,S1665-1146201700050034,tolerancia,o
264,S1665-1146201700050034,y,o
264,S1665-1146201700050034,seguridad,o
264,S1665-1146201700050034,entre,o
264,S1665-1146201700050034,la,o
264,S1665-1146201700050034,preparacion,i
264,S1665-1146201700050034,intestinal,i
264,S1665-1146201700050034,para,o
264,S1665-1146201700050034,colonoscopia,i
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,1,o
264,S1665-1146201700050034,dia,o
264,S1665-1146201700050034,con,o
264,S1665-1146201700050034,PEG,i
264,S1665-1146201700050034,3350,i
264,S1665-1146201700050034,polietilenglicol,i
264,S1665-1146201700050034,4,o
264,S1665-1146201700050034,gkgdia,o
264,S1665-1146201700050034,bisacodilo,i
264,S1665-1146201700050034,y,o
264,S1665-1146201700050034,la,o
264,S1665-1146201700050034,preparacion,i
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,2,o
264,S1665-1146201700050034,dias,o
264,S1665-1146201700050034,con,o
264,S1665-1146201700050034,PEG,i
264,S1665-1146201700050034,3350,i
264,S1665-1146201700050034,2,o
264,S1665-1146201700050034,gkgdia,o
264,S1665-1146201700050034,bisacodilo,i
264,S1665-1146201700050034,fue,o
264,S1665-1146201700050034,semejante,o
264,S1665-1146201700050034,La,o
264,S1665-1146201700050034,calidad,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,la,o
264,S1665-1146201700050034,limpieza,o
264,S1665-1146201700050034,fue,o
264,S1665-1146201700050034,buena,o
264,S1665-1146201700050034,en,o
264,S1665-1146201700050034,ambos,o
264,S1665-1146201700050034,grupos,o
264,S1665-1146201700050034,siendo,o
264,S1665-1146201700050034,parcialmente,o
264,S1665-1146201700050034,mas,o
264,S1665-1146201700050034,eficaz,o
264,S1665-1146201700050034,en,o
264,S1665-1146201700050034,el,o
264,S1665-1146201700050034,grupo,o
264,S1665-1146201700050034,de,o
264,S1665-1146201700050034,1,o
264,S1665-1146201700050034,dia,o
264,S1665-1146201700050034,con,o
264,S1665-1146201700050034,PEG,i
264,S1665-1146201700050034,3350,i
264,S1665-1146201700050034,polietilenglicol,i
264,S1665-1146201700050034,4,o
264,S1665-1146201700050034,gkgdia,o
265,S1683-98032019000100011,Eficacia,o
265,S1683-98032019000100011,del,o
265,S1683-98032019000100011,propofolfentanilo,o
265,S1683-98032019000100011,comparada,o
265,S1683-98032019000100011,con,o
265,S1683-98032019000100011,propofolketamina,o
265,S1683-98032019000100011,en,o
265,S1683-98032019000100011,procedimientos,i
265,S1683-98032019000100011,dolorosos,i
265,S1683-98032019000100011,mayores,o
265,S1683-98032019000100011,en,o
265,S1683-98032019000100011,un,o
265,S1683-98032019000100011,Departamento,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,Emergencia,o
265,S1683-98032019000100011,Pediatrica,o
265,S1683-98032019000100011,Objetivo,o
265,S1683-98032019000100011,Comparar,i
265,S1683-98032019000100011,la,i
265,S1683-98032019000100011,eficacia,i
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,la,o
265,S1683-98032019000100011,combinacion,o
265,S1683-98032019000100011,propofol,i
265,S1683-98032019000100011,fentanilo,i
265,S1683-98032019000100011,P,o
265,S1683-98032019000100011,F,o
265,S1683-98032019000100011,con,o
265,S1683-98032019000100011,propofol,i
265,S1683-98032019000100011,ketamina,i
265,S1683-98032019000100011,P,o
265,S1683-98032019000100011,K,o
265,S1683-98032019000100011,en,o
265,S1683-98032019000100011,procedimientos,i
265,S1683-98032019000100011,dolorosos,i
265,S1683-98032019000100011,mayores,o
265,S1683-98032019000100011,en,o
265,S1683-98032019000100011,un,o
265,S1683-98032019000100011,Departamento,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,Emergencias,o
265,S1683-98032019000100011,Pediatricas,o
265,S1683-98032019000100011,DEP,o
265,S1683-98032019000100011,Diseño,o
265,S1683-98032019000100011,Ensayo,o
265,S1683-98032019000100011,aleatorizado,o
265,S1683-98032019000100011,controlado,o
265,S1683-98032019000100011,abierto,o
265,S1683-98032019000100011,con,o
265,S1683-98032019000100011,cegamiento,o
265,S1683-98032019000100011,del,o
265,S1683-98032019000100011,evaluador,o
265,S1683-98032019000100011,Material,o
265,S1683-98032019000100011,y,o
265,S1683-98032019000100011,Metodos,o
265,S1683-98032019000100011,Se,o
265,S1683-98032019000100011,incluyeron,o
265,S1683-98032019000100011,pacientes,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,6,o
265,S1683-98032019000100011,meses,o
265,S1683-98032019000100011,a,o
265,S1683-98032019000100011,18,o
265,S1683-98032019000100011,años,o
265,S1683-98032019000100011,con,o
265,S1683-98032019000100011,una,o
265,S1683-98032019000100011,clasificacion,o
265,S1683-98032019000100011,ASA,o
265,S1683-98032019000100011,menor,o
265,S1683-98032019000100011,o,o
265,S1683-98032019000100011,igual,o
265,S1683-98032019000100011,a,o
265,S1683-98032019000100011,3,o
265,S1683-98032019000100011,sometidos,o
265,S1683-98032019000100011,a,o
265,S1683-98032019000100011,sedacion,i
265,S1683-98032019000100011,y,o
265,S1683-98032019000100011,analgesia,i
265,S1683-98032019000100011,para,o
265,S1683-98032019000100011,la,o
265,S1683-98032019000100011,realizacion,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,procedimientos,i
265,S1683-98032019000100011,dolorosos,i
265,S1683-98032019000100011,Intervenciones,i
265,S1683-98032019000100011,Los,o
265,S1683-98032019000100011,sujetos,o
265,S1683-98032019000100011,fueron,o
265,S1683-98032019000100011,asignados,i
265,S1683-98032019000100011,al,i
265,S1683-98032019000100011,azar,i
265,S1683-98032019000100011,para,o
265,S1683-98032019000100011,recibir,o
265,S1683-98032019000100011,propofolfentanilo,o
265,S1683-98032019000100011,o,o
265,S1683-98032019000100011,propofolketamina,o
265,S1683-98032019000100011,Se,o
265,S1683-98032019000100011,evaluaron,o
265,S1683-98032019000100011,las,o
265,S1683-98032019000100011,complicaciones,i
265,S1683-98032019000100011,Las,o
265,S1683-98032019000100011,variables,o
265,S1683-98032019000100011,fueron,o
265,S1683-98032019000100011,datos,o
265,S1683-98032019000100011,demograficos,o
265,S1683-98032019000100011,tipos,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,procedimientos,i
265,S1683-98032019000100011,tiempo,o
265,S1683-98032019000100011,hasta,o
265,S1683-98032019000100011,la,o
265,S1683-98032019000100011,adecuada,o
265,S1683-98032019000100011,sedacion,i
265,S1683-98032019000100011,y,o
265,S1683-98032019000100011,analgesia,i
265,S1683-98032019000100011,dosis,o
265,S1683-98032019000100011,adicionales,o
265,S1683-98032019000100011,requeridas,o
265,S1683-98032019000100011,tiempo,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,recuperacion,o
265,S1683-98032019000100011,y,o
265,S1683-98032019000100011,efectos,i
265,S1683-98032019000100011,adversos,i
265,S1683-98032019000100011,Resultados,o
265,S1683-98032019000100011,Se,o
265,S1683-98032019000100011,analizaron,o
265,S1683-98032019000100011,sesenta,o
265,S1683-98032019000100011,procedimientos,i
265,S1683-98032019000100011,30,o
265,S1683-98032019000100011,por,o
265,S1683-98032019000100011,grupo,o
265,S1683-98032019000100011,No,o
265,S1683-98032019000100011,hubo,o
265,S1683-98032019000100011,diferencias,o
265,S1683-98032019000100011,en,o
265,S1683-98032019000100011,la,o
265,S1683-98032019000100011,edad,o
265,S1683-98032019000100011,el,o
265,S1683-98032019000100011,sexo,o
265,S1683-98032019000100011,el,o
265,S1683-98032019000100011,tipo,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,procedimiento,i
265,S1683-98032019000100011,la,o
265,S1683-98032019000100011,duracion,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,la,o
265,S1683-98032019000100011,infusion,i
265,S1683-98032019000100011,y,o
265,S1683-98032019000100011,la,o
265,S1683-98032019000100011,duracion,o
265,S1683-98032019000100011,del,o
265,S1683-98032019000100011,procedimiento,i
265,S1683-98032019000100011,o,o
265,S1683-98032019000100011,el,o
265,S1683-98032019000100011,tiempo,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,recuperacion,o
265,S1683-98032019000100011,El,o
265,S1683-98032019000100011,tiempo,o
265,S1683-98032019000100011,para,o
265,S1683-98032019000100011,lograr,o
265,S1683-98032019000100011,la,o
265,S1683-98032019000100011,sedacion,i
265,S1683-98032019000100011,minutos,o
265,S1683-98032019000100011,fue,o
265,S1683-98032019000100011,mayor,o
265,S1683-98032019000100011,con,o
265,S1683-98032019000100011,P,o
265,S1683-98032019000100011,F,o
265,S1683-98032019000100011,que,o
265,S1683-98032019000100011,con,o
265,S1683-98032019000100011,P,o
265,S1683-98032019000100011,K,o
265,S1683-98032019000100011,2,o
265,S1683-98032019000100011,14,o
265,S1683-98032019000100011,rango,o
265,S1683-98032019000100011,intercuartilo,o
265,S1683-98032019000100011,vs,o
265,S1683-98032019000100011,1,o
265,S1683-98032019000100011,rango,o
265,S1683-98032019000100011,intercuartil,o
265,S1683-98032019000100011,a,o
265,S1683-98032019000100011,11,o
265,S1683-98032019000100011,El,o
265,S1683-98032019000100011,tiempo,o
265,S1683-98032019000100011,minutos,o
265,S1683-98032019000100011,para,o
265,S1683-98032019000100011,lograr,o
265,S1683-98032019000100011,una,o
265,S1683-98032019000100011,analgesia,i
265,S1683-98032019000100011,adecuada,o
265,S1683-98032019000100011,con,o
265,S1683-98032019000100011,P,o
265,S1683-98032019000100011,F,o
265,S1683-98032019000100011,fue,o
265,S1683-98032019000100011,2,o
265,S1683-98032019000100011,15,o
265,S1683-98032019000100011,rango,o
265,S1683-98032019000100011,intercuartilo,o
265,S1683-98032019000100011,vs,o
265,S1683-98032019000100011,1,o
265,S1683-98032019000100011,11,o
265,S1683-98032019000100011,25,o
265,S1683-98032019000100011,rango,o
265,S1683-98032019000100011,intercuartilo,o
265,S1683-98032019000100011,p,o
265,S1683-98032019000100011,0001,o
265,S1683-98032019000100011,El,o
265,S1683-98032019000100011,P,o
265,S1683-98032019000100011,F,o
265,S1683-98032019000100011,requirio,o
265,S1683-98032019000100011,mas,o
265,S1683-98032019000100011,dosis,o
265,S1683-98032019000100011,adicionales,o
265,S1683-98032019000100011,80,o
265,S1683-98032019000100011,frente,o
265,S1683-98032019000100011,a,o
265,S1683-98032019000100011,43,o
265,S1683-98032019000100011,p,o
265,S1683-98032019000100011,0004,o
265,S1683-98032019000100011,y,o
265,S1683-98032019000100011,tuvo,o
265,S1683-98032019000100011,mas,o
265,S1683-98032019000100011,efectos,i
265,S1683-98032019000100011,secundarios,i
265,S1683-98032019000100011,46,o
265,S1683-98032019000100011,6,o
265,S1683-98032019000100011,intervalo,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,confianza,o
265,S1683-98032019000100011,IC,o
265,S1683-98032019000100011,del,o
265,S1683-98032019000100011,95,o
265,S1683-98032019000100011,70,o
265,S1683-98032019000100011,a,o
265,S1683-98032019000100011,100,o
265,S1683-98032019000100011,versus,o
265,S1683-98032019000100011,20,o
265,S1683-98032019000100011,95,o
265,S1683-98032019000100011,CI2,o
265,S1683-98032019000100011,a,o
265,S1683-98032019000100011,59,o
265,S1683-98032019000100011,p,o
265,S1683-98032019000100011,0024,o
265,S1683-98032019000100011,La,o
265,S1683-98032019000100011,proporcion,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,efectos,i
265,S1683-98032019000100011,adversos,i
265,S1683-98032019000100011,graves,o
265,S1683-98032019000100011,con,o
265,S1683-98032019000100011,PF,o
265,S1683-98032019000100011,vs,o
265,S1683-98032019000100011,PK,o
265,S1683-98032019000100011,fue,o
265,S1683-98032019000100011,6,o
265,S1683-98032019000100011,95,o
265,S1683-98032019000100011,CI18,o
265,S1683-98032019000100011,a,o
265,S1683-98032019000100011,2,o
265,S1683-98032019000100011,versus,o
265,S1683-98032019000100011,0,o
265,S1683-98032019000100011,95,o
265,S1683-98032019000100011,CI0,o
265,S1683-98032019000100011,a,o
265,S1683-98032019000100011,0,o
265,S1683-98032019000100011,p,o
265,S1683-98032019000100011,0246,o
265,S1683-98032019000100011,Conclusiones,o
265,S1683-98032019000100011,Concluimos,o
265,S1683-98032019000100011,que,o
265,S1683-98032019000100011,las,o
265,S1683-98032019000100011,combinaciones,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,Propofol,i
265,S1683-98032019000100011,Fentanilo,i
265,S1683-98032019000100011,y,o
265,S1683-98032019000100011,PropofolKetamina,o
265,S1683-98032019000100011,son,o
265,S1683-98032019000100011,eficaces,o
265,S1683-98032019000100011,en,o
265,S1683-98032019000100011,alcanzar,o
265,S1683-98032019000100011,la,o
265,S1683-98032019000100011,sedoanalgesia,i
265,S1683-98032019000100011,en,o
265,S1683-98032019000100011,procedimientos,i
265,S1683-98032019000100011,muy,o
265,S1683-98032019000100011,dolorosos,i
265,S1683-98032019000100011,y,o
265,S1683-98032019000100011,cortos,o
265,S1683-98032019000100011,Presentando,o
265,S1683-98032019000100011,la,o
265,S1683-98032019000100011,primera,o
265,S1683-98032019000100011,combinacion,o
265,S1683-98032019000100011,mas,o
265,S1683-98032019000100011,efectos,i
265,S1683-98032019000100011,secundarios,i
265,S1683-98032019000100011,y,o
265,S1683-98032019000100011,requiriendo,o
265,S1683-98032019000100011,mas,o
265,S1683-98032019000100011,tiempo,o
265,S1683-98032019000100011,y,o
265,S1683-98032019000100011,dosis,o
265,S1683-98032019000100011,adicionales,o
265,S1683-98032019000100011,para,o
265,S1683-98032019000100011,lograr,o
265,S1683-98032019000100011,los,o
265,S1683-98032019000100011,niveles,o
265,S1683-98032019000100011,deseados,o
265,S1683-98032019000100011,de,o
265,S1683-98032019000100011,sedoanalgesia,i
266,S1688-93392017000200057,Ensayo,i
266,S1688-93392017000200057,clinico,i
266,S1688-93392017000200057,aleatorizado,i
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,elevacion,i
266,S1688-93392017000200057,sinusal,i
266,S1688-93392017000200057,por,i
266,S1688-93392017000200057,abordaje,i
266,S1688-93392017000200057,lateral,i
266,S1688-93392017000200057,con,o
266,S1688-93392017000200057,hueso,i
266,S1688-93392017000200057,mineral,i
266,S1688-93392017000200057,bovino,i
266,S1688-93392017000200057,desproteinizado,i
266,S1688-93392017000200057,hmbd,o
266,S1688-93392017000200057,comparando,o
266,S1688-93392017000200057,dos,o
266,S1688-93392017000200057,tamaños,o
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,particulas,o
266,S1688-93392017000200057,resultados,o
266,S1688-93392017000200057,clinicos,o
266,S1688-93392017000200057,e,o
266,S1688-93392017000200057,histologicos,o
266,S1688-93392017000200057,El,o
266,S1688-93392017000200057,tratamiento,i
266,S1688-93392017000200057,del,o
266,S1688-93392017000200057,maxilar,i
266,S1688-93392017000200057,superior,i
266,S1688-93392017000200057,edentulo,i
266,S1688-93392017000200057,presenta,o
266,S1688-93392017000200057,frecuentemente,o
266,S1688-93392017000200057,limitaciones,o
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,disponibilidad,o
266,S1688-93392017000200057,osea,i
266,S1688-93392017000200057,en,o
266,S1688-93392017000200057,el,o
266,S1688-93392017000200057,sector,o
266,S1688-93392017000200057,posterior,o
266,S1688-93392017000200057,Los,o
266,S1688-93392017000200057,procedimientos,i
266,S1688-93392017000200057,de,i
266,S1688-93392017000200057,elevacion,i
266,S1688-93392017000200057,sinusal,i
266,S1688-93392017000200057,adquieren,o
266,S1688-93392017000200057,una,o
266,S1688-93392017000200057,relevancia,o
266,S1688-93392017000200057,notoria,o
266,S1688-93392017000200057,para,o
266,S1688-93392017000200057,su,o
266,S1688-93392017000200057,resolucion,o
266,S1688-93392017000200057,La,o
266,S1688-93392017000200057,utilizacion,o
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,hueso,i
266,S1688-93392017000200057,mineral,i
266,S1688-93392017000200057,bovino,i
266,S1688-93392017000200057,desproteinizado,i
266,S1688-93392017000200057,como,o
266,S1688-93392017000200057,oseoconductor,o
266,S1688-93392017000200057,esta,o
266,S1688-93392017000200057,ampliamente,o
266,S1688-93392017000200057,documentada,o
266,S1688-93392017000200057,El,o
266,S1688-93392017000200057,presente,o
266,S1688-93392017000200057,estudio,o
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,boca,i
266,S1688-93392017000200057,dividida,o
266,S1688-93392017000200057,comparo,o
266,S1688-93392017000200057,en,o
266,S1688-93392017000200057,20,o
266,S1688-93392017000200057,pacientes,o
266,S1688-93392017000200057,la,o
266,S1688-93392017000200057,formacion,o
266,S1688-93392017000200057,osea,i
266,S1688-93392017000200057,en,o
266,S1688-93392017000200057,senos,i
266,S1688-93392017000200057,elevados,o
266,S1688-93392017000200057,utilizando,o
266,S1688-93392017000200057,aleatoriamente,i
266,S1688-93392017000200057,particulas,o
266,S1688-93392017000200057,S,o
266,S1688-93392017000200057,0251,o
266,S1688-93392017000200057,mm,o
266,S1688-93392017000200057,vs,o
266,S1688-93392017000200057,particulas,o
266,S1688-93392017000200057,L,o
266,S1688-93392017000200057,12,o
266,S1688-93392017000200057,mm,o
266,S1688-93392017000200057,El,o
266,S1688-93392017000200057,analisis,i
266,S1688-93392017000200057,histomorfometrico,i
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,las,o
266,S1688-93392017000200057,biopsias,i
266,S1688-93392017000200057,obtenidas,o
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,los,o
266,S1688-93392017000200057,sitios,o
266,S1688-93392017000200057,a,o
266,S1688-93392017000200057,implantar,i
266,S1688-93392017000200057,mostro,o
266,S1688-93392017000200057,para,o
266,S1688-93392017000200057,el,o
266,S1688-93392017000200057,grupo,o
266,S1688-93392017000200057,S,o
266,S1688-93392017000200057,un,o
266,S1688-93392017000200057,426,o
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,nuevo,o
266,S1688-93392017000200057,hueso,i
266,S1688-93392017000200057,425,o
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,tejidos,i
266,S1688-93392017000200057,no,o
266,S1688-93392017000200057,mineralizados,o
266,S1688-93392017000200057,y,o
266,S1688-93392017000200057,144,o
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,particulas,o
266,S1688-93392017000200057,El,o
266,S1688-93392017000200057,grupo,o
266,S1688-93392017000200057,L,o
266,S1688-93392017000200057,exhibio,o
266,S1688-93392017000200057,un,o
266,S1688-93392017000200057,472,o
266,S1688-93392017000200057,383,o
266,S1688-93392017000200057,y,o
266,S1688-93392017000200057,137,o
266,S1688-93392017000200057,respectivamente,o
266,S1688-93392017000200057,Al,o
266,S1688-93392017000200057,aplicar,o
266,S1688-93392017000200057,la,o
266,S1688-93392017000200057,prueba,o
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,los,o
266,S1688-93392017000200057,rangos,o
266,S1688-93392017000200057,con,o
266,S1688-93392017000200057,signo,o
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,Wilcoxon,o
266,S1688-93392017000200057,se,o
266,S1688-93392017000200057,observo,o
266,S1688-93392017000200057,un,o
266,S1688-93392017000200057,valor,o
266,S1688-93392017000200057,P01454,o
266,S1688-93392017000200057,significacion,o
266,S1688-93392017000200057,05,o
266,S1688-93392017000200057,no,o
266,S1688-93392017000200057,existiendo,o
266,S1688-93392017000200057,diferencia,o
266,S1688-93392017000200057,estadisticamente,o
266,S1688-93392017000200057,significativa,o
266,S1688-93392017000200057,entre,o
266,S1688-93392017000200057,ambos,o
266,S1688-93392017000200057,grupos,o
266,S1688-93392017000200057,No,o
266,S1688-93392017000200057,existio,o
266,S1688-93392017000200057,rotura,i
266,S1688-93392017000200057,de,i
266,S1688-93392017000200057,membrana,i
266,S1688-93392017000200057,atribuible,o
266,S1688-93392017000200057,a,o
266,S1688-93392017000200057,la,o
266,S1688-93392017000200057,osteotomia,i
266,S1688-93392017000200057,produciendose,o
266,S1688-93392017000200057,en,o
266,S1688-93392017000200057,dos,o
266,S1688-93392017000200057,casos,o
266,S1688-93392017000200057,durante,o
266,S1688-93392017000200057,el,o
266,S1688-93392017000200057,decolamiento,i
266,S1688-93392017000200057,La,o
266,S1688-93392017000200057,tasa,o
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,supervivencia,o
266,S1688-93392017000200057,de,o
266,S1688-93392017000200057,los,o
266,S1688-93392017000200057,implantes,o
266,S1688-93392017000200057,fue,o
266,S1688-93392017000200057,del,o
266,S1688-93392017000200057,100,o
266,S1688-93392017000200057,en,o
266,S1688-93392017000200057,1,o
266,S1688-93392017000200057,año,o
267,S1695-403317303995,Comparacion,o
267,S1695-403317303995,de,o
267,S1695-403317303995,niveles,i
267,S1695-403317303995,de,i
267,S1695-403317303995,glucemia,i
267,S1695-403317303995,postoperatoria,o
267,S1695-403317303995,usando,o
267,S1695-403317303995,sueros,i
267,S1695-403317303995,con,o
267,S1695-403317303995,diferente,o
267,S1695-403317303995,concentracion,o
267,S1695-403317303995,de,o
267,S1695-403317303995,glucosa,i
267,S1695-403317303995,Objetivo,o
267,S1695-403317303995,Comparar,o
267,S1695-403317303995,los,o
267,S1695-403317303995,niveles,i
267,S1695-403317303995,de,i
267,S1695-403317303995,glucemia,i
267,S1695-403317303995,e,o
267,S1695-403317303995,incidencia,o
267,S1695-403317303995,de,o
267,S1695-403317303995,hiperglucemia,i
267,S1695-403317303995,en,o
267,S1695-403317303995,el,o
267,S1695-403317303995,postoperatorio,o
267,S1695-403317303995,de,o
267,S1695-403317303995,cirugia,i
267,S1695-403317303995,general,i
267,S1695-403317303995,usando,o
267,S1695-403317303995,sueros,i
267,S1695-403317303995,con,o
267,S1695-403317303995,diferente,o
267,S1695-403317303995,concentracion,o
267,S1695-403317303995,de,o
267,S1695-403317303995,glucosa,i
267,S1695-403317303995,Metodologia,o
267,S1695-403317303995,Ensayo,o
267,S1695-403317303995,clinico,o
267,S1695-403317303995,aleatorizado,o
267,S1695-403317303995,abierto,o
267,S1695-403317303995,no,o
267,S1695-403317303995,ciego,o
267,S1695-403317303995,en,o
267,S1695-403317303995,pacientes,o
267,S1695-403317303995,no,o
267,S1695-403317303995,diabeticos,i
267,S1695-403317303995,que,o
267,S1695-403317303995,ingresan,i
267,S1695-403317303995,en,i
267,S1695-403317303995,Cuidados,i
267,S1695-403317303995,Intensivos,i
267,S1695-403317303995,Pediatricos,o
267,S1695-403317303995,tras,o
267,S1695-403317303995,cirugia,i
267,S1695-403317303995,electiva,o
267,S1695-403317303995,de,o
267,S1695-403317303995,6,o
267,S1695-403317303995,meses,o
267,S1695-403317303995,a,o
267,S1695-403317303995,14,o
267,S1695-403317303995,años,o
267,S1695-403317303995,peso,o
267,S1695-403317303995,superior,o
267,S1695-403317303995,a,o
267,S1695-403317303995,6kg,o
267,S1695-403317303995,glucemia60mgdl,o
267,S1695-403317303995,y,o
267,S1695-403317303995,firma,o
267,S1695-403317303995,de,o
267,S1695-403317303995,consentimiento,i
267,S1695-403317303995,informado,i
267,S1695-403317303995,manteniendose,o
267,S1695-403317303995,a,o
267,S1695-403317303995,dieta,i
267,S1695-403317303995,con,o
267,S1695-403317303995,sueroterapia,i
267,S1695-403317303995,de,i
267,S1695-403317303995,mantenimiento,i
267,S1695-403317303995,intravenosa,i
267,S1695-403317303995,mediante,o
267,S1695-403317303995,suero,i
267,S1695-403317303995,con,i
267,S1695-403317303995,glucosa,i
267,S1695-403317303995,al,o
267,S1695-403317303995,33,o
267,S1695-403317303995,o,o
267,S1695-403317303995,5,o
267,S1695-403317303995,Se,o
267,S1695-403317303995,determinan,o
267,S1695-403317303995,niveles,i
267,S1695-403317303995,de,i
267,S1695-403317303995,glucemia,i
267,S1695-403317303995,preoperatoria,o
267,S1695-403317303995,al,o
267,S1695-403317303995,ingreso,i
267,S1695-403317303995,y,o
267,S1695-403317303995,a,o
267,S1695-403317303995,las,o
267,S1695-403317303995,8,o
267,S1695-403317303995,24,o
267,S1695-403317303995,y,o
267,S1695-403317303995,48h,o
267,S1695-403317303995,comparando,o
267,S1695-403317303995,los,o
267,S1695-403317303995,valores,o
267,S1695-403317303995,medios,o
267,S1695-403317303995,y,o
267,S1695-403317303995,la,o
267,S1695-403317303995,incidencia,o
267,S1695-403317303995,de,o
267,S1695-403317303995,hiperglucemia,i
267,S1695-403317303995,glucemia,i
267,S1695-403317303995,150mgdl,o
267,S1695-403317303995,en,o
267,S1695-403317303995,ambos,o
267,S1695-403317303995,grupos,o
267,S1695-403317303995,Resultados,o
267,S1695-403317303995,Un,o
267,S1695-403317303995,total,o
267,S1695-403317303995,de,o
267,S1695-403317303995,60,o
267,S1695-403317303995,pacientes,o
267,S1695-403317303995,recibieron,o
267,S1695-403317303995,suero,i
267,S1695-403317303995,glucosalino,i
267,S1695-403317303995,13,o
267,S1695-403317303995,51mEql,o
267,S1695-403317303995,de,o
267,S1695-403317303995,sodio,i
267,S1695-403317303995,y,o
267,S1695-403317303995,33gl,o
267,S1695-403317303995,de,o
267,S1695-403317303995,glucosa,i
267,S1695-403317303995,y,o
267,S1695-403317303995,70,o
267,S1695-403317303995,pacientes,o
267,S1695-403317303995,suero,i
267,S1695-403317303995,glucosalino,i
267,S1695-403317303995,509,o
267,S1695-403317303995,154mEql,o
267,S1695-403317303995,de,o
267,S1695-403317303995,sodio,i
267,S1695-403317303995,y,o
267,S1695-403317303995,50gl,o
267,S1695-403317303995,de,o
267,S1695-403317303995,glucosa,i
267,S1695-403317303995,La,o
267,S1695-403317303995,glucemia,i
267,S1695-403317303995,media,o
267,S1695-403317303995,fue,o
267,S1695-403317303995,mayor,o
267,S1695-403317303995,en,o
267,S1695-403317303995,el,o
267,S1695-403317303995,grupo,o
267,S1695-403317303995,al,o
267,S1695-403317303995,5,o
267,S1695-403317303995,sin,o
267,S1695-403317303995,diferencia,o
267,S1695-403317303995,estadistica,o
267,S1695-403317303995,No,o
267,S1695-403317303995,hubo,o
267,S1695-403317303995,diferencia,o
267,S1695-403317303995,en,o
267,S1695-403317303995,la,o
267,S1695-403317303995,incidencia,o
267,S1695-403317303995,de,o
267,S1695-403317303995,hiperglucemia,i
267,S1695-403317303995,8h,o
267,S1695-403317303995,26,o
267,S1695-403317303995,del,o
267,S1695-403317303995,grupo,o
267,S1695-403317303995,33,o
267,S1695-403317303995,vs,o
267,S1695-403317303995,213,o
267,S1695-403317303995,del,o
267,S1695-403317303995,grupo,o
267,S1695-403317303995,5,o
267,S1695-403317303995,p063,o
267,S1695-403317303995,24h,o
267,S1695-403317303995,20,o
267,S1695-403317303995,vs,o
267,S1695-403317303995,227,o
267,S1695-403317303995,p08,o
267,S1695-403317303995,48h,o
267,S1695-403317303995,19,o
267,S1695-403317303995,vs,o
267,S1695-403317303995,231,o
267,S1695-403317303995,p078,o
267,S1695-403317303995,Conclusiones,o
267,S1695-403317303995,En,o
267,S1695-403317303995,el,o
267,S1695-403317303995,postoperatorio,o
267,S1695-403317303995,de,o
267,S1695-403317303995,cirugia,i
267,S1695-403317303995,general,i
267,S1695-403317303995,el,o
267,S1695-403317303995,uso,o
267,S1695-403317303995,de,o
267,S1695-403317303995,soluciones,i
267,S1695-403317303995,glucosadas,i
267,S1695-403317303995,al,o
267,S1695-403317303995,33,o
267,S1695-403317303995,consigue,o
267,S1695-403317303995,niveles,i
267,S1695-403317303995,de,i
267,S1695-403317303995,glucemia,i
267,S1695-403317303995,similares,o
267,S1695-403317303995,a,o
267,S1695-403317303995,los,o
267,S1695-403317303995,detectados,o
267,S1695-403317303995,en,o
267,S1695-403317303995,pacientes,o
267,S1695-403317303995,que,o
267,S1695-403317303995,reciben,o
267,S1695-403317303995,suero,i
267,S1695-403317303995,con,i
267,S1695-403317303995,glucosa,i
267,S1695-403317303995,5,o
267,S1695-403317303995,con,o
267,S1695-403317303995,una,o
267,S1695-403317303995,incidencia,o
267,S1695-403317303995,de,o
267,S1695-403317303995,hiperglucemia,i
267,S1695-403317303995,similar,o
268,S1698-44472004000500011,Eficacia,o
268,S1698-44472004000500011,analgesica,o
268,S1698-44472004000500011,del,o
268,S1698-44472004000500011,diclofenaco,i
268,S1698-44472004000500011,sodico,i
268,S1698-44472004000500011,vs,o
268,S1698-44472004000500011,ibuprofeno,i
268,S1698-44472004000500011,despues,o
268,S1698-44472004000500011,de,o
268,S1698-44472004000500011,la,o
268,S1698-44472004000500011,extraccion,i
268,S1698-44472004000500011,quirurgica,i
268,S1698-44472004000500011,de,i
268,S1698-44472004000500011,un,i
268,S1698-44472004000500011,tercer,i
268,S1698-44472004000500011,molar,i
268,S1698-44472004000500011,inferior,i
268,S1698-44472004000500011,incluido,i
268,S1698-44472004000500011,Objetivo,o
268,S1698-44472004000500011,En,o
268,S1698-44472004000500011,este,o
268,S1698-44472004000500011,estudio,o
268,S1698-44472004000500011,evaluamos,i
268,S1698-44472004000500011,la,i
268,S1698-44472004000500011,eficacia,i
268,S1698-44472004000500011,analgesica,o
268,S1698-44472004000500011,del,o
268,S1698-44472004000500011,diclofenaco,i
268,S1698-44472004000500011,sodico,i
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,comparacion,o
268,S1698-44472004000500011,con,o
268,S1698-44472004000500011,el,o
268,S1698-44472004000500011,ibuprofeno,i
268,S1698-44472004000500011,despues,o
268,S1698-44472004000500011,de,o
268,S1698-44472004000500011,la,o
268,S1698-44472004000500011,extraccion,i
268,S1698-44472004000500011,quirurgica,i
268,S1698-44472004000500011,de,i
268,S1698-44472004000500011,un,i
268,S1698-44472004000500011,tercer,i
268,S1698-44472004000500011,molar,i
268,S1698-44472004000500011,inferior,i
268,S1698-44472004000500011,incluido,i
268,S1698-44472004000500011,Diseño,o
268,S1698-44472004000500011,de,o
268,S1698-44472004000500011,estudio,o
268,S1698-44472004000500011,Los,o
268,S1698-44472004000500011,pacientes,o
268,S1698-44472004000500011,que,o
268,S1698-44472004000500011,participaron,o
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,el,o
268,S1698-44472004000500011,estudio,o
268,S1698-44472004000500011,fueron,o
268,S1698-44472004000500011,distribuidos,i
268,S1698-44472004000500011,de,i
268,S1698-44472004000500011,forma,i
268,S1698-44472004000500011,aleatoria,i
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,dos,o
268,S1698-44472004000500011,grupos,o
268,S1698-44472004000500011,Uno,o
268,S1698-44472004000500011,fue,o
268,S1698-44472004000500011,el,o
268,S1698-44472004000500011,grupo,o
268,S1698-44472004000500011,ibuprofeno,i
268,S1698-44472004000500011,y,o
268,S1698-44472004000500011,el,o
268,S1698-44472004000500011,otro,o
268,S1698-44472004000500011,el,o
268,S1698-44472004000500011,grupo,o
268,S1698-44472004000500011,diclofenaco,i
268,S1698-44472004000500011,La,o
268,S1698-44472004000500011,intervencion,i
268,S1698-44472004000500011,practicada,o
268,S1698-44472004000500011,fue,o
268,S1698-44472004000500011,la,o
268,S1698-44472004000500011,extraccion,i
268,S1698-44472004000500011,quirurgica,i
268,S1698-44472004000500011,de,i
268,S1698-44472004000500011,un,i
268,S1698-44472004000500011,tercer,i
268,S1698-44472004000500011,molar,i
268,S1698-44472004000500011,inferior,i
268,S1698-44472004000500011,cuya,o
268,S1698-44472004000500011,dificultad,o
268,S1698-44472004000500011,fue,o
268,S1698-44472004000500011,determinada,o
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,funcion,o
268,S1698-44472004000500011,del,o
268,S1698-44472004000500011,grado,o
268,S1698-44472004000500011,de,o
268,S1698-44472004000500011,inclusion,o
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,todos,o
268,S1698-44472004000500011,los,o
268,S1698-44472004000500011,pacientes,o
268,S1698-44472004000500011,Las,o
268,S1698-44472004000500011,variables,o
268,S1698-44472004000500011,registradas,o
268,S1698-44472004000500011,fueron,o
268,S1698-44472004000500011,la,o
268,S1698-44472004000500011,intensidad,o
268,S1698-44472004000500011,del,o
268,S1698-44472004000500011,dolor,i
268,S1698-44472004000500011,y,o
268,S1698-44472004000500011,la,o
268,S1698-44472004000500011,necesidad,o
268,S1698-44472004000500011,de,o
268,S1698-44472004000500011,medicacion,i
268,S1698-44472004000500011,de,o
268,S1698-44472004000500011,rescate,i
268,S1698-44472004000500011,durante,o
268,S1698-44472004000500011,un,o
268,S1698-44472004000500011,periodo,o
268,S1698-44472004000500011,de,o
268,S1698-44472004000500011,una,o
268,S1698-44472004000500011,semana,o
268,S1698-44472004000500011,Los,o
268,S1698-44472004000500011,registros,o
268,S1698-44472004000500011,se,o
268,S1698-44472004000500011,realizaron,o
268,S1698-44472004000500011,una,o
268,S1698-44472004000500011,vez,o
268,S1698-44472004000500011,al,o
268,S1698-44472004000500011,dia,o
268,S1698-44472004000500011,a,o
268,S1698-44472004000500011,la,o
268,S1698-44472004000500011,misma,o
268,S1698-44472004000500011,hora,o
268,S1698-44472004000500011,y,o
268,S1698-44472004000500011,registrados,o
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,un,o
268,S1698-44472004000500011,cuaderno,o
268,S1698-44472004000500011,por,o
268,S1698-44472004000500011,parte,o
268,S1698-44472004000500011,del,o
268,S1698-44472004000500011,paciente,o
268,S1698-44472004000500011,Resultados,o
268,S1698-44472004000500011,Un,o
268,S1698-44472004000500011,total,o
268,S1698-44472004000500011,de,o
268,S1698-44472004000500011,81,o
268,S1698-44472004000500011,pacientes,o
268,S1698-44472004000500011,871,o
268,S1698-44472004000500011,fueron,o
268,S1698-44472004000500011,incluidos,o
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,el,o
268,S1698-44472004000500011,estudio,o
268,S1698-44472004000500011,Los,o
268,S1698-44472004000500011,valores,o
268,S1698-44472004000500011,fueron,o
268,S1698-44472004000500011,similares,o
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,las,o
268,S1698-44472004000500011,primeras,o
268,S1698-44472004000500011,48,o
268,S1698-44472004000500011,horas,o
268,S1698-44472004000500011,postoperatorias,o
268,S1698-44472004000500011,pero,o
268,S1698-44472004000500011,a,o
268,S1698-44472004000500011,partir,o
268,S1698-44472004000500011,del,o
268,S1698-44472004000500011,tercer,o
268,S1698-44472004000500011,dia,o
268,S1698-44472004000500011,existio,o
268,S1698-44472004000500011,una,o
268,S1698-44472004000500011,tendencia,o
268,S1698-44472004000500011,del,o
268,S1698-44472004000500011,grupo,o
268,S1698-44472004000500011,diclofenaco,i
268,S1698-44472004000500011,a,o
268,S1698-44472004000500011,mostrar,o
268,S1698-44472004000500011,valores,o
268,S1698-44472004000500011,de,o
268,S1698-44472004000500011,dolor,i
268,S1698-44472004000500011,superiores,o
268,S1698-44472004000500011,aunque,o
268,S1698-44472004000500011,sin,o
268,S1698-44472004000500011,llegar,o
268,S1698-44472004000500011,a,o
268,S1698-44472004000500011,existir,o
268,S1698-44472004000500011,diferencias,o
268,S1698-44472004000500011,estadisticamente,o
268,S1698-44472004000500011,significativas,o
268,S1698-44472004000500011,p005,o
268,S1698-44472004000500011,Esta,o
268,S1698-44472004000500011,tendencia,o
268,S1698-44472004000500011,a,o
268,S1698-44472004000500011,presentar,o
268,S1698-44472004000500011,mayor,o
268,S1698-44472004000500011,dolor,i
268,S1698-44472004000500011,durante,o
268,S1698-44472004000500011,el,o
268,S1698-44472004000500011,periodo,o
268,S1698-44472004000500011,postoperatorio,o
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,el,o
268,S1698-44472004000500011,grupo,o
268,S1698-44472004000500011,diclofenaco,i
268,S1698-44472004000500011,tambien,o
268,S1698-44472004000500011,se,o
268,S1698-44472004000500011,vio,o
268,S1698-44472004000500011,reflejada,o
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,el,o
268,S1698-44472004000500011,requerimiento,o
268,S1698-44472004000500011,del,o
268,S1698-44472004000500011,analgesico,i
268,S1698-44472004000500011,de,o
268,S1698-44472004000500011,rescate,i
268,S1698-44472004000500011,y,o
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,el,o
268,S1698-44472004000500011,numero,o
268,S1698-44472004000500011,de,o
268,S1698-44472004000500011,comprimidos,o
268,S1698-44472004000500011,empleados,o
268,S1698-44472004000500011,Conclusiones,o
268,S1698-44472004000500011,No,o
268,S1698-44472004000500011,se,o
268,S1698-44472004000500011,evidenciaron,o
268,S1698-44472004000500011,diferencias,o
268,S1698-44472004000500011,estadisticamente,o
268,S1698-44472004000500011,significativas,o
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,cuanto,o
268,S1698-44472004000500011,a,o
268,S1698-44472004000500011,la,o
268,S1698-44472004000500011,eficacia,o
268,S1698-44472004000500011,analgesica,o
268,S1698-44472004000500011,del,o
268,S1698-44472004000500011,diclofenaco,i
268,S1698-44472004000500011,sodico,i
268,S1698-44472004000500011,respecto,o
268,S1698-44472004000500011,al,o
268,S1698-44472004000500011,ibuprofeno,i
268,S1698-44472004000500011,aunque,o
268,S1698-44472004000500011,si,o
268,S1698-44472004000500011,pudo,o
268,S1698-44472004000500011,observarse,o
268,S1698-44472004000500011,una,o
268,S1698-44472004000500011,mayor,o
268,S1698-44472004000500011,tendencia,o
268,S1698-44472004000500011,hacia,o
268,S1698-44472004000500011,la,o
268,S1698-44472004000500011,necesidad,o
268,S1698-44472004000500011,de,o
268,S1698-44472004000500011,mas,o
268,S1698-44472004000500011,medicacion,i
268,S1698-44472004000500011,suplementaria,o
268,S1698-44472004000500011,durante,o
268,S1698-44472004000500011,los,o
268,S1698-44472004000500011,2,o
268,S1698-44472004000500011,primeros,o
268,S1698-44472004000500011,dias,o
268,S1698-44472004000500011,del,o
268,S1698-44472004000500011,postoperatorio,o
268,S1698-44472004000500011,en,o
268,S1698-44472004000500011,el,o
268,S1698-44472004000500011,grupo,o
268,S1698-44472004000500011,diclofenaco,i
268,S1698-44472004000500011,pero,o
268,S1698-44472004000500011,sin,o
268,S1698-44472004000500011,adquirir,o
268,S1698-44472004000500011,significacion,o
268,S1698-44472004000500011,estadistica,o
268,S1698-44472004000500011,p005,o
269,S1698-44472005000200007,Aspectos,o
269,S1698-44472005000200007,periodontales,i
269,S1698-44472005000200007,en,o
269,S1698-44472005000200007,mujeres,o
269,S1698-44472005000200007,menopausicas,i
269,S1698-44472005000200007,con,o
269,S1698-44472005000200007,terapia,i
269,S1698-44472005000200007,hormonal,i
269,S1698-44472005000200007,sustitutiva,i
269,S1698-44472005000200007,OBJETIVOS,o
269,S1698-44472005000200007,Actualmente,o
269,S1698-44472005000200007,gran,o
269,S1698-44472005000200007,numero,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,mujeres,o
269,S1698-44472005000200007,utilizan,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,THS,i
269,S1698-44472005000200007,para,o
269,S1698-44472005000200007,controlar,o
269,S1698-44472005000200007,sus,o
269,S1698-44472005000200007,problemas,i
269,S1698-44472005000200007,hormonales,i
269,S1698-44472005000200007,durante,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,menopausia,i
269,S1698-44472005000200007,Del,o
269,S1698-44472005000200007,mismo,o
269,S1698-44472005000200007,modo,o
269,S1698-44472005000200007,un,o
269,S1698-44472005000200007,porcentaje,o
269,S1698-44472005000200007,alto,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,ellas,o
269,S1698-44472005000200007,presentan,o
269,S1698-44472005000200007,problemas,i
269,S1698-44472005000200007,en,i
269,S1698-44472005000200007,la,i
269,S1698-44472005000200007,cavidad,i
269,S1698-44472005000200007,bucal,i
269,S1698-44472005000200007,a,o
269,S1698-44472005000200007,nivel,o
269,S1698-44472005000200007,del,o
269,S1698-44472005000200007,periodonto,i
269,S1698-44472005000200007,Es,o
269,S1698-44472005000200007,por,o
269,S1698-44472005000200007,ello,o
269,S1698-44472005000200007,que,o
269,S1698-44472005000200007,se,o
269,S1698-44472005000200007,ha,o
269,S1698-44472005000200007,marcado,o
269,S1698-44472005000200007,el,o
269,S1698-44472005000200007,siguiente,o
269,S1698-44472005000200007,objetivo,o
269,S1698-44472005000200007,para,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,realizacion,o
269,S1698-44472005000200007,del,o
269,S1698-44472005000200007,trabajo,o
269,S1698-44472005000200007,Analizar,o
269,S1698-44472005000200007,el,o
269,S1698-44472005000200007,efecto,o
269,S1698-44472005000200007,que,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,menopausia,i
269,S1698-44472005000200007,al,o
269,S1698-44472005000200007,producirse,o
269,S1698-44472005000200007,una,o
269,S1698-44472005000200007,disminucion,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,hormonas,i
269,S1698-44472005000200007,fundamentalmente,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,estrogenos,i
269,S1698-44472005000200007,puede,o
269,S1698-44472005000200007,tener,o
269,S1698-44472005000200007,sobre,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,salud,o
269,S1698-44472005000200007,bucodental,i
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,mujer,o
269,S1698-44472005000200007,y,o
269,S1698-44472005000200007,en,o
269,S1698-44472005000200007,concreto,o
269,S1698-44472005000200007,sobre,o
269,S1698-44472005000200007,las,o
269,S1698-44472005000200007,caracteristicas,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,encia,i
269,S1698-44472005000200007,y,o
269,S1698-44472005000200007,el,o
269,S1698-44472005000200007,periodonto,i
269,S1698-44472005000200007,verificando,o
269,S1698-44472005000200007,si,o
269,S1698-44472005000200007,estas,o
269,S1698-44472005000200007,caracteristicas,o
269,S1698-44472005000200007,en,o
269,S1698-44472005000200007,cuanto,o
269,S1698-44472005000200007,a,o
269,S1698-44472005000200007,recesion,i
269,S1698-44472005000200007,gingival,i
269,S1698-44472005000200007,dolor,i
269,S1698-44472005000200007,movilidad,i
269,S1698-44472005000200007,dental,i
269,S1698-44472005000200007,y,o
269,S1698-44472005000200007,bolsas,i
269,S1698-44472005000200007,periodontales,i
269,S1698-44472005000200007,nos,o
269,S1698-44472005000200007,permiten,o
269,S1698-44472005000200007,valorar,o
269,S1698-44472005000200007,el,o
269,S1698-44472005000200007,grado,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,descalcificacion,i
269,S1698-44472005000200007,en,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,mujer,o
269,S1698-44472005000200007,menopausica,i
269,S1698-44472005000200007,PACIENTES,o
269,S1698-44472005000200007,Mujeres,o
269,S1698-44472005000200007,en,o
269,S1698-44472005000200007,epoca,o
269,S1698-44472005000200007,menopausica,i
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,40,o
269,S1698-44472005000200007,a,o
269,S1698-44472005000200007,58,o
269,S1698-44472005000200007,años,o
269,S1698-44472005000200007,sometidas,o
269,S1698-44472005000200007,a,o
269,S1698-44472005000200007,terapia,i
269,S1698-44472005000200007,hormonal,i
269,S1698-44472005000200007,sustitutiva,i
269,S1698-44472005000200007,y,o
269,S1698-44472005000200007,que,o
269,S1698-44472005000200007,presentaban,o
269,S1698-44472005000200007,problemas,o
269,S1698-44472005000200007,gingivoperiodontales,o
269,S1698-44472005000200007,La,o
269,S1698-44472005000200007,poblacion,o
269,S1698-44472005000200007,total,o
269,S1698-44472005000200007,del,o
269,S1698-44472005000200007,estudio,o
269,S1698-44472005000200007,se,o
269,S1698-44472005000200007,constituyo,o
269,S1698-44472005000200007,con,o
269,S1698-44472005000200007,210,o
269,S1698-44472005000200007,pacientes,o
269,S1698-44472005000200007,Se,o
269,S1698-44472005000200007,dividieron,o
269,S1698-44472005000200007,en,o
269,S1698-44472005000200007,dos,o
269,S1698-44472005000200007,grupos,o
269,S1698-44472005000200007,uno,o
269,S1698-44472005000200007,que,o
269,S1698-44472005000200007,recibio,o
269,S1698-44472005000200007,THS,i
269,S1698-44472005000200007,con,o
269,S1698-44472005000200007,parches,o
269,S1698-44472005000200007,y,o
269,S1698-44472005000200007,otro,o
269,S1698-44472005000200007,que,o
269,S1698-44472005000200007,no,o
269,S1698-44472005000200007,recibio,o
269,S1698-44472005000200007,dicha,o
269,S1698-44472005000200007,terapia,i
269,S1698-44472005000200007,METODO,o
269,S1698-44472005000200007,Se,o
269,S1698-44472005000200007,establecio,o
269,S1698-44472005000200007,para,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,recogida,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,datos,o
269,S1698-44472005000200007,un,o
269,S1698-44472005000200007,protocolo,i
269,S1698-44472005000200007,ginecologico,i
269,S1698-44472005000200007,y,i
269,S1698-44472005000200007,otro,i
269,S1698-44472005000200007,odontoestomatologico,i
269,S1698-44472005000200007,Se,o
269,S1698-44472005000200007,realizo,o
269,S1698-44472005000200007,una,o
269,S1698-44472005000200007,estadistica,o
269,S1698-44472005000200007,descriptiva,o
269,S1698-44472005000200007,para,o
269,S1698-44472005000200007,las,o
269,S1698-44472005000200007,variables,o
269,S1698-44472005000200007,sociodemograficas,o
269,S1698-44472005000200007,analisis,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,varianza,o
269,S1698-44472005000200007,test,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,MacNemar,o
269,S1698-44472005000200007,y,o
269,S1698-44472005000200007,test,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,StuartMaxwell,o
269,S1698-44472005000200007,para,o
269,S1698-44472005000200007,valorar,i
269,S1698-44472005000200007,la,i
269,S1698-44472005000200007,eficacia,i
269,S1698-44472005000200007,del,o
269,S1698-44472005000200007,tratamiento,i
269,S1698-44472005000200007,RESULTADOS,o
269,S1698-44472005000200007,El,o
269,S1698-44472005000200007,rango,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,edad,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,las,o
269,S1698-44472005000200007,pacientes,o
269,S1698-44472005000200007,estudiadas,o
269,S1698-44472005000200007,fue,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,49,o
269,S1698-44472005000200007,años,o
269,S1698-44472005000200007,La,o
269,S1698-44472005000200007,THS,i
269,S1698-44472005000200007,actua,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,factor,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,proteccion,o
269,S1698-44472005000200007,en,o
269,S1698-44472005000200007,el,o
269,S1698-44472005000200007,dolor,i
269,S1698-44472005000200007,dental,i
269,S1698-44472005000200007,y,o
269,S1698-44472005000200007,mejora,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,movilidad,i
269,S1698-44472005000200007,dental,i
269,S1698-44472005000200007,y,o
269,S1698-44472005000200007,el,o
269,S1698-44472005000200007,sondaje,i
269,S1698-44472005000200007,de,i
269,S1698-44472005000200007,bolsas,i
269,S1698-44472005000200007,periodontales,i
269,S1698-44472005000200007,No,o
269,S1698-44472005000200007,se,o
269,S1698-44472005000200007,encontraron,o
269,S1698-44472005000200007,resultados,o
269,S1698-44472005000200007,significativos,o
269,S1698-44472005000200007,respecto,o
269,S1698-44472005000200007,a,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,variable,o
269,S1698-44472005000200007,recesion,i
269,S1698-44472005000200007,gingival,i
269,S1698-44472005000200007,tanto,o
269,S1698-44472005000200007,en,o
269,S1698-44472005000200007,las,o
269,S1698-44472005000200007,pacientes,o
269,S1698-44472005000200007,que,o
269,S1698-44472005000200007,no,o
269,S1698-44472005000200007,recibieron,o
269,S1698-44472005000200007,THS,i
269,S1698-44472005000200007,como,o
269,S1698-44472005000200007,en,o
269,S1698-44472005000200007,las,o
269,S1698-44472005000200007,que,o
269,S1698-44472005000200007,fueron,o
269,S1698-44472005000200007,tratadas,i
269,S1698-44472005000200007,con,i
269,S1698-44472005000200007,parches,i
269,S1698-44472005000200007,CONCLUSIONES,o
269,S1698-44472005000200007,La,o
269,S1698-44472005000200007,respuesta,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,THS,i
269,S1698-44472005000200007,con,o
269,S1698-44472005000200007,respecto,o
269,S1698-44472005000200007,a,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,enfermedad,i
269,S1698-44472005000200007,periodontal,i
269,S1698-44472005000200007,esta,o
269,S1698-44472005000200007,propiciada,o
269,S1698-44472005000200007,probablemente,o
269,S1698-44472005000200007,por,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,presencia,o
269,S1698-44472005000200007,de,o
269,S1698-44472005000200007,los,o
269,S1698-44472005000200007,receptores,i
269,S1698-44472005000200007,estrogenicos,i
269,S1698-44472005000200007,localizados,o
269,S1698-44472005000200007,en,o
269,S1698-44472005000200007,la,o
269,S1698-44472005000200007,encia,i
269,S1698-44472005000200007,y,o
269,S1698-44472005000200007,el,o
269,S1698-44472005000200007,ligamento,i
269,S1698-44472005000200007,periodontal,i
270,S1698-69462006000500013,Uso,o
270,S1698-69462006000500013,de,o
270,S1698-69462006000500013,metilprednisolona,i
270,S1698-69462006000500013,versus,o
270,S1698-69462006000500013,diclofenaco,i
270,S1698-69462006000500013,en,o
270,S1698-69462006000500013,el,o
270,S1698-69462006000500013,control,o
270,S1698-69462006000500013,de,o
270,S1698-69462006000500013,la,o
270,S1698-69462006000500013,inflamacion,i
270,S1698-69462006000500013,y,o
270,S1698-69462006000500013,el,o
270,S1698-69462006000500013,trismo,i
270,S1698-69462006000500013,tras,o
270,S1698-69462006000500013,la,o
270,S1698-69462006000500013,cirugia,i
270,S1698-69462006000500013,del,i
270,S1698-69462006000500013,tercer,i
270,S1698-69462006000500013,molar,i
270,S1698-69462006000500013,inferior,i
270,S1698-69462006000500013,Objetivo,o
270,S1698-69462006000500013,Comparar,o
270,S1698-69462006000500013,el,o
270,S1698-69462006000500013,efecto,o
270,S1698-69462006000500013,sobre,o
270,S1698-69462006000500013,la,o
270,S1698-69462006000500013,inflamacion,i
270,S1698-69462006000500013,y,o
270,S1698-69462006000500013,el,o
270,S1698-69462006000500013,trismo,i
270,S1698-69462006000500013,de,o
270,S1698-69462006000500013,la,o
270,S1698-69462006000500013,metilprednisolona,i
270,S1698-69462006000500013,corticoide,i
270,S1698-69462006000500013,versus,o
270,S1698-69462006000500013,diclofenaco,i
270,S1698-69462006000500013,antiinflamatorio,i
270,S1698-69462006000500013,no,o
270,S1698-69462006000500013,esteroideoAINE,o
270,S1698-69462006000500013,tras,o
270,S1698-69462006000500013,la,o
270,S1698-69462006000500013,cirugia,i
270,S1698-69462006000500013,del,i
270,S1698-69462006000500013,tercer,i
270,S1698-69462006000500013,molar,i
270,S1698-69462006000500013,inferior,i
270,S1698-69462006000500013,Diseño,o
270,S1698-69462006000500013,del,o
270,S1698-69462006000500013,estudio,o
270,S1698-69462006000500013,Estudio,i
270,S1698-69462006000500013,prospectivo,i
270,S1698-69462006000500013,sobre,o
270,S1698-69462006000500013,73,o
270,S1698-69462006000500013,pacientes,o
270,S1698-69462006000500013,sometidos,o
270,S1698-69462006000500013,a,o
270,S1698-69462006000500013,la,o
270,S1698-69462006000500013,extraccion,i
270,S1698-69462006000500013,quirurgica,i
270,S1698-69462006000500013,de,i
270,S1698-69462006000500013,los,i
270,S1698-69462006000500013,terceros,i
270,S1698-69462006000500013,molares,i
270,S1698-69462006000500013,inferiores,i
270,S1698-69462006000500013,Fueron,o
270,S1698-69462006000500013,divididos,i
270,S1698-69462006000500013,de,i
270,S1698-69462006000500013,forma,i
270,S1698-69462006000500013,aleatoria,i
270,S1698-69462006000500013,en,o
270,S1698-69462006000500013,dos,o
270,S1698-69462006000500013,grupos,o
270,S1698-69462006000500013,De,o
270,S1698-69462006000500013,diclofenaco,i
270,S1698-69462006000500013,y,o
270,S1698-69462006000500013,de,o
270,S1698-69462006000500013,metilprednisolona,i
270,S1698-69462006000500013,Se,o
270,S1698-69462006000500013,cumplimento,o
270,S1698-69462006000500013,una,o
270,S1698-69462006000500013,ficha,o
270,S1698-69462006000500013,donde,o
270,S1698-69462006000500013,se,o
270,S1698-69462006000500013,hizo,o
270,S1698-69462006000500013,constar,o
270,S1698-69462006000500013,los,o
270,S1698-69462006000500013,datos,o
270,S1698-69462006000500013,epidemiologicos,o
270,S1698-69462006000500013,y,o
270,S1698-69462006000500013,clinicos,o
270,S1698-69462006000500013,preoperatorios,o
270,S1698-69462006000500013,y,o
270,S1698-69462006000500013,postoperatorios,o
270,S1698-69462006000500013,en,o
270,S1698-69462006000500013,relacion,o
270,S1698-69462006000500013,a,o
270,S1698-69462006000500013,la,o
270,S1698-69462006000500013,inflamacion,i
270,S1698-69462006000500013,y,o
270,S1698-69462006000500013,el,o
270,S1698-69462006000500013,trismo,i
270,S1698-69462006000500013,tres,o
270,S1698-69462006000500013,medidas,o
270,S1698-69462006000500013,faciales,i
270,S1698-69462006000500013,y,o
270,S1698-69462006000500013,apertura,o
270,S1698-69462006000500013,bucal,i
270,S1698-69462006000500013,Se,o
270,S1698-69462006000500013,uso,o
270,S1698-69462006000500013,el,o
270,S1698-69462006000500013,programa,o
270,S1698-69462006000500013,estadistico,o
270,S1698-69462006000500013,BMDP,o
270,S1698-69462006000500013,para,o
270,S1698-69462006000500013,hacer,o
270,S1698-69462006000500013,un,o
270,S1698-69462006000500013,amplio,o
270,S1698-69462006000500013,tratamiento,o
270,S1698-69462006000500013,de,o
270,S1698-69462006000500013,los,o
270,S1698-69462006000500013,datos,o
270,S1698-69462006000500013,Resultados,o
270,S1698-69462006000500013,A,o
270,S1698-69462006000500013,las,o
270,S1698-69462006000500013,24,o
270,S1698-69462006000500013,horas,o
270,S1698-69462006000500013,el,o
270,S1698-69462006000500013,grupo,o
270,S1698-69462006000500013,tratado,i
270,S1698-69462006000500013,con,o
270,S1698-69462006000500013,diclofenaco,i
270,S1698-69462006000500013,presentaba,o
270,S1698-69462006000500013,mayor,o
270,S1698-69462006000500013,inflamacion,i
270,S1698-69462006000500013,en,o
270,S1698-69462006000500013,una,o
270,S1698-69462006000500013,de,o
270,S1698-69462006000500013,las,o
270,S1698-69462006000500013,medidas,o
270,S1698-69462006000500013,faciales,i
270,S1698-69462006000500013,p005,o
270,S1698-69462006000500013,no,o
270,S1698-69462006000500013,asi,o
270,S1698-69462006000500013,en,o
270,S1698-69462006000500013,las,o
270,S1698-69462006000500013,otras,o
270,S1698-69462006000500013,dos,o
270,S1698-69462006000500013,medidas,o
270,S1698-69462006000500013,El,o
270,S1698-69462006000500013,trismo,i
270,S1698-69462006000500013,se,o
270,S1698-69462006000500013,comporto,o
270,S1698-69462006000500013,de,o
270,S1698-69462006000500013,forma,o
270,S1698-69462006000500013,similar,o
270,S1698-69462006000500013,en,o
270,S1698-69462006000500013,ambos,o
270,S1698-69462006000500013,grupos,o
270,S1698-69462006000500013,Conclusiones,o
270,S1698-69462006000500013,No,o
270,S1698-69462006000500013,se,o
270,S1698-69462006000500013,encontraron,o
270,S1698-69462006000500013,diferencias,o
270,S1698-69462006000500013,en,o
270,S1698-69462006000500013,el,o
270,S1698-69462006000500013,trismo,i
270,S1698-69462006000500013,segun,o
270,S1698-69462006000500013,el,o
270,S1698-69462006000500013,antiinflamatorio,i
270,S1698-69462006000500013,usado,o
270,S1698-69462006000500013,y,o
270,S1698-69462006000500013,aunque,o
270,S1698-69462006000500013,la,o
270,S1698-69462006000500013,inflamacion,i
270,S1698-69462006000500013,fue,o
270,S1698-69462006000500013,algo,o
270,S1698-69462006000500013,menor,o
270,S1698-69462006000500013,en,o
270,S1698-69462006000500013,el,o
270,S1698-69462006000500013,grupo,o
270,S1698-69462006000500013,de,o
270,S1698-69462006000500013,experimentacion,i
270,S1698-69462006000500013,tratado,i
270,S1698-69462006000500013,con,o
270,S1698-69462006000500013,corticoides,i
270,S1698-69462006000500013,la,o
270,S1698-69462006000500013,diferencia,o
270,S1698-69462006000500013,no,o
270,S1698-69462006000500013,fue,o
270,S1698-69462006000500013,tan,o
270,S1698-69462006000500013,significativa,o
270,S1698-69462006000500013,como,o
270,S1698-69462006000500013,para,o
270,S1698-69462006000500013,justificar,o
270,S1698-69462006000500013,su,o
270,S1698-69462006000500013,uso,o
271,S1699-65852002000100003,Efectos,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,un,o
271,S1699-65852002000100003,gel,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,tetraciclina,i
271,S1699-65852002000100003,al,o
271,S1699-65852002000100003,5,o
271,S1699-65852002000100003,sobre,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,niveles,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,P,o
271,S1699-65852002000100003,gingivalis,o
271,S1699-65852002000100003,P,o
271,S1699-65852002000100003,intermedia,o
271,S1699-65852002000100003,y,o
271,S1699-65852002000100003,A,o
271,S1699-65852002000100003,actinomycetemcomitans,o
271,S1699-65852002000100003,El,o
271,S1699-65852002000100003,objetivo,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,la,o
271,S1699-65852002000100003,presente,o
271,S1699-65852002000100003,investigacion,o
271,S1699-65852002000100003,fue,o
271,S1699-65852002000100003,estudiar,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,efectos,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,un,o
271,S1699-65852002000100003,gel,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,tetraciclina,i
271,S1699-65852002000100003,al,o
271,S1699-65852002000100003,5,o
271,S1699-65852002000100003,sobre,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,niveles,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,3,o
271,S1699-65852002000100003,microorganismos,o
271,S1699-65852002000100003,asociados,o
271,S1699-65852002000100003,al,o
271,S1699-65852002000100003,desarrollo,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,la,o
271,S1699-65852002000100003,periodontitis,i
271,S1699-65852002000100003,rapidamente,i
271,S1699-65852002000100003,progresiva,i
271,S1699-65852002000100003,PRP,i
271,S1699-65852002000100003,En,o
271,S1699-65852002000100003,un,o
271,S1699-65852002000100003,total,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,20,o
271,S1699-65852002000100003,pacientes,o
271,S1699-65852002000100003,con,o
271,S1699-65852002000100003,PRP,i
271,S1699-65852002000100003,se,o
271,S1699-65852002000100003,seleccionaron,o
271,S1699-65852002000100003,5,o
271,S1699-65852002000100003,dientes,i
271,S1699-65852002000100003,por,o
271,S1699-65852002000100003,paciente,o
271,S1699-65852002000100003,con,o
271,S1699-65852002000100003,bolsas,i
271,S1699-65852002000100003,periodontales,i
271,S1699-65852002000100003,a,o
271,S1699-65852002000100003,5,o
271,S1699-65852002000100003,mm,o
271,S1699-65852002000100003,con,o
271,S1699-65852002000100003,sangrado,i
271,S1699-65852002000100003,al,o
271,S1699-65852002000100003,sondaje,i
271,S1699-65852002000100003,periodontal,i
271,S1699-65852002000100003,en,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,cuales,o
271,S1699-65852002000100003,se,o
271,S1699-65852002000100003,efectuaron,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,siguientes,o
271,S1699-65852002000100003,tratamientos,i
271,S1699-65852002000100003,1,o
271,S1699-65852002000100003,Control,o
271,S1699-65852002000100003,2,o
271,S1699-65852002000100003,Aplicacion,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,un,o
271,S1699-65852002000100003,gel,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,tetraciclina,i
271,S1699-65852002000100003,al,o
271,S1699-65852002000100003,5,o
271,S1699-65852002000100003,T,o
271,S1699-65852002000100003,3,o
271,S1699-65852002000100003,Placebo,i
271,S1699-65852002000100003,Pl,o
271,S1699-65852002000100003,4,o
271,S1699-65852002000100003,Raspado,i
271,S1699-65852002000100003,y,i
271,S1699-65852002000100003,alisado,i
271,S1699-65852002000100003,radicular,i
271,S1699-65852002000100003,RA,o
271,S1699-65852002000100003,5,o
271,S1699-65852002000100003,T,o
271,S1699-65852002000100003,RA,o
271,S1699-65852002000100003,De,o
271,S1699-65852002000100003,forma,o
271,S1699-65852002000100003,previa,o
271,S1699-65852002000100003,en,o
271,S1699-65852002000100003,cada,o
271,S1699-65852002000100003,sitio,o
271,S1699-65852002000100003,seleccionado,o
271,S1699-65852002000100003,se,o
271,S1699-65852002000100003,tornaron,o
271,S1699-65852002000100003,muestras,i
271,S1699-65852002000100003,de,i
271,S1699-65852002000100003,placa,i
271,S1699-65852002000100003,subgingival,i
271,S1699-65852002000100003,con,o
271,S1699-65852002000100003,un,o
271,S1699-65852002000100003,cono,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,papel,o
271,S1699-65852002000100003,esteril,o
271,S1699-65852002000100003,para,o
271,S1699-65852002000100003,detectar,o
271,S1699-65852002000100003,y,o
271,S1699-65852002000100003,cuantificar,o
271,S1699-65852002000100003,la,o
271,S1699-65852002000100003,presencia,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,P,o
271,S1699-65852002000100003,gingivalis,o
271,S1699-65852002000100003,P,o
271,S1699-65852002000100003,intermedia,o
271,S1699-65852002000100003,y,o
271,S1699-65852002000100003,A,o
271,S1699-65852002000100003,actinomycetemcomitans,o
271,S1699-65852002000100003,mediante,o
271,S1699-65852002000100003,el,o
271,S1699-65852002000100003,uso,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,sondas,i
271,S1699-65852002000100003,DNA,i
271,S1699-65852002000100003,OMNIGENE,o
271,S1699-65852002000100003,USA,o
271,S1699-65852002000100003,Se,o
271,S1699-65852002000100003,dieron,o
271,S1699-65852002000100003,instrucciones,i
271,S1699-65852002000100003,de,i
271,S1699-65852002000100003,higiene,i
271,S1699-65852002000100003,oral,i
271,S1699-65852002000100003,y,o
271,S1699-65852002000100003,se,o
271,S1699-65852002000100003,efectuo,o
271,S1699-65852002000100003,un,o
271,S1699-65852002000100003,nuevo,o
271,S1699-65852002000100003,control,i
271,S1699-65852002000100003,microbiologico,i
271,S1699-65852002000100003,a,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,60,o
271,S1699-65852002000100003,dias,o
271,S1699-65852002000100003,El,o
271,S1699-65852002000100003,analisis,o
271,S1699-65852002000100003,estadistico,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,resultados,o
271,S1699-65852002000100003,demostro,o
271,S1699-65852002000100003,lo,o
271,S1699-65852002000100003,siguiente,o
271,S1699-65852002000100003,1,o
271,S1699-65852002000100003,Ninguno,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,tratamientos,i
271,S1699-65852002000100003,redujo,o
271,S1699-65852002000100003,significativamente,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,niveles,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,A,o
271,S1699-65852002000100003,actinomycetemcomitans,o
271,S1699-65852002000100003,2,o
271,S1699-65852002000100003,Se,o
271,S1699-65852002000100003,detecto,o
271,S1699-65852002000100003,una,o
271,S1699-65852002000100003,reduccion,o
271,S1699-65852002000100003,significativa,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,P,o
271,S1699-65852002000100003,gingivalis,o
271,S1699-65852002000100003,en,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,sitios,o
271,S1699-65852002000100003,tratados,i
271,S1699-65852002000100003,con,o
271,S1699-65852002000100003,RA,o
271,S1699-65852002000100003,p,o
271,S1699-65852002000100003,002,o
271,S1699-65852002000100003,o,o
271,S1699-65852002000100003,cuando,o
271,S1699-65852002000100003,este,o
271,S1699-65852002000100003,ultimo,o
271,S1699-65852002000100003,tratamiento,i
271,S1699-65852002000100003,se,o
271,S1699-65852002000100003,asocio,o
271,S1699-65852002000100003,a,o
271,S1699-65852002000100003,T,o
271,S1699-65852002000100003,p,o
271,S1699-65852002000100003,005,o
271,S1699-65852002000100003,3,o
271,S1699-65852002000100003,Todos,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,tratamientos,i
271,S1699-65852002000100003,redujeron,o
271,S1699-65852002000100003,significativamente,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,niveles,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,P,o
271,S1699-65852002000100003,intermedia,o
271,S1699-65852002000100003,Aunque,o
271,S1699-65852002000100003,las,o
271,S1699-65852002000100003,tetraciclinas,i
271,S1699-65852002000100003,incluyen,o
271,S1699-65852002000100003,en,o
271,S1699-65852002000100003,su,o
271,S1699-65852002000100003,espectro,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,accion,o
271,S1699-65852002000100003,a,o
271,S1699-65852002000100003,las,o
271,S1699-65852002000100003,bacterias,o
271,S1699-65852002000100003,estudiadas,o
271,S1699-65852002000100003,y,o
271,S1699-65852002000100003,alcanzan,o
271,S1699-65852002000100003,altas,o
271,S1699-65852002000100003,concentracion,o
271,S1699-65852002000100003,despues,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,su,o
271,S1699-65852002000100003,aplicacion,o
271,S1699-65852002000100003,en,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,sitios,o
271,S1699-65852002000100003,respectivos,o
271,S1699-65852002000100003,los,o
271,S1699-65852002000100003,reducidos,o
271,S1699-65852002000100003,efectos,o
271,S1699-65852002000100003,microbiologicos,o
271,S1699-65852002000100003,encontrados,o
271,S1699-65852002000100003,podrian,o
271,S1699-65852002000100003,explicarse,o
271,S1699-65852002000100003,por,o
271,S1699-65852002000100003,su,o
271,S1699-65852002000100003,rapida,o
271,S1699-65852002000100003,remocion,o
271,S1699-65852002000100003,por,o
271,S1699-65852002000100003,el,o
271,S1699-65852002000100003,fluido,i
271,S1699-65852002000100003,gingival,i
271,S1699-65852002000100003,desde,o
271,S1699-65852002000100003,su,o
271,S1699-65852002000100003,sitio,o
271,S1699-65852002000100003,de,o
271,S1699-65852002000100003,aplicacion,o
271,S1699-65852002000100003,en,o
271,S1699-65852002000100003,las,o
271,S1699-65852002000100003,localizaciones,o
271,S1699-65852002000100003,estudiadas,o
272,S1699-65852002000200004,El,o
272,S1699-65852002000200004,Metronidazol,i
272,S1699-65852002000200004,en,o
272,S1699-65852002000200004,los,o
272,S1699-65852002000200004,agrandamientos,i
272,S1699-65852002000200004,gingivales,i
272,S1699-65852002000200004,secundarios,o
272,S1699-65852002000200004,a,o
272,S1699-65852002000200004,Ciclosporina,i
272,S1699-65852002000200004,A,i
272,S1699-65852002000200004,Introduccion,o
272,S1699-65852002000200004,El,o
272,S1699-65852002000200004,agrandamiento,i
272,S1699-65852002000200004,gingival,i
272,S1699-65852002000200004,AG,i
272,S1699-65852002000200004,secundario,o
272,S1699-65852002000200004,a,o
272,S1699-65852002000200004,farmacos,i
272,S1699-65852002000200004,continua,o
272,S1699-65852002000200004,siendo,o
272,S1699-65852002000200004,un,o
272,S1699-65852002000200004,problema,o
272,S1699-65852002000200004,importante,o
272,S1699-65852002000200004,para,o
272,S1699-65852002000200004,los,o
272,S1699-65852002000200004,periodoncistas,o
272,S1699-65852002000200004,Han,o
272,S1699-65852002000200004,sido,o
272,S1699-65852002000200004,comunicadas,o
272,S1699-65852002000200004,remisiones,o
272,S1699-65852002000200004,parciales,o
272,S1699-65852002000200004,o,o
272,S1699-65852002000200004,totales,o
272,S1699-65852002000200004,del,o
272,S1699-65852002000200004,AG,i
272,S1699-65852002000200004,tras,o
272,S1699-65852002000200004,tratamientos,i
272,S1699-65852002000200004,cortos,o
272,S1699-65852002000200004,con,o
272,S1699-65852002000200004,diversos,o
272,S1699-65852002000200004,antibioticos,i
272,S1699-65852002000200004,Metodos,o
272,S1699-65852002000200004,Hemos,o
272,S1699-65852002000200004,realizado,o
272,S1699-65852002000200004,un,o
272,S1699-65852002000200004,estudio,i
272,S1699-65852002000200004,aleatorio,i
272,S1699-65852002000200004,controlado,i
272,S1699-65852002000200004,a,i
272,S1699-65852002000200004,doble,i
272,S1699-65852002000200004,ciego,i
272,S1699-65852002000200004,para,o
272,S1699-65852002000200004,determinar,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,efecto,o
272,S1699-65852002000200004,del,o
272,S1699-65852002000200004,tratamiento,i
272,S1699-65852002000200004,con,o
272,S1699-65852002000200004,metronidazol,i
272,S1699-65852002000200004,durante,o
272,S1699-65852002000200004,siete,o
272,S1699-65852002000200004,dias,o
272,S1699-65852002000200004,250,o
272,S1699-65852002000200004,mg3,o
272,S1699-65852002000200004,veces,o
272,S1699-65852002000200004,al,o
272,S1699-65852002000200004,dia,o
272,S1699-65852002000200004,sobre,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,AG,i
272,S1699-65852002000200004,incipiente,o
272,S1699-65852002000200004,secundario,o
272,S1699-65852002000200004,a,o
272,S1699-65852002000200004,ciclosporina,i
272,S1699-65852002000200004,A,i
272,S1699-65852002000200004,en,o
272,S1699-65852002000200004,pacientes,o
272,S1699-65852002000200004,adultos,o
272,S1699-65852002000200004,trasplantados,i
272,S1699-65852002000200004,renales,i
272,S1699-65852002000200004,La,o
272,S1699-65852002000200004,valoracion,i
272,S1699-65852002000200004,cuantitativa,i
272,S1699-65852002000200004,del,o
272,S1699-65852002000200004,AG,i
272,S1699-65852002000200004,se,o
272,S1699-65852002000200004,realizo,o
272,S1699-65852002000200004,semiautomaticamente,o
272,S1699-65852002000200004,con,o
272,S1699-65852002000200004,tecnicas,o
272,S1699-65852002000200004,de,o
272,S1699-65852002000200004,Analisis,i
272,S1699-65852002000200004,Digital,i
272,S1699-65852002000200004,de,i
272,S1699-65852002000200004,Imagen,i
272,S1699-65852002000200004,Resultados,o
272,S1699-65852002000200004,En,o
272,S1699-65852002000200004,ninguno,o
272,S1699-65852002000200004,de,o
272,S1699-65852002000200004,los,o
272,S1699-65852002000200004,26,o
272,S1699-65852002000200004,pacientes,o
272,S1699-65852002000200004,incluidos,o
272,S1699-65852002000200004,en,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,estudio,o
272,S1699-65852002000200004,se,o
272,S1699-65852002000200004,obtuvo,o
272,S1699-65852002000200004,la,o
272,S1699-65852002000200004,remision,o
272,S1699-65852002000200004,completa,o
272,S1699-65852002000200004,del,o
272,S1699-65852002000200004,AG,i
272,S1699-65852002000200004,al,o
272,S1699-65852002000200004,finalizar,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,estudio,o
272,S1699-65852002000200004,El,o
272,S1699-65852002000200004,indice,o
272,S1699-65852002000200004,de,o
272,S1699-65852002000200004,AG,i
272,S1699-65852002000200004,obtenido,o
272,S1699-65852002000200004,a,o
272,S1699-65852002000200004,tiempo,o
272,S1699-65852002000200004,cero,o
272,S1699-65852002000200004,fue,o
272,S1699-65852002000200004,en,o
272,S1699-65852002000200004,los,o
272,S1699-65852002000200004,pacientes,o
272,S1699-65852002000200004,tratados,i
272,S1699-65852002000200004,con,o
272,S1699-65852002000200004,metronidazol,i
272,S1699-65852002000200004,grupo,o
272,S1699-65852002000200004,MNZ,i
272,S1699-65852002000200004,090,o
272,S1699-65852002000200004,016,o
272,S1699-65852002000200004,y,o
272,S1699-65852002000200004,en,o
272,S1699-65852002000200004,los,o
272,S1699-65852002000200004,controles,o
272,S1699-65852002000200004,grupo,o
272,S1699-65852002000200004,placebo,i
272,S1699-65852002000200004,111,o
272,S1699-65852002000200004,033Transcurridos,o
272,S1699-65852002000200004,30,o
272,S1699-65852002000200004,dias,o
272,S1699-65852002000200004,de,o
272,S1699-65852002000200004,evolucion,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,indice,o
272,S1699-65852002000200004,de,o
272,S1699-65852002000200004,AG,i
272,S1699-65852002000200004,en,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,grupo,o
272,S1699-65852002000200004,MNZ,i
272,S1699-65852002000200004,no,o
272,S1699-65852002000200004,se,o
272,S1699-65852002000200004,modifico,o
272,S1699-65852002000200004,092,o
272,S1699-65852002000200004,028,o
272,S1699-65852002000200004,y,o
272,S1699-65852002000200004,en,o
272,S1699-65852002000200004,los,o
272,S1699-65852002000200004,pacientes,o
272,S1699-65852002000200004,que,o
272,S1699-65852002000200004,tomaron,o
272,S1699-65852002000200004,placebo,i
272,S1699-65852002000200004,se,o
272,S1699-65852002000200004,incremento,o
272,S1699-65852002000200004,ligeramente,o
272,S1699-65852002000200004,118,o
272,S1699-65852002000200004,03,o
272,S1699-65852002000200004,aunque,o
272,S1699-65852002000200004,sin,o
272,S1699-65852002000200004,llegar,o
272,S1699-65852002000200004,a,o
272,S1699-65852002000200004,ser,o
272,S1699-65852002000200004,estadisticamente,o
272,S1699-65852002000200004,significativo,o
272,S1699-65852002000200004,El,o
272,S1699-65852002000200004,indice,o
272,S1699-65852002000200004,AG,i
272,S1699-65852002000200004,disminuyo,o
272,S1699-65852002000200004,en,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,544,o
272,S1699-65852002000200004,de,o
272,S1699-65852002000200004,los,o
272,S1699-65852002000200004,pacientes,o
272,S1699-65852002000200004,del,o
272,S1699-65852002000200004,grupo,o
272,S1699-65852002000200004,MNZ,i
272,S1699-65852002000200004,mientras,o
272,S1699-65852002000200004,que,o
272,S1699-65852002000200004,solo,o
272,S1699-65852002000200004,lo,o
272,S1699-65852002000200004,hizo,o
272,S1699-65852002000200004,en,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,231,o
272,S1699-65852002000200004,en,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,grupo,o
272,S1699-65852002000200004,placebo,i
272,S1699-65852002000200004,A,o
272,S1699-65852002000200004,pesar,o
272,S1699-65852002000200004,de,o
272,S1699-65852002000200004,que,o
272,S1699-65852002000200004,no,o
272,S1699-65852002000200004,existieron,o
272,S1699-65852002000200004,diferencias,o
272,S1699-65852002000200004,en,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,indice,o
272,S1699-65852002000200004,de,o
272,S1699-65852002000200004,AG,i
272,S1699-65852002000200004,entre,o
272,S1699-65852002000200004,los,o
272,S1699-65852002000200004,dos,o
272,S1699-65852002000200004,grupo,o
272,S1699-65852002000200004,al,o
272,S1699-65852002000200004,principio,o
272,S1699-65852002000200004,del,o
272,S1699-65852002000200004,ensayo,o
272,S1699-65852002000200004,al,o
272,S1699-65852002000200004,finalizar,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,mismo,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,mayor,o
272,S1699-65852002000200004,incremento,o
272,S1699-65852002000200004,del,o
272,S1699-65852002000200004,lAG,o
272,S1699-65852002000200004,en,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,grupo,o
272,S1699-65852002000200004,placebo,i
272,S1699-65852002000200004,dio,o
272,S1699-65852002000200004,como,o
272,S1699-65852002000200004,resultado,o
272,S1699-65852002000200004,una,o
272,S1699-65852002000200004,diferencia,o
272,S1699-65852002000200004,estadisticamente,o
272,S1699-65852002000200004,significativa,o
272,S1699-65852002000200004,MNZ,i
272,S1699-65852002000200004,092,o
272,S1699-65852002000200004,028,o
272,S1699-65852002000200004,vs,o
272,S1699-65852002000200004,placebo,i
272,S1699-65852002000200004,118,o
272,S1699-65852002000200004,03,o
272,S1699-65852002000200004,p005,o
272,S1699-65852002000200004,t,o
272,S1699-65852002000200004,de,o
272,S1699-65852002000200004,Student,o
272,S1699-65852002000200004,diferencia,o
272,S1699-65852002000200004,que,o
272,S1699-65852002000200004,se,o
272,S1699-65852002000200004,acentuo,o
272,S1699-65852002000200004,cuando,o
272,S1699-65852002000200004,se,o
272,S1699-65852002000200004,compararon,o
272,S1699-65852002000200004,solo,o
272,S1699-65852002000200004,los,o
272,S1699-65852002000200004,pacientes,o
272,S1699-65852002000200004,de,o
272,S1699-65852002000200004,ambos,o
272,S1699-65852002000200004,grupos,o
272,S1699-65852002000200004,con,o
272,S1699-65852002000200004,AG,i
272,S1699-65852002000200004,clinico,o
272,S1699-65852002000200004,grado,o
272,S1699-65852002000200004,1,o
272,S1699-65852002000200004,o,o
272,S1699-65852002000200004,2,o
272,S1699-65852002000200004,MNZ,i
272,S1699-65852002000200004,096,o
272,S1699-65852002000200004,031,o
272,S1699-65852002000200004,vs,o
272,S1699-65852002000200004,placebo,i
272,S1699-65852002000200004,124,o
272,S1699-65852002000200004,031,o
272,S1699-65852002000200004,t,o
272,S1699-65852002000200004,de,o
272,S1699-65852002000200004,Student,o
272,S1699-65852002000200004,p005,o
272,S1699-65852002000200004,Conclusion,o
272,S1699-65852002000200004,Los,o
272,S1699-65852002000200004,resultados,o
272,S1699-65852002000200004,del,o
272,S1699-65852002000200004,presente,o
272,S1699-65852002000200004,estudio,o
272,S1699-65852002000200004,indican,o
272,S1699-65852002000200004,que,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,tratamiento,i
272,S1699-65852002000200004,con,o
272,S1699-65852002000200004,metronidazol,i
272,S1699-65852002000200004,durante,o
272,S1699-65852002000200004,siete,o
272,S1699-65852002000200004,dias,o
272,S1699-65852002000200004,no,o
272,S1699-65852002000200004,induce,o
272,S1699-65852002000200004,la,o
272,S1699-65852002000200004,regresion,o
272,S1699-65852002000200004,completa,o
272,S1699-65852002000200004,de,o
272,S1699-65852002000200004,los,o
272,S1699-65852002000200004,agrandamientos,i
272,S1699-65852002000200004,gingivales,i
272,S1699-65852002000200004,producidos,o
272,S1699-65852002000200004,por,o
272,S1699-65852002000200004,CsA,i
272,S1699-65852002000200004,pero,o
272,S1699-65852002000200004,puede,o
272,S1699-65852002000200004,frenar,o
272,S1699-65852002000200004,parcialmente,o
272,S1699-65852002000200004,el,o
272,S1699-65852002000200004,curso,o
272,S1699-65852002000200004,clinico,o
272,S1699-65852002000200004,del,o
272,S1699-65852002000200004,AG,i
272,S1699-65852002000200004,posiblemente,o
272,S1699-65852002000200004,al,o
272,S1699-65852002000200004,reducir,o
272,S1699-65852002000200004,la,o
272,S1699-65852002000200004,sobreinfeccion,i
272,S1699-65852002000200004,bacteriana,i
272,S1699-65852002000200004,y,o
272,S1699-65852002000200004,la,o
272,S1699-65852002000200004,inflamacion,i
272,S1699-65852002000200004,gingival,i
273,S1726-46342011000400009,Efecto,o
273,S1726-46342011000400009,del,o
273,S1726-46342011000400009,aceite,i
273,S1726-46342011000400009,de,i
273,S1726-46342011000400009,sacha,i
273,S1726-46342011000400009,inchi,i
273,S1726-46342011000400009,plukenetia,o
273,S1726-46342011000400009,volubilis,o
273,S1726-46342011000400009,l,o
273,S1726-46342011000400009,sobre,o
273,S1726-46342011000400009,el,o
273,S1726-46342011000400009,perfil,i
273,S1726-46342011000400009,lipidico,i
273,S1726-46342011000400009,en,o
273,S1726-46342011000400009,pacientes,o
273,S1726-46342011000400009,con,o
273,S1726-46342011000400009,hiperlipoproteinemia,i
273,S1726-46342011000400009,El,o
273,S1726-46342011000400009,presente,o
273,S1726-46342011000400009,es,o
273,S1726-46342011000400009,un,o
273,S1726-46342011000400009,trabajo,o
273,S1726-46342011000400009,experimental,o
273,S1726-46342011000400009,piloto,o
273,S1726-46342011000400009,abierto,o
273,S1726-46342011000400009,para,o
273,S1726-46342011000400009,conocer,o
273,S1726-46342011000400009,el,o
273,S1726-46342011000400009,efecto,o
273,S1726-46342011000400009,dosis,o
273,S1726-46342011000400009,efectiva,o
273,S1726-46342011000400009,y,o
273,S1726-46342011000400009,efectos,i
273,S1726-46342011000400009,secundarios,i
273,S1726-46342011000400009,del,o
273,S1726-46342011000400009,aceite,i
273,S1726-46342011000400009,de,i
273,S1726-46342011000400009,sacha,i
273,S1726-46342011000400009,inchi,i
273,S1726-46342011000400009,Plukenetia,o
273,S1726-46342011000400009,volubilis,o
273,S1726-46342011000400009,L,o
273,S1726-46342011000400009,en,o
273,S1726-46342011000400009,el,o
273,S1726-46342011000400009,perfil,i
273,S1726-46342011000400009,lipidico,i
273,S1726-46342011000400009,de,o
273,S1726-46342011000400009,pacientes,o
273,S1726-46342011000400009,con,o
273,S1726-46342011000400009,hipercolesterolemia,i
273,S1726-46342011000400009,para,o
273,S1726-46342011000400009,ello,o
273,S1726-46342011000400009,se,o
273,S1726-46342011000400009,incluyo,o
273,S1726-46342011000400009,a,o
273,S1726-46342011000400009,24,o
273,S1726-46342011000400009,pacientes,o
273,S1726-46342011000400009,de,o
273,S1726-46342011000400009,35,o
273,S1726-46342011000400009,a,o
273,S1726-46342011000400009,75,o
273,S1726-46342011000400009,años,o
273,S1726-46342011000400009,en,o
273,S1726-46342011000400009,quienes,o
273,S1726-46342011000400009,se,o
273,S1726-46342011000400009,determino,o
273,S1726-46342011000400009,los,o
273,S1726-46342011000400009,valores,i
273,S1726-46342011000400009,sanguineos,i
273,S1726-46342011000400009,de,i
273,S1726-46342011000400009,colesterol,i
273,S1726-46342011000400009,total,i
273,S1726-46342011000400009,CT,i
273,S1726-46342011000400009,HDL,i
273,S1726-46342011000400009,trigliceridos,i
273,S1726-46342011000400009,Tg,i
273,S1726-46342011000400009,glucosa,i
273,S1726-46342011000400009,acidos,i
273,S1726-46342011000400009,grasos,i
273,S1726-46342011000400009,no,i
273,S1726-46342011000400009,esterificados,i
273,S1726-46342011000400009,AGNE,i
273,S1726-46342011000400009,e,o
273,S1726-46342011000400009,insulina,i
273,S1726-46342011000400009,Se,o
273,S1726-46342011000400009,aleatorizo,i
273,S1726-46342011000400009,a,o
273,S1726-46342011000400009,los,o
273,S1726-46342011000400009,participantes,o
273,S1726-46342011000400009,para,o
273,S1726-46342011000400009,recibir,o
273,S1726-46342011000400009,5,o
273,S1726-46342011000400009,mL,o
273,S1726-46342011000400009,o,o
273,S1726-46342011000400009,10,o
273,S1726-46342011000400009,mL,o
273,S1726-46342011000400009,de,o
273,S1726-46342011000400009,una,o
273,S1726-46342011000400009,suspension,o
273,S1726-46342011000400009,conteniendo,o
273,S1726-46342011000400009,2gr5ml,o
273,S1726-46342011000400009,de,o
273,S1726-46342011000400009,aceite,i
273,S1726-46342011000400009,de,i
273,S1726-46342011000400009,sacha,i
273,S1726-46342011000400009,inchi,i
273,S1726-46342011000400009,durante,o
273,S1726-46342011000400009,cuatro,o
273,S1726-46342011000400009,meses,o
273,S1726-46342011000400009,La,o
273,S1726-46342011000400009,ingesta,o
273,S1726-46342011000400009,del,o
273,S1726-46342011000400009,aceite,i
273,S1726-46342011000400009,produjo,o
273,S1726-46342011000400009,caida,o
273,S1726-46342011000400009,en,o
273,S1726-46342011000400009,los,o
273,S1726-46342011000400009,valores,o
273,S1726-46342011000400009,promedio,o
273,S1726-46342011000400009,del,o
273,S1726-46342011000400009,CT,i
273,S1726-46342011000400009,y,o
273,S1726-46342011000400009,AGNE,i
273,S1726-46342011000400009,con,o
273,S1726-46342011000400009,elevacion,o
273,S1726-46342011000400009,del,o
273,S1726-46342011000400009,cHDL,o
273,S1726-46342011000400009,en,o
273,S1726-46342011000400009,ambos,o
273,S1726-46342011000400009,grupos,o
273,S1726-46342011000400009,La,o
273,S1726-46342011000400009,dosis,o
273,S1726-46342011000400009,de,o
273,S1726-46342011000400009,10,o
273,S1726-46342011000400009,mL,o
273,S1726-46342011000400009,se,o
273,S1726-46342011000400009,asocio,o
273,S1726-46342011000400009,a,o
273,S1726-46342011000400009,mayores,o
273,S1726-46342011000400009,niveles,i
273,S1726-46342011000400009,de,i
273,S1726-46342011000400009,insulina,i
273,S1726-46342011000400009,en,o
273,S1726-46342011000400009,el,o
273,S1726-46342011000400009,grupo,o
273,S1726-46342011000400009,aleatorizado,i
273,S1726-46342011000400009,a,o
273,S1726-46342011000400009,recibir,o
273,S1726-46342011000400009,10,o
273,S1726-46342011000400009,ml,o
273,S1726-46342011000400009,El,o
273,S1726-46342011000400009,aceite,i
273,S1726-46342011000400009,de,i
273,S1726-46342011000400009,sacha,i
273,S1726-46342011000400009,inchi,i
273,S1726-46342011000400009,parece,o
273,S1726-46342011000400009,tener,o
273,S1726-46342011000400009,efectos,o
273,S1726-46342011000400009,beneficos,o
273,S1726-46342011000400009,sobre,o
273,S1726-46342011000400009,el,o
273,S1726-46342011000400009,perfil,i
273,S1726-46342011000400009,lipidico,i
273,S1726-46342011000400009,en,o
273,S1726-46342011000400009,pacientes,o
273,S1726-46342011000400009,con,o
273,S1726-46342011000400009,dislipidemia,i
273,S1726-46342011000400009,requiriendose,o
273,S1726-46342011000400009,la,o
273,S1726-46342011000400009,evaluacion,i
273,S1726-46342011000400009,de,i
273,S1726-46342011000400009,su,i
273,S1726-46342011000400009,eficacia,i
273,S1726-46342011000400009,y,i
273,S1726-46342011000400009,seguridad,i
273,S1726-46342011000400009,en,o
273,S1726-46342011000400009,ensayos,i
273,S1726-46342011000400009,clinicos,i
273,S1726-46342011000400009,aleatorizados,i
274,S1726-67182009000200003,Calidad,o
274,S1726-67182009000200003,en,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,anestesia,i
274,S1726-67182009000200003,espinal,i
274,S1726-67182009000200003,con,o
274,S1726-67182009000200003,bupivacaina,i
274,S1726-67182009000200003,mas,o
274,S1726-67182009000200003,fentanyl,i
274,S1726-67182009000200003,para,o
274,S1726-67182009000200003,pacientes,o
274,S1726-67182009000200003,con,o
274,S1726-67182009000200003,fractura,i
274,S1726-67182009000200003,intertrocanterica,i
274,S1726-67182009000200003,de,i
274,S1726-67182009000200003,cadera,i
274,S1726-67182009000200003,Introduccion,o
274,S1726-67182009000200003,La,o
274,S1726-67182009000200003,anestesia,i
274,S1726-67182009000200003,espinal,i
274,S1726-67182009000200003,es,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,tecnica,o
274,S1726-67182009000200003,mas,o
274,S1726-67182009000200003,utilizada,o
274,S1726-67182009000200003,en,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,cirugia,i
274,S1726-67182009000200003,de,i
274,S1726-67182009000200003,la,i
274,S1726-67182009000200003,fractura,i
274,S1726-67182009000200003,de,i
274,S1726-67182009000200003,cadera,i
274,S1726-67182009000200003,Se,o
274,S1726-67182009000200003,ha,o
274,S1726-67182009000200003,intentado,o
274,S1726-67182009000200003,disminuir,o
274,S1726-67182009000200003,las,o
274,S1726-67182009000200003,dosis,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,anestesico,i
274,S1726-67182009000200003,local,i
274,S1726-67182009000200003,al,o
274,S1726-67182009000200003,añadir,o
274,S1726-67182009000200003,opioides,i
274,S1726-67182009000200003,sin,o
274,S1726-67182009000200003,que,o
274,S1726-67182009000200003,se,o
274,S1726-67182009000200003,afecte,o
274,S1726-67182009000200003,su,o
274,S1726-67182009000200003,calidad,o
274,S1726-67182009000200003,Objetivo,o
274,S1726-67182009000200003,Analizar,o
274,S1726-67182009000200003,el,o
274,S1726-67182009000200003,comportamiento,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,tension,i
274,S1726-67182009000200003,arterial,i
274,S1726-67182009000200003,media,i
274,S1726-67182009000200003,asi,o
274,S1726-67182009000200003,como,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,calidad,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,anestesia,i
274,S1726-67182009000200003,al,o
274,S1726-67182009000200003,emplear,o
274,S1726-67182009000200003,bajas,o
274,S1726-67182009000200003,dosis,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,bupivacaina,i
274,S1726-67182009000200003,con,o
274,S1726-67182009000200003,fentanyl,i
274,S1726-67182009000200003,subaracnoidea,o
274,S1726-67182009000200003,en,o
274,S1726-67182009000200003,el,o
274,S1726-67182009000200003,anciano,o
274,S1726-67182009000200003,operado,i
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,fractura,i
274,S1726-67182009000200003,de,i
274,S1726-67182009000200003,cadera,i
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,urgencia,o
274,S1726-67182009000200003,Metodologia,o
274,S1726-67182009000200003,Se,o
274,S1726-67182009000200003,diseño,o
274,S1726-67182009000200003,un,o
274,S1726-67182009000200003,estudio,i
274,S1726-67182009000200003,prospectivo,i
274,S1726-67182009000200003,aleatorizado,i
274,S1726-67182009000200003,y,i
274,S1726-67182009000200003,doble,i
274,S1726-67182009000200003,ciego,i
274,S1726-67182009000200003,en,o
274,S1726-67182009000200003,430,o
274,S1726-67182009000200003,pacientes,o
274,S1726-67182009000200003,con,o
274,S1726-67182009000200003,fractura,i
274,S1726-67182009000200003,intertrocanterica,i
274,S1726-67182009000200003,de,i
274,S1726-67182009000200003,cadera,i
274,S1726-67182009000200003,distribuidos,o
274,S1726-67182009000200003,en,o
274,S1726-67182009000200003,dos,o
274,S1726-67182009000200003,grupos,o
274,S1726-67182009000200003,En,o
274,S1726-67182009000200003,el,o
274,S1726-67182009000200003,grupo,o
274,S1726-67182009000200003,F,o
274,S1726-67182009000200003,se,o
274,S1726-67182009000200003,suministro,o
274,S1726-67182009000200003,fentanilo,i
274,S1726-67182009000200003,50,o
274,S1726-67182009000200003,µg,o
274,S1726-67182009000200003,y,o
274,S1726-67182009000200003,bupivacaina,i
274,S1726-67182009000200003,5,o
274,S1726-67182009000200003,mg,o
274,S1726-67182009000200003,en,o
274,S1726-67182009000200003,el,o
274,S1726-67182009000200003,grupo,o
274,S1726-67182009000200003,B,o
274,S1726-67182009000200003,10,o
274,S1726-67182009000200003,mg,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,bupivacaina,i
274,S1726-67182009000200003,Despues,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,raquianestesia,i
274,S1726-67182009000200003,fueron,o
274,S1726-67182009000200003,analizadas,o
274,S1726-67182009000200003,las,o
274,S1726-67182009000200003,variables,o
274,S1726-67182009000200003,tension,i
274,S1726-67182009000200003,arterial,i
274,S1726-67182009000200003,media,i
274,S1726-67182009000200003,necesidad,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,vasoconstrictor,i
274,S1726-67182009000200003,tiempo,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,latencia,o
274,S1726-67182009000200003,para,o
274,S1726-67182009000200003,bloqueo,i
274,S1726-67182009000200003,motor,o
274,S1726-67182009000200003,y,o
274,S1726-67182009000200003,sensitivo,o
274,S1726-67182009000200003,asi,o
274,S1726-67182009000200003,como,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,calidad,o
274,S1726-67182009000200003,del,o
274,S1726-67182009000200003,bloqueo,i
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,los,o
274,S1726-67182009000200003,mismos,o
274,S1726-67182009000200003,y,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,presencia,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,efectos,i
274,S1726-67182009000200003,adversos,i
274,S1726-67182009000200003,Resultados,o
274,S1726-67182009000200003,Los,o
274,S1726-67182009000200003,grupos,o
274,S1726-67182009000200003,fueron,o
274,S1726-67182009000200003,homogeneos,o
274,S1726-67182009000200003,El,o
274,S1726-67182009000200003,grupo,o
274,S1726-67182009000200003,F,o
274,S1726-67182009000200003,presento,o
274,S1726-67182009000200003,mayor,o
274,S1726-67182009000200003,estabilidad,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,tension,i
274,S1726-67182009000200003,arterial,i
274,S1726-67182009000200003,media,i
274,S1726-67182009000200003,El,o
274,S1726-67182009000200003,nivel,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,bloqueo,i
274,S1726-67182009000200003,fue,o
274,S1726-67182009000200003,suficiente,o
274,S1726-67182009000200003,en,o
274,S1726-67182009000200003,todos,o
274,S1726-67182009000200003,los,o
274,S1726-67182009000200003,casos,o
274,S1726-67182009000200003,para,o
274,S1726-67182009000200003,realizar,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,intervencion,i
274,S1726-67182009000200003,aunque,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,intensidad,o
274,S1726-67182009000200003,del,o
274,S1726-67182009000200003,bloqueo,i
274,S1726-67182009000200003,motor,o
274,S1726-67182009000200003,fue,o
274,S1726-67182009000200003,menor,o
274,S1726-67182009000200003,en,o
274,S1726-67182009000200003,los,o
274,S1726-67182009000200003,pacientes,o
274,S1726-67182009000200003,del,o
274,S1726-67182009000200003,grupo,o
274,S1726-67182009000200003,F,o
274,S1726-67182009000200003,p,o
274,S1726-67182009000200003,001,o
274,S1726-67182009000200003,En,o
274,S1726-67182009000200003,el,o
274,S1726-67182009000200003,grupo,o
274,S1726-67182009000200003,F,o
274,S1726-67182009000200003,el,o
274,S1726-67182009000200003,efecto,i
274,S1726-67182009000200003,secundario,i
274,S1726-67182009000200003,mas,o
274,S1726-67182009000200003,frecuente,o
274,S1726-67182009000200003,fue,o
274,S1726-67182009000200003,el,o
274,S1726-67182009000200003,prurito,i
274,S1726-67182009000200003,p,o
274,S1726-67182009000200003,001,o
274,S1726-67182009000200003,y,o
274,S1726-67182009000200003,en,o
274,S1726-67182009000200003,el,o
274,S1726-67182009000200003,grupo,o
274,S1726-67182009000200003,B,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,hipotension,i
274,S1726-67182009000200003,arterial,i
274,S1726-67182009000200003,p,o
274,S1726-67182009000200003,001,o
274,S1726-67182009000200003,Conclusion,o
274,S1726-67182009000200003,La,o
274,S1726-67182009000200003,asociacion,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,fentanyl,i
274,S1726-67182009000200003,al,o
274,S1726-67182009000200003,anestesico,i
274,S1726-67182009000200003,local,i
274,S1726-67182009000200003,en,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,anestesia,i
274,S1726-67182009000200003,subaracnoidea,i
274,S1726-67182009000200003,en,o
274,S1726-67182009000200003,el,o
274,S1726-67182009000200003,paciente,o
274,S1726-67182009000200003,anciano,o
274,S1726-67182009000200003,es,o
274,S1726-67182009000200003,una,o
274,S1726-67182009000200003,tecnica,o
274,S1726-67182009000200003,efectiva,o
274,S1726-67182009000200003,que,o
274,S1726-67182009000200003,permite,o
274,S1726-67182009000200003,mantener,o
274,S1726-67182009000200003,una,o
274,S1726-67182009000200003,mayor,o
274,S1726-67182009000200003,estabilidad,o
274,S1726-67182009000200003,hemodinamica,o
274,S1726-67182009000200003,con,o
274,S1726-67182009000200003,una,o
274,S1726-67182009000200003,reduccion,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,la,o
274,S1726-67182009000200003,dosis,o
274,S1726-67182009000200003,de,o
274,S1726-67182009000200003,bupivacaina,i
275,S1726-67182013000300005,Ketamina,i
275,S1726-67182013000300005,como,o
275,S1726-67182013000300005,medicamento,i
275,S1726-67182013000300005,coadyuvante,i
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,control,i
275,S1726-67182013000300005,del,i
275,S1726-67182013000300005,dolor,i
275,S1726-67182013000300005,perioperatorio,i
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,la,o
275,S1726-67182013000300005,cirugia,i
275,S1726-67182013000300005,abdominal,i
275,S1726-67182013000300005,mayor,o
275,S1726-67182013000300005,Introduccion,o
275,S1726-67182013000300005,la,o
275,S1726-67182013000300005,combinacion,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,ketamina,i
275,S1726-67182013000300005,con,o
275,S1726-67182013000300005,morfina,i
275,S1726-67182013000300005,disminuye,o
275,S1726-67182013000300005,tanto,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,dolor,i
275,S1726-67182013000300005,como,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,consumo,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,esta,o
275,S1726-67182013000300005,ultima,o
275,S1726-67182013000300005,durante,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,periodo,o
275,S1726-67182013000300005,postoperatorio,o
275,S1726-67182013000300005,Sin,o
275,S1726-67182013000300005,embargo,o
275,S1726-67182013000300005,la,o
275,S1726-67182013000300005,dosis,o
275,S1726-67182013000300005,optima,o
275,S1726-67182013000300005,y,o
275,S1726-67182013000300005,la,o
275,S1726-67182013000300005,duracion,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,la,o
275,S1726-67182013000300005,ketamina,i
275,S1726-67182013000300005,aun,o
275,S1726-67182013000300005,estan,o
275,S1726-67182013000300005,por,o
275,S1726-67182013000300005,determinar,o
275,S1726-67182013000300005,Objetivos,o
275,S1726-67182013000300005,evaluar,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,efecto,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,la,o
275,S1726-67182013000300005,administracion,i
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,ketamina,i
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,consumo,o
275,S1726-67182013000300005,postoperatorio,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,morfina,i
275,S1726-67182013000300005,reduccion,o
275,S1726-67182013000300005,del,o
275,S1726-67182013000300005,dolor,i
275,S1726-67182013000300005,y,o
275,S1726-67182013000300005,efectos,i
275,S1726-67182013000300005,adversos,i
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,la,o
275,S1726-67182013000300005,ketamina,i
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,la,o
275,S1726-67182013000300005,cirugia,i
275,S1726-67182013000300005,abdominal,i
275,S1726-67182013000300005,mayor,o
275,S1726-67182013000300005,Metodo,o
275,S1726-67182013000300005,se,o
275,S1726-67182013000300005,realizo,o
275,S1726-67182013000300005,un,o
275,S1726-67182013000300005,estudio,o
275,S1726-67182013000300005,prospectivo,o
275,S1726-67182013000300005,aleatorio,o
275,S1726-67182013000300005,doble,o
275,S1726-67182013000300005,ciego,o
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,75,o
275,S1726-67182013000300005,pacientes,o
275,S1726-67182013000300005,programados,o
275,S1726-67182013000300005,para,o
275,S1726-67182013000300005,cirugia,i
275,S1726-67182013000300005,abdominal,i
275,S1726-67182013000300005,mayor,o
275,S1726-67182013000300005,divididos,o
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,tres,o
275,S1726-67182013000300005,grupos,o
275,S1726-67182013000300005,1,o
275,S1726-67182013000300005,Grupo,o
275,S1726-67182013000300005,PERI,o
275,S1726-67182013000300005,recibio,o
275,S1726-67182013000300005,ketamina,i
275,S1726-67182013000300005,intraoperatoria,o
275,S1726-67182013000300005,y,o
275,S1726-67182013000300005,postoperatoria,o
275,S1726-67182013000300005,48,o
275,S1726-67182013000300005,horas,o
275,S1726-67182013000300005,despues,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,la,o
275,S1726-67182013000300005,cirugia,i
275,S1726-67182013000300005,2,o
275,S1726-67182013000300005,ìgkgmin,o
275,S1726-67182013000300005,despues,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,un,o
275,S1726-67182013000300005,bolo,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,05,o
275,S1726-67182013000300005,mgkg,o
275,S1726-67182013000300005,2,o
275,S1726-67182013000300005,Grupo,o
275,S1726-67182013000300005,INTRA,o
275,S1726-67182013000300005,recibio,o
275,S1726-67182013000300005,solamente,o
275,S1726-67182013000300005,ketamina,i
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,intraoperatorio,o
275,S1726-67182013000300005,2,o
275,S1726-67182013000300005,ìgkgmin,o
275,S1726-67182013000300005,despues,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,un,o
275,S1726-67182013000300005,bolo,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,05,o
275,S1726-67182013000300005,mgkg,o
275,S1726-67182013000300005,3,o
275,S1726-67182013000300005,Grupo,o
275,S1726-67182013000300005,CTRL,o
275,S1726-67182013000300005,recibio,o
275,S1726-67182013000300005,placebo,i
275,S1726-67182013000300005,Se,o
275,S1726-67182013000300005,evaluo,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,consumo,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,morfina,i
275,S1726-67182013000300005,la,o
275,S1726-67182013000300005,escala,i
275,S1726-67182013000300005,analoga,i
275,S1726-67182013000300005,visual,i
275,S1726-67182013000300005,y,o
275,S1726-67182013000300005,los,o
275,S1726-67182013000300005,efectos,i
275,S1726-67182013000300005,adversos,i
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,las,o
275,S1726-67182013000300005,primeras,o
275,S1726-67182013000300005,48,o
275,S1726-67182013000300005,horas,o
275,S1726-67182013000300005,Resultados,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,consumo,o
275,S1726-67182013000300005,acumulativo,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,morfina,i
275,S1726-67182013000300005,24,o
275,S1726-67182013000300005,horas,o
275,S1726-67182013000300005,despues,o
275,S1726-67182013000300005,del,o
275,S1726-67182013000300005,proceder,i
275,S1726-67182013000300005,anestesico,i
275,S1726-67182013000300005,quirurgico,i
275,S1726-67182013000300005,fue,o
275,S1726-67182013000300005,significativamente,o
275,S1726-67182013000300005,menor,o
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,grupo,o
275,S1726-67182013000300005,PERI,o
275,S1726-67182013000300005,27,o
275,S1726-67182013000300005,mg,o
275,S1726-67182013000300005,17,o
275,S1726-67182013000300005,que,o
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,INTRA,o
275,S1726-67182013000300005,48,o
275,S1726-67182013000300005,mg,o
275,S1726-67182013000300005,405,o
275,S1726-67182013000300005,y,o
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,CTRL,o
275,S1726-67182013000300005,50,o
275,S1726-67182013000300005,mg,o
275,S1726-67182013000300005,22,o
275,S1726-67182013000300005,p,o
275,S1726-67182013000300005,0005,o
275,S1726-67182013000300005,La,o
275,S1726-67182013000300005,escala,i
275,S1726-67182013000300005,analoga,i
275,S1726-67182013000300005,visual,i
275,S1726-67182013000300005,fue,o
275,S1726-67182013000300005,significativamente,o
275,S1726-67182013000300005,menor,o
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,los,o
275,S1726-67182013000300005,grupos,o
275,S1726-67182013000300005,PERI,o
275,S1726-67182013000300005,e,o
275,S1726-67182013000300005,INTRA,o
275,S1726-67182013000300005,que,o
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,CTRL,o
275,S1726-67182013000300005,p,o
275,S1726-67182013000300005,0002,o
275,S1726-67182013000300005,Una,o
275,S1726-67182013000300005,mayor,o
275,S1726-67182013000300005,incidencia,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,nauseas,i
275,S1726-67182013000300005,se,o
275,S1726-67182013000300005,observo,o
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,grupo,o
275,S1726-67182013000300005,CTRL,o
275,S1726-67182013000300005,comparado,o
275,S1726-67182013000300005,con,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,PERI,o
275,S1726-67182013000300005,41,o
275,S1726-67182013000300005,vs,o
275,S1726-67182013000300005,8,o
275,S1726-67182013000300005,p,o
275,S1726-67182013000300005,0005,o
275,S1726-67182013000300005,Conclusiones,o
275,S1726-67182013000300005,bajas,o
275,S1726-67182013000300005,dosis,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,ketamina,i
275,S1726-67182013000300005,mejora,o
275,S1726-67182013000300005,la,o
275,S1726-67182013000300005,analgesia,i
275,S1726-67182013000300005,postoperatoria,i
275,S1726-67182013000300005,con,o
275,S1726-67182013000300005,una,o
275,S1726-67182013000300005,disminucion,o
275,S1726-67182013000300005,del,o
275,S1726-67182013000300005,consumo,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,morfina,i
275,S1726-67182013000300005,cuando,o
275,S1726-67182013000300005,es,o
275,S1726-67182013000300005,administrada,o
275,S1726-67182013000300005,por,o
275,S1726-67182013000300005,48,o
275,S1726-67182013000300005,horas,o
275,S1726-67182013000300005,en,o
275,S1726-67182013000300005,el,o
275,S1726-67182013000300005,postoperatorio,o
275,S1726-67182013000300005,con,o
275,S1726-67182013000300005,baja,o
275,S1726-67182013000300005,incidencia,o
275,S1726-67182013000300005,de,o
275,S1726-67182013000300005,efectos,i
275,S1726-67182013000300005,adversos,i
276,S1729-519X2013000300020,Tratamiento,i
276,S1729-519X2013000300020,con,o
276,S1729-519X2013000300020,eritropoyetina,i
276,S1729-519X2013000300020,recombinante,i
276,S1729-519X2013000300020,humana,i
276,S1729-519X2013000300020,hipertrofia,i
276,S1729-519X2013000300020,ventricular,i
276,S1729-519X2013000300020,izquierda,i
276,S1729-519X2013000300020,y,o
276,S1729-519X2013000300020,balance,o
276,S1729-519X2013000300020,beneficio,o
276,S1729-519X2013000300020,riesgo,o
276,S1729-519X2013000300020,en,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,ERC3b,o
276,S1729-519X2013000300020,Introduccion,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,anemia,i
276,S1729-519X2013000300020,renal,i
276,S1729-519X2013000300020,es,o
276,S1729-519X2013000300020,frecuente,o
276,S1729-519X2013000300020,en,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,enfermedad,i
276,S1729-519X2013000300020,renal,i
276,S1729-519X2013000300020,cronica,i
276,S1729-519X2013000300020,avanzada,o
276,S1729-519X2013000300020,ERC,i
276,S1729-519X2013000300020,3b4,o
276,S1729-519X2013000300020,y,o
276,S1729-519X2013000300020,el,o
276,S1729-519X2013000300020,tratamiento,i
276,S1729-519X2013000300020,con,o
276,S1729-519X2013000300020,eritropoyetina,i
276,S1729-519X2013000300020,recombinante,i
276,S1729-519X2013000300020,humana,i
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,mejora,o
276,S1729-519X2013000300020,pero,o
276,S1729-519X2013000300020,aun,o
276,S1729-519X2013000300020,esta,o
276,S1729-519X2013000300020,a,o
276,S1729-519X2013000300020,debate,o
276,S1729-519X2013000300020,cual,o
276,S1729-519X2013000300020,meta,o
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,hemoglobina,i
276,S1729-519X2013000300020,alcanzar,o
276,S1729-519X2013000300020,y,o
276,S1729-519X2013000300020,cual,o
276,S1729-519X2013000300020,es,o
276,S1729-519X2013000300020,su,o
276,S1729-519X2013000300020,repercusion,o
276,S1729-519X2013000300020,sobre,o
276,S1729-519X2013000300020,las,o
276,S1729-519X2013000300020,funciones,o
276,S1729-519X2013000300020,cardiacas,i
276,S1729-519X2013000300020,Objetivo,o
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,este,o
276,S1729-519X2013000300020,trabajo,o
276,S1729-519X2013000300020,fue,o
276,S1729-519X2013000300020,evaluar,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,mejoria,o
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,anemia,i
276,S1729-519X2013000300020,tratada,i
276,S1729-519X2013000300020,con,o
276,S1729-519X2013000300020,EPOrHu,i
276,S1729-519X2013000300020,sobre,o
276,S1729-519X2013000300020,parametros,o
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,funcion,o
276,S1729-519X2013000300020,cardiovascular,i
276,S1729-519X2013000300020,ventricular,i
276,S1729-519X2013000300020,izquierda,o
276,S1729-519X2013000300020,en,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,ERC,i
276,S1729-519X2013000300020,3b4,o
276,S1729-519X2013000300020,y,o
276,S1729-519X2013000300020,el,o
276,S1729-519X2013000300020,riesgo,o
276,S1729-519X2013000300020,beneficio,o
276,S1729-519X2013000300020,Material,o
276,S1729-519X2013000300020,y,o
276,S1729-519X2013000300020,metodos,o
276,S1729-519X2013000300020,ensayo,o
276,S1729-519X2013000300020,clinico,o
276,S1729-519X2013000300020,abierto,o
276,S1729-519X2013000300020,no,o
276,S1729-519X2013000300020,controlado,o
276,S1729-519X2013000300020,no,o
276,S1729-519X2013000300020,aleatorizado,o
276,S1729-519X2013000300020,multicentrico,o
276,S1729-519X2013000300020,prospectivo,o
276,S1729-519X2013000300020,seguimiento,i
276,S1729-519X2013000300020,durante,o
276,S1729-519X2013000300020,56,o
276,S1729-519X2013000300020,semanas,o
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,seguimiento,i
276,S1729-519X2013000300020,Se,o
276,S1729-519X2013000300020,evaluan,o
276,S1729-519X2013000300020,los,o
276,S1729-519X2013000300020,cambios,o
276,S1729-519X2013000300020,en,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,Tasa,i
276,S1729-519X2013000300020,de,i
276,S1729-519X2013000300020,Filtracion,i
276,S1729-519X2013000300020,Glomerular,i
276,S1729-519X2013000300020,por,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,formula,o
276,S1729-519X2013000300020,del,o
276,S1729-519X2013000300020,MDRD,i
276,S1729-519X2013000300020,y,o
276,S1729-519X2013000300020,por,o
276,S1729-519X2013000300020,ecocardiografia,i
276,S1729-519X2013000300020,en,o
276,S1729-519X2013000300020,relacion,o
276,S1729-519X2013000300020,al,o
276,S1729-519X2013000300020,nivel,o
276,S1729-519X2013000300020,basal,o
276,S1729-519X2013000300020,al,o
276,S1729-519X2013000300020,final,o
276,S1729-519X2013000300020,del,o
276,S1729-519X2013000300020,seguimiento,i
276,S1729-519X2013000300020,estimada,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,variacion,o
276,S1729-519X2013000300020,al,o
276,S1729-519X2013000300020,año,o
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,HVI,i
276,S1729-519X2013000300020,Resultados,o
276,S1729-519X2013000300020,se,o
276,S1729-519X2013000300020,observo,o
276,S1729-519X2013000300020,un,o
276,S1729-519X2013000300020,incremento,o
276,S1729-519X2013000300020,significativo,o
276,S1729-519X2013000300020,del,o
276,S1729-519X2013000300020,hematocrito,i
276,S1729-519X2013000300020,en,o
276,S1729-519X2013000300020,todos,o
276,S1729-519X2013000300020,los,o
276,S1729-519X2013000300020,pacientes,o
276,S1729-519X2013000300020,al,o
276,S1729-519X2013000300020,final,o
276,S1729-519X2013000300020,del,o
276,S1729-519X2013000300020,estudio,o
276,S1729-519X2013000300020,n,o
276,S1729-519X2013000300020,33,o
276,S1729-519X2013000300020,029,o
276,S1729-519X2013000300020,002,o
276,S1729-519X2013000300020,V,o
276,S1729-519X2013000300020,versus,o
276,S1729-519X2013000300020,038,o
276,S1729-519X2013000300020,003,o
276,S1729-519X2013000300020,P,o
276,S1729-519X2013000300020,Wilcoxon,o
276,S1729-519X2013000300020,0000,o
276,S1729-519X2013000300020,Al,o
276,S1729-519X2013000300020,eco,i
276,S1729-519X2013000300020,inicial,o
276,S1729-519X2013000300020,el,o
276,S1729-519X2013000300020,909,o
276,S1729-519X2013000300020,tenian,o
276,S1729-519X2013000300020,HVI,i
276,S1729-519X2013000300020,y,o
276,S1729-519X2013000300020,al,o
276,S1729-519X2013000300020,final,o
276,S1729-519X2013000300020,solo,o
276,S1729-519X2013000300020,el,o
276,S1729-519X2013000300020,788,o
276,S1729-519X2013000300020,con,o
276,S1729-519X2013000300020,una,o
276,S1729-519X2013000300020,disminucion,o
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,22,o
276,S1729-519X2013000300020,mm,o
276,S1729-519X2013000300020,14,o
276,S1729-519X2013000300020,a,o
276,S1729-519X2013000300020,118,o
276,S1729-519X2013000300020,mm,o
276,S1729-519X2013000300020,y,o
276,S1729-519X2013000300020,una,o
276,S1729-519X2013000300020,correlacion,o
276,S1729-519X2013000300020,inversa,o
276,S1729-519X2013000300020,lineal,o
276,S1729-519X2013000300020,entre,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,HVI,i
276,S1729-519X2013000300020,y,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,mejoria,o
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,hemoglobina,i
276,S1729-519X2013000300020,r,o
276,S1729-519X2013000300020,0379,o
276,S1729-519X2013000300020,p,o
276,S1729-519X2013000300020,0030,o
276,S1729-519X2013000300020,La,o
276,S1729-519X2013000300020,progresion,o
276,S1729-519X2013000300020,del,o
276,S1729-519X2013000300020,daño,i
276,S1729-519X2013000300020,renal,i
276,S1729-519X2013000300020,fue,o
276,S1729-519X2013000300020,lenta,o
276,S1729-519X2013000300020,mLmin,o
276,S1729-519X2013000300020,En,o
276,S1729-519X2013000300020,los,o
276,S1729-519X2013000300020,pacientes,o
276,S1729-519X2013000300020,diabeticos,i
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,372,o
276,S1729-519X2013000300020,84,o
276,S1729-519X2013000300020,versus,o
276,S1729-519X2013000300020,347,o
276,S1729-519X2013000300020,67,o
276,S1729-519X2013000300020,p,o
276,S1729-519X2013000300020,Wilcoxon0119,o
276,S1729-519X2013000300020,y,o
276,S1729-519X2013000300020,en,o
276,S1729-519X2013000300020,los,o
276,S1729-519X2013000300020,no,o
276,S1729-519X2013000300020,diabeticos,i
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,351,o
276,S1729-519X2013000300020,78336,o
276,S1729-519X2013000300020,77,o
276,S1729-519X2013000300020,p,o
276,S1729-519X2013000300020,Wilcoxon,o
276,S1729-519X2013000300020,0119,o
276,S1729-519X2013000300020,El,o
276,S1729-519X2013000300020,485,o
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,los,o
276,S1729-519X2013000300020,pacientes,o
276,S1729-519X2013000300020,presentaron,o
276,S1729-519X2013000300020,algun,o
276,S1729-519X2013000300020,tipo,o
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,evento,i
276,S1729-519X2013000300020,adverso,i
276,S1729-519X2013000300020,ninguno,o
276,S1729-519X2013000300020,fallecio,i
276,S1729-519X2013000300020,o,o
276,S1729-519X2013000300020,comenzo,o
276,S1729-519X2013000300020,hemodialisis,i
276,S1729-519X2013000300020,durante,o
276,S1729-519X2013000300020,el,o
276,S1729-519X2013000300020,seguimiento,i
276,S1729-519X2013000300020,El,o
276,S1729-519X2013000300020,Balance,o
276,S1729-519X2013000300020,Beneficio,o
276,S1729-519X2013000300020,Riesgo,o
276,S1729-519X2013000300020,EA,i
276,S1729-519X2013000300020,moderados,o
276,S1729-519X2013000300020,o,o
276,S1729-519X2013000300020,graves,o
276,S1729-519X2013000300020,estimados,o
276,S1729-519X2013000300020,por,o
276,S1729-519X2013000300020,el,o
276,S1729-519X2013000300020,calculo,o
276,S1729-519X2013000300020,del,o
276,S1729-519X2013000300020,Factor,o
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,Bayes,o
276,S1729-519X2013000300020,fue,o
276,S1729-519X2013000300020,a,o
276,S1729-519X2013000300020,favor,o
276,S1729-519X2013000300020,del,o
276,S1729-519X2013000300020,Beneficio,o
276,S1729-519X2013000300020,FB15,o
276,S1729-519X2013000300020,Conclusiones,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,correccion,o
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,anemia,i
276,S1729-519X2013000300020,renal,i
276,S1729-519X2013000300020,en,o
276,S1729-519X2013000300020,pacientes,o
276,S1729-519X2013000300020,con,o
276,S1729-519X2013000300020,ERC3b,o
276,S1729-519X2013000300020,con,o
276,S1729-519X2013000300020,EPOrHu,i
276,S1729-519X2013000300020,cubana,o
276,S1729-519X2013000300020,mejora,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,HVI,i
276,S1729-519X2013000300020,sin,o
276,S1729-519X2013000300020,provocar,o
276,S1729-519X2013000300020,otros,o
276,S1729-519X2013000300020,daños,i
276,S1729-519X2013000300020,Este,o
276,S1729-519X2013000300020,trabajo,o
276,S1729-519X2013000300020,apoya,o
276,S1729-519X2013000300020,el,o
276,S1729-519X2013000300020,tratamiento,i
276,S1729-519X2013000300020,de,o
276,S1729-519X2013000300020,la,o
276,S1729-519X2013000300020,anemia,i
276,S1729-519X2013000300020,severa,o
276,S1729-519X2013000300020,con,o
276,S1729-519X2013000300020,EPOrHU,i
277,S1729-519X2016000500004,Eficacia,o
277,S1729-519X2016000500004,y,o
277,S1729-519X2016000500004,seguridad,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,la,o
277,S1729-519X2016000500004,insuflacion,i
277,S1729-519X2016000500004,con,i
277,S1729-519X2016000500004,CO2,i
277,S1729-519X2016000500004,durante,o
277,S1729-519X2016000500004,la,o
277,S1729-519X2016000500004,colonoscopia,i
277,S1729-519X2016000500004,Ensayo,i
277,S1729-519X2016000500004,clinico,i
277,S1729-519X2016000500004,Introduccion,o
277,S1729-519X2016000500004,La,o
277,S1729-519X2016000500004,colonoscopia,i
277,S1729-519X2016000500004,es,o
277,S1729-519X2016000500004,la,o
277,S1729-519X2016000500004,tecnica,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,eleccion,o
277,S1729-519X2016000500004,para,o
277,S1729-519X2016000500004,el,o
277,S1729-519X2016000500004,estudio,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,la,o
277,S1729-519X2016000500004,enfermedad,i
277,S1729-519X2016000500004,del,i
277,S1729-519X2016000500004,colon,i
277,S1729-519X2016000500004,y,o
277,S1729-519X2016000500004,una,o
277,S1729-519X2016000500004,opcion,o
277,S1729-519X2016000500004,terapeutica,o
277,S1729-519X2016000500004,en,o
277,S1729-519X2016000500004,ciertas,o
277,S1729-519X2016000500004,patologias,i
277,S1729-519X2016000500004,La,o
277,S1729-519X2016000500004,insuflacion,i
277,S1729-519X2016000500004,del,i
277,S1729-519X2016000500004,colon,i
277,S1729-519X2016000500004,habitualmente,o
277,S1729-519X2016000500004,con,o
277,S1729-519X2016000500004,aire,o
277,S1729-519X2016000500004,ambiente,o
277,S1729-519X2016000500004,durante,o
277,S1729-519X2016000500004,su,o
277,S1729-519X2016000500004,realizacion,o
277,S1729-519X2016000500004,contribuye,o
277,S1729-519X2016000500004,a,o
277,S1729-519X2016000500004,que,o
277,S1729-519X2016000500004,esta,o
277,S1729-519X2016000500004,pueda,o
277,S1729-519X2016000500004,ser,o
277,S1729-519X2016000500004,una,o
277,S1729-519X2016000500004,tecnica,o
277,S1729-519X2016000500004,dolorosa,i
277,S1729-519X2016000500004,La,o
277,S1729-519X2016000500004,insuflacion,i
277,S1729-519X2016000500004,con,i
277,S1729-519X2016000500004,dioxido,i
277,S1729-519X2016000500004,de,i
277,S1729-519X2016000500004,carbono,i
277,S1729-519X2016000500004,CO2,i
277,S1729-519X2016000500004,se,o
277,S1729-519X2016000500004,ha,o
277,S1729-519X2016000500004,asociado,o
277,S1729-519X2016000500004,con,o
277,S1729-519X2016000500004,menos,o
277,S1729-519X2016000500004,dolor,i
277,S1729-519X2016000500004,abdominal,i
277,S1729-519X2016000500004,Objetivo,o
277,S1729-519X2016000500004,Evaluar,i
277,S1729-519X2016000500004,la,i
277,S1729-519X2016000500004,eficacia,i
277,S1729-519X2016000500004,y,i
277,S1729-519X2016000500004,seguridad,i
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,la,o
277,S1729-519X2016000500004,insuflacion,i
277,S1729-519X2016000500004,con,i
277,S1729-519X2016000500004,CO2,i
277,S1729-519X2016000500004,durante,o
277,S1729-519X2016000500004,la,o
277,S1729-519X2016000500004,colonoscopia,i
277,S1729-519X2016000500004,Material,o
277,S1729-519X2016000500004,y,o
277,S1729-519X2016000500004,Metodos,o
277,S1729-519X2016000500004,Se,o
277,S1729-519X2016000500004,realizo,o
277,S1729-519X2016000500004,un,o
277,S1729-519X2016000500004,ensayo,o
277,S1729-519X2016000500004,clinico,o
277,S1729-519X2016000500004,aleatorizado,o
277,S1729-519X2016000500004,y,o
277,S1729-519X2016000500004,controlado,o
277,S1729-519X2016000500004,FaseIIb,o
277,S1729-519X2016000500004,a,o
277,S1729-519X2016000500004,doble,o
277,S1729-519X2016000500004,ciego,o
277,S1729-519X2016000500004,Universo,o
277,S1729-519X2016000500004,todos,o
277,S1729-519X2016000500004,los,o
277,S1729-519X2016000500004,pacientes,o
277,S1729-519X2016000500004,con,o
277,S1729-519X2016000500004,indicacion,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,colonoscopia,i
277,S1729-519X2016000500004,que,o
277,S1729-519X2016000500004,cumplieron,o
277,S1729-519X2016000500004,con,o
277,S1729-519X2016000500004,los,o
277,S1729-519X2016000500004,criterios,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,seleccion,o
277,S1729-519X2016000500004,y,o
277,S1729-519X2016000500004,acudieron,o
277,S1729-519X2016000500004,en,o
277,S1729-519X2016000500004,el,o
277,S1729-519X2016000500004,periodo,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,octubre,o
277,S1729-519X2016000500004,a,o
277,S1729-519X2016000500004,diciembre,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,2014,o
277,S1729-519X2016000500004,al,o
277,S1729-519X2016000500004,Centro,o
277,S1729-519X2016000500004,Nacional,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,Cirugia,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,Minimo,o
277,S1729-519X2016000500004,Acceso,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,La,o
277,S1729-519X2016000500004,Habana,o
277,S1729-519X2016000500004,La,o
277,S1729-519X2016000500004,muestra,o
277,S1729-519X2016000500004,quedo,o
277,S1729-519X2016000500004,conformada,o
277,S1729-519X2016000500004,por,o
277,S1729-519X2016000500004,un,o
277,S1729-519X2016000500004,total,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,100,o
277,S1729-519X2016000500004,pacientes,o
277,S1729-519X2016000500004,mayores,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,18,o
277,S1729-519X2016000500004,años,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,los,o
277,S1729-519X2016000500004,cuales,o
277,S1729-519X2016000500004,se,o
277,S1729-519X2016000500004,les,o
277,S1729-519X2016000500004,realizo,o
277,S1729-519X2016000500004,a,o
277,S1729-519X2016000500004,50,o
277,S1729-519X2016000500004,la,o
277,S1729-519X2016000500004,tecnica,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,insuflacion,i
277,S1729-519X2016000500004,con,i
277,S1729-519X2016000500004,aire,i
277,S1729-519X2016000500004,y,o
277,S1729-519X2016000500004,50,o
277,S1729-519X2016000500004,con,o
277,S1729-519X2016000500004,insuflacion,i
277,S1729-519X2016000500004,con,i
277,S1729-519X2016000500004,CO2,i
277,S1729-519X2016000500004,Resultados,o
277,S1729-519X2016000500004,El,o
277,S1729-519X2016000500004,dolor,i
277,S1729-519X2016000500004,abdominal,i
277,S1729-519X2016000500004,tras,o
277,S1729-519X2016000500004,realizarse,o
277,S1729-519X2016000500004,la,o
277,S1729-519X2016000500004,colonoscopia,i
277,S1729-519X2016000500004,fue,o
277,S1729-519X2016000500004,significativamente,o
277,S1729-519X2016000500004,menor,o
277,S1729-519X2016000500004,en,o
277,S1729-519X2016000500004,el,o
277,S1729-519X2016000500004,grupo,o
277,S1729-519X2016000500004,CO2,i
277,S1729-519X2016000500004,La,o
277,S1729-519X2016000500004,hipoxemia,i
277,S1729-519X2016000500004,y,o
277,S1729-519X2016000500004,las,o
277,S1729-519X2016000500004,dosis,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,propofol,i
277,S1729-519X2016000500004,empleadas,o
277,S1729-519X2016000500004,fueron,o
277,S1729-519X2016000500004,similares,o
277,S1729-519X2016000500004,en,o
277,S1729-519X2016000500004,ambos,o
277,S1729-519X2016000500004,grupos,o
277,S1729-519X2016000500004,Los,o
277,S1729-519X2016000500004,valores,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,presion,o
277,S1729-519X2016000500004,media,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,CO2,i
277,S1729-519X2016000500004,fueron,o
277,S1729-519X2016000500004,mayores,o
277,S1729-519X2016000500004,en,o
277,S1729-519X2016000500004,el,o
277,S1729-519X2016000500004,grupo,o
277,S1729-519X2016000500004,CO2,i
277,S1729-519X2016000500004,durante,o
277,S1729-519X2016000500004,el,o
277,S1729-519X2016000500004,proceder,o
277,S1729-519X2016000500004,pero,o
277,S1729-519X2016000500004,dentro,o
277,S1729-519X2016000500004,del,o
277,S1729-519X2016000500004,rango,o
277,S1729-519X2016000500004,normal,o
277,S1729-519X2016000500004,sin,o
277,S1729-519X2016000500004,complicaciones,i
277,S1729-519X2016000500004,clinicas,i
277,S1729-519X2016000500004,Conclusiones,o
277,S1729-519X2016000500004,El,o
277,S1729-519X2016000500004,uso,o
277,S1729-519X2016000500004,de,o
277,S1729-519X2016000500004,CO2,i
277,S1729-519X2016000500004,en,o
277,S1729-519X2016000500004,la,o
277,S1729-519X2016000500004,colonoscopia,i
277,S1729-519X2016000500004,causa,o
277,S1729-519X2016000500004,significativamente,o
277,S1729-519X2016000500004,menos,o
277,S1729-519X2016000500004,dolor,i
277,S1729-519X2016000500004,en,o
277,S1729-519X2016000500004,la,o
277,S1729-519X2016000500004,primera,o
277,S1729-519X2016000500004,hora,o
277,S1729-519X2016000500004,Su,o
277,S1729-519X2016000500004,uso,o
277,S1729-519X2016000500004,en,o
277,S1729-519X2016000500004,pacientes,o
277,S1729-519X2016000500004,con,o
277,S1729-519X2016000500004,sedacion,i
277,S1729-519X2016000500004,profunda,i
277,S1729-519X2016000500004,es,o
277,S1729-519X2016000500004,seguro,o
277,S1729-519X2016000500004,y,o
277,S1729-519X2016000500004,la,o
277,S1729-519X2016000500004,tecnica,o
277,S1729-519X2016000500004,no,o
277,S1729-519X2016000500004,se,o
277,S1729-519X2016000500004,ve,o
277,S1729-519X2016000500004,modificada,o
277,S1729-519X2016000500004,ni,o
277,S1729-519X2016000500004,sus,o
277,S1729-519X2016000500004,tiempos,o
277,S1729-519X2016000500004,reducidos,o
278,S1729-519X2018000400540,Eficacia,o
278,S1729-519X2018000400540,diagnostica,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,anticuerpos,i
278,S1729-519X2018000400540,antipeptidos,i
278,S1729-519X2018000400540,citrulinados,i
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,segunda,o
278,S1729-519X2018000400540,y,o
278,S1729-519X2018000400540,tercera,o
278,S1729-519X2018000400540,generaciones,o
278,S1729-519X2018000400540,para,o
278,S1729-519X2018000400540,la,o
278,S1729-519X2018000400540,artritis,i
278,S1729-519X2018000400540,reumatoide,i
278,S1729-519X2018000400540,Introduccion,o
278,S1729-519X2018000400540,La,o
278,S1729-519X2018000400540,artritis,i
278,S1729-519X2018000400540,reumatoide,i
278,S1729-519X2018000400540,es,o
278,S1729-519X2018000400540,una,o
278,S1729-519X2018000400540,enfermedad,i
278,S1729-519X2018000400540,autoinmune,i
278,S1729-519X2018000400540,caracterizada,o
278,S1729-519X2018000400540,por,o
278,S1729-519X2018000400540,la,o
278,S1729-519X2018000400540,presencia,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,anticuerpos,i
278,S1729-519X2018000400540,contra,i
278,S1729-519X2018000400540,peptidos,i
278,S1729-519X2018000400540,citrulinados,i
278,S1729-519X2018000400540,que,o
278,S1729-519X2018000400540,constituyen,o
278,S1729-519X2018000400540,indicadores,o
278,S1729-519X2018000400540,para,o
278,S1729-519X2018000400540,el,o
278,S1729-519X2018000400540,diagnostico,i
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,la,o
278,S1729-519X2018000400540,enfermedad,i
278,S1729-519X2018000400540,Es,o
278,S1729-519X2018000400540,necesario,o
278,S1729-519X2018000400540,determinar,o
278,S1729-519X2018000400540,la,o
278,S1729-519X2018000400540,utilidad,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,diferentes,o
278,S1729-519X2018000400540,metodos,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,determinacion,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,estos,o
278,S1729-519X2018000400540,anticuerpos,i
278,S1729-519X2018000400540,para,o
278,S1729-519X2018000400540,el,o
278,S1729-519X2018000400540,diagnostico,i
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,pacientes,o
278,S1729-519X2018000400540,cubanos,o
278,S1729-519X2018000400540,con,o
278,S1729-519X2018000400540,artritis,i
278,S1729-519X2018000400540,reumatoide,i
278,S1729-519X2018000400540,Objetivo,o
278,S1729-519X2018000400540,Determinar,i
278,S1729-519X2018000400540,la,i
278,S1729-519X2018000400540,eficacia,i
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,los,o
278,S1729-519X2018000400540,ensayos,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,determinacion,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,anticuerpos,i
278,S1729-519X2018000400540,antiCCP2,o
278,S1729-519X2018000400540,y,o
278,S1729-519X2018000400540,antiCCP3,o
278,S1729-519X2018000400540,para,o
278,S1729-519X2018000400540,el,o
278,S1729-519X2018000400540,diagnostico,i
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,pacientes,o
278,S1729-519X2018000400540,cubanos,o
278,S1729-519X2018000400540,con,o
278,S1729-519X2018000400540,artritis,i
278,S1729-519X2018000400540,reumatoide,i
278,S1729-519X2018000400540,Material,o
278,S1729-519X2018000400540,y,o
278,S1729-519X2018000400540,metodo,o
278,S1729-519X2018000400540,Participaron,o
278,S1729-519X2018000400540,101,o
278,S1729-519X2018000400540,pacientes,o
278,S1729-519X2018000400540,con,o
278,S1729-519X2018000400540,artritis,i
278,S1729-519X2018000400540,reumatoide,i
278,S1729-519X2018000400540,58,o
278,S1729-519X2018000400540,pacientes,o
278,S1729-519X2018000400540,con,o
278,S1729-519X2018000400540,otras,o
278,S1729-519X2018000400540,enfermedades,i
278,S1729-519X2018000400540,reumaticas,i
278,S1729-519X2018000400540,e,i
278,S1729-519X2018000400540,inflamatorias,i
278,S1729-519X2018000400540,y,o
278,S1729-519X2018000400540,43,o
278,S1729-519X2018000400540,individuos,o
278,S1729-519X2018000400540,sanos,o
278,S1729-519X2018000400540,Se,o
278,S1729-519X2018000400540,determino,i
278,S1729-519X2018000400540,la,i
278,S1729-519X2018000400540,eficacia,i
278,S1729-519X2018000400540,diagnostica,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,los,o
278,S1729-519X2018000400540,anticuerpos,i
278,S1729-519X2018000400540,factor,i
278,S1729-519X2018000400540,reumatoideo,i
278,S1729-519X2018000400540,FR,i
278,S1729-519X2018000400540,antiCCP2,o
278,S1729-519X2018000400540,y,o
278,S1729-519X2018000400540,antiCCP3,o
278,S1729-519X2018000400540,medidos,o
278,S1729-519X2018000400540,mediante,o
278,S1729-519X2018000400540,ELISA,i
278,S1729-519X2018000400540,con,o
278,S1729-519X2018000400540,el,o
278,S1729-519X2018000400540,calculo,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,la,o
278,S1729-519X2018000400540,sensibilidad,o
278,S1729-519X2018000400540,especificidad,o
278,S1729-519X2018000400540,valores,o
278,S1729-519X2018000400540,predictivos,o
278,S1729-519X2018000400540,positivos,o
278,S1729-519X2018000400540,y,o
278,S1729-519X2018000400540,negativos,o
278,S1729-519X2018000400540,Resultados,o
278,S1729-519X2018000400540,El,o
278,S1729-519X2018000400540,ensayo,o
278,S1729-519X2018000400540,antiCCP2,o
278,S1729-519X2018000400540,mostro,o
278,S1729-519X2018000400540,un,o
278,S1729-519X2018000400540,mejor,o
278,S1729-519X2018000400540,balance,o
278,S1729-519X2018000400540,sensibilidad,o
278,S1729-519X2018000400540,485,o
278,S1729-519X2018000400540,y,o
278,S1729-519X2018000400540,especificidad,o
278,S1729-519X2018000400540,980,o
278,S1729-519X2018000400540,Cuando,o
278,S1729-519X2018000400540,se,o
278,S1729-519X2018000400540,fijo,o
278,S1729-519X2018000400540,la,o
278,S1729-519X2018000400540,especificidad,o
278,S1729-519X2018000400540,a,o
278,S1729-519X2018000400540,98,o
278,S1729-519X2018000400540,se,o
278,S1729-519X2018000400540,observo,o
278,S1729-519X2018000400540,la,o
278,S1729-519X2018000400540,menor,o
278,S1729-519X2018000400540,sensibilidad,o
278,S1729-519X2018000400540,para,o
278,S1729-519X2018000400540,el,o
278,S1729-519X2018000400540,FR,i
278,S1729-519X2018000400540,403,o
278,S1729-519X2018000400540,Utilizar,o
278,S1729-519X2018000400540,los,o
278,S1729-519X2018000400540,ensayos,o
278,S1729-519X2018000400540,antiCCP2,o
278,S1729-519X2018000400540,y,o
278,S1729-519X2018000400540,FR,i
278,S1729-519X2018000400540,aumento,o
278,S1729-519X2018000400540,la,o
278,S1729-519X2018000400540,especificidad,o
278,S1729-519X2018000400540,a,o
278,S1729-519X2018000400540,100,o
278,S1729-519X2018000400540,Todos,o
278,S1729-519X2018000400540,los,o
278,S1729-519X2018000400540,autoanticuerpos,i
278,S1729-519X2018000400540,mostraron,o
278,S1729-519X2018000400540,asociacion,o
278,S1729-519X2018000400540,con,o
278,S1729-519X2018000400540,la,o
278,S1729-519X2018000400540,proteina,i
278,S1729-519X2018000400540,C,i
278,S1729-519X2018000400540,reactiva,i
278,S1729-519X2018000400540,y,o
278,S1729-519X2018000400540,correlacion,o
278,S1729-519X2018000400540,con,o
278,S1729-519X2018000400540,la,o
278,S1729-519X2018000400540,velocidad,i
278,S1729-519X2018000400540,de,i
278,S1729-519X2018000400540,sedimentacion,i
278,S1729-519X2018000400540,globular,i
278,S1729-519X2018000400540,Solamente,o
278,S1729-519X2018000400540,los,o
278,S1729-519X2018000400540,anticuerpos,i
278,S1729-519X2018000400540,antiCCP2,o
278,S1729-519X2018000400540,no,o
278,S1729-519X2018000400540,mostraron,o
278,S1729-519X2018000400540,correlacion,o
278,S1729-519X2018000400540,con,o
278,S1729-519X2018000400540,el,o
278,S1729-519X2018000400540,indicador,o
278,S1729-519X2018000400540,clinico,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,actividad,o
278,S1729-519X2018000400540,DAS,o
278,S1729-519X2018000400540,28,o
278,S1729-519X2018000400540,Conclusiones,o
278,S1729-519X2018000400540,Los,o
278,S1729-519X2018000400540,anticuerpos,i
278,S1729-519X2018000400540,antiCCP2,o
278,S1729-519X2018000400540,son,o
278,S1729-519X2018000400540,los,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,mayor,o
278,S1729-519X2018000400540,eficacia,o
278,S1729-519X2018000400540,para,o
278,S1729-519X2018000400540,el,o
278,S1729-519X2018000400540,diagnostico,i
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,pacientes,o
278,S1729-519X2018000400540,cubanos,o
278,S1729-519X2018000400540,con,o
278,S1729-519X2018000400540,artritis,i
278,S1729-519X2018000400540,reumatoide,i
278,S1729-519X2018000400540,La,o
278,S1729-519X2018000400540,determinacion,i
278,S1729-519X2018000400540,de,i
278,S1729-519X2018000400540,FR,i
278,S1729-519X2018000400540,permite,o
278,S1729-519X2018000400540,identificar,o
278,S1729-519X2018000400540,pacientes,o
278,S1729-519X2018000400540,con,o
278,S1729-519X2018000400540,artritis,i
278,S1729-519X2018000400540,reumatoide,i
278,S1729-519X2018000400540,seronegativos,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,anticuerpos,i
278,S1729-519X2018000400540,antiCCP2,o
278,S1729-519X2018000400540,por,o
278,S1729-519X2018000400540,lo,o
278,S1729-519X2018000400540,que,o
278,S1729-519X2018000400540,la,o
278,S1729-519X2018000400540,combinacion,o
278,S1729-519X2018000400540,de,o
278,S1729-519X2018000400540,ambos,o
278,S1729-519X2018000400540,inmunoensayos,i
278,S1729-519X2018000400540,produce,o
278,S1729-519X2018000400540,una,o
278,S1729-519X2018000400540,mejoria,o
278,S1729-519X2018000400540,en,o
278,S1729-519X2018000400540,la,o
278,S1729-519X2018000400540,eficacia,o
278,S1729-519X2018000400540,diagnostica,o
279,S1852-236X2016000100002,Evaluacion,i
279,S1852-236X2016000100002,del,i
279,S1852-236X2016000100002,uso,i
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,corticoides,i
279,S1852-236X2016000100002,inhalados,o
279,S1852-236X2016000100002,en,o
279,S1852-236X2016000100002,altas,o
279,S1852-236X2016000100002,dosis,o
279,S1852-236X2016000100002,para,o
279,S1852-236X2016000100002,el,o
279,S1852-236X2016000100002,tratamiento,i
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,crisis,i
279,S1852-236X2016000100002,asmatica,i
279,S1852-236X2016000100002,Introduccion,o
279,S1852-236X2016000100002,El,o
279,S1852-236X2016000100002,asma,i
279,S1852-236X2016000100002,es,o
279,S1852-236X2016000100002,una,o
279,S1852-236X2016000100002,enfermedad,i
279,S1852-236X2016000100002,heterogenea,o
279,S1852-236X2016000100002,caracterizada,o
279,S1852-236X2016000100002,por,o
279,S1852-236X2016000100002,la,o
279,S1852-236X2016000100002,inflamacion,i
279,S1852-236X2016000100002,cronica,i
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,la,o
279,S1852-236X2016000100002,via,i
279,S1852-236X2016000100002,aerea,i
279,S1852-236X2016000100002,Se,o
279,S1852-236X2016000100002,caracteriza,o
279,S1852-236X2016000100002,por,o
279,S1852-236X2016000100002,sintomas,i
279,S1852-236X2016000100002,respiratorios,i
279,S1852-236X2016000100002,como,o
279,S1852-236X2016000100002,sibilancias,i
279,S1852-236X2016000100002,disnea,i
279,S1852-236X2016000100002,opresion,i
279,S1852-236X2016000100002,en,i
279,S1852-236X2016000100002,el,i
279,S1852-236X2016000100002,pecho,i
279,S1852-236X2016000100002,tos,i
279,S1852-236X2016000100002,que,o
279,S1852-236X2016000100002,varia,o
279,S1852-236X2016000100002,en,o
279,S1852-236X2016000100002,el,o
279,S1852-236X2016000100002,tiempo,o
279,S1852-236X2016000100002,y,o
279,S1852-236X2016000100002,en,o
279,S1852-236X2016000100002,la,o
279,S1852-236X2016000100002,intensidad,o
279,S1852-236X2016000100002,ademas,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,presentar,o
279,S1852-236X2016000100002,limitacion,o
279,S1852-236X2016000100002,variable,o
279,S1852-236X2016000100002,al,o
279,S1852-236X2016000100002,flujo,o
279,S1852-236X2016000100002,aereo,o
279,S1852-236X2016000100002,Afecta,o
279,S1852-236X2016000100002,del,o
279,S1852-236X2016000100002,1,o
279,S1852-236X2016000100002,al,o
279,S1852-236X2016000100002,18,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,la,o
279,S1852-236X2016000100002,poblacion,o
279,S1852-236X2016000100002,mundial,o
279,S1852-236X2016000100002,Existe,o
279,S1852-236X2016000100002,evidencia,o
279,S1852-236X2016000100002,que,o
279,S1852-236X2016000100002,sugiere,o
279,S1852-236X2016000100002,que,o
279,S1852-236X2016000100002,los,o
279,S1852-236X2016000100002,corticoides,i
279,S1852-236X2016000100002,inhalados,o
279,S1852-236X2016000100002,pueden,o
279,S1852-236X2016000100002,mostrar,o
279,S1852-236X2016000100002,efectos,o
279,S1852-236X2016000100002,terapeuticos,o
279,S1852-236X2016000100002,tempranos,o
279,S1852-236X2016000100002,3,o
279,S1852-236X2016000100002,h,o
279,S1852-236X2016000100002,Esta,o
279,S1852-236X2016000100002,rapida,o
279,S1852-236X2016000100002,respuesta,o
279,S1852-236X2016000100002,se,o
279,S1852-236X2016000100002,encontraria,o
279,S1852-236X2016000100002,vinculada,o
279,S1852-236X2016000100002,a,o
279,S1852-236X2016000100002,un,o
279,S1852-236X2016000100002,efecto,o
279,S1852-236X2016000100002,topico,o
279,S1852-236X2016000100002,vasoconstriccion,i
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,la,o
279,S1852-236X2016000100002,mucosa,i
279,S1852-236X2016000100002,de,i
279,S1852-236X2016000100002,la,i
279,S1852-236X2016000100002,via,i
279,S1852-236X2016000100002,aerea,i
279,S1852-236X2016000100002,debido,o
279,S1852-236X2016000100002,a,o
279,S1852-236X2016000100002,la,o
279,S1852-236X2016000100002,potenciacion,o
279,S1852-236X2016000100002,del,o
279,S1852-236X2016000100002,efecto,o
279,S1852-236X2016000100002,adrenergico,o
279,S1852-236X2016000100002,por,o
279,S1852-236X2016000100002,modificacion,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,los,o
279,S1852-236X2016000100002,receptores,o
279,S1852-236X2016000100002,postsinapticos,o
279,S1852-236X2016000100002,Materiales,o
279,S1852-236X2016000100002,y,o
279,S1852-236X2016000100002,metodos,o
279,S1852-236X2016000100002,Se,o
279,S1852-236X2016000100002,realizo,o
279,S1852-236X2016000100002,un,o
279,S1852-236X2016000100002,estudio,o
279,S1852-236X2016000100002,prospectivo,o
279,S1852-236X2016000100002,aleatorizado,o
279,S1852-236X2016000100002,analitico,o
279,S1852-236X2016000100002,longitudinal,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,cohorte,o
279,S1852-236X2016000100002,y,o
279,S1852-236X2016000100002,experimental,o
279,S1852-236X2016000100002,en,o
279,S1852-236X2016000100002,pacientes,o
279,S1852-236X2016000100002,con,o
279,S1852-236X2016000100002,crisis,i
279,S1852-236X2016000100002,de,i
279,S1852-236X2016000100002,asma,i
279,S1852-236X2016000100002,atendidos,o
279,S1852-236X2016000100002,en,o
279,S1852-236X2016000100002,la,o
279,S1852-236X2016000100002,guardia,o
279,S1852-236X2016000100002,externa,o
279,S1852-236X2016000100002,del,o
279,S1852-236X2016000100002,Hospital,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,Rehabilitacion,o
279,S1852-236X2016000100002,Respiratoria,o
279,S1852-236X2016000100002,Maria,o
279,S1852-236X2016000100002,Ferrer,o
279,S1852-236X2016000100002,Resultados,o
279,S1852-236X2016000100002,Se,o
279,S1852-236X2016000100002,evaluo,o
279,S1852-236X2016000100002,a,o
279,S1852-236X2016000100002,un,o
279,S1852-236X2016000100002,total,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,71,o
279,S1852-236X2016000100002,pacientes,o
279,S1852-236X2016000100002,en,o
279,S1852-236X2016000100002,un,o
279,S1852-236X2016000100002,periodo,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,10,o
279,S1852-236X2016000100002,meses,o
279,S1852-236X2016000100002,todos,o
279,S1852-236X2016000100002,ingresaron,i
279,S1852-236X2016000100002,por,o
279,S1852-236X2016000100002,el,o
279,S1852-236X2016000100002,servicio,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,guardia,o
279,S1852-236X2016000100002,del,o
279,S1852-236X2016000100002,Hospital,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,Rehabilitacion,o
279,S1852-236X2016000100002,Respiratoria,o
279,S1852-236X2016000100002,Maria,o
279,S1852-236X2016000100002,Ferrer,o
279,S1852-236X2016000100002,y,o
279,S1852-236X2016000100002,accedieron,o
279,S1852-236X2016000100002,a,o
279,S1852-236X2016000100002,participar,o
279,S1852-236X2016000100002,del,o
279,S1852-236X2016000100002,protocolo,i
279,S1852-236X2016000100002,firmando,o
279,S1852-236X2016000100002,un,o
279,S1852-236X2016000100002,consentimiento,i
279,S1852-236X2016000100002,informado,i
279,S1852-236X2016000100002,Ambos,o
279,S1852-236X2016000100002,grupos,o
279,S1852-236X2016000100002,presentaron,o
279,S1852-236X2016000100002,un,o
279,S1852-236X2016000100002,63,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,respuesta,o
279,S1852-236X2016000100002,significativa,o
279,S1852-236X2016000100002,FEV1,i
279,S1852-236X2016000100002,60,o
279,S1852-236X2016000100002,a,o
279,S1852-236X2016000100002,los,o
279,S1852-236X2016000100002,30,o
279,S1852-236X2016000100002,minutos,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,iniciado,o
279,S1852-236X2016000100002,el,o
279,S1852-236X2016000100002,tratamiento,i
279,S1852-236X2016000100002,p,o
279,S1852-236X2016000100002,072,o
279,S1852-236X2016000100002,Al,o
279,S1852-236X2016000100002,fnal,o
279,S1852-236X2016000100002,del,o
279,S1852-236X2016000100002,protocolo,i
279,S1852-236X2016000100002,180,o
279,S1852-236X2016000100002,minutos,o
279,S1852-236X2016000100002,el,o
279,S1852-236X2016000100002,grupo,o
279,S1852-236X2016000100002,control,o
279,S1852-236X2016000100002,salbutamol,i
279,S1852-236X2016000100002,bromuro,i
279,S1852-236X2016000100002,de,i
279,S1852-236X2016000100002,ipratropio,i
279,S1852-236X2016000100002,presento,o
279,S1852-236X2016000100002,3,o
279,S1852-236X2016000100002,pacientes,o
279,S1852-236X2016000100002,que,o
279,S1852-236X2016000100002,no,o
279,S1852-236X2016000100002,lograron,o
279,S1852-236X2016000100002,el,o
279,S1852-236X2016000100002,objetivo,o
279,S1852-236X2016000100002,del,o
279,S1852-236X2016000100002,FEV1,i
279,S1852-236X2016000100002,60,o
279,S1852-236X2016000100002,a,o
279,S1852-236X2016000100002,comparacion,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,2,o
279,S1852-236X2016000100002,pacientes,o
279,S1852-236X2016000100002,en,o
279,S1852-236X2016000100002,el,o
279,S1852-236X2016000100002,grupo,o
279,S1852-236X2016000100002,tratado,i
279,S1852-236X2016000100002,con,o
279,S1852-236X2016000100002,corticoides,i
279,S1852-236X2016000100002,inhalados,o
279,S1852-236X2016000100002,a,o
279,S1852-236X2016000100002,altas,o
279,S1852-236X2016000100002,dosis,o
279,S1852-236X2016000100002,P,o
279,S1852-236X2016000100002,097,o
279,S1852-236X2016000100002,Conclusion,o
279,S1852-236X2016000100002,Actualmente,o
279,S1852-236X2016000100002,el,o
279,S1852-236X2016000100002,uso,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,corticoides,i
279,S1852-236X2016000100002,inhalados,o
279,S1852-236X2016000100002,a,o
279,S1852-236X2016000100002,altas,o
279,S1852-236X2016000100002,dosis,o
279,S1852-236X2016000100002,en,o
279,S1852-236X2016000100002,crisis,i
279,S1852-236X2016000100002,de,i
279,S1852-236X2016000100002,asma,i
279,S1852-236X2016000100002,es,o
279,S1852-236X2016000100002,una,o
279,S1852-236X2016000100002,opcion,o
279,S1852-236X2016000100002,terapeutica,o
279,S1852-236X2016000100002,para,o
279,S1852-236X2016000100002,pacientes,o
279,S1852-236X2016000100002,con,o
279,S1852-236X2016000100002,crisis,i
279,S1852-236X2016000100002,moderadas,o
279,S1852-236X2016000100002,a,o
279,S1852-236X2016000100002,severas,o
279,S1852-236X2016000100002,Nuestro,o
279,S1852-236X2016000100002,estudio,o
279,S1852-236X2016000100002,no,o
279,S1852-236X2016000100002,obtuvo,o
279,S1852-236X2016000100002,valores,o
279,S1852-236X2016000100002,significativos,o
279,S1852-236X2016000100002,que,o
279,S1852-236X2016000100002,apoyen,o
279,S1852-236X2016000100002,el,o
279,S1852-236X2016000100002,uso,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,esta,o
279,S1852-236X2016000100002,medicacion,i
279,S1852-236X2016000100002,para,o
279,S1852-236X2016000100002,reducir,o
279,S1852-236X2016000100002,la,o
279,S1852-236X2016000100002,incidencia,o
279,S1852-236X2016000100002,de,o
279,S1852-236X2016000100002,internaciones,i
279,S1852-236X2016000100002,o,o
279,S1852-236X2016000100002,mejorar,o
279,S1852-236X2016000100002,significativamente,o
279,S1852-236X2016000100002,la,o
279,S1852-236X2016000100002,funcion,o
279,S1852-236X2016000100002,pulmonar,o
280,S1852-74342014000300004,Acido,i
280,S1852-74342014000300004,tranexamico,i
280,S1852-74342014000300004,endovenoso,o
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,el,o
280,S1852-74342014000300004,reemplazo,i
280,S1852-74342014000300004,total,i
280,S1852-74342014000300004,de,i
280,S1852-74342014000300004,rodilla,i
280,S1852-74342014000300004,sin,o
280,S1852-74342014000300004,manguito,o
280,S1852-74342014000300004,hemostatico,o
280,S1852-74342014000300004,Estudio,i
280,S1852-74342014000300004,prospectivo,i
280,S1852-74342014000300004,aleatorizado,i
280,S1852-74342014000300004,Introduccion,o
280,S1852-74342014000300004,La,o
280,S1852-74342014000300004,artroplastia,i
280,S1852-74342014000300004,de,i
280,S1852-74342014000300004,rodilla,i
280,S1852-74342014000300004,se,o
280,S1852-74342014000300004,asocia,o
280,S1852-74342014000300004,a,o
280,S1852-74342014000300004,grandes,o
280,S1852-74342014000300004,perdidas,i
280,S1852-74342014000300004,de,i
280,S1852-74342014000300004,sangre,i
280,S1852-74342014000300004,perioperatorias,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,posoperatorias,o
280,S1852-74342014000300004,6001500,o
280,S1852-74342014000300004,ml,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,a,o
280,S1852-74342014000300004,porcentajes,o
280,S1852-74342014000300004,de,o
280,S1852-74342014000300004,transfusion,i
280,S1852-74342014000300004,de,i
280,S1852-74342014000300004,sangre,i
280,S1852-74342014000300004,hasta,o
280,S1852-74342014000300004,del,o
280,S1852-74342014000300004,50,o
280,S1852-74342014000300004,El,o
280,S1852-74342014000300004,objetivo,o
280,S1852-74342014000300004,es,o
280,S1852-74342014000300004,estudiar,o
280,S1852-74342014000300004,el,o
280,S1852-74342014000300004,efecto,o
280,S1852-74342014000300004,del,o
280,S1852-74342014000300004,acido,i
280,S1852-74342014000300004,tranexamico,i
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,la,o
280,S1852-74342014000300004,artroplastia,i
280,S1852-74342014000300004,primaria,i
280,S1852-74342014000300004,de,i
280,S1852-74342014000300004,rodilla,i
280,S1852-74342014000300004,sin,o
280,S1852-74342014000300004,manguito,o
280,S1852-74342014000300004,hemostatico,o
280,S1852-74342014000300004,valorando,o
280,S1852-74342014000300004,la,o
280,S1852-74342014000300004,perdida,i
280,S1852-74342014000300004,sanguinea,i
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,el,o
280,S1852-74342014000300004,posoperatorio,o
280,S1852-74342014000300004,Materiales,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,Metodos,o
280,S1852-74342014000300004,Los,o
280,S1852-74342014000300004,pacientes,o
280,S1852-74342014000300004,fueron,o
280,S1852-74342014000300004,asignados,o
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,forma,o
280,S1852-74342014000300004,aleatoria,o
280,S1852-74342014000300004,a,o
280,S1852-74342014000300004,dos,o
280,S1852-74342014000300004,grupos,o
280,S1852-74342014000300004,Grupo,o
280,S1852-74342014000300004,A,o
280,S1852-74342014000300004,con,o
280,S1852-74342014000300004,acido,i
280,S1852-74342014000300004,tranexamico,i
280,S1852-74342014000300004,25,o
280,S1852-74342014000300004,pacientes,o
280,S1852-74342014000300004,715,o
280,S1852-74342014000300004,años,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,Grupo,o
280,S1852-74342014000300004,B,o
280,S1852-74342014000300004,sin,o
280,S1852-74342014000300004,acido,i
280,S1852-74342014000300004,tranexamico,i
280,S1852-74342014000300004,25,o
280,S1852-74342014000300004,pacientes,o
280,S1852-74342014000300004,72,o
280,S1852-74342014000300004,años,o
280,S1852-74342014000300004,Se,o
280,S1852-74342014000300004,determino,o
280,S1852-74342014000300004,la,o
280,S1852-74342014000300004,hemoglobina,i
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,el,o
280,S1852-74342014000300004,hematocrito,i
280,S1852-74342014000300004,antes,o
280,S1852-74342014000300004,de,o
280,S1852-74342014000300004,la,o
280,S1852-74342014000300004,cirugia,i
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,a,o
280,S1852-74342014000300004,las,o
280,S1852-74342014000300004,24,o
280,S1852-74342014000300004,48,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,72,o
280,S1852-74342014000300004,h,o
280,S1852-74342014000300004,Se,o
280,S1852-74342014000300004,midio,o
280,S1852-74342014000300004,el,o
280,S1852-74342014000300004,debito,o
280,S1852-74342014000300004,del,o
280,S1852-74342014000300004,suctor,o
280,S1852-74342014000300004,a,o
280,S1852-74342014000300004,las,o
280,S1852-74342014000300004,24,o
280,S1852-74342014000300004,h,o
280,S1852-74342014000300004,Resultados,o
280,S1852-74342014000300004,El,o
280,S1852-74342014000300004,hematocrito,i
280,S1852-74342014000300004,posoperatorio,o
280,S1852-74342014000300004,a,o
280,S1852-74342014000300004,las,o
280,S1852-74342014000300004,24,o
280,S1852-74342014000300004,48,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,72,o
280,S1852-74342014000300004,h,o
280,S1852-74342014000300004,fue,o
280,S1852-74342014000300004,del,o
280,S1852-74342014000300004,334,o
280,S1852-74342014000300004,315,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,308,o
280,S1852-74342014000300004,respectivamente,o
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,el,o
280,S1852-74342014000300004,grupo,o
280,S1852-74342014000300004,A,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,del,o
280,S1852-74342014000300004,285,o
280,S1852-74342014000300004,279,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,27,o
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,el,o
280,S1852-74342014000300004,grupo,o
280,S1852-74342014000300004,B,o
280,S1852-74342014000300004,p,o
280,S1852-74342014000300004,0001,o
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,los,o
280,S1852-74342014000300004,3,o
280,S1852-74342014000300004,registros,o
280,S1852-74342014000300004,Los,o
280,S1852-74342014000300004,valores,i
280,S1852-74342014000300004,de,i
280,S1852-74342014000300004,hemoglobina,i
280,S1852-74342014000300004,fueron,o
280,S1852-74342014000300004,11,o
280,S1852-74342014000300004,103,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,10,o
280,S1852-74342014000300004,gdl,o
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,el,o
280,S1852-74342014000300004,grupo,o
280,S1852-74342014000300004,A,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,94,o
280,S1852-74342014000300004,93,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,9,o
280,S1852-74342014000300004,gdl,o
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,el,o
280,S1852-74342014000300004,grupo,o
280,S1852-74342014000300004,B,o
280,S1852-74342014000300004,respectivamente,o
280,S1852-74342014000300004,p,o
280,S1852-74342014000300004,0001,o
280,S1852-74342014000300004,p,o
280,S1852-74342014000300004,0004,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,p,o
280,S1852-74342014000300004,0002,o
280,S1852-74342014000300004,La,o
280,S1852-74342014000300004,coleccion,o
280,S1852-74342014000300004,del,o
280,S1852-74342014000300004,drenaje,i
280,S1852-74342014000300004,a,o
280,S1852-74342014000300004,las,o
280,S1852-74342014000300004,24,o
280,S1852-74342014000300004,h,o
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,el,o
280,S1852-74342014000300004,grupo,o
280,S1852-74342014000300004,A,o
280,S1852-74342014000300004,fue,o
280,S1852-74342014000300004,de,o
280,S1852-74342014000300004,3634,o
280,S1852-74342014000300004,ml,o
280,S1852-74342014000300004,141,o
280,S1852-74342014000300004,ml,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,el,o
280,S1852-74342014000300004,grupo,o
280,S1852-74342014000300004,B,o
280,S1852-74342014000300004,fue,o
280,S1852-74342014000300004,de,o
280,S1852-74342014000300004,626,o
280,S1852-74342014000300004,ml,o
280,S1852-74342014000300004,260,o
280,S1852-74342014000300004,ml,o
280,S1852-74342014000300004,p,o
280,S1852-74342014000300004,0001,o
280,S1852-74342014000300004,Se,o
280,S1852-74342014000300004,transfundio,i
280,S1852-74342014000300004,al,o
280,S1852-74342014000300004,32,o
280,S1852-74342014000300004,de,o
280,S1852-74342014000300004,los,o
280,S1852-74342014000300004,pacientes,o
280,S1852-74342014000300004,del,o
280,S1852-74342014000300004,grupo,o
280,S1852-74342014000300004,B,o
280,S1852-74342014000300004,y,o
280,S1852-74342014000300004,a,o
280,S1852-74342014000300004,ninguno,o
280,S1852-74342014000300004,del,o
280,S1852-74342014000300004,grupo,o
280,S1852-74342014000300004,A,o
280,S1852-74342014000300004,No,o
280,S1852-74342014000300004,se,o
280,S1852-74342014000300004,registraron,o
280,S1852-74342014000300004,casos,o
280,S1852-74342014000300004,de,o
280,S1852-74342014000300004,enfermedad,i
280,S1852-74342014000300004,tromboembolica,i
280,S1852-74342014000300004,Conclusion,o
280,S1852-74342014000300004,El,o
280,S1852-74342014000300004,uso,o
280,S1852-74342014000300004,de,o
280,S1852-74342014000300004,acido,i
280,S1852-74342014000300004,tranexamico,i
280,S1852-74342014000300004,disminuye,o
280,S1852-74342014000300004,la,o
280,S1852-74342014000300004,perdida,i
280,S1852-74342014000300004,de,i
280,S1852-74342014000300004,sangre,i
280,S1852-74342014000300004,posoperatoria,o
280,S1852-74342014000300004,asociada,o
280,S1852-74342014000300004,a,o
280,S1852-74342014000300004,la,o
280,S1852-74342014000300004,artroplastia,i
280,S1852-74342014000300004,de,i
280,S1852-74342014000300004,rodilla,i
280,S1852-74342014000300004,esto,o
280,S1852-74342014000300004,se,o
280,S1852-74342014000300004,refleja,o
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,menores,o
280,S1852-74342014000300004,porcentajes,o
280,S1852-74342014000300004,de,o
280,S1852-74342014000300004,transfusion,i
280,S1852-74342014000300004,de,i
280,S1852-74342014000300004,sangre,i
280,S1852-74342014000300004,sin,o
280,S1852-74342014000300004,un,o
280,S1852-74342014000300004,aumento,o
280,S1852-74342014000300004,en,o
280,S1852-74342014000300004,el,o
280,S1852-74342014000300004,riesgo,o
280,S1852-74342014000300004,de,o
280,S1852-74342014000300004,complicaciones,i
281,S1852-74342016000400003,Anestesia,i
281,S1852-74342016000400003,raquidea,i
281,S1852-74342016000400003,versus,o
281,S1852-74342016000400003,anestesia,i
281,S1852-74342016000400003,intrarticular,i
281,S1852-74342016000400003,en,o
281,S1852-74342016000400003,cirugia,i
281,S1852-74342016000400003,artroscopica,i
281,S1852-74342016000400003,de,i
281,S1852-74342016000400003,rodilla,i
281,S1852-74342016000400003,Introduccion,o
281,S1852-74342016000400003,La,o
281,S1852-74342016000400003,artroscopia,i
281,S1852-74342016000400003,de,i
281,S1852-74342016000400003,rodilla,i
281,S1852-74342016000400003,es,o
281,S1852-74342016000400003,el,o
281,S1852-74342016000400003,procedimiento,i
281,S1852-74342016000400003,quirurgico,i
281,S1852-74342016000400003,mas,o
281,S1852-74342016000400003,comun,o
281,S1852-74342016000400003,para,o
281,S1852-74342016000400003,tratar,o
281,S1852-74342016000400003,pacientes,o
281,S1852-74342016000400003,con,o
281,S1852-74342016000400003,lesiones,i
281,S1852-74342016000400003,meniscales,i
281,S1852-74342016000400003,o,i
281,S1852-74342016000400003,condrales,i
281,S1852-74342016000400003,El,o
281,S1852-74342016000400003,objetivo,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,este,o
281,S1852-74342016000400003,trabajo,o
281,S1852-74342016000400003,fue,o
281,S1852-74342016000400003,comparar,i
281,S1852-74342016000400003,la,i
281,S1852-74342016000400003,eficacia,i
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,anestesia,i
281,S1852-74342016000400003,raquidea,i
281,S1852-74342016000400003,versus,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,intrarticular,o
281,S1852-74342016000400003,en,o
281,S1852-74342016000400003,artroscopias,i
281,S1852-74342016000400003,simples,i
281,S1852-74342016000400003,de,i
281,S1852-74342016000400003,rodilla,i
281,S1852-74342016000400003,evaluar,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,calidad,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,anestesia,i
281,S1852-74342016000400003,describir,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,incidencia,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,los,o
281,S1852-74342016000400003,efectos,i
281,S1852-74342016000400003,adversos,i
281,S1852-74342016000400003,y,o
281,S1852-74342016000400003,determinar,o
281,S1852-74342016000400003,las,o
281,S1852-74342016000400003,complicaciones,i
281,S1852-74342016000400003,en,o
281,S1852-74342016000400003,ambos,o
281,S1852-74342016000400003,casos,o
281,S1852-74342016000400003,Materiales,o
281,S1852-74342016000400003,y,o
281,S1852-74342016000400003,Metodos,o
281,S1852-74342016000400003,Estudio,o
281,S1852-74342016000400003,prospectivo,o
281,S1852-74342016000400003,aleatorizado,o
281,S1852-74342016000400003,para,o
281,S1852-74342016000400003,comparar,o
281,S1852-74342016000400003,dos,o
281,S1852-74342016000400003,procedimientos,i
281,S1852-74342016000400003,anestesicos,i
281,S1852-74342016000400003,mediante,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,evaluacion,i
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,edad,o
281,S1852-74342016000400003,el,o
281,S1852-74342016000400003,tiempo,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,cirugia,i
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,duracion,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,anestesia,i
281,S1852-74342016000400003,el,o
281,S1852-74342016000400003,tiempo,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,internacion,i
281,S1852-74342016000400003,el,o
281,S1852-74342016000400003,dolor,i
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,conformidad,o
281,S1852-74342016000400003,con,o
281,S1852-74342016000400003,el,o
281,S1852-74342016000400003,procedimiento,i
281,S1852-74342016000400003,y,o
281,S1852-74342016000400003,los,o
281,S1852-74342016000400003,costos,o
281,S1852-74342016000400003,Se,o
281,S1852-74342016000400003,utilizo,o
281,S1852-74342016000400003,el,o
281,S1852-74342016000400003,test,o
281,S1852-74342016000400003,t,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,Student,o
281,S1852-74342016000400003,para,o
281,S1852-74342016000400003,las,o
281,S1852-74342016000400003,estadisticas,o
281,S1852-74342016000400003,y,o
281,S1852-74342016000400003,probabilidades,o
281,S1852-74342016000400003,Nivel,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,significacion,o
281,S1852-74342016000400003,p,o
281,S1852-74342016000400003,005,o
281,S1852-74342016000400003,Resultados,o
281,S1852-74342016000400003,Se,o
281,S1852-74342016000400003,incluyo,o
281,S1852-74342016000400003,a,o
281,S1852-74342016000400003,70,o
281,S1852-74342016000400003,pacientes,o
281,S1852-74342016000400003,35,o
281,S1852-74342016000400003,fueron,o
281,S1852-74342016000400003,operados,i
281,S1852-74342016000400003,con,o
281,S1852-74342016000400003,anestesia,i
281,S1852-74342016000400003,intrarticular,i
281,S1852-74342016000400003,y,o
281,S1852-74342016000400003,35,o
281,S1852-74342016000400003,con,o
281,S1852-74342016000400003,anestesia,i
281,S1852-74342016000400003,raquidea,i
281,S1852-74342016000400003,El,o
281,S1852-74342016000400003,tiempo,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,internacion,i
281,S1852-74342016000400003,fue,o
281,S1852-74342016000400003,mayor,o
281,S1852-74342016000400003,en,o
281,S1852-74342016000400003,el,o
281,S1852-74342016000400003,grupo,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,anestesia,i
281,S1852-74342016000400003,raquidea,i
281,S1852-74342016000400003,734,o
281,S1852-74342016000400003,h,o
281,S1852-74342016000400003,rango,o
281,S1852-74342016000400003,411,o
281,S1852-74342016000400003,que,o
281,S1852-74342016000400003,en,o
281,S1852-74342016000400003,el,o
281,S1852-74342016000400003,grupo,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,anestesia,i
281,S1852-74342016000400003,intrarticular,i
281,S1852-74342016000400003,343,o
281,S1852-74342016000400003,h,o
281,S1852-74342016000400003,rango,o
281,S1852-74342016000400003,25,o
281,S1852-74342016000400003,p,o
281,S1852-74342016000400003,00001,o
281,S1852-74342016000400003,En,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,variable,o
281,S1852-74342016000400003,costo,o
281,S1852-74342016000400003,hubo,o
281,S1852-74342016000400003,una,o
281,S1852-74342016000400003,diferencia,o
281,S1852-74342016000400003,significativa,o
281,S1852-74342016000400003,a,o
281,S1852-74342016000400003,favor,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,anestesia,i
281,S1852-74342016000400003,intrarticular,i
281,S1852-74342016000400003,con,o
281,S1852-74342016000400003,respecto,o
281,S1852-74342016000400003,a,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,anestesia,i
281,S1852-74342016000400003,raquidea,i
281,S1852-74342016000400003,p,o
281,S1852-74342016000400003,00001,o
281,S1852-74342016000400003,Conclusion,o
281,S1852-74342016000400003,Las,o
281,S1852-74342016000400003,ventajas,o
281,S1852-74342016000400003,encontradas,o
281,S1852-74342016000400003,a,o
281,S1852-74342016000400003,favor,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,anestesia,i
281,S1852-74342016000400003,intrarticular,i
281,S1852-74342016000400003,fueron,o
281,S1852-74342016000400003,estadias,o
281,S1852-74342016000400003,hospitalarias,o
281,S1852-74342016000400003,acortadas,o
281,S1852-74342016000400003,se,o
281,S1852-74342016000400003,evitaron,o
281,S1852-74342016000400003,efectos,i
281,S1852-74342016000400003,indeseables,i
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,la,o
281,S1852-74342016000400003,anestesia,i
281,S1852-74342016000400003,raquidea,i
281,S1852-74342016000400003,bloqueo,o
281,S1852-74342016000400003,motor,o
281,S1852-74342016000400003,nauseas,i
281,S1852-74342016000400003,vomitos,i
281,S1852-74342016000400003,hipotension,i
281,S1852-74342016000400003,perdida,i
281,S1852-74342016000400003,transitoria,i
281,S1852-74342016000400003,de,i
281,S1852-74342016000400003,esfinter,i
281,S1852-74342016000400003,urinario,i
281,S1852-74342016000400003,y,o
281,S1852-74342016000400003,retencion,i
281,S1852-74342016000400003,urinaria,i
281,S1852-74342016000400003,globo,i
281,S1852-74342016000400003,vesical,i
281,S1852-74342016000400003,disminucion,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,los,o
281,S1852-74342016000400003,costos,o
281,S1852-74342016000400003,y,o
281,S1852-74342016000400003,mayor,o
281,S1852-74342016000400003,aceptacion,o
281,S1852-74342016000400003,de,o
281,S1852-74342016000400003,los,o
281,S1852-74342016000400003,pacientes,o
282,S1889-836X2013000100003,Efectos,o
282,S1889-836X2013000100003,del,o
282,S1889-836X2013000100003,calcio,i
282,S1889-836X2013000100003,y,o
282,S1889-836X2013000100003,la,o
282,S1889-836X2013000100003,vitamina,i
282,S1889-836X2013000100003,D,i
282,S1889-836X2013000100003,con,o
282,S1889-836X2013000100003,y,o
282,S1889-836X2013000100003,sin,o
282,S1889-836X2013000100003,lactulosa,i
282,S1889-836X2013000100003,en,o
282,S1889-836X2013000100003,la,o
282,S1889-836X2013000100003,densidad,o
282,S1889-836X2013000100003,mineral,o
282,S1889-836X2013000100003,osea,i
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,mujeres,o
282,S1889-836X2013000100003,postmenopausicas,i
282,S1889-836X2013000100003,con,o
282,S1889-836X2013000100003,osteopenia,i
282,S1889-836X2013000100003,Ensayo,i
282,S1889-836X2013000100003,piloto,i
282,S1889-836X2013000100003,controlado,i
282,S1889-836X2013000100003,y,i
282,S1889-836X2013000100003,aleatorizado,i
282,S1889-836X2013000100003,Introduccion,o
282,S1889-836X2013000100003,La,o
282,S1889-836X2013000100003,lactulosa,i
282,S1889-836X2013000100003,es,o
282,S1889-836X2013000100003,un,o
282,S1889-836X2013000100003,oligosacarido,i
282,S1889-836X2013000100003,ampliamente,o
282,S1889-836X2013000100003,utilizado,o
282,S1889-836X2013000100003,como,o
282,S1889-836X2013000100003,laxante,i
282,S1889-836X2013000100003,entre,o
282,S1889-836X2013000100003,otros,o
282,S1889-836X2013000100003,usos,o
282,S1889-836X2013000100003,que,o
282,S1889-836X2013000100003,ha,o
282,S1889-836X2013000100003,demostrado,o
282,S1889-836X2013000100003,aumentar,o
282,S1889-836X2013000100003,la,o
282,S1889-836X2013000100003,absorcion,o
282,S1889-836X2013000100003,intestinal,i
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,calcio,i
282,S1889-836X2013000100003,por,o
282,S1889-836X2013000100003,lo,o
282,S1889-836X2013000100003,que,o
282,S1889-836X2013000100003,potencialmente,o
282,S1889-836X2013000100003,podria,o
282,S1889-836X2013000100003,tener,o
282,S1889-836X2013000100003,un,o
282,S1889-836X2013000100003,efecto,o
282,S1889-836X2013000100003,beneficioso,o
282,S1889-836X2013000100003,sobre,o
282,S1889-836X2013000100003,la,o
282,S1889-836X2013000100003,masa,o
282,S1889-836X2013000100003,osea,i
282,S1889-836X2013000100003,y,o
282,S1889-836X2013000100003,podria,o
282,S1889-836X2013000100003,permitir,o
282,S1889-836X2013000100003,reducir,o
282,S1889-836X2013000100003,las,o
282,S1889-836X2013000100003,dosis,o
282,S1889-836X2013000100003,habituales,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,calcio,i
282,S1889-836X2013000100003,evitando,o
282,S1889-836X2013000100003,sus,o
282,S1889-836X2013000100003,efectos,i
282,S1889-836X2013000100003,secundarios,i
282,S1889-836X2013000100003,Objetivos,o
282,S1889-836X2013000100003,Se,o
282,S1889-836X2013000100003,presentan,o
282,S1889-836X2013000100003,los,o
282,S1889-836X2013000100003,resultados,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,un,o
282,S1889-836X2013000100003,estudio,i
282,S1889-836X2013000100003,piloto,i
282,S1889-836X2013000100003,aleatorizado,o
282,S1889-836X2013000100003,doble,o
282,S1889-836X2013000100003,ciego,o
282,S1889-836X2013000100003,doble,o
282,S1889-836X2013000100003,simulacion,o
282,S1889-836X2013000100003,multicentrico,o
282,S1889-836X2013000100003,cuyo,o
282,S1889-836X2013000100003,objetivo,o
282,S1889-836X2013000100003,fue,o
282,S1889-836X2013000100003,valorar,o
282,S1889-836X2013000100003,si,o
282,S1889-836X2013000100003,la,o
282,S1889-836X2013000100003,adicion,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,lactulosa,i
282,S1889-836X2013000100003,a,o
282,S1889-836X2013000100003,500,o
282,S1889-836X2013000100003,mg,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,calcio,i
282,S1889-836X2013000100003,y,o
282,S1889-836X2013000100003,400,o
282,S1889-836X2013000100003,UI,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,vitamina,i
282,S1889-836X2013000100003,D,i
282,S1889-836X2013000100003,durante,o
282,S1889-836X2013000100003,12,o
282,S1889-836X2013000100003,meses,o
282,S1889-836X2013000100003,contribuia,o
282,S1889-836X2013000100003,a,o
282,S1889-836X2013000100003,mantener,o
282,S1889-836X2013000100003,la,o
282,S1889-836X2013000100003,densidad,o
282,S1889-836X2013000100003,mineral,o
282,S1889-836X2013000100003,osea,i
282,S1889-836X2013000100003,DMO,i
282,S1889-836X2013000100003,en,o
282,S1889-836X2013000100003,mujeres,o
282,S1889-836X2013000100003,postmenopausicas,i
282,S1889-836X2013000100003,con,o
282,S1889-836X2013000100003,osteopenia,i
282,S1889-836X2013000100003,frente,o
282,S1889-836X2013000100003,a,o
282,S1889-836X2013000100003,la,o
282,S1889-836X2013000100003,dosis,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,1000,o
282,S1889-836X2013000100003,mgdia,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,calcio,i
282,S1889-836X2013000100003,y,o
282,S1889-836X2013000100003,un,o
282,S1889-836X2013000100003,mismo,o
282,S1889-836X2013000100003,suplemento,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,vitamina,i
282,S1889-836X2013000100003,D,i
282,S1889-836X2013000100003,Material,o
282,S1889-836X2013000100003,y,o
282,S1889-836X2013000100003,metodos,o
282,S1889-836X2013000100003,Las,o
282,S1889-836X2013000100003,mujeres,o
282,S1889-836X2013000100003,del,o
282,S1889-836X2013000100003,grupo,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,lactulosa,i
282,S1889-836X2013000100003,n19,o
282,S1889-836X2013000100003,tomaron,o
282,S1889-836X2013000100003,15,o
282,S1889-836X2013000100003,mLdia,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,lactulosa,i
282,S1889-836X2013000100003,equivalente,o
282,S1889-836X2013000100003,a,o
282,S1889-836X2013000100003,1005,o
282,S1889-836X2013000100003,g,o
282,S1889-836X2013000100003,400,o
282,S1889-836X2013000100003,UIdia,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,vitamina,i
282,S1889-836X2013000100003,D3,i
282,S1889-836X2013000100003,y,o
282,S1889-836X2013000100003,500,o
282,S1889-836X2013000100003,mgdia,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,carbonato,i
282,S1889-836X2013000100003,de,i
282,S1889-836X2013000100003,calcio,i
282,S1889-836X2013000100003,y,o
282,S1889-836X2013000100003,500,o
282,S1889-836X2013000100003,mgdia,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,placebo,i
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,calcio,i
282,S1889-836X2013000100003,mientras,o
282,S1889-836X2013000100003,que,o
282,S1889-836X2013000100003,a,o
282,S1889-836X2013000100003,las,o
282,S1889-836X2013000100003,mujeres,o
282,S1889-836X2013000100003,del,o
282,S1889-836X2013000100003,grupo,o
282,S1889-836X2013000100003,placebo,i
282,S1889-836X2013000100003,n22,o
282,S1889-836X2013000100003,se,o
282,S1889-836X2013000100003,les,o
282,S1889-836X2013000100003,administro,o
282,S1889-836X2013000100003,lactulosa,i
282,S1889-836X2013000100003,placebo,i
282,S1889-836X2013000100003,400,o
282,S1889-836X2013000100003,UIdia,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,vitamina,i
282,S1889-836X2013000100003,D3,i
282,S1889-836X2013000100003,y,o
282,S1889-836X2013000100003,1000,o
282,S1889-836X2013000100003,mgdia,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,carbonato,i
282,S1889-836X2013000100003,de,i
282,S1889-836X2013000100003,calcio,i
282,S1889-836X2013000100003,Los,o
282,S1889-836X2013000100003,valores,o
282,S1889-836X2013000100003,iniciales,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,la,o
282,S1889-836X2013000100003,ingesta,o
282,S1889-836X2013000100003,diaria,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,calcio,i
282,S1889-836X2013000100003,fueron,o
282,S1889-836X2013000100003,similares,o
282,S1889-836X2013000100003,en,o
282,S1889-836X2013000100003,ambos,o
282,S1889-836X2013000100003,grupos,o
282,S1889-836X2013000100003,Se,o
282,S1889-836X2013000100003,utilizo,o
282,S1889-836X2013000100003,un,o
282,S1889-836X2013000100003,modelo,o
282,S1889-836X2013000100003,general,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,regresion,o
282,S1889-836X2013000100003,lineal,o
282,S1889-836X2013000100003,para,o
282,S1889-836X2013000100003,valorar,o
282,S1889-836X2013000100003,las,o
282,S1889-836X2013000100003,diferencias,o
282,S1889-836X2013000100003,finales,o
282,S1889-836X2013000100003,en,o
282,S1889-836X2013000100003,comparacion,o
282,S1889-836X2013000100003,con,o
282,S1889-836X2013000100003,los,o
282,S1889-836X2013000100003,valores,o
282,S1889-836X2013000100003,iniciales,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,la,o
282,S1889-836X2013000100003,DMO,i
282,S1889-836X2013000100003,en,o
282,S1889-836X2013000100003,ambos,o
282,S1889-836X2013000100003,grupos,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,estudio,o
282,S1889-836X2013000100003,Resultados,o
282,S1889-836X2013000100003,Las,o
282,S1889-836X2013000100003,diferencias,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,la,o
282,S1889-836X2013000100003,DMO,i
282,S1889-836X2013000100003,entre,o
282,S1889-836X2013000100003,el,o
282,S1889-836X2013000100003,grupo,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,la,o
282,S1889-836X2013000100003,lactulosa,i
282,S1889-836X2013000100003,y,o
282,S1889-836X2013000100003,el,o
282,S1889-836X2013000100003,del,o
282,S1889-836X2013000100003,placebo,i
282,S1889-836X2013000100003,no,o
282,S1889-836X2013000100003,fueron,o
282,S1889-836X2013000100003,estadisticamente,o
282,S1889-836X2013000100003,significativas,o
282,S1889-836X2013000100003,en,o
282,S1889-836X2013000100003,el,o
282,S1889-836X2013000100003,conjunto,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,datos,o
282,S1889-836X2013000100003,por,o
282,S1889-836X2013000100003,protocolo,i
282,S1889-836X2013000100003,PP,o
282,S1889-836X2013000100003,0012,o
282,S1889-836X2013000100003,95,o
282,S1889-836X2013000100003,IC,o
282,S1889-836X2013000100003,0031,o
282,S1889-836X2013000100003,a,o
282,S1889-836X2013000100003,0007,o
282,S1889-836X2013000100003,p0224,o
282,S1889-836X2013000100003,ni,o
282,S1889-836X2013000100003,en,o
282,S1889-836X2013000100003,el,o
282,S1889-836X2013000100003,analisis,i
282,S1889-836X2013000100003,por,i
282,S1889-836X2013000100003,intencion,i
282,S1889-836X2013000100003,de,i
282,S1889-836X2013000100003,tratar,i
282,S1889-836X2013000100003,ITT,o
282,S1889-836X2013000100003,0005,o
282,S1889-836X2013000100003,95,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,IC,o
282,S1889-836X2013000100003,0025,o
282,S1889-836X2013000100003,a,o
282,S1889-836X2013000100003,0016,o
282,S1889-836X2013000100003,p0651,o
282,S1889-836X2013000100003,Conclusiones,o
282,S1889-836X2013000100003,Los,o
282,S1889-836X2013000100003,resultados,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,este,o
282,S1889-836X2013000100003,estudio,i
282,S1889-836X2013000100003,piloto,i
282,S1889-836X2013000100003,permiten,o
282,S1889-836X2013000100003,concluir,o
282,S1889-836X2013000100003,que,o
282,S1889-836X2013000100003,existe,o
282,S1889-836X2013000100003,un,o
282,S1889-836X2013000100003,efecto,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,mantenimiento,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,la,o
282,S1889-836X2013000100003,DMO,i
282,S1889-836X2013000100003,en,o
282,S1889-836X2013000100003,mujeres,o
282,S1889-836X2013000100003,postmenopausicas,i
282,S1889-836X2013000100003,con,o
282,S1889-836X2013000100003,baja,o
282,S1889-836X2013000100003,masa,o
282,S1889-836X2013000100003,osea,i
282,S1889-836X2013000100003,tras,o
282,S1889-836X2013000100003,1,o
282,S1889-836X2013000100003,año,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,tratamiento,i
282,S1889-836X2013000100003,con,o
282,S1889-836X2013000100003,lactulosa,i
282,S1889-836X2013000100003,asociada,o
282,S1889-836X2013000100003,a,o
282,S1889-836X2013000100003,dosis,o
282,S1889-836X2013000100003,bajas,o
282,S1889-836X2013000100003,de,o
282,S1889-836X2013000100003,calcio,i
282,S1889-836X2013000100003,y,o
282,S1889-836X2013000100003,vitamina,i
282,S1889-836X2013000100003,D,i
283,S2254-28842013000500055,Tratamiento,i
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,anorexia,i
283,S2254-28842013000500055,en,o
283,S2254-28842013000500055,hemodialisis,i
283,S2254-28842013000500055,Placebo,i
283,S2254-28842013000500055,vs,o
283,S2254-28842013000500055,Megestrol,i
283,S2254-28842013000500055,Introduccion,o
283,S2254-28842013000500055,La,o
283,S2254-28842013000500055,anorexia,i
283,S2254-28842013000500055,es,o
283,S2254-28842013000500055,un,o
283,S2254-28842013000500055,sintoma,i
283,S2254-28842013000500055,frecuente,o
283,S2254-28842013000500055,en,o
283,S2254-28842013000500055,el,o
283,S2254-28842013000500055,paciente,o
283,S2254-28842013000500055,dializado,i
283,S2254-28842013000500055,que,o
283,S2254-28842013000500055,le,o
283,S2254-28842013000500055,genera,o
283,S2254-28842013000500055,ansiedad,i
283,S2254-28842013000500055,y,o
283,S2254-28842013000500055,afecta,o
283,S2254-28842013000500055,a,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,calidad,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,vida,o
283,S2254-28842013000500055,percibida,o
283,S2254-28842013000500055,En,o
283,S2254-28842013000500055,muchas,o
283,S2254-28842013000500055,ocasiones,o
283,S2254-28842013000500055,no,o
283,S2254-28842013000500055,se,o
283,S2254-28842013000500055,detecta,o
283,S2254-28842013000500055,un,o
283,S2254-28842013000500055,factor,o
283,S2254-28842013000500055,desencadenante,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,misma,o
283,S2254-28842013000500055,La,o
283,S2254-28842013000500055,respuesta,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,anorexia,i
283,S2254-28842013000500055,a,o
283,S2254-28842013000500055,los,o
283,S2254-28842013000500055,agentes,i
283,S2254-28842013000500055,estimulantes,i
283,S2254-28842013000500055,del,i
283,S2254-28842013000500055,apetito,i
283,S2254-28842013000500055,esta,o
283,S2254-28842013000500055,condicionada,o
283,S2254-28842013000500055,por,o
283,S2254-28842013000500055,el,o
283,S2254-28842013000500055,caracter,o
283,S2254-28842013000500055,subjetivo,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,misma,o
283,S2254-28842013000500055,y,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,sugestibilidad,o
283,S2254-28842013000500055,del,o
283,S2254-28842013000500055,paciente,o
283,S2254-28842013000500055,Para,o
283,S2254-28842013000500055,obviar,o
283,S2254-28842013000500055,este,o
283,S2254-28842013000500055,problema,o
283,S2254-28842013000500055,hemos,o
283,S2254-28842013000500055,estudiado,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,respuesta,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,anorexia,i
283,S2254-28842013000500055,al,o
283,S2254-28842013000500055,acetato,i
283,S2254-28842013000500055,de,i
283,S2254-28842013000500055,megestrol,i
283,S2254-28842013000500055,en,o
283,S2254-28842013000500055,un,o
283,S2254-28842013000500055,estudio,i
283,S2254-28842013000500055,aleatorizado,i
283,S2254-28842013000500055,y,i
283,S2254-28842013000500055,controlado,i
283,S2254-28842013000500055,Material,o
283,S2254-28842013000500055,y,o
283,S2254-28842013000500055,metodos,o
283,S2254-28842013000500055,Durante,o
283,S2254-28842013000500055,los,o
283,S2254-28842013000500055,años,o
283,S2254-28842013000500055,2011,o
283,S2254-28842013000500055,y,o
283,S2254-28842013000500055,2012,o
283,S2254-28842013000500055,fueron,o
283,S2254-28842013000500055,tratados,i
283,S2254-28842013000500055,en,o
283,S2254-28842013000500055,nuestra,o
283,S2254-28842013000500055,Unidad,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,Hemodialisis,o
283,S2254-28842013000500055,122,o
283,S2254-28842013000500055,pacientes,o
283,S2254-28842013000500055,Diecinueve,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,ellos,o
283,S2254-28842013000500055,se,o
283,S2254-28842013000500055,quejaron,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,anorexia,i
283,S2254-28842013000500055,sin,o
283,S2254-28842013000500055,que,o
283,S2254-28842013000500055,hubiera,o
283,S2254-28842013000500055,un,o
283,S2254-28842013000500055,factor,o
283,S2254-28842013000500055,desencadenante,o
283,S2254-28842013000500055,conocido,o
283,S2254-28842013000500055,De,i
283,S2254-28842013000500055,forma,i
283,S2254-28842013000500055,aleatorizada,i
283,S2254-28842013000500055,fueron,o
283,S2254-28842013000500055,tratados,i
283,S2254-28842013000500055,con,o
283,S2254-28842013000500055,acetato,i
283,S2254-28842013000500055,de,i
283,S2254-28842013000500055,megestrol,i
283,S2254-28842013000500055,160,o
283,S2254-28842013000500055,mgdia,o
283,S2254-28842013000500055,10,o
283,S2254-28842013000500055,pacientes,o
283,S2254-28842013000500055,4,o
283,S2254-28842013000500055,varones,o
283,S2254-28842013000500055,y,o
283,S2254-28842013000500055,6,o
283,S2254-28842013000500055,mujeres,o
283,S2254-28842013000500055,y,o
283,S2254-28842013000500055,con,o
283,S2254-28842013000500055,placebo,i
283,S2254-28842013000500055,9,o
283,S2254-28842013000500055,pacientes,o
283,S2254-28842013000500055,4,o
283,S2254-28842013000500055,varones,o
283,S2254-28842013000500055,y,o
283,S2254-28842013000500055,5,o
283,S2254-28842013000500055,mujeres,o
283,S2254-28842013000500055,Hemos,o
283,S2254-28842013000500055,analizado,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,evolucion,o
283,S2254-28842013000500055,durante,o
283,S2254-28842013000500055,tres,o
283,S2254-28842013000500055,meses,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,anorexia,i
283,S2254-28842013000500055,y,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,parametros,o
283,S2254-28842013000500055,basicos,o
283,S2254-28842013000500055,relacionados,o
283,S2254-28842013000500055,con,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,nutricion,o
283,S2254-28842013000500055,La,o
283,S2254-28842013000500055,evolucion,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,anorexia,i
283,S2254-28842013000500055,se,o
283,S2254-28842013000500055,realizo,o
283,S2254-28842013000500055,con,o
283,S2254-28842013000500055,una,o
283,S2254-28842013000500055,escala,o
283,S2254-28842013000500055,Likert,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,apetito,o
283,S2254-28842013000500055,Resultados,o
283,S2254-28842013000500055,En,o
283,S2254-28842013000500055,el,o
283,S2254-28842013000500055,momento,o
283,S2254-28842013000500055,basal,o
283,S2254-28842013000500055,no,o
283,S2254-28842013000500055,hubo,o
283,S2254-28842013000500055,diferencias,o
283,S2254-28842013000500055,en,o
283,S2254-28842013000500055,ambos,o
283,S2254-28842013000500055,grupos,o
283,S2254-28842013000500055,en,o
283,S2254-28842013000500055,lo,o
283,S2254-28842013000500055,que,o
283,S2254-28842013000500055,respecta,o
283,S2254-28842013000500055,a,o
283,S2254-28842013000500055,edad,o
283,S2254-28842013000500055,genero,o
283,S2254-28842013000500055,peso,o
283,S2254-28842013000500055,tiempo,o
283,S2254-28842013000500055,en,o
283,S2254-28842013000500055,dialisis,i
283,S2254-28842013000500055,ni,o
283,S2254-28842013000500055,perdida,i
283,S2254-28842013000500055,de,i
283,S2254-28842013000500055,peso,i
283,S2254-28842013000500055,en,o
283,S2254-28842013000500055,los,o
283,S2254-28842013000500055,dos,o
283,S2254-28842013000500055,meses,o
283,S2254-28842013000500055,previos,o
283,S2254-28842013000500055,A,o
283,S2254-28842013000500055,los,o
283,S2254-28842013000500055,tres,o
283,S2254-28842013000500055,meses,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,tratamiento,i
283,S2254-28842013000500055,refirieron,o
283,S2254-28842013000500055,mejoria,o
283,S2254-28842013000500055,del,o
283,S2254-28842013000500055,apetito,o
283,S2254-28842013000500055,mas,o
283,S2254-28842013000500055,pacientes,o
283,S2254-28842013000500055,en,o
283,S2254-28842013000500055,el,o
283,S2254-28842013000500055,grupo,o
283,S2254-28842013000500055,tratado,i
283,S2254-28842013000500055,con,o
283,S2254-28842013000500055,acetato,i
283,S2254-28842013000500055,de,i
283,S2254-28842013000500055,megestrol,i
283,S2254-28842013000500055,9,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,10,o
283,S2254-28842013000500055,que,o
283,S2254-28842013000500055,en,o
283,S2254-28842013000500055,el,o
283,S2254-28842013000500055,grupo,o
283,S2254-28842013000500055,tratado,i
283,S2254-28842013000500055,con,i
283,S2254-28842013000500055,placebo,i
283,S2254-28842013000500055,4,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,9,o
283,S2254-28842013000500055,p0046,o
283,S2254-28842013000500055,test,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,Fisher,o
283,S2254-28842013000500055,En,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,tabla,o
283,S2254-28842013000500055,se,o
283,S2254-28842013000500055,representa,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,evolucion,o
283,S2254-28842013000500055,del,o
283,S2254-28842013000500055,peso,o
283,S2254-28842013000500055,y,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,otros,o
283,S2254-28842013000500055,parametros,o
283,S2254-28842013000500055,nutricionales,o
283,S2254-28842013000500055,Conclusiones,o
283,S2254-28842013000500055,En,o
283,S2254-28842013000500055,pacientes,o
283,S2254-28842013000500055,dializados,i
283,S2254-28842013000500055,que,o
283,S2254-28842013000500055,se,o
283,S2254-28842013000500055,quejan,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,anorexia,i
283,S2254-28842013000500055,sin,o
283,S2254-28842013000500055,factor,o
283,S2254-28842013000500055,desencadenante,o
283,S2254-28842013000500055,conocido,o
283,S2254-28842013000500055,la,o
283,S2254-28842013000500055,mejoria,o
283,S2254-28842013000500055,subjetiva,o
283,S2254-28842013000500055,del,o
283,S2254-28842013000500055,apetito,o
283,S2254-28842013000500055,es,o
283,S2254-28842013000500055,mayor,o
283,S2254-28842013000500055,con,o
283,S2254-28842013000500055,acetato,i
283,S2254-28842013000500055,de,i
283,S2254-28842013000500055,megestrol,i
283,S2254-28842013000500055,que,o
283,S2254-28842013000500055,con,o
283,S2254-28842013000500055,placebo,i
283,S2254-28842013000500055,Aunque,o
283,S2254-28842013000500055,el,o
283,S2254-28842013000500055,placebo,i
283,S2254-28842013000500055,induce,o
283,S2254-28842013000500055,una,o
283,S2254-28842013000500055,mejoria,o
283,S2254-28842013000500055,del,o
283,S2254-28842013000500055,apetito,o
283,S2254-28842013000500055,en,o
283,S2254-28842013000500055,algunos,o
283,S2254-28842013000500055,pacientes,o
283,S2254-28842013000500055,solamente,o
283,S2254-28842013000500055,en,o
283,S2254-28842013000500055,el,o
283,S2254-28842013000500055,grupo,o
283,S2254-28842013000500055,tratado,i
283,S2254-28842013000500055,con,o
283,S2254-28842013000500055,acetato,i
283,S2254-28842013000500055,de,i
283,S2254-28842013000500055,megestrol,i
283,S2254-28842013000500055,se,o
283,S2254-28842013000500055,consigue,o
283,S2254-28842013000500055,una,o
283,S2254-28842013000500055,mejoria,o
283,S2254-28842013000500055,de,o
283,S2254-28842013000500055,los,o
283,S2254-28842013000500055,parametros,o
283,S2254-28842013000500055,nutricionales,o
283,S2254-28842013000500055,objetivos,o
284,S2254-28842014000100002,Evaluacion,i
284,S2254-28842014000100002,del,i
284,S2254-28842014000100002,dolor,i
284,S2254-28842014000100002,en,o
284,S2254-28842014000100002,la,o
284,S2254-28842014000100002,puncion,i
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,una,o
284,S2254-28842014000100002,fistula,i
284,S2254-28842014000100002,arteriovenosa,i
284,S2254-28842014000100002,para,o
284,S2254-28842014000100002,hemodialisis,i
284,S2254-28842014000100002,comparando,o
284,S2254-28842014000100002,pomada,i
284,S2254-28842014000100002,anestesica,i
284,S2254-28842014000100002,frente,o
284,S2254-28842014000100002,a,o
284,S2254-28842014000100002,frio,i
284,S2254-28842014000100002,local,i
284,S2254-28842014000100002,El,o
284,S2254-28842014000100002,dolor,i
284,S2254-28842014000100002,en,o
284,S2254-28842014000100002,pacientes,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,hemodialisis,i
284,S2254-28842014000100002,no,o
284,S2254-28842014000100002,es,o
284,S2254-28842014000100002,valorado,o
284,S2254-28842014000100002,en,o
284,S2254-28842014000100002,su,o
284,S2254-28842014000100002,totalidad,o
284,S2254-28842014000100002,y,o
284,S2254-28842014000100002,no,o
284,S2254-28842014000100002,se,o
284,S2254-28842014000100002,tiene,o
284,S2254-28842014000100002,en,o
284,S2254-28842014000100002,cuenta,o
284,S2254-28842014000100002,las,o
284,S2254-28842014000100002,limitaciones,o
284,S2254-28842014000100002,que,o
284,S2254-28842014000100002,provoca,o
284,S2254-28842014000100002,en,o
284,S2254-28842014000100002,la,o
284,S2254-28842014000100002,calidad,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,vida,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,estos,o
284,S2254-28842014000100002,pacientes,o
284,S2254-28842014000100002,Se,o
284,S2254-28842014000100002,realizo,o
284,S2254-28842014000100002,un,o
284,S2254-28842014000100002,estudio,i
284,S2254-28842014000100002,observacional,i
284,S2254-28842014000100002,analitico,i
284,S2254-28842014000100002,en,o
284,S2254-28842014000100002,el,o
284,S2254-28842014000100002,que,o
284,S2254-28842014000100002,se,o
284,S2254-28842014000100002,analizo,o
284,S2254-28842014000100002,el,o
284,S2254-28842014000100002,grado,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,dolor,i
284,S2254-28842014000100002,al,o
284,S2254-28842014000100002,que,o
284,S2254-28842014000100002,es,o
284,S2254-28842014000100002,sometido,o
284,S2254-28842014000100002,el,o
284,S2254-28842014000100002,paciente,o
284,S2254-28842014000100002,en,o
284,S2254-28842014000100002,hemodialisis,i
284,S2254-28842014000100002,cuando,o
284,S2254-28842014000100002,se,o
284,S2254-28842014000100002,punciona,i
284,S2254-28842014000100002,su,o
284,S2254-28842014000100002,fistula,i
284,S2254-28842014000100002,arteriovenosa,i
284,S2254-28842014000100002,Para,o
284,S2254-28842014000100002,ello,o
284,S2254-28842014000100002,comparamos,o
284,S2254-28842014000100002,el,o
284,S2254-28842014000100002,dolor,i
284,S2254-28842014000100002,que,o
284,S2254-28842014000100002,producia,o
284,S2254-28842014000100002,dicha,o
284,S2254-28842014000100002,puncion,i
284,S2254-28842014000100002,si,o
284,S2254-28842014000100002,antes,o
284,S2254-28842014000100002,utilizabamos,o
284,S2254-28842014000100002,uno,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,estos,o
284,S2254-28842014000100002,tres,o
284,S2254-28842014000100002,metodos,o
284,S2254-28842014000100002,POMADA,i
284,S2254-28842014000100002,ANESTESICA,i
284,S2254-28842014000100002,Emla,i
284,S2254-28842014000100002,PLACEBO,i
284,S2254-28842014000100002,crema,i
284,S2254-28842014000100002,hidratante,i
284,S2254-28842014000100002,y,o
284,S2254-28842014000100002,HIELO,i
284,S2254-28842014000100002,Tambien,o
284,S2254-28842014000100002,hemos,o
284,S2254-28842014000100002,evaluado,o
284,S2254-28842014000100002,si,o
284,S2254-28842014000100002,el,o
284,S2254-28842014000100002,metodo,o
284,S2254-28842014000100002,utilizado,o
284,S2254-28842014000100002,interfiere,o
284,S2254-28842014000100002,en,o
284,S2254-28842014000100002,los,o
284,S2254-28842014000100002,parametros,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,dialisis,i
284,S2254-28842014000100002,durante,o
284,S2254-28842014000100002,la,o
284,S2254-28842014000100002,sesion,o
284,S2254-28842014000100002,Estudiamos,o
284,S2254-28842014000100002,a,o
284,S2254-28842014000100002,28,o
284,S2254-28842014000100002,pacientes,o
284,S2254-28842014000100002,23,o
284,S2254-28842014000100002,hombres,o
284,S2254-28842014000100002,y,o
284,S2254-28842014000100002,5,o
284,S2254-28842014000100002,mujeres,o
284,S2254-28842014000100002,portadores,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,fistula,i
284,S2254-28842014000100002,Las,o
284,S2254-28842014000100002,variables,o
284,S2254-28842014000100002,medidas,o
284,S2254-28842014000100002,fueron,o
284,S2254-28842014000100002,dolor,i
284,S2254-28842014000100002,escala,o
284,S2254-28842014000100002,EVA,i
284,S2254-28842014000100002,flujo,i
284,S2254-28842014000100002,sanguineo,i
284,S2254-28842014000100002,presion,i
284,S2254-28842014000100002,arterial,i
284,S2254-28842014000100002,presion,i
284,S2254-28842014000100002,venosa,i
284,S2254-28842014000100002,y,o
284,S2254-28842014000100002,tiempo,i
284,S2254-28842014000100002,de,i
284,S2254-28842014000100002,coagulacion,i
284,S2254-28842014000100002,Estas,o
284,S2254-28842014000100002,variables,o
284,S2254-28842014000100002,fueron,o
284,S2254-28842014000100002,recogidas,o
284,S2254-28842014000100002,durante,o
284,S2254-28842014000100002,las,o
284,S2254-28842014000100002,tres,o
284,S2254-28842014000100002,semanas,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,duracion,o
284,S2254-28842014000100002,del,o
284,S2254-28842014000100002,estudio,o
284,S2254-28842014000100002,36,o
284,S2254-28842014000100002,sesiones,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,hemodialisis,i
284,S2254-28842014000100002,en,o
284,S2254-28842014000100002,graficas,o
284,S2254-28842014000100002,Se,o
284,S2254-28842014000100002,analizaron,o
284,S2254-28842014000100002,las,o
284,S2254-28842014000100002,36,o
284,S2254-28842014000100002,sesiones,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,hemodialisis,i
284,S2254-28842014000100002,mediante,o
284,S2254-28842014000100002,el,o
284,S2254-28842014000100002,uso,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,una,o
284,S2254-28842014000100002,grafica,o
284,S2254-28842014000100002,Por,o
284,S2254-28842014000100002,un,o
284,S2254-28842014000100002,lado,o
284,S2254-28842014000100002,observamos,o
284,S2254-28842014000100002,que,o
284,S2254-28842014000100002,el,o
284,S2254-28842014000100002,metodo,o
284,S2254-28842014000100002,elegido,o
284,S2254-28842014000100002,Emla,i
284,S2254-28842014000100002,es,o
284,S2254-28842014000100002,estadisticamente,o
284,S2254-28842014000100002,significativo,o
284,S2254-28842014000100002,pvalor,o
284,S2254-28842014000100002,p0004,o
284,S2254-28842014000100002,por,o
284,S2254-28842014000100002,otro,o
284,S2254-28842014000100002,lado,o
284,S2254-28842014000100002,no,o
284,S2254-28842014000100002,existen,o
284,S2254-28842014000100002,diferencias,o
284,S2254-28842014000100002,significativas,o
284,S2254-28842014000100002,entre,o
284,S2254-28842014000100002,el,o
284,S2254-28842014000100002,metodo,o
284,S2254-28842014000100002,usado,o
284,S2254-28842014000100002,y,o
284,S2254-28842014000100002,el,o
284,S2254-28842014000100002,resto,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,parametros,o
284,S2254-28842014000100002,recogidos,o
284,S2254-28842014000100002,durante,o
284,S2254-28842014000100002,la,o
284,S2254-28842014000100002,sesion,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,hemodialisis,i
284,S2254-28842014000100002,p0194,o
284,S2254-28842014000100002,p0278,o
284,S2254-28842014000100002,p0902,o
284,S2254-28842014000100002,p0445,o
284,S2254-28842014000100002,Con,o
284,S2254-28842014000100002,respecto,o
284,S2254-28842014000100002,al,o
284,S2254-28842014000100002,metodo,o
284,S2254-28842014000100002,utilizado,o
284,S2254-28842014000100002,los,o
284,S2254-28842014000100002,pacientes,o
284,S2254-28842014000100002,eligieron,o
284,S2254-28842014000100002,como,o
284,S2254-28842014000100002,mejor,o
284,S2254-28842014000100002,metodo,o
284,S2254-28842014000100002,la,o
284,S2254-28842014000100002,Emla,i
284,S2254-28842014000100002,con,o
284,S2254-28842014000100002,un,o
284,S2254-28842014000100002,6786,o
284,S2254-28842014000100002,Segun,o
284,S2254-28842014000100002,los,o
284,S2254-28842014000100002,datos,o
284,S2254-28842014000100002,obtenidos,o
284,S2254-28842014000100002,podemos,o
284,S2254-28842014000100002,concluir,o
284,S2254-28842014000100002,que,o
284,S2254-28842014000100002,no,o
284,S2254-28842014000100002,existen,o
284,S2254-28842014000100002,diferencias,o
284,S2254-28842014000100002,estadisticas,o
284,S2254-28842014000100002,en,o
284,S2254-28842014000100002,las,o
284,S2254-28842014000100002,diferentes,o
284,S2254-28842014000100002,variables,o
284,S2254-28842014000100002,estudiadas,o
284,S2254-28842014000100002,El,o
284,S2254-28842014000100002,uso,o
284,S2254-28842014000100002,de,o
284,S2254-28842014000100002,Emla,i
284,S2254-28842014000100002,obtiene,o
284,S2254-28842014000100002,mejor,o
284,S2254-28842014000100002,resultado,o
284,S2254-28842014000100002,en,o
284,S2254-28842014000100002,cuanto,o
284,S2254-28842014000100002,al,o
284,S2254-28842014000100002,dolor,i
284,S2254-28842014000100002,pero,o
284,S2254-28842014000100002,no,o
284,S2254-28842014000100002,varia,o
284,S2254-28842014000100002,ningun,o
284,S2254-28842014000100002,otro,o
284,S2254-28842014000100002,parametro,o
284,S2254-28842014000100002,al,o
284,S2254-28842014000100002,igual,o
284,S2254-28842014000100002,que,o
284,S2254-28842014000100002,los,o
284,S2254-28842014000100002,otros,o
284,S2254-28842014000100002,dos,o
284,S2254-28842014000100002,metodos,o
285,S2254-28842019000300012,Analisis,o
285,S2254-28842019000300012,del,o
285,S2254-28842019000300012,uso,o
285,S2254-28842019000300012,y,o
285,S2254-28842019000300012,complicaciones,i
285,S2254-28842019000300012,del,i
285,S2254-28842019000300012,acceso,i
285,S2254-28842019000300012,vascular,i
285,S2254-28842019000300012,periferico,i
285,S2254-28842019000300012,en,o
285,S2254-28842019000300012,la,o
285,S2254-28842019000300012,tecnica,o
285,S2254-28842019000300012,del,o
285,S2254-28842019000300012,recambio,i
285,S2254-28842019000300012,plasmatico,i
285,S2254-28842019000300012,terapeutico,i
285,S2254-28842019000300012,mediante,o
285,S2254-28842019000300012,centrifugacion,i
285,S2254-28842019000300012,Introduccion,o
285,S2254-28842019000300012,El,o
285,S2254-28842019000300012,recambio,i
285,S2254-28842019000300012,plasmatico,i
285,S2254-28842019000300012,terapeutico,i
285,S2254-28842019000300012,es,o
285,S2254-28842019000300012,una,o
285,S2254-28842019000300012,tecnica,i
285,S2254-28842019000300012,extracorporea,i
285,S2254-28842019000300012,de,i
285,S2254-28842019000300012,depuracion,i
285,S2254-28842019000300012,sanguinea,i
285,S2254-28842019000300012,El,o
285,S2254-28842019000300012,recambio,i
285,S2254-28842019000300012,plasmatico,i
285,S2254-28842019000300012,terapeutico,i
285,S2254-28842019000300012,mediante,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,metodo,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,centrifugacion,i
285,S2254-28842019000300012,plasmacentrifugacion,i
285,S2254-28842019000300012,requiere,o
285,S2254-28842019000300012,flujos,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,50,o
285,S2254-28842019000300012,mlmin,o
285,S2254-28842019000300012,lo,o
285,S2254-28842019000300012,que,o
285,S2254-28842019000300012,permite,o
285,S2254-28842019000300012,realizar,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,intercambio,o
285,S2254-28842019000300012,con,o
285,S2254-28842019000300012,accesos,o
285,S2254-28842019000300012,vasculares,i
285,S2254-28842019000300012,perifericos,o
285,S2254-28842019000300012,El,o
285,S2254-28842019000300012,principal,o
285,S2254-28842019000300012,objetivo,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,este,o
285,S2254-28842019000300012,estudio,o
285,S2254-28842019000300012,fue,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,analizar,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,uso,o
285,S2254-28842019000300012,y,o
285,S2254-28842019000300012,las,o
285,S2254-28842019000300012,complicaciones,i
285,S2254-28842019000300012,del,i
285,S2254-28842019000300012,acceso,i
285,S2254-28842019000300012,vascular,i
285,S2254-28842019000300012,periferico,i
285,S2254-28842019000300012,en,o
285,S2254-28842019000300012,las,o
285,S2254-28842019000300012,sesiones,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,plasmacentrifugacion,i
285,S2254-28842019000300012,Material,o
285,S2254-28842019000300012,y,o
285,S2254-28842019000300012,Metodo,o
285,S2254-28842019000300012,Estudio,i
285,S2254-28842019000300012,observacional,i
285,S2254-28842019000300012,descriptivo,i
285,S2254-28842019000300012,longitudinal,i
285,S2254-28842019000300012,sobre,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,analisis,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,complicaciones,i
285,S2254-28842019000300012,del,i
285,S2254-28842019000300012,acceso,i
285,S2254-28842019000300012,vascular,i
285,S2254-28842019000300012,periferico,i
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,las,o
285,S2254-28842019000300012,sesiones,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,plasmacentrifugacion,i
285,S2254-28842019000300012,realizadas,o
285,S2254-28842019000300012,entre,o
285,S2254-28842019000300012,enero,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,2017,o
285,S2254-28842019000300012,y,o
285,S2254-28842019000300012,marzo,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,2018,o
285,S2254-28842019000300012,Resultados,o
285,S2254-28842019000300012,Inclusion,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,un,o
285,S2254-28842019000300012,total,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,93,o
285,S2254-28842019000300012,sesiones,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,plasmacentrifugacion,i
285,S2254-28842019000300012,estas,o
285,S2254-28842019000300012,sesiones,o
285,S2254-28842019000300012,fueron,o
285,S2254-28842019000300012,llevadas,o
285,S2254-28842019000300012,a,o
285,S2254-28842019000300012,cabo,o
285,S2254-28842019000300012,en,o
285,S2254-28842019000300012,9,o
285,S2254-28842019000300012,pacientes,o
285,S2254-28842019000300012,con,o
285,S2254-28842019000300012,una,o
285,S2254-28842019000300012,mediana,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,7,o
285,S2254-28842019000300012,P256,o
285,S2254-28842019000300012,P75105,o
285,S2254-28842019000300012,sesiones,o
285,S2254-28842019000300012,por,o
285,S2254-28842019000300012,paciente,o
285,S2254-28842019000300012,El,o
285,S2254-28842019000300012,6666,o
285,S2254-28842019000300012,n6,o
285,S2254-28842019000300012,fueron,o
285,S2254-28842019000300012,mujeres,o
285,S2254-28842019000300012,En,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,8924,o
285,S2254-28842019000300012,n83,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,las,o
285,S2254-28842019000300012,sesiones,o
285,S2254-28842019000300012,se,o
285,S2254-28842019000300012,uso,o
285,S2254-28842019000300012,la,o
285,S2254-28842019000300012,centrifugacion,i
285,S2254-28842019000300012,y,o
285,S2254-28842019000300012,en,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,1075,o
285,S2254-28842019000300012,n10,o
285,S2254-28842019000300012,la,o
285,S2254-28842019000300012,fotoaferesis,i
285,S2254-28842019000300012,La,o
285,S2254-28842019000300012,etiologia,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,enfermedad,i
285,S2254-28842019000300012,para,o
285,S2254-28842019000300012,estos,o
285,S2254-28842019000300012,pacientes,o
285,S2254-28842019000300012,fue,o
285,S2254-28842019000300012,renal,i
285,S2254-28842019000300012,en,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,5555,o
285,S2254-28842019000300012,n5,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,los,o
285,S2254-28842019000300012,casos,o
285,S2254-28842019000300012,neurologica,i
285,S2254-28842019000300012,en,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,3333,o
285,S2254-28842019000300012,n3,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,los,o
285,S2254-28842019000300012,casos,o
285,S2254-28842019000300012,y,o
285,S2254-28842019000300012,dermatologica,i
285,S2254-28842019000300012,en,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,1111,o
285,S2254-28842019000300012,n1,o
285,S2254-28842019000300012,De,o
285,S2254-28842019000300012,las,o
285,S2254-28842019000300012,93,o
285,S2254-28842019000300012,sesiones,o
285,S2254-28842019000300012,totales,o
285,S2254-28842019000300012,hubo,o
285,S2254-28842019000300012,problemas,o
285,S2254-28842019000300012,relacionados,o
285,S2254-28842019000300012,con,o
285,S2254-28842019000300012,la,o
285,S2254-28842019000300012,canalizacion,i
285,S2254-28842019000300012,de,i
285,S2254-28842019000300012,un,i
285,S2254-28842019000300012,acceso,i
285,S2254-28842019000300012,vascular,i
285,S2254-28842019000300012,periferico,i
285,S2254-28842019000300012,en,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,5269,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,las,o
285,S2254-28842019000300012,sesiones,o
285,S2254-28842019000300012,n49,o
285,S2254-28842019000300012,Conclusiones,o
285,S2254-28842019000300012,Debido,o
285,S2254-28842019000300012,a,o
285,S2254-28842019000300012,que,o
285,S2254-28842019000300012,en,o
285,S2254-28842019000300012,mas,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,la,o
285,S2254-28842019000300012,mitad,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,las,o
285,S2254-28842019000300012,sesiones,o
285,S2254-28842019000300012,se,o
285,S2254-28842019000300012,presentaron,o
285,S2254-28842019000300012,complicaciones,i
285,S2254-28842019000300012,en,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,abordaje,o
285,S2254-28842019000300012,del,o
285,S2254-28842019000300012,acceso,o
285,S2254-28842019000300012,vascular,i
285,S2254-28842019000300012,periferico,o
285,S2254-28842019000300012,se,o
285,S2254-28842019000300012,concluye,o
285,S2254-28842019000300012,que,o
285,S2254-28842019000300012,es,o
285,S2254-28842019000300012,necesario,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,estudio,i
285,S2254-28842019000300012,vascular,i
285,S2254-28842019000300012,ambulatorio,o
285,S2254-28842019000300012,del,o
285,S2254-28842019000300012,paciente,o
285,S2254-28842019000300012,antes,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,la,o
285,S2254-28842019000300012,primera,o
285,S2254-28842019000300012,sesion,o
285,S2254-28842019000300012,pudiendo,o
285,S2254-28842019000300012,ser,o
285,S2254-28842019000300012,util,o
285,S2254-28842019000300012,el,o
285,S2254-28842019000300012,uso,o
285,S2254-28842019000300012,de,o
285,S2254-28842019000300012,la,o
285,S2254-28842019000300012,puncion,i
285,S2254-28842019000300012,ecoguiada,i
286,S2304-51322017000400004,Evaluacion,i
286,S2304-51322017000400004,de,i
286,S2304-51322017000400004,la,i
286,S2304-51322017000400004,mejoria,i
286,S2304-51322017000400004,de,i
286,S2304-51322017000400004,la,i
286,S2304-51322017000400004,sexualidad,i
286,S2304-51322017000400004,en,o
286,S2304-51322017000400004,mujeres,o
286,S2304-51322017000400004,intervenidas,i
286,S2304-51322017000400004,por,o
286,S2304-51322017000400004,incontinencia,i
286,S2304-51322017000400004,urinaria,i
286,S2304-51322017000400004,La,o
286,S2304-51322017000400004,incontinencia,i
286,S2304-51322017000400004,urinaria,i
286,S2304-51322017000400004,IU,i
286,S2304-51322017000400004,afecta,o
286,S2304-51322017000400004,1,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,cada,o
286,S2304-51322017000400004,4,o
286,S2304-51322017000400004,mujeres,o
286,S2304-51322017000400004,presentandose,o
286,S2304-51322017000400004,a,o
286,S2304-51322017000400004,cualquier,o
286,S2304-51322017000400004,edad,o
286,S2304-51322017000400004,Son,o
286,S2304-51322017000400004,muchos,o
286,S2304-51322017000400004,los,o
286,S2304-51322017000400004,factores,o
286,S2304-51322017000400004,involucrados,o
286,S2304-51322017000400004,en,o
286,S2304-51322017000400004,su,o
286,S2304-51322017000400004,aparicion,o
286,S2304-51322017000400004,pero,o
286,S2304-51322017000400004,el,o
286,S2304-51322017000400004,debilitamiento,i
286,S2304-51322017000400004,del,o
286,S2304-51322017000400004,suelo,i
286,S2304-51322017000400004,pelvico,i
286,S2304-51322017000400004,es,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,principal,o
286,S2304-51322017000400004,causa,o
286,S2304-51322017000400004,Objetivo,o
286,S2304-51322017000400004,Analizar,i
286,S2304-51322017000400004,la,i
286,S2304-51322017000400004,funcion,i
286,S2304-51322017000400004,sexual,i
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,las,o
286,S2304-51322017000400004,mujeres,o
286,S2304-51322017000400004,despues,o
286,S2304-51322017000400004,del,o
286,S2304-51322017000400004,manejo,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,IU,i
286,S2304-51322017000400004,con,o
286,S2304-51322017000400004,rehabilitacion,i
286,S2304-51322017000400004,o,o
286,S2304-51322017000400004,el,o
286,S2304-51322017000400004,uso,i
286,S2304-51322017000400004,del,i
286,S2304-51322017000400004,laser,i
286,S2304-51322017000400004,Diseño,o
286,S2304-51322017000400004,Ensayo,o
286,S2304-51322017000400004,clinico,o
286,S2304-51322017000400004,aleatorizado,o
286,S2304-51322017000400004,prospectivo,o
286,S2304-51322017000400004,controlado,o
286,S2304-51322017000400004,y,o
286,S2304-51322017000400004,abierto,o
286,S2304-51322017000400004,Participantes,o
286,S2304-51322017000400004,Mujeres,o
286,S2304-51322017000400004,que,o
286,S2304-51322017000400004,consultaron,i
286,S2304-51322017000400004,por,o
286,S2304-51322017000400004,IU,i
286,S2304-51322017000400004,en,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,Clinica,o
286,S2304-51322017000400004,La,o
286,S2304-51322017000400004,Sagrada,o
286,S2304-51322017000400004,Familia,o
286,S2304-51322017000400004,Armenia,o
286,S2304-51322017000400004,Quindio,o
286,S2304-51322017000400004,Colombia,o
286,S2304-51322017000400004,Intervenciones,i
286,S2304-51322017000400004,Las,o
286,S2304-51322017000400004,mujeres,o
286,S2304-51322017000400004,diagnosticadas,i
286,S2304-51322017000400004,con,o
286,S2304-51322017000400004,incontinencia,i
286,S2304-51322017000400004,urinaria,i
286,S2304-51322017000400004,fueron,o
286,S2304-51322017000400004,tratadas,i
286,S2304-51322017000400004,con,i
286,S2304-51322017000400004,rehabilitacion,i
286,S2304-51322017000400004,y,o
286,S2304-51322017000400004,uso,i
286,S2304-51322017000400004,de,i
286,S2304-51322017000400004,laser,i
286,S2304-51322017000400004,entre,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,enero,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,2015,o
286,S2304-51322017000400004,y,o
286,S2304-51322017000400004,abril,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,2017,o
286,S2304-51322017000400004,Principales,o
286,S2304-51322017000400004,medidas,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,resultados,o
286,S2304-51322017000400004,Evaluacion,i
286,S2304-51322017000400004,de,i
286,S2304-51322017000400004,la,i
286,S2304-51322017000400004,sexualidad,i
286,S2304-51322017000400004,luego,o
286,S2304-51322017000400004,del,o
286,S2304-51322017000400004,manejo,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,IU,i
286,S2304-51322017000400004,con,o
286,S2304-51322017000400004,rehabilitacion,i
286,S2304-51322017000400004,o,o
286,S2304-51322017000400004,uso,i
286,S2304-51322017000400004,de,i
286,S2304-51322017000400004,laser,i
286,S2304-51322017000400004,Resultados,o
286,S2304-51322017000400004,Se,o
286,S2304-51322017000400004,analizaron,o
286,S2304-51322017000400004,45,o
286,S2304-51322017000400004,mujeres,o
286,S2304-51322017000400004,edad,o
286,S2304-51322017000400004,promedio,o
286,S2304-51322017000400004,47199,o
286,S2304-51322017000400004,años,o
286,S2304-51322017000400004,En,o
286,S2304-51322017000400004,el,o
286,S2304-51322017000400004,total,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,poblacion,o
286,S2304-51322017000400004,estudiada,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,prevalencia,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,IU,i
286,S2304-51322017000400004,de,i
286,S2304-51322017000400004,esfuerzo,i
286,S2304-51322017000400004,fue,o
286,S2304-51322017000400004,555,o
286,S2304-51322017000400004,355,o
286,S2304-51322017000400004,con,o
286,S2304-51322017000400004,IU,i
286,S2304-51322017000400004,mixta,i
286,S2304-51322017000400004,y,o
286,S2304-51322017000400004,88,o
286,S2304-51322017000400004,con,o
286,S2304-51322017000400004,IU,i
286,S2304-51322017000400004,de,i
286,S2304-51322017000400004,urgencia,i
286,S2304-51322017000400004,el,o
286,S2304-51322017000400004,866,o
286,S2304-51322017000400004,tenia,o
286,S2304-51322017000400004,laxitud,o
286,S2304-51322017000400004,vaginal,i
286,S2304-51322017000400004,en,o
286,S2304-51322017000400004,288,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,IU,i
286,S2304-51322017000400004,se,o
286,S2304-51322017000400004,presentaba,o
286,S2304-51322017000400004,durante,o
286,S2304-51322017000400004,el,o
286,S2304-51322017000400004,coito,o
286,S2304-51322017000400004,y,o
286,S2304-51322017000400004,en,o
286,S2304-51322017000400004,311,o
286,S2304-51322017000400004,se,o
286,S2304-51322017000400004,observo,o
286,S2304-51322017000400004,prolapso,i
286,S2304-51322017000400004,anterior,i
286,S2304-51322017000400004,mayor,o
286,S2304-51322017000400004,o,o
286,S2304-51322017000400004,igual,o
286,S2304-51322017000400004,al,o
286,S2304-51322017000400004,grado,o
286,S2304-51322017000400004,II,o
286,S2304-51322017000400004,El,o
286,S2304-51322017000400004,indice,o
286,S2304-51322017000400004,funcion,o
286,S2304-51322017000400004,sexual,o
286,S2304-51322017000400004,femenina,o
286,S2304-51322017000400004,en,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,poblacion,o
286,S2304-51322017000400004,general,o
286,S2304-51322017000400004,fue,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,26451,o
286,S2304-51322017000400004,puntos,o
286,S2304-51322017000400004,al,o
286,S2304-51322017000400004,inicio,o
286,S2304-51322017000400004,del,o
286,S2304-51322017000400004,tratamiento,i
286,S2304-51322017000400004,en,o
286,S2304-51322017000400004,el,o
286,S2304-51322017000400004,grupo,o
286,S2304-51322017000400004,A,o
286,S2304-51322017000400004,fue,o
286,S2304-51322017000400004,27357,o
286,S2304-51322017000400004,y,o
286,S2304-51322017000400004,en,o
286,S2304-51322017000400004,el,o
286,S2304-51322017000400004,grupo,o
286,S2304-51322017000400004,B,o
286,S2304-51322017000400004,26754,o
286,S2304-51322017000400004,A,o
286,S2304-51322017000400004,las,o
286,S2304-51322017000400004,18,o
286,S2304-51322017000400004,semanas,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,ultima,o
286,S2304-51322017000400004,sesion,o
286,S2304-51322017000400004,fue,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,30951,o
286,S2304-51322017000400004,y,o
286,S2304-51322017000400004,32733,o
286,S2304-51322017000400004,respectivamente,o
286,S2304-51322017000400004,Se,o
286,S2304-51322017000400004,observo,o
286,S2304-51322017000400004,una,o
286,S2304-51322017000400004,prevalencia,o
286,S2304-51322017000400004,inicial,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,trastornos,i
286,S2304-51322017000400004,sexuales,i
286,S2304-51322017000400004,para,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,poblacion,o
286,S2304-51322017000400004,general,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,866,o
286,S2304-51322017000400004,y,o
286,S2304-51322017000400004,al,o
286,S2304-51322017000400004,final,o
286,S2304-51322017000400004,del,o
286,S2304-51322017000400004,155,o
286,S2304-51322017000400004,Conclusiones,o
286,S2304-51322017000400004,Las,o
286,S2304-51322017000400004,mujeres,o
286,S2304-51322017000400004,sometidas,o
286,S2304-51322017000400004,a,o
286,S2304-51322017000400004,rehabilitacion,i
286,S2304-51322017000400004,tuvieron,o
286,S2304-51322017000400004,mejoria,o
286,S2304-51322017000400004,en,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,respuesta,o
286,S2304-51322017000400004,sexual,o
286,S2304-51322017000400004,La,o
286,S2304-51322017000400004,efectividad,o
286,S2304-51322017000400004,del,o
286,S2304-51322017000400004,laser,o
286,S2304-51322017000400004,en,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,resolucion,o
286,S2304-51322017000400004,de,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,IU,i
286,S2304-51322017000400004,fue,o
286,S2304-51322017000400004,superior,o
286,S2304-51322017000400004,a,o
286,S2304-51322017000400004,la,o
286,S2304-51322017000400004,rehabilitacion,i
287,S2304-51322018000400016,Cirugia,i
287,S2304-51322018000400016,fetal,i
287,S2304-51322018000400016,en,o
287,S2304-51322018000400016,tumores,i
287,S2304-51322018000400016,pulmonares,i
287,S2304-51322018000400016,mediante,o
287,S2304-51322018000400016,escleroterapia,i
287,S2304-51322018000400016,Las,o
287,S2304-51322018000400016,tumoraciones,i
287,S2304-51322018000400016,o,o
287,S2304-51322018000400016,masas,i
287,S2304-51322018000400016,pulmonares,i
287,S2304-51322018000400016,fetales,i
287,S2304-51322018000400016,microquisticas,i
287,S2304-51322018000400016,tales,o
287,S2304-51322018000400016,como,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,malformacion,i
287,S2304-51322018000400016,adenomatoidea,i
287,S2304-51322018000400016,quistica,i
287,S2304-51322018000400016,congenita,i
287,S2304-51322018000400016,CCAM,i
287,S2304-51322018000400016,por,o
287,S2304-51322018000400016,sus,o
287,S2304-51322018000400016,siglas,o
287,S2304-51322018000400016,en,o
287,S2304-51322018000400016,ingles,o
287,S2304-51322018000400016,y,o
287,S2304-51322018000400016,el,o
287,S2304-51322018000400016,secuestro,i
287,S2304-51322018000400016,bronco,i
287,S2304-51322018000400016,pulmonar,i
287,S2304-51322018000400016,SBP,o
287,S2304-51322018000400016,representan,o
287,S2304-51322018000400016,patologias,i
287,S2304-51322018000400016,congenitas,i
287,S2304-51322018000400016,poco,o
287,S2304-51322018000400016,frecuentes,o
287,S2304-51322018000400016,diagnosticadas,i
287,S2304-51322018000400016,por,i
287,S2304-51322018000400016,ultrasonido,i
287,S2304-51322018000400016,durante,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,evaluacion,i
287,S2304-51322018000400016,prenatal,i
287,S2304-51322018000400016,con,o
287,S2304-51322018000400016,un,o
287,S2304-51322018000400016,alto,o
287,S2304-51322018000400016,indice,o
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,mortalidad,o
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,95,o
287,S2304-51322018000400016,como,o
287,S2304-51322018000400016,consecuencia,o
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,las,o
287,S2304-51322018000400016,complicaciones,i
287,S2304-51322018000400016,prenatales,i
287,S2304-51322018000400016,por,o
287,S2304-51322018000400016,hidropesia,i
287,S2304-51322018000400016,y,o
287,S2304-51322018000400016,fallecimiento,i
287,S2304-51322018000400016,posnatal,o
287,S2304-51322018000400016,debido,o
287,S2304-51322018000400016,a,o
287,S2304-51322018000400016,hipoplasia,i
287,S2304-51322018000400016,pulmonar,i
287,S2304-51322018000400016,Las,o
287,S2304-51322018000400016,terapias,i
287,S2304-51322018000400016,de,i
287,S2304-51322018000400016,minima,i
287,S2304-51322018000400016,invasion,i
287,S2304-51322018000400016,usando,o
287,S2304-51322018000400016,agentes,i
287,S2304-51322018000400016,esclerosantes,i
287,S2304-51322018000400016,han,o
287,S2304-51322018000400016,tomado,o
287,S2304-51322018000400016,posicionamiento,o
287,S2304-51322018000400016,entre,o
287,S2304-51322018000400016,las,o
287,S2304-51322018000400016,tecnicas,o
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,bajo,o
287,S2304-51322018000400016,costo,o
287,S2304-51322018000400016,y,o
287,S2304-51322018000400016,alta,o
287,S2304-51322018000400016,efectividad,o
287,S2304-51322018000400016,para,o
287,S2304-51322018000400016,dichas,o
287,S2304-51322018000400016,patologias,i
287,S2304-51322018000400016,Metodologia,o
287,S2304-51322018000400016,Se,o
287,S2304-51322018000400016,realizo,o
287,S2304-51322018000400016,un,o
287,S2304-51322018000400016,estudio,o
287,S2304-51322018000400016,clinico,o
287,S2304-51322018000400016,prospectivo,o
287,S2304-51322018000400016,aleatorio,o
287,S2304-51322018000400016,ciego,o
287,S2304-51322018000400016,en,o
287,S2304-51322018000400016,17,o
287,S2304-51322018000400016,embarazadas,o
287,S2304-51322018000400016,con,o
287,S2304-51322018000400016,diagnostico,i
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,CCAM,i
287,S2304-51322018000400016,microquistica,i
287,S2304-51322018000400016,o,o
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,lesion,i
287,S2304-51322018000400016,hibrida,o
287,S2304-51322018000400016,CCAM,i
287,S2304-51322018000400016,SBP,o
287,S2304-51322018000400016,tratadas,i
287,S2304-51322018000400016,con,o
287,S2304-51322018000400016,betametasona,i
287,S2304-51322018000400016,o,o
287,S2304-51322018000400016,con,o
287,S2304-51322018000400016,polidocanol,i
287,S2304-51322018000400016,optando,o
287,S2304-51322018000400016,por,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,terapia,i
287,S2304-51322018000400016,alternativa,i
287,S2304-51322018000400016,en,o
287,S2304-51322018000400016,caso,o
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,fallar,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,tecnica,o
287,S2304-51322018000400016,inicial,o
287,S2304-51322018000400016,Resultados,o
287,S2304-51322018000400016,En,o
287,S2304-51322018000400016,49,o
287,S2304-51322018000400016,444,o
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,los,o
287,S2304-51322018000400016,9,o
287,S2304-51322018000400016,casos,o
287,S2304-51322018000400016,tratados,i
287,S2304-51322018000400016,con,o
287,S2304-51322018000400016,betametasona,i
287,S2304-51322018000400016,se,o
287,S2304-51322018000400016,requirio,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,terapia,i
287,S2304-51322018000400016,alternativa,i
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,esclerosis,i
287,S2304-51322018000400016,con,o
287,S2304-51322018000400016,polidocanol,i
287,S2304-51322018000400016,para,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,resolucion,o
287,S2304-51322018000400016,del,o
287,S2304-51322018000400016,cuadro,o
287,S2304-51322018000400016,que,o
287,S2304-51322018000400016,comprometia,o
287,S2304-51322018000400016,el,o
287,S2304-51322018000400016,estado,o
287,S2304-51322018000400016,fetal,i
287,S2304-51322018000400016,La,o
287,S2304-51322018000400016,involucion,o
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,lesion,i
287,S2304-51322018000400016,pulmonar,i
287,S2304-51322018000400016,y,o
287,S2304-51322018000400016,del,o
287,S2304-51322018000400016,cuadro,i
287,S2304-51322018000400016,hidropico,i
287,S2304-51322018000400016,fue,o
287,S2304-51322018000400016,mas,o
287,S2304-51322018000400016,rapida,o
287,S2304-51322018000400016,y,o
287,S2304-51322018000400016,progresiva,o
287,S2304-51322018000400016,con,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,escleroterapia,i
287,S2304-51322018000400016,percutanea,i
287,S2304-51322018000400016,en,o
287,S2304-51322018000400016,comparacion,o
287,S2304-51322018000400016,con,o
287,S2304-51322018000400016,el,o
287,S2304-51322018000400016,efecto,o
287,S2304-51322018000400016,esteroideo,o
287,S2304-51322018000400016,materno,o
287,S2304-51322018000400016,Los,o
287,S2304-51322018000400016,resultados,o
287,S2304-51322018000400016,perinatales,o
287,S2304-51322018000400016,fueron,o
287,S2304-51322018000400016,asimismo,o
287,S2304-51322018000400016,mas,o
287,S2304-51322018000400016,satisfactorios,o
287,S2304-51322018000400016,en,o
287,S2304-51322018000400016,el,o
287,S2304-51322018000400016,grupo,o
287,S2304-51322018000400016,con,o
287,S2304-51322018000400016,polidocanol,i
287,S2304-51322018000400016,917,o
287,S2304-51322018000400016,que,o
287,S2304-51322018000400016,en,o
287,S2304-51322018000400016,el,o
287,S2304-51322018000400016,grupo,o
287,S2304-51322018000400016,con,o
287,S2304-51322018000400016,el,o
287,S2304-51322018000400016,esteroide,i
287,S2304-51322018000400016,60,o
287,S2304-51322018000400016,Conclusiones,o
287,S2304-51322018000400016,Se,o
287,S2304-51322018000400016,comprobo,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,eficacia,o
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,escleroterapia,i
287,S2304-51322018000400016,percutanea,i
287,S2304-51322018000400016,con,o
287,S2304-51322018000400016,polidocanol,i
287,S2304-51322018000400016,para,o
287,S2304-51322018000400016,el,o
287,S2304-51322018000400016,tratamiento,i
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,CCAM,i
287,S2304-51322018000400016,y,o
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,lesion,i
287,S2304-51322018000400016,hibrida,o
287,S2304-51322018000400016,con,o
287,S2304-51322018000400016,resolucion,o
287,S2304-51322018000400016,mas,o
287,S2304-51322018000400016,rapida,o
287,S2304-51322018000400016,y,o
287,S2304-51322018000400016,eficaz,o
287,S2304-51322018000400016,de,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,patologia,i
287,S2304-51322018000400016,en,o
287,S2304-51322018000400016,los,o
287,S2304-51322018000400016,casos,o
287,S2304-51322018000400016,donde,o
287,S2304-51322018000400016,existia,o
287,S2304-51322018000400016,resistencia,i
287,S2304-51322018000400016,a,o
287,S2304-51322018000400016,la,o
287,S2304-51322018000400016,terapia,i
287,S2304-51322018000400016,esteroidea,i
287,S2304-51322018000400016,previamente,o
287,S2304-51322018000400016,administrada,o
288,S2306-41022014000300003,Efectividad,o
288,S2306-41022014000300003,de,o
288,S2306-41022014000300003,dos,o
288,S2306-41022014000300003,medicamentos,i
288,S2306-41022014000300003,intrarticulares,o
288,S2306-41022014000300003,en,o
288,S2306-41022014000300003,pacientes,o
288,S2306-41022014000300003,con,o
288,S2306-41022014000300003,artrosis,i
288,S2306-41022014000300003,de,i
288,S2306-41022014000300003,rodilla,i
288,S2306-41022014000300003,colageno,i
288,S2306-41022014000300003,polimerizado,i
288,S2306-41022014000300003,versus,o
288,S2306-41022014000300003,hylano,i
288,S2306-41022014000300003,gf,i
288,S2306-41022014000300003,20,i
288,S2306-41022014000300003,El,o
288,S2306-41022014000300003,tratamiento,i
288,S2306-41022014000300003,de,o
288,S2306-41022014000300003,la,o
288,S2306-41022014000300003,osteoartrosis,i
288,S2306-41022014000300003,se,o
288,S2306-41022014000300003,enfoca,o
288,S2306-41022014000300003,en,o
288,S2306-41022014000300003,mejorar,o
288,S2306-41022014000300003,el,o
288,S2306-41022014000300003,dolor,i
288,S2306-41022014000300003,y,o
288,S2306-41022014000300003,la,o
288,S2306-41022014000300003,calidad,o
288,S2306-41022014000300003,de,o
288,S2306-41022014000300003,vida,o
288,S2306-41022014000300003,de,o
288,S2306-41022014000300003,los,o
288,S2306-41022014000300003,portadores,o
288,S2306-41022014000300003,Los,o
288,S2306-41022014000300003,antiinflamatorios,i
288,S2306-41022014000300003,no,i
288,S2306-41022014000300003,esteroideos,i
288,S2306-41022014000300003,son,o
288,S2306-41022014000300003,la,o
288,S2306-41022014000300003,primera,o
288,S2306-41022014000300003,eleccion,o
288,S2306-41022014000300003,pero,o
288,S2306-41022014000300003,su,o
288,S2306-41022014000300003,efectividad,o
288,S2306-41022014000300003,es,o
288,S2306-41022014000300003,cuestionable,o
288,S2306-41022014000300003,por,o
288,S2306-41022014000300003,el,o
288,S2306-41022014000300003,riesgo,o
288,S2306-41022014000300003,de,o
288,S2306-41022014000300003,gastropatia,i
288,S2306-41022014000300003,y,o
288,S2306-41022014000300003,falla,i
288,S2306-41022014000300003,renal,i
288,S2306-41022014000300003,secundarias,o
288,S2306-41022014000300003,Los,o
288,S2306-41022014000300003,medicamentos,i
288,S2306-41022014000300003,de,o
288,S2306-41022014000300003,uso,o
288,S2306-41022014000300003,intrarticular,o
288,S2306-41022014000300003,son,o
288,S2306-41022014000300003,una,o
288,S2306-41022014000300003,alternativa,o
288,S2306-41022014000300003,segura,o
288,S2306-41022014000300003,y,o
288,S2306-41022014000300003,efectiva,o
288,S2306-41022014000300003,para,o
288,S2306-41022014000300003,mejorar,o
288,S2306-41022014000300003,los,o
288,S2306-41022014000300003,sintomas,i
288,S2306-41022014000300003,y,o
288,S2306-41022014000300003,la,o
288,S2306-41022014000300003,funcion,o
288,S2306-41022014000300003,pueden,o
288,S2306-41022014000300003,retrasar,o
288,S2306-41022014000300003,la,o
288,S2306-41022014000300003,cirugia,i
288,S2306-41022014000300003,pero,o
288,S2306-41022014000300003,desconocemos,o
288,S2306-41022014000300003,si,o
288,S2306-41022014000300003,son,o
288,S2306-41022014000300003,modificadores,o
288,S2306-41022014000300003,de,o
288,S2306-41022014000300003,la,o
288,S2306-41022014000300003,enfermedad,i
288,S2306-41022014000300003,Nuestro,o
288,S2306-41022014000300003,objetivo,o
288,S2306-41022014000300003,fue,o
288,S2306-41022014000300003,comparar,o
288,S2306-41022014000300003,la,o
288,S2306-41022014000300003,funcion,o
288,S2306-41022014000300003,y,o
288,S2306-41022014000300003,dolor,i
288,S2306-41022014000300003,de,i
288,S2306-41022014000300003,rodilla,i
288,S2306-41022014000300003,en,o
288,S2306-41022014000300003,pacientes,o
288,S2306-41022014000300003,con,o
288,S2306-41022014000300003,osteoartrosis,i
288,S2306-41022014000300003,al,o
288,S2306-41022014000300003,termino,o
288,S2306-41022014000300003,del,o
288,S2306-41022014000300003,tratamiento,i
288,S2306-41022014000300003,asignado,o
288,S2306-41022014000300003,Nuestra,o
288,S2306-41022014000300003,hipotesis,o
288,S2306-41022014000300003,es,o
288,S2306-41022014000300003,que,o
288,S2306-41022014000300003,no,o
288,S2306-41022014000300003,existe,o
288,S2306-41022014000300003,diferencia,o
288,S2306-41022014000300003,en,o
288,S2306-41022014000300003,los,o
288,S2306-41022014000300003,resultados,o
288,S2306-41022014000300003,entre,o
288,S2306-41022014000300003,ambos,o
288,S2306-41022014000300003,grupos,o
288,S2306-41022014000300003,Material,o
288,S2306-41022014000300003,y,o
288,S2306-41022014000300003,metodos,o
288,S2306-41022014000300003,Estudio,o
288,S2306-41022014000300003,prospectivo,o
288,S2306-41022014000300003,aleatorio,o
288,S2306-41022014000300003,simple,o
288,S2306-41022014000300003,no,o
288,S2306-41022014000300003,cegado,o
288,S2306-41022014000300003,estudiamos,o
288,S2306-41022014000300003,a,o
288,S2306-41022014000300003,dos,o
288,S2306-41022014000300003,grupos,o
288,S2306-41022014000300003,de,o
288,S2306-41022014000300003,pacientes,o
288,S2306-41022014000300003,con,o
288,S2306-41022014000300003,osteoartrosis,i
288,S2306-41022014000300003,de,i
288,S2306-41022014000300003,rodilla,i
288,S2306-41022014000300003,El,o
288,S2306-41022014000300003,Grupo,o
288,S2306-41022014000300003,1,o
288,S2306-41022014000300003,fue,o
288,S2306-41022014000300003,tratado,i
288,S2306-41022014000300003,con,o
288,S2306-41022014000300003,colageno,i
288,S2306-41022014000300003,PVP,i
288,S2306-41022014000300003,y,o
288,S2306-41022014000300003,el,o
288,S2306-41022014000300003,Grupo,o
288,S2306-41022014000300003,2,o
288,S2306-41022014000300003,recibio,o
288,S2306-41022014000300003,hylano,o
288,S2306-41022014000300003,GF20,o
288,S2306-41022014000300003,Se,o
288,S2306-41022014000300003,les,o
288,S2306-41022014000300003,aplico,i
288,S2306-41022014000300003,el,i
288,S2306-41022014000300003,cuestionario,i
288,S2306-41022014000300003,subjetivo,o
288,S2306-41022014000300003,del,o
288,S2306-41022014000300003,Comite,o
288,S2306-41022014000300003,Internacional,o
288,S2306-41022014000300003,de,o
288,S2306-41022014000300003,Rodilla,o
288,S2306-41022014000300003,IKDC,o
288,S2306-41022014000300003,y,o
288,S2306-41022014000300003,el,o
288,S2306-41022014000300003,dolor,i
288,S2306-41022014000300003,se,o
288,S2306-41022014000300003,midio,o
288,S2306-41022014000300003,mediante,o
288,S2306-41022014000300003,escala,i
288,S2306-41022014000300003,visual,i
288,S2306-41022014000300003,analoga,i
288,S2306-41022014000300003,al,o
288,S2306-41022014000300003,inicio,o
288,S2306-41022014000300003,del,o
288,S2306-41022014000300003,tratamiento,i
288,S2306-41022014000300003,al,o
288,S2306-41022014000300003,mes,o
288,S2306-41022014000300003,y,o
288,S2306-41022014000300003,tres,o
288,S2306-41022014000300003,meses,o
288,S2306-41022014000300003,posteriores,o
288,S2306-41022014000300003,al,o
288,S2306-41022014000300003,termino,o
288,S2306-41022014000300003,del,o
288,S2306-41022014000300003,mismo,o
288,S2306-41022014000300003,Resultados,o
288,S2306-41022014000300003,La,o
288,S2306-41022014000300003,disminucion,o
288,S2306-41022014000300003,en,o
288,S2306-41022014000300003,el,o
288,S2306-41022014000300003,dolor,i
288,S2306-41022014000300003,medido,o
288,S2306-41022014000300003,con,o
288,S2306-41022014000300003,escala,i
288,S2306-41022014000300003,visual,i
288,S2306-41022014000300003,analoga,i
288,S2306-41022014000300003,resulta,o
288,S2306-41022014000300003,estadisticamente,o
288,S2306-41022014000300003,significativa,o
288,S2306-41022014000300003,en,o
288,S2306-41022014000300003,ambos,o
288,S2306-41022014000300003,grupos,o
288,S2306-41022014000300003,sin,o
288,S2306-41022014000300003,embargo,o
288,S2306-41022014000300003,al,o
288,S2306-41022014000300003,comparar,o
288,S2306-41022014000300003,ambos,o
288,S2306-41022014000300003,grupos,o
288,S2306-41022014000300003,no,o
288,S2306-41022014000300003,encontramos,o
288,S2306-41022014000300003,diferencias,o
288,S2306-41022014000300003,Asi,o
288,S2306-41022014000300003,mismo,o
288,S2306-41022014000300003,se,o
288,S2306-41022014000300003,comportan,o
288,S2306-41022014000300003,los,o
288,S2306-41022014000300003,resultados,o
288,S2306-41022014000300003,del,o
288,S2306-41022014000300003,IKDC,o
288,S2306-41022014000300003,en,o
288,S2306-41022014000300003,ambos,o
288,S2306-41022014000300003,grupos,o
288,S2306-41022014000300003,no,o
288,S2306-41022014000300003,hay,o
288,S2306-41022014000300003,diferencia,o
288,S2306-41022014000300003,solo,o
288,S2306-41022014000300003,se,o
288,S2306-41022014000300003,encuentra,o
288,S2306-41022014000300003,diferencia,o
288,S2306-41022014000300003,entre,o
288,S2306-41022014000300003,las,o
288,S2306-41022014000300003,mediciones,o
288,S2306-41022014000300003,basales,o
288,S2306-41022014000300003,y,o
288,S2306-41022014000300003,el,o
288,S2306-41022014000300003,resultado,o
288,S2306-41022014000300003,final,o
289,S2306-41022014000400005,Uso,i
289,S2306-41022014000400005,de,i
289,S2306-41022014000400005,recuperador,i
289,S2306-41022014000400005,de,i
289,S2306-41022014000400005,sangre,i
289,S2306-41022014000400005,durante,o
289,S2306-41022014000400005,la,o
289,S2306-41022014000400005,artroplastia,i
289,S2306-41022014000400005,de,i
289,S2306-41022014000400005,rodilla,i
289,S2306-41022014000400005,Antecedentes,o
289,S2306-41022014000400005,La,o
289,S2306-41022014000400005,gonartrosis,i
289,S2306-41022014000400005,es,o
289,S2306-41022014000400005,una,o
289,S2306-41022014000400005,patologia,i
289,S2306-41022014000400005,degenerativa,i
289,S2306-41022014000400005,que,o
289,S2306-41022014000400005,limita,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,forma,o
289,S2306-41022014000400005,importante,o
289,S2306-41022014000400005,la,o
289,S2306-41022014000400005,funcionalidad,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,una,o
289,S2306-41022014000400005,persona,o
289,S2306-41022014000400005,Se,o
289,S2306-41022014000400005,recurre,o
289,S2306-41022014000400005,al,o
289,S2306-41022014000400005,manejo,o
289,S2306-41022014000400005,quirurgico,o
289,S2306-41022014000400005,cuando,o
289,S2306-41022014000400005,el,o
289,S2306-41022014000400005,paciente,o
289,S2306-41022014000400005,presenta,o
289,S2306-41022014000400005,una,o
289,S2306-41022014000400005,limitacion,o
289,S2306-41022014000400005,funcional,o
289,S2306-41022014000400005,importante,o
289,S2306-41022014000400005,asi,o
289,S2306-41022014000400005,como,o
289,S2306-41022014000400005,dolor,i
289,S2306-41022014000400005,intenso,i
289,S2306-41022014000400005,La,o
289,S2306-41022014000400005,artroplastia,i
289,S2306-41022014000400005,de,i
289,S2306-41022014000400005,rodilla,i
289,S2306-41022014000400005,es,o
289,S2306-41022014000400005,una,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,las,o
289,S2306-41022014000400005,cirugias,i
289,S2306-41022014000400005,con,o
289,S2306-41022014000400005,mejores,o
289,S2306-41022014000400005,resultados,o
289,S2306-41022014000400005,funcionales,o
289,S2306-41022014000400005,en,o
289,S2306-41022014000400005,pacientes,o
289,S2306-41022014000400005,con,o
289,S2306-41022014000400005,esta,o
289,S2306-41022014000400005,patologia,i
289,S2306-41022014000400005,pero,o
289,S2306-41022014000400005,dentro,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,sus,o
289,S2306-41022014000400005,limitaciones,o
289,S2306-41022014000400005,esta,o
289,S2306-41022014000400005,la,o
289,S2306-41022014000400005,posibilidad,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,un,o
289,S2306-41022014000400005,sangrado,i
289,S2306-41022014000400005,importante,o
289,S2306-41022014000400005,y,o
289,S2306-41022014000400005,por,o
289,S2306-41022014000400005,consiguiente,o
289,S2306-41022014000400005,la,o
289,S2306-41022014000400005,necesidad,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,hemotransfundir,i
289,S2306-41022014000400005,al,o
289,S2306-41022014000400005,paciente,o
289,S2306-41022014000400005,El,o
289,S2306-41022014000400005,objetivo,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,este,o
289,S2306-41022014000400005,estudio,o
289,S2306-41022014000400005,fue,o
289,S2306-41022014000400005,evaluar,o
289,S2306-41022014000400005,la,o
289,S2306-41022014000400005,necesidad,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,hemotransfundir,i
289,S2306-41022014000400005,a,o
289,S2306-41022014000400005,los,o
289,S2306-41022014000400005,pacientes,o
289,S2306-41022014000400005,operados,i
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,artroplastia,i
289,S2306-41022014000400005,de,i
289,S2306-41022014000400005,rodilla,i
289,S2306-41022014000400005,que,o
289,S2306-41022014000400005,utilizaron,i
289,S2306-41022014000400005,recuperador,i
289,S2306-41022014000400005,sanguineo,i
289,S2306-41022014000400005,en,o
289,S2306-41022014000400005,el,o
289,S2306-41022014000400005,postoperatorio,o
289,S2306-41022014000400005,y,o
289,S2306-41022014000400005,las,o
289,S2306-41022014000400005,diferencias,o
289,S2306-41022014000400005,entre,o
289,S2306-41022014000400005,los,o
289,S2306-41022014000400005,costos,o
289,S2306-41022014000400005,del,o
289,S2306-41022014000400005,recuperador,i
289,S2306-41022014000400005,sanguineo,i
289,S2306-41022014000400005,y,o
289,S2306-41022014000400005,la,o
289,S2306-41022014000400005,transfusion,i
289,S2306-41022014000400005,clasica,o
289,S2306-41022014000400005,Metodos,o
289,S2306-41022014000400005,Estudio,o
289,S2306-41022014000400005,retrospectivo,o
289,S2306-41022014000400005,transversal,o
289,S2306-41022014000400005,y,o
289,S2306-41022014000400005,retrolectivo,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,300,o
289,S2306-41022014000400005,expedientes,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,pacientes,o
289,S2306-41022014000400005,operados,i
289,S2306-41022014000400005,en,o
289,S2306-41022014000400005,el,o
289,S2306-41022014000400005,Hospital,o
289,S2306-41022014000400005,Angeles,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,Queretaro,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,artroplastia,i
289,S2306-41022014000400005,de,i
289,S2306-41022014000400005,rodilla,i
289,S2306-41022014000400005,que,o
289,S2306-41022014000400005,utilizaron,i
289,S2306-41022014000400005,recuperador,i
289,S2306-41022014000400005,sanguineo,i
289,S2306-41022014000400005,que,o
289,S2306-41022014000400005,requirieron,o
289,S2306-41022014000400005,hemotransfusion,i
289,S2306-41022014000400005,alogenica,i
289,S2306-41022014000400005,entre,o
289,S2306-41022014000400005,Octubre,o
289,S2306-41022014000400005,2001,o
289,S2306-41022014000400005,y,o
289,S2306-41022014000400005,Junio,o
289,S2306-41022014000400005,2013,o
289,S2306-41022014000400005,Resultados,o
289,S2306-41022014000400005,De,o
289,S2306-41022014000400005,las,o
289,S2306-41022014000400005,246,o
289,S2306-41022014000400005,rodillas,i
289,S2306-41022014000400005,operadas,i
289,S2306-41022014000400005,solamente,o
289,S2306-41022014000400005,tres,o
289,S2306-41022014000400005,requirieron,o
289,S2306-41022014000400005,hemotransfusion,i
289,S2306-41022014000400005,alogenica,i
289,S2306-41022014000400005,Ninguna,o
289,S2306-41022014000400005,complicacioninfeccion,o
289,S2306-41022014000400005,con,o
289,S2306-41022014000400005,el,o
289,S2306-41022014000400005,uso,i
289,S2306-41022014000400005,de,i
289,S2306-41022014000400005,recuperador,i
289,S2306-41022014000400005,sanguineo,i
289,S2306-41022014000400005,La,o
289,S2306-41022014000400005,edad,o
289,S2306-41022014000400005,promedio,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,los,o
289,S2306-41022014000400005,pacientes,o
289,S2306-41022014000400005,fue,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,671,o
289,S2306-41022014000400005,978,o
289,S2306-41022014000400005,años,o
289,S2306-41022014000400005,con,o
289,S2306-41022014000400005,un,o
289,S2306-41022014000400005,predominio,o
289,S2306-41022014000400005,femenino,o
289,S2306-41022014000400005,siendo,o
289,S2306-41022014000400005,estos,o
289,S2306-41022014000400005,141,o
289,S2306-41022014000400005,605,o
289,S2306-41022014000400005,en,o
289,S2306-41022014000400005,comparacion,o
289,S2306-41022014000400005,con,o
289,S2306-41022014000400005,92,o
289,S2306-41022014000400005,395,o
289,S2306-41022014000400005,masculinos,o
289,S2306-41022014000400005,La,o
289,S2306-41022014000400005,sangre,i
289,S2306-41022014000400005,recolectada,o
289,S2306-41022014000400005,via,o
289,S2306-41022014000400005,recuperador,i
289,S2306-41022014000400005,sanguineo,i
289,S2306-41022014000400005,vario,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,150,o
289,S2306-41022014000400005,a,o
289,S2306-41022014000400005,1225,o
289,S2306-41022014000400005,ml,o
289,S2306-41022014000400005,con,o
289,S2306-41022014000400005,un,o
289,S2306-41022014000400005,promedio,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,318,o
289,S2306-41022014000400005,1006,o
289,S2306-41022014000400005,ml,o
289,S2306-41022014000400005,la,o
289,S2306-41022014000400005,cual,o
289,S2306-41022014000400005,fue,o
289,S2306-41022014000400005,retransfundida,i
289,S2306-41022014000400005,a,o
289,S2306-41022014000400005,cada,o
289,S2306-41022014000400005,paciente,o
289,S2306-41022014000400005,Conclusiones,o
289,S2306-41022014000400005,El,o
289,S2306-41022014000400005,uso,i
289,S2306-41022014000400005,de,i
289,S2306-41022014000400005,recapturador,i
289,S2306-41022014000400005,sanguineo,i
289,S2306-41022014000400005,en,o
289,S2306-41022014000400005,pacientes,o
289,S2306-41022014000400005,postoperados,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,artroplastia,i
289,S2306-41022014000400005,de,i
289,S2306-41022014000400005,rodilla,i
289,S2306-41022014000400005,disminuye,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,forma,o
289,S2306-41022014000400005,importante,o
289,S2306-41022014000400005,la,o
289,S2306-41022014000400005,necesidad,o
289,S2306-41022014000400005,de,o
289,S2306-41022014000400005,hemotransfusion,i
289,S2306-41022014000400005,alogenica,i
290,S2306-41022015000100004,Estudio,i
290,S2306-41022015000100004,comparativo,i
290,S2306-41022015000100004,entre,o
290,S2306-41022015000100004,placainjerto,o
290,S2306-41022015000100004,cajaplaca,o
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,caja,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,PEEK,i
290,S2306-41022015000100004,en,o
290,S2306-41022015000100004,artrodesis,i
290,S2306-41022015000100004,de,i
290,S2306-41022015000100004,la,i
290,S2306-41022015000100004,columna,i
290,S2306-41022015000100004,cervical,i
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,conducto,i
290,S2306-41022015000100004,cervical,i
290,S2306-41022015000100004,estrecho,i
290,S2306-41022015000100004,Introduccion,o
290,S2306-41022015000100004,Se,o
290,S2306-41022015000100004,han,o
290,S2306-41022015000100004,desarrollado,o
290,S2306-41022015000100004,una,o
290,S2306-41022015000100004,variedad,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,sistemas,o
290,S2306-41022015000100004,para,o
290,S2306-41022015000100004,fijar,i
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,artrodesar,i
290,S2306-41022015000100004,la,o
290,S2306-41022015000100004,columna,i
290,S2306-41022015000100004,cervical,i
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,las,o
290,S2306-41022015000100004,ventajas,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,reducir,o
290,S2306-41022015000100004,del,o
290,S2306-41022015000100004,riesgo,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,seudoartrosis,i
290,S2306-41022015000100004,extrusion,i
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,colapso,i
290,S2306-41022015000100004,del,i
290,S2306-41022015000100004,injerto,i
290,S2306-41022015000100004,asi,o
290,S2306-41022015000100004,como,o
290,S2306-41022015000100004,una,o
290,S2306-41022015000100004,mayor,o
290,S2306-41022015000100004,precision,o
290,S2306-41022015000100004,en,o
290,S2306-41022015000100004,la,o
290,S2306-41022015000100004,alineacion,o
290,S2306-41022015000100004,sagital,i
290,S2306-41022015000100004,por,o
290,S2306-41022015000100004,tal,o
290,S2306-41022015000100004,motivo,o
290,S2306-41022015000100004,requerimos,o
290,S2306-41022015000100004,comparar,o
290,S2306-41022015000100004,resultados,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,placainjerto,o
290,S2306-41022015000100004,cajaplaca,o
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,cajaPEEK,o
290,S2306-41022015000100004,en,o
290,S2306-41022015000100004,pacientes,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,conducto,i
290,S2306-41022015000100004,cervical,i
290,S2306-41022015000100004,estrecho,i
290,S2306-41022015000100004,Material,o
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,metodos,o
290,S2306-41022015000100004,Estudio,o
290,S2306-41022015000100004,prospectivo,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,intervencion,o
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,comparativo,o
290,S2306-41022015000100004,formando,o
290,S2306-41022015000100004,tres,o
290,S2306-41022015000100004,grupos,o
290,S2306-41022015000100004,grupo,o
290,S2306-41022015000100004,I,o
290,S2306-41022015000100004,artrodesis,i
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,placainjerto,o
290,S2306-41022015000100004,grupo,o
290,S2306-41022015000100004,II,o
290,S2306-41022015000100004,cajaplaca,o
290,S2306-41022015000100004,grupo,o
290,S2306-41022015000100004,III,o
290,S2306-41022015000100004,cajaPEEK,o
290,S2306-41022015000100004,La,o
290,S2306-41022015000100004,evaluacion,i
290,S2306-41022015000100004,funcional,i
290,S2306-41022015000100004,pre,o
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,postoperatoria,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,escala,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,discapacidad,i
290,S2306-41022015000100004,cervical,i
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,escala,o
290,S2306-41022015000100004,visual,o
290,S2306-41022015000100004,analoga,o
290,S2306-41022015000100004,EVA,i
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,dolor,i
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,radiografias,i
290,S2306-41022015000100004,columna,i
290,S2306-41022015000100004,cervical,i
290,S2306-41022015000100004,Se,o
290,S2306-41022015000100004,analizaron,o
290,S2306-41022015000100004,los,o
290,S2306-41022015000100004,resultados,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,pruebas,o
290,S2306-41022015000100004,no,o
290,S2306-41022015000100004,parametricas,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,rangos,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,signo,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,Wilcoxon,o
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,Kruskal,o
290,S2306-41022015000100004,Wallis,o
290,S2306-41022015000100004,para,o
290,S2306-41022015000100004,comparacion,o
290,S2306-41022015000100004,entre,o
290,S2306-41022015000100004,mas,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,dos,o
290,S2306-41022015000100004,grupos,o
290,S2306-41022015000100004,Con,o
290,S2306-41022015000100004,nivel,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,significancia,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,005,o
290,S2306-41022015000100004,Resultados,o
290,S2306-41022015000100004,Muestra,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,37,o
290,S2306-41022015000100004,pacientes,o
290,S2306-41022015000100004,para,o
290,S2306-41022015000100004,el,o
290,S2306-41022015000100004,grupo,o
290,S2306-41022015000100004,I,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,n,o
290,S2306-41022015000100004,12,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,22,o
290,S2306-41022015000100004,niveles,o
290,S2306-41022015000100004,grupo,o
290,S2306-41022015000100004,II,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,n,o
290,S2306-41022015000100004,11,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,19,o
290,S2306-41022015000100004,niveles,o
290,S2306-41022015000100004,grupo,o
290,S2306-41022015000100004,III,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,n,o
290,S2306-41022015000100004,14,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,25,o
290,S2306-41022015000100004,niveles,o
290,S2306-41022015000100004,La,o
290,S2306-41022015000100004,mayoria,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,pacientes,o
290,S2306-41022015000100004,entre,o
290,S2306-41022015000100004,la,o
290,S2306-41022015000100004,sexta,o
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,octava,o
290,S2306-41022015000100004,decada,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,la,o
290,S2306-41022015000100004,vida,o
290,S2306-41022015000100004,Al,o
290,S2306-41022015000100004,año,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,postoperados,o
290,S2306-41022015000100004,el,o
290,S2306-41022015000100004,indice,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,discapacidad,i
290,S2306-41022015000100004,cervical,i
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,mejoria,o
290,S2306-41022015000100004,del,o
290,S2306-41022015000100004,dolor,i
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,EVA,i
290,S2306-41022015000100004,mostraron,o
290,S2306-41022015000100004,mejoria,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,diferencia,o
290,S2306-41022015000100004,estadistica,o
290,S2306-41022015000100004,en,o
290,S2306-41022015000100004,los,o
290,S2306-41022015000100004,tres,o
290,S2306-41022015000100004,grupos,o
290,S2306-41022015000100004,p,o
290,S2306-41022015000100004,0001,o
290,S2306-41022015000100004,Sin,o
290,S2306-41022015000100004,embargo,o
290,S2306-41022015000100004,las,o
290,S2306-41022015000100004,mediciones,i
290,S2306-41022015000100004,radiograficas,i
290,S2306-41022015000100004,al,o
290,S2306-41022015000100004,año,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,seguimiento,i
290,S2306-41022015000100004,mostraron,o
290,S2306-41022015000100004,una,o
290,S2306-41022015000100004,mejoria,o
290,S2306-41022015000100004,significativa,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,la,o
290,S2306-41022015000100004,lordosis,i
290,S2306-41022015000100004,segmentaria,i
290,S2306-41022015000100004,p,o
290,S2306-41022015000100004,002,o
290,S2306-41022015000100004,solo,o
290,S2306-41022015000100004,en,o
290,S2306-41022015000100004,pacientes,o
290,S2306-41022015000100004,operados,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,placainjerto,o
290,S2306-41022015000100004,Conclusiones,o
290,S2306-41022015000100004,El,o
290,S2306-41022015000100004,uso,i
290,S2306-41022015000100004,de,i
290,S2306-41022015000100004,la,i
290,S2306-41022015000100004,placa,i
290,S2306-41022015000100004,injerto,i
290,S2306-41022015000100004,ofrece,o
290,S2306-41022015000100004,mejores,o
290,S2306-41022015000100004,resultados,o
290,S2306-41022015000100004,clinicos,o
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,radiograficos,i
290,S2306-41022015000100004,en,o
290,S2306-41022015000100004,comparacion,o
290,S2306-41022015000100004,con,o
290,S2306-41022015000100004,la,o
290,S2306-41022015000100004,cajaplaca,o
290,S2306-41022015000100004,y,o
290,S2306-41022015000100004,cajaPEEK,o
290,S2306-41022015000100004,al,o
290,S2306-41022015000100004,año,o
290,S2306-41022015000100004,de,o
290,S2306-41022015000100004,seguimiento,i
291,S2306-41022015000100005,Control,i
291,S2306-41022015000100005,del,i
291,S2306-41022015000100005,dolor,i
291,S2306-41022015000100005,postoperatorio,i
291,S2306-41022015000100005,mediante,o
291,S2306-41022015000100005,morfina,i
291,S2306-41022015000100005,intratecal,o
291,S2306-41022015000100005,en,o
291,S2306-41022015000100005,pacientes,o
291,S2306-41022015000100005,intervenidos,i
291,S2306-41022015000100005,por,o
291,S2306-41022015000100005,fusion,i
291,S2306-41022015000100005,vertebral,i
291,S2306-41022015000100005,instrumentada,i
291,S2306-41022015000100005,Antecedentes,o
291,S2306-41022015000100005,El,o
291,S2306-41022015000100005,manejo,o
291,S2306-41022015000100005,adecuado,o
291,S2306-41022015000100005,del,o
291,S2306-41022015000100005,dolor,i
291,S2306-41022015000100005,postoperatorio,i
291,S2306-41022015000100005,en,o
291,S2306-41022015000100005,pacientes,o
291,S2306-41022015000100005,intervenidos,i
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,artrodesis,i
291,S2306-41022015000100005,vertebral,i
291,S2306-41022015000100005,instrumentada,i
291,S2306-41022015000100005,es,o
291,S2306-41022015000100005,esencial,o
291,S2306-41022015000100005,para,o
291,S2306-41022015000100005,disminuir,o
291,S2306-41022015000100005,la,o
291,S2306-41022015000100005,morbimortalidad,o
291,S2306-41022015000100005,postoperatoria,o
291,S2306-41022015000100005,El,o
291,S2306-41022015000100005,uso,o
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,morfina,i
291,S2306-41022015000100005,por,o
291,S2306-41022015000100005,via,o
291,S2306-41022015000100005,intratecal,o
291,S2306-41022015000100005,podria,o
291,S2306-41022015000100005,proporcionar,o
291,S2306-41022015000100005,una,o
291,S2306-41022015000100005,analgesia,i
291,S2306-41022015000100005,efectiva,o
291,S2306-41022015000100005,minimizando,o
291,S2306-41022015000100005,la,o
291,S2306-41022015000100005,dosis,o
291,S2306-41022015000100005,necesaria,o
291,S2306-41022015000100005,y,o
291,S2306-41022015000100005,los,o
291,S2306-41022015000100005,efectos,i
291,S2306-41022015000100005,adversos,i
291,S2306-41022015000100005,secundarios,i
291,S2306-41022015000100005,El,o
291,S2306-41022015000100005,objetivo,o
291,S2306-41022015000100005,del,o
291,S2306-41022015000100005,estudio,o
291,S2306-41022015000100005,es,o
291,S2306-41022015000100005,valorar,i
291,S2306-41022015000100005,la,i
291,S2306-41022015000100005,eficacia,i
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,la,o
291,S2306-41022015000100005,morfina,i
291,S2306-41022015000100005,intratecal,o
291,S2306-41022015000100005,en,o
291,S2306-41022015000100005,el,o
291,S2306-41022015000100005,control,i
291,S2306-41022015000100005,del,i
291,S2306-41022015000100005,dolor,i
291,S2306-41022015000100005,postoperatorio,i
291,S2306-41022015000100005,en,o
291,S2306-41022015000100005,pacientes,o
291,S2306-41022015000100005,intervenidos,i
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,artrodesis,i
291,S2306-41022015000100005,vertebral,i
291,S2306-41022015000100005,instrumentada,i
291,S2306-41022015000100005,Material,o
291,S2306-41022015000100005,y,o
291,S2306-41022015000100005,metodos,o
291,S2306-41022015000100005,Se,o
291,S2306-41022015000100005,realizo,o
291,S2306-41022015000100005,un,o
291,S2306-41022015000100005,estudio,i
291,S2306-41022015000100005,prospectivo,i
291,S2306-41022015000100005,aleatorizado,i
291,S2306-41022015000100005,incluyendo,o
291,S2306-41022015000100005,a,o
291,S2306-41022015000100005,46,o
291,S2306-41022015000100005,pacientes,o
291,S2306-41022015000100005,intervenidos,i
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,fusion,i
291,S2306-41022015000100005,vertebral,i
291,S2306-41022015000100005,instrumentada,i
291,S2306-41022015000100005,Los,o
291,S2306-41022015000100005,pacientes,o
291,S2306-41022015000100005,fueron,o
291,S2306-41022015000100005,divididos,i
291,S2306-41022015000100005,mediante,i
291,S2306-41022015000100005,randomizacion,i
291,S2306-41022015000100005,al,i
291,S2306-41022015000100005,azar,i
291,S2306-41022015000100005,en,o
291,S2306-41022015000100005,dos,o
291,S2306-41022015000100005,grupos,o
291,S2306-41022015000100005,uno,o
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,los,o
291,S2306-41022015000100005,cuales,o
291,S2306-41022015000100005,recibio,o
291,S2306-41022015000100005,una,o
291,S2306-41022015000100005,dosis,o
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,morfina,i
291,S2306-41022015000100005,intratecal,o
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,0003,o
291,S2306-41022015000100005,mgkg,o
291,S2306-41022015000100005,antes,o
291,S2306-41022015000100005,del,o
291,S2306-41022015000100005,cierre,i
291,S2306-41022015000100005,de,i
291,S2306-41022015000100005,la,i
291,S2306-41022015000100005,herida,i
291,S2306-41022015000100005,quirurgica,i
291,S2306-41022015000100005,Durante,o
291,S2306-41022015000100005,el,o
291,S2306-41022015000100005,postoperatorio,o
291,S2306-41022015000100005,se,o
291,S2306-41022015000100005,registro,o
291,S2306-41022015000100005,frecuencia,i
291,S2306-41022015000100005,respiratoria,i
291,S2306-41022015000100005,PCO2,i
291,S2306-41022015000100005,PO2,i
291,S2306-41022015000100005,necesidad,o
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,analgesia,i
291,S2306-41022015000100005,coadyuvante,i
291,S2306-41022015000100005,y,o
291,S2306-41022015000100005,valoracion,i
291,S2306-41022015000100005,subjetiva,i
291,S2306-41022015000100005,del,i
291,S2306-41022015000100005,dolor,i
291,S2306-41022015000100005,mediante,o
291,S2306-41022015000100005,la,o
291,S2306-41022015000100005,escala,i
291,S2306-41022015000100005,visual,i
291,S2306-41022015000100005,analogica,i
291,S2306-41022015000100005,EVA,i
291,S2306-41022015000100005,a,o
291,S2306-41022015000100005,las,o
291,S2306-41022015000100005,6,o
291,S2306-41022015000100005,24,o
291,S2306-41022015000100005,y,o
291,S2306-41022015000100005,48,o
291,S2306-41022015000100005,horas,o
291,S2306-41022015000100005,tras,o
291,S2306-41022015000100005,la,o
291,S2306-41022015000100005,intervencion,i
291,S2306-41022015000100005,Los,o
291,S2306-41022015000100005,resultados,o
291,S2306-41022015000100005,fueron,o
291,S2306-41022015000100005,analizados,o
291,S2306-41022015000100005,mediante,o
291,S2306-41022015000100005,pruebas,o
291,S2306-41022015000100005,no,o
291,S2306-41022015000100005,parametricas,o
291,S2306-41022015000100005,Resultados,o
291,S2306-41022015000100005,Los,o
291,S2306-41022015000100005,pacientes,o
291,S2306-41022015000100005,que,o
291,S2306-41022015000100005,recibieron,o
291,S2306-41022015000100005,morfina,i
291,S2306-41022015000100005,intratecal,o
291,S2306-41022015000100005,presentaron,o
291,S2306-41022015000100005,una,o
291,S2306-41022015000100005,disminucion,o
291,S2306-41022015000100005,estadisticamente,o
291,S2306-41022015000100005,significativa,o
291,S2306-41022015000100005,del,o
291,S2306-41022015000100005,dolor,i
291,S2306-41022015000100005,postoperatorio,i
291,S2306-41022015000100005,durante,o
291,S2306-41022015000100005,las,o
291,S2306-41022015000100005,primeras,o
291,S2306-41022015000100005,48,o
291,S2306-41022015000100005,h,o
291,S2306-41022015000100005,con,o
291,S2306-41022015000100005,una,o
291,S2306-41022015000100005,puntuacion,o
291,S2306-41022015000100005,EVA,i
291,S2306-41022015000100005,promedio,o
291,S2306-41022015000100005,cercana,o
291,S2306-41022015000100005,a,o
291,S2306-41022015000100005,3,o
291,S2306-41022015000100005,En,o
291,S2306-41022015000100005,241,o
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,los,o
291,S2306-41022015000100005,pacientes,o
291,S2306-41022015000100005,presentaron,o
291,S2306-41022015000100005,complicaciones,i
291,S2306-41022015000100005,asociadas,o
291,S2306-41022015000100005,al,o
291,S2306-41022015000100005,uso,o
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,cloruro,i
291,S2306-41022015000100005,morfico,i
291,S2306-41022015000100005,tales,o
291,S2306-41022015000100005,como,o
291,S2306-41022015000100005,nauseas,i
291,S2306-41022015000100005,o,o
291,S2306-41022015000100005,vomitos,i
291,S2306-41022015000100005,sin,o
291,S2306-41022015000100005,diferencias,o
291,S2306-41022015000100005,significativas,o
291,S2306-41022015000100005,respecto,o
291,S2306-41022015000100005,al,o
291,S2306-41022015000100005,grupo,o
291,S2306-41022015000100005,control,o
291,S2306-41022015000100005,Conclusiones,o
291,S2306-41022015000100005,El,o
291,S2306-41022015000100005,uso,o
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,morfina,i
291,S2306-41022015000100005,intratecal,o
291,S2306-41022015000100005,es,o
291,S2306-41022015000100005,una,o
291,S2306-41022015000100005,opcion,o
291,S2306-41022015000100005,terapeutica,o
291,S2306-41022015000100005,segura,o
291,S2306-41022015000100005,y,o
291,S2306-41022015000100005,efectiva,o
291,S2306-41022015000100005,en,o
291,S2306-41022015000100005,el,o
291,S2306-41022015000100005,control,i
291,S2306-41022015000100005,del,i
291,S2306-41022015000100005,dolor,i
291,S2306-41022015000100005,postquirurgico,i
291,S2306-41022015000100005,precoz,o
291,S2306-41022015000100005,en,o
291,S2306-41022015000100005,pacientes,o
291,S2306-41022015000100005,intervenidos,i
291,S2306-41022015000100005,de,o
291,S2306-41022015000100005,fusion,i
291,S2306-41022015000100005,vertebral,i
291,S2306-41022015000100005,instrumentada,i
291,S2306-41022015000100005,permitiendo,o
291,S2306-41022015000100005,una,o
291,S2306-41022015000100005,recuperacion,o
291,S2306-41022015000100005,mas,o
291,S2306-41022015000100005,comoda,o
291,S2306-41022015000100005,y,o
291,S2306-41022015000100005,rapida,o
292,S2306-41022015000200007,Ensayo,i
292,S2306-41022015000200007,quirurgico,i
292,S2306-41022015000200007,aleatorio,i
292,S2306-41022015000200007,controlado,i
292,S2306-41022015000200007,de,i
292,S2306-41022015000200007,dos,i
292,S2306-41022015000200007,procedimientos,i
292,S2306-41022015000200007,para,o
292,S2306-41022015000200007,hallux,i
292,S2306-41022015000200007,valgus,i
292,S2306-41022015000200007,fracaso,o
292,S2306-41022015000200007,en,o
292,S2306-41022015000200007,el,o
292,S2306-41022015000200007,reclutamiento,o
292,S2306-41022015000200007,Antecedentes,o
292,S2306-41022015000200007,Los,o
292,S2306-41022015000200007,ensayos,i
292,S2306-41022015000200007,quirurgicos,i
292,S2306-41022015000200007,aleatorizados,i
292,S2306-41022015000200007,controlados,i
292,S2306-41022015000200007,EQAC,o
292,S2306-41022015000200007,son,o
292,S2306-41022015000200007,la,o
292,S2306-41022015000200007,mejor,o
292,S2306-41022015000200007,manera,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,validar,o
292,S2306-41022015000200007,los,o
292,S2306-41022015000200007,nuevos,o
292,S2306-41022015000200007,tratamientos,i
292,S2306-41022015000200007,quirurgicos,i
292,S2306-41022015000200007,sin,o
292,S2306-41022015000200007,embargo,o
292,S2306-41022015000200007,comprenden,o
292,S2306-41022015000200007,una,o
292,S2306-41022015000200007,fraccion,o
292,S2306-41022015000200007,muy,o
292,S2306-41022015000200007,pequeña,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,los,o
292,S2306-41022015000200007,articulos,o
292,S2306-41022015000200007,publicados,o
292,S2306-41022015000200007,en,o
292,S2306-41022015000200007,la,o
292,S2306-41022015000200007,literatura,o
292,S2306-41022015000200007,Una,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,las,o
292,S2306-41022015000200007,razones,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,la,o
292,S2306-41022015000200007,falta,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,exito,o
292,S2306-41022015000200007,es,o
292,S2306-41022015000200007,el,o
292,S2306-41022015000200007,hecho,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,no,o
292,S2306-41022015000200007,reclutar,o
292,S2306-41022015000200007,un,o
292,S2306-41022015000200007,numero,o
292,S2306-41022015000200007,adecuado,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,pacientes,o
292,S2306-41022015000200007,Metodos,o
292,S2306-41022015000200007,Se,o
292,S2306-41022015000200007,presentan,o
292,S2306-41022015000200007,los,o
292,S2306-41022015000200007,resultados,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,14,o
292,S2306-41022015000200007,meses,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,reclutamiento,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,un,o
292,S2306-41022015000200007,EQAC,o
292,S2306-41022015000200007,que,o
292,S2306-41022015000200007,compara,o
292,S2306-41022015000200007,dos,o
292,S2306-41022015000200007,procedimientos,i
292,S2306-41022015000200007,quirurgicos,i
292,S2306-41022015000200007,para,o
292,S2306-41022015000200007,el,o
292,S2306-41022015000200007,tratamiento,i
292,S2306-41022015000200007,del,o
292,S2306-41022015000200007,hallux,i
292,S2306-41022015000200007,valgus,i
292,S2306-41022015000200007,doloroso,i
292,S2306-41022015000200007,El,o
292,S2306-41022015000200007,estudio,o
292,S2306-41022015000200007,es,o
292,S2306-41022015000200007,no,o
292,S2306-41022015000200007,ciego,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,no,o
292,S2306-41022015000200007,inferioridad,o
292,S2306-41022015000200007,y,o
292,S2306-41022015000200007,paralelo,o
292,S2306-41022015000200007,con,o
292,S2306-41022015000200007,una,o
292,S2306-41022015000200007,meta,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,inclusion,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,100,o
292,S2306-41022015000200007,sujetos,o
292,S2306-41022015000200007,en,o
292,S2306-41022015000200007,24,o
292,S2306-41022015000200007,meses,o
292,S2306-41022015000200007,Resultados,o
292,S2306-41022015000200007,En,o
292,S2306-41022015000200007,los,o
292,S2306-41022015000200007,primeros,o
292,S2306-41022015000200007,14,o
292,S2306-41022015000200007,meses,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,reclutamiento,o
292,S2306-41022015000200007,94,o
292,S2306-41022015000200007,pacientes,o
292,S2306-41022015000200007,fueron,o
292,S2306-41022015000200007,evaluados,i
292,S2306-41022015000200007,para,i
292,S2306-41022015000200007,su,i
292,S2306-41022015000200007,elegibilidad,i
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,los,o
292,S2306-41022015000200007,cuales,o
292,S2306-41022015000200007,54,o
292,S2306-41022015000200007,fueron,o
292,S2306-41022015000200007,excluidos,o
292,S2306-41022015000200007,y,o
292,S2306-41022015000200007,40,o
292,S2306-41022015000200007,cumplian,o
292,S2306-41022015000200007,con,o
292,S2306-41022015000200007,criterios,o
292,S2306-41022015000200007,segun,o
292,S2306-41022015000200007,protocolo,i
292,S2306-41022015000200007,De,o
292,S2306-41022015000200007,estos,o
292,S2306-41022015000200007,40,o
292,S2306-41022015000200007,13,o
292,S2306-41022015000200007,fueron,o
292,S2306-41022015000200007,incluidos,o
292,S2306-41022015000200007,en,o
292,S2306-41022015000200007,el,o
292,S2306-41022015000200007,proceso,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,aleatorizacion,i
292,S2306-41022015000200007,pero,o
292,S2306-41022015000200007,solo,o
292,S2306-41022015000200007,11,o
292,S2306-41022015000200007,fueron,o
292,S2306-41022015000200007,sometidos,o
292,S2306-41022015000200007,a,o
292,S2306-41022015000200007,los,o
292,S2306-41022015000200007,procedimientos,i
292,S2306-41022015000200007,quirurgicos,i
292,S2306-41022015000200007,ya,o
292,S2306-41022015000200007,que,o
292,S2306-41022015000200007,dos,o
292,S2306-41022015000200007,se,o
292,S2306-41022015000200007,rehusaron,o
292,S2306-41022015000200007,a,o
292,S2306-41022015000200007,dicho,o
292,S2306-41022015000200007,proceso,o
292,S2306-41022015000200007,el,o
292,S2306-41022015000200007,dia,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,la,o
292,S2306-41022015000200007,cirugia,i
292,S2306-41022015000200007,De,o
292,S2306-41022015000200007,los,o
292,S2306-41022015000200007,27,o
292,S2306-41022015000200007,pacientes,o
292,S2306-41022015000200007,elegibles,o
292,S2306-41022015000200007,restantes,o
292,S2306-41022015000200007,en,o
292,S2306-41022015000200007,22,o
292,S2306-41022015000200007,no,o
292,S2306-41022015000200007,hubo,o
292,S2306-41022015000200007,mas,o
292,S2306-41022015000200007,contacto,o
292,S2306-41022015000200007,despues,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,completar,o
292,S2306-41022015000200007,la,o
292,S2306-41022015000200007,evaluacion,i
292,S2306-41022015000200007,de,i
292,S2306-41022015000200007,elegibilidad,i
292,S2306-41022015000200007,y,o
292,S2306-41022015000200007,siete,o
292,S2306-41022015000200007,se,o
292,S2306-41022015000200007,negaron,o
292,S2306-41022015000200007,al,o
292,S2306-41022015000200007,procedimiento,i
292,S2306-41022015000200007,aleatorio,i
292,S2306-41022015000200007,Los,o
292,S2306-41022015000200007,resultados,o
292,S2306-41022015000200007,indican,o
292,S2306-41022015000200007,que,o
292,S2306-41022015000200007,el,o
292,S2306-41022015000200007,estudio,o
292,S2306-41022015000200007,no,o
292,S2306-41022015000200007,recluta,o
292,S2306-41022015000200007,un,o
292,S2306-41022015000200007,numero,o
292,S2306-41022015000200007,suficiente,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,sujetos,o
292,S2306-41022015000200007,Conclusiones,o
292,S2306-41022015000200007,Los,o
292,S2306-41022015000200007,datos,o
292,S2306-41022015000200007,muestran,o
292,S2306-41022015000200007,que,o
292,S2306-41022015000200007,los,o
292,S2306-41022015000200007,investigadores,o
292,S2306-41022015000200007,que,o
292,S2306-41022015000200007,planean,o
292,S2306-41022015000200007,realizar,o
292,S2306-41022015000200007,un,o
292,S2306-41022015000200007,EQAC,o
292,S2306-41022015000200007,deben,o
292,S2306-41022015000200007,ser,o
292,S2306-41022015000200007,conscientes,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,la,o
292,S2306-41022015000200007,gran,o
292,S2306-41022015000200007,cantidad,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,esfuerzo,o
292,S2306-41022015000200007,y,o
292,S2306-41022015000200007,recursos,o
292,S2306-41022015000200007,financieros,o
292,S2306-41022015000200007,necesarios,o
292,S2306-41022015000200007,para,o
292,S2306-41022015000200007,alcanzar,o
292,S2306-41022015000200007,las,o
292,S2306-41022015000200007,metas,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,reclutamiento,o
292,S2306-41022015000200007,de,o
292,S2306-41022015000200007,pacientes,o
293,S2306-41022017000500217,Infiltracion,i
293,S2306-41022017000500217,intraarticular,i
293,S2306-41022017000500217,con,o
293,S2306-41022017000500217,sulfato,i
293,S2306-41022017000500217,de,i
293,S2306-41022017000500217,magnesio,i
293,S2306-41022017000500217,y,o
293,S2306-41022017000500217,bupivacaina,i
293,S2306-41022017000500217,en,o
293,S2306-41022017000500217,fracturas,i
293,S2306-41022017000500217,de,i
293,S2306-41022017000500217,radio,i
293,S2306-41022017000500217,distal,i
293,S2306-41022017000500217,Estudio,i
293,S2306-41022017000500217,piloto,i
293,S2306-41022017000500217,Antecedentes,o
293,S2306-41022017000500217,Las,o
293,S2306-41022017000500217,fracturas,i
293,S2306-41022017000500217,de,i
293,S2306-41022017000500217,radio,i
293,S2306-41022017000500217,distal,i
293,S2306-41022017000500217,constituyen,o
293,S2306-41022017000500217,hasta,o
293,S2306-41022017000500217,15,o
293,S2306-41022017000500217,de,o
293,S2306-41022017000500217,todas,o
293,S2306-41022017000500217,las,o
293,S2306-41022017000500217,lesiones,i
293,S2306-41022017000500217,oseas,i
293,S2306-41022017000500217,en,o
293,S2306-41022017000500217,los,o
293,S2306-41022017000500217,adultos,o
293,S2306-41022017000500217,La,o
293,S2306-41022017000500217,rehabilitacion,i
293,S2306-41022017000500217,es,o
293,S2306-41022017000500217,clave,o
293,S2306-41022017000500217,en,o
293,S2306-41022017000500217,la,o
293,S2306-41022017000500217,recuperacion,o
293,S2306-41022017000500217,de,o
293,S2306-41022017000500217,la,o
293,S2306-41022017000500217,movilidad,o
293,S2306-41022017000500217,y,o
293,S2306-41022017000500217,la,o
293,S2306-41022017000500217,capacidad,o
293,S2306-41022017000500217,funcional,o
293,S2306-41022017000500217,El,o
293,S2306-41022017000500217,sulfato,i
293,S2306-41022017000500217,de,i
293,S2306-41022017000500217,magnesio,i
293,S2306-41022017000500217,intraarticular,o
293,S2306-41022017000500217,ha,o
293,S2306-41022017000500217,sido,o
293,S2306-41022017000500217,utilizado,o
293,S2306-41022017000500217,para,o
293,S2306-41022017000500217,control,i
293,S2306-41022017000500217,postoperatorio,i
293,S2306-41022017000500217,del,i
293,S2306-41022017000500217,dolor,i
293,S2306-41022017000500217,el,o
293,S2306-41022017000500217,objetivo,o
293,S2306-41022017000500217,fue,o
293,S2306-41022017000500217,determinar,o
293,S2306-41022017000500217,la,o
293,S2306-41022017000500217,mejoria,o
293,S2306-41022017000500217,del,o
293,S2306-41022017000500217,dolor,i
293,S2306-41022017000500217,y,o
293,S2306-41022017000500217,la,o
293,S2306-41022017000500217,capacidad,o
293,S2306-41022017000500217,funcional,o
293,S2306-41022017000500217,de,o
293,S2306-41022017000500217,los,o
293,S2306-41022017000500217,pacientes,o
293,S2306-41022017000500217,con,o
293,S2306-41022017000500217,fractura,i
293,S2306-41022017000500217,de,i
293,S2306-41022017000500217,radio,i
293,S2306-41022017000500217,distal,i
293,S2306-41022017000500217,usando,o
293,S2306-41022017000500217,sulfato,i
293,S2306-41022017000500217,de,i
293,S2306-41022017000500217,magnesio,i
293,S2306-41022017000500217,intraarticular,o
293,S2306-41022017000500217,Material,o
293,S2306-41022017000500217,y,o
293,S2306-41022017000500217,metodos,o
293,S2306-41022017000500217,Pacientes,o
293,S2306-41022017000500217,con,o
293,S2306-41022017000500217,fractura,i
293,S2306-41022017000500217,de,i
293,S2306-41022017000500217,radio,i
293,S2306-41022017000500217,distal,i
293,S2306-41022017000500217,tratados,i
293,S2306-41022017000500217,con,i
293,S2306-41022017000500217,clavos,i
293,S2306-41022017000500217,percutaneos,i
293,S2306-41022017000500217,e,o
293,S2306-41022017000500217,inmovilizacion,i
293,S2306-41022017000500217,fueron,o
293,S2306-41022017000500217,incluidos,i
293,S2306-41022017000500217,al,i
293,S2306-41022017000500217,azar,i
293,S2306-41022017000500217,en,o
293,S2306-41022017000500217,dos,o
293,S2306-41022017000500217,grupos,o
293,S2306-41022017000500217,Grupo,o
293,S2306-41022017000500217,1,o
293,S2306-41022017000500217,infiltrado,i
293,S2306-41022017000500217,con,o
293,S2306-41022017000500217,10,o
293,S2306-41022017000500217,ml,o
293,S2306-41022017000500217,de,o
293,S2306-41022017000500217,sulfato,i
293,S2306-41022017000500217,de,i
293,S2306-41022017000500217,magnesio,i
293,S2306-41022017000500217,y,o
293,S2306-41022017000500217,15,o
293,S2306-41022017000500217,ml,o
293,S2306-41022017000500217,de,o
293,S2306-41022017000500217,agua,i
293,S2306-41022017000500217,esteril,i
293,S2306-41022017000500217,en,o
293,S2306-41022017000500217,el,o
293,S2306-41022017000500217,grupo,o
293,S2306-41022017000500217,2,o
293,S2306-41022017000500217,esta,o
293,S2306-41022017000500217,ultima,o
293,S2306-41022017000500217,fue,o
293,S2306-41022017000500217,sustituida,o
293,S2306-41022017000500217,por,o
293,S2306-41022017000500217,1,o
293,S2306-41022017000500217,ml,o
293,S2306-41022017000500217,de,o
293,S2306-41022017000500217,bupivacaina,i
293,S2306-41022017000500217,5,o
293,S2306-41022017000500217,mgml,o
293,S2306-41022017000500217,La,o
293,S2306-41022017000500217,infiltracion,i
293,S2306-41022017000500217,se,o
293,S2306-41022017000500217,realizo,o
293,S2306-41022017000500217,al,o
293,S2306-41022017000500217,retiro,i
293,S2306-41022017000500217,de,i
293,S2306-41022017000500217,la,i
293,S2306-41022017000500217,inmovilizacion,i
293,S2306-41022017000500217,El,o
293,S2306-41022017000500217,dolor,i
293,S2306-41022017000500217,funcionalidad,o
293,S2306-41022017000500217,y,o
293,S2306-41022017000500217,rangos,o
293,S2306-41022017000500217,de,o
293,S2306-41022017000500217,movimiento,o
293,S2306-41022017000500217,fueron,o
293,S2306-41022017000500217,evaluados,o
293,S2306-41022017000500217,Resultados,o
293,S2306-41022017000500217,20,o
293,S2306-41022017000500217,pacientes,o
293,S2306-41022017000500217,ocho,o
293,S2306-41022017000500217,masculinos,o
293,S2306-41022017000500217,y,o
293,S2306-41022017000500217,12,o
293,S2306-41022017000500217,femeninos,o
293,S2306-41022017000500217,con,o
293,S2306-41022017000500217,edad,o
293,S2306-41022017000500217,promedio,o
293,S2306-41022017000500217,de,o
293,S2306-41022017000500217,53,o
293,S2306-41022017000500217,años,o
293,S2306-41022017000500217,17,o
293,S2306-41022017000500217,DE,o
293,S2306-41022017000500217,fueron,o
293,S2306-41022017000500217,evaluados,o
293,S2306-41022017000500217,Se,o
293,S2306-41022017000500217,encontro,o
293,S2306-41022017000500217,disminucion,o
293,S2306-41022017000500217,significativa,o
293,S2306-41022017000500217,en,o
293,S2306-41022017000500217,el,o
293,S2306-41022017000500217,dolor,i
293,S2306-41022017000500217,al,o
293,S2306-41022017000500217,primer,o
293,S2306-41022017000500217,minuto,o
293,S2306-41022017000500217,y,o
293,S2306-41022017000500217,a,o
293,S2306-41022017000500217,los,o
293,S2306-41022017000500217,tres,o
293,S2306-41022017000500217,minutos,o
293,S2306-41022017000500217,despues,o
293,S2306-41022017000500217,de,o
293,S2306-41022017000500217,la,o
293,S2306-41022017000500217,infiltracion,i
293,S2306-41022017000500217,en,o
293,S2306-41022017000500217,el,o
293,S2306-41022017000500217,grupo,o
293,S2306-41022017000500217,2,o
293,S2306-41022017000500217,p,o
293,S2306-41022017000500217,005,o
293,S2306-41022017000500217,Ambos,o
293,S2306-41022017000500217,grupos,o
293,S2306-41022017000500217,presentaron,o
293,S2306-41022017000500217,una,o
293,S2306-41022017000500217,mejoria,o
293,S2306-41022017000500217,significativa,o
293,S2306-41022017000500217,en,o
293,S2306-41022017000500217,la,o
293,S2306-41022017000500217,funcionalidad,o
293,S2306-41022017000500217,articular,i
293,S2306-41022017000500217,a,o
293,S2306-41022017000500217,las,o
293,S2306-41022017000500217,dos,o
293,S2306-41022017000500217,semanas,o
293,S2306-41022017000500217,p,o
293,S2306-41022017000500217,005,o
293,S2306-41022017000500217,asi,o
293,S2306-41022017000500217,como,o
293,S2306-41022017000500217,una,o
293,S2306-41022017000500217,mejoria,o
293,S2306-41022017000500217,gradual,o
293,S2306-41022017000500217,en,o
293,S2306-41022017000500217,la,o
293,S2306-41022017000500217,movilidad,o
293,S2306-41022017000500217,articular,i
293,S2306-41022017000500217,en,o
293,S2306-41022017000500217,ese,o
293,S2306-41022017000500217,mismo,o
293,S2306-41022017000500217,periodo,o
293,S2306-41022017000500217,p,o
293,S2306-41022017000500217,005,o
293,S2306-41022017000500217,Conclusiones,o
293,S2306-41022017000500217,La,o
293,S2306-41022017000500217,infiltracion,i
293,S2306-41022017000500217,de,o
293,S2306-41022017000500217,sulfato,i
293,S2306-41022017000500217,de,i
293,S2306-41022017000500217,magnesio,i
293,S2306-41022017000500217,en,o
293,S2306-41022017000500217,combinacion,o
293,S2306-41022017000500217,con,o
293,S2306-41022017000500217,bupivacaina,i
293,S2306-41022017000500217,ayuda,o
293,S2306-41022017000500217,a,o
293,S2306-41022017000500217,disminuir,o
293,S2306-41022017000500217,el,o
293,S2306-41022017000500217,dolor,i
294,S2307-04202019000200019,Efecto,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,los,o
294,S2307-04202019000200019,protocolos,i
294,S2307-04202019000200019,perioperatorios,i
294,S2307-04202019000200019,de,i
294,S2307-04202019000200019,recuperacion,i
294,S2307-04202019000200019,mejorada,i
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,convencional,o
294,S2307-04202019000200019,sobre,o
294,S2307-04202019000200019,la,o
294,S2307-04202019000200019,glicemia,i
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,porcentaje,i
294,S2307-04202019000200019,de,i
294,S2307-04202019000200019,linfocitos,i
294,S2307-04202019000200019,en,o
294,S2307-04202019000200019,pacientes,o
294,S2307-04202019000200019,icon,o
294,S2307-04202019000200019,cancer,i
294,S2307-04202019000200019,colorrectal,i
294,S2307-04202019000200019,en,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,Instituto,o
294,S2307-04202019000200019,Nacional,o
294,S2307-04202019000200019,del,o
294,S2307-04202019000200019,Cancer,o
294,S2307-04202019000200019,Prof,o
294,S2307-04202019000200019,Dr,o
294,S2307-04202019000200019,Manuel,o
294,S2307-04202019000200019,Riveros,o
294,S2307-04202019000200019,Introduccion,o
294,S2307-04202019000200019,Este,o
294,S2307-04202019000200019,estudio,o
294,S2307-04202019000200019,se,o
294,S2307-04202019000200019,realizo,o
294,S2307-04202019000200019,basado,o
294,S2307-04202019000200019,en,o
294,S2307-04202019000200019,las,o
294,S2307-04202019000200019,evidencias,o
294,S2307-04202019000200019,cientificas,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,los,o
294,S2307-04202019000200019,protocolos,i
294,S2307-04202019000200019,ERAS,o
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,ACERTO,o
294,S2307-04202019000200019,a,o
294,S2307-04202019000200019,partir,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,los,o
294,S2307-04202019000200019,cuales,o
294,S2307-04202019000200019,se,o
294,S2307-04202019000200019,armo,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,Protocolo,i
294,S2307-04202019000200019,de,i
294,S2307-04202019000200019,Recuperacion,i
294,S2307-04202019000200019,Mejorada,i
294,S2307-04202019000200019,adaptado,o
294,S2307-04202019000200019,a,o
294,S2307-04202019000200019,las,o
294,S2307-04202019000200019,posibilidades,o
294,S2307-04202019000200019,del,o
294,S2307-04202019000200019,Instituto,o
294,S2307-04202019000200019,Nacional,o
294,S2307-04202019000200019,del,o
294,S2307-04202019000200019,Cancer,o
294,S2307-04202019000200019,con,o
294,S2307-04202019000200019,lo,o
294,S2307-04202019000200019,que,o
294,S2307-04202019000200019,se,o
294,S2307-04202019000200019,busca,o
294,S2307-04202019000200019,reducir,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,estres,i
294,S2307-04202019000200019,metabolico,i
294,S2307-04202019000200019,la,o
294,S2307-04202019000200019,respuesta,o
294,S2307-04202019000200019,inmunologica,o
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,favorecer,o
294,S2307-04202019000200019,la,o
294,S2307-04202019000200019,recuperacion,o
294,S2307-04202019000200019,postoperatoria,o
294,S2307-04202019000200019,del,o
294,S2307-04202019000200019,paciente,o
294,S2307-04202019000200019,Objetivo,o
294,S2307-04202019000200019,Comparar,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,efecto,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,los,o
294,S2307-04202019000200019,protocolos,i
294,S2307-04202019000200019,perioperatorios,i
294,S2307-04202019000200019,de,i
294,S2307-04202019000200019,recuperacion,i
294,S2307-04202019000200019,mejorada,i
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,convencional,o
294,S2307-04202019000200019,sobre,o
294,S2307-04202019000200019,la,o
294,S2307-04202019000200019,glicemia,i
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,porcentaje,i
294,S2307-04202019000200019,de,i
294,S2307-04202019000200019,linfocitos,i
294,S2307-04202019000200019,en,o
294,S2307-04202019000200019,pacientes,o
294,S2307-04202019000200019,con,o
294,S2307-04202019000200019,cancer,i
294,S2307-04202019000200019,colorrectal,i
294,S2307-04202019000200019,Materiales,o
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,Metodos,o
294,S2307-04202019000200019,Se,o
294,S2307-04202019000200019,realizo,o
294,S2307-04202019000200019,un,o
294,S2307-04202019000200019,ensayo,o
294,S2307-04202019000200019,clinico,o
294,S2307-04202019000200019,cuasiexperimental,o
294,S2307-04202019000200019,no,o
294,S2307-04202019000200019,aleatorizado,o
294,S2307-04202019000200019,sin,o
294,S2307-04202019000200019,enmascaramiento,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,34,o
294,S2307-04202019000200019,pacientes,o
294,S2307-04202019000200019,con,o
294,S2307-04202019000200019,cancer,i
294,S2307-04202019000200019,colorrectal,i
294,S2307-04202019000200019,sometidos,o
294,S2307-04202019000200019,a,o
294,S2307-04202019000200019,cirugia,i
294,S2307-04202019000200019,abierta,i
294,S2307-04202019000200019,Un,o
294,S2307-04202019000200019,grupo,o
294,S2307-04202019000200019,control,o
294,S2307-04202019000200019,con,o
294,S2307-04202019000200019,manejo,o
294,S2307-04202019000200019,convencional,o
294,S2307-04202019000200019,n18,o
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,grupo,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,intervencion,i
294,S2307-04202019000200019,n16,o
294,S2307-04202019000200019,en,o
294,S2307-04202019000200019,quienes,o
294,S2307-04202019000200019,se,o
294,S2307-04202019000200019,aplico,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,protocolo,i
294,S2307-04202019000200019,de,i
294,S2307-04202019000200019,recuperacion,i
294,S2307-04202019000200019,mejorada,i
294,S2307-04202019000200019,la,o
294,S2307-04202019000200019,variable,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,resultado,o
294,S2307-04202019000200019,fue,o
294,S2307-04202019000200019,la,o
294,S2307-04202019000200019,glicemia,i
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,recuento,i
294,S2307-04202019000200019,de,i
294,S2307-04202019000200019,linfocitos,i
294,S2307-04202019000200019,se,o
294,S2307-04202019000200019,midieron,o
294,S2307-04202019000200019,otras,o
294,S2307-04202019000200019,variables,o
294,S2307-04202019000200019,clinicas,o
294,S2307-04202019000200019,como,o
294,S2307-04202019000200019,complicaciones,i
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,demograficas,o
294,S2307-04202019000200019,Resultados,o
294,S2307-04202019000200019,La,o
294,S2307-04202019000200019,diferencia,o
294,S2307-04202019000200019,glicemica,o
294,S2307-04202019000200019,entre,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,pre,o
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,postoperatorio,o
294,S2307-04202019000200019,en,o
294,S2307-04202019000200019,pacientes,o
294,S2307-04202019000200019,del,o
294,S2307-04202019000200019,grupo,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,estudio,o
294,S2307-04202019000200019,fue,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,423209,o
294,S2307-04202019000200019,mgdL,o
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,525,o
294,S2307-04202019000200019,5281,o
294,S2307-04202019000200019,mgdL,o
294,S2307-04202019000200019,en,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,grupo,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,intervencion,i
294,S2307-04202019000200019,con,o
294,S2307-04202019000200019,una,o
294,S2307-04202019000200019,p0009,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,porcentaje,i
294,S2307-04202019000200019,de,i
294,S2307-04202019000200019,linfocitos,i
294,S2307-04202019000200019,en,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,grupo,o
294,S2307-04202019000200019,control,o
294,S2307-04202019000200019,fue,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,13771095,o
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,718521,o
294,S2307-04202019000200019,en,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,grupo,o
294,S2307-04202019000200019,de,o
294,S2307-04202019000200019,intervencion,i
294,S2307-04202019000200019,con,o
294,S2307-04202019000200019,una,o
294,S2307-04202019000200019,p0015,o
294,S2307-04202019000200019,estadisticamente,o
294,S2307-04202019000200019,significativos,o
294,S2307-04202019000200019,Conclusion,o
294,S2307-04202019000200019,Aplicar,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,Protocolo,i
294,S2307-04202019000200019,de,i
294,S2307-04202019000200019,Recuperacion,i
294,S2307-04202019000200019,Mejorada,i
294,S2307-04202019000200019,es,o
294,S2307-04202019000200019,factible,o
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,disminuye,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,impacto,o
294,S2307-04202019000200019,glicemico,o
294,S2307-04202019000200019,y,o
294,S2307-04202019000200019,el,o
294,S2307-04202019000200019,porcentaje,i
294,S2307-04202019000200019,de,i
294,S2307-04202019000200019,linfocitos,i
294,S2307-04202019000200019,en,o
294,S2307-04202019000200019,relacion,o
294,S2307-04202019000200019,al,o
294,S2307-04202019000200019,manejo,o
294,S2307-04202019000200019,convencional,o
295,S2340-98942017000100021,Intervenciones,i
295,S2340-98942017000100021,farmaceuticas,i
295,S2340-98942017000100021,en,o
295,S2340-98942017000100021,pacientes,o
295,S2340-98942017000100021,con,o
295,S2340-98942017000100021,Diabetes,i
295,S2340-98942017000100021,Mellitus,i
295,S2340-98942017000100021,Tipo,i
295,S2340-98942017000100021,2,i
295,S2340-98942017000100021,Introduccion,o
295,S2340-98942017000100021,La,o
295,S2340-98942017000100021,Atencion,i
295,S2340-98942017000100021,Farmaceutica,i
295,S2340-98942017000100021,es,o
295,S2340-98942017000100021,la,o
295,S2340-98942017000100021,provision,o
295,S2340-98942017000100021,responsable,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,la,o
295,S2340-98942017000100021,farmacoterapia,i
295,S2340-98942017000100021,con,o
295,S2340-98942017000100021,el,o
295,S2340-98942017000100021,proposito,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,alcanzar,o
295,S2340-98942017000100021,resultados,o
295,S2340-98942017000100021,concretos,o
295,S2340-98942017000100021,que,o
295,S2340-98942017000100021,mejoren,o
295,S2340-98942017000100021,la,o
295,S2340-98942017000100021,calidad,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,vida,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,los,o
295,S2340-98942017000100021,pacientes,o
295,S2340-98942017000100021,Objetivo,o
295,S2340-98942017000100021,Evaluar,o
295,S2340-98942017000100021,el,o
295,S2340-98942017000100021,impacto,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,las,o
295,S2340-98942017000100021,intervenciones,i
295,S2340-98942017000100021,farmaceuticas,i
295,S2340-98942017000100021,en,o
295,S2340-98942017000100021,pacientes,o
295,S2340-98942017000100021,con,o
295,S2340-98942017000100021,Diabetes,i
295,S2340-98942017000100021,Mellitus,i
295,S2340-98942017000100021,Tipo,i
295,S2340-98942017000100021,2,i
295,S2340-98942017000100021,Metodologia,o
295,S2340-98942017000100021,Ensayo,i
295,S2340-98942017000100021,Clinico,i
295,S2340-98942017000100021,Aleatorizado,i
295,S2340-98942017000100021,con,o
295,S2340-98942017000100021,medicion,i
295,S2340-98942017000100021,de,i
295,S2340-98942017000100021,variables,i
295,S2340-98942017000100021,antes,o
295,S2340-98942017000100021,y,o
295,S2340-98942017000100021,despues,o
295,S2340-98942017000100021,No,o
295,S2340-98942017000100021,probabilistico,o
295,S2340-98942017000100021,De,o
295,S2340-98942017000100021,conveniencia,o
295,S2340-98942017000100021,Participaron,o
295,S2340-98942017000100021,32,o
295,S2340-98942017000100021,pacientes,o
295,S2340-98942017000100021,del,o
295,S2340-98942017000100021,grupo,o
295,S2340-98942017000100021,intervenido,i
295,S2340-98942017000100021,y,o
295,S2340-98942017000100021,32,o
295,S2340-98942017000100021,en,o
295,S2340-98942017000100021,grupo,o
295,S2340-98942017000100021,control,o
295,S2340-98942017000100021,Se,o
295,S2340-98942017000100021,realizaron,o
295,S2340-98942017000100021,entrevistas,i
295,S2340-98942017000100021,mensuales,o
295,S2340-98942017000100021,en,o
295,S2340-98942017000100021,un,o
295,S2340-98942017000100021,periodo,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,intervencion,i
295,S2340-98942017000100021,farmaceutica,i
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,6,o
295,S2340-98942017000100021,meses,o
295,S2340-98942017000100021,desde,o
295,S2340-98942017000100021,octubre,o
295,S2340-98942017000100021,2011,o
295,S2340-98942017000100021,hasta,o
295,S2340-98942017000100021,junio,o
295,S2340-98942017000100021,2012,o
295,S2340-98942017000100021,Se,o
295,S2340-98942017000100021,registraron,o
295,S2340-98942017000100021,solo,o
295,S2340-98942017000100021,3,o
295,S2340-98942017000100021,abandonos,o
295,S2340-98942017000100021,Resultados,o
295,S2340-98942017000100021,La,o
295,S2340-98942017000100021,edad,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,los,o
295,S2340-98942017000100021,pacientes,o
295,S2340-98942017000100021,fue,o
295,S2340-98942017000100021,556106,o
295,S2340-98942017000100021,años,o
295,S2340-98942017000100021,Los,o
295,S2340-98942017000100021,pacientes,o
295,S2340-98942017000100021,del,o
295,S2340-98942017000100021,grupo,o
295,S2340-98942017000100021,intervenido,i
295,S2340-98942017000100021,mejoraron,o
295,S2340-98942017000100021,la,o
295,S2340-98942017000100021,glicemia,i
295,S2340-98942017000100021,en,o
295,S2340-98942017000100021,34,o
295,S2340-98942017000100021,donde,o
295,S2340-98942017000100021,24,o
295,S2340-98942017000100021,pacientes,o
295,S2340-98942017000100021,tenian,o
295,S2340-98942017000100021,el,o
295,S2340-98942017000100021,valor,o
295,S2340-98942017000100021,130,o
295,S2340-98942017000100021,mgdL,o
295,S2340-98942017000100021,la,o
295,S2340-98942017000100021,hemoglobina,i
295,S2340-98942017000100021,glicosilada,i
295,S2340-98942017000100021,mejoro,o
295,S2340-98942017000100021,19,o
295,S2340-98942017000100021,donde,o
295,S2340-98942017000100021,15,o
295,S2340-98942017000100021,pacientes,o
295,S2340-98942017000100021,lograron,o
295,S2340-98942017000100021,los,o
295,S2340-98942017000100021,parametros,o
295,S2340-98942017000100021,deseados,o
295,S2340-98942017000100021,65,o
295,S2340-98942017000100021,La,o
295,S2340-98942017000100021,calidad,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,vida,o
295,S2340-98942017000100021,del,o
295,S2340-98942017000100021,grupo,o
295,S2340-98942017000100021,intervenido,i
295,S2340-98942017000100021,aumento,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,563,o
295,S2340-98942017000100021,a,o
295,S2340-98942017000100021,713,o
295,S2340-98942017000100021,y,o
295,S2340-98942017000100021,fue,o
295,S2340-98942017000100021,medido,o
295,S2340-98942017000100021,con,o
295,S2340-98942017000100021,el,o
295,S2340-98942017000100021,cuestionario,o
295,S2340-98942017000100021,SF36,o
295,S2340-98942017000100021,En,o
295,S2340-98942017000100021,el,o
295,S2340-98942017000100021,grupo,o
295,S2340-98942017000100021,intervenido,i
295,S2340-98942017000100021,se,o
295,S2340-98942017000100021,encontraron,o
295,S2340-98942017000100021,80,o
295,S2340-98942017000100021,problemas,i
295,S2340-98942017000100021,relacionados,i
295,S2340-98942017000100021,con,i
295,S2340-98942017000100021,medicamentos,i
295,S2340-98942017000100021,en,o
295,S2340-98942017000100021,27,o
295,S2340-98942017000100021,pacientes,o
295,S2340-98942017000100021,se,o
295,S2340-98942017000100021,resolvieron,o
295,S2340-98942017000100021,59,o
295,S2340-98942017000100021,al,o
295,S2340-98942017000100021,final,o
295,S2340-98942017000100021,del,o
295,S2340-98942017000100021,estudio,o
295,S2340-98942017000100021,12,o
295,S2340-98942017000100021,pacientes,o
295,S2340-98942017000100021,resolvieron,o
295,S2340-98942017000100021,todos,o
295,S2340-98942017000100021,los,o
295,S2340-98942017000100021,problemas,i
295,S2340-98942017000100021,relacionados,i
295,S2340-98942017000100021,con,i
295,S2340-98942017000100021,medicamentos,i
295,S2340-98942017000100021,se,o
295,S2340-98942017000100021,realizaron,o
295,S2340-98942017000100021,254,o
295,S2340-98942017000100021,intervenciones,i
295,S2340-98942017000100021,farmaceuticas,i
295,S2340-98942017000100021,el,o
295,S2340-98942017000100021,nivel,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,conocimiento,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,los,o
295,S2340-98942017000100021,pacientes,o
295,S2340-98942017000100021,sobre,o
295,S2340-98942017000100021,la,o
295,S2340-98942017000100021,enfermedad,i
295,S2340-98942017000100021,mejoro,o
295,S2340-98942017000100021,en,o
295,S2340-98942017000100021,41,o
295,S2340-98942017000100021,el,o
295,S2340-98942017000100021,conocimiento,o
295,S2340-98942017000100021,sobre,o
295,S2340-98942017000100021,sus,o
295,S2340-98942017000100021,medicamentos,i
295,S2340-98942017000100021,mejoro,o
295,S2340-98942017000100021,en,o
295,S2340-98942017000100021,53,o
295,S2340-98942017000100021,Conclusion,o
295,S2340-98942017000100021,Las,o
295,S2340-98942017000100021,intervenciones,i
295,S2340-98942017000100021,farmaceuticas,i
295,S2340-98942017000100021,mejoraron,o
295,S2340-98942017000100021,los,o
295,S2340-98942017000100021,parametros,o
295,S2340-98942017000100021,clinicos,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,glicemia,i
295,S2340-98942017000100021,hemoglobina,i
295,S2340-98942017000100021,glicosilada,i
295,S2340-98942017000100021,optimizaron,o
295,S2340-98942017000100021,el,o
295,S2340-98942017000100021,uso,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,medicamentos,i
295,S2340-98942017000100021,disminuyeron,o
295,S2340-98942017000100021,los,o
295,S2340-98942017000100021,problemas,i
295,S2340-98942017000100021,relacionados,i
295,S2340-98942017000100021,con,i
295,S2340-98942017000100021,medicamentos,i
295,S2340-98942017000100021,mejoraron,o
295,S2340-98942017000100021,la,o
295,S2340-98942017000100021,calidad,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,vida,o
295,S2340-98942017000100021,de,o
295,S2340-98942017000100021,los,o
295,S2340-98942017000100021,pacientes,o
296,S2448-87712016000200005,Eficacia,o
296,S2448-87712016000200005,de,o
296,S2448-87712016000200005,dexmedetomidina,i
296,S2448-87712016000200005,como,o
296,S2448-87712016000200005,medicacion,i
296,S2448-87712016000200005,anestesica,i
296,S2448-87712016000200005,vs,o
296,S2448-87712016000200005,midazolam,i
296,S2448-87712016000200005,en,o
296,S2448-87712016000200005,pacientes,o
296,S2448-87712016000200005,pediatricos,o
296,S2448-87712016000200005,La,o
296,S2448-87712016000200005,medicacion,i
296,S2448-87712016000200005,anestesica,i
296,S2448-87712016000200005,debe,o
296,S2448-87712016000200005,ser,o
296,S2448-87712016000200005,obligatoria,o
296,S2448-87712016000200005,en,o
296,S2448-87712016000200005,los,o
296,S2448-87712016000200005,pacientes,o
296,S2448-87712016000200005,pediatricos,o
296,S2448-87712016000200005,y,o
296,S2448-87712016000200005,parte,o
296,S2448-87712016000200005,integral,o
296,S2448-87712016000200005,y,o
296,S2448-87712016000200005,fundamental,o
296,S2448-87712016000200005,en,o
296,S2448-87712016000200005,la,o
296,S2448-87712016000200005,practica,o
296,S2448-87712016000200005,de,o
296,S2448-87712016000200005,la,o
296,S2448-87712016000200005,anestesia,i
296,S2448-87712016000200005,pediatrica,o
296,S2448-87712016000200005,la,o
296,S2448-87712016000200005,medicacion,i
296,S2448-87712016000200005,puede,o
296,S2448-87712016000200005,ser,o
296,S2448-87712016000200005,administrada,o
296,S2448-87712016000200005,por,o
296,S2448-87712016000200005,diversas,o
296,S2448-87712016000200005,vias,o
296,S2448-87712016000200005,oral,o
296,S2448-87712016000200005,nasal,o
296,S2448-87712016000200005,intramuscular,o
296,S2448-87712016000200005,sublingual,o
296,S2448-87712016000200005,y,o
296,S2448-87712016000200005,rectal,o
296,S2448-87712016000200005,El,o
296,S2448-87712016000200005,midazolam,i
296,S2448-87712016000200005,es,o
296,S2448-87712016000200005,el,o
296,S2448-87712016000200005,farmaco,i
296,S2448-87712016000200005,mas,o
296,S2448-87712016000200005,utilizado,o
296,S2448-87712016000200005,Sin,o
296,S2448-87712016000200005,embargo,o
296,S2448-87712016000200005,el,o
296,S2448-87712016000200005,empleo,o
296,S2448-87712016000200005,de,o
296,S2448-87712016000200005,la,o
296,S2448-87712016000200005,dexmedetomidina,i
296,S2448-87712016000200005,en,o
296,S2448-87712016000200005,sedacion,i
296,S2448-87712016000200005,pediatrica,o
296,S2448-87712016000200005,en,o
296,S2448-87712016000200005,los,o
296,S2448-87712016000200005,ultimos,o
296,S2448-87712016000200005,años,o
296,S2448-87712016000200005,ha,o
296,S2448-87712016000200005,tomado,o
296,S2448-87712016000200005,prioridad,o
296,S2448-87712016000200005,en,o
296,S2448-87712016000200005,diferentes,o
296,S2448-87712016000200005,situaciones,o
296,S2448-87712016000200005,Metodos,o
296,S2448-87712016000200005,Se,o
296,S2448-87712016000200005,diseño,o
296,S2448-87712016000200005,un,o
296,S2448-87712016000200005,estudio,o
296,S2448-87712016000200005,experimental,o
296,S2448-87712016000200005,prospectivo,o
296,S2448-87712016000200005,aleatorizado,o
296,S2448-87712016000200005,transversal,o
296,S2448-87712016000200005,Se,o
296,S2448-87712016000200005,incluyeron,o
296,S2448-87712016000200005,sesenta,o
296,S2448-87712016000200005,niños,o
296,S2448-87712016000200005,de,o
296,S2448-87712016000200005,ambos,o
296,S2448-87712016000200005,sexos,o
296,S2448-87712016000200005,entre,o
296,S2448-87712016000200005,510,o
296,S2448-87712016000200005,años,o
296,S2448-87712016000200005,para,o
296,S2448-87712016000200005,cirugia,i
296,S2448-87712016000200005,electiva,o
296,S2448-87712016000200005,La,o
296,S2448-87712016000200005,muestra,o
296,S2448-87712016000200005,fue,o
296,S2448-87712016000200005,dividida,o
296,S2448-87712016000200005,en,o
296,S2448-87712016000200005,dos,o
296,S2448-87712016000200005,grupos,o
296,S2448-87712016000200005,iguales,o
296,S2448-87712016000200005,El,o
296,S2448-87712016000200005,grupo,o
296,S2448-87712016000200005,M,o
296,S2448-87712016000200005,recibio,o
296,S2448-87712016000200005,midazolam,i
296,S2448-87712016000200005,oral,o
296,S2448-87712016000200005,1,o
296,S2448-87712016000200005,mgk,o
296,S2448-87712016000200005,El,o
296,S2448-87712016000200005,grupo,o
296,S2448-87712016000200005,D,o
296,S2448-87712016000200005,recibio,o
296,S2448-87712016000200005,dexmedetomidina,i
296,S2448-87712016000200005,intranasal,o
296,S2448-87712016000200005,05,o
296,S2448-87712016000200005,mgk,o
296,S2448-87712016000200005,La,o
296,S2448-87712016000200005,dosis,o
296,S2448-87712016000200005,fue,o
296,S2448-87712016000200005,administrada,o
296,S2448-87712016000200005,30,o
296,S2448-87712016000200005,minutos,o
296,S2448-87712016000200005,previos,o
296,S2448-87712016000200005,al,o
296,S2448-87712016000200005,ingreso,i
296,S2448-87712016000200005,al,o
296,S2448-87712016000200005,quirofano,o
296,S2448-87712016000200005,Se,o
296,S2448-87712016000200005,incluyeron,o
296,S2448-87712016000200005,las,o
296,S2448-87712016000200005,escalas,o
296,S2448-87712016000200005,para,o
296,S2448-87712016000200005,sedacion,i
296,S2448-87712016000200005,separacion,o
296,S2448-87712016000200005,de,o
296,S2448-87712016000200005,padres,o
296,S2448-87712016000200005,y,o
296,S2448-87712016000200005,respuesta,o
296,S2448-87712016000200005,a,o
296,S2448-87712016000200005,la,o
296,S2448-87712016000200005,venopuncion,i
296,S2448-87712016000200005,Consolidando,o
296,S2448-87712016000200005,los,o
296,S2448-87712016000200005,resultados,o
296,S2448-87712016000200005,como,o
296,S2448-87712016000200005,medicacion,i
296,S2448-87712016000200005,efectiva,o
296,S2448-87712016000200005,o,o
296,S2448-87712016000200005,no,o
296,S2448-87712016000200005,efectiva,o
296,S2448-87712016000200005,Resultados,o
296,S2448-87712016000200005,Se,o
296,S2448-87712016000200005,obtuvo,o
296,S2448-87712016000200005,medicacion,i
296,S2448-87712016000200005,efectiva,o
296,S2448-87712016000200005,y,o
296,S2448-87712016000200005,en,o
296,S2448-87712016000200005,27,o
296,S2448-87712016000200005,pacientes,o
296,S2448-87712016000200005,del,o
296,S2448-87712016000200005,grupo,o
296,S2448-87712016000200005,D,o
296,S2448-87712016000200005,y,o
296,S2448-87712016000200005,16,o
296,S2448-87712016000200005,pacientes,o
296,S2448-87712016000200005,del,o
296,S2448-87712016000200005,grupo,o
296,S2448-87712016000200005,M,o
296,S2448-87712016000200005,Con,o
296,S2448-87712016000200005,un,o
296,S2448-87712016000200005,riesgo,o
296,S2448-87712016000200005,relativo,o
296,S2448-87712016000200005,de,o
296,S2448-87712016000200005,152,o
296,S2448-87712016000200005,Tres,o
296,S2448-87712016000200005,niños,o
296,S2448-87712016000200005,del,o
296,S2448-87712016000200005,grupo,o
296,S2448-87712016000200005,M,o
296,S2448-87712016000200005,fueron,o
296,S2448-87712016000200005,eliminados,o
296,S2448-87712016000200005,por,o
296,S2448-87712016000200005,escupir,o
296,S2448-87712016000200005,el,o
296,S2448-87712016000200005,farmaco,i
296,S2448-87712016000200005,y,o
296,S2448-87712016000200005,ninguno,o
296,S2448-87712016000200005,del,o
296,S2448-87712016000200005,grupo,o
296,S2448-87712016000200005,D,o
296,S2448-87712016000200005,Conclusion,o
296,S2448-87712016000200005,Ambos,o
296,S2448-87712016000200005,medicamentos,i
296,S2448-87712016000200005,son,o
296,S2448-87712016000200005,una,o
296,S2448-87712016000200005,buena,o
296,S2448-87712016000200005,opcion,o
296,S2448-87712016000200005,para,o
296,S2448-87712016000200005,la,o
296,S2448-87712016000200005,medicacion,i
296,S2448-87712016000200005,anestesica,i
296,S2448-87712016000200005,Dexmedetomidina,i
296,S2448-87712016000200005,presento,o
296,S2448-87712016000200005,mejor,o
296,S2448-87712016000200005,separacion,o
296,S2448-87712016000200005,de,o
296,S2448-87712016000200005,los,o
296,S2448-87712016000200005,niños,o
296,S2448-87712016000200005,de,o
296,S2448-87712016000200005,los,o
296,S2448-87712016000200005,padres,o
296,S2448-87712016000200005,al,o
296,S2448-87712016000200005,momento,o
296,S2448-87712016000200005,de,o
296,S2448-87712016000200005,transferirlos,o
296,S2448-87712016000200005,a,o
296,S2448-87712016000200005,la,o
296,S2448-87712016000200005,sala,o
296,S2448-87712016000200005,de,o
296,S2448-87712016000200005,quirofano,o
296,S2448-87712016000200005,Pero,o
296,S2448-87712016000200005,no,o
296,S2448-87712016000200005,es,o
296,S2448-87712016000200005,suficiente,o
296,S2448-87712016000200005,como,o
296,S2448-87712016000200005,para,o
296,S2448-87712016000200005,realizar,o
296,S2448-87712016000200005,la,o
296,S2448-87712016000200005,venopuncion,i
296,S2448-87712016000200005,sin,o
296,S2448-87712016000200005,causar,o
296,S2448-87712016000200005,dolor,i
297,S2448-87712016000300038,Control,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,nausea,i
297,S2448-87712016000300038,y,i
297,S2448-87712016000300038,vomito,i
297,S2448-87712016000300038,postoperatorio,i
297,S2448-87712016000300038,en,o
297,S2448-87712016000300038,pacientes,o
297,S2448-87712016000300038,con,o
297,S2448-87712016000300038,colecistectomia,i
297,S2448-87712016000300038,laparoscopica,i
297,S2448-87712016000300038,La,o
297,S2448-87712016000300038,nausea,i
297,S2448-87712016000300038,y,o
297,S2448-87712016000300038,el,o
297,S2448-87712016000300038,vomito,i
297,S2448-87712016000300038,son,o
297,S2448-87712016000300038,un,o
297,S2448-87712016000300038,problema,o
297,S2448-87712016000300038,frecuente,o
297,S2448-87712016000300038,en,o
297,S2448-87712016000300038,pacientes,o
297,S2448-87712016000300038,que,o
297,S2448-87712016000300038,reciben,o
297,S2448-87712016000300038,cirugia,i
297,S2448-87712016000300038,y,o
297,S2448-87712016000300038,anestesia,i
297,S2448-87712016000300038,Es,o
297,S2448-87712016000300038,un,o
297,S2448-87712016000300038,parametro,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,inconformidad,o
297,S2448-87712016000300038,e,o
297,S2448-87712016000300038,insatisfaccion,o
297,S2448-87712016000300038,para,o
297,S2448-87712016000300038,el,o
297,S2448-87712016000300038,paciente,o
297,S2448-87712016000300038,La,o
297,S2448-87712016000300038,presencia,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,nausea,i
297,S2448-87712016000300038,y,i
297,S2448-87712016000300038,vomito,i
297,S2448-87712016000300038,originan,o
297,S2448-87712016000300038,un,o
297,S2448-87712016000300038,costo,o
297,S2448-87712016000300038,para,o
297,S2448-87712016000300038,pacientes,o
297,S2448-87712016000300038,y,o
297,S2448-87712016000300038,hospitales,o
297,S2448-87712016000300038,el,o
297,S2448-87712016000300038,cual,o
297,S2448-87712016000300038,se,o
297,S2448-87712016000300038,intenta,o
297,S2448-87712016000300038,disminuir,o
297,S2448-87712016000300038,cada,o
297,S2448-87712016000300038,dia,o
297,S2448-87712016000300038,Hay,o
297,S2448-87712016000300038,pacientes,o
297,S2448-87712016000300038,y,o
297,S2448-87712016000300038,cirugias,i
297,S2448-87712016000300038,que,o
297,S2448-87712016000300038,son,o
297,S2448-87712016000300038,mas,o
297,S2448-87712016000300038,susceptibles,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,producir,o
297,S2448-87712016000300038,el,o
297,S2448-87712016000300038,sintoma,i
297,S2448-87712016000300038,Material,o
297,S2448-87712016000300038,y,o
297,S2448-87712016000300038,metodo,o
297,S2448-87712016000300038,Estudio,i
297,S2448-87712016000300038,clinico,i
297,S2448-87712016000300038,aleatorizado,i
297,S2448-87712016000300038,y,i
297,S2448-87712016000300038,prospectivo,i
297,S2448-87712016000300038,para,o
297,S2448-87712016000300038,evaluar,o
297,S2448-87712016000300038,la,o
297,S2448-87712016000300038,prevencion,i
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,nausea,i
297,S2448-87712016000300038,y,i
297,S2448-87712016000300038,vomito,i
297,S2448-87712016000300038,con,o
297,S2448-87712016000300038,desxametasona,i
297,S2448-87712016000300038,y,o
297,S2448-87712016000300038,la,o
297,S2448-87712016000300038,combinacion,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,dexametasonaondansetron,o
297,S2448-87712016000300038,Se,o
297,S2448-87712016000300038,estudiaron,o
297,S2448-87712016000300038,60,o
297,S2448-87712016000300038,pacientes,o
297,S2448-87712016000300038,divididos,o
297,S2448-87712016000300038,en,o
297,S2448-87712016000300038,dos,o
297,S2448-87712016000300038,grupos,o
297,S2448-87712016000300038,Dexametasona,i
297,S2448-87712016000300038,contra,o
297,S2448-87712016000300038,la,o
297,S2448-87712016000300038,mezcla,o
297,S2448-87712016000300038,dexametasonaondansetron,o
297,S2448-87712016000300038,en,o
297,S2448-87712016000300038,colecistectomia,i
297,S2448-87712016000300038,laparoscopica,i
297,S2448-87712016000300038,mediante,o
297,S2448-87712016000300038,la,o
297,S2448-87712016000300038,aplicacion,o
297,S2448-87712016000300038,del,o
297,S2448-87712016000300038,modelo,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,Apfel,o
297,S2448-87712016000300038,Resultados,o
297,S2448-87712016000300038,La,o
297,S2448-87712016000300038,incidencia,o
297,S2448-87712016000300038,mayor,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,eventos,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,nausea,i
297,S2448-87712016000300038,y,i
297,S2448-87712016000300038,vomito,i
297,S2448-87712016000300038,se,o
297,S2448-87712016000300038,presento,o
297,S2448-87712016000300038,en,o
297,S2448-87712016000300038,el,o
297,S2448-87712016000300038,grupo,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,dexametasona,i
297,S2448-87712016000300038,36,o
297,S2448-87712016000300038,vs,o
297,S2448-87712016000300038,16,o
297,S2448-87712016000300038,Hubo,o
297,S2448-87712016000300038,mayor,o
297,S2448-87712016000300038,riesgo,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,nausea,i
297,S2448-87712016000300038,y,i
297,S2448-87712016000300038,vomito,i
297,S2448-87712016000300038,en,o
297,S2448-87712016000300038,el,o
297,S2448-87712016000300038,grupo,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,dexametasona,i
297,S2448-87712016000300038,416,o
297,S2448-87712016000300038,vs,o
297,S2448-87712016000300038,333,o
297,S2448-87712016000300038,Las,o
297,S2448-87712016000300038,mujeres,o
297,S2448-87712016000300038,fueron,o
297,S2448-87712016000300038,las,o
297,S2448-87712016000300038,mas,o
297,S2448-87712016000300038,afectadas,o
297,S2448-87712016000300038,por,o
297,S2448-87712016000300038,nausea,i
297,S2448-87712016000300038,y,i
297,S2448-87712016000300038,vomito,i
297,S2448-87712016000300038,especialmente,o
297,S2448-87712016000300038,las,o
297,S2448-87712016000300038,mas,o
297,S2448-87712016000300038,jovenes,o
297,S2448-87712016000300038,Conclusion,o
297,S2448-87712016000300038,La,o
297,S2448-87712016000300038,combinacion,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,dos,o
297,S2448-87712016000300038,medicamentos,i
297,S2448-87712016000300038,con,o
297,S2448-87712016000300038,diferente,o
297,S2448-87712016000300038,mecanismo,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,accion,o
297,S2448-87712016000300038,ofrece,o
297,S2448-87712016000300038,mejores,o
297,S2448-87712016000300038,alternativas,o
297,S2448-87712016000300038,especialmente,o
297,S2448-87712016000300038,en,o
297,S2448-87712016000300038,aquellos,o
297,S2448-87712016000300038,pacientes,o
297,S2448-87712016000300038,con,o
297,S2448-87712016000300038,varios,o
297,S2448-87712016000300038,factores,o
297,S2448-87712016000300038,de,o
297,S2448-87712016000300038,riesgo,o
297,S2448-87712016000300038,como,o
297,S2448-87712016000300038,puede,o
297,S2448-87712016000300038,ser,o
297,S2448-87712016000300038,la,o
297,S2448-87712016000300038,colecistectomia,i
297,S2448-87712016000300038,laparoscopica,i
297,S2448-87712016000300038,mujeres,o
297,S2448-87712016000300038,jovenes,o
297,S2448-87712016000300038,y,o
297,S2448-87712016000300038,anestesia,i
297,S2448-87712016000300038,general,i
297,S2448-87712016000300038,con,o
297,S2448-87712016000300038,fentanilos,i
298,S2448-87712017000200009,Perfusion,i
298,S2448-87712017000200009,intravenosa,i
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,lidocaina,i
298,S2448-87712017000200009,en,o
298,S2448-87712017000200009,el,o
298,S2448-87712017000200009,postoperatorio,o
298,S2448-87712017000200009,inmediato,o
298,S2448-87712017000200009,en,o
298,S2448-87712017000200009,colecistectomia,i
298,S2448-87712017000200009,laparoscopica,i
298,S2448-87712017000200009,Se,o
298,S2448-87712017000200009,conoce,o
298,S2448-87712017000200009,desde,o
298,S2448-87712017000200009,hace,o
298,S2448-87712017000200009,muchos,o
298,S2448-87712017000200009,años,o
298,S2448-87712017000200009,que,o
298,S2448-87712017000200009,la,o
298,S2448-87712017000200009,administracion,i
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,lidocaina,i
298,S2448-87712017000200009,intravenosa,o
298,S2448-87712017000200009,a,o
298,S2448-87712017000200009,dosis,o
298,S2448-87712017000200009,bajas,o
298,S2448-87712017000200009,produce,o
298,S2448-87712017000200009,analgesia,i
298,S2448-87712017000200009,y,o
298,S2448-87712017000200009,una,o
298,S2448-87712017000200009,reduccion,o
298,S2448-87712017000200009,en,o
298,S2448-87712017000200009,el,o
298,S2448-87712017000200009,consumo,o
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,opioides,i
298,S2448-87712017000200009,u,o
298,S2448-87712017000200009,otros,o
298,S2448-87712017000200009,anestesicos,i
298,S2448-87712017000200009,utilizados,o
298,S2448-87712017000200009,durante,o
298,S2448-87712017000200009,el,o
298,S2448-87712017000200009,transanestesico,o
298,S2448-87712017000200009,con,o
298,S2448-87712017000200009,minimos,o
298,S2448-87712017000200009,efectos,i
298,S2448-87712017000200009,secundarios,i
298,S2448-87712017000200009,El,o
298,S2448-87712017000200009,objetivo,o
298,S2448-87712017000200009,del,o
298,S2448-87712017000200009,estudio,o
298,S2448-87712017000200009,fue,o
298,S2448-87712017000200009,estudiar,o
298,S2448-87712017000200009,el,o
298,S2448-87712017000200009,comportamiento,o
298,S2448-87712017000200009,clinico,o
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,la,o
298,S2448-87712017000200009,lidocaina,i
298,S2448-87712017000200009,intravenosa,o
298,S2448-87712017000200009,para,o
298,S2448-87712017000200009,control,i
298,S2448-87712017000200009,del,i
298,S2448-87712017000200009,dolor,i
298,S2448-87712017000200009,postoperatorio,i
298,S2448-87712017000200009,en,o
298,S2448-87712017000200009,las,o
298,S2448-87712017000200009,primeras,o
298,S2448-87712017000200009,horas,o
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,cirugia,i
298,S2448-87712017000200009,Material,o
298,S2448-87712017000200009,y,o
298,S2448-87712017000200009,metodo,o
298,S2448-87712017000200009,Se,o
298,S2448-87712017000200009,diseño,o
298,S2448-87712017000200009,un,o
298,S2448-87712017000200009,ensayo,o
298,S2448-87712017000200009,clinico,o
298,S2448-87712017000200009,controlado,o
298,S2448-87712017000200009,aleatorizado,o
298,S2448-87712017000200009,doble,o
298,S2448-87712017000200009,ciego,o
298,S2448-87712017000200009,88,o
298,S2448-87712017000200009,pacientes,o
298,S2448-87712017000200009,programados,o
298,S2448-87712017000200009,para,o
298,S2448-87712017000200009,colecistectomia,i
298,S2448-87712017000200009,laparoscopica,i
298,S2448-87712017000200009,bajo,o
298,S2448-87712017000200009,anestesia,i
298,S2448-87712017000200009,general,i
298,S2448-87712017000200009,Se,o
298,S2448-87712017000200009,formaron,o
298,S2448-87712017000200009,dos,o
298,S2448-87712017000200009,grupos,o
298,S2448-87712017000200009,el,o
298,S2448-87712017000200009,grupo,o
298,S2448-87712017000200009,L,o
298,S2448-87712017000200009,formado,o
298,S2448-87712017000200009,por,o
298,S2448-87712017000200009,44,o
298,S2448-87712017000200009,pacientes,o
298,S2448-87712017000200009,recibio,o
298,S2448-87712017000200009,lidocaina,i
298,S2448-87712017000200009,15,o
298,S2448-87712017000200009,mgkgh,o
298,S2448-87712017000200009,La,o
298,S2448-87712017000200009,infusion,i
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,lidocaina,i
298,S2448-87712017000200009,se,o
298,S2448-87712017000200009,inicio,o
298,S2448-87712017000200009,inmediatamente,o
298,S2448-87712017000200009,despues,o
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,la,o
298,S2448-87712017000200009,intubacion,i
298,S2448-87712017000200009,traqueal,i
298,S2448-87712017000200009,y,o
298,S2448-87712017000200009,se,o
298,S2448-87712017000200009,suspendio,o
298,S2448-87712017000200009,al,o
298,S2448-87712017000200009,suturar,i
298,S2448-87712017000200009,la,i
298,S2448-87712017000200009,piel,i
298,S2448-87712017000200009,El,o
298,S2448-87712017000200009,grupo,o
298,S2448-87712017000200009,B,o
298,S2448-87712017000200009,o,o
298,S2448-87712017000200009,grupo,o
298,S2448-87712017000200009,control,o
298,S2448-87712017000200009,recibio,o
298,S2448-87712017000200009,una,o
298,S2448-87712017000200009,infusion,i
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,solucion,i
298,S2448-87712017000200009,fisiologica,i
298,S2448-87712017000200009,como,o
298,S2448-87712017000200009,placebo,i
298,S2448-87712017000200009,Durante,o
298,S2448-87712017000200009,el,o
298,S2448-87712017000200009,periodo,o
298,S2448-87712017000200009,postoperatorio,o
298,S2448-87712017000200009,inmediato,o
298,S2448-87712017000200009,se,o
298,S2448-87712017000200009,valoro,i
298,S2448-87712017000200009,intensidad,i
298,S2448-87712017000200009,del,i
298,S2448-87712017000200009,dolor,i
298,S2448-87712017000200009,por,o
298,S2448-87712017000200009,medio,o
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,la,o
298,S2448-87712017000200009,Escala,i
298,S2448-87712017000200009,Verbal,i
298,S2448-87712017000200009,Analoga,i
298,S2448-87712017000200009,EVA,i
298,S2448-87712017000200009,al,o
298,S2448-87712017000200009,ingreso,i
298,S2448-87712017000200009,a,o
298,S2448-87712017000200009,la,o
298,S2448-87712017000200009,UCPA,o
298,S2448-87712017000200009,a,o
298,S2448-87712017000200009,los,o
298,S2448-87712017000200009,30,o
298,S2448-87712017000200009,60,o
298,S2448-87712017000200009,y,o
298,S2448-87712017000200009,90,o
298,S2448-87712017000200009,minutos,o
298,S2448-87712017000200009,Resultados,o
298,S2448-87712017000200009,El,o
298,S2448-87712017000200009,grupo,o
298,S2448-87712017000200009,L,o
298,S2448-87712017000200009,presento,o
298,S2448-87712017000200009,menor,o
298,S2448-87712017000200009,indice,o
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,dolor,i
298,S2448-87712017000200009,leve,o
298,S2448-87712017000200009,moderado,o
298,S2448-87712017000200009,y,o
298,S2448-87712017000200009,grave,o
298,S2448-87712017000200009,en,o
298,S2448-87712017000200009,la,o
298,S2448-87712017000200009,mayoria,o
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,los,o
298,S2448-87712017000200009,momentos,o
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,evaluacion,i
298,S2448-87712017000200009,del,i
298,S2448-87712017000200009,dolor,i
298,S2448-87712017000200009,en,o
298,S2448-87712017000200009,relacion,o
298,S2448-87712017000200009,al,o
298,S2448-87712017000200009,grupo,o
298,S2448-87712017000200009,control,o
298,S2448-87712017000200009,Conclusiones,o
298,S2448-87712017000200009,La,o
298,S2448-87712017000200009,administracion,i
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,una,o
298,S2448-87712017000200009,infusion,i
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,lidocaina,i
298,S2448-87712017000200009,durante,o
298,S2448-87712017000200009,el,o
298,S2448-87712017000200009,periodo,o
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,mayor,o
298,S2448-87712017000200009,estimulacion,o
298,S2448-87712017000200009,quirurgica,o
298,S2448-87712017000200009,disminuye,o
298,S2448-87712017000200009,la,o
298,S2448-87712017000200009,intensidad,o
298,S2448-87712017000200009,de,o
298,S2448-87712017000200009,dolor,i
298,S2448-87712017000200009,en,o
298,S2448-87712017000200009,el,o
298,S2448-87712017000200009,postoperatorio,o
298,S2448-87712017000200009,inmediato,o
299,S2448-89092017000400230,Efecto,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,aspirina,i
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,mortalidad,o
299,S2448-89092017000400230,del,o
299,S2448-89092017000400230,sindrome,i
299,S2448-89092017000400230,de,i
299,S2448-89092017000400230,distres,i
299,S2448-89092017000400230,respiratorio,i
299,S2448-89092017000400230,agudo,i
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,pacientes,o
299,S2448-89092017000400230,internados,i
299,S2448-89092017000400230,en,i
299,S2448-89092017000400230,la,i
299,S2448-89092017000400230,Unidad,i
299,S2448-89092017000400230,de,i
299,S2448-89092017000400230,Cuidados,i
299,S2448-89092017000400230,Intensivos,i
299,S2448-89092017000400230,del,o
299,S2448-89092017000400230,Hospital,o
299,S2448-89092017000400230,Juarez,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,Mexico,o
299,S2448-89092017000400230,Objetivo,o
299,S2448-89092017000400230,Determinar,o
299,S2448-89092017000400230,el,o
299,S2448-89092017000400230,efecto,o
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,morbimortalidad,o
299,S2448-89092017000400230,del,o
299,S2448-89092017000400230,uso,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,aspirina,i
299,S2448-89092017000400230,despues,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,28,o
299,S2448-89092017000400230,dias,o
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,pacientes,o
299,S2448-89092017000400230,con,o
299,S2448-89092017000400230,SDRA,i
299,S2448-89092017000400230,Material,o
299,S2448-89092017000400230,y,o
299,S2448-89092017000400230,metodos,o
299,S2448-89092017000400230,Se,o
299,S2448-89092017000400230,realizo,o
299,S2448-89092017000400230,un,o
299,S2448-89092017000400230,ensayo,o
299,S2448-89092017000400230,clinico,o
299,S2448-89092017000400230,experimental,o
299,S2448-89092017000400230,prospectivo,o
299,S2448-89092017000400230,aleatorizado,o
299,S2448-89092017000400230,simple,o
299,S2448-89092017000400230,durante,o
299,S2448-89092017000400230,el,o
299,S2448-89092017000400230,periodo,o
299,S2448-89092017000400230,comprendido,o
299,S2448-89092017000400230,del,o
299,S2448-89092017000400230,01,o
299,S2448-89092017000400230,diciembre,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,2015,o
299,S2448-89092017000400230,al,o
299,S2448-89092017000400230,30,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,junio,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,2016,o
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,UCI,o
299,S2448-89092017000400230,del,o
299,S2448-89092017000400230,Hospital,o
299,S2448-89092017000400230,Juarez,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,Mexico,o
299,S2448-89092017000400230,Se,o
299,S2448-89092017000400230,incluyeron,o
299,S2448-89092017000400230,todos,o
299,S2448-89092017000400230,los,o
299,S2448-89092017000400230,pacientes,o
299,S2448-89092017000400230,que,o
299,S2448-89092017000400230,ingresaron,i
299,S2448-89092017000400230,a,i
299,S2448-89092017000400230,la,i
299,S2448-89092017000400230,UCI,i
299,S2448-89092017000400230,durante,o
299,S2448-89092017000400230,el,o
299,S2448-89092017000400230,periodo,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,estudio,o
299,S2448-89092017000400230,con,o
299,S2448-89092017000400230,diagnostico,i
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,SDRA,i
299,S2448-89092017000400230,y,o
299,S2448-89092017000400230,se,o
299,S2448-89092017000400230,dividieron,o
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,dos,o
299,S2448-89092017000400230,grupos,o
299,S2448-89092017000400230,de,i
299,S2448-89092017000400230,manera,i
299,S2448-89092017000400230,aleatoria,i
299,S2448-89092017000400230,Al,o
299,S2448-89092017000400230,grupo,o
299,S2448-89092017000400230,A,o
299,S2448-89092017000400230,se,o
299,S2448-89092017000400230,le,o
299,S2448-89092017000400230,administraron,o
299,S2448-89092017000400230,100,o
299,S2448-89092017000400230,mg,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,aspirina,i
299,S2448-89092017000400230,ademas,o
299,S2448-89092017000400230,del,o
299,S2448-89092017000400230,tratamiento,i
299,S2448-89092017000400230,estandar,i
299,S2448-89092017000400230,para,o
299,S2448-89092017000400230,SDRA,i
299,S2448-89092017000400230,y,o
299,S2448-89092017000400230,el,o
299,S2448-89092017000400230,grupo,o
299,S2448-89092017000400230,B,o
299,S2448-89092017000400230,solo,o
299,S2448-89092017000400230,recibio,o
299,S2448-89092017000400230,tratamiento,i
299,S2448-89092017000400230,medico,i
299,S2448-89092017000400230,estandar,i
299,S2448-89092017000400230,para,o
299,S2448-89092017000400230,SDRA,i
299,S2448-89092017000400230,Se,o
299,S2448-89092017000400230,cuantificaron,o
299,S2448-89092017000400230,los,o
299,S2448-89092017000400230,cambios,o
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,los,o
299,S2448-89092017000400230,valores,i
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,PaO2FiO2,o
299,S2448-89092017000400230,los,o
299,S2448-89092017000400230,valores,i
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,DAaO2,o
299,S2448-89092017000400230,y,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,Cstat,o
299,S2448-89092017000400230,dias,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,ventilacion,i
299,S2448-89092017000400230,mecanica,i
299,S2448-89092017000400230,asi,o
299,S2448-89092017000400230,como,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,asociacion,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,los,o
299,S2448-89092017000400230,valores,i
299,S2448-89092017000400230,del,o
299,S2448-89092017000400230,score,o
299,S2448-89092017000400230,APACHE,o
299,S2448-89092017000400230,II,o
299,S2448-89092017000400230,y,o
299,S2448-89092017000400230,su,o
299,S2448-89092017000400230,relacion,o
299,S2448-89092017000400230,con,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,morbimortalidad,o
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,ambos,o
299,S2448-89092017000400230,grupos,o
299,S2448-89092017000400230,Se,o
299,S2448-89092017000400230,utilizo,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,prueba,o
299,S2448-89092017000400230,estadistica,o
299,S2448-89092017000400230,T,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,Student,o
299,S2448-89092017000400230,para,o
299,S2448-89092017000400230,variables,o
299,S2448-89092017000400230,independientes,o
299,S2448-89092017000400230,Resultados,o
299,S2448-89092017000400230,La,o
299,S2448-89092017000400230,mortalidad,o
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,el,o
299,S2448-89092017000400230,grupo,o
299,S2448-89092017000400230,A,o
299,S2448-89092017000400230,fue,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,60,o
299,S2448-89092017000400230,versus,o
299,S2448-89092017000400230,80,o
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,el,o
299,S2448-89092017000400230,grupo,o
299,S2448-89092017000400230,B,o
299,S2448-89092017000400230,No,o
299,S2448-89092017000400230,se,o
299,S2448-89092017000400230,evidencio,o
299,S2448-89092017000400230,diferencia,o
299,S2448-89092017000400230,entre,o
299,S2448-89092017000400230,ambos,o
299,S2448-89092017000400230,grupos,o
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,PaO2FiO2,o
299,S2448-89092017000400230,p,o
299,S2448-89092017000400230,0097,o
299,S2448-89092017000400230,En,o
299,S2448-89092017000400230,el,o
299,S2448-89092017000400230,grupo,o
299,S2448-89092017000400230,A,o
299,S2448-89092017000400230,se,o
299,S2448-89092017000400230,observo,o
299,S2448-89092017000400230,una,o
299,S2448-89092017000400230,media,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,dias,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,ventilacion,i
299,S2448-89092017000400230,mecanica,i
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,158,o
299,S2448-89092017000400230,dias,o
299,S2448-89092017000400230,versus,o
299,S2448-89092017000400230,168,o
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,el,o
299,S2448-89092017000400230,grupo,o
299,S2448-89092017000400230,B,o
299,S2448-89092017000400230,p,o
299,S2448-89092017000400230,0860,o
299,S2448-89092017000400230,IC,o
299,S2448-89092017000400230,95,o
299,S2448-89092017000400230,respecto,o
299,S2448-89092017000400230,a,o
299,S2448-89092017000400230,los,o
299,S2448-89092017000400230,dias,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,estancia,o
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,UCI,o
299,S2448-89092017000400230,y,o
299,S2448-89092017000400230,estancia,o
299,S2448-89092017000400230,intrahospitalaria,o
299,S2448-89092017000400230,no,o
299,S2448-89092017000400230,hubo,o
299,S2448-89092017000400230,diferencia,o
299,S2448-89092017000400230,estadisticamente,o
299,S2448-89092017000400230,significativa,o
299,S2448-89092017000400230,Conclusiones,o
299,S2448-89092017000400230,El,o
299,S2448-89092017000400230,uso,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,aspirina,i
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,pacientes,o
299,S2448-89092017000400230,con,o
299,S2448-89092017000400230,SDRA,i
299,S2448-89092017000400230,establecido,o
299,S2448-89092017000400230,independientemente,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,su,o
299,S2448-89092017000400230,gravedad,o
299,S2448-89092017000400230,no,o
299,S2448-89092017000400230,disminuye,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,mortalidad,o
299,S2448-89092017000400230,ni,o
299,S2448-89092017000400230,acorta,o
299,S2448-89092017000400230,los,o
299,S2448-89092017000400230,dias,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,estancia,o
299,S2448-89092017000400230,en,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,UCI,o
299,S2448-89092017000400230,o,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,estancia,o
299,S2448-89092017000400230,hospitalaria,o
299,S2448-89092017000400230,como,o
299,S2448-89092017000400230,tampoco,o
299,S2448-89092017000400230,reduce,o
299,S2448-89092017000400230,los,o
299,S2448-89092017000400230,dias,o
299,S2448-89092017000400230,de,o
299,S2448-89092017000400230,ventilacion,i
299,S2448-89092017000400230,mecanica,i
299,S2448-89092017000400230,ni,o
299,S2448-89092017000400230,mejora,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,PaO2FiO2,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,DAaO2,o
299,S2448-89092017000400230,o,o
299,S2448-89092017000400230,la,o
299,S2448-89092017000400230,Cstat,o
